,title,publish_time,journal,url,abstract,doi,cord_uid,words
292,Emerging Technologies for the Detection of Rabies Virus: Challenges and Hopes in the 21st Century,2009-09-29,PLoS Negl Trop Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745658/,"The diagnosis of rabies is routinely based on clinical and epidemiological information, especially when exposures are reported in rabies-endemic countries. Diagnostic tests using conventional assays that appear to be negative, even when undertaken late in the disease and despite the clinical diagnosis, have a tendency, at times, to be unreliable. These tests are rarely optimal and entirely dependent on the nature and quality of the sample supplied. In the course of the past three decades, the application of molecular biology has aided in the development of tests that result in a more rapid detection of rabies virus. These tests enable viral strain identification from clinical specimens. Currently, there are a number of molecular tests that can be used to complement conventional tests in rabies diagnosis. Indeed the challenges in the 21st century for the development of rabies diagnostics are not of a technical nature; these tests are available now. The challenges in the 21st century for diagnostic test developers are two-fold: firstly, to achieve internationally accepted validation of a test that will then lead to its acceptance by organisations globally. Secondly, the areas of the world where such tests are needed are mainly in developing regions where financial and logistical barriers prevent their implementation. Although developing countries with a poor healthcare infrastructure recognise that molecular-based diagnostic assays will be unaffordable for routine use, the cost/benefit ratio should still be measured. Adoption of rapid and affordable rabies diagnostic tests for use in developing countries highlights the importance of sharing and transferring technology through laboratory twinning between the developed and the developing countries. Importantly for developing countries, the benefit of molecular methods as tools is the capability for a differential diagnosis of human diseases that present with similar clinical symptoms. Antemortem testing for human rabies is now possible using molecular techniques. These barriers are not insurmountable and it is our expectation that if such tests are accepted and implemented where they are most needed, they will provide substantial improvements for rabies diagnosis and surveillance. The advent of molecular biology and new technological initiatives that combine advances in biology with other disciplines will support the development of techniques capable of high throughput testing with a low turnaround time for rabies diagnosis.",10.1371/journal.pntd.0000530,d0eur1hq,"['The', 'diagnosis', 'of', 'rabies', 'is', 'routinely', 'based', 'on', 'clinical', 'and', 'epidemiological', 'information', 'especially', 'when', 'exposures', 'are', 'reported', 'in', 'rabies', 'endemic', 'countries', 'Diagnostic', 'tests', 'using', 'conventional', 'assays', 'that', 'appear', 'to', 'be', 'negative', 'even', 'when', 'undertaken', 'late', 'in', 'the', 'disease', 'and', 'despite', 'the', 'clinical', 'diagnosis', 'have', 'a', 'tendency', 'at', 'times', 'to', 'be', 'unreliable', 'These', 'tests', 'are', 'rarely', 'optimal', 'and', 'entirely', 'dependent', 'on', 'the', 'nature', 'and', 'quality', 'of', 'the', 'sample', 'supplied', 'In', 'the', 'course', 'of', 'the', 'past', 'three', 'decades', 'the', 'application', 'of', 'molecular', 'biology', 'has', 'aided', 'in', 'the', 'development', 'of', 'tests', 'that', 'result', 'in', 'a', 'more', 'rapid', 'detection', 'of', 'rabies', 'virus', 'These', 'tests', 'enable', 'viral', 'strain', 'identification', 'from', 'clinical', 'specimens', 'Currently', 'there', 'are', 'a', 'number', 'of', 'molecular', 'tests', 'that', 'can', 'be', 'used', 'to', 'complement', 'conventional', 'tests', 'in', 'rabies', 'diagnosis', 'Indeed', 'the', 'challenges', 'in', 'the', '21st', 'century', 'for', 'the', 'development', 'of', 'rabies', 'diagnostics', 'are', 'not', 'of', 'a', 'technical', 'nature', 'these', 'tests', 'are', 'available', 'now', 'The', 'challenges', 'in', 'the', '21st', 'century', 'for', 'diagnostic', 'test', 'developers', 'are', 'two', 'fold', 'firstly', 'to', 'achieve', 'internationally', 'accepted', 'validation', 'of', 'a', 'test', 'that', 'will', 'then', 'lead', 'to', 'its', 'acceptance', 'by', 'organisations', 'globally', 'Secondly', 'the', 'areas', 'of', 'the', 'world', 'where', 'such', 'tests', 'are', 'needed', 'are', 'mainly', 'in', 'developing', 'regions', 'where', 'financial', 'and', 'logistical', 'barriers', 'prevent', 'their', 'implementation', 'Although', 'developing', 'countries', 'with', 'a', 'poor', 'healthcare', 'infrastructure', 'recognise', 'that', 'molecular', 'based', 'diagnostic', 'assays', 'will', 'be', 'unaffordable', 'for', 'routine', 'use', 'the', 'cost', 'benefit', 'ratio', 'should', 'still', 'be', 'measured', 'Adoption', 'of', 'rapid', 'and', 'affordable', 'rabies', 'diagnostic', 'tests', 'for', 'use', 'in', 'developing', 'countries', 'highlights', 'the', 'importance', 'of', 'sharing', 'and', 'transferring', 'technology', 'through', 'laboratory', 'twinning', 'between', 'the', 'developed', 'and', 'the', 'developing', 'countries', 'Importantly', 'for', 'developing', 'countries', 'the', 'benefit', 'of', 'molecular', 'methods', 'as', 'tools', 'is', 'the', 'capability', 'for', 'a', 'differential', 'diagnosis', 'of', 'human', 'diseases', 'that', 'present', 'with', 'similar', 'clinical', 'symptoms', 'Antemortem', 'testing', 'for', 'human', 'rabies', 'is', 'now', 'possible', 'using', 'molecular', 'techniques', 'These', 'barriers', 'are', 'not', 'insurmountable', 'and', 'it', 'is', 'our', 'expectation', 'that', 'if', 'such', 'tests', 'are', 'accepted', 'and', 'implemented', 'where', 'they', 'are', 'most', 'needed', 'they', 'will', 'provide', 'substantial', 'improvements', 'for', 'rabies', 'diagnosis', 'and', 'surveillance', 'The', 'advent', 'of', 'molecular', 'biology', 'and', 'new', 'technological', 'initiatives', 'that', 'combine', 'advances', 'in', 'biology', 'with', 'other', 'disciplines', 'will', 'support', 'the', 'development', 'of', 'techniques', 'capable', 'of', 'high', 'throughput', 'testing', 'with', 'a', 'low', 'turnaround', 'time', 'for', 'rabies', 'diagnosis', '']"
559,"A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity—Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings",2011-05-09,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090398/,"BACKGROUND: Molecular assays targeted to nucleic acid (NA) markers are becoming increasingly important to medical diagnostics. However, these are typically confined to wealthy, developed countries; or, to the national reference laboratories of developing-world countries. There are many infectious diseases that are endemic in low-resource settings (LRS) where the lack of simple, instrument-free, NA diagnostic tests is a critical barrier to timely treatment. One of the primary barriers to the practicality and availability of NA assays in LRS has been the complexity and power requirements of polymerase chain reaction (PCR) instrumentation (another is sample preparation). METHODOLOGY/PRINCIPAL FINDINGS: In this article, we investigate the hypothesis that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays. We assess the heater's equivalence to commercially available PCR instruments through the characterization of the temperature profiles produced, and a minimal method comparison. Versions of the prototype for several different isothermal techniques are presented. CONCLUSIONS/SIGNIFICANCE: We demonstrate that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays, and that the results of those assays are not significantly different from ones incubated in parallel in commercially available PCR instruments. These results clearly suggest the potential of the non-instrumented nucleic acid amplification (NINA) heater for molecular diagnostics in LRS. When combined with other innovations in development that eliminate power requirements for sample preparation, cold reagent storage, and readout, the NINA heater will comprise part of a kit that should enable electricity-free NA testing for many important analytes.",10.1371/journal.pone.0019738,qol5poan,"['BACKGROUND', 'Molecular', 'assays', 'targeted', 'to', 'nucleic', 'acid', 'NA', 'markers', 'are', 'becoming', 'increasingly', 'important', 'to', 'medical', 'diagnostics', 'However', 'these', 'are', 'typically', 'confined', 'to', 'wealthy', 'developed', 'countries', 'or', 'to', 'the', 'national', 'reference', 'laboratories', 'of', 'developing', 'world', 'countries', 'There', 'are', 'many', 'infectious', 'diseases', 'that', 'are', 'endemic', 'in', 'low', 'resource', 'settings', 'LRS', 'where', 'the', 'lack', 'of', 'simple', 'instrument', 'free', 'NA', 'diagnostic', 'tests', 'is', 'a', 'critical', 'barrier', 'to', 'timely', 'treatment', 'One', 'of', 'the', 'primary', 'barriers', 'to', 'the', 'practicality', 'and', 'availability', 'of', 'NA', 'assays', 'in', 'LRS', 'has', 'been', 'the', 'complexity', 'and', 'power', 'requirements', 'of', 'polymerase', 'chain', 'reaction', 'PCR', 'instrumentation', 'another', 'is', 'sample', 'preparation', 'METHODOLOGY', 'PRINCIPAL', 'FINDINGS', 'In', 'this', 'article', 'we', 'investigate', 'the', 'hypothesis', 'that', 'an', 'electricity', 'free', 'heater', 'based', 'on', 'exothermic', 'chemical', 'reactions', 'and', 'engineered', 'phase', 'change', 'materials', 'can', 'successfully', 'incubate', 'isothermal', 'NA', 'amplification', 'assays', 'We', 'assess', 'the', 'heater', 's', 'equivalence', 'to', 'commercially', 'available', 'PCR', 'instruments', 'through', 'the', 'characterization', 'of', 'the', 'temperature', 'profiles', 'produced', 'and', 'a', 'minimal', 'method', 'comparison', 'Versions', 'of', 'the', 'prototype', 'for', 'several', 'different', 'isothermal', 'techniques', 'are', 'presented', 'CONCLUSIONS', 'SIGNIFICANCE', 'We', 'demonstrate', 'that', 'an', 'electricity', 'free', 'heater', 'based', 'on', 'exothermic', 'chemical', 'reactions', 'and', 'engineered', 'phase', 'change', 'materials', 'can', 'successfully', 'incubate', 'isothermal', 'NA', 'amplification', 'assays', 'and', 'that', 'the', 'results', 'of', 'those', 'assays', 'are', 'not', 'significantly', 'different', 'from', 'ones', 'incubated', 'in', 'parallel', 'in', 'commercially', 'available', 'PCR', 'instruments', 'These', 'results', 'clearly', 'suggest', 'the', 'potential', 'of', 'the', 'non', 'instrumented', 'nucleic', 'acid', 'amplification', 'NINA', 'heater', 'for', 'molecular', 'diagnostics', 'in', 'LRS', 'When', 'combined', 'with', 'other', 'innovations', 'in', 'development', 'that', 'eliminate', 'power', 'requirements', 'for', 'sample', 'preparation', 'cold', 'reagent', 'storage', 'and', 'readout', 'the', 'NINA', 'heater', 'will', 'comprise', 'part', 'of', 'a', 'kit', 'that', 'should', 'enable', 'electricity', 'free', 'NA', 'testing', 'for', 'many', 'important', 'analytes', '']"
617,Identification of a Highly Conserved H1 Subtype-Specific Epitope with Diagnostic Potential in the Hemagglutinin Protein of Influenza A Virus,2011-08-19,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158760/,"Subtype specificity of influenza A virus (IAV) is determined by its two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). For HA, 16 distinct subtypes (H1–H16) exist, while nine exist for NA. The epidemic strains of H1N1 IAV change frequently and cause annual seasonal epidemics as well as occasional pandemics, such as the notorious 1918 influenza pandemic. The recent introduction of pandemic A/H1N1 IAV (H1N1pdm virus) into humans re-emphasizes the public health concern about H1N1 IAV. Several studies have identified conserved epitopes within specific HA subtypes that can be used for diagnostics. However, immune specific epitopes in H1N1 IAV have not been completely assessed. In this study, linear epitopes on the H1N1pdm viral HA protein were identified by peptide scanning using libraries of overlapping peptides against convalescent sera from H1N1pdm patients. One epitope, P5 (aa 58–72) was found to be immunodominant in patients and to evoke high titer antibodies in mice. Multiple sequence alignments and in silico coverage analysis showed that this epitope is highly conserved in influenza H1 HA [with a coverage of 91.6% (9,860/10,767)] and almost completely absent in other subtypes [with a coverage of 3.3% (792/23,895)]. This previously unidentified linear epitope is located outside the five well-recognized antigenic sites in HA. A peptide ELISA method based on this epitope was developed and showed high correlation (χ(2) = 51.81, P<0.01, Pearson correlation coefficient R = 0.741) with a hemagglutination inhibition test. The highly conserved H1 subtype-specific immunodominant epitope may form the basis for developing novel assays for sero-diagnosis and active surveillance against H1N1 IAVs.",10.1371/journal.pone.0023374,ff2zadol,"['Subtype', 'specificity', 'of', 'influenza', 'A', 'virus', 'IAV', 'is', 'determined', 'by', 'its', 'two', 'surface', 'glycoproteins', 'hemagglutinin', 'HA', 'and', 'neuraminidase', 'NA', 'For', 'HA', '16', 'distinct', 'subtypes', 'H1', 'H16', 'exist', 'while', 'nine', 'exist', 'for', 'NA', 'The', 'epidemic', 'strains', 'of', 'H1N1', 'IAV', 'change', 'frequently', 'and', 'cause', 'annual', 'seasonal', 'epidemics', 'as', 'well', 'as', 'occasional', 'pandemics', 'such', 'as', 'the', 'notorious', '1918', 'influenza', 'pandemic', 'The', 'recent', 'introduction', 'of', 'pandemic', 'A', 'H1N1', 'IAV', 'H1N1pdm', 'virus', 'into', 'humans', 're', 'emphasizes', 'the', 'public', 'health', 'concern', 'about', 'H1N1', 'IAV', 'Several', 'studies', 'have', 'identified', 'conserved', 'epitopes', 'within', 'specific', 'HA', 'subtypes', 'that', 'can', 'be', 'used', 'for', 'diagnostics', 'However', 'immune', 'specific', 'epitopes', 'in', 'H1N1', 'IAV', 'have', 'not', 'been', 'completely', 'assessed', 'In', 'this', 'study', 'linear', 'epitopes', 'on', 'the', 'H1N1pdm', 'viral', 'HA', 'protein', 'were', 'identified', 'by', 'peptide', 'scanning', 'using', 'libraries', 'of', 'overlapping', 'peptides', 'against', 'convalescent', 'sera', 'from', 'H1N1pdm', 'patients', 'One', 'epitope', 'P5', 'aa', '58', '72', 'was', 'found', 'to', 'be', 'immunodominant', 'in', 'patients', 'and', 'to', 'evoke', 'high', 'titer', 'antibodies', 'in', 'mice', 'Multiple', 'sequence', 'alignments', 'and', 'in', 'silico', 'coverage', 'analysis', 'showed', 'that', 'this', 'epitope', 'is', 'highly', 'conserved', 'in', 'influenza', 'H1', 'HA', 'with', 'a', 'coverage', 'of', '91', '6', '9', '860', '10', '767', 'and', 'almost', 'completely', 'absent', 'in', 'other', 'subtypes', 'with', 'a', 'coverage', 'of', '3', '3', '792', '23', '895', 'This', 'previously', 'unidentified', 'linear', 'epitope', 'is', 'located', 'outside', 'the', 'five', 'well', 'recognized', 'antigenic', 'sites', 'in', 'HA', 'A', 'peptide', 'ELISA', 'method', 'based', 'on', 'this', 'epitope', 'was', 'developed', 'and', 'showed', 'high', 'correlation', 'χ', '2', '51', '81', 'P', '0', '01', 'Pearson', 'correlation', 'coefficient', 'R', '0', '741', 'with', 'a', 'hemagglutination', 'inhibition', 'test', 'The', 'highly', 'conserved', 'H1', 'subtype', 'specific', 'immunodominant', 'epitope', 'may', 'form', 'the', 'basis', 'for', 'developing', 'novel', 'assays', 'for', 'sero', 'diagnosis', 'and', 'active', 'surveillance', 'against', 'H1N1', 'IAVs', '']"
771,Isothermal Amplification Using a Chemical Heating Device for Point-of-Care Detection of HIV-1,2012-02-23,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285652/,"BACKGROUND: To date, the use of traditional nucleic acid amplification tests (NAAT) for detection of HIV-1 DNA or RNA has been restricted to laboratory settings due to time, equipment, and technical expertise requirements. The availability of a rapid NAAT with applicability for resource-limited or point-of-care (POC) settings would fill a great need in HIV diagnostics, allowing for timely diagnosis or confirmation of infection status, as well as facilitating the diagnosis of acute infection, screening and evaluation of infants born to HIV-infected mothers. Isothermal amplification methods, such as reverse-transcription, loop-mediated isothermal amplification (RT-LAMP), exhibit characteristics that are ideal for POC settings, since they are typically quicker, easier to perform, and allow for integration into low-tech, portable heating devices. METHODOLOGY/SIGNIFICANT FINDINGS: In this study, we evaluated the HIV-1 RT-LAMP assay using portable, non-instrumented nucleic acid amplification (NINA) heating devices that generate heat from the exothermic reaction of calcium oxide and water. The NINA heating devices exhibited stable temperatures throughout the amplification reaction and consistent amplification results between three separate devices and a thermalcycler. The performance of the NINA heaters was validated using whole blood specimens from HIV-1 infected patients. CONCLUSION: The RT-LAMP isothermal amplification method used in conjunction with a chemical heating device provides a portable, rapid and robust NAAT platform that has the potential to facilitate HIV-1 testing in resource-limited settings and POC.",10.1371/journal.pone.0031432,hvaie7ay,"['BACKGROUND', 'To', 'date', 'the', 'use', 'of', 'traditional', 'nucleic', 'acid', 'amplification', 'tests', 'NAAT', 'for', 'detection', 'of', 'HIV', '1', 'DNA', 'or', 'RNA', 'has', 'been', 'restricted', 'to', 'laboratory', 'settings', 'due', 'to', 'time', 'equipment', 'and', 'technical', 'expertise', 'requirements', 'The', 'availability', 'of', 'a', 'rapid', 'NAAT', 'with', 'applicability', 'for', 'resource', 'limited', 'or', 'point', 'of', 'care', 'POC', 'settings', 'would', 'fill', 'a', 'great', 'need', 'in', 'HIV', 'diagnostics', 'allowing', 'for', 'timely', 'diagnosis', 'or', 'confirmation', 'of', 'infection', 'status', 'as', 'well', 'as', 'facilitating', 'the', 'diagnosis', 'of', 'acute', 'infection', 'screening', 'and', 'evaluation', 'of', 'infants', 'born', 'to', 'HIV', 'infected', 'mothers', 'Isothermal', 'amplification', 'methods', 'such', 'as', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'exhibit', 'characteristics', 'that', 'are', 'ideal', 'for', 'POC', 'settings', 'since', 'they', 'are', 'typically', 'quicker', 'easier', 'to', 'perform', 'and', 'allow', 'for', 'integration', 'into', 'low', 'tech', 'portable', 'heating', 'devices', 'METHODOLOGY', 'SIGNIFICANT', 'FINDINGS', 'In', 'this', 'study', 'we', 'evaluated', 'the', 'HIV', '1', 'RT', 'LAMP', 'assay', 'using', 'portable', 'non', 'instrumented', 'nucleic', 'acid', 'amplification', 'NINA', 'heating', 'devices', 'that', 'generate', 'heat', 'from', 'the', 'exothermic', 'reaction', 'of', 'calcium', 'oxide', 'and', 'water', 'The', 'NINA', 'heating', 'devices', 'exhibited', 'stable', 'temperatures', 'throughout', 'the', 'amplification', 'reaction', 'and', 'consistent', 'amplification', 'results', 'between', 'three', 'separate', 'devices', 'and', 'a', 'thermalcycler', 'The', 'performance', 'of', 'the', 'NINA', 'heaters', 'was', 'validated', 'using', 'whole', 'blood', 'specimens', 'from', 'HIV', '1', 'infected', 'patients', 'CONCLUSION', 'The', 'RT', 'LAMP', 'isothermal', 'amplification', 'method', 'used', 'in', 'conjunction', 'with', 'a', 'chemical', 'heating', 'device', 'provides', 'a', 'portable', 'rapid', 'and', 'robust', 'NAAT', 'platform', 'that', 'has', 'the', 'potential', 'to', 'facilitate', 'HIV', '1', 'testing', 'in', 'resource', 'limited', 'settings', 'and', 'POC', '']"
788,Use and Evaluation of Molecular Diagnostics for Pneumonia Etiology Studies,2012-03-08,Clinical Infectious Diseases,https://academic.oup.com/cid/article-pdf/54/suppl_2/S153/20938419/cir1060.pdf,"Comprehensive microbiological testing will be a core function of the Pneumonia Etiology Research for Child Health (PERCH) project. The development stage of PERCH provided the time and resources necessary for us to conduct a comprehensive review of the current state of respiratory diagnostics. These efforts allowed us to articulate the unique requirements of PERCH, establish that molecular methods would be central to our testing strategy, and focus on a short list of candidate platforms. This process also highlighted critical challenges in the general design and interpretation of diagnostic evaluation studies, particularly in the field of respiratory infections. Although our final molecular diagnostic platform was ultimately selected on the basis of operational and strategic considerations determined by the specific context of PERCH, our review highlighted several conceptual and practical challenges in respiratory diagnostics that have broader relevance for the performance and interpretation of pneumonia research studies.",10.1093/cid/cir1060,z5p3a64x,"['Comprehensive', 'microbiological', 'testing', 'will', 'be', 'a', 'core', 'function', 'of', 'the', 'Pneumonia', 'Etiology', 'Research', 'for', 'Child', 'Health', 'PERCH', 'project', 'The', 'development', 'stage', 'of', 'PERCH', 'provided', 'the', 'time', 'and', 'resources', 'necessary', 'for', 'us', 'to', 'conduct', 'a', 'comprehensive', 'review', 'of', 'the', 'current', 'state', 'of', 'respiratory', 'diagnostics', 'These', 'efforts', 'allowed', 'us', 'to', 'articulate', 'the', 'unique', 'requirements', 'of', 'PERCH', 'establish', 'that', 'molecular', 'methods', 'would', 'be', 'central', 'to', 'our', 'testing', 'strategy', 'and', 'focus', 'on', 'a', 'short', 'list', 'of', 'candidate', 'platforms', 'This', 'process', 'also', 'highlighted', 'critical', 'challenges', 'in', 'the', 'general', 'design', 'and', 'interpretation', 'of', 'diagnostic', 'evaluation', 'studies', 'particularly', 'in', 'the', 'field', 'of', 'respiratory', 'infections', 'Although', 'our', 'final', 'molecular', 'diagnostic', 'platform', 'was', 'ultimately', 'selected', 'on', 'the', 'basis', 'of', 'operational', 'and', 'strategic', 'considerations', 'determined', 'by', 'the', 'specific', 'context', 'of', 'PERCH', 'our', 'review', 'highlighted', 'several', 'conceptual', 'and', 'practical', 'challenges', 'in', 'respiratory', 'diagnostics', 'that', 'have', 'broader', 'relevance', 'for', 'the', 'performance', 'and', 'interpretation', 'of', 'pneumonia', 'research', 'studies', '']"
1221,Expression of Recombinant Antibodies,2013-07-29,Front Immunol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725456/,"Recombinant antibodies are highly specific detection probes in research, diagnostics, and have emerged over the last two decades as the fastest growing class of therapeutic proteins. Antibody generation has been dramatically accelerated by in vitro selection systems, particularly phage display. An increasing variety of recombinant production systems have been developed, ranging from Gram-negative and positive bacteria, yeasts and filamentous fungi, insect cell lines, mammalian cells to transgenic plants and animals. Currently, almost all therapeutic antibodies are still produced in mammalian cell lines in order to reduce the risk of immunogenicity due to altered, non-human glycosylation patterns. However, recent developments of glycosylation-engineered yeast, insect cell lines, and transgenic plants are promising to obtain antibodies with “human-like” post-translational modifications. Furthermore, smaller antibody fragments including bispecific antibodies without any glycosylation are successfully produced in bacteria and have advanced to clinical testing. The first therapeutic antibody products from a non-mammalian source can be expected in coming next years. In this review, we focus on current antibody production systems including their usability for different applications.",10.3389/fimmu.2013.00217,06o7pa3d,"['Recombinant', 'antibodies', 'are', 'highly', 'specific', 'detection', 'probes', 'in', 'research', 'diagnostics', 'and', 'have', 'emerged', 'over', 'the', 'last', 'two', 'decades', 'as', 'the', 'fastest', 'growing', 'class', 'of', 'therapeutic', 'proteins', 'Antibody', 'generation', 'has', 'been', 'dramatically', 'accelerated', 'by', 'in', 'vitro', 'selection', 'systems', 'particularly', 'phage', 'display', 'An', 'increasing', 'variety', 'of', 'recombinant', 'production', 'systems', 'have', 'been', 'developed', 'ranging', 'from', 'Gram', 'negative', 'and', 'positive', 'bacteria', 'yeasts', 'and', 'filamentous', 'fungi', 'insect', 'cell', 'lines', 'mammalian', 'cells', 'to', 'transgenic', 'plants', 'and', 'animals', 'Currently', 'almost', 'all', 'therapeutic', 'antibodies', 'are', 'still', 'produced', 'in', 'mammalian', 'cell', 'lines', 'in', 'order', 'to', 'reduce', 'the', 'risk', 'of', 'immunogenicity', 'due', 'to', 'altered', 'non', 'human', 'glycosylation', 'patterns', 'However', 'recent', 'developments', 'of', 'glycosylation', 'engineered', 'yeast', 'insect', 'cell', 'lines', 'and', 'transgenic', 'plants', 'are', 'promising', 'to', 'obtain', 'antibodies', 'with', 'human', 'like', 'post', 'translational', 'modifications', 'Furthermore', 'smaller', 'antibody', 'fragments', 'including', 'bispecific', 'antibodies', 'without', 'any', 'glycosylation', 'are', 'successfully', 'produced', 'in', 'bacteria', 'and', 'have', 'advanced', 'to', 'clinical', 'testing', 'The', 'first', 'therapeutic', 'antibody', 'products', 'from', 'a', 'non', 'mammalian', 'source', 'can', 'be', 'expected', 'in', 'coming', 'next', 'years', 'In', 'this', 'review', 'we', 'focus', 'on', 'current', 'antibody', 'production', 'systems', 'including', 'their', 'usability', 'for', 'different', 'applications', '']"
1348,"Pandemic Influenza Virus 2009 H1N1 and Adenovirus in a High Risk Population of Young Adults: Epidemiology, Comparison of Clinical Presentations, and Coinfection",2014-01-08,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885690/,"BACKGROUND: In 2009, pandemic H1N1 influenza virus (2009 H1N1) emerged worldwide, causing morbidity and mortality that disproportionately affected young adults. Upper respiratory infection (URI), largely due to adenovirus, is an endemic cause of morbidity in military training. Whether clinical presentations differ or excess morbidity results from coinfection is unclear. METHODS: The Center for Advanced Molecular Detection evaluates epidemiology and rapid diagnostics of respiratory pathogens in trainees with URI. From May 1, 2009, to November 30, 2009, demographic, clinical, and PCR data from throat and nasal specimens for adenovirus and 2009 H1N1 were prospectively collected. RESULTS: 375 trainees with URI enrolled and were tested for both adenovirus and 2009 H1N1 by PCR (median age 20; 89% male). Adenovirus PCR was positive in 72% (96% serotype E-4) and 2009 H1N1 in 20%. Males were more likely to have adenovirus and females more likely to have 2009 H1N1 (p = 0.047). Subjects with 2009 H1N1 presented an average of 1 week earlier in training, had shorter illness duration before enrollment, less sore throat, diarrhea, and fewer abnormal findings on throat exam. Coryza and cough were more common with 2009 H1N1 compared to adenovirus. Subjects with 2009 H1N1 were less likely to have adenovirus than those without, despite persistently high frequencies of adenovirus detections during peak 2009 H1N1 weeks (15% vs. 83%, p < 0.01). Coinfection with adenovirus and 2009 H1N1 was rare (4%). Rates of hospitalization and pneumonia did not differ between the adenovirus, 2009 H1N1, or coinfected groups. CONCLUSION: Military trainees with 2009 H1N1 vs. adenovirus have differing clinical presentations, and males are more likely to have adenovirus. Despite high frequencies of adenovirus infection, coinfection with adenovirus and 2009 H1N1 is rare and apparently does not result in increased morbidity.",10.1371/journal.pone.0085094,z8cbbit3,"['BACKGROUND', 'In', '2009', 'pandemic', 'H1N1', 'influenza', 'virus', '2009', 'H1N1', 'emerged', 'worldwide', 'causing', 'morbidity', 'and', 'mortality', 'that', 'disproportionately', 'affected', 'young', 'adults', 'Upper', 'respiratory', 'infection', 'URI', 'largely', 'due', 'to', 'adenovirus', 'is', 'an', 'endemic', 'cause', 'of', 'morbidity', 'in', 'military', 'training', 'Whether', 'clinical', 'presentations', 'differ', 'or', 'excess', 'morbidity', 'results', 'from', 'coinfection', 'is', 'unclear', 'METHODS', 'The', 'Center', 'for', 'Advanced', 'Molecular', 'Detection', 'evaluates', 'epidemiology', 'and', 'rapid', 'diagnostics', 'of', 'respiratory', 'pathogens', 'in', 'trainees', 'with', 'URI', 'From', 'May', '1', '2009', 'to', 'November', '30', '2009', 'demographic', 'clinical', 'and', 'PCR', 'data', 'from', 'throat', 'and', 'nasal', 'specimens', 'for', 'adenovirus', 'and', '2009', 'H1N1', 'were', 'prospectively', 'collected', 'RESULTS', '375', 'trainees', 'with', 'URI', 'enrolled', 'and', 'were', 'tested', 'for', 'both', 'adenovirus', 'and', '2009', 'H1N1', 'by', 'PCR', 'median', 'age', '20', '89', 'male', 'Adenovirus', 'PCR', 'was', 'positive', 'in', '72', '96', 'serotype', 'E', '4', 'and', '2009', 'H1N1', 'in', '20', 'Males', 'were', 'more', 'likely', 'to', 'have', 'adenovirus', 'and', 'females', 'more', 'likely', 'to', 'have', '2009', 'H1N1', 'p', '0', '047', 'Subjects', 'with', '2009', 'H1N1', 'presented', 'an', 'average', 'of', '1', 'week', 'earlier', 'in', 'training', 'had', 'shorter', 'illness', 'duration', 'before', 'enrollment', 'less', 'sore', 'throat', 'diarrhea', 'and', 'fewer', 'abnormal', 'findings', 'on', 'throat', 'exam', 'Coryza', 'and', 'cough', 'were', 'more', 'common', 'with', '2009', 'H1N1', 'compared', 'to', 'adenovirus', 'Subjects', 'with', '2009', 'H1N1', 'were', 'less', 'likely', 'to', 'have', 'adenovirus', 'than', 'those', 'without', 'despite', 'persistently', 'high', 'frequencies', 'of', 'adenovirus', 'detections', 'during', 'peak', '2009', 'H1N1', 'weeks', '15', 'vs', '83', 'p', '0', '01', 'Coinfection', 'with', 'adenovirus', 'and', '2009', 'H1N1', 'was', 'rare', '4', 'Rates', 'of', 'hospitalization', 'and', 'pneumonia', 'did', 'not', 'differ', 'between', 'the', 'adenovirus', '2009', 'H1N1', 'or', 'coinfected', 'groups', 'CONCLUSION', 'Military', 'trainees', 'with', '2009', 'H1N1', 'vs', 'adenovirus', 'have', 'differing', 'clinical', 'presentations', 'and', 'males', 'are', 'more', 'likely', 'to', 'have', 'adenovirus', 'Despite', 'high', 'frequencies', 'of', 'adenovirus', 'infection', 'coinfection', 'with', 'adenovirus', 'and', '2009', 'H1N1', 'is', 'rare', 'and', 'apparently', 'does', 'not', 'result', 'in', 'increased', 'morbidity', '']"
1592,Multiplex isothermal solid-phase recombinase polymerase amplification for the specific and fast DNA-based detection of three bacterial pathogens,2014-02-18,Mikrochim Acta,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167443/,"We report on the development of an on-chip RPA (recombinase polymerase amplification) with simultaneous multiplex isothermal amplification and detection on a solid surface. The isothermal RPA was applied to amplify specific target sequences from the pathogens Neisseria gonorrhoeae, Salmonella enterica and methicillin-resistant Staphylococcus aureus (MRSA) using genomic DNA. Additionally, a positive plasmid control was established as an internal control. The four targets were amplified simultaneously in a quadruplex reaction. The amplicon is labeled during on-chip RPA by reverse oligonucleotide primers coupled to a fluorophore. Both amplification and spatially resolved signal generation take place on immobilized forward primers bount to expoxy-silanized glass surfaces in a pump-driven hybridization chamber. The combination of microarray technology and sensitive isothermal nucleic acid amplification at 38 °C allows for a multiparameter analysis on a rather small area. The on-chip RPA was characterized in terms of reaction time, sensitivity and inhibitory conditions. A successful enzymatic reaction is completed in <20 min and results in detection limits of 10 colony-forming units for methicillin-resistant Staphylococcus aureus and Salmonella enterica and 100 colony-forming units for Neisseria gonorrhoeae. The results show this method to be useful with respect to point-of-care testing and to enable simplified and miniaturized nucleic acid-based diagnostics. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00604-014-1198-5) contains supplementary material, which is available to authorized users.",10.1007/s00604-014-1198-5,huz0tpmi,"['We', 'report', 'on', 'the', 'development', 'of', 'an', 'on', 'chip', 'RPA', 'recombinase', 'polymerase', 'amplification', 'with', 'simultaneous', 'multiplex', 'isothermal', 'amplification', 'and', 'detection', 'on', 'a', 'solid', 'surface', 'The', 'isothermal', 'RPA', 'was', 'applied', 'to', 'amplify', 'specific', 'target', 'sequences', 'from', 'the', 'pathogens', 'Neisseria', 'gonorrhoeae', 'Salmonella', 'enterica', 'and', 'methicillin', 'resistant', 'Staphylococcus', 'aureus', 'MRSA', 'using', 'genomic', 'DNA', 'Additionally', 'a', 'positive', 'plasmid', 'control', 'was', 'established', 'as', 'an', 'internal', 'control', 'The', 'four', 'targets', 'were', 'amplified', 'simultaneously', 'in', 'a', 'quadruplex', 'reaction', 'The', 'amplicon', 'is', 'labeled', 'during', 'on', 'chip', 'RPA', 'by', 'reverse', 'oligonucleotide', 'primers', 'coupled', 'to', 'a', 'fluorophore', 'Both', 'amplification', 'and', 'spatially', 'resolved', 'signal', 'generation', 'take', 'place', 'on', 'immobilized', 'forward', 'primers', 'bount', 'to', 'expoxy', 'silanized', 'glass', 'surfaces', 'in', 'a', 'pump', 'driven', 'hybridization', 'chamber', 'The', 'combination', 'of', 'microarray', 'technology', 'and', 'sensitive', 'isothermal', 'nucleic', 'acid', 'amplification', 'at', '38', 'C', 'allows', 'for', 'a', 'multiparameter', 'analysis', 'on', 'a', 'rather', 'small', 'area', 'The', 'on', 'chip', 'RPA', 'was', 'characterized', 'in', 'terms', 'of', 'reaction', 'time', 'sensitivity', 'and', 'inhibitory', 'conditions', 'A', 'successful', 'enzymatic', 'reaction', 'is', 'completed', 'in', '20', 'min', 'and', 'results', 'in', 'detection', 'limits', 'of', '10', 'colony', 'forming', 'units', 'for', 'methicillin', 'resistant', 'Staphylococcus', 'aureus', 'and', 'Salmonella', 'enterica', 'and', '100', 'colony', 'forming', 'units', 'for', 'Neisseria', 'gonorrhoeae', 'The', 'results', 'show', 'this', 'method', 'to', 'be', 'useful', 'with', 'respect', 'to', 'point', 'of', 'care', 'testing', 'and', 'to', 'enable', 'simplified', 'and', 'miniaturized', 'nucleic', 'acid', 'based', 'diagnostics', 'Figure', 'see', 'text', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1007', 's00604', '014', '1198', '5', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
2096,Real-Time Reverse Transcription PCR Assay for Detection of Senecavirus A in Swine Vesicular Diagnostic Specimens,2016-01-12,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710529/,"Senecavirus A (SV-A), formerly, Seneca Valley virus (SVV), has been detected in swine with vesicular lesions and is thought to be associated with swine idiopathic vesicular disease (SIVD), a vesicular disease syndrome that lacks a defined causative agent. The clinical presentation of SIVD resembles that of other more contagious and economically devastating vesicular diseases, such as foot-and-mouth disease (FMD), swine vesicular disease (SVD), and vesicular stomatitis (VS), that typically require immediate rule out diagnostics to lift restrictions on animal quarantine, movement, and trade. This study presents the development of a sensitive, SYBR Green RT-qPCR assay suitable for detection of SV-A in diagnostic swine specimens. After testing 50 pigs with clinical signs consistent with vesicular disease, 44 (88%) were found to be positive for SV-A by RT-qPCR as compared to none from a negative cohort of 35 animals without vesicular disease, indicating that the assay is able to successfully detect the virus in an endemic population. SV-A RNA was also detectable at a low level in sera from a subset of pigs that presented with (18%) or without (6%) vesicular signs. In 2015, there has been an increase in the occurrence of SV-A in the US, and over 200 specimens submitted to our laboratory for vesicular investigation have tested positive for the virus using this method. SV-A RNA was detectable in all common types of vesicular specimens including swabs and tissue from hoof lesions, oral and snout epithelium, oral swabs, scabs, and internal organ tissues such as liver and lymph node. Genome sequencing analysis from recent virus isolates was performed to confirm target amplicon specificity and was aligned to previous isolates.",10.1371/journal.pone.0146211,bzwfs0i5,"['Senecavirus', 'A', 'SV', 'A', 'formerly', 'Seneca', 'Valley', 'virus', 'SVV', 'has', 'been', 'detected', 'in', 'swine', 'with', 'vesicular', 'lesions', 'and', 'is', 'thought', 'to', 'be', 'associated', 'with', 'swine', 'idiopathic', 'vesicular', 'disease', 'SIVD', 'a', 'vesicular', 'disease', 'syndrome', 'that', 'lacks', 'a', 'defined', 'causative', 'agent', 'The', 'clinical', 'presentation', 'of', 'SIVD', 'resembles', 'that', 'of', 'other', 'more', 'contagious', 'and', 'economically', 'devastating', 'vesicular', 'diseases', 'such', 'as', 'foot', 'and', 'mouth', 'disease', 'FMD', 'swine', 'vesicular', 'disease', 'SVD', 'and', 'vesicular', 'stomatitis', 'VS', 'that', 'typically', 'require', 'immediate', 'rule', 'out', 'diagnostics', 'to', 'lift', 'restrictions', 'on', 'animal', 'quarantine', 'movement', 'and', 'trade', 'This', 'study', 'presents', 'the', 'development', 'of', 'a', 'sensitive', 'SYBR', 'Green', 'RT', 'qPCR', 'assay', 'suitable', 'for', 'detection', 'of', 'SV', 'A', 'in', 'diagnostic', 'swine', 'specimens', 'After', 'testing', '50', 'pigs', 'with', 'clinical', 'signs', 'consistent', 'with', 'vesicular', 'disease', '44', '88', 'were', 'found', 'to', 'be', 'positive', 'for', 'SV', 'A', 'by', 'RT', 'qPCR', 'as', 'compared', 'to', 'none', 'from', 'a', 'negative', 'cohort', 'of', '35', 'animals', 'without', 'vesicular', 'disease', 'indicating', 'that', 'the', 'assay', 'is', 'able', 'to', 'successfully', 'detect', 'the', 'virus', 'in', 'an', 'endemic', 'population', 'SV', 'A', 'RNA', 'was', 'also', 'detectable', 'at', 'a', 'low', 'level', 'in', 'sera', 'from', 'a', 'subset', 'of', 'pigs', 'that', 'presented', 'with', '18', 'or', 'without', '6', 'vesicular', 'signs', 'In', '2015', 'there', 'has', 'been', 'an', 'increase', 'in', 'the', 'occurrence', 'of', 'SV', 'A', 'in', 'the', 'US', 'and', 'over', '200', 'specimens', 'submitted', 'to', 'our', 'laboratory', 'for', 'vesicular', 'investigation', 'have', 'tested', 'positive', 'for', 'the', 'virus', 'using', 'this', 'method', 'SV', 'A', 'RNA', 'was', 'detectable', 'in', 'all', 'common', 'types', 'of', 'vesicular', 'specimens', 'including', 'swabs', 'and', 'tissue', 'from', 'hoof', 'lesions', 'oral', 'and', 'snout', 'epithelium', 'oral', 'swabs', 'scabs', 'and', 'internal', 'organ', 'tissues', 'such', 'as', 'liver', 'and', 'lymph', 'node', 'Genome', 'sequencing', 'analysis', 'from', 'recent', 'virus', 'isolates', 'was', 'performed', 'to', 'confirm', 'target', 'amplicon', 'specificity', 'and', 'was', 'aligned', 'to', 'previous', 'isolates', '']"
2336,"Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015): Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015",2016-07-20,BMC Genomics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959372/,"O1 Regulation of genes by telomere length over long distances Jerry W. Shay O2 The microtubule destabilizer KIF2A regulates the postnatal establishment of neuronal circuits in addition to prenatal cell survival, cell migration, and axon elongation, and its loss leading to malformation of cortical development and severe epilepsy Noriko Homma, Ruyun Zhou, Muhammad Imran Naseer, Adeel G. Chaudhary, Mohammed Al-Qahtani, Nobutaka Hirokawa O3 Integration of metagenomics and metabolomics in gut microbiome research Maryam Goudarzi, Albert J. Fornace Jr. O4 A unique integrated system to discern pathogenesis of central nervous system tumors Saleh Baeesa, Deema Hussain, Mohammed Bangash, Fahad Alghamdi, Hans-Juergen Schulten, Angel Carracedo, Ishaq Khan, Hanadi Qashqari, Nawal Madkhali, Mohamad Saka, Kulvinder S. Saini, Awatif Jamal, Jaudah Al-Maghrabi, Adel Abuzenadah, Adeel Chaudhary, Mohammed Al Qahtani, Ghazi Damanhouri O5 RPL27A is a target of miR-595 and deficiency contributes to ribosomal dysgenesis Heba Alkhatabi O6 Next generation DNA sequencing panels for haemostatic and platelet disorders and for Fanconi anaemia in routine diagnostic service Anne Goodeve, Laura Crookes, Nikolas Niksic, Nicholas Beauchamp O7 Targeted sequencing panels and their utilization in personalized medicine Adel M. Abuzenadah O8 International biobanking in the era of precision medicine Jim Vaught O9 Biobank and biodata for clinical and forensic applications Bruce Budowle, Mourad Assidi, Abdelbaset Buhmeida O10 Tissue microarray technique: a powerful adjunct tool for molecular profiling of solid tumors Jaudah Al-Maghrabi O11 The CEGMR biobanking unit: achievements, challenges and future plans Abdelbaset Buhmeida, Mourad Assidi, Leena Merdad O12 Phylomedicine of tumors Sudhir Kumar, Sayaka Miura, Karen Gomez O13 Clinical implementation of pharmacogenomics for colorectal cancer treatment Angel Carracedo, Mahmood Rasool O14 From association to causality: translation of GWAS findings for genomic medicine Ahmed Rebai O15 E-GRASP: an interactive database and web application for efficient analysis of disease-associated genetic information Sajjad Karim, Hend F Nour Eldin, Heba Abusamra, Elham M Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar O16 The supercomputer facility “AZIZ” at KAU: utility and future prospects Hossam Faheem O17 New research into the causes of male infertility Ashok Agarwa O18 The Klinefelter syndrome: recent progress in pathophysiology and management Eberhard Nieschlag, Joachim Wistuba, Oliver S. Damm, Mohd A. Beg, Taha A. Abdel-Meguid, Hisham A. Mosli, Osama S. Bajouh, Adel M. Abuzenadah, Mohammed H. Al-Qahtani O19 A new look to reproductive medicine in the era of genomics Serdar Coskun P1 Wnt signalling receptors expression in Saudi breast cancer patients Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Ashraf Dallol, Jaudah Al-Maghrabi, Sahar Hakamy, Wejdan Al-Qahtani, Asia Al-Harbi, Shireen Hussain, Mourad Assidi, Mohammed Al-Qahtani, Adel Abuzenadah P2 Analysis of oxidative stress interactome during spermatogenesis: a systems biology approach to reproduction Burak Ozkosem, Rick DuBois P3 Interleukin-18 gene variants are strongly associated with idiopathic recurrent pregnancy loss. Safia S Messaoudi, Maryam T Dandana, Touhami Mahjoub, Wassim Y Almawi P4 Effect of environmental factors on gene-gene and gene-environment reactions: model and theoretical study applied to environmental interventions using genotype S. Abdalla, M. Nabil Al-Aama P5 Genomics and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumor Asmaa Elzawahry, Tsuyoshi Takahashi, Sachiyo Mimaki, Eisaku Furukawa, Rie Nakatsuka, Isao Kurosaka, Takahiko Nishigaki, Hiromi Nakamura, Satoshi Serada, Tetsuji Naka, Seiichi Hirota, Tatsuhiro Shibata, Katsuya Tsuchihara, Toshirou Nishida, Mamoru Kato P6 In-Silico analysis of putative HCV epitopes against Pakistani human leukocyte antigen background: an approach towards development of future vaccines for Pakistani population Sajid Mehmood, Naeem Mahmood Ashraf, Awais Asif, Muhammad Bilal, Malik Siddique Mehmood, Aadil Hussain P7 Inhibition of AChE and BuChE with the natural compounds of Bacopa monerri for the treatment of Alzheimer’s disease: a bioinformatics approach Qazi Mohammad Sajid Jamal, Mughees Uddin Siddiqui, Mohammad A. Alzohairy, Mohammad A. Al Karaawi P8 Her2 expression in urothelial cell carcinoma of the bladder in Saudi Arabia Taoufik Nedjadi, Jaudah Al-Maghrabi, Mourad Assidi, Heba Al-Khattabi, Adel Al-Ammari, Ahmed Al-Sayyad, Abdelbaset Buhmeida, Mohammed Al-Qahtani P9 Association of angiotensinogen single nucleotide polymorphisms with Preeclampsia in patients from North Africa Hédia Zitouni, Nozha Raguema, Marwa Ben Ali, Wided Malah, Raja Lfalah, Wassim Almawi, Touhami Mahjoub P10 Systems biology analysis reveals relations between normal skin, benign nevi and malignant melanoma Mohammed Elanbari, Andrey Ptitsyn P11 The apoptotic effect of thymoquinone in Jurkat cells Sana Mahjoub, Rabeb El Ghali, Bechir Achour, Nidhal Ben Amor, Mourad Assidi, Brahim N'siri, Hamid Morjani P12 Sonic hedgehog contributes in bladder cancer invasion in Saudi Arabia Taoufik Nedjadi, Adel Al-Ammari, Ahmed Al-Sayyad, Nada Salem, Esam Azhar, Jaudah Al-Maghrabi P13 Association of Interleukin 18 gene promoter polymorphisms - 607A/C and -137 G/C with colorectal cancer onset in a sample of Tunisian population Vera Chayeb, Maryam Dendena, Hedia Zitouni, Khedija Zouari-Limayem, Touhami Mahjoub P14 Pathological expression of interleukin-6, -11, leukemia inhibitory factor and their receptors in tubal gestation with and without tubal cytomegalovirus infection Bassem Refaat, Ahmed M Ashshi, Sarah A Batwa P15 Phenotypic and genetic profiling of avian pathogenic and human diarrhegenic Escherichia coli in Egypt Hazem Ramadan, Amal Awad, Ahmed Ateya P16 Cancer-targeting dual gene virotherapy as a promising therapeutic strategy for treatment of hepatocellular carcinoma Adel Galal Ahmed El-Shemi, Ahmad Ashshi, Mohammed Basalamah, Youjin Na, Chae-Ok YUN P17 Cancer dual gene therapy with oncolytic adenoviruses expressing TRAIL and IL-12 transgenes markedly eradicated human hepatocellular carcinoma both in vitro and in vivo Adel Galal Ahmed El-Shemi, Ahmad Ashshi, Mohammed Basalamah, Youjin Na, Chae-Ok Yun P18 Therapy with paricalcitol attenuates tumor growth and augments tumoricidal and anti-oncogenic effects of 5-fluorouracil on animal model of colon cancer Adel Galal El-Shemi, Bassem Refaat, Osama Kensara, Amr Abdelfattah P19 The effects of Rubus idaeus extract on normal human lymphocytes and cancer cell line Batol Imran Dheeb, Mohammed M. F. Al-Halbosiy, Rghad Kadhim Al lihabi, Basim Mohammed Khashman P20 Etanercept, a TNF-alpha inhibitor, alleviates mechanical hypersensitivity and spontaneous pain in a rat model of chemotherapy-induced neuropathic pain Djouhri, Laiche, Chaudhary Adeel, Nedjadi, Taoufik P21 Sleeping beauty mutagenesis system identified genes and neuronal transcription factor network involved in pediatric solid tumour (medulloblastoma) Hani Al-Afghani, Maria Łastowska, Haya H Al-Balool, Harsh Sheth, Emma Mercer, Jonathan M Coxhead, Chris PF Redfern, Heiko Peters, Alastair D Burt, Mauro Santibanez-Koref, Chris M Bacon, Louis Chesler, Alistair G Rust, David J Adams, Daniel Williamson, Steven C Clifford, Michael S Jackson P22 Involvement of interleukin-1 in vitiligo pathogenesis Mala Singh, Mohmmad Shoab Mansuri, Shahnawaz D. Jadeja, Hima Patel, Yogesh S. Marfatia, Rasheedunnisa Begum P23 Cytogenetics abnormalities in 12,884 referred population for chromosomal analysis and the role of FISH in refining the diagnosis (cytogenetic experience 2004-2013) Amal M Mohamed, Alaa K Kamel, Nivin A Helmy, Sayda A Hammad, Hesham F Kayed, Marwa I Shehab, Assad El Gerzawy, Maha M. Ead, Ola M Ead, Mona Mekkawy, Innas Mazen, Mona El-Ruby P24 Analysis of binding properties of angiotensin-converting enzyme 2 through in silico method S. M. A. Shahid, Qazi Mohammad Sajid Jamal, J. M. Arif, Mohtashim Lohani P25 Relationship of genetics markers cis and trans to the β-S globin gene with fetal hemoglobin expression in Tunisian sickle cell patients Moumni Imen, Chaouch Leila, Ouragini Houyem, Douzi Kais, Chaouachi Dorra Mellouli Fethi, Bejaoui Mohamed, Abbes Salem P26 Analysis of estrogen receptor alpha gene polymorphisms in breast cancer: link to genetic predisposition in Sudanese women Areeg Faggad, Amanuel T Gebreslasie, Hani Y Zaki, Badreldin E Abdalla P27 KCNQI gene polymorphism and its association with CVD and T2DM in the Saudi population Maha S AlShammari, Rhaya Al-Ali, Nader Al-Balawi , Mansour Al-Enazi, Ali Al-Muraikhi, Fadi Busaleh, Ali Al-Sahwan, Francis Borgio, Abdulazeez Sayyed, Amein Al-Ali, Sadananda Acharya P28 Clinical, neuroimaging and cytogenetic study of a patient with microcephaly capillary malformation syndrome Maha S. Zaki, Hala T. El-Bassyouni, Marwa I. Shehab P29 Altered expression of CD200R1 on dendritic cells of patients with inflammatory bowel diseases: in silico investigations and clinical evaluations Mohammed F. Elshal, Kaleemuddin M., Alia M. Aldahlawi, Omar Saadah, J. Philip McCoy P30 Development of real time PCR diagnostic protocol specific for the Saudi Arabian H1N1 viral strains Adel E El-Tarras, Nabil S Awad, Abdulla A Alharthi, Mohamed M M Ibrahim P31 Identification of novel genetic variations affecting Osteoarthritis patients Haneen S Alsehli, Ashraf Dallol, Abdullah M Gari, Mohammed M Abbas, Roaa A Kadam, Mazen M. Gari, Mohmmed H Alkaff, Adel M Abuzenadah, Mamdooh A Gari P32 An integrated database of GWAS SNVs and their evolutionary properties Heba Abusamra, Sajjad Karim, Hend F Nour eldin, Elham M Alhathli, Nada Salem, Sudhir Kumar, Mohammed H Al-Qahtani P33 Familial hypercholesterolemia in Saudi Arabia: prime time for a national registry and genetic analysis Fatima A. Moradi, Omran M. Rashidi, Zuhier A. Awan P34 Comparative genomics and network-based analyses of early hepatocellular carcinoma Ibrahim Hamza Kaya, Olfat Al-Harazi, Dilek Colak P35 A TALEN-based oncolytic viral vector approach to knock out ABCB1 gene mediated chemoresistance in cancer stem cells Nabila A Alkousi, Takis Athanasopoulos P36 Cartilage differentiation and gene expression of synovial fluid mesenchymal stem cells derived from osteoarthritis patients Afnan O Bahmaid, Etimad A Alhwait, Mamdooh A Gari, Haneen S Alsehli, Mohammed M Abbas, Mohammed H Alkaf, Roaa Kadam, Ashraf Dallol, Gauthaman Kalamegam P37 E-GRASP: Adding an evolutionary component to the genome-wide repository of associations (GRASP) resource Hend F Nour Eldin, Sajjad Karim, Heba Abusamra, Elham Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar P38 Screening of AGL gene mutation in Saudi family with glycogen storage disease Type III Salma N Alsayed, Fawziah H Aljohani, Samaher M Habeeb, Rawan A Almashali, Sulman Basit, Samia M Ahmed P39 High throughput proteomic data suggest modulation of cAMP dependent protein kinase A and mitochondrial function in infertile patients with varicocele Rakesh Sharma, Ashok Agarwal, Damayanthi Durairajanayagam, Luna Samanta, Muhammad Abu-Elmagd, Adel M. Abuzenadah, Edmund S. Sabanegh, Mourad Assidi, Mohammed Al-Qahtani P40 Significant protein profile alterations in men with primary and secondary infertility Ashok Agarwal, Rakesh Sharma, Luna Samanta, Damayanthi Durairajanayagam, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani, Adel M. Abuzenadah, Edmund S. Sabanegh P41 Spermatozoa maturation in infertile patients involves compromised expression of heat shock proteins Luna Samanta, Ashok Agarwal, Rakesh Sharma, Zhihong Cui, Mourad Assidi, Adel M. Abuzenadah, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P42 Array comparative genomic hybridization approach to search genomic answers for spontaneous recurrent abortion in Saudi Arabia Alaa A Alboogmi, Nuha A Alansari, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Hasan S Jamal, Abdullraheem Rozi(,) Zeenat Mirza, Adel M Abuzenadah, Sajjad Karim, Mohammed H Al-Qahtani P43 Global gene expression profiling of Saudi kidney cancer patients Sajjad Karim, Hans-Juergen Schulten, Ahmad J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Zeenat Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P44 Downregulated StAR gene and male reproductive dysfunction caused by nifedipine and ethosuximide Rasha A Ebiya, Samia M Darwish, Metwally M. Montaser P45 Clustering based gene expression feature selection method: A computational approach to enrich the classifier efficiency of differentially expressed genes Heba Abusamra, Vladimir B. Bajic P46 Prognostic significance of Osteopontin expression profile in colorectal carcinoma Jaudah Al-Maghrabi, Wafaey Gomaa, Mehenaz Hanbazazh, Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Saher Hakamy, Ghali Baba, Abdelbaset Buhmeida, Mohammed Al-Qahtani P47 High Glypican-3 expression pattern predicts longer disease-specific survival in colorectal carcinoma Jaudah Al-Maghrabi, Abdullah Al-Harbi, Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Sahar Hakamy, Ghalia Baba, Abdelbaset Buhmeida, Mohammed Al-Qahtani P48 An evolutionary re-assessment of GWAS single nucleotide variants implicated in the Cholesterol traits Elham M Alhathli, Sajjad Karim, Nada Salem, Hend Nour Eldin, Heba Abusamra, Sudhir Kumar, Mohammed H Al-Qahtani P49 Derivation and characterization of human Wharton’s jelly stem cells (hWJSCs) in vitro for future therapeutic applications Aisha A Alyamani, Gauthaman Kalamegam, Etimad A Alhwait, Mamdooh A Gari, Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa A Kadam, Mohammed Al-Qahtani P50 Attitudes of healthcare students toward biomedical research in the post-genomic era Rawan Gadi, Abdelbaset Buhmeida, Mourad Assidi , Adeel Chaudhary, Leena Merdad P51 Evaluation of the immunomodulatory effects of thymoquinone on human bone marrow mesenchymal stem cells (BM-MSCs) from osteoarthritic patients Saadiah M Alfakeeh, Etimad A Alhwait, Mamdooh A Gari, Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa Kadam, Gauthaman Kalamegam P52 Implication of IL-10 and IL-28 polymorphism with successful anti-HCV therapy and viral clearance Rubi Ghazala, Shilu Mathew, M.Haroon Hamed, Mourad Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P53 Selection of flavonoids against obesity protein (FTO) using in silico and in vitro approaches Shilu Mathew, Lobna Mira, Manal Shaabad, Shireen Hussain, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P54 Computational selection and in vitro validation of flavonoids as new antidepressant agents Shilu Mathew, Manal Shaabad, Lobna Mira, Shireen Hussain, Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P55 In Silico prediction and prioritization of aging candidate genes associated with progressive telomere shortening Ahmed Rebai, Mourad Assidi, Abdelbaset Buhmeida, Muhammad Abu-Elmagd, Ashraf Dallol, Jerry W Shay P56 Identification of new cancer testis antigen genes in diverse types of malignant human tumour cells Mikhlid H Almutairi P57 More comprehensive forensic genetic marker analyses for accurate human remains identification using massively parallel sequencing (MPS) Angie Ambers, Jennifer Churchill, Jonathan King, Monika Stoljarova, Harrell Gill-King, Mourad Assidi, Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Muhammad Al-Qatani, Bruce Budowle P58 Flow cytometry approach towards treatment men infertility in Saudi Arabia Muhammad Abu-Elmagd, Farid Ahmed, Ashraf Dallol, Mourad Assidi, Taha Abo Almagd, Sahar Hakamy, Ashok Agarwal, Muhammad Al-Qahtani, Adel Abuzenadah P59 Tissue microarray based validation of CyclinD1 expression in renal cell carcinoma of Saudi kidney patients Sajjad Karim, Hans-Juergen Schulten, Ahmad J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Abdelbaset Buhmaida, Zeenat Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P60 Assessment of gold nanoparticles in molecular diagnostics and DNA damage studies Rukhsana Satar, Mahmood Rasool, Waseem Ahmad, Nazia Nazam, Mohamad I Lone, Muhammad I Naseer, Mohammad S Jamal, Syed K Zaidi, Peter N Pushparaj, Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani P61 Surfing the biospecimen management and processing workflow at CEGMR Biobank Hanan Bashier, Abrar Al Qahtani, Shilu Mathew, Amal M. Nour, Heba Alkhatabi, Adel M. Abu Zenadah, Abdelbaset Buhmeida, Mourad Assidi, Muhammed Al Qahtani P62 Autism Spectrum Disorder: knowledge, attitude and awareness in Jeddah, Kingdom of Saudi Arabia Muhammad Faheem, Shilu Mathew, Shiny Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P63 Simultaneous genetic screening of the coagulation pathway genes using the Thromboscan targeted sequencing panel Hani A. Alhadrami, Ashraf Dallol, Adel Abuzenadah P64 Genome wide array comparative genomic hybridization analysis in patients with syndromic congenital heart defects Ibtessam R. Hussein, Adeel G. Chaudhary, Rima S Bader, Randa Bassiouni, Maha Alquaiti, Fai Ashgan, Hans Schulten, Mohamed Nabil Alama, Mohammad H. Al Qahtani P65 Toxocogenetic evaluation of 1, 2-Dichloroethane in bone marrow, blood and cells of immune system using conventional, molecular and flowcytometric approaches Mohammad I Lone, Nazia Nizam, Waseem Ahmad, Mohammad A Jafri, Mahmood Rasool, Shakeel A Ansari, Muhammed H Al-Qahtani P66 Molecular cytogenetic diagnosis of sexual development disorders in newborn: A case of ambiguous genitalia Eradah Alshihri, Muhammad Abu-Elmagd, Lina Alharbi, Mourad Assidi, Mohammed Al-Qahtani P67 Identification of disease specific gene expression clusters and pathways in hepatocellular carcinoma using In Silico methodologies Shilu Mathew, Peter Pushparaj Natesan, Muhammed Al Qahtani P68 Human Wharton’s Jelly stem cell conditioned medium inhibits primary ovarian cancer cells in vitro: Identification of probable targets and mechanisms using systems biology Gauthaman Kalamegam, Peter Natesan Pushparaj, Fazal Khan, Roaa Kadam, Farid Ahmed, Mourad Assidi, Khalid Hussain Wali Sait, Nisreen Anfinan, Mohammed Al Qahtani P69 Mutation spectrum of ASPM (Abnormal Spindle-like, Microcephaly-associated) gene in Saudi Arabian population Muhammad I Naseer, Adeel G Chaudhary, Mohammad S Jamal, Shilu Mathew, Lobna S Mira, Peter N Pushparaj, Shakeel A Ansari, Mahmood Rasool, Mohammed H AlQahtani P70 Identification and characterization of novel genes and mutations of primary microcephaly in Saudi Arabian population Muhammad I Naseer, Adeel G Chaudhary, Shilu Mathew, Lobna S Mira, Mohammad S Jamal, Sameera Sogaty, Randa I Bassiouni, Mahmood Rasool, Mohammed H AlQahtani P71 Molecular genetic analysis of hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Saudi Arabian population Mahmood Rasool, Shakeel A Ansari, Mohammad S Jamal, Peter N Pushparaj, Abdulrahman MS Sibiani, Waseem Ahmad, Abdelbaset Buhmeida, Mohammad A Jafri, Mohiuddin K Warsi, Muhammad I Naseer, Mohammed H Al-Qahtani P72 Function predication of hypothetical proteins from genome database of chlamydia trachomatis Rubi, Kundan Kumar, Ahmad AT Naqvi, Faizan Ahmad, Md I Hassan, Mohammad S Jamal, Mahmood Rasool, Mohammed H AlQahtani P73 Transcription factors as novel molecular targets for skin cancer Ashraf Ali, Jummanah Jarullah, Mahmood Rasool, Abdelbasit Buhmeida, Shahida Khan, Ghufrana Abdussami, Maryam Mahfooz, Mohammad A Kamal, Ghazi A Damanhouri, Mohammad S Jamal P74 An In Silico analysis of Plumbagin binding to apoptosis executioner: Caspase-3 and Caspase-7 Bushra Jarullah, Jummanah Jarullah, Mohammad SS Jarullah, Ashraf Ali, Mahmood Rasool, Mohammad S Jamal P75 Single cell genomics applications for preimplantation genetic screening optimization: Comparative analysis of whole genome amplification technologies Mourad Assidi, Muhammad Abu-Elmagd, Osama Bajouh, Peter Natesan Pushparaj, Mohammed Al-Qahtani, Adel Abuzenadah P76 ZFP36 regulates miRs-34a in anti-IgM triggered immature B cells Mohammad S Jamal, Jummanah Jarullah, Abdulah EA Mathkoor, Hashim MA Alsalmi, Anas MM Oun, Ghazi A Damanhauri, Mahmood Rasool, Mohammed H AlQahtani P77 Identification of a novel mutation in the STAMBP gene in a family with microcephaly-capillary malformation syndrome Muhammad I. Naseer, Mahmood Rasool, Sameera Sogaty, Adeel G. Chudhary, Yousif A. Abutalib, Daniele Merico, Susan Walker, Christian R. Marshall, Mehdi Zarrei, Stephen W. Scherer, Mohammad H. Al-Qahtani P78 Copy number variations in Saudi patients with intellectual disability and epilepsy Muhammad I. Naseer, Muhammad Faheem, Adeel G. Chaudhary, Mahmood Rasool, Gauthaman Kalamegam, Fai Talal Ashgan, Mourad Assidi, Farid Ahmed, Syed Kashif Zaidi, Mohammed M. Jan, Mohammad H. Al-Qahtani P79 Prognostic significance of CD44 expression profile in colorectal carcinoma Maryam Al-Zahrani, Sahira Lary, Sahar Hakamy, Ashraf Dallol, Mahmoud Al-Ahwal, Jaudah Al-Maghrabi, Emmanuel Dermitzakis, Adel Abuzenadah, Abdelbaset Buhmeida, Mohammed Al-Qahtani P80 Association of the endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications Abeer A Al-refai, Mona Saleh, Rehab I Yassien, Mahmmoud Kamel, Rabab M Habeb P81 SNPs array to screen genetic variation among diabetic patients Najlaa Filimban, Ashraf Dallol, Nadia Ghannam, Mohammed Al-Qahtani, Adel Mohammed Abuzenadah P82 Detection and genotyping of Helicobacter pylori among gastric cancer patients from Saudi Arabian population Fehmida Bibi, Sana Akhtar, Esam I. Azhar, Muhammad Yasir, Muhammad I. Nasser, Asif A. Jiman-Fatani, Ali Sawan P83 Antimicrobial drug resistance and molecular detection of susceptibility to Fluoroquinolones among clinical isolates of Salmonella species from Jeddah-Saudi Arabia Ruaa A Lahzah, Asho Ali P84 Identification of the toxic and virulence nature of MAP1138c protein of Mycobacterium avium subsp. paratuberculosis Syed A Hassan, Seyed E Hasnain, Iftikhar A Tayubi, Hamza A Abujabal, Alaa O Magrabi P85 In vitro and in silico evaluation of miR137 in human breast cancer Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj, Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour, Mohammed Al-Qahtani P86 Auruka gene is over-expressed in Saudi breast cancer Manal Shabaad, Shilu Mathew, Ashraf Dallol, Adnan Merdad, Abdelbaset Buhmeida, Mohammed Al-Qahtani P87 The potential of immunogenomics in personalized healthcare Mourad Assidi, Muhammad Abu-Elmagd, Kalamegam Gauthaman, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Peter Natesan Pushparaj, Mohammed Al-Qahtani P88 In Silico physiochemical and structural characterization of a putative ORF MAP0591 and its implication in the pathogenesis of Mycobacterium paratuberculosis in ruminants and humans Syed A Hassan, Iftikhar A Tayubi, Hani MA Aljahdali P89 Effects of heat shock on human bone marrow mesenchymal stem cells (BM-MSCs): Implications in regenerative medicine Reham Al Nono, Mamdooh Gari, Haneen Alsehli, Farid Ahmed, Mohammed Abbas, Gauthaman Kalamegam, Mohammed Al-Qahtani P90 In Silico analyses of the molecular targets of Resveratrol unravels its importance in mast cell mediated allergic responses Shilu Mathew, Fazal Khan, Mahmood Rasool, Mohammed Sarwar Jamal, Muhammad Imran Naseer, Zeenat Mirza, Sajjad Karim, Shakeel Ansari, Mourad Assidi, Gauthaman Kalamegam, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Peter Natesan Pushparaj, Mohammed Al-Qahtani P91 Effects of environmental particulate matter on bone-marrow mesenchymal stem cells Muhammad Abu-Elmagd, Gauthaman Kalamegam, Roaa Kadam, Mansour A Alghamdi, Magdy Shamy, Max Costa, Mamdouh I Khoder, Mourad Assidi, Peter Natesan Pushparaj, Mamdooh Gari, Mohammed Al-Qahtani P92 Distinctive charge clusters in human virus proteomes Najla Kharrat, Sabrine Belmabrouk, Rania Abdelhedi, Riadh Benmarzoug, Mourad Assidi, Mohammed H. Al Qahtani, Ahmed Rebai P93 In vitro experimental model and approach in identification of new biomarkers of inflammatory forms of arthritis Ghazi Dhamanhouri, Peter Natesan Pushparaj, Abdelwahab Noorwali, Mohammad Khalid Alwasiyah, Afnan Bahamaid, Saadiah Alfakeeh, Aisha Alyamani, Haneen Alsehli, Mohammed Abbas, Mamdooh Gari, Ali Mobasheri, Gauthaman Kalamegam, Mohammed Al-Qahtani P94 Molecular docking of GABA(A) receptor subunit γ-2 with novel anti-epileptic compounds Muhammad Faheem, Shilu Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P95 Breast cancer knowledge, awareness, and practices among Saudi females residing in Jeddah Shilu Mathew, Muhammad Faheem, Shiny Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P96 Anti-inflammatory role of Sesamin by Attenuation of Iba1/TNF-α/ICAM-1/iNOS signaling in Diabetic Retinopathy Mohammad Sarwar Jamal, Syed Kashif Zaidi, Raziuddin Khan, Kanchan Bhatia, Mohammed H. Al-Qahtani, Saif Ahmad P97 Identification of drug lead molecule against vp35 protein of Ebola virus: An In-Silico approach Iftikhar AslamTayubi, Manish Tripathi, Syed Asif Hassan, Rahul Shrivastava P98 An approach to personalized medicine from SNP-calling through disease analysis using whole exome-sequencing of three sub-continental populations Iftikhar A Tayubi, Syed Hassan, Hamza A.S Abujabal P99 Low versus high frequency of Glucose –6 – Phosphate Dehydrogenase (G6PD) deficiency in urban against tribal population of Gujarat – A signal to natural selection Ishani Shah, Bushra Jarullah, Mohammad S Jamal, Jummanah Jarullah P100 Spontaneous preterm birth and single nucleotide gene polymorphisms: a recent update Ishfaq A Sheikh, Ejaz Ahmad, Mohammad S Jamal, Mohd Rehan, Muhammad Abu-Elmagd, Iftikhar A Tayubi, Samera F AlBasri, Osama S Bajouh, Rola F Turki, Adel M Abuzenadah, Ghazi A Damanhouri, Mohd A Beg, Mohammed Al-Qahtani P101 Prevalence of congenital heart diseases among Down syndrome cases in Saudi Arabia: role of molecular genetics in the pathogenesis Sahar AF Hammoudah, Khalid M AlHarbi, Lama M El-Attar, Ahmed MZ Darwish P102 Combinatorial efficacy of specific pathway inhibitors in breast cancer cells Sara M Ibrahim, Ashraf Dallol(,) Hani Choudhry, Adel Abuzenadah, Jalaludden Awlia, Adeel Chaudhary, Farid Ahmed, Mohammed Al-Qahtani P103 MiR-143 and miR-145 cluster as potential replacement medicine for the treatment of cancer Mohammad A Jafri, Muhammad Abu-Elmagd, Mourad Assidi, Mohammed Al-Qahtani P104 Metagenomic profile of gut microbiota during pregnancy in Saudi population Imran khan, Muhammad Yasir, Esam I. Azhar, Sameera Al-basri, Elie Barbour, Taha Kumosani P105 Exploration of anticancer targets of selected metabolites of Phoenix dactylifera L. using systems biological approaches Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj, Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour P106 CD226 and CD40 gene polymorphism in susceptibility to Juvenile rheumatoid arthritis in Egyptian patients Heba M. EL Sayed, Eman A. Hafez P107 Paediatric exome sequencing in autism spectrum disorder ascertained in Saudi families Hans-Juergen Schulten, Aisha Hassan Elaimi, Ibtessam R Hussein, Randa Ibrahim Bassiouni, Mohammad Khalid Alwasiyah, Richard F Wintle, Adeel Chaudhary, Stephen W Scherer, Mohammed Al-Qahtani P108 Crystal structure of the complex formed between Phospholipase A(2) and the central core hydrophobic fragment of Alzheimer’s β- amyloid peptide: a reductionist approach Zeenat Mirza, Vikram Gopalakrishna Pillai, Sajjad Karim, Sujata Sharma, Punit Kaur, Alagiri Srinivasan, Tej P Singh, Mohammed Al-Qahtani P109 Differential expression profiling between meningiomas from female and male patients Reem Alotibi, Alaa Al-Ahmadi, Fatima Al-Adwani, Deema Hussein, Sajjad Karim, Mona Al-Sharif, Awatif Jamal, Fahad Al-Ghamdi, Jaudah Al-Maghrabi, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Hans-Juergen Schulten, Mohammed Al-Qahtani P110 Neurospheres as models of early brain development and therapeutics Muhammad Faheem, Peter Natesan Pushparaj, Shilu Mathew, Taha Abdullah Kumosani, Gauthaman Kalamegam, Mohammed Al-Qahtani P111 Identification of a recurrent causative missense mutation p.(W577C) at the LDLR exon 12 in familial hypercholesterolemia affected Saudi families Faisal A Al-Allaf, Zainularifeen Abduljaleel, Abdullah Alashwal, Mohiuddin M. Taher, Abdellatif Bouazzaoui, Halah Abalkhail, Faisal A. Ba-Hammam, Mohammad Athar P112 Epithelial ovarian carcinoma (EOC): Systems oncological approach to identify diagnostic, prognostic and therapeutic biomarkers Gauthaman Kalamegam, Peter Natesan Pushparaj, Muhammad Abu-Elmagd, Farid Ahmed Khalid HussainWali Sait, Nisreen Anfinan, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Mourad Assidi, Mohammed Al-Qahtani P113 Crohn’s disease phenotype in northern Tunisian population Naira Ben Mami, Yosr Z Haffani, Mouna Medhioub, Lamine Hamzaoui, Ameur Cherif, Msadok Azouz P114 Establishment of In Silico approaches to decipher the potential toxicity and mechanism of action of drug candidates and environmental agents Gauthaman Kalamegam, Fazal Khan, Shilu Mathew, Mohammed Imran Nasser, Mahmood Rasool, Farid Ahmed, Peter Natesan Pushparaj, Mohammed Al-Qahtani P115 1q Gain predicts poor prognosis marker for young breast cancer patients Shereen A Turkistany, Lina M Al-harbi, Ashraf Dallol, Jamal Sabir, Adeel Chaudhary, Adel Abuzenadah P116 Disorders of sex chromosomes in a diagnostic genomic medicine unit in Saudi Arabia: Prevalence, diagnosis and future guidelines Basmah Al-Madoudi, Bayan Al-Aslani, Khulud Al-Harbi, Rwan Al-Jahdali, Hanadi Qudaih, Emad Al Hamzy, Mourad Assidi, Mohammed Al Qahtani P117 Combination of WYE354 and Sunitinib demonstrate synergistic inhibition of acute myeloid leukemia in vitro Asad M Ilyas, Youssri Ahmed, Mamdooh Gari, Farid Ahmed, Mohammed Alqahtani P118 Integrated use of evolutionary information in GWAS reveals important SNPs in Asthma Nada Salem, Sajjad Karim, Elham M Alhathli, Heba Abusamra, Hend F Nour Eldin, Mohammed H Al-Qahtani, Sudhir Kumar P119 Assessment of BRAF, IDH1, IDH2, and EGFR mutations in a series of primary brain tumors Fatima Al-Adwani, Deema Hussein, Mona Al-Sharif, Awatif Jamal, Fahad Al-Ghamdi, Jaudah Al-Maghrabi, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Mohammed Al-Qahtani, Hans-Juergen Schulten P120 Expression profiles distinguish oligodendrogliomas from glioblastoma multiformes with or without oligodendroglioma component Alaa Alamandi, Reem Alotibi, Deema Hussein, Sajjad Karim, Jaudah Al-Maghrabi, Fahad Al-Ghamdi, Awatif Jamal, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Hans-Juergen Schulten, Mohammed Al-Qahtani P121 Hierarchical clustering in thyroid goiters and hyperplastic lesions Ohoud Subhi, Nadia Bagatian, Sajjad Karim, Adel Al-Johari, Osman Abdel Al-Hamour, Hosam Al-Aradati, Abdulmonem Al-Mutawa, Faisal Al-Mashat, Jaudah Al-Maghrabi, Hans-Juergen Schulten, Mohammad Al-Qahtani P122 Differential expression analysis in thyroiditis and papillary thyroid carcinomas with or without coexisting thyroiditis Nadia Bagatian, Ohoud Subhi, Sajjad Karim, Adel Al-Johari, Osman Abdel Al-Hamour, Abdulmonem Al-Mutawa, Hosam Al-Aradati, Faisal Al-Mashat, Mohammad Al-Qahtani, Hans-Juergen Schulten, Jaudah Al-Maghrabi P123 Metagenomic analysis of waste water microbiome in Sausdi Arabia Muhammad W shah, Muhammad Yasir, Esam I Azhar, Saad Al-Masoodi P124 Molecular characterization of Helicobacter pylori from faecal samples of Tunisian patients with gastric cancer Yosr Z Haffani, Msadok Azouz, Emna Khamla, Chaima Jlassi, Ahmed S. Masmoudi, Ameur Cherif, Lassaad Belbahri P125 Diagnostic application of the oncoscan(©) panel for the identification of hereditary cancer syndrome Shadi Al-Khayyat, Roba Attas, Atlal Abu-Sanad, Mohammed Abuzinadah, Adnan MerdadAshraf Dallol, Adeel Chaudhary, Mohammed Al-Qahtani, Adel Abuzenadah P126 Characterization of clinical and neurocognitive features in a family with a novel OGT gene missense mutation c. 1193G > A/ (p. Ala319Thr) Habib Bouazzi, Carlos Trujillo, Mohammad Khalid Alwasiyah, Mohammed Al-Qahtani P127 Case report: a rare homozygous deletion mutation of TMEM70 gene associated with 3-Methylglutaconic Aciduria and cataract in a Saudi patient Maha Alotaibi, Rami Nassir P128 Isolation and purification of antimicrobial milk proteins Ishfaq A Sheikh, Mohammad A Kamal, Essam H Jiffri, Ghulam M Ashraf, Mohd A Beg P129 Integrated analysis reveals association of ATP8B1 gene with colorectal cancer Mohammad A Aziz, Rizwan Ali, Mahmood Rasool, Mohammad S Jamal, Nusaibah samman, Ghufrana Abdussami, Sathish Periyasamy, Mohiuddin K Warsi, Mohammed Aldress, Majed Al Otaibi, Zeyad Al Yousef, Mohamed Boudjelal, Abdelbasit Buhmeida, Mohammed H Al-Qahtani, Ibrahim AlAbdulkarim P130 Implication of IL-10 and IL-28 polymorphism with successful anti-HCV therapy and viral clearance Rubi Ghazala, Shilu Mathew, M. Haroon Hamed, Mourad Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P131 Interactions of endocrine disruptor di-(2-ethylhexyl) phthalate (DEHP) and its metabolite mono-2-ethylhexyl phthalate (MEHP) with progesterone receptor Ishfaq A Sheikh, Muhammad Abu-Elmagd, Rola F Turki, Ghazi A Damanhouri, Mohd A. Beg P132 Association of HCV nucleotide polymorphism in the development of hepatocellular carcinoma Mohd Suhail, Abid Qureshi, Adil Jamal, Peter Natesan Pushparaj, Mohammad Al-Qahtani, Ishtiaq Qadri P133 Gene expression profiling by DNA microarrays in colon cancer treated with chelidonine alkaloid Mahmoud Z El-Readi, Safaa Y Eid, Michael Wink P134 Successful in vitro fertilization after eight failed trials Ahmed M. Isa, Lulu Alnuaim, Johara Almutawa, Basim Abu-Rafae, Saleh Alasiri, Saleh Binsaleh P135 Genetic sensitivity analysis using SCGE, cell cycle and mitochondrial membrane potential in OPs stressed leukocytes in Rattus norvegicus through flow cytometric input Nazia Nazam, Mohamad I Lone, Waseem Ahmad, Shakeel A Ansari, Mohamed H Alqahtani",10.1186/s12864-016-2858-0,pd1g119c,"['O1', 'Regulation', 'of', 'genes', 'by', 'telomere', 'length', 'over', 'long', 'distances', 'Jerry', 'W', 'Shay', 'O2', 'The', 'microtubule', 'destabilizer', 'KIF2A', 'regulates', 'the', 'postnatal', 'establishment', 'of', 'neuronal', 'circuits', 'in', 'addition', 'to', 'prenatal', 'cell', 'survival', 'cell', 'migration', 'and', 'axon', 'elongation', 'and', 'its', 'loss', 'leading', 'to', 'malformation', 'of', 'cortical', 'development', 'and', 'severe', 'epilepsy', 'Noriko', 'Homma', 'Ruyun', 'Zhou', 'Muhammad', 'Imran', 'Naseer', 'Adeel', 'G', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Nobutaka', 'Hirokawa', 'O3', 'Integration', 'of', 'metagenomics', 'and', 'metabolomics', 'in', 'gut', 'microbiome', 'research', 'Maryam', 'Goudarzi', 'Albert', 'J', 'Fornace', 'Jr', 'O4', 'A', 'unique', 'integrated', 'system', 'to', 'discern', 'pathogenesis', 'of', 'central', 'nervous', 'system', 'tumors', 'Saleh', 'Baeesa', 'Deema', 'Hussain', 'Mohammed', 'Bangash', 'Fahad', 'Alghamdi', 'Hans', 'Juergen', 'Schulten', 'Angel', 'Carracedo', 'Ishaq', 'Khan', 'Hanadi', 'Qashqari', 'Nawal', 'Madkhali', 'Mohamad', 'Saka', 'Kulvinder', 'S', 'Saini', 'Awatif', 'Jamal', 'Jaudah', 'Al', 'Maghrabi', 'Adel', 'Abuzenadah', 'Adeel', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Ghazi', 'Damanhouri', 'O5', 'RPL27A', 'is', 'a', 'target', 'of', 'miR', '595', 'and', 'deficiency', 'contributes', 'to', 'ribosomal', 'dysgenesis', 'Heba', 'Alkhatabi', 'O6', 'Next', 'generation', 'DNA', 'sequencing', 'panels', 'for', 'haemostatic', 'and', 'platelet', 'disorders', 'and', 'for', 'Fanconi', 'anaemia', 'in', 'routine', 'diagnostic', 'service', 'Anne', 'Goodeve', 'Laura', 'Crookes', 'Nikolas', 'Niksic', 'Nicholas', 'Beauchamp', 'O7', 'Targeted', 'sequencing', 'panels', 'and', 'their', 'utilization', 'in', 'personalized', 'medicine', 'Adel', 'M', 'Abuzenadah', 'O8', 'International', 'biobanking', 'in', 'the', 'era', 'of', 'precision', 'medicine', 'Jim', 'Vaught', 'O9', 'Biobank', 'and', 'biodata', 'for', 'clinical', 'and', 'forensic', 'applications', 'Bruce', 'Budowle', 'Mourad', 'Assidi', 'Abdelbaset', 'Buhmeida', 'O10', 'Tissue', 'microarray', 'technique', 'a', 'powerful', 'adjunct', 'tool', 'for', 'molecular', 'profiling', 'of', 'solid', 'tumors', 'Jaudah', 'Al', 'Maghrabi', 'O11', 'The', 'CEGMR', 'biobanking', 'unit', 'achievements', 'challenges', 'and', 'future', 'plans', 'Abdelbaset', 'Buhmeida', 'Mourad', 'Assidi', 'Leena', 'Merdad', 'O12', 'Phylomedicine', 'of', 'tumors', 'Sudhir', 'Kumar', 'Sayaka', 'Miura', 'Karen', 'Gomez', 'O13', 'Clinical', 'implementation', 'of', 'pharmacogenomics', 'for', 'colorectal', 'cancer', 'treatment', 'Angel', 'Carracedo', 'Mahmood', 'Rasool', 'O14', 'From', 'association', 'to', 'causality', 'translation', 'of', 'GWAS', 'findings', 'for', 'genomic', 'medicine', 'Ahmed', 'Rebai', 'O15', 'E', 'GRASP', 'an', 'interactive', 'database', 'and', 'web', 'application', 'for', 'efficient', 'analysis', 'of', 'disease', 'associated', 'genetic', 'information', 'Sajjad', 'Karim', 'Hend', 'F', 'Nour', 'Eldin', 'Heba', 'Abusamra', 'Elham', 'M', 'Alhathli', 'Nada', 'Salem', 'Mohammed', 'H', 'Al', 'Qahtani', 'Sudhir', 'Kumar', 'O16', 'The', 'supercomputer', 'facility', 'AZIZ', 'at', 'KAU', 'utility', 'and', 'future', 'prospects', 'Hossam', 'Faheem', 'O17', 'New', 'research', 'into', 'the', 'causes', 'of', 'male', 'infertility', 'Ashok', 'Agarwa', 'O18', 'The', 'Klinefelter', 'syndrome', 'recent', 'progress', 'in', 'pathophysiology', 'and', 'management', 'Eberhard', 'Nieschlag', 'Joachim', 'Wistuba', 'Oliver', 'S', 'Damm', 'Mohd', 'A', 'Beg', 'Taha', 'A', 'Abdel', 'Meguid', 'Hisham', 'A', 'Mosli', 'Osama', 'S', 'Bajouh', 'Adel', 'M', 'Abuzenadah', 'Mohammed', 'H', 'Al', 'Qahtani', 'O19', 'A', 'new', 'look', 'to', 'reproductive', 'medicine', 'in', 'the', 'era', 'of', 'genomics', 'Serdar', 'Coskun', 'P1', 'Wnt', 'signalling', 'receptors', 'expression', 'in', 'Saudi', 'breast', 'cancer', 'patients', 'Muhammad', 'Abu', 'Elmagd', 'Abdelbaset', 'Buhmeida', 'Ashraf', 'Dallol', 'Jaudah', 'Al', 'Maghrabi', 'Sahar', 'Hakamy', 'Wejdan', 'Al', 'Qahtani', 'Asia', 'Al', 'Harbi', 'Shireen', 'Hussain', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P2', 'Analysis', 'of', 'oxidative', 'stress', 'interactome', 'during', 'spermatogenesis', 'a', 'systems', 'biology', 'approach', 'to', 'reproduction', 'Burak', 'Ozkosem', 'Rick', 'DuBois', 'P3', 'Interleukin', '18', 'gene', 'variants', 'are', 'strongly', 'associated', 'with', 'idiopathic', 'recurrent', 'pregnancy', 'loss', 'Safia', 'S', 'Messaoudi', 'Maryam', 'T', 'Dandana', 'Touhami', 'Mahjoub', 'Wassim', 'Y', 'Almawi', 'P4', 'Effect', 'of', 'environmental', 'factors', 'on', 'gene', 'gene', 'and', 'gene', 'environment', 'reactions', 'model', 'and', 'theoretical', 'study', 'applied', 'to', 'environmental', 'interventions', 'using', 'genotype', 'S', 'Abdalla', 'M', 'Nabil', 'Al', 'Aama', 'P5', 'Genomics', 'and', 'transcriptomic', 'analysis', 'of', 'imatinib', 'resistance', 'in', 'gastrointestinal', 'stromal', 'tumor', 'Asmaa', 'Elzawahry', 'Tsuyoshi', 'Takahashi', 'Sachiyo', 'Mimaki', 'Eisaku', 'Furukawa', 'Rie', 'Nakatsuka', 'Isao', 'Kurosaka', 'Takahiko', 'Nishigaki', 'Hiromi', 'Nakamura', 'Satoshi', 'Serada', 'Tetsuji', 'Naka', 'Seiichi', 'Hirota', 'Tatsuhiro', 'Shibata', 'Katsuya', 'Tsuchihara', 'Toshirou', 'Nishida', 'Mamoru', 'Kato', 'P6', 'In', 'Silico', 'analysis', 'of', 'putative', 'HCV', 'epitopes', 'against', 'Pakistani', 'human', 'leukocyte', 'antigen', 'background', 'an', 'approach', 'towards', 'development', 'of', 'future', 'vaccines', 'for', 'Pakistani', 'population', 'Sajid', 'Mehmood', 'Naeem', 'Mahmood', 'Ashraf', 'Awais', 'Asif', 'Muhammad', 'Bilal', 'Malik', 'Siddique', 'Mehmood', 'Aadil', 'Hussain', 'P7', 'Inhibition', 'of', 'AChE', 'and', 'BuChE', 'with', 'the', 'natural', 'compounds', 'of', 'Bacopa', 'monerri', 'for', 'the', 'treatment', 'of', 'Alzheimer', 's', 'disease', 'a', 'bioinformatics', 'approach', 'Qazi', 'Mohammad', 'Sajid', 'Jamal', 'Mughees', 'Uddin', 'Siddiqui', 'Mohammad', 'A', 'Alzohairy', 'Mohammad', 'A', 'Al', 'Karaawi', 'P8', 'Her2', 'expression', 'in', 'urothelial', 'cell', 'carcinoma', 'of', 'the', 'bladder', 'in', 'Saudi', 'Arabia', 'Taoufik', 'Nedjadi', 'Jaudah', 'Al', 'Maghrabi', 'Mourad', 'Assidi', 'Heba', 'Al', 'Khattabi', 'Adel', 'Al', 'Ammari', 'Ahmed', 'Al', 'Sayyad', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P9', 'Association', 'of', 'angiotensinogen', 'single', 'nucleotide', 'polymorphisms', 'with', 'Preeclampsia', 'in', 'patients', 'from', 'North', 'Africa', 'Hédia', 'Zitouni', 'Nozha', 'Raguema', 'Marwa', 'Ben', 'Ali', 'Wided', 'Malah', 'Raja', 'Lfalah', 'Wassim', 'Almawi', 'Touhami', 'Mahjoub', 'P10', 'Systems', 'biology', 'analysis', 'reveals', 'relations', 'between', 'normal', 'skin', 'benign', 'nevi', 'and', 'malignant', 'melanoma', 'Mohammed', 'Elanbari', 'Andrey', 'Ptitsyn', 'P11', 'The', 'apoptotic', 'effect', 'of', 'thymoquinone', 'in', 'Jurkat', 'cells', 'Sana', 'Mahjoub', 'Rabeb', 'El', 'Ghali', 'Bechir', 'Achour', 'Nidhal', 'Ben', 'Amor', 'Mourad', 'Assidi', 'Brahim', 'N', 'siri', 'Hamid', 'Morjani', 'P12', 'Sonic', 'hedgehog', 'contributes', 'in', 'bladder', 'cancer', 'invasion', 'in', 'Saudi', 'Arabia', 'Taoufik', 'Nedjadi', 'Adel', 'Al', 'Ammari', 'Ahmed', 'Al', 'Sayyad', 'Nada', 'Salem', 'Esam', 'Azhar', 'Jaudah', 'Al', 'Maghrabi', 'P13', 'Association', 'of', 'Interleukin', '18', 'gene', 'promoter', 'polymorphisms', '607A', 'C', 'and', '137', 'G', 'C', 'with', 'colorectal', 'cancer', 'onset', 'in', 'a', 'sample', 'of', 'Tunisian', 'population', 'Vera', 'Chayeb', 'Maryam', 'Dendena', 'Hedia', 'Zitouni', 'Khedija', 'Zouari', 'Limayem', 'Touhami', 'Mahjoub', 'P14', 'Pathological', 'expression', 'of', 'interleukin', '6', '11', 'leukemia', 'inhibitory', 'factor', 'and', 'their', 'receptors', 'in', 'tubal', 'gestation', 'with', 'and', 'without', 'tubal', 'cytomegalovirus', 'infection', 'Bassem', 'Refaat', 'Ahmed', 'M', 'Ashshi', 'Sarah', 'A', 'Batwa', 'P15', 'Phenotypic', 'and', 'genetic', 'profiling', 'of', 'avian', 'pathogenic', 'and', 'human', 'diarrhegenic', 'Escherichia', 'coli', 'in', 'Egypt', 'Hazem', 'Ramadan', 'Amal', 'Awad', 'Ahmed', 'Ateya', 'P16', 'Cancer', 'targeting', 'dual', 'gene', 'virotherapy', 'as', 'a', 'promising', 'therapeutic', 'strategy', 'for', 'treatment', 'of', 'hepatocellular', 'carcinoma', 'Adel', 'Galal', 'Ahmed', 'El', 'Shemi', 'Ahmad', 'Ashshi', 'Mohammed', 'Basalamah', 'Youjin', 'Na', 'Chae', 'Ok', 'YUN', 'P17', 'Cancer', 'dual', 'gene', 'therapy', 'with', 'oncolytic', 'adenoviruses', 'expressing', 'TRAIL', 'and', 'IL', '12', 'transgenes', 'markedly', 'eradicated', 'human', 'hepatocellular', 'carcinoma', 'both', 'in', 'vitro', 'and', 'in', 'vivo', 'Adel', 'Galal', 'Ahmed', 'El', 'Shemi', 'Ahmad', 'Ashshi', 'Mohammed', 'Basalamah', 'Youjin', 'Na', 'Chae', 'Ok', 'Yun', 'P18', 'Therapy', 'with', 'paricalcitol', 'attenuates', 'tumor', 'growth', 'and', 'augments', 'tumoricidal', 'and', 'anti', 'oncogenic', 'effects', 'of', '5', 'fluorouracil', 'on', 'animal', 'model', 'of', 'colon', 'cancer', 'Adel', 'Galal', 'El', 'Shemi', 'Bassem', 'Refaat', 'Osama', 'Kensara', 'Amr', 'Abdelfattah', 'P19', 'The', 'effects', 'of', 'Rubus', 'idaeus', 'extract', 'on', 'normal', 'human', 'lymphocytes', 'and', 'cancer', 'cell', 'line', 'Batol', 'Imran', 'Dheeb', 'Mohammed', 'M', 'F', 'Al', 'Halbosiy', 'Rghad', 'Kadhim', 'Al', 'lihabi', 'Basim', 'Mohammed', 'Khashman', 'P20', 'Etanercept', 'a', 'TNF', 'alpha', 'inhibitor', 'alleviates', 'mechanical', 'hypersensitivity', 'and', 'spontaneous', 'pain', 'in', 'a', 'rat', 'model', 'of', 'chemotherapy', 'induced', 'neuropathic', 'pain', 'Djouhri', 'Laiche', 'Chaudhary', 'Adeel', 'Nedjadi', 'Taoufik', 'P21', 'Sleeping', 'beauty', 'mutagenesis', 'system', 'identified', 'genes', 'and', 'neuronal', 'transcription', 'factor', 'network', 'involved', 'in', 'pediatric', 'solid', 'tumour', 'medulloblastoma', 'Hani', 'Al', 'Afghani', 'Maria', 'Łastowska', 'Haya', 'H', 'Al', 'Balool', 'Harsh', 'Sheth', 'Emma', 'Mercer', 'Jonathan', 'M', 'Coxhead', 'Chris', 'PF', 'Redfern', 'Heiko', 'Peters', 'Alastair', 'D', 'Burt', 'Mauro', 'Santibanez', 'Koref', 'Chris', 'M', 'Bacon', 'Louis', 'Chesler', 'Alistair', 'G', 'Rust', 'David', 'J', 'Adams', 'Daniel', 'Williamson', 'Steven', 'C', 'Clifford', 'Michael', 'S', 'Jackson', 'P22', 'Involvement', 'of', 'interleukin', '1', 'in', 'vitiligo', 'pathogenesis', 'Mala', 'Singh', 'Mohmmad', 'Shoab', 'Mansuri', 'Shahnawaz', 'D', 'Jadeja', 'Hima', 'Patel', 'Yogesh', 'S', 'Marfatia', 'Rasheedunnisa', 'Begum', 'P23', 'Cytogenetics', 'abnormalities', 'in', '12', '884', 'referred', 'population', 'for', 'chromosomal', 'analysis', 'and', 'the', 'role', 'of', 'FISH', 'in', 'refining', 'the', 'diagnosis', 'cytogenetic', 'experience', '2004', '2013', 'Amal', 'M', 'Mohamed', 'Alaa', 'K', 'Kamel', 'Nivin', 'A', 'Helmy', 'Sayda', 'A', 'Hammad', 'Hesham', 'F', 'Kayed', 'Marwa', 'I', 'Shehab', 'Assad', 'El', 'Gerzawy', 'Maha', 'M', 'Ead', 'Ola', 'M', 'Ead', 'Mona', 'Mekkawy', 'Innas', 'Mazen', 'Mona', 'El', 'Ruby', 'P24', 'Analysis', 'of', 'binding', 'properties', 'of', 'angiotensin', 'converting', 'enzyme', '2', 'through', 'in', 'silico', 'method', 'S', 'M', 'A', 'Shahid', 'Qazi', 'Mohammad', 'Sajid', 'Jamal', 'J', 'M', 'Arif', 'Mohtashim', 'Lohani', 'P25', 'Relationship', 'of', 'genetics', 'markers', 'cis', 'and', 'trans', 'to', 'the', 'β', 'S', 'globin', 'gene', 'with', 'fetal', 'hemoglobin', 'expression', 'in', 'Tunisian', 'sickle', 'cell', 'patients', 'Moumni', 'Imen', 'Chaouch', 'Leila', 'Ouragini', 'Houyem', 'Douzi', 'Kais', 'Chaouachi', 'Dorra', 'Mellouli', 'Fethi', 'Bejaoui', 'Mohamed', 'Abbes', 'Salem', 'P26', 'Analysis', 'of', 'estrogen', 'receptor', 'alpha', 'gene', 'polymorphisms', 'in', 'breast', 'cancer', 'link', 'to', 'genetic', 'predisposition', 'in', 'Sudanese', 'women', 'Areeg', 'Faggad', 'Amanuel', 'T', 'Gebreslasie', 'Hani', 'Y', 'Zaki', 'Badreldin', 'E', 'Abdalla', 'P27', 'KCNQI', 'gene', 'polymorphism', 'and', 'its', 'association', 'with', 'CVD', 'and', 'T2DM', 'in', 'the', 'Saudi', 'population', 'Maha', 'S', 'AlShammari', 'Rhaya', 'Al', 'Ali', 'Nader', 'Al', 'Balawi', 'Mansour', 'Al', 'Enazi', 'Ali', 'Al', 'Muraikhi', 'Fadi', 'Busaleh', 'Ali', 'Al', 'Sahwan', 'Francis', 'Borgio', 'Abdulazeez', 'Sayyed', 'Amein', 'Al', 'Ali', 'Sadananda', 'Acharya', 'P28', 'Clinical', 'neuroimaging', 'and', 'cytogenetic', 'study', 'of', 'a', 'patient', 'with', 'microcephaly', 'capillary', 'malformation', 'syndrome', 'Maha', 'S', 'Zaki', 'Hala', 'T', 'El', 'Bassyouni', 'Marwa', 'I', 'Shehab', 'P29', 'Altered', 'expression', 'of', 'CD200R1', 'on', 'dendritic', 'cells', 'of', 'patients', 'with', 'inflammatory', 'bowel', 'diseases', 'in', 'silico', 'investigations', 'and', 'clinical', 'evaluations', 'Mohammed', 'F', 'Elshal', 'Kaleemuddin', 'M', 'Alia', 'M', 'Aldahlawi', 'Omar', 'Saadah', 'J', 'Philip', 'McCoy', 'P30', 'Development', 'of', 'real', 'time', 'PCR', 'diagnostic', 'protocol', 'specific', 'for', 'the', 'Saudi', 'Arabian', 'H1N1', 'viral', 'strains', 'Adel', 'E', 'El', 'Tarras', 'Nabil', 'S', 'Awad', 'Abdulla', 'A', 'Alharthi', 'Mohamed', 'M', 'M', 'Ibrahim', 'P31', 'Identification', 'of', 'novel', 'genetic', 'variations', 'affecting', 'Osteoarthritis', 'patients', 'Haneen', 'S', 'Alsehli', 'Ashraf', 'Dallol', 'Abdullah', 'M', 'Gari', 'Mohammed', 'M', 'Abbas', 'Roaa', 'A', 'Kadam', 'Mazen', 'M', 'Gari', 'Mohmmed', 'H', 'Alkaff', 'Adel', 'M', 'Abuzenadah', 'Mamdooh', 'A', 'Gari', 'P32', 'An', 'integrated', 'database', 'of', 'GWAS', 'SNVs', 'and', 'their', 'evolutionary', 'properties', 'Heba', 'Abusamra', 'Sajjad', 'Karim', 'Hend', 'F', 'Nour', 'eldin', 'Elham', 'M', 'Alhathli', 'Nada', 'Salem', 'Sudhir', 'Kumar', 'Mohammed', 'H', 'Al', 'Qahtani', 'P33', 'Familial', 'hypercholesterolemia', 'in', 'Saudi', 'Arabia', 'prime', 'time', 'for', 'a', 'national', 'registry', 'and', 'genetic', 'analysis', 'Fatima', 'A', 'Moradi', 'Omran', 'M', 'Rashidi', 'Zuhier', 'A', 'Awan', 'P34', 'Comparative', 'genomics', 'and', 'network', 'based', 'analyses', 'of', 'early', 'hepatocellular', 'carcinoma', 'Ibrahim', 'Hamza', 'Kaya', 'Olfat', 'Al', 'Harazi', 'Dilek', 'Colak', 'P35', 'A', 'TALEN', 'based', 'oncolytic', 'viral', 'vector', 'approach', 'to', 'knock', 'out', 'ABCB1', 'gene', 'mediated', 'chemoresistance', 'in', 'cancer', 'stem', 'cells', 'Nabila', 'A', 'Alkousi', 'Takis', 'Athanasopoulos', 'P36', 'Cartilage', 'differentiation', 'and', 'gene', 'expression', 'of', 'synovial', 'fluid', 'mesenchymal', 'stem', 'cells', 'derived', 'from', 'osteoarthritis', 'patients', 'Afnan', 'O', 'Bahmaid', 'Etimad', 'A', 'Alhwait', 'Mamdooh', 'A', 'Gari', 'Haneen', 'S', 'Alsehli', 'Mohammed', 'M', 'Abbas', 'Mohammed', 'H', 'Alkaf', 'Roaa', 'Kadam', 'Ashraf', 'Dallol', 'Gauthaman', 'Kalamegam', 'P37', 'E', 'GRASP', 'Adding', 'an', 'evolutionary', 'component', 'to', 'the', 'genome', 'wide', 'repository', 'of', 'associations', 'GRASP', 'resource', 'Hend', 'F', 'Nour', 'Eldin', 'Sajjad', 'Karim', 'Heba', 'Abusamra', 'Elham', 'Alhathli', 'Nada', 'Salem', 'Mohammed', 'H', 'Al', 'Qahtani', 'Sudhir', 'Kumar', 'P38', 'Screening', 'of', 'AGL', 'gene', 'mutation', 'in', 'Saudi', 'family', 'with', 'glycogen', 'storage', 'disease', 'Type', 'III', 'Salma', 'N', 'Alsayed', 'Fawziah', 'H', 'Aljohani', 'Samaher', 'M', 'Habeeb', 'Rawan', 'A', 'Almashali', 'Sulman', 'Basit', 'Samia', 'M', 'Ahmed', 'P39', 'High', 'throughput', 'proteomic', 'data', 'suggest', 'modulation', 'of', 'cAMP', 'dependent', 'protein', 'kinase', 'A', 'and', 'mitochondrial', 'function', 'in', 'infertile', 'patients', 'with', 'varicocele', 'Rakesh', 'Sharma', 'Ashok', 'Agarwal', 'Damayanthi', 'Durairajanayagam', 'Luna', 'Samanta', 'Muhammad', 'Abu', 'Elmagd', 'Adel', 'M', 'Abuzenadah', 'Edmund', 'S', 'Sabanegh', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P40', 'Significant', 'protein', 'profile', 'alterations', 'in', 'men', 'with', 'primary', 'and', 'secondary', 'infertility', 'Ashok', 'Agarwal', 'Rakesh', 'Sharma', 'Luna', 'Samanta', 'Damayanthi', 'Durairajanayagam', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'M', 'Abuzenadah', 'Edmund', 'S', 'Sabanegh', 'P41', 'Spermatozoa', 'maturation', 'in', 'infertile', 'patients', 'involves', 'compromised', 'expression', 'of', 'heat', 'shock', 'proteins', 'Luna', 'Samanta', 'Ashok', 'Agarwal', 'Rakesh', 'Sharma', 'Zhihong', 'Cui', 'Mourad', 'Assidi', 'Adel', 'M', 'Abuzenadah', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'P42', 'Array', 'comparative', 'genomic', 'hybridization', 'approach', 'to', 'search', 'genomic', 'answers', 'for', 'spontaneous', 'recurrent', 'abortion', 'in', 'Saudi', 'Arabia', 'Alaa', 'A', 'Alboogmi', 'Nuha', 'A', 'Alansari', 'Maha', 'M', 'Al', 'Quaiti', 'Fai', 'T', 'Ashgan', 'Afnan', 'Bandah', 'Hasan', 'S', 'Jamal', 'Abdullraheem', 'Rozi', 'Zeenat', 'Mirza', 'Adel', 'M', 'Abuzenadah', 'Sajjad', 'Karim', 'Mohammed', 'H', 'Al', 'Qahtani', 'P43', 'Global', 'gene', 'expression', 'profiling', 'of', 'Saudi', 'kidney', 'cancer', 'patients', 'Sajjad', 'Karim', 'Hans', 'Juergen', 'Schulten', 'Ahmad', 'J', 'Al', 'Sayyad', 'Hasan', 'MA', 'Farsi', 'Jaudah', 'A', 'Al', 'Maghrabi', 'Zeenat', 'Mirza', 'Reem', 'Alotibi', 'Alaa', 'Al', 'Ahmadi', 'Nuha', 'A', 'Alansari', 'Alaa', 'A', 'Albogmi', 'Maha', 'M', 'Al', 'Quaiti', 'Fai', 'T', 'Ashgan', 'Afnan', 'Bandah', 'Mohammed', 'H', 'Al', 'Qahtani', 'P44', 'Downregulated', 'StAR', 'gene', 'and', 'male', 'reproductive', 'dysfunction', 'caused', 'by', 'nifedipine', 'and', 'ethosuximide', 'Rasha', 'A', 'Ebiya', 'Samia', 'M', 'Darwish', 'Metwally', 'M', 'Montaser', 'P45', 'Clustering', 'based', 'gene', 'expression', 'feature', 'selection', 'method', 'A', 'computational', 'approach', 'to', 'enrich', 'the', 'classifier', 'efficiency', 'of', 'differentially', 'expressed', 'genes', 'Heba', 'Abusamra', 'Vladimir', 'B', 'Bajic', 'P46', 'Prognostic', 'significance', 'of', 'Osteopontin', 'expression', 'profile', 'in', 'colorectal', 'carcinoma', 'Jaudah', 'Al', 'Maghrabi', 'Wafaey', 'Gomaa', 'Mehenaz', 'Hanbazazh', 'Mahmoud', 'Al', 'Ahwal', 'Asia', 'Al', 'Harbi', 'Wejdan', 'Al', 'Qahtani', 'Saher', 'Hakamy', 'Ghali', 'Baba', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P47', 'High', 'Glypican', '3', 'expression', 'pattern', 'predicts', 'longer', 'disease', 'specific', 'survival', 'in', 'colorectal', 'carcinoma', 'Jaudah', 'Al', 'Maghrabi', 'Abdullah', 'Al', 'Harbi', 'Mahmoud', 'Al', 'Ahwal', 'Asia', 'Al', 'Harbi', 'Wejdan', 'Al', 'Qahtani', 'Sahar', 'Hakamy', 'Ghalia', 'Baba', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P48', 'An', 'evolutionary', 're', 'assessment', 'of', 'GWAS', 'single', 'nucleotide', 'variants', 'implicated', 'in', 'the', 'Cholesterol', 'traits', 'Elham', 'M', 'Alhathli', 'Sajjad', 'Karim', 'Nada', 'Salem', 'Hend', 'Nour', 'Eldin', 'Heba', 'Abusamra', 'Sudhir', 'Kumar', 'Mohammed', 'H', 'Al', 'Qahtani', 'P49', 'Derivation', 'and', 'characterization', 'of', 'human', 'Wharton', 's', 'jelly', 'stem', 'cells', 'hWJSCs', 'in', 'vitro', 'for', 'future', 'therapeutic', 'applications', 'Aisha', 'A', 'Alyamani', 'Gauthaman', 'Kalamegam', 'Etimad', 'A', 'Alhwait', 'Mamdooh', 'A', 'Gari', 'Mohammed', 'M', 'Abbas', 'Mohammed', 'H', 'Alkaf', 'Haneen', 'S', 'Alsehli', 'Roaa', 'A', 'Kadam', 'Mohammed', 'Al', 'Qahtani', 'P50', 'Attitudes', 'of', 'healthcare', 'students', 'toward', 'biomedical', 'research', 'in', 'the', 'post', 'genomic', 'era', 'Rawan', 'Gadi', 'Abdelbaset', 'Buhmeida', 'Mourad', 'Assidi', 'Adeel', 'Chaudhary', 'Leena', 'Merdad', 'P51', 'Evaluation', 'of', 'the', 'immunomodulatory', 'effects', 'of', 'thymoquinone', 'on', 'human', 'bone', 'marrow', 'mesenchymal', 'stem', 'cells', 'BM', 'MSCs', 'from', 'osteoarthritic', 'patients', 'Saadiah', 'M', 'Alfakeeh', 'Etimad', 'A', 'Alhwait', 'Mamdooh', 'A', 'Gari', 'Mohammed', 'M', 'Abbas', 'Mohammed', 'H', 'Alkaf', 'Haneen', 'S', 'Alsehli', 'Roaa', 'Kadam', 'Gauthaman', 'Kalamegam', 'P52', 'Implication', 'of', 'IL', '10', 'and', 'IL', '28', 'polymorphism', 'with', 'successful', 'anti', 'HCV', 'therapy', 'and', 'viral', 'clearance', 'Rubi', 'Ghazala', 'Shilu', 'Mathew', 'M', 'Haroon', 'Hamed', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'Ishtiaq', 'Qadri', 'P53', 'Selection', 'of', 'flavonoids', 'against', 'obesity', 'protein', 'FTO', 'using', 'in', 'silico', 'and', 'in', 'vitro', 'approaches', 'Shilu', 'Mathew', 'Lobna', 'Mira', 'Manal', 'Shaabad', 'Shireen', 'Hussain', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'P54', 'Computational', 'selection', 'and', 'in', 'vitro', 'validation', 'of', 'flavonoids', 'as', 'new', 'antidepressant', 'agents', 'Shilu', 'Mathew', 'Manal', 'Shaabad', 'Lobna', 'Mira', 'Shireen', 'Hussain', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Mohammed', 'Al', 'Qahtani', 'P55', 'In', 'Silico', 'prediction', 'and', 'prioritization', 'of', 'aging', 'candidate', 'genes', 'associated', 'with', 'progressive', 'telomere', 'shortening', 'Ahmed', 'Rebai', 'Mourad', 'Assidi', 'Abdelbaset', 'Buhmeida', 'Muhammad', 'Abu', 'Elmagd', 'Ashraf', 'Dallol', 'Jerry', 'W', 'Shay', 'P56', 'Identification', 'of', 'new', 'cancer', 'testis', 'antigen', 'genes', 'in', 'diverse', 'types', 'of', 'malignant', 'human', 'tumour', 'cells', 'Mikhlid', 'H', 'Almutairi', 'P57', 'More', 'comprehensive', 'forensic', 'genetic', 'marker', 'analyses', 'for', 'accurate', 'human', 'remains', 'identification', 'using', 'massively', 'parallel', 'sequencing', 'MPS', 'Angie', 'Ambers', 'Jennifer', 'Churchill', 'Jonathan', 'King', 'Monika', 'Stoljarova', 'Harrell', 'Gill', 'King', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Abdelbaset', 'Buhmeida', 'Muhammad', 'Al', 'Qatani', 'Bruce', 'Budowle', 'P58', 'Flow', 'cytometry', 'approach', 'towards', 'treatment', 'men', 'infertility', 'in', 'Saudi', 'Arabia', 'Muhammad', 'Abu', 'Elmagd', 'Farid', 'Ahmed', 'Ashraf', 'Dallol', 'Mourad', 'Assidi', 'Taha', 'Abo', 'Almagd', 'Sahar', 'Hakamy', 'Ashok', 'Agarwal', 'Muhammad', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P59', 'Tissue', 'microarray', 'based', 'validation', 'of', 'CyclinD1', 'expression', 'in', 'renal', 'cell', 'carcinoma', 'of', 'Saudi', 'kidney', 'patients', 'Sajjad', 'Karim', 'Hans', 'Juergen', 'Schulten', 'Ahmad', 'J', 'Al', 'Sayyad', 'Hasan', 'MA', 'Farsi', 'Jaudah', 'A', 'Al', 'Maghrabi', 'Abdelbaset', 'Buhmaida', 'Zeenat', 'Mirza', 'Reem', 'Alotibi', 'Alaa', 'Al', 'Ahmadi', 'Nuha', 'A', 'Alansari', 'Alaa', 'A', 'Albogmi', 'Maha', 'M', 'Al', 'Quaiti', 'Fai', 'T', 'Ashgan', 'Afnan', 'Bandah', 'Mohammed', 'H', 'Al', 'Qahtani', 'P60', 'Assessment', 'of', 'gold', 'nanoparticles', 'in', 'molecular', 'diagnostics', 'and', 'DNA', 'damage', 'studies', 'Rukhsana', 'Satar', 'Mahmood', 'Rasool', 'Waseem', 'Ahmad', 'Nazia', 'Nazam', 'Mohamad', 'I', 'Lone', 'Muhammad', 'I', 'Naseer', 'Mohammad', 'S', 'Jamal', 'Syed', 'K', 'Zaidi', 'Peter', 'N', 'Pushparaj', 'Mohammad', 'A', 'Jafri', 'Shakeel', 'A', 'Ansari', 'Mohammed', 'H', 'Alqahtani', 'P61', 'Surfing', 'the', 'biospecimen', 'management', 'and', 'processing', 'workflow', 'at', 'CEGMR', 'Biobank', 'Hanan', 'Bashier', 'Abrar', 'Al', 'Qahtani', 'Shilu', 'Mathew', 'Amal', 'M', 'Nour', 'Heba', 'Alkhatabi', 'Adel', 'M', 'Abu', 'Zenadah', 'Abdelbaset', 'Buhmeida', 'Mourad', 'Assidi', 'Muhammed', 'Al', 'Qahtani', 'P62', 'Autism', 'Spectrum', 'Disorder', 'knowledge', 'attitude', 'and', 'awareness', 'in', 'Jeddah', 'Kingdom', 'of', 'Saudi', 'Arabia', 'Muhammad', 'Faheem', 'Shilu', 'Mathew', 'Shiny', 'Mathew', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'H', 'Al', 'Qahtani', 'P63', 'Simultaneous', 'genetic', 'screening', 'of', 'the', 'coagulation', 'pathway', 'genes', 'using', 'the', 'Thromboscan', 'targeted', 'sequencing', 'panel', 'Hani', 'A', 'Alhadrami', 'Ashraf', 'Dallol', 'Adel', 'Abuzenadah', 'P64', 'Genome', 'wide', 'array', 'comparative', 'genomic', 'hybridization', 'analysis', 'in', 'patients', 'with', 'syndromic', 'congenital', 'heart', 'defects', 'Ibtessam', 'R', 'Hussein', 'Adeel', 'G', 'Chaudhary', 'Rima', 'S', 'Bader', 'Randa', 'Bassiouni', 'Maha', 'Alquaiti', 'Fai', 'Ashgan', 'Hans', 'Schulten', 'Mohamed', 'Nabil', 'Alama', 'Mohammad', 'H', 'Al', 'Qahtani', 'P65', 'Toxocogenetic', 'evaluation', 'of', '1', '2', 'Dichloroethane', 'in', 'bone', 'marrow', 'blood', 'and', 'cells', 'of', 'immune', 'system', 'using', 'conventional', 'molecular', 'and', 'flowcytometric', 'approaches', 'Mohammad', 'I', 'Lone', 'Nazia', 'Nizam', 'Waseem', 'Ahmad', 'Mohammad', 'A', 'Jafri', 'Mahmood', 'Rasool', 'Shakeel', 'A', 'Ansari', 'Muhammed', 'H', 'Al', 'Qahtani', 'P66', 'Molecular', 'cytogenetic', 'diagnosis', 'of', 'sexual', 'development', 'disorders', 'in', 'newborn', 'A', 'case', 'of', 'ambiguous', 'genitalia', 'Eradah', 'Alshihri', 'Muhammad', 'Abu', 'Elmagd', 'Lina', 'Alharbi', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P67', 'Identification', 'of', 'disease', 'specific', 'gene', 'expression', 'clusters', 'and', 'pathways', 'in', 'hepatocellular', 'carcinoma', 'using', 'In', 'Silico', 'methodologies', 'Shilu', 'Mathew', 'Peter', 'Pushparaj', 'Natesan', 'Muhammed', 'Al', 'Qahtani', 'P68', 'Human', 'Wharton', 's', 'Jelly', 'stem', 'cell', 'conditioned', 'medium', 'inhibits', 'primary', 'ovarian', 'cancer', 'cells', 'in', 'vitro', 'Identification', 'of', 'probable', 'targets', 'and', 'mechanisms', 'using', 'systems', 'biology', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Fazal', 'Khan', 'Roaa', 'Kadam', 'Farid', 'Ahmed', 'Mourad', 'Assidi', 'Khalid', 'Hussain', 'Wali', 'Sait', 'Nisreen', 'Anfinan', 'Mohammed', 'Al', 'Qahtani', 'P69', 'Mutation', 'spectrum', 'of', 'ASPM', 'Abnormal', 'Spindle', 'like', 'Microcephaly', 'associated', 'gene', 'in', 'Saudi', 'Arabian', 'population', 'Muhammad', 'I', 'Naseer', 'Adeel', 'G', 'Chaudhary', 'Mohammad', 'S', 'Jamal', 'Shilu', 'Mathew', 'Lobna', 'S', 'Mira', 'Peter', 'N', 'Pushparaj', 'Shakeel', 'A', 'Ansari', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P70', 'Identification', 'and', 'characterization', 'of', 'novel', 'genes', 'and', 'mutations', 'of', 'primary', 'microcephaly', 'in', 'Saudi', 'Arabian', 'population', 'Muhammad', 'I', 'Naseer', 'Adeel', 'G', 'Chaudhary', 'Shilu', 'Mathew', 'Lobna', 'S', 'Mira', 'Mohammad', 'S', 'Jamal', 'Sameera', 'Sogaty', 'Randa', 'I', 'Bassiouni', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P71', 'Molecular', 'genetic', 'analysis', 'of', 'hereditary', 'nonpolyposis', 'colorectal', 'cancer', 'Lynch', 'Syndrome', 'in', 'Saudi', 'Arabian', 'population', 'Mahmood', 'Rasool', 'Shakeel', 'A', 'Ansari', 'Mohammad', 'S', 'Jamal', 'Peter', 'N', 'Pushparaj', 'Abdulrahman', 'MS', 'Sibiani', 'Waseem', 'Ahmad', 'Abdelbaset', 'Buhmeida', 'Mohammad', 'A', 'Jafri', 'Mohiuddin', 'K', 'Warsi', 'Muhammad', 'I', 'Naseer', 'Mohammed', 'H', 'Al', 'Qahtani', 'P72', 'Function', 'predication', 'of', 'hypothetical', 'proteins', 'from', 'genome', 'database', 'of', 'chlamydia', 'trachomatis', 'Rubi', 'Kundan', 'Kumar', 'Ahmad', 'AT', 'Naqvi', 'Faizan', 'Ahmad', 'Md', 'I', 'Hassan', 'Mohammad', 'S', 'Jamal', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P73', 'Transcription', 'factors', 'as', 'novel', 'molecular', 'targets', 'for', 'skin', 'cancer', 'Ashraf', 'Ali', 'Jummanah', 'Jarullah', 'Mahmood', 'Rasool', 'Abdelbasit', 'Buhmeida', 'Shahida', 'Khan', 'Ghufrana', 'Abdussami', 'Maryam', 'Mahfooz', 'Mohammad', 'A', 'Kamal', 'Ghazi', 'A', 'Damanhouri', 'Mohammad', 'S', 'Jamal', 'P74', 'An', 'In', 'Silico', 'analysis', 'of', 'Plumbagin', 'binding', 'to', 'apoptosis', 'executioner', 'Caspase', '3', 'and', 'Caspase', '7', 'Bushra', 'Jarullah', 'Jummanah', 'Jarullah', 'Mohammad', 'SS', 'Jarullah', 'Ashraf', 'Ali', 'Mahmood', 'Rasool', 'Mohammad', 'S', 'Jamal', 'P75', 'Single', 'cell', 'genomics', 'applications', 'for', 'preimplantation', 'genetic', 'screening', 'optimization', 'Comparative', 'analysis', 'of', 'whole', 'genome', 'amplification', 'technologies', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Osama', 'Bajouh', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P76', 'ZFP36', 'regulates', 'miRs', '34a', 'in', 'anti', 'IgM', 'triggered', 'immature', 'B', 'cells', 'Mohammad', 'S', 'Jamal', 'Jummanah', 'Jarullah', 'Abdulah', 'EA', 'Mathkoor', 'Hashim', 'MA', 'Alsalmi', 'Anas', 'MM', 'Oun', 'Ghazi', 'A', 'Damanhauri', 'Mahmood', 'Rasool', 'Mohammed', 'H', 'AlQahtani', 'P77', 'Identification', 'of', 'a', 'novel', 'mutation', 'in', 'the', 'STAMBP', 'gene', 'in', 'a', 'family', 'with', 'microcephaly', 'capillary', 'malformation', 'syndrome', 'Muhammad', 'I', 'Naseer', 'Mahmood', 'Rasool', 'Sameera', 'Sogaty', 'Adeel', 'G', 'Chudhary', 'Yousif', 'A', 'Abutalib', 'Daniele', 'Merico', 'Susan', 'Walker', 'Christian', 'R', 'Marshall', 'Mehdi', 'Zarrei', 'Stephen', 'W', 'Scherer', 'Mohammad', 'H', 'Al', 'Qahtani', 'P78', 'Copy', 'number', 'variations', 'in', 'Saudi', 'patients', 'with', 'intellectual', 'disability', 'and', 'epilepsy', 'Muhammad', 'I', 'Naseer', 'Muhammad', 'Faheem', 'Adeel', 'G', 'Chaudhary', 'Mahmood', 'Rasool', 'Gauthaman', 'Kalamegam', 'Fai', 'Talal', 'Ashgan', 'Mourad', 'Assidi', 'Farid', 'Ahmed', 'Syed', 'Kashif', 'Zaidi', 'Mohammed', 'M', 'Jan', 'Mohammad', 'H', 'Al', 'Qahtani', 'P79', 'Prognostic', 'significance', 'of', 'CD44', 'expression', 'profile', 'in', 'colorectal', 'carcinoma', 'Maryam', 'Al', 'Zahrani', 'Sahira', 'Lary', 'Sahar', 'Hakamy', 'Ashraf', 'Dallol', 'Mahmoud', 'Al', 'Ahwal', 'Jaudah', 'Al', 'Maghrabi', 'Emmanuel', 'Dermitzakis', 'Adel', 'Abuzenadah', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P80', 'Association', 'of', 'the', 'endothelial', 'nitric', 'oxide', 'synthase', 'eNOS', 'gene', 'G894T', 'polymorphism', 'with', 'hypertension', 'risk', 'and', 'complications', 'Abeer', 'A', 'Al', 'refai', 'Mona', 'Saleh', 'Rehab', 'I', 'Yassien', 'Mahmmoud', 'Kamel', 'Rabab', 'M', 'Habeb', 'P81', 'SNPs', 'array', 'to', 'screen', 'genetic', 'variation', 'among', 'diabetic', 'patients', 'Najlaa', 'Filimban', 'Ashraf', 'Dallol', 'Nadia', 'Ghannam', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Mohammed', 'Abuzenadah', 'P82', 'Detection', 'and', 'genotyping', 'of', 'Helicobacter', 'pylori', 'among', 'gastric', 'cancer', 'patients', 'from', 'Saudi', 'Arabian', 'population', 'Fehmida', 'Bibi', 'Sana', 'Akhtar', 'Esam', 'I', 'Azhar', 'Muhammad', 'Yasir', 'Muhammad', 'I', 'Nasser', 'Asif', 'A', 'Jiman', 'Fatani', 'Ali', 'Sawan', 'P83', 'Antimicrobial', 'drug', 'resistance', 'and', 'molecular', 'detection', 'of', 'susceptibility', 'to', 'Fluoroquinolones', 'among', 'clinical', 'isolates', 'of', 'Salmonella', 'species', 'from', 'Jeddah', 'Saudi', 'Arabia', 'Ruaa', 'A', 'Lahzah', 'Asho', 'Ali', 'P84', 'Identification', 'of', 'the', 'toxic', 'and', 'virulence', 'nature', 'of', 'MAP1138c', 'protein', 'of', 'Mycobacterium', 'avium', 'subsp', 'paratuberculosis', 'Syed', 'A', 'Hassan', 'Seyed', 'E', 'Hasnain', 'Iftikhar', 'A', 'Tayubi', 'Hamza', 'A', 'Abujabal', 'Alaa', 'O', 'Magrabi', 'P85', 'In', 'vitro', 'and', 'in', 'silico', 'evaluation', 'of', 'miR137', 'in', 'human', 'breast', 'cancer', 'Fazal', 'Khan', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Adel', 'Abuzenada', 'Taha', 'Abduallah', 'Kumosani', 'Elie', 'Barbour', 'Mohammed', 'Al', 'Qahtani', 'P86', 'Auruka', 'gene', 'is', 'over', 'expressed', 'in', 'Saudi', 'breast', 'cancer', 'Manal', 'Shabaad', 'Shilu', 'Mathew', 'Ashraf', 'Dallol', 'Adnan', 'Merdad', 'Abdelbaset', 'Buhmeida', 'Mohammed', 'Al', 'Qahtani', 'P87', 'The', 'potential', 'of', 'immunogenomics', 'in', 'personalized', 'healthcare', 'Mourad', 'Assidi', 'Muhammad', 'Abu', 'Elmagd', 'Kalamegam', 'Gauthaman', 'Mamdooh', 'Gari', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'P88', 'In', 'Silico', 'physiochemical', 'and', 'structural', 'characterization', 'of', 'a', 'putative', 'ORF', 'MAP0591', 'and', 'its', 'implication', 'in', 'the', 'pathogenesis', 'of', 'Mycobacterium', 'paratuberculosis', 'in', 'ruminants', 'and', 'humans', 'Syed', 'A', 'Hassan', 'Iftikhar', 'A', 'Tayubi', 'Hani', 'MA', 'Aljahdali', 'P89', 'Effects', 'of', 'heat', 'shock', 'on', 'human', 'bone', 'marrow', 'mesenchymal', 'stem', 'cells', 'BM', 'MSCs', 'Implications', 'in', 'regenerative', 'medicine', 'Reham', 'Al', 'Nono', 'Mamdooh', 'Gari', 'Haneen', 'Alsehli', 'Farid', 'Ahmed', 'Mohammed', 'Abbas', 'Gauthaman', 'Kalamegam', 'Mohammed', 'Al', 'Qahtani', 'P90', 'In', 'Silico', 'analyses', 'of', 'the', 'molecular', 'targets', 'of', 'Resveratrol', 'unravels', 'its', 'importance', 'in', 'mast', 'cell', 'mediated', 'allergic', 'responses', 'Shilu', 'Mathew', 'Fazal', 'Khan', 'Mahmood', 'Rasool', 'Mohammed', 'Sarwar', 'Jamal', 'Muhammad', 'Imran', 'Naseer', 'Zeenat', 'Mirza', 'Sajjad', 'Karim', 'Shakeel', 'Ansari', 'Mourad', 'Assidi', 'Gauthaman', 'Kalamegam', 'Mamdooh', 'Gari', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'P91', 'Effects', 'of', 'environmental', 'particulate', 'matter', 'on', 'bone', 'marrow', 'mesenchymal', 'stem', 'cells', 'Muhammad', 'Abu', 'Elmagd', 'Gauthaman', 'Kalamegam', 'Roaa', 'Kadam', 'Mansour', 'A', 'Alghamdi', 'Magdy', 'Shamy', 'Max', 'Costa', 'Mamdouh', 'I', 'Khoder', 'Mourad', 'Assidi', 'Peter', 'Natesan', 'Pushparaj', 'Mamdooh', 'Gari', 'Mohammed', 'Al', 'Qahtani', 'P92', 'Distinctive', 'charge', 'clusters', 'in', 'human', 'virus', 'proteomes', 'Najla', 'Kharrat', 'Sabrine', 'Belmabrouk', 'Rania', 'Abdelhedi', 'Riadh', 'Benmarzoug', 'Mourad', 'Assidi', 'Mohammed', 'H', 'Al', 'Qahtani', 'Ahmed', 'Rebai', 'P93', 'In', 'vitro', 'experimental', 'model', 'and', 'approach', 'in', 'identification', 'of', 'new', 'biomarkers', 'of', 'inflammatory', 'forms', 'of', 'arthritis', 'Ghazi', 'Dhamanhouri', 'Peter', 'Natesan', 'Pushparaj', 'Abdelwahab', 'Noorwali', 'Mohammad', 'Khalid', 'Alwasiyah', 'Afnan', 'Bahamaid', 'Saadiah', 'Alfakeeh', 'Aisha', 'Alyamani', 'Haneen', 'Alsehli', 'Mohammed', 'Abbas', 'Mamdooh', 'Gari', 'Ali', 'Mobasheri', 'Gauthaman', 'Kalamegam', 'Mohammed', 'Al', 'Qahtani', 'P94', 'Molecular', 'docking', 'of', 'GABA', 'A', 'receptor', 'subunit', 'γ', '2', 'with', 'novel', 'anti', 'epileptic', 'compounds', 'Muhammad', 'Faheem', 'Shilu', 'Mathew', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'H', 'Al', 'Qahtani', 'P95', 'Breast', 'cancer', 'knowledge', 'awareness', 'and', 'practices', 'among', 'Saudi', 'females', 'residing', 'in', 'Jeddah', 'Shilu', 'Mathew', 'Muhammad', 'Faheem', 'Shiny', 'Mathew', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'H', 'Al', 'Qahtani', 'P96', 'Anti', 'inflammatory', 'role', 'of', 'Sesamin', 'by', 'Attenuation', 'of', 'Iba1', 'TNF', 'α', 'ICAM', '1', 'iNOS', 'signaling', 'in', 'Diabetic', 'Retinopathy', 'Mohammad', 'Sarwar', 'Jamal', 'Syed', 'Kashif', 'Zaidi', 'Raziuddin', 'Khan', 'Kanchan', 'Bhatia', 'Mohammed', 'H', 'Al', 'Qahtani', 'Saif', 'Ahmad', 'P97', 'Identification', 'of', 'drug', 'lead', 'molecule', 'against', 'vp35', 'protein', 'of', 'Ebola', 'virus', 'An', 'In', 'Silico', 'approach', 'Iftikhar', 'AslamTayubi', 'Manish', 'Tripathi', 'Syed', 'Asif', 'Hassan', 'Rahul', 'Shrivastava', 'P98', 'An', 'approach', 'to', 'personalized', 'medicine', 'from', 'SNP', 'calling', 'through', 'disease', 'analysis', 'using', 'whole', 'exome', 'sequencing', 'of', 'three', 'sub', 'continental', 'populations', 'Iftikhar', 'A', 'Tayubi', 'Syed', 'Hassan', 'Hamza', 'A', 'S', 'Abujabal', 'P99', 'Low', 'versus', 'high', 'frequency', 'of', 'Glucose', '6', 'Phosphate', 'Dehydrogenase', 'G6PD', 'deficiency', 'in', 'urban', 'against', 'tribal', 'population', 'of', 'Gujarat', 'A', 'signal', 'to', 'natural', 'selection', 'Ishani', 'Shah', 'Bushra', 'Jarullah', 'Mohammad', 'S', 'Jamal', 'Jummanah', 'Jarullah', 'P100', 'Spontaneous', 'preterm', 'birth', 'and', 'single', 'nucleotide', 'gene', 'polymorphisms', 'a', 'recent', 'update', 'Ishfaq', 'A', 'Sheikh', 'Ejaz', 'Ahmad', 'Mohammad', 'S', 'Jamal', 'Mohd', 'Rehan', 'Muhammad', 'Abu', 'Elmagd', 'Iftikhar', 'A', 'Tayubi', 'Samera', 'F', 'AlBasri', 'Osama', 'S', 'Bajouh', 'Rola', 'F', 'Turki', 'Adel', 'M', 'Abuzenadah', 'Ghazi', 'A', 'Damanhouri', 'Mohd', 'A', 'Beg', 'Mohammed', 'Al', 'Qahtani', 'P101', 'Prevalence', 'of', 'congenital', 'heart', 'diseases', 'among', 'Down', 'syndrome', 'cases', 'in', 'Saudi', 'Arabia', 'role', 'of', 'molecular', 'genetics', 'in', 'the', 'pathogenesis', 'Sahar', 'AF', 'Hammoudah', 'Khalid', 'M', 'AlHarbi', 'Lama', 'M', 'El', 'Attar', 'Ahmed', 'MZ', 'Darwish', 'P102', 'Combinatorial', 'efficacy', 'of', 'specific', 'pathway', 'inhibitors', 'in', 'breast', 'cancer', 'cells', 'Sara', 'M', 'Ibrahim', 'Ashraf', 'Dallol', 'Hani', 'Choudhry', 'Adel', 'Abuzenadah', 'Jalaludden', 'Awlia', 'Adeel', 'Chaudhary', 'Farid', 'Ahmed', 'Mohammed', 'Al', 'Qahtani', 'P103', 'MiR', '143', 'and', 'miR', '145', 'cluster', 'as', 'potential', 'replacement', 'medicine', 'for', 'the', 'treatment', 'of', 'cancer', 'Mohammad', 'A', 'Jafri', 'Muhammad', 'Abu', 'Elmagd', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P104', 'Metagenomic', 'profile', 'of', 'gut', 'microbiota', 'during', 'pregnancy', 'in', 'Saudi', 'population', 'Imran', 'khan', 'Muhammad', 'Yasir', 'Esam', 'I', 'Azhar', 'Sameera', 'Al', 'basri', 'Elie', 'Barbour', 'Taha', 'Kumosani', 'P105', 'Exploration', 'of', 'anticancer', 'targets', 'of', 'selected', 'metabolites', 'of', 'Phoenix', 'dactylifera', 'L', 'using', 'systems', 'biological', 'approaches', 'Fazal', 'Khan', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Adel', 'Abuzenada', 'Taha', 'Abduallah', 'Kumosani', 'Elie', 'Barbour', 'P106', 'CD226', 'and', 'CD40', 'gene', 'polymorphism', 'in', 'susceptibility', 'to', 'Juvenile', 'rheumatoid', 'arthritis', 'in', 'Egyptian', 'patients', 'Heba', 'M', 'EL', 'Sayed', 'Eman', 'A', 'Hafez', 'P107', 'Paediatric', 'exome', 'sequencing', 'in', 'autism', 'spectrum', 'disorder', 'ascertained', 'in', 'Saudi', 'families', 'Hans', 'Juergen', 'Schulten', 'Aisha', 'Hassan', 'Elaimi', 'Ibtessam', 'R', 'Hussein', 'Randa', 'Ibrahim', 'Bassiouni', 'Mohammad', 'Khalid', 'Alwasiyah', 'Richard', 'F', 'Wintle', 'Adeel', 'Chaudhary', 'Stephen', 'W', 'Scherer', 'Mohammed', 'Al', 'Qahtani', 'P108', 'Crystal', 'structure', 'of', 'the', 'complex', 'formed', 'between', 'Phospholipase', 'A', '2', 'and', 'the', 'central', 'core', 'hydrophobic', 'fragment', 'of', 'Alzheimer', 's', 'β', 'amyloid', 'peptide', 'a', 'reductionist', 'approach', 'Zeenat', 'Mirza', 'Vikram', 'Gopalakrishna', 'Pillai', 'Sajjad', 'Karim', 'Sujata', 'Sharma', 'Punit', 'Kaur', 'Alagiri', 'Srinivasan', 'Tej', 'P', 'Singh', 'Mohammed', 'Al', 'Qahtani', 'P109', 'Differential', 'expression', 'profiling', 'between', 'meningiomas', 'from', 'female', 'and', 'male', 'patients', 'Reem', 'Alotibi', 'Alaa', 'Al', 'Ahmadi', 'Fatima', 'Al', 'Adwani', 'Deema', 'Hussein', 'Sajjad', 'Karim', 'Mona', 'Al', 'Sharif', 'Awatif', 'Jamal', 'Fahad', 'Al', 'Ghamdi', 'Jaudah', 'Al', 'Maghrabi', 'Saleh', 'S', 'Baeesa', 'Mohammed', 'Bangash', 'Adeel', 'Chaudhary', 'Hans', 'Juergen', 'Schulten', 'Mohammed', 'Al', 'Qahtani', 'P110', 'Neurospheres', 'as', 'models', 'of', 'early', 'brain', 'development', 'and', 'therapeutics', 'Muhammad', 'Faheem', 'Peter', 'Natesan', 'Pushparaj', 'Shilu', 'Mathew', 'Taha', 'Abdullah', 'Kumosani', 'Gauthaman', 'Kalamegam', 'Mohammed', 'Al', 'Qahtani', 'P111', 'Identification', 'of', 'a', 'recurrent', 'causative', 'missense', 'mutation', 'p', 'W577C', 'at', 'the', 'LDLR', 'exon', '12', 'in', 'familial', 'hypercholesterolemia', 'affected', 'Saudi', 'families', 'Faisal', 'A', 'Al', 'Allaf', 'Zainularifeen', 'Abduljaleel', 'Abdullah', 'Alashwal', 'Mohiuddin', 'M', 'Taher', 'Abdellatif', 'Bouazzaoui', 'Halah', 'Abalkhail', 'Faisal', 'A', 'Ba', 'Hammam', 'Mohammad', 'Athar', 'P112', 'Epithelial', 'ovarian', 'carcinoma', 'EOC', 'Systems', 'oncological', 'approach', 'to', 'identify', 'diagnostic', 'prognostic', 'and', 'therapeutic', 'biomarkers', 'Gauthaman', 'Kalamegam', 'Peter', 'Natesan', 'Pushparaj', 'Muhammad', 'Abu', 'Elmagd', 'Farid', 'Ahmed', 'Khalid', 'HussainWali', 'Sait', 'Nisreen', 'Anfinan', 'Mamdooh', 'Gari', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P113', 'Crohn', 's', 'disease', 'phenotype', 'in', 'northern', 'Tunisian', 'population', 'Naira', 'Ben', 'Mami', 'Yosr', 'Z', 'Haffani', 'Mouna', 'Medhioub', 'Lamine', 'Hamzaoui', 'Ameur', 'Cherif', 'Msadok', 'Azouz', 'P114', 'Establishment', 'of', 'In', 'Silico', 'approaches', 'to', 'decipher', 'the', 'potential', 'toxicity', 'and', 'mechanism', 'of', 'action', 'of', 'drug', 'candidates', 'and', 'environmental', 'agents', 'Gauthaman', 'Kalamegam', 'Fazal', 'Khan', 'Shilu', 'Mathew', 'Mohammed', 'Imran', 'Nasser', 'Mahmood', 'Rasool', 'Farid', 'Ahmed', 'Peter', 'Natesan', 'Pushparaj', 'Mohammed', 'Al', 'Qahtani', 'P115', '1q', 'Gain', 'predicts', 'poor', 'prognosis', 'marker', 'for', 'young', 'breast', 'cancer', 'patients', 'Shereen', 'A', 'Turkistany', 'Lina', 'M', 'Al', 'harbi', 'Ashraf', 'Dallol', 'Jamal', 'Sabir', 'Adeel', 'Chaudhary', 'Adel', 'Abuzenadah', 'P116', 'Disorders', 'of', 'sex', 'chromosomes', 'in', 'a', 'diagnostic', 'genomic', 'medicine', 'unit', 'in', 'Saudi', 'Arabia', 'Prevalence', 'diagnosis', 'and', 'future', 'guidelines', 'Basmah', 'Al', 'Madoudi', 'Bayan', 'Al', 'Aslani', 'Khulud', 'Al', 'Harbi', 'Rwan', 'Al', 'Jahdali', 'Hanadi', 'Qudaih', 'Emad', 'Al', 'Hamzy', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'P117', 'Combination', 'of', 'WYE354', 'and', 'Sunitinib', 'demonstrate', 'synergistic', 'inhibition', 'of', 'acute', 'myeloid', 'leukemia', 'in', 'vitro', 'Asad', 'M', 'Ilyas', 'Youssri', 'Ahmed', 'Mamdooh', 'Gari', 'Farid', 'Ahmed', 'Mohammed', 'Alqahtani', 'P118', 'Integrated', 'use', 'of', 'evolutionary', 'information', 'in', 'GWAS', 'reveals', 'important', 'SNPs', 'in', 'Asthma', 'Nada', 'Salem', 'Sajjad', 'Karim', 'Elham', 'M', 'Alhathli', 'Heba', 'Abusamra', 'Hend', 'F', 'Nour', 'Eldin', 'Mohammed', 'H', 'Al', 'Qahtani', 'Sudhir', 'Kumar', 'P119', 'Assessment', 'of', 'BRAF', 'IDH1', 'IDH2', 'and', 'EGFR', 'mutations', 'in', 'a', 'series', 'of', 'primary', 'brain', 'tumors', 'Fatima', 'Al', 'Adwani', 'Deema', 'Hussein', 'Mona', 'Al', 'Sharif', 'Awatif', 'Jamal', 'Fahad', 'Al', 'Ghamdi', 'Jaudah', 'Al', 'Maghrabi', 'Saleh', 'S', 'Baeesa', 'Mohammed', 'Bangash', 'Adeel', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Hans', 'Juergen', 'Schulten', 'P120', 'Expression', 'profiles', 'distinguish', 'oligodendrogliomas', 'from', 'glioblastoma', 'multiformes', 'with', 'or', 'without', 'oligodendroglioma', 'component', 'Alaa', 'Alamandi', 'Reem', 'Alotibi', 'Deema', 'Hussein', 'Sajjad', 'Karim', 'Jaudah', 'Al', 'Maghrabi', 'Fahad', 'Al', 'Ghamdi', 'Awatif', 'Jamal', 'Saleh', 'S', 'Baeesa', 'Mohammed', 'Bangash', 'Adeel', 'Chaudhary', 'Hans', 'Juergen', 'Schulten', 'Mohammed', 'Al', 'Qahtani', 'P121', 'Hierarchical', 'clustering', 'in', 'thyroid', 'goiters', 'and', 'hyperplastic', 'lesions', 'Ohoud', 'Subhi', 'Nadia', 'Bagatian', 'Sajjad', 'Karim', 'Adel', 'Al', 'Johari', 'Osman', 'Abdel', 'Al', 'Hamour', 'Hosam', 'Al', 'Aradati', 'Abdulmonem', 'Al', 'Mutawa', 'Faisal', 'Al', 'Mashat', 'Jaudah', 'Al', 'Maghrabi', 'Hans', 'Juergen', 'Schulten', 'Mohammad', 'Al', 'Qahtani', 'P122', 'Differential', 'expression', 'analysis', 'in', 'thyroiditis', 'and', 'papillary', 'thyroid', 'carcinomas', 'with', 'or', 'without', 'coexisting', 'thyroiditis', 'Nadia', 'Bagatian', 'Ohoud', 'Subhi', 'Sajjad', 'Karim', 'Adel', 'Al', 'Johari', 'Osman', 'Abdel', 'Al', 'Hamour', 'Abdulmonem', 'Al', 'Mutawa', 'Hosam', 'Al', 'Aradati', 'Faisal', 'Al', 'Mashat', 'Mohammad', 'Al', 'Qahtani', 'Hans', 'Juergen', 'Schulten', 'Jaudah', 'Al', 'Maghrabi', 'P123', 'Metagenomic', 'analysis', 'of', 'waste', 'water', 'microbiome', 'in', 'Sausdi', 'Arabia', 'Muhammad', 'W', 'shah', 'Muhammad', 'Yasir', 'Esam', 'I', 'Azhar', 'Saad', 'Al', 'Masoodi', 'P124', 'Molecular', 'characterization', 'of', 'Helicobacter', 'pylori', 'from', 'faecal', 'samples', 'of', 'Tunisian', 'patients', 'with', 'gastric', 'cancer', 'Yosr', 'Z', 'Haffani', 'Msadok', 'Azouz', 'Emna', 'Khamla', 'Chaima', 'Jlassi', 'Ahmed', 'S', 'Masmoudi', 'Ameur', 'Cherif', 'Lassaad', 'Belbahri', 'P125', 'Diagnostic', 'application', 'of', 'the', 'oncoscan', 'panel', 'for', 'the', 'identification', 'of', 'hereditary', 'cancer', 'syndrome', 'Shadi', 'Al', 'Khayyat', 'Roba', 'Attas', 'Atlal', 'Abu', 'Sanad', 'Mohammed', 'Abuzinadah', 'Adnan', 'MerdadAshraf', 'Dallol', 'Adeel', 'Chaudhary', 'Mohammed', 'Al', 'Qahtani', 'Adel', 'Abuzenadah', 'P126', 'Characterization', 'of', 'clinical', 'and', 'neurocognitive', 'features', 'in', 'a', 'family', 'with', 'a', 'novel', 'OGT', 'gene', 'missense', 'mutation', 'c', '1193G', 'A', 'p', 'Ala319Thr', 'Habib', 'Bouazzi', 'Carlos', 'Trujillo', 'Mohammad', 'Khalid', 'Alwasiyah', 'Mohammed', 'Al', 'Qahtani', 'P127', 'Case', 'report', 'a', 'rare', 'homozygous', 'deletion', 'mutation', 'of', 'TMEM70', 'gene', 'associated', 'with', '3', 'Methylglutaconic', 'Aciduria', 'and', 'cataract', 'in', 'a', 'Saudi', 'patient', 'Maha', 'Alotaibi', 'Rami', 'Nassir', 'P128', 'Isolation', 'and', 'purification', 'of', 'antimicrobial', 'milk', 'proteins', 'Ishfaq', 'A', 'Sheikh', 'Mohammad', 'A', 'Kamal', 'Essam', 'H', 'Jiffri', 'Ghulam', 'M', 'Ashraf', 'Mohd', 'A', 'Beg', 'P129', 'Integrated', 'analysis', 'reveals', 'association', 'of', 'ATP8B1', 'gene', 'with', 'colorectal', 'cancer', 'Mohammad', 'A', 'Aziz', 'Rizwan', 'Ali', 'Mahmood', 'Rasool', 'Mohammad', 'S', 'Jamal', 'Nusaibah', 'samman', 'Ghufrana', 'Abdussami', 'Sathish', 'Periyasamy', 'Mohiuddin', 'K', 'Warsi', 'Mohammed', 'Aldress', 'Majed', 'Al', 'Otaibi', 'Zeyad', 'Al', 'Yousef', 'Mohamed', 'Boudjelal', 'Abdelbasit', 'Buhmeida', 'Mohammed', 'H', 'Al', 'Qahtani', 'Ibrahim', 'AlAbdulkarim', 'P130', 'Implication', 'of', 'IL', '10', 'and', 'IL', '28', 'polymorphism', 'with', 'successful', 'anti', 'HCV', 'therapy', 'and', 'viral', 'clearance', 'Rubi', 'Ghazala', 'Shilu', 'Mathew', 'M', 'Haroon', 'Hamed', 'Mourad', 'Assidi', 'Mohammed', 'Al', 'Qahtani', 'Ishtiaq', 'Qadri', 'P131', 'Interactions', 'of', 'endocrine', 'disruptor', 'di', '2', 'ethylhexyl', 'phthalate', 'DEHP', 'and', 'its', 'metabolite', 'mono', '2', 'ethylhexyl', 'phthalate', 'MEHP', 'with', 'progesterone', 'receptor', 'Ishfaq', 'A', 'Sheikh', 'Muhammad', 'Abu', 'Elmagd', 'Rola', 'F', 'Turki', 'Ghazi', 'A', 'Damanhouri', 'Mohd', 'A', 'Beg', 'P132', 'Association', 'of', 'HCV', 'nucleotide', 'polymorphism', 'in', 'the', 'development', 'of', 'hepatocellular', 'carcinoma', 'Mohd', 'Suhail', 'Abid', 'Qureshi', 'Adil', 'Jamal', 'Peter', 'Natesan', 'Pushparaj', 'Mohammad', 'Al', 'Qahtani', 'Ishtiaq', 'Qadri', 'P133', 'Gene', 'expression', 'profiling', 'by', 'DNA', 'microarrays', 'in', 'colon', 'cancer', 'treated', 'with', 'chelidonine', 'alkaloid', 'Mahmoud', 'Z', 'El', 'Readi', 'Safaa', 'Y', 'Eid', 'Michael', 'Wink', 'P134', 'Successful', 'in', 'vitro', 'fertilization', 'after', 'eight', 'failed', 'trials', 'Ahmed', 'M', 'Isa', 'Lulu', 'Alnuaim', 'Johara', 'Almutawa', 'Basim', 'Abu', 'Rafae', 'Saleh', 'Alasiri', 'Saleh', 'Binsaleh', 'P135', 'Genetic', 'sensitivity', 'analysis', 'using', 'SCGE', 'cell', 'cycle', 'and', 'mitochondrial', 'membrane', 'potential', 'in', 'OPs', 'stressed', 'leukocytes', 'in', 'Rattus', 'norvegicus', 'through', 'flow', 'cytometric', 'input', 'Nazia', 'Nazam', 'Mohamad', 'I', 'Lone', 'Waseem', 'Ahmad', 'Shakeel', 'A', 'Ansari', 'Mohamed', 'H', 'Alqahtani']"
2367,"Integrated Microfluidic Nucleic Acid Isolation, Isothermal Amplification, and Amplicon Quantification",2015-10-20,Microarrays (Basel),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996405/,"Microfluidic components and systems for rapid (<60 min), low-cost, convenient, field-deployable sequence-specific nucleic acid-based amplification tests (NAATs) are described. A microfluidic point-of-care (POC) diagnostics test to quantify HIV viral load from blood samples serves as a representative and instructive example to discuss the technical issues and capabilities of “lab on a chip” NAAT devices. A portable, miniaturized POC NAAT with performance comparable to conventional PCR (polymerase-chain reaction)-based tests in clinical laboratories can be realized with a disposable, palm-sized, plastic microfluidic chip in which: (1) nucleic acids (NAs) are extracted from relatively large (~mL) volume sample lysates using an embedded porous silica glass fiber or cellulose binding phase (“membrane”) to capture sample NAs in a flow-through, filtration mode; (2) NAs captured on the membrane are isothermally (~65 °C) amplified; (3) amplicon production is monitored by real-time fluorescence detection, such as with a smartphone CCD camera serving as a low-cost detector; and (4) paraffin-encapsulated, lyophilized reagents for temperature-activated release are pre-stored in the chip. Limits of Detection (LOD) better than 10(3) virons/sample can be achieved. A modified chip with conduits hosting a diffusion-mode amplification process provides a simple visual indicator to readily quantify sample NA template. In addition, a companion microfluidic device for extracting plasma from whole blood without a centrifuge, generating cell-free plasma for chip-based molecular diagnostics, is described. Extensions to a myriad of related applications including, for example, food testing, cancer screening, and insect genotyping are briefly surveyed.",10.3390/microarrays4040474,ggtxuulg,"['Microfluidic', 'components', 'and', 'systems', 'for', 'rapid', '60', 'min', 'low', 'cost', 'convenient', 'field', 'deployable', 'sequence', 'specific', 'nucleic', 'acid', 'based', 'amplification', 'tests', 'NAATs', 'are', 'described', 'A', 'microfluidic', 'point', 'of', 'care', 'POC', 'diagnostics', 'test', 'to', 'quantify', 'HIV', 'viral', 'load', 'from', 'blood', 'samples', 'serves', 'as', 'a', 'representative', 'and', 'instructive', 'example', 'to', 'discuss', 'the', 'technical', 'issues', 'and', 'capabilities', 'of', 'lab', 'on', 'a', 'chip', 'NAAT', 'devices', 'A', 'portable', 'miniaturized', 'POC', 'NAAT', 'with', 'performance', 'comparable', 'to', 'conventional', 'PCR', 'polymerase', 'chain', 'reaction', 'based', 'tests', 'in', 'clinical', 'laboratories', 'can', 'be', 'realized', 'with', 'a', 'disposable', 'palm', 'sized', 'plastic', 'microfluidic', 'chip', 'in', 'which', '1', 'nucleic', 'acids', 'NAs', 'are', 'extracted', 'from', 'relatively', 'large', 'mL', 'volume', 'sample', 'lysates', 'using', 'an', 'embedded', 'porous', 'silica', 'glass', 'fiber', 'or', 'cellulose', 'binding', 'phase', 'membrane', 'to', 'capture', 'sample', 'NAs', 'in', 'a', 'flow', 'through', 'filtration', 'mode', '2', 'NAs', 'captured', 'on', 'the', 'membrane', 'are', 'isothermally', '65', 'C', 'amplified', '3', 'amplicon', 'production', 'is', 'monitored', 'by', 'real', 'time', 'fluorescence', 'detection', 'such', 'as', 'with', 'a', 'smartphone', 'CCD', 'camera', 'serving', 'as', 'a', 'low', 'cost', 'detector', 'and', '4', 'paraffin', 'encapsulated', 'lyophilized', 'reagents', 'for', 'temperature', 'activated', 'release', 'are', 'pre', 'stored', 'in', 'the', 'chip', 'Limits', 'of', 'Detection', 'LOD', 'better', 'than', '10', '3', 'virons', 'sample', 'can', 'be', 'achieved', 'A', 'modified', 'chip', 'with', 'conduits', 'hosting', 'a', 'diffusion', 'mode', 'amplification', 'process', 'provides', 'a', 'simple', 'visual', 'indicator', 'to', 'readily', 'quantify', 'sample', 'NA', 'template', 'In', 'addition', 'a', 'companion', 'microfluidic', 'device', 'for', 'extracting', 'plasma', 'from', 'whole', 'blood', 'without', 'a', 'centrifuge', 'generating', 'cell', 'free', 'plasma', 'for', 'chip', 'based', 'molecular', 'diagnostics', 'is', 'described', 'Extensions', 'to', 'a', 'myriad', 'of', 'related', 'applications', 'including', 'for', 'example', 'food', 'testing', 'cancer', 'screening', 'and', 'insect', 'genotyping', 'are', 'briefly', 'surveyed', '']"
2478,Recombinase polymerase amplification assay for rapid detection of lumpy skin disease virus,2016-11-02,BMC Vet Res,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094145/,"BACKGROUND: Lumpy skin disease virus (LSDV) is a Capripoxvirus infecting cattle and Buffalos. Lumpy skin disease (LSD) leads to significant economic losses due to hide damage, reduction of milk production, mastitis, infertility and mortalities (10 %). Early detection of the virus is crucial to start appropriate outbreak control measures. Veterinarians rely on the presence of the characteristic clinical signs of LSD. Laboratory diagnostics including virus isolation, sequencing and real-time polymerase chain reaction (PCR) are performed at well-equipped laboratories. In this study, a portable, simple, and rapid recombinase polymerase amplification (RPA) assay for the detection of LSDV-genome for the use on farms was developed. RESULTS: The LSDV RPA assay was performed at 42 °C and detected down to 179 DNA copies/reaction in a maximum of 15 min. Unspecific amplification was observed with neither LSDV-negative samples (n = 12) nor nucleic acid preparations from orf virus, bovine papular stomatitis virus, cowpoxvirus, Peste des petits ruminants and Blue tongue virus (serotypes 1, 6 and 8). The clinical sensitivity of the LSDV RPA assay matched 100 % (n = 22) to real-time PCR results. In addition, the LSDV RPA assay detected sheep and goat poxviruses. CONCLUSION: The LSDV RPA assay is a rapid and sensitive test that could be implemented in field or at quarantine stations for the identification of LSDV infected case. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-016-0875-5) contains supplementary material, which is available to authorized users.",10.1186/s12917-016-0875-5,mvkao3ye,"['BACKGROUND', 'Lumpy', 'skin', 'disease', 'virus', 'LSDV', 'is', 'a', 'Capripoxvirus', 'infecting', 'cattle', 'and', 'Buffalos', 'Lumpy', 'skin', 'disease', 'LSD', 'leads', 'to', 'significant', 'economic', 'losses', 'due', 'to', 'hide', 'damage', 'reduction', 'of', 'milk', 'production', 'mastitis', 'infertility', 'and', 'mortalities', '10', 'Early', 'detection', 'of', 'the', 'virus', 'is', 'crucial', 'to', 'start', 'appropriate', 'outbreak', 'control', 'measures', 'Veterinarians', 'rely', 'on', 'the', 'presence', 'of', 'the', 'characteristic', 'clinical', 'signs', 'of', 'LSD', 'Laboratory', 'diagnostics', 'including', 'virus', 'isolation', 'sequencing', 'and', 'real', 'time', 'polymerase', 'chain', 'reaction', 'PCR', 'are', 'performed', 'at', 'well', 'equipped', 'laboratories', 'In', 'this', 'study', 'a', 'portable', 'simple', 'and', 'rapid', 'recombinase', 'polymerase', 'amplification', 'RPA', 'assay', 'for', 'the', 'detection', 'of', 'LSDV', 'genome', 'for', 'the', 'use', 'on', 'farms', 'was', 'developed', 'RESULTS', 'The', 'LSDV', 'RPA', 'assay', 'was', 'performed', 'at', '42', 'C', 'and', 'detected', 'down', 'to', '179', 'DNA', 'copies', 'reaction', 'in', 'a', 'maximum', 'of', '15', 'min', 'Unspecific', 'amplification', 'was', 'observed', 'with', 'neither', 'LSDV', 'negative', 'samples', 'n', '12', 'nor', 'nucleic', 'acid', 'preparations', 'from', 'orf', 'virus', 'bovine', 'papular', 'stomatitis', 'virus', 'cowpoxvirus', 'Peste', 'des', 'petits', 'ruminants', 'and', 'Blue', 'tongue', 'virus', 'serotypes', '1', '6', 'and', '8', 'The', 'clinical', 'sensitivity', 'of', 'the', 'LSDV', 'RPA', 'assay', 'matched', '100', 'n', '22', 'to', 'real', 'time', 'PCR', 'results', 'In', 'addition', 'the', 'LSDV', 'RPA', 'assay', 'detected', 'sheep', 'and', 'goat', 'poxviruses', 'CONCLUSION', 'The', 'LSDV', 'RPA', 'assay', 'is', 'a', 'rapid', 'and', 'sensitive', 'test', 'that', 'could', 'be', 'implemented', 'in', 'field', 'or', 'at', 'quarantine', 'stations', 'for', 'the', 'identification', 'of', 'LSDV', 'infected', 'case', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1186', 's12917', '016', '0875', '5', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
2694,Internal control for real-time polymerase chain reaction based on MS2 bacteriophage for RNA viruses diagnostics,2017-04-06,Mem Inst Oswaldo Cruz,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398160/,"BACKGROUND: Real-time reverse transcription polymerase chain reaction (RT-PCR) is routinely used to detect viral infections. In Brazil, it is mandatory the use of nucleic acid tests to detect hepatitis C virus (HCV), hepatitis B virus and human immunodeficiency virus in blood banks because of the immunological window. The use of an internal control (IC) is necessary to differentiate the true negative results from those consequent from a failure in some step of the nucleic acid test. OBJECTIVES: The aim of this study was the construction of virus-modified particles, based on MS2 bacteriophage, to be used as IC for the diagnosis of RNA viruses. METHODS: The MS2 genome was cloned into the pET47b(+) plasmid, generating pET47b(+)-MS2. MS2-like particles were produced through the synthesis of MS2 RNA genome by T7 RNA polymerase. These particles were used as non-competitive IC in assays for RNA virus diagnostics. In addition, a competitive control for HCV diagnosis was developed by cloning a mutated HCV sequence into the MS2 replicase gene of pET47b(+)-MS2, which produces a non-propagating MS2 particle. The utility of MS2-like particles as IC was evaluated in a one-step format multiplex real-time RT-PCR for HCV detection. FINDINGS: We demonstrated that both competitive and non-competitive IC could be successfully used to monitor the HCV amplification performance, including the extraction, reverse transcription, amplification and detection steps, without compromising the detection of samples with low target concentrations. In conclusion, MS2-like particles generated by this strategy proved to be useful IC for RNA virus diagnosis, with advantage that they are produced by a low cost protocol. An attractive feature of this system is that it allows the construction of a multicontrol by the insertion of sequences from more than one pathogen, increasing its applicability for diagnosing different RNA viruses.",10.1590/0074-02760160380,mtk3qxue,"['BACKGROUND', 'Real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'is', 'routinely', 'used', 'to', 'detect', 'viral', 'infections', 'In', 'Brazil', 'it', 'is', 'mandatory', 'the', 'use', 'of', 'nucleic', 'acid', 'tests', 'to', 'detect', 'hepatitis', 'C', 'virus', 'HCV', 'hepatitis', 'B', 'virus', 'and', 'human', 'immunodeficiency', 'virus', 'in', 'blood', 'banks', 'because', 'of', 'the', 'immunological', 'window', 'The', 'use', 'of', 'an', 'internal', 'control', 'IC', 'is', 'necessary', 'to', 'differentiate', 'the', 'true', 'negative', 'results', 'from', 'those', 'consequent', 'from', 'a', 'failure', 'in', 'some', 'step', 'of', 'the', 'nucleic', 'acid', 'test', 'OBJECTIVES', 'The', 'aim', 'of', 'this', 'study', 'was', 'the', 'construction', 'of', 'virus', 'modified', 'particles', 'based', 'on', 'MS2', 'bacteriophage', 'to', 'be', 'used', 'as', 'IC', 'for', 'the', 'diagnosis', 'of', 'RNA', 'viruses', 'METHODS', 'The', 'MS2', 'genome', 'was', 'cloned', 'into', 'the', 'pET47b', 'plasmid', 'generating', 'pET47b', 'MS2', 'MS2', 'like', 'particles', 'were', 'produced', 'through', 'the', 'synthesis', 'of', 'MS2', 'RNA', 'genome', 'by', 'T7', 'RNA', 'polymerase', 'These', 'particles', 'were', 'used', 'as', 'non', 'competitive', 'IC', 'in', 'assays', 'for', 'RNA', 'virus', 'diagnostics', 'In', 'addition', 'a', 'competitive', 'control', 'for', 'HCV', 'diagnosis', 'was', 'developed', 'by', 'cloning', 'a', 'mutated', 'HCV', 'sequence', 'into', 'the', 'MS2', 'replicase', 'gene', 'of', 'pET47b', 'MS2', 'which', 'produces', 'a', 'non', 'propagating', 'MS2', 'particle', 'The', 'utility', 'of', 'MS2', 'like', 'particles', 'as', 'IC', 'was', 'evaluated', 'in', 'a', 'one', 'step', 'format', 'multiplex', 'real', 'time', 'RT', 'PCR', 'for', 'HCV', 'detection', 'FINDINGS', 'We', 'demonstrated', 'that', 'both', 'competitive', 'and', 'non', 'competitive', 'IC', 'could', 'be', 'successfully', 'used', 'to', 'monitor', 'the', 'HCV', 'amplification', 'performance', 'including', 'the', 'extraction', 'reverse', 'transcription', 'amplification', 'and', 'detection', 'steps', 'without', 'compromising', 'the', 'detection', 'of', 'samples', 'with', 'low', 'target', 'concentrations', 'In', 'conclusion', 'MS2', 'like', 'particles', 'generated', 'by', 'this', 'strategy', 'proved', 'to', 'be', 'useful', 'IC', 'for', 'RNA', 'virus', 'diagnosis', 'with', 'advantage', 'that', 'they', 'are', 'produced', 'by', 'a', 'low', 'cost', 'protocol', 'An', 'attractive', 'feature', 'of', 'this', 'system', 'is', 'that', 'it', 'allows', 'the', 'construction', 'of', 'a', 'multicontrol', 'by', 'the', 'insertion', 'of', 'sequences', 'from', 'more', 'than', 'one', 'pathogen', 'increasing', 'its', 'applicability', 'for', 'diagnosing', 'different', 'RNA', 'viruses', '']"
2785,"36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016",2016-04-20,Crit Care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493079/,"P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis P002 - Lower serum immunoglobulin G2 level does not predispose to severe flu. J. Solé-Violán, M. López-Rodríguez, E. Herrera-Ramos, J. Ruíz-Hernández, L. Borderías, J. Horcajada, N. González-Quevedo, O. Rajas, M. Briones, F. Rodríguez de Castro, C. Rodríguez Gallego P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis F. Esen, G. Orhun, P. Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. Tuzun P004 - Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopenia R. Riff, O. Naamani, A. Douvdevani P005 - Analysis of neutrophil by hyper spectral imaging - A preliminary report R. Takegawa, H. Yoshida, T. Hirose, N. Yamamoto, H. Hagiya, M. Ojima, Y. Akeda, O. Tasaki, K. Tomono, T. Shimazu P006 - Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgery S. Ono, T. Kubo, S. Suda, T. Ueno, T. Ikeda P007 - Serial change of c1 inhibitor in patients with sepsis – A prospective observational study T. Hirose, H. Ogura, H. Takahashi, M. Ojima, J. Kang, Y. Nakamura, T. Kojima, T. Shimazu P008 - Comparison of bacteremia and sepsis on sepsis related biomarkers T. Ikeda, S. Suda, Y. Izutani, T. Ueno, S. Ono P009 - The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purification T. Taniguchi, M. O P010 - Validation of a new sensitive point of care device for rapid measurement of procalcitonin C. Dinter, J. Lotz, B. Eilers, C. Wissmann, R. Lott P011 - Infection biomarkers in primary care patients with acute respiratory tract infections – Comparison of procalcitonin and C-reactive protein M. M. Meili, P. S. Schuetz P012 - Do we need a lower procalcitonin cut off? H. Hawa, M. Sharshir, M. Aburageila, N. Salahuddin P013 - The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria V. Chantziara, S. Georgiou, A. Tsimogianni, P. Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, G. Micha, E. Chinou, G. Michaloudis P014 - Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiber A. Kodaira, T. Ikeda, S. Ono, T. Ueno, S. Suda, Y. Izutani, H. Imaizumi P015 - Diagnostic usefullness of combination biomarkers on ICU admission M. V. De la Torre-Prados, A. Garcia-De la Torre, A. Enguix-Armada, A. Puerto-Morlan, V. Perez-Valero, A. Garcia-Alcantara P016 - Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patients N. Bolton, J. Dudziak, S. Bonney, A. Tridente, P. Nee P017 - Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients G. Nicolaes, M. Wiewel, M. Schultz, K. Wildhagen, J. Horn, R. Schrijver, T. Van der Poll, C. Reutelingsperger P018 - Il-8: is this a more reliable biomarker for sepsis severity than CRP, Procalcitonin, E-selectin, IL-6 and TNF-[alpha] S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P019 - Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study E. G. Gayat, J. Struck, A. Cariou, N. Deye, B. Guidet, S. Jabert, J. Launay, M. Legrand, M. Léone, M. Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa P020 - Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock R. Arnold, M. Capan, A. Linder, P. Akesson P021 - Kinetics and prognostic value of presepsin (sCD14) in septic patients. A pilot study M. Popescu, D. Tomescu P022 - Comparison of CD64 levels performed by the facs and accellix systems C. L. Sprung, R. Calderon Morales, G. Munteanu, E. Orenbuch-Harroch, P. Levin, H. Kasdan, A. Reiter, T. Volker, Y. Himmel, Y. Cohen, J. Meissonnier P023 - Diagnosing sepsis in 5 minutes: Nanofluidic technology study with pancreatic-stone protein (PSP/ reg) L. Girard, F. Rebeaud P024 - How nanotechnology-based approaches could contribute to sepsis prevention, diagnosis and treatment I. Herrmann P025 - Il7r transcriptional expression analysis during septic shock B. Delwarde, E. Peronnet, E. Cerrato, F. Venet, A. Lepape, T. Rimmelé, G. Monneret, J. Textoris P026 - Disbalance of microbial metabolites of aromatic acids affects the severity in critically ill patients N. Beloborodova, V. Moroz, A. Osipov, A. Bedova, Y. Sarshor, A. Pautova, A. Sergeev, E. Chernevskaya P027 - Copeptin predicts 10-year all-cause mortality in community patients J. Odermatt, R. Bolliger, L. Hersberger, M. Ottiger, M. Christ-Crain, B. Mueller, P. Schuetz P028 - Identification of differential proteomic response in septic patients secondary to community and hospital acquired pneumonia N. K. Sharma, A. K. Tashima, M. K. Brunialti, F. R. Machado, M. Assuncao, O. Rigato, R. Salomao P029 - Monocyte HLA-DR expression in community-acquired bacteremic sepsis - dynamics associated to aetiology and prediction of secondary sepsis S. C. Cajander, G. Rasmussen, E. Tina, B. Söderquist, J. Källman, K. Strålin P030 - Soluble B- and T-lymphocyte attenuator: A possible prognostic marker in sepsis A. L. Lange, J. S. Sundén-Cullberg, A. M. Magnuson, O. H. Hultgren P031 - Fractal dimension: A new biomarker for quantifying clot microstructure in patients across the sepsis spectrum G. Davies, S. Pillai, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P032 - Comparison between the new biomarker for coagulation, clot microstructure (Df) with rotational thromboelastometry (ROTEM) in patients across the sepsis spectrum S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P033 - Changes in fibrinolysis across the sepsis spectrum: The use of rotational thromboelastometry (ROTEM) lysis index (LI60) and D-Dimer concentration S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P034 - The intensive care infection score – a promising marker for the prediction of infection and its severity. P. Van der Geest, M. Mohseni, J. Linssen, R. De Jonge, S. Duran, J. Groeneveld P035 - Challenges in the clinical diagnosis of sepsis R. Miller III, B. K. Lopansri, L. C. McHugh, A. Seldon, J. P. Burke P036 - Does zero heat flux thermometry more accurately identify sepsis on intensive care? J. Johnston, R. Reece-Anthony, A. Bond, A. Molokhia P037 - Advancing quality (AQ) sepsis programme: Improving early identification & treatment of sepsis in North West England. C. Mcgrath, E. Nsutebu P038 - Prehospital transport of acute septic patients P. Bank Pedersen, D. Pilsgaard Henriksen, S. Mikkelsen, A. Touborg Lassen P039 - Vasodilatory plant extracts gel as an alternative treatment for fever in critically ill patients R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P040 - Host response and outcome of hypothermic sepsis M. A. Wiewel, M. B. Harmon, L. A. Van Vught, B. P. Scicluna, A. J. Hoogendijk, J. Horn, A. H. Zwinderman, O. L. Cremer, M. J. Bonten, M. J. Schultz, T. Van der Poll, N. P. Juffermans, W. J. Wiersinga P041 - Septic shock alert over SIRS criteria has an impact on outcome but needs to be revised G. Eren, Y Tekdos, M. Dogan, O. Acicbe, E. Kaya, O. Hergunsel P042 - Association between previous prescription of βblockers and mortality rate among septic patients: A retrospective observational study S. Alsolamy, G. Ghamdi, L. Alswaidan, S. Alharbi, F. Alenezi, Y. Arabi P043 - Recognition and treatment of sepsis on labour ward– teaching & information resources can improve knowledge J. Heaton, A. Boyce, L. Nolan, J. Johnston, A. Dukoff-Gordon, A. Dean, A. Molokhia P044 - Culture negative sepsis in the ICU – what is unique to this patient population? T. Mann Ben Yehudah P045 - Organ dysfunction in severe sepsis patients identified in administrative data in Germany, 2007-2013 C. Fleischmann, D. Thomas-Rueddel, C. Haas, U. Dennler, K. Reinhart P046 - A comparison of residents’ knowledge regarding; the Surviving Sepsis Campaign 2012 guideline O. Suntornlohanakul, B. Khwannimit P047 - Effectiveness of a septic shock bundle to improve outcomes in the ICU F. Breckenridge, A. Puxty P048 - Dose of norepinephrine in the first 24 hours as a parameter evaluating the effectiveness of treatment in patients with severe sepsis and septic shock P. Szturz, P. Folwarzcny, J. Svancara, R. Kula, P. Sevcik P049 - Norepinephrine or vasopressin + norepinephrine in septic shock. A retrospective series of 39 patients L. Caneva, A. Casazza, E. Bellazzi, S. Marra, L. Pagani, M. Vetere, R. Vanzino, D. Ciprandi, R. Preda, R. Boschi, L. Carnevale P050 - Methylene blue effectiveness as contributory treatment in patients with septic shock V. Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. Cetina P051 - Coagulation disorders in patients with severe sepsis and DIC evaluated with thromboelastometry. B Adamik, D Jakubczyk, A Kübler P052 - Frequency and outcome of early sepsis-associated coagulopathy A. Radford, T. Lee, J. Singer, J. Boyd, D. Fineberg, M. Williams, J. Russell P053 - Assessment of coagulopathy in cancer patients with severe sepsis or septic shock. A case-control pilot study E. Scarlatescu, D. Tomescu, G. Droc, S. Arama P054 - Thromboelastometry in critically ill patients with disseminated intravascular coagulation M. Müller, M. Straat, S. S. Zeerleder, N. P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock C. F. Fuchs, C. S. Scheer, S. W. Wauschkuhn, M. V. Vollmer, K. M. Meissner, S. K. Kuhn, K. H. Hahnenkamp, S. R. Rehberg, M. G. Gründling P056 - Neutrophil Extracellular Traps (NETs) production under hypoxic condition N. Yamamoto, M. Ojima, S. Hamaguchi, T. Hirose, Y. Akeda, R. Takegawa, O. Tasaki, T. Shimazu, K. Tomono P057 - Impact of ultraviolet air sterilizer in intensive care unit room, and clinical outcomes of patients E. Gómez-Sánchez, M. Heredia-Rodríguez, E. Álvarez-Fuente, M. Lorenzo-López, E. Gómez-Pesquera, M. Aragón-Camino, P. Liu-Zhu, A. Sánchez-López, A. Hernández-Lozano, M. T. Peláez-Jareño, E. Tamayo P058 - Focus of infection in severe sepsis - comparison of administrative data and prospective cohorts from Germany D. O. Thomas-Rüddel, C. Fleischmann, C. Haas, U. Dennler, K. Reinhart P059 - “Zero CLABSI” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU V. Adora, A. Kar, A. Chakraborty, S. Roy, A. Bandyopadhyay, M. Das P060 - Novel molecular techniques to identify central venous catheter (CVC) associated blood stream infections (BSIs) T. Mann Ben Yehudah, G. Ben Yehudah, M. Salim, N. Kumar, L. Arabi, T. Burger, P. Lephart, E. Toth-martin P061 - Zero clabsi” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU R. Rao, A. Kar, A. Chakraborty P062 - Prevention of central line-associated bloodstream infections in intensive care units: An international online survey C. Valencia, N. Hammami, S. Blot, J. L. Vincent, M. L. Lambert P063 - 30 days antimicrobial efficacy of non-leaching central venous catheters J. Brunke, T. Riemann, I. Roschke P064 - Efficacy of noble metal alloy-coated catheter in prevention of bacteriuria R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P065 - Predicting bacteremic urinary tract infection in community setting: A prospective observational study S. Nimitvilai, K. Jintanapramote, S. Jarupongprapa P066 - Eight-year analysis of acinetobacter spp. monobacteremia in surgical and medical intensive care units at university hospital in Lithuania D. Adukauskiene, D. Valanciene P067 - Group A and group B streptococcal infections in intensive care unit – our experience in a tertiary centre G. Bose, V. Lostarakos, B. Carr P068 - Improved detection of spontaneous bacterial peritonitis by uritop + tm strip test and inoculation of blood culture bottles with ascitic fluid S. Khedher, A. Maaoui, A. Ezzamouri, M. Salem P069 - Increased risk of cellulitis in patients with congestive heart failure: a population based cohort study J. Chen P070 - Outcomes of severe cellulitis and necrotizing fasciitis in the critically ill D. R. Cranendonk, L. A. Van Vught, M. A. Wiewel, O. L. Cremer, J. Horn, M. J. Bonten, M. J. Schultz, T. Van der Poll, W. J. Wiersinga P071 - Botulism outbreak associated with people who inject drugs (PWIDs) in Scotland. M. Day, G. Penrice, K. Roy, P. Robertson, G. Godbole, B. Jones, M. Booth, L. Donaldson P072 - Surveillance of ESBL-producing enterobacteriaceae fecal carriers in the ICU Y. Kawano, H. Ishikura P073 - Prevalence of ESBL and carbapenemase producing uropathogens in a newly opened hospital in south India S. Sreevidya, N. Brahmananda Reddy, P. Muraray Govind, R. Pratheema, J. Devachandran Apollo Speciality Hospital - OMR, Chennai, India P074 - Prevalence, risk factors and outcomes of methicillin-resistant staphylococcus aureus nasal colonization in critically ill patients H. Al-Dorzi, M. Almutairi, B. Alhamadi, A. Crizaldo Toledo, R. Khan, B. Al Raiy, Y. Arabi P075 - Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: Is there an association? H. Talaie P076 - Multidrug-resistant organisms in a Dutch ICU J. A. Van Oers, A. Harts, E. Nieuwkoop, P. Vos P077 - Epidemiology and risk factors of ICU acquired infections caused by multidrug-resistant gram negative bacilli Y. Boussarsar, F. Boutouta, S. Kamoun, I. Mezghani, S. Koubaji, A. Ben Souissi, A. Riahi, M. S. Mebazaa P078 - Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins E. Giamarellos-Bourboulis, N. Tziolos, C. Routsi, C. Katsenos, I. Tsangaris, I. Pneumatikos, G. Vlachogiannis, V. Theodorou, A. Prekates, E. Antypa, V. Koulouras, N. Kapravelos, C. Gogos, E. Antoniadou, K. Mandragos, A. Armaganidis P079 - Must change the medical practice in ICU? A. R. Robles Caballero, B. Civantos, J. C. Figueira, J. López P080 - Mediterranean spotted fever in an infectious diseases intensive care unit A. Silva-Pinto, F. Ceia, A. Sarmento, L. Santos P081 - Clinical features and outcomes of patients with Middle East respiratory syndrome requiring admission to a saudi intensive care unit: A retrospective analysis of 31 cases G. Almekhlafi, Y. Sakr P082 - The ICU response to a hospital outbreak of Middle East respiratory syndrome coronavirus infection H. Al-Dorzi, R. Khan, S. Baharoon, A. Aldawood, A. Matroud, J. Alchin, S. Al Johani, H. Balkhy, Y. Arabi P083 - Middle East respiratory syndrome: Surveillance data analysis S. Alsolamy, S. Y. Yousif, B. O. Alotabi, A. S. Alsaawi P085 - Use of Taqman array card molecular diagnostics in severe pneumonia: A case series J. Ang, MD Curran, D. Enoch, V. Navapurkar, A. Conway Morris P086 - ‘BUNS’: An investigation protocol improves the ICU management of pneumonia R. Sharvill, J. Astin P087 - Pneumonia in patients following secondary peritonitis: epidemiological features and impact on mortality M. Heredia-Rodríguez, E. Gómez-Sánchez, M. T. Peláez-Jareño, E. Gómez-Pesquera, M. Lorenzo-López, P. Liu-Zhu, M. Aragón-Camino, A. Hernández-Lozano, A. Sánchez-López, E. Álvarez-Fuente, E. Tamayo P088 - The use of the “CURB-65 score” by emergency room clinicians in a large teaching hospital J. Patel, C. Kruger P089 - Incidence of community acquired pneumonia with viral infection in mechanically ventilated patients in the medical intensive care unit J. O’Neal, H. Rhodes, J. Jancik P090 - The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Against S aureus B. François, P. F. Laterre, P. Eggimann, A. Torres, M. Sánchez, P. F. Dequin, G. L. Bassi, J. Chastre, H. S. Jafri P091 - Risk factors and microbiological profile for nosocomial infections in trauma patients M. Ben Romdhane, Z. Douira, S. Kamoun, M. Bousselmi, A. Ben Souissi, Y. Boussarsar, A. Riahi, M.S. Mebazaa P092 - Correlation between percentages of ventilated patients developed vap and use of antimicrobial agents in ICU patients. A. Vakalos, V. Avramidis P093 - A comparison of two ventilator associated pneumonia surveillance techniques T. H. Craven, G. Wojcik, K. Kefala, J. McCoubrey, J. Reilly, R. Paterson, D. Inverarity, I. Laurenson, T. S. Walsh P094 - Lung ultrasound before and after fiberbronchoscopy - modifications may improve ventilator-associated pneumonia diagnosis S. Mongodi, B. Bouhemad, A. Orlando, A. Stella, G. Via, G. Iotti, A. Braschi, F. Mojoli P095 - Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia M. Haliloglu, B. Bilgili, U. Kasapoglu, I. Sayan, M. Süzer Aslan, A. Yalcın, I. Cinel P096 - Impact of pRBCs transfusion on percentage of ventilated patients developed VAP in ICU patients A. Vakalos, V. Avramidis P097 - The impact of a series of interventions on the rate of ventilator associated pneumonia in a large teaching hospital H. E. Ellis, K. Bauchmuller, D. Miller, A Temple P098 - The EVADE study: Prevention of Nosocomial Pneumonia (NP) caused by P aeruginosa with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa virulence factors J. Chastre, B. François, A. Torres, C. E. Luyt, M. Sánchez, M. Singer, H. S. Jafri P099 - Short-term inhaled colistin adjunctive therapy for ventilator-associated pneumonia Y. Nassar, M. S. Ayad P100 - Effect of aerosolised colistin on weaning from mechanical ventilation A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P101 - Septic shock is an independent risk factor for colistin-induced severe acute kidney injury: a retrospective cohort study B. Bilgili, M. Haliloglu, F. Gul, I. Cinel P102 - Nosocomial pneumonia - emphasis on inhaled tobramycin A. Kuzovlev, A. Shabanov, S. Polovnikov, V. Moroz P103 - In vitro evaluation of amikacin inhale and commercial nebulizers in a mechanical ventilator N. Kadrichu, T. Dang, K. Corkery, P. Challoner P104 - The effects of nebulized amikacin/fosfomycin and systemic meropenem on severe amikacin-resistant meropenem-susceptible P.aeruginosa pneumonia G. Li Bassi, E. Aguilera, C. Chiurazzi, C. Travierso, A. Motos, L. Fernandez, R. Amaro, T. Senussi, F. Idone, J. Bobi, M. Rigol, A. Torres P105 - Optimization of gentamicin peak concentrations in critically ill patients C. J. Hodiamont, N. P. Juffermans, J. M. Janssen, C. S. Bouman, R. A. Mathôt, M. D. De Jong, R. M. Van Hest P106 - Systematic review of cefepime induced neurotoxicity L. Payne, G. L. Fraser P107 - Unasyn® causes QT prolongation during treatment of intensive care patients B. Tudor, M. Lahner, G. Roth, C. Krenn P108 - Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients – Tehran, Iran H. Talaie P109 - Phage therapy against antimicrobial resistance, design of the first clinical study phagoburn P. Jault, J. Gabard, T. Leclerc, S. Jennes, Y. Que, A. Rousseau, F. Ravat P110 - Antibiotic dosing errors in critically ill patients with severe sepsis or septic shock H. Al-Dorzi, A. Eissa, S. Al-Harbi, T. Aldabbagh, R. Khan, Y. Arabi P111 - Does empiric antifungal therapy improve survival in septic critically ill patients? (immunocompromised excluded) A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P112 - Neurocysticercosis-Qatar experience F. Paramba, N. Purayil, V. Naushad, O. Mohammad, V. Negi, P. Chandra P113 - Early indicators in acute haemorrhagic shock A. Kleinsasser P114 - Filtering of red blood cells reduces the inflammatory response of pulmonary cells in an in vitro model of mechanical ventilation M. R. Witrz, J. F. Buchner-Doeven, A. M. Tuip-de Boer, J. C. Goslings, N. P. Juffermans P115 - Microparticles from red blood cell transfusion induce a pro-coagulant and pro-inflammatory endothelial cell response M. Van Hezel, M. Straat, A Boing, R Van Bruggen, N Juffermans P116 - The contribution of cytokines on thrombosis development during hospitalization in ICU D. Markopoulou, K. Venetsanou, V. Kaldis, D. Koutete, D. Chroni, I. Alamanos P117 - Prophylactic enoxaparin dosing and adjustment through anti-xa monitoring in an inpatient burn unit L. Koch, J. Jancik, H. Rhodes, E. Walter P118 - Determination of optimal cut-off values of haemoglobin, platelet count and fibrinogen at 24 hours after injury associated with mortality in trauma patients K. Maekawa, M. Hayakawa, S. Kushimoto, A. Shiraishi, H. Kato, J. Sasaki, H. Ogura, T. Matauoka, T. Uejima, N. Morimura, H. Ishikura, A. Hagiwara, M. Takeda P119 - Trauma-induced coagulopathy - prothrombin complex concentrate vs fresh frozen plasma O. Tarabrin, S. Shcherbakow, D. Gavrychenko, G. Mazurenko, V. Ivanova, O. Chystikov P120 - First study to prove the superiority of prothrombin complex concentrates on mortality rate over fresh frozen plasma in patients with acute bleeding C. Plourde, J. Lessard, J. Chauny, R. Daoust P121 - Prothrombin complex concentrate vs fresh frozen plasma in obstetric massive bleeding S. Shcherbakow, O. Tarabrin, D. Gavrychenko, G. Mazurenko, O. Chystikov P122 - Impact of FFP transfusion on VAP in ICU patients A. Vakalos, V. Avramidis P123 - Preoperative platelet function test and the thrombin generation assay are predictive for blood loss after cardiac surgery L. Kropman, L. In het Panhuis, J. Konings, D. Huskens, E. Schurgers, M. Roest, B. De Laat, M. Lance P124 - Rotational thromboelastometry versus standard coagulation tests before surgical interventions M. Durila, P. Lukas, M. Astraverkhava, J. Jonas P125 - Correction of impaired clot quality and stability by fibrinogen and activated prothrombin complex concentrate in a model of severe thrombocytopenia I. Budnik, B. Shenkman P126 - Assessment of point-of-care prothrombin time analyzer as a monitor after cardiopulmonary bypass H. Hayami, Y. Koide, T. Goto P127 - Disseminated intravascular coagulation (dic) is underdiagnosed in critically ill patients: do we need d-dimer measurements? R. Iqbal, Y. Alhamdi, N. Venugopal, S. Abrams, C. Downey, C. H. Toh, I. D. Welters P128 - Validity of the age-adjusted d-dimer cutoff in patients with COPD B. Bombay, J. M. Chauny, R. D. Daoust, J. L. Lessard, M. M. Marquis, J. P. Paquet P129 - A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulmonary bypass surgery K. Siemens, D. Sangaran, B. J. Hunt, A. Durward, A. Nyman, I. A. Murdoch, S. M. Tibby P130 - Nadir hemoglobulin during cardiopulmonary bypass: impact on postoperative morbidity and mortality F. Ampatzidou, D. Moisidou, E. Dalampini, M. Nastou, E. Vasilarou, V. Kalaizi, H. Chatzikostenoglou, G. Drossos P131 - Red blood cell transfusion do not influence the prognostic value of RDW in critically ill patients S. Spadaro, A. Fogagnolo, T. Fiore, A. Schiavi, V. Fontana, F. Taccone, C. Volta P132 - Reasons for admission in the paediatric intensive care unit and the need for blood and blood products transfusions E. Chochliourou, E. Volakli, A. Violaki, E. Samkinidou, G. Evlavis, V. Panagiotidou, M. Sdougka P133 - The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-centre study R. Mothukuri, C. Battle, K. Guy, G. Mills, P. Evans P134 - An integrated major haemorrhage protocol for pre-hospital and retrieval medical teams J. Wijesuriya, S. Keogh P135 - The impact of transfusion thresholds on mortality and cardiovascular events in patients with cardiovascular disease (non-cardiac surgery): a systematic review and meta-analysis A. Docherty, R. O’Donnell, S. Brunskill, M. Trivella, C. Doree, L. Holst, M. Parker, M. Gregersen, J. Almeida, T. Walsh, S. Stanworth P136 - The relationship between poor pre-operative immune status and outcome from cardiac surgery is specific to the peri-operative antigenic threat S. Moravcova, J. Mansell, A. Rogers, R. A. Smith, C. Hamilton-Davies P137 - Impact of simple clinical practice guidelines for reducing post-operative atrial fibrillation after cardiac surgery. A. Omar, M. Allam, O. Bilala, A. Kindawi, H. Ewila P138 - Dexamethasone administration during cardiopulmonary bypass has no beneficial effects on elective postoperative cardiac surgery patients F. Ampatzidou, D. Moisidou, M. Nastou, E. Dalampini, A. Malamas, E. Vasilarou, G. Drossos P139 - Intra-aortic balloon counterpulsation in patients undergoing cardiac surgery (IABCS): preliminary results G. Ferreira, J. Caldas, J. Fukushima, E. A. Osawa, E. Arita, L. Camara, S. Zeferino, J. Jardim, F. Gaioto, L. Dallan, F. B. Jatene, R. Kalil Filho, .F Galas, L. A. Hajjar P140 - Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury C. Mitaka, T. Ohnuma, T. Murayama, F. Kunimoto, M. Nagashima, T. Takei, M. Tomita P141 - Acute kidney injury influence on high sensitive troponin measurements after cardiac surgery A. Omar, K. Mahmoud, S. Hanoura, S. Sudarsanan, P. Sivadasan, H. Othamn, Y. Shouman, R. Singh, A. Al Khulaifi P142 - Complex evaluation of endothelial dysfunction markers for prognosis of outcomes in patients undergoing cardiac surgery I. Mandel, S. Mikheev, I. Suhodolo, V. Kiselev, Y. Svirko, Y. Podoksenov P143 - New-onset atrial fibrillation in intensive care: incidence, management and outcome S. A. Jenkins, R. Griffin P144 - One single spot measurement of the sublingual microcirculation during acute pulmonary hypertension in a pig model of shock M. S. Tovar Doncel, A. Lima, C. Aldecoa, C. Ince P145 - Assessment of levosimendan as a therapeutic option to recruit the microcirculation in cardiogenic shock – initial experience in cardiac ICU A. Taha, A. Shafie, M. Mostafa, N. Syed, H. Hon P146 - Terlipressin vs. norepinephrine in the Potential Multiorgan Donor(PMD) F. Righetti, E. Colombaroli, G. Castellano P147 - Echocardiography in the potential heart donor exposed to substitution hormonotherapy F. Righetti, E. Colombaroli P148 - Machine learning can reduce rate of monitor alarms M. Hravnak, L. C. Chen, A. D. Dubrawski, G. C. Clermont, M. R. Pinsky P149 - Peripherally inserted central catheters placed in the ICU S. Gonzalez, D. Macias, J. Acosta, P. Jimenez, A. Loza, A. Lesmes, F. Lucena, C. Leon P150 - Recordings of abnormal central venous pressure waveform morphology during an episode of pulmonary hypertension in a porcine shock model M. S. Tovar Doncel, C. Ince, C. Aldecoa, A. Lima P151 - Ultrasound guided central venous access technique among French intensivists M. Bastide, J. Richecoeur, E. Frenoy, C. Lemaire, B. Sauneuf, F. Tamion, S. Nseir, D. Du Cheyron, H. Dupont, J. Maizel P152 - Predictive ability of the Pv-aCO2 gap in patients with shock M. Shaban, R. Kolko, N. Salahuddin, M. Sharshir, M. AbuRageila, A. AlHussain P153 - Comparison of echocardiography and pulmonary artery catheter measurements of hemodynamic parameters in critical ill patients P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, M. Slama P154 - The volume clamp method for noninvasive cardiac output measurement in postoperative cardiothoracic surgery patients: a comparison with intermittent pulmonary artery thermodilution J. Wagner, A. Körner, M. Kubik, S. Kluge, D. Reuter, B. Saugel P155 - Hemodynamic monitoring in patients with septic shock (SS) – CPCCO (continuous pulse contour cardiac output) vs. TEE (transesophageal echocardiography) E. Colombaroli, F. Righetti, G. Castellano P156 - Cardiac output measurement with transthoracic echocardiography in critically ill patients: a pragmatic clinical study T. Tran, D. De Bels, A. Cudia, M. Strachinaru, P. Ghottignies, J. Devriendt, C. Pierrakos P157 - Left ventricular outflow tract velocity time integral correlates with stroke volume index in mechanically ventilated patients Ó. Martínez González, R. Blancas, J. Luján, D. Ballesteros, C. Martínez Díaz, A. Núñez, C. Martín Parra, B. López Matamala, M. Alonso Fernández, M. Chana P158 - Transpulmonary thermodilution (TPTD) derived from femoral vs. jugular central venous catheter: validation of a previously published correction formula and a proprietary correction formula for global end-diastolic volume index (GEDVI) W. Huber, M. Eckmann, F. Elkmann, A. Gruber, I. Klein, R. M. Schmid, T. Lahmer P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P159 - Venous return driving pressure and resistance in acute blood volume changes P. W. Moller, S. Sondergaard, S. M. Jakob, J. Takala, D. Berger P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P161 - Analysis of duration of post-operative goal-directed therapy protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff, C. Ryan, D. Dawson, A. Rhodes, M. Cecconi P162 - Hemodynamic optimization – back to square one? M. Cronhjort, O. Wall, E. Nyberg, R. Zeng, C. Svensen, J. Mårtensson, E. Joelsson-Alm P163 - Effectiveness of fluid thoracic content measurement by bioimpedance guiding intravascular volume optimization in patients with septic shock M. Aguilar Arzapalo, L. Barradas, V. Lopez, M. Cetina P164 - A systematic review on the role of internal jugular vein ultrasound measurements in assessment of volume status in critical shock patients N. Parenti, C. Palazzi, L. A. Amidei, F. B. Borrelli, S. C. Campanale, F. T. Tagliazucchi, G. S. Sedoni, D. L. Lucchesi, E. C. Carella, A. L Luciani P165 - Importance of recognizing dehydration in medical Intensive Care Unit M. Mackovic, N. Maric, M. Bakula P166 - Effect of volume for a fluid challenge in septic patients H. Aya, A. Rhodes, R. M. Grounds, N. Fletcher, M. Cecconi P167 - Fluid bolus practices in a large Australian intensive care unit B. Avard, P. Zhang P168 - Liberal late fluid management is associated with longer ventilation duration and worst outcome in severe trauma patients: a retrospective cohort of 294 patients M. Mezidi, J. Charbit, M. Ould-Chikh, P. Deras, C. Maury, O. Martinez, X. Capdevila P169 - Association of fluids and outcomes in emergency department patients hospitalized with community-acquired pneumonia P. Hou, W. Z. Linde-Zwirble, I. D. Douglas, N. S. Shapiro P170 - Association of positive fluid balance with poor outcome in medicosurgical ICU patients A. Ben Souissi, I. Mezghani, Y. Ben Aicha, S. Kamoun, B. Laribi, B. Jeribi, A. Riahi, M. S. Mebazaa P171 - Impact of fluid balance to organ dysfunction in critically ill patients C. Pereira, R. Marinho, R. Antunes, A. Marinho P172 - Volume bolus in ICU patients: do we need to balance our crystalloids? M. Crivits, M. Raes, J. Decruyenaere, E. Hoste P173 - The use of 6 % HES solution do not reduce total fluid requirement in the therapy of patients with burn shock V. Bagin, V. Rudnov, A. Savitsky, M. Astafyeva, I. Korobko, V. Vein P174 - Electron microscopic assessment of acute kidney injury in septic sheep resuscitated with crystalloids or different colloids T. Kampmeier , P. Arnemann, M. Hessler, A. Wald, K. Bockbreder, A. Morelli, H. Van Aken, S. Rehberg, C. Ertmer P175 - Alterations of conjunctival microcirculation in a sheep model of haemorrhagic shock and resuscitation with 0.9 % saline or balanced tetrastarch P. Arnemann, M. Hessler, T. Kampmeier, S. Rehberg, H. Van Aken, C. Ince, C. Ertmer P176 - A single centre nested pilot study investigating the effect of using 0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid therapy on gastrointestinal feeding intolerance in mechanically ventilated patients receiving nasogastric enteral nutrition S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, A. Psirides, P. Young P177 - A single centre nested pilot study investigating the effect on post-operative bleeding of using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid therapy in adults in ICU after heart surgery S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, P. Young P178 - Extreme hypernatremia and sepsis in a patient with Huntington’s dementia: a conundrum in fluid management H. Venkatesh, S. Ramachandran, A. Basu, H. Nair P179 - Diagnosis and management of severe hypernatraemia in the critical care setting S. Egan, J. Bates P180 - Correlation between arterial blood gas and electrolyte disturbances during hospitalization and outcome in critically ill patients S. Oliveira, N. R. Rangel Neto, F. Q. Reis P181 - Missing the “I” in MUDPILES – a rare cause of high anion gap metabolic acidosis (HAGMA) C. P. Lee, X. L. Lin, C. Choong , K. M. Eu, W. Y. Sim , K. S. Tee, J. Pau , J. Abisheganaden P182 - Plasma NGAL and urinary output: potential parameters for early initiation of renal replacement therapy K. Maas, H. De Geus P183 - Renal replacement therapy for critically ill patients: an intermittent continuity E. Lafuente, R. Marinho, J. Moura, R. Antunes, A. Marinho P184 - A survey of practices related to renal replacement therapy in critically ill patients in the north of England. T. E. Doris, D. Monkhouse, T. Shipley, S. Kardasz, I Gonzalez P185 - High initiation creatinine associated with lower 28-day mortality in critically ill patients necessitating continuous renal replacement therapy S. Stads, A. J. Groeneveld P186 - The impact of Karnofsky performance scale on outcomes in acute kidney injury patients receiving renal replacement therapy on the intensive care unit I. Elsayed, N. Ward, A. Tridente, A. Raithatha P187 - Severe hypophosphatemia during citrate-anticoagulated CRRT A. Steuber, C. Pelletier, S. Schroeder, E. Michael, T. Slowinski, D. Kindgen-Milles P188 - Citrate regional anticoagulation for post dilution continuous renal replacement therapy S. Ghabina P189 - Citrate 18 mmol/l improves anticoagulation during RRT with adsorbing filters F. Turani, A. Belli, S. Busatti, G. Barettin, F. Candidi, F. Gargano, R. Barchetta, M. Falco P190 - Calcium gluconate instead of calcium chloride in citrate-anticoagulated CVVHD O. Demirkiran, M. Kosuk, S. Bozbay P191 - Enhanced clearance of interleukin-6 with continuous veno-venous haemodialysis (CVVHD) using Ultraflux EMiC2 vs. Ultraflux AV1000S V. Weber, J. Hartmann, S. Harm, I. Linsberger, T. Eichhorn, G. Valicek, G. Miestinger, C. Hoermann P192 - Removal of bilirubin with a new adsorbent system: in vitro kinetics S. Faenza, D. Ricci, E. Mancini, C. Gemelli, A. Cuoghi, S. Magnani, M. Atti P193 - Case series of patients with severe sepsis and septic shock treated with a new extracorporeal sorbent T. Laddomada, A. Doronzio, B. Balicco P194 - In vitro adsorption of a broad spectrum of inflammatory mediators with CytoSorb® hemoadsorbent polymer beads M. C. Gruda, P. O’Sullivan, V. P. Dan, T. Guliashvili, A. Scheirer, T. D. Golobish, V. J. Capponi, P. P. Chan P195 - Observations in early vs. late use of cytosorb therapy in critically ill patients K. Kogelmann, M. Drüner, D. Jarczak P196 - Oxiris membrane decreases endotoxin during rrt in septic patients with basal EAA > 0,6 F. Turani, A. B. Belli, S. M. Martni, V. C. Cotticelli, F. Mounajergi, R. Barchetta P197 - An observational prospective study on the onset of augmented renal clearance: the first report S. Morimoto, H. Ishikura P198 - An ultrasound- guided algorithm for the management of oliguria in severe sepsis I. Hussain, N. Salahuddin, A. Nadeem, K. Ghorab, K. Maghrabi P199 - Ultrasound in acute kidney injury (aki). First findings of farius, an education-programme in structural ultrasonography S. K. Kloesel, C. Goldfuss, A. Stieglitz, A. S. Stieglitz, L. Krstevska, G. Albuszies P200 - Effectiveness of renal angina index score predicting acute kidney injury on critically ill patients M. Aguilar Arzapalo, L. Barradas, V. Lopez, A. Escalante, G. Jimmy, M. Cetina P201 - Time length below blood pressure thresholds and progression of acute kidney injury in critically ill patients with or without sepsis: a retrospective, exploratory cohort study J. Izawa, T. Iwami, S. Uchino, M. Takinami, T. Kitamura, T. Kawamura P202 - Anaemia does not affect renal recovery in acute kidney injury J. G. Powell-Tuck, S. Crichton, M. Raimundo, L. Camporota, D. Wyncoll, M. Ostermann P203 - Estimated glomerular filtration rate based on serum creatinine: actual practice in Dutch ICU’s A. Hana, H. R. De Geus P204 - Comparison of estimated glomerular filtration rate calculated by mdrd, ckd-epi-serum-creatinine and ckd-epi-cystatin-c in adult critically ill patients H. R. De Geus, A. Hana P205 - Early diagnosis of septic acute kidney injury in medical critical care patients with a urine cell cycle arrest marker: insulin like growth factor binding protein-7 (IGFBP-7) M. Aydogdu, N. Boyaci, S. Yuksel, G. Gursel, A. B. Cayci Sivri P206 - Urinary neutrophil gelatinase-associated lipocalin as early biomarker of severe acute kidney injury in intensive care J. Meza-Márquez, J. Nava-López, R. Carrillo-Esper P207 - Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting A. Dardashti, A. Grubb P208 - The biomarker nephrocheck™ can discriminate the septic shock patients with an akin 1 or 2 acute renal failure who will not progress toward the akin 3 level J. Maizel, M. Wetzstein, D. Titeca, L. Kontar, F. Brazier, B. De Cagny, A. Riviere, T. Soupison, M. Joris, M. Slama P209 - A worldwide multicentre evaluation of acute kidney injury in septic and non-septic critically ill patients: the intensive care over nations (icon) audit E. Peters, H. Njimi, P. Pickkers, J. L. Vincent P210 - Does enhanced recovery after surgery reduce the incidence of acute kidney injury in those undergoing major gynae-oncological surgery? M. Waraich , J. Doyle, T. Samuels, L. Forni P211 - Identification of risk factors for the development of acute kidney injury after lower limb arthroplasty N. Desai, R. Baumber, P. Gunning, A. Sell P212 - Incidences and associations of acute kidney injury after major trauma S. Lin, H. Torrence, M. O’Dwyer, C. Kirwan, J. Prowle P213 - Acute kidney injury of major trauma patients T Kim P214 - Trajectory of serum creatinine after major surgery and the diagnosis of acute kidney injury M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P215 - Epidemiology of acute kidney injury after cardiac surgery. A single center retrospective study S. Hanoura , A. Omar, H. Othamn, S. Sudarsanan , M. Allam, M. Maksoud, R. Singh, A. Al Khulaifi P216 - Post-operative acute kidney injury after major non-cardiac surgery and its association with death in the following year M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P217 - Factors affecting acute renal failure in intensive care unit and effect of these factors on mortality O. Uzundere, D. Memis , M. Ýnal, A. , N. Turan P218 - Results of the live kidney transplantations according to national data of turkish organ and tissue information system M. A. Aydin, H. Basar, I. Sencan, A. Kapuagasi, M. Ozturk, Z. Uzundurukan, D. Gokmen, A. Ozcan, C. Kaymak P219 - Anaesthesia procedure and intensive therapy in patients with neck phlegmon V. A. Artemenko, A. Budnyuk P220 - Nasal high flow oygen for acute respiratory failure: a systematic review R. Pugh , S. Bhandari P221 - Setting optimal flow rate during high flow nasal cannula support: preliminary results T. Mauri, C. Turrini, T. Langer, P. Taccone, C. A. Volta, C. Marenghi, L. Gattinoni, A. Pesenti P222 - Dose to dose consistency across two different gas flow rates using cystic fibrosis and normal adult breathing profiles during nasal high flow oxygen therapy L. Sweeney, A . O’ Sullivan, P. Kelly, E. Mukeria, R. MacLoughlin P223 - Final results of an evaluation of airway medix closed suction system compared to a standard closed suction system M. Pfeffer, J. T. Thomas, G. B. Bregman, G. K. Karp, E. K. Kishinevsky, D. S. Stavi, N. A. Adi P224 - Different cuff materials and different leak tests - one size does not fit all T. Poropat, R. Knafelj P225 - Observational study on the value of the cuff-leak test and the onset of upper airway obstruction after extubation E. Llopart, M. Batlle, C. De Haro, J. Mesquida, A. Artigas P226 - A device for emergency transtracheal lung ventilation D. Pavlovic, L. Lewerentz, A. Spassov, R. Schneider P227 - Long-term outcome and health-related quality of life in patients discharged from the intensive care unit with a tracheostomy and with or without prolonged mechanical ventilation S. De Smet, S. De Raedt, E. Derom, P Depuydt, S. Oeyen, D. Benoit, J. Decruyenaere P228 - Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients (trachus): a randomized clinical trial A. Gobatto, B. Bese, P. Tierno, L. Melro, P. Mendes, F. Cadamuro, M. Park, L. M. Malbouisson P229 - Is it safe to discharge patients with tracheostomy from the ICU to the ward? B. C. Civanto, J. L. Lopez, A. Robles, J. Figueira, S. Yus, A. Garcia P230 - The application of tracheostomy in children in ICU A. Oglinda, G. Ciobanu, C. Oglinda, L. Schirca, T. Sertinean, V. Lupu P231 - The impact of passive humidifiers on aerosol drug delivery during mechanical ventilation P. Kelly, A. O’Sullivan, L. Sweeney, R. MacLoughlin P232 - Evaluation of vibrating mesh and jet nebuliser performance at two different attachment setups in line with a humidifier nebuliser system A. O’Sullivan, P. Kelly, L. Sweeney, E. Mukeria, M. Wolny , R. MacLoughlin P233 - Psv-niv versus cpap in the treatment of acute cardiogenic pulmonary edema A. Pagano, F. Numis, G. Vison, L. Saldamarco, T. Russo, G. Porta, F. Paladino P234 - Noninvasive ventilation in patients with haematologic malignancy: a retrospective review C. Bell, J. Liu, J. Debacker, C. Lee, E. Tamberg, V. Campbell, S. Mehta P235 - Use of non-invasive ventilation in infectious diseases besides classical indications A. Silva-Pinto, A. Sarmento, L. Santos P236 - The impact of fragility on noninvasive mechanical ventilation application and results in the ICU Ý. Kara, F. Yýldýrým, A. Zerman, Z. Güllü, N. Boyacý, B. Basarýk Aydogan, Ü. Gaygýsýz, K. Gönderen, G. Arýk, M. Turkoglu, M. Aydogdu, G. Aygencel, Z. Ülger, G. Gursel P237 - Effects of metabolic alkalosis on noninvasive ventilation success and ICU outcome in patients with hypercapnic respiratory failure N. Boyacý, Z. Isýkdogan, Ö. Özdedeoglu, Z. Güllü, M. Badoglu, U. Gaygýsýz, M. Aydogdu, G. Gursel P238 - Asynchrony index and breathing patterns of acute exacerbation copd patients assisted with noninvasive pressure support ventilation and neurally adjusted ventilatory assist N. Kongpolprom, C. Sittipunt P239 - High frequency jet ventilation for severe acute hypoxemia A. Eden, Y. Kokhanovsky, S. Bursztein – De Myttenaere, R. Pizov P240 - HFOV revisited: a 7 year retrospective analysis of patients receiving HFOV who met oscillate trial entry criteria L. Neilans, N. MacIntyre P241 - Implementation of a goal-directed mechanical ventilation order set driven by respiratory therapists can improve compliance with best practices for mechanical ventilation M. Radosevich, B. Wanta, V. Weber, T. Meyer, N. Smischney, D. Brown, D. Diedrich P242 - A reduction in tidal volumes for ventilated patients on ICU calculated from IBW. can it minimise mortality in comparison to traditional strategies? A . Fuller, P. McLindon, K. Sim P243 - Predictive value of lung aeration scoring using lung ultrasound in weaning failure M. Shoaeir, K. Noeam, A. Mahrous, R. Matsa, A. Ali P244 - Conventional versus automated weaning from mechanical ventilation using SmartCare™ C. Dridi, S. Koubaji, S. Kamoun, F. Haddad, A. Ben Souissi, B. Laribi, A. Riahi, M. S. Mebazaa P245 - Ultrasonographic evaluation protocol for weaning from mechanichal ventilation A. Pérez-Calatayud, R. Carrillo-Esper, A. Zepeda-Mendoza, M. Diaz-Carrillo, E. Arch-Tirado P246 - Diaphragm ultrasonography: a method for weaning patients from mechanical ventilation S. Carbognin, L. Pelacani, F. Zannoni, A. Agnoli, G. Gagliardi P247 - Dorsal diaphragmatic excursion tracks transpulmonary pressure in ventilated ARDS patients: a potential non-invasive indicator of lung recruitment? R. Cho, A. Adams , S. Lunos, S. Ambur, R. Shapiro, M. Prekker P248 - Pulse oximetry in the icu patient: is the perfusion index of any value? M. Thijssen, L. Janssen, N. Foudraine P249 - Ventilation is a better assessment of respiratory status than EtCO2 C. J. Voscopoulos, J. Freeman P250 - Evaluation of the relationship between non-invasive minute ventilation and end-tidal CO2 in patients undergoing general vs spinal anesthesia C. J. Voscopoulos, J. Freeman, E. George P251 - Respiratory volume monitoring provides early warning of respiratory depression and can be used to reduce false alarms in non-intubated patients C. J. Voscopoulos, D. Eversole, J. Freeman, E. George P252 - P/i index: a predictive edi-derived weaning index during nava S. Muttini, R. Bigi, G. Villani, N. Patroniti P253 - Adequacy of ventilation in patients receiving opioids in the post anesthesia care unit: minute ventilation versus respiratory rate G. Williams, C. J. Voscopoulos, J. Freeman, E. George P254 - Comparison of regional and global expiratory time constants measured by electrical impedance tomography (EIT) A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis P255 - Electrical impedance tomography: robustness of a new pixel wise regional expiratory time constant calculation A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis P256 - Validation of regional and global expiratory time constant measurement by electrical impedance tomography in ards and obstructive pulmonary diseases C. K. Karagiannidis, A. W. Waldmann, S. B. Böhm, S. Strassmann, W. W. Windisch P257 - Transpulmonary pressure in a model with elastic recoiling lung and expanding chest wall P. Persson, S. Lundin, O. Stenqvist P258 - Lactate in pleural and abdominal effusion G. Porta, F. Numis, C. S. Serra, A. P. Pagano, M. M. Masarone, L. R. Rinaldi, A. A. Amelia, M. F. Fascione, L. A. Adinolfi, E. R. Ruggiero P259 - Outcome of patients admitted to the intensive care with pulmonary fibrosis F. Asota, K. O’Rourke, S. Ranjan, P. Morgan P260 - Sedation and analgesia practice in extra-corporeal membrane oxygenation (ECMO)-treated patients with acute respiratory distress syndrome (ARDS): a retrospective study J. W. DeBacker, E. Tamberg, L. O’Neill, L. Munshi, L. Burry, E. Fan, S. Mehta P261 - Characteristics and outcomes of patients deemed not eligible when referred for veno-venous extracorporeal membrane oxygenation (vv-ECMO) S. Poo, K. Mahendran, J. Fowles, C. Gerrard, A. Vuylsteke P262 - The SAVE SMR for veno-arterial ECMO R. Loveridge, C. Chaddock, S. Patel, V. Kakar, C. Willars, T. Hurst, C. Park, T. Best, A. Vercueil, G. Auzinger P263 - A simplified score to predict early (48 h) mortality in patients being considered for VA-ECMO A. Borgman, A. G. Proudfoot, E. Grins, K. E. Emiley, J. Schuitema, S. J. Fitch, G. Marco, J. Sturgill, M. G. Dickinson, M. Strueber, A. Khaghani, P. Wilton, S. M. Jovinge P264 - Lung function six months post extra corporeal membrane oxygenation (ECMO) for severe acute respiratory failure in adult survivors C. Sampson, S. Harris-Fox P265 - Bicarbonate dialysis removes carbon dioxide in hypoventilated rodents. M. E. Cove, L. H. Vu, A. Sen, W. J. Federspiel, J. A. Kellum P266 - Procalcitonin as predictor of primary graft dysfunction and mortality in post-lung transplantation C. Mazo Torre, J. Riera, S. Ramirez, B. Borgatta, L. Lagunes, J. Rello P267 - New molecular biomarkers of acute respiratory distress syndrome in abdominal sepsis A. K. Kuzovlev, V. Moroz, A. Goloubev, S. Polovnikov, S. Nenchuk P268 - Tight junction’s proteins claudin -5 and regulation by tnf in experimental murine lung injury model of ali/ards V. Karavana, C. Glynos, A. Asimakos, K. Pappas, C. Vrettou, M. Magkou, E. Ischaki, G. Stathopoulos, S. Zakynthinos P269 - Cell counts in endobronchial aspirate to assess airway inflammation in ARDS patients: a pilot study S. Spadaro, I. Kozhevnikova, F. Dalla Corte, S. Grasso, P. Casolari, G. Caramori, C. Volta P270 - Epidemiological and clinical profile of patients with acute respiratory distress syndrome in the surgical intensive care unit surgical, hospital JRA, Antananarivo T. Andrianjafiarinoa, T. Randriamandrato, T. Rajaonera P271 - Effect of high PEEP after recruitment maneuver on right ventricular function in ARDS. Is it good for the lung and for the heart? S. El-Dash, ELV Costa, MR Tucci, F Leleu, L Kontar, B. De Cagny, F. Brazier, D. Titeca, G. Bacari-Risal, J. Maizel, M. Amato, M. Slama P272 - Effect of recruitment maneuver on left ventricular systolic strain P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, S. El Dash, M. Slama P273 - Inhaled nitric oxide – is switching supplier cost effective? Remmington, A. Fischer, S. Squire, M. Boichat P274 - Epidemiological study of severe acute pancreatitis in Japan, comparison of the etiology and the patient outcomes on 1159 patients. H. Honzawa, H. Yasuda, T. Adati, S. Suzaki, M. Horibe, M. Sasaki, M. Sanui P275 - Extracorporeal liver support therapy. Experience in an intensive care unit R. Marinho, J. Daniel, H. Miranda, A. Marinho P276 - Accuracy of mortality prediction models in acute versus acute-on-chronic liver failure in the intensive care setting K. Milinis, M. Cooper, G. R. Williams, E. McCarron, S. Simants, I. Patanwala, I. Welters P277 - Risk of coronary artery disease in patients with chronic liver disease: a population based cohort study Y. Su P278 - 20 years of liver transplantation in Santiago de Compostela (Spain). Experience review J. Fernández Villanueva, R. Fernández Garda, A. López Lago, E. Rodríguez Ruíz, R. Hernández Vaquero, S. Tomé Martínez de Rituerto, E. Varo Pérez P279 - Diarrhea is a risk factor for liver injury and may lead to intestinal failure associated liver disease in critical illness N. Lefel, F. Schaap, D. Bergmans, S. Olde Damink, M. Van de Poll P280 - Bowel care on the intensive care unit: constipation guideline compliance and complications K. Tizard, C. Lister, L. Poole P281 - Malnutrition assessed by phase angle determines outcomes in low risk cardiac surgery patients D. Ringaitiene, D. Gineityte, V. Vicka, I. Norkiene, J. Sipylaite P282 - Preoperative fasting times in an irish hospital A. O’Loughlin, V. Maraj, J. Dowling P283 - Costs and final outcome of early x delayed feeding in a private Brazil ICU M. B. Velasco, D. M. Dalcomune, E. B. Dias, S. L. Fernandes P284 - Can ventilator derived energy expenditure measurements replace indirect calorimetry? T. Oshima, S. Graf, C. Heidegger, L. Genton, V. Karsegard, Y. Dupertuis, C. Pichard P285 - Revisiting the refeeding syndrome: results of a systematic review N. Friedli, Z. Stanga, B. Mueller, P. Schuetz P286 - Compliance with the new protocol for parenteral nutrition in our ICU L. Vandersteen, B. Stessel, S. Evers, A. Van Assche, L. Jamaer, J. Dubois P287 - Nutrition may be another treatment in the intensive care unit where less is more? R. Marinho, H. Castro, J. Moura, J. Valente, P. Martins, P. Casteloes, C. Magalhaes, S. Cabral, M. Santos, B. Oliveira, A. Salgueiro, A. Marinho P288 - Should we provide more protein to critically ill patients? R. Marinho, M. Santos, E. Lafuente, H. Castro, S. Cabral, J. Moura, P. Martins, B. Oliveira, A. Salgueiro, S. Duarte, S. Castro, M. Melo, P. Casteloes, A. Marinho P289 Protein provision in an adult intensive care unit S. Gray P290 - Prevalence and clinical outcomes of vitamin d deficiency in the medical critically ill patients in Songklanagarind hospital K. Maipang, R. Bhurayanontachai P291 - Vitamin d deficiency strongly predicts adverse medical outcome across different medical inpatient populations: results from a prospective study L. G. Grädel, P. Schütz P292 - Omega-3 fatty acids in patients undergoing cardiac surgery: a systematic review and meta-analysis P. Langlois, W. Manzanares P293 - Can 5-hydroxytriptophan prevent post-traumatic stress disorder in critically ill patients? R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P294 - Parenteral selenium in the critically ill: an updated systematic review and meta-analysis W. Manzanares, P. Langlois, M. Lemieux, G. Elke, F. Bloos, K. Reinhart, D. Heyland P295 - Probiotics in the critically ill: an updated systematic review and meta-analysis P. Langlois, M. Lemieux, I. Aramendi, D. Heyland, W. Manzanares P296 - Diabetes with hyperglycemic crisis episodes may be associated with higher risk of pancreatic cancer: a population-based cohort study Y. Su P297 - Incidence of hypoglycemia in an intensive care unit depending on insulin protocol R. Marinho, N. Babo, A. Marinho P298 - Severity of the diseases is two-dimensionally correlated to blood glucose, including blood glucose variability, especially in moderately to severely ill patients with glucose intolerance. M. Hoshino, Y. Haraguchi, S. Kajiwara, T. Mitsuhashi, T. Tsubata, M. Aida P299 - A study of glycemic control by subcutaneous glargine injection transition from continuous regular insulin infusion in critically ill patients T. Rattanapraphat, R. Bhurayanontachai, C. Kongkamol, B. Khwannimit P300 - Glycemic control in Portuguese intensive care unit R. Marinho, M. Santos, H. Castro, E. Lafuente, A. Salgueiro, S. Cabral, P. Martins, J. Moura, B. Oliveira, M. Melo, B. Xavier, J. Valente, C. Magalhaes, P. Casteloes, A. Marinho P301 - Impact of hyperglycemia duration on the day of operation on short-term outcome of cardiac surgery patients D. Moisidou, F. Ampatzidou, C. Koutsogiannidis, M. Moschopoulou, G. Drossos P302 - Lactate levels in diabetic ketoacidosis patients at ICU admissions G. Taskin, M. Çakir, AK Güler, A. Taskin, N. Öcal, S. Özer, L. Yamanel P303 - Intensive care implications of merging heart attack centre units in London J. M. Wong, C. Fitton, S. Anwar, S. Stacey P304 - Special characteristics of in-hospital cardiac arrests M. Aggou, B. Fyntanidou, S. Patsatzakis, E. Oloktsidou, K. Lolakos, E. Papapostolou, V. Grosomanidis P305 - Clinical evaluation of ICU-admitted patients who were resuscitated in the general medicine ward S. Suda , T. Ikeda, S. Ono, T. Ueno, Y. Izutani P306 - Serious game evaluation of a one-hour training basic life support session for secondary school students: new tools for future bystanders S. Gaudry, V. Desailly, P. Pasquier, PB Brun, AT Tesnieres, JD Ricard, D. Dreyfuss, A. Mignon P307 - Public and clinical staff perceptions and knowledge of CPR compared to local and national data J. C White, A. Molokhia, A. Dean, A. Stilwell, G. Friedlaender P308 Dispatcher-assisted telephone cardiopulmonary resuscitation using a French-language compression-ventilation pediatric protocol M. Peters, S. Stipulante, A. Delfosse, AF Donneau, A. Ghuysen P309 Dantrolene versus amiodarone for resuscitation – an experimental study C. Feldmann, D. Freitag, W. Dersch, M. Irqsusi, D. Eschbach, T. Steinfeldt, H. Wulf, T. Wiesmann P310 Long term survival and functional neurological outcome in comatose survivors undergoing therapeutic hypothermia N. Kongpolprom, J. Cholkraisuwat P311 Impact of kidney disease on mortality and neurological outcome in out-of-hospital cardiac arrest: a prospective observational study S. Beitland , E. Nakstad, H. Stær-Jensen , T. Drægni , G. Andersen , D. Jacobsen , C. Brunborg, B. Waldum-Grevbo , K. Sunde P312 ICU dependency of patients admitted after primary percutaneous coronary intervention (PPCI) following out of the hospital cardiac arrest K. Hoyland, D. Pandit P313 Prognostic indicators and outcome prediction model for patients with return of spontaneous circulation from cardiopulmonary arrest: comprehensive registry of in-hospital intensive care on OHCA survival (critical) study in Osaka, Japan K. Hayakawa P314 Cerebral oxygen saturation during resuscitation in a porcine model of cardiac arrest E. Oloktsidou, K. Kotzampassi, B. Fyntanidou, S. Patsatzakis, L. Loukipoudi, E. Doumaki, V. Grosomanidis P315 Presumption of cardiopulmonary resuscitation for sustaining cerebral oxidation using regional cerebral saturation of oxygen: observational cohort study (press study) H. Yasuda P316 EEG reactivity in patients after cardiac arrest: a close look at stimuli MM Admiraal, M. Van Assen, MJ Van Putten, M. Tjepkema-Cloostermans, AF Van Rootselaar, J. Horn P317 Prognostic value of neuron-specific enolase after cardiac arrest F. Ragusa, A. Marudi , S. Baroni, A. Gaspari, E. Bertellini P318 Correlation between electroencephalographic findings and serum neuron specific enolase with outcome of post cardiac arrest patients A. Taha, T. Abdullah, S. Abdel Monem P319 Introduction of a targeted temperature management strategy following cardiac arrest in a district general hospital intensive care unit. S. Alcorn, S. McNeill, S. Russell P320 The evolution of cerebral oxygen saturation in post-cardiac arrest patients treated with therapeutic hypothermia W. Eertmans, C. Genbrugge, I. Meex, J. Dens, F. Jans, C. De Deyne P321 Prognostic factors and neurological outcomes of therapeutic hypothermia in comatose survivors from cardiac arrest: 8-year single center experience J. Cholkraisuwat, N. Kongpolprom P322 Adherence to targeted temperature management after out of hospital cardiac arrest B. Avard, R. Burns P323 Implementation of a therapeutic hypothermia protocol for comatose survivors of out-of-hospital cardiac arrest. A. Patarchi, T. Spina P324 Factors associated with ventilator weaning after targeted temperature management for cardiac arrest patients in japan H. Tanaka, N. Otani, S. Ode, S. Ishimatsu P325 Differential activation of c-fos in paraventricular nuclei of the hypothalamus and thalamus of the rat following myocardial infarction J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin, M. H. Won P326 Monitoring of cTroponin I in patients with acute ischemic stroke - predictor of inhospital mortality S. Dakova, Z. Ramsheva, K. Ramshev P327 Hyperthermic preconditioning severely accelerates neuronal damage in the gerbil ischemic hippocampal dentate gyrus via decreasing sods expressions J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P328 Failure in neuroprotection of remote limb ischemic post conditioning in the hippocampus of a gerbil model of transient cerebral ischemia J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P329 Brain death and admission diagnosis in neurologic intensive care unit, a correlation? A Marudi, S Baroni, A Gaspari, E Bertellini P330 Brain magnetic resonance imaging findings in patients with septic shock G. Orhun, E. Senturk, P. E. Ozcan, S. Sencer, C. Ulusoy, E. Tuzun, F . Esen P331 Benefits of L-carnitine in valproic acid induced encephalopathy R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P332Automatic analysis of EEG reactivity in comatose patients M. Van Assen, M. M. Admiraal, M. J. Van Putten, M. Tjepkema-Cloostermans, A. F. Van Rootselaar, J. Horn P333 Usefulness of common ICU severity scoring systems in predicting outcome after spontaneous intracerebral hemorrhage M. Fallenius, M. B. Skrifvars, M. Reinikainen, S. Bendel, R. Raj P334 Evalution of patients with suspected subarachnoid haemorrhage and negative ct imaging M. Abu-Habsa, C. Hymers, A. Borowska, H. Sivadhas, S. Sahiba, S. Perkins P335 Timing of endovascular and surgical treatment for aneurysmal subarachnoid haemorrhage: early but not so fast. J. Rubio, J. A. Rubio, R. Sierra P336 Red blood cell transfusion in aneurysmal subarachnoid hemorrhage – the Sahara cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P337 - Aneurysmal subarachnoid hemorrhage and anemia: a canadian multi-centre retrospective cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P338 - Does the neutrophil-to-lymphocyte (NLR) ratio predict symptomatic vasospasm or delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (SAH)? T. Groza, N. Moreau, D. Castanares-Zapatero, P. Hantson P339 - ICU-acquired infections in aneurysmal subarachnoid hemorrhage patients: impact on ICU and hospital length of stay M. Carbonara , F. Ortolano, T. Zoerle, S. Magnoni, S. Pifferi, V. Conte, N. Stocchetti P340 - Cerebral metabolic effects of normobaric hyperoxia during the acute phase of aneurysmal subarachnoid hemorrhage L. Carteron, T. Suys, C. Patet, H. Quintard, M. Oddo P341 - Postoperative care for elective craniotomy: where is best done? J. A. Rubio, J. Rubio, R. Sierra P342 - 5-year follow-up of patients after transplantation of organs from donors from neurocritical care V. Spatenkova, E. Pokorna, P. Suchomel P343 - Evaluation of levetiracetam pharmacokinetics after severe traumatic brain injury in neurocritical care patients at a level one trauma center N. Ebert, J. Jancik, H. Rhodes P344 - Model based time series cluster analysis to determine unique patient states in traumatic brain injury T. Bylinski, C. Hawthorne, M. Shaw, I. Piper, J. Kinsella P345 - Brain compartment monitoring capabilities from ICP to BI (bioimpedance) during HS (hypertonic saline) administration. State of art simulation outcome depending on brain swelling type A. K. Kink , I. R. Rätsep P346 - Transfusion of red blood cells in patients with traumatic brain injury admitted to Canadian trauma health centers: a multicenter cohort study A. Boutin, L. Moore, M. Chasse, R. Zarychanski, F. Lauzier, S. English, L. McIntyre, J. Lacroix, D. Griesdale, P. Lessard-Bonaventure, A. F. Turgeon P347 - Hemoglobin thresholds and red blood cell transfusions in adult patients with moderate or severe traumatic brain injury: a retrospective cohort study A. Boutin, L. Moore, R. Green, P. Lessard-Bonaventure, M. Erdogan, M. Butler, F. Lauzier, M. Chasse, S. English, L. McIntyre, R. Zarychanski, J. Lacroix, D. Griesdale, P. Desjardins, D. A. Fergusson, A. F. Turgeon P348 - Characteristics of patients with gunshot wounds to the head - an observational Brazilian study B. Goncalves, B. Vidal, C. Valdez, A. C. Rodrigues, L. Miguez, G. Moralez P349 - Base excess as predictor for ICU admission and the injury severity in blunt trauma patients T. Hong P350 - Enhancement of usual emergency department care with proadrenomedullin to improve outcome prediction - Results from the multi-national, prospective, observational TRIAGE study A. Kutz, P. Hausfater, D. Amin, T. Struja, S. Haubitz, A. Huber, B. Mueller, P. Schuetz P351 - Developing an innovative emergency medicine point-of-care simulation programme T. Brown, J. Collinson, C. Pritchett, T. Slade P352 - The InSim program: an in situ simulation program for junior trainees in intensive care M. Le Guen, S. Hellings, R. Ramsaran P353 - Impact of excessive and inappropriate troponin testing in the emergency setting how good are we A. Alsheikhly P354 - The development of time tracking monitor at emergency department T. Abe P355 - Role of focussed echocardiography in emergency assessment of syncope L. Kanapeckaite, M. Abu-Habsa, R. Bahl P356 - Insertion of an open-ended 14-gauge catheter through the chest wall causes a significant pneumothorax in a self-ventilating swine model M. Q Russell, K. J. Real, M. Abu-Habsa , R. M. Lyon, N. P. Oveland P357 - Ez-io® intraosseous access teaching in the workplace using a mobile ‘tea trolley’ training method J. Penketh, M. Mcdonald, F. Kelly P358 - Black widow envenomation in Saudi Arabia: a prospective observational case series M. Alfafi, S. Alsolamy, W. Almutairi, B. Alotaibi P359 - Mechanical ventilation in patients with overdose not yet intubated on icu admission A. E. Van den Berg, Y. Schriel, L. Dawson, I. A. Meynaar P360 - Central nervous system depressants poisoning and ventilator associated pneumonia: an underrated risk factor in toxicological intensive care unit H. Talaie P361 - Acute barium intoxication treated with hemodiafiltration D. Silva, S. Fernandes, J. Gouveia, J. Santos Silva P362 - Major trauma presenting to the emergency department. the spectrum of cycling injuries in Ireland J. Foley, A. Kaskovagheorgescu, D. Evoy, J. Cronin, J. Ryan P363 - Burns from French military operations: a 14-year retrospective observational analysis. M. Huck, C. Hoffmann, J. Renner, P. Laitselart, N. Donat, A. Cirodde, J. V. Schaal, Y. Masson, A. Nau, T. Leclerc P364 - A comparison of mortality scores in burns patients on the intensive care unit. O. Howarth, K. Davenport, P. Jeanrenaud, S. Raftery P365 - Clasification of pain and its treatment and an intensive care rehabiliation clinic P. MacTavish, H. Devine, J. McPeake, M. Daniel, J. Kinsella, T. Quasim P366 - Pain management adequacy in critical care areas ,the process and the barriers perceived by critical care nurses S. Alrabiee, A. Alrashid , S. Alsolamy P367 - Pain assessment in critically ill adult patients: validation of the Turkish version of the critical-care pain observation tool O. Gundogan, C. Bor, E. Akýn Korhan, K. Demirag , M. Uyar P368 - An audit of pain and sedation assessments in the intensive care unit: recommendations for clinical practice F. Frame, C. Ashton, L. Bergstrom Niska P369 - Impact of pharmaceutical care on treatment of pain and agitation in medical intensive care unit P. Dilokpattanamongkol, T. Suansanae, C. Suthisisang, S. Morakul, C. Karnjanarachata, V. Tangsujaritvijit P370 - Agitation in trauma ICU, prevention and outcome S. Mahmood, H. Al Thani, A. Almenyar P371 Correlation between percentages of ventilated patients developed vap and use of sedative agents in icu patients. A. Vakalos , V. Avramidis P372 - Improving recording of sedation events in the Emergency Department: The implementation of the SIVA International Taskforce adverse event reporting tool for procedural sedation R. Sharvill, J. Penketh P373 - Impact of sedative drug use on the length of mechanical ventilation S. E. Morton, Y. S. Chiew, C. Pretty, J. G. Chase, G. M. Shaw P374 - Co-administration of nitric oxide and sevoflurane using anaconda R. Knafelj, P. Kordis P375 - A retrospective study of the use of Dexmedetomidine in an oncological critical care setting S. Patel, V. Grover P376 - Dexmedetomidine and posttraumatic stress disorder incidence in alcohol withdrawal icu patients I. Kuchyn, K. Bielka P377 - Hemodynamic effects of dexmedetomidine in a porcine model of septic shock Z. Aidoni, V. Grosomanidis, K. Kotzampassi, G. Stavrou, B. Fyntanidou, S. Patsatzakis, C. Skourtis P378 - Ketamine for analgosedation in severe hypoxic respiratory failure S. D. Lee, K. Williams, I. D. Weltes P379 - Madness from the moon? lunar cycle and the incidence of delirium on the intensive care unit S. Berhane, C. Arrowsmith, C. Peters, S. Robert P380 - Impaired dynamic cerebral autoregulation after coronary artery bypass grafting and association with postoperative delirium J. Caldas, R. B. Panerai, T. G. Robinson, L. Camara, G. Ferreira, E. Borg-Seng-Shu, M. De Lima Oliveira, N. C. Mian, L. Santos, R. Nogueira, S. P. Zeferino, M. Jacobsen Teixeira, F. Galas, L. A. Hajjar P381 - Risk factors predicting prolonged intensive care unit length of stay after major elective surgery. P. Killeen, M. McPhail, W. Bernal, J. Maggs, J. Wendon, T. Hughes P382 - Systemic inflammatory response syndrome criteria and hospital mortality prediction in a brazilian cohort of critically ill patients L. U. Taniguchi, E. M. Siqueira, J. M. Vieira Jr, L. C. Azevedo P383 - Evaluating the efficacy of a risk predictor panel in identifying patients at elevated risk of morbidity following emergency admission A. N. Ahmad, M. Abu-Habsa, R. Bahl, E. Helme, S. Hadfield, R. Loveridge P384 - A retrospective comparison of outcomes for elective surgical patients admitted post-operatively to the critical care unit or general ward J. Shak, C. Senver, R. Howard-Griffin P385 - Effect of obesity on mortality in surgical critically ill patients. P. Wacharasint, P. Fuengfoo, N. Sukcharoen, R. Rangsin P386 - The national early warning score (news) reliably improves adverse clinical outcome prediction in community-acquired pneumonia - results from a 6 year follow-up D. Sbiti-Rohr, P. Schuetz P387 - Clinical usefulness of the charlson¡¯s weighted index of comorbidities _as prognostic factor in patients with prolonged acute mechanical ventilation H. Na, S. Song, S. Lee, E. Jeong, K. Lee P388 - Comparison of mortality prediction scoring systems in patients with cirrhosis admitted to general intensive care unit M. Cooper, K. Milinis, G. Williams, E. McCarron, S. Simants, I. Patanwala, I. D. Welters P389 - Impact of admission source and time of admission on outcome of pediatric intensive care patients: retrospective 15 years study E. Zoumpelouli, EA Volakli, V. Chrysohoidou, S. Georgiou, K. Charisopoulou, E. Kotzapanagiotou, V. Panagiotidou, K. Manavidou, Z. Stathi, M. Sdougka P390 - Heart rate variability and outcomes prediction in critical illness N. Salahuddin, B. AlGhamdi, Q. Marashly, K. Zaza, M. Sharshir, M. Khurshid, Z. Ali, M. Malgapo, M. Jamil, A. Shafquat, M. Shoukri, M. Hijazi P391 - The incidence and outcome of hyperlactatemia in the post anaesthesia care unit T. Abe, S. Uchino, M. Takinami P392 - Correlation between arterial blood gas disturbances and arterial lactate levels during hospitalization and outcome in critically septic patients N. R. Rangel Neto, S. Oliveira, F. Q. Reis, F. A. Rocha P393 - External validation of saps 3 and mpm iii scores in 48,816 patients from 72 brazilian icus G. Moralez, K. Ebecken, L. S. Rabello, M. F. Lima, R. Hatum, F. V. De Marco, A. Alves, J. E. Pinto, M. Godoy, P. E. Brasil, F. A. Bozza, J. I. Salluh, M. Soares P394 - The frailty penalty: pre-admission functional status confounds mortality prediction models in critically ill patients J. Krinsley, G. Kang P395 - ‘sooner rather than later”: how delayed discharge from critical care leads to increased out of hours discharges and subsequent increase in in-hospital mortality. J. Perry, H. Hines P396 - Identifying poor outcome patient groups in a resource-constrained critical care unit K. M. Wilkinson, C. Tordoff, B. Sloan, M. C. Bellamy P397 - Effects of icu weekend admission and discharge on mortality. E. Moreira, F. Verga, M. Barbato, G. Burghi P398 - Organizational factors, outcomes and resource use in 9,946 cancer patients admitted to 70 ICUs M Soares, U. V. Silva, L. C. Azevedo, A. P. Torelly, J. M. Kahn, D. C. Angus, M. F. Knibel, P. E. Brasil, F. A. Bozza, J. I. Salluh P399 - Evaluation of oncological critically ill patients, severity score and outcome compared to not oncological in a particular hospital cti. M. B. Velasco, D. M. Dalcomune P400 - Outcomes of patients admitted to a large uk critical care department with palliative oncological diagnoses R. Marshall, T. Gilpin, A. Tridente, A. Raithatha P401 - Predictors of mortality in febrile neutropenic patients with haematological malignancies admitted to an intensive care unit of a cancer center D. Mota, B. Loureiro, J. Dias, O. Afonso, F. Coelho, A. Martins, F. Faria P402 - Patients with hematologic malignancies requiring invasive mechanical ventilation: characteristics and predictors of mortality H. Al-Dorzi, H. Al Orainni , F. AlEid, H. Tlaygeh, A. Itani, A. Hejazi, Y. Arabi P403 - Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review S. Gaudry, J. Messika, J. D. Ricard, S. Guillo, B. Pasquet, E. Dubief, D. Dreyfuss, F. Tubach P404 - Alopecia in survivors of critical illness: a qualitative study C . Battle, K. James, P. Temblett P405 - The impact of mental health on icu admission L. Davies, C. Battle, C. Lynch P406 - Cognitive impairment 5 years after ICU discharge S. Pereira, S. Cavaco, J. Fernandes, I. Moreira, E. Almeida, F. Seabra Pereira, M. Malheiro, F. Cardoso, I. Aragão, T. Cardoso P407 - Apache ii versus apache iv for octagenerians in medical icu M. Fister, R. Knafelj P408 - Outcomes of octagenarians in an indian icu P. Muraray Govind, N. Brahmananda Reddy, R. Pratheema, E. D. Arul, J. Devachandran P409 - Mortality and outcomes in elderly patients 80 years of age or older admitted to the icu M. B. Velasco , D. M. Dalcomune P410 - Octagenerians in medical icu - adding days to life or life to days? R. Knafelj, M. Fister P411 - The very elderly admitted to intensive care unit: outcomes and economic evaluation N. Chin-Yee, G. D’Egidio, K. Thavorn, D. Heyland, K. Kyeremanteng P412 - The very elderly in intensive care: relationship between acuity of illness and long-term mortality A. G. Murchison, K. Swalwell, J. Mandeville, D. Stott P413 - Acquired weakness in an oncological intensive care unit I. Guerreiro P414 - Musculoskeletal problems in intensive care unit (ICU) patients post-discharge H. Devine, P. MacTavish, J. McPeake, T. Quasim, J. Kinsella, M. Daniel P415 - Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness C. Goossens M. B. Marques, S. Derde, S. Vander Perre, T. Dufour, S. E. Thiessen, F. Güiza, T. Janssens, G. Hermans, I. Vanhorebeek, K. De Bock, G. Van den Berghe, L. Langouche P416 - Physical outcome measures for critical care patients following intensive care unit (icu) discharge H. Devine, P. MacTavish, T. Quasim, J. Kinsella, M. Daniel, J. McPeake P417 - Improving active mobilisation in a general intensive care unit B. Miles , S. Madden, H. Devine P418 - Mobilization in patients on vasoactive drugs use – a pilot study. M. Weiler, P. Marques, C. Rodrigues, M. Boeira, K. Brenner, C. Leães, A. Machado, R. Townsend, J. Andrade P419 - Pharmacy intervention at an intensive care rehabilitation clinic P. MacTavish, J. McPeake, H. Devine, J. Kinsella, M. Daniel, R. Kishore, C. Fenlon, T. Quasim P420 - Interactive gaming is feasible and potentially increases icu patients’ motivation to be engaged in rehabilitation programs T. Fiks, A. Ruijter, M. Te Raa, P. Spronk P421 - Simulation-based design of a robust stopping rule to ensure patient safety Y. S. Chiew, P. Docherty, J. Dickson, E. Moltchanova, C. Scarrot, C. Pretty, G. M. Shaw, J. G. Chase P422 - Are daily blood tests on the intensive care unit necessary? T. Hall, W. C. Ngu, J. M. Jack, P. Morgan P423 - Measuring urine output in ward patients: is it helpful? B. Avard, A. Pavli, X. Gee P424 - The incidence of pressure ulcers in an adult mixed intensive care unit in turkey C . Bor, E. Akin Korhan, K. Demirag, M. Uyar P425 - Intensivist/patient ratios in closed ICUs in Alexandria, Egypt; an overview M. Shirazy, A. Fayed P426 - Eicu (electronic intensive care unit): impact on ALOS (average length of stay) in a developing country like India S. Gupta, A. Kaushal, S. Dewan, A. Varma P427 - Predicting deterioration in general ward using early deterioration indicator E. Ghosh, L. Yang, L. Eshelman, B. Lord, E. Carlson P428 - High impact enhanced critical care outreach - the imobile service: making a difference E. Helme, R. Broderick, S. Hadfield, R. Loveridge P429 - Impact of bed availability and cognitive load on intensive care unit (ICU) bed allocation: a vignette-based trial J. Ramos, D. Forte P430 - Characteristics of critically ill patients admitted through the emergency department F. Yang, P. Hou P431 - Admission to critical care: the quantification of functional reserve J. Dudziak, J. Feeney, K. Wilkinson, K. Bauchmuller, K. Shuker, M. Faulds, A. Raithatha, D. Bryden, L. England, N. Bolton, A. Tridente P432 - Admission to critical care: the importance of frailty K. Bauchmuller, K Shuker, A Tridente, M Faulds, A Matheson, J. Gaynor, D Bryden, S South Yorkshire Hospitals Research Collaboration P433 - Development of an instrument to aid triage decisions for intensive care unit admission J. Ramos, B. Peroni, R. Daglius-Dias, L. Miranda, C. Cohen, C. Carvalho, I . Velasco, D. Forte P434 - Using selective serotonin re-uptake inhibitors and serotonin-norepinephrine re-uptake inhibitors in critical care: a systematic review of the evidence for benefit or harm J. M. Kelly, A. Neill, G. Rubenfeld, N. Masson, A. Min P435 - Measuring adaptive coping of hospitalized patients with a severe medical condition:the sickness insight in coping questionnaire (sicq) E. Boezeman, J. Hofhuis , A. Hovingh, R. De Vries, P. Spronk P436 - Results of a national survey regarding intensive care medicine training G. Cabral-Campello, I. Aragão, T. Cardoso P437 - Work engagement among healthcare professionals in the intensive care unit M. Van Mol, M. Nijkamp, E . Kompanje P438 - Empowering the intensive care practitioners. is it a burnout ameliorating intervention? P. Ostrowski, A. Omar P439 - Icu patients suffer from circadian rhythm desynchronisation K. Kiss , B. Köves, V. Csernus, Z. Molnár P440 - Noise reduction in the ICU: feasible ? Y. Hoydonckx, S. Vanwing, B. Stessel, A. Van Assche, L. Jamaer, J. Dubois P441 - Accidental removal of invasive devices in the critical patient into the bed-washing. does the presence of professional nurse modify his incidence? V. Medo, R. Galvez, J. P. Miranda P442 - Deprivation of liberty safeguards (dols): audit of compliance in a of a 16-bed specialist cancer critical care unit. C. Stone, T. Wigmore P443 - Use of a modified cristal score to predict futility of critical care in the elderly Y. Arunan, A. Wheeler, K. Bauchmuller, D. Bryden P444 - Improvement of Referral Rate to Palliative Care for Patients with Poor Prognosis in Neurosurgical Intensive Care Unit Y. Wong, C. Poi, C. Gu P445 - Factors associated with limitation of life supporting care (lsc) in a medico-surgical intermediate care unit, and outcome of patients with lsc limitation: a monocentric, six-month study. P. Molmy, N. Van Grunderbeeck, O. Nigeon, M. Lemyze, D. Thevenin, J. Mallat P446 - Palliative care consultation and intensive care unit admission request: a cohort study J. Ramos, M. Correa, R. T. Carvalho, D. Forte P447 - Nursing and medicine together in postsurgical intensive care unit: situations of prognostic conflict at the end of life. our critical care nurses suffer with our medical activism? A. Fernandez, C. McBride P448 - End of life who may decide E. Koonthalloor, C. Walsh P449 - Correctly diagnosing death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud P450 - Skin procurement performed by intensive care physicians: yes, we can. A. Marudi , S. Baroni, F. Ragusa, E. Bertellini P451 - Death analysis in pediatric intensive care patients E. A. Volakli , E. Chochliourou, M. Dimitriadou, A. Violaki, P. Mantzafleri, E. Samkinidou, O. Vrani, A. Arbouti, T. Varsami, M. Sdougka P452 - The potential impact of euthanasia on organ donation: analysis of data from belgium J. A. Bollen, T. C. Van Smaalen, W. C. De Jongh, M. M. Ten Hoopen, D. Ysebaert, L. W. Van Heurn, W. N. Van Mook P453 - Communication within an intensive care setting K. Sim, A. Fuller P454 - Development and implementation of a longitudinal communication curriculum for critical care medicine fellows A. Roze des Ordons, P. Couillard, C. Doig P455 - Staff-family conflict in a multi-ethnic intensive care unit R. V. Van Keer, R. D. Deschepper, A. F. Francke, L. H. Huyghens, J. B. Bilsen P456 - Does the source of admission to critical care affect family satisfaction? B. Nyamaizi, C. Dalrymple, A. Molokhia, A. Dobru P457 - A simple alternative to the family satisfaction survey (fs-icu) E. Marrinan, A. Ankuli, A. Molokhia P458 - A study to explore the experiences of patient and family volunteers in a critical care environment: a phenomenological analysis J. McPeake, R. Struthers, R. Crawford , H. Devine , P. Mactavish , T. Quasim P459 - Prevalence and risk factors of anxiety and depression in relatives of burn patients. P. Morelli, M. Degiovanangelo, F. Lemos, V. MArtinez, F. Verga, J. Cabrera, G. Burghi P460 - Guidance of visiting children at an adult intensive care unit (icu) A. Rutten , S. Van Ieperen, S. De Geer, M. Van Vugt, E. Der Kinderen P461 - Visiting policies in Italian pediatric ICUs: an update A. Giannini, G Miccinesi, T Marchesi, E Prandi",10.1186/s13054-016-1208-6,1vimqhdp,"['P001', 'Sepsis', 'impairs', 'the', 'capillary', 'response', 'within', 'hypoxic', 'capillaries', 'and', 'decreases', 'erythrocyte', 'oxygen', 'dependent', 'ATP', 'efflux', 'R', 'M', 'Bateman', 'M', 'D', 'Sharpe', 'J', 'E', 'Jagger', 'C', 'G', 'Ellis', 'P002', 'Lower', 'serum', 'immunoglobulin', 'G2', 'level', 'does', 'not', 'predispose', 'to', 'severe', 'flu', 'J', 'Solé', 'Violán', 'M', 'López', 'Rodríguez', 'E', 'Herrera', 'Ramos', 'J', 'Ruíz', 'Hernández', 'L', 'Borderías', 'J', 'Horcajada', 'N', 'González', 'Quevedo', 'O', 'Rajas', 'M', 'Briones', 'F', 'Rodríguez', 'de', 'Castro', 'C', 'Rodríguez', 'Gallego', 'P003', 'Brain', 'protective', 'effects', 'of', 'intravenous', 'immunoglobulin', 'through', 'inhibition', 'of', 'complement', 'activation', 'and', 'apoptosis', 'in', 'a', 'rat', 'model', 'of', 'sepsis', 'F', 'Esen', 'G', 'Orhun', 'P', 'Ergin', 'Ozcan', 'E', 'Senturk', 'C', 'Ugur', 'Yilmaz', 'N', 'Orhan', 'N', 'Arican', 'M', 'Kaya', 'M', 'Kucukerden', 'M', 'Giris', 'U', 'Akcan', 'S', 'Bilgic', 'Gazioglu', 'E', 'Tuzun', 'P004', 'Adenosine', 'a1', 'receptor', 'dysfunction', 'is', 'associated', 'with', 'leukopenia', 'A', 'possible', 'mechanism', 'for', 'sepsis', 'induced', 'leukopenia', 'R', 'Riff', 'O', 'Naamani', 'A', 'Douvdevani', 'P005', 'Analysis', 'of', 'neutrophil', 'by', 'hyper', 'spectral', 'imaging', 'A', 'preliminary', 'report', 'R', 'Takegawa', 'H', 'Yoshida', 'T', 'Hirose', 'N', 'Yamamoto', 'H', 'Hagiya', 'M', 'Ojima', 'Y', 'Akeda', 'O', 'Tasaki', 'K', 'Tomono', 'T', 'Shimazu', 'P006', 'Chemiluminescent', 'intensity', 'assessed', 'by', 'eaa', 'predicts', 'the', 'incidence', 'of', 'postoperative', 'infectious', 'complications', 'following', 'gastrointestinal', 'surgery', 'S', 'Ono', 'T', 'Kubo', 'S', 'Suda', 'T', 'Ueno', 'T', 'Ikeda', 'P007', 'Serial', 'change', 'of', 'c1', 'inhibitor', 'in', 'patients', 'with', 'sepsis', 'A', 'prospective', 'observational', 'study', 'T', 'Hirose', 'H', 'Ogura', 'H', 'Takahashi', 'M', 'Ojima', 'J', 'Kang', 'Y', 'Nakamura', 'T', 'Kojima', 'T', 'Shimazu', 'P008', 'Comparison', 'of', 'bacteremia', 'and', 'sepsis', 'on', 'sepsis', 'related', 'biomarkers', 'T', 'Ikeda', 'S', 'Suda', 'Y', 'Izutani', 'T', 'Ueno', 'S', 'Ono', 'P009', 'The', 'changes', 'of', 'procalcitonin', 'levels', 'in', 'critical', 'patients', 'with', 'abdominal', 'septic', 'shock', 'during', 'blood', 'purification', 'T', 'Taniguchi', 'M', 'O', 'P010', 'Validation', 'of', 'a', 'new', 'sensitive', 'point', 'of', 'care', 'device', 'for', 'rapid', 'measurement', 'of', 'procalcitonin', 'C', 'Dinter', 'J', 'Lotz', 'B', 'Eilers', 'C', 'Wissmann', 'R', 'Lott', 'P011', 'Infection', 'biomarkers', 'in', 'primary', 'care', 'patients', 'with', 'acute', 'respiratory', 'tract', 'infections', 'Comparison', 'of', 'procalcitonin', 'and', 'C', 'reactive', 'protein', 'M', 'M', 'Meili', 'P', 'S', 'Schuetz', 'P012', 'Do', 'we', 'need', 'a', 'lower', 'procalcitonin', 'cut', 'off', 'H', 'Hawa', 'M', 'Sharshir', 'M', 'Aburageila', 'N', 'Salahuddin', 'P013', 'The', 'predictive', 'role', 'of', 'C', 'reactive', 'protein', 'and', 'procalcitonin', 'biomarkers', 'in', 'central', 'nervous', 'system', 'infections', 'with', 'extensively', 'drug', 'resistant', 'bacteria', 'V', 'Chantziara', 'S', 'Georgiou', 'A', 'Tsimogianni', 'P', 'Alexandropoulos', 'A', 'Vassi', 'F', 'Lagiou', 'M', 'Valta', 'G', 'Micha', 'E', 'Chinou', 'G', 'Michaloudis', 'P014', 'Changes', 'in', 'endotoxin', 'activity', 'assay', 'and', 'procalcitonin', 'levels', 'after', 'direct', 'hemoperfusion', 'with', 'polymyxin', 'b', 'immobilized', 'fiber', 'A', 'Kodaira', 'T', 'Ikeda', 'S', 'Ono', 'T', 'Ueno', 'S', 'Suda', 'Y', 'Izutani', 'H', 'Imaizumi', 'P015', 'Diagnostic', 'usefullness', 'of', 'combination', 'biomarkers', 'on', 'ICU', 'admission', 'M', 'V', 'De', 'la', 'Torre', 'Prados', 'A', 'Garcia', 'De', 'la', 'Torre', 'A', 'Enguix', 'Armada', 'A', 'Puerto', 'Morlan', 'V', 'Perez', 'Valero', 'A', 'Garcia', 'Alcantara', 'P016', 'Platelet', 'function', 'analysis', 'utilising', 'the', 'PFA', '100', 'does', 'not', 'predict', 'infection', 'bacteraemia', 'sepsis', 'or', 'outcome', 'in', 'critically', 'ill', 'patients', 'N', 'Bolton', 'J', 'Dudziak', 'S', 'Bonney', 'A', 'Tridente', 'P', 'Nee', 'P017', 'Extracellular', 'histone', 'H3', 'levels', 'are', 'inversely', 'correlated', 'with', 'antithrombin', 'levels', 'and', 'platelet', 'counts', 'and', 'are', 'associated', 'with', 'mortality', 'in', 'sepsis', 'patients', 'G', 'Nicolaes', 'M', 'Wiewel', 'M', 'Schultz', 'K', 'Wildhagen', 'J', 'Horn', 'R', 'Schrijver', 'T', 'Van', 'der', 'Poll', 'C', 'Reutelingsperger', 'P018', 'Il', '8', 'is', 'this', 'a', 'more', 'reliable', 'biomarker', 'for', 'sepsis', 'severity', 'than', 'CRP', 'Procalcitonin', 'E', 'selectin', 'IL', '6', 'and', 'TNF', 'alpha', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P019', 'Relation', 'between', 'adrenomedullin', 'and', 'short', 'term', 'outcome', 'in', 'ICU', 'patients', 'Results', 'from', 'the', 'frog', 'ICU', 'study', 'E', 'G', 'Gayat', 'J', 'Struck', 'A', 'Cariou', 'N', 'Deye', 'B', 'Guidet', 'S', 'Jabert', 'J', 'Launay', 'M', 'Legrand', 'M', 'Léone', 'M', 'Resche', 'Rigon', 'E', 'Vicaut', 'A', 'Vieillard', 'Baron', 'A', 'Mebazaa', 'P020', 'Impact', 'of', 'disease', 'severity', 'assessment', 'on', 'performance', 'of', 'heparin', 'binding', 'protein', 'for', 'the', 'prediction', 'of', 'septic', 'shock', 'R', 'Arnold', 'M', 'Capan', 'A', 'Linder', 'P', 'Akesson', 'P021', 'Kinetics', 'and', 'prognostic', 'value', 'of', 'presepsin', 'sCD14', 'in', 'septic', 'patients', 'A', 'pilot', 'study', 'M', 'Popescu', 'D', 'Tomescu', 'P022', 'Comparison', 'of', 'CD64', 'levels', 'performed', 'by', 'the', 'facs', 'and', 'accellix', 'systems', 'C', 'L', 'Sprung', 'R', 'Calderon', 'Morales', 'G', 'Munteanu', 'E', 'Orenbuch', 'Harroch', 'P', 'Levin', 'H', 'Kasdan', 'A', 'Reiter', 'T', 'Volker', 'Y', 'Himmel', 'Y', 'Cohen', 'J', 'Meissonnier', 'P023', 'Diagnosing', 'sepsis', 'in', '5', 'minutes', 'Nanofluidic', 'technology', 'study', 'with', 'pancreatic', 'stone', 'protein', 'PSP', 'reg', 'L', 'Girard', 'F', 'Rebeaud', 'P024', 'How', 'nanotechnology', 'based', 'approaches', 'could', 'contribute', 'to', 'sepsis', 'prevention', 'diagnosis', 'and', 'treatment', 'I', 'Herrmann', 'P025', 'Il7r', 'transcriptional', 'expression', 'analysis', 'during', 'septic', 'shock', 'B', 'Delwarde', 'E', 'Peronnet', 'E', 'Cerrato', 'F', 'Venet', 'A', 'Lepape', 'T', 'Rimmelé', 'G', 'Monneret', 'J', 'Textoris', 'P026', 'Disbalance', 'of', 'microbial', 'metabolites', 'of', 'aromatic', 'acids', 'affects', 'the', 'severity', 'in', 'critically', 'ill', 'patients', 'N', 'Beloborodova', 'V', 'Moroz', 'A', 'Osipov', 'A', 'Bedova', 'Y', 'Sarshor', 'A', 'Pautova', 'A', 'Sergeev', 'E', 'Chernevskaya', 'P027', 'Copeptin', 'predicts', '10', 'year', 'all', 'cause', 'mortality', 'in', 'community', 'patients', 'J', 'Odermatt', 'R', 'Bolliger', 'L', 'Hersberger', 'M', 'Ottiger', 'M', 'Christ', 'Crain', 'B', 'Mueller', 'P', 'Schuetz', 'P028', 'Identification', 'of', 'differential', 'proteomic', 'response', 'in', 'septic', 'patients', 'secondary', 'to', 'community', 'and', 'hospital', 'acquired', 'pneumonia', 'N', 'K', 'Sharma', 'A', 'K', 'Tashima', 'M', 'K', 'Brunialti', 'F', 'R', 'Machado', 'M', 'Assuncao', 'O', 'Rigato', 'R', 'Salomao', 'P029', 'Monocyte', 'HLA', 'DR', 'expression', 'in', 'community', 'acquired', 'bacteremic', 'sepsis', 'dynamics', 'associated', 'to', 'aetiology', 'and', 'prediction', 'of', 'secondary', 'sepsis', 'S', 'C', 'Cajander', 'G', 'Rasmussen', 'E', 'Tina', 'B', 'Söderquist', 'J', 'Källman', 'K', 'Strålin', 'P030', 'Soluble', 'B', 'and', 'T', 'lymphocyte', 'attenuator', 'A', 'possible', 'prognostic', 'marker', 'in', 'sepsis', 'A', 'L', 'Lange', 'J', 'S', 'Sundén', 'Cullberg', 'A', 'M', 'Magnuson', 'O', 'H', 'Hultgren', 'P031', 'Fractal', 'dimension', 'A', 'new', 'biomarker', 'for', 'quantifying', 'clot', 'microstructure', 'in', 'patients', 'across', 'the', 'sepsis', 'spectrum', 'G', 'Davies', 'S', 'Pillai', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P032', 'Comparison', 'between', 'the', 'new', 'biomarker', 'for', 'coagulation', 'clot', 'microstructure', 'Df', 'with', 'rotational', 'thromboelastometry', 'ROTEM', 'in', 'patients', 'across', 'the', 'sepsis', 'spectrum', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P033', 'Changes', 'in', 'fibrinolysis', 'across', 'the', 'sepsis', 'spectrum', 'The', 'use', 'of', 'rotational', 'thromboelastometry', 'ROTEM', 'lysis', 'index', 'LI60', 'and', 'D', 'Dimer', 'concentration', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P034', 'The', 'intensive', 'care', 'infection', 'score', 'a', 'promising', 'marker', 'for', 'the', 'prediction', 'of', 'infection', 'and', 'its', 'severity', 'P', 'Van', 'der', 'Geest', 'M', 'Mohseni', 'J', 'Linssen', 'R', 'De', 'Jonge', 'S', 'Duran', 'J', 'Groeneveld', 'P035', 'Challenges', 'in', 'the', 'clinical', 'diagnosis', 'of', 'sepsis', 'R', 'Miller', 'III', 'B', 'K', 'Lopansri', 'L', 'C', 'McHugh', 'A', 'Seldon', 'J', 'P', 'Burke', 'P036', 'Does', 'zero', 'heat', 'flux', 'thermometry', 'more', 'accurately', 'identify', 'sepsis', 'on', 'intensive', 'care', 'J', 'Johnston', 'R', 'Reece', 'Anthony', 'A', 'Bond', 'A', 'Molokhia', 'P037', 'Advancing', 'quality', 'AQ', 'sepsis', 'programme', 'Improving', 'early', 'identification', 'treatment', 'of', 'sepsis', 'in', 'North', 'West', 'England', 'C', 'Mcgrath', 'E', 'Nsutebu', 'P038', 'Prehospital', 'transport', 'of', 'acute', 'septic', 'patients', 'P', 'Bank', 'Pedersen', 'D', 'Pilsgaard', 'Henriksen', 'S', 'Mikkelsen', 'A', 'Touborg', 'Lassen', 'P039', 'Vasodilatory', 'plant', 'extracts', 'gel', 'as', 'an', 'alternative', 'treatment', 'for', 'fever', 'in', 'critically', 'ill', 'patients', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P040', 'Host', 'response', 'and', 'outcome', 'of', 'hypothermic', 'sepsis', 'M', 'A', 'Wiewel', 'M', 'B', 'Harmon', 'L', 'A', 'Van', 'Vught', 'B', 'P', 'Scicluna', 'A', 'J', 'Hoogendijk', 'J', 'Horn', 'A', 'H', 'Zwinderman', 'O', 'L', 'Cremer', 'M', 'J', 'Bonten', 'M', 'J', 'Schultz', 'T', 'Van', 'der', 'Poll', 'N', 'P', 'Juffermans', 'W', 'J', 'Wiersinga', 'P041', 'Septic', 'shock', 'alert', 'over', 'SIRS', 'criteria', 'has', 'an', 'impact', 'on', 'outcome', 'but', 'needs', 'to', 'be', 'revised', 'G', 'Eren', 'Y', 'Tekdos', 'M', 'Dogan', 'O', 'Acicbe', 'E', 'Kaya', 'O', 'Hergunsel', 'P042', 'Association', 'between', 'previous', 'prescription', 'of', 'βblockers', 'and', 'mortality', 'rate', 'among', 'septic', 'patients', 'A', 'retrospective', 'observational', 'study', 'S', 'Alsolamy', 'G', 'Ghamdi', 'L', 'Alswaidan', 'S', 'Alharbi', 'F', 'Alenezi', 'Y', 'Arabi', 'P043', 'Recognition', 'and', 'treatment', 'of', 'sepsis', 'on', 'labour', 'ward', 'teaching', 'information', 'resources', 'can', 'improve', 'knowledge', 'J', 'Heaton', 'A', 'Boyce', 'L', 'Nolan', 'J', 'Johnston', 'A', 'Dukoff', 'Gordon', 'A', 'Dean', 'A', 'Molokhia', 'P044', 'Culture', 'negative', 'sepsis', 'in', 'the', 'ICU', 'what', 'is', 'unique', 'to', 'this', 'patient', 'population', 'T', 'Mann', 'Ben', 'Yehudah', 'P045', 'Organ', 'dysfunction', 'in', 'severe', 'sepsis', 'patients', 'identified', 'in', 'administrative', 'data', 'in', 'Germany', '2007', '2013', 'C', 'Fleischmann', 'D', 'Thomas', 'Rueddel', 'C', 'Haas', 'U', 'Dennler', 'K', 'Reinhart', 'P046', 'A', 'comparison', 'of', 'residents', 'knowledge', 'regarding', 'the', 'Surviving', 'Sepsis', 'Campaign', '2012', 'guideline', 'O', 'Suntornlohanakul', 'B', 'Khwannimit', 'P047', 'Effectiveness', 'of', 'a', 'septic', 'shock', 'bundle', 'to', 'improve', 'outcomes', 'in', 'the', 'ICU', 'F', 'Breckenridge', 'A', 'Puxty', 'P048', 'Dose', 'of', 'norepinephrine', 'in', 'the', 'first', '24', 'hours', 'as', 'a', 'parameter', 'evaluating', 'the', 'effectiveness', 'of', 'treatment', 'in', 'patients', 'with', 'severe', 'sepsis', 'and', 'septic', 'shock', 'P', 'Szturz', 'P', 'Folwarzcny', 'J', 'Svancara', 'R', 'Kula', 'P', 'Sevcik', 'P049', 'Norepinephrine', 'or', 'vasopressin', 'norepinephrine', 'in', 'septic', 'shock', 'A', 'retrospective', 'series', 'of', '39', 'patients', 'L', 'Caneva', 'A', 'Casazza', 'E', 'Bellazzi', 'S', 'Marra', 'L', 'Pagani', 'M', 'Vetere', 'R', 'Vanzino', 'D', 'Ciprandi', 'R', 'Preda', 'R', 'Boschi', 'L', 'Carnevale', 'P050', 'Methylene', 'blue', 'effectiveness', 'as', 'contributory', 'treatment', 'in', 'patients', 'with', 'septic', 'shock', 'V', 'Lopez', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'A', 'Escalante', 'J', 'Gongora', 'M', 'Cetina', 'P051', 'Coagulation', 'disorders', 'in', 'patients', 'with', 'severe', 'sepsis', 'and', 'DIC', 'evaluated', 'with', 'thromboelastometry', 'B', 'Adamik', 'D', 'Jakubczyk', 'A', 'Kübler', 'P052', 'Frequency', 'and', 'outcome', 'of', 'early', 'sepsis', 'associated', 'coagulopathy', 'A', 'Radford', 'T', 'Lee', 'J', 'Singer', 'J', 'Boyd', 'D', 'Fineberg', 'M', 'Williams', 'J', 'Russell', 'P053', 'Assessment', 'of', 'coagulopathy', 'in', 'cancer', 'patients', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', 'A', 'case', 'control', 'pilot', 'study', 'E', 'Scarlatescu', 'D', 'Tomescu', 'G', 'Droc', 'S', 'Arama', 'P054', 'Thromboelastometry', 'in', 'critically', 'ill', 'patients', 'with', 'disseminated', 'intravascular', 'coagulation', 'M', 'Müller', 'M', 'Straat', 'S', 'S', 'Zeerleder', 'N', 'P', 'Juffermans', 'P055', 'Cessation', 'of', 'a', 'preexisting', 'chronic', 'antiplatelet', 'therapy', 'is', 'associated', 'with', 'increased', 'mortality', 'rates', 'in', 'severe', 'sepsis', 'and', 'septic', 'shock', 'C', 'F', 'Fuchs', 'C', 'S', 'Scheer', 'S', 'W', 'Wauschkuhn', 'M', 'V', 'Vollmer', 'K', 'M', 'Meissner', 'S', 'K', 'Kuhn', 'K', 'H', 'Hahnenkamp', 'S', 'R', 'Rehberg', 'M', 'G', 'Gründling', 'P056', 'Neutrophil', 'Extracellular', 'Traps', 'NETs', 'production', 'under', 'hypoxic', 'condition', 'N', 'Yamamoto', 'M', 'Ojima', 'S', 'Hamaguchi', 'T', 'Hirose', 'Y', 'Akeda', 'R', 'Takegawa', 'O', 'Tasaki', 'T', 'Shimazu', 'K', 'Tomono', 'P057', 'Impact', 'of', 'ultraviolet', 'air', 'sterilizer', 'in', 'intensive', 'care', 'unit', 'room', 'and', 'clinical', 'outcomes', 'of', 'patients', 'E', 'Gómez', 'Sánchez', 'M', 'Heredia', 'Rodríguez', 'E', 'Álvarez', 'Fuente', 'M', 'Lorenzo', 'López', 'E', 'Gómez', 'Pesquera', 'M', 'Aragón', 'Camino', 'P', 'Liu', 'Zhu', 'A', 'Sánchez', 'López', 'A', 'Hernández', 'Lozano', 'M', 'T', 'Peláez', 'Jareño', 'E', 'Tamayo', 'P058', 'Focus', 'of', 'infection', 'in', 'severe', 'sepsis', 'comparison', 'of', 'administrative', 'data', 'and', 'prospective', 'cohorts', 'from', 'Germany', 'D', 'O', 'Thomas', 'Rüddel', 'C', 'Fleischmann', 'C', 'Haas', 'U', 'Dennler', 'K', 'Reinhart', 'P059', 'Zero', 'CLABSI', 'can', 'we', 'get', 'there', 'Obstacles', 'on', 'the', '4', 'year', 'journey', 'and', 'our', 'strategies', 'to', 'overcome', 'them', 'experience', 'from', 'an', 'Indian', 'ICU', 'V', 'Adora', 'A', 'Kar', 'A', 'Chakraborty', 'S', 'Roy', 'A', 'Bandyopadhyay', 'M', 'Das', 'P060', 'Novel', 'molecular', 'techniques', 'to', 'identify', 'central', 'venous', 'catheter', 'CVC', 'associated', 'blood', 'stream', 'infections', 'BSIs', 'T', 'Mann', 'Ben', 'Yehudah', 'G', 'Ben', 'Yehudah', 'M', 'Salim', 'N', 'Kumar', 'L', 'Arabi', 'T', 'Burger', 'P', 'Lephart', 'E', 'Toth', 'martin', 'P061', 'Zero', 'clabsi', 'can', 'we', 'get', 'there', 'Obstacles', 'on', 'the', '4', 'year', 'journey', 'and', 'our', 'strategies', 'to', 'overcome', 'them', 'experience', 'from', 'an', 'Indian', 'ICU', 'R', 'Rao', 'A', 'Kar', 'A', 'Chakraborty', 'P062', 'Prevention', 'of', 'central', 'line', 'associated', 'bloodstream', 'infections', 'in', 'intensive', 'care', 'units', 'An', 'international', 'online', 'survey', 'C', 'Valencia', 'N', 'Hammami', 'S', 'Blot', 'J', 'L', 'Vincent', 'M', 'L', 'Lambert', 'P063', '30', 'days', 'antimicrobial', 'efficacy', 'of', 'non', 'leaching', 'central', 'venous', 'catheters', 'J', 'Brunke', 'T', 'Riemann', 'I', 'Roschke', 'P064', 'Efficacy', 'of', 'noble', 'metal', 'alloy', 'coated', 'catheter', 'in', 'prevention', 'of', 'bacteriuria', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P065', 'Predicting', 'bacteremic', 'urinary', 'tract', 'infection', 'in', 'community', 'setting', 'A', 'prospective', 'observational', 'study', 'S', 'Nimitvilai', 'K', 'Jintanapramote', 'S', 'Jarupongprapa', 'P066', 'Eight', 'year', 'analysis', 'of', 'acinetobacter', 'spp', 'monobacteremia', 'in', 'surgical', 'and', 'medical', 'intensive', 'care', 'units', 'at', 'university', 'hospital', 'in', 'Lithuania', 'D', 'Adukauskiene', 'D', 'Valanciene', 'P067', 'Group', 'A', 'and', 'group', 'B', 'streptococcal', 'infections', 'in', 'intensive', 'care', 'unit', 'our', 'experience', 'in', 'a', 'tertiary', 'centre', 'G', 'Bose', 'V', 'Lostarakos', 'B', 'Carr', 'P068', 'Improved', 'detection', 'of', 'spontaneous', 'bacterial', 'peritonitis', 'by', 'uritop', 'tm', 'strip', 'test', 'and', 'inoculation', 'of', 'blood', 'culture', 'bottles', 'with', 'ascitic', 'fluid', 'S', 'Khedher', 'A', 'Maaoui', 'A', 'Ezzamouri', 'M', 'Salem', 'P069', 'Increased', 'risk', 'of', 'cellulitis', 'in', 'patients', 'with', 'congestive', 'heart', 'failure', 'a', 'population', 'based', 'cohort', 'study', 'J', 'Chen', 'P070', 'Outcomes', 'of', 'severe', 'cellulitis', 'and', 'necrotizing', 'fasciitis', 'in', 'the', 'critically', 'ill', 'D', 'R', 'Cranendonk', 'L', 'A', 'Van', 'Vught', 'M', 'A', 'Wiewel', 'O', 'L', 'Cremer', 'J', 'Horn', 'M', 'J', 'Bonten', 'M', 'J', 'Schultz', 'T', 'Van', 'der', 'Poll', 'W', 'J', 'Wiersinga', 'P071', 'Botulism', 'outbreak', 'associated', 'with', 'people', 'who', 'inject', 'drugs', 'PWIDs', 'in', 'Scotland', 'M', 'Day', 'G', 'Penrice', 'K', 'Roy', 'P', 'Robertson', 'G', 'Godbole', 'B', 'Jones', 'M', 'Booth', 'L', 'Donaldson', 'P072', 'Surveillance', 'of', 'ESBL', 'producing', 'enterobacteriaceae', 'fecal', 'carriers', 'in', 'the', 'ICU', 'Y', 'Kawano', 'H', 'Ishikura', 'P073', 'Prevalence', 'of', 'ESBL', 'and', 'carbapenemase', 'producing', 'uropathogens', 'in', 'a', 'newly', 'opened', 'hospital', 'in', 'south', 'India', 'S', 'Sreevidya', 'N', 'Brahmananda', 'Reddy', 'P', 'Muraray', 'Govind', 'R', 'Pratheema', 'J', 'Devachandran', 'Apollo', 'Speciality', 'Hospital', 'OMR', 'Chennai', 'India', 'P074', 'Prevalence', 'risk', 'factors', 'and', 'outcomes', 'of', 'methicillin', 'resistant', 'staphylococcus', 'aureus', 'nasal', 'colonization', 'in', 'critically', 'ill', 'patients', 'H', 'Al', 'Dorzi', 'M', 'Almutairi', 'B', 'Alhamadi', 'A', 'Crizaldo', 'Toledo', 'R', 'Khan', 'B', 'Al', 'Raiy', 'Y', 'Arabi', 'P075', 'Multidrug', 'resistant', 'Acinetobacter', 'baumannii', 'infection', 'in', 'intensive', 'care', 'unit', 'patients', 'in', 'a', 'hospital', 'with', 'building', 'construction', 'Is', 'there', 'an', 'association', 'H', 'Talaie', 'P076', 'Multidrug', 'resistant', 'organisms', 'in', 'a', 'Dutch', 'ICU', 'J', 'A', 'Van', 'Oers', 'A', 'Harts', 'E', 'Nieuwkoop', 'P', 'Vos', 'P077', 'Epidemiology', 'and', 'risk', 'factors', 'of', 'ICU', 'acquired', 'infections', 'caused', 'by', 'multidrug', 'resistant', 'gram', 'negative', 'bacilli', 'Y', 'Boussarsar', 'F', 'Boutouta', 'S', 'Kamoun', 'I', 'Mezghani', 'S', 'Koubaji', 'A', 'Ben', 'Souissi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P078', 'Improving', 'outcomes', 'of', 'severe', 'infections', 'by', 'multidrug', 'resistant', 'pathogens', 'with', 'polyclonal', 'IgM', 'enriched', 'immunoglobulins', 'E', 'Giamarellos', 'Bourboulis', 'N', 'Tziolos', 'C', 'Routsi', 'C', 'Katsenos', 'I', 'Tsangaris', 'I', 'Pneumatikos', 'G', 'Vlachogiannis', 'V', 'Theodorou', 'A', 'Prekates', 'E', 'Antypa', 'V', 'Koulouras', 'N', 'Kapravelos', 'C', 'Gogos', 'E', 'Antoniadou', 'K', 'Mandragos', 'A', 'Armaganidis', 'P079', 'Must', 'change', 'the', 'medical', 'practice', 'in', 'ICU', 'A', 'R', 'Robles', 'Caballero', 'B', 'Civantos', 'J', 'C', 'Figueira', 'J', 'López', 'P080', 'Mediterranean', 'spotted', 'fever', 'in', 'an', 'infectious', 'diseases', 'intensive', 'care', 'unit', 'A', 'Silva', 'Pinto', 'F', 'Ceia', 'A', 'Sarmento', 'L', 'Santos', 'P081', 'Clinical', 'features', 'and', 'outcomes', 'of', 'patients', 'with', 'Middle', 'East', 'respiratory', 'syndrome', 'requiring', 'admission', 'to', 'a', 'saudi', 'intensive', 'care', 'unit', 'A', 'retrospective', 'analysis', 'of', '31', 'cases', 'G', 'Almekhlafi', 'Y', 'Sakr', 'P082', 'The', 'ICU', 'response', 'to', 'a', 'hospital', 'outbreak', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'H', 'Al', 'Dorzi', 'R', 'Khan', 'S', 'Baharoon', 'A', 'Aldawood', 'A', 'Matroud', 'J', 'Alchin', 'S', 'Al', 'Johani', 'H', 'Balkhy', 'Y', 'Arabi', 'P083', 'Middle', 'East', 'respiratory', 'syndrome', 'Surveillance', 'data', 'analysis', 'S', 'Alsolamy', 'S', 'Y', 'Yousif', 'B', 'O', 'Alotabi', 'A', 'S', 'Alsaawi', 'P085', 'Use', 'of', 'Taqman', 'array', 'card', 'molecular', 'diagnostics', 'in', 'severe', 'pneumonia', 'A', 'case', 'series', 'J', 'Ang', 'MD', 'Curran', 'D', 'Enoch', 'V', 'Navapurkar', 'A', 'Conway', 'Morris', 'P086', 'BUNS', 'An', 'investigation', 'protocol', 'improves', 'the', 'ICU', 'management', 'of', 'pneumonia', 'R', 'Sharvill', 'J', 'Astin', 'P087', 'Pneumonia', 'in', 'patients', 'following', 'secondary', 'peritonitis', 'epidemiological', 'features', 'and', 'impact', 'on', 'mortality', 'M', 'Heredia', 'Rodríguez', 'E', 'Gómez', 'Sánchez', 'M', 'T', 'Peláez', 'Jareño', 'E', 'Gómez', 'Pesquera', 'M', 'Lorenzo', 'López', 'P', 'Liu', 'Zhu', 'M', 'Aragón', 'Camino', 'A', 'Hernández', 'Lozano', 'A', 'Sánchez', 'López', 'E', 'Álvarez', 'Fuente', 'E', 'Tamayo', 'P088', 'The', 'use', 'of', 'the', 'CURB', '65', 'score', 'by', 'emergency', 'room', 'clinicians', 'in', 'a', 'large', 'teaching', 'hospital', 'J', 'Patel', 'C', 'Kruger', 'P089', 'Incidence', 'of', 'community', 'acquired', 'pneumonia', 'with', 'viral', 'infection', 'in', 'mechanically', 'ventilated', 'patients', 'in', 'the', 'medical', 'intensive', 'care', 'unit', 'J', 'O', 'Neal', 'H', 'Rhodes', 'J', 'Jancik', 'P090', 'The', 'SAATELLITE', 'Study', 'Prevention', 'of', 'S', 'aureus', 'Nosocomial', 'Pneumonia', 'NP', 'with', 'MEDI4893', 'a', 'Human', 'Monoclonal', 'Antibody', 'mAb', 'Against', 'S', 'aureus', 'B', 'François', 'P', 'F', 'Laterre', 'P', 'Eggimann', 'A', 'Torres', 'M', 'Sánchez', 'P', 'F', 'Dequin', 'G', 'L', 'Bassi', 'J', 'Chastre', 'H', 'S', 'Jafri', 'P091', 'Risk', 'factors', 'and', 'microbiological', 'profile', 'for', 'nosocomial', 'infections', 'in', 'trauma', 'patients', 'M', 'Ben', 'Romdhane', 'Z', 'Douira', 'S', 'Kamoun', 'M', 'Bousselmi', 'A', 'Ben', 'Souissi', 'Y', 'Boussarsar', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P092', 'Correlation', 'between', 'percentages', 'of', 'ventilated', 'patients', 'developed', 'vap', 'and', 'use', 'of', 'antimicrobial', 'agents', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P093', 'A', 'comparison', 'of', 'two', 'ventilator', 'associated', 'pneumonia', 'surveillance', 'techniques', 'T', 'H', 'Craven', 'G', 'Wojcik', 'K', 'Kefala', 'J', 'McCoubrey', 'J', 'Reilly', 'R', 'Paterson', 'D', 'Inverarity', 'I', 'Laurenson', 'T', 'S', 'Walsh', 'P094', 'Lung', 'ultrasound', 'before', 'and', 'after', 'fiberbronchoscopy', 'modifications', 'may', 'improve', 'ventilator', 'associated', 'pneumonia', 'diagnosis', 'S', 'Mongodi', 'B', 'Bouhemad', 'A', 'Orlando', 'A', 'Stella', 'G', 'Via', 'G', 'Iotti', 'A', 'Braschi', 'F', 'Mojoli', 'P095', 'Comparing', 'the', 'accuracy', 'of', 'predictors', 'of', 'mortality', 'in', 'ventilator', 'associated', 'pneumonia', 'M', 'Haliloglu', 'B', 'Bilgili', 'U', 'Kasapoglu', 'I', 'Sayan', 'M', 'Süzer', 'Aslan', 'A', 'Yalcın', 'I', 'Cinel', 'P096', 'Impact', 'of', 'pRBCs', 'transfusion', 'on', 'percentage', 'of', 'ventilated', 'patients', 'developed', 'VAP', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P097', 'The', 'impact', 'of', 'a', 'series', 'of', 'interventions', 'on', 'the', 'rate', 'of', 'ventilator', 'associated', 'pneumonia', 'in', 'a', 'large', 'teaching', 'hospital', 'H', 'E', 'Ellis', 'K', 'Bauchmuller', 'D', 'Miller', 'A', 'Temple', 'P098', 'The', 'EVADE', 'study', 'Prevention', 'of', 'Nosocomial', 'Pneumonia', 'NP', 'caused', 'by', 'P', 'aeruginosa', 'with', 'MEDI3902', 'a', 'Novel', 'Bispecific', 'Monoclonal', 'Antibody', 'against', 'P', 'aeruginosa', 'virulence', 'factors', 'J', 'Chastre', 'B', 'François', 'A', 'Torres', 'C', 'E', 'Luyt', 'M', 'Sánchez', 'M', 'Singer', 'H', 'S', 'Jafri', 'P099', 'Short', 'term', 'inhaled', 'colistin', 'adjunctive', 'therapy', 'for', 'ventilator', 'associated', 'pneumonia', 'Y', 'Nassar', 'M', 'S', 'Ayad', 'P100', 'Effect', 'of', 'aerosolised', 'colistin', 'on', 'weaning', 'from', 'mechanical', 'ventilation', 'A', 'Trifi', 'S', 'Abdellatif', 'F', 'Daly', 'R', 'Nasri', 'S', 'Ben', 'Lakhal', 'P101', 'Septic', 'shock', 'is', 'an', 'independent', 'risk', 'factor', 'for', 'colistin', 'induced', 'severe', 'acute', 'kidney', 'injury', 'a', 'retrospective', 'cohort', 'study', 'B', 'Bilgili', 'M', 'Haliloglu', 'F', 'Gul', 'I', 'Cinel', 'P102', 'Nosocomial', 'pneumonia', 'emphasis', 'on', 'inhaled', 'tobramycin', 'A', 'Kuzovlev', 'A', 'Shabanov', 'S', 'Polovnikov', 'V', 'Moroz', 'P103', 'In', 'vitro', 'evaluation', 'of', 'amikacin', 'inhale', 'and', 'commercial', 'nebulizers', 'in', 'a', 'mechanical', 'ventilator', 'N', 'Kadrichu', 'T', 'Dang', 'K', 'Corkery', 'P', 'Challoner', 'P104', 'The', 'effects', 'of', 'nebulized', 'amikacin', 'fosfomycin', 'and', 'systemic', 'meropenem', 'on', 'severe', 'amikacin', 'resistant', 'meropenem', 'susceptible', 'P', 'aeruginosa', 'pneumonia', 'G', 'Li', 'Bassi', 'E', 'Aguilera', 'C', 'Chiurazzi', 'C', 'Travierso', 'A', 'Motos', 'L', 'Fernandez', 'R', 'Amaro', 'T', 'Senussi', 'F', 'Idone', 'J', 'Bobi', 'M', 'Rigol', 'A', 'Torres', 'P105', 'Optimization', 'of', 'gentamicin', 'peak', 'concentrations', 'in', 'critically', 'ill', 'patients', 'C', 'J', 'Hodiamont', 'N', 'P', 'Juffermans', 'J', 'M', 'Janssen', 'C', 'S', 'Bouman', 'R', 'A', 'Mathôt', 'M', 'D', 'De', 'Jong', 'R', 'M', 'Van', 'Hest', 'P106', 'Systematic', 'review', 'of', 'cefepime', 'induced', 'neurotoxicity', 'L', 'Payne', 'G', 'L', 'Fraser', 'P107', 'Unasyn', 'causes', 'QT', 'prolongation', 'during', 'treatment', 'of', 'intensive', 'care', 'patients', 'B', 'Tudor', 'M', 'Lahner', 'G', 'Roth', 'C', 'Krenn', 'P108', 'Comparative', 'study', 'between', 'teicoplanin', 'and', 'vancomycin', 'in', 'methicillin', 'resistant', 'staphylococcus', 'aureus', 'mrsa', 'infectious', 'of', 'toxicological', 'intensive', 'care', 'unit', 'ticu', 'patients', 'Tehran', 'Iran', 'H', 'Talaie', 'P109', 'Phage', 'therapy', 'against', 'antimicrobial', 'resistance', 'design', 'of', 'the', 'first', 'clinical', 'study', 'phagoburn', 'P', 'Jault', 'J', 'Gabard', 'T', 'Leclerc', 'S', 'Jennes', 'Y', 'Que', 'A', 'Rousseau', 'F', 'Ravat', 'P110', 'Antibiotic', 'dosing', 'errors', 'in', 'critically', 'ill', 'patients', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', 'H', 'Al', 'Dorzi', 'A', 'Eissa', 'S', 'Al', 'Harbi', 'T', 'Aldabbagh', 'R', 'Khan', 'Y', 'Arabi', 'P111', 'Does', 'empiric', 'antifungal', 'therapy', 'improve', 'survival', 'in', 'septic', 'critically', 'ill', 'patients', 'immunocompromised', 'excluded', 'A', 'Trifi', 'S', 'Abdellatif', 'F', 'Daly', 'R', 'Nasri', 'S', 'Ben', 'Lakhal', 'P112', 'Neurocysticercosis', 'Qatar', 'experience', 'F', 'Paramba', 'N', 'Purayil', 'V', 'Naushad', 'O', 'Mohammad', 'V', 'Negi', 'P', 'Chandra', 'P113', 'Early', 'indicators', 'in', 'acute', 'haemorrhagic', 'shock', 'A', 'Kleinsasser', 'P114', 'Filtering', 'of', 'red', 'blood', 'cells', 'reduces', 'the', 'inflammatory', 'response', 'of', 'pulmonary', 'cells', 'in', 'an', 'in', 'vitro', 'model', 'of', 'mechanical', 'ventilation', 'M', 'R', 'Witrz', 'J', 'F', 'Buchner', 'Doeven', 'A', 'M', 'Tuip', 'de', 'Boer', 'J', 'C', 'Goslings', 'N', 'P', 'Juffermans', 'P115', 'Microparticles', 'from', 'red', 'blood', 'cell', 'transfusion', 'induce', 'a', 'pro', 'coagulant', 'and', 'pro', 'inflammatory', 'endothelial', 'cell', 'response', 'M', 'Van', 'Hezel', 'M', 'Straat', 'A', 'Boing', 'R', 'Van', 'Bruggen', 'N', 'Juffermans', 'P116', 'The', 'contribution', 'of', 'cytokines', 'on', 'thrombosis', 'development', 'during', 'hospitalization', 'in', 'ICU', 'D', 'Markopoulou', 'K', 'Venetsanou', 'V', 'Kaldis', 'D', 'Koutete', 'D', 'Chroni', 'I', 'Alamanos', 'P117', 'Prophylactic', 'enoxaparin', 'dosing', 'and', 'adjustment', 'through', 'anti', 'xa', 'monitoring', 'in', 'an', 'inpatient', 'burn', 'unit', 'L', 'Koch', 'J', 'Jancik', 'H', 'Rhodes', 'E', 'Walter', 'P118', 'Determination', 'of', 'optimal', 'cut', 'off', 'values', 'of', 'haemoglobin', 'platelet', 'count', 'and', 'fibrinogen', 'at', '24', 'hours', 'after', 'injury', 'associated', 'with', 'mortality', 'in', 'trauma', 'patients', 'K', 'Maekawa', 'M', 'Hayakawa', 'S', 'Kushimoto', 'A', 'Shiraishi', 'H', 'Kato', 'J', 'Sasaki', 'H', 'Ogura', 'T', 'Matauoka', 'T', 'Uejima', 'N', 'Morimura', 'H', 'Ishikura', 'A', 'Hagiwara', 'M', 'Takeda', 'P119', 'Trauma', 'induced', 'coagulopathy', 'prothrombin', 'complex', 'concentrate', 'vs', 'fresh', 'frozen', 'plasma', 'O', 'Tarabrin', 'S', 'Shcherbakow', 'D', 'Gavrychenko', 'G', 'Mazurenko', 'V', 'Ivanova', 'O', 'Chystikov', 'P120', 'First', 'study', 'to', 'prove', 'the', 'superiority', 'of', 'prothrombin', 'complex', 'concentrates', 'on', 'mortality', 'rate', 'over', 'fresh', 'frozen', 'plasma', 'in', 'patients', 'with', 'acute', 'bleeding', 'C', 'Plourde', 'J', 'Lessard', 'J', 'Chauny', 'R', 'Daoust', 'P121', 'Prothrombin', 'complex', 'concentrate', 'vs', 'fresh', 'frozen', 'plasma', 'in', 'obstetric', 'massive', 'bleeding', 'S', 'Shcherbakow', 'O', 'Tarabrin', 'D', 'Gavrychenko', 'G', 'Mazurenko', 'O', 'Chystikov', 'P122', 'Impact', 'of', 'FFP', 'transfusion', 'on', 'VAP', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P123', 'Preoperative', 'platelet', 'function', 'test', 'and', 'the', 'thrombin', 'generation', 'assay', 'are', 'predictive', 'for', 'blood', 'loss', 'after', 'cardiac', 'surgery', 'L', 'Kropman', 'L', 'In', 'het', 'Panhuis', 'J', 'Konings', 'D', 'Huskens', 'E', 'Schurgers', 'M', 'Roest', 'B', 'De', 'Laat', 'M', 'Lance', 'P124', 'Rotational', 'thromboelastometry', 'versus', 'standard', 'coagulation', 'tests', 'before', 'surgical', 'interventions', 'M', 'Durila', 'P', 'Lukas', 'M', 'Astraverkhava', 'J', 'Jonas', 'P125', 'Correction', 'of', 'impaired', 'clot', 'quality', 'and', 'stability', 'by', 'fibrinogen', 'and', 'activated', 'prothrombin', 'complex', 'concentrate', 'in', 'a', 'model', 'of', 'severe', 'thrombocytopenia', 'I', 'Budnik', 'B', 'Shenkman', 'P126', 'Assessment', 'of', 'point', 'of', 'care', 'prothrombin', 'time', 'analyzer', 'as', 'a', 'monitor', 'after', 'cardiopulmonary', 'bypass', 'H', 'Hayami', 'Y', 'Koide', 'T', 'Goto', 'P127', 'Disseminated', 'intravascular', 'coagulation', 'dic', 'is', 'underdiagnosed', 'in', 'critically', 'ill', 'patients', 'do', 'we', 'need', 'd', 'dimer', 'measurements', 'R', 'Iqbal', 'Y', 'Alhamdi', 'N', 'Venugopal', 'S', 'Abrams', 'C', 'Downey', 'C', 'H', 'Toh', 'I', 'D', 'Welters', 'P128', 'Validity', 'of', 'the', 'age', 'adjusted', 'd', 'dimer', 'cutoff', 'in', 'patients', 'with', 'COPD', 'B', 'Bombay', 'J', 'M', 'Chauny', 'R', 'D', 'Daoust', 'J', 'L', 'Lessard', 'M', 'M', 'Marquis', 'J', 'P', 'Paquet', 'P129', 'A', 'scoping', 'review', 'of', 'strategies', 'for', 'prevention', 'and', 'management', 'of', 'bleeding', 'following', 'paediatric', 'cardiopulmonary', 'bypass', 'surgery', 'K', 'Siemens', 'D', 'Sangaran', 'B', 'J', 'Hunt', 'A', 'Durward', 'A', 'Nyman', 'I', 'A', 'Murdoch', 'S', 'M', 'Tibby', 'P130', 'Nadir', 'hemoglobulin', 'during', 'cardiopulmonary', 'bypass', 'impact', 'on', 'postoperative', 'morbidity', 'and', 'mortality', 'F', 'Ampatzidou', 'D', 'Moisidou', 'E', 'Dalampini', 'M', 'Nastou', 'E', 'Vasilarou', 'V', 'Kalaizi', 'H', 'Chatzikostenoglou', 'G', 'Drossos', 'P131', 'Red', 'blood', 'cell', 'transfusion', 'do', 'not', 'influence', 'the', 'prognostic', 'value', 'of', 'RDW', 'in', 'critically', 'ill', 'patients', 'S', 'Spadaro', 'A', 'Fogagnolo', 'T', 'Fiore', 'A', 'Schiavi', 'V', 'Fontana', 'F', 'Taccone', 'C', 'Volta', 'P132', 'Reasons', 'for', 'admission', 'in', 'the', 'paediatric', 'intensive', 'care', 'unit', 'and', 'the', 'need', 'for', 'blood', 'and', 'blood', 'products', 'transfusions', 'E', 'Chochliourou', 'E', 'Volakli', 'A', 'Violaki', 'E', 'Samkinidou', 'G', 'Evlavis', 'V', 'Panagiotidou', 'M', 'Sdougka', 'P133', 'The', 'implementation', 'of', 'a', 'massive', 'haemorrhage', 'protocol', 'mhp', 'for', 'the', 'management', 'of', 'major', 'trauma', 'a', 'ten', 'year', 'single', 'centre', 'study', 'R', 'Mothukuri', 'C', 'Battle', 'K', 'Guy', 'G', 'Mills', 'P', 'Evans', 'P134', 'An', 'integrated', 'major', 'haemorrhage', 'protocol', 'for', 'pre', 'hospital', 'and', 'retrieval', 'medical', 'teams', 'J', 'Wijesuriya', 'S', 'Keogh', 'P135', 'The', 'impact', 'of', 'transfusion', 'thresholds', 'on', 'mortality', 'and', 'cardiovascular', 'events', 'in', 'patients', 'with', 'cardiovascular', 'disease', 'non', 'cardiac', 'surgery', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'A', 'Docherty', 'R', 'O', 'Donnell', 'S', 'Brunskill', 'M', 'Trivella', 'C', 'Doree', 'L', 'Holst', 'M', 'Parker', 'M', 'Gregersen', 'J', 'Almeida', 'T', 'Walsh', 'S', 'Stanworth', 'P136', 'The', 'relationship', 'between', 'poor', 'pre', 'operative', 'immune', 'status', 'and', 'outcome', 'from', 'cardiac', 'surgery', 'is', 'specific', 'to', 'the', 'peri', 'operative', 'antigenic', 'threat', 'S', 'Moravcova', 'J', 'Mansell', 'A', 'Rogers', 'R', 'A', 'Smith', 'C', 'Hamilton', 'Davies', 'P137', 'Impact', 'of', 'simple', 'clinical', 'practice', 'guidelines', 'for', 'reducing', 'post', 'operative', 'atrial', 'fibrillation', 'after', 'cardiac', 'surgery', 'A', 'Omar', 'M', 'Allam', 'O', 'Bilala', 'A', 'Kindawi', 'H', 'Ewila', 'P138', 'Dexamethasone', 'administration', 'during', 'cardiopulmonary', 'bypass', 'has', 'no', 'beneficial', 'effects', 'on', 'elective', 'postoperative', 'cardiac', 'surgery', 'patients', 'F', 'Ampatzidou', 'D', 'Moisidou', 'M', 'Nastou', 'E', 'Dalampini', 'A', 'Malamas', 'E', 'Vasilarou', 'G', 'Drossos', 'P139', 'Intra', 'aortic', 'balloon', 'counterpulsation', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'IABCS', 'preliminary', 'results', 'G', 'Ferreira', 'J', 'Caldas', 'J', 'Fukushima', 'E', 'A', 'Osawa', 'E', 'Arita', 'L', 'Camara', 'S', 'Zeferino', 'J', 'Jardim', 'F', 'Gaioto', 'L', 'Dallan', 'F', 'B', 'Jatene', 'R', 'Kalil', 'Filho', 'F', 'Galas', 'L', 'A', 'Hajjar', 'P140', 'Effects', 'of', 'low', 'dose', 'atrial', 'natriuretic', 'peptide', 'infusion', 'on', 'cardiac', 'surgery', 'associated', 'acute', 'kidney', 'injury', 'C', 'Mitaka', 'T', 'Ohnuma', 'T', 'Murayama', 'F', 'Kunimoto', 'M', 'Nagashima', 'T', 'Takei', 'M', 'Tomita', 'P141', 'Acute', 'kidney', 'injury', 'influence', 'on', 'high', 'sensitive', 'troponin', 'measurements', 'after', 'cardiac', 'surgery', 'A', 'Omar', 'K', 'Mahmoud', 'S', 'Hanoura', 'S', 'Sudarsanan', 'P', 'Sivadasan', 'H', 'Othamn', 'Y', 'Shouman', 'R', 'Singh', 'A', 'Al', 'Khulaifi', 'P142', 'Complex', 'evaluation', 'of', 'endothelial', 'dysfunction', 'markers', 'for', 'prognosis', 'of', 'outcomes', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'I', 'Mandel', 'S', 'Mikheev', 'I', 'Suhodolo', 'V', 'Kiselev', 'Y', 'Svirko', 'Y', 'Podoksenov', 'P143', 'New', 'onset', 'atrial', 'fibrillation', 'in', 'intensive', 'care', 'incidence', 'management', 'and', 'outcome', 'S', 'A', 'Jenkins', 'R', 'Griffin', 'P144', 'One', 'single', 'spot', 'measurement', 'of', 'the', 'sublingual', 'microcirculation', 'during', 'acute', 'pulmonary', 'hypertension', 'in', 'a', 'pig', 'model', 'of', 'shock', 'M', 'S', 'Tovar', 'Doncel', 'A', 'Lima', 'C', 'Aldecoa', 'C', 'Ince', 'P145', 'Assessment', 'of', 'levosimendan', 'as', 'a', 'therapeutic', 'option', 'to', 'recruit', 'the', 'microcirculation', 'in', 'cardiogenic', 'shock', 'initial', 'experience', 'in', 'cardiac', 'ICU', 'A', 'Taha', 'A', 'Shafie', 'M', 'Mostafa', 'N', 'Syed', 'H', 'Hon', 'P146', 'Terlipressin', 'vs', 'norepinephrine', 'in', 'the', 'Potential', 'Multiorgan', 'Donor', 'PMD', 'F', 'Righetti', 'E', 'Colombaroli', 'G', 'Castellano', 'P147', 'Echocardiography', 'in', 'the', 'potential', 'heart', 'donor', 'exposed', 'to', 'substitution', 'hormonotherapy', 'F', 'Righetti', 'E', 'Colombaroli', 'P148', 'Machine', 'learning', 'can', 'reduce', 'rate', 'of', 'monitor', 'alarms', 'M', 'Hravnak', 'L', 'C', 'Chen', 'A', 'D', 'Dubrawski', 'G', 'C', 'Clermont', 'M', 'R', 'Pinsky', 'P149', 'Peripherally', 'inserted', 'central', 'catheters', 'placed', 'in', 'the', 'ICU', 'S', 'Gonzalez', 'D', 'Macias', 'J', 'Acosta', 'P', 'Jimenez', 'A', 'Loza', 'A', 'Lesmes', 'F', 'Lucena', 'C', 'Leon', 'P150', 'Recordings', 'of', 'abnormal', 'central', 'venous', 'pressure', 'waveform', 'morphology', 'during', 'an', 'episode', 'of', 'pulmonary', 'hypertension', 'in', 'a', 'porcine', 'shock', 'model', 'M', 'S', 'Tovar', 'Doncel', 'C', 'Ince', 'C', 'Aldecoa', 'A', 'Lima', 'P151', 'Ultrasound', 'guided', 'central', 'venous', 'access', 'technique', 'among', 'French', 'intensivists', 'M', 'Bastide', 'J', 'Richecoeur', 'E', 'Frenoy', 'C', 'Lemaire', 'B', 'Sauneuf', 'F', 'Tamion', 'S', 'Nseir', 'D', 'Du', 'Cheyron', 'H', 'Dupont', 'J', 'Maizel', 'P152', 'Predictive', 'ability', 'of', 'the', 'Pv', 'aCO2', 'gap', 'in', 'patients', 'with', 'shock', 'M', 'Shaban', 'R', 'Kolko', 'N', 'Salahuddin', 'M', 'Sharshir', 'M', 'AbuRageila', 'A', 'AlHussain', 'P153', 'Comparison', 'of', 'echocardiography', 'and', 'pulmonary', 'artery', 'catheter', 'measurements', 'of', 'hemodynamic', 'parameters', 'in', 'critical', 'ill', 'patients', 'P', 'Mercado', 'J', 'Maizel', 'L', 'Kontar', 'D', 'Titeca', 'F', 'Brazier', 'A', 'Riviere', 'M', 'Joris', 'T', 'Soupison', 'B', 'De', 'Cagny', 'M', 'Slama', 'P154', 'The', 'volume', 'clamp', 'method', 'for', 'noninvasive', 'cardiac', 'output', 'measurement', 'in', 'postoperative', 'cardiothoracic', 'surgery', 'patients', 'a', 'comparison', 'with', 'intermittent', 'pulmonary', 'artery', 'thermodilution', 'J', 'Wagner', 'A', 'Körner', 'M', 'Kubik', 'S', 'Kluge', 'D', 'Reuter', 'B', 'Saugel', 'P155', 'Hemodynamic', 'monitoring', 'in', 'patients', 'with', 'septic', 'shock', 'SS', 'CPCCO', 'continuous', 'pulse', 'contour', 'cardiac', 'output', 'vs', 'TEE', 'transesophageal', 'echocardiography', 'E', 'Colombaroli', 'F', 'Righetti', 'G', 'Castellano', 'P156', 'Cardiac', 'output', 'measurement', 'with', 'transthoracic', 'echocardiography', 'in', 'critically', 'ill', 'patients', 'a', 'pragmatic', 'clinical', 'study', 'T', 'Tran', 'D', 'De', 'Bels', 'A', 'Cudia', 'M', 'Strachinaru', 'P', 'Ghottignies', 'J', 'Devriendt', 'C', 'Pierrakos', 'P157', 'Left', 'ventricular', 'outflow', 'tract', 'velocity', 'time', 'integral', 'correlates', 'with', 'stroke', 'volume', 'index', 'in', 'mechanically', 'ventilated', 'patients', 'Ó', 'Martínez', 'González', 'R', 'Blancas', 'J', 'Luján', 'D', 'Ballesteros', 'C', 'Martínez', 'Díaz', 'A', 'Núñez', 'C', 'Martín', 'Parra', 'B', 'López', 'Matamala', 'M', 'Alonso', 'Fernández', 'M', 'Chana', 'P158', 'Transpulmonary', 'thermodilution', 'TPTD', 'derived', 'from', 'femoral', 'vs', 'jugular', 'central', 'venous', 'catheter', 'validation', 'of', 'a', 'previously', 'published', 'correction', 'formula', 'and', 'a', 'proprietary', 'correction', 'formula', 'for', 'global', 'end', 'diastolic', 'volume', 'index', 'GEDVI', 'W', 'Huber', 'M', 'Eckmann', 'F', 'Elkmann', 'A', 'Gruber', 'I', 'Klein', 'R', 'M', 'Schmid', 'T', 'Lahmer', 'P160', 'Dynamic', 'arterial', 'elastance', 'calculated', 'with', 'lidcoplus', 'monitor', 'does', 'not', 'predict', 'changes', 'in', 'arterial', 'pressure', 'after', 'a', 'fluid', 'challenge', 'in', 'postsurgical', 'patients', 'D', 'Bastoni', 'H', 'Aya', 'L', 'Toscani', 'L', 'Pigozzi', 'A', 'Rhodes', 'M', 'Cecconi', 'P159', 'Venous', 'return', 'driving', 'pressure', 'and', 'resistance', 'in', 'acute', 'blood', 'volume', 'changes', 'P', 'W', 'Moller', 'S', 'Sondergaard', 'S', 'M', 'Jakob', 'J', 'Takala', 'D', 'Berger', 'P160', 'Dynamic', 'arterial', 'elastance', 'calculated', 'with', 'lidcoplus', 'monitor', 'does', 'not', 'predict', 'changes', 'in', 'arterial', 'pressure', 'after', 'a', 'fluid', 'challenge', 'in', 'postsurgical', 'patients', 'D', 'Bastoni', 'H', 'Aya', 'L', 'Toscani', 'L', 'Pigozzi', 'A', 'Rhodes', 'M', 'Cecconi', 'P161', 'Analysis', 'of', 'duration', 'of', 'post', 'operative', 'goal', 'directed', 'therapy', 'protocol', 'C', 'Ostrowska', 'H', 'Aya', 'A', 'Abbas', 'J', 'Mellinghoff', 'C', 'Ryan', 'D', 'Dawson', 'A', 'Rhodes', 'M', 'Cecconi', 'P162', 'Hemodynamic', 'optimization', 'back', 'to', 'square', 'one', 'M', 'Cronhjort', 'O', 'Wall', 'E', 'Nyberg', 'R', 'Zeng', 'C', 'Svensen', 'J', 'Mårtensson', 'E', 'Joelsson', 'Alm', 'P163', 'Effectiveness', 'of', 'fluid', 'thoracic', 'content', 'measurement', 'by', 'bioimpedance', 'guiding', 'intravascular', 'volume', 'optimization', 'in', 'patients', 'with', 'septic', 'shock', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'V', 'Lopez', 'M', 'Cetina', 'P164', 'A', 'systematic', 'review', 'on', 'the', 'role', 'of', 'internal', 'jugular', 'vein', 'ultrasound', 'measurements', 'in', 'assessment', 'of', 'volume', 'status', 'in', 'critical', 'shock', 'patients', 'N', 'Parenti', 'C', 'Palazzi', 'L', 'A', 'Amidei', 'F', 'B', 'Borrelli', 'S', 'C', 'Campanale', 'F', 'T', 'Tagliazucchi', 'G', 'S', 'Sedoni', 'D', 'L', 'Lucchesi', 'E', 'C', 'Carella', 'A', 'L', 'Luciani', 'P165', 'Importance', 'of', 'recognizing', 'dehydration', 'in', 'medical', 'Intensive', 'Care', 'Unit', 'M', 'Mackovic', 'N', 'Maric', 'M', 'Bakula', 'P166', 'Effect', 'of', 'volume', 'for', 'a', 'fluid', 'challenge', 'in', 'septic', 'patients', 'H', 'Aya', 'A', 'Rhodes', 'R', 'M', 'Grounds', 'N', 'Fletcher', 'M', 'Cecconi', 'P167', 'Fluid', 'bolus', 'practices', 'in', 'a', 'large', 'Australian', 'intensive', 'care', 'unit', 'B', 'Avard', 'P', 'Zhang', 'P168', 'Liberal', 'late', 'fluid', 'management', 'is', 'associated', 'with', 'longer', 'ventilation', 'duration', 'and', 'worst', 'outcome', 'in', 'severe', 'trauma', 'patients', 'a', 'retrospective', 'cohort', 'of', '294', 'patients', 'M', 'Mezidi', 'J', 'Charbit', 'M', 'Ould', 'Chikh', 'P', 'Deras', 'C', 'Maury', 'O', 'Martinez', 'X', 'Capdevila', 'P169', 'Association', 'of', 'fluids', 'and', 'outcomes', 'in', 'emergency', 'department', 'patients', 'hospitalized', 'with', 'community', 'acquired', 'pneumonia', 'P', 'Hou', 'W', 'Z', 'Linde', 'Zwirble', 'I', 'D', 'Douglas', 'N', 'S', 'Shapiro', 'P170', 'Association', 'of', 'positive', 'fluid', 'balance', 'with', 'poor', 'outcome', 'in', 'medicosurgical', 'ICU', 'patients', 'A', 'Ben', 'Souissi', 'I', 'Mezghani', 'Y', 'Ben', 'Aicha', 'S', 'Kamoun', 'B', 'Laribi', 'B', 'Jeribi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P171', 'Impact', 'of', 'fluid', 'balance', 'to', 'organ', 'dysfunction', 'in', 'critically', 'ill', 'patients', 'C', 'Pereira', 'R', 'Marinho', 'R', 'Antunes', 'A', 'Marinho', 'P172', 'Volume', 'bolus', 'in', 'ICU', 'patients', 'do', 'we', 'need', 'to', 'balance', 'our', 'crystalloids', 'M', 'Crivits', 'M', 'Raes', 'J', 'Decruyenaere', 'E', 'Hoste', 'P173', 'The', 'use', 'of', '6', 'HES', 'solution', 'do', 'not', 'reduce', 'total', 'fluid', 'requirement', 'in', 'the', 'therapy', 'of', 'patients', 'with', 'burn', 'shock', 'V', 'Bagin', 'V', 'Rudnov', 'A', 'Savitsky', 'M', 'Astafyeva', 'I', 'Korobko', 'V', 'Vein', 'P174', 'Electron', 'microscopic', 'assessment', 'of', 'acute', 'kidney', 'injury', 'in', 'septic', 'sheep', 'resuscitated', 'with', 'crystalloids', 'or', 'different', 'colloids', 'T', 'Kampmeier', 'P', 'Arnemann', 'M', 'Hessler', 'A', 'Wald', 'K', 'Bockbreder', 'A', 'Morelli', 'H', 'Van', 'Aken', 'S', 'Rehberg', 'C', 'Ertmer', 'P175', 'Alterations', 'of', 'conjunctival', 'microcirculation', 'in', 'a', 'sheep', 'model', 'of', 'haemorrhagic', 'shock', 'and', 'resuscitation', 'with', '0', '9', 'saline', 'or', 'balanced', 'tetrastarch', 'P', 'Arnemann', 'M', 'Hessler', 'T', 'Kampmeier', 'S', 'Rehberg', 'H', 'Van', 'Aken', 'C', 'Ince', 'C', 'Ertmer', 'P176', 'A', 'single', 'centre', 'nested', 'pilot', 'study', 'investigating', 'the', 'effect', 'of', 'using', '0', '9', 'saline', 'or', 'Plasma', 'Lyte', '148', 'as', 'crystalloid', 'fluid', 'therapy', 'on', 'gastrointestinal', 'feeding', 'intolerance', 'in', 'mechanically', 'ventilated', 'patients', 'receiving', 'nasogastric', 'enteral', 'nutrition', 'S', 'Reddy', 'M', 'Bailey', 'R', 'Beasley', 'R', 'Bellomo', 'D', 'Mackle', 'A', 'Psirides', 'P', 'Young', 'P177', 'A', 'single', 'centre', 'nested', 'pilot', 'study', 'investigating', 'the', 'effect', 'on', 'post', 'operative', 'bleeding', 'of', 'using', '0', '9', 'saline', 'or', 'Plasma', 'Lyte', '148', 'as', 'crystalloid', 'fluid', 'therapy', 'in', 'adults', 'in', 'ICU', 'after', 'heart', 'surgery', 'S', 'Reddy', 'M', 'Bailey', 'R', 'Beasley', 'R', 'Bellomo', 'D', 'Mackle', 'P', 'Young', 'P178', 'Extreme', 'hypernatremia', 'and', 'sepsis', 'in', 'a', 'patient', 'with', 'Huntington', 's', 'dementia', 'a', 'conundrum', 'in', 'fluid', 'management', 'H', 'Venkatesh', 'S', 'Ramachandran', 'A', 'Basu', 'H', 'Nair', 'P179', 'Diagnosis', 'and', 'management', 'of', 'severe', 'hypernatraemia', 'in', 'the', 'critical', 'care', 'setting', 'S', 'Egan', 'J', 'Bates', 'P180', 'Correlation', 'between', 'arterial', 'blood', 'gas', 'and', 'electrolyte', 'disturbances', 'during', 'hospitalization', 'and', 'outcome', 'in', 'critically', 'ill', 'patients', 'S', 'Oliveira', 'N', 'R', 'Rangel', 'Neto', 'F', 'Q', 'Reis', 'P181', 'Missing', 'the', 'I', 'in', 'MUDPILES', 'a', 'rare', 'cause', 'of', 'high', 'anion', 'gap', 'metabolic', 'acidosis', 'HAGMA', 'C', 'P', 'Lee', 'X', 'L', 'Lin', 'C', 'Choong', 'K', 'M', 'Eu', 'W', 'Y', 'Sim', 'K', 'S', 'Tee', 'J', 'Pau', 'J', 'Abisheganaden', 'P182', 'Plasma', 'NGAL', 'and', 'urinary', 'output', 'potential', 'parameters', 'for', 'early', 'initiation', 'of', 'renal', 'replacement', 'therapy', 'K', 'Maas', 'H', 'De', 'Geus', 'P183', 'Renal', 'replacement', 'therapy', 'for', 'critically', 'ill', 'patients', 'an', 'intermittent', 'continuity', 'E', 'Lafuente', 'R', 'Marinho', 'J', 'Moura', 'R', 'Antunes', 'A', 'Marinho', 'P184', 'A', 'survey', 'of', 'practices', 'related', 'to', 'renal', 'replacement', 'therapy', 'in', 'critically', 'ill', 'patients', 'in', 'the', 'north', 'of', 'England', 'T', 'E', 'Doris', 'D', 'Monkhouse', 'T', 'Shipley', 'S', 'Kardasz', 'I', 'Gonzalez', 'P185', 'High', 'initiation', 'creatinine', 'associated', 'with', 'lower', '28', 'day', 'mortality', 'in', 'critically', 'ill', 'patients', 'necessitating', 'continuous', 'renal', 'replacement', 'therapy', 'S', 'Stads', 'A', 'J', 'Groeneveld', 'P186', 'The', 'impact', 'of', 'Karnofsky', 'performance', 'scale', 'on', 'outcomes', 'in', 'acute', 'kidney', 'injury', 'patients', 'receiving', 'renal', 'replacement', 'therapy', 'on', 'the', 'intensive', 'care', 'unit', 'I', 'Elsayed', 'N', 'Ward', 'A', 'Tridente', 'A', 'Raithatha', 'P187', 'Severe', 'hypophosphatemia', 'during', 'citrate', 'anticoagulated', 'CRRT', 'A', 'Steuber', 'C', 'Pelletier', 'S', 'Schroeder', 'E', 'Michael', 'T', 'Slowinski', 'D', 'Kindgen', 'Milles', 'P188', 'Citrate', 'regional', 'anticoagulation', 'for', 'post', 'dilution', 'continuous', 'renal', 'replacement', 'therapy', 'S', 'Ghabina', 'P189', 'Citrate', '18', 'mmol', 'l', 'improves', 'anticoagulation', 'during', 'RRT', 'with', 'adsorbing', 'filters', 'F', 'Turani', 'A', 'Belli', 'S', 'Busatti', 'G', 'Barettin', 'F', 'Candidi', 'F', 'Gargano', 'R', 'Barchetta', 'M', 'Falco', 'P190', 'Calcium', 'gluconate', 'instead', 'of', 'calcium', 'chloride', 'in', 'citrate', 'anticoagulated', 'CVVHD', 'O', 'Demirkiran', 'M', 'Kosuk', 'S', 'Bozbay', 'P191', 'Enhanced', 'clearance', 'of', 'interleukin', '6', 'with', 'continuous', 'veno', 'venous', 'haemodialysis', 'CVVHD', 'using', 'Ultraflux', 'EMiC2', 'vs', 'Ultraflux', 'AV1000S', 'V', 'Weber', 'J', 'Hartmann', 'S', 'Harm', 'I', 'Linsberger', 'T', 'Eichhorn', 'G', 'Valicek', 'G', 'Miestinger', 'C', 'Hoermann', 'P192', 'Removal', 'of', 'bilirubin', 'with', 'a', 'new', 'adsorbent', 'system', 'in', 'vitro', 'kinetics', 'S', 'Faenza', 'D', 'Ricci', 'E', 'Mancini', 'C', 'Gemelli', 'A', 'Cuoghi', 'S', 'Magnani', 'M', 'Atti', 'P193', 'Case', 'series', 'of', 'patients', 'with', 'severe', 'sepsis', 'and', 'septic', 'shock', 'treated', 'with', 'a', 'new', 'extracorporeal', 'sorbent', 'T', 'Laddomada', 'A', 'Doronzio', 'B', 'Balicco', 'P194', 'In', 'vitro', 'adsorption', 'of', 'a', 'broad', 'spectrum', 'of', 'inflammatory', 'mediators', 'with', 'CytoSorb', 'hemoadsorbent', 'polymer', 'beads', 'M', 'C', 'Gruda', 'P', 'O', 'Sullivan', 'V', 'P', 'Dan', 'T', 'Guliashvili', 'A', 'Scheirer', 'T', 'D', 'Golobish', 'V', 'J', 'Capponi', 'P', 'P', 'Chan', 'P195', 'Observations', 'in', 'early', 'vs', 'late', 'use', 'of', 'cytosorb', 'therapy', 'in', 'critically', 'ill', 'patients', 'K', 'Kogelmann', 'M', 'Drüner', 'D', 'Jarczak', 'P196', 'Oxiris', 'membrane', 'decreases', 'endotoxin', 'during', 'rrt', 'in', 'septic', 'patients', 'with', 'basal', 'EAA', '0', '6', 'F', 'Turani', 'A', 'B', 'Belli', 'S', 'M', 'Martni', 'V', 'C', 'Cotticelli', 'F', 'Mounajergi', 'R', 'Barchetta', 'P197', 'An', 'observational', 'prospective', 'study', 'on', 'the', 'onset', 'of', 'augmented', 'renal', 'clearance', 'the', 'first', 'report', 'S', 'Morimoto', 'H', 'Ishikura', 'P198', 'An', 'ultrasound', 'guided', 'algorithm', 'for', 'the', 'management', 'of', 'oliguria', 'in', 'severe', 'sepsis', 'I', 'Hussain', 'N', 'Salahuddin', 'A', 'Nadeem', 'K', 'Ghorab', 'K', 'Maghrabi', 'P199', 'Ultrasound', 'in', 'acute', 'kidney', 'injury', 'aki', 'First', 'findings', 'of', 'farius', 'an', 'education', 'programme', 'in', 'structural', 'ultrasonography', 'S', 'K', 'Kloesel', 'C', 'Goldfuss', 'A', 'Stieglitz', 'A', 'S', 'Stieglitz', 'L', 'Krstevska', 'G', 'Albuszies', 'P200', 'Effectiveness', 'of', 'renal', 'angina', 'index', 'score', 'predicting', 'acute', 'kidney', 'injury', 'on', 'critically', 'ill', 'patients', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'V', 'Lopez', 'A', 'Escalante', 'G', 'Jimmy', 'M', 'Cetina', 'P201', 'Time', 'length', 'below', 'blood', 'pressure', 'thresholds', 'and', 'progression', 'of', 'acute', 'kidney', 'injury', 'in', 'critically', 'ill', 'patients', 'with', 'or', 'without', 'sepsis', 'a', 'retrospective', 'exploratory', 'cohort', 'study', 'J', 'Izawa', 'T', 'Iwami', 'S', 'Uchino', 'M', 'Takinami', 'T', 'Kitamura', 'T', 'Kawamura', 'P202', 'Anaemia', 'does', 'not', 'affect', 'renal', 'recovery', 'in', 'acute', 'kidney', 'injury', 'J', 'G', 'Powell', 'Tuck', 'S', 'Crichton', 'M', 'Raimundo', 'L', 'Camporota', 'D', 'Wyncoll', 'M', 'Ostermann', 'P203', 'Estimated', 'glomerular', 'filtration', 'rate', 'based', 'on', 'serum', 'creatinine', 'actual', 'practice', 'in', 'Dutch', 'ICU', 's', 'A', 'Hana', 'H', 'R', 'De', 'Geus', 'P204', 'Comparison', 'of', 'estimated', 'glomerular', 'filtration', 'rate', 'calculated', 'by', 'mdrd', 'ckd', 'epi', 'serum', 'creatinine', 'and', 'ckd', 'epi', 'cystatin', 'c', 'in', 'adult', 'critically', 'ill', 'patients', 'H', 'R', 'De', 'Geus', 'A', 'Hana', 'P205', 'Early', 'diagnosis', 'of', 'septic', 'acute', 'kidney', 'injury', 'in', 'medical', 'critical', 'care', 'patients', 'with', 'a', 'urine', 'cell', 'cycle', 'arrest', 'marker', 'insulin', 'like', 'growth', 'factor', 'binding', 'protein', '7', 'IGFBP', '7', 'M', 'Aydogdu', 'N', 'Boyaci', 'S', 'Yuksel', 'G', 'Gursel', 'A', 'B', 'Cayci', 'Sivri', 'P206', 'Urinary', 'neutrophil', 'gelatinase', 'associated', 'lipocalin', 'as', 'early', 'biomarker', 'of', 'severe', 'acute', 'kidney', 'injury', 'in', 'intensive', 'care', 'J', 'Meza', 'Márquez', 'J', 'Nava', 'López', 'R', 'Carrillo', 'Esper', 'P207', 'Shrunken', 'pore', 'syndrome', 'is', 'associated', 'with', 'a', 'sharp', 'rise', 'in', 'mortality', 'in', 'patients', 'undergoing', 'elective', 'coronary', 'artery', 'bypass', 'grafting', 'A', 'Dardashti', 'A', 'Grubb', 'P208', 'The', 'biomarker', 'nephrocheck', 'can', 'discriminate', 'the', 'septic', 'shock', 'patients', 'with', 'an', 'akin', '1', 'or', '2', 'acute', 'renal', 'failure', 'who', 'will', 'not', 'progress', 'toward', 'the', 'akin', '3', 'level', 'J', 'Maizel', 'M', 'Wetzstein', 'D', 'Titeca', 'L', 'Kontar', 'F', 'Brazier', 'B', 'De', 'Cagny', 'A', 'Riviere', 'T', 'Soupison', 'M', 'Joris', 'M', 'Slama', 'P209', 'A', 'worldwide', 'multicentre', 'evaluation', 'of', 'acute', 'kidney', 'injury', 'in', 'septic', 'and', 'non', 'septic', 'critically', 'ill', 'patients', 'the', 'intensive', 'care', 'over', 'nations', 'icon', 'audit', 'E', 'Peters', 'H', 'Njimi', 'P', 'Pickkers', 'J', 'L', 'Vincent', 'P210', 'Does', 'enhanced', 'recovery', 'after', 'surgery', 'reduce', 'the', 'incidence', 'of', 'acute', 'kidney', 'injury', 'in', 'those', 'undergoing', 'major', 'gynae', 'oncological', 'surgery', 'M', 'Waraich', 'J', 'Doyle', 'T', 'Samuels', 'L', 'Forni', 'P211', 'Identification', 'of', 'risk', 'factors', 'for', 'the', 'development', 'of', 'acute', 'kidney', 'injury', 'after', 'lower', 'limb', 'arthroplasty', 'N', 'Desai', 'R', 'Baumber', 'P', 'Gunning', 'A', 'Sell', 'P212', 'Incidences', 'and', 'associations', 'of', 'acute', 'kidney', 'injury', 'after', 'major', 'trauma', 'S', 'Lin', 'H', 'Torrence', 'M', 'O', 'Dwyer', 'C', 'Kirwan', 'J', 'Prowle', 'P213', 'Acute', 'kidney', 'injury', 'of', 'major', 'trauma', 'patients', 'T', 'Kim', 'P214', 'Trajectory', 'of', 'serum', 'creatinine', 'after', 'major', 'surgery', 'and', 'the', 'diagnosis', 'of', 'acute', 'kidney', 'injury', 'M', 'E', 'O', 'Connor', 'R', 'W', 'Hewson', 'C', 'J', 'Kirwan', 'R', 'M', 'Pearse', 'J', 'Prowle', 'P215', 'Epidemiology', 'of', 'acute', 'kidney', 'injury', 'after', 'cardiac', 'surgery', 'A', 'single', 'center', 'retrospective', 'study', 'S', 'Hanoura', 'A', 'Omar', 'H', 'Othamn', 'S', 'Sudarsanan', 'M', 'Allam', 'M', 'Maksoud', 'R', 'Singh', 'A', 'Al', 'Khulaifi', 'P216', 'Post', 'operative', 'acute', 'kidney', 'injury', 'after', 'major', 'non', 'cardiac', 'surgery', 'and', 'its', 'association', 'with', 'death', 'in', 'the', 'following', 'year', 'M', 'E', 'O', 'Connor', 'R', 'W', 'Hewson', 'C', 'J', 'Kirwan', 'R', 'M', 'Pearse', 'J', 'Prowle', 'P217', 'Factors', 'affecting', 'acute', 'renal', 'failure', 'in', 'intensive', 'care', 'unit', 'and', 'effect', 'of', 'these', 'factors', 'on', 'mortality', 'O', 'Uzundere', 'D', 'Memis', 'M', 'Ýnal', 'A', 'N', 'Turan', 'P218', 'Results', 'of', 'the', 'live', 'kidney', 'transplantations', 'according', 'to', 'national', 'data', 'of', 'turkish', 'organ', 'and', 'tissue', 'information', 'system', 'M', 'A', 'Aydin', 'H', 'Basar', 'I', 'Sencan', 'A', 'Kapuagasi', 'M', 'Ozturk', 'Z', 'Uzundurukan', 'D', 'Gokmen', 'A', 'Ozcan', 'C', 'Kaymak', 'P219', 'Anaesthesia', 'procedure', 'and', 'intensive', 'therapy', 'in', 'patients', 'with', 'neck', 'phlegmon', 'V', 'A', 'Artemenko', 'A', 'Budnyuk', 'P220', 'Nasal', 'high', 'flow', 'oygen', 'for', 'acute', 'respiratory', 'failure', 'a', 'systematic', 'review', 'R', 'Pugh', 'S', 'Bhandari', 'P221', 'Setting', 'optimal', 'flow', 'rate', 'during', 'high', 'flow', 'nasal', 'cannula', 'support', 'preliminary', 'results', 'T', 'Mauri', 'C', 'Turrini', 'T', 'Langer', 'P', 'Taccone', 'C', 'A', 'Volta', 'C', 'Marenghi', 'L', 'Gattinoni', 'A', 'Pesenti', 'P222', 'Dose', 'to', 'dose', 'consistency', 'across', 'two', 'different', 'gas', 'flow', 'rates', 'using', 'cystic', 'fibrosis', 'and', 'normal', 'adult', 'breathing', 'profiles', 'during', 'nasal', 'high', 'flow', 'oxygen', 'therapy', 'L', 'Sweeney', 'A', 'O', 'Sullivan', 'P', 'Kelly', 'E', 'Mukeria', 'R', 'MacLoughlin', 'P223', 'Final', 'results', 'of', 'an', 'evaluation', 'of', 'airway', 'medix', 'closed', 'suction', 'system', 'compared', 'to', 'a', 'standard', 'closed', 'suction', 'system', 'M', 'Pfeffer', 'J', 'T', 'Thomas', 'G', 'B', 'Bregman', 'G', 'K', 'Karp', 'E', 'K', 'Kishinevsky', 'D', 'S', 'Stavi', 'N', 'A', 'Adi', 'P224', 'Different', 'cuff', 'materials', 'and', 'different', 'leak', 'tests', 'one', 'size', 'does', 'not', 'fit', 'all', 'T', 'Poropat', 'R', 'Knafelj', 'P225', 'Observational', 'study', 'on', 'the', 'value', 'of', 'the', 'cuff', 'leak', 'test', 'and', 'the', 'onset', 'of', 'upper', 'airway', 'obstruction', 'after', 'extubation', 'E', 'Llopart', 'M', 'Batlle', 'C', 'De', 'Haro', 'J', 'Mesquida', 'A', 'Artigas', 'P226', 'A', 'device', 'for', 'emergency', 'transtracheal', 'lung', 'ventilation', 'D', 'Pavlovic', 'L', 'Lewerentz', 'A', 'Spassov', 'R', 'Schneider', 'P227', 'Long', 'term', 'outcome', 'and', 'health', 'related', 'quality', 'of', 'life', 'in', 'patients', 'discharged', 'from', 'the', 'intensive', 'care', 'unit', 'with', 'a', 'tracheostomy', 'and', 'with', 'or', 'without', 'prolonged', 'mechanical', 'ventilation', 'S', 'De', 'Smet', 'S', 'De', 'Raedt', 'E', 'Derom', 'P', 'Depuydt', 'S', 'Oeyen', 'D', 'Benoit', 'J', 'Decruyenaere', 'P228', 'Ultrasound', 'guided', 'percutaneous', 'dilational', 'tracheostomy', 'versus', 'bronchoscopy', 'guided', 'percutaneous', 'dilational', 'tracheostomy', 'in', 'critically', 'ill', 'patients', 'trachus', 'a', 'randomized', 'clinical', 'trial', 'A', 'Gobatto', 'B', 'Bese', 'P', 'Tierno', 'L', 'Melro', 'P', 'Mendes', 'F', 'Cadamuro', 'M', 'Park', 'L', 'M', 'Malbouisson', 'P229', 'Is', 'it', 'safe', 'to', 'discharge', 'patients', 'with', 'tracheostomy', 'from', 'the', 'ICU', 'to', 'the', 'ward', 'B', 'C', 'Civanto', 'J', 'L', 'Lopez', 'A', 'Robles', 'J', 'Figueira', 'S', 'Yus', 'A', 'Garcia', 'P230', 'The', 'application', 'of', 'tracheostomy', 'in', 'children', 'in', 'ICU', 'A', 'Oglinda', 'G', 'Ciobanu', 'C', 'Oglinda', 'L', 'Schirca', 'T', 'Sertinean', 'V', 'Lupu', 'P231', 'The', 'impact', 'of', 'passive', 'humidifiers', 'on', 'aerosol', 'drug', 'delivery', 'during', 'mechanical', 'ventilation', 'P', 'Kelly', 'A', 'O', 'Sullivan', 'L', 'Sweeney', 'R', 'MacLoughlin', 'P232', 'Evaluation', 'of', 'vibrating', 'mesh', 'and', 'jet', 'nebuliser', 'performance', 'at', 'two', 'different', 'attachment', 'setups', 'in', 'line', 'with', 'a', 'humidifier', 'nebuliser', 'system', 'A', 'O', 'Sullivan', 'P', 'Kelly', 'L', 'Sweeney', 'E', 'Mukeria', 'M', 'Wolny', 'R', 'MacLoughlin', 'P233', 'Psv', 'niv', 'versus', 'cpap', 'in', 'the', 'treatment', 'of', 'acute', 'cardiogenic', 'pulmonary', 'edema', 'A', 'Pagano', 'F', 'Numis', 'G', 'Vison', 'L', 'Saldamarco', 'T', 'Russo', 'G', 'Porta', 'F', 'Paladino', 'P234', 'Noninvasive', 'ventilation', 'in', 'patients', 'with', 'haematologic', 'malignancy', 'a', 'retrospective', 'review', 'C', 'Bell', 'J', 'Liu', 'J', 'Debacker', 'C', 'Lee', 'E', 'Tamberg', 'V', 'Campbell', 'S', 'Mehta', 'P235', 'Use', 'of', 'non', 'invasive', 'ventilation', 'in', 'infectious', 'diseases', 'besides', 'classical', 'indications', 'A', 'Silva', 'Pinto', 'A', 'Sarmento', 'L', 'Santos', 'P236', 'The', 'impact', 'of', 'fragility', 'on', 'noninvasive', 'mechanical', 'ventilation', 'application', 'and', 'results', 'in', 'the', 'ICU', 'Ý', 'Kara', 'F', 'Yýldýrým', 'A', 'Zerman', 'Z', 'Güllü', 'N', 'Boyacý', 'B', 'Basarýk', 'Aydogan', 'Ü', 'Gaygýsýz', 'K', 'Gönderen', 'G', 'Arýk', 'M', 'Turkoglu', 'M', 'Aydogdu', 'G', 'Aygencel', 'Z', 'Ülger', 'G', 'Gursel', 'P237', 'Effects', 'of', 'metabolic', 'alkalosis', 'on', 'noninvasive', 'ventilation', 'success', 'and', 'ICU', 'outcome', 'in', 'patients', 'with', 'hypercapnic', 'respiratory', 'failure', 'N', 'Boyacý', 'Z', 'Isýkdogan', 'Ö', 'Özdedeoglu', 'Z', 'Güllü', 'M', 'Badoglu', 'U', 'Gaygýsýz', 'M', 'Aydogdu', 'G', 'Gursel', 'P238', 'Asynchrony', 'index', 'and', 'breathing', 'patterns', 'of', 'acute', 'exacerbation', 'copd', 'patients', 'assisted', 'with', 'noninvasive', 'pressure', 'support', 'ventilation', 'and', 'neurally', 'adjusted', 'ventilatory', 'assist', 'N', 'Kongpolprom', 'C', 'Sittipunt', 'P239', 'High', 'frequency', 'jet', 'ventilation', 'for', 'severe', 'acute', 'hypoxemia', 'A', 'Eden', 'Y', 'Kokhanovsky', 'S', 'Bursztein', 'De', 'Myttenaere', 'R', 'Pizov', 'P240', 'HFOV', 'revisited', 'a', '7', 'year', 'retrospective', 'analysis', 'of', 'patients', 'receiving', 'HFOV', 'who', 'met', 'oscillate', 'trial', 'entry', 'criteria', 'L', 'Neilans', 'N', 'MacIntyre', 'P241', 'Implementation', 'of', 'a', 'goal', 'directed', 'mechanical', 'ventilation', 'order', 'set', 'driven', 'by', 'respiratory', 'therapists', 'can', 'improve', 'compliance', 'with', 'best', 'practices', 'for', 'mechanical', 'ventilation', 'M', 'Radosevich', 'B', 'Wanta', 'V', 'Weber', 'T', 'Meyer', 'N', 'Smischney', 'D', 'Brown', 'D', 'Diedrich', 'P242', 'A', 'reduction', 'in', 'tidal', 'volumes', 'for', 'ventilated', 'patients', 'on', 'ICU', 'calculated', 'from', 'IBW', 'can', 'it', 'minimise', 'mortality', 'in', 'comparison', 'to', 'traditional', 'strategies', 'A', 'Fuller', 'P', 'McLindon', 'K', 'Sim', 'P243', 'Predictive', 'value', 'of', 'lung', 'aeration', 'scoring', 'using', 'lung', 'ultrasound', 'in', 'weaning', 'failure', 'M', 'Shoaeir', 'K', 'Noeam', 'A', 'Mahrous', 'R', 'Matsa', 'A', 'Ali', 'P244', 'Conventional', 'versus', 'automated', 'weaning', 'from', 'mechanical', 'ventilation', 'using', 'SmartCare', 'C', 'Dridi', 'S', 'Koubaji', 'S', 'Kamoun', 'F', 'Haddad', 'A', 'Ben', 'Souissi', 'B', 'Laribi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P245', 'Ultrasonographic', 'evaluation', 'protocol', 'for', 'weaning', 'from', 'mechanichal', 'ventilation', 'A', 'Pérez', 'Calatayud', 'R', 'Carrillo', 'Esper', 'A', 'Zepeda', 'Mendoza', 'M', 'Diaz', 'Carrillo', 'E', 'Arch', 'Tirado', 'P246', 'Diaphragm', 'ultrasonography', 'a', 'method', 'for', 'weaning', 'patients', 'from', 'mechanical', 'ventilation', 'S', 'Carbognin', 'L', 'Pelacani', 'F', 'Zannoni', 'A', 'Agnoli', 'G', 'Gagliardi', 'P247', 'Dorsal', 'diaphragmatic', 'excursion', 'tracks', 'transpulmonary', 'pressure', 'in', 'ventilated', 'ARDS', 'patients', 'a', 'potential', 'non', 'invasive', 'indicator', 'of', 'lung', 'recruitment', 'R', 'Cho', 'A', 'Adams', 'S', 'Lunos', 'S', 'Ambur', 'R', 'Shapiro', 'M', 'Prekker', 'P248', 'Pulse', 'oximetry', 'in', 'the', 'icu', 'patient', 'is', 'the', 'perfusion', 'index', 'of', 'any', 'value', 'M', 'Thijssen', 'L', 'Janssen', 'N', 'Foudraine', 'P249', 'Ventilation', 'is', 'a', 'better', 'assessment', 'of', 'respiratory', 'status', 'than', 'EtCO2', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'P250', 'Evaluation', 'of', 'the', 'relationship', 'between', 'non', 'invasive', 'minute', 'ventilation', 'and', 'end', 'tidal', 'CO2', 'in', 'patients', 'undergoing', 'general', 'vs', 'spinal', 'anesthesia', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'E', 'George', 'P251', 'Respiratory', 'volume', 'monitoring', 'provides', 'early', 'warning', 'of', 'respiratory', 'depression', 'and', 'can', 'be', 'used', 'to', 'reduce', 'false', 'alarms', 'in', 'non', 'intubated', 'patients', 'C', 'J', 'Voscopoulos', 'D', 'Eversole', 'J', 'Freeman', 'E', 'George', 'P252', 'P', 'i', 'index', 'a', 'predictive', 'edi', 'derived', 'weaning', 'index', 'during', 'nava', 'S', 'Muttini', 'R', 'Bigi', 'G', 'Villani', 'N', 'Patroniti', 'P253', 'Adequacy', 'of', 'ventilation', 'in', 'patients', 'receiving', 'opioids', 'in', 'the', 'post', 'anesthesia', 'care', 'unit', 'minute', 'ventilation', 'versus', 'respiratory', 'rate', 'G', 'Williams', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'E', 'George', 'P254', 'Comparison', 'of', 'regional', 'and', 'global', 'expiratory', 'time', 'constants', 'measured', 'by', 'electrical', 'impedance', 'tomography', 'EIT', 'A', 'Waldmann', 'S', 'Böhm', 'W', 'Windisch', 'S', 'Strassmann', 'C', 'Karagiannidis', 'P255', 'Electrical', 'impedance', 'tomography', 'robustness', 'of', 'a', 'new', 'pixel', 'wise', 'regional', 'expiratory', 'time', 'constant', 'calculation', 'A', 'Waldmann', 'S', 'Böhm', 'W', 'Windisch', 'S', 'Strassmann', 'C', 'Karagiannidis', 'P256', 'Validation', 'of', 'regional', 'and', 'global', 'expiratory', 'time', 'constant', 'measurement', 'by', 'electrical', 'impedance', 'tomography', 'in', 'ards', 'and', 'obstructive', 'pulmonary', 'diseases', 'C', 'K', 'Karagiannidis', 'A', 'W', 'Waldmann', 'S', 'B', 'Böhm', 'S', 'Strassmann', 'W', 'W', 'Windisch', 'P257', 'Transpulmonary', 'pressure', 'in', 'a', 'model', 'with', 'elastic', 'recoiling', 'lung', 'and', 'expanding', 'chest', 'wall', 'P', 'Persson', 'S', 'Lundin', 'O', 'Stenqvist', 'P258', 'Lactate', 'in', 'pleural', 'and', 'abdominal', 'effusion', 'G', 'Porta', 'F', 'Numis', 'C', 'S', 'Serra', 'A', 'P', 'Pagano', 'M', 'M', 'Masarone', 'L', 'R', 'Rinaldi', 'A', 'A', 'Amelia', 'M', 'F', 'Fascione', 'L', 'A', 'Adinolfi', 'E', 'R', 'Ruggiero', 'P259', 'Outcome', 'of', 'patients', 'admitted', 'to', 'the', 'intensive', 'care', 'with', 'pulmonary', 'fibrosis', 'F', 'Asota', 'K', 'O', 'Rourke', 'S', 'Ranjan', 'P', 'Morgan', 'P260', 'Sedation', 'and', 'analgesia', 'practice', 'in', 'extra', 'corporeal', 'membrane', 'oxygenation', 'ECMO', 'treated', 'patients', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'ARDS', 'a', 'retrospective', 'study', 'J', 'W', 'DeBacker', 'E', 'Tamberg', 'L', 'O', 'Neill', 'L', 'Munshi', 'L', 'Burry', 'E', 'Fan', 'S', 'Mehta', 'P261', 'Characteristics', 'and', 'outcomes', 'of', 'patients', 'deemed', 'not', 'eligible', 'when', 'referred', 'for', 'veno', 'venous', 'extracorporeal', 'membrane', 'oxygenation', 'vv', 'ECMO', 'S', 'Poo', 'K', 'Mahendran', 'J', 'Fowles', 'C', 'Gerrard', 'A', 'Vuylsteke', 'P262', 'The', 'SAVE', 'SMR', 'for', 'veno', 'arterial', 'ECMO', 'R', 'Loveridge', 'C', 'Chaddock', 'S', 'Patel', 'V', 'Kakar', 'C', 'Willars', 'T', 'Hurst', 'C', 'Park', 'T', 'Best', 'A', 'Vercueil', 'G', 'Auzinger', 'P263', 'A', 'simplified', 'score', 'to', 'predict', 'early', '48', 'h', 'mortality', 'in', 'patients', 'being', 'considered', 'for', 'VA', 'ECMO', 'A', 'Borgman', 'A', 'G', 'Proudfoot', 'E', 'Grins', 'K', 'E', 'Emiley', 'J', 'Schuitema', 'S', 'J', 'Fitch', 'G', 'Marco', 'J', 'Sturgill', 'M', 'G', 'Dickinson', 'M', 'Strueber', 'A', 'Khaghani', 'P', 'Wilton', 'S', 'M', 'Jovinge', 'P264', 'Lung', 'function', 'six', 'months', 'post', 'extra', 'corporeal', 'membrane', 'oxygenation', 'ECMO', 'for', 'severe', 'acute', 'respiratory', 'failure', 'in', 'adult', 'survivors', 'C', 'Sampson', 'S', 'Harris', 'Fox', 'P265', 'Bicarbonate', 'dialysis', 'removes', 'carbon', 'dioxide', 'in', 'hypoventilated', 'rodents', 'M', 'E', 'Cove', 'L', 'H', 'Vu', 'A', 'Sen', 'W', 'J', 'Federspiel', 'J', 'A', 'Kellum', 'P266', 'Procalcitonin', 'as', 'predictor', 'of', 'primary', 'graft', 'dysfunction', 'and', 'mortality', 'in', 'post', 'lung', 'transplantation', 'C', 'Mazo', 'Torre', 'J', 'Riera', 'S', 'Ramirez', 'B', 'Borgatta', 'L', 'Lagunes', 'J', 'Rello', 'P267', 'New', 'molecular', 'biomarkers', 'of', 'acute', 'respiratory', 'distress', 'syndrome', 'in', 'abdominal', 'sepsis', 'A', 'K', 'Kuzovlev', 'V', 'Moroz', 'A', 'Goloubev', 'S', 'Polovnikov', 'S', 'Nenchuk', 'P268', 'Tight', 'junction', 's', 'proteins', 'claudin', '5', 'and', 'regulation', 'by', 'tnf', 'in', 'experimental', 'murine', 'lung', 'injury', 'model', 'of', 'ali', 'ards', 'V', 'Karavana', 'C', 'Glynos', 'A', 'Asimakos', 'K', 'Pappas', 'C', 'Vrettou', 'M', 'Magkou', 'E', 'Ischaki', 'G', 'Stathopoulos', 'S', 'Zakynthinos', 'P269', 'Cell', 'counts', 'in', 'endobronchial', 'aspirate', 'to', 'assess', 'airway', 'inflammation', 'in', 'ARDS', 'patients', 'a', 'pilot', 'study', 'S', 'Spadaro', 'I', 'Kozhevnikova', 'F', 'Dalla', 'Corte', 'S', 'Grasso', 'P', 'Casolari', 'G', 'Caramori', 'C', 'Volta', 'P270', 'Epidemiological', 'and', 'clinical', 'profile', 'of', 'patients', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'in', 'the', 'surgical', 'intensive', 'care', 'unit', 'surgical', 'hospital', 'JRA', 'Antananarivo', 'T', 'Andrianjafiarinoa', 'T', 'Randriamandrato', 'T', 'Rajaonera', 'P271', 'Effect', 'of', 'high', 'PEEP', 'after', 'recruitment', 'maneuver', 'on', 'right', 'ventricular', 'function', 'in', 'ARDS', 'Is', 'it', 'good', 'for', 'the', 'lung', 'and', 'for', 'the', 'heart', 'S', 'El', 'Dash', 'ELV', 'Costa', 'MR', 'Tucci', 'F', 'Leleu', 'L', 'Kontar', 'B', 'De', 'Cagny', 'F', 'Brazier', 'D', 'Titeca', 'G', 'Bacari', 'Risal', 'J', 'Maizel', 'M', 'Amato', 'M', 'Slama', 'P272', 'Effect', 'of', 'recruitment', 'maneuver', 'on', 'left', 'ventricular', 'systolic', 'strain', 'P', 'Mercado', 'J', 'Maizel', 'L', 'Kontar', 'D', 'Titeca', 'F', 'Brazier', 'A', 'Riviere', 'M', 'Joris', 'T', 'Soupison', 'B', 'De', 'Cagny', 'S', 'El', 'Dash', 'M', 'Slama', 'P273', 'Inhaled', 'nitric', 'oxide', 'is', 'switching', 'supplier', 'cost', 'effective', 'Remmington', 'A', 'Fischer', 'S', 'Squire', 'M', 'Boichat', 'P274', 'Epidemiological', 'study', 'of', 'severe', 'acute', 'pancreatitis', 'in', 'Japan', 'comparison', 'of', 'the', 'etiology', 'and', 'the', 'patient', 'outcomes', 'on', '1159', 'patients', 'H', 'Honzawa', 'H', 'Yasuda', 'T', 'Adati', 'S', 'Suzaki', 'M', 'Horibe', 'M', 'Sasaki', 'M', 'Sanui', 'P275', 'Extracorporeal', 'liver', 'support', 'therapy', 'Experience', 'in', 'an', 'intensive', 'care', 'unit', 'R', 'Marinho', 'J', 'Daniel', 'H', 'Miranda', 'A', 'Marinho', 'P276', 'Accuracy', 'of', 'mortality', 'prediction', 'models', 'in', 'acute', 'versus', 'acute', 'on', 'chronic', 'liver', 'failure', 'in', 'the', 'intensive', 'care', 'setting', 'K', 'Milinis', 'M', 'Cooper', 'G', 'R', 'Williams', 'E', 'McCarron', 'S', 'Simants', 'I', 'Patanwala', 'I', 'Welters', 'P277', 'Risk', 'of', 'coronary', 'artery', 'disease', 'in', 'patients', 'with', 'chronic', 'liver', 'disease', 'a', 'population', 'based', 'cohort', 'study', 'Y', 'Su', 'P278', '20', 'years', 'of', 'liver', 'transplantation', 'in', 'Santiago', 'de', 'Compostela', 'Spain', 'Experience', 'review', 'J', 'Fernández', 'Villanueva', 'R', 'Fernández', 'Garda', 'A', 'López', 'Lago', 'E', 'Rodríguez', 'Ruíz', 'R', 'Hernández', 'Vaquero', 'S', 'Tomé', 'Martínez', 'de', 'Rituerto', 'E', 'Varo', 'Pérez', 'P279', 'Diarrhea', 'is', 'a', 'risk', 'factor', 'for', 'liver', 'injury', 'and', 'may', 'lead', 'to', 'intestinal', 'failure', 'associated', 'liver', 'disease', 'in', 'critical', 'illness', 'N', 'Lefel', 'F', 'Schaap', 'D', 'Bergmans', 'S', 'Olde', 'Damink', 'M', 'Van', 'de', 'Poll', 'P280', 'Bowel', 'care', 'on', 'the', 'intensive', 'care', 'unit', 'constipation', 'guideline', 'compliance', 'and', 'complications', 'K', 'Tizard', 'C', 'Lister', 'L', 'Poole', 'P281', 'Malnutrition', 'assessed', 'by', 'phase', 'angle', 'determines', 'outcomes', 'in', 'low', 'risk', 'cardiac', 'surgery', 'patients', 'D', 'Ringaitiene', 'D', 'Gineityte', 'V', 'Vicka', 'I', 'Norkiene', 'J', 'Sipylaite', 'P282', 'Preoperative', 'fasting', 'times', 'in', 'an', 'irish', 'hospital', 'A', 'O', 'Loughlin', 'V', 'Maraj', 'J', 'Dowling', 'P283', 'Costs', 'and', 'final', 'outcome', 'of', 'early', 'x', 'delayed', 'feeding', 'in', 'a', 'private', 'Brazil', 'ICU', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'E', 'B', 'Dias', 'S', 'L', 'Fernandes', 'P284', 'Can', 'ventilator', 'derived', 'energy', 'expenditure', 'measurements', 'replace', 'indirect', 'calorimetry', 'T', 'Oshima', 'S', 'Graf', 'C', 'Heidegger', 'L', 'Genton', 'V', 'Karsegard', 'Y', 'Dupertuis', 'C', 'Pichard', 'P285', 'Revisiting', 'the', 'refeeding', 'syndrome', 'results', 'of', 'a', 'systematic', 'review', 'N', 'Friedli', 'Z', 'Stanga', 'B', 'Mueller', 'P', 'Schuetz', 'P286', 'Compliance', 'with', 'the', 'new', 'protocol', 'for', 'parenteral', 'nutrition', 'in', 'our', 'ICU', 'L', 'Vandersteen', 'B', 'Stessel', 'S', 'Evers', 'A', 'Van', 'Assche', 'L', 'Jamaer', 'J', 'Dubois', 'P287', 'Nutrition', 'may', 'be', 'another', 'treatment', 'in', 'the', 'intensive', 'care', 'unit', 'where', 'less', 'is', 'more', 'R', 'Marinho', 'H', 'Castro', 'J', 'Moura', 'J', 'Valente', 'P', 'Martins', 'P', 'Casteloes', 'C', 'Magalhaes', 'S', 'Cabral', 'M', 'Santos', 'B', 'Oliveira', 'A', 'Salgueiro', 'A', 'Marinho', 'P288', 'Should', 'we', 'provide', 'more', 'protein', 'to', 'critically', 'ill', 'patients', 'R', 'Marinho', 'M', 'Santos', 'E', 'Lafuente', 'H', 'Castro', 'S', 'Cabral', 'J', 'Moura', 'P', 'Martins', 'B', 'Oliveira', 'A', 'Salgueiro', 'S', 'Duarte', 'S', 'Castro', 'M', 'Melo', 'P', 'Casteloes', 'A', 'Marinho', 'P289', 'Protein', 'provision', 'in', 'an', 'adult', 'intensive', 'care', 'unit', 'S', 'Gray', 'P290', 'Prevalence', 'and', 'clinical', 'outcomes', 'of', 'vitamin', 'd', 'deficiency', 'in', 'the', 'medical', 'critically', 'ill', 'patients', 'in', 'Songklanagarind', 'hospital', 'K', 'Maipang', 'R', 'Bhurayanontachai', 'P291', 'Vitamin', 'd', 'deficiency', 'strongly', 'predicts', 'adverse', 'medical', 'outcome', 'across', 'different', 'medical', 'inpatient', 'populations', 'results', 'from', 'a', 'prospective', 'study', 'L', 'G', 'Grädel', 'P', 'Schütz', 'P292', 'Omega', '3', 'fatty', 'acids', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'P', 'Langlois', 'W', 'Manzanares', 'P293', 'Can', '5', 'hydroxytriptophan', 'prevent', 'post', 'traumatic', 'stress', 'disorder', 'in', 'critically', 'ill', 'patients', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P294', 'Parenteral', 'selenium', 'in', 'the', 'critically', 'ill', 'an', 'updated', 'systematic', 'review', 'and', 'meta', 'analysis', 'W', 'Manzanares', 'P', 'Langlois', 'M', 'Lemieux', 'G', 'Elke', 'F', 'Bloos', 'K', 'Reinhart', 'D', 'Heyland', 'P295', 'Probiotics', 'in', 'the', 'critically', 'ill', 'an', 'updated', 'systematic', 'review', 'and', 'meta', 'analysis', 'P', 'Langlois', 'M', 'Lemieux', 'I', 'Aramendi', 'D', 'Heyland', 'W', 'Manzanares', 'P296', 'Diabetes', 'with', 'hyperglycemic', 'crisis', 'episodes', 'may', 'be', 'associated', 'with', 'higher', 'risk', 'of', 'pancreatic', 'cancer', 'a', 'population', 'based', 'cohort', 'study', 'Y', 'Su', 'P297', 'Incidence', 'of', 'hypoglycemia', 'in', 'an', 'intensive', 'care', 'unit', 'depending', 'on', 'insulin', 'protocol', 'R', 'Marinho', 'N', 'Babo', 'A', 'Marinho', 'P298', 'Severity', 'of', 'the', 'diseases', 'is', 'two', 'dimensionally', 'correlated', 'to', 'blood', 'glucose', 'including', 'blood', 'glucose', 'variability', 'especially', 'in', 'moderately', 'to', 'severely', 'ill', 'patients', 'with', 'glucose', 'intolerance', 'M', 'Hoshino', 'Y', 'Haraguchi', 'S', 'Kajiwara', 'T', 'Mitsuhashi', 'T', 'Tsubata', 'M', 'Aida', 'P299', 'A', 'study', 'of', 'glycemic', 'control', 'by', 'subcutaneous', 'glargine', 'injection', 'transition', 'from', 'continuous', 'regular', 'insulin', 'infusion', 'in', 'critically', 'ill', 'patients', 'T', 'Rattanapraphat', 'R', 'Bhurayanontachai', 'C', 'Kongkamol', 'B', 'Khwannimit', 'P300', 'Glycemic', 'control', 'in', 'Portuguese', 'intensive', 'care', 'unit', 'R', 'Marinho', 'M', 'Santos', 'H', 'Castro', 'E', 'Lafuente', 'A', 'Salgueiro', 'S', 'Cabral', 'P', 'Martins', 'J', 'Moura', 'B', 'Oliveira', 'M', 'Melo', 'B', 'Xavier', 'J', 'Valente', 'C', 'Magalhaes', 'P', 'Casteloes', 'A', 'Marinho', 'P301', 'Impact', 'of', 'hyperglycemia', 'duration', 'on', 'the', 'day', 'of', 'operation', 'on', 'short', 'term', 'outcome', 'of', 'cardiac', 'surgery', 'patients', 'D', 'Moisidou', 'F', 'Ampatzidou', 'C', 'Koutsogiannidis', 'M', 'Moschopoulou', 'G', 'Drossos', 'P302', 'Lactate', 'levels', 'in', 'diabetic', 'ketoacidosis', 'patients', 'at', 'ICU', 'admissions', 'G', 'Taskin', 'M', 'Çakir', 'AK', 'Güler', 'A', 'Taskin', 'N', 'Öcal', 'S', 'Özer', 'L', 'Yamanel', 'P303', 'Intensive', 'care', 'implications', 'of', 'merging', 'heart', 'attack', 'centre', 'units', 'in', 'London', 'J', 'M', 'Wong', 'C', 'Fitton', 'S', 'Anwar', 'S', 'Stacey', 'P304', 'Special', 'characteristics', 'of', 'in', 'hospital', 'cardiac', 'arrests', 'M', 'Aggou', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'E', 'Oloktsidou', 'K', 'Lolakos', 'E', 'Papapostolou', 'V', 'Grosomanidis', 'P305', 'Clinical', 'evaluation', 'of', 'ICU', 'admitted', 'patients', 'who', 'were', 'resuscitated', 'in', 'the', 'general', 'medicine', 'ward', 'S', 'Suda', 'T', 'Ikeda', 'S', 'Ono', 'T', 'Ueno', 'Y', 'Izutani', 'P306', 'Serious', 'game', 'evaluation', 'of', 'a', 'one', 'hour', 'training', 'basic', 'life', 'support', 'session', 'for', 'secondary', 'school', 'students', 'new', 'tools', 'for', 'future', 'bystanders', 'S', 'Gaudry', 'V', 'Desailly', 'P', 'Pasquier', 'PB', 'Brun', 'AT', 'Tesnieres', 'JD', 'Ricard', 'D', 'Dreyfuss', 'A', 'Mignon', 'P307', 'Public', 'and', 'clinical', 'staff', 'perceptions', 'and', 'knowledge', 'of', 'CPR', 'compared', 'to', 'local', 'and', 'national', 'data', 'J', 'C', 'White', 'A', 'Molokhia', 'A', 'Dean', 'A', 'Stilwell', 'G', 'Friedlaender', 'P308', 'Dispatcher', 'assisted', 'telephone', 'cardiopulmonary', 'resuscitation', 'using', 'a', 'French', 'language', 'compression', 'ventilation', 'pediatric', 'protocol', 'M', 'Peters', 'S', 'Stipulante', 'A', 'Delfosse', 'AF', 'Donneau', 'A', 'Ghuysen', 'P309', 'Dantrolene', 'versus', 'amiodarone', 'for', 'resuscitation', 'an', 'experimental', 'study', 'C', 'Feldmann', 'D', 'Freitag', 'W', 'Dersch', 'M', 'Irqsusi', 'D', 'Eschbach', 'T', 'Steinfeldt', 'H', 'Wulf', 'T', 'Wiesmann', 'P310', 'Long', 'term', 'survival', 'and', 'functional', 'neurological', 'outcome', 'in', 'comatose', 'survivors', 'undergoing', 'therapeutic', 'hypothermia', 'N', 'Kongpolprom', 'J', 'Cholkraisuwat', 'P311', 'Impact', 'of', 'kidney', 'disease', 'on', 'mortality', 'and', 'neurological', 'outcome', 'in', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'a', 'prospective', 'observational', 'study', 'S', 'Beitland', 'E', 'Nakstad', 'H', 'Stær', 'Jensen', 'T', 'Drægni', 'G', 'Andersen', 'D', 'Jacobsen', 'C', 'Brunborg', 'B', 'Waldum', 'Grevbo', 'K', 'Sunde', 'P312', 'ICU', 'dependency', 'of', 'patients', 'admitted', 'after', 'primary', 'percutaneous', 'coronary', 'intervention', 'PPCI', 'following', 'out', 'of', 'the', 'hospital', 'cardiac', 'arrest', 'K', 'Hoyland', 'D', 'Pandit', 'P313', 'Prognostic', 'indicators', 'and', 'outcome', 'prediction', 'model', 'for', 'patients', 'with', 'return', 'of', 'spontaneous', 'circulation', 'from', 'cardiopulmonary', 'arrest', 'comprehensive', 'registry', 'of', 'in', 'hospital', 'intensive', 'care', 'on', 'OHCA', 'survival', 'critical', 'study', 'in', 'Osaka', 'Japan', 'K', 'Hayakawa', 'P314', 'Cerebral', 'oxygen', 'saturation', 'during', 'resuscitation', 'in', 'a', 'porcine', 'model', 'of', 'cardiac', 'arrest', 'E', 'Oloktsidou', 'K', 'Kotzampassi', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'L', 'Loukipoudi', 'E', 'Doumaki', 'V', 'Grosomanidis', 'P315', 'Presumption', 'of', 'cardiopulmonary', 'resuscitation', 'for', 'sustaining', 'cerebral', 'oxidation', 'using', 'regional', 'cerebral', 'saturation', 'of', 'oxygen', 'observational', 'cohort', 'study', 'press', 'study', 'H', 'Yasuda', 'P316', 'EEG', 'reactivity', 'in', 'patients', 'after', 'cardiac', 'arrest', 'a', 'close', 'look', 'at', 'stimuli', 'MM', 'Admiraal', 'M', 'Van', 'Assen', 'MJ', 'Van', 'Putten', 'M', 'Tjepkema', 'Cloostermans', 'AF', 'Van', 'Rootselaar', 'J', 'Horn', 'P317', 'Prognostic', 'value', 'of', 'neuron', 'specific', 'enolase', 'after', 'cardiac', 'arrest', 'F', 'Ragusa', 'A', 'Marudi', 'S', 'Baroni', 'A', 'Gaspari', 'E', 'Bertellini', 'P318', 'Correlation', 'between', 'electroencephalographic', 'findings', 'and', 'serum', 'neuron', 'specific', 'enolase', 'with', 'outcome', 'of', 'post', 'cardiac', 'arrest', 'patients', 'A', 'Taha', 'T', 'Abdullah', 'S', 'Abdel', 'Monem', 'P319', 'Introduction', 'of', 'a', 'targeted', 'temperature', 'management', 'strategy', 'following', 'cardiac', 'arrest', 'in', 'a', 'district', 'general', 'hospital', 'intensive', 'care', 'unit', 'S', 'Alcorn', 'S', 'McNeill', 'S', 'Russell', 'P320', 'The', 'evolution', 'of', 'cerebral', 'oxygen', 'saturation', 'in', 'post', 'cardiac', 'arrest', 'patients', 'treated', 'with', 'therapeutic', 'hypothermia', 'W', 'Eertmans', 'C', 'Genbrugge', 'I', 'Meex', 'J', 'Dens', 'F', 'Jans', 'C', 'De', 'Deyne', 'P321', 'Prognostic', 'factors', 'and', 'neurological', 'outcomes', 'of', 'therapeutic', 'hypothermia', 'in', 'comatose', 'survivors', 'from', 'cardiac', 'arrest', '8', 'year', 'single', 'center', 'experience', 'J', 'Cholkraisuwat', 'N', 'Kongpolprom', 'P322', 'Adherence', 'to', 'targeted', 'temperature', 'management', 'after', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'B', 'Avard', 'R', 'Burns', 'P323', 'Implementation', 'of', 'a', 'therapeutic', 'hypothermia', 'protocol', 'for', 'comatose', 'survivors', 'of', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'A', 'Patarchi', 'T', 'Spina', 'P324', 'Factors', 'associated', 'with', 'ventilator', 'weaning', 'after', 'targeted', 'temperature', 'management', 'for', 'cardiac', 'arrest', 'patients', 'in', 'japan', 'H', 'Tanaka', 'N', 'Otani', 'S', 'Ode', 'S', 'Ishimatsu', 'P325', 'Differential', 'activation', 'of', 'c', 'fos', 'in', 'paraventricular', 'nuclei', 'of', 'the', 'hypothalamus', 'and', 'thalamus', 'of', 'the', 'rat', 'following', 'myocardial', 'infarction', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'M', 'H', 'Won', 'P326', 'Monitoring', 'of', 'cTroponin', 'I', 'in', 'patients', 'with', 'acute', 'ischemic', 'stroke', 'predictor', 'of', 'inhospital', 'mortality', 'S', 'Dakova', 'Z', 'Ramsheva', 'K', 'Ramshev', 'P327', 'Hyperthermic', 'preconditioning', 'severely', 'accelerates', 'neuronal', 'damage', 'in', 'the', 'gerbil', 'ischemic', 'hippocampal', 'dentate', 'gyrus', 'via', 'decreasing', 'sods', 'expressions', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'P328', 'Failure', 'in', 'neuroprotection', 'of', 'remote', 'limb', 'ischemic', 'post', 'conditioning', 'in', 'the', 'hippocampus', 'of', 'a', 'gerbil', 'model', 'of', 'transient', 'cerebral', 'ischemia', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'P329', 'Brain', 'death', 'and', 'admission', 'diagnosis', 'in', 'neurologic', 'intensive', 'care', 'unit', 'a', 'correlation', 'A', 'Marudi', 'S', 'Baroni', 'A', 'Gaspari', 'E', 'Bertellini', 'P330', 'Brain', 'magnetic', 'resonance', 'imaging', 'findings', 'in', 'patients', 'with', 'septic', 'shock', 'G', 'Orhun', 'E', 'Senturk', 'P', 'E', 'Ozcan', 'S', 'Sencer', 'C', 'Ulusoy', 'E', 'Tuzun', 'F', 'Esen', 'P331', 'Benefits', 'of', 'L', 'carnitine', 'in', 'valproic', 'acid', 'induced', 'encephalopathy', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P332Automatic', 'analysis', 'of', 'EEG', 'reactivity', 'in', 'comatose', 'patients', 'M', 'Van', 'Assen', 'M', 'M', 'Admiraal', 'M', 'J', 'Van', 'Putten', 'M', 'Tjepkema', 'Cloostermans', 'A', 'F', 'Van', 'Rootselaar', 'J', 'Horn', 'P333', 'Usefulness', 'of', 'common', 'ICU', 'severity', 'scoring', 'systems', 'in', 'predicting', 'outcome', 'after', 'spontaneous', 'intracerebral', 'hemorrhage', 'M', 'Fallenius', 'M', 'B', 'Skrifvars', 'M', 'Reinikainen', 'S', 'Bendel', 'R', 'Raj', 'P334', 'Evalution', 'of', 'patients', 'with', 'suspected', 'subarachnoid', 'haemorrhage', 'and', 'negative', 'ct', 'imaging', 'M', 'Abu', 'Habsa', 'C', 'Hymers', 'A', 'Borowska', 'H', 'Sivadhas', 'S', 'Sahiba', 'S', 'Perkins', 'P335', 'Timing', 'of', 'endovascular', 'and', 'surgical', 'treatment', 'for', 'aneurysmal', 'subarachnoid', 'haemorrhage', 'early', 'but', 'not', 'so', 'fast', 'J', 'Rubio', 'J', 'A', 'Rubio', 'R', 'Sierra', 'P336', 'Red', 'blood', 'cell', 'transfusion', 'in', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'the', 'Sahara', 'cohort', 'study', 'S', 'English', 'M', 'Chasse', 'A', 'Turgeon', 'F', 'Lauzier', 'D', 'Griesdale', 'A', 'Garland', 'D', 'Fergusson', 'R', 'Zarychanski', 'A', 'Tinmouth', 'C', 'Van', 'Walraven', 'K', 'Montroy', 'J', 'Ziegler', 'R', 'Dupont', 'Chouinard', 'R', 'Carignan', 'A', 'Dhaliwal', 'C', 'Lum', 'J', 'Sinclair', 'G', 'Pagliarello', 'L', 'McIntyre', 'P337', 'Aneurysmal', 'subarachnoid', 'hemorrhage', 'and', 'anemia', 'a', 'canadian', 'multi', 'centre', 'retrospective', 'cohort', 'study', 'S', 'English', 'M', 'Chasse', 'A', 'Turgeon', 'F', 'Lauzier', 'D', 'Griesdale', 'A', 'Garland', 'D', 'Fergusson', 'R', 'Zarychanski', 'A', 'Tinmouth', 'C', 'Van', 'Walraven', 'K', 'Montroy', 'J', 'Ziegler', 'R', 'Dupont', 'Chouinard', 'R', 'Carignan', 'A', 'Dhaliwal', 'C', 'Lum', 'J', 'Sinclair', 'G', 'Pagliarello', 'L', 'McIntyre', 'P338', 'Does', 'the', 'neutrophil', 'to', 'lymphocyte', 'NLR', 'ratio', 'predict', 'symptomatic', 'vasospasm', 'or', 'delayed', 'cerebral', 'ischemia', 'DCI', 'after', 'aneurysmal', 'subarachnoid', 'haemorrhage', 'SAH', 'T', 'Groza', 'N', 'Moreau', 'D', 'Castanares', 'Zapatero', 'P', 'Hantson', 'P339', 'ICU', 'acquired', 'infections', 'in', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'patients', 'impact', 'on', 'ICU', 'and', 'hospital', 'length', 'of', 'stay', 'M', 'Carbonara', 'F', 'Ortolano', 'T', 'Zoerle', 'S', 'Magnoni', 'S', 'Pifferi', 'V', 'Conte', 'N', 'Stocchetti', 'P340', 'Cerebral', 'metabolic', 'effects', 'of', 'normobaric', 'hyperoxia', 'during', 'the', 'acute', 'phase', 'of', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'L', 'Carteron', 'T', 'Suys', 'C', 'Patet', 'H', 'Quintard', 'M', 'Oddo', 'P341', 'Postoperative', 'care', 'for', 'elective', 'craniotomy', 'where', 'is', 'best', 'done', 'J', 'A', 'Rubio', 'J', 'Rubio', 'R', 'Sierra', 'P342', '5', 'year', 'follow', 'up', 'of', 'patients', 'after', 'transplantation', 'of', 'organs', 'from', 'donors', 'from', 'neurocritical', 'care', 'V', 'Spatenkova', 'E', 'Pokorna', 'P', 'Suchomel', 'P343', 'Evaluation', 'of', 'levetiracetam', 'pharmacokinetics', 'after', 'severe', 'traumatic', 'brain', 'injury', 'in', 'neurocritical', 'care', 'patients', 'at', 'a', 'level', 'one', 'trauma', 'center', 'N', 'Ebert', 'J', 'Jancik', 'H', 'Rhodes', 'P344', 'Model', 'based', 'time', 'series', 'cluster', 'analysis', 'to', 'determine', 'unique', 'patient', 'states', 'in', 'traumatic', 'brain', 'injury', 'T', 'Bylinski', 'C', 'Hawthorne', 'M', 'Shaw', 'I', 'Piper', 'J', 'Kinsella', 'P345', 'Brain', 'compartment', 'monitoring', 'capabilities', 'from', 'ICP', 'to', 'BI', 'bioimpedance', 'during', 'HS', 'hypertonic', 'saline', 'administration', 'State', 'of', 'art', 'simulation', 'outcome', 'depending', 'on', 'brain', 'swelling', 'type', 'A', 'K', 'Kink', 'I', 'R', 'Rätsep', 'P346', 'Transfusion', 'of', 'red', 'blood', 'cells', 'in', 'patients', 'with', 'traumatic', 'brain', 'injury', 'admitted', 'to', 'Canadian', 'trauma', 'health', 'centers', 'a', 'multicenter', 'cohort', 'study', 'A', 'Boutin', 'L', 'Moore', 'M', 'Chasse', 'R', 'Zarychanski', 'F', 'Lauzier', 'S', 'English', 'L', 'McIntyre', 'J', 'Lacroix', 'D', 'Griesdale', 'P', 'Lessard', 'Bonaventure', 'A', 'F', 'Turgeon', 'P347', 'Hemoglobin', 'thresholds', 'and', 'red', 'blood', 'cell', 'transfusions', 'in', 'adult', 'patients', 'with', 'moderate', 'or', 'severe', 'traumatic', 'brain', 'injury', 'a', 'retrospective', 'cohort', 'study', 'A', 'Boutin', 'L', 'Moore', 'R', 'Green', 'P', 'Lessard', 'Bonaventure', 'M', 'Erdogan', 'M', 'Butler', 'F', 'Lauzier', 'M', 'Chasse', 'S', 'English', 'L', 'McIntyre', 'R', 'Zarychanski', 'J', 'Lacroix', 'D', 'Griesdale', 'P', 'Desjardins', 'D', 'A', 'Fergusson', 'A', 'F', 'Turgeon', 'P348', 'Characteristics', 'of', 'patients', 'with', 'gunshot', 'wounds', 'to', 'the', 'head', 'an', 'observational', 'Brazilian', 'study', 'B', 'Goncalves', 'B', 'Vidal', 'C', 'Valdez', 'A', 'C', 'Rodrigues', 'L', 'Miguez', 'G', 'Moralez', 'P349', 'Base', 'excess', 'as', 'predictor', 'for', 'ICU', 'admission', 'and', 'the', 'injury', 'severity', 'in', 'blunt', 'trauma', 'patients', 'T', 'Hong', 'P350', 'Enhancement', 'of', 'usual', 'emergency', 'department', 'care', 'with', 'proadrenomedullin', 'to', 'improve', 'outcome', 'prediction', 'Results', 'from', 'the', 'multi', 'national', 'prospective', 'observational', 'TRIAGE', 'study', 'A', 'Kutz', 'P', 'Hausfater', 'D', 'Amin', 'T', 'Struja', 'S', 'Haubitz', 'A', 'Huber', 'B', 'Mueller', 'P', 'Schuetz', 'P351', 'Developing', 'an', 'innovative', 'emergency', 'medicine', 'point', 'of', 'care', 'simulation', 'programme', 'T', 'Brown', 'J', 'Collinson', 'C', 'Pritchett', 'T', 'Slade', 'P352', 'The', 'InSim', 'program', 'an', 'in', 'situ', 'simulation', 'program', 'for', 'junior', 'trainees', 'in', 'intensive', 'care', 'M', 'Le', 'Guen', 'S', 'Hellings', 'R', 'Ramsaran', 'P353', 'Impact', 'of', 'excessive', 'and', 'inappropriate', 'troponin', 'testing', 'in', 'the', 'emergency', 'setting', 'how', 'good', 'are', 'we', 'A', 'Alsheikhly', 'P354', 'The', 'development', 'of', 'time', 'tracking', 'monitor', 'at', 'emergency', 'department', 'T', 'Abe', 'P355', 'Role', 'of', 'focussed', 'echocardiography', 'in', 'emergency', 'assessment', 'of', 'syncope', 'L', 'Kanapeckaite', 'M', 'Abu', 'Habsa', 'R', 'Bahl', 'P356', 'Insertion', 'of', 'an', 'open', 'ended', '14', 'gauge', 'catheter', 'through', 'the', 'chest', 'wall', 'causes', 'a', 'significant', 'pneumothorax', 'in', 'a', 'self', 'ventilating', 'swine', 'model', 'M', 'Q', 'Russell', 'K', 'J', 'Real', 'M', 'Abu', 'Habsa', 'R', 'M', 'Lyon', 'N', 'P', 'Oveland', 'P357', 'Ez', 'io', 'intraosseous', 'access', 'teaching', 'in', 'the', 'workplace', 'using', 'a', 'mobile', 'tea', 'trolley', 'training', 'method', 'J', 'Penketh', 'M', 'Mcdonald', 'F', 'Kelly', 'P358', 'Black', 'widow', 'envenomation', 'in', 'Saudi', 'Arabia', 'a', 'prospective', 'observational', 'case', 'series', 'M', 'Alfafi', 'S', 'Alsolamy', 'W', 'Almutairi', 'B', 'Alotaibi', 'P359', 'Mechanical', 'ventilation', 'in', 'patients', 'with', 'overdose', 'not', 'yet', 'intubated', 'on', 'icu', 'admission', 'A', 'E', 'Van', 'den', 'Berg', 'Y', 'Schriel', 'L', 'Dawson', 'I', 'A', 'Meynaar', 'P360', 'Central', 'nervous', 'system', 'depressants', 'poisoning', 'and', 'ventilator', 'associated', 'pneumonia', 'an', 'underrated', 'risk', 'factor', 'in', 'toxicological', 'intensive', 'care', 'unit', 'H', 'Talaie', 'P361', 'Acute', 'barium', 'intoxication', 'treated', 'with', 'hemodiafiltration', 'D', 'Silva', 'S', 'Fernandes', 'J', 'Gouveia', 'J', 'Santos', 'Silva', 'P362', 'Major', 'trauma', 'presenting', 'to', 'the', 'emergency', 'department', 'the', 'spectrum', 'of', 'cycling', 'injuries', 'in', 'Ireland', 'J', 'Foley', 'A', 'Kaskovagheorgescu', 'D', 'Evoy', 'J', 'Cronin', 'J', 'Ryan', 'P363', 'Burns', 'from', 'French', 'military', 'operations', 'a', '14', 'year', 'retrospective', 'observational', 'analysis', 'M', 'Huck', 'C', 'Hoffmann', 'J', 'Renner', 'P', 'Laitselart', 'N', 'Donat', 'A', 'Cirodde', 'J', 'V', 'Schaal', 'Y', 'Masson', 'A', 'Nau', 'T', 'Leclerc', 'P364', 'A', 'comparison', 'of', 'mortality', 'scores', 'in', 'burns', 'patients', 'on', 'the', 'intensive', 'care', 'unit', 'O', 'Howarth', 'K', 'Davenport', 'P', 'Jeanrenaud', 'S', 'Raftery', 'P365', 'Clasification', 'of', 'pain', 'and', 'its', 'treatment', 'and', 'an', 'intensive', 'care', 'rehabiliation', 'clinic', 'P', 'MacTavish', 'H', 'Devine', 'J', 'McPeake', 'M', 'Daniel', 'J', 'Kinsella', 'T', 'Quasim', 'P366', 'Pain', 'management', 'adequacy', 'in', 'critical', 'care', 'areas', 'the', 'process', 'and', 'the', 'barriers', 'perceived', 'by', 'critical', 'care', 'nurses', 'S', 'Alrabiee', 'A', 'Alrashid', 'S', 'Alsolamy', 'P367', 'Pain', 'assessment', 'in', 'critically', 'ill', 'adult', 'patients', 'validation', 'of', 'the', 'Turkish', 'version', 'of', 'the', 'critical', 'care', 'pain', 'observation', 'tool', 'O', 'Gundogan', 'C', 'Bor', 'E', 'Akýn', 'Korhan', 'K', 'Demirag', 'M', 'Uyar', 'P368', 'An', 'audit', 'of', 'pain', 'and', 'sedation', 'assessments', 'in', 'the', 'intensive', 'care', 'unit', 'recommendations', 'for', 'clinical', 'practice', 'F', 'Frame', 'C', 'Ashton', 'L', 'Bergstrom', 'Niska', 'P369', 'Impact', 'of', 'pharmaceutical', 'care', 'on', 'treatment', 'of', 'pain', 'and', 'agitation', 'in', 'medical', 'intensive', 'care', 'unit', 'P', 'Dilokpattanamongkol', 'T', 'Suansanae', 'C', 'Suthisisang', 'S', 'Morakul', 'C', 'Karnjanarachata', 'V', 'Tangsujaritvijit', 'P370', 'Agitation', 'in', 'trauma', 'ICU', 'prevention', 'and', 'outcome', 'S', 'Mahmood', 'H', 'Al', 'Thani', 'A', 'Almenyar', 'P371', 'Correlation', 'between', 'percentages', 'of', 'ventilated', 'patients', 'developed', 'vap', 'and', 'use', 'of', 'sedative', 'agents', 'in', 'icu', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P372', 'Improving', 'recording', 'of', 'sedation', 'events', 'in', 'the', 'Emergency', 'Department', 'The', 'implementation', 'of', 'the', 'SIVA', 'International', 'Taskforce', 'adverse', 'event', 'reporting', 'tool', 'for', 'procedural', 'sedation', 'R', 'Sharvill', 'J', 'Penketh', 'P373', 'Impact', 'of', 'sedative', 'drug', 'use', 'on', 'the', 'length', 'of', 'mechanical', 'ventilation', 'S', 'E', 'Morton', 'Y', 'S', 'Chiew', 'C', 'Pretty', 'J', 'G', 'Chase', 'G', 'M', 'Shaw', 'P374', 'Co', 'administration', 'of', 'nitric', 'oxide', 'and', 'sevoflurane', 'using', 'anaconda', 'R', 'Knafelj', 'P', 'Kordis', 'P375', 'A', 'retrospective', 'study', 'of', 'the', 'use', 'of', 'Dexmedetomidine', 'in', 'an', 'oncological', 'critical', 'care', 'setting', 'S', 'Patel', 'V', 'Grover', 'P376', 'Dexmedetomidine', 'and', 'posttraumatic', 'stress', 'disorder', 'incidence', 'in', 'alcohol', 'withdrawal', 'icu', 'patients', 'I', 'Kuchyn', 'K', 'Bielka', 'P377', 'Hemodynamic', 'effects', 'of', 'dexmedetomidine', 'in', 'a', 'porcine', 'model', 'of', 'septic', 'shock', 'Z', 'Aidoni', 'V', 'Grosomanidis', 'K', 'Kotzampassi', 'G', 'Stavrou', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'C', 'Skourtis', 'P378', 'Ketamine', 'for', 'analgosedation', 'in', 'severe', 'hypoxic', 'respiratory', 'failure', 'S', 'D', 'Lee', 'K', 'Williams', 'I', 'D', 'Weltes', 'P379', 'Madness', 'from', 'the', 'moon', 'lunar', 'cycle', 'and', 'the', 'incidence', 'of', 'delirium', 'on', 'the', 'intensive', 'care', 'unit', 'S', 'Berhane', 'C', 'Arrowsmith', 'C', 'Peters', 'S', 'Robert', 'P380', 'Impaired', 'dynamic', 'cerebral', 'autoregulation', 'after', 'coronary', 'artery', 'bypass', 'grafting', 'and', 'association', 'with', 'postoperative', 'delirium', 'J', 'Caldas', 'R', 'B', 'Panerai', 'T', 'G', 'Robinson', 'L', 'Camara', 'G', 'Ferreira', 'E', 'Borg', 'Seng', 'Shu', 'M', 'De', 'Lima', 'Oliveira', 'N', 'C', 'Mian', 'L', 'Santos', 'R', 'Nogueira', 'S', 'P', 'Zeferino', 'M', 'Jacobsen', 'Teixeira', 'F', 'Galas', 'L', 'A', 'Hajjar', 'P381', 'Risk', 'factors', 'predicting', 'prolonged', 'intensive', 'care', 'unit', 'length', 'of', 'stay', 'after', 'major', 'elective', 'surgery', 'P', 'Killeen', 'M', 'McPhail', 'W', 'Bernal', 'J', 'Maggs', 'J', 'Wendon', 'T', 'Hughes', 'P382', 'Systemic', 'inflammatory', 'response', 'syndrome', 'criteria', 'and', 'hospital', 'mortality', 'prediction', 'in', 'a', 'brazilian', 'cohort', 'of', 'critically', 'ill', 'patients', 'L', 'U', 'Taniguchi', 'E', 'M', 'Siqueira', 'J', 'M', 'Vieira', 'Jr', 'L', 'C', 'Azevedo', 'P383', 'Evaluating', 'the', 'efficacy', 'of', 'a', 'risk', 'predictor', 'panel', 'in', 'identifying', 'patients', 'at', 'elevated', 'risk', 'of', 'morbidity', 'following', 'emergency', 'admission', 'A', 'N', 'Ahmad', 'M', 'Abu', 'Habsa', 'R', 'Bahl', 'E', 'Helme', 'S', 'Hadfield', 'R', 'Loveridge', 'P384', 'A', 'retrospective', 'comparison', 'of', 'outcomes', 'for', 'elective', 'surgical', 'patients', 'admitted', 'post', 'operatively', 'to', 'the', 'critical', 'care', 'unit', 'or', 'general', 'ward', 'J', 'Shak', 'C', 'Senver', 'R', 'Howard', 'Griffin', 'P385', 'Effect', 'of', 'obesity', 'on', 'mortality', 'in', 'surgical', 'critically', 'ill', 'patients', 'P', 'Wacharasint', 'P', 'Fuengfoo', 'N', 'Sukcharoen', 'R', 'Rangsin', 'P386', 'The', 'national', 'early', 'warning', 'score', 'news', 'reliably', 'improves', 'adverse', 'clinical', 'outcome', 'prediction', 'in', 'community', 'acquired', 'pneumonia', 'results', 'from', 'a', '6', 'year', 'follow', 'up', 'D', 'Sbiti', 'Rohr', 'P', 'Schuetz', 'P387', 'Clinical', 'usefulness', 'of', 'the', 'charlson', 's', 'weighted', 'index', 'of', 'comorbidities', 'as', 'prognostic', 'factor', 'in', 'patients', 'with', 'prolonged', 'acute', 'mechanical', 'ventilation', 'H', 'Na', 'S', 'Song', 'S', 'Lee', 'E', 'Jeong', 'K', 'Lee', 'P388', 'Comparison', 'of', 'mortality', 'prediction', 'scoring', 'systems', 'in', 'patients', 'with', 'cirrhosis', 'admitted', 'to', 'general', 'intensive', 'care', 'unit', 'M', 'Cooper', 'K', 'Milinis', 'G', 'Williams', 'E', 'McCarron', 'S', 'Simants', 'I', 'Patanwala', 'I', 'D', 'Welters', 'P389', 'Impact', 'of', 'admission', 'source', 'and', 'time', 'of', 'admission', 'on', 'outcome', 'of', 'pediatric', 'intensive', 'care', 'patients', 'retrospective', '15', 'years', 'study', 'E', 'Zoumpelouli', 'EA', 'Volakli', 'V', 'Chrysohoidou', 'S', 'Georgiou', 'K', 'Charisopoulou', 'E', 'Kotzapanagiotou', 'V', 'Panagiotidou', 'K', 'Manavidou', 'Z', 'Stathi', 'M', 'Sdougka', 'P390', 'Heart', 'rate', 'variability', 'and', 'outcomes', 'prediction', 'in', 'critical', 'illness', 'N', 'Salahuddin', 'B', 'AlGhamdi', 'Q', 'Marashly', 'K', 'Zaza', 'M', 'Sharshir', 'M', 'Khurshid', 'Z', 'Ali', 'M', 'Malgapo', 'M', 'Jamil', 'A', 'Shafquat', 'M', 'Shoukri', 'M', 'Hijazi', 'P391', 'The', 'incidence', 'and', 'outcome', 'of', 'hyperlactatemia', 'in', 'the', 'post', 'anaesthesia', 'care', 'unit', 'T', 'Abe', 'S', 'Uchino', 'M', 'Takinami', 'P392', 'Correlation', 'between', 'arterial', 'blood', 'gas', 'disturbances', 'and', 'arterial', 'lactate', 'levels', 'during', 'hospitalization', 'and', 'outcome', 'in', 'critically', 'septic', 'patients', 'N', 'R', 'Rangel', 'Neto', 'S', 'Oliveira', 'F', 'Q', 'Reis', 'F', 'A', 'Rocha', 'P393', 'External', 'validation', 'of', 'saps', '3', 'and', 'mpm', 'iii', 'scores', 'in', '48', '816', 'patients', 'from', '72', 'brazilian', 'icus', 'G', 'Moralez', 'K', 'Ebecken', 'L', 'S', 'Rabello', 'M', 'F', 'Lima', 'R', 'Hatum', 'F', 'V', 'De', 'Marco', 'A', 'Alves', 'J', 'E', 'Pinto', 'M', 'Godoy', 'P', 'E', 'Brasil', 'F', 'A', 'Bozza', 'J', 'I', 'Salluh', 'M', 'Soares', 'P394', 'The', 'frailty', 'penalty', 'pre', 'admission', 'functional', 'status', 'confounds', 'mortality', 'prediction', 'models', 'in', 'critically', 'ill', 'patients', 'J', 'Krinsley', 'G', 'Kang', 'P395', 'sooner', 'rather', 'than', 'later', 'how', 'delayed', 'discharge', 'from', 'critical', 'care', 'leads', 'to', 'increased', 'out', 'of', 'hours', 'discharges', 'and', 'subsequent', 'increase', 'in', 'in', 'hospital', 'mortality', 'J', 'Perry', 'H', 'Hines', 'P396', 'Identifying', 'poor', 'outcome', 'patient', 'groups', 'in', 'a', 'resource', 'constrained', 'critical', 'care', 'unit', 'K', 'M', 'Wilkinson', 'C', 'Tordoff', 'B', 'Sloan', 'M', 'C', 'Bellamy', 'P397', 'Effects', 'of', 'icu', 'weekend', 'admission', 'and', 'discharge', 'on', 'mortality', 'E', 'Moreira', 'F', 'Verga', 'M', 'Barbato', 'G', 'Burghi', 'P398', 'Organizational', 'factors', 'outcomes', 'and', 'resource', 'use', 'in', '9', '946', 'cancer', 'patients', 'admitted', 'to', '70', 'ICUs', 'M', 'Soares', 'U', 'V', 'Silva', 'L', 'C', 'Azevedo', 'A', 'P', 'Torelly', 'J', 'M', 'Kahn', 'D', 'C', 'Angus', 'M', 'F', 'Knibel', 'P', 'E', 'Brasil', 'F', 'A', 'Bozza', 'J', 'I', 'Salluh', 'P399', 'Evaluation', 'of', 'oncological', 'critically', 'ill', 'patients', 'severity', 'score', 'and', 'outcome', 'compared', 'to', 'not', 'oncological', 'in', 'a', 'particular', 'hospital', 'cti', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'P400', 'Outcomes', 'of', 'patients', 'admitted', 'to', 'a', 'large', 'uk', 'critical', 'care', 'department', 'with', 'palliative', 'oncological', 'diagnoses', 'R', 'Marshall', 'T', 'Gilpin', 'A', 'Tridente', 'A', 'Raithatha', 'P401', 'Predictors', 'of', 'mortality', 'in', 'febrile', 'neutropenic', 'patients', 'with', 'haematological', 'malignancies', 'admitted', 'to', 'an', 'intensive', 'care', 'unit', 'of', 'a', 'cancer', 'center', 'D', 'Mota', 'B', 'Loureiro', 'J', 'Dias', 'O', 'Afonso', 'F', 'Coelho', 'A', 'Martins', 'F', 'Faria', 'P402', 'Patients', 'with', 'hematologic', 'malignancies', 'requiring', 'invasive', 'mechanical', 'ventilation', 'characteristics', 'and', 'predictors', 'of', 'mortality', 'H', 'Al', 'Dorzi', 'H', 'Al', 'Orainni', 'F', 'AlEid', 'H', 'Tlaygeh', 'A', 'Itani', 'A', 'Hejazi', 'Y', 'Arabi', 'P403', 'Patient', 'important', 'outcomes', 'in', 'randomized', 'controlled', 'trials', 'in', 'critically', 'ill', 'patients', 'a', 'systematic', 'review', 'S', 'Gaudry', 'J', 'Messika', 'J', 'D', 'Ricard', 'S', 'Guillo', 'B', 'Pasquet', 'E', 'Dubief', 'D', 'Dreyfuss', 'F', 'Tubach', 'P404', 'Alopecia', 'in', 'survivors', 'of', 'critical', 'illness', 'a', 'qualitative', 'study', 'C', 'Battle', 'K', 'James', 'P', 'Temblett', 'P405', 'The', 'impact', 'of', 'mental', 'health', 'on', 'icu', 'admission', 'L', 'Davies', 'C', 'Battle', 'C', 'Lynch', 'P406', 'Cognitive', 'impairment', '5', 'years', 'after', 'ICU', 'discharge', 'S', 'Pereira', 'S', 'Cavaco', 'J', 'Fernandes', 'I', 'Moreira', 'E', 'Almeida', 'F', 'Seabra', 'Pereira', 'M', 'Malheiro', 'F', 'Cardoso', 'I', 'Aragão', 'T', 'Cardoso', 'P407', 'Apache', 'ii', 'versus', 'apache', 'iv', 'for', 'octagenerians', 'in', 'medical', 'icu', 'M', 'Fister', 'R', 'Knafelj', 'P408', 'Outcomes', 'of', 'octagenarians', 'in', 'an', 'indian', 'icu', 'P', 'Muraray', 'Govind', 'N', 'Brahmananda', 'Reddy', 'R', 'Pratheema', 'E', 'D', 'Arul', 'J', 'Devachandran', 'P409', 'Mortality', 'and', 'outcomes', 'in', 'elderly', 'patients', '80', 'years', 'of', 'age', 'or', 'older', 'admitted', 'to', 'the', 'icu', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'P410', 'Octagenerians', 'in', 'medical', 'icu', 'adding', 'days', 'to', 'life', 'or', 'life', 'to', 'days', 'R', 'Knafelj', 'M', 'Fister', 'P411', 'The', 'very', 'elderly', 'admitted', 'to', 'intensive', 'care', 'unit', 'outcomes', 'and', 'economic', 'evaluation', 'N', 'Chin', 'Yee', 'G', 'D', 'Egidio', 'K', 'Thavorn', 'D', 'Heyland', 'K', 'Kyeremanteng', 'P412', 'The', 'very', 'elderly', 'in', 'intensive', 'care', 'relationship', 'between', 'acuity', 'of', 'illness', 'and', 'long', 'term', 'mortality', 'A', 'G', 'Murchison', 'K', 'Swalwell', 'J', 'Mandeville', 'D', 'Stott', 'P413', 'Acquired', 'weakness', 'in', 'an', 'oncological', 'intensive', 'care', 'unit', 'I', 'Guerreiro', 'P414', 'Musculoskeletal', 'problems', 'in', 'intensive', 'care', 'unit', 'ICU', 'patients', 'post', 'discharge', 'H', 'Devine', 'P', 'MacTavish', 'J', 'McPeake', 'T', 'Quasim', 'J', 'Kinsella', 'M', 'Daniel', 'P415', 'Premorbid', 'obesity', 'but', 'not', 'nutrition', 'prevents', 'critical', 'illness', 'induced', 'muscle', 'wasting', 'and', 'weakness', 'C', 'Goossens', 'M', 'B', 'Marques', 'S', 'Derde', 'S', 'Vander', 'Perre', 'T', 'Dufour', 'S', 'E', 'Thiessen', 'F', 'Güiza', 'T', 'Janssens', 'G', 'Hermans', 'I', 'Vanhorebeek', 'K', 'De', 'Bock', 'G', 'Van', 'den', 'Berghe', 'L', 'Langouche', 'P416', 'Physical', 'outcome', 'measures', 'for', 'critical', 'care', 'patients', 'following', 'intensive', 'care', 'unit', 'icu', 'discharge', 'H', 'Devine', 'P', 'MacTavish', 'T', 'Quasim', 'J', 'Kinsella', 'M', 'Daniel', 'J', 'McPeake', 'P417', 'Improving', 'active', 'mobilisation', 'in', 'a', 'general', 'intensive', 'care', 'unit', 'B', 'Miles', 'S', 'Madden', 'H', 'Devine', 'P418', 'Mobilization', 'in', 'patients', 'on', 'vasoactive', 'drugs', 'use', 'a', 'pilot', 'study', 'M', 'Weiler', 'P', 'Marques', 'C', 'Rodrigues', 'M', 'Boeira', 'K', 'Brenner', 'C', 'Leães', 'A', 'Machado', 'R', 'Townsend', 'J', 'Andrade', 'P419', 'Pharmacy', 'intervention', 'at', 'an', 'intensive', 'care', 'rehabilitation', 'clinic', 'P', 'MacTavish', 'J', 'McPeake', 'H', 'Devine', 'J', 'Kinsella', 'M', 'Daniel', 'R', 'Kishore', 'C', 'Fenlon', 'T', 'Quasim', 'P420', 'Interactive', 'gaming', 'is', 'feasible', 'and', 'potentially', 'increases', 'icu', 'patients', 'motivation', 'to', 'be', 'engaged', 'in', 'rehabilitation', 'programs', 'T', 'Fiks', 'A', 'Ruijter', 'M', 'Te', 'Raa', 'P', 'Spronk', 'P421', 'Simulation', 'based', 'design', 'of', 'a', 'robust', 'stopping', 'rule', 'to', 'ensure', 'patient', 'safety', 'Y', 'S', 'Chiew', 'P', 'Docherty', 'J', 'Dickson', 'E', 'Moltchanova', 'C', 'Scarrot', 'C', 'Pretty', 'G', 'M', 'Shaw', 'J', 'G', 'Chase', 'P422', 'Are', 'daily', 'blood', 'tests', 'on', 'the', 'intensive', 'care', 'unit', 'necessary', 'T', 'Hall', 'W', 'C', 'Ngu', 'J', 'M', 'Jack', 'P', 'Morgan', 'P423', 'Measuring', 'urine', 'output', 'in', 'ward', 'patients', 'is', 'it', 'helpful', 'B', 'Avard', 'A', 'Pavli', 'X', 'Gee', 'P424', 'The', 'incidence', 'of', 'pressure', 'ulcers', 'in', 'an', 'adult', 'mixed', 'intensive', 'care', 'unit', 'in', 'turkey', 'C', 'Bor', 'E', 'Akin', 'Korhan', 'K', 'Demirag', 'M', 'Uyar', 'P425', 'Intensivist', 'patient', 'ratios', 'in', 'closed', 'ICUs', 'in', 'Alexandria', 'Egypt', 'an', 'overview', 'M', 'Shirazy', 'A', 'Fayed', 'P426', 'Eicu', 'electronic', 'intensive', 'care', 'unit', 'impact', 'on', 'ALOS', 'average', 'length', 'of', 'stay', 'in', 'a', 'developing', 'country', 'like', 'India', 'S', 'Gupta', 'A', 'Kaushal', 'S', 'Dewan', 'A', 'Varma', 'P427', 'Predicting', 'deterioration', 'in', 'general', 'ward', 'using', 'early', 'deterioration', 'indicator', 'E', 'Ghosh', 'L', 'Yang', 'L', 'Eshelman', 'B', 'Lord', 'E', 'Carlson', 'P428', 'High', 'impact', 'enhanced', 'critical', 'care', 'outreach', 'the', 'imobile', 'service', 'making', 'a', 'difference', 'E', 'Helme', 'R', 'Broderick', 'S', 'Hadfield', 'R', 'Loveridge', 'P429', 'Impact', 'of', 'bed', 'availability', 'and', 'cognitive', 'load', 'on', 'intensive', 'care', 'unit', 'ICU', 'bed', 'allocation', 'a', 'vignette', 'based', 'trial', 'J', 'Ramos', 'D', 'Forte', 'P430', 'Characteristics', 'of', 'critically', 'ill', 'patients', 'admitted', 'through', 'the', 'emergency', 'department', 'F', 'Yang', 'P', 'Hou', 'P431', 'Admission', 'to', 'critical', 'care', 'the', 'quantification', 'of', 'functional', 'reserve', 'J', 'Dudziak', 'J', 'Feeney', 'K', 'Wilkinson', 'K', 'Bauchmuller', 'K', 'Shuker', 'M', 'Faulds', 'A', 'Raithatha', 'D', 'Bryden', 'L', 'England', 'N', 'Bolton', 'A', 'Tridente', 'P432', 'Admission', 'to', 'critical', 'care', 'the', 'importance', 'of', 'frailty', 'K', 'Bauchmuller', 'K', 'Shuker', 'A', 'Tridente', 'M', 'Faulds', 'A', 'Matheson', 'J', 'Gaynor', 'D', 'Bryden', 'S', 'South', 'Yorkshire', 'Hospitals', 'Research', 'Collaboration', 'P433', 'Development', 'of', 'an', 'instrument', 'to', 'aid', 'triage', 'decisions', 'for', 'intensive', 'care', 'unit', 'admission', 'J', 'Ramos', 'B', 'Peroni', 'R', 'Daglius', 'Dias', 'L', 'Miranda', 'C', 'Cohen', 'C', 'Carvalho', 'I', 'Velasco', 'D', 'Forte', 'P434', 'Using', 'selective', 'serotonin', 're', 'uptake', 'inhibitors', 'and', 'serotonin', 'norepinephrine', 're', 'uptake', 'inhibitors', 'in', 'critical', 'care', 'a', 'systematic', 'review', 'of', 'the', 'evidence', 'for', 'benefit', 'or', 'harm', 'J', 'M', 'Kelly', 'A', 'Neill', 'G', 'Rubenfeld', 'N', 'Masson', 'A', 'Min', 'P435', 'Measuring', 'adaptive', 'coping', 'of', 'hospitalized', 'patients', 'with', 'a', 'severe', 'medical', 'condition', 'the', 'sickness', 'insight', 'in', 'coping', 'questionnaire', 'sicq', 'E', 'Boezeman', 'J', 'Hofhuis', 'A', 'Hovingh', 'R', 'De', 'Vries', 'P', 'Spronk', 'P436', 'Results', 'of', 'a', 'national', 'survey', 'regarding', 'intensive', 'care', 'medicine', 'training', 'G', 'Cabral', 'Campello', 'I', 'Aragão', 'T', 'Cardoso', 'P437', 'Work', 'engagement', 'among', 'healthcare', 'professionals', 'in', 'the', 'intensive', 'care', 'unit', 'M', 'Van', 'Mol', 'M', 'Nijkamp', 'E', 'Kompanje', 'P438', 'Empowering', 'the', 'intensive', 'care', 'practitioners', 'is', 'it', 'a', 'burnout', 'ameliorating', 'intervention', 'P', 'Ostrowski', 'A', 'Omar', 'P439', 'Icu', 'patients', 'suffer', 'from', 'circadian', 'rhythm', 'desynchronisation', 'K', 'Kiss', 'B', 'Köves', 'V', 'Csernus', 'Z', 'Molnár', 'P440', 'Noise', 'reduction', 'in', 'the', 'ICU', 'feasible', 'Y', 'Hoydonckx', 'S', 'Vanwing', 'B', 'Stessel', 'A', 'Van', 'Assche', 'L', 'Jamaer', 'J', 'Dubois', 'P441', 'Accidental', 'removal', 'of', 'invasive', 'devices', 'in', 'the', 'critical', 'patient', 'into', 'the', 'bed', 'washing', 'does', 'the', 'presence', 'of', 'professional', 'nurse', 'modify', 'his', 'incidence', 'V', 'Medo', 'R', 'Galvez', 'J', 'P', 'Miranda', 'P442', 'Deprivation', 'of', 'liberty', 'safeguards', 'dols', 'audit', 'of', 'compliance', 'in', 'a', 'of', 'a', '16', 'bed', 'specialist', 'cancer', 'critical', 'care', 'unit', 'C', 'Stone', 'T', 'Wigmore', 'P443', 'Use', 'of', 'a', 'modified', 'cristal', 'score', 'to', 'predict', 'futility', 'of', 'critical', 'care', 'in', 'the', 'elderly', 'Y', 'Arunan', 'A', 'Wheeler', 'K', 'Bauchmuller', 'D', 'Bryden', 'P444', 'Improvement', 'of', 'Referral', 'Rate', 'to', 'Palliative', 'Care', 'for', 'Patients', 'with', 'Poor', 'Prognosis', 'in', 'Neurosurgical', 'Intensive', 'Care', 'Unit', 'Y', 'Wong', 'C', 'Poi', 'C', 'Gu', 'P445', 'Factors', 'associated', 'with', 'limitation', 'of', 'life', 'supporting', 'care', 'lsc', 'in', 'a', 'medico', 'surgical', 'intermediate', 'care', 'unit', 'and', 'outcome', 'of', 'patients', 'with', 'lsc', 'limitation', 'a', 'monocentric', 'six', 'month', 'study', 'P', 'Molmy', 'N', 'Van', 'Grunderbeeck', 'O', 'Nigeon', 'M', 'Lemyze', 'D', 'Thevenin', 'J', 'Mallat', 'P446', 'Palliative', 'care', 'consultation', 'and', 'intensive', 'care', 'unit', 'admission', 'request', 'a', 'cohort', 'study', 'J', 'Ramos', 'M', 'Correa', 'R', 'T', 'Carvalho', 'D', 'Forte', 'P447', 'Nursing', 'and', 'medicine', 'together', 'in', 'postsurgical', 'intensive', 'care', 'unit', 'situations', 'of', 'prognostic', 'conflict', 'at', 'the', 'end', 'of', 'life', 'our', 'critical', 'care', 'nurses', 'suffer', 'with', 'our', 'medical', 'activism', 'A', 'Fernandez', 'C', 'McBride', 'P448', 'End', 'of', 'life', 'who', 'may', 'decide', 'E', 'Koonthalloor', 'C', 'Walsh', 'P449', 'Correctly', 'diagnosing', 'death', 'A', 'Webber', 'M', 'Ashe', 'K', 'Smith', 'P', 'Jeanrenaud', 'P450', 'Skin', 'procurement', 'performed', 'by', 'intensive', 'care', 'physicians', 'yes', 'we', 'can', 'A', 'Marudi', 'S', 'Baroni', 'F', 'Ragusa', 'E', 'Bertellini', 'P451', 'Death', 'analysis', 'in', 'pediatric', 'intensive', 'care', 'patients', 'E', 'A', 'Volakli', 'E', 'Chochliourou', 'M', 'Dimitriadou', 'A', 'Violaki', 'P', 'Mantzafleri', 'E', 'Samkinidou', 'O', 'Vrani', 'A', 'Arbouti', 'T', 'Varsami', 'M', 'Sdougka', 'P452', 'The', 'potential', 'impact', 'of', 'euthanasia', 'on', 'organ', 'donation', 'analysis', 'of', 'data', 'from', 'belgium', 'J', 'A', 'Bollen', 'T', 'C', 'Van', 'Smaalen', 'W', 'C', 'De', 'Jongh', 'M', 'M', 'Ten', 'Hoopen', 'D', 'Ysebaert', 'L', 'W', 'Van', 'Heurn', 'W', 'N', 'Van', 'Mook', 'P453', 'Communication', 'within', 'an', 'intensive', 'care', 'setting', 'K', 'Sim', 'A', 'Fuller', 'P454', 'Development', 'and', 'implementation', 'of', 'a', 'longitudinal', 'communication', 'curriculum', 'for', 'critical', 'care', 'medicine', 'fellows', 'A', 'Roze', 'des', 'Ordons', 'P', 'Couillard', 'C', 'Doig', 'P455', 'Staff', 'family', 'conflict', 'in', 'a', 'multi', 'ethnic', 'intensive', 'care', 'unit', 'R', 'V', 'Van', 'Keer', 'R', 'D', 'Deschepper', 'A', 'F', 'Francke', 'L', 'H', 'Huyghens', 'J', 'B', 'Bilsen', 'P456', 'Does', 'the', 'source', 'of', 'admission', 'to', 'critical', 'care', 'affect', 'family', 'satisfaction', 'B', 'Nyamaizi', 'C', 'Dalrymple', 'A', 'Molokhia', 'A', 'Dobru', 'P457', 'A', 'simple', 'alternative', 'to', 'the', 'family', 'satisfaction', 'survey', 'fs', 'icu', 'E', 'Marrinan', 'A', 'Ankuli', 'A', 'Molokhia', 'P458', 'A', 'study', 'to', 'explore', 'the', 'experiences', 'of', 'patient', 'and', 'family', 'volunteers', 'in', 'a', 'critical', 'care', 'environment', 'a', 'phenomenological', 'analysis', 'J', 'McPeake', 'R', 'Struthers', 'R', 'Crawford', 'H', 'Devine', 'P', 'Mactavish', 'T', 'Quasim', 'P459', 'Prevalence', 'and', 'risk', 'factors', 'of', 'anxiety', 'and', 'depression', 'in', 'relatives', 'of', 'burn', 'patients', 'P', 'Morelli', 'M', 'Degiovanangelo', 'F', 'Lemos', 'V', 'MArtinez', 'F', 'Verga', 'J', 'Cabrera', 'G', 'Burghi', 'P460', 'Guidance', 'of', 'visiting', 'children', 'at', 'an', 'adult', 'intensive', 'care', 'unit', 'icu', 'A', 'Rutten', 'S', 'Van', 'Ieperen', 'S', 'De', 'Geer', 'M', 'Van', 'Vugt', 'E', 'Der', 'Kinderen', 'P461', 'Visiting', 'policies', 'in', 'Italian', 'pediatric', 'ICUs', 'an', 'update', 'A', 'Giannini', 'G', 'Miccinesi', 'T', 'Marchesi', 'E', 'Prandi']"
2882,Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy,2017-07-04,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617939/,"Salivary diagnostics is an emerging field for the encroachment of point of care technology (PoCT). The necessity of the development of point-of-care (PoC) technology, the potential of saliva, identification and validation of biomarkers through salivary diagnostic toolboxes, and a broad overview of emerging technologies is discussed in this review. Furthermore, novel advanced techniques incorporated in devices for the early detection and diagnosis of several oral and systemic diseases in a non-invasive, easily-monitored, less time consuming, and in a personalised way is explicated. The latest technology detection systems and clinical utilities of saliva as a liquid biopsy, electric field-induced release and measurement (EFIRM), biosensors, smartphone technology, microfluidics, paper-based technology, and how their futuristic perspectives can improve salivary diagnostics and reduce hospital stays by replacing it with chairside screening is also highlighted.",10.3390/diagnostics7030039,agzklj3p,"['Salivary', 'diagnostics', 'is', 'an', 'emerging', 'field', 'for', 'the', 'encroachment', 'of', 'point', 'of', 'care', 'technology', 'PoCT', 'The', 'necessity', 'of', 'the', 'development', 'of', 'point', 'of', 'care', 'PoC', 'technology', 'the', 'potential', 'of', 'saliva', 'identification', 'and', 'validation', 'of', 'biomarkers', 'through', 'salivary', 'diagnostic', 'toolboxes', 'and', 'a', 'broad', 'overview', 'of', 'emerging', 'technologies', 'is', 'discussed', 'in', 'this', 'review', 'Furthermore', 'novel', 'advanced', 'techniques', 'incorporated', 'in', 'devices', 'for', 'the', 'early', 'detection', 'and', 'diagnosis', 'of', 'several', 'oral', 'and', 'systemic', 'diseases', 'in', 'a', 'non', 'invasive', 'easily', 'monitored', 'less', 'time', 'consuming', 'and', 'in', 'a', 'personalised', 'way', 'is', 'explicated', 'The', 'latest', 'technology', 'detection', 'systems', 'and', 'clinical', 'utilities', 'of', 'saliva', 'as', 'a', 'liquid', 'biopsy', 'electric', 'field', 'induced', 'release', 'and', 'measurement', 'EFIRM', 'biosensors', 'smartphone', 'technology', 'microfluidics', 'paper', 'based', 'technology', 'and', 'how', 'their', 'futuristic', 'perspectives', 'can', 'improve', 'salivary', 'diagnostics', 'and', 'reduce', 'hospital', 'stays', 'by', 'replacing', 'it', 'with', 'chairside', 'screening', 'is', 'also', 'highlighted', '']"
2912,Development and evaluation of a rapid molecular diagnostic test for Zika virus infection by reverse transcription loop-mediated isothermal amplification,2017-10-18,Sci Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647432/,"The recent outbreak of Zika virus (ZIKV) disease caused an enormous number of infections in Central and South America, and the unusual increase in the number of infants born with microcephaly associated with ZIKV infection aroused global concern. Here, we developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay using a portable device for the detection of ZIKV. The assay specifically detected ZIKV strains of both Asian and African genotypes without cross-reactivity with other arboviruses, including Dengue and Chikungunya viruses. The assay detected viral RNA at 14.5 TCID(50)/mL in virus-spiked serum or urine samples within 15 min, although it was slightly less sensitive than reference real time RT-PCR assay. We then evaluated the utility of this assay as a molecular diagnostic test using 90 plasma or serum samples and 99 urine samples collected from 120 suspected cases of arbovirus infection in the states of Paraíba and Pernambuco, Brazil in 2016. The results of this assay were consistent with those of the reference RT-PCR test. This portable RT-LAMP assay was highly specific for ZIKV, and enable rapid diagnosis of the virus infection. Our results provide new insights into ZIKV molecular diagnostics and may improve preparedness for future outbreaks.",10.1038/s41598-017-13836-9,lrkscs71,"['The', 'recent', 'outbreak', 'of', 'Zika', 'virus', 'ZIKV', 'disease', 'caused', 'an', 'enormous', 'number', 'of', 'infections', 'in', 'Central', 'and', 'South', 'America', 'and', 'the', 'unusual', 'increase', 'in', 'the', 'number', 'of', 'infants', 'born', 'with', 'microcephaly', 'associated', 'with', 'ZIKV', 'infection', 'aroused', 'global', 'concern', 'Here', 'we', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'using', 'a', 'portable', 'device', 'for', 'the', 'detection', 'of', 'ZIKV', 'The', 'assay', 'specifically', 'detected', 'ZIKV', 'strains', 'of', 'both', 'Asian', 'and', 'African', 'genotypes', 'without', 'cross', 'reactivity', 'with', 'other', 'arboviruses', 'including', 'Dengue', 'and', 'Chikungunya', 'viruses', 'The', 'assay', 'detected', 'viral', 'RNA', 'at', '14', '5', 'TCID', '50', 'mL', 'in', 'virus', 'spiked', 'serum', 'or', 'urine', 'samples', 'within', '15', 'min', 'although', 'it', 'was', 'slightly', 'less', 'sensitive', 'than', 'reference', 'real', 'time', 'RT', 'PCR', 'assay', 'We', 'then', 'evaluated', 'the', 'utility', 'of', 'this', 'assay', 'as', 'a', 'molecular', 'diagnostic', 'test', 'using', '90', 'plasma', 'or', 'serum', 'samples', 'and', '99', 'urine', 'samples', 'collected', 'from', '120', 'suspected', 'cases', 'of', 'arbovirus', 'infection', 'in', 'the', 'states', 'of', 'Paraíba', 'and', 'Pernambuco', 'Brazil', 'in', '2016', 'The', 'results', 'of', 'this', 'assay', 'were', 'consistent', 'with', 'those', 'of', 'the', 'reference', 'RT', 'PCR', 'test', 'This', 'portable', 'RT', 'LAMP', 'assay', 'was', 'highly', 'specific', 'for', 'ZIKV', 'and', 'enable', 'rapid', 'diagnosis', 'of', 'the', 'virus', 'infection', 'Our', 'results', 'provide', 'new', 'insights', 'into', 'ZIKV', 'molecular', 'diagnostics', 'and', 'may', 'improve', 'preparedness', 'for', 'future', 'outbreaks', '']"
2989,Identifying volatile metabolite signatures for the diagnosis of bacterial respiratory tract infection using electronic nose technology: A pilot study,2017-12-18,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734722/,"OBJECTIVES: New point of care diagnostics are urgently needed to reduce the over-prescription of antimicrobials for bacterial respiratory tract infection (RTI). We performed a pilot cross sectional study to assess the feasibility of gas-capillary column ion mobility spectrometer (GC-IMS), for the analysis of volatile organic compounds (VOC) in exhaled breath to diagnose bacterial RTI in hospital inpatients. METHODS: 71 patients were prospectively recruited from the Acute Medical Unit of the Royal Liverpool University Hospital between March and May 2016 and classified as confirmed or probable bacterial or viral RTI on the basis of microbiologic, biochemical and radiologic testing. Breath samples were collected at the patient’s bedside directly into the electronic nose device, which recorded a VOC spectrum for each sample. Sparse principal component analysis and sparse logistic regression were used to develop a diagnostic model to classify VOC spectra as being caused by bacterial or non-bacterial RTI. RESULTS: Summary area under the receiver operator characteristic curve was 0.73 (95% CI 0.61–0.86), summary sensitivity and specificity were 62% (95% CI 41–80%) and 80% (95% CI 64–91%) respectively (p = 0.00147). CONCLUSIONS: GC-IMS analysis of exhaled VOC for the diagnosis of bacterial RTI shows promise in this pilot study and further trials are warranted to assess this technique.",10.1371/journal.pone.0188879,asa4a7k4,"['OBJECTIVES', 'New', 'point', 'of', 'care', 'diagnostics', 'are', 'urgently', 'needed', 'to', 'reduce', 'the', 'over', 'prescription', 'of', 'antimicrobials', 'for', 'bacterial', 'respiratory', 'tract', 'infection', 'RTI', 'We', 'performed', 'a', 'pilot', 'cross', 'sectional', 'study', 'to', 'assess', 'the', 'feasibility', 'of', 'gas', 'capillary', 'column', 'ion', 'mobility', 'spectrometer', 'GC', 'IMS', 'for', 'the', 'analysis', 'of', 'volatile', 'organic', 'compounds', 'VOC', 'in', 'exhaled', 'breath', 'to', 'diagnose', 'bacterial', 'RTI', 'in', 'hospital', 'inpatients', 'METHODS', '71', 'patients', 'were', 'prospectively', 'recruited', 'from', 'the', 'Acute', 'Medical', 'Unit', 'of', 'the', 'Royal', 'Liverpool', 'University', 'Hospital', 'between', 'March', 'and', 'May', '2016', 'and', 'classified', 'as', 'confirmed', 'or', 'probable', 'bacterial', 'or', 'viral', 'RTI', 'on', 'the', 'basis', 'of', 'microbiologic', 'biochemical', 'and', 'radiologic', 'testing', 'Breath', 'samples', 'were', 'collected', 'at', 'the', 'patient', 's', 'bedside', 'directly', 'into', 'the', 'electronic', 'nose', 'device', 'which', 'recorded', 'a', 'VOC', 'spectrum', 'for', 'each', 'sample', 'Sparse', 'principal', 'component', 'analysis', 'and', 'sparse', 'logistic', 'regression', 'were', 'used', 'to', 'develop', 'a', 'diagnostic', 'model', 'to', 'classify', 'VOC', 'spectra', 'as', 'being', 'caused', 'by', 'bacterial', 'or', 'non', 'bacterial', 'RTI', 'RESULTS', 'Summary', 'area', 'under', 'the', 'receiver', 'operator', 'characteristic', 'curve', 'was', '0', '73', '95', 'CI', '0', '61', '0', '86', 'summary', 'sensitivity', 'and', 'specificity', 'were', '62', '95', 'CI', '41', '80', 'and', '80', '95', 'CI', '64', '91', 'respectively', 'p', '0', '00147', 'CONCLUSIONS', 'GC', 'IMS', 'analysis', 'of', 'exhaled', 'VOC', 'for', 'the', 'diagnosis', 'of', 'bacterial', 'RTI', 'shows', 'promise', 'in', 'this', 'pilot', 'study', 'and', 'further', 'trials', 'are', 'warranted', 'to', 'assess', 'this', 'technique', '']"
3252,Performance of TEM-PCR vs Culture for Bacterial Identification in Pediatric Musculoskeletal Infections,2018-05-22,Open Forum Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007387/,"Improved diagnostics are needed for children with musculoskeletal infections (MSKIs). We assessed the performance of target-enriched multiplex polymerase chain reaction (TEM-PCR) in children with MSKI. TEM-PCR was concordant with culture in pathogen identification and antibiotic susceptibility testing, while increasing the overall yield of pathogen detection. This technology has the potential to inform judicious antimicrobial use early in the disease course.",10.1093/ofid/ofy119,ky1b1yhv,"['Improved', 'diagnostics', 'are', 'needed', 'for', 'children', 'with', 'musculoskeletal', 'infections', 'MSKIs', 'We', 'assessed', 'the', 'performance', 'of', 'target', 'enriched', 'multiplex', 'polymerase', 'chain', 'reaction', 'TEM', 'PCR', 'in', 'children', 'with', 'MSKI', 'TEM', 'PCR', 'was', 'concordant', 'with', 'culture', 'in', 'pathogen', 'identification', 'and', 'antibiotic', 'susceptibility', 'testing', 'while', 'increasing', 'the', 'overall', 'yield', 'of', 'pathogen', 'detection', 'This', 'technology', 'has', 'the', 'potential', 'to', 'inform', 'judicious', 'antimicrobial', 'use', 'early', 'in', 'the', 'disease', 'course', '']"
3295,Automated TruTip nucleic acid extraction and purification from raw sputum,2018-07-05,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033430/,"Automated nucleic acid extraction from primary (raw) sputum continues to be a significant technical challenge for molecular diagnostics. In this work, we developed a prototype open-architecture, automated nucleic acid workstation that includes a mechanical homogenization and lysis function integrated with heating and TruTip purification; optimized an extraction protocol for raw sputum; and evaluated system performance on primary clinical specimens. Eight samples could be processed within 70 min. The system efficiently homogenized primary sputa and doubled nucleic acid recovery relative to an automated protocol that did not incorporate sample homogenization. Nucleic acid recovery was at least five times higher from raw sputum as compared to that of matched sediments regardless of smear or culture grade, and the automated workstation reproducibly recovered PCR-detectable DNA to at least 80 CFU mL(-1) raw sputum. M. tuberculosis DNA was recovered and detected from 122/123 (99.2%) and 124/124 (100%) primary sputum and sediment extracts, respectively. There was no detectable cross-contamination across 53 automated system runs and amplification or fluorescent inhibitors (if present) were not detectable. The open fluidic architecture of the prototype automated workstation yields purified sputum DNA that can be used for any molecular diagnostic test. The ability to transfer TruTip protocols between personalized, on-demand pipetting tools and the fully automated workstation also affords public health agencies an opportunity to standardize sputum nucleic acid sample preparation procedures, reagents, and quality control across multiple levels of the health care system.",10.1371/journal.pone.0199869,y7amwfrt,"['Automated', 'nucleic', 'acid', 'extraction', 'from', 'primary', 'raw', 'sputum', 'continues', 'to', 'be', 'a', 'significant', 'technical', 'challenge', 'for', 'molecular', 'diagnostics', 'In', 'this', 'work', 'we', 'developed', 'a', 'prototype', 'open', 'architecture', 'automated', 'nucleic', 'acid', 'workstation', 'that', 'includes', 'a', 'mechanical', 'homogenization', 'and', 'lysis', 'function', 'integrated', 'with', 'heating', 'and', 'TruTip', 'purification', 'optimized', 'an', 'extraction', 'protocol', 'for', 'raw', 'sputum', 'and', 'evaluated', 'system', 'performance', 'on', 'primary', 'clinical', 'specimens', 'Eight', 'samples', 'could', 'be', 'processed', 'within', '70', 'min', 'The', 'system', 'efficiently', 'homogenized', 'primary', 'sputa', 'and', 'doubled', 'nucleic', 'acid', 'recovery', 'relative', 'to', 'an', 'automated', 'protocol', 'that', 'did', 'not', 'incorporate', 'sample', 'homogenization', 'Nucleic', 'acid', 'recovery', 'was', 'at', 'least', 'five', 'times', 'higher', 'from', 'raw', 'sputum', 'as', 'compared', 'to', 'that', 'of', 'matched', 'sediments', 'regardless', 'of', 'smear', 'or', 'culture', 'grade', 'and', 'the', 'automated', 'workstation', 'reproducibly', 'recovered', 'PCR', 'detectable', 'DNA', 'to', 'at', 'least', '80', 'CFU', 'mL', '1', 'raw', 'sputum', 'M', 'tuberculosis', 'DNA', 'was', 'recovered', 'and', 'detected', 'from', '122', '123', '99', '2', 'and', '124', '124', '100', 'primary', 'sputum', 'and', 'sediment', 'extracts', 'respectively', 'There', 'was', 'no', 'detectable', 'cross', 'contamination', 'across', '53', 'automated', 'system', 'runs', 'and', 'amplification', 'or', 'fluorescent', 'inhibitors', 'if', 'present', 'were', 'not', 'detectable', 'The', 'open', 'fluidic', 'architecture', 'of', 'the', 'prototype', 'automated', 'workstation', 'yields', 'purified', 'sputum', 'DNA', 'that', 'can', 'be', 'used', 'for', 'any', 'molecular', 'diagnostic', 'test', 'The', 'ability', 'to', 'transfer', 'TruTip', 'protocols', 'between', 'personalized', 'on', 'demand', 'pipetting', 'tools', 'and', 'the', 'fully', 'automated', 'workstation', 'also', 'affords', 'public', 'health', 'agencies', 'an', 'opportunity', 'to', 'standardize', 'sputum', 'nucleic', 'acid', 'sample', 'preparation', 'procedures', 'reagents', 'and', 'quality', 'control', 'across', 'multiple', 'levels', 'of', 'the', 'health', 'care', 'system', '']"
3605,Assay Challenges for Emerging Infectious Diseases: The Zika Experience,2018-10-02,Vaccines (Basel),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313918/,"From the perspective of vaccine development, it is imperative to accurately diagnose target infections in order to exclude subjects with prior exposure from evaluations of vaccine effectiveness, to track incident infection during the course of a clinical trial and to differentiate immune reactions due to natural infections from responses that are vaccine related. When vaccine development is accelerated to a rapid pace in response to emerging infectious disease threats, the challenges to develop such diagnostic tools is even greater. This was observed through the recent expansion of Zika virus infections into the Western Hemisphere in 2014–2017. When initial Zika vaccine clinical trials were being designed and launched in response to the outbreak, there were no standardized sets of viral and immunological assays, and no approved diagnostic tests for Zika virus infection. The diagnosis of Zika virus infection is still an area of active research and development on many fronts. Here we review emerging infectious disease vaccine clinical assay development and trial execution with a special focus on the state of Zika virus clinical assays and diagnostics.",10.3390/vaccines6040070,ypefqm71,"['From', 'the', 'perspective', 'of', 'vaccine', 'development', 'it', 'is', 'imperative', 'to', 'accurately', 'diagnose', 'target', 'infections', 'in', 'order', 'to', 'exclude', 'subjects', 'with', 'prior', 'exposure', 'from', 'evaluations', 'of', 'vaccine', 'effectiveness', 'to', 'track', 'incident', 'infection', 'during', 'the', 'course', 'of', 'a', 'clinical', 'trial', 'and', 'to', 'differentiate', 'immune', 'reactions', 'due', 'to', 'natural', 'infections', 'from', 'responses', 'that', 'are', 'vaccine', 'related', 'When', 'vaccine', 'development', 'is', 'accelerated', 'to', 'a', 'rapid', 'pace', 'in', 'response', 'to', 'emerging', 'infectious', 'disease', 'threats', 'the', 'challenges', 'to', 'develop', 'such', 'diagnostic', 'tools', 'is', 'even', 'greater', 'This', 'was', 'observed', 'through', 'the', 'recent', 'expansion', 'of', 'Zika', 'virus', 'infections', 'into', 'the', 'Western', 'Hemisphere', 'in', '2014', '2017', 'When', 'initial', 'Zika', 'vaccine', 'clinical', 'trials', 'were', 'being', 'designed', 'and', 'launched', 'in', 'response', 'to', 'the', 'outbreak', 'there', 'were', 'no', 'standardized', 'sets', 'of', 'viral', 'and', 'immunological', 'assays', 'and', 'no', 'approved', 'diagnostic', 'tests', 'for', 'Zika', 'virus', 'infection', 'The', 'diagnosis', 'of', 'Zika', 'virus', 'infection', 'is', 'still', 'an', 'area', 'of', 'active', 'research', 'and', 'development', 'on', 'many', 'fronts', 'Here', 'we', 'review', 'emerging', 'infectious', 'disease', 'vaccine', 'clinical', 'assay', 'development', 'and', 'trial', 'execution', 'with', 'a', 'special', 'focus', 'on', 'the', 'state', 'of', 'Zika', 'virus', 'clinical', 'assays', 'and', 'diagnostics', '']"
3715,Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease,2019-02-20,BMJ Glob Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407549/,"Crimean-Congo haemorrhagic fever (CCHF) is a widespread tickborne disease that circulates in wild and domestic animal hosts, and causes severe and often fatal haemorrhagic fever in infected humans. Due to the lack of treatment options or vaccines, and a high fatality rate, CCHF virus (CCHFV) is considered a high-priority pathogen according to the WHO R&D Blueprint. Several commercial reverse transcriptase PCR (RT-PCR) and serological diagnostic assays for CCHFV are already available, including febrile agent panels to distinguish CCHFV from other viral haemorrhagic fever agents; however, the majority of international laboratories use inhouse assays. As CCHFV has numerous amplifying animal hosts, a cross-sectoral ‘One Health’ approach to outbreak prevention is recommended to enhance notifications and enable early warning for genetic and epidemiological shifts in the human, animal and tick populations. However, a lack of guidance for surveillance in animals, harmonisation of case identification and validated serodiagnostic kits for animal testing hinders efforts to strengthen surveillance systems. Additionally, as RT-PCR tests tend to be lineage-specific for regional circulating strains, there is a need for pan-lineage sensitive diagnostics. Adaptation of existing tests to point-of-care molecular diagnostic platforms that can be implemented in clinic or field-based settings would be of value given the potential for CCHFV outbreaks in remote or low-resource areas. Finally, improved access to clinical specimens for validation of diagnostics would help to accelerate development of new tests. These gaps should be addressed by updated target product profiles for CCHFV diagnostics.",10.1136/bmjgh-2018-001114,u5tvbej3,"['Crimean', 'Congo', 'haemorrhagic', 'fever', 'CCHF', 'is', 'a', 'widespread', 'tickborne', 'disease', 'that', 'circulates', 'in', 'wild', 'and', 'domestic', 'animal', 'hosts', 'and', 'causes', 'severe', 'and', 'often', 'fatal', 'haemorrhagic', 'fever', 'in', 'infected', 'humans', 'Due', 'to', 'the', 'lack', 'of', 'treatment', 'options', 'or', 'vaccines', 'and', 'a', 'high', 'fatality', 'rate', 'CCHF', 'virus', 'CCHFV', 'is', 'considered', 'a', 'high', 'priority', 'pathogen', 'according', 'to', 'the', 'WHO', 'R', 'D', 'Blueprint', 'Several', 'commercial', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'and', 'serological', 'diagnostic', 'assays', 'for', 'CCHFV', 'are', 'already', 'available', 'including', 'febrile', 'agent', 'panels', 'to', 'distinguish', 'CCHFV', 'from', 'other', 'viral', 'haemorrhagic', 'fever', 'agents', 'however', 'the', 'majority', 'of', 'international', 'laboratories', 'use', 'inhouse', 'assays', 'As', 'CCHFV', 'has', 'numerous', 'amplifying', 'animal', 'hosts', 'a', 'cross', 'sectoral', 'One', 'Health', 'approach', 'to', 'outbreak', 'prevention', 'is', 'recommended', 'to', 'enhance', 'notifications', 'and', 'enable', 'early', 'warning', 'for', 'genetic', 'and', 'epidemiological', 'shifts', 'in', 'the', 'human', 'animal', 'and', 'tick', 'populations', 'However', 'a', 'lack', 'of', 'guidance', 'for', 'surveillance', 'in', 'animals', 'harmonisation', 'of', 'case', 'identification', 'and', 'validated', 'serodiagnostic', 'kits', 'for', 'animal', 'testing', 'hinders', 'efforts', 'to', 'strengthen', 'surveillance', 'systems', 'Additionally', 'as', 'RT', 'PCR', 'tests', 'tend', 'to', 'be', 'lineage', 'specific', 'for', 'regional', 'circulating', 'strains', 'there', 'is', 'a', 'need', 'for', 'pan', 'lineage', 'sensitive', 'diagnostics', 'Adaptation', 'of', 'existing', 'tests', 'to', 'point', 'of', 'care', 'molecular', 'diagnostic', 'platforms', 'that', 'can', 'be', 'implemented', 'in', 'clinic', 'or', 'field', 'based', 'settings', 'would', 'be', 'of', 'value', 'given', 'the', 'potential', 'for', 'CCHFV', 'outbreaks', 'in', 'remote', 'or', 'low', 'resource', 'areas', 'Finally', 'improved', 'access', 'to', 'clinical', 'specimens', 'for', 'validation', 'of', 'diagnostics', 'would', 'help', 'to', 'accelerate', 'development', 'of', 'new', 'tests', 'These', 'gaps', 'should', 'be', 'addressed', 'by', 'updated', 'target', 'product', 'profiles', 'for', 'CCHFV', 'diagnostics', '']"
3716,Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings,2019-02-07,BMJ Glob Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407561/,"Lassa fever virus (LASV) causes acute viral haemorrhagic fever with symptoms similar to those seen with Ebola virus infections. LASV is endemic to West Africa and is transmitted through contact with excretions of infected Mastomys natalensis rodents and other rodent species. Due to a high fatality rate, lack of treatment options and difficulties with prevention and control, LASV is one of the high-priority pathogens included in the WHO R&D Blueprint. The WHO LASV vaccine strategy relies on availability of effective diagnostic tests. Current diagnostics for LASV include in-house and commercial (primarily research-only) laboratory-based serological and nucleic acid amplification tests. There are two commercially available (for research use only) rapid diagnostic tests (RDTs), and a number of multiplex panels for differential detection of LASV infection from other endemic diseases with similar symptoms have been evaluated. However, a number of diagnostic gaps remain. Lineage detection is a challenge due to the genomic diversity of LASV, as pan-lineage sensitivity for both molecular and immunological detection is necessary for surveillance and outbreak response. While pan-lineage ELISA and RDTs are commercially available (for research use only), validation and external quality assessment (EQA) is needed to confirm detection sensitivity for all known or relevant strains. Variable sensitivity of LASV PCR tests also highlights the need for improved validation and EQA. Given that LASV outbreaks typically occur in low-resource settings, more options for point-of-care testing would be valuable. These requirements should be taken into account in target product profiles for improved LASV diagnostics.",10.1136/bmjgh-2018-001116,np9tsmvs,"['Lassa', 'fever', 'virus', 'LASV', 'causes', 'acute', 'viral', 'haemorrhagic', 'fever', 'with', 'symptoms', 'similar', 'to', 'those', 'seen', 'with', 'Ebola', 'virus', 'infections', 'LASV', 'is', 'endemic', 'to', 'West', 'Africa', 'and', 'is', 'transmitted', 'through', 'contact', 'with', 'excretions', 'of', 'infected', 'Mastomys', 'natalensis', 'rodents', 'and', 'other', 'rodent', 'species', 'Due', 'to', 'a', 'high', 'fatality', 'rate', 'lack', 'of', 'treatment', 'options', 'and', 'difficulties', 'with', 'prevention', 'and', 'control', 'LASV', 'is', 'one', 'of', 'the', 'high', 'priority', 'pathogens', 'included', 'in', 'the', 'WHO', 'R', 'D', 'Blueprint', 'The', 'WHO', 'LASV', 'vaccine', 'strategy', 'relies', 'on', 'availability', 'of', 'effective', 'diagnostic', 'tests', 'Current', 'diagnostics', 'for', 'LASV', 'include', 'in', 'house', 'and', 'commercial', 'primarily', 'research', 'only', 'laboratory', 'based', 'serological', 'and', 'nucleic', 'acid', 'amplification', 'tests', 'There', 'are', 'two', 'commercially', 'available', 'for', 'research', 'use', 'only', 'rapid', 'diagnostic', 'tests', 'RDTs', 'and', 'a', 'number', 'of', 'multiplex', 'panels', 'for', 'differential', 'detection', 'of', 'LASV', 'infection', 'from', 'other', 'endemic', 'diseases', 'with', 'similar', 'symptoms', 'have', 'been', 'evaluated', 'However', 'a', 'number', 'of', 'diagnostic', 'gaps', 'remain', 'Lineage', 'detection', 'is', 'a', 'challenge', 'due', 'to', 'the', 'genomic', 'diversity', 'of', 'LASV', 'as', 'pan', 'lineage', 'sensitivity', 'for', 'both', 'molecular', 'and', 'immunological', 'detection', 'is', 'necessary', 'for', 'surveillance', 'and', 'outbreak', 'response', 'While', 'pan', 'lineage', 'ELISA', 'and', 'RDTs', 'are', 'commercially', 'available', 'for', 'research', 'use', 'only', 'validation', 'and', 'external', 'quality', 'assessment', 'EQA', 'is', 'needed', 'to', 'confirm', 'detection', 'sensitivity', 'for', 'all', 'known', 'or', 'relevant', 'strains', 'Variable', 'sensitivity', 'of', 'LASV', 'PCR', 'tests', 'also', 'highlights', 'the', 'need', 'for', 'improved', 'validation', 'and', 'EQA', 'Given', 'that', 'LASV', 'outbreaks', 'typically', 'occur', 'in', 'low', 'resource', 'settings', 'more', 'options', 'for', 'point', 'of', 'care', 'testing', 'would', 'be', 'valuable', 'These', 'requirements', 'should', 'be', 'taken', 'into', 'account', 'in', 'target', 'product', 'profiles', 'for', 'improved', 'LASV', 'diagnostics', '']"
4187,Bornaviruses in naturally infected Psittacus erithacus in Portugal: insights of molecular epidemiology and ecology,2019-11-06,Infect Ecol Epidemiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844444/,"Background: The genus Orthobornavirus comprises non-segmented, negative-stranded RNA viruses able to infect humans, mammals, reptiles and various birds. Parrot bornavirus 1 to 8 (PaBV-1 to 8) causes neurological and/or gastrointestinal syndromes and death on psittacines. We aimed to identify and to produce epidemiologic knowledge about the etiologic agent associated with a death of two female Psittacus erithacus (grey parrot). Methods and Results: Both parrots were submitted for a complete standardised necropsy. Tissue samples were analysed by PCR. The findings in necropsy were compatible with bornavirus infection. Analysis revealed PaBV-4 related with genotypes detected in captive and in wild birds. The N and X proteins of PaBV-4 were more related to avian bornaviruses, while phosphoprotein was more related to variegated squirrel bornavirus 1 (VSBV-1). Within the P gene/phosphoprotein a highly conserved region between and within bornavirus species was found. Conclusions: Portugal is on the routes of the intensive world trade of psittacines. Broad screening studies are required to help understanding the role of wild birds in the emergence and spread of pathogenic bornaviruses. PaBV-4 phosphoprotein is closer to VSBV-1 associated with lethal encephalitis in humans than with some of the avian bornaviruses. The highly conserved P gene/phosphoprotein region is a good target for molecular diagnostics screenings.",10.1080/20008686.2019.1685632,m59czkya,"['Background', 'The', 'genus', 'Orthobornavirus', 'comprises', 'non', 'segmented', 'negative', 'stranded', 'RNA', 'viruses', 'able', 'to', 'infect', 'humans', 'mammals', 'reptiles', 'and', 'various', 'birds', 'Parrot', 'bornavirus', '1', 'to', '8', 'PaBV', '1', 'to', '8', 'causes', 'neurological', 'and', 'or', 'gastrointestinal', 'syndromes', 'and', 'death', 'on', 'psittacines', 'We', 'aimed', 'to', 'identify', 'and', 'to', 'produce', 'epidemiologic', 'knowledge', 'about', 'the', 'etiologic', 'agent', 'associated', 'with', 'a', 'death', 'of', 'two', 'female', 'Psittacus', 'erithacus', 'grey', 'parrot', 'Methods', 'and', 'Results', 'Both', 'parrots', 'were', 'submitted', 'for', 'a', 'complete', 'standardised', 'necropsy', 'Tissue', 'samples', 'were', 'analysed', 'by', 'PCR', 'The', 'findings', 'in', 'necropsy', 'were', 'compatible', 'with', 'bornavirus', 'infection', 'Analysis', 'revealed', 'PaBV', '4', 'related', 'with', 'genotypes', 'detected', 'in', 'captive', 'and', 'in', 'wild', 'birds', 'The', 'N', 'and', 'X', 'proteins', 'of', 'PaBV', '4', 'were', 'more', 'related', 'to', 'avian', 'bornaviruses', 'while', 'phosphoprotein', 'was', 'more', 'related', 'to', 'variegated', 'squirrel', 'bornavirus', '1', 'VSBV', '1', 'Within', 'the', 'P', 'gene', 'phosphoprotein', 'a', 'highly', 'conserved', 'region', 'between', 'and', 'within', 'bornavirus', 'species', 'was', 'found', 'Conclusions', 'Portugal', 'is', 'on', 'the', 'routes', 'of', 'the', 'intensive', 'world', 'trade', 'of', 'psittacines', 'Broad', 'screening', 'studies', 'are', 'required', 'to', 'help', 'understanding', 'the', 'role', 'of', 'wild', 'birds', 'in', 'the', 'emergence', 'and', 'spread', 'of', 'pathogenic', 'bornaviruses', 'PaBV', '4', 'phosphoprotein', 'is', 'closer', 'to', 'VSBV', '1', 'associated', 'with', 'lethal', 'encephalitis', 'in', 'humans', 'than', 'with', 'some', 'of', 'the', 'avian', 'bornaviruses', 'The', 'highly', 'conserved', 'P', 'gene', 'phosphoprotein', 'region', 'is', 'a', 'good', 'target', 'for', 'molecular', 'diagnostics', 'screenings', '']"
4349,Advances in Directly Amplifying Nucleic Acids from Complex Samples,2019-09-30,Biosensors (Basel),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955841/,"Advances in nucleic acid amplification technologies have revolutionized diagnostics for systemic, inherited, and infectious diseases. Current assays and platforms, however, often require lengthy experimental procedures and multiple instruments to remove contaminants and inhibitors from clinically-relevant, complex samples. This requirement of sample preparation has been a bottleneck for using nucleic acid amplification tests (NAATs) at the point of care (POC), though advances in “lab-on-chip” platforms that integrate sample preparation and NAATs have made great strides in this space. Alternatively, direct NAATs—techniques that minimize or even bypass sample preparation—present promising strategies for developing POC diagnostic tools for analyzing real-world samples. In this review, we discuss the current status of direct NAATs. Specifically, we surveyed potential testing systems published from 1989 to 2017, and analyzed their performances in terms of robustness, sensitivity, clinical relevance, and suitability for POC diagnostics. We introduce bubble plots to facilitate our analysis, as bubble plots enable effective visualization of the performances of these direct NAATs. Through our review, we hope to initiate an in-depth examination of direct NAATs and their potential for realizing POC diagnostics, and ultimately transformative technologies that can further enhance healthcare.",10.3390/bios9040117,32w6g7qk,"['Advances', 'in', 'nucleic', 'acid', 'amplification', 'technologies', 'have', 'revolutionized', 'diagnostics', 'for', 'systemic', 'inherited', 'and', 'infectious', 'diseases', 'Current', 'assays', 'and', 'platforms', 'however', 'often', 'require', 'lengthy', 'experimental', 'procedures', 'and', 'multiple', 'instruments', 'to', 'remove', 'contaminants', 'and', 'inhibitors', 'from', 'clinically', 'relevant', 'complex', 'samples', 'This', 'requirement', 'of', 'sample', 'preparation', 'has', 'been', 'a', 'bottleneck', 'for', 'using', 'nucleic', 'acid', 'amplification', 'tests', 'NAATs', 'at', 'the', 'point', 'of', 'care', 'POC', 'though', 'advances', 'in', 'lab', 'on', 'chip', 'platforms', 'that', 'integrate', 'sample', 'preparation', 'and', 'NAATs', 'have', 'made', 'great', 'strides', 'in', 'this', 'space', 'Alternatively', 'direct', 'NAATs', 'techniques', 'that', 'minimize', 'or', 'even', 'bypass', 'sample', 'preparation', 'present', 'promising', 'strategies', 'for', 'developing', 'POC', 'diagnostic', 'tools', 'for', 'analyzing', 'real', 'world', 'samples', 'In', 'this', 'review', 'we', 'discuss', 'the', 'current', 'status', 'of', 'direct', 'NAATs', 'Specifically', 'we', 'surveyed', 'potential', 'testing', 'systems', 'published', 'from', '1989', 'to', '2017', 'and', 'analyzed', 'their', 'performances', 'in', 'terms', 'of', 'robustness', 'sensitivity', 'clinical', 'relevance', 'and', 'suitability', 'for', 'POC', 'diagnostics', 'We', 'introduce', 'bubble', 'plots', 'to', 'facilitate', 'our', 'analysis', 'as', 'bubble', 'plots', 'enable', 'effective', 'visualization', 'of', 'the', 'performances', 'of', 'these', 'direct', 'NAATs', 'Through', 'our', 'review', 'we', 'hope', 'to', 'initiate', 'an', 'in', 'depth', 'examination', 'of', 'direct', 'NAATs', 'and', 'their', 'potential', 'for', 'realizing', 'POC', 'diagnostics', 'and', 'ultimately', 'transformative', 'technologies', 'that', 'can', 'further', 'enhance', 'healthcare', '']"
4459,"Geospatial Science and Point-of-Care Testing: Creating Solutions for Population Access, Emergencies, Outbreaks, and Disasters",2019-11-26,Front Public Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988819/,"Objectives: (a) To understand how to integrate geospatial concepts when implementing point-of-care testing (POCT); (b) to facilitate emergency, outbreak, and disaster preparedness and emergency management in healthcare small-world networks; (c) to enhance community resilience by using POCT in tandem with geographic information systems (GISs) and other geospatial tools; and (d) to advance crisis standards of care at points of need, adaptable and scalable for public health practice in limited-resource countries and other global settings. Content: Visual logistics help integrate and synthesize POCT and geospatial concepts. The resulting geospatial solutions presented here comprise: (1) small-world networks and regional topography; (2) space-time transformation, hubs, and asset mapping; (3) spatial and geospatial care paths™; (4) GIS-POCT; (5) isolation laboratories, diagnostics isolators, and mobile laboratories for highly infectious diseases; (6) alternate care facilities; (7) roaming POCT—airborne, ambulances, space, and wearables; (8) connected and wireless POCT outside hospitals; (9) unmanned aerial vehicles; (10) geospatial practice—demographic care unit resource scoring, geographic risk assessment, and national POCT policy and guidelines; (11) the hybrid laboratory; and (12) point-of-careology. Value: Small-world networks and their connectivity facilitate efficient and effective placement of POCT for optimal response, rescue, diagnosis, and treatment. Spatial care paths™ speed transport from primary encounters to referral centers bypassing topographic bottlenecks, process gaps, and time-consuming interruptions. Regional GISs position POCT close to where patients live to facilitate rapid triage, decrease therapeutic turnaround time, and conserve economic resources. Geospatial care paths™ encompass demographic and population access features. Timeliness creates value during acute illness, complex crises, and unexpected disasters. Isolation laboratories equipped with POCT help stop outbreaks and safely support critically ill patients with highly infectious diseases. POCT-enabled spatial grids can map sentinel cases and establish geographic limits of epidemics for ring vaccination. Impact: Geospatial solutions generate inherently optimal and logical placement of POCT conceptually, physically, and temporally as a means to improve crisis response and spatial resilience. If public health professionals, geospatial scientists, and POCT specialists join forces, new collaborative teamwork can create faster response and higher impact during disasters, complex crises, outbreaks, and epidemics, as well as more efficient primary, urgent, and emergency community care.",10.3389/fpubh.2019.00329,yyp4a0ei,"['Objectives', 'a', 'To', 'understand', 'how', 'to', 'integrate', 'geospatial', 'concepts', 'when', 'implementing', 'point', 'of', 'care', 'testing', 'POCT', 'b', 'to', 'facilitate', 'emergency', 'outbreak', 'and', 'disaster', 'preparedness', 'and', 'emergency', 'management', 'in', 'healthcare', 'small', 'world', 'networks', 'c', 'to', 'enhance', 'community', 'resilience', 'by', 'using', 'POCT', 'in', 'tandem', 'with', 'geographic', 'information', 'systems', 'GISs', 'and', 'other', 'geospatial', 'tools', 'and', 'd', 'to', 'advance', 'crisis', 'standards', 'of', 'care', 'at', 'points', 'of', 'need', 'adaptable', 'and', 'scalable', 'for', 'public', 'health', 'practice', 'in', 'limited', 'resource', 'countries', 'and', 'other', 'global', 'settings', 'Content', 'Visual', 'logistics', 'help', 'integrate', 'and', 'synthesize', 'POCT', 'and', 'geospatial', 'concepts', 'The', 'resulting', 'geospatial', 'solutions', 'presented', 'here', 'comprise', '1', 'small', 'world', 'networks', 'and', 'regional', 'topography', '2', 'space', 'time', 'transformation', 'hubs', 'and', 'asset', 'mapping', '3', 'spatial', 'and', 'geospatial', 'care', 'paths', '4', 'GIS', 'POCT', '5', 'isolation', 'laboratories', 'diagnostics', 'isolators', 'and', 'mobile', 'laboratories', 'for', 'highly', 'infectious', 'diseases', '6', 'alternate', 'care', 'facilities', '7', 'roaming', 'POCT', 'airborne', 'ambulances', 'space', 'and', 'wearables', '8', 'connected', 'and', 'wireless', 'POCT', 'outside', 'hospitals', '9', 'unmanned', 'aerial', 'vehicles', '10', 'geospatial', 'practice', 'demographic', 'care', 'unit', 'resource', 'scoring', 'geographic', 'risk', 'assessment', 'and', 'national', 'POCT', 'policy', 'and', 'guidelines', '11', 'the', 'hybrid', 'laboratory', 'and', '12', 'point', 'of', 'careology', 'Value', 'Small', 'world', 'networks', 'and', 'their', 'connectivity', 'facilitate', 'efficient', 'and', 'effective', 'placement', 'of', 'POCT', 'for', 'optimal', 'response', 'rescue', 'diagnosis', 'and', 'treatment', 'Spatial', 'care', 'paths', 'speed', 'transport', 'from', 'primary', 'encounters', 'to', 'referral', 'centers', 'bypassing', 'topographic', 'bottlenecks', 'process', 'gaps', 'and', 'time', 'consuming', 'interruptions', 'Regional', 'GISs', 'position', 'POCT', 'close', 'to', 'where', 'patients', 'live', 'to', 'facilitate', 'rapid', 'triage', 'decrease', 'therapeutic', 'turnaround', 'time', 'and', 'conserve', 'economic', 'resources', 'Geospatial', 'care', 'paths', 'encompass', 'demographic', 'and', 'population', 'access', 'features', 'Timeliness', 'creates', 'value', 'during', 'acute', 'illness', 'complex', 'crises', 'and', 'unexpected', 'disasters', 'Isolation', 'laboratories', 'equipped', 'with', 'POCT', 'help', 'stop', 'outbreaks', 'and', 'safely', 'support', 'critically', 'ill', 'patients', 'with', 'highly', 'infectious', 'diseases', 'POCT', 'enabled', 'spatial', 'grids', 'can', 'map', 'sentinel', 'cases', 'and', 'establish', 'geographic', 'limits', 'of', 'epidemics', 'for', 'ring', 'vaccination', 'Impact', 'Geospatial', 'solutions', 'generate', 'inherently', 'optimal', 'and', 'logical', 'placement', 'of', 'POCT', 'conceptually', 'physically', 'and', 'temporally', 'as', 'a', 'means', 'to', 'improve', 'crisis', 'response', 'and', 'spatial', 'resilience', 'If', 'public', 'health', 'professionals', 'geospatial', 'scientists', 'and', 'POCT', 'specialists', 'join', 'forces', 'new', 'collaborative', 'teamwork', 'can', 'create', 'faster', 'response', 'and', 'higher', 'impact', 'during', 'disasters', 'complex', 'crises', 'outbreaks', 'and', 'epidemics', 'as', 'well', 'as', 'more', 'efficient', 'primary', 'urgent', 'and', 'emergency', 'community', 'care', '']"
4486,Qualitative Research: Institutional Preparedness During Threats of Infectious Disease Outbreaks,2020-01-23,Biomed Res Int,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998699/,"BACKGROUND: As demonstrated during the global Ebola crisis of 2014–2016, healthcare institutions in high resource settings need support concerning preparedness during threats of infectious disease outbreaks. This study aimed to exploratively develop a standardized preparedness system to use during unfolding threats of severe infectious diseases. METHODS: A qualitative three-step study among infectious disease prevention and control experts was performed. First, interviews (n = 5) were conducted to identify which factors trigger preparedness activities during an unfolding threat. Second, these triggers informed the design of a phased preparedness system which was tested in a focus group discussion (n = 5) were conducted to identify which factors trigger preparedness activities during an unfolding threat. Second, these triggers informed the design of a phased preparedness system which was tested in a focus group discussion (n = 5) were conducted to identify which factors trigger preparedness activities during an unfolding threat. Second, these triggers informed the design of a phased preparedness system which was tested in a focus group discussion ( RESULTS: Four preparedness phases were identified: preparedness phase green is a situation without the presence of the infectious disease threat that requires centralized care, anywhere in the world. Phase yellow is an outbreak in the world with some likelihood of imported cases. Phase orange is a realistic chance of an unexpected case within the country, or unrest developing among population or staff; phase red is cases admitted to hospitals in the country, potentially causing a shortage of resources. Specific preparedness activities included infection prevention, diagnostics, patient care, staff, and communication. Consensus was reached on the need for the development of a preparedness system and national coordination during threats. CONCLUSIONS: In this study, we developed a standardized system to support institutional preparedness during an increasing threat. Use of this system by both curative healthcare institutions and the (municipal) public health service, could help to effectively communicate and align preparedness activities during future threats of severe infectious diseases.",10.1155/2020/5861894,g6ki6vyy,"['BACKGROUND', 'As', 'demonstrated', 'during', 'the', 'global', 'Ebola', 'crisis', 'of', '2014', '2016', 'healthcare', 'institutions', 'in', 'high', 'resource', 'settings', 'need', 'support', 'concerning', 'preparedness', 'during', 'threats', 'of', 'infectious', 'disease', 'outbreaks', 'This', 'study', 'aimed', 'to', 'exploratively', 'develop', 'a', 'standardized', 'preparedness', 'system', 'to', 'use', 'during', 'unfolding', 'threats', 'of', 'severe', 'infectious', 'diseases', 'METHODS', 'A', 'qualitative', 'three', 'step', 'study', 'among', 'infectious', 'disease', 'prevention', 'and', 'control', 'experts', 'was', 'performed', 'First', 'interviews', 'n', '5', 'were', 'conducted', 'to', 'identify', 'which', 'factors', 'trigger', 'preparedness', 'activities', 'during', 'an', 'unfolding', 'threat', 'Second', 'these', 'triggers', 'informed', 'the', 'design', 'of', 'a', 'phased', 'preparedness', 'system', 'which', 'was', 'tested', 'in', 'a', 'focus', 'group', 'discussion', 'n', '5', 'were', 'conducted', 'to', 'identify', 'which', 'factors', 'trigger', 'preparedness', 'activities', 'during', 'an', 'unfolding', 'threat', 'Second', 'these', 'triggers', 'informed', 'the', 'design', 'of', 'a', 'phased', 'preparedness', 'system', 'which', 'was', 'tested', 'in', 'a', 'focus', 'group', 'discussion', 'n', '5', 'were', 'conducted', 'to', 'identify', 'which', 'factors', 'trigger', 'preparedness', 'activities', 'during', 'an', 'unfolding', 'threat', 'Second', 'these', 'triggers', 'informed', 'the', 'design', 'of', 'a', 'phased', 'preparedness', 'system', 'which', 'was', 'tested', 'in', 'a', 'focus', 'group', 'discussion', 'RESULTS', 'Four', 'preparedness', 'phases', 'were', 'identified', 'preparedness', 'phase', 'green', 'is', 'a', 'situation', 'without', 'the', 'presence', 'of', 'the', 'infectious', 'disease', 'threat', 'that', 'requires', 'centralized', 'care', 'anywhere', 'in', 'the', 'world', 'Phase', 'yellow', 'is', 'an', 'outbreak', 'in', 'the', 'world', 'with', 'some', 'likelihood', 'of', 'imported', 'cases', 'Phase', 'orange', 'is', 'a', 'realistic', 'chance', 'of', 'an', 'unexpected', 'case', 'within', 'the', 'country', 'or', 'unrest', 'developing', 'among', 'population', 'or', 'staff', 'phase', 'red', 'is', 'cases', 'admitted', 'to', 'hospitals', 'in', 'the', 'country', 'potentially', 'causing', 'a', 'shortage', 'of', 'resources', 'Specific', 'preparedness', 'activities', 'included', 'infection', 'prevention', 'diagnostics', 'patient', 'care', 'staff', 'and', 'communication', 'Consensus', 'was', 'reached', 'on', 'the', 'need', 'for', 'the', 'development', 'of', 'a', 'preparedness', 'system', 'and', 'national', 'coordination', 'during', 'threats', 'CONCLUSIONS', 'In', 'this', 'study', 'we', 'developed', 'a', 'standardized', 'system', 'to', 'support', 'institutional', 'preparedness', 'during', 'an', 'increasing', 'threat', 'Use', 'of', 'this', 'system', 'by', 'both', 'curative', 'healthcare', 'institutions', 'and', 'the', 'municipal', 'public', 'health', 'service', 'could', 'help', 'to', 'effectively', 'communicate', 'and', 'align', 'preparedness', 'activities', 'during', 'future', 'threats', 'of', 'severe', 'infectious', 'diseases', '']"
4553,Loop-Mediated Isothermal Amplification (LAMP) for the Diagnosis of Zika Virus: A Review,2019-12-23,Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019470/,"The recent outbreak of Zika virus (ZIKV) in the Americas and its devastating developmental and neurological manifestations has prompted the development of field-based diagnostics that are rapid, reliable, handheld, specific, sensitive, and inexpensive. The gold standard molecular method for lab-based diagnosis of ZIKV, from either patient samples or insect vectors, is reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The method, however, is costly and requires lab-based equipment and expertise, which severely limits its use as a point-of-care (POC) tool in resource-poor settings. Moreover, given the lack of antivirals or approved vaccines for ZIKV infection, a POC diagnostic test is urgently needed for the early detection of new outbreaks and to adequately manage patients. Loop-mediated isothermal amplification (LAMP) is a compelling alternative to RT-qPCR for ZIKV and other arboviruses. This low-cost molecular system can be freeze-dried for distribution and exhibits high specificity, sensitivity, and efficiency. A growing body of evidence suggests that LAMP assays can provide greater accessibility to much-needed diagnostics for ZIKV infections, especially in developing countries where the ZIKV is now endemic. This review summarizes the different LAMP methods that have been developed for the virus and summarizes their features, advantages, and limitations.",10.3390/v12010019,yxuyhc7p,"['The', 'recent', 'outbreak', 'of', 'Zika', 'virus', 'ZIKV', 'in', 'the', 'Americas', 'and', 'its', 'devastating', 'developmental', 'and', 'neurological', 'manifestations', 'has', 'prompted', 'the', 'development', 'of', 'field', 'based', 'diagnostics', 'that', 'are', 'rapid', 'reliable', 'handheld', 'specific', 'sensitive', 'and', 'inexpensive', 'The', 'gold', 'standard', 'molecular', 'method', 'for', 'lab', 'based', 'diagnosis', 'of', 'ZIKV', 'from', 'either', 'patient', 'samples', 'or', 'insect', 'vectors', 'is', 'reverse', 'transcription', 'quantitative', 'polymerase', 'chain', 'reaction', 'RT', 'qPCR', 'The', 'method', 'however', 'is', 'costly', 'and', 'requires', 'lab', 'based', 'equipment', 'and', 'expertise', 'which', 'severely', 'limits', 'its', 'use', 'as', 'a', 'point', 'of', 'care', 'POC', 'tool', 'in', 'resource', 'poor', 'settings', 'Moreover', 'given', 'the', 'lack', 'of', 'antivirals', 'or', 'approved', 'vaccines', 'for', 'ZIKV', 'infection', 'a', 'POC', 'diagnostic', 'test', 'is', 'urgently', 'needed', 'for', 'the', 'early', 'detection', 'of', 'new', 'outbreaks', 'and', 'to', 'adequately', 'manage', 'patients', 'Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'a', 'compelling', 'alternative', 'to', 'RT', 'qPCR', 'for', 'ZIKV', 'and', 'other', 'arboviruses', 'This', 'low', 'cost', 'molecular', 'system', 'can', 'be', 'freeze', 'dried', 'for', 'distribution', 'and', 'exhibits', 'high', 'specificity', 'sensitivity', 'and', 'efficiency', 'A', 'growing', 'body', 'of', 'evidence', 'suggests', 'that', 'LAMP', 'assays', 'can', 'provide', 'greater', 'accessibility', 'to', 'much', 'needed', 'diagnostics', 'for', 'ZIKV', 'infections', 'especially', 'in', 'developing', 'countries', 'where', 'the', 'ZIKV', 'is', 'now', 'endemic', 'This', 'review', 'summarizes', 'the', 'different', 'LAMP', 'methods', 'that', 'have', 'been', 'developed', 'for', 'the', 'virus', 'and', 'summarizes', 'their', 'features', 'advantages', 'and', 'limitations', '']"
4669,Animal sources for zoonotic transmission of psittacosis: a systematic review,2020-03-04,BMC Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057575/,"BACKGROUND: Human psittacosis, caused by Chlamydia (C.) psittaci, is likely underdiagnosed and underreported, since tests for C. psittaci are often not included in routine microbiological diagnostics. Source tracing traditionally focuses on psittacine pet birds, but recently other animal species have been gaining more attention as possible sources for human psittacosis. This review aims to provide an overview of all suspected animal sources of human psittacosis cases reported in the international literature. In addition, for each animal species the strength of evidence for zoonotic transmission was estimated. METHODS: A systematic literature search was conducted using four databases (Pubmed, Embase, Scopus and Proquest). Articles were included when there was mention of at least one human case of psittacosis and a possible animal source. Investigators independently extracted data from the included articles and estimated strength of evidence for zoonotic transmission, based on a self-developed scoring system taking into account number of human cases, epidemiological evidence and laboratory test results in human, animals, and the environment. RESULTS: Eighty articles were included, which provided information on 136 different situations of possible zoonotic transmission. The maximum score for zoonotic transmission was highest for turkeys, followed by ducks, owls, and the category ‘other poultry’. Articles reporting about zoonotic transmission from unspecified birds, psittaciformes and columbiformes provided a relatively low strength of evidence. A genotypical match between human and animal samples was reported twenty-eight times, including transmission from chickens, turkeys, guinea fowl, peafowl, pigeons, ducks, geese, songbirds, parrot-like birds and owls. CONCLUSIONS: Strong evidence exists for zoonotic transmission from turkeys, chickens and ducks, in addition to the more traditionally reported parrot-like animal sources. Based on our scoring system, the evidence was generally stronger for poultry than for parrot-like birds. Psittaciformes should not be disregarded as an important source of human psittacosis, still clinicians and public health officials should include poultry and birds species other than parrots in medical history and source tracing.",10.1186/s12879-020-4918-y,2ix5sdqk,"['BACKGROUND', 'Human', 'psittacosis', 'caused', 'by', 'Chlamydia', 'C', 'psittaci', 'is', 'likely', 'underdiagnosed', 'and', 'underreported', 'since', 'tests', 'for', 'C', 'psittaci', 'are', 'often', 'not', 'included', 'in', 'routine', 'microbiological', 'diagnostics', 'Source', 'tracing', 'traditionally', 'focuses', 'on', 'psittacine', 'pet', 'birds', 'but', 'recently', 'other', 'animal', 'species', 'have', 'been', 'gaining', 'more', 'attention', 'as', 'possible', 'sources', 'for', 'human', 'psittacosis', 'This', 'review', 'aims', 'to', 'provide', 'an', 'overview', 'of', 'all', 'suspected', 'animal', 'sources', 'of', 'human', 'psittacosis', 'cases', 'reported', 'in', 'the', 'international', 'literature', 'In', 'addition', 'for', 'each', 'animal', 'species', 'the', 'strength', 'of', 'evidence', 'for', 'zoonotic', 'transmission', 'was', 'estimated', 'METHODS', 'A', 'systematic', 'literature', 'search', 'was', 'conducted', 'using', 'four', 'databases', 'Pubmed', 'Embase', 'Scopus', 'and', 'Proquest', 'Articles', 'were', 'included', 'when', 'there', 'was', 'mention', 'of', 'at', 'least', 'one', 'human', 'case', 'of', 'psittacosis', 'and', 'a', 'possible', 'animal', 'source', 'Investigators', 'independently', 'extracted', 'data', 'from', 'the', 'included', 'articles', 'and', 'estimated', 'strength', 'of', 'evidence', 'for', 'zoonotic', 'transmission', 'based', 'on', 'a', 'self', 'developed', 'scoring', 'system', 'taking', 'into', 'account', 'number', 'of', 'human', 'cases', 'epidemiological', 'evidence', 'and', 'laboratory', 'test', 'results', 'in', 'human', 'animals', 'and', 'the', 'environment', 'RESULTS', 'Eighty', 'articles', 'were', 'included', 'which', 'provided', 'information', 'on', '136', 'different', 'situations', 'of', 'possible', 'zoonotic', 'transmission', 'The', 'maximum', 'score', 'for', 'zoonotic', 'transmission', 'was', 'highest', 'for', 'turkeys', 'followed', 'by', 'ducks', 'owls', 'and', 'the', 'category', 'other', 'poultry', 'Articles', 'reporting', 'about', 'zoonotic', 'transmission', 'from', 'unspecified', 'birds', 'psittaciformes', 'and', 'columbiformes', 'provided', 'a', 'relatively', 'low', 'strength', 'of', 'evidence', 'A', 'genotypical', 'match', 'between', 'human', 'and', 'animal', 'samples', 'was', 'reported', 'twenty', 'eight', 'times', 'including', 'transmission', 'from', 'chickens', 'turkeys', 'guinea', 'fowl', 'peafowl', 'pigeons', 'ducks', 'geese', 'songbirds', 'parrot', 'like', 'birds', 'and', 'owls', 'CONCLUSIONS', 'Strong', 'evidence', 'exists', 'for', 'zoonotic', 'transmission', 'from', 'turkeys', 'chickens', 'and', 'ducks', 'in', 'addition', 'to', 'the', 'more', 'traditionally', 'reported', 'parrot', 'like', 'animal', 'sources', 'Based', 'on', 'our', 'scoring', 'system', 'the', 'evidence', 'was', 'generally', 'stronger', 'for', 'poultry', 'than', 'for', 'parrot', 'like', 'birds', 'Psittaciformes', 'should', 'not', 'be', 'disregarded', 'as', 'an', 'important', 'source', 'of', 'human', 'psittacosis', 'still', 'clinicians', 'and', 'public', 'health', 'officials', 'should', 'include', 'poultry', 'and', 'birds', 'species', 'other', 'than', 'parrots', 'in', 'medical', 'history', 'and', 'source', 'tracing', '']"
4706,Diagnostic accuracy and utility of three dengue diagnostic tests for the diagnosis of acute dengue infection in Malaysia,2020-03-12,BMC Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069157/,"BACKGROUND: Dengue is an emerging infectious disease that infects up to 390 million people yearly. The growing demand of dengue diagnostics especially in low-resource settings gave rise to many rapid diagnostic tests (RDT). This study evaluated the accuracy and utility of ViroTrack Dengue Acute - a new biosensors-based dengue NS1 RDT, SD Bioline Dengue Duo NS1/IgM/IgG combo - a commercially available RDT, and SD Dengue NS1 Ag enzyme-linked immunosorbent assay (ELISA), for the diagnosis of acute dengue infection. METHODS: This prospective cross-sectional study consecutively recruited 494 patients with suspected dengue from a health clinic in Malaysia. Both RDTs were performed onsite. The evaluated ELISA and reference tests were performed in a virology laboratory. The reference tests comprised of a reverse transcription-polymerase chain reaction and three ELISAs for the detection of dengue NS1 antigen, IgM and IgG antibodies, respectively. The diagnostic performance of evaluated tests was computed using STATA version 12. RESULTS: The sensitivity and specificity of ViroTrack were 62.3% (95%CI 55.6–68.7) and 95.0% (95%CI 91.7–97.3), versus 66.5% (95%CI 60.0–72.6) and 95.4% (95%CI 92.1–97.6) for SD NS1 ELISA, and 52.4% (95%CI 45.7–59.1) and 97.7% (95%CI 95.1–99.2) for NS1 component of SD Bioline, respectively. The combination of the latter with its IgM and IgG components were able to increase test sensitivity to 82.4% (95%CI 76.8–87.1) with corresponding decrease in specificity to 87.4% (95%CI 82.8–91.2). Although a positive test on any of the NS1 assays would increase the probability of dengue to above 90% in a patient, a negative result would only reduce this probability to 23.0–29.3%. In contrast, this probability of false negative diagnosis would be further reduced to 14.7% (95%CI 11.4–18.6) if SD Bioline NS1/IgM/IgG combo was negative. CONCLUSIONS: The performance of ViroTrack Dengue Acute was comparable to SD Dengue NS1 Ag ELISA. Addition of serology components to SD Bioline Dengue Duo significantly improved its sensitivity and reduced its false negative rate such that it missed the fewest dengue patients, making it a better point-of-care diagnostic tool. New RDT like ViroTrack Dengue Acute may be a potential alternative to existing RDT if its combination with serology components is proven better in future studies.",10.1186/s12879-020-4911-5,r50atew9,"['BACKGROUND', 'Dengue', 'is', 'an', 'emerging', 'infectious', 'disease', 'that', 'infects', 'up', 'to', '390', 'million', 'people', 'yearly', 'The', 'growing', 'demand', 'of', 'dengue', 'diagnostics', 'especially', 'in', 'low', 'resource', 'settings', 'gave', 'rise', 'to', 'many', 'rapid', 'diagnostic', 'tests', 'RDT', 'This', 'study', 'evaluated', 'the', 'accuracy', 'and', 'utility', 'of', 'ViroTrack', 'Dengue', 'Acute', 'a', 'new', 'biosensors', 'based', 'dengue', 'NS1', 'RDT', 'SD', 'Bioline', 'Dengue', 'Duo', 'NS1', 'IgM', 'IgG', 'combo', 'a', 'commercially', 'available', 'RDT', 'and', 'SD', 'Dengue', 'NS1', 'Ag', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'for', 'the', 'diagnosis', 'of', 'acute', 'dengue', 'infection', 'METHODS', 'This', 'prospective', 'cross', 'sectional', 'study', 'consecutively', 'recruited', '494', 'patients', 'with', 'suspected', 'dengue', 'from', 'a', 'health', 'clinic', 'in', 'Malaysia', 'Both', 'RDTs', 'were', 'performed', 'onsite', 'The', 'evaluated', 'ELISA', 'and', 'reference', 'tests', 'were', 'performed', 'in', 'a', 'virology', 'laboratory', 'The', 'reference', 'tests', 'comprised', 'of', 'a', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'and', 'three', 'ELISAs', 'for', 'the', 'detection', 'of', 'dengue', 'NS1', 'antigen', 'IgM', 'and', 'IgG', 'antibodies', 'respectively', 'The', 'diagnostic', 'performance', 'of', 'evaluated', 'tests', 'was', 'computed', 'using', 'STATA', 'version', '12', 'RESULTS', 'The', 'sensitivity', 'and', 'specificity', 'of', 'ViroTrack', 'were', '62', '3', '95', 'CI', '55', '6', '68', '7', 'and', '95', '0', '95', 'CI', '91', '7', '97', '3', 'versus', '66', '5', '95', 'CI', '60', '0', '72', '6', 'and', '95', '4', '95', 'CI', '92', '1', '97', '6', 'for', 'SD', 'NS1', 'ELISA', 'and', '52', '4', '95', 'CI', '45', '7', '59', '1', 'and', '97', '7', '95', 'CI', '95', '1', '99', '2', 'for', 'NS1', 'component', 'of', 'SD', 'Bioline', 'respectively', 'The', 'combination', 'of', 'the', 'latter', 'with', 'its', 'IgM', 'and', 'IgG', 'components', 'were', 'able', 'to', 'increase', 'test', 'sensitivity', 'to', '82', '4', '95', 'CI', '76', '8', '87', '1', 'with', 'corresponding', 'decrease', 'in', 'specificity', 'to', '87', '4', '95', 'CI', '82', '8', '91', '2', 'Although', 'a', 'positive', 'test', 'on', 'any', 'of', 'the', 'NS1', 'assays', 'would', 'increase', 'the', 'probability', 'of', 'dengue', 'to', 'above', '90', 'in', 'a', 'patient', 'a', 'negative', 'result', 'would', 'only', 'reduce', 'this', 'probability', 'to', '23', '0', '29', '3', 'In', 'contrast', 'this', 'probability', 'of', 'false', 'negative', 'diagnosis', 'would', 'be', 'further', 'reduced', 'to', '14', '7', '95', 'CI', '11', '4', '18', '6', 'if', 'SD', 'Bioline', 'NS1', 'IgM', 'IgG', 'combo', 'was', 'negative', 'CONCLUSIONS', 'The', 'performance', 'of', 'ViroTrack', 'Dengue', 'Acute', 'was', 'comparable', 'to', 'SD', 'Dengue', 'NS1', 'Ag', 'ELISA', 'Addition', 'of', 'serology', 'components', 'to', 'SD', 'Bioline', 'Dengue', 'Duo', 'significantly', 'improved', 'its', 'sensitivity', 'and', 'reduced', 'its', 'false', 'negative', 'rate', 'such', 'that', 'it', 'missed', 'the', 'fewest', 'dengue', 'patients', 'making', 'it', 'a', 'better', 'point', 'of', 'care', 'diagnostic', 'tool', 'New', 'RDT', 'like', 'ViroTrack', 'Dengue', 'Acute', 'may', 'be', 'a', 'potential', 'alternative', 'to', 'existing', 'RDT', 'if', 'its', 'combination', 'with', 'serology', 'components', 'is', 'proven', 'better', 'in', 'future', 'studies', '']"
4784,Microfluidics in macro-biomolecules analysis: macro inside in a nano world,2010-06-13,Anal Bioanal Chem,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079953/,"Use of microfluidic devices in the life sciences and medicine has created the possibility of performing investigations at the molecular level. Moreover, microfluidic devices are also part of the technological framework that has enabled a new type of scientific information to be revealed, i.e. that based on intensive screening of complete sets of gene and protein sequences. A deeper bioanalytical perspective may provide quantitative and qualitative tools, enabling study of various diseases and, eventually, may offer support for the development of accurate and reliable methods for clinical assessment. This would open the way to molecule-based diagnostics, i.e. establish accurate diagnosis and disease prognosis based on identification and/or quantification of biomacromolecules, for example proteins or nucleic acids. Finally, the development of disposable and portable devices for molecule-based diagnosis would provide the perfect translation of the science behind life-science research into practical applications dedicated to patients and health practitioners. This review provides an analytical perspective of the impact of microfluidics on the detection and characterization of bio-macromolecules involved in pathological processes. The main features of molecule-based diagnostics and the specific requirements for the diagnostic devices are discussed. Further, the techniques currently used for testing bio-macromolecules for potential diagnostic purposes are identified, emphasizing the newest developments. Subsequently, the challenges of this type of application and the status of commercially available devices are highlighted, and future trends are noted.",10.1007/s00216-010-3857-7,ale7xhcf,"['Use', 'of', 'microfluidic', 'devices', 'in', 'the', 'life', 'sciences', 'and', 'medicine', 'has', 'created', 'the', 'possibility', 'of', 'performing', 'investigations', 'at', 'the', 'molecular', 'level', 'Moreover', 'microfluidic', 'devices', 'are', 'also', 'part', 'of', 'the', 'technological', 'framework', 'that', 'has', 'enabled', 'a', 'new', 'type', 'of', 'scientific', 'information', 'to', 'be', 'revealed', 'i', 'e', 'that', 'based', 'on', 'intensive', 'screening', 'of', 'complete', 'sets', 'of', 'gene', 'and', 'protein', 'sequences', 'A', 'deeper', 'bioanalytical', 'perspective', 'may', 'provide', 'quantitative', 'and', 'qualitative', 'tools', 'enabling', 'study', 'of', 'various', 'diseases', 'and', 'eventually', 'may', 'offer', 'support', 'for', 'the', 'development', 'of', 'accurate', 'and', 'reliable', 'methods', 'for', 'clinical', 'assessment', 'This', 'would', 'open', 'the', 'way', 'to', 'molecule', 'based', 'diagnostics', 'i', 'e', 'establish', 'accurate', 'diagnosis', 'and', 'disease', 'prognosis', 'based', 'on', 'identification', 'and', 'or', 'quantification', 'of', 'biomacromolecules', 'for', 'example', 'proteins', 'or', 'nucleic', 'acids', 'Finally', 'the', 'development', 'of', 'disposable', 'and', 'portable', 'devices', 'for', 'molecule', 'based', 'diagnosis', 'would', 'provide', 'the', 'perfect', 'translation', 'of', 'the', 'science', 'behind', 'life', 'science', 'research', 'into', 'practical', 'applications', 'dedicated', 'to', 'patients', 'and', 'health', 'practitioners', 'This', 'review', 'provides', 'an', 'analytical', 'perspective', 'of', 'the', 'impact', 'of', 'microfluidics', 'on', 'the', 'detection', 'and', 'characterization', 'of', 'bio', 'macromolecules', 'involved', 'in', 'pathological', 'processes', 'The', 'main', 'features', 'of', 'molecule', 'based', 'diagnostics', 'and', 'the', 'specific', 'requirements', 'for', 'the', 'diagnostic', 'devices', 'are', 'discussed', 'Further', 'the', 'techniques', 'currently', 'used', 'for', 'testing', 'bio', 'macromolecules', 'for', 'potential', 'diagnostic', 'purposes', 'are', 'identified', 'emphasizing', 'the', 'newest', 'developments', 'Subsequently', 'the', 'challenges', 'of', 'this', 'type', 'of', 'application', 'and', 'the', 'status', 'of', 'commercially', 'available', 'devices', 'are', 'highlighted', 'and', 'future', 'trends', 'are', 'noted', '']"
5357,The use of loop-mediated isothermal DNA amplification for the detection and identification of the anthrax pathogen,2017-09-20,Mol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088587/,The results of detection and identification of Bacillus anthracis strains in loop-mediated isothermal DNA amplification (LAMP) reaction performed under optimized conditions with original primers and thermostable DNA polymerase are presented. Reproducible LAMP-based detection of chromosomal and plasmid DNA targets specific for B. anthracis strains has been demonstrated. No cross reactions with DNA from bacterial strains of other species of the B. cereus group were detected. The development of tests for anthrax-pathogen detection based on the optimized reaction of loop isothermal DNA amplification is planned. These tests will be convenient for clinical studies and field diagnostics due to the absence of requirements for sophisticated equipment.,10.3103/s0891416817020094,7rdvjylx,"['The', 'results', 'of', 'detection', 'and', 'identification', 'of', 'Bacillus', 'anthracis', 'strains', 'in', 'loop', 'mediated', 'isothermal', 'DNA', 'amplification', 'LAMP', 'reaction', 'performed', 'under', 'optimized', 'conditions', 'with', 'original', 'primers', 'and', 'thermostable', 'DNA', 'polymerase', 'are', 'presented', 'Reproducible', 'LAMP', 'based', 'detection', 'of', 'chromosomal', 'and', 'plasmid', 'DNA', 'targets', 'specific', 'for', 'B', 'anthracis', 'strains', 'has', 'been', 'demonstrated', 'No', 'cross', 'reactions', 'with', 'DNA', 'from', 'bacterial', 'strains', 'of', 'other', 'species', 'of', 'the', 'B', 'cereus', 'group', 'were', 'detected', 'The', 'development', 'of', 'tests', 'for', 'anthrax', 'pathogen', 'detection', 'based', 'on', 'the', 'optimized', 'reaction', 'of', 'loop', 'isothermal', 'DNA', 'amplification', 'is', 'planned', 'These', 'tests', 'will', 'be', 'convenient', 'for', 'clinical', 'studies', 'and', 'field', 'diagnostics', 'due', 'to', 'the', 'absence', 'of', 'requirements', 'for', 'sophisticated', 'equipment', '']"
5730,Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology,2020-03-24,Sci Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093460/,"The detection of pathogen-specific antibodies remains a cornerstone of clinical diagnostics. Yet, many test exhibit undesirable performance or are completely lacking. Given this, we developed serum epitope repertoire analysis (SERA), a method to rapidly discover conserved, pathogen-specific antigens and their epitopes, and applied it to develop an assay for Chagas disease caused by the protozoan parasite Trypanosoma cruzi. Antibody binding peptide motifs were identified from 28 Chagas repertoires using a bacterial display random 12-mer peptide library and next-generation sequencing (NGS). Thirty-three motifs were selected and mapped to candidate Chagas antigens. In a blinded validation set (n = 72), 30/30 Chagas were positive, 30/30 non-Chagas were negative, and 1/12 Leishmania sp. was positive. After unblinding, a Leishmania cross-reactive epitope was identified and removed from the panel. The Chagas assay exhibited 100% sensitivity (30/30) and specificity (90/90) in a second blinded validation set including individuals with other parasitic infections. Amongst additional epitope repertoires with unknown Chagas serostatus, assay specificity was 99.8% (998/1000). Thus, the Chagas assay achieved a combined sensitivity and specificity equivalent or superior to diagnostic algorithms that rely on three separate tests to achieve high specificity. NGS-based serology via SERA provides an effective approach to discover antigenic epitopes and develop high performance multiplex serological assays.",10.1038/s41598-020-62256-9,equnyib7,"['The', 'detection', 'of', 'pathogen', 'specific', 'antibodies', 'remains', 'a', 'cornerstone', 'of', 'clinical', 'diagnostics', 'Yet', 'many', 'test', 'exhibit', 'undesirable', 'performance', 'or', 'are', 'completely', 'lacking', 'Given', 'this', 'we', 'developed', 'serum', 'epitope', 'repertoire', 'analysis', 'SERA', 'a', 'method', 'to', 'rapidly', 'discover', 'conserved', 'pathogen', 'specific', 'antigens', 'and', 'their', 'epitopes', 'and', 'applied', 'it', 'to', 'develop', 'an', 'assay', 'for', 'Chagas', 'disease', 'caused', 'by', 'the', 'protozoan', 'parasite', 'Trypanosoma', 'cruzi', 'Antibody', 'binding', 'peptide', 'motifs', 'were', 'identified', 'from', '28', 'Chagas', 'repertoires', 'using', 'a', 'bacterial', 'display', 'random', '12', 'mer', 'peptide', 'library', 'and', 'next', 'generation', 'sequencing', 'NGS', 'Thirty', 'three', 'motifs', 'were', 'selected', 'and', 'mapped', 'to', 'candidate', 'Chagas', 'antigens', 'In', 'a', 'blinded', 'validation', 'set', 'n', '72', '30', '30', 'Chagas', 'were', 'positive', '30', '30', 'non', 'Chagas', 'were', 'negative', 'and', '1', '12', 'Leishmania', 'sp', 'was', 'positive', 'After', 'unblinding', 'a', 'Leishmania', 'cross', 'reactive', 'epitope', 'was', 'identified', 'and', 'removed', 'from', 'the', 'panel', 'The', 'Chagas', 'assay', 'exhibited', '100', 'sensitivity', '30', '30', 'and', 'specificity', '90', '90', 'in', 'a', 'second', 'blinded', 'validation', 'set', 'including', 'individuals', 'with', 'other', 'parasitic', 'infections', 'Amongst', 'additional', 'epitope', 'repertoires', 'with', 'unknown', 'Chagas', 'serostatus', 'assay', 'specificity', 'was', '99', '8', '998', '1000', 'Thus', 'the', 'Chagas', 'assay', 'achieved', 'a', 'combined', 'sensitivity', 'and', 'specificity', 'equivalent', 'or', 'superior', 'to', 'diagnostic', 'algorithms', 'that', 'rely', 'on', 'three', 'separate', 'tests', 'to', 'achieve', 'high', 'specificity', 'NGS', 'based', 'serology', 'via', 'SERA', 'provides', 'an', 'effective', 'approach', 'to', 'discover', 'antigenic', 'epitopes', 'and', 'develop', 'high', 'performance', 'multiplex', 'serological', 'assays', '']"
6172,Verbreitung von Hantavirusinfektionen in Deutschland,2004,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095999/,"Hantaviruses belong to the group of “emerging” viruses. Pathogenic European hantaviruses can cause a human disease designated “hemorrhagic fever with renal syndrome” of varying severity. In general, diagnostics of hantavirus infections are based on immunofluorescence assays using virus-infected cells or enzyme immunoassays and Western blot tests using recombinant nucleocapsid proteins. For highly sensitive detection of hantavirus-specific antibodies in the enzyme immunoassay, a homologous hantavirus nucleocapsid protein is needed as a diagnostic antigen. Serological typing of hantavirus infections can be obtained by neutralization assays, which in certain cases require the use of late convalescent sera. The seroprevalence in the normal German population is about 1%. In professionally exposed risk groups, e. g., forest workers, a seroprevalence higher than that in the normal population was observed. Endemic regions for hantavirus infections are located mainly in Baden-Württemberg. In the years 2001–2003 an annual number of about 200 clinically apparent hantavirus infections were registered in Germany. Neutralization assays detected almost exclusively human infections caused by Puumala and Dobrava viruses, only very rarely by Tula virus. Until this day in Germany mainly mild to moderate courses of human hantavirus infections have been documented. Besides infections caused by “German” hantaviruses, up to 10% of the clinically apparent hantavirus infections registered annually in Germany are caused by infections imported from other countries, mainly from Europe. So far only very limited molecular genetic data about the circulating hantaviruses in Germany are available. Additional investigations are needed to get a more precise picture about the distribution of hantaviruses in Germany and to calculate the resulting risk for the human population.",10.1007/s00103-004-0858-8,gfir11bf,"['Hantaviruses', 'belong', 'to', 'the', 'group', 'of', 'emerging', 'viruses', 'Pathogenic', 'European', 'hantaviruses', 'can', 'cause', 'a', 'human', 'disease', 'designated', 'hemorrhagic', 'fever', 'with', 'renal', 'syndrome', 'of', 'varying', 'severity', 'In', 'general', 'diagnostics', 'of', 'hantavirus', 'infections', 'are', 'based', 'on', 'immunofluorescence', 'assays', 'using', 'virus', 'infected', 'cells', 'or', 'enzyme', 'immunoassays', 'and', 'Western', 'blot', 'tests', 'using', 'recombinant', 'nucleocapsid', 'proteins', 'For', 'highly', 'sensitive', 'detection', 'of', 'hantavirus', 'specific', 'antibodies', 'in', 'the', 'enzyme', 'immunoassay', 'a', 'homologous', 'hantavirus', 'nucleocapsid', 'protein', 'is', 'needed', 'as', 'a', 'diagnostic', 'antigen', 'Serological', 'typing', 'of', 'hantavirus', 'infections', 'can', 'be', 'obtained', 'by', 'neutralization', 'assays', 'which', 'in', 'certain', 'cases', 'require', 'the', 'use', 'of', 'late', 'convalescent', 'sera', 'The', 'seroprevalence', 'in', 'the', 'normal', 'German', 'population', 'is', 'about', '1', 'In', 'professionally', 'exposed', 'risk', 'groups', 'e', 'g', 'forest', 'workers', 'a', 'seroprevalence', 'higher', 'than', 'that', 'in', 'the', 'normal', 'population', 'was', 'observed', 'Endemic', 'regions', 'for', 'hantavirus', 'infections', 'are', 'located', 'mainly', 'in', 'Baden', 'Württemberg', 'In', 'the', 'years', '2001', '2003', 'an', 'annual', 'number', 'of', 'about', '200', 'clinically', 'apparent', 'hantavirus', 'infections', 'were', 'registered', 'in', 'Germany', 'Neutralization', 'assays', 'detected', 'almost', 'exclusively', 'human', 'infections', 'caused', 'by', 'Puumala', 'and', 'Dobrava', 'viruses', 'only', 'very', 'rarely', 'by', 'Tula', 'virus', 'Until', 'this', 'day', 'in', 'Germany', 'mainly', 'mild', 'to', 'moderate', 'courses', 'of', 'human', 'hantavirus', 'infections', 'have', 'been', 'documented', 'Besides', 'infections', 'caused', 'by', 'German', 'hantaviruses', 'up', 'to', '10', 'of', 'the', 'clinically', 'apparent', 'hantavirus', 'infections', 'registered', 'annually', 'in', 'Germany', 'are', 'caused', 'by', 'infections', 'imported', 'from', 'other', 'countries', 'mainly', 'from', 'Europe', 'So', 'far', 'only', 'very', 'limited', 'molecular', 'genetic', 'data', 'about', 'the', 'circulating', 'hantaviruses', 'in', 'Germany', 'are', 'available', 'Additional', 'investigations', 'are', 'needed', 'to', 'get', 'a', 'more', 'precise', 'picture', 'about', 'the', 'distribution', 'of', 'hantaviruses', 'in', 'Germany', 'and', 'to', 'calculate', 'the', 'resulting', 'risk', 'for', 'the', 'human', 'population', '']"
6369,Non-invasive lung disease diagnostics from exhaled microdroplets of lung fluid: perspectives and technical challenges,2018-01-01,J Breath Res,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099678/,"The combination of ultra-sensitive assay techniques and recent improvements in the instrumentation used to collect microdroplets of lung fluid (MLF) from exhaled breath has enabled the development of non-invasive lung disease diagnostics that are based on MLF analysis. In one example of this approach, electrospun nylon filters were used to collect MLFs from patients with pulmonary tuberculosis. The filters were washed to obtain liquid probes, which were then tested for human immunoglobulin A (h-IgA) and fractions of h-IgA specific to ESAT-6 and Psts-1, two antigens secreted by Mycobacterium tuberculosis. Probes collected for 10 min contained 100–1500 fg of h-IgA and, in patients with pulmonary tuberculosis, a portion of these h-IgA molecules showed specificity to the secreted antigens. Separate MLFs and their dry residues were successfully collected using an electrostatic collector and impactor developed especially for this purpose. Visualization of MLF dry residues by atomic force microscopy made it possible to estimate the lipid content in each MLF and revealed mucin molecules in some MLFs. This exciting new approach will likely make it possible to detect biomarkers in individual MLFs. MLFs emerging from an infection site (‘hot’ microdroplets) are expected to be enriched with infection biomarkers. This paper discusses possible experimental approaches to detecting biomarkers in single MLFs, as well as certain technological problems that need to be resolved in order to develop new non-invasive diagnostics based on analysing biomarkers in separate MLFs.",10.1088/1752-7163/aa88e4,n6jsx47v,"['The', 'combination', 'of', 'ultra', 'sensitive', 'assay', 'techniques', 'and', 'recent', 'improvements', 'in', 'the', 'instrumentation', 'used', 'to', 'collect', 'microdroplets', 'of', 'lung', 'fluid', 'MLF', 'from', 'exhaled', 'breath', 'has', 'enabled', 'the', 'development', 'of', 'non', 'invasive', 'lung', 'disease', 'diagnostics', 'that', 'are', 'based', 'on', 'MLF', 'analysis', 'In', 'one', 'example', 'of', 'this', 'approach', 'electrospun', 'nylon', 'filters', 'were', 'used', 'to', 'collect', 'MLFs', 'from', 'patients', 'with', 'pulmonary', 'tuberculosis', 'The', 'filters', 'were', 'washed', 'to', 'obtain', 'liquid', 'probes', 'which', 'were', 'then', 'tested', 'for', 'human', 'immunoglobulin', 'A', 'h', 'IgA', 'and', 'fractions', 'of', 'h', 'IgA', 'specific', 'to', 'ESAT', '6', 'and', 'Psts', '1', 'two', 'antigens', 'secreted', 'by', 'Mycobacterium', 'tuberculosis', 'Probes', 'collected', 'for', '10', 'min', 'contained', '100', '1500', 'fg', 'of', 'h', 'IgA', 'and', 'in', 'patients', 'with', 'pulmonary', 'tuberculosis', 'a', 'portion', 'of', 'these', 'h', 'IgA', 'molecules', 'showed', 'specificity', 'to', 'the', 'secreted', 'antigens', 'Separate', 'MLFs', 'and', 'their', 'dry', 'residues', 'were', 'successfully', 'collected', 'using', 'an', 'electrostatic', 'collector', 'and', 'impactor', 'developed', 'especially', 'for', 'this', 'purpose', 'Visualization', 'of', 'MLF', 'dry', 'residues', 'by', 'atomic', 'force', 'microscopy', 'made', 'it', 'possible', 'to', 'estimate', 'the', 'lipid', 'content', 'in', 'each', 'MLF', 'and', 'revealed', 'mucin', 'molecules', 'in', 'some', 'MLFs', 'This', 'exciting', 'new', 'approach', 'will', 'likely', 'make', 'it', 'possible', 'to', 'detect', 'biomarkers', 'in', 'individual', 'MLFs', 'MLFs', 'emerging', 'from', 'an', 'infection', 'site', 'hot', 'microdroplets', 'are', 'expected', 'to', 'be', 'enriched', 'with', 'infection', 'biomarkers', 'This', 'paper', 'discusses', 'possible', 'experimental', 'approaches', 'to', 'detecting', 'biomarkers', 'in', 'single', 'MLFs', 'as', 'well', 'as', 'certain', 'technological', 'problems', 'that', 'need', 'to', 'be', 'resolved', 'in', 'order', 'to', 'develop', 'new', 'non', 'invasive', 'diagnostics', 'based', 'on', 'analysing', 'biomarkers', 'in', 'separate', 'MLFs', '']"
7020,Endemic Mycoses: What’s New About Old Diseases?,2016-03-18,Curr Clin Microbiol Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102464/,"Infections with geographically constrained dimorphic fungi cause the endemic mycoses, which include blastomycosis, coccidioidomycosis, emmonsiosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and penicilliosis. In the last 5 years, our understanding of the epidemiology, diagnostics, and to a lesser extent management of these diseases has advanced. Specifically, the application of molecular techniques for genotyping fungal pathogens has resulted in the recognition of cryptic species within several genera, including Blastomyces, and Paracoccidioides; the reclassification of Penicillium marneffei, the agent of penicilliosis, to the genus Talaromyces; and the global emergence of dimorphic fungi of the genus Emmonsia, cause disease in immunocompromised persons. New and refined diagnostic tests are available based on the detection of circulating antigens and antibodies, mass spectrometry, and targeted gene amplification. In contrast, the development of new therapeutic options remains stalled, although isavuconazole may hold promise. Finally, advances have been made in the prospect of viable vaccines for preventing animal and human disease.",10.1007/s40588-016-0034-6,hrsk5l73,"['Infections', 'with', 'geographically', 'constrained', 'dimorphic', 'fungi', 'cause', 'the', 'endemic', 'mycoses', 'which', 'include', 'blastomycosis', 'coccidioidomycosis', 'emmonsiosis', 'histoplasmosis', 'paracoccidioidomycosis', 'sporotrichosis', 'and', 'penicilliosis', 'In', 'the', 'last', '5', 'years', 'our', 'understanding', 'of', 'the', 'epidemiology', 'diagnostics', 'and', 'to', 'a', 'lesser', 'extent', 'management', 'of', 'these', 'diseases', 'has', 'advanced', 'Specifically', 'the', 'application', 'of', 'molecular', 'techniques', 'for', 'genotyping', 'fungal', 'pathogens', 'has', 'resulted', 'in', 'the', 'recognition', 'of', 'cryptic', 'species', 'within', 'several', 'genera', 'including', 'Blastomyces', 'and', 'Paracoccidioides', 'the', 'reclassification', 'of', 'Penicillium', 'marneffei', 'the', 'agent', 'of', 'penicilliosis', 'to', 'the', 'genus', 'Talaromyces', 'and', 'the', 'global', 'emergence', 'of', 'dimorphic', 'fungi', 'of', 'the', 'genus', 'Emmonsia', 'cause', 'disease', 'in', 'immunocompromised', 'persons', 'New', 'and', 'refined', 'diagnostic', 'tests', 'are', 'available', 'based', 'on', 'the', 'detection', 'of', 'circulating', 'antigens', 'and', 'antibodies', 'mass', 'spectrometry', 'and', 'targeted', 'gene', 'amplification', 'In', 'contrast', 'the', 'development', 'of', 'new', 'therapeutic', 'options', 'remains', 'stalled', 'although', 'isavuconazole', 'may', 'hold', 'promise', 'Finally', 'advances', 'have', 'been', 'made', 'in', 'the', 'prospect', 'of', 'viable', 'vaccines', 'for', 'preventing', 'animal', 'and', 'human', 'disease', '']"
7257,Challenges in the Etiology and Diagnosis of Acute Febrile Illness in Children in Low- and Middle-Income Countries,2016-04-07,J Pediatric Infect Dis Soc,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107506/,"Acute febrile illness is a common cause of hospital admission, and its associated infectious causes contribute to substantial morbidity and death among children worldwide, especially in low- and middle-income countries. Declining transmission of malaria in many regions, combined with the increasing use of rapid diagnostic tests for malaria, has led to the increasing recognition of leptospirosis, rickettsioses, respiratory viruses, and arboviruses as etiologic agents of fevers. However, clinical discrimination between these etiologies can be difficult. Overtreatment with antimalarial drugs is common, even in the setting of a negative test result, as is overtreatment with empiric antibacterial drugs. Viral etiologies remain underrecognized and poorly investigated. More-sensitive diagnostics have led to additional dilemmas in discriminating whether a positive test result reflects a causative pathogen. Here, we review and summarize the current epidemiology and focus particularly on children and the challenges for future research.",10.1093/jpids/piw016,na90gzux,"['Acute', 'febrile', 'illness', 'is', 'a', 'common', 'cause', 'of', 'hospital', 'admission', 'and', 'its', 'associated', 'infectious', 'causes', 'contribute', 'to', 'substantial', 'morbidity', 'and', 'death', 'among', 'children', 'worldwide', 'especially', 'in', 'low', 'and', 'middle', 'income', 'countries', 'Declining', 'transmission', 'of', 'malaria', 'in', 'many', 'regions', 'combined', 'with', 'the', 'increasing', 'use', 'of', 'rapid', 'diagnostic', 'tests', 'for', 'malaria', 'has', 'led', 'to', 'the', 'increasing', 'recognition', 'of', 'leptospirosis', 'rickettsioses', 'respiratory', 'viruses', 'and', 'arboviruses', 'as', 'etiologic', 'agents', 'of', 'fevers', 'However', 'clinical', 'discrimination', 'between', 'these', 'etiologies', 'can', 'be', 'difficult', 'Overtreatment', 'with', 'antimalarial', 'drugs', 'is', 'common', 'even', 'in', 'the', 'setting', 'of', 'a', 'negative', 'test', 'result', 'as', 'is', 'overtreatment', 'with', 'empiric', 'antibacterial', 'drugs', 'Viral', 'etiologies', 'remain', 'underrecognized', 'and', 'poorly', 'investigated', 'More', 'sensitive', 'diagnostics', 'have', 'led', 'to', 'additional', 'dilemmas', 'in', 'discriminating', 'whether', 'a', 'positive', 'test', 'result', 'reflects', 'a', 'causative', 'pathogen', 'Here', 'we', 'review', 'and', 'summarize', 'the', 'current', 'epidemiology', 'and', 'focus', 'particularly', 'on', 'children', 'and', 'the', 'challenges', 'for', 'future', 'research', '']"
7969,Respiratory Infections,2014-04-06,Infectious Complications in Cancer Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121575/,"The respiratory tract is a common site of infection in cancer patients and is associated with substantial moribidity and mortality in this population. Cancer, chemotherapy, and radiation can all cause noninfectious pulmonary infiltrates and respiratory symptoms that can masquerade as a respiratory tract infection. Cancer patients are at a particular risk for infection by a wide variety of different viruses, fungi, and bacteria that can be difficult to treat. Although noninvasive diagnostics have significantly improved recently, patients with severe pneumonia and those not responding to usual therapy should be candidates for aggressive diagnostic testing and tissue sampling. Initial therapy should be carefully chosen and individually tailored to account for the individual patient’s underlying risk factors for multi-drug-resistant pathogens, viral pathogens, or fungi. Once diagnostic testing returns, therapy should be altered to appropriately narrow the spectrum of coverage.",10.1007/978-3-319-04220-6_7,7v1qq404,"['The', 'respiratory', 'tract', 'is', 'a', 'common', 'site', 'of', 'infection', 'in', 'cancer', 'patients', 'and', 'is', 'associated', 'with', 'substantial', 'moribidity', 'and', 'mortality', 'in', 'this', 'population', 'Cancer', 'chemotherapy', 'and', 'radiation', 'can', 'all', 'cause', 'noninfectious', 'pulmonary', 'infiltrates', 'and', 'respiratory', 'symptoms', 'that', 'can', 'masquerade', 'as', 'a', 'respiratory', 'tract', 'infection', 'Cancer', 'patients', 'are', 'at', 'a', 'particular', 'risk', 'for', 'infection', 'by', 'a', 'wide', 'variety', 'of', 'different', 'viruses', 'fungi', 'and', 'bacteria', 'that', 'can', 'be', 'difficult', 'to', 'treat', 'Although', 'noninvasive', 'diagnostics', 'have', 'significantly', 'improved', 'recently', 'patients', 'with', 'severe', 'pneumonia', 'and', 'those', 'not', 'responding', 'to', 'usual', 'therapy', 'should', 'be', 'candidates', 'for', 'aggressive', 'diagnostic', 'testing', 'and', 'tissue', 'sampling', 'Initial', 'therapy', 'should', 'be', 'carefully', 'chosen', 'and', 'individually', 'tailored', 'to', 'account', 'for', 'the', 'individual', 'patient', 's', 'underlying', 'risk', 'factors', 'for', 'multi', 'drug', 'resistant', 'pathogens', 'viral', 'pathogens', 'or', 'fungi', 'Once', 'diagnostic', 'testing', 'returns', 'therapy', 'should', 'be', 'altered', 'to', 'appropriately', 'narrow', 'the', 'spectrum', 'of', 'coverage', '']"
8211,Clinical virology in real time,2002-12-03,J Clin Virol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128152/,"The ability to detect nucleic acids has had and still has a major impact on diagnostics in clinical virology. Both quantitative and qualitative techniques, whether signal or target amplification based systems, are currently used routinely in most if not all virology laboratories. Technological improvements, from automated sample isolation to real time amplification technology, have given the ability to develop and introduce systems for most viruses of clinical interest, and to obtain clinical relevant information needed for optimal antiviral treatment options. Both polymerase chain reaction (PCR) and nucleic acid sequence-based amplification (NASBA) can currently be used together with real time detection to generate results in a short turn-around time and to determine whether variants relevant for antiviral resistance are present. These new technologies enable the introduction of an individual patient disease management concept. Within our clinical setting, we have introduced this e.g. for quantitative detection of Epstein–Barr Virus (EBV) in T-dell depleted allogeneic stem cell transplant patients. This enabled us to develop models for pre-emptive anti B-cell immunotherapy for EBV reactivation, thereby effectively reducing not the incidence of EBV-lymphoproliferative disease but the virus related mortality. Furthermore, additional clinically relevant viruses can now easily be detected simultaneously. It also becomes more feasible to introduce molecular testing for those viruses that can easily be detected using classical virological methods, like culture techniques or antigen detection. Prospective studies are needed to evaluate the clinical importance of the additional positive samples detected. It should however be made clear that a complete exchange of technologies is unlikely to occur, and that some complementary technologies should stay operational enabling the discovery of new viruses. The implementation of these molecular diagnostic technologies furthermore warrants the use and introduction of standardized materials as well as participation in international quality control programs. Finally, the use of an internal control throughout the whole procedure not only ensures the accuracy of the results generated, but also is necessary to enable precise quantification of these results and to determine detection thresholds more accurately. Since so many targets do have clinical implications, laboratories might prefer to use universal internal controls before the in-house developed assays should be introduced in clinical virology.",10.1016/s1386-6532(02)00197-x,mmls866r,"['The', 'ability', 'to', 'detect', 'nucleic', 'acids', 'has', 'had', 'and', 'still', 'has', 'a', 'major', 'impact', 'on', 'diagnostics', 'in', 'clinical', 'virology', 'Both', 'quantitative', 'and', 'qualitative', 'techniques', 'whether', 'signal', 'or', 'target', 'amplification', 'based', 'systems', 'are', 'currently', 'used', 'routinely', 'in', 'most', 'if', 'not', 'all', 'virology', 'laboratories', 'Technological', 'improvements', 'from', 'automated', 'sample', 'isolation', 'to', 'real', 'time', 'amplification', 'technology', 'have', 'given', 'the', 'ability', 'to', 'develop', 'and', 'introduce', 'systems', 'for', 'most', 'viruses', 'of', 'clinical', 'interest', 'and', 'to', 'obtain', 'clinical', 'relevant', 'information', 'needed', 'for', 'optimal', 'antiviral', 'treatment', 'options', 'Both', 'polymerase', 'chain', 'reaction', 'PCR', 'and', 'nucleic', 'acid', 'sequence', 'based', 'amplification', 'NASBA', 'can', 'currently', 'be', 'used', 'together', 'with', 'real', 'time', 'detection', 'to', 'generate', 'results', 'in', 'a', 'short', 'turn', 'around', 'time', 'and', 'to', 'determine', 'whether', 'variants', 'relevant', 'for', 'antiviral', 'resistance', 'are', 'present', 'These', 'new', 'technologies', 'enable', 'the', 'introduction', 'of', 'an', 'individual', 'patient', 'disease', 'management', 'concept', 'Within', 'our', 'clinical', 'setting', 'we', 'have', 'introduced', 'this', 'e', 'g', 'for', 'quantitative', 'detection', 'of', 'Epstein', 'Barr', 'Virus', 'EBV', 'in', 'T', 'dell', 'depleted', 'allogeneic', 'stem', 'cell', 'transplant', 'patients', 'This', 'enabled', 'us', 'to', 'develop', 'models', 'for', 'pre', 'emptive', 'anti', 'B', 'cell', 'immunotherapy', 'for', 'EBV', 'reactivation', 'thereby', 'effectively', 'reducing', 'not', 'the', 'incidence', 'of', 'EBV', 'lymphoproliferative', 'disease', 'but', 'the', 'virus', 'related', 'mortality', 'Furthermore', 'additional', 'clinically', 'relevant', 'viruses', 'can', 'now', 'easily', 'be', 'detected', 'simultaneously', 'It', 'also', 'becomes', 'more', 'feasible', 'to', 'introduce', 'molecular', 'testing', 'for', 'those', 'viruses', 'that', 'can', 'easily', 'be', 'detected', 'using', 'classical', 'virological', 'methods', 'like', 'culture', 'techniques', 'or', 'antigen', 'detection', 'Prospective', 'studies', 'are', 'needed', 'to', 'evaluate', 'the', 'clinical', 'importance', 'of', 'the', 'additional', 'positive', 'samples', 'detected', 'It', 'should', 'however', 'be', 'made', 'clear', 'that', 'a', 'complete', 'exchange', 'of', 'technologies', 'is', 'unlikely', 'to', 'occur', 'and', 'that', 'some', 'complementary', 'technologies', 'should', 'stay', 'operational', 'enabling', 'the', 'discovery', 'of', 'new', 'viruses', 'The', 'implementation', 'of', 'these', 'molecular', 'diagnostic', 'technologies', 'furthermore', 'warrants', 'the', 'use', 'and', 'introduction', 'of', 'standardized', 'materials', 'as', 'well', 'as', 'participation', 'in', 'international', 'quality', 'control', 'programs', 'Finally', 'the', 'use', 'of', 'an', 'internal', 'control', 'throughout', 'the', 'whole', 'procedure', 'not', 'only', 'ensures', 'the', 'accuracy', 'of', 'the', 'results', 'generated', 'but', 'also', 'is', 'necessary', 'to', 'enable', 'precise', 'quantification', 'of', 'these', 'results', 'and', 'to', 'determine', 'detection', 'thresholds', 'more', 'accurately', 'Since', 'so', 'many', 'targets', 'do', 'have', 'clinical', 'implications', 'laboratories', 'might', 'prefer', 'to', 'use', 'universal', 'internal', 'controls', 'before', 'the', 'in', 'house', 'developed', 'assays', 'should', 'be', 'introduced', 'in', 'clinical', 'virology', '']"
8355,Molecular diagnostic techniques,2005-03-01,Medicine (Abingdon),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129055/,"Molecular diagnostic techniques will continue to transform clinical microbiology. They provide more rapid and sensitive testing that impacts directly on clinical management of infected patients. Molecular diagnostic tests arose from the need to detect micro-organisms that are slow or difficult to grow, or that are present in only small numbers. Nucleic acid amplification techniques (e.g. polymerase chain reaction, PCR) can detect DNA or RNA specific to certain micro-organisms and do not rely on either the recovery of the pathogen or an immune response in the infected patient. Alternative nucleic acid amplification methods have emerged recently because of increasing commercial interest in infectious disease diagnostics and the comprehensive patient protection of PCR technology. Such techniques are gaining widespread acceptance, and have displaced more conventional gold-standard testing in some areas of infectious disease (e.g. viral load testing in HIV-1 infected patients, diagnosis of Chlamydia trachomatis infection). Genetic characterization techniques are increasingly used to determine the relatedness of micro-organisms in the clinical setting. These methods are useful in establishing routes or sources of infection in outbreaks of disease, and are powerful epidemiological tools in large-scale clinical investigations. Recently, there has been a move towards pathogen characterization techniques based on direct nucleotide sequencing (e.g. single nucleotide polymorphism analysis, multi-locus sequence typing). These techniques offer unambiguous, portable data that can be exchanged via the Internet, strengthening collaborative efforts in the field of infectious disease research.",10.1383/medc.33.3.26.61126,bviip1sp,"['Molecular', 'diagnostic', 'techniques', 'will', 'continue', 'to', 'transform', 'clinical', 'microbiology', 'They', 'provide', 'more', 'rapid', 'and', 'sensitive', 'testing', 'that', 'impacts', 'directly', 'on', 'clinical', 'management', 'of', 'infected', 'patients', 'Molecular', 'diagnostic', 'tests', 'arose', 'from', 'the', 'need', 'to', 'detect', 'micro', 'organisms', 'that', 'are', 'slow', 'or', 'difficult', 'to', 'grow', 'or', 'that', 'are', 'present', 'in', 'only', 'small', 'numbers', 'Nucleic', 'acid', 'amplification', 'techniques', 'e', 'g', 'polymerase', 'chain', 'reaction', 'PCR', 'can', 'detect', 'DNA', 'or', 'RNA', 'specific', 'to', 'certain', 'micro', 'organisms', 'and', 'do', 'not', 'rely', 'on', 'either', 'the', 'recovery', 'of', 'the', 'pathogen', 'or', 'an', 'immune', 'response', 'in', 'the', 'infected', 'patient', 'Alternative', 'nucleic', 'acid', 'amplification', 'methods', 'have', 'emerged', 'recently', 'because', 'of', 'increasing', 'commercial', 'interest', 'in', 'infectious', 'disease', 'diagnostics', 'and', 'the', 'comprehensive', 'patient', 'protection', 'of', 'PCR', 'technology', 'Such', 'techniques', 'are', 'gaining', 'widespread', 'acceptance', 'and', 'have', 'displaced', 'more', 'conventional', 'gold', 'standard', 'testing', 'in', 'some', 'areas', 'of', 'infectious', 'disease', 'e', 'g', 'viral', 'load', 'testing', 'in', 'HIV', '1', 'infected', 'patients', 'diagnosis', 'of', 'Chlamydia', 'trachomatis', 'infection', 'Genetic', 'characterization', 'techniques', 'are', 'increasingly', 'used', 'to', 'determine', 'the', 'relatedness', 'of', 'micro', 'organisms', 'in', 'the', 'clinical', 'setting', 'These', 'methods', 'are', 'useful', 'in', 'establishing', 'routes', 'or', 'sources', 'of', 'infection', 'in', 'outbreaks', 'of', 'disease', 'and', 'are', 'powerful', 'epidemiological', 'tools', 'in', 'large', 'scale', 'clinical', 'investigations', 'Recently', 'there', 'has', 'been', 'a', 'move', 'towards', 'pathogen', 'characterization', 'techniques', 'based', 'on', 'direct', 'nucleotide', 'sequencing', 'e', 'g', 'single', 'nucleotide', 'polymorphism', 'analysis', 'multi', 'locus', 'sequence', 'typing', 'These', 'techniques', 'offer', 'unambiguous', 'portable', 'data', 'that', 'can', 'be', 'exchanged', 'via', 'the', 'Internet', 'strengthening', 'collaborative', 'efforts', 'in', 'the', 'field', 'of', 'infectious', 'disease', 'research', '']"
9607,High prevalence of urogenital infection/inflammation in patients with azoospermia does not impede surgical sperm retrieval,2019-08-27,Andrologia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147116/,"Considering infection/inflammation to be an important risk factor in male infertility, the aim of this study was to make a comprehensive evaluation of the prevalence of urogenital tract infection/inflammation and its potential impact on sperm retrieval in azoospermic patients. In this prospective study, 71 patients with azoospermia were subjected to an extensive andrological workup including comprehensive microbiological diagnostics (2‐glass test, semen, testicular swab and testicular tissue analysis) and testicular biopsy/testicular sperm extraction (TESE). Medical history suggested urogenital tract infection/inflammation in 7% of patients, 11% harboured STIs, 14% showed significant bacteriospermia, 15% had seminal inflammation, 17% fulfilled the MAGI definition, and 27% had relevant pathogens. At the testicular level, 1 patient had a swab positive for bacteria, no viruses were detected, tissue specimens never indicated pathogens, whereas histopathology revealed focal immune cell infiltrates in 23% of samples. Testicular sperm retrieval rate was 100% in obstructive and 46% in nonobstructive azoospermia. None of the infection/inflammation‐related variables was associated with the success of sperm retrieval or inflammatory lesions in the testis. The high prevalence of urogenital infection/inflammation among azoospermic men underpins their role as significant aetiologic factors in male infertility. However, this observation does not refer to the chances of sperm retrieval at the time of surgery/TESE.",10.1111/and.13401,rgwe2pkx,"['Considering', 'infection', 'inflammation', 'to', 'be', 'an', 'important', 'risk', 'factor', 'in', 'male', 'infertility', 'the', 'aim', 'of', 'this', 'study', 'was', 'to', 'make', 'a', 'comprehensive', 'evaluation', 'of', 'the', 'prevalence', 'of', 'urogenital', 'tract', 'infection', 'inflammation', 'and', 'its', 'potential', 'impact', 'on', 'sperm', 'retrieval', 'in', 'azoospermic', 'patients', 'In', 'this', 'prospective', 'study', '71', 'patients', 'with', 'azoospermia', 'were', 'subjected', 'to', 'an', 'extensive', 'andrological', 'workup', 'including', 'comprehensive', 'microbiological', 'diagnostics', '2', 'glass', 'test', 'semen', 'testicular', 'swab', 'and', 'testicular', 'tissue', 'analysis', 'and', 'testicular', 'biopsy', 'testicular', 'sperm', 'extraction', 'TESE', 'Medical', 'history', 'suggested', 'urogenital', 'tract', 'infection', 'inflammation', 'in', '7', 'of', 'patients', '11', 'harboured', 'STIs', '14', 'showed', 'significant', 'bacteriospermia', '15', 'had', 'seminal', 'inflammation', '17', 'fulfilled', 'the', 'MAGI', 'definition', 'and', '27', 'had', 'relevant', 'pathogens', 'At', 'the', 'testicular', 'level', '1', 'patient', 'had', 'a', 'swab', 'positive', 'for', 'bacteria', 'no', 'viruses', 'were', 'detected', 'tissue', 'specimens', 'never', 'indicated', 'pathogens', 'whereas', 'histopathology', 'revealed', 'focal', 'immune', 'cell', 'infiltrates', 'in', '23', 'of', 'samples', 'Testicular', 'sperm', 'retrieval', 'rate', 'was', '100', 'in', 'obstructive', 'and', '46', 'in', 'nonobstructive', 'azoospermia', 'None', 'of', 'the', 'infection', 'inflammation', 'related', 'variables', 'was', 'associated', 'with', 'the', 'success', 'of', 'sperm', 'retrieval', 'or', 'inflammatory', 'lesions', 'in', 'the', 'testis', 'The', 'high', 'prevalence', 'of', 'urogenital', 'infection', 'inflammation', 'among', 'azoospermic', 'men', 'underpins', 'their', 'role', 'as', 'significant', 'aetiologic', 'factors', 'in', 'male', 'infertility', 'However', 'this', 'observation', 'does', 'not', 'refer', 'to', 'the', 'chances', 'of', 'sperm', 'retrieval', 'at', 'the', 'time', 'of', 'surgery', 'TESE', '']"
10596,"Development and validation of a portable, point-of-care canine distemper virus qPCR test",2020-04-22,PLoS One,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176111/,"Canine distemper virus (CDV) is a multi-host pathogen that can cause significant mortality in domestic, wild terrestrial and marine mammals. It is a major conservation threat in some endangered species. Infection can result in severe respiratory disease and fatal encephalitis. Diagnosis and disease monitoring in wildlife, and differentiation of CDV from rabies (a life-threatening zoonotic disease that can produce similar neurologic signs), would benefit from the availability of a portable, point-of-care (POC) diagnostic test. We therefore developed a quantitative RT-PCR assay for CDV using shelf-stable, lyophilized reagents and target-specific primers and probes for use with the handheld Biomeme two3(™) qPCR thermocycler. Biomeme’s extraction methodology, lyophilized reagents, and thermocycler were compared to our standard laboratory-based methods to assess sensitivity, efficiency and overall test performance. Results using a positive control plasmid for CDV showed comparable sensitivity (detection of 50 copies) and PCR efficiency between the two platforms, and CDV detection was similar between platforms when tested using a modified live CDV vaccine. Significantly higher Ct values (average Ct = 5.1 cycles) were observed using the Biomeme platform on known CDV positive animal samples. CDV detection using the Biomeme platform was similar in 25 of 26 samples from suspect CDV cases when compared to standard virology laboratory testing. One false positive was observed that was negative upon retest. The Biomeme methodology can be adapted for detection of specific targets, and this portable technology saves time by eliminating the need for local or international sample transport for laboratory-based diagnostics. However, results of our testing suggest that decreased diagnostic sensitivity (higher Ct values) relative to laboratory-based methods was observed using animal samples, so careful validation and optimization are essential. Portable qPCR platforms can empower biologists and wildlife health professionals in remote and low-resource settings, which will greatly improve our understanding of CDV disease ecology and associated conservation threats in wildlife.",10.1371/journal.pone.0232044,dgmoppg5,"['Canine', 'distemper', 'virus', 'CDV', 'is', 'a', 'multi', 'host', 'pathogen', 'that', 'can', 'cause', 'significant', 'mortality', 'in', 'domestic', 'wild', 'terrestrial', 'and', 'marine', 'mammals', 'It', 'is', 'a', 'major', 'conservation', 'threat', 'in', 'some', 'endangered', 'species', 'Infection', 'can', 'result', 'in', 'severe', 'respiratory', 'disease', 'and', 'fatal', 'encephalitis', 'Diagnosis', 'and', 'disease', 'monitoring', 'in', 'wildlife', 'and', 'differentiation', 'of', 'CDV', 'from', 'rabies', 'a', 'life', 'threatening', 'zoonotic', 'disease', 'that', 'can', 'produce', 'similar', 'neurologic', 'signs', 'would', 'benefit', 'from', 'the', 'availability', 'of', 'a', 'portable', 'point', 'of', 'care', 'POC', 'diagnostic', 'test', 'We', 'therefore', 'developed', 'a', 'quantitative', 'RT', 'PCR', 'assay', 'for', 'CDV', 'using', 'shelf', 'stable', 'lyophilized', 'reagents', 'and', 'target', 'specific', 'primers', 'and', 'probes', 'for', 'use', 'with', 'the', 'handheld', 'Biomeme', 'two3', 'qPCR', 'thermocycler', 'Biomeme', 's', 'extraction', 'methodology', 'lyophilized', 'reagents', 'and', 'thermocycler', 'were', 'compared', 'to', 'our', 'standard', 'laboratory', 'based', 'methods', 'to', 'assess', 'sensitivity', 'efficiency', 'and', 'overall', 'test', 'performance', 'Results', 'using', 'a', 'positive', 'control', 'plasmid', 'for', 'CDV', 'showed', 'comparable', 'sensitivity', 'detection', 'of', '50', 'copies', 'and', 'PCR', 'efficiency', 'between', 'the', 'two', 'platforms', 'and', 'CDV', 'detection', 'was', 'similar', 'between', 'platforms', 'when', 'tested', 'using', 'a', 'modified', 'live', 'CDV', 'vaccine', 'Significantly', 'higher', 'Ct', 'values', 'average', 'Ct', '5', '1', 'cycles', 'were', 'observed', 'using', 'the', 'Biomeme', 'platform', 'on', 'known', 'CDV', 'positive', 'animal', 'samples', 'CDV', 'detection', 'using', 'the', 'Biomeme', 'platform', 'was', 'similar', 'in', '25', 'of', '26', 'samples', 'from', 'suspect', 'CDV', 'cases', 'when', 'compared', 'to', 'standard', 'virology', 'laboratory', 'testing', 'One', 'false', 'positive', 'was', 'observed', 'that', 'was', 'negative', 'upon', 'retest', 'The', 'Biomeme', 'methodology', 'can', 'be', 'adapted', 'for', 'detection', 'of', 'specific', 'targets', 'and', 'this', 'portable', 'technology', 'saves', 'time', 'by', 'eliminating', 'the', 'need', 'for', 'local', 'or', 'international', 'sample', 'transport', 'for', 'laboratory', 'based', 'diagnostics', 'However', 'results', 'of', 'our', 'testing', 'suggest', 'that', 'decreased', 'diagnostic', 'sensitivity', 'higher', 'Ct', 'values', 'relative', 'to', 'laboratory', 'based', 'methods', 'was', 'observed', 'using', 'animal', 'samples', 'so', 'careful', 'validation', 'and', 'optimization', 'are', 'essential', 'Portable', 'qPCR', 'platforms', 'can', 'empower', 'biologists', 'and', 'wildlife', 'health', 'professionals', 'in', 'remote', 'and', 'low', 'resource', 'settings', 'which', 'will', 'greatly', 'improve', 'our', 'understanding', 'of', 'CDV', 'disease', 'ecology', 'and', 'associated', 'conservation', 'threats', 'in', 'wildlife', '']"
10786,Point-of-Care Technologies for Health Care,2011-03-10,IEEE Trans Biomed Eng,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192160/,"The increasingly global focus on health care issues continues to underline the importance of point-of-care technologies and their ability to provide cost-effective solutions that address many unmet health care needs. Further, the current crisis in health care costs has critically underscored the need for research and development into highly effective, but low cost means of delivering health care. With a focus on providing clinically actionable information at or near the patient, point-of-care devices provide clinicians with information that is critical to the management of patient care while they are still with the patient. Rapid information results in various advantages for POC testing in different kinds of health care settings. In primary care settings in developed countries, the shortened timeline between testing and availability of results reduces the need for extra office visits or follow-up phone calls to convey testing results and adjust clinical intervention. This strategy can reduce cost and increase access of otherwise underserved populations to medical care. For diseases that are infectious, such as sexually transmitted infections or respiratory diseases, POC testing can facilitate treatment modalities quickly, thus preventing further spread of the infection for better and timely clinical management. In acute care settings, timely access to diagnostic information is most critical for providing an effective medical response. In disaster settings, POC diagnostics can speed triage and enable rapid establishment and delivery of medical services.",10.1109/tbme.2011.2109251,c5j0cd3u,"['The', 'increasingly', 'global', 'focus', 'on', 'health', 'care', 'issues', 'continues', 'to', 'underline', 'the', 'importance', 'of', 'point', 'of', 'care', 'technologies', 'and', 'their', 'ability', 'to', 'provide', 'cost', 'effective', 'solutions', 'that', 'address', 'many', 'unmet', 'health', 'care', 'needs', 'Further', 'the', 'current', 'crisis', 'in', 'health', 'care', 'costs', 'has', 'critically', 'underscored', 'the', 'need', 'for', 'research', 'and', 'development', 'into', 'highly', 'effective', 'but', 'low', 'cost', 'means', 'of', 'delivering', 'health', 'care', 'With', 'a', 'focus', 'on', 'providing', 'clinically', 'actionable', 'information', 'at', 'or', 'near', 'the', 'patient', 'point', 'of', 'care', 'devices', 'provide', 'clinicians', 'with', 'information', 'that', 'is', 'critical', 'to', 'the', 'management', 'of', 'patient', 'care', 'while', 'they', 'are', 'still', 'with', 'the', 'patient', 'Rapid', 'information', 'results', 'in', 'various', 'advantages', 'for', 'POC', 'testing', 'in', 'different', 'kinds', 'of', 'health', 'care', 'settings', 'In', 'primary', 'care', 'settings', 'in', 'developed', 'countries', 'the', 'shortened', 'timeline', 'between', 'testing', 'and', 'availability', 'of', 'results', 'reduces', 'the', 'need', 'for', 'extra', 'office', 'visits', 'or', 'follow', 'up', 'phone', 'calls', 'to', 'convey', 'testing', 'results', 'and', 'adjust', 'clinical', 'intervention', 'This', 'strategy', 'can', 'reduce', 'cost', 'and', 'increase', 'access', 'of', 'otherwise', 'underserved', 'populations', 'to', 'medical', 'care', 'For', 'diseases', 'that', 'are', 'infectious', 'such', 'as', 'sexually', 'transmitted', 'infections', 'or', 'respiratory', 'diseases', 'POC', 'testing', 'can', 'facilitate', 'treatment', 'modalities', 'quickly', 'thus', 'preventing', 'further', 'spread', 'of', 'the', 'infection', 'for', 'better', 'and', 'timely', 'clinical', 'management', 'In', 'acute', 'care', 'settings', 'timely', 'access', 'to', 'diagnostic', 'information', 'is', 'most', 'critical', 'for', 'providing', 'an', 'effective', 'medical', 'response', 'In', 'disaster', 'settings', 'POC', 'diagnostics', 'can', 'speed', 'triage', 'and', 'enable', 'rapid', 'establishment', 'and', 'delivery', 'of', 'medical', 'services', '']"
11008,Neue intensivmedizinische Herausforderungen durch Klimawandel und globale Erderwärmung,2020-05-12,Anaesthesist,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216862/,"BACKGROUND: In the last five decades a continuous increase in the average global temperature has been recorded. Furthermore, natural disasters (e.g. heat waves, severe storms, floods and large forest fires) are becoming more frequent. The impact of global warming and climate change on health involves an increase in respiratory, cardiovascular, renal and cognitive mental diseases. Furthermore, a change in the frequency and patterns of infectious diseases can also be observed in Europe. MATERIAL AND METHODS: This article presents the most important studies that investigated diseases associated with the climate change, with special reference to those that represent a challenge for intensive care medicine. RESULTS: Currently available epidemiological data and statistical extrapolations indicate that diseases resulting from the climate change (acute infection-related respiratory and intestinal diseases, exacerbation of pre-existing pulmonary lesions, heat-related dehydration, cerebral insults and myocardial infarction) are relevant for intensive care medicine. Particular emphasis is placed on a significant increase in acute kidney damage during heat waves. A previously unknown pattern of infectious diseases necessitates new knowledge and targeted management. In some studies, persisting mental impairments were registered during heat waves and natural disasters, e.g. posttraumatic stress disorder. CONCLUSION: Intensive care medicine must be prepared for the challenges due to global warming and climate change. Slow but continuous changes (e.g. rise in temperature) as well as acute changes (e.g. heat waves and natural disasters) will induce an increased need for intensive medical care services (e.g. an increase in the need for renal replacement procedures). Intensive care physicians will need to be familiar with the diagnostics and management of diseases associated with the climate change. An initiative of the specialist societies involved would be welcomed.",10.1007/s00101-020-00783-w,5qgge2da,"['BACKGROUND', 'In', 'the', 'last', 'five', 'decades', 'a', 'continuous', 'increase', 'in', 'the', 'average', 'global', 'temperature', 'has', 'been', 'recorded', 'Furthermore', 'natural', 'disasters', 'e', 'g', 'heat', 'waves', 'severe', 'storms', 'floods', 'and', 'large', 'forest', 'fires', 'are', 'becoming', 'more', 'frequent', 'The', 'impact', 'of', 'global', 'warming', 'and', 'climate', 'change', 'on', 'health', 'involves', 'an', 'increase', 'in', 'respiratory', 'cardiovascular', 'renal', 'and', 'cognitive', 'mental', 'diseases', 'Furthermore', 'a', 'change', 'in', 'the', 'frequency', 'and', 'patterns', 'of', 'infectious', 'diseases', 'can', 'also', 'be', 'observed', 'in', 'Europe', 'MATERIAL', 'AND', 'METHODS', 'This', 'article', 'presents', 'the', 'most', 'important', 'studies', 'that', 'investigated', 'diseases', 'associated', 'with', 'the', 'climate', 'change', 'with', 'special', 'reference', 'to', 'those', 'that', 'represent', 'a', 'challenge', 'for', 'intensive', 'care', 'medicine', 'RESULTS', 'Currently', 'available', 'epidemiological', 'data', 'and', 'statistical', 'extrapolations', 'indicate', 'that', 'diseases', 'resulting', 'from', 'the', 'climate', 'change', 'acute', 'infection', 'related', 'respiratory', 'and', 'intestinal', 'diseases', 'exacerbation', 'of', 'pre', 'existing', 'pulmonary', 'lesions', 'heat', 'related', 'dehydration', 'cerebral', 'insults', 'and', 'myocardial', 'infarction', 'are', 'relevant', 'for', 'intensive', 'care', 'medicine', 'Particular', 'emphasis', 'is', 'placed', 'on', 'a', 'significant', 'increase', 'in', 'acute', 'kidney', 'damage', 'during', 'heat', 'waves', 'A', 'previously', 'unknown', 'pattern', 'of', 'infectious', 'diseases', 'necessitates', 'new', 'knowledge', 'and', 'targeted', 'management', 'In', 'some', 'studies', 'persisting', 'mental', 'impairments', 'were', 'registered', 'during', 'heat', 'waves', 'and', 'natural', 'disasters', 'e', 'g', 'posttraumatic', 'stress', 'disorder', 'CONCLUSION', 'Intensive', 'care', 'medicine', 'must', 'be', 'prepared', 'for', 'the', 'challenges', 'due', 'to', 'global', 'warming', 'and', 'climate', 'change', 'Slow', 'but', 'continuous', 'changes', 'e', 'g', 'rise', 'in', 'temperature', 'as', 'well', 'as', 'acute', 'changes', 'e', 'g', 'heat', 'waves', 'and', 'natural', 'disasters', 'will', 'induce', 'an', 'increased', 'need', 'for', 'intensive', 'medical', 'care', 'services', 'e', 'g', 'an', 'increase', 'in', 'the', 'need', 'for', 'renal', 'replacement', 'procedures', 'Intensive', 'care', 'physicians', 'will', 'need', 'to', 'be', 'familiar', 'with', 'the', 'diagnostics', 'and', 'management', 'of', 'diseases', 'associated', 'with', 'the', 'climate', 'change', 'An', 'initiative', 'of', 'the', 'specialist', 'societies', 'involved', 'would', 'be', 'welcomed', '']"
11096,Neue Impfstoffe gegen Tuberkulose,2019-11-29,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222064/,"With about 10 million active disease cases and 1.5 million deaths in 2018, tuberculosis (TB) remains one of the most threatening infectious diseases. Yet, the World Health Organization (WHO) aims to reduce morbidity and mortality by 90 and 95%, respectively, between 2015 and 2035. Although diagnostics, therapeutics, and a vaccine are available, it is beyond doubt that better intervention measures are needed to accomplish this ambitious goal. The vaccine bacille Calmette-Guérin (BCG) partially protects infants against TB, but it is virtually ineffective against pulmonary TB in adolescents and adults. The efficacy of this vaccine, however, has not yet been fully exploited. In addition, new vaccine candidates are currently being assessed in clinical trials. Because a quarter of all people are latently infected with Mycobacterium tuberculosis (Mtb), new vaccines must be applied not only prior to infection (pre-exposure vaccination) but also after infection (postexposure vaccination). Prevention of infection, prevention of disease, and prevention of recurrence are currently assessed as clinical endpoints. Because protection against TB is primarily mediated by T lymphocytes, TB vaccine development focuses on protective T cell responses. Protein adjuvant formulations, viral vectors, and killed and live bacterial vaccines are currently being assessed in clinical trials. Moreover, therapeutic vaccination is clinically tested, notably in adjunct to canonical drug therapy to multiresistant TB. It is likely that a single vaccine cannot accomplish the various indications and that different vaccination strategies are required.",10.1007/s00103-019-03065-y,bgehvxo7,"['With', 'about', '10', 'million', 'active', 'disease', 'cases', 'and', '1', '5', 'million', 'deaths', 'in', '2018', 'tuberculosis', 'TB', 'remains', 'one', 'of', 'the', 'most', 'threatening', 'infectious', 'diseases', 'Yet', 'the', 'World', 'Health', 'Organization', 'WHO', 'aims', 'to', 'reduce', 'morbidity', 'and', 'mortality', 'by', '90', 'and', '95', 'respectively', 'between', '2015', 'and', '2035', 'Although', 'diagnostics', 'therapeutics', 'and', 'a', 'vaccine', 'are', 'available', 'it', 'is', 'beyond', 'doubt', 'that', 'better', 'intervention', 'measures', 'are', 'needed', 'to', 'accomplish', 'this', 'ambitious', 'goal', 'The', 'vaccine', 'bacille', 'Calmette', 'Guérin', 'BCG', 'partially', 'protects', 'infants', 'against', 'TB', 'but', 'it', 'is', 'virtually', 'ineffective', 'against', 'pulmonary', 'TB', 'in', 'adolescents', 'and', 'adults', 'The', 'efficacy', 'of', 'this', 'vaccine', 'however', 'has', 'not', 'yet', 'been', 'fully', 'exploited', 'In', 'addition', 'new', 'vaccine', 'candidates', 'are', 'currently', 'being', 'assessed', 'in', 'clinical', 'trials', 'Because', 'a', 'quarter', 'of', 'all', 'people', 'are', 'latently', 'infected', 'with', 'Mycobacterium', 'tuberculosis', 'Mtb', 'new', 'vaccines', 'must', 'be', 'applied', 'not', 'only', 'prior', 'to', 'infection', 'pre', 'exposure', 'vaccination', 'but', 'also', 'after', 'infection', 'postexposure', 'vaccination', 'Prevention', 'of', 'infection', 'prevention', 'of', 'disease', 'and', 'prevention', 'of', 'recurrence', 'are', 'currently', 'assessed', 'as', 'clinical', 'endpoints', 'Because', 'protection', 'against', 'TB', 'is', 'primarily', 'mediated', 'by', 'T', 'lymphocytes', 'TB', 'vaccine', 'development', 'focuses', 'on', 'protective', 'T', 'cell', 'responses', 'Protein', 'adjuvant', 'formulations', 'viral', 'vectors', 'and', 'killed', 'and', 'live', 'bacterial', 'vaccines', 'are', 'currently', 'being', 'assessed', 'in', 'clinical', 'trials', 'Moreover', 'therapeutic', 'vaccination', 'is', 'clinically', 'tested', 'notably', 'in', 'adjunct', 'to', 'canonical', 'drug', 'therapy', 'to', 'multiresistant', 'TB', 'It', 'is', 'likely', 'that', 'a', 'single', 'vaccine', 'cannot', 'accomplish', 'the', 'various', 'indications', 'and', 'that', 'different', 'vaccination', 'strategies', 'are', 'required', '']"
11228,Treatment of Ebola-related critical illness,2020-02-13,Intensive Care Med,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223059/,"PURPOSE: To explore contemporary clincial case management of patients with Ebola virus disease. METHODS: A narrative review from a clinical perspective of clinical features, diagnostic tests, treatments and outcomes of patients with Ebola virus disease. RESULTS: Substantial advances have been made in the care of patients with Ebola virus disease (EVD), precipitated by the unprecedented extent of the 2014–2016 outbreak. There has been improved point-of-care diagnostics, improved characterization of the clinical course of EVD, improved patient-optimized standards of care, evaluation of effective anti-Ebola therapies, administration of effective vaccines, and development of innovative Ebola treatment units. A better understanding of the Ebola virus disease clinical syndrome has led to the appreciation of a central role for critical care clinicians—over 50% of patients have life-threatening complications, including hypotension, severe electrolyte imbalance, acute kidney injury, metabolic acidosis and respiratory failure. Accordingly, patients often require critical care interventions such as monitoring of vital signs, intravenous fluid resuscitation, intravenous vasoactive medications, frequent diagnostic laboratory testing, renal replacement therapy, oxygen and occasionally mechanical ventilation. CONCLUSION: With advanced training and adherence to infection prevention and control practices, clinical interventions, including critical care, are feasible and safe to perform in critically ill patients. With specific anti-Ebola medications, most patients can survive Ebola virus infection.",10.1007/s00134-020-05949-z,fvg4thmr,"['PURPOSE', 'To', 'explore', 'contemporary', 'clincial', 'case', 'management', 'of', 'patients', 'with', 'Ebola', 'virus', 'disease', 'METHODS', 'A', 'narrative', 'review', 'from', 'a', 'clinical', 'perspective', 'of', 'clinical', 'features', 'diagnostic', 'tests', 'treatments', 'and', 'outcomes', 'of', 'patients', 'with', 'Ebola', 'virus', 'disease', 'RESULTS', 'Substantial', 'advances', 'have', 'been', 'made', 'in', 'the', 'care', 'of', 'patients', 'with', 'Ebola', 'virus', 'disease', 'EVD', 'precipitated', 'by', 'the', 'unprecedented', 'extent', 'of', 'the', '2014', '2016', 'outbreak', 'There', 'has', 'been', 'improved', 'point', 'of', 'care', 'diagnostics', 'improved', 'characterization', 'of', 'the', 'clinical', 'course', 'of', 'EVD', 'improved', 'patient', 'optimized', 'standards', 'of', 'care', 'evaluation', 'of', 'effective', 'anti', 'Ebola', 'therapies', 'administration', 'of', 'effective', 'vaccines', 'and', 'development', 'of', 'innovative', 'Ebola', 'treatment', 'units', 'A', 'better', 'understanding', 'of', 'the', 'Ebola', 'virus', 'disease', 'clinical', 'syndrome', 'has', 'led', 'to', 'the', 'appreciation', 'of', 'a', 'central', 'role', 'for', 'critical', 'care', 'clinicians', 'over', '50', 'of', 'patients', 'have', 'life', 'threatening', 'complications', 'including', 'hypotension', 'severe', 'electrolyte', 'imbalance', 'acute', 'kidney', 'injury', 'metabolic', 'acidosis', 'and', 'respiratory', 'failure', 'Accordingly', 'patients', 'often', 'require', 'critical', 'care', 'interventions', 'such', 'as', 'monitoring', 'of', 'vital', 'signs', 'intravenous', 'fluid', 'resuscitation', 'intravenous', 'vasoactive', 'medications', 'frequent', 'diagnostic', 'laboratory', 'testing', 'renal', 'replacement', 'therapy', 'oxygen', 'and', 'occasionally', 'mechanical', 'ventilation', 'CONCLUSION', 'With', 'advanced', 'training', 'and', 'adherence', 'to', 'infection', 'prevention', 'and', 'control', 'practices', 'clinical', 'interventions', 'including', 'critical', 'care', 'are', 'feasible', 'and', 'safe', 'to', 'perform', 'in', 'critically', 'ill', 'patients', 'With', 'specific', 'anti', 'Ebola', 'medications', 'most', 'patients', 'can', 'survive', 'Ebola', 'virus', 'infection', '']"
11814,An immunoassay cassette with a handheld reader for HIV urine testing in point-of-care diagnostics,2020-05-21,Biomed Microdevices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239691/,"Currently, most HIV tests are performed with blood samples, or alternatively saliva samples are used for HIV testing. Simple HIV tests need to be performed in hospitals or other medical agencies instead of more invasive HIV blood tests. To enable point-of-care (POC) HIV diagnostics, based on a recently developed lateral flow strip for HIV urine testing, a microfluidic immunoassay cassette with a handheld optical reader is developed. Based on lateral flow strip with gold colloid reporter, the integrated immunoassay cassette can perform sample introduction, metering, discharging, applying and detection which simplifies HIV testing. An indicator is incorporated into the cassette to guide sample introduction based on color change, and further, the excess test sample is stored inside the sealed cassette to avoid any contamination. The low-cost handheld optical reader can provide a test result within a few seconds, which is useful for simple, sensitive and affordable HIV onsite detection. Instead of using normal white LEDs, a customized back light module embedded with green LEDs is adopted to illuminate the lateral flow strip with an appropriate working current to achieve optimal performance. Compared to the standard lateral flow strips using a benchtop reader, with the disposable immunoassay cassette assisted by the handheld optical reader, more convenient, easier-to-operate, and more affordable HIV urine testing can be achieved in POC diagnostics.",10.1007/s10544-020-00494-4,15wtv6bt,"['Currently', 'most', 'HIV', 'tests', 'are', 'performed', 'with', 'blood', 'samples', 'or', 'alternatively', 'saliva', 'samples', 'are', 'used', 'for', 'HIV', 'testing', 'Simple', 'HIV', 'tests', 'need', 'to', 'be', 'performed', 'in', 'hospitals', 'or', 'other', 'medical', 'agencies', 'instead', 'of', 'more', 'invasive', 'HIV', 'blood', 'tests', 'To', 'enable', 'point', 'of', 'care', 'POC', 'HIV', 'diagnostics', 'based', 'on', 'a', 'recently', 'developed', 'lateral', 'flow', 'strip', 'for', 'HIV', 'urine', 'testing', 'a', 'microfluidic', 'immunoassay', 'cassette', 'with', 'a', 'handheld', 'optical', 'reader', 'is', 'developed', 'Based', 'on', 'lateral', 'flow', 'strip', 'with', 'gold', 'colloid', 'reporter', 'the', 'integrated', 'immunoassay', 'cassette', 'can', 'perform', 'sample', 'introduction', 'metering', 'discharging', 'applying', 'and', 'detection', 'which', 'simplifies', 'HIV', 'testing', 'An', 'indicator', 'is', 'incorporated', 'into', 'the', 'cassette', 'to', 'guide', 'sample', 'introduction', 'based', 'on', 'color', 'change', 'and', 'further', 'the', 'excess', 'test', 'sample', 'is', 'stored', 'inside', 'the', 'sealed', 'cassette', 'to', 'avoid', 'any', 'contamination', 'The', 'low', 'cost', 'handheld', 'optical', 'reader', 'can', 'provide', 'a', 'test', 'result', 'within', 'a', 'few', 'seconds', 'which', 'is', 'useful', 'for', 'simple', 'sensitive', 'and', 'affordable', 'HIV', 'onsite', 'detection', 'Instead', 'of', 'using', 'normal', 'white', 'LEDs', 'a', 'customized', 'back', 'light', 'module', 'embedded', 'with', 'green', 'LEDs', 'is', 'adopted', 'to', 'illuminate', 'the', 'lateral', 'flow', 'strip', 'with', 'an', 'appropriate', 'working', 'current', 'to', 'achieve', 'optimal', 'performance', 'Compared', 'to', 'the', 'standard', 'lateral', 'flow', 'strips', 'using', 'a', 'benchtop', 'reader', 'with', 'the', 'disposable', 'immunoassay', 'cassette', 'assisted', 'by', 'the', 'handheld', 'optical', 'reader', 'more', 'convenient', 'easier', 'to', 'operate', 'and', 'more', 'affordable', 'HIV', 'urine', 'testing', 'can', 'be', 'achieved', 'in', 'POC', 'diagnostics', '']"
12213,Human Parvoviruses May Affect the Development and Clinical Course of Meningitis and Meningoencephalitis,2020-06-03,Brain Sci,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349785/,"Meningitis and meningoencephalitis are neurological inflammatory diseases, and although routine diagnostics include testing of a wide range of pathogens, still in many cases, no causative agent is detected. Human parvovirus B19 (B19V), human bocaviruses 1–4 (HBoV1–4), and human parvovirus 4 (hPARV4) are members of the Parvoviridae family and are associated with a wide range of clinical manifestations including neurological disorders. The main aim of this study was to determine whether human parvoviruses infection markers are present among patients with meningitis/meningoencephalitis in Latvia as well as to clarify the role of these viruses on the clinical course of the mentioned diseases. Our study revealed HBoV1–4 and B19V genomic sequences in 52.38% and 16.67% of patients, respectively. Furthermore, symptoms such as the presence of a headache and its severity, fatigue, disorientation, and difficulties to concentrate were significantly frequently present in patients with active parvovirus infection in comparison with parvoviruses negative patients, therefore we suggest that HBoV1–4 and B19V infection should be included in the diagnostics to reduce the number of meningitis/meningoencephalitis with unknown/unexplained etiology.",10.3390/brainsci10060339,iyex5wcg,"['Meningitis', 'and', 'meningoencephalitis', 'are', 'neurological', 'inflammatory', 'diseases', 'and', 'although', 'routine', 'diagnostics', 'include', 'testing', 'of', 'a', 'wide', 'range', 'of', 'pathogens', 'still', 'in', 'many', 'cases', 'no', 'causative', 'agent', 'is', 'detected', 'Human', 'parvovirus', 'B19', 'B19V', 'human', 'bocaviruses', '1', '4', 'HBoV1', '4', 'and', 'human', 'parvovirus', '4', 'hPARV4', 'are', 'members', 'of', 'the', 'Parvoviridae', 'family', 'and', 'are', 'associated', 'with', 'a', 'wide', 'range', 'of', 'clinical', 'manifestations', 'including', 'neurological', 'disorders', 'The', 'main', 'aim', 'of', 'this', 'study', 'was', 'to', 'determine', 'whether', 'human', 'parvoviruses', 'infection', 'markers', 'are', 'present', 'among', 'patients', 'with', 'meningitis', 'meningoencephalitis', 'in', 'Latvia', 'as', 'well', 'as', 'to', 'clarify', 'the', 'role', 'of', 'these', 'viruses', 'on', 'the', 'clinical', 'course', 'of', 'the', 'mentioned', 'diseases', 'Our', 'study', 'revealed', 'HBoV1', '4', 'and', 'B19V', 'genomic', 'sequences', 'in', '52', '38', 'and', '16', '67', 'of', 'patients', 'respectively', 'Furthermore', 'symptoms', 'such', 'as', 'the', 'presence', 'of', 'a', 'headache', 'and', 'its', 'severity', 'fatigue', 'disorientation', 'and', 'difficulties', 'to', 'concentrate', 'were', 'significantly', 'frequently', 'present', 'in', 'patients', 'with', 'active', 'parvovirus', 'infection', 'in', 'comparison', 'with', 'parvoviruses', 'negative', 'patients', 'therefore', 'we', 'suggest', 'that', 'HBoV1', '4', 'and', 'B19V', 'infection', 'should', 'be', 'included', 'in', 'the', 'diagnostics', 'to', 'reduce', 'the', 'number', 'of', 'meningitis', 'meningoencephalitis', 'with', 'unknown', 'unexplained', 'etiology', '']"
12643,452. Spectrum of Respiratory Pathogens Detected by Multiplex PCR in a Study of Respiratory Tract Infections Among Travelers,2018-11-26,Open Forum Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254379/,"BACKGROUND: Respiratory tract infections (RTI) are a significant cause of health problems, accounting for about 10% of consultations in returning travelers. Nevertheless, the precise microbial etiology is not identified in many cases. METHODS: Prospectively collected 63 respiratory specimens (sputum or throat swab) from patients presented with respiratory symptoms (cough, sputum, chest pain, dyspnea, tachypnea, or abnormal findings of chest auscultation) after travel were tested using multiplex real-time PCR. The FTD Respiratory pathogens 33 (Fast-track diagnostics, Ltd.) can simultaneously detect 33 different respiratory pathogens directly from respiratory specimens. This test ran in the PCR-Only mode on BD MAX™ (Nippon Becton Dickinson Company, Ltd.) and LightCycler480 System (Roche). RESULTS: Fifty-nine consecutive cases were included in the study. Thirty-nine cases were diagnosed as non-specific upper respiratory tract infections, five cases were influenza, bronchitis, pneumonia, threecases was acute sinusitis, and one case was acute pharyngitis, dengue fever. Twenty-four cases had returned from travel in Southeast Asia, nine from Africa, and 8 from Latin America, seven from South Asia, six from middle east, threefrom North America, threefrom East Asia, 2 from Oceania, and one from Europe. Of the 59 specimens analyzed, 48 (81.4%) tested positive for pathogens whereas 11 tested negative. Commonly detected pathogens were Haemophilus influenzae (14 cases; 23.7%), influenza A (10 cases; 17.0%), rhinovirus (9 cases; 15.2%), Staphylococcus aureus (8 cases; 13.6%), Moraxella catarrhalis (8 cases; 13.6%), Streptococcus pneumonia, coronaviruses OC43, and Mycoplasma pneumoniae (4 cases; 6.8%, respectively). Multiple pathogens were detected in 30.5% of the specimens. In 14 cases (23.7%), both virus and bacteria were detected from one specimen. CONCLUSION: Not only viruses, bacterial pathogens were detected frequently than expected in the patients of RTI. Comprehensive molecular testing such as multiplex real-time PCR would change our understandings of epidemiology of RTI among travelers. [Image: see text] DISCLOSURES: All authors: No reported disclosures.",10.1093/ofid/ofy210.461,ijjpaxlo,"['BACKGROUND', 'Respiratory', 'tract', 'infections', 'RTI', 'are', 'a', 'significant', 'cause', 'of', 'health', 'problems', 'accounting', 'for', 'about', '10', 'of', 'consultations', 'in', 'returning', 'travelers', 'Nevertheless', 'the', 'precise', 'microbial', 'etiology', 'is', 'not', 'identified', 'in', 'many', 'cases', 'METHODS', 'Prospectively', 'collected', '63', 'respiratory', 'specimens', 'sputum', 'or', 'throat', 'swab', 'from', 'patients', 'presented', 'with', 'respiratory', 'symptoms', 'cough', 'sputum', 'chest', 'pain', 'dyspnea', 'tachypnea', 'or', 'abnormal', 'findings', 'of', 'chest', 'auscultation', 'after', 'travel', 'were', 'tested', 'using', 'multiplex', 'real', 'time', 'PCR', 'The', 'FTD', 'Respiratory', 'pathogens', '33', 'Fast', 'track', 'diagnostics', 'Ltd', 'can', 'simultaneously', 'detect', '33', 'different', 'respiratory', 'pathogens', 'directly', 'from', 'respiratory', 'specimens', 'This', 'test', 'ran', 'in', 'the', 'PCR', 'Only', 'mode', 'on', 'BD', 'MAX', 'Nippon', 'Becton', 'Dickinson', 'Company', 'Ltd', 'and', 'LightCycler480', 'System', 'Roche', 'RESULTS', 'Fifty', 'nine', 'consecutive', 'cases', 'were', 'included', 'in', 'the', 'study', 'Thirty', 'nine', 'cases', 'were', 'diagnosed', 'as', 'non', 'specific', 'upper', 'respiratory', 'tract', 'infections', 'five', 'cases', 'were', 'influenza', 'bronchitis', 'pneumonia', 'threecases', 'was', 'acute', 'sinusitis', 'and', 'one', 'case', 'was', 'acute', 'pharyngitis', 'dengue', 'fever', 'Twenty', 'four', 'cases', 'had', 'returned', 'from', 'travel', 'in', 'Southeast', 'Asia', 'nine', 'from', 'Africa', 'and', '8', 'from', 'Latin', 'America', 'seven', 'from', 'South', 'Asia', 'six', 'from', 'middle', 'east', 'threefrom', 'North', 'America', 'threefrom', 'East', 'Asia', '2', 'from', 'Oceania', 'and', 'one', 'from', 'Europe', 'Of', 'the', '59', 'specimens', 'analyzed', '48', '81', '4', 'tested', 'positive', 'for', 'pathogens', 'whereas', '11', 'tested', 'negative', 'Commonly', 'detected', 'pathogens', 'were', 'Haemophilus', 'influenzae', '14', 'cases', '23', '7', 'influenza', 'A', '10', 'cases', '17', '0', 'rhinovirus', '9', 'cases', '15', '2', 'Staphylococcus', 'aureus', '8', 'cases', '13', '6', 'Moraxella', 'catarrhalis', '8', 'cases', '13', '6', 'Streptococcus', 'pneumonia', 'coronaviruses', 'OC43', 'and', 'Mycoplasma', 'pneumoniae', '4', 'cases', '6', '8', 'respectively', 'Multiple', 'pathogens', 'were', 'detected', 'in', '30', '5', 'of', 'the', 'specimens', 'In', '14', 'cases', '23', '7', 'both', 'virus', 'and', 'bacteria', 'were', 'detected', 'from', 'one', 'specimen', 'CONCLUSION', 'Not', 'only', 'viruses', 'bacterial', 'pathogens', 'were', 'detected', 'frequently', 'than', 'expected', 'in', 'the', 'patients', 'of', 'RTI', 'Comprehensive', 'molecular', 'testing', 'such', 'as', 'multiplex', 'real', 'time', 'PCR', 'would', 'change', 'our', 'understandings', 'of', 'epidemiology', 'of', 'RTI', 'among', 'travelers', 'Image', 'see', 'text', 'DISCLOSURES', 'All', 'authors', 'No', 'reported', 'disclosures', '']"
12815,Advances in molecular phytodiagnostics – new solutions for old problems,2006-07-13,Eur J Plant Pathol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087944/,"In the last decade, developments in molecular (nucleic acid-based) diagnostic methods have made significant improvements in the detection of plant pathogens. By using methods such as the polymerase chain reaction (PCR), the range of targets that can now be reliably diagnosed has grown to the extent that there are now extremely few, known pathogens that cannot be identified accurately by using laboratory-based diagnostics. However, while the detection of pathogens in individual, infected samples is becoming simpler, there are still many scenarios that present a major challenge to diagnosticians and plant pathologists. Amongst these are the detection of pathogens in soil or viruses in their vectors, high throughput testing and the development of generic methods, that allow samples to be simultaneously screened for large numbers of pathogens. Another major challenge is to develop robust technologies that avoid the reliance on well-equipped central laboratories and making reliable diagnostics available to pathologists in the field or in less-developed countries. In recent years, much of the research carried out on phytodiagnostics has focussed in these areas and as a result many novel, routine diagnostic tests are becoming available. This has been possible due to the introduction of new molecular technologies such real-time PCR and microarrays. These advances have been complemented by the development of new nucleic acid extraction methods, increased automation, reliable internal controls, assay multiplexing and generic amplification methods. With developments in new hardware, field-portable real-time PCR is now also a reality and offers the prospect of ultra-rapid, on-site molecular diagnostics for the first time. In this paper, the development and implementation of new diagnostic methods based upon novel molecular techniques is presented, with specific examples given to demonstrate how these new methods can be used to overcome some long-standing problems.",10.1007/s10658-006-9037-0,mfc3rdov,"['In', 'the', 'last', 'decade', 'developments', 'in', 'molecular', 'nucleic', 'acid', 'based', 'diagnostic', 'methods', 'have', 'made', 'significant', 'improvements', 'in', 'the', 'detection', 'of', 'plant', 'pathogens', 'By', 'using', 'methods', 'such', 'as', 'the', 'polymerase', 'chain', 'reaction', 'PCR', 'the', 'range', 'of', 'targets', 'that', 'can', 'now', 'be', 'reliably', 'diagnosed', 'has', 'grown', 'to', 'the', 'extent', 'that', 'there', 'are', 'now', 'extremely', 'few', 'known', 'pathogens', 'that', 'cannot', 'be', 'identified', 'accurately', 'by', 'using', 'laboratory', 'based', 'diagnostics', 'However', 'while', 'the', 'detection', 'of', 'pathogens', 'in', 'individual', 'infected', 'samples', 'is', 'becoming', 'simpler', 'there', 'are', 'still', 'many', 'scenarios', 'that', 'present', 'a', 'major', 'challenge', 'to', 'diagnosticians', 'and', 'plant', 'pathologists', 'Amongst', 'these', 'are', 'the', 'detection', 'of', 'pathogens', 'in', 'soil', 'or', 'viruses', 'in', 'their', 'vectors', 'high', 'throughput', 'testing', 'and', 'the', 'development', 'of', 'generic', 'methods', 'that', 'allow', 'samples', 'to', 'be', 'simultaneously', 'screened', 'for', 'large', 'numbers', 'of', 'pathogens', 'Another', 'major', 'challenge', 'is', 'to', 'develop', 'robust', 'technologies', 'that', 'avoid', 'the', 'reliance', 'on', 'well', 'equipped', 'central', 'laboratories', 'and', 'making', 'reliable', 'diagnostics', 'available', 'to', 'pathologists', 'in', 'the', 'field', 'or', 'in', 'less', 'developed', 'countries', 'In', 'recent', 'years', 'much', 'of', 'the', 'research', 'carried', 'out', 'on', 'phytodiagnostics', 'has', 'focussed', 'in', 'these', 'areas', 'and', 'as', 'a', 'result', 'many', 'novel', 'routine', 'diagnostic', 'tests', 'are', 'becoming', 'available', 'This', 'has', 'been', 'possible', 'due', 'to', 'the', 'introduction', 'of', 'new', 'molecular', 'technologies', 'such', 'real', 'time', 'PCR', 'and', 'microarrays', 'These', 'advances', 'have', 'been', 'complemented', 'by', 'the', 'development', 'of', 'new', 'nucleic', 'acid', 'extraction', 'methods', 'increased', 'automation', 'reliable', 'internal', 'controls', 'assay', 'multiplexing', 'and', 'generic', 'amplification', 'methods', 'With', 'developments', 'in', 'new', 'hardware', 'field', 'portable', 'real', 'time', 'PCR', 'is', 'now', 'also', 'a', 'reality', 'and', 'offers', 'the', 'prospect', 'of', 'ultra', 'rapid', 'on', 'site', 'molecular', 'diagnostics', 'for', 'the', 'first', 'time', 'In', 'this', 'paper', 'the', 'development', 'and', 'implementation', 'of', 'new', 'diagnostic', 'methods', 'based', 'upon', 'novel', 'molecular', 'techniques', 'is', 'presented', 'with', 'specific', 'examples', 'given', 'to', 'demonstrate', 'how', 'these', 'new', 'methods', 'can', 'be', 'used', 'to', 'overcome', 'some', 'long', 'standing', 'problems', '']"
12830,Pneumonien bei immunsupprimierten Patienten,2018-03-16,Pneumologe (Berl),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088144/,"Pneumonia occurs frequently in immunocompromised patients and often shows a complicated course of disease when compared to immunocompetent persons. The type of pathogen involved is directly associated with the type of immunosuppression and includes a wide variety of pathogens. Congenital and primary immunodeficiencies often appear during childhood. Acquired immunodeficiencies are most commonly caused by immunosuppressive medication. The concept of immunosuppression can be extended to patients with COPD or elderly patients because the variety of pathogens and specific features regarding frequency and course of the disease are similar to immunosuppressed patients. Computed tomography can provide an indication of the pathogen and is superior to the chest x‑ray in this respect. Blood cultures, antigen and PCR tests are non-invasive diagnostic tools for pathogen diagnostics. Invasive tests include fiberoptic bronchoscopy and complete the diagnostic methods of identifying the causative pathogen.",10.1007/s10405-018-0174-x,ye6wuwgd,"['Pneumonia', 'occurs', 'frequently', 'in', 'immunocompromised', 'patients', 'and', 'often', 'shows', 'a', 'complicated', 'course', 'of', 'disease', 'when', 'compared', 'to', 'immunocompetent', 'persons', 'The', 'type', 'of', 'pathogen', 'involved', 'is', 'directly', 'associated', 'with', 'the', 'type', 'of', 'immunosuppression', 'and', 'includes', 'a', 'wide', 'variety', 'of', 'pathogens', 'Congenital', 'and', 'primary', 'immunodeficiencies', 'often', 'appear', 'during', 'childhood', 'Acquired', 'immunodeficiencies', 'are', 'most', 'commonly', 'caused', 'by', 'immunosuppressive', 'medication', 'The', 'concept', 'of', 'immunosuppression', 'can', 'be', 'extended', 'to', 'patients', 'with', 'COPD', 'or', 'elderly', 'patients', 'because', 'the', 'variety', 'of', 'pathogens', 'and', 'specific', 'features', 'regarding', 'frequency', 'and', 'course', 'of', 'the', 'disease', 'are', 'similar', 'to', 'immunosuppressed', 'patients', 'Computed', 'tomography', 'can', 'provide', 'an', 'indication', 'of', 'the', 'pathogen', 'and', 'is', 'superior', 'to', 'the', 'chest', 'x', 'ray', 'in', 'this', 'respect', 'Blood', 'cultures', 'antigen', 'and', 'PCR', 'tests', 'are', 'non', 'invasive', 'diagnostic', 'tools', 'for', 'pathogen', 'diagnostics', 'Invasive', 'tests', 'include', 'fiberoptic', 'bronchoscopy', 'and', 'complete', 'the', 'diagnostic', 'methods', 'of', 'identifying', 'the', 'causative', 'pathogen', '']"
13444,The polymerase chain reaction and pathology practice,2009-07-03,Diagn Histopathol (Oxf),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105915/,"Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management. The polymerase chain reaction (PCR) is foremost amongst these techniques. This review explains the principles of PCR and the methodological factors that contribute to a successful assay. Key PCR technique variations, such as reverse transcription (RT)-PCR and quantitative real-time (q) PCR, are described and an overview is provided of how PCR products are analysed. The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases, for tumour diagnostics and in molecular forensic applications such as specimen identity confirmation.",10.1016/j.mpdhp.2009.04.001,1whpth5g,"['Pathology', 'practice', 'is', 'increasingly', 'augmented', 'with', 'molecular', 'tests', 'for', 'improved', 'diagnostics', 'and', 'patient', 'management', 'The', 'polymerase', 'chain', 'reaction', 'PCR', 'is', 'foremost', 'amongst', 'these', 'techniques', 'This', 'review', 'explains', 'the', 'principles', 'of', 'PCR', 'and', 'the', 'methodological', 'factors', 'that', 'contribute', 'to', 'a', 'successful', 'assay', 'Key', 'PCR', 'technique', 'variations', 'such', 'as', 'reverse', 'transcription', 'RT', 'PCR', 'and', 'quantitative', 'real', 'time', 'q', 'PCR', 'are', 'described', 'and', 'an', 'overview', 'is', 'provided', 'of', 'how', 'PCR', 'products', 'are', 'analysed', 'The', 'review', 'includes', 'examples', 'of', 'PCR', 'usage', 'in', 'clinical', 'practice', 'for', 'the', 'detection', 'of', 'infectious', 'and', 'genetic', 'diseases', 'for', 'tumour', 'diagnostics', 'and', 'in', 'molecular', 'forensic', 'applications', 'such', 'as', 'specimen', 'identity', 'confirmation', '']"
13463,Respiratory Viral Infections in Multiple Myeloma Patients,2017-10-04,Open Forum Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107065/,"BACKGROUND: Multiple myeloma (MM) patients are at increased risk of respiratory viral infections (RVIs) due to disease-related alterations in their immune systems. Data in the literature specific to MM patients is limited. We reviewed four years of multiplex respiratory viral panel (RVP) data in MM patients at our institution to evaluate incidence and seasonality of RVIs. methods. The results from all positive RVPs, obtained via nasopharyngeal swab and as identified by polymerase chain reaction during the years 2013 to 2016, were analyzed. A positive result less than 6 weeks apart was considered a duplicate and removed. All specimens were analyzed in the molecular diagnostics laboratory using the eSensor® Respiratory Viral Panel (GenMark Dx, Carlsbad, CA). This assay is a qualitative nucleic acid multiplex in vitro diagnostic test that provides for the simultaneous detection and identification of 14 respiratory viral nucleic acids. Results. RVIs were reported in every month in all four years. The peak months were January and February, driven by the peak activity of Influenza and respiratory syncytial virus (RSV). Rhinovirus was isolated the most frequently. The least isolated was Adenovirus. A seasonality was observed with Influenza, RSV, human parainfluenza and human metapneumovirus; however, infections with each virus occurred outside of peak months including an outbreak of Influenza in July and August 2013. The total number of viral infections varied each year as did the total number for each virus. The year 2015 had the lowest number of RVIs reported at 427, followed by the year 2016 with the most RVIs reported at 515. However, 2016 was not the peak incidence for each virus; it was the peak incidence for RSV and Rhinovirus. In fact, Influenza had its lowest number of cases in 2016. Conclusion. At our institution, we have shown that RVIs are more common than previously described in MM patients. RVIs occur in every month throughout the year. Although a seasonality is seen with these viral infections, infections do occur outside of the months considered to be peak months for each virus. Infection control policies, therefore, must be enforced year round. More studies, however, are needed to assess the proportion of community vs. healthcare acquired. Two DISCLOSURES: All authors: No reported disclosures.",10.1093/ofid/ofx163.1970,ki3ys6pg,"['BACKGROUND', 'Multiple', 'myeloma', 'MM', 'patients', 'are', 'at', 'increased', 'risk', 'of', 'respiratory', 'viral', 'infections', 'RVIs', 'due', 'to', 'disease', 'related', 'alterations', 'in', 'their', 'immune', 'systems', 'Data', 'in', 'the', 'literature', 'specific', 'to', 'MM', 'patients', 'is', 'limited', 'We', 'reviewed', 'four', 'years', 'of', 'multiplex', 'respiratory', 'viral', 'panel', 'RVP', 'data', 'in', 'MM', 'patients', 'at', 'our', 'institution', 'to', 'evaluate', 'incidence', 'and', 'seasonality', 'of', 'RVIs', 'methods', 'The', 'results', 'from', 'all', 'positive', 'RVPs', 'obtained', 'via', 'nasopharyngeal', 'swab', 'and', 'as', 'identified', 'by', 'polymerase', 'chain', 'reaction', 'during', 'the', 'years', '2013', 'to', '2016', 'were', 'analyzed', 'A', 'positive', 'result', 'less', 'than', '6', 'weeks', 'apart', 'was', 'considered', 'a', 'duplicate', 'and', 'removed', 'All', 'specimens', 'were', 'analyzed', 'in', 'the', 'molecular', 'diagnostics', 'laboratory', 'using', 'the', 'eSensor', 'Respiratory', 'Viral', 'Panel', 'GenMark', 'Dx', 'Carlsbad', 'CA', 'This', 'assay', 'is', 'a', 'qualitative', 'nucleic', 'acid', 'multiplex', 'in', 'vitro', 'diagnostic', 'test', 'that', 'provides', 'for', 'the', 'simultaneous', 'detection', 'and', 'identification', 'of', '14', 'respiratory', 'viral', 'nucleic', 'acids', 'Results', 'RVIs', 'were', 'reported', 'in', 'every', 'month', 'in', 'all', 'four', 'years', 'The', 'peak', 'months', 'were', 'January', 'and', 'February', 'driven', 'by', 'the', 'peak', 'activity', 'of', 'Influenza', 'and', 'respiratory', 'syncytial', 'virus', 'RSV', 'Rhinovirus', 'was', 'isolated', 'the', 'most', 'frequently', 'The', 'least', 'isolated', 'was', 'Adenovirus', 'A', 'seasonality', 'was', 'observed', 'with', 'Influenza', 'RSV', 'human', 'parainfluenza', 'and', 'human', 'metapneumovirus', 'however', 'infections', 'with', 'each', 'virus', 'occurred', 'outside', 'of', 'peak', 'months', 'including', 'an', 'outbreak', 'of', 'Influenza', 'in', 'July', 'and', 'August', '2013', 'The', 'total', 'number', 'of', 'viral', 'infections', 'varied', 'each', 'year', 'as', 'did', 'the', 'total', 'number', 'for', 'each', 'virus', 'The', 'year', '2015', 'had', 'the', 'lowest', 'number', 'of', 'RVIs', 'reported', 'at', '427', 'followed', 'by', 'the', 'year', '2016', 'with', 'the', 'most', 'RVIs', 'reported', 'at', '515', 'However', '2016', 'was', 'not', 'the', 'peak', 'incidence', 'for', 'each', 'virus', 'it', 'was', 'the', 'peak', 'incidence', 'for', 'RSV', 'and', 'Rhinovirus', 'In', 'fact', 'Influenza', 'had', 'its', 'lowest', 'number', 'of', 'cases', 'in', '2016', 'Conclusion', 'At', 'our', 'institution', 'we', 'have', 'shown', 'that', 'RVIs', 'are', 'more', 'common', 'than', 'previously', 'described', 'in', 'MM', 'patients', 'RVIs', 'occur', 'in', 'every', 'month', 'throughout', 'the', 'year', 'Although', 'a', 'seasonality', 'is', 'seen', 'with', 'these', 'viral', 'infections', 'infections', 'do', 'occur', 'outside', 'of', 'the', 'months', 'considered', 'to', 'be', 'peak', 'months', 'for', 'each', 'virus', 'Infection', 'control', 'policies', 'therefore', 'must', 'be', 'enforced', 'year', 'round', 'More', 'studies', 'however', 'are', 'needed', 'to', 'assess', 'the', 'proportion', 'of', 'community', 'vs', 'healthcare', 'acquired', 'Two', 'DISCLOSURES', 'All', 'authors', 'No', 'reported', 'disclosures', '']"
13566,Molecular diagnostic techniques,2009-09-19,Medicine (Abingdon),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108329/,"Clinical microbiology laboratories increasingly rely on molecular diagnostic techniques. The various formats of nucleic acid amplification are the most frequently used molecular tests in the diagnosis of infectious diseases. In many clinical settings, polymerase chain reaction (PCR) is clearly the method of choice due to its exquisite sensitivity and specificity. Today, many conventional PCR methods are being replaced by real-time PCR, which allows more rapid detection and quantification of the PCR product, as well as detection of different strains of the pathogen by melting curve analysis. The ability to measure the quantity of microbe by quantitative PCR has become increasingly important, providing information on the progression and prognosis of disease, and effectiveness of treatment. Other widely used molecular diagnostic techniques are isothermal amplification methods and nucleic acid hybridization techniques. Microarray is a technique which holds promise and has an exceptional sensitivity and the capacity to detect several pathogens simultaneously. However, microarrays are currently too expensive to be adapted for routine diagnostics, and their diagnostic use requires broad-based nucleic acid amplification prior to analysis which is not well established. Several molecular methods can be used for genotyping, which allows the identification of different subtypes of the pathogen; genotyping plays a role in the risk assessment and management of infections. Clinicians need to recognize the enhanced accuracy and speed of the molecular diagnostic techniques for the diagnosis of infections, but also to understand their limitations. Laboratory results should always be interpreted in the context of the clinical presentation of the patient, and appropriate site, quality, and timing of specimen collection are required for reliable test results.",10.1016/j.mpmed.2009.07.012,fff0pd1b,"['Clinical', 'microbiology', 'laboratories', 'increasingly', 'rely', 'on', 'molecular', 'diagnostic', 'techniques', 'The', 'various', 'formats', 'of', 'nucleic', 'acid', 'amplification', 'are', 'the', 'most', 'frequently', 'used', 'molecular', 'tests', 'in', 'the', 'diagnosis', 'of', 'infectious', 'diseases', 'In', 'many', 'clinical', 'settings', 'polymerase', 'chain', 'reaction', 'PCR', 'is', 'clearly', 'the', 'method', 'of', 'choice', 'due', 'to', 'its', 'exquisite', 'sensitivity', 'and', 'specificity', 'Today', 'many', 'conventional', 'PCR', 'methods', 'are', 'being', 'replaced', 'by', 'real', 'time', 'PCR', 'which', 'allows', 'more', 'rapid', 'detection', 'and', 'quantification', 'of', 'the', 'PCR', 'product', 'as', 'well', 'as', 'detection', 'of', 'different', 'strains', 'of', 'the', 'pathogen', 'by', 'melting', 'curve', 'analysis', 'The', 'ability', 'to', 'measure', 'the', 'quantity', 'of', 'microbe', 'by', 'quantitative', 'PCR', 'has', 'become', 'increasingly', 'important', 'providing', 'information', 'on', 'the', 'progression', 'and', 'prognosis', 'of', 'disease', 'and', 'effectiveness', 'of', 'treatment', 'Other', 'widely', 'used', 'molecular', 'diagnostic', 'techniques', 'are', 'isothermal', 'amplification', 'methods', 'and', 'nucleic', 'acid', 'hybridization', 'techniques', 'Microarray', 'is', 'a', 'technique', 'which', 'holds', 'promise', 'and', 'has', 'an', 'exceptional', 'sensitivity', 'and', 'the', 'capacity', 'to', 'detect', 'several', 'pathogens', 'simultaneously', 'However', 'microarrays', 'are', 'currently', 'too', 'expensive', 'to', 'be', 'adapted', 'for', 'routine', 'diagnostics', 'and', 'their', 'diagnostic', 'use', 'requires', 'broad', 'based', 'nucleic', 'acid', 'amplification', 'prior', 'to', 'analysis', 'which', 'is', 'not', 'well', 'established', 'Several', 'molecular', 'methods', 'can', 'be', 'used', 'for', 'genotyping', 'which', 'allows', 'the', 'identification', 'of', 'different', 'subtypes', 'of', 'the', 'pathogen', 'genotyping', 'plays', 'a', 'role', 'in', 'the', 'risk', 'assessment', 'and', 'management', 'of', 'infections', 'Clinicians', 'need', 'to', 'recognize', 'the', 'enhanced', 'accuracy', 'and', 'speed', 'of', 'the', 'molecular', 'diagnostic', 'techniques', 'for', 'the', 'diagnosis', 'of', 'infections', 'but', 'also', 'to', 'understand', 'their', 'limitations', 'Laboratory', 'results', 'should', 'always', 'be', 'interpreted', 'in', 'the', 'context', 'of', 'the', 'clinical', 'presentation', 'of', 'the', 'patient', 'and', 'appropriate', 'site', 'quality', 'and', 'timing', 'of', 'specimen', 'collection', 'are', 'required', 'for', 'reliable', 'test', 'results', '']"
13703,Molecular Diagnostics,2016-10-23,Basic and Applied Aspects of Biotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115026/,"Effective and early management of diseases requires record of the history, behavioral parameters, and travel information. These are helpful for the diagnosis, prevention, and control of the disease. There have been several advancements in the methods for diagnosing infectious diseases. The wide spectrum of tests such as biochemical evaluation, microbiological tools, immunological and molecular biology techniques, etc., is available. Each type of diagnostic technique is strong and reliable in its own sense but poses certain limitations. These limitations may be complemented by using a combination of tests. Older techniques such as microscopy and culturing of organisms from clinical specimens are error-free but are very labor intensive and extremely time consuming. There is a need to develop rapid and sensitive tests that can be used in both high- and low-resource settings. Molecular diagnostics such as Western blot, ELISA, PCR, DNA, and protein microarrays are revolutionizing the clinical practice of infectious diseases. Their effects are significant in acute-care settings where timely and accurate diagnostic tools are critical for patient treatment decisions and outcomes.",10.1007/978-981-10-0875-7_9,a9a82of4,"['Effective', 'and', 'early', 'management', 'of', 'diseases', 'requires', 'record', 'of', 'the', 'history', 'behavioral', 'parameters', 'and', 'travel', 'information', 'These', 'are', 'helpful', 'for', 'the', 'diagnosis', 'prevention', 'and', 'control', 'of', 'the', 'disease', 'There', 'have', 'been', 'several', 'advancements', 'in', 'the', 'methods', 'for', 'diagnosing', 'infectious', 'diseases', 'The', 'wide', 'spectrum', 'of', 'tests', 'such', 'as', 'biochemical', 'evaluation', 'microbiological', 'tools', 'immunological', 'and', 'molecular', 'biology', 'techniques', 'etc', 'is', 'available', 'Each', 'type', 'of', 'diagnostic', 'technique', 'is', 'strong', 'and', 'reliable', 'in', 'its', 'own', 'sense', 'but', 'poses', 'certain', 'limitations', 'These', 'limitations', 'may', 'be', 'complemented', 'by', 'using', 'a', 'combination', 'of', 'tests', 'Older', 'techniques', 'such', 'as', 'microscopy', 'and', 'culturing', 'of', 'organisms', 'from', 'clinical', 'specimens', 'are', 'error', 'free', 'but', 'are', 'very', 'labor', 'intensive', 'and', 'extremely', 'time', 'consuming', 'There', 'is', 'a', 'need', 'to', 'develop', 'rapid', 'and', 'sensitive', 'tests', 'that', 'can', 'be', 'used', 'in', 'both', 'high', 'and', 'low', 'resource', 'settings', 'Molecular', 'diagnostics', 'such', 'as', 'Western', 'blot', 'ELISA', 'PCR', 'DNA', 'and', 'protein', 'microarrays', 'are', 'revolutionizing', 'the', 'clinical', 'practice', 'of', 'infectious', 'diseases', 'Their', 'effects', 'are', 'significant', 'in', 'acute', 'care', 'settings', 'where', 'timely', 'and', 'accurate', 'diagnostic', 'tools', 'are', 'critical', 'for', 'patient', 'treatment', 'decisions', 'and', 'outcomes', '']"
13900,An Introduction to Biotechnology,2016-10-23,Basic and Applied Aspects of Biotechnology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119977/,"Biotechnology is multidisciplinary field which has major impact on our lives. The technology is known since years which involves working with cells or cell-derived molecules for various applications. It has wide range of uses and is termed “technology of hope” which impact human health, well being of other life forms and our environment. It has revolutionized diagnostics and therapeutics; however, the major challenges to the human beings have been threats posed by deadly virus infections as avian flu, Chikungunya, Ebola, Influenza A, SARS, West Nile, and the latest Zika virus. Personalized medicine is increasingly recognized in healthcare system. In this chapter, the readers would understand the applications of biotechnology in human health care system. It has also impacted the environment which is loaded by toxic compounds due to human industrialization and urbanization. Bioremediation process utilizes use of natural or recombinant organisms for the cleanup of environmental toxic pollutants. The development of insect and pest resistant crops and herbicide tolerant crops has greatly reduced the environmental load of toxic insecticides and pesticides. The increase in crop productivity for solving world food and feed problem is addressed in agricultural biotechnology. The technological advancements have focused on development of alternate, renewable, and sustainable energy sources for production of biofuels. Marine biotechnology explores the products which can be obtained from aquatic organisms. As with every research area, the field of biotechnology is associated with many ethical issues and unseen fears. These are important in defining laws governing the feasibility and approval for the conduct of particular research.",10.1007/978-981-10-0875-7_1,qt0keeow,"['Biotechnology', 'is', 'multidisciplinary', 'field', 'which', 'has', 'major', 'impact', 'on', 'our', 'lives', 'The', 'technology', 'is', 'known', 'since', 'years', 'which', 'involves', 'working', 'with', 'cells', 'or', 'cell', 'derived', 'molecules', 'for', 'various', 'applications', 'It', 'has', 'wide', 'range', 'of', 'uses', 'and', 'is', 'termed', 'technology', 'of', 'hope', 'which', 'impact', 'human', 'health', 'well', 'being', 'of', 'other', 'life', 'forms', 'and', 'our', 'environment', 'It', 'has', 'revolutionized', 'diagnostics', 'and', 'therapeutics', 'however', 'the', 'major', 'challenges', 'to', 'the', 'human', 'beings', 'have', 'been', 'threats', 'posed', 'by', 'deadly', 'virus', 'infections', 'as', 'avian', 'flu', 'Chikungunya', 'Ebola', 'Influenza', 'A', 'SARS', 'West', 'Nile', 'and', 'the', 'latest', 'Zika', 'virus', 'Personalized', 'medicine', 'is', 'increasingly', 'recognized', 'in', 'healthcare', 'system', 'In', 'this', 'chapter', 'the', 'readers', 'would', 'understand', 'the', 'applications', 'of', 'biotechnology', 'in', 'human', 'health', 'care', 'system', 'It', 'has', 'also', 'impacted', 'the', 'environment', 'which', 'is', 'loaded', 'by', 'toxic', 'compounds', 'due', 'to', 'human', 'industrialization', 'and', 'urbanization', 'Bioremediation', 'process', 'utilizes', 'use', 'of', 'natural', 'or', 'recombinant', 'organisms', 'for', 'the', 'cleanup', 'of', 'environmental', 'toxic', 'pollutants', 'The', 'development', 'of', 'insect', 'and', 'pest', 'resistant', 'crops', 'and', 'herbicide', 'tolerant', 'crops', 'has', 'greatly', 'reduced', 'the', 'environmental', 'load', 'of', 'toxic', 'insecticides', 'and', 'pesticides', 'The', 'increase', 'in', 'crop', 'productivity', 'for', 'solving', 'world', 'food', 'and', 'feed', 'problem', 'is', 'addressed', 'in', 'agricultural', 'biotechnology', 'The', 'technological', 'advancements', 'have', 'focused', 'on', 'development', 'of', 'alternate', 'renewable', 'and', 'sustainable', 'energy', 'sources', 'for', 'production', 'of', 'biofuels', 'Marine', 'biotechnology', 'explores', 'the', 'products', 'which', 'can', 'be', 'obtained', 'from', 'aquatic', 'organisms', 'As', 'with', 'every', 'research', 'area', 'the', 'field', 'of', 'biotechnology', 'is', 'associated', 'with', 'many', 'ethical', 'issues', 'and', 'unseen', 'fears', 'These', 'are', 'important', 'in', 'defining', 'laws', 'governing', 'the', 'feasibility', 'and', 'approval', 'for', 'the', 'conduct', 'of', 'particular', 'research', '']"
13915,The Many Roads to an Ideal Paper-based Device,2018-12-11,Paper-based Diagnostics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119996/,"The recent Zika and Ebola virus outbreaks highlight the need for low-cost diagnostics that can be rapidly deployed and used outside of established clinical infrastructure. This demand for robust point-of-care (POC) diagnostics is further driven by the increasing burden of drug-resistant diseases, concern for food and water safety, and bioterrorism. As has been discussed in previous chapters, paper-based tests provide a simple and compelling solution to such needs.",10.1007/978-3-319-96870-4_6,9rarl8r7,"['The', 'recent', 'Zika', 'and', 'Ebola', 'virus', 'outbreaks', 'highlight', 'the', 'need', 'for', 'low', 'cost', 'diagnostics', 'that', 'can', 'be', 'rapidly', 'deployed', 'and', 'used', 'outside', 'of', 'established', 'clinical', 'infrastructure', 'This', 'demand', 'for', 'robust', 'point', 'of', 'care', 'POC', 'diagnostics', 'is', 'further', 'driven', 'by', 'the', 'increasing', 'burden', 'of', 'drug', 'resistant', 'diseases', 'concern', 'for', 'food', 'and', 'water', 'safety', 'and', 'bioterrorism', 'As', 'has', 'been', 'discussed', 'in', 'previous', 'chapters', 'paper', 'based', 'tests', 'provide', 'a', 'simple', 'and', 'compelling', 'solution', 'to', 'such', 'needs', '']"
14163,Novel Molecular Diagnostics and Therapeutic Tools for Livestock Diseases,2018-04-26,Advances in Animal Biotechnology and its Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120337/,"Recent novelties in diverse diagnostics and therapeutic tools in animal health sector have paved a brighter and clearer way ahead. These are proved to be better in detection, management, control and eradication of animal sufferings caused by various infectious and non-infectious diseases. These innovations have potential impact that extends beyond the animal health and welfare. The advancements have significantly contributed towards improvement in the economy of the country as well as food security. In the present competitive era of evolution, the organisms have inculcated a number of new strategies for survival and spread. Therefore, science needs to continuously evolve more sensitive, specific and high-throughput tools to overcome pathogen cleverness to escape from host immune surveillance. For visible or remarkable changes, it is necessary to use full potential of these advanced molecular techniques into current animal health standards and practices. Under ‘One Health’ concept, the health of animals and humans has to be taken care simultaneously. At present, these advanced molecular diagnostic methods play a significant role in the detection of new and emerging pathogens of livestock. The acquired information also helps to study the interrelationships of pathogens, their hosts and their surroundings. Additionally new vaccines bridging human and animal health development may be discovered. Latest developments in the field of diagnostics and vaccine design through genomics approach have also laid the foundation to enhance the diagnosis and surveillance and in turn helped in the control of infectious diseases. Latest high-throughput DNA sequencing platforms are currently being used for identification and detailed analysis of both disease pathogen and host genomes. The high-throughput data generated using these platforms need to be analysed adopting the bioinformatics and computational genomics that have taken a very high pace nowadays. In the context of animal health, the data analysis may provide some key opportunities for the development of better diagnostic and therapeutic tools for emerging or re-emerging diseases. Such novel and potent technologies put forward a significantly new scenario of disease knowledge, which enables more accurate predictions leading to faster and greater management responses to combat potentially devastating disease crises.",10.1007/978-981-10-4702-2_14,280kwlev,"['Recent', 'novelties', 'in', 'diverse', 'diagnostics', 'and', 'therapeutic', 'tools', 'in', 'animal', 'health', 'sector', 'have', 'paved', 'a', 'brighter', 'and', 'clearer', 'way', 'ahead', 'These', 'are', 'proved', 'to', 'be', 'better', 'in', 'detection', 'management', 'control', 'and', 'eradication', 'of', 'animal', 'sufferings', 'caused', 'by', 'various', 'infectious', 'and', 'non', 'infectious', 'diseases', 'These', 'innovations', 'have', 'potential', 'impact', 'that', 'extends', 'beyond', 'the', 'animal', 'health', 'and', 'welfare', 'The', 'advancements', 'have', 'significantly', 'contributed', 'towards', 'improvement', 'in', 'the', 'economy', 'of', 'the', 'country', 'as', 'well', 'as', 'food', 'security', 'In', 'the', 'present', 'competitive', 'era', 'of', 'evolution', 'the', 'organisms', 'have', 'inculcated', 'a', 'number', 'of', 'new', 'strategies', 'for', 'survival', 'and', 'spread', 'Therefore', 'science', 'needs', 'to', 'continuously', 'evolve', 'more', 'sensitive', 'specific', 'and', 'high', 'throughput', 'tools', 'to', 'overcome', 'pathogen', 'cleverness', 'to', 'escape', 'from', 'host', 'immune', 'surveillance', 'For', 'visible', 'or', 'remarkable', 'changes', 'it', 'is', 'necessary', 'to', 'use', 'full', 'potential', 'of', 'these', 'advanced', 'molecular', 'techniques', 'into', 'current', 'animal', 'health', 'standards', 'and', 'practices', 'Under', 'One', 'Health', 'concept', 'the', 'health', 'of', 'animals', 'and', 'humans', 'has', 'to', 'be', 'taken', 'care', 'simultaneously', 'At', 'present', 'these', 'advanced', 'molecular', 'diagnostic', 'methods', 'play', 'a', 'significant', 'role', 'in', 'the', 'detection', 'of', 'new', 'and', 'emerging', 'pathogens', 'of', 'livestock', 'The', 'acquired', 'information', 'also', 'helps', 'to', 'study', 'the', 'interrelationships', 'of', 'pathogens', 'their', 'hosts', 'and', 'their', 'surroundings', 'Additionally', 'new', 'vaccines', 'bridging', 'human', 'and', 'animal', 'health', 'development', 'may', 'be', 'discovered', 'Latest', 'developments', 'in', 'the', 'field', 'of', 'diagnostics', 'and', 'vaccine', 'design', 'through', 'genomics', 'approach', 'have', 'also', 'laid', 'the', 'foundation', 'to', 'enhance', 'the', 'diagnosis', 'and', 'surveillance', 'and', 'in', 'turn', 'helped', 'in', 'the', 'control', 'of', 'infectious', 'diseases', 'Latest', 'high', 'throughput', 'DNA', 'sequencing', 'platforms', 'are', 'currently', 'being', 'used', 'for', 'identification', 'and', 'detailed', 'analysis', 'of', 'both', 'disease', 'pathogen', 'and', 'host', 'genomes', 'The', 'high', 'throughput', 'data', 'generated', 'using', 'these', 'platforms', 'need', 'to', 'be', 'analysed', 'adopting', 'the', 'bioinformatics', 'and', 'computational', 'genomics', 'that', 'have', 'taken', 'a', 'very', 'high', 'pace', 'nowadays', 'In', 'the', 'context', 'of', 'animal', 'health', 'the', 'data', 'analysis', 'may', 'provide', 'some', 'key', 'opportunities', 'for', 'the', 'development', 'of', 'better', 'diagnostic', 'and', 'therapeutic', 'tools', 'for', 'emerging', 'or', 're', 'emerging', 'diseases', 'Such', 'novel', 'and', 'potent', 'technologies', 'put', 'forward', 'a', 'significantly', 'new', 'scenario', 'of', 'disease', 'knowledge', 'which', 'enables', 'more', 'accurate', 'predictions', 'leading', 'to', 'faster', 'and', 'greater', 'management', 'responses', 'to', 'combat', 'potentially', 'devastating', 'disease', 'crises', '']"
14323,Microarrays as Research Tools and Diagnostic Devices,2015-03-11,RNA and DNA Diagnostics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120549/,"Molecular diagnostics comprises a main analytical division in clinical laboratory diagnostics. The analysis of RNA or DNA helps to diagnose infectious diseases and identify genetic determined disorders or even cancer. Starting from mono-parametric tests within the last years, technologies have evolved that allow for the detection of many parameters in parallel, e.g., by using multiplex nucleic acid amplification techniques, microarrays, or next-generation sequencing technologies. The introduction of closed-tube systems as well as lab-on-a-chip devices further resulted in a higher automation degree with a reduced contamination risk. These applications complement or even stepwise replace classical methods in clinical microbiology like virus cultures, resistance determination, microscopic and metabolic analyses, as well as biochemical or immunohistochemical assays. In addition, novel diagnostic markers appear, like noncoding RNAs and miRNAs providing additional room for novel biomarkers. This article provides an overview of microarrays as diagnostics devices and research tools. Introduced in 1995 for transcription analysis, microarrays are used today to detect several different biomolecules like DNA, RNA, miRNA, and proteins among others. Mainly used in research, some microarrays also found their way to clinical diagnostics. Further, closed lab-on-a-chip devices that use DNA microarrays as detection tools are discussed, and additionally, an outlook toward applications of next-generation sequencing tools in diagnostics will be given.",10.1007/978-3-319-17305-4_13,uusmg786,"['Molecular', 'diagnostics', 'comprises', 'a', 'main', 'analytical', 'division', 'in', 'clinical', 'laboratory', 'diagnostics', 'The', 'analysis', 'of', 'RNA', 'or', 'DNA', 'helps', 'to', 'diagnose', 'infectious', 'diseases', 'and', 'identify', 'genetic', 'determined', 'disorders', 'or', 'even', 'cancer', 'Starting', 'from', 'mono', 'parametric', 'tests', 'within', 'the', 'last', 'years', 'technologies', 'have', 'evolved', 'that', 'allow', 'for', 'the', 'detection', 'of', 'many', 'parameters', 'in', 'parallel', 'e', 'g', 'by', 'using', 'multiplex', 'nucleic', 'acid', 'amplification', 'techniques', 'microarrays', 'or', 'next', 'generation', 'sequencing', 'technologies', 'The', 'introduction', 'of', 'closed', 'tube', 'systems', 'as', 'well', 'as', 'lab', 'on', 'a', 'chip', 'devices', 'further', 'resulted', 'in', 'a', 'higher', 'automation', 'degree', 'with', 'a', 'reduced', 'contamination', 'risk', 'These', 'applications', 'complement', 'or', 'even', 'stepwise', 'replace', 'classical', 'methods', 'in', 'clinical', 'microbiology', 'like', 'virus', 'cultures', 'resistance', 'determination', 'microscopic', 'and', 'metabolic', 'analyses', 'as', 'well', 'as', 'biochemical', 'or', 'immunohistochemical', 'assays', 'In', 'addition', 'novel', 'diagnostic', 'markers', 'appear', 'like', 'noncoding', 'RNAs', 'and', 'miRNAs', 'providing', 'additional', 'room', 'for', 'novel', 'biomarkers', 'This', 'article', 'provides', 'an', 'overview', 'of', 'microarrays', 'as', 'diagnostics', 'devices', 'and', 'research', 'tools', 'Introduced', 'in', '1995', 'for', 'transcription', 'analysis', 'microarrays', 'are', 'used', 'today', 'to', 'detect', 'several', 'different', 'biomolecules', 'like', 'DNA', 'RNA', 'miRNA', 'and', 'proteins', 'among', 'others', 'Mainly', 'used', 'in', 'research', 'some', 'microarrays', 'also', 'found', 'their', 'way', 'to', 'clinical', 'diagnostics', 'Further', 'closed', 'lab', 'on', 'a', 'chip', 'devices', 'that', 'use', 'DNA', 'microarrays', 'as', 'detection', 'tools', 'are', 'discussed', 'and', 'additionally', 'an', 'outlook', 'toward', 'applications', 'of', 'next', 'generation', 'sequencing', 'tools', 'in', 'diagnostics', 'will', 'be', 'given', '']"
14440,Pathogen Detection in the Genomic Era,2006,Advanced Techniques in Diagnostic Microbiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120690/,"In the 21st century, one of the greatest challenges to public health and clinical microbiologists is the rapid detection and identification of emerging and reemerging pathogens. Complex factors such as genetic variation in the host and pathogen, environmental changes, population pressures, and global travel can all influence the emergence of infectious diseases. The SARS epidemic of 2003 highlighted the potential of an emerging pathogen to spread globally in a very short time frame (Peruski and Peruski, 2003). The diagnostics of such infectious diseases has been greatly affected in the past 20 years. No longer is cultivation and microscopy the only means of detecting infectious agents. With the introduction of molecular diagnostics, the ability to detect minute amounts of microbial nucleic acids in clinical specimens has revolutionized clinical microbiology. In particular, the utility of PCR allows the detection and quantitation of specific agents in a matter of hours. PCR sequencing of specific segments of nucleic acid allows for the determination of specific drug resistance that now aids in guiding viral therapies.",10.1007/0-387-32892-0_28,bs77jap1,"['In', 'the', '21st', 'century', 'one', 'of', 'the', 'greatest', 'challenges', 'to', 'public', 'health', 'and', 'clinical', 'microbiologists', 'is', 'the', 'rapid', 'detection', 'and', 'identification', 'of', 'emerging', 'and', 'reemerging', 'pathogens', 'Complex', 'factors', 'such', 'as', 'genetic', 'variation', 'in', 'the', 'host', 'and', 'pathogen', 'environmental', 'changes', 'population', 'pressures', 'and', 'global', 'travel', 'can', 'all', 'influence', 'the', 'emergence', 'of', 'infectious', 'diseases', 'The', 'SARS', 'epidemic', 'of', '2003', 'highlighted', 'the', 'potential', 'of', 'an', 'emerging', 'pathogen', 'to', 'spread', 'globally', 'in', 'a', 'very', 'short', 'time', 'frame', 'Peruski', 'and', 'Peruski', '2003', 'The', 'diagnostics', 'of', 'such', 'infectious', 'diseases', 'has', 'been', 'greatly', 'affected', 'in', 'the', 'past', '20', 'years', 'No', 'longer', 'is', 'cultivation', 'and', 'microscopy', 'the', 'only', 'means', 'of', 'detecting', 'infectious', 'agents', 'With', 'the', 'introduction', 'of', 'molecular', 'diagnostics', 'the', 'ability', 'to', 'detect', 'minute', 'amounts', 'of', 'microbial', 'nucleic', 'acids', 'in', 'clinical', 'specimens', 'has', 'revolutionized', 'clinical', 'microbiology', 'In', 'particular', 'the', 'utility', 'of', 'PCR', 'allows', 'the', 'detection', 'and', 'quantitation', 'of', 'specific', 'agents', 'in', 'a', 'matter', 'of', 'hours', 'PCR', 'sequencing', 'of', 'specific', 'segments', 'of', 'nucleic', 'acid', 'allows', 'for', 'the', 'determination', 'of', 'specific', 'drug', 'resistance', 'that', 'now', 'aids', 'in', 'guiding', 'viral', 'therapies', '']"
14541,Diagnosis of Viral Infections,2017-05-05,"Viral Infections in Children, Volume I",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120824/,"Accurate diagnosis of viral infections enhances the ability of the clinician to make decisions on appropriate treatment of patients, evaluate disease progression and prevent misuse of antibiotics. Knowledge of the pathogen involved also allow implementation of infection control and monitoring of success of antiviral treatments that may affect the prognosis of patients. Epidemiological data collected through accurate diagnostics play an important role in public health through identification and control of outbreaks, implementation of appropriate diagnostic tests, vaccination programs and treatment but also to recognize common and emerging pathogens in a community. It is key that the clinician have an understanding of appropriate specimens to send to the laboratory and the value of specific nucleic acid and serological testing for different viral pathogens. Molecular techniques have revolutionized viral diagnoses over the past decade and enhanced both the sensitivity and specificity of tests and the speed by which a diagnosis can be made and new tests be developed. The continued use of serology for viruses with a short viremia, or for chronic infections should however complement these tests. This chapter aims to provide an overview of the available tests, the principles of testing and appropriate tests to select for different viruses and syndromes. Also provided is a glimpse of new developments in diagnostics that may further enhance the capacity to make a conclusive diagnosis in the near future.",10.1007/978-3-319-54033-7_6,z31g3mr5,"['Accurate', 'diagnosis', 'of', 'viral', 'infections', 'enhances', 'the', 'ability', 'of', 'the', 'clinician', 'to', 'make', 'decisions', 'on', 'appropriate', 'treatment', 'of', 'patients', 'evaluate', 'disease', 'progression', 'and', 'prevent', 'misuse', 'of', 'antibiotics', 'Knowledge', 'of', 'the', 'pathogen', 'involved', 'also', 'allow', 'implementation', 'of', 'infection', 'control', 'and', 'monitoring', 'of', 'success', 'of', 'antiviral', 'treatments', 'that', 'may', 'affect', 'the', 'prognosis', 'of', 'patients', 'Epidemiological', 'data', 'collected', 'through', 'accurate', 'diagnostics', 'play', 'an', 'important', 'role', 'in', 'public', 'health', 'through', 'identification', 'and', 'control', 'of', 'outbreaks', 'implementation', 'of', 'appropriate', 'diagnostic', 'tests', 'vaccination', 'programs', 'and', 'treatment', 'but', 'also', 'to', 'recognize', 'common', 'and', 'emerging', 'pathogens', 'in', 'a', 'community', 'It', 'is', 'key', 'that', 'the', 'clinician', 'have', 'an', 'understanding', 'of', 'appropriate', 'specimens', 'to', 'send', 'to', 'the', 'laboratory', 'and', 'the', 'value', 'of', 'specific', 'nucleic', 'acid', 'and', 'serological', 'testing', 'for', 'different', 'viral', 'pathogens', 'Molecular', 'techniques', 'have', 'revolutionized', 'viral', 'diagnoses', 'over', 'the', 'past', 'decade', 'and', 'enhanced', 'both', 'the', 'sensitivity', 'and', 'specificity', 'of', 'tests', 'and', 'the', 'speed', 'by', 'which', 'a', 'diagnosis', 'can', 'be', 'made', 'and', 'new', 'tests', 'be', 'developed', 'The', 'continued', 'use', 'of', 'serology', 'for', 'viruses', 'with', 'a', 'short', 'viremia', 'or', 'for', 'chronic', 'infections', 'should', 'however', 'complement', 'these', 'tests', 'This', 'chapter', 'aims', 'to', 'provide', 'an', 'overview', 'of', 'the', 'available', 'tests', 'the', 'principles', 'of', 'testing', 'and', 'appropriate', 'tests', 'to', 'select', 'for', 'different', 'viruses', 'and', 'syndromes', 'Also', 'provided', 'is', 'a', 'glimpse', 'of', 'new', 'developments', 'in', 'diagnostics', 'that', 'may', 'further', 'enhance', 'the', 'capacity', 'to', 'make', 'a', 'conclusive', 'diagnosis', 'in', 'the', 'near', 'future', '']"
14731,Nanomolecular Diagnostics,2017-03-21,The Handbook of Nanomedicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121078/,"Clinical application of molecular technologies to elucidate, diagnose and monitor human diseases is referred to as molecular diagnosis. It is a broader term than DNA (deoxyribonucleic acid) diagnostics and refers to the use of technologies that use DNA, RNA (ribonucleic acid), genes or proteins as bases for diagnostic tests. The scope of the subject is much wider and includes in vivo imaging and diagnosis at single molecule level. A more detailed description of molecular diagnostics is presented elsewhere (Jain 2017a).",10.1007/978-1-4939-6966-1_4,xiep0udu,"['Clinical', 'application', 'of', 'molecular', 'technologies', 'to', 'elucidate', 'diagnose', 'and', 'monitor', 'human', 'diseases', 'is', 'referred', 'to', 'as', 'molecular', 'diagnosis', 'It', 'is', 'a', 'broader', 'term', 'than', 'DNA', 'deoxyribonucleic', 'acid', 'diagnostics', 'and', 'refers', 'to', 'the', 'use', 'of', 'technologies', 'that', 'use', 'DNA', 'RNA', 'ribonucleic', 'acid', 'genes', 'or', 'proteins', 'as', 'bases', 'for', 'diagnostic', 'tests', 'The', 'scope', 'of', 'the', 'subject', 'is', 'much', 'wider', 'and', 'includes', 'in', 'vivo', 'imaging', 'and', 'diagnosis', 'at', 'single', 'molecule', 'level', 'A', 'more', 'detailed', 'description', 'of', 'molecular', 'diagnostics', 'is', 'presented', 'elsewhere', 'Jain', '2017a', '']"
14757,Virology,2017-07-20,Molecular Diagnostics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121112/,"Molecular techniques have become indispensable in viral diagnostics. Current applications include: (1) The detection of (unknown) viral infections in clinical samples. (2) Quantitative monitoring of viral load. (3) Genotyping of viral strains. (4) Detection of mutations in the viral genome that are associated with viral resistance. Proper sample acquisition and sample transport, as well as accurate DNA or RNA isolation are a prerequisite for reliable test results in molecular diagnostics of viral infections. In-house as well as commercial assays can be used for the amplification of viral DNA or RNA for the detection of viral infections and viral load monitoring. Many virus species consist of several subspecies, genotypes or variants. This molecular variation has to be taken into account when applying molecular diagnostics. More complicated diagnostics for genotyping or the detection of mutations related to therapy failure often rely on sequencing, although for some viral targets commercial assays are available. In this chapter, applications are described in which molecular methods have become the most important form of viral diagnostics. Molecular test results have a direct impact on patient management and as such, results have to be reliable, standardized and reproducible. Therefore, quality control and standardization are important issues!",10.1007/978-981-10-4511-0_3,iajblrff,"['Molecular', 'techniques', 'have', 'become', 'indispensable', 'in', 'viral', 'diagnostics', 'Current', 'applications', 'include', '1', 'The', 'detection', 'of', 'unknown', 'viral', 'infections', 'in', 'clinical', 'samples', '2', 'Quantitative', 'monitoring', 'of', 'viral', 'load', '3', 'Genotyping', 'of', 'viral', 'strains', '4', 'Detection', 'of', 'mutations', 'in', 'the', 'viral', 'genome', 'that', 'are', 'associated', 'with', 'viral', 'resistance', 'Proper', 'sample', 'acquisition', 'and', 'sample', 'transport', 'as', 'well', 'as', 'accurate', 'DNA', 'or', 'RNA', 'isolation', 'are', 'a', 'prerequisite', 'for', 'reliable', 'test', 'results', 'in', 'molecular', 'diagnostics', 'of', 'viral', 'infections', 'In', 'house', 'as', 'well', 'as', 'commercial', 'assays', 'can', 'be', 'used', 'for', 'the', 'amplification', 'of', 'viral', 'DNA', 'or', 'RNA', 'for', 'the', 'detection', 'of', 'viral', 'infections', 'and', 'viral', 'load', 'monitoring', 'Many', 'virus', 'species', 'consist', 'of', 'several', 'subspecies', 'genotypes', 'or', 'variants', 'This', 'molecular', 'variation', 'has', 'to', 'be', 'taken', 'into', 'account', 'when', 'applying', 'molecular', 'diagnostics', 'More', 'complicated', 'diagnostics', 'for', 'genotyping', 'or', 'the', 'detection', 'of', 'mutations', 'related', 'to', 'therapy', 'failure', 'often', 'rely', 'on', 'sequencing', 'although', 'for', 'some', 'viral', 'targets', 'commercial', 'assays', 'are', 'available', 'In', 'this', 'chapter', 'applications', 'are', 'described', 'in', 'which', 'molecular', 'methods', 'have', 'become', 'the', 'most', 'important', 'form', 'of', 'viral', 'diagnostics', 'Molecular', 'test', 'results', 'have', 'a', 'direct', 'impact', 'on', 'patient', 'management', 'and', 'as', 'such', 'results', 'have', 'to', 'be', 'reliable', 'standardized', 'and', 'reproducible', 'Therefore', 'quality', 'control', 'and', 'standardization', 'are', 'important', 'issues', '']"
15390,Healthcare-Associated Viral Infections: Considerations for Nosocomial Transmission and Infection Control,2018-07-16,Healthcare-Associated Infections in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121921/,"Nosocomial and healthcare-associated viral infections are major contributors to patient morbidity and mortality, prolonged hospitalization, and increased healthcare costs in all pediatric age groups. Healthcare workers are also at risk of acquiring nosocomial viral infections, affecting their own health, as well as facilitating spread of the infection to other patients, their family, and the community. Healthcare-associated viral infections may occur in a variety of healthcare settings, including clinics, emergency centers, urgent care centers, procedure suites, operating rooms, hospital wards, nurseries, and intensive care units. In addition, non-patient care areas, such as the cafeteria, waiting areas, and playrooms may also be a source of viral infections that can spread in the healthcare setting. These infections may be device-related or transmitted via blood products or organ donation and respiratory droplets, through food including human milk, person to person, or via air ducts, fomites, and surfaces. They most commonly involve the respiratory and gastrointestinal tracts; however, all organ systems may potentially be involved. Both DNA and RNA viruses, either common or exotic, may contribute to healthcare-associated viral infections. Advances in molecular viral diagnostics have enabled rapid detection and routine surveillance for viral infections and now allow early identification of viruses. Prompt identification allows timely containment measures to minimize transmission to other patients or healthcare workers and avoids hospital, community, and global outbreaks.",10.1007/978-3-319-98122-2_14,pni1lwhd,"['Nosocomial', 'and', 'healthcare', 'associated', 'viral', 'infections', 'are', 'major', 'contributors', 'to', 'patient', 'morbidity', 'and', 'mortality', 'prolonged', 'hospitalization', 'and', 'increased', 'healthcare', 'costs', 'in', 'all', 'pediatric', 'age', 'groups', 'Healthcare', 'workers', 'are', 'also', 'at', 'risk', 'of', 'acquiring', 'nosocomial', 'viral', 'infections', 'affecting', 'their', 'own', 'health', 'as', 'well', 'as', 'facilitating', 'spread', 'of', 'the', 'infection', 'to', 'other', 'patients', 'their', 'family', 'and', 'the', 'community', 'Healthcare', 'associated', 'viral', 'infections', 'may', 'occur', 'in', 'a', 'variety', 'of', 'healthcare', 'settings', 'including', 'clinics', 'emergency', 'centers', 'urgent', 'care', 'centers', 'procedure', 'suites', 'operating', 'rooms', 'hospital', 'wards', 'nurseries', 'and', 'intensive', 'care', 'units', 'In', 'addition', 'non', 'patient', 'care', 'areas', 'such', 'as', 'the', 'cafeteria', 'waiting', 'areas', 'and', 'playrooms', 'may', 'also', 'be', 'a', 'source', 'of', 'viral', 'infections', 'that', 'can', 'spread', 'in', 'the', 'healthcare', 'setting', 'These', 'infections', 'may', 'be', 'device', 'related', 'or', 'transmitted', 'via', 'blood', 'products', 'or', 'organ', 'donation', 'and', 'respiratory', 'droplets', 'through', 'food', 'including', 'human', 'milk', 'person', 'to', 'person', 'or', 'via', 'air', 'ducts', 'fomites', 'and', 'surfaces', 'They', 'most', 'commonly', 'involve', 'the', 'respiratory', 'and', 'gastrointestinal', 'tracts', 'however', 'all', 'organ', 'systems', 'may', 'potentially', 'be', 'involved', 'Both', 'DNA', 'and', 'RNA', 'viruses', 'either', 'common', 'or', 'exotic', 'may', 'contribute', 'to', 'healthcare', 'associated', 'viral', 'infections', 'Advances', 'in', 'molecular', 'viral', 'diagnostics', 'have', 'enabled', 'rapid', 'detection', 'and', 'routine', 'surveillance', 'for', 'viral', 'infections', 'and', 'now', 'allow', 'early', 'identification', 'of', 'viruses', 'Prompt', 'identification', 'allows', 'timely', 'containment', 'measures', 'to', 'minimize', 'transmission', 'to', 'other', 'patients', 'or', 'healthcare', 'workers', 'and', 'avoids', 'hospital', 'community', 'and', 'global', 'outbreaks', '']"
15427,Point-of-Care Diagnostics,2014-12-04,Holographic Sensors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121962/,"Rapid tests that are low-cost and portable are the first line of defence in healthcare systems. Dipstick and lateral-flow are the two universal assay formats as they are lightweight and compact, and provide qualitative results without external instrumentation. However, existing formats have limitations in the quantification of analyte concentrations. Hence, the demand for sample preparation, improved sensitivity and user-interface has challenged the commercial products. Recently, capabilities, sensors and readout devices were expanded to multiplexable assays platforms, which might transcend the capabilities of existing design format of diagnostic tests. This chapter outlines the evolution of diagnostic devices and current trends in the development of qualitative and quantitative sensing devices for applications in healthcare, veterinary medicine, environmental monitoring and food safety. The chapter also discusses design parameters for diagnostics, their functionalisation to increase the capabilities and the performance, emerging sensing platforms and readout technologies. The factors which limit the emerging rapid diagnostics to become commercial products are also discussed.",10.1007/978-3-319-13584-7_1,4lavnvgo,"['Rapid', 'tests', 'that', 'are', 'low', 'cost', 'and', 'portable', 'are', 'the', 'first', 'line', 'of', 'defence', 'in', 'healthcare', 'systems', 'Dipstick', 'and', 'lateral', 'flow', 'are', 'the', 'two', 'universal', 'assay', 'formats', 'as', 'they', 'are', 'lightweight', 'and', 'compact', 'and', 'provide', 'qualitative', 'results', 'without', 'external', 'instrumentation', 'However', 'existing', 'formats', 'have', 'limitations', 'in', 'the', 'quantification', 'of', 'analyte', 'concentrations', 'Hence', 'the', 'demand', 'for', 'sample', 'preparation', 'improved', 'sensitivity', 'and', 'user', 'interface', 'has', 'challenged', 'the', 'commercial', 'products', 'Recently', 'capabilities', 'sensors', 'and', 'readout', 'devices', 'were', 'expanded', 'to', 'multiplexable', 'assays', 'platforms', 'which', 'might', 'transcend', 'the', 'capabilities', 'of', 'existing', 'design', 'format', 'of', 'diagnostic', 'tests', 'This', 'chapter', 'outlines', 'the', 'evolution', 'of', 'diagnostic', 'devices', 'and', 'current', 'trends', 'in', 'the', 'development', 'of', 'qualitative', 'and', 'quantitative', 'sensing', 'devices', 'for', 'applications', 'in', 'healthcare', 'veterinary', 'medicine', 'environmental', 'monitoring', 'and', 'food', 'safety', 'The', 'chapter', 'also', 'discusses', 'design', 'parameters', 'for', 'diagnostics', 'their', 'functionalisation', 'to', 'increase', 'the', 'capabilities', 'and', 'the', 'performance', 'emerging', 'sensing', 'platforms', 'and', 'readout', 'technologies', 'The', 'factors', 'which', 'limit', 'the', 'emerging', 'rapid', 'diagnostics', 'to', 'become', 'commercial', 'products', 'are', 'also', 'discussed', '']"
15733,Diagnosis of Tuberculosis: Nanodiagnostics Approaches,2019-09-25,NanoBioMedicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122355/,"Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide. The burden of TB is alarmingly high in developing countries, where diagnosis latent TB infection (LTBI), Extra-pulmonary tuberculosis (EPTB), drug-resistant tuberculosis (DR-TB), HIV-associated TB, and paediatric TB is still a challenge. This is mainly due to delayed or misdiagnosis of TB, which continues to fuel its worldwide epidemic. The ideal diagnostic test is still unavailable, and conventional methods remain a necessity for TB diagnosis, though with poor diagnostic ability. The nanoparticles have shown potential for the improvement of drug delivery, reducing treatment frequency and diagnosis of various diseases. The engineering of antigens/antibody nanocarriers represents an exciting front in the field of diagnostics, potentially flagging the way toward development of better diagnostics for TB. This chapter discusses the presently available tests for TB diagnostics and also highlights the recent advancement in the nanotechnology-based detection tests for M. tuberculosis.",10.1007/978-981-32-9898-9_11,suavsu0x,"['Tuberculosis', 'TB', 'remains', 'one', 'of', 'the', 'most', 'devastating', 'infectious', 'diseases', 'worldwide', 'The', 'burden', 'of', 'TB', 'is', 'alarmingly', 'high', 'in', 'developing', 'countries', 'where', 'diagnosis', 'latent', 'TB', 'infection', 'LTBI', 'Extra', 'pulmonary', 'tuberculosis', 'EPTB', 'drug', 'resistant', 'tuberculosis', 'DR', 'TB', 'HIV', 'associated', 'TB', 'and', 'paediatric', 'TB', 'is', 'still', 'a', 'challenge', 'This', 'is', 'mainly', 'due', 'to', 'delayed', 'or', 'misdiagnosis', 'of', 'TB', 'which', 'continues', 'to', 'fuel', 'its', 'worldwide', 'epidemic', 'The', 'ideal', 'diagnostic', 'test', 'is', 'still', 'unavailable', 'and', 'conventional', 'methods', 'remain', 'a', 'necessity', 'for', 'TB', 'diagnosis', 'though', 'with', 'poor', 'diagnostic', 'ability', 'The', 'nanoparticles', 'have', 'shown', 'potential', 'for', 'the', 'improvement', 'of', 'drug', 'delivery', 'reducing', 'treatment', 'frequency', 'and', 'diagnosis', 'of', 'various', 'diseases', 'The', 'engineering', 'of', 'antigens', 'antibody', 'nanocarriers', 'represents', 'an', 'exciting', 'front', 'in', 'the', 'field', 'of', 'diagnostics', 'potentially', 'flagging', 'the', 'way', 'toward', 'development', 'of', 'better', 'diagnostics', 'for', 'TB', 'This', 'chapter', 'discusses', 'the', 'presently', 'available', 'tests', 'for', 'TB', 'diagnostics', 'and', 'also', 'highlights', 'the', 'recent', 'advancement', 'in', 'the', 'nanotechnology', 'based', 'detection', 'tests', 'for', 'M', 'tuberculosis', '']"
16354,Utilization Management in a Large Community Hospital,2016-12-01,Utilization Management in the Clinical Laboratory and Other Ancillary Services,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123185/,"The utilization management of laboratory tests in a large community hospital is similar to academic and smaller community hospitals. There are numerous factors that influence laboratory utilization. Outside influences like hospitals buying physician practices, increasing numbers of hospitalists, and hospital consolidation will influence the number and complexity of the test menu that will need to be monitored for over and/or under utilization in the central laboratory and reference laboratory. CLIA’88 outlines the four test categories including point-of-care testing (waived) and provider-performed microscopy that need laboratory test utilization management. Incremental cost analysis is the most efficient method for evaluating utilization reduction cost savings. Economies of scale define reduced unit cost per test as test volume increases. Outreach programs in large community hospitals provide additional laboratory tests from non-patients in physician offices, nursing homes, and other hospitals. Disruptive innovations are changing the present paradigms in clinical diagnostics, like wearable sensors, MALDI-TOF, multiplex infectious disease panels, cell-free DNA, and others. Obsolete tests need to be universally defined and accepted by manufacturers, physicians, laboratories, and hospitals, to eliminate access to their reagents and testing platforms.",10.1007/978-3-319-34199-6_14,4l7scdqk,"['The', 'utilization', 'management', 'of', 'laboratory', 'tests', 'in', 'a', 'large', 'community', 'hospital', 'is', 'similar', 'to', 'academic', 'and', 'smaller', 'community', 'hospitals', 'There', 'are', 'numerous', 'factors', 'that', 'influence', 'laboratory', 'utilization', 'Outside', 'influences', 'like', 'hospitals', 'buying', 'physician', 'practices', 'increasing', 'numbers', 'of', 'hospitalists', 'and', 'hospital', 'consolidation', 'will', 'influence', 'the', 'number', 'and', 'complexity', 'of', 'the', 'test', 'menu', 'that', 'will', 'need', 'to', 'be', 'monitored', 'for', 'over', 'and', 'or', 'under', 'utilization', 'in', 'the', 'central', 'laboratory', 'and', 'reference', 'laboratory', 'CLIA', '88', 'outlines', 'the', 'four', 'test', 'categories', 'including', 'point', 'of', 'care', 'testing', 'waived', 'and', 'provider', 'performed', 'microscopy', 'that', 'need', 'laboratory', 'test', 'utilization', 'management', 'Incremental', 'cost', 'analysis', 'is', 'the', 'most', 'efficient', 'method', 'for', 'evaluating', 'utilization', 'reduction', 'cost', 'savings', 'Economies', 'of', 'scale', 'define', 'reduced', 'unit', 'cost', 'per', 'test', 'as', 'test', 'volume', 'increases', 'Outreach', 'programs', 'in', 'large', 'community', 'hospitals', 'provide', 'additional', 'laboratory', 'tests', 'from', 'non', 'patients', 'in', 'physician', 'offices', 'nursing', 'homes', 'and', 'other', 'hospitals', 'Disruptive', 'innovations', 'are', 'changing', 'the', 'present', 'paradigms', 'in', 'clinical', 'diagnostics', 'like', 'wearable', 'sensors', 'MALDI', 'TOF', 'multiplex', 'infectious', 'disease', 'panels', 'cell', 'free', 'DNA', 'and', 'others', 'Obsolete', 'tests', 'need', 'to', 'be', 'universally', 'defined', 'and', 'accepted', 'by', 'manufacturers', 'physicians', 'laboratories', 'and', 'hospitals', 'to', 'eliminate', 'access', 'to', 'their', 'reagents', 'and', 'testing', 'platforms', '']"
16764,Nanomolecular Diagnostics,2012-06-12,The Handbook of Nanomedicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123705/,"Clinical application of molecular technologies to elucidate, diagnose, and monitor human diseases is referred to as molecular diagnosis. It is a broader term than DNA (deoxyribonucleic acid) diagnostics and refers to the use of technologies that use DNA, RNA (ribonucleic acid), genes, or proteins as bases for diagnostic tests. The scope of the subject is much wider and includes in vivo imaging and diagnosis at the single-molecule level. A more detailed description of molecular diagnostics is presented elsewhere (Jain 2012a).",10.1007/978-1-61779-983-9_4,9hlx36e9,"['Clinical', 'application', 'of', 'molecular', 'technologies', 'to', 'elucidate', 'diagnose', 'and', 'monitor', 'human', 'diseases', 'is', 'referred', 'to', 'as', 'molecular', 'diagnosis', 'It', 'is', 'a', 'broader', 'term', 'than', 'DNA', 'deoxyribonucleic', 'acid', 'diagnostics', 'and', 'refers', 'to', 'the', 'use', 'of', 'technologies', 'that', 'use', 'DNA', 'RNA', 'ribonucleic', 'acid', 'genes', 'or', 'proteins', 'as', 'bases', 'for', 'diagnostic', 'tests', 'The', 'scope', 'of', 'the', 'subject', 'is', 'much', 'wider', 'and', 'includes', 'in', 'vivo', 'imaging', 'and', 'diagnosis', 'at', 'the', 'single', 'molecule', 'level', 'A', 'more', 'detailed', 'description', 'of', 'molecular', 'diagnostics', 'is', 'presented', 'elsewhere', 'Jain', '2012a', '']"
17093,Introduction to In Vitro Diagnostic Devices,2015-07-17,In-Vitro Diagnostic Devices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124134/,"Healthcare investment keeps on increasing substantially in recent years. Such investment has also focused on fighting major diseases, enabled by the novel invention of cost-effective and valid drug development for treatment and side effect reduction, along with improved vector control. In addition, the demand for diagnostics that is essential in determining prognosis, identifying disease stages, monitoring treatment, and assessing the spreading as health services has expanded. Molecular-based diagnostics is critical for prevention, identification, and treatment of disease. Current laboratory analyses support correct diagnosis in over 70 % of all diseases and can be used to aid the continuous monitoring of drug therapy. However, classic diagnostic technologies are not completely well suited to meeting the expanded testing requirement because they rely on complicated sample purification and sophisticated instruments which are labor-intensive, timely, and expensive and require well-trained operators. One of the main challenges for industry is to develop fast, relatively accurate, easy-to-use, and inexpensive devices. In addition to the improved efficiency in laboratory diagnostics, there has been a trend toward a more decentralized diagnostics which occurs directly at patients’ bedside, in outpatient clinics, or at the sites of accidents, so-called point-of-care (POC) systems. The concept of POC testing is mainly for the patient, so short turnaround time, minimum sample preparation, reagent storage and transferring, user-friendly analytical instruments, and digital or visible quantitative or semiquantitative single readout are required. POC test is a great option of potential in vitro diagnostics (IVD) for resource-limited settings. It is clear that on-site or minimum sample preparation and on-chip storage limit the delays that caused by transport and preparation of clinical samples. Shorter turnaround time leads to rapid clinical decision-making and may save fatal consequences. No previous knowledge in sample analysis should be required, so elders can perform the tests at home with minimum training to improve health outcome. Lateral-flow immunoassay (LFIA) devices, for example, which were originally proposed in the 1980s, remain popular largely because of their design simplicity. The purpose of this article is to introduce readers with basic information regarding the LFIA approach that we think the most representative product of IVD test for solving global health issues.",10.1007/978-3-319-19737-1_1,u6m7vy6l,"['Healthcare', 'investment', 'keeps', 'on', 'increasing', 'substantially', 'in', 'recent', 'years', 'Such', 'investment', 'has', 'also', 'focused', 'on', 'fighting', 'major', 'diseases', 'enabled', 'by', 'the', 'novel', 'invention', 'of', 'cost', 'effective', 'and', 'valid', 'drug', 'development', 'for', 'treatment', 'and', 'side', 'effect', 'reduction', 'along', 'with', 'improved', 'vector', 'control', 'In', 'addition', 'the', 'demand', 'for', 'diagnostics', 'that', 'is', 'essential', 'in', 'determining', 'prognosis', 'identifying', 'disease', 'stages', 'monitoring', 'treatment', 'and', 'assessing', 'the', 'spreading', 'as', 'health', 'services', 'has', 'expanded', 'Molecular', 'based', 'diagnostics', 'is', 'critical', 'for', 'prevention', 'identification', 'and', 'treatment', 'of', 'disease', 'Current', 'laboratory', 'analyses', 'support', 'correct', 'diagnosis', 'in', 'over', '70', 'of', 'all', 'diseases', 'and', 'can', 'be', 'used', 'to', 'aid', 'the', 'continuous', 'monitoring', 'of', 'drug', 'therapy', 'However', 'classic', 'diagnostic', 'technologies', 'are', 'not', 'completely', 'well', 'suited', 'to', 'meeting', 'the', 'expanded', 'testing', 'requirement', 'because', 'they', 'rely', 'on', 'complicated', 'sample', 'purification', 'and', 'sophisticated', 'instruments', 'which', 'are', 'labor', 'intensive', 'timely', 'and', 'expensive', 'and', 'require', 'well', 'trained', 'operators', 'One', 'of', 'the', 'main', 'challenges', 'for', 'industry', 'is', 'to', 'develop', 'fast', 'relatively', 'accurate', 'easy', 'to', 'use', 'and', 'inexpensive', 'devices', 'In', 'addition', 'to', 'the', 'improved', 'efficiency', 'in', 'laboratory', 'diagnostics', 'there', 'has', 'been', 'a', 'trend', 'toward', 'a', 'more', 'decentralized', 'diagnostics', 'which', 'occurs', 'directly', 'at', 'patients', 'bedside', 'in', 'outpatient', 'clinics', 'or', 'at', 'the', 'sites', 'of', 'accidents', 'so', 'called', 'point', 'of', 'care', 'POC', 'systems', 'The', 'concept', 'of', 'POC', 'testing', 'is', 'mainly', 'for', 'the', 'patient', 'so', 'short', 'turnaround', 'time', 'minimum', 'sample', 'preparation', 'reagent', 'storage', 'and', 'transferring', 'user', 'friendly', 'analytical', 'instruments', 'and', 'digital', 'or', 'visible', 'quantitative', 'or', 'semiquantitative', 'single', 'readout', 'are', 'required', 'POC', 'test', 'is', 'a', 'great', 'option', 'of', 'potential', 'in', 'vitro', 'diagnostics', 'IVD', 'for', 'resource', 'limited', 'settings', 'It', 'is', 'clear', 'that', 'on', 'site', 'or', 'minimum', 'sample', 'preparation', 'and', 'on', 'chip', 'storage', 'limit', 'the', 'delays', 'that', 'caused', 'by', 'transport', 'and', 'preparation', 'of', 'clinical', 'samples', 'Shorter', 'turnaround', 'time', 'leads', 'to', 'rapid', 'clinical', 'decision', 'making', 'and', 'may', 'save', 'fatal', 'consequences', 'No', 'previous', 'knowledge', 'in', 'sample', 'analysis', 'should', 'be', 'required', 'so', 'elders', 'can', 'perform', 'the', 'tests', 'at', 'home', 'with', 'minimum', 'training', 'to', 'improve', 'health', 'outcome', 'Lateral', 'flow', 'immunoassay', 'LFIA', 'devices', 'for', 'example', 'which', 'were', 'originally', 'proposed', 'in', 'the', '1980s', 'remain', 'popular', 'largely', 'because', 'of', 'their', 'design', 'simplicity', 'The', 'purpose', 'of', 'this', 'article', 'is', 'to', 'introduce', 'readers', 'with', 'basic', 'information', 'regarding', 'the', 'LFIA', 'approach', 'that', 'we', 'think', 'the', 'most', 'representative', 'product', 'of', 'IVD', 'test', 'for', 'solving', 'global', 'health', 'issues', '']"
20084,Microbiology,2019-05-28,Hunter's Tropical Medicine and Emerging Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152427/,"The management and containment of many treatable and preventable infectious diseases in resource-poor countries is limited by the failure to make an accurate diagnosis. Most of the world's population lacks access to accurate, affordable, easy-to-use, quality-assured, reliable, and accessible diagnostic tests and misdiagnosis of infectious diseases is common and compromises patient care. Laboratory diagnostics are also needed for the detection and surveillance of the increasing levels of antimicrobial resistance. Accurate clinical diagnosis in resource-poor settings relies strongly on the laboratory service, and the need to support the development of a quality-assured laboratory service in such settings is increasingly recognized. International organizations are actively working with local and national providers to improve laboratory services. The development of laboratory services will contribute to improved health for the local population, protection against emerging pathogens, and ensure better use of scarce health care resources.",10.1016/b978-0-323-55512-8.00021-1,soqeje4z,"['The', 'management', 'and', 'containment', 'of', 'many', 'treatable', 'and', 'preventable', 'infectious', 'diseases', 'in', 'resource', 'poor', 'countries', 'is', 'limited', 'by', 'the', 'failure', 'to', 'make', 'an', 'accurate', 'diagnosis', 'Most', 'of', 'the', 'world', 's', 'population', 'lacks', 'access', 'to', 'accurate', 'affordable', 'easy', 'to', 'use', 'quality', 'assured', 'reliable', 'and', 'accessible', 'diagnostic', 'tests', 'and', 'misdiagnosis', 'of', 'infectious', 'diseases', 'is', 'common', 'and', 'compromises', 'patient', 'care', 'Laboratory', 'diagnostics', 'are', 'also', 'needed', 'for', 'the', 'detection', 'and', 'surveillance', 'of', 'the', 'increasing', 'levels', 'of', 'antimicrobial', 'resistance', 'Accurate', 'clinical', 'diagnosis', 'in', 'resource', 'poor', 'settings', 'relies', 'strongly', 'on', 'the', 'laboratory', 'service', 'and', 'the', 'need', 'to', 'support', 'the', 'development', 'of', 'a', 'quality', 'assured', 'laboratory', 'service', 'in', 'such', 'settings', 'is', 'increasingly', 'recognized', 'International', 'organizations', 'are', 'actively', 'working', 'with', 'local', 'and', 'national', 'providers', 'to', 'improve', 'laboratory', 'services', 'The', 'development', 'of', 'laboratory', 'services', 'will', 'contribute', 'to', 'improved', 'health', 'for', 'the', 'local', 'population', 'protection', 'against', 'emerging', 'pathogens', 'and', 'ensure', 'better', 'use', 'of', 'scarce', 'health', 'care', 'resources', '']"
20164,Acute Pulmonary Complications of Bone Marrow and Stem Cell Transplantation,2016-06-11,Hematologic Abnormalities and Acute Lung Syndromes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153438/,"Recipients of hematopoietic cell transplantation (HCT) are at risk for a variety of acute pulmonary complications including infectious pneumonias and noninfectious acute lung injury syndromes. With advances in HCT technology, prophylaxis and supportive care, overall survival after HCT has improved and the epidemiology of respiratory complications has shifted from early onset to late onset after HCT. However, acute respiratory failure remains the most common indication for admission to an intensive care unit in this population and prognosis is generally poor. Given the broad differential diagnosis of radiographic pulmonary abnormalities in HCT recipients, prompt evaluation with noninvasive testing and invasive diagnostics such as bronchoscopy is warranted. This chapter reviews the current understanding of etiology, diagnostic considerations and treatment of significant acute pulmonary complications in HCT, including idiopathic pneumonia syndrome, cryptogenic organizing pneumonia, and cytomegalovirus pneumonia.",10.1007/978-3-319-41912-1_8,4e4dmb9y,"['Recipients', 'of', 'hematopoietic', 'cell', 'transplantation', 'HCT', 'are', 'at', 'risk', 'for', 'a', 'variety', 'of', 'acute', 'pulmonary', 'complications', 'including', 'infectious', 'pneumonias', 'and', 'noninfectious', 'acute', 'lung', 'injury', 'syndromes', 'With', 'advances', 'in', 'HCT', 'technology', 'prophylaxis', 'and', 'supportive', 'care', 'overall', 'survival', 'after', 'HCT', 'has', 'improved', 'and', 'the', 'epidemiology', 'of', 'respiratory', 'complications', 'has', 'shifted', 'from', 'early', 'onset', 'to', 'late', 'onset', 'after', 'HCT', 'However', 'acute', 'respiratory', 'failure', 'remains', 'the', 'most', 'common', 'indication', 'for', 'admission', 'to', 'an', 'intensive', 'care', 'unit', 'in', 'this', 'population', 'and', 'prognosis', 'is', 'generally', 'poor', 'Given', 'the', 'broad', 'differential', 'diagnosis', 'of', 'radiographic', 'pulmonary', 'abnormalities', 'in', 'HCT', 'recipients', 'prompt', 'evaluation', 'with', 'noninvasive', 'testing', 'and', 'invasive', 'diagnostics', 'such', 'as', 'bronchoscopy', 'is', 'warranted', 'This', 'chapter', 'reviews', 'the', 'current', 'understanding', 'of', 'etiology', 'diagnostic', 'considerations', 'and', 'treatment', 'of', 'significant', 'acute', 'pulmonary', 'complications', 'in', 'HCT', 'including', 'idiopathic', 'pneumonia', 'syndrome', 'cryptogenic', 'organizing', 'pneumonia', 'and', 'cytomegalovirus', 'pneumonia', '']"
20170,Global Microbial Identifier,2017-01-24,Applied Genomics of Foodborne Pathogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153444/,"Human and animal populations are increasingly confronted with emerging and re-emerging infections and often such infections are exchanged between these populations, e.g. through food. A more effective and uniform approach to the prevention of these microbial threats is essential. The technological advances in the next generation sequencing field and decreasing costs of these tests provide novel opportunities in understanding the dynamics of infection—even in real time—through the analysis of microbial genome diversity. The projected significant increase in whole (microbial) genome sequencing (WGS) will likely also enable a much better understanding of the pathogenesis of the infection and the molecular basis of the host response to infection. But the full potential of these advances will only transpire if the data in this area become transferable and thereby comparable, preferably in open-source systems. There is therefore an obvious need to develop a global system of whole microbial genome databases to aggregate, share, mine and use microbiological genomic data, to address global public health and clinical challenges, and most importantly to identify and diagnose infectious diseases. The global microbial identifier (GMI) initiative, aims to build a database of whole microbial genome sequencing data linked to relevant metadata, which can be used to identify microorganisms, their communities and the diseases they cause. It would be a platform for storing whole genome sequencing (WGS) data of microorganisms, for the identification of relevant genes and for the comparison of genomes to detect outbreaks and emerging pathogens. To harness the full potential of WGS, a shared global database of genomes linked to relevant metadata and the necessary software tools needs to be generated, hence the global microbial identifier (GMI) initiative. This tool will ideally be used in amongst others in the diagnosis of infectious diseases in humans and animals, in the identification of microorganisms in food and environment, and to track and trace microbial agents in all arenas globally. This will require standardization and extensive investments in computational analytical tools. In addition, the wider introduction of WGS in clinical diagnostics can accelerate developments in health care in many poor countries. This overview describes the growing network of stakeholders behind GMI, the contours of the database, and the IT structures needed to serve the GMI user community. It discusses what essentially can be done by a global GMI tool and how the GMI organization could help achieve these goals.",10.1007/978-3-319-43751-4_2,lkw7ony8,"['Human', 'and', 'animal', 'populations', 'are', 'increasingly', 'confronted', 'with', 'emerging', 'and', 're', 'emerging', 'infections', 'and', 'often', 'such', 'infections', 'are', 'exchanged', 'between', 'these', 'populations', 'e', 'g', 'through', 'food', 'A', 'more', 'effective', 'and', 'uniform', 'approach', 'to', 'the', 'prevention', 'of', 'these', 'microbial', 'threats', 'is', 'essential', 'The', 'technological', 'advances', 'in', 'the', 'next', 'generation', 'sequencing', 'field', 'and', 'decreasing', 'costs', 'of', 'these', 'tests', 'provide', 'novel', 'opportunities', 'in', 'understanding', 'the', 'dynamics', 'of', 'infection', 'even', 'in', 'real', 'time', 'through', 'the', 'analysis', 'of', 'microbial', 'genome', 'diversity', 'The', 'projected', 'significant', 'increase', 'in', 'whole', 'microbial', 'genome', 'sequencing', 'WGS', 'will', 'likely', 'also', 'enable', 'a', 'much', 'better', 'understanding', 'of', 'the', 'pathogenesis', 'of', 'the', 'infection', 'and', 'the', 'molecular', 'basis', 'of', 'the', 'host', 'response', 'to', 'infection', 'But', 'the', 'full', 'potential', 'of', 'these', 'advances', 'will', 'only', 'transpire', 'if', 'the', 'data', 'in', 'this', 'area', 'become', 'transferable', 'and', 'thereby', 'comparable', 'preferably', 'in', 'open', 'source', 'systems', 'There', 'is', 'therefore', 'an', 'obvious', 'need', 'to', 'develop', 'a', 'global', 'system', 'of', 'whole', 'microbial', 'genome', 'databases', 'to', 'aggregate', 'share', 'mine', 'and', 'use', 'microbiological', 'genomic', 'data', 'to', 'address', 'global', 'public', 'health', 'and', 'clinical', 'challenges', 'and', 'most', 'importantly', 'to', 'identify', 'and', 'diagnose', 'infectious', 'diseases', 'The', 'global', 'microbial', 'identifier', 'GMI', 'initiative', 'aims', 'to', 'build', 'a', 'database', 'of', 'whole', 'microbial', 'genome', 'sequencing', 'data', 'linked', 'to', 'relevant', 'metadata', 'which', 'can', 'be', 'used', 'to', 'identify', 'microorganisms', 'their', 'communities', 'and', 'the', 'diseases', 'they', 'cause', 'It', 'would', 'be', 'a', 'platform', 'for', 'storing', 'whole', 'genome', 'sequencing', 'WGS', 'data', 'of', 'microorganisms', 'for', 'the', 'identification', 'of', 'relevant', 'genes', 'and', 'for', 'the', 'comparison', 'of', 'genomes', 'to', 'detect', 'outbreaks', 'and', 'emerging', 'pathogens', 'To', 'harness', 'the', 'full', 'potential', 'of', 'WGS', 'a', 'shared', 'global', 'database', 'of', 'genomes', 'linked', 'to', 'relevant', 'metadata', 'and', 'the', 'necessary', 'software', 'tools', 'needs', 'to', 'be', 'generated', 'hence', 'the', 'global', 'microbial', 'identifier', 'GMI', 'initiative', 'This', 'tool', 'will', 'ideally', 'be', 'used', 'in', 'amongst', 'others', 'in', 'the', 'diagnosis', 'of', 'infectious', 'diseases', 'in', 'humans', 'and', 'animals', 'in', 'the', 'identification', 'of', 'microorganisms', 'in', 'food', 'and', 'environment', 'and', 'to', 'track', 'and', 'trace', 'microbial', 'agents', 'in', 'all', 'arenas', 'globally', 'This', 'will', 'require', 'standardization', 'and', 'extensive', 'investments', 'in', 'computational', 'analytical', 'tools', 'In', 'addition', 'the', 'wider', 'introduction', 'of', 'WGS', 'in', 'clinical', 'diagnostics', 'can', 'accelerate', 'developments', 'in', 'health', 'care', 'in', 'many', 'poor', 'countries', 'This', 'overview', 'describes', 'the', 'growing', 'network', 'of', 'stakeholders', 'behind', 'GMI', 'the', 'contours', 'of', 'the', 'database', 'and', 'the', 'IT', 'structures', 'needed', 'to', 'serve', 'the', 'GMI', 'user', 'community', 'It', 'discusses', 'what', 'essentially', 'can', 'be', 'done', 'by', 'a', 'global', 'GMI', 'tool', 'and', 'how', 'the', 'GMI', 'organization', 'could', 'help', 'achieve', 'these', 'goals', '']"
20244,Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine,2014-06-27,Monoclonal Antibodies Against Bacteria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155467/,"This chapter discusses the current and future applications of monoclonal antibodies against bacteria in veterinary medicine. It discusses the existing applications of monoclonal antibodies, including the use of pilus-specific monoclonal antibodies for passive immunization of calves and piglets against enteropathogenic E. coli (EPEC) infections as well as the development of rapid diagnostic test kits for field diagnosis of EPEC infections. The potential applications of monoclonal antibodies for passive immunization against a variety of veterinary pathogens are passive immunization against Moraxella bovis (pinkeye), Bacteroides nodosus (foot rot), EPEC enterotoxin (enteric colibacillosis), Pasteurella haemolytica (pneumonic pasteurellosis), and Streptococcus equi (strangles). Three main areas of application for monoclonal antibodies against bacterial antigens in veterinary medicine are passive immunization, improved immunodiagnostics, and immunotherapy. Monoclonal antibodies, because of their specificity, unlimited availability, and high titer, represent excellent passive immunizing agents. However, their potential usefulness in preventing infection must be evaluated on a case-by-case basis.",10.1016/b978-0-12-463003-1.50018-6,hxph2xid,"['This', 'chapter', 'discusses', 'the', 'current', 'and', 'future', 'applications', 'of', 'monoclonal', 'antibodies', 'against', 'bacteria', 'in', 'veterinary', 'medicine', 'It', 'discusses', 'the', 'existing', 'applications', 'of', 'monoclonal', 'antibodies', 'including', 'the', 'use', 'of', 'pilus', 'specific', 'monoclonal', 'antibodies', 'for', 'passive', 'immunization', 'of', 'calves', 'and', 'piglets', 'against', 'enteropathogenic', 'E', 'coli', 'EPEC', 'infections', 'as', 'well', 'as', 'the', 'development', 'of', 'rapid', 'diagnostic', 'test', 'kits', 'for', 'field', 'diagnosis', 'of', 'EPEC', 'infections', 'The', 'potential', 'applications', 'of', 'monoclonal', 'antibodies', 'for', 'passive', 'immunization', 'against', 'a', 'variety', 'of', 'veterinary', 'pathogens', 'are', 'passive', 'immunization', 'against', 'Moraxella', 'bovis', 'pinkeye', 'Bacteroides', 'nodosus', 'foot', 'rot', 'EPEC', 'enterotoxin', 'enteric', 'colibacillosis', 'Pasteurella', 'haemolytica', 'pneumonic', 'pasteurellosis', 'and', 'Streptococcus', 'equi', 'strangles', 'Three', 'main', 'areas', 'of', 'application', 'for', 'monoclonal', 'antibodies', 'against', 'bacterial', 'antigens', 'in', 'veterinary', 'medicine', 'are', 'passive', 'immunization', 'improved', 'immunodiagnostics', 'and', 'immunotherapy', 'Monoclonal', 'antibodies', 'because', 'of', 'their', 'specificity', 'unlimited', 'availability', 'and', 'high', 'titer', 'represent', 'excellent', 'passive', 'immunizing', 'agents', 'However', 'their', 'potential', 'usefulness', 'in', 'preventing', 'infection', 'must', 'be', 'evaluated', 'on', 'a', 'case', 'by', 'case', 'basis', '']"
20795,Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism,2018-06-25,Adv Funct Mater,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161833/,"Highly pathogenic avian influenza virus (HPAIV) infections have occurred continuously and crossed the species barrier to humans, leading to fatalities. A polymerase chain reaction based molecular test is currently the most sensitive diagnostic tool for HPAIV; however, the results must be analyzed in centralized diagnosis systems by a trained individual. This requirement leads to delays in quarantine and isolation. To control the spread of HPAIV, rapid and accurate diagnostics suitable for field testing are needed, and the tests must facilitate a differential diagnosis between HPAIV and low pathogenic avian influenza virus (LPAIV), which undergo cleavage specifically by trypsin‐ or furin‐like proteases, respectively. In this study, a differential avian influenza virus rapid test kit is developed and evaluated in vitro and using clinical specimens from HPAIV H5N1‐infected animals. It is demonstrated that this rapid test kit provides highly sensitive and specific detection of HPAIV and LPAIV and is thus a useful field diagnostic tool for H5N1 HPAIV outbreaks and for rapid quarantine control of the disease.",10.1002/adfm.201800960,mbndm4sk,"['Highly', 'pathogenic', 'avian', 'influenza', 'virus', 'HPAIV', 'infections', 'have', 'occurred', 'continuously', 'and', 'crossed', 'the', 'species', 'barrier', 'to', 'humans', 'leading', 'to', 'fatalities', 'A', 'polymerase', 'chain', 'reaction', 'based', 'molecular', 'test', 'is', 'currently', 'the', 'most', 'sensitive', 'diagnostic', 'tool', 'for', 'HPAIV', 'however', 'the', 'results', 'must', 'be', 'analyzed', 'in', 'centralized', 'diagnosis', 'systems', 'by', 'a', 'trained', 'individual', 'This', 'requirement', 'leads', 'to', 'delays', 'in', 'quarantine', 'and', 'isolation', 'To', 'control', 'the', 'spread', 'of', 'HPAIV', 'rapid', 'and', 'accurate', 'diagnostics', 'suitable', 'for', 'field', 'testing', 'are', 'needed', 'and', 'the', 'tests', 'must', 'facilitate', 'a', 'differential', 'diagnosis', 'between', 'HPAIV', 'and', 'low', 'pathogenic', 'avian', 'influenza', 'virus', 'LPAIV', 'which', 'undergo', 'cleavage', 'specifically', 'by', 'trypsin', 'or', 'furin', 'like', 'proteases', 'respectively', 'In', 'this', 'study', 'a', 'differential', 'avian', 'influenza', 'virus', 'rapid', 'test', 'kit', 'is', 'developed', 'and', 'evaluated', 'in', 'vitro', 'and', 'using', 'clinical', 'specimens', 'from', 'HPAIV', 'H5N1', 'infected', 'animals', 'It', 'is', 'demonstrated', 'that', 'this', 'rapid', 'test', 'kit', 'provides', 'highly', 'sensitive', 'and', 'specific', 'detection', 'of', 'HPAIV', 'and', 'LPAIV', 'and', 'is', 'thus', 'a', 'useful', 'field', 'diagnostic', 'tool', 'for', 'H5N1', 'HPAIV', 'outbreaks', 'and', 'for', 'rapid', 'quarantine', 'control', 'of', 'the', 'disease', '']"
20985,A systematic approach to calf Gastroenteric disease,2011-03-24,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165598/,Gastrointestinal disease represents one of the most significant problems in calf health accounting for up to 50% of the mortality in pre‐weaned dairy heifer calves. The multifactorial nature of disease process necessitates a systematic approach to on farm investigations to ensure correct diagnosis and enable the implementation of appropriate management changes. This article describes a stepwise approach in which the disease process is characterised and its pattern described. Having next identified factors impacting on mucosal health and immunity and potential bio security breakdowns; targeted diagnostics testing can be performed allowing therapeutic and management recommendations to be made.,10.1111/j.2044-3870.2010.00022.x,qhezhbri,"['Gastrointestinal', 'disease', 'represents', 'one', 'of', 'the', 'most', 'significant', 'problems', 'in', 'calf', 'health', 'accounting', 'for', 'up', 'to', '50', 'of', 'the', 'mortality', 'in', 'pre', 'weaned', 'dairy', 'heifer', 'calves', 'The', 'multifactorial', 'nature', 'of', 'disease', 'process', 'necessitates', 'a', 'systematic', 'approach', 'to', 'on', 'farm', 'investigations', 'to', 'ensure', 'correct', 'diagnosis', 'and', 'enable', 'the', 'implementation', 'of', 'appropriate', 'management', 'changes', 'This', 'article', 'describes', 'a', 'stepwise', 'approach', 'in', 'which', 'the', 'disease', 'process', 'is', 'characterised', 'and', 'its', 'pattern', 'described', 'Having', 'next', 'identified', 'factors', 'impacting', 'on', 'mucosal', 'health', 'and', 'immunity', 'and', 'potential', 'bio', 'security', 'breakdowns', 'targeted', 'diagnostics', 'testing', 'can', 'be', 'performed', 'allowing', 'therapeutic', 'and', 'management', 'recommendations', 'to', 'be', 'made', '']"
21791,Molecular biological tests,2018,Point-of-Care Testing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176160/,"Molecular biological testing has become a mainstay in the repertoire of infectious disease diagnostics like in no other field of medicine. Direct pathogen detection primarily relies upon two main methods: the polymerase chain reaction (PCR) and immunochromatography – often supplied as test strips or test cards. Alongside pathogen detection, the PCR method has the advantage that it can simultaneously analyze resistance determinants and/or virulence factors. In the age of multidrug-resistant (nosocomial) pathogens, rapid and reliable molecular biological differentiation is becoming increasingly important given the urgency indicated to effectively isolate affected patients at the earliest possible chance.",10.1007/978-3-662-54497-6_10,v6antoj6,"['Molecular', 'biological', 'testing', 'has', 'become', 'a', 'mainstay', 'in', 'the', 'repertoire', 'of', 'infectious', 'disease', 'diagnostics', 'like', 'in', 'no', 'other', 'field', 'of', 'medicine', 'Direct', 'pathogen', 'detection', 'primarily', 'relies', 'upon', 'two', 'main', 'methods', 'the', 'polymerase', 'chain', 'reaction', 'PCR', 'and', 'immunochromatography', 'often', 'supplied', 'as', 'test', 'strips', 'or', 'test', 'cards', 'Alongside', 'pathogen', 'detection', 'the', 'PCR', 'method', 'has', 'the', 'advantage', 'that', 'it', 'can', 'simultaneously', 'analyze', 'resistance', 'determinants', 'and', 'or', 'virulence', 'factors', 'In', 'the', 'age', 'of', 'multidrug', 'resistant', 'nosocomial', 'pathogens', 'rapid', 'and', 'reliable', 'molecular', 'biological', 'differentiation', 'is', 'becoming', 'increasingly', 'important', 'given', 'the', 'urgency', 'indicated', 'to', 'effectively', 'isolate', 'affected', 'patients', 'at', 'the', 'earliest', 'possible', 'chance', '']"
23820,"Molecular Pathology Economics 101: an Overview of Molecular Diagnostics Coding, Coverage and Reimbursement",2020-06-03,J Mol Diagn,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267794/,"Widespread indications for use of molecular diagnostics in various aspects of clinical medicine have driven proliferation of testing. The rapid adoption and continuous technological evolution of molecular diagnostics have often strained the development and maintenance of a functional underlying framework of coding, coverage, and reimbursement policies, thereby presenting challenges to various stakeholders including molecular professionals, payers, and patients. A multidisciplinary working group convened by the Association for Molecular Pathology Economic Affairs Committee was tasked to describe the complex landscape of molecular pathology economics and highlight opportunities for member engagement. In this manuscript, on the basis of review and synthesis of government regulations and procedures, published payer policy documents, peer-reviewed literature, and expert consensus, the Working Group navigates the ecosystem of molecular pathology economics in terms of stakeholders, coding systems and processes, coverage policy determination, and pricing mechanisms. The composition and interrelatedness of various working groups and committees are emphasized in order to highlight the functional underpinnings of the system. Molecular professionals must be conversant in the language and complex inner workings of molecular pathology economics in order to lead successful, viable laboratories and advocate effectively for policy development on their behalf. This overview is provided to be a resource to molecular professionals as they navigate the reimbursement landscape.",10.1016/j.jmoldx.2020.05.008,72gr3hv3,"['Widespread', 'indications', 'for', 'use', 'of', 'molecular', 'diagnostics', 'in', 'various', 'aspects', 'of', 'clinical', 'medicine', 'have', 'driven', 'proliferation', 'of', 'testing', 'The', 'rapid', 'adoption', 'and', 'continuous', 'technological', 'evolution', 'of', 'molecular', 'diagnostics', 'have', 'often', 'strained', 'the', 'development', 'and', 'maintenance', 'of', 'a', 'functional', 'underlying', 'framework', 'of', 'coding', 'coverage', 'and', 'reimbursement', 'policies', 'thereby', 'presenting', 'challenges', 'to', 'various', 'stakeholders', 'including', 'molecular', 'professionals', 'payers', 'and', 'patients', 'A', 'multidisciplinary', 'working', 'group', 'convened', 'by', 'the', 'Association', 'for', 'Molecular', 'Pathology', 'Economic', 'Affairs', 'Committee', 'was', 'tasked', 'to', 'describe', 'the', 'complex', 'landscape', 'of', 'molecular', 'pathology', 'economics', 'and', 'highlight', 'opportunities', 'for', 'member', 'engagement', 'In', 'this', 'manuscript', 'on', 'the', 'basis', 'of', 'review', 'and', 'synthesis', 'of', 'government', 'regulations', 'and', 'procedures', 'published', 'payer', 'policy', 'documents', 'peer', 'reviewed', 'literature', 'and', 'expert', 'consensus', 'the', 'Working', 'Group', 'navigates', 'the', 'ecosystem', 'of', 'molecular', 'pathology', 'economics', 'in', 'terms', 'of', 'stakeholders', 'coding', 'systems', 'and', 'processes', 'coverage', 'policy', 'determination', 'and', 'pricing', 'mechanisms', 'The', 'composition', 'and', 'interrelatedness', 'of', 'various', 'working', 'groups', 'and', 'committees', 'are', 'emphasized', 'in', 'order', 'to', 'highlight', 'the', 'functional', 'underpinnings', 'of', 'the', 'system', 'Molecular', 'professionals', 'must', 'be', 'conversant', 'in', 'the', 'language', 'and', 'complex', 'inner', 'workings', 'of', 'molecular', 'pathology', 'economics', 'in', 'order', 'to', 'lead', 'successful', 'viable', 'laboratories', 'and', 'advocate', 'effectively', 'for', 'policy', 'development', 'on', 'their', 'behalf', 'This', 'overview', 'is', 'provided', 'to', 'be', 'a', 'resource', 'to', 'molecular', 'professionals', 'as', 'they', 'navigate', 'the', 'reimbursement', 'landscape', '']"
24923,Risk assessment for influenza D in Europe,2020-06-04,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300431/,"Recent studies have identified a new genus of the Orthomyxoviridae family, Influenza D virus (IDV). This virus was shown to infect farm animals including swine and cattle, and to efficiently replicate and transmit in ferrets, the animal model of choice for transmission of influenza A virus to humans. This partnering grant on IDV addressed the need for capacity building at EU level to improve the EU's scientific assessment capacity and international competitiveness. We have promoted cross‐disciplinary cooperation between the partner institutes representing six Member States (BE, FR, IT, LU, NL and SE). We have shown that the available antigen and genome test systems allow reliable influenza D diagnostics in partners laboratories, while for a few of the applied antibody testing methods adjustments are recommended. Tools were developed to study virus‐host range, with a gain of knowledge on host and tissue tropism of IDV in farm animals but also in wild life and very preliminary data was generated on human tissues. Serological results in European cattle suggest that influenza D virus is enzootic. Virus diversity is still unfolding: new virus introductions were identified, as well as new reassortants whose differential clinical impact or cross‐protection levels are still poorly understood. Considering drivers of emergence, IDV was in the top five in comparison with 29 other diseases. The main risk factors of IDV in cattle are related to the animal density, presence of respiratory clinical signs in cattle and contact rates between animals. Simplified quantitative IDV risk assessment exposure model indicated a possible infection of human by IDV through aerosols in cattle farms. Further studies are warranted to fully assess the risk of IDV for both animal and Human health in Europe.",10.2903/sp.efsa.2020.en-1853,43i5gkqs,"['Recent', 'studies', 'have', 'identified', 'a', 'new', 'genus', 'of', 'the', 'Orthomyxoviridae', 'family', 'Influenza', 'D', 'virus', 'IDV', 'This', 'virus', 'was', 'shown', 'to', 'infect', 'farm', 'animals', 'including', 'swine', 'and', 'cattle', 'and', 'to', 'efficiently', 'replicate', 'and', 'transmit', 'in', 'ferrets', 'the', 'animal', 'model', 'of', 'choice', 'for', 'transmission', 'of', 'influenza', 'A', 'virus', 'to', 'humans', 'This', 'partnering', 'grant', 'on', 'IDV', 'addressed', 'the', 'need', 'for', 'capacity', 'building', 'at', 'EU', 'level', 'to', 'improve', 'the', 'EU', 's', 'scientific', 'assessment', 'capacity', 'and', 'international', 'competitiveness', 'We', 'have', 'promoted', 'cross', 'disciplinary', 'cooperation', 'between', 'the', 'partner', 'institutes', 'representing', 'six', 'Member', 'States', 'BE', 'FR', 'IT', 'LU', 'NL', 'and', 'SE', 'We', 'have', 'shown', 'that', 'the', 'available', 'antigen', 'and', 'genome', 'test', 'systems', 'allow', 'reliable', 'influenza', 'D', 'diagnostics', 'in', 'partners', 'laboratories', 'while', 'for', 'a', 'few', 'of', 'the', 'applied', 'antibody', 'testing', 'methods', 'adjustments', 'are', 'recommended', 'Tools', 'were', 'developed', 'to', 'study', 'virus', 'host', 'range', 'with', 'a', 'gain', 'of', 'knowledge', 'on', 'host', 'and', 'tissue', 'tropism', 'of', 'IDV', 'in', 'farm', 'animals', 'but', 'also', 'in', 'wild', 'life', 'and', 'very', 'preliminary', 'data', 'was', 'generated', 'on', 'human', 'tissues', 'Serological', 'results', 'in', 'European', 'cattle', 'suggest', 'that', 'influenza', 'D', 'virus', 'is', 'enzootic', 'Virus', 'diversity', 'is', 'still', 'unfolding', 'new', 'virus', 'introductions', 'were', 'identified', 'as', 'well', 'as', 'new', 'reassortants', 'whose', 'differential', 'clinical', 'impact', 'or', 'cross', 'protection', 'levels', 'are', 'still', 'poorly', 'understood', 'Considering', 'drivers', 'of', 'emergence', 'IDV', 'was', 'in', 'the', 'top', 'five', 'in', 'comparison', 'with', '29', 'other', 'diseases', 'The', 'main', 'risk', 'factors', 'of', 'IDV', 'in', 'cattle', 'are', 'related', 'to', 'the', 'animal', 'density', 'presence', 'of', 'respiratory', 'clinical', 'signs', 'in', 'cattle', 'and', 'contact', 'rates', 'between', 'animals', 'Simplified', 'quantitative', 'IDV', 'risk', 'assessment', 'exposure', 'model', 'indicated', 'a', 'possible', 'infection', 'of', 'human', 'by', 'IDV', 'through', 'aerosols', 'in', 'cattle', 'farms', 'Further', 'studies', 'are', 'warranted', 'to', 'fully', 'assess', 'the', 'risk', 'of', 'IDV', 'for', 'both', 'animal', 'and', 'Human', 'health', 'in', 'Europe', '']"
25150,Application of the Stochastic Gradient Method in the Construction of the Main Components of PCA in the Task Diagnosis of Multiple Sclerosis in Children,2020-05-23,Computational Science - ICCS 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303678/,"Many different medical problems are characterized by quite large spatial dimensions, which causes the task of recognizing patterns to become troublesome. This is a well-known phenomenon called curse of dimensionality. These problems force the creation of various methods of reducing dimensionality. These methods are based on selection and extraction of features. The most commonly used method in literature, regarding the later, is the analysis of the main components of pca. The natural problem of this method is the possibility of applying it to linear space. It is a natural problem to develop the pca concept for cases of nonlinear feature spaces, optimization of feature selection for principal components and the inclusion of classes in the task of supervised learning. An important problem in the perspective of machine learning is not only a reduction of features and attributes but also separation of classes. The developed method was tested in two computer experiments using real data of multiple sclerosis in children. The discussed problem, even from the very nature of the data itself, is important because it can contribute to practical implementations in medical diagnostics. The purpose of the research is to develop a method of extracting features with the application of the stochastic gradient method in the task diagnosis of multiple sclerosis in children. This solution could contribute to the increasing quality of classification and thus may be the basis for building systems that support the medical diagnostics in recognition of multiple sclerosis in children.",10.1007/978-3-030-50423-6_3,kx01dvxt,"['Many', 'different', 'medical', 'problems', 'are', 'characterized', 'by', 'quite', 'large', 'spatial', 'dimensions', 'which', 'causes', 'the', 'task', 'of', 'recognizing', 'patterns', 'to', 'become', 'troublesome', 'This', 'is', 'a', 'well', 'known', 'phenomenon', 'called', 'curse', 'of', 'dimensionality', 'These', 'problems', 'force', 'the', 'creation', 'of', 'various', 'methods', 'of', 'reducing', 'dimensionality', 'These', 'methods', 'are', 'based', 'on', 'selection', 'and', 'extraction', 'of', 'features', 'The', 'most', 'commonly', 'used', 'method', 'in', 'literature', 'regarding', 'the', 'later', 'is', 'the', 'analysis', 'of', 'the', 'main', 'components', 'of', 'pca', 'The', 'natural', 'problem', 'of', 'this', 'method', 'is', 'the', 'possibility', 'of', 'applying', 'it', 'to', 'linear', 'space', 'It', 'is', 'a', 'natural', 'problem', 'to', 'develop', 'the', 'pca', 'concept', 'for', 'cases', 'of', 'nonlinear', 'feature', 'spaces', 'optimization', 'of', 'feature', 'selection', 'for', 'principal', 'components', 'and', 'the', 'inclusion', 'of', 'classes', 'in', 'the', 'task', 'of', 'supervised', 'learning', 'An', 'important', 'problem', 'in', 'the', 'perspective', 'of', 'machine', 'learning', 'is', 'not', 'only', 'a', 'reduction', 'of', 'features', 'and', 'attributes', 'but', 'also', 'separation', 'of', 'classes', 'The', 'developed', 'method', 'was', 'tested', 'in', 'two', 'computer', 'experiments', 'using', 'real', 'data', 'of', 'multiple', 'sclerosis', 'in', 'children', 'The', 'discussed', 'problem', 'even', 'from', 'the', 'very', 'nature', 'of', 'the', 'data', 'itself', 'is', 'important', 'because', 'it', 'can', 'contribute', 'to', 'practical', 'implementations', 'in', 'medical', 'diagnostics', 'The', 'purpose', 'of', 'the', 'research', 'is', 'to', 'develop', 'a', 'method', 'of', 'extracting', 'features', 'with', 'the', 'application', 'of', 'the', 'stochastic', 'gradient', 'method', 'in', 'the', 'task', 'diagnosis', 'of', 'multiple', 'sclerosis', 'in', 'children', 'This', 'solution', 'could', 'contribute', 'to', 'the', 'increasing', 'quality', 'of', 'classification', 'and', 'thus', 'may', 'be', 'the', 'basis', 'for', 'building', 'systems', 'that', 'support', 'the', 'medical', 'diagnostics', 'in', 'recognition', 'of', 'multiple', 'sclerosis', 'in', 'children', '']"
26552,"Clinical characteristics and outcomes of patients with H1N1 influenza pneumonia admitted at a tertiary care hospital in Karachi, Pakistan",2020-07-05,Pneumonia (Nathan),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335362/,"INTRODUCTION: Influenza viruses specifically, A and B mainly contribute to seasonal outbreaks that occur globally. However, due to limited diagnostics for influenza there is little data regarding clinical outcomes of patients with H1N1 pneumonia in our region. Our objective was to determine the clinical characteristics and outcomes of patients hospitalized with H1N1 pneumonia at a tertiary care facility in Karachi, Pakistan. METHODS: A retrospective study of adult patients admitted with influenza pneumonia from November 2017 to February 2018 at a tertiary care hospital in Karachi, Pakistan. Patient characteristics were compared between influenza A H1N1 and other types of influenza using multivariable logistic regression analysis and subgroup analysis for factors associated with mortality in H1N1 Pneumonia was performed. RESULTS: Out of 497 adult patients with community acquired pneumonia (CAP), 172 fulfilled the criteria for Influenza like illness (ILI). 88 patients had PCR confirmed Influenza pneumonia of whom n = 57 (65%) had Influenza A H1N1. The mean age of patients 53.5 years (SD: 17.3) and 60% were male. The overall mortality from Influenza in this study was 15.9% (n = 14); out of these 11 (78.5%) had Influenza A H1N1. Multivariable analysis showed that the increase in length of hospital admission was significantly associated with H1N1 Influenza A infection (OR: 1.47 CI: 1.2–1.8). Factors associated with mortality showed that presence of ARDS, Septic shock and multi-organ failure was highly significantly associated with death (p-value < 0.001) along with deranged liver function tests (p-value 0.01) and presence of nosocomial infection (p-value 0.027). CONCLUSION: Influenza A H1N1 is associated with greater length of stay compared with infection due to other types of Influenza and mortality in H1N1 Pneumonia was found to be associated with presence of nosocomial infection among several other factors which may have implications given higher rates in a low-middle income country.",10.1186/s41479-020-00070-7,23j0jvgj,"['INTRODUCTION', 'Influenza', 'viruses', 'specifically', 'A', 'and', 'B', 'mainly', 'contribute', 'to', 'seasonal', 'outbreaks', 'that', 'occur', 'globally', 'However', 'due', 'to', 'limited', 'diagnostics', 'for', 'influenza', 'there', 'is', 'little', 'data', 'regarding', 'clinical', 'outcomes', 'of', 'patients', 'with', 'H1N1', 'pneumonia', 'in', 'our', 'region', 'Our', 'objective', 'was', 'to', 'determine', 'the', 'clinical', 'characteristics', 'and', 'outcomes', 'of', 'patients', 'hospitalized', 'with', 'H1N1', 'pneumonia', 'at', 'a', 'tertiary', 'care', 'facility', 'in', 'Karachi', 'Pakistan', 'METHODS', 'A', 'retrospective', 'study', 'of', 'adult', 'patients', 'admitted', 'with', 'influenza', 'pneumonia', 'from', 'November', '2017', 'to', 'February', '2018', 'at', 'a', 'tertiary', 'care', 'hospital', 'in', 'Karachi', 'Pakistan', 'Patient', 'characteristics', 'were', 'compared', 'between', 'influenza', 'A', 'H1N1', 'and', 'other', 'types', 'of', 'influenza', 'using', 'multivariable', 'logistic', 'regression', 'analysis', 'and', 'subgroup', 'analysis', 'for', 'factors', 'associated', 'with', 'mortality', 'in', 'H1N1', 'Pneumonia', 'was', 'performed', 'RESULTS', 'Out', 'of', '497', 'adult', 'patients', 'with', 'community', 'acquired', 'pneumonia', 'CAP', '172', 'fulfilled', 'the', 'criteria', 'for', 'Influenza', 'like', 'illness', 'ILI', '88', 'patients', 'had', 'PCR', 'confirmed', 'Influenza', 'pneumonia', 'of', 'whom', 'n', '57', '65', 'had', 'Influenza', 'A', 'H1N1', 'The', 'mean', 'age', 'of', 'patients', '53', '5', 'years', 'SD', '17', '3', 'and', '60', 'were', 'male', 'The', 'overall', 'mortality', 'from', 'Influenza', 'in', 'this', 'study', 'was', '15', '9', 'n', '14', 'out', 'of', 'these', '11', '78', '5', 'had', 'Influenza', 'A', 'H1N1', 'Multivariable', 'analysis', 'showed', 'that', 'the', 'increase', 'in', 'length', 'of', 'hospital', 'admission', 'was', 'significantly', 'associated', 'with', 'H1N1', 'Influenza', 'A', 'infection', 'OR', '1', '47', 'CI', '1', '2', '1', '8', 'Factors', 'associated', 'with', 'mortality', 'showed', 'that', 'presence', 'of', 'ARDS', 'Septic', 'shock', 'and', 'multi', 'organ', 'failure', 'was', 'highly', 'significantly', 'associated', 'with', 'death', 'p', 'value', '0', '001', 'along', 'with', 'deranged', 'liver', 'function', 'tests', 'p', 'value', '0', '01', 'and', 'presence', 'of', 'nosocomial', 'infection', 'p', 'value', '0', '027', 'CONCLUSION', 'Influenza', 'A', 'H1N1', 'is', 'associated', 'with', 'greater', 'length', 'of', 'stay', 'compared', 'with', 'infection', 'due', 'to', 'other', 'types', 'of', 'Influenza', 'and', 'mortality', 'in', 'H1N1', 'Pneumonia', 'was', 'found', 'to', 'be', 'associated', 'with', 'presence', 'of', 'nosocomial', 'infection', 'among', 'several', 'other', 'factors', 'which', 'may', 'have', 'implications', 'given', 'higher', 'rates', 'in', 'a', 'low', 'middle', 'income', 'country', '']"
26615,Legislating in the Time of a Pandemic: Window of Opportunity or Invitation for Recklessness?,2020-06-15,J Law Biosci,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337772/,"The COVID-19 epidemic has been exacerbated by failures in diagnostic testing for the virus in the United States. In response to these problems, two bills have been introduced in Congress to not only reform emergency use of diagnostic tests, but to fundamentally reform diagnostics regulation in non-emergencies. There has been a long-standing recognition that current U.S. regulation of diagnostics is outdated and problematic, and the history of public health legislation is that emergencies and crises have been the primary motivating factor to break Congressional inertia and to implement new legislation. Thus, the COVID-19 may create a useful “window of opportunity” to pass much-needed legislative reform of diagnostic regulation in both emergency and non-emergency contexts. At the same time, rushing radical legislative changes, especially if they have not been subject to careful stakeholder engagement and Congressional deliberation in advance, is precarious and could result in reckless and disruptive changes. We review and apply the historical lessons of legislating in response to a crisis and conclude the one but not both of the pending legislative proposals may satisfy the criteria for an appropriate opportunistic change for diagnostics regulation.",10.1093/jlb/lsaa042,dtfmcqh6,"['The', 'COVID', '19', 'epidemic', 'has', 'been', 'exacerbated', 'by', 'failures', 'in', 'diagnostic', 'testing', 'for', 'the', 'virus', 'in', 'the', 'United', 'States', 'In', 'response', 'to', 'these', 'problems', 'two', 'bills', 'have', 'been', 'introduced', 'in', 'Congress', 'to', 'not', 'only', 'reform', 'emergency', 'use', 'of', 'diagnostic', 'tests', 'but', 'to', 'fundamentally', 'reform', 'diagnostics', 'regulation', 'in', 'non', 'emergencies', 'There', 'has', 'been', 'a', 'long', 'standing', 'recognition', 'that', 'current', 'U', 'S', 'regulation', 'of', 'diagnostics', 'is', 'outdated', 'and', 'problematic', 'and', 'the', 'history', 'of', 'public', 'health', 'legislation', 'is', 'that', 'emergencies', 'and', 'crises', 'have', 'been', 'the', 'primary', 'motivating', 'factor', 'to', 'break', 'Congressional', 'inertia', 'and', 'to', 'implement', 'new', 'legislation', 'Thus', 'the', 'COVID', '19', 'may', 'create', 'a', 'useful', 'window', 'of', 'opportunity', 'to', 'pass', 'much', 'needed', 'legislative', 'reform', 'of', 'diagnostic', 'regulation', 'in', 'both', 'emergency', 'and', 'non', 'emergency', 'contexts', 'At', 'the', 'same', 'time', 'rushing', 'radical', 'legislative', 'changes', 'especially', 'if', 'they', 'have', 'not', 'been', 'subject', 'to', 'careful', 'stakeholder', 'engagement', 'and', 'Congressional', 'deliberation', 'in', 'advance', 'is', 'precarious', 'and', 'could', 'result', 'in', 'reckless', 'and', 'disruptive', 'changes', 'We', 'review', 'and', 'apply', 'the', 'historical', 'lessons', 'of', 'legislating', 'in', 'response', 'to', 'a', 'crisis', 'and', 'conclude', 'the', 'one', 'but', 'not', 'both', 'of', 'the', 'pending', 'legislative', 'proposals', 'may', 'satisfy', 'the', 'criteria', 'for', 'an', 'appropriate', 'opportunistic', 'change', 'for', 'diagnostics', 'regulation', '']"
27521,A Review of the Diagnosis and Management of Hepatitis E,2020-07-17,Curr Treat Options Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366488/,"PURPOSE OF REVIEW: We aim to provide the readers an up-to-date knowledge of the structure, epidemiology, and transmission followed by a detailed discussion on testing, diagnostics and management of hepatitis E virus infection. We have also included a comprehensive review of hepatitis E in pregnancy. RECENT FINDINGS: European Association for the Study of the Liver established clinical practice guidelines for testing and treatment of suspected hepatitis E virus infections in 2018. Evidence suggests chronic hepatitis E may follow a course similar to hepatitis B/C with progression to cirrhosis and possibly hepatocellular carcinoma in immunocompromised patients. SUMMARY: Hepatitis E virus is the most common cause of acute viral hepatitis worldwide. A combination of serology and nucleic acid amplification testing is the recommended strategy for suspected patients. Ribavirin therapy for a period of 3 months is the drug of choice for severe acute hepatitis, acute-on chronic liver failure, and chronic infections from hepatitis E virus in immunocompromised patients who are unresponsive to decreased immunosuppression. PEGylated interferon α can be used for ribavirin-resistant liver transplant patients with chronic hepatitis E. Further research in therapeutic options is essential considering the stormy course of hepatitis E infection during pregnancy and teratogenicity of all available options.",10.1007/s40506-020-00235-4,06ur0oip,"['PURPOSE', 'OF', 'REVIEW', 'We', 'aim', 'to', 'provide', 'the', 'readers', 'an', 'up', 'to', 'date', 'knowledge', 'of', 'the', 'structure', 'epidemiology', 'and', 'transmission', 'followed', 'by', 'a', 'detailed', 'discussion', 'on', 'testing', 'diagnostics', 'and', 'management', 'of', 'hepatitis', 'E', 'virus', 'infection', 'We', 'have', 'also', 'included', 'a', 'comprehensive', 'review', 'of', 'hepatitis', 'E', 'in', 'pregnancy', 'RECENT', 'FINDINGS', 'European', 'Association', 'for', 'the', 'Study', 'of', 'the', 'Liver', 'established', 'clinical', 'practice', 'guidelines', 'for', 'testing', 'and', 'treatment', 'of', 'suspected', 'hepatitis', 'E', 'virus', 'infections', 'in', '2018', 'Evidence', 'suggests', 'chronic', 'hepatitis', 'E', 'may', 'follow', 'a', 'course', 'similar', 'to', 'hepatitis', 'B', 'C', 'with', 'progression', 'to', 'cirrhosis', 'and', 'possibly', 'hepatocellular', 'carcinoma', 'in', 'immunocompromised', 'patients', 'SUMMARY', 'Hepatitis', 'E', 'virus', 'is', 'the', 'most', 'common', 'cause', 'of', 'acute', 'viral', 'hepatitis', 'worldwide', 'A', 'combination', 'of', 'serology', 'and', 'nucleic', 'acid', 'amplification', 'testing', 'is', 'the', 'recommended', 'strategy', 'for', 'suspected', 'patients', 'Ribavirin', 'therapy', 'for', 'a', 'period', 'of', '3', 'months', 'is', 'the', 'drug', 'of', 'choice', 'for', 'severe', 'acute', 'hepatitis', 'acute', 'on', 'chronic', 'liver', 'failure', 'and', 'chronic', 'infections', 'from', 'hepatitis', 'E', 'virus', 'in', 'immunocompromised', 'patients', 'who', 'are', 'unresponsive', 'to', 'decreased', 'immunosuppression', 'PEGylated', 'interferon', 'α', 'can', 'be', 'used', 'for', 'ribavirin', 'resistant', 'liver', 'transplant', 'patients', 'with', 'chronic', 'hepatitis', 'E', 'Further', 'research', 'in', 'therapeutic', 'options', 'is', 'essential', 'considering', 'the', 'stormy', 'course', 'of', 'hepatitis', 'E', 'infection', 'during', 'pregnancy', 'and', 'teratogenicity', 'of', 'all', 'available', 'options', '']"
28537,Improvements in Patient Monitoring for the Intensive Care Unit: Survey Study.,2020-05-13,Journal of medical Internet research,https://doi.org/10.2196/19091; https://www.ncbi.nlm.nih.gov/pubmed/32459655/,"BACKGROUND Due to demographic change and, more recently, the Coronavirus Disease 2019 (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be related to the lack of user involvement in research and development. OBJECTIVE This study focused on satisfaction of ICU staff with the current patient monitoring and their suggestions for future improvements. We aimed to identify aspects disturbing patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff is willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further desired to uncover differences in the responses of the professional groups. METHODS This survey study was realized with ICU staff from four ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire by analyzing a preceding qualitative interview study with ICU staff about clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and Chi-square tests to compare the distributions of item responses of the professional groups. RESULTS Eighty-six of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated to feel confident using the patient monitoring, but high rates of false positive alarms and the many sensor cables were considered to disturb patient care. Wireless sensors, reduction of false positive alarms and hospital standard operating procedures (SOP) for alarm management were demanded. Responses to the display devices proposed for remote patient monitoring were split. Regarding its use, most respondents indicated responsibility for multiple wards or earlier alerting. AI for ICUs would be useful for early detection of complications and increased risk of mortality, as well as to have guidelines for therapy and diagnostics proposed. Transparency, interoperability, usability, and staff training were essential to promote usage of an AI. The majority wanted to learn more about new technologies for ICU and desired more time for it. Physicians had fewer reservations than nurses about using mobile phones for remote monitoring, and AI-based intelligent alarm management. CONCLUSIONS This survey study among ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm SOPs, introducing wireless sensors, preparing for the use of AI, and enhancing digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. CLINICALTRIAL ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",10.2196/19091,kml27hvb,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'the', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'related', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'the', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'disturbing', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'is', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'desired', 'to', 'uncover', 'differences', 'in', 'the', 'responses', 'of', 'the', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'realized', 'with', 'ICU', 'staff', 'from', 'four', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'Chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'Eighty', 'six', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'to', 'feel', 'confident', 'using', 'the', 'patient', 'monitoring', 'but', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'were', 'considered', 'to', 'disturb', 'patient', 'care', 'Wireless', 'sensors', 'reduction', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'SOP', 'for', 'alarm', 'management', 'were', 'demanded', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'split', 'Regarding', 'its', 'use', 'most', 'respondents', 'indicated', 'responsibility', 'for', 'multiple', 'wards', 'or', 'earlier', 'alerting', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'increased', 'risk', 'of', 'mortality', 'as', 'well', 'as', 'to', 'have', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'proposed', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'usage', 'of', 'an', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'ICU', 'and', 'desired', 'more', 'time', 'for', 'it', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'and', 'AI', 'based', 'intelligent', 'alarm', 'management', 'CONCLUSIONS', 'This', 'survey', 'study', 'among', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'SOPs', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'CLINICALTRIAL', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
28760,Advances in multiparametric molecular diagnostics technologies for respiratory tract infections.,2013,Current opinion in pulmonary medicine,https://doi.org/10.1097/mcp.0b013e32835f1b32; https://www.ncbi.nlm.nih.gov/pubmed/23425918/,"PURPOSE OF REVIEW Respiratory tract infections (RTIs) are caused by a variety of bacterial, viral, fungal, and other pathogens and cause millions of deaths each year. Current standard microbiological culture-based tests are laborious and time consuming. Thus, patients are initially treated empirically, leading to inappropriate use of antibiotics. The purpose of this article is to provide clinicians and scientists with a review of recently available commercial multiparametric molecular diagnostics tests for the detection of RTIs so that they can be considered for use instead of, or in combination with, traditional culture techniques. RECENT FINDINGS Several technologies have become commercially available for the multiparametric molecular detection of RTIs in the past decade including tests based on PCR-array, PCR-mass spectrometry, and multiplex qPCR technologies. The majority of these tests are for the detection of viruses, but more recently companies have begun to focus on detection of viruses, bacteria, and associated drug resistances in a single product to maximize the information provided to the clinician by a single test. SUMMARY We describe the recent advances in commercial multiparametric molecular diagnostics technologies for the diagnosis of RTIs. Combining the specific and sensitive molecular detection of bacteria, viruses, fungi, and drug resistances is key if molecular methods are to replace traditional culture. The reliability of the molecular drug-resistance markers chosen, the need for the quantitative detection of some organisms, and throughput are also important considerations for new technology developers.",10.1097/mcp.0b013e32835f1b32,hkqzmlo9,"['PURPOSE', 'OF', 'REVIEW', 'Respiratory', 'tract', 'infections', 'RTIs', 'are', 'caused', 'by', 'a', 'variety', 'of', 'bacterial', 'viral', 'fungal', 'and', 'other', 'pathogens', 'and', 'cause', 'millions', 'of', 'deaths', 'each', 'year', 'Current', 'standard', 'microbiological', 'culture', 'based', 'tests', 'are', 'laborious', 'and', 'time', 'consuming', 'Thus', 'patients', 'are', 'initially', 'treated', 'empirically', 'leading', 'to', 'inappropriate', 'use', 'of', 'antibiotics', 'The', 'purpose', 'of', 'this', 'article', 'is', 'to', 'provide', 'clinicians', 'and', 'scientists', 'with', 'a', 'review', 'of', 'recently', 'available', 'commercial', 'multiparametric', 'molecular', 'diagnostics', 'tests', 'for', 'the', 'detection', 'of', 'RTIs', 'so', 'that', 'they', 'can', 'be', 'considered', 'for', 'use', 'instead', 'of', 'or', 'in', 'combination', 'with', 'traditional', 'culture', 'techniques', 'RECENT', 'FINDINGS', 'Several', 'technologies', 'have', 'become', 'commercially', 'available', 'for', 'the', 'multiparametric', 'molecular', 'detection', 'of', 'RTIs', 'in', 'the', 'past', 'decade', 'including', 'tests', 'based', 'on', 'PCR', 'array', 'PCR', 'mass', 'spectrometry', 'and', 'multiplex', 'qPCR', 'technologies', 'The', 'majority', 'of', 'these', 'tests', 'are', 'for', 'the', 'detection', 'of', 'viruses', 'but', 'more', 'recently', 'companies', 'have', 'begun', 'to', 'focus', 'on', 'detection', 'of', 'viruses', 'bacteria', 'and', 'associated', 'drug', 'resistances', 'in', 'a', 'single', 'product', 'to', 'maximize', 'the', 'information', 'provided', 'to', 'the', 'clinician', 'by', 'a', 'single', 'test', 'SUMMARY', 'We', 'describe', 'the', 'recent', 'advances', 'in', 'commercial', 'multiparametric', 'molecular', 'diagnostics', 'technologies', 'for', 'the', 'diagnosis', 'of', 'RTIs', 'Combining', 'the', 'specific', 'and', 'sensitive', 'molecular', 'detection', 'of', 'bacteria', 'viruses', 'fungi', 'and', 'drug', 'resistances', 'is', 'key', 'if', 'molecular', 'methods', 'are', 'to', 'replace', 'traditional', 'culture', 'The', 'reliability', 'of', 'the', 'molecular', 'drug', 'resistance', 'markers', 'chosen', 'the', 'need', 'for', 'the', 'quantitative', 'detection', 'of', 'some', 'organisms', 'and', 'throughput', 'are', 'also', 'important', 'considerations', 'for', 'new', 'technology', 'developers', '']"
28766,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois.",2020-07-09,Current opinion in rheumatology,https://doi.org/10.1097/bor.0000000000000728; https://www.ncbi.nlm.nih.gov/pubmed/32657802/,"BACKGROUND Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",10.1097/bor.0000000000000728,ugx8unte,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
29169,The challenge of diagnostic metagenomics.,2018,Expert review of molecular diagnostics,https://doi.org/10.1080/14737159.2018.1487292; https://www.ncbi.nlm.nih.gov/pubmed/29898605/,"INTRODUCTION Diagnostic metagenomics and its associated trail of publications are spreading across the world. Multiple clinical labs in the United States, Europe, and Asia have gone to considerable lengths to optimize and validate a range of protocols for agnostically detecting viral, bacterial, fungal, and eukaryotic parasite nucleic acid across a range of patient specimens to aid in diagnosis for particularly recalcitrant cases. Others see a role for diagnostic metagenomics as a frontline diagnostic to replace other microbiological testing. Areas covered: There are considerable barriers to adoption for diagnostic metagenomics, including analytical sensitivity, interpretation, actionability, turnaround time, antimicrobial susceptibility, clinical utility, laboratory workflow, trial comparators, cost, and reimbursement. Expert commentary: Metagenomics is unlikely to become 'one test to rule them all' any time soon, not least because it is not indicative of historical infection like some of the highest volume tests in the clinical virology lab, viral serologies. The high cost and low marginal utility compared to 'standard of care' diagnostics have forced metagenomics to be mostly used for last-ditch cases. However, waiting for such patients to declare themselves as being diagnostically challenging in turn likely lessens the diagnostic yield and actionability of the information. Significant reductions in the cost of metagenomic sequencing are required for it to move up in the diagnostic pipeline. This review covers these associated obstacles of metagenomics, arguing for a parsimonious role in last-ditch diagnostics and awaiting the answer of many outstanding questions regarding its adoption.",10.1080/14737159.2018.1487292,i4djqpbn,"['INTRODUCTION', 'Diagnostic', 'metagenomics', 'and', 'its', 'associated', 'trail', 'of', 'publications', 'are', 'spreading', 'across', 'the', 'world', 'Multiple', 'clinical', 'labs', 'in', 'the', 'United', 'States', 'Europe', 'and', 'Asia', 'have', 'gone', 'to', 'considerable', 'lengths', 'to', 'optimize', 'and', 'validate', 'a', 'range', 'of', 'protocols', 'for', 'agnostically', 'detecting', 'viral', 'bacterial', 'fungal', 'and', 'eukaryotic', 'parasite', 'nucleic', 'acid', 'across', 'a', 'range', 'of', 'patient', 'specimens', 'to', 'aid', 'in', 'diagnosis', 'for', 'particularly', 'recalcitrant', 'cases', 'Others', 'see', 'a', 'role', 'for', 'diagnostic', 'metagenomics', 'as', 'a', 'frontline', 'diagnostic', 'to', 'replace', 'other', 'microbiological', 'testing', 'Areas', 'covered', 'There', 'are', 'considerable', 'barriers', 'to', 'adoption', 'for', 'diagnostic', 'metagenomics', 'including', 'analytical', 'sensitivity', 'interpretation', 'actionability', 'turnaround', 'time', 'antimicrobial', 'susceptibility', 'clinical', 'utility', 'laboratory', 'workflow', 'trial', 'comparators', 'cost', 'and', 'reimbursement', 'Expert', 'commentary', 'Metagenomics', 'is', 'unlikely', 'to', 'become', 'one', 'test', 'to', 'rule', 'them', 'all', 'any', 'time', 'soon', 'not', 'least', 'because', 'it', 'is', 'not', 'indicative', 'of', 'historical', 'infection', 'like', 'some', 'of', 'the', 'highest', 'volume', 'tests', 'in', 'the', 'clinical', 'virology', 'lab', 'viral', 'serologies', 'The', 'high', 'cost', 'and', 'low', 'marginal', 'utility', 'compared', 'to', 'standard', 'of', 'care', 'diagnostics', 'have', 'forced', 'metagenomics', 'to', 'be', 'mostly', 'used', 'for', 'last', 'ditch', 'cases', 'However', 'waiting', 'for', 'such', 'patients', 'to', 'declare', 'themselves', 'as', 'being', 'diagnostically', 'challenging', 'in', 'turn', 'likely', 'lessens', 'the', 'diagnostic', 'yield', 'and', 'actionability', 'of', 'the', 'information', 'Significant', 'reductions', 'in', 'the', 'cost', 'of', 'metagenomic', 'sequencing', 'are', 'required', 'for', 'it', 'to', 'move', 'up', 'in', 'the', 'diagnostic', 'pipeline', 'This', 'review', 'covers', 'these', 'associated', 'obstacles', 'of', 'metagenomics', 'arguing', 'for', 'a', 'parsimonious', 'role', 'in', 'last', 'ditch', 'diagnostics', 'and', 'awaiting', 'the', 'answer', 'of', 'many', 'outstanding', 'questions', 'regarding', 'its', 'adoption', '']"
30524,Automated nucleic acid isolation in viral molecular diagnostics: evaluation of the QIAsymphony SP.,2012,British journal of biomedical science,https://doi.org/10.1080/09674845.2012.11669917; https://www.ncbi.nlm.nih.gov/pubmed/22558800/,"The Qiagen QIAsymphony SP is a high-throughput (up to 96 samples per run), fully-automated nucleic acid isolation system. It was implemented in the authors' laboratory to cope with the high demand for pandemic H1N1 influenza testing in 2009. This study evaluated the QIAsymphony SP for viral nucleic acid isolation from quality control materials, pure cultures and various clinical specimens. The effect of varying sample volume on detection sensitivity was investigated using serial 10-fold dilutions of pure viral specimens and target nucleic acids were detected by real-time polymerase chain reaction (PCR) assays. Little variability in detection sensitivity was observed for all the viral targets tested, although variation in cycle threshold values was apparent in some cases. Importantly, pathogens were detectable over a broad concentration range and from diverse clinical specimens. Removal of PCR inhibitors was generally effective, as demonstrated by detection of viral nucleic acids and/or internal controls. The results demonstrate that the QIAsymphony SP is suitable for use in routine virology molecular diagnostics, and provides a high-throughput capacity, which is needed in peak seasons of infection or in centralised laboratories.",10.1080/09674845.2012.11669917,o0hu0flg,"['The', 'Qiagen', 'QIAsymphony', 'SP', 'is', 'a', 'high', 'throughput', 'up', 'to', '96', 'samples', 'per', 'run', 'fully', 'automated', 'nucleic', 'acid', 'isolation', 'system', 'It', 'was', 'implemented', 'in', 'the', 'authors', 'laboratory', 'to', 'cope', 'with', 'the', 'high', 'demand', 'for', 'pandemic', 'H1N1', 'influenza', 'testing', 'in', '2009', 'This', 'study', 'evaluated', 'the', 'QIAsymphony', 'SP', 'for', 'viral', 'nucleic', 'acid', 'isolation', 'from', 'quality', 'control', 'materials', 'pure', 'cultures', 'and', 'various', 'clinical', 'specimens', 'The', 'effect', 'of', 'varying', 'sample', 'volume', 'on', 'detection', 'sensitivity', 'was', 'investigated', 'using', 'serial', '10', 'fold', 'dilutions', 'of', 'pure', 'viral', 'specimens', 'and', 'target', 'nucleic', 'acids', 'were', 'detected', 'by', 'real', 'time', 'polymerase', 'chain', 'reaction', 'PCR', 'assays', 'Little', 'variability', 'in', 'detection', 'sensitivity', 'was', 'observed', 'for', 'all', 'the', 'viral', 'targets', 'tested', 'although', 'variation', 'in', 'cycle', 'threshold', 'values', 'was', 'apparent', 'in', 'some', 'cases', 'Importantly', 'pathogens', 'were', 'detectable', 'over', 'a', 'broad', 'concentration', 'range', 'and', 'from', 'diverse', 'clinical', 'specimens', 'Removal', 'of', 'PCR', 'inhibitors', 'was', 'generally', 'effective', 'as', 'demonstrated', 'by', 'detection', 'of', 'viral', 'nucleic', 'acids', 'and', 'or', 'internal', 'controls', 'The', 'results', 'demonstrate', 'that', 'the', 'QIAsymphony', 'SP', 'is', 'suitable', 'for', 'use', 'in', 'routine', 'virology', 'molecular', 'diagnostics', 'and', 'provides', 'a', 'high', 'throughput', 'capacity', 'which', 'is', 'needed', 'in', 'peak', 'seasons', 'of', 'infection', 'or', 'in', 'centralised', 'laboratories', '']"
30780,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens.,2020-04-27,Journal of clinical microbiology,https://doi.org/10.1128/jcm.00743-20; https://www.ncbi.nlm.nih.gov/pubmed/32341143/,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (Modified CDC), the Simplexa COVID-19 Direct (Diasorin Molecular), GenMark ePlex SARS-CoV-2 assay (GenMark) and the Hologic Panther Fusion® SARS-CoV-2 assay (Hologic). This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.",10.1128/jcm.00743-20,b0qtzzac,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'the', 'novel', 'human', 'coronavirus', 'that', 'causes', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'first', 'discovered', 'in', 'December', '2019', 'as', 'the', 'cause', 'of', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'non', 'specific', 'and', 'symptoms', 'overlap', 'with', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Furthermore', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'have', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'Emergency', 'Use', 'Authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'the', 'New', 'York', 'SARS', 'CoV', '2', 'Real', 'time', 'Reverse', 'Transcriptase', 'RT', 'PCR', 'Diagnostic', 'Panel', 'Modified', 'CDC', 'the', 'Simplexa', 'COVID', '19', 'Direct', 'Diasorin', 'Molecular', 'GenMark', 'ePlex', 'SARS', 'CoV', '2', 'assay', 'GenMark', 'and', 'the', 'Hologic', 'Panther', 'Fusion', 'SARS', 'CoV', '2', 'assay', 'Hologic', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
30950,Emerging microbiology diagnostics for transplant infections: On the cusp of a paradigm shift.,2020-01-14,Transplantation,https://doi.org/10.1097/tp.0000000000003123; https://www.ncbi.nlm.nih.gov/pubmed/31972701/,"In light of the heightened risk for infection associated with solid organ and hematopoietic stem cell transplantation, rapid and accurate microbiology diagnostics are essential to the practice of transplant clinicians, including infectious diseases specialists. In the last decade, diagnostic microbiology has seen a shift towards culture-independent techniques including single-target and multiplexed molecular testing, mass-spectrometry, and magnetic resonance-based methods which have together greatly expanded the array of pathogens identified, increased processing speed and throughput, allowed for detection of resistance determinants, and ultimately improved the outcomes of infected transplant recipients. More recently, a newer generation of diagnostics with immense potential has emerged, including multiplexed molecular panels directly applicable to blood and blood culture specimens, next-generation metagenomics and gas chromatography mass spectrometry. Though these methods have some recognized drawbacks, many have already demonstrated improved diagnostic sensitivity and a positive impact on clinical outcomes in transplant and immunocompromised patients.",10.1097/tp.0000000000003123,p2bp5in2,"['In', 'light', 'of', 'the', 'heightened', 'risk', 'for', 'infection', 'associated', 'with', 'solid', 'organ', 'and', 'hematopoietic', 'stem', 'cell', 'transplantation', 'rapid', 'and', 'accurate', 'microbiology', 'diagnostics', 'are', 'essential', 'to', 'the', 'practice', 'of', 'transplant', 'clinicians', 'including', 'infectious', 'diseases', 'specialists', 'In', 'the', 'last', 'decade', 'diagnostic', 'microbiology', 'has', 'seen', 'a', 'shift', 'towards', 'culture', 'independent', 'techniques', 'including', 'single', 'target', 'and', 'multiplexed', 'molecular', 'testing', 'mass', 'spectrometry', 'and', 'magnetic', 'resonance', 'based', 'methods', 'which', 'have', 'together', 'greatly', 'expanded', 'the', 'array', 'of', 'pathogens', 'identified', 'increased', 'processing', 'speed', 'and', 'throughput', 'allowed', 'for', 'detection', 'of', 'resistance', 'determinants', 'and', 'ultimately', 'improved', 'the', 'outcomes', 'of', 'infected', 'transplant', 'recipients', 'More', 'recently', 'a', 'newer', 'generation', 'of', 'diagnostics', 'with', 'immense', 'potential', 'has', 'emerged', 'including', 'multiplexed', 'molecular', 'panels', 'directly', 'applicable', 'to', 'blood', 'and', 'blood', 'culture', 'specimens', 'next', 'generation', 'metagenomics', 'and', 'gas', 'chromatography', 'mass', 'spectrometry', 'Though', 'these', 'methods', 'have', 'some', 'recognized', 'drawbacks', 'many', 'have', 'already', 'demonstrated', 'improved', 'diagnostic', 'sensitivity', 'and', 'a', 'positive', 'impact', 'on', 'clinical', 'outcomes', 'in', 'transplant', 'and', 'immunocompromised', 'patients', '']"
31475,Sequencing of animal viruses: quality data assurance for NGS bioinformatics.,2019-11-21,Virology journal,https://doi.org/10.1186/s12985-019-1223-8; https://www.ncbi.nlm.nih.gov/pubmed/31752912/,"BACKGROUND Next generation sequencing (NGS) is becoming widely used among diagnostics and research laboratories, and nowadays it is applied to a variety of disciplines, including veterinary virology. The NGS workflow comprises several steps, namely sample processing, library preparation, sequencing and primary/secondary/tertiary bioinformatics (BI) analyses. The latter is constituted by a complex process extremely difficult to standardize, due to the variety of tools and metrics available. Thus, it is of the utmost importance to assess the comparability of results obtained through different methods and in different laboratories. To achieve this goal, we have organized a proficiency test focused on the bioinformatics components for the generation of complete genome sequences of salmonid rhabdoviruses. METHODS Three partners, that performed virus sequencing using different commercial library preparation kits and NGS platforms, gathered together and shared with each other 75 raw datasets which were analyzed separately by the participants to produce a consensus sequence according to their own bioinformatics pipeline. Results were then compared to highlight discrepancies, and a subset of inconsistencies were investigated more in detail. RESULTS In total, we observed 526 discrepancies, of which 39.5% were located at genome termini, 14.1% at intergenic regions and 46.4% at coding regions. Among these, 10 SNPs and 99 indels caused changes in the protein products. Overall reproducibility was 99.94%. Based on the analysis of a subset of inconsistencies investigated more in-depth, manual curation appeared the most critical step affecting sequence comparability, suggesting that the harmonization of this phase is crucial to obtain comparable results. The analysis of a calibrator sample allowed assessing BI accuracy, being 99.983%. CONCLUSIONS We demonstrated the applicability and the usefulness of BI proficiency testing to assure the quality of NGS data, and recommend a wider implementation of such exercises to guarantee sequence data uniformity among different virology laboratories.",10.1186/s12985-019-1223-8,sjwyaz3g,"['BACKGROUND', 'Next', 'generation', 'sequencing', 'NGS', 'is', 'becoming', 'widely', 'used', 'among', 'diagnostics', 'and', 'research', 'laboratories', 'and', 'nowadays', 'it', 'is', 'applied', 'to', 'a', 'variety', 'of', 'disciplines', 'including', 'veterinary', 'virology', 'The', 'NGS', 'workflow', 'comprises', 'several', 'steps', 'namely', 'sample', 'processing', 'library', 'preparation', 'sequencing', 'and', 'primary', 'secondary', 'tertiary', 'bioinformatics', 'BI', 'analyses', 'The', 'latter', 'is', 'constituted', 'by', 'a', 'complex', 'process', 'extremely', 'difficult', 'to', 'standardize', 'due', 'to', 'the', 'variety', 'of', 'tools', 'and', 'metrics', 'available', 'Thus', 'it', 'is', 'of', 'the', 'utmost', 'importance', 'to', 'assess', 'the', 'comparability', 'of', 'results', 'obtained', 'through', 'different', 'methods', 'and', 'in', 'different', 'laboratories', 'To', 'achieve', 'this', 'goal', 'we', 'have', 'organized', 'a', 'proficiency', 'test', 'focused', 'on', 'the', 'bioinformatics', 'components', 'for', 'the', 'generation', 'of', 'complete', 'genome', 'sequences', 'of', 'salmonid', 'rhabdoviruses', 'METHODS', 'Three', 'partners', 'that', 'performed', 'virus', 'sequencing', 'using', 'different', 'commercial', 'library', 'preparation', 'kits', 'and', 'NGS', 'platforms', 'gathered', 'together', 'and', 'shared', 'with', 'each', 'other', '75', 'raw', 'datasets', 'which', 'were', 'analyzed', 'separately', 'by', 'the', 'participants', 'to', 'produce', 'a', 'consensus', 'sequence', 'according', 'to', 'their', 'own', 'bioinformatics', 'pipeline', 'Results', 'were', 'then', 'compared', 'to', 'highlight', 'discrepancies', 'and', 'a', 'subset', 'of', 'inconsistencies', 'were', 'investigated', 'more', 'in', 'detail', 'RESULTS', 'In', 'total', 'we', 'observed', '526', 'discrepancies', 'of', 'which', '39', '5', 'were', 'located', 'at', 'genome', 'termini', '14', '1', 'at', 'intergenic', 'regions', 'and', '46', '4', 'at', 'coding', 'regions', 'Among', 'these', '10', 'SNPs', 'and', '99', 'indels', 'caused', 'changes', 'in', 'the', 'protein', 'products', 'Overall', 'reproducibility', 'was', '99', '94', 'Based', 'on', 'the', 'analysis', 'of', 'a', 'subset', 'of', 'inconsistencies', 'investigated', 'more', 'in', 'depth', 'manual', 'curation', 'appeared', 'the', 'most', 'critical', 'step', 'affecting', 'sequence', 'comparability', 'suggesting', 'that', 'the', 'harmonization', 'of', 'this', 'phase', 'is', 'crucial', 'to', 'obtain', 'comparable', 'results', 'The', 'analysis', 'of', 'a', 'calibrator', 'sample', 'allowed', 'assessing', 'BI', 'accuracy', 'being', '99', '983', 'CONCLUSIONS', 'We', 'demonstrated', 'the', 'applicability', 'and', 'the', 'usefulness', 'of', 'BI', 'proficiency', 'testing', 'to', 'assure', 'the', 'quality', 'of', 'NGS', 'data', 'and', 'recommend', 'a', 'wider', 'implementation', 'of', 'such', 'exercises', 'to', 'guarantee', 'sequence', 'data', 'uniformity', 'among', 'different', 'virology', 'laboratories', '']"
32608,Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection.,2014,Scandinavian journal of infectious diseases,https://doi.org/10.3109/00365548.2014.951681; https://www.ncbi.nlm.nih.gov/pubmed/25288382/,"Recently, molecular methods capable of detecting almost all microbial agents that may cause acute respiratory infection have been introduced. The FilmArray Respiratory Panel assay, which integrates nucleic acid extraction, nested amplification and detection in a reaction pouch preloaded with all reagents required for detection of 17 viruses and 3 bacteria, was compared with an in-house real-time PCR that detects these agents in 8 parallel amplifications. When 128 clinical samples representing 18 of these agents were analysed by both assays the agreement was excellent, with kappa values ranging between 0.54 and 1.0. Discordances were mainly observed for adenovirus, but not when version 1.7 of FilmArray was used. The results show that these assays detect a wide range of pathogens with similar performance. FilmArray provides results after approximately 1 h, including ≈ 5 min hands-on time, and does not require advanced equipment or expertise in molecular diagnostics, making it a useful point-of-care-test for acute respiratory infections.",10.3109/00365548.2014.951681,9akav68d,"['Recently', 'molecular', 'methods', 'capable', 'of', 'detecting', 'almost', 'all', 'microbial', 'agents', 'that', 'may', 'cause', 'acute', 'respiratory', 'infection', 'have', 'been', 'introduced', 'The', 'FilmArray', 'Respiratory', 'Panel', 'assay', 'which', 'integrates', 'nucleic', 'acid', 'extraction', 'nested', 'amplification', 'and', 'detection', 'in', 'a', 'reaction', 'pouch', 'preloaded', 'with', 'all', 'reagents', 'required', 'for', 'detection', 'of', '17', 'viruses', 'and', '3', 'bacteria', 'was', 'compared', 'with', 'an', 'in', 'house', 'real', 'time', 'PCR', 'that', 'detects', 'these', 'agents', 'in', '8', 'parallel', 'amplifications', 'When', '128', 'clinical', 'samples', 'representing', '18', 'of', 'these', 'agents', 'were', 'analysed', 'by', 'both', 'assays', 'the', 'agreement', 'was', 'excellent', 'with', 'kappa', 'values', 'ranging', 'between', '0', '54', 'and', '1', '0', 'Discordances', 'were', 'mainly', 'observed', 'for', 'adenovirus', 'but', 'not', 'when', 'version', '1', '7', 'of', 'FilmArray', 'was', 'used', 'The', 'results', 'show', 'that', 'these', 'assays', 'detect', 'a', 'wide', 'range', 'of', 'pathogens', 'with', 'similar', 'performance', 'FilmArray', 'provides', 'results', 'after', 'approximately', '1', 'h', 'including', '5', 'min', 'hands', 'on', 'time', 'and', 'does', 'not', 'require', 'advanced', 'equipment', 'or', 'expertise', 'in', 'molecular', 'diagnostics', 'making', 'it', 'a', 'useful', 'point', 'of', 'care', 'test', 'for', 'acute', 'respiratory', 'infections', '']"
33401,Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).,2020-05-11,Acta bio-medica : Atenei Parmensis,https://doi.org/10.23750/abm.v91i2.9548; https://www.ncbi.nlm.nih.gov/pubmed/32420937/,"Laboratory medicine provides an almost irreplaceable contribution to the diagnostic reasoning and managed care of most human pathologies. The novel coronavirus disease 2019 (COVID-19) is not an exception to this paradigm. Although the relatively recent emergence does not allow to draw definitive conclusions on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, some standpoints can be conveyed. First and foremost, it seems now clear that we will be living together with this virus for quite a long time, so that our vigilance and responsiveness against the emergence of new local outbreaks shall be maintained at the highest possible levels. The etiological diagnosis of COVID-19 is, and will remain for the foreseeable future, deeply based on direct identification of viral RNA by means of molecular biology techniques in biological materials, especially upper and lower respiratory tract specimens. Whether other materials, such as blood, urine, stools, saliva and throat washing, will become valid alternatives has not been unequivocally defined so far. As concerns serological testing, promising information can be garnered from preliminary investigations, showing that the vast majority of COVID-19 patients seem to develop a sustained immune response against the virus, characterized especially by emergence of anti-SARS-CoV-2 IgG and IgA, 1 to 2 weeks after the onset of fever and/or respiratory symptoms. Whether these antibodies will have persistent neutralizing activity against the virus is still to be elucidated on individual and general basis. The availability of rapid tests for detecting either viral antigens or anti-SARS-CoV-2 antibodies are a potentially viable opportunity for purposes of epidemiologic surveillance, though more information is needed on accuracy and reliability of these portable immunoassays.",10.23750/abm.v91i2.9548,r2rnnsfh,"['Laboratory', 'medicine', 'provides', 'an', 'almost', 'irreplaceable', 'contribution', 'to', 'the', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'most', 'human', 'pathologies', 'The', 'novel', 'coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'not', 'an', 'exception', 'to', 'this', 'paradigm', 'Although', 'the', 'relatively', 'recent', 'emergence', 'does', 'not', 'allow', 'to', 'draw', 'definitive', 'conclusions', 'on', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'diagnostics', 'some', 'standpoints', 'can', 'be', 'conveyed', 'First', 'and', 'foremost', 'it', 'seems', 'now', 'clear', 'that', 'we', 'will', 'be', 'living', 'together', 'with', 'this', 'virus', 'for', 'quite', 'a', 'long', 'time', 'so', 'that', 'our', 'vigilance', 'and', 'responsiveness', 'against', 'the', 'emergence', 'of', 'new', 'local', 'outbreaks', 'shall', 'be', 'maintained', 'at', 'the', 'highest', 'possible', 'levels', 'The', 'etiological', 'diagnosis', 'of', 'COVID', '19', 'is', 'and', 'will', 'remain', 'for', 'the', 'foreseeable', 'future', 'deeply', 'based', 'on', 'direct', 'identification', 'of', 'viral', 'RNA', 'by', 'means', 'of', 'molecular', 'biology', 'techniques', 'in', 'biological', 'materials', 'especially', 'upper', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'Whether', 'other', 'materials', 'such', 'as', 'blood', 'urine', 'stools', 'saliva', 'and', 'throat', 'washing', 'will', 'become', 'valid', 'alternatives', 'has', 'not', 'been', 'unequivocally', 'defined', 'so', 'far', 'As', 'concerns', 'serological', 'testing', 'promising', 'information', 'can', 'be', 'garnered', 'from', 'preliminary', 'investigations', 'showing', 'that', 'the', 'vast', 'majority', 'of', 'COVID', '19', 'patients', 'seem', 'to', 'develop', 'a', 'sustained', 'immune', 'response', 'against', 'the', 'virus', 'characterized', 'especially', 'by', 'emergence', 'of', 'anti', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', '1', 'to', '2', 'weeks', 'after', 'the', 'onset', 'of', 'fever', 'and', 'or', 'respiratory', 'symptoms', 'Whether', 'these', 'antibodies', 'will', 'have', 'persistent', 'neutralizing', 'activity', 'against', 'the', 'virus', 'is', 'still', 'to', 'be', 'elucidated', 'on', 'individual', 'and', 'general', 'basis', 'The', 'availability', 'of', 'rapid', 'tests', 'for', 'detecting', 'either', 'viral', 'antigens', 'or', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'are', 'a', 'potentially', 'viable', 'opportunity', 'for', 'purposes', 'of', 'epidemiologic', 'surveillance', 'though', 'more', 'information', 'is', 'needed', 'on', 'accuracy', 'and', 'reliability', 'of', 'these', 'portable', 'immunoassays', '']"
34389,Traumatic stress in the age of COVID-19: A call to close critical gaps and adapt to new realities.,2020-05-01,"Psychological trauma : theory, research, practice and policy",https://doi.org/10.1037/tra0000592; https://www.ncbi.nlm.nih.gov/pubmed/32271070/,"THE ISSUE Coronavirus-19 (COVID-19) is transforming every aspect of our lives. Identified in late 2019, COVID-19 quickly became characterized as a global pandemic by March of 2020. Given the rapid acceleration of transmission, and the lack of preparedness to prevent and treat this virus, the negative impacts of COVID-19 are rippling through every facet of society. Although large numbers of people throughout the world will show resilience to the profound loss, stress, and fear associated with COVID-19, the virus will likely exacerbate existing mental health disorders and contribute to the onset of new stress-related disorders for many. RECOMMENDATIONS The field of traumatic stress should address the serious needs that will emerge now and well into the future. However, we propose that these efforts may be limited, in part, by ongoing gaps that exist within our research and clinical care. In particular, we suggest that COVID-19 requires us to prioritize and mobilize as a research and clinical community around several key areas: (a) diagnostics, (b) prevention, (c) public outreach and communication, (d) working with medical staff and mainstreaming into nonmental health services, and (e) COVID-19-specific trauma research. As members of our community begin to rapidly develop and test interventions for COVID-19-related distress, we hope that those in positions of leadership in the field of traumatic stress consider limits of our current approaches, and invest the intellectual and financial resources urgently needed in order to innovate, forge partnerships, and develop the technologies to support those in greatest need. (PsycInfo Database Record (c) 2020 APA, all rights reserved).",10.1037/tra0000592,732itf1s,"['THE', 'ISSUE', 'Coronavirus', '19', 'COVID', '19', 'is', 'transforming', 'every', 'aspect', 'of', 'our', 'lives', 'Identified', 'in', 'late', '2019', 'COVID', '19', 'quickly', 'became', 'characterized', 'as', 'a', 'global', 'pandemic', 'by', 'March', 'of', '2020', 'Given', 'the', 'rapid', 'acceleration', 'of', 'transmission', 'and', 'the', 'lack', 'of', 'preparedness', 'to', 'prevent', 'and', 'treat', 'this', 'virus', 'the', 'negative', 'impacts', 'of', 'COVID', '19', 'are', 'rippling', 'through', 'every', 'facet', 'of', 'society', 'Although', 'large', 'numbers', 'of', 'people', 'throughout', 'the', 'world', 'will', 'show', 'resilience', 'to', 'the', 'profound', 'loss', 'stress', 'and', 'fear', 'associated', 'with', 'COVID', '19', 'the', 'virus', 'will', 'likely', 'exacerbate', 'existing', 'mental', 'health', 'disorders', 'and', 'contribute', 'to', 'the', 'onset', 'of', 'new', 'stress', 'related', 'disorders', 'for', 'many', 'RECOMMENDATIONS', 'The', 'field', 'of', 'traumatic', 'stress', 'should', 'address', 'the', 'serious', 'needs', 'that', 'will', 'emerge', 'now', 'and', 'well', 'into', 'the', 'future', 'However', 'we', 'propose', 'that', 'these', 'efforts', 'may', 'be', 'limited', 'in', 'part', 'by', 'ongoing', 'gaps', 'that', 'exist', 'within', 'our', 'research', 'and', 'clinical', 'care', 'In', 'particular', 'we', 'suggest', 'that', 'COVID', '19', 'requires', 'us', 'to', 'prioritize', 'and', 'mobilize', 'as', 'a', 'research', 'and', 'clinical', 'community', 'around', 'several', 'key', 'areas', 'a', 'diagnostics', 'b', 'prevention', 'c', 'public', 'outreach', 'and', 'communication', 'd', 'working', 'with', 'medical', 'staff', 'and', 'mainstreaming', 'into', 'nonmental', 'health', 'services', 'and', 'e', 'COVID', '19', 'specific', 'trauma', 'research', 'As', 'members', 'of', 'our', 'community', 'begin', 'to', 'rapidly', 'develop', 'and', 'test', 'interventions', 'for', 'COVID', '19', 'related', 'distress', 'we', 'hope', 'that', 'those', 'in', 'positions', 'of', 'leadership', 'in', 'the', 'field', 'of', 'traumatic', 'stress', 'consider', 'limits', 'of', 'our', 'current', 'approaches', 'and', 'invest', 'the', 'intellectual', 'and', 'financial', 'resources', 'urgently', 'needed', 'in', 'order', 'to', 'innovate', 'forge', 'partnerships', 'and', 'develop', 'the', 'technologies', 'to', 'support', 'those', 'in', 'greatest', 'need', 'PsycInfo', 'Database', 'Record', 'c', '2020', 'APA', 'all', 'rights', 'reserved', '']"
34751,Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings.,2016,Expert review of molecular diagnostics,https://doi.org/10.1586/14737159.2016.1142877; https://www.ncbi.nlm.nih.gov/pubmed/26777725/,"The striking prevalence of HIV, TB and malaria, as well as outbreaks of emerging infectious diseases, such as influenza A (H7N9), Ebola and MERS, poses great challenges for patient care in resource-limited settings (RLS). However, advanced diagnostic technologies cannot be implemented in RLS largely due to economic constraints. Simple and inexpensive point-of-care (POC) diagnostics, which rely less on environmental context and operator training, have thus been extensively studied to achieve early diagnosis and treatment monitoring in non-laboratory settings. Despite great input from material science, biomedical engineering and nanotechnology for developing POC diagnostics, significant technical challenges are yet to be overcome. Summarized here are the technical challenges associated with POC diagnostics from a RLS perspective and the latest advances in addressing these challenges are reviewed.",10.1586/14737159.2016.1142877,zonxetwx,"['The', 'striking', 'prevalence', 'of', 'HIV', 'TB', 'and', 'malaria', 'as', 'well', 'as', 'outbreaks', 'of', 'emerging', 'infectious', 'diseases', 'such', 'as', 'influenza', 'A', 'H7N9', 'Ebola', 'and', 'MERS', 'poses', 'great', 'challenges', 'for', 'patient', 'care', 'in', 'resource', 'limited', 'settings', 'RLS', 'However', 'advanced', 'diagnostic', 'technologies', 'cannot', 'be', 'implemented', 'in', 'RLS', 'largely', 'due', 'to', 'economic', 'constraints', 'Simple', 'and', 'inexpensive', 'point', 'of', 'care', 'POC', 'diagnostics', 'which', 'rely', 'less', 'on', 'environmental', 'context', 'and', 'operator', 'training', 'have', 'thus', 'been', 'extensively', 'studied', 'to', 'achieve', 'early', 'diagnosis', 'and', 'treatment', 'monitoring', 'in', 'non', 'laboratory', 'settings', 'Despite', 'great', 'input', 'from', 'material', 'science', 'biomedical', 'engineering', 'and', 'nanotechnology', 'for', 'developing', 'POC', 'diagnostics', 'significant', 'technical', 'challenges', 'are', 'yet', 'to', 'be', 'overcome', 'Summarized', 'here', 'are', 'the', 'technical', 'challenges', 'associated', 'with', 'POC', 'diagnostics', 'from', 'a', 'RLS', 'perspective', 'and', 'the', 'latest', 'advances', 'in', 'addressing', 'these', 'challenges', 'are', 'reviewed', '']"
34879,The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection.,2020-06-28,Swiss medical weekly,https://doi.org/10.4414/smw.2020.20312; https://www.ncbi.nlm.nih.gov/pubmed/32662060/,"We present the case of an oncology patient admitted to our hospital during the current COVID-19 pandemic with clinical and radiological features strongly suggestive of interstitial pneumonia. Multiple laboratory tests were negative for SARS-CoV-2 (polymerase chain reaction testing of nasopharyngeal swabs, and of induced sputum and stool samples, investigation of serum immunoglobulins G and M). In the setting of an immunocompromised status due to recent chemotherapy cycles for lung adenocarcinoma and prolonged corticosteroid therapy (due to frequent exacerbations of chronic obstructive pulmonary disease in recent months), we actively searched for the pathological agent and found it to be Pneumocystis jirovecii. The patient started specific antibiotic treatment but finally had a negative outcome due to the progression of the lung adenocarcinoma. The importance of differential diagnostics in clinical practice should be a given, especially during times of pandemic. The novel coronavirus infection introduced new guidelines for and approaches to the investigation of immunocompromised patients, so it is especially important not to forget the basis of differential diagnosis, to and adopt a thorough approach when assessing these complex patients. We want to stress the importance of thorough investigation to avoid misdiagnosis of atypical pathogens in the current setting of SARS-CoV-2 pandemic.",10.4414/smw.2020.20312,kczyj503,"['We', 'present', 'the', 'case', 'of', 'an', 'oncology', 'patient', 'admitted', 'to', 'our', 'hospital', 'during', 'the', 'current', 'COVID', '19', 'pandemic', 'with', 'clinical', 'and', 'radiological', 'features', 'strongly', 'suggestive', 'of', 'interstitial', 'pneumonia', 'Multiple', 'laboratory', 'tests', 'were', 'negative', 'for', 'SARS', 'CoV', '2', 'polymerase', 'chain', 'reaction', 'testing', 'of', 'nasopharyngeal', 'swabs', 'and', 'of', 'induced', 'sputum', 'and', 'stool', 'samples', 'investigation', 'of', 'serum', 'immunoglobulins', 'G', 'and', 'M', 'In', 'the', 'setting', 'of', 'an', 'immunocompromised', 'status', 'due', 'to', 'recent', 'chemotherapy', 'cycles', 'for', 'lung', 'adenocarcinoma', 'and', 'prolonged', 'corticosteroid', 'therapy', 'due', 'to', 'frequent', 'exacerbations', 'of', 'chronic', 'obstructive', 'pulmonary', 'disease', 'in', 'recent', 'months', 'we', 'actively', 'searched', 'for', 'the', 'pathological', 'agent', 'and', 'found', 'it', 'to', 'be', 'Pneumocystis', 'jirovecii', 'The', 'patient', 'started', 'specific', 'antibiotic', 'treatment', 'but', 'finally', 'had', 'a', 'negative', 'outcome', 'due', 'to', 'the', 'progression', 'of', 'the', 'lung', 'adenocarcinoma', 'The', 'importance', 'of', 'differential', 'diagnostics', 'in', 'clinical', 'practice', 'should', 'be', 'a', 'given', 'especially', 'during', 'times', 'of', 'pandemic', 'The', 'novel', 'coronavirus', 'infection', 'introduced', 'new', 'guidelines', 'for', 'and', 'approaches', 'to', 'the', 'investigation', 'of', 'immunocompromised', 'patients', 'so', 'it', 'is', 'especially', 'important', 'not', 'to', 'forget', 'the', 'basis', 'of', 'differential', 'diagnosis', 'to', 'and', 'adopt', 'a', 'thorough', 'approach', 'when', 'assessing', 'these', 'complex', 'patients', 'We', 'want', 'to', 'stress', 'the', 'importance', 'of', 'thorough', 'investigation', 'to', 'avoid', 'misdiagnosis', 'of', 'atypical', 'pathogens', 'in', 'the', 'current', 'setting', 'of', 'SARS', 'CoV', '2', 'pandemic', '']"
36756,"Narrowing of the Diagnostic Gap of Acute Gastroenteritis in Children 0-6 Years of Age Using a Combination of Classical and Molecular Techniques, Delivers Challenges in Syndromic Approach Diagnostics.",2016,The Pediatric infectious disease journal,https://doi.org/10.1097/inf.0000000000001208; https://www.ncbi.nlm.nih.gov/pubmed/27276177/,"BACKGROUND Twenty-five percent to 50% of acute gastroenteritis (AGE) cases remain etiologically undiagnosed. Our main aim was to determine the most appropriate list of enteric pathogens to be included in the daily diagnostics scheme of AGE, ensuring the lowest possible diagnostic gap. METHODS Two hundred ninety seven children ≤6 years of age, admitted to hospital in Slovenia, October 2011 to October 2012, with AGE, and 88 ≤6 years old healthy children were included in the study. A broad spectrum of enteric pathogens was targeted with molecular methods, including 8 viruses, 6 bacteria and 2 parasites. RESULTS At least one enteric pathogen was detected in 91.2% of cases with AGE and 27.3% of controls. Viruses were the most prevalent (82.5% and 15.9%), followed by bacteria (27.3% and 10.2%) and parasites (3.0% and 1.1%) in cases and controls, respectively. A high proportion (41.8%) of mixed infections was observed in the cases. For cases with undetermined etiology (8.8%), stool samples were analyzed with next generation sequencing, and a potential viral pathogen was detected in 17 additional samples (5.8%). CONCLUSIONS Our study suggests that tests for rotaviruses, noroviruses genogroup II, adenoviruses 40/41, astroviruses, Campylobacter spp. and Salmonella sp. should be included in the initial diagnostic algorithm, which revealed the etiology in 83.5% of children tested. The use of molecular methods in diagnostics of gastroenteritis is preferable because of their high sensitivity, specificity, fast performance and the possibility of establishing the concentration of the target. The latter may be valuable for assessing the clinical significance of the detected enteric, particularly viral pathogens.",10.1097/inf.0000000000001208,ihv9ktal,"['BACKGROUND', 'Twenty', 'five', 'percent', 'to', '50', 'of', 'acute', 'gastroenteritis', 'AGE', 'cases', 'remain', 'etiologically', 'undiagnosed', 'Our', 'main', 'aim', 'was', 'to', 'determine', 'the', 'most', 'appropriate', 'list', 'of', 'enteric', 'pathogens', 'to', 'be', 'included', 'in', 'the', 'daily', 'diagnostics', 'scheme', 'of', 'AGE', 'ensuring', 'the', 'lowest', 'possible', 'diagnostic', 'gap', 'METHODS', 'Two', 'hundred', 'ninety', 'seven', 'children', '6', 'years', 'of', 'age', 'admitted', 'to', 'hospital', 'in', 'Slovenia', 'October', '2011', 'to', 'October', '2012', 'with', 'AGE', 'and', '88', '6', 'years', 'old', 'healthy', 'children', 'were', 'included', 'in', 'the', 'study', 'A', 'broad', 'spectrum', 'of', 'enteric', 'pathogens', 'was', 'targeted', 'with', 'molecular', 'methods', 'including', '8', 'viruses', '6', 'bacteria', 'and', '2', 'parasites', 'RESULTS', 'At', 'least', 'one', 'enteric', 'pathogen', 'was', 'detected', 'in', '91', '2', 'of', 'cases', 'with', 'AGE', 'and', '27', '3', 'of', 'controls', 'Viruses', 'were', 'the', 'most', 'prevalent', '82', '5', 'and', '15', '9', 'followed', 'by', 'bacteria', '27', '3', 'and', '10', '2', 'and', 'parasites', '3', '0', 'and', '1', '1', 'in', 'cases', 'and', 'controls', 'respectively', 'A', 'high', 'proportion', '41', '8', 'of', 'mixed', 'infections', 'was', 'observed', 'in', 'the', 'cases', 'For', 'cases', 'with', 'undetermined', 'etiology', '8', '8', 'stool', 'samples', 'were', 'analyzed', 'with', 'next', 'generation', 'sequencing', 'and', 'a', 'potential', 'viral', 'pathogen', 'was', 'detected', 'in', '17', 'additional', 'samples', '5', '8', 'CONCLUSIONS', 'Our', 'study', 'suggests', 'that', 'tests', 'for', 'rotaviruses', 'noroviruses', 'genogroup', 'II', 'adenoviruses', '40', '41', 'astroviruses', 'Campylobacter', 'spp', 'and', 'Salmonella', 'sp', 'should', 'be', 'included', 'in', 'the', 'initial', 'diagnostic', 'algorithm', 'which', 'revealed', 'the', 'etiology', 'in', '83', '5', 'of', 'children', 'tested', 'The', 'use', 'of', 'molecular', 'methods', 'in', 'diagnostics', 'of', 'gastroenteritis', 'is', 'preferable', 'because', 'of', 'their', 'high', 'sensitivity', 'specificity', 'fast', 'performance', 'and', 'the', 'possibility', 'of', 'establishing', 'the', 'concentration', 'of', 'the', 'target', 'The', 'latter', 'may', 'be', 'valuable', 'for', 'assessing', 'the', 'clinical', 'significance', 'of', 'the', 'detected', 'enteric', 'particularly', 'viral', 'pathogens', '']"
36804,"Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?",2020-07-07,Viruses,https://doi.org/10.3390/v12070735; https://www.ncbi.nlm.nih.gov/pubmed/32646015/,"Standard precautions to minimize the risk of SARS-CoV-2 transmission implies that infected cell cultures and clinical specimens may undergo some sort of inactivation to reduce or abolish infectivity. We evaluated three heat inactivation protocols (56 °C-30 min, 60 °C-60 min and 92 °C-15 min) on SARS-CoV-2 using (i) infected cell culture supernatant, (ii) virus-spiked human sera (iii) and nasopharyngeal samples according to the recommendations of the European norm NF EN 14476-A2. Regardless of the protocol and the type of samples, a 4 Log10 TCID50 reduction was observed. However, samples containing viral loads > 6 Log10 TCID50 were still infectious after 56 °C-30 min and 60 °C-60 min, although infectivity was < 10 TCID50. The protocols 56 °C-30 min and 60 °C-60 min had little influence on the RNA copies detection, whereas 92 °C-15 min drastically reduced the limit of detection, which suggests that this protocol should be avoided for inactivation ahead of molecular diagnostics. Lastly, 56 °C-30 min treatment of serum specimens had a negligible influence on the results of IgG detection using a commercial ELISA test, whereas a drastic decrease in neutralizing titers was observed.",10.3390/v12070735,wvixyfsv,"['Standard', 'precautions', 'to', 'minimize', 'the', 'risk', 'of', 'SARS', 'CoV', '2', 'transmission', 'implies', 'that', 'infected', 'cell', 'cultures', 'and', 'clinical', 'specimens', 'may', 'undergo', 'some', 'sort', 'of', 'inactivation', 'to', 'reduce', 'or', 'abolish', 'infectivity', 'We', 'evaluated', 'three', 'heat', 'inactivation', 'protocols', '56', 'C', '30', 'min', '60', 'C', '60', 'min', 'and', '92', 'C', '15', 'min', 'on', 'SARS', 'CoV', '2', 'using', 'i', 'infected', 'cell', 'culture', 'supernatant', 'ii', 'virus', 'spiked', 'human', 'sera', 'iii', 'and', 'nasopharyngeal', 'samples', 'according', 'to', 'the', 'recommendations', 'of', 'the', 'European', 'norm', 'NF', 'EN', '14476', 'A2', 'Regardless', 'of', 'the', 'protocol', 'and', 'the', 'type', 'of', 'samples', 'a', '4', 'Log10', 'TCID50', 'reduction', 'was', 'observed', 'However', 'samples', 'containing', 'viral', 'loads', '6', 'Log10', 'TCID50', 'were', 'still', 'infectious', 'after', '56', 'C', '30', 'min', 'and', '60', 'C', '60', 'min', 'although', 'infectivity', 'was', '10', 'TCID50', 'The', 'protocols', '56', 'C', '30', 'min', 'and', '60', 'C', '60', 'min', 'had', 'little', 'influence', 'on', 'the', 'RNA', 'copies', 'detection', 'whereas', '92', 'C', '15', 'min', 'drastically', 'reduced', 'the', 'limit', 'of', 'detection', 'which', 'suggests', 'that', 'this', 'protocol', 'should', 'be', 'avoided', 'for', 'inactivation', 'ahead', 'of', 'molecular', 'diagnostics', 'Lastly', '56', 'C', '30', 'min', 'treatment', 'of', 'serum', 'specimens', 'had', 'a', 'negligible', 'influence', 'on', 'the', 'results', 'of', 'IgG', 'detection', 'using', 'a', 'commercial', 'ELISA', 'test', 'whereas', 'a', 'drastic', 'decrease', 'in', 'neutralizing', 'titers', 'was', 'observed', '']"
36832,Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests.,2020-07-06,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,https://doi.org/10.1016/j.jcv.2020.104544; https://www.ncbi.nlm.nih.gov/pubmed/32663788/,"The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has been followed by the rapid development of antibody tests. To assess the utility of the tests for clinical use and seroepidemiologic studies, we examined the sensitivity of commercial antibody tests from Roche, Abbott, Novatec, Virotech Siemens, Euroimmun, and Mediagnost in a prospective diagnostic study. The tests were evaluated with 73 sera from SARS CoV-2 RNA positive individuals with mild to moderate disease or asymptomatic infection. Sera were obtained at 2-3 weeks (N = 25) or > 4 weeks (N = 48) after symptom onset and viral RNA test. The overall sensitivity of the tests ranged from 64.4-93.2%. The most sensitive assays recognized 95.8-100 % of the sera obtained after 4 weeks or later. Sera drawn at 2-3 weeks were recognized with lower sensitivity indicating that the optimal time point for serologic testing is later than 3 weeks after onset of the disease. Nucleoprotein- and glycoproteinbased assays had similar sensitivity indicating that tests with both antigens are suitable for serological diagnostics. Breakdown of the test results showed that nucleoprotein- and glycoprotein-based tests of comparable sensitivity reacted with different sets of sera. The observation indicates that a combination of nucleoprotein- and glycoprotein-based tests would increase the percentage of positive results.",10.1016/j.jcv.2020.104544,555g14yx,"['The', 'emergence', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'followed', 'by', 'the', 'rapid', 'development', 'of', 'antibody', 'tests', 'To', 'assess', 'the', 'utility', 'of', 'the', 'tests', 'for', 'clinical', 'use', 'and', 'seroepidemiologic', 'studies', 'we', 'examined', 'the', 'sensitivity', 'of', 'commercial', 'antibody', 'tests', 'from', 'Roche', 'Abbott', 'Novatec', 'Virotech', 'Siemens', 'Euroimmun', 'and', 'Mediagnost', 'in', 'a', 'prospective', 'diagnostic', 'study', 'The', 'tests', 'were', 'evaluated', 'with', '73', 'sera', 'from', 'SARS', 'CoV', '2', 'RNA', 'positive', 'individuals', 'with', 'mild', 'to', 'moderate', 'disease', 'or', 'asymptomatic', 'infection', 'Sera', 'were', 'obtained', 'at', '2', '3', 'weeks', 'N', '25', 'or', '4', 'weeks', 'N', '48', 'after', 'symptom', 'onset', 'and', 'viral', 'RNA', 'test', 'The', 'overall', 'sensitivity', 'of', 'the', 'tests', 'ranged', 'from', '64', '4', '93', '2', 'The', 'most', 'sensitive', 'assays', 'recognized', '95', '8', '100', 'of', 'the', 'sera', 'obtained', 'after', '4', 'weeks', 'or', 'later', 'Sera', 'drawn', 'at', '2', '3', 'weeks', 'were', 'recognized', 'with', 'lower', 'sensitivity', 'indicating', 'that', 'the', 'optimal', 'time', 'point', 'for', 'serologic', 'testing', 'is', 'later', 'than', '3', 'weeks', 'after', 'onset', 'of', 'the', 'disease', 'Nucleoprotein', 'and', 'glycoproteinbased', 'assays', 'had', 'similar', 'sensitivity', 'indicating', 'that', 'tests', 'with', 'both', 'antigens', 'are', 'suitable', 'for', 'serological', 'diagnostics', 'Breakdown', 'of', 'the', 'test', 'results', 'showed', 'that', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'of', 'comparable', 'sensitivity', 'reacted', 'with', 'different', 'sets', 'of', 'sera', 'The', 'observation', 'indicates', 'that', 'a', 'combination', 'of', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'would', 'increase', 'the', 'percentage', 'of', 'positive', 'results', '']"
37742,mNGS in clinical microbiology laboratories: on the road to maturity.,2019,Critical reviews in microbiology,https://doi.org/10.1080/1040841x.2019.1681933; https://www.ncbi.nlm.nih.gov/pubmed/31691607/,"Metagenomic next-generation sequencing (mNGS) is increasingly being applied in clinical laboratories for unbiased culture-independent diagnosis. Whether it can be a next routine pathogen identification tool has become a topic of concern. We review the current implementation of this new technology for infectious disease diagnostics and discuss the feasibility of transforming mNGS into a routine diagnostic test. Since 2008, numerous studies from over 20 countries have revealed the practicality of mNGS in the work-up of undiagnosed infectious diseases. mNGS performs well in identifying rare, novel, difficult-to-detect and coinfected pathogens directly from clinical samples and presents great potential in resistance prediction by sequencing the antibiotic resistance genes, providing new diagnostic evidence that can be used to guide treatment options and improve antibiotic stewardship. Many physicians recognized mNGS as a last resort method to address clinical infection problems. Although several hurdles, such as workflow validation, quality control, method standardisation, and data interpretation, remain before mNGS can be implemented routinely in clinical laboratories, they are temporary and can be overcome by rapidly evolving technologies. With more validated workflows, lower cost and turnaround time, and simplified interpretation criteria, mNGS will be widely accepted in clinical practice. Overall, mNGS is transforming the landscape of clinical microbiology laboratories, and to ensure that it is properly utilised in clinical diagnosis, both physicians and microbiologists should have a thorough understanding of the power and limitations of this method.",10.1080/1040841x.2019.1681933,jumd7mck,"['Metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'is', 'increasingly', 'being', 'applied', 'in', 'clinical', 'laboratories', 'for', 'unbiased', 'culture', 'independent', 'diagnosis', 'Whether', 'it', 'can', 'be', 'a', 'next', 'routine', 'pathogen', 'identification', 'tool', 'has', 'become', 'a', 'topic', 'of', 'concern', 'We', 'review', 'the', 'current', 'implementation', 'of', 'this', 'new', 'technology', 'for', 'infectious', 'disease', 'diagnostics', 'and', 'discuss', 'the', 'feasibility', 'of', 'transforming', 'mNGS', 'into', 'a', 'routine', 'diagnostic', 'test', 'Since', '2008', 'numerous', 'studies', 'from', 'over', '20', 'countries', 'have', 'revealed', 'the', 'practicality', 'of', 'mNGS', 'in', 'the', 'work', 'up', 'of', 'undiagnosed', 'infectious', 'diseases', 'mNGS', 'performs', 'well', 'in', 'identifying', 'rare', 'novel', 'difficult', 'to', 'detect', 'and', 'coinfected', 'pathogens', 'directly', 'from', 'clinical', 'samples', 'and', 'presents', 'great', 'potential', 'in', 'resistance', 'prediction', 'by', 'sequencing', 'the', 'antibiotic', 'resistance', 'genes', 'providing', 'new', 'diagnostic', 'evidence', 'that', 'can', 'be', 'used', 'to', 'guide', 'treatment', 'options', 'and', 'improve', 'antibiotic', 'stewardship', 'Many', 'physicians', 'recognized', 'mNGS', 'as', 'a', 'last', 'resort', 'method', 'to', 'address', 'clinical', 'infection', 'problems', 'Although', 'several', 'hurdles', 'such', 'as', 'workflow', 'validation', 'quality', 'control', 'method', 'standardisation', 'and', 'data', 'interpretation', 'remain', 'before', 'mNGS', 'can', 'be', 'implemented', 'routinely', 'in', 'clinical', 'laboratories', 'they', 'are', 'temporary', 'and', 'can', 'be', 'overcome', 'by', 'rapidly', 'evolving', 'technologies', 'With', 'more', 'validated', 'workflows', 'lower', 'cost', 'and', 'turnaround', 'time', 'and', 'simplified', 'interpretation', 'criteria', 'mNGS', 'will', 'be', 'widely', 'accepted', 'in', 'clinical', 'practice', 'Overall', 'mNGS', 'is', 'transforming', 'the', 'landscape', 'of', 'clinical', 'microbiology', 'laboratories', 'and', 'to', 'ensure', 'that', 'it', 'is', 'properly', 'utilised', 'in', 'clinical', 'diagnosis', 'both', 'physicians', 'and', 'microbiologists', 'should', 'have', 'a', 'thorough', 'understanding', 'of', 'the', 'power', 'and', 'limitations', 'of', 'this', 'method', '']"
38220,Human picobirnaviruses identified by molecular screening of diarrhea samples.,2010,Journal of clinical microbiology,https://doi.org/10.1128/jcm.02452-09; https://www.ncbi.nlm.nih.gov/pubmed/20335418/,"The global threat of (re)emerging infectious viruses requires a more effective approach regarding virus surveillance and diagnostic assays, as current diagnostics are often virus species specific and not able to detect highly divergent or unknown viruses. A systematic exploration of viruses that infect humans is the key to effectively counter the potential public health threat caused by new and emerging infectious diseases. The human gut is a known reservoir of a wide variety of microorganisms, including viruses. In this study, Dutch clinical diarrhea samples for which no etiological agent could be identified by available cell culture, serological, or nucleic acid-based tests were gathered. Large-scale molecular RNA virus screening based on host nucleic acid depletion, sequence-independent amplification, and sequencing of partially purified viral RNA from a limited number of clinical diarrhea samples revealed four eukaryotic virus species. Among the detected viruses were a rhinovirus and a new picobirnavirus variant. In total, approximately 20% of clinical diarrhea samples contained human picobirnavirus sequences. The Dutch picobirnaviruses belonged to different phylogenetic clades and did not group with other picobirnaviruses according to year of isolation or host species. Interestingly, the average age of patients infected with picobirnavirus was significantly higher than that of uninfected patients. Our data show that sequence-independent amplification of partially purified viral RNA is an efficient procedure for identification of known and highly divergent new RNA viruses in clinical diarrhea samples.",10.1128/jcm.02452-09,xysa7dzh,"['The', 'global', 'threat', 'of', 're', 'emerging', 'infectious', 'viruses', 'requires', 'a', 'more', 'effective', 'approach', 'regarding', 'virus', 'surveillance', 'and', 'diagnostic', 'assays', 'as', 'current', 'diagnostics', 'are', 'often', 'virus', 'species', 'specific', 'and', 'not', 'able', 'to', 'detect', 'highly', 'divergent', 'or', 'unknown', 'viruses', 'A', 'systematic', 'exploration', 'of', 'viruses', 'that', 'infect', 'humans', 'is', 'the', 'key', 'to', 'effectively', 'counter', 'the', 'potential', 'public', 'health', 'threat', 'caused', 'by', 'new', 'and', 'emerging', 'infectious', 'diseases', 'The', 'human', 'gut', 'is', 'a', 'known', 'reservoir', 'of', 'a', 'wide', 'variety', 'of', 'microorganisms', 'including', 'viruses', 'In', 'this', 'study', 'Dutch', 'clinical', 'diarrhea', 'samples', 'for', 'which', 'no', 'etiological', 'agent', 'could', 'be', 'identified', 'by', 'available', 'cell', 'culture', 'serological', 'or', 'nucleic', 'acid', 'based', 'tests', 'were', 'gathered', 'Large', 'scale', 'molecular', 'RNA', 'virus', 'screening', 'based', 'on', 'host', 'nucleic', 'acid', 'depletion', 'sequence', 'independent', 'amplification', 'and', 'sequencing', 'of', 'partially', 'purified', 'viral', 'RNA', 'from', 'a', 'limited', 'number', 'of', 'clinical', 'diarrhea', 'samples', 'revealed', 'four', 'eukaryotic', 'virus', 'species', 'Among', 'the', 'detected', 'viruses', 'were', 'a', 'rhinovirus', 'and', 'a', 'new', 'picobirnavirus', 'variant', 'In', 'total', 'approximately', '20', 'of', 'clinical', 'diarrhea', 'samples', 'contained', 'human', 'picobirnavirus', 'sequences', 'The', 'Dutch', 'picobirnaviruses', 'belonged', 'to', 'different', 'phylogenetic', 'clades', 'and', 'did', 'not', 'group', 'with', 'other', 'picobirnaviruses', 'according', 'to', 'year', 'of', 'isolation', 'or', 'host', 'species', 'Interestingly', 'the', 'average', 'age', 'of', 'patients', 'infected', 'with', 'picobirnavirus', 'was', 'significantly', 'higher', 'than', 'that', 'of', 'uninfected', 'patients', 'Our', 'data', 'show', 'that', 'sequence', 'independent', 'amplification', 'of', 'partially', 'purified', 'viral', 'RNA', 'is', 'an', 'efficient', 'procedure', 'for', 'identification', 'of', 'known', 'and', 'highly', 'divergent', 'new', 'RNA', 'viruses', 'in', 'clinical', 'diarrhea', 'samples', '']"
38321,A relationship between acute respiratory illnesses and weather.,2014,Epidemiology and infection,https://doi.org/10.1017/s0950268813001854; https://www.ncbi.nlm.nih.gov/pubmed/23906336/,"Weekly data from 7 years (2004-2010) of primary-care counts of acute respiratory illnesses (ARIs) and local weather readings were used to adjust a multivariate time-series vector error correction model with covariates (VECMX). Weather variables were included through a partial least squares index that consisted of weekly minimum temperature (coefficient = - 0·26), weekly median of relative humidity (coefficient = 0·22) and weekly accumulated rainfall (coefficient = 0·5). The VECMX long-term test reported significance for trend (0·01, P = 0·00) and weather index (1·69, P = 0·00). Short-term relationship was influenced by seasonality. The model accounted for 76% of the variability in the series (adj. R 2 = 0·76), and the co-integration diagnostics confirmed its appropriateness. The procedure is easily reproducible by researchers in all climates, can be used to identify relevant weather fluctuations affecting the incidence of ARIs, and could help clarify the influence of contact rates on the spread of these diseases.",10.1017/s0950268813001854,34ekacrw,"['Weekly', 'data', 'from', '7', 'years', '2004', '2010', 'of', 'primary', 'care', 'counts', 'of', 'acute', 'respiratory', 'illnesses', 'ARIs', 'and', 'local', 'weather', 'readings', 'were', 'used', 'to', 'adjust', 'a', 'multivariate', 'time', 'series', 'vector', 'error', 'correction', 'model', 'with', 'covariates', 'VECMX', 'Weather', 'variables', 'were', 'included', 'through', 'a', 'partial', 'least', 'squares', 'index', 'that', 'consisted', 'of', 'weekly', 'minimum', 'temperature', 'coefficient', '0', '26', 'weekly', 'median', 'of', 'relative', 'humidity', 'coefficient', '0', '22', 'and', 'weekly', 'accumulated', 'rainfall', 'coefficient', '0', '5', 'The', 'VECMX', 'long', 'term', 'test', 'reported', 'significance', 'for', 'trend', '0', '01', 'P', '0', '00', 'and', 'weather', 'index', '1', '69', 'P', '0', '00', 'Short', 'term', 'relationship', 'was', 'influenced', 'by', 'seasonality', 'The', 'model', 'accounted', 'for', '76', 'of', 'the', 'variability', 'in', 'the', 'series', 'adj', 'R', '2', '0', '76', 'and', 'the', 'co', 'integration', 'diagnostics', 'confirmed', 'its', 'appropriateness', 'The', 'procedure', 'is', 'easily', 'reproducible', 'by', 'researchers', 'in', 'all', 'climates', 'can', 'be', 'used', 'to', 'identify', 'relevant', 'weather', 'fluctuations', 'affecting', 'the', 'incidence', 'of', 'ARIs', 'and', 'could', 'help', 'clarify', 'the', 'influence', 'of', 'contact', 'rates', 'on', 'the', 'spread', 'of', 'these', 'diseases', '']"
38556,A bead-based suspension array for the multiplexed detection of begomoviruses and their whitefly vectors.,2014,Journal of virological methods,https://doi.org/10.1016/j.jviromet.2013.12.014; https://www.ncbi.nlm.nih.gov/pubmed/24388931/,"Bead-based suspension array systems enable simultaneous fluorescence-based identification of multiple nucleic acid targets in a single reaction. This study describes the development of a novel approach to plant virus and vector diagnostics, a multiplexed 7-plex array that comprises a hierarchical set of assays for the simultaneous detection of begomoviruses and Bemisia tabaci, from both plant and whitefly samples. The multiplexed array incorporates genus, species and strain-specific assays, offering a unique approach for identifying both known and unknown viruses and B. tabaci species. When tested against a large panel of sequence-characterized begomovirus and whitefly samples, the array was shown to be 100% specific to the homologous target. Additionally, the multiplexed array was highly sensitive, efficiently and concurrently determining both virus and whitefly identity from single viruliferous whitefly samples. The detection limit for one assay within the multiplexed array that specifically detects Tomato yellow leaf curl virus-Israel (TYLCV-IL) was quantified as 200fg of TYLCV-IL DNA, directly equivalent to that of TYLCV-specific qPCR. Highly reproducible results were obtained over multiple tests. The flexible multiplexed array described in this study has great potential for use in plant quarantine, biosecurity and disease management programs worldwide.",10.1016/j.jviromet.2013.12.014,r6sdf6xa,"['Bead', 'based', 'suspension', 'array', 'systems', 'enable', 'simultaneous', 'fluorescence', 'based', 'identification', 'of', 'multiple', 'nucleic', 'acid', 'targets', 'in', 'a', 'single', 'reaction', 'This', 'study', 'describes', 'the', 'development', 'of', 'a', 'novel', 'approach', 'to', 'plant', 'virus', 'and', 'vector', 'diagnostics', 'a', 'multiplexed', '7', 'plex', 'array', 'that', 'comprises', 'a', 'hierarchical', 'set', 'of', 'assays', 'for', 'the', 'simultaneous', 'detection', 'of', 'begomoviruses', 'and', 'Bemisia', 'tabaci', 'from', 'both', 'plant', 'and', 'whitefly', 'samples', 'The', 'multiplexed', 'array', 'incorporates', 'genus', 'species', 'and', 'strain', 'specific', 'assays', 'offering', 'a', 'unique', 'approach', 'for', 'identifying', 'both', 'known', 'and', 'unknown', 'viruses', 'and', 'B', 'tabaci', 'species', 'When', 'tested', 'against', 'a', 'large', 'panel', 'of', 'sequence', 'characterized', 'begomovirus', 'and', 'whitefly', 'samples', 'the', 'array', 'was', 'shown', 'to', 'be', '100', 'specific', 'to', 'the', 'homologous', 'target', 'Additionally', 'the', 'multiplexed', 'array', 'was', 'highly', 'sensitive', 'efficiently', 'and', 'concurrently', 'determining', 'both', 'virus', 'and', 'whitefly', 'identity', 'from', 'single', 'viruliferous', 'whitefly', 'samples', 'The', 'detection', 'limit', 'for', 'one', 'assay', 'within', 'the', 'multiplexed', 'array', 'that', 'specifically', 'detects', 'Tomato', 'yellow', 'leaf', 'curl', 'virus', 'Israel', 'TYLCV', 'IL', 'was', 'quantified', 'as', '200fg', 'of', 'TYLCV', 'IL', 'DNA', 'directly', 'equivalent', 'to', 'that', 'of', 'TYLCV', 'specific', 'qPCR', 'Highly', 'reproducible', 'results', 'were', 'obtained', 'over', 'multiple', 'tests', 'The', 'flexible', 'multiplexed', 'array', 'described', 'in', 'this', 'study', 'has', 'great', 'potential', 'for', 'use', 'in', 'plant', 'quarantine', 'biosecurity', 'and', 'disease', 'management', 'programs', 'worldwide', '']"
39008,Under the microscope: From pathogens to probiotics and back.,2015,Bioengineered,https://doi.org/10.1080/21655979.2015.1089368; https://www.ncbi.nlm.nih.gov/pubmed/26339986/,"The review centers on the human gastrointestinal tract; focusing first on the bacterial stress responses needed to overcome the physiochemical defenses of the host, specifically how these stress survival strategies can be used as targets for alternative infection control strategies. The concluding section focuses on recent developments in molecular diagnostics; centring on the shifting paradigm from culture to molecular based diagnostics.",10.1080/21655979.2015.1089368,jw9uyzdu,"['The', 'review', 'centers', 'on', 'the', 'human', 'gastrointestinal', 'tract', 'focusing', 'first', 'on', 'the', 'bacterial', 'stress', 'responses', 'needed', 'to', 'overcome', 'the', 'physiochemical', 'defenses', 'of', 'the', 'host', 'specifically', 'how', 'these', 'stress', 'survival', 'strategies', 'can', 'be', 'used', 'as', 'targets', 'for', 'alternative', 'infection', 'control', 'strategies', 'The', 'concluding', 'section', 'focuses', 'on', 'recent', 'developments', 'in', 'molecular', 'diagnostics', 'centring', 'on', 'the', 'shifting', 'paradigm', 'from', 'culture', 'to', 'molecular', 'based', 'diagnostics', '']"
39523,Periprosthetic joint infection: what is on the horizon?,2012,The International journal of artificial organs,https://doi.org/10.5301/ijao.5000145; https://www.ncbi.nlm.nih.gov/pubmed/23371923/,"Periprosthetic joint infection (PJI) will emerge as one of the most important issues for both orthopedic surgeons and researchers active in the field over the coming decades. Although the rate of PJI has not changed significantly over the past decade, the affected patients (hosts) being treated often present with more comorbidities than in the past, and the organisms responsible for these infections are evolving to become more difficult to treat. Fortunately, though, major strides in basic, translational, and clinical research have occurred in recent years that have armed the clinician with an armamentarium of techniques and technologies to better diagnose, prevent, and treat PJI. Advances in diagnostics, including refinements in established biomarkers, the introduction of point of service tests, developments in molecular techniques, and new techniques in advanced imaging will allow us to correctly identify the infecting pathogens and their virulence factors. Utilizing developed risk indexes to stratify and medically optimize our patients, modifying implants to incorporate antimicrobial and anti-biofilm properties, and developing clinically applicable vaccines and biofilm inhibiting enzymes will address our struggles in preventing PJI. Success of our future treatment strategies will hinge on refining the indications and technique of our current surgical procedures as well as the rational use of biofilm disrupting technologies and photodynamic therapy. Finally, the field of metabolomics, though still relatively in its infancy, likely holds the key to a novel diagnostic and treatment approach to infection and a more profound understanding of the pathophysiology of PJI on the human body.",10.5301/ijao.5000145,t9rsm119,"['Periprosthetic', 'joint', 'infection', 'PJI', 'will', 'emerge', 'as', 'one', 'of', 'the', 'most', 'important', 'issues', 'for', 'both', 'orthopedic', 'surgeons', 'and', 'researchers', 'active', 'in', 'the', 'field', 'over', 'the', 'coming', 'decades', 'Although', 'the', 'rate', 'of', 'PJI', 'has', 'not', 'changed', 'significantly', 'over', 'the', 'past', 'decade', 'the', 'affected', 'patients', 'hosts', 'being', 'treated', 'often', 'present', 'with', 'more', 'comorbidities', 'than', 'in', 'the', 'past', 'and', 'the', 'organisms', 'responsible', 'for', 'these', 'infections', 'are', 'evolving', 'to', 'become', 'more', 'difficult', 'to', 'treat', 'Fortunately', 'though', 'major', 'strides', 'in', 'basic', 'translational', 'and', 'clinical', 'research', 'have', 'occurred', 'in', 'recent', 'years', 'that', 'have', 'armed', 'the', 'clinician', 'with', 'an', 'armamentarium', 'of', 'techniques', 'and', 'technologies', 'to', 'better', 'diagnose', 'prevent', 'and', 'treat', 'PJI', 'Advances', 'in', 'diagnostics', 'including', 'refinements', 'in', 'established', 'biomarkers', 'the', 'introduction', 'of', 'point', 'of', 'service', 'tests', 'developments', 'in', 'molecular', 'techniques', 'and', 'new', 'techniques', 'in', 'advanced', 'imaging', 'will', 'allow', 'us', 'to', 'correctly', 'identify', 'the', 'infecting', 'pathogens', 'and', 'their', 'virulence', 'factors', 'Utilizing', 'developed', 'risk', 'indexes', 'to', 'stratify', 'and', 'medically', 'optimize', 'our', 'patients', 'modifying', 'implants', 'to', 'incorporate', 'antimicrobial', 'and', 'anti', 'biofilm', 'properties', 'and', 'developing', 'clinically', 'applicable', 'vaccines', 'and', 'biofilm', 'inhibiting', 'enzymes', 'will', 'address', 'our', 'struggles', 'in', 'preventing', 'PJI', 'Success', 'of', 'our', 'future', 'treatment', 'strategies', 'will', 'hinge', 'on', 'refining', 'the', 'indications', 'and', 'technique', 'of', 'our', 'current', 'surgical', 'procedures', 'as', 'well', 'as', 'the', 'rational', 'use', 'of', 'biofilm', 'disrupting', 'technologies', 'and', 'photodynamic', 'therapy', 'Finally', 'the', 'field', 'of', 'metabolomics', 'though', 'still', 'relatively', 'in', 'its', 'infancy', 'likely', 'holds', 'the', 'key', 'to', 'a', 'novel', 'diagnostic', 'and', 'treatment', 'approach', 'to', 'infection', 'and', 'a', 'more', 'profound', 'understanding', 'of', 'the', 'pathophysiology', 'of', 'PJI', 'on', 'the', 'human', 'body', '']"
39663,Polymerase Chain Reaction-Electrospray-Time-of-Flight Mass Spectrometry Versus Culture for Bacterial Detection in Septic Arthritis and Osteoarthritis.,2016,Genetic testing and molecular biomarkers,https://doi.org/10.1089/gtmb.2016.0080; https://www.ncbi.nlm.nih.gov/pubmed/27749085/,"BACKGROUND Preliminary studies have identified known bacterial pathogens in the knees of patients with osteoarthritis (OA) before arthroplasty. AIMS The current study was designed to determine the incidence and types of bacteria present in the synovial fluid of native knee joints from adult patients with diagnoses of septic arthritis and OA. PATIENTS AND METHODS Patients were enrolled between October 2010 and January 2013. Synovial fluid samples from the affected knee were collected and evaluated with both traditional microbial culture and polymerase chain reaction-electrospray ionization-time-of-flight mass spectrometry (molecular diagnostics [MDx]) to prospectively characterize the microbial content. Patients were grouped by diagnosis into one of two cohorts, those with clinical suspicion of septic arthritis (n = 44) and those undergoing primary arthroplasty of the knee for OA (n = 21). In all cases where discrepant culture and MDx results were obtained, we performed species-specific 16S rRNA fluorescence in situ hybridization (FISH) as a confirmatory test. RESULTS MDx testing identified bacteria in 50% of the suspected septic arthritis cases and 29% of the arthroplasty cases, whereas culture detected bacteria in only 16% of the former and 0% of the latter group. The overall difference in detection rates for culture and MDx was very highly significant, p-value = 2.384 × 10-7. All of the culture-positive cases were typed as Staphylococcus aureus. Two of the septic arthritis cases were polymicrobial as was one of the OA cases by MDx. FISH testing of the specimens with discordant results supported the MDx findings in 91% (19/21) of the cases, including one case where culture detected S. aureus and MDx detected Streptococcus agalactiae. CONCLUSIONS MDx were more sensitive than culture, as confirmed by FISH. FISH only identifies bacteria that are embedded or infiltrated within the tissue and is thus not susceptible to contamination. Not all suspected cases of septic arthritis contain bacteria, but a significant percent of patients with OA, and no signs of infection, have FISH-confirmed bacterial biofilms present in the knee.",10.1089/gtmb.2016.0080,25ty1bif,"['BACKGROUND', 'Preliminary', 'studies', 'have', 'identified', 'known', 'bacterial', 'pathogens', 'in', 'the', 'knees', 'of', 'patients', 'with', 'osteoarthritis', 'OA', 'before', 'arthroplasty', 'AIMS', 'The', 'current', 'study', 'was', 'designed', 'to', 'determine', 'the', 'incidence', 'and', 'types', 'of', 'bacteria', 'present', 'in', 'the', 'synovial', 'fluid', 'of', 'native', 'knee', 'joints', 'from', 'adult', 'patients', 'with', 'diagnoses', 'of', 'septic', 'arthritis', 'and', 'OA', 'PATIENTS', 'AND', 'METHODS', 'Patients', 'were', 'enrolled', 'between', 'October', '2010', 'and', 'January', '2013', 'Synovial', 'fluid', 'samples', 'from', 'the', 'affected', 'knee', 'were', 'collected', 'and', 'evaluated', 'with', 'both', 'traditional', 'microbial', 'culture', 'and', 'polymerase', 'chain', 'reaction', 'electrospray', 'ionization', 'time', 'of', 'flight', 'mass', 'spectrometry', 'molecular', 'diagnostics', 'MDx', 'to', 'prospectively', 'characterize', 'the', 'microbial', 'content', 'Patients', 'were', 'grouped', 'by', 'diagnosis', 'into', 'one', 'of', 'two', 'cohorts', 'those', 'with', 'clinical', 'suspicion', 'of', 'septic', 'arthritis', 'n', '44', 'and', 'those', 'undergoing', 'primary', 'arthroplasty', 'of', 'the', 'knee', 'for', 'OA', 'n', '21', 'In', 'all', 'cases', 'where', 'discrepant', 'culture', 'and', 'MDx', 'results', 'were', 'obtained', 'we', 'performed', 'species', 'specific', '16S', 'rRNA', 'fluorescence', 'in', 'situ', 'hybridization', 'FISH', 'as', 'a', 'confirmatory', 'test', 'RESULTS', 'MDx', 'testing', 'identified', 'bacteria', 'in', '50', 'of', 'the', 'suspected', 'septic', 'arthritis', 'cases', 'and', '29', 'of', 'the', 'arthroplasty', 'cases', 'whereas', 'culture', 'detected', 'bacteria', 'in', 'only', '16', 'of', 'the', 'former', 'and', '0', 'of', 'the', 'latter', 'group', 'The', 'overall', 'difference', 'in', 'detection', 'rates', 'for', 'culture', 'and', 'MDx', 'was', 'very', 'highly', 'significant', 'p', 'value', '2', '384', '10', '7', 'All', 'of', 'the', 'culture', 'positive', 'cases', 'were', 'typed', 'as', 'Staphylococcus', 'aureus', 'Two', 'of', 'the', 'septic', 'arthritis', 'cases', 'were', 'polymicrobial', 'as', 'was', 'one', 'of', 'the', 'OA', 'cases', 'by', 'MDx', 'FISH', 'testing', 'of', 'the', 'specimens', 'with', 'discordant', 'results', 'supported', 'the', 'MDx', 'findings', 'in', '91', '19', '21', 'of', 'the', 'cases', 'including', 'one', 'case', 'where', 'culture', 'detected', 'S', 'aureus', 'and', 'MDx', 'detected', 'Streptococcus', 'agalactiae', 'CONCLUSIONS', 'MDx', 'were', 'more', 'sensitive', 'than', 'culture', 'as', 'confirmed', 'by', 'FISH', 'FISH', 'only', 'identifies', 'bacteria', 'that', 'are', 'embedded', 'or', 'infiltrated', 'within', 'the', 'tissue', 'and', 'is', 'thus', 'not', 'susceptible', 'to', 'contamination', 'Not', 'all', 'suspected', 'cases', 'of', 'septic', 'arthritis', 'contain', 'bacteria', 'but', 'a', 'significant', 'percent', 'of', 'patients', 'with', 'OA', 'and', 'no', 'signs', 'of', 'infection', 'have', 'FISH', 'confirmed', 'bacterial', 'biofilms', 'present', 'in', 'the', 'knee', '']"
39729,United States FDA's emergency use authorization of Ebola virus diagnostics: current impact and lessons for the future.,2015,Expert review of molecular diagnostics,https://doi.org/10.1586/14737159.2015.1077117; https://www.ncbi.nlm.nih.gov/pubmed/26394699/,"The Ebola outbreak that took hold in West Africa in 2014 outran the epidemic response capacity of many organizations. Five months after the epidemic was first declared, there were still only two laboratories in West Africa with the capacity to confirm Ebola virus infection. In the summer of 2014, before the first case of imported Ebola occurred in the USA, the US FDA announced it would issue Emergency Use Authorizations for Ebola virus in vitro diagnostics to speed their availability. Between October 2014 and March 2015, the FDA issued Emergency Use Authorizations for nine diagnostic products. The actions of the FDA not only allowed nationwide deployment of Ebola virus testing capacity in the USA but also established an attractive regulatory goalpost for companies developing assays for use in West Africa. Here, we comment on the diagnostic assays for which the FDA has issued emergency authorizations and their fitness for purpose.",10.1586/14737159.2015.1077117,qb4zizor,"['The', 'Ebola', 'outbreak', 'that', 'took', 'hold', 'in', 'West', 'Africa', 'in', '2014', 'outran', 'the', 'epidemic', 'response', 'capacity', 'of', 'many', 'organizations', 'Five', 'months', 'after', 'the', 'epidemic', 'was', 'first', 'declared', 'there', 'were', 'still', 'only', 'two', 'laboratories', 'in', 'West', 'Africa', 'with', 'the', 'capacity', 'to', 'confirm', 'Ebola', 'virus', 'infection', 'In', 'the', 'summer', 'of', '2014', 'before', 'the', 'first', 'case', 'of', 'imported', 'Ebola', 'occurred', 'in', 'the', 'USA', 'the', 'US', 'FDA', 'announced', 'it', 'would', 'issue', 'Emergency', 'Use', 'Authorizations', 'for', 'Ebola', 'virus', 'in', 'vitro', 'diagnostics', 'to', 'speed', 'their', 'availability', 'Between', 'October', '2014', 'and', 'March', '2015', 'the', 'FDA', 'issued', 'Emergency', 'Use', 'Authorizations', 'for', 'nine', 'diagnostic', 'products', 'The', 'actions', 'of', 'the', 'FDA', 'not', 'only', 'allowed', 'nationwide', 'deployment', 'of', 'Ebola', 'virus', 'testing', 'capacity', 'in', 'the', 'USA', 'but', 'also', 'established', 'an', 'attractive', 'regulatory', 'goalpost', 'for', 'companies', 'developing', 'assays', 'for', 'use', 'in', 'West', 'Africa', 'Here', 'we', 'comment', 'on', 'the', 'diagnostic', 'assays', 'for', 'which', 'the', 'FDA', 'has', 'issued', 'emergency', 'authorizations', 'and', 'their', 'fitness', 'for', 'purpose', '']"
39788,"Clinical display, diagnostics and genetic implication of novel Coronavirus (COVID-19) epidemic.",2020-04-01,European review for medical and pharmacological sciences,https://doi.org/10.26355/eurrev_202004_21047; https://www.ncbi.nlm.nih.gov/pubmed/32374001/,"COVID-19 pandemic can cause irreparable damage to the involved society. This study aimed to provide a summary of the up-to-dated clinical display, diagnostics, molecular and genetic implications for COVID-19 infected patients. In this review, 73 research articles published before 25 March 2020 were analyzed to better understand the clinical characteristics of patients and to introduce the available serological, hematology and molecular diagnostic methods. Apart from articles extracted from PubMed and Google Scholar, WHO (https://www.who.int/), NHC (National Health Commission of the People's Republic of China (http://www.nhc.gov.cn/), NICE (National Institute for Health and Clinical Excellence, https://www.nice.org.uk/), CDC (Centers for Disease Control and Prevention, https://www.cdc.gov/), and National Administration of Traditional Chinese Medicine (http://www.satcm.gov.cn/) were also accessed to search for eligible studies. Papers published between January 1, 2020, and 25 March 2020 were searched in English and the terms ""2019-nCoV, Covid-19, Clinical Characteristics OR manifestation, method of detection, COVID-19 Genome and molecular test"" were used. As the pandemic continues to evolve, there have been reports about the possibility of asymptomatic transmission of this newly emerged pneumonia virus. We highlighted the role of HLA haplotype in virus infection as HLA typing will provide susceptibility information for personalized prevention, diagnosis, and treatment in future studies. All the data in this article will assist researchers and clinicians to develop their clinical views regarding infected patients and to emphasize the origin of SARS-CoV-2 for diagnostics.",10.26355/eurrev_202004_21047,kpw8brqk,"['COVID', '19', 'pandemic', 'can', 'cause', 'irreparable', 'damage', 'to', 'the', 'involved', 'society', 'This', 'study', 'aimed', 'to', 'provide', 'a', 'summary', 'of', 'the', 'up', 'to', 'dated', 'clinical', 'display', 'diagnostics', 'molecular', 'and', 'genetic', 'implications', 'for', 'COVID', '19', 'infected', 'patients', 'In', 'this', 'review', '73', 'research', 'articles', 'published', 'before', '25', 'March', '2020', 'were', 'analyzed', 'to', 'better', 'understand', 'the', 'clinical', 'characteristics', 'of', 'patients', 'and', 'to', 'introduce', 'the', 'available', 'serological', 'hematology', 'and', 'molecular', 'diagnostic', 'methods', 'Apart', 'from', 'articles', 'extracted', 'from', 'PubMed', 'and', 'Google', 'Scholar', 'WHO', 'https', 'www', 'who', 'int', 'NHC', 'National', 'Health', 'Commission', 'of', 'the', 'People', 's', 'Republic', 'of', 'China', 'http', 'www', 'nhc', 'gov', 'cn', 'NICE', 'National', 'Institute', 'for', 'Health', 'and', 'Clinical', 'Excellence', 'https', 'www', 'nice', 'org', 'uk', 'CDC', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'https', 'www', 'cdc', 'gov', 'and', 'National', 'Administration', 'of', 'Traditional', 'Chinese', 'Medicine', 'http', 'www', 'satcm', 'gov', 'cn', 'were', 'also', 'accessed', 'to', 'search', 'for', 'eligible', 'studies', 'Papers', 'published', 'between', 'January', '1', '2020', 'and', '25', 'March', '2020', 'were', 'searched', 'in', 'English', 'and', 'the', 'terms', '2019', 'nCoV', 'Covid', '19', 'Clinical', 'Characteristics', 'OR', 'manifestation', 'method', 'of', 'detection', 'COVID', '19', 'Genome', 'and', 'molecular', 'test', 'were', 'used', 'As', 'the', 'pandemic', 'continues', 'to', 'evolve', 'there', 'have', 'been', 'reports', 'about', 'the', 'possibility', 'of', 'asymptomatic', 'transmission', 'of', 'this', 'newly', 'emerged', 'pneumonia', 'virus', 'We', 'highlighted', 'the', 'role', 'of', 'HLA', 'haplotype', 'in', 'virus', 'infection', 'as', 'HLA', 'typing', 'will', 'provide', 'susceptibility', 'information', 'for', 'personalized', 'prevention', 'diagnosis', 'and', 'treatment', 'in', 'future', 'studies', 'All', 'the', 'data', 'in', 'this', 'article', 'will', 'assist', 'researchers', 'and', 'clinicians', 'to', 'develop', 'their', 'clinical', 'views', 'regarding', 'infected', 'patients', 'and', 'to', 'emphasize', 'the', 'origin', 'of', 'SARS', 'CoV', '2', 'for', 'diagnostics', '']"
40201,Technology-driven diagnostics: From smart doctor to smartphone.,2016,Critical reviews in clinical laboratory sciences,https://doi.org/10.3109/10408363.2016.1149689; https://www.ncbi.nlm.nih.gov/pubmed/26857116/,"This review explores recent innovations in four seemingly unrelated areas of medical diagnostics, which, when used concurrently, promise to revolutionize the future of medicine. Novel microfluidics and microelectronics, combined with smartphones, allow individuals to test themselves at anytime and anywhere, thus providing instant health information. An emerging development is the availability of genomic testing directly to consumers for assessing disease predisposition. Some organizations have opened diagnostic laboratories in pharmacies and other public outlets, are encouraging consumers to test themselves, and claim that by doing so consumers will be empowered to diagnose the early disease that could be effectively treated or prevented. Another recent development is the initiation of large studies that aim to better understand wellness and disease processes, through the frequent and sometimes continuous monitoring of hundreds or thousands of parameters. These are then analyzed by health coaches who advise participants on follow-up steps to correct the abnormalities and return to wellness. A number of these approaches have now entered the health market and the services can be purchased. It is highly likely that further technological innovations will contribute to the popularity of these approaches among millions of health-conscious consumers. However, the evidence for the effectiveness of these strategies to prevent or detect early disease, or to promote wellness, does not yet exist. We here analyze the perceived benefits and (neglected) harms of these approaches, in an effort to balance the optimism about their utility, until the evidence for their benefit is clearly demonstrated.",10.3109/10408363.2016.1149689,hquyuclf,"['This', 'review', 'explores', 'recent', 'innovations', 'in', 'four', 'seemingly', 'unrelated', 'areas', 'of', 'medical', 'diagnostics', 'which', 'when', 'used', 'concurrently', 'promise', 'to', 'revolutionize', 'the', 'future', 'of', 'medicine', 'Novel', 'microfluidics', 'and', 'microelectronics', 'combined', 'with', 'smartphones', 'allow', 'individuals', 'to', 'test', 'themselves', 'at', 'anytime', 'and', 'anywhere', 'thus', 'providing', 'instant', 'health', 'information', 'An', 'emerging', 'development', 'is', 'the', 'availability', 'of', 'genomic', 'testing', 'directly', 'to', 'consumers', 'for', 'assessing', 'disease', 'predisposition', 'Some', 'organizations', 'have', 'opened', 'diagnostic', 'laboratories', 'in', 'pharmacies', 'and', 'other', 'public', 'outlets', 'are', 'encouraging', 'consumers', 'to', 'test', 'themselves', 'and', 'claim', 'that', 'by', 'doing', 'so', 'consumers', 'will', 'be', 'empowered', 'to', 'diagnose', 'the', 'early', 'disease', 'that', 'could', 'be', 'effectively', 'treated', 'or', 'prevented', 'Another', 'recent', 'development', 'is', 'the', 'initiation', 'of', 'large', 'studies', 'that', 'aim', 'to', 'better', 'understand', 'wellness', 'and', 'disease', 'processes', 'through', 'the', 'frequent', 'and', 'sometimes', 'continuous', 'monitoring', 'of', 'hundreds', 'or', 'thousands', 'of', 'parameters', 'These', 'are', 'then', 'analyzed', 'by', 'health', 'coaches', 'who', 'advise', 'participants', 'on', 'follow', 'up', 'steps', 'to', 'correct', 'the', 'abnormalities', 'and', 'return', 'to', 'wellness', 'A', 'number', 'of', 'these', 'approaches', 'have', 'now', 'entered', 'the', 'health', 'market', 'and', 'the', 'services', 'can', 'be', 'purchased', 'It', 'is', 'highly', 'likely', 'that', 'further', 'technological', 'innovations', 'will', 'contribute', 'to', 'the', 'popularity', 'of', 'these', 'approaches', 'among', 'millions', 'of', 'health', 'conscious', 'consumers', 'However', 'the', 'evidence', 'for', 'the', 'effectiveness', 'of', 'these', 'strategies', 'to', 'prevent', 'or', 'detect', 'early', 'disease', 'or', 'to', 'promote', 'wellness', 'does', 'not', 'yet', 'exist', 'We', 'here', 'analyze', 'the', 'perceived', 'benefits', 'and', 'neglected', 'harms', 'of', 'these', 'approaches', 'in', 'an', 'effort', 'to', 'balance', 'the', 'optimism', 'about', 'their', 'utility', 'until', 'the', 'evidence', 'for', 'their', 'benefit', 'is', 'clearly', 'demonstrated', '']"
40248,Nucleic acid amplification-based diagnosis of respiratory virus infections.,2010,Expert review of anti-infective therapy,https://doi.org/10.1586/eri.10.121; https://www.ncbi.nlm.nih.gov/pubmed/21073292/,"The appearance of eight new respiratory viruses in the human population in the past 9 years, including two new pandemics (SARS coronavirus in 2003 and swine-origin influenza A/H1N1 in 2009), has tested the ability of virology laboratories to develop diagnostic tests to identify these viruses. Nucleic acid amplification tests (NATs) that first appeared two decades ago have been developed for both conventional and emerging viruses and now form the backbone of the clinical laboratory. NATs provide fast, accurate and sensitive detection of respiratory viruses and have significantly increased our understanding of the epidemiology of these viruses. Multiplex PCR assays have been introduced recently and several commercial tests are now available. The final chapter in the evolution of respiratory virus diagnostics will be the addition of allelic discrimination and detection of single nucleotide polymorphisms associated with antiviral resistance to multiplex assays. These resistance assays together with new viral load tests will enable clinical laboratories to provide physicians with important information for optimal treatment of patients.",10.1586/eri.10.121,558e6nnl,"['The', 'appearance', 'of', 'eight', 'new', 'respiratory', 'viruses', 'in', 'the', 'human', 'population', 'in', 'the', 'past', '9', 'years', 'including', 'two', 'new', 'pandemics', 'SARS', 'coronavirus', 'in', '2003', 'and', 'swine', 'origin', 'influenza', 'A', 'H1N1', 'in', '2009', 'has', 'tested', 'the', 'ability', 'of', 'virology', 'laboratories', 'to', 'develop', 'diagnostic', 'tests', 'to', 'identify', 'these', 'viruses', 'Nucleic', 'acid', 'amplification', 'tests', 'NATs', 'that', 'first', 'appeared', 'two', 'decades', 'ago', 'have', 'been', 'developed', 'for', 'both', 'conventional', 'and', 'emerging', 'viruses', 'and', 'now', 'form', 'the', 'backbone', 'of', 'the', 'clinical', 'laboratory', 'NATs', 'provide', 'fast', 'accurate', 'and', 'sensitive', 'detection', 'of', 'respiratory', 'viruses', 'and', 'have', 'significantly', 'increased', 'our', 'understanding', 'of', 'the', 'epidemiology', 'of', 'these', 'viruses', 'Multiplex', 'PCR', 'assays', 'have', 'been', 'introduced', 'recently', 'and', 'several', 'commercial', 'tests', 'are', 'now', 'available', 'The', 'final', 'chapter', 'in', 'the', 'evolution', 'of', 'respiratory', 'virus', 'diagnostics', 'will', 'be', 'the', 'addition', 'of', 'allelic', 'discrimination', 'and', 'detection', 'of', 'single', 'nucleotide', 'polymorphisms', 'associated', 'with', 'antiviral', 'resistance', 'to', 'multiplex', 'assays', 'These', 'resistance', 'assays', 'together', 'with', 'new', 'viral', 'load', 'tests', 'will', 'enable', 'clinical', 'laboratories', 'to', 'provide', 'physicians', 'with', 'important', 'information', 'for', 'optimal', 'treatment', 'of', 'patients', '']"
40272,Molecular and point-of-care diagnostics for Ebola and new threats: National POCT policy and guidelines will stop epidemics.,2018,Expert review of molecular diagnostics,https://doi.org/10.1080/14737159.2018.1491793; https://www.ncbi.nlm.nih.gov/pubmed/29933717/,"INTRODUCTION US hospitals that admitted Ebola virus disease (EVD) patients mitigated risk by using point-or-care testing (POCT) for critical support in isolation units. Success proved unequivocally the need for POCT. Additionally, molecular diagnostics have been used to help stop new outbreaks, and even handheld diagnostic solutions are emerging. Areas covered: This update of 'Molecular detection and point-of-care testing in Ebola virus disease and other threats' [Expert Reviews 2015;15(10):1249-1255], assesses the impact of EVD epidemics, documents insights from recent reviews, summarizes evolving POC molecular technologies, presents General Accountability Office (GAO) recommendations, identifies the role of POC Coordinators, and casts a vision for national POCT policies and guidelines. Factual updating comprised summarizing EVD outbreaks including 2017-2018, analyzing reviews and evidence-based publications since the 2014-2016 epidemic, and tabulating published technical and molecular diagnostics. New graphics illustrate POC error mitigation/risk reduction, a framework for national POCT policy and guidelines, modular adaptations for country-specific solutions, and a logic diagram for future progress embedding artificial intelligence. Expert commentary: The USA is still not prepared for highly infectious diseases. Key is lack of community rapid response and resilience, which must be enhanced not via mechanisms distant, but instead by molecular diagnostics directly at critical points of need.",10.1080/14737159.2018.1491793,u2dz1f5o,"['INTRODUCTION', 'US', 'hospitals', 'that', 'admitted', 'Ebola', 'virus', 'disease', 'EVD', 'patients', 'mitigated', 'risk', 'by', 'using', 'point', 'or', 'care', 'testing', 'POCT', 'for', 'critical', 'support', 'in', 'isolation', 'units', 'Success', 'proved', 'unequivocally', 'the', 'need', 'for', 'POCT', 'Additionally', 'molecular', 'diagnostics', 'have', 'been', 'used', 'to', 'help', 'stop', 'new', 'outbreaks', 'and', 'even', 'handheld', 'diagnostic', 'solutions', 'are', 'emerging', 'Areas', 'covered', 'This', 'update', 'of', 'Molecular', 'detection', 'and', 'point', 'of', 'care', 'testing', 'in', 'Ebola', 'virus', 'disease', 'and', 'other', 'threats', 'Expert', 'Reviews', '2015', '15', '10', '1249', '1255', 'assesses', 'the', 'impact', 'of', 'EVD', 'epidemics', 'documents', 'insights', 'from', 'recent', 'reviews', 'summarizes', 'evolving', 'POC', 'molecular', 'technologies', 'presents', 'General', 'Accountability', 'Office', 'GAO', 'recommendations', 'identifies', 'the', 'role', 'of', 'POC', 'Coordinators', 'and', 'casts', 'a', 'vision', 'for', 'national', 'POCT', 'policies', 'and', 'guidelines', 'Factual', 'updating', 'comprised', 'summarizing', 'EVD', 'outbreaks', 'including', '2017', '2018', 'analyzing', 'reviews', 'and', 'evidence', 'based', 'publications', 'since', 'the', '2014', '2016', 'epidemic', 'and', 'tabulating', 'published', 'technical', 'and', 'molecular', 'diagnostics', 'New', 'graphics', 'illustrate', 'POC', 'error', 'mitigation', 'risk', 'reduction', 'a', 'framework', 'for', 'national', 'POCT', 'policy', 'and', 'guidelines', 'modular', 'adaptations', 'for', 'country', 'specific', 'solutions', 'and', 'a', 'logic', 'diagram', 'for', 'future', 'progress', 'embedding', 'artificial', 'intelligence', 'Expert', 'commentary', 'The', 'USA', 'is', 'still', 'not', 'prepared', 'for', 'highly', 'infectious', 'diseases', 'Key', 'is', 'lack', 'of', 'community', 'rapid', 'response', 'and', 'resilience', 'which', 'must', 'be', 'enhanced', 'not', 'via', 'mechanisms', 'distant', 'but', 'instead', 'by', 'molecular', 'diagnostics', 'directly', 'at', 'critical', 'points', 'of', 'need', '']"
41290,Community-acquired pneumonia.,2015,Current opinion in pulmonary medicine,https://doi.org/10.1097/mcp.0000000000000150; https://www.ncbi.nlm.nih.gov/pubmed/25775050/,"PURPOSE OF REVIEW Community-acquired pneumonia (CAP) is the most common infectious disease cause of death. We summarize recent findings regarding the epidemiology of CAP in adults, efficacy of vaccines against Streptococcus pneumoniae, diagnostics, and discuss the current controversy between CAP and healthcare-associated pneumonia (HCAP). RECENT FINDINGS The emergence of the Middle East respiratory syndrome coronavirus and the avian influenza A strain H7N9 are of concern but still these are infrequent causes of CAP. Recent data indicate that vaccinating children also protects adults against CAP by generating significant herd immunity, and that the conjugated pneumococcal vaccine in adults may offer some efficacy in preventing CAP caused by vaccine serotypes. The immunochromotagraphic urinary antigen test has improved the diagnostic yield for the aetiology of CAP, and initial data demonstrate that a novel multiplex urinary antigen test will further increase the sensitivity for detection of S. pneumoniae. There has been significant concern that a relatively recently described pneumonia category, HCAP, requires empirical treatment for potentially multidrug-resistant organisms (MDRO). However, new evidence shows that (at least in Europe) pneumonia caused by MDRO remains uncommon even in HCAP category patients. SUMMARY CAP remains a major cause of morbidity and mortality. Advances in vaccination and diagnosis should help reduce the amount of disease due to S. pneumoniae, the commonest cause of CAP. Outside of the United States, MDRO are relatively uncommon causes of CAP, and the increased mortality of HCAP category patients seems to be related to their comorbidities and age rather than microbial aetiology.",10.1097/mcp.0000000000000150,53y7ilzb,"['PURPOSE', 'OF', 'REVIEW', 'Community', 'acquired', 'pneumonia', 'CAP', 'is', 'the', 'most', 'common', 'infectious', 'disease', 'cause', 'of', 'death', 'We', 'summarize', 'recent', 'findings', 'regarding', 'the', 'epidemiology', 'of', 'CAP', 'in', 'adults', 'efficacy', 'of', 'vaccines', 'against', 'Streptococcus', 'pneumoniae', 'diagnostics', 'and', 'discuss', 'the', 'current', 'controversy', 'between', 'CAP', 'and', 'healthcare', 'associated', 'pneumonia', 'HCAP', 'RECENT', 'FINDINGS', 'The', 'emergence', 'of', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'and', 'the', 'avian', 'influenza', 'A', 'strain', 'H7N9', 'are', 'of', 'concern', 'but', 'still', 'these', 'are', 'infrequent', 'causes', 'of', 'CAP', 'Recent', 'data', 'indicate', 'that', 'vaccinating', 'children', 'also', 'protects', 'adults', 'against', 'CAP', 'by', 'generating', 'significant', 'herd', 'immunity', 'and', 'that', 'the', 'conjugated', 'pneumococcal', 'vaccine', 'in', 'adults', 'may', 'offer', 'some', 'efficacy', 'in', 'preventing', 'CAP', 'caused', 'by', 'vaccine', 'serotypes', 'The', 'immunochromotagraphic', 'urinary', 'antigen', 'test', 'has', 'improved', 'the', 'diagnostic', 'yield', 'for', 'the', 'aetiology', 'of', 'CAP', 'and', 'initial', 'data', 'demonstrate', 'that', 'a', 'novel', 'multiplex', 'urinary', 'antigen', 'test', 'will', 'further', 'increase', 'the', 'sensitivity', 'for', 'detection', 'of', 'S', 'pneumoniae', 'There', 'has', 'been', 'significant', 'concern', 'that', 'a', 'relatively', 'recently', 'described', 'pneumonia', 'category', 'HCAP', 'requires', 'empirical', 'treatment', 'for', 'potentially', 'multidrug', 'resistant', 'organisms', 'MDRO', 'However', 'new', 'evidence', 'shows', 'that', 'at', 'least', 'in', 'Europe', 'pneumonia', 'caused', 'by', 'MDRO', 'remains', 'uncommon', 'even', 'in', 'HCAP', 'category', 'patients', 'SUMMARY', 'CAP', 'remains', 'a', 'major', 'cause', 'of', 'morbidity', 'and', 'mortality', 'Advances', 'in', 'vaccination', 'and', 'diagnosis', 'should', 'help', 'reduce', 'the', 'amount', 'of', 'disease', 'due', 'to', 'S', 'pneumoniae', 'the', 'commonest', 'cause', 'of', 'CAP', 'Outside', 'of', 'the', 'United', 'States', 'MDRO', 'are', 'relatively', 'uncommon', 'causes', 'of', 'CAP', 'and', 'the', 'increased', 'mortality', 'of', 'HCAP', 'category', 'patients', 'seems', 'to', 'be', 'related', 'to', 'their', 'comorbidities', 'and', 'age', 'rather', 'than', 'microbial', 'aetiology', '']"
41575,Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections.,2019,Clinical microbiology reviews,https://doi.org/10.1128/cmr.00042-18; https://www.ncbi.nlm.nih.gov/pubmed/30541871/,"Respiratory viral infections are associated with a wide range of acute syndromes and infectious disease processes in children and adults worldwide. Many viruses are implicated in these infections, and these viruses are spread largely via respiratory means between humans but also occasionally from animals to humans. This article is an American Society for Microbiology (ASM)-sponsored Practical Guidance for Clinical Microbiology (PGCM) document identifying best practices for diagnosis and characterization of viruses that cause acute respiratory infections and replaces the most recent prior version of the ASM-sponsored Cumitech 21 document, Laboratory Diagnosis of Viral Respiratory Disease, published in 1986. The scope of the original document was quite broad, with an emphasis on clinical diagnosis of a wide variety of infectious agents and laboratory focus on antigen detection and viral culture. The new PGCM document is designed to be used by laboratorians in a wide variety of diagnostic and public health microbiology/virology laboratory settings worldwide. The article provides guidance to a rapidly changing field of diagnostics and outlines the epidemiology and clinical impact of acute respiratory viral infections, including preferred methods of specimen collection and current methods for diagnosis and characterization of viral pathogens causing acute respiratory tract infections. Compared to the case in 1986, molecular techniques are now the preferred diagnostic approaches for the detection of acute respiratory viruses, and they allow for automation, high-throughput workflows, and near-patient testing. These changes require quality assurance programs to prevent laboratory contamination as well as strong preanalytical screening approaches to utilize laboratory resources appropriately. Appropriate guidance from laboratorians to stakeholders will allow for appropriate specimen collection, as well as correct test ordering that will quickly identify highly transmissible emerging pathogens.",10.1128/cmr.00042-18,3hgupch5,"['Respiratory', 'viral', 'infections', 'are', 'associated', 'with', 'a', 'wide', 'range', 'of', 'acute', 'syndromes', 'and', 'infectious', 'disease', 'processes', 'in', 'children', 'and', 'adults', 'worldwide', 'Many', 'viruses', 'are', 'implicated', 'in', 'these', 'infections', 'and', 'these', 'viruses', 'are', 'spread', 'largely', 'via', 'respiratory', 'means', 'between', 'humans', 'but', 'also', 'occasionally', 'from', 'animals', 'to', 'humans', 'This', 'article', 'is', 'an', 'American', 'Society', 'for', 'Microbiology', 'ASM', 'sponsored', 'Practical', 'Guidance', 'for', 'Clinical', 'Microbiology', 'PGCM', 'document', 'identifying', 'best', 'practices', 'for', 'diagnosis', 'and', 'characterization', 'of', 'viruses', 'that', 'cause', 'acute', 'respiratory', 'infections', 'and', 'replaces', 'the', 'most', 'recent', 'prior', 'version', 'of', 'the', 'ASM', 'sponsored', 'Cumitech', '21', 'document', 'Laboratory', 'Diagnosis', 'of', 'Viral', 'Respiratory', 'Disease', 'published', 'in', '1986', 'The', 'scope', 'of', 'the', 'original', 'document', 'was', 'quite', 'broad', 'with', 'an', 'emphasis', 'on', 'clinical', 'diagnosis', 'of', 'a', 'wide', 'variety', 'of', 'infectious', 'agents', 'and', 'laboratory', 'focus', 'on', 'antigen', 'detection', 'and', 'viral', 'culture', 'The', 'new', 'PGCM', 'document', 'is', 'designed', 'to', 'be', 'used', 'by', 'laboratorians', 'in', 'a', 'wide', 'variety', 'of', 'diagnostic', 'and', 'public', 'health', 'microbiology', 'virology', 'laboratory', 'settings', 'worldwide', 'The', 'article', 'provides', 'guidance', 'to', 'a', 'rapidly', 'changing', 'field', 'of', 'diagnostics', 'and', 'outlines', 'the', 'epidemiology', 'and', 'clinical', 'impact', 'of', 'acute', 'respiratory', 'viral', 'infections', 'including', 'preferred', 'methods', 'of', 'specimen', 'collection', 'and', 'current', 'methods', 'for', 'diagnosis', 'and', 'characterization', 'of', 'viral', 'pathogens', 'causing', 'acute', 'respiratory', 'tract', 'infections', 'Compared', 'to', 'the', 'case', 'in', '1986', 'molecular', 'techniques', 'are', 'now', 'the', 'preferred', 'diagnostic', 'approaches', 'for', 'the', 'detection', 'of', 'acute', 'respiratory', 'viruses', 'and', 'they', 'allow', 'for', 'automation', 'high', 'throughput', 'workflows', 'and', 'near', 'patient', 'testing', 'These', 'changes', 'require', 'quality', 'assurance', 'programs', 'to', 'prevent', 'laboratory', 'contamination', 'as', 'well', 'as', 'strong', 'preanalytical', 'screening', 'approaches', 'to', 'utilize', 'laboratory', 'resources', 'appropriately', 'Appropriate', 'guidance', 'from', 'laboratorians', 'to', 'stakeholders', 'will', 'allow', 'for', 'appropriate', 'specimen', 'collection', 'as', 'well', 'as', 'correct', 'test', 'ordering', 'that', 'will', 'quickly', 'identify', 'highly', 'transmissible', 'emerging', 'pathogens', '']"
41886,Enhancing colorimetric loop-mediated isothermal amplification speed and sensitivity with guanidine chloride.,2020-07-08,BioTechniques,https://doi.org/10.2144/btn-2020-0078; https://www.ncbi.nlm.nih.gov/pubmed/32635743/,"Loop-mediated isothermal amplification (LAMP) is a versatile technique for detection of target DNA and RNA, enabling rapid molecular diagnostic assays with minimal equipment. The global SARS-CoV-2 pandemic has presented an urgent need for new and better diagnostic methods, with colorimetric LAMP utilized in numerous studies for SARS-CoV-2 detection. However, the sensitivity of colorimetric LAMP in early reports has been below that of the standard RT-qPCR tests, and we sought to improve performance. Here we report the use of guanidine hydrochloride and combined primer sets to increase speed and sensitivity in colorimetric LAMP, bringing this simple method up to the standards of sophisticated techniques and enabling accurate, high-throughput diagnostics.",10.2144/btn-2020-0078,4og213rp,"['Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'a', 'versatile', 'technique', 'for', 'detection', 'of', 'target', 'DNA', 'and', 'RNA', 'enabling', 'rapid', 'molecular', 'diagnostic', 'assays', 'with', 'minimal', 'equipment', 'The', 'global', 'SARS', 'CoV', '2', 'pandemic', 'has', 'presented', 'an', 'urgent', 'need', 'for', 'new', 'and', 'better', 'diagnostic', 'methods', 'with', 'colorimetric', 'LAMP', 'utilized', 'in', 'numerous', 'studies', 'for', 'SARS', 'CoV', '2', 'detection', 'However', 'the', 'sensitivity', 'of', 'colorimetric', 'LAMP', 'in', 'early', 'reports', 'has', 'been', 'below', 'that', 'of', 'the', 'standard', 'RT', 'qPCR', 'tests', 'and', 'we', 'sought', 'to', 'improve', 'performance', 'Here', 'we', 'report', 'the', 'use', 'of', 'guanidine', 'hydrochloride', 'and', 'combined', 'primer', 'sets', 'to', 'increase', 'speed', 'and', 'sensitivity', 'in', 'colorimetric', 'LAMP', 'bringing', 'this', 'simple', 'method', 'up', 'to', 'the', 'standards', 'of', 'sophisticated', 'techniques', 'and', 'enabling', 'accurate', 'high', 'throughput', 'diagnostics', '']"
42334,HEALTH-SCREENING PROTOCOLS FOR VINACEOUS AMAZONS (AMAZONA VINACEA) IN A REINTRODUCTION PROJECT.,2015,Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,https://doi.org/10.1638/2013-0152.1; https://www.ncbi.nlm.nih.gov/pubmed/26667526/,"Reintroduction is a growing field in the conservation of endangered species. The vinaceous Amazon parrot (Amazona vinacea) is extinct in several areas, and a project to release confiscated individuals to their former range is currently underway. The objective of this study was to evaluate and improve the selection and treatment of individual release candidates by detecting possible pathogen carriers using samples taken before and during release. As part of prerelease health protocols, samples were obtained from 29 parrots on three different occasions while in captivity and once after their release. Samples were screened for paramyxovirus type 1, avian influenza, poxvirus, coronavirus, psittacine herpesvirus 1, Chlamydia psittaci , enteropathogenic Escherichia coli (EPEC), Salmonella spp., and endoparasites. The majority of samples returned negative results, with the exception of two individuals that tested positive for C. psittaci in the first sampling and for Ascaridia spp. in the second pooled sampling. Treatments for C. psittaci and endoparasites were administered prior to release, and negative results were obtained in subsequent exams. The number of positive results for E. coli (non-EPEC) decreased during the rehabilitation period. Adequate quarantine procedures and health examinations greatly minimize disease risks. The protocols employed in this study resulted in acceptable health status in accordance with current environmental legislation in Brazil. Additionally, protocols allowed informed decisions to release candidates, minimized risks, and favored the selection of healthy individuals, thereby contributing to the recovery of this species. It is important to determine appropriate minimum health-screening protocols when advanced diagnostics may not be available or high costs make the tests prohibitive in countries where confiscations occur. We hypothesize that a minimum panel of tests of pooled samples can serve as an alternative approach that minimizes costs and overall workload and supports projects intended to restore and promote flagship species and hamper their illegal trade.",10.1638/2013-0152.1,z9p5s3ud,"['Reintroduction', 'is', 'a', 'growing', 'field', 'in', 'the', 'conservation', 'of', 'endangered', 'species', 'The', 'vinaceous', 'Amazon', 'parrot', 'Amazona', 'vinacea', 'is', 'extinct', 'in', 'several', 'areas', 'and', 'a', 'project', 'to', 'release', 'confiscated', 'individuals', 'to', 'their', 'former', 'range', 'is', 'currently', 'underway', 'The', 'objective', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'and', 'improve', 'the', 'selection', 'and', 'treatment', 'of', 'individual', 'release', 'candidates', 'by', 'detecting', 'possible', 'pathogen', 'carriers', 'using', 'samples', 'taken', 'before', 'and', 'during', 'release', 'As', 'part', 'of', 'prerelease', 'health', 'protocols', 'samples', 'were', 'obtained', 'from', '29', 'parrots', 'on', 'three', 'different', 'occasions', 'while', 'in', 'captivity', 'and', 'once', 'after', 'their', 'release', 'Samples', 'were', 'screened', 'for', 'paramyxovirus', 'type', '1', 'avian', 'influenza', 'poxvirus', 'coronavirus', 'psittacine', 'herpesvirus', '1', 'Chlamydia', 'psittaci', 'enteropathogenic', 'Escherichia', 'coli', 'EPEC', 'Salmonella', 'spp', 'and', 'endoparasites', 'The', 'majority', 'of', 'samples', 'returned', 'negative', 'results', 'with', 'the', 'exception', 'of', 'two', 'individuals', 'that', 'tested', 'positive', 'for', 'C', 'psittaci', 'in', 'the', 'first', 'sampling', 'and', 'for', 'Ascaridia', 'spp', 'in', 'the', 'second', 'pooled', 'sampling', 'Treatments', 'for', 'C', 'psittaci', 'and', 'endoparasites', 'were', 'administered', 'prior', 'to', 'release', 'and', 'negative', 'results', 'were', 'obtained', 'in', 'subsequent', 'exams', 'The', 'number', 'of', 'positive', 'results', 'for', 'E', 'coli', 'non', 'EPEC', 'decreased', 'during', 'the', 'rehabilitation', 'period', 'Adequate', 'quarantine', 'procedures', 'and', 'health', 'examinations', 'greatly', 'minimize', 'disease', 'risks', 'The', 'protocols', 'employed', 'in', 'this', 'study', 'resulted', 'in', 'acceptable', 'health', 'status', 'in', 'accordance', 'with', 'current', 'environmental', 'legislation', 'in', 'Brazil', 'Additionally', 'protocols', 'allowed', 'informed', 'decisions', 'to', 'release', 'candidates', 'minimized', 'risks', 'and', 'favored', 'the', 'selection', 'of', 'healthy', 'individuals', 'thereby', 'contributing', 'to', 'the', 'recovery', 'of', 'this', 'species', 'It', 'is', 'important', 'to', 'determine', 'appropriate', 'minimum', 'health', 'screening', 'protocols', 'when', 'advanced', 'diagnostics', 'may', 'not', 'be', 'available', 'or', 'high', 'costs', 'make', 'the', 'tests', 'prohibitive', 'in', 'countries', 'where', 'confiscations', 'occur', 'We', 'hypothesize', 'that', 'a', 'minimum', 'panel', 'of', 'tests', 'of', 'pooled', 'samples', 'can', 'serve', 'as', 'an', 'alternative', 'approach', 'that', 'minimizes', 'costs', 'and', 'overall', 'workload', 'and', 'supports', 'projects', 'intended', 'to', 'restore', 'and', 'promote', 'flagship', 'species', 'and', 'hamper', 'their', 'illegal', 'trade', '']"
42914,Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination.,2020-05-20,Emerging infectious diseases,https://doi.org/10.3201/eid2608.201843; https://www.ncbi.nlm.nih.gov/pubmed/32433015/,"The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries.",10.3201/eid2608.201843,z1jr2urk,"['The', 'emergence', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'created', 'an', 'exceptional', 'situation', 'in', 'which', 'numerous', 'laboratories', 'in', 'Europe', 'simultaneously', 'implemented', 'SARS', 'CoV', '2', 'diagnostics', 'These', 'laboratories', 'reported', 'in', 'February', '2020', 'that', 'commercial', 'primer', 'and', 'probe', 'batches', 'for', 'SARS', 'CoV', '2', 'detection', 'were', 'contaminated', 'with', 'synthetic', 'control', 'material', 'causing', 'delays', 'of', 'regional', 'testing', 'roll', 'out', 'in', 'various', 'countries', '']"
43075,Severe community-acquired pneumonia: optimal management.,2017,Current opinion in infectious diseases,https://doi.org/10.1097/qco.0000000000000349; https://www.ncbi.nlm.nih.gov/pubmed/28067676/,"PURPOSE OF REVIEW Community-acquired pneumonia (CAP) is the leading cause of mortality among infectious diseases. Several efforts have been implemented to achieve better outcomes, but an important proportion of patients continue dying. This review focuses on the newest research on prognostic factors and diagnostics, opening new perspectives in the management of CAP. RECENT FINDINGS CAP survival improved in recent years despite an increasing incidence of severe presentations. Appropriateness of antimicrobial choice, combination therapy and early administration of antibiotics has proved to be decisive. Novel biomarkers, as monocyte human leukocyte antigen-DR, presepsin and proadrenomedullin, have been explored for the prediction of severe CAP; moreover, the application of new techniques in metabolomics, genomics and microbiomics in the field of infections may contribute to predicting clinical instability and worse outcomes, showing that precise individual phenotypes are key factors for survival. CAP with unidentified organism is still an issue of concern, but new rapid molecular tests improve yield rates, revealing an unexpected high prevalence of viral detection and proving their usefulness also in the recognition of bacterial causes. SUMMARY Precision medicine applied to risk stratification and diagnosis, together with rapid microbiologic molecular testing, may contribute to optimizing the management of CAP, with potential additional reduction of mortality rates.",10.1097/qco.0000000000000349,dhp55s3k,"['PURPOSE', 'OF', 'REVIEW', 'Community', 'acquired', 'pneumonia', 'CAP', 'is', 'the', 'leading', 'cause', 'of', 'mortality', 'among', 'infectious', 'diseases', 'Several', 'efforts', 'have', 'been', 'implemented', 'to', 'achieve', 'better', 'outcomes', 'but', 'an', 'important', 'proportion', 'of', 'patients', 'continue', 'dying', 'This', 'review', 'focuses', 'on', 'the', 'newest', 'research', 'on', 'prognostic', 'factors', 'and', 'diagnostics', 'opening', 'new', 'perspectives', 'in', 'the', 'management', 'of', 'CAP', 'RECENT', 'FINDINGS', 'CAP', 'survival', 'improved', 'in', 'recent', 'years', 'despite', 'an', 'increasing', 'incidence', 'of', 'severe', 'presentations', 'Appropriateness', 'of', 'antimicrobial', 'choice', 'combination', 'therapy', 'and', 'early', 'administration', 'of', 'antibiotics', 'has', 'proved', 'to', 'be', 'decisive', 'Novel', 'biomarkers', 'as', 'monocyte', 'human', 'leukocyte', 'antigen', 'DR', 'presepsin', 'and', 'proadrenomedullin', 'have', 'been', 'explored', 'for', 'the', 'prediction', 'of', 'severe', 'CAP', 'moreover', 'the', 'application', 'of', 'new', 'techniques', 'in', 'metabolomics', 'genomics', 'and', 'microbiomics', 'in', 'the', 'field', 'of', 'infections', 'may', 'contribute', 'to', 'predicting', 'clinical', 'instability', 'and', 'worse', 'outcomes', 'showing', 'that', 'precise', 'individual', 'phenotypes', 'are', 'key', 'factors', 'for', 'survival', 'CAP', 'with', 'unidentified', 'organism', 'is', 'still', 'an', 'issue', 'of', 'concern', 'but', 'new', 'rapid', 'molecular', 'tests', 'improve', 'yield', 'rates', 'revealing', 'an', 'unexpected', 'high', 'prevalence', 'of', 'viral', 'detection', 'and', 'proving', 'their', 'usefulness', 'also', 'in', 'the', 'recognition', 'of', 'bacterial', 'causes', 'SUMMARY', 'Precision', 'medicine', 'applied', 'to', 'risk', 'stratification', 'and', 'diagnosis', 'together', 'with', 'rapid', 'microbiologic', 'molecular', 'testing', 'may', 'contribute', 'to', 'optimizing', 'the', 'management', 'of', 'CAP', 'with', 'potential', 'additional', 'reduction', 'of', 'mortality', 'rates', '']"
43280,Trends and innovations in biosensors for COVID-19 mass testing.,2020-05-04,Chembiochem : a European journal of chemical biology,https://doi.org/10.1002/cbic.202000250; https://www.ncbi.nlm.nih.gov/pubmed/32367615/,"Fast and widespread diagnosis is crucial to fight against the outbreak of COVID-19. The present work surveys the landscape of available and emerging biosensor technologies for COVID-19 testing. Molecular diagnostic assays based on quantitative Reverse Transcription Polymerase Chain Reaction are used in most clinical laboratories. The COVID-19 pandemic has overwhelmed the testing capacity and motivated the development of fast point-of-care tests and the adoption of isothermal DNA amplification. Antigenic and serological rapid tests based on lateral flow immunoassays suffer from low sensitivity. Advanced digital systems enhance the performance at the expense of speed and large equipment requirement. Emerging technologies, including CRISPR gene-editing tools, benefit from high sensitivity and selectivity of molecular diagnostics and the easy use of lateral flow assays. DNA sequencing and sample pooling strategies are highlighted to bring out the full capacity of the available biosensor technologies and accelerate mass testing.",10.1002/cbic.202000250,nswmhpzf,"['Fast', 'and', 'widespread', 'diagnosis', 'is', 'crucial', 'to', 'fight', 'against', 'the', 'outbreak', 'of', 'COVID', '19', 'The', 'present', 'work', 'surveys', 'the', 'landscape', 'of', 'available', 'and', 'emerging', 'biosensor', 'technologies', 'for', 'COVID', '19', 'testing', 'Molecular', 'diagnostic', 'assays', 'based', 'on', 'quantitative', 'Reverse', 'Transcription', 'Polymerase', 'Chain', 'Reaction', 'are', 'used', 'in', 'most', 'clinical', 'laboratories', 'The', 'COVID', '19', 'pandemic', 'has', 'overwhelmed', 'the', 'testing', 'capacity', 'and', 'motivated', 'the', 'development', 'of', 'fast', 'point', 'of', 'care', 'tests', 'and', 'the', 'adoption', 'of', 'isothermal', 'DNA', 'amplification', 'Antigenic', 'and', 'serological', 'rapid', 'tests', 'based', 'on', 'lateral', 'flow', 'immunoassays', 'suffer', 'from', 'low', 'sensitivity', 'Advanced', 'digital', 'systems', 'enhance', 'the', 'performance', 'at', 'the', 'expense', 'of', 'speed', 'and', 'large', 'equipment', 'requirement', 'Emerging', 'technologies', 'including', 'CRISPR', 'gene', 'editing', 'tools', 'benefit', 'from', 'high', 'sensitivity', 'and', 'selectivity', 'of', 'molecular', 'diagnostics', 'and', 'the', 'easy', 'use', 'of', 'lateral', 'flow', 'assays', 'DNA', 'sequencing', 'and', 'sample', 'pooling', 'strategies', 'are', 'highlighted', 'to', 'bring', 'out', 'the', 'full', 'capacity', 'of', 'the', 'available', 'biosensor', 'technologies', 'and', 'accelerate', 'mass', 'testing', '']"
43827,Achieving molecular diagnostics for Lyme disease.,2013,Expert review of molecular diagnostics,https://doi.org/10.1586/14737159.2013.850418; https://www.ncbi.nlm.nih.gov/pubmed/24151851/,"Early Lyme disease is often difficult to diagnose. Left untreated, symptoms can last for many years leading to chronic health problems. Serological tests for the presence of antibodies that react to Borrelia burgdorferi antigens are generally used to support a clinical diagnosis. Due to the biologically delayed antibody response, serology is negative in many patients in the initial 3 weeks after infection and a single test cannot be used to demonstrate active disease, although certain specialized tests provide strong correlation. Because of these limitations there exists a need for better diagnostics for Lyme disease that can detect Borrelia genomic material at the onset of symptoms.",10.1586/14737159.2013.850418,u31i00w6,"['Early', 'Lyme', 'disease', 'is', 'often', 'difficult', 'to', 'diagnose', 'Left', 'untreated', 'symptoms', 'can', 'last', 'for', 'many', 'years', 'leading', 'to', 'chronic', 'health', 'problems', 'Serological', 'tests', 'for', 'the', 'presence', 'of', 'antibodies', 'that', 'react', 'to', 'Borrelia', 'burgdorferi', 'antigens', 'are', 'generally', 'used', 'to', 'support', 'a', 'clinical', 'diagnosis', 'Due', 'to', 'the', 'biologically', 'delayed', 'antibody', 'response', 'serology', 'is', 'negative', 'in', 'many', 'patients', 'in', 'the', 'initial', '3', 'weeks', 'after', 'infection', 'and', 'a', 'single', 'test', 'cannot', 'be', 'used', 'to', 'demonstrate', 'active', 'disease', 'although', 'certain', 'specialized', 'tests', 'provide', 'strong', 'correlation', 'Because', 'of', 'these', 'limitations', 'there', 'exists', 'a', 'need', 'for', 'better', 'diagnostics', 'for', 'Lyme', 'disease', 'that', 'can', 'detect', 'Borrelia', 'genomic', 'material', 'at', 'the', 'onset', 'of', 'symptoms', '']"
44377,Practical approach to emergencies in lung transplant recipients: how we do it.,2012,Respiration; international review of thoracic diseases,https://doi.org/10.1159/000339345; https://www.ncbi.nlm.nih.gov/pubmed/22832220/,"Lung transplant recipients (LTRs) are prone to medical complications and emergencies due to the transplanted organ being in constant direct contact with the environment and the need for life-long profound immunosuppression (IS). As a result of these specific circumstances, the medical and surgical management of LTRs frequently differs from usual standard care. Therefore, we outline here some of the principles we take into account when dealing with the most frequent medical emergencies encountered in our lung transplant cohort in Zurich. The main topics dealt with are: diagnostics and treatment of infections, gastrointestinal emergencies, IS and other medication issues as well as work-up of unclear inflammatory signs and peri-operative precautions in LTRs. Early post-operative transplant complications, rare medical emergencies and surgical problems are not covered. Our report is intended to help internists and pulmonologists new to the field to obtain a better understanding of the peculiarities of LTRs and their management.",10.1159/000339345,p5ki3d7z,"['Lung', 'transplant', 'recipients', 'LTRs', 'are', 'prone', 'to', 'medical', 'complications', 'and', 'emergencies', 'due', 'to', 'the', 'transplanted', 'organ', 'being', 'in', 'constant', 'direct', 'contact', 'with', 'the', 'environment', 'and', 'the', 'need', 'for', 'life', 'long', 'profound', 'immunosuppression', 'IS', 'As', 'a', 'result', 'of', 'these', 'specific', 'circumstances', 'the', 'medical', 'and', 'surgical', 'management', 'of', 'LTRs', 'frequently', 'differs', 'from', 'usual', 'standard', 'care', 'Therefore', 'we', 'outline', 'here', 'some', 'of', 'the', 'principles', 'we', 'take', 'into', 'account', 'when', 'dealing', 'with', 'the', 'most', 'frequent', 'medical', 'emergencies', 'encountered', 'in', 'our', 'lung', 'transplant', 'cohort', 'in', 'Zurich', 'The', 'main', 'topics', 'dealt', 'with', 'are', 'diagnostics', 'and', 'treatment', 'of', 'infections', 'gastrointestinal', 'emergencies', 'IS', 'and', 'other', 'medication', 'issues', 'as', 'well', 'as', 'work', 'up', 'of', 'unclear', 'inflammatory', 'signs', 'and', 'peri', 'operative', 'precautions', 'in', 'LTRs', 'Early', 'post', 'operative', 'transplant', 'complications', 'rare', 'medical', 'emergencies', 'and', 'surgical', 'problems', 'are', 'not', 'covered', 'Our', 'report', 'is', 'intended', 'to', 'help', 'internists', 'and', 'pulmonologists', 'new', 'to', 'the', 'field', 'to', 'obtain', 'a', 'better', 'understanding', 'of', 'the', 'peculiarities', 'of', 'LTRs', 'and', 'their', 'management', '']"
44398,Syndromic Panel-Based Testing in Clinical Microbiology.,2018,Clinical microbiology reviews,https://doi.org/10.1128/cmr.00024-17; https://www.ncbi.nlm.nih.gov/pubmed/29142077/,"The recent development of commercial panel-based molecular diagnostics for the rapid detection of pathogens in positive blood culture bottles, respiratory specimens, stool, and cerebrospinal fluid has resulted in a paradigm shift in clinical microbiology and clinical practice. This review focuses on U.S. Food and Drug Administration (FDA)-approved/cleared multiplex molecular panels with more than five targets designed to assist in the diagnosis of bloodstream, respiratory tract, gastrointestinal, or central nervous system infections. While these panel-based assays have the clear advantages of a rapid turnaround time and the detection of a large number of microorganisms and promise to improve health care, they present certain challenges, including cost and the definition of ideal test utilization strategies (i.e., optimal ordering) and test interpretation.",10.1128/cmr.00024-17,gsprsbug,"['The', 'recent', 'development', 'of', 'commercial', 'panel', 'based', 'molecular', 'diagnostics', 'for', 'the', 'rapid', 'detection', 'of', 'pathogens', 'in', 'positive', 'blood', 'culture', 'bottles', 'respiratory', 'specimens', 'stool', 'and', 'cerebrospinal', 'fluid', 'has', 'resulted', 'in', 'a', 'paradigm', 'shift', 'in', 'clinical', 'microbiology', 'and', 'clinical', 'practice', 'This', 'review', 'focuses', 'on', 'U', 'S', 'Food', 'and', 'Drug', 'Administration', 'FDA', 'approved', 'cleared', 'multiplex', 'molecular', 'panels', 'with', 'more', 'than', 'five', 'targets', 'designed', 'to', 'assist', 'in', 'the', 'diagnosis', 'of', 'bloodstream', 'respiratory', 'tract', 'gastrointestinal', 'or', 'central', 'nervous', 'system', 'infections', 'While', 'these', 'panel', 'based', 'assays', 'have', 'the', 'clear', 'advantages', 'of', 'a', 'rapid', 'turnaround', 'time', 'and', 'the', 'detection', 'of', 'a', 'large', 'number', 'of', 'microorganisms', 'and', 'promise', 'to', 'improve', 'health', 'care', 'they', 'present', 'certain', 'challenges', 'including', 'cost', 'and', 'the', 'definition', 'of', 'ideal', 'test', 'utilization', 'strategies', 'i', 'e', 'optimal', 'ordering', 'and', 'test', 'interpretation', '']"
44582,Persistence of adenovirus nucleic acids in nasopharyngeal secretions: a diagnostic conundrum.,2010,The Pediatric infectious disease journal,https://doi.org/10.1097/inf.0b013e3181d743c8; https://www.ncbi.nlm.nih.gov/pubmed/20308936/,"BACKGROUND Polymerase chain reaction (PCR) assays increase the rate of viral detection in clinical specimens, compared with conventional virologic methods. Studies suggest that PCR may detect virus nucleic acid (NA) that persists in the respiratory tract. METHODS We analyzed virologic data from children having frequent upper respiratory infections (URI), who were followed up in a longitudinal study. Nasopharyngeal secretions were collected at URI onset and when acute otitis media was diagnosed; virus studies were performed using conventional diagnostics and PCR. Repeated presence of adenovirus by PCR was further studied by sequencing and phylogenetic analysis. RESULTS Of 581 URI episodes in 76 children, 510 viruses were detected. Of the viruses detected by PCR, 15% were those detected previously; repeated positives occurred most frequently with adenovirus. Sequencing results were available in 13 children with repeated adenovirus detection; the following 4 patterns of infection were identified (16 instances): (1) adenovirus of the same serotype and strain detected continuously (n = 8 instances), (2) adenovirus of different serotypes detected during sequential URI episodes (n = 3), (3) adenovirus of the same serotype but different strains detected during sequential URI episodes (n = 3), and (4) adenovirus of the same serotype and strain detected intermittently (n = 2). CONCLUSIONS Among children with frequent URIs, repeated positive PCR results for adenovirus NA may represent a new serotype/strain, or persistence of viral NA. Results must be interpreted with caution; clinical correlation and presence of other viruses are important. Further longitudinal studies of children during and after infection are required for better understanding of the clinical significance of positive PCR tests for adenovirus NA in the respiratory tract.",10.1097/inf.0b013e3181d743c8,sdy6lbew,"['BACKGROUND', 'Polymerase', 'chain', 'reaction', 'PCR', 'assays', 'increase', 'the', 'rate', 'of', 'viral', 'detection', 'in', 'clinical', 'specimens', 'compared', 'with', 'conventional', 'virologic', 'methods', 'Studies', 'suggest', 'that', 'PCR', 'may', 'detect', 'virus', 'nucleic', 'acid', 'NA', 'that', 'persists', 'in', 'the', 'respiratory', 'tract', 'METHODS', 'We', 'analyzed', 'virologic', 'data', 'from', 'children', 'having', 'frequent', 'upper', 'respiratory', 'infections', 'URI', 'who', 'were', 'followed', 'up', 'in', 'a', 'longitudinal', 'study', 'Nasopharyngeal', 'secretions', 'were', 'collected', 'at', 'URI', 'onset', 'and', 'when', 'acute', 'otitis', 'media', 'was', 'diagnosed', 'virus', 'studies', 'were', 'performed', 'using', 'conventional', 'diagnostics', 'and', 'PCR', 'Repeated', 'presence', 'of', 'adenovirus', 'by', 'PCR', 'was', 'further', 'studied', 'by', 'sequencing', 'and', 'phylogenetic', 'analysis', 'RESULTS', 'Of', '581', 'URI', 'episodes', 'in', '76', 'children', '510', 'viruses', 'were', 'detected', 'Of', 'the', 'viruses', 'detected', 'by', 'PCR', '15', 'were', 'those', 'detected', 'previously', 'repeated', 'positives', 'occurred', 'most', 'frequently', 'with', 'adenovirus', 'Sequencing', 'results', 'were', 'available', 'in', '13', 'children', 'with', 'repeated', 'adenovirus', 'detection', 'the', 'following', '4', 'patterns', 'of', 'infection', 'were', 'identified', '16', 'instances', '1', 'adenovirus', 'of', 'the', 'same', 'serotype', 'and', 'strain', 'detected', 'continuously', 'n', '8', 'instances', '2', 'adenovirus', 'of', 'different', 'serotypes', 'detected', 'during', 'sequential', 'URI', 'episodes', 'n', '3', '3', 'adenovirus', 'of', 'the', 'same', 'serotype', 'but', 'different', 'strains', 'detected', 'during', 'sequential', 'URI', 'episodes', 'n', '3', 'and', '4', 'adenovirus', 'of', 'the', 'same', 'serotype', 'and', 'strain', 'detected', 'intermittently', 'n', '2', 'CONCLUSIONS', 'Among', 'children', 'with', 'frequent', 'URIs', 'repeated', 'positive', 'PCR', 'results', 'for', 'adenovirus', 'NA', 'may', 'represent', 'a', 'new', 'serotype', 'strain', 'or', 'persistence', 'of', 'viral', 'NA', 'Results', 'must', 'be', 'interpreted', 'with', 'caution', 'clinical', 'correlation', 'and', 'presence', 'of', 'other', 'viruses', 'are', 'important', 'Further', 'longitudinal', 'studies', 'of', 'children', 'during', 'and', 'after', 'infection', 'are', 'required', 'for', 'better', 'understanding', 'of', 'the', 'clinical', 'significance', 'of', 'positive', 'PCR', 'tests', 'for', 'adenovirus', 'NA', 'in', 'the', 'respiratory', 'tract', '']"
45612,Comparison of the fast track diagnostics respiratory 21 and Seegene Allplex multiplex polymerase chain reaction assays for the detection of respiratory viruses.,2017,British journal of biomedical science,https://doi.org/10.1080/09674845.2017.1278885; https://www.ncbi.nlm.nih.gov/pubmed/28367738/,"BACKGROUND Real-time multiplex PCR assays are increasingly used for respiratory virus detection, and offer automated analysis in a closed tube system, but they have the disadvantage of low-throughput due to multiplexing limitations. In this study, the established fast-track respiratory 21 assay (FTD) (fast-track diagnostics, Junglinster Luxembourg) was compared to the new Seegene Allplex assay (Seegene) (Seegene Inc. Seoul, Korea) which offers greater multiplexing as multiple targets can be detected in each fluorescence channel. The Seegene Allplex assay is quicker to perform than previous Seegene respiratory multiplex assays. MATERIALS AND METHODS The assays were evaluated using 199 mostly upper respiratory tract samples. RESULTS A respiratory pathogen was found in 127/199 (63.8%) of samples by the FTD assay and 123/199 (61.8%) using the Seegene assay. Kappa agreement was between 0.87 and 1 for all targets except human bocavirus and adenovirus. CONCLUSION Although the performance of the assays were similar, the Seegene assay had the advantage of simultaneous detection of two gene targets for each of the common Influenza A subtypes, improved throughput of 30 samples per run and automated result analysis. The FTD assay could only test 17 samples per run but validation for use on several different real-time thermal cyclers made it easier to integrate into an existing laboratory system. Both assays were cost effective compared to in-house multiplex PCR respiratory virus screening.",10.1080/09674845.2017.1278885,s9aalhst,"['BACKGROUND', 'Real', 'time', 'multiplex', 'PCR', 'assays', 'are', 'increasingly', 'used', 'for', 'respiratory', 'virus', 'detection', 'and', 'offer', 'automated', 'analysis', 'in', 'a', 'closed', 'tube', 'system', 'but', 'they', 'have', 'the', 'disadvantage', 'of', 'low', 'throughput', 'due', 'to', 'multiplexing', 'limitations', 'In', 'this', 'study', 'the', 'established', 'fast', 'track', 'respiratory', '21', 'assay', 'FTD', 'fast', 'track', 'diagnostics', 'Junglinster', 'Luxembourg', 'was', 'compared', 'to', 'the', 'new', 'Seegene', 'Allplex', 'assay', 'Seegene', 'Seegene', 'Inc', 'Seoul', 'Korea', 'which', 'offers', 'greater', 'multiplexing', 'as', 'multiple', 'targets', 'can', 'be', 'detected', 'in', 'each', 'fluorescence', 'channel', 'The', 'Seegene', 'Allplex', 'assay', 'is', 'quicker', 'to', 'perform', 'than', 'previous', 'Seegene', 'respiratory', 'multiplex', 'assays', 'MATERIALS', 'AND', 'METHODS', 'The', 'assays', 'were', 'evaluated', 'using', '199', 'mostly', 'upper', 'respiratory', 'tract', 'samples', 'RESULTS', 'A', 'respiratory', 'pathogen', 'was', 'found', 'in', '127', '199', '63', '8', 'of', 'samples', 'by', 'the', 'FTD', 'assay', 'and', '123', '199', '61', '8', 'using', 'the', 'Seegene', 'assay', 'Kappa', 'agreement', 'was', 'between', '0', '87', 'and', '1', 'for', 'all', 'targets', 'except', 'human', 'bocavirus', 'and', 'adenovirus', 'CONCLUSION', 'Although', 'the', 'performance', 'of', 'the', 'assays', 'were', 'similar', 'the', 'Seegene', 'assay', 'had', 'the', 'advantage', 'of', 'simultaneous', 'detection', 'of', 'two', 'gene', 'targets', 'for', 'each', 'of', 'the', 'common', 'Influenza', 'A', 'subtypes', 'improved', 'throughput', 'of', '30', 'samples', 'per', 'run', 'and', 'automated', 'result', 'analysis', 'The', 'FTD', 'assay', 'could', 'only', 'test', '17', 'samples', 'per', 'run', 'but', 'validation', 'for', 'use', 'on', 'several', 'different', 'real', 'time', 'thermal', 'cyclers', 'made', 'it', 'easier', 'to', 'integrate', 'into', 'an', 'existing', 'laboratory', 'system', 'Both', 'assays', 'were', 'cost', 'effective', 'compared', 'to', 'in', 'house', 'multiplex', 'PCR', 'respiratory', 'virus', 'screening', '']"
45781,Assessing the Detection of Middle East Respiratory Syndrome Coronavirus IgG in Suspected and Proven Cases of Middle East Respiratory Syndrome Coronavirus Infection.,2017,Viral immunology,https://doi.org/10.1089/vim.2017.0091; https://www.ncbi.nlm.nih.gov/pubmed/28873020/,"Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory disease with significant mortality. Two testing methods are currently used for MERS-CoV diagnostics: nucleic acid detection (the gold standard) and serological analysis. In this study, we evaluated the detection of MERS-CoV-IgG in suspected and proven cases of MERS-CoV infection. We enrolled 174 patients: 113 had respiratory symptoms/suspected MERS-CoV infection, 31 had confirmed influenza A or B infection, 23 had a recent confirmed MERS-CoV infection, and 7 had confirmed MERS-CoV infection 1 year before. All underwent MERS-CoV RNA and MERS-CoV-IgG testing. Thirty patients were found to be MERS-CoV RNA positive; however, during serological analysis, only 6 (3.4%) patients were positive for MERS-CoV-IgG, 1 (0.6%) patient was equivocal, and 167 (96%) patients were negative. Among the serological positives, four were recently MERS-CoV RNA positive and two were MERS-CoV RNA negative. No cross-reactivity to influenza A or B was detected. Based on the lack of correlation between nucleic acid and serological analysis, we conclude that MERS-CoV-IgG testing may not be suitable for diagnosing acute infection or estimating its prevalence during an outbreak. In addition, our findings show that MERS-CoV-IgG may not have significant value in determining disease severity or prognosis.",10.1089/vim.2017.0091,rziotno9,"['Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'causes', 'severe', 'respiratory', 'disease', 'with', 'significant', 'mortality', 'Two', 'testing', 'methods', 'are', 'currently', 'used', 'for', 'MERS', 'CoV', 'diagnostics', 'nucleic', 'acid', 'detection', 'the', 'gold', 'standard', 'and', 'serological', 'analysis', 'In', 'this', 'study', 'we', 'evaluated', 'the', 'detection', 'of', 'MERS', 'CoV', 'IgG', 'in', 'suspected', 'and', 'proven', 'cases', 'of', 'MERS', 'CoV', 'infection', 'We', 'enrolled', '174', 'patients', '113', 'had', 'respiratory', 'symptoms', 'suspected', 'MERS', 'CoV', 'infection', '31', 'had', 'confirmed', 'influenza', 'A', 'or', 'B', 'infection', '23', 'had', 'a', 'recent', 'confirmed', 'MERS', 'CoV', 'infection', 'and', '7', 'had', 'confirmed', 'MERS', 'CoV', 'infection', '1', 'year', 'before', 'All', 'underwent', 'MERS', 'CoV', 'RNA', 'and', 'MERS', 'CoV', 'IgG', 'testing', 'Thirty', 'patients', 'were', 'found', 'to', 'be', 'MERS', 'CoV', 'RNA', 'positive', 'however', 'during', 'serological', 'analysis', 'only', '6', '3', '4', 'patients', 'were', 'positive', 'for', 'MERS', 'CoV', 'IgG', '1', '0', '6', 'patient', 'was', 'equivocal', 'and', '167', '96', 'patients', 'were', 'negative', 'Among', 'the', 'serological', 'positives', 'four', 'were', 'recently', 'MERS', 'CoV', 'RNA', 'positive', 'and', 'two', 'were', 'MERS', 'CoV', 'RNA', 'negative', 'No', 'cross', 'reactivity', 'to', 'influenza', 'A', 'or', 'B', 'was', 'detected', 'Based', 'on', 'the', 'lack', 'of', 'correlation', 'between', 'nucleic', 'acid', 'and', 'serological', 'analysis', 'we', 'conclude', 'that', 'MERS', 'CoV', 'IgG', 'testing', 'may', 'not', 'be', 'suitable', 'for', 'diagnosing', 'acute', 'infection', 'or', 'estimating', 'its', 'prevalence', 'during', 'an', 'outbreak', 'In', 'addition', 'our', 'findings', 'show', 'that', 'MERS', 'CoV', 'IgG', 'may', 'not', 'have', 'significant', 'value', 'in', 'determining', 'disease', 'severity', 'or', 'prognosis', '']"
46079,Clinical next-generation sequencing in patients with non-small cell lung cancer.,2015,Cancer,https://doi.org/10.1002/cncr.29089; https://www.ncbi.nlm.nih.gov/pubmed/25345567/,"BACKGROUND A clinical assay was implemented to perform next-generation sequencing (NGS) of genes commonly mutated in multiple cancer types. This report describes the feasibility and diagnostic yield of this assay in 381 consecutive patients with non-small cell lung cancer (NSCLC). METHODS Clinical targeted sequencing of 23 genes was performed with DNA from formalin-fixed, paraffin-embedded (FFPE) tumor tissue. The assay used Agilent SureSelect hybrid capture followed by Illumina HiSeq 2000, MiSeq, or HiSeq 2500 sequencing in a College of American Pathologists-accredited, Clinical Laboratory Improvement Amendments-certified laboratory. Single-nucleotide variants and insertion/deletion events were reported. This assay was performed before methods were developed to detect rearrangements by NGS. RESULTS Two hundred nine of all requisitioned samples (55%) were successfully sequenced. The most common reason for not performing the sequencing was an insufficient quantity of tissue available in the blocks (29%). Excisional, endoscopic, and core biopsy specimens were sufficient for testing in 95%, 66%, and 40% of the cases, respectively. The median turnaround time (TAT) in the pathology laboratory was 21 days, and there was a trend of an improved TAT with more rapid sequencing platforms. Sequencing yielded a mean coverage of 1318×. Potentially actionable mutations (ie, predictive or prognostic) were identified in 46% of 209 samples and were most commonly found in KRAS (28%), epidermal growth factor receptor (14%), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (4%), phosphatase and tensin homolog (1%), and BRAF (1%). Five percent of the samples had multiple actionable mutations. A targeted therapy was instituted on the basis of NGS in 11% of the sequenced patients or in 6% of all patients. CONCLUSIONS NGS-based diagnostics are feasible in NSCLC and provide clinically relevant information from readily available FFPE tissue. The sample type is associated with the probability of successful testing.",10.1002/cncr.29089,mypjqap7,"['BACKGROUND', 'A', 'clinical', 'assay', 'was', 'implemented', 'to', 'perform', 'next', 'generation', 'sequencing', 'NGS', 'of', 'genes', 'commonly', 'mutated', 'in', 'multiple', 'cancer', 'types', 'This', 'report', 'describes', 'the', 'feasibility', 'and', 'diagnostic', 'yield', 'of', 'this', 'assay', 'in', '381', 'consecutive', 'patients', 'with', 'non', 'small', 'cell', 'lung', 'cancer', 'NSCLC', 'METHODS', 'Clinical', 'targeted', 'sequencing', 'of', '23', 'genes', 'was', 'performed', 'with', 'DNA', 'from', 'formalin', 'fixed', 'paraffin', 'embedded', 'FFPE', 'tumor', 'tissue', 'The', 'assay', 'used', 'Agilent', 'SureSelect', 'hybrid', 'capture', 'followed', 'by', 'Illumina', 'HiSeq', '2000', 'MiSeq', 'or', 'HiSeq', '2500', 'sequencing', 'in', 'a', 'College', 'of', 'American', 'Pathologists', 'accredited', 'Clinical', 'Laboratory', 'Improvement', 'Amendments', 'certified', 'laboratory', 'Single', 'nucleotide', 'variants', 'and', 'insertion', 'deletion', 'events', 'were', 'reported', 'This', 'assay', 'was', 'performed', 'before', 'methods', 'were', 'developed', 'to', 'detect', 'rearrangements', 'by', 'NGS', 'RESULTS', 'Two', 'hundred', 'nine', 'of', 'all', 'requisitioned', 'samples', '55', 'were', 'successfully', 'sequenced', 'The', 'most', 'common', 'reason', 'for', 'not', 'performing', 'the', 'sequencing', 'was', 'an', 'insufficient', 'quantity', 'of', 'tissue', 'available', 'in', 'the', 'blocks', '29', 'Excisional', 'endoscopic', 'and', 'core', 'biopsy', 'specimens', 'were', 'sufficient', 'for', 'testing', 'in', '95', '66', 'and', '40', 'of', 'the', 'cases', 'respectively', 'The', 'median', 'turnaround', 'time', 'TAT', 'in', 'the', 'pathology', 'laboratory', 'was', '21', 'days', 'and', 'there', 'was', 'a', 'trend', 'of', 'an', 'improved', 'TAT', 'with', 'more', 'rapid', 'sequencing', 'platforms', 'Sequencing', 'yielded', 'a', 'mean', 'coverage', 'of', '1318', 'Potentially', 'actionable', 'mutations', 'ie', 'predictive', 'or', 'prognostic', 'were', 'identified', 'in', '46', 'of', '209', 'samples', 'and', 'were', 'most', 'commonly', 'found', 'in', 'KRAS', '28', 'epidermal', 'growth', 'factor', 'receptor', '14', 'phosphatidylinositol', '4', '5', 'bisphosphate', '3', 'kinase', 'catalytic', 'subunit', 'alpha', '4', 'phosphatase', 'and', 'tensin', 'homolog', '1', 'and', 'BRAF', '1', 'Five', 'percent', 'of', 'the', 'samples', 'had', 'multiple', 'actionable', 'mutations', 'A', 'targeted', 'therapy', 'was', 'instituted', 'on', 'the', 'basis', 'of', 'NGS', 'in', '11', 'of', 'the', 'sequenced', 'patients', 'or', 'in', '6', 'of', 'all', 'patients', 'CONCLUSIONS', 'NGS', 'based', 'diagnostics', 'are', 'feasible', 'in', 'NSCLC', 'and', 'provide', 'clinically', 'relevant', 'information', 'from', 'readily', 'available', 'FFPE', 'tissue', 'The', 'sample', 'type', 'is', 'associated', 'with', 'the', 'probability', 'of', 'successful', 'testing', '']"
46309,COVID-19 diagnostics in context.,2020-06-03,Science translational medicine,https://doi.org/10.1126/scitranslmed.abc1931; https://www.ncbi.nlm.nih.gov/pubmed/32493791/,"The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.",10.1126/scitranslmed.abc1931,n9ju3flv,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'has', 'highlighted', 'the', 'need', 'for', 'different', 'types', 'of', 'diagnostics', 'comparative', 'validation', 'of', 'new', 'tests', 'faster', 'approval', 'by', 'federal', 'agencies', 'and', 'rapid', 'production', 'of', 'test', 'kits', 'to', 'meet', 'global', 'demands', 'In', 'this', 'Perspective', 'we', 'discuss', 'the', 'utility', 'and', 'challenges', 'of', 'current', 'diagnostics', 'for', 'COVID', '19', '']"
46998,"Vascular content, tone, integrity, and haemodynamics for guiding fluid therapy: a conceptual approach.",2014,British journal of anaesthesia,https://doi.org/10.1093/bja/aeu298; https://www.ncbi.nlm.nih.gov/pubmed/25231767/,"BACKGROUND Despite many clinical trials and investigative efforts to determine appropriate therapeutic intervention(s) for shock, this topic remains controversial. The use of i.v. fluid has represented the cornerstone for the treatment of hypoperfusion for two centuries. METHODS As a part of International Acute Dialysis Quality Initiative XII Fluids Workgroup meeting, we sought to incorporate recent advances in our understanding of vascular biology into a more comprehensive yet accessible approach to the patient with hypoperfusion. In this workgroup, we attempted to develop a framework that incorporates key aspects of the vasculature into a diagnostic approach. RESULTS The four main components of our proposal involve the assessment of the blood flow (BF), vascular content (vC), the vascular barrier (vB), and vascular tone (vT). Any significant perturbation in any of these domains can lead to hypoperfusion at both the macro- and micro-circulatory level. We have termed the BF, vC, vB, and vT diagnostic approach the vascular component (VC) approach. CONCLUSIONS The VC approach to hypoperfusion has potential advantages to the current diagnostic system. This approach also has the distinct advantage that it can be used to assess the systemic, regional, and micro-vasculature, thereby harmonizing the approach to clinical vascular diagnostics across these levels. The VC approach will need to be tested prospectively to determine if this system can in fact improve outcomes in patients who suffer from hypoperfusion.",10.1093/bja/aeu298,2fvxikgl,"['BACKGROUND', 'Despite', 'many', 'clinical', 'trials', 'and', 'investigative', 'efforts', 'to', 'determine', 'appropriate', 'therapeutic', 'intervention', 's', 'for', 'shock', 'this', 'topic', 'remains', 'controversial', 'The', 'use', 'of', 'i', 'v', 'fluid', 'has', 'represented', 'the', 'cornerstone', 'for', 'the', 'treatment', 'of', 'hypoperfusion', 'for', 'two', 'centuries', 'METHODS', 'As', 'a', 'part', 'of', 'International', 'Acute', 'Dialysis', 'Quality', 'Initiative', 'XII', 'Fluids', 'Workgroup', 'meeting', 'we', 'sought', 'to', 'incorporate', 'recent', 'advances', 'in', 'our', 'understanding', 'of', 'vascular', 'biology', 'into', 'a', 'more', 'comprehensive', 'yet', 'accessible', 'approach', 'to', 'the', 'patient', 'with', 'hypoperfusion', 'In', 'this', 'workgroup', 'we', 'attempted', 'to', 'develop', 'a', 'framework', 'that', 'incorporates', 'key', 'aspects', 'of', 'the', 'vasculature', 'into', 'a', 'diagnostic', 'approach', 'RESULTS', 'The', 'four', 'main', 'components', 'of', 'our', 'proposal', 'involve', 'the', 'assessment', 'of', 'the', 'blood', 'flow', 'BF', 'vascular', 'content', 'vC', 'the', 'vascular', 'barrier', 'vB', 'and', 'vascular', 'tone', 'vT', 'Any', 'significant', 'perturbation', 'in', 'any', 'of', 'these', 'domains', 'can', 'lead', 'to', 'hypoperfusion', 'at', 'both', 'the', 'macro', 'and', 'micro', 'circulatory', 'level', 'We', 'have', 'termed', 'the', 'BF', 'vC', 'vB', 'and', 'vT', 'diagnostic', 'approach', 'the', 'vascular', 'component', 'VC', 'approach', 'CONCLUSIONS', 'The', 'VC', 'approach', 'to', 'hypoperfusion', 'has', 'potential', 'advantages', 'to', 'the', 'current', 'diagnostic', 'system', 'This', 'approach', 'also', 'has', 'the', 'distinct', 'advantage', 'that', 'it', 'can', 'be', 'used', 'to', 'assess', 'the', 'systemic', 'regional', 'and', 'micro', 'vasculature', 'thereby', 'harmonizing', 'the', 'approach', 'to', 'clinical', 'vascular', 'diagnostics', 'across', 'these', 'levels', 'The', 'VC', 'approach', 'will', 'need', 'to', 'be', 'tested', 'prospectively', 'to', 'determine', 'if', 'this', 'system', 'can', 'in', 'fact', 'improve', 'outcomes', 'in', 'patients', 'who', 'suffer', 'from', 'hypoperfusion', '']"
47289,Implementation science: the laboratory as a command centre.,2017,Current opinion in HIV and AIDS,https://doi.org/10.1097/coh.0000000000000349; https://www.ncbi.nlm.nih.gov/pubmed/28079592/,"PURPOSE OF REVIEW Recent advances in point-of-care technologies to ensure universal access to affordable quality-assured diagnostics have the potential to transform patient management, surveillance programmes, and control of infectious diseases. Decentralization of testing can put tremendous stresses on fragile health systems if the laboratory is not involved in the planning, introduction, and scale-up strategies. RECENT FINDINGS The impact of investments in novel technologies can only be realized if these tests are evaluated, adopted, and scaled up within the healthcare system with appropriate planning and understanding of the local contexts in which these technologies will be used. SUMMARY In this digital age, the laboratory needs to take on the role of the Command Centre for technology introduction and implementation. Implementation science is needed to understand the political, cultural, economic, and behavioural context for technology introduction. The new paradigm should include: building a comprehensive system of laboratories and point-of-care testing sites to provide quality-assured diagnostic services with good laboratory-clinic interface to build trust in test results and linkage to care; building and coordinating a comprehensive national surveillance and communication system for disease control and global health emergencies; conducting research to monitor the impact of new tools and interventions on improving patient care.",10.1097/coh.0000000000000349,4ka59pbp,"['PURPOSE', 'OF', 'REVIEW', 'Recent', 'advances', 'in', 'point', 'of', 'care', 'technologies', 'to', 'ensure', 'universal', 'access', 'to', 'affordable', 'quality', 'assured', 'diagnostics', 'have', 'the', 'potential', 'to', 'transform', 'patient', 'management', 'surveillance', 'programmes', 'and', 'control', 'of', 'infectious', 'diseases', 'Decentralization', 'of', 'testing', 'can', 'put', 'tremendous', 'stresses', 'on', 'fragile', 'health', 'systems', 'if', 'the', 'laboratory', 'is', 'not', 'involved', 'in', 'the', 'planning', 'introduction', 'and', 'scale', 'up', 'strategies', 'RECENT', 'FINDINGS', 'The', 'impact', 'of', 'investments', 'in', 'novel', 'technologies', 'can', 'only', 'be', 'realized', 'if', 'these', 'tests', 'are', 'evaluated', 'adopted', 'and', 'scaled', 'up', 'within', 'the', 'healthcare', 'system', 'with', 'appropriate', 'planning', 'and', 'understanding', 'of', 'the', 'local', 'contexts', 'in', 'which', 'these', 'technologies', 'will', 'be', 'used', 'SUMMARY', 'In', 'this', 'digital', 'age', 'the', 'laboratory', 'needs', 'to', 'take', 'on', 'the', 'role', 'of', 'the', 'Command', 'Centre', 'for', 'technology', 'introduction', 'and', 'implementation', 'Implementation', 'science', 'is', 'needed', 'to', 'understand', 'the', 'political', 'cultural', 'economic', 'and', 'behavioural', 'context', 'for', 'technology', 'introduction', 'The', 'new', 'paradigm', 'should', 'include', 'building', 'a', 'comprehensive', 'system', 'of', 'laboratories', 'and', 'point', 'of', 'care', 'testing', 'sites', 'to', 'provide', 'quality', 'assured', 'diagnostic', 'services', 'with', 'good', 'laboratory', 'clinic', 'interface', 'to', 'build', 'trust', 'in', 'test', 'results', 'and', 'linkage', 'to', 'care', 'building', 'and', 'coordinating', 'a', 'comprehensive', 'national', 'surveillance', 'and', 'communication', 'system', 'for', 'disease', 'control', 'and', 'global', 'health', 'emergencies', 'conducting', 'research', 'to', 'monitor', 'the', 'impact', 'of', 'new', 'tools', 'and', 'interventions', 'on', 'improving', 'patient', 'care', '']"
48177,"A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay.",2020-07-20,Journal of clinical microbiology,https://doi.org/10.1128/jcm.01598-20; https://www.ncbi.nlm.nih.gov/pubmed/32690547/,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas® SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas® SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.",10.1128/jcm.01598-20,lpoelp91,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'qRT', 'PCR', 'assays', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'positions', 'in', 'the', 'viral', 'genome', 'While', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'variants', 'that', 'might', 'compromise', 'these', 'assays', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'U', 'transition', 'at', 'position', '26', '340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'SARS', 'CoV', '2', 'E', 'gene', 'qRT', 'PCR', 'in', 'eight', 'patients', 'As', 'the', 'cobas', 'SARS', 'CoV', '2', 'assay', 'targets', 'two', 'positions', 'in', 'the', 'genome', 'the', 'individuals', 'carrying', 'this', 'variant', 'were', 'still', 'called', 'as', 'SARS', 'CoV', '2', 'positive', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'to', 'carry', 'closely', 'related', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'at', 'least', 'four', 'times', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'to', 'avoid', 'false', 'negatives', '']"
48535,Culture-Independent Diagnostics for Health Security.,2016,Health security,https://doi.org/10.1089/hs.2015.0074; https://www.ncbi.nlm.nih.gov/pubmed/27314653/,"The past decade has seen considerable development in the diagnostic application of nonculture methods, including nucleic acid amplification-based methods and mass spectrometry, for the diagnosis of infectious diseases. The implications of these new culture-independent diagnostic tests (CIDTs) include bypassing the need to culture organisms, thus potentially affecting public health surveillance systems, which continue to use isolates as the basis of their surveillance programs and to assess phenotypic resistance to antimicrobial agents. CIDTs may also affect the way public health practitioners detect and respond to a bioterrorism event. In response to a request from the Department of Homeland Security, Los Alamos National Laboratory and the Centers for Disease Control and Prevention cosponsored a workshop to review the impact of CIDTs on the rapid detection and identification of biothreat agents. Four panel discussions were held that covered nucleic acid amplification-based diagnostics, mass spectrometry, antibody-based diagnostics, and next-generation sequencing. Exploiting the extensive expertise available at this workshop, we identified the key features, benefits, and limitations of the various CIDT methods for providing rapid pathogen identification that are critical to the response and mitigation of a bioterrorism event. After the workshop we conducted a thorough review of the literature, investigating the current state of these 4 culture-independent diagnostic methods. This article combines information from the literature review and the insights obtained at the workshop.",10.1089/hs.2015.0074,5r6kl6tk,"['The', 'past', 'decade', 'has', 'seen', 'considerable', 'development', 'in', 'the', 'diagnostic', 'application', 'of', 'nonculture', 'methods', 'including', 'nucleic', 'acid', 'amplification', 'based', 'methods', 'and', 'mass', 'spectrometry', 'for', 'the', 'diagnosis', 'of', 'infectious', 'diseases', 'The', 'implications', 'of', 'these', 'new', 'culture', 'independent', 'diagnostic', 'tests', 'CIDTs', 'include', 'bypassing', 'the', 'need', 'to', 'culture', 'organisms', 'thus', 'potentially', 'affecting', 'public', 'health', 'surveillance', 'systems', 'which', 'continue', 'to', 'use', 'isolates', 'as', 'the', 'basis', 'of', 'their', 'surveillance', 'programs', 'and', 'to', 'assess', 'phenotypic', 'resistance', 'to', 'antimicrobial', 'agents', 'CIDTs', 'may', 'also', 'affect', 'the', 'way', 'public', 'health', 'practitioners', 'detect', 'and', 'respond', 'to', 'a', 'bioterrorism', 'event', 'In', 'response', 'to', 'a', 'request', 'from', 'the', 'Department', 'of', 'Homeland', 'Security', 'Los', 'Alamos', 'National', 'Laboratory', 'and', 'the', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'cosponsored', 'a', 'workshop', 'to', 'review', 'the', 'impact', 'of', 'CIDTs', 'on', 'the', 'rapid', 'detection', 'and', 'identification', 'of', 'biothreat', 'agents', 'Four', 'panel', 'discussions', 'were', 'held', 'that', 'covered', 'nucleic', 'acid', 'amplification', 'based', 'diagnostics', 'mass', 'spectrometry', 'antibody', 'based', 'diagnostics', 'and', 'next', 'generation', 'sequencing', 'Exploiting', 'the', 'extensive', 'expertise', 'available', 'at', 'this', 'workshop', 'we', 'identified', 'the', 'key', 'features', 'benefits', 'and', 'limitations', 'of', 'the', 'various', 'CIDT', 'methods', 'for', 'providing', 'rapid', 'pathogen', 'identification', 'that', 'are', 'critical', 'to', 'the', 'response', 'and', 'mitigation', 'of', 'a', 'bioterrorism', 'event', 'After', 'the', 'workshop', 'we', 'conducted', 'a', 'thorough', 'review', 'of', 'the', 'literature', 'investigating', 'the', 'current', 'state', 'of', 'these', '4', 'culture', 'independent', 'diagnostic', 'methods', 'This', 'article', 'combines', 'information', 'from', 'the', 'literature', 'review', 'and', 'the', 'insights', 'obtained', 'at', 'the', 'workshop', '']"
48602,Nanoplasmonic On-Chip PCR for Rapid Precision Molecular Diagnostics.,2020-02-26,ACS applied materials & interfaces,https://doi.org/10.1021/acsami.9b23591; https://www.ncbi.nlm.nih.gov/pubmed/32101396/,"Emerging molecular diagnosis requires ultrafast polymerase chain reaction (PCR) on chip for rapid precise detection of infectious diseases in the point-of-care test. Here we report nanoplasmonic on-chip PCR for rapid precision molecular diagnostics. The nanoplasmonic pillar arrays (NPA) comprise gold nanoislands on the top and sidewall of large-scale glass nanopillar arrays. The nanoplasmonic pillars enhance light absorption of a white light-emitting diode (LED) over the whole visible range due to strong electromagnetic hotspots between the nanoislands. As a result, they effectively induce photothermal heating for ultrafast PCR thermal cycling. The temperature profile of NPA exhibit 30 cycles between 98 ℃ and 60 ℃ for total 3 min 30 sec during the cyclic excitation of white LED light. The experimental results also demonstrate the rapid DNA amplification of both 0.1 ng μl-1 of λ-DNA in 20 thermal cycles and 0.1 ng μl-1 of complementary DNA of Middle East respiratory syndrome coronavirus in 30 thermal cycles using a conventional PCR volume of 15 μl. This nanoplasmonic PCR technique provides a new opportunity for rapid precision molecular diagnostics.",10.1021/acsami.9b23591,jp0idc7d,"['Emerging', 'molecular', 'diagnosis', 'requires', 'ultrafast', 'polymerase', 'chain', 'reaction', 'PCR', 'on', 'chip', 'for', 'rapid', 'precise', 'detection', 'of', 'infectious', 'diseases', 'in', 'the', 'point', 'of', 'care', 'test', 'Here', 'we', 'report', 'nanoplasmonic', 'on', 'chip', 'PCR', 'for', 'rapid', 'precision', 'molecular', 'diagnostics', 'The', 'nanoplasmonic', 'pillar', 'arrays', 'NPA', 'comprise', 'gold', 'nanoislands', 'on', 'the', 'top', 'and', 'sidewall', 'of', 'large', 'scale', 'glass', 'nanopillar', 'arrays', 'The', 'nanoplasmonic', 'pillars', 'enhance', 'light', 'absorption', 'of', 'a', 'white', 'light', 'emitting', 'diode', 'LED', 'over', 'the', 'whole', 'visible', 'range', 'due', 'to', 'strong', 'electromagnetic', 'hotspots', 'between', 'the', 'nanoislands', 'As', 'a', 'result', 'they', 'effectively', 'induce', 'photothermal', 'heating', 'for', 'ultrafast', 'PCR', 'thermal', 'cycling', 'The', 'temperature', 'profile', 'of', 'NPA', 'exhibit', '30', 'cycles', 'between', '98', 'and', '60', 'for', 'total', '3', 'min', '30', 'sec', 'during', 'the', 'cyclic', 'excitation', 'of', 'white', 'LED', 'light', 'The', 'experimental', 'results', 'also', 'demonstrate', 'the', 'rapid', 'DNA', 'amplification', 'of', 'both', '0', '1', 'ng', 'μl', '1', 'of', 'λ', 'DNA', 'in', '20', 'thermal', 'cycles', 'and', '0', '1', 'ng', 'μl', '1', 'of', 'complementary', 'DNA', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'in', '30', 'thermal', 'cycles', 'using', 'a', 'conventional', 'PCR', 'volume', 'of', '15', 'μl', 'This', 'nanoplasmonic', 'PCR', 'technique', 'provides', 'a', 'new', 'opportunity', 'for', 'rapid', 'precision', 'molecular', 'diagnostics', '']"
49244,"Recombinase polymerase amplification: Emergence as a critical molecular technology for rapid, low-resource diagnostics.",2015,Expert review of molecular diagnostics,https://doi.org/10.1586/14737159.2015.1090877; https://www.ncbi.nlm.nih.gov/pubmed/26517245/,"Isothermal molecular diagnostics are bridging the technology gap between traditional diagnostics and polymerase chain reaction-based methods. These new techniques enable timely and accurate testing, especially in settings where there is a lack of infrastructure to support polymerase chain reaction facilities. Despite this, there is a significant lack of uptake of these technologies in developing countries where they are highly needed. Among these novel isothermal technologies, recombinase polymerase amplification (RPA) holds particular potential for use in developing countries. This rapid nucleic acid amplification approach is fast, highly sensitive and specific, and amenable to countries with a high burden of infectious diseases. Implementation of RPA technology in developing countries is critically required to assess limitations and potentials of the diagnosis of infectious disease, and may help identify impediments that prevent adoption of new molecular technologies in low resource- and low skill settings. This review focuses on approaching diagnosis of infectious disease with RPA.",10.1586/14737159.2015.1090877,c4iwx39e,"['Isothermal', 'molecular', 'diagnostics', 'are', 'bridging', 'the', 'technology', 'gap', 'between', 'traditional', 'diagnostics', 'and', 'polymerase', 'chain', 'reaction', 'based', 'methods', 'These', 'new', 'techniques', 'enable', 'timely', 'and', 'accurate', 'testing', 'especially', 'in', 'settings', 'where', 'there', 'is', 'a', 'lack', 'of', 'infrastructure', 'to', 'support', 'polymerase', 'chain', 'reaction', 'facilities', 'Despite', 'this', 'there', 'is', 'a', 'significant', 'lack', 'of', 'uptake', 'of', 'these', 'technologies', 'in', 'developing', 'countries', 'where', 'they', 'are', 'highly', 'needed', 'Among', 'these', 'novel', 'isothermal', 'technologies', 'recombinase', 'polymerase', 'amplification', 'RPA', 'holds', 'particular', 'potential', 'for', 'use', 'in', 'developing', 'countries', 'This', 'rapid', 'nucleic', 'acid', 'amplification', 'approach', 'is', 'fast', 'highly', 'sensitive', 'and', 'specific', 'and', 'amenable', 'to', 'countries', 'with', 'a', 'high', 'burden', 'of', 'infectious', 'diseases', 'Implementation', 'of', 'RPA', 'technology', 'in', 'developing', 'countries', 'is', 'critically', 'required', 'to', 'assess', 'limitations', 'and', 'potentials', 'of', 'the', 'diagnosis', 'of', 'infectious', 'disease', 'and', 'may', 'help', 'identify', 'impediments', 'that', 'prevent', 'adoption', 'of', 'new', 'molecular', 'technologies', 'in', 'low', 'resource', 'and', 'low', 'skill', 'settings', 'This', 'review', 'focuses', 'on', 'approaching', 'diagnosis', 'of', 'infectious', 'disease', 'with', 'RPA', '']"
49397,Impact of COVID-19 Pandemic on Laboratory Utilization.,2020-07-14,The journal of applied laboratory medicine,https://doi.org/10.1093/jalm/jfaa121; https://www.ncbi.nlm.nih.gov/pubmed/32663258/,"BACKGROUND Coronavirus Disease 2019 (COVID-19) was formally characterized as a pandemic on March 11, 2020. Since that time, the COVID-19 pandemic has led to unprecedented demand for healthcare resources. The purpose of this study was to identify changes in laboratory test utilization in the setting of increasing local incidence of COVID-19. METHODS We performed a retrospective assessment of laboratory test order and specimen container utilization at a single, urban tertiary care medical center. Data were extracted from the laboratory information system database over a 10-week period, spanning the primordial inflection of COVID-19 incidence in our region. Total testing volumes were calculated during the first and last two-weeks of the observation period and used as reference points to examine the absolute and relative differences in test order volume between the pre-pandemic and COVID-19 surge periods. RESULTS Between February 2, 2020 and April 11, 2020, there were 873,397 tests ordered and final verified. The in-house SARS-CoV-2 PCR positivity rate for admitted patients in the last week of the observation period was 30.8%. Significant increases in workload were observed in the send-out laboratory section and for COVID-19 diagnosis (PCR) and management-related testing. Otherwise, there was a net decrease in overall demand across nearly all laboratory sections. Increases in testing were noted for tests related to COVID-19 management. Viral transport media and citrated blue top containers demonstrated increases in utilization. CONCLUSION Increasing local incidence of COVID-19 had a profound impact on laboratory operations. While volume increases were seen for laboratory tests related to COVID-19 diagnostics and management, including some with limited evidence to support their use, overall testing volumes decreased substantially. During events such as COVID-19, monitoring of such patterns can help inform laboratory management, staffing, and test stewardship recommendations for managing resource and supply availability.",10.1093/jalm/jfaa121,n74wvika,"['BACKGROUND', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'was', 'formally', 'characterized', 'as', 'a', 'pandemic', 'on', 'March', '11', '2020', 'Since', 'that', 'time', 'the', 'COVID', '19', 'pandemic', 'has', 'led', 'to', 'unprecedented', 'demand', 'for', 'healthcare', 'resources', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'identify', 'changes', 'in', 'laboratory', 'test', 'utilization', 'in', 'the', 'setting', 'of', 'increasing', 'local', 'incidence', 'of', 'COVID', '19', 'METHODS', 'We', 'performed', 'a', 'retrospective', 'assessment', 'of', 'laboratory', 'test', 'order', 'and', 'specimen', 'container', 'utilization', 'at', 'a', 'single', 'urban', 'tertiary', 'care', 'medical', 'center', 'Data', 'were', 'extracted', 'from', 'the', 'laboratory', 'information', 'system', 'database', 'over', 'a', '10', 'week', 'period', 'spanning', 'the', 'primordial', 'inflection', 'of', 'COVID', '19', 'incidence', 'in', 'our', 'region', 'Total', 'testing', 'volumes', 'were', 'calculated', 'during', 'the', 'first', 'and', 'last', 'two', 'weeks', 'of', 'the', 'observation', 'period', 'and', 'used', 'as', 'reference', 'points', 'to', 'examine', 'the', 'absolute', 'and', 'relative', 'differences', 'in', 'test', 'order', 'volume', 'between', 'the', 'pre', 'pandemic', 'and', 'COVID', '19', 'surge', 'periods', 'RESULTS', 'Between', 'February', '2', '2020', 'and', 'April', '11', '2020', 'there', 'were', '873', '397', 'tests', 'ordered', 'and', 'final', 'verified', 'The', 'in', 'house', 'SARS', 'CoV', '2', 'PCR', 'positivity', 'rate', 'for', 'admitted', 'patients', 'in', 'the', 'last', 'week', 'of', 'the', 'observation', 'period', 'was', '30', '8', 'Significant', 'increases', 'in', 'workload', 'were', 'observed', 'in', 'the', 'send', 'out', 'laboratory', 'section', 'and', 'for', 'COVID', '19', 'diagnosis', 'PCR', 'and', 'management', 'related', 'testing', 'Otherwise', 'there', 'was', 'a', 'net', 'decrease', 'in', 'overall', 'demand', 'across', 'nearly', 'all', 'laboratory', 'sections', 'Increases', 'in', 'testing', 'were', 'noted', 'for', 'tests', 'related', 'to', 'COVID', '19', 'management', 'Viral', 'transport', 'media', 'and', 'citrated', 'blue', 'top', 'containers', 'demonstrated', 'increases', 'in', 'utilization', 'CONCLUSION', 'Increasing', 'local', 'incidence', 'of', 'COVID', '19', 'had', 'a', 'profound', 'impact', 'on', 'laboratory', 'operations', 'While', 'volume', 'increases', 'were', 'seen', 'for', 'laboratory', 'tests', 'related', 'to', 'COVID', '19', 'diagnostics', 'and', 'management', 'including', 'some', 'with', 'limited', 'evidence', 'to', 'support', 'their', 'use', 'overall', 'testing', 'volumes', 'decreased', 'substantially', 'During', 'events', 'such', 'as', 'COVID', '19', 'monitoring', 'of', 'such', 'patterns', 'can', 'help', 'inform', 'laboratory', 'management', 'staffing', 'and', 'test', 'stewardship', 'recommendations', 'for', 'managing', 'resource', 'and', 'supply', 'availability', '']"
49504,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management.,2020-04-29,IEEE reviews in biomedical engineering,https://doi.org/10.1109/rbme.2020.2991444; https://www.ncbi.nlm.nih.gov/pubmed/32356761/,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",10.1109/rbme.2020.2991444,6wlbl0wg,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
49643,Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts.,2020-07-01,Journal of dental research,https://doi.org/10.1177/0022034520936245; https://www.ncbi.nlm.nih.gov/pubmed/32609569/,"Orofacial clefts and their management impose a substantial burden on patients, on their families, and on the health system. Under the current standard of care, affected patients are subjected to a lifelong journey of corrective surgeries and multidisciplinary management to replace bone and soft tissues, as well as restore esthetics and physiologic functions while restoring self-esteem and psychological health. Hence, a better understanding of the dynamic interplay of molecular signaling pathways at critical phases of palate development is necessary to pioneer novel prenatal interventions. Such pathways include transforming growth factor-β (Tgfβ), sonic hedgehog (Shh), wingless-integrated site (Wnt)/β-catenin, bone morphogenetic protein (Bmp), and fibroblast growth factor (Fgf) and its associated receptors, among others. Here, we summarize commonly used surgical methods used to correct cleft defects postnatally. We also review the advances made in prenatal diagnostics of clefts through imaging and genomics and the various in utero surgical corrections that have been attempted thus far. An overview of how key mediators of signaling that drive palatogenesis are emphasized in the context of the framework and rationale for the development and testing of therapeutics in animal model systems and in humans is provided. The pros and cons of in utero therapies that can potentially restore molecular homeostasis needed for the proper growth and fusion of palatal shelves are presented. The theme advanced throughout this review is the need to develop preclinical molecular therapies that could ultimately be translated into human trials that can correct orofacial clefts at earlier stages of development.",10.1177/0022034520936245,to4qy8nm,"['Orofacial', 'clefts', 'and', 'their', 'management', 'impose', 'a', 'substantial', 'burden', 'on', 'patients', 'on', 'their', 'families', 'and', 'on', 'the', 'health', 'system', 'Under', 'the', 'current', 'standard', 'of', 'care', 'affected', 'patients', 'are', 'subjected', 'to', 'a', 'lifelong', 'journey', 'of', 'corrective', 'surgeries', 'and', 'multidisciplinary', 'management', 'to', 'replace', 'bone', 'and', 'soft', 'tissues', 'as', 'well', 'as', 'restore', 'esthetics', 'and', 'physiologic', 'functions', 'while', 'restoring', 'self', 'esteem', 'and', 'psychological', 'health', 'Hence', 'a', 'better', 'understanding', 'of', 'the', 'dynamic', 'interplay', 'of', 'molecular', 'signaling', 'pathways', 'at', 'critical', 'phases', 'of', 'palate', 'development', 'is', 'necessary', 'to', 'pioneer', 'novel', 'prenatal', 'interventions', 'Such', 'pathways', 'include', 'transforming', 'growth', 'factor', 'β', 'Tgfβ', 'sonic', 'hedgehog', 'Shh', 'wingless', 'integrated', 'site', 'Wnt', 'β', 'catenin', 'bone', 'morphogenetic', 'protein', 'Bmp', 'and', 'fibroblast', 'growth', 'factor', 'Fgf', 'and', 'its', 'associated', 'receptors', 'among', 'others', 'Here', 'we', 'summarize', 'commonly', 'used', 'surgical', 'methods', 'used', 'to', 'correct', 'cleft', 'defects', 'postnatally', 'We', 'also', 'review', 'the', 'advances', 'made', 'in', 'prenatal', 'diagnostics', 'of', 'clefts', 'through', 'imaging', 'and', 'genomics', 'and', 'the', 'various', 'in', 'utero', 'surgical', 'corrections', 'that', 'have', 'been', 'attempted', 'thus', 'far', 'An', 'overview', 'of', 'how', 'key', 'mediators', 'of', 'signaling', 'that', 'drive', 'palatogenesis', 'are', 'emphasized', 'in', 'the', 'context', 'of', 'the', 'framework', 'and', 'rationale', 'for', 'the', 'development', 'and', 'testing', 'of', 'therapeutics', 'in', 'animal', 'model', 'systems', 'and', 'in', 'humans', 'is', 'provided', 'The', 'pros', 'and', 'cons', 'of', 'in', 'utero', 'therapies', 'that', 'can', 'potentially', 'restore', 'molecular', 'homeostasis', 'needed', 'for', 'the', 'proper', 'growth', 'and', 'fusion', 'of', 'palatal', 'shelves', 'are', 'presented', 'The', 'theme', 'advanced', 'throughout', 'this', 'review', 'is', 'the', 'need', 'to', 'develop', 'preclinical', 'molecular', 'therapies', 'that', 'could', 'ultimately', 'be', 'translated', 'into', 'human', 'trials', 'that', 'can', 'correct', 'orofacial', 'clefts', 'at', 'earlier', 'stages', 'of', 'development', '']"
49654,Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases.,2019,Genes,https://doi.org/10.3390/genes10090661; https://www.ncbi.nlm.nih.gov/pubmed/31470675/,"Metagenomic next-generation sequencing (mNGS) can capture the full spectrum of viral pathogens in a specimen and has the potential to become an all-in-one solution for virus diagnostics. To date, clinical application is still in an early phase and limitations remain. Here, we evaluated the impact of viral mNGS for cases analyzed over two years in a tertiary diagnostics unit. High throughput mNGS was performed upon request by the treating clinician in cases where the etiology of infection remained unknown or the initial differential diagnosis was very broad. The results were compared to conventional routine testing regarding outcome and workload. In total, 163 specimens from 105 patients were sequenced. The main sample types were cerebrospinal fluid (34%), blood (33%) and throat swabs (10%). In the majority of the cases, viral encephalitis/meningitis or respiratory infection was suspected. In parallel, conventional virus diagnostic tests were performed (mean 18.5 individually probed targets/patients). mNGS detected viruses in 34 cases (32%). While often confirmatory, in multiple cases, the identified viruses were not included in the selected routine diagnostic tests. Two years of mNGS in a tertiary diagnostics unit demonstrated the advantages of a single, untargeted approach for comprehensive, rapid and efficient virus diagnostics, confirming the utility of mNGS in complementing current routine tests.",10.3390/genes10090661,g1h6zb7s,"['Metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'can', 'capture', 'the', 'full', 'spectrum', 'of', 'viral', 'pathogens', 'in', 'a', 'specimen', 'and', 'has', 'the', 'potential', 'to', 'become', 'an', 'all', 'in', 'one', 'solution', 'for', 'virus', 'diagnostics', 'To', 'date', 'clinical', 'application', 'is', 'still', 'in', 'an', 'early', 'phase', 'and', 'limitations', 'remain', 'Here', 'we', 'evaluated', 'the', 'impact', 'of', 'viral', 'mNGS', 'for', 'cases', 'analyzed', 'over', 'two', 'years', 'in', 'a', 'tertiary', 'diagnostics', 'unit', 'High', 'throughput', 'mNGS', 'was', 'performed', 'upon', 'request', 'by', 'the', 'treating', 'clinician', 'in', 'cases', 'where', 'the', 'etiology', 'of', 'infection', 'remained', 'unknown', 'or', 'the', 'initial', 'differential', 'diagnosis', 'was', 'very', 'broad', 'The', 'results', 'were', 'compared', 'to', 'conventional', 'routine', 'testing', 'regarding', 'outcome', 'and', 'workload', 'In', 'total', '163', 'specimens', 'from', '105', 'patients', 'were', 'sequenced', 'The', 'main', 'sample', 'types', 'were', 'cerebrospinal', 'fluid', '34', 'blood', '33', 'and', 'throat', 'swabs', '10', 'In', 'the', 'majority', 'of', 'the', 'cases', 'viral', 'encephalitis', 'meningitis', 'or', 'respiratory', 'infection', 'was', 'suspected', 'In', 'parallel', 'conventional', 'virus', 'diagnostic', 'tests', 'were', 'performed', 'mean', '18', '5', 'individually', 'probed', 'targets', 'patients', 'mNGS', 'detected', 'viruses', 'in', '34', 'cases', '32', 'While', 'often', 'confirmatory', 'in', 'multiple', 'cases', 'the', 'identified', 'viruses', 'were', 'not', 'included', 'in', 'the', 'selected', 'routine', 'diagnostic', 'tests', 'Two', 'years', 'of', 'mNGS', 'in', 'a', 'tertiary', 'diagnostics', 'unit', 'demonstrated', 'the', 'advantages', 'of', 'a', 'single', 'untargeted', 'approach', 'for', 'comprehensive', 'rapid', 'and', 'efficient', 'virus', 'diagnostics', 'confirming', 'the', 'utility', 'of', 'mNGS', 'in', 'complementing', 'current', 'routine', 'tests', '']"
50274,Molecular diagnosis of respiratory virus infections.,2011,Critical reviews in clinical laboratory sciences,https://doi.org/10.3109/10408363.2011.640976; https://www.ncbi.nlm.nih.gov/pubmed/22185616/,"The appearance of eight new respiratory viruses, including the SARS coronavirus in 2003 and swine-origin influenza A/H1N1 in 2009, in the human population in the past nine years has tested the ability of virology laboratories to develop diagnostic tests to identify these viruses. Nucleic acid based amplification tests (NATs) for respiratory viruses were first introduced two decades ago and today are utilized for the detection of both conventional and emerging viruses. These tests are more sensitive than other diagnostic approaches, including virus isolation in cell culture, shell vial culture (SVC), antigen detection by direct fluorescent antibody (DFA) staining, and rapid enzyme immunoassay (EIA), and now form the backbone of clinical virology laboratory testing around the world. NATs not only provide fast, accurate and sensitive detection of respiratory viruses in clinical specimens but also have increased our understanding of the epidemiology of both new emerging viruses such as the pandemic H1N1 influenza virus of 2009, and conventional viruses such as the common cold viruses, including rhinovirus and coronavirus. Multiplex polymerase chain reaction (PCR) assays introduced in the last five years detect up to 19 different viruses in a single test. Several multiplex PCR tests are now commercially available and tests are working their way into clinical laboratories. The final chapter in the evolution of respiratory virus diagnostics has been the addition of allelic discrimination and detection of single nucleotide polymorphisms associated with antiviral resistance. These assays are now being multiplexed with primary detection and subtyping assays, especially in the case of influenza virus. These resistance assays, together with viral load assays, will enable clinical laboratories to provide physicians with new and important information for optimal treatment of respiratory virus infections.",10.3109/10408363.2011.640976,lulg7gw7,"['The', 'appearance', 'of', 'eight', 'new', 'respiratory', 'viruses', 'including', 'the', 'SARS', 'coronavirus', 'in', '2003', 'and', 'swine', 'origin', 'influenza', 'A', 'H1N1', 'in', '2009', 'in', 'the', 'human', 'population', 'in', 'the', 'past', 'nine', 'years', 'has', 'tested', 'the', 'ability', 'of', 'virology', 'laboratories', 'to', 'develop', 'diagnostic', 'tests', 'to', 'identify', 'these', 'viruses', 'Nucleic', 'acid', 'based', 'amplification', 'tests', 'NATs', 'for', 'respiratory', 'viruses', 'were', 'first', 'introduced', 'two', 'decades', 'ago', 'and', 'today', 'are', 'utilized', 'for', 'the', 'detection', 'of', 'both', 'conventional', 'and', 'emerging', 'viruses', 'These', 'tests', 'are', 'more', 'sensitive', 'than', 'other', 'diagnostic', 'approaches', 'including', 'virus', 'isolation', 'in', 'cell', 'culture', 'shell', 'vial', 'culture', 'SVC', 'antigen', 'detection', 'by', 'direct', 'fluorescent', 'antibody', 'DFA', 'staining', 'and', 'rapid', 'enzyme', 'immunoassay', 'EIA', 'and', 'now', 'form', 'the', 'backbone', 'of', 'clinical', 'virology', 'laboratory', 'testing', 'around', 'the', 'world', 'NATs', 'not', 'only', 'provide', 'fast', 'accurate', 'and', 'sensitive', 'detection', 'of', 'respiratory', 'viruses', 'in', 'clinical', 'specimens', 'but', 'also', 'have', 'increased', 'our', 'understanding', 'of', 'the', 'epidemiology', 'of', 'both', 'new', 'emerging', 'viruses', 'such', 'as', 'the', 'pandemic', 'H1N1', 'influenza', 'virus', 'of', '2009', 'and', 'conventional', 'viruses', 'such', 'as', 'the', 'common', 'cold', 'viruses', 'including', 'rhinovirus', 'and', 'coronavirus', 'Multiplex', 'polymerase', 'chain', 'reaction', 'PCR', 'assays', 'introduced', 'in', 'the', 'last', 'five', 'years', 'detect', 'up', 'to', '19', 'different', 'viruses', 'in', 'a', 'single', 'test', 'Several', 'multiplex', 'PCR', 'tests', 'are', 'now', 'commercially', 'available', 'and', 'tests', 'are', 'working', 'their', 'way', 'into', 'clinical', 'laboratories', 'The', 'final', 'chapter', 'in', 'the', 'evolution', 'of', 'respiratory', 'virus', 'diagnostics', 'has', 'been', 'the', 'addition', 'of', 'allelic', 'discrimination', 'and', 'detection', 'of', 'single', 'nucleotide', 'polymorphisms', 'associated', 'with', 'antiviral', 'resistance', 'These', 'assays', 'are', 'now', 'being', 'multiplexed', 'with', 'primary', 'detection', 'and', 'subtyping', 'assays', 'especially', 'in', 'the', 'case', 'of', 'influenza', 'virus', 'These', 'resistance', 'assays', 'together', 'with', 'viral', 'load', 'assays', 'will', 'enable', 'clinical', 'laboratories', 'to', 'provide', 'physicians', 'with', 'new', 'and', 'important', 'information', 'for', 'optimal', 'treatment', 'of', 'respiratory', 'virus', 'infections', '']"
52620,Respiratory tract infections in the immunocompromised.,2013,Current opinion in pulmonary medicine,https://doi.org/10.1097/mcp.0b013e32835f82a9; https://www.ncbi.nlm.nih.gov/pubmed/23508112/,"PURPOSE OF REVIEW Pulmonary infections are particularly common in the immunosuppressed host. This review discusses emerging threats, newer modalities of diagnostic tests and emerging treatment options, and also highlights the increasing problem of antimicrobial resistance. RECENT FINDINGS Nosocomial pneumonia is increasingly due to multidrug-resistant Gram-negative organisms in immunosuppressed patients. Viral pneumonias remain a very significant threat, present atypically and carry a high mortality. Aspergillosis remains the most common fungal infection, and infections due to Mucorales are increasing. Multidrug-resistant tuberculosis is on the increase throughout the world. Mixed infections are common and early bronchoscopy with appropriate microbiological tests, including molecular diagnostics, optimise management and reduce mortality. CONCLUSION Pulmonary infection remains the most frequent infectious complication in the immunocompromised host. These complex infections are often mixed, have atypical presentations and can be due to multidrug-resistant organisms. Multidisciplinary involvement in specialist centres with appropriate diagnostics, treatment and infection control improves outcome. There is a desperate need for new antimicrobial agents active against Gram-negative pathogens.",10.1097/mcp.0b013e32835f82a9,dqzsux5q,"['PURPOSE', 'OF', 'REVIEW', 'Pulmonary', 'infections', 'are', 'particularly', 'common', 'in', 'the', 'immunosuppressed', 'host', 'This', 'review', 'discusses', 'emerging', 'threats', 'newer', 'modalities', 'of', 'diagnostic', 'tests', 'and', 'emerging', 'treatment', 'options', 'and', 'also', 'highlights', 'the', 'increasing', 'problem', 'of', 'antimicrobial', 'resistance', 'RECENT', 'FINDINGS', 'Nosocomial', 'pneumonia', 'is', 'increasingly', 'due', 'to', 'multidrug', 'resistant', 'Gram', 'negative', 'organisms', 'in', 'immunosuppressed', 'patients', 'Viral', 'pneumonias', 'remain', 'a', 'very', 'significant', 'threat', 'present', 'atypically', 'and', 'carry', 'a', 'high', 'mortality', 'Aspergillosis', 'remains', 'the', 'most', 'common', 'fungal', 'infection', 'and', 'infections', 'due', 'to', 'Mucorales', 'are', 'increasing', 'Multidrug', 'resistant', 'tuberculosis', 'is', 'on', 'the', 'increase', 'throughout', 'the', 'world', 'Mixed', 'infections', 'are', 'common', 'and', 'early', 'bronchoscopy', 'with', 'appropriate', 'microbiological', 'tests', 'including', 'molecular', 'diagnostics', 'optimise', 'management', 'and', 'reduce', 'mortality', 'CONCLUSION', 'Pulmonary', 'infection', 'remains', 'the', 'most', 'frequent', 'infectious', 'complication', 'in', 'the', 'immunocompromised', 'host', 'These', 'complex', 'infections', 'are', 'often', 'mixed', 'have', 'atypical', 'presentations', 'and', 'can', 'be', 'due', 'to', 'multidrug', 'resistant', 'organisms', 'Multidisciplinary', 'involvement', 'in', 'specialist', 'centres', 'with', 'appropriate', 'diagnostics', 'treatment', 'and', 'infection', 'control', 'improves', 'outcome', 'There', 'is', 'a', 'desperate', 'need', 'for', 'new', 'antimicrobial', 'agents', 'active', 'against', 'Gram', 'negative', 'pathogens', '']"
52770,"Liver lobe torsion in pet rabbits: clinical consequences, diagnosis, and treatment.",2014,The veterinary clinics of North America. Exotic animal practice,https://doi.org/10.1016/j.cvex.2014.01.004; https://www.ncbi.nlm.nih.gov/pubmed/24767741/,"This article reviews diagnosis and management of liver lobe torsion in rabbits. Practitioners should recommend initial diagnostics including radiographs and blood work on rabbits presenting with nonspecific signs of gastrointestinal (GI) stasis to better determine possible etiology and make the best treatment recommendations. If hepatic enzyme elevation is found in a rabbit with GI stasis, abdominal ultrasound is recommended to rule out liver lobe torsion. Prompt diagnosis and liver lobectomy are recommended for best outcome in rabbits with liver lobe torsion.",10.1016/j.cvex.2014.01.004,u6u2a4oz,"['This', 'article', 'reviews', 'diagnosis', 'and', 'management', 'of', 'liver', 'lobe', 'torsion', 'in', 'rabbits', 'Practitioners', 'should', 'recommend', 'initial', 'diagnostics', 'including', 'radiographs', 'and', 'blood', 'work', 'on', 'rabbits', 'presenting', 'with', 'nonspecific', 'signs', 'of', 'gastrointestinal', 'GI', 'stasis', 'to', 'better', 'determine', 'possible', 'etiology', 'and', 'make', 'the', 'best', 'treatment', 'recommendations', 'If', 'hepatic', 'enzyme', 'elevation', 'is', 'found', 'in', 'a', 'rabbit', 'with', 'GI', 'stasis', 'abdominal', 'ultrasound', 'is', 'recommended', 'to', 'rule', 'out', 'liver', 'lobe', 'torsion', 'Prompt', 'diagnosis', 'and', 'liver', 'lobectomy', 'are', 'recommended', 'for', 'best', 'outcome', 'in', 'rabbits', 'with', 'liver', 'lobe', 'torsion', '']"
53645,Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays.,2018,Journal of clinical microbiology,https://doi.org/10.1128/jcm.00278-18; https://www.ncbi.nlm.nih.gov/pubmed/29769281/,"Molecular diagnostics for influenza and respiratory syncytial virus (RSV) have become commonplace, and various tests and systems have been cleared by the FDA for use in the United States. We performed a retrospective study to compare the Cepheid Xpress Flu/RSV assay with the Xpert Flu/RSV XC assay, using laboratory-developed tests (LDTs) as the reference method. The Xpress assay was 100% accurate compared to LDTs, whereas the Xpert Flu/RSV XC assay was 96.0% accurate. The Xpress test was determined to be faster and more sensitive than the XC assay.",10.1128/jcm.00278-18,nlvwlk4d,"['Molecular', 'diagnostics', 'for', 'influenza', 'and', 'respiratory', 'syncytial', 'virus', 'RSV', 'have', 'become', 'commonplace', 'and', 'various', 'tests', 'and', 'systems', 'have', 'been', 'cleared', 'by', 'the', 'FDA', 'for', 'use', 'in', 'the', 'United', 'States', 'We', 'performed', 'a', 'retrospective', 'study', 'to', 'compare', 'the', 'Cepheid', 'Xpress', 'Flu', 'RSV', 'assay', 'with', 'the', 'Xpert', 'Flu', 'RSV', 'XC', 'assay', 'using', 'laboratory', 'developed', 'tests', 'LDTs', 'as', 'the', 'reference', 'method', 'The', 'Xpress', 'assay', 'was', '100', 'accurate', 'compared', 'to', 'LDTs', 'whereas', 'the', 'Xpert', 'Flu', 'RSV', 'XC', 'assay', 'was', '96', '0', 'accurate', 'The', 'Xpress', 'test', 'was', 'determined', 'to', 'be', 'faster', 'and', 'more', 'sensitive', 'than', 'the', 'XC', 'assay', '']"
53737,Scientific Advances in Thoracic Oncology 2016.,2017,Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,https://doi.org/10.1016/j.jtho.2017.05.019; https://www.ncbi.nlm.nih.gov/pubmed/28579481/,"Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.",10.1016/j.jtho.2017.05.019,jhfg6d3f,"['Lung', 'cancer', 'care', 'is', 'rapidly', 'changing', 'with', 'advances', 'in', 'genomic', 'testing', 'the', 'development', 'of', 'next', 'generation', 'targeted', 'kinase', 'inhibitors', 'and', 'the', 'continued', 'broad', 'study', 'of', 'immunotherapy', 'in', 'new', 'settings', 'and', 'potential', 'combinations', 'The', 'International', 'Association', 'for', 'the', 'Study', 'of', 'Lung', 'Cancer', 'and', 'the', 'Journal', 'of', 'Thoracic', 'Oncology', 'publish', 'this', 'annual', 'update', 'to', 'help', 'readers', 'keep', 'pace', 'with', 'these', 'important', 'developments', 'Experts', 'in', 'thoracic', 'cancer', 'and', 'care', 'provide', 'focused', 'updates', 'across', 'multiple', 'areas', 'including', 'prevention', 'and', 'early', 'detection', 'molecular', 'diagnostics', 'pathology', 'and', 'staging', 'surgery', 'adjuvant', 'therapy', 'radiotherapy', 'molecular', 'targeted', 'therapy', 'and', 'immunotherapy', 'for', 'NSCLC', 'SCLC', 'and', 'mesothelioma', 'Quality', 'and', 'value', 'of', 'care', 'and', 'perspectives', 'on', 'the', 'future', 'of', 'lung', 'cancer', 'research', 'and', 'treatment', 'have', 'also', 'been', 'included', 'in', 'this', 'concise', 'review', '']"
53877,Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA's Diagnostics Committee.,2020-05-05,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,https://doi.org/10.1093/cid/ciaa508; https://www.ncbi.nlm.nih.gov/pubmed/32369578/,"The clinical signs and symptoms of acute respiratory tract infections (RTIs) are not pathogen specific. Highly sensitive and specific nucleic acid amplification tests have become the diagnostic reference standard for viruses and translation of bacterial assays from basic research to routine clinical practice represents an exciting advance in respiratory medicine. Most recently, molecular diagnostics have played an essential role in the global health response to the novel coronavirus pandemic. How best to use newer molecular tests for RTI in combination with clinical judgment and traditional methods can be bewildering given the plethora of available assays and rapidly evolving technologies. Here, we summarize the current state of the art with respect to the diagnosis of viral and bacterial RTIs, provide a practical framework for diagnostic decision-making using selected patient-centered vignettes, and make recommendations for future studies to advance the field.",10.1093/cid/ciaa508,gti6tm0q,"['The', 'clinical', 'signs', 'and', 'symptoms', 'of', 'acute', 'respiratory', 'tract', 'infections', 'RTIs', 'are', 'not', 'pathogen', 'specific', 'Highly', 'sensitive', 'and', 'specific', 'nucleic', 'acid', 'amplification', 'tests', 'have', 'become', 'the', 'diagnostic', 'reference', 'standard', 'for', 'viruses', 'and', 'translation', 'of', 'bacterial', 'assays', 'from', 'basic', 'research', 'to', 'routine', 'clinical', 'practice', 'represents', 'an', 'exciting', 'advance', 'in', 'respiratory', 'medicine', 'Most', 'recently', 'molecular', 'diagnostics', 'have', 'played', 'an', 'essential', 'role', 'in', 'the', 'global', 'health', 'response', 'to', 'the', 'novel', 'coronavirus', 'pandemic', 'How', 'best', 'to', 'use', 'newer', 'molecular', 'tests', 'for', 'RTI', 'in', 'combination', 'with', 'clinical', 'judgment', 'and', 'traditional', 'methods', 'can', 'be', 'bewildering', 'given', 'the', 'plethora', 'of', 'available', 'assays', 'and', 'rapidly', 'evolving', 'technologies', 'Here', 'we', 'summarize', 'the', 'current', 'state', 'of', 'the', 'art', 'with', 'respect', 'to', 'the', 'diagnosis', 'of', 'viral', 'and', 'bacterial', 'RTIs', 'provide', 'a', 'practical', 'framework', 'for', 'diagnostic', 'decision', 'making', 'using', 'selected', 'patient', 'centered', 'vignettes', 'and', 'make', 'recommendations', 'for', 'future', 'studies', 'to', 'advance', 'the', 'field', '']"
55194,"Prevalence of Selected Zoonotic Diseases and Risk Factors at a Human-Wildlife-Livestock Interface in Mpumalanga Province, South Africa.",2018,Vector borne and zoonotic diseases,https://doi.org/10.1089/vbz.2017.2158; https://www.ncbi.nlm.nih.gov/pubmed/29664701/,"A lack of surveillance and diagnostics for zoonotic diseases in rural human clinics limits clinical awareness of these diseases. We assessed the prevalence of nine zoonotic pathogens in a pastoral, low-income, HIV-endemic community bordering wildlife reserves in South Africa. Two groups of participants were included: malaria-negative acute febrile illness (AFI) patients, called febrilers, at three clinics (n = 74) and second, farmers, herders, and veterinary staff found at five government cattle dip-tanks, called dip-tanksters (n = 64). Blood samples were tested using one PCR (Bartonella spp.) and eight antibody-ELISAs, and questionnaires were conducted to assess risk factors. Seventy-seven percent of febrilers and 98% of dip-tanksters had at least one positive test. Bartonella spp. (PCR 9.5%), spotted fever group (SFG) Rickettsia spp. (IgM 24.1%), Coxiella burnetii. (IgM 2.3%), and Leptospira spp. (IgM 6.8%) were present in febrilers and could have been the cause of their fever. Dip-tanksters and febrilers had evidence of past infection to Rickettsia spp. (IgG 92.2% and 63.4%, respectively) and C. burnetii (IgG 60.9% and 37.8%, respectively). No Brucella infection or current Bartonella infection was found in the dip-tanksters, although they had higher levels of recent exposure to Leptospira spp. (IgM 21.9%) compared to the febrilers. Low levels of West Nile and Sindbis, and no Rift Valley fever virus exposure were found in either groups. The only risk factor found to be significant was attending dip-tanks in febrilers for Q fever (p = 0.007). Amoxicillin is the local standard treatment for AFI, but would not be effective for Bartonella spp. infections, SFG rickettsiosis, Q fever infections, or the viral infections. There is a need to revise AFI treatment algorithms, educate medical and veterinary staff about these pathogens, especially SFG rickettsiosis and Q fever, support disease surveillance systems, and inform the population about reducing tick and surface water contact.",10.1089/vbz.2017.2158,14fktd12,"['A', 'lack', 'of', 'surveillance', 'and', 'diagnostics', 'for', 'zoonotic', 'diseases', 'in', 'rural', 'human', 'clinics', 'limits', 'clinical', 'awareness', 'of', 'these', 'diseases', 'We', 'assessed', 'the', 'prevalence', 'of', 'nine', 'zoonotic', 'pathogens', 'in', 'a', 'pastoral', 'low', 'income', 'HIV', 'endemic', 'community', 'bordering', 'wildlife', 'reserves', 'in', 'South', 'Africa', 'Two', 'groups', 'of', 'participants', 'were', 'included', 'malaria', 'negative', 'acute', 'febrile', 'illness', 'AFI', 'patients', 'called', 'febrilers', 'at', 'three', 'clinics', 'n', '74', 'and', 'second', 'farmers', 'herders', 'and', 'veterinary', 'staff', 'found', 'at', 'five', 'government', 'cattle', 'dip', 'tanks', 'called', 'dip', 'tanksters', 'n', '64', 'Blood', 'samples', 'were', 'tested', 'using', 'one', 'PCR', 'Bartonella', 'spp', 'and', 'eight', 'antibody', 'ELISAs', 'and', 'questionnaires', 'were', 'conducted', 'to', 'assess', 'risk', 'factors', 'Seventy', 'seven', 'percent', 'of', 'febrilers', 'and', '98', 'of', 'dip', 'tanksters', 'had', 'at', 'least', 'one', 'positive', 'test', 'Bartonella', 'spp', 'PCR', '9', '5', 'spotted', 'fever', 'group', 'SFG', 'Rickettsia', 'spp', 'IgM', '24', '1', 'Coxiella', 'burnetii', 'IgM', '2', '3', 'and', 'Leptospira', 'spp', 'IgM', '6', '8', 'were', 'present', 'in', 'febrilers', 'and', 'could', 'have', 'been', 'the', 'cause', 'of', 'their', 'fever', 'Dip', 'tanksters', 'and', 'febrilers', 'had', 'evidence', 'of', 'past', 'infection', 'to', 'Rickettsia', 'spp', 'IgG', '92', '2', 'and', '63', '4', 'respectively', 'and', 'C', 'burnetii', 'IgG', '60', '9', 'and', '37', '8', 'respectively', 'No', 'Brucella', 'infection', 'or', 'current', 'Bartonella', 'infection', 'was', 'found', 'in', 'the', 'dip', 'tanksters', 'although', 'they', 'had', 'higher', 'levels', 'of', 'recent', 'exposure', 'to', 'Leptospira', 'spp', 'IgM', '21', '9', 'compared', 'to', 'the', 'febrilers', 'Low', 'levels', 'of', 'West', 'Nile', 'and', 'Sindbis', 'and', 'no', 'Rift', 'Valley', 'fever', 'virus', 'exposure', 'were', 'found', 'in', 'either', 'groups', 'The', 'only', 'risk', 'factor', 'found', 'to', 'be', 'significant', 'was', 'attending', 'dip', 'tanks', 'in', 'febrilers', 'for', 'Q', 'fever', 'p', '0', '007', 'Amoxicillin', 'is', 'the', 'local', 'standard', 'treatment', 'for', 'AFI', 'but', 'would', 'not', 'be', 'effective', 'for', 'Bartonella', 'spp', 'infections', 'SFG', 'rickettsiosis', 'Q', 'fever', 'infections', 'or', 'the', 'viral', 'infections', 'There', 'is', 'a', 'need', 'to', 'revise', 'AFI', 'treatment', 'algorithms', 'educate', 'medical', 'and', 'veterinary', 'staff', 'about', 'these', 'pathogens', 'especially', 'SFG', 'rickettsiosis', 'and', 'Q', 'fever', 'support', 'disease', 'surveillance', 'systems', 'and', 'inform', 'the', 'population', 'about', 'reducing', 'tick', 'and', 'surface', 'water', 'contact', '']"
55417,Sex differences in the traumatic stress response: PTSD symptoms in women recapitulated in female rats.,2018,Biology of sex differences,https://doi.org/10.1186/s13293-018-0191-9; https://www.ncbi.nlm.nih.gov/pubmed/29976248/,"BACKGROUND Post-traumatic stress disorder (PTSD) affects men and women differently. Not only are women twice as likely as men to develop PTSD, they experience different symptoms and comorbidities associated with PTSD. Yet the dearth of preclinical research on females leaves a notable gap in understanding the underlying neuropathology of this sex difference. METHODS Using two standard measures of PTSD-like responses in rats, the acoustic startle response (ASR) and dexamethasone suppression test (DST), we tested the effects of traumatic stress in adult male and female rats using two rodent models of PTSD, single prolonged stress and predator exposure. We then examined the neural correlates underlying these responses with cFos and glucocorticoid receptor immunohistochemistry in brain regions implicated in the traumatic stress response. RESULTS We now report that adult male and female rats across two models of PTSD show consistent sex-specific responses that recapitulate fundamental differences of PTSD in men and women. Trauma-exposed males showed the well-established hyper-responsive phenotype of enhanced ASR and exaggerated negative feedback control of the hypothalamic-pituitary-adrenal axis, while the same traumatic event had little effect on these same measures in females. Dramatic sex differences in how trauma affected cFos and glucocorticoid receptor expression in the brain lend further support to the idea that the trauma response of male and female rats is fundamentally different. CONCLUSIONS Two standard measures, ASR and DST, might suggest that females are resilient to the effects of traumatic stress, but other measures make it clear that females are not resilient, but simply respond differently to trauma. The next important question to answer is why. We conclude that males and females show fundamentally different responses to trauma that do not simply reflect differences in resilience. The divergent effects of trauma in the brains of males and females begin to shed light on the neurobiological underpinnings of these sex differences, paving the way for improved diagnostics and therapeutics that effectively treat both men and women.",10.1186/s13293-018-0191-9,hgjjtyy2,"['BACKGROUND', 'Post', 'traumatic', 'stress', 'disorder', 'PTSD', 'affects', 'men', 'and', 'women', 'differently', 'Not', 'only', 'are', 'women', 'twice', 'as', 'likely', 'as', 'men', 'to', 'develop', 'PTSD', 'they', 'experience', 'different', 'symptoms', 'and', 'comorbidities', 'associated', 'with', 'PTSD', 'Yet', 'the', 'dearth', 'of', 'preclinical', 'research', 'on', 'females', 'leaves', 'a', 'notable', 'gap', 'in', 'understanding', 'the', 'underlying', 'neuropathology', 'of', 'this', 'sex', 'difference', 'METHODS', 'Using', 'two', 'standard', 'measures', 'of', 'PTSD', 'like', 'responses', 'in', 'rats', 'the', 'acoustic', 'startle', 'response', 'ASR', 'and', 'dexamethasone', 'suppression', 'test', 'DST', 'we', 'tested', 'the', 'effects', 'of', 'traumatic', 'stress', 'in', 'adult', 'male', 'and', 'female', 'rats', 'using', 'two', 'rodent', 'models', 'of', 'PTSD', 'single', 'prolonged', 'stress', 'and', 'predator', 'exposure', 'We', 'then', 'examined', 'the', 'neural', 'correlates', 'underlying', 'these', 'responses', 'with', 'cFos', 'and', 'glucocorticoid', 'receptor', 'immunohistochemistry', 'in', 'brain', 'regions', 'implicated', 'in', 'the', 'traumatic', 'stress', 'response', 'RESULTS', 'We', 'now', 'report', 'that', 'adult', 'male', 'and', 'female', 'rats', 'across', 'two', 'models', 'of', 'PTSD', 'show', 'consistent', 'sex', 'specific', 'responses', 'that', 'recapitulate', 'fundamental', 'differences', 'of', 'PTSD', 'in', 'men', 'and', 'women', 'Trauma', 'exposed', 'males', 'showed', 'the', 'well', 'established', 'hyper', 'responsive', 'phenotype', 'of', 'enhanced', 'ASR', 'and', 'exaggerated', 'negative', 'feedback', 'control', 'of', 'the', 'hypothalamic', 'pituitary', 'adrenal', 'axis', 'while', 'the', 'same', 'traumatic', 'event', 'had', 'little', 'effect', 'on', 'these', 'same', 'measures', 'in', 'females', 'Dramatic', 'sex', 'differences', 'in', 'how', 'trauma', 'affected', 'cFos', 'and', 'glucocorticoid', 'receptor', 'expression', 'in', 'the', 'brain', 'lend', 'further', 'support', 'to', 'the', 'idea', 'that', 'the', 'trauma', 'response', 'of', 'male', 'and', 'female', 'rats', 'is', 'fundamentally', 'different', 'CONCLUSIONS', 'Two', 'standard', 'measures', 'ASR', 'and', 'DST', 'might', 'suggest', 'that', 'females', 'are', 'resilient', 'to', 'the', 'effects', 'of', 'traumatic', 'stress', 'but', 'other', 'measures', 'make', 'it', 'clear', 'that', 'females', 'are', 'not', 'resilient', 'but', 'simply', 'respond', 'differently', 'to', 'trauma', 'The', 'next', 'important', 'question', 'to', 'answer', 'is', 'why', 'We', 'conclude', 'that', 'males', 'and', 'females', 'show', 'fundamentally', 'different', 'responses', 'to', 'trauma', 'that', 'do', 'not', 'simply', 'reflect', 'differences', 'in', 'resilience', 'The', 'divergent', 'effects', 'of', 'trauma', 'in', 'the', 'brains', 'of', 'males', 'and', 'females', 'begin', 'to', 'shed', 'light', 'on', 'the', 'neurobiological', 'underpinnings', 'of', 'these', 'sex', 'differences', 'paving', 'the', 'way', 'for', 'improved', 'diagnostics', 'and', 'therapeutics', 'that', 'effectively', 'treat', 'both', 'men', 'and', 'women', '']"
55469,The genomics of emerging pathogens.,2013,Annual review of genomics and human genetics,https://doi.org/10.1146/annurev-genom-091212-153446; https://www.ncbi.nlm.nih.gov/pubmed/24003855/,"Globalization and industrialization have dramatically altered the vulnerability of human and animal populations to emerging and reemerging infectious diseases while shifting both the scale and pace of disease outbreaks. Fortunately, the advent of high-throughput DNA sequencing platforms has also increased the speed with which such pathogens can be detected and characterized as part of an outbreak response effort. It is now possible to sequence the genome of a pathogen rapidly, inexpensively, and with high sensitivity, transforming the fields of diagnostics, surveillance, forensic analysis, and pathogenesis. Here, we review advances in methods for microbial discovery and characterization, as well as strategies for testing the clinical and public health significance of microbe-disease associations. Finally, we discuss how genetic data can inform our understanding of the general process of pathogen emergence.",10.1146/annurev-genom-091212-153446,gsh9nhy5,"['Globalization', 'and', 'industrialization', 'have', 'dramatically', 'altered', 'the', 'vulnerability', 'of', 'human', 'and', 'animal', 'populations', 'to', 'emerging', 'and', 'reemerging', 'infectious', 'diseases', 'while', 'shifting', 'both', 'the', 'scale', 'and', 'pace', 'of', 'disease', 'outbreaks', 'Fortunately', 'the', 'advent', 'of', 'high', 'throughput', 'DNA', 'sequencing', 'platforms', 'has', 'also', 'increased', 'the', 'speed', 'with', 'which', 'such', 'pathogens', 'can', 'be', 'detected', 'and', 'characterized', 'as', 'part', 'of', 'an', 'outbreak', 'response', 'effort', 'It', 'is', 'now', 'possible', 'to', 'sequence', 'the', 'genome', 'of', 'a', 'pathogen', 'rapidly', 'inexpensively', 'and', 'with', 'high', 'sensitivity', 'transforming', 'the', 'fields', 'of', 'diagnostics', 'surveillance', 'forensic', 'analysis', 'and', 'pathogenesis', 'Here', 'we', 'review', 'advances', 'in', 'methods', 'for', 'microbial', 'discovery', 'and', 'characterization', 'as', 'well', 'as', 'strategies', 'for', 'testing', 'the', 'clinical', 'and', 'public', 'health', 'significance', 'of', 'microbe', 'disease', 'associations', 'Finally', 'we', 'discuss', 'how', 'genetic', 'data', 'can', 'inform', 'our', 'understanding', 'of', 'the', 'general', 'process', 'of', 'pathogen', 'emergence', '']"
55719,Analysis of Airborne Biomarkers for Point-of-Care Diagnostics.,2014,Journal of laboratory automation,https://doi.org/10.1177/2211068213517119; https://www.ncbi.nlm.nih.gov/pubmed/24464813/,"Treatable diseases continue to exact a heavy burden worldwide despite powerful advances in treatment. Diagnostics play crucial roles in the detection, management, and ultimate prevention of these diseases by guiding the allocation of precious medical resources. Motivated by globalization and evolving disease, and enabled by advances in molecular pathology, the scientific community has produced an explosion of research on miniaturized integrated biosensor platforms for disease detection. Low-cost, automated tests promise accessibility in low-resource settings by loosening constraints around infrastructure and usability. To address the challenges raised by invasive and intrusive sample collection, researchers are exploring alternative biomarkers in various specimens. Specifically, patient-generated airborne biomarkers suit minimally invasive collection and automated analysis. Disease biomarkers are known to exist in aerosols and volatile compounds in breath, odor, and headspace, media that can be exploited for field-ready diagnostics. This article reviews global disease priorities and the characteristics of low-resource settings. It surveys existing technologies for the analysis of bioaerosols and volatile organic compounds, and emerging technologies that could enable their translation to the point of care. Engineering advances promise to enable appropriate diagnostics by detecting chemical and microbial markers. Nonetheless, further innovation and cost reduction are needed for these technologies to broadly affect global health.",10.1177/2211068213517119,09gnwfoy,"['Treatable', 'diseases', 'continue', 'to', 'exact', 'a', 'heavy', 'burden', 'worldwide', 'despite', 'powerful', 'advances', 'in', 'treatment', 'Diagnostics', 'play', 'crucial', 'roles', 'in', 'the', 'detection', 'management', 'and', 'ultimate', 'prevention', 'of', 'these', 'diseases', 'by', 'guiding', 'the', 'allocation', 'of', 'precious', 'medical', 'resources', 'Motivated', 'by', 'globalization', 'and', 'evolving', 'disease', 'and', 'enabled', 'by', 'advances', 'in', 'molecular', 'pathology', 'the', 'scientific', 'community', 'has', 'produced', 'an', 'explosion', 'of', 'research', 'on', 'miniaturized', 'integrated', 'biosensor', 'platforms', 'for', 'disease', 'detection', 'Low', 'cost', 'automated', 'tests', 'promise', 'accessibility', 'in', 'low', 'resource', 'settings', 'by', 'loosening', 'constraints', 'around', 'infrastructure', 'and', 'usability', 'To', 'address', 'the', 'challenges', 'raised', 'by', 'invasive', 'and', 'intrusive', 'sample', 'collection', 'researchers', 'are', 'exploring', 'alternative', 'biomarkers', 'in', 'various', 'specimens', 'Specifically', 'patient', 'generated', 'airborne', 'biomarkers', 'suit', 'minimally', 'invasive', 'collection', 'and', 'automated', 'analysis', 'Disease', 'biomarkers', 'are', 'known', 'to', 'exist', 'in', 'aerosols', 'and', 'volatile', 'compounds', 'in', 'breath', 'odor', 'and', 'headspace', 'media', 'that', 'can', 'be', 'exploited', 'for', 'field', 'ready', 'diagnostics', 'This', 'article', 'reviews', 'global', 'disease', 'priorities', 'and', 'the', 'characteristics', 'of', 'low', 'resource', 'settings', 'It', 'surveys', 'existing', 'technologies', 'for', 'the', 'analysis', 'of', 'bioaerosols', 'and', 'volatile', 'organic', 'compounds', 'and', 'emerging', 'technologies', 'that', 'could', 'enable', 'their', 'translation', 'to', 'the', 'point', 'of', 'care', 'Engineering', 'advances', 'promise', 'to', 'enable', 'appropriate', 'diagnostics', 'by', 'detecting', 'chemical', 'and', 'microbial', 'markers', 'Nonetheless', 'further', 'innovation', 'and', 'cost', 'reduction', 'are', 'needed', 'for', 'these', 'technologies', 'to', 'broadly', 'affect', 'global', 'health', '']"
55982,EMERGENCY ANESTHESIA AND EXPLORATORY LAPAROTOMY IN A COMPROMISED PACIFIC WHITE-SIDED DOLPHIN (LAGENORHYNCHUS OBLIQUIDENS).,2017,Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,https://doi.org/10.1638/2016-228r1.1; https://www.ncbi.nlm.nih.gov/pubmed/28749265/,"Anesthesia and surgery in cetaceans have inherent risks and have rarely been utilized as viable treatment options. This report represents the first known multidisciplinary team approach to emergency laparotomy in a compromised, 22-yr-old, female Pacific white-sided dolphin ( Lagenorhynchus obliquidens ). The inciting clinical signs and ancillary diagnostics were consistent with a mechanical ileus. Although no torsion or obstruction was apparent during surgery, severe enteritis and peritonitis were noted. Postoperatively, the animal was maintained on aggressive medical management with continuous supportive care until succumbing 3 days later with clinical pathology indicative of terminal sepsis and profound inflammation. Postmortem findings included generalized vascular stasis and segmental intestinal volvulus with infarction. To the authors' knowledge, this is one of the most-complex surgical and anesthetic procedures performed in a cetacean. Though the outcome was unsuccessful, this case represents the aquatic veterinary community's collective advances in the ability to treat cetaceans under human care.",10.1638/2016-228r1.1,qaul7afg,"['Anesthesia', 'and', 'surgery', 'in', 'cetaceans', 'have', 'inherent', 'risks', 'and', 'have', 'rarely', 'been', 'utilized', 'as', 'viable', 'treatment', 'options', 'This', 'report', 'represents', 'the', 'first', 'known', 'multidisciplinary', 'team', 'approach', 'to', 'emergency', 'laparotomy', 'in', 'a', 'compromised', '22', 'yr', 'old', 'female', 'Pacific', 'white', 'sided', 'dolphin', 'Lagenorhynchus', 'obliquidens', 'The', 'inciting', 'clinical', 'signs', 'and', 'ancillary', 'diagnostics', 'were', 'consistent', 'with', 'a', 'mechanical', 'ileus', 'Although', 'no', 'torsion', 'or', 'obstruction', 'was', 'apparent', 'during', 'surgery', 'severe', 'enteritis', 'and', 'peritonitis', 'were', 'noted', 'Postoperatively', 'the', 'animal', 'was', 'maintained', 'on', 'aggressive', 'medical', 'management', 'with', 'continuous', 'supportive', 'care', 'until', 'succumbing', '3', 'days', 'later', 'with', 'clinical', 'pathology', 'indicative', 'of', 'terminal', 'sepsis', 'and', 'profound', 'inflammation', 'Postmortem', 'findings', 'included', 'generalized', 'vascular', 'stasis', 'and', 'segmental', 'intestinal', 'volvulus', 'with', 'infarction', 'To', 'the', 'authors', 'knowledge', 'this', 'is', 'one', 'of', 'the', 'most', 'complex', 'surgical', 'and', 'anesthetic', 'procedures', 'performed', 'in', 'a', 'cetacean', 'Though', 'the', 'outcome', 'was', 'unsuccessful', 'this', 'case', 'represents', 'the', 'aquatic', 'veterinary', 'community', 's', 'collective', 'advances', 'in', 'the', 'ability', 'to', 'treat', 'cetaceans', 'under', 'human', 'care', '']"
56928,"Management of Resistant, Atypical and Culture-negative Periprosthetic Joint Infections after Hip and Knee Arthroplasty.",2016,The open orthopaedics journal,https://doi.org/10.2174/1874325001610010615; https://www.ncbi.nlm.nih.gov/pubmed/28503214/,"BACKGROUND Periprosthetic joint infection (PJI) is a devastating complication following lower extremity total joint arthroplasty (TJA). It is a leading cause of morbidity and revision following TJA. As such, PJI is a significant driver of healthcare costs. The prevalence of PJI related to resistant and atypical organisms is increasing, and approximately 10-30% of PJIs are culture-negative. The purpose of this review is to summarize the current epidemiology, diagnostics, and management of PJI associated with resistant and atypical pathogens and of culture-negative PJIs. METHODS The published literature related to the epidemiology, diagnosis, and management of atypical, drug-resistant, and culture-negative PJI is reviewed. RESULTS The clinical diagnosis of PJI is often challenging, particularly when pathogens are fastidious or when antibiotics have been administered empirically. Molecular diagnostic studies, such as synovial α-defensin, may provide rapid, accurate identification of PJI, even in the setting of concurrent antibiotics administration or systemic inflammatory disease. Once PJI is diagnosed, two-stage exchange arthroplasty remains the gold standard for treating PJI with resistant microorganisms, since there is a high rate of treatment failure with irrigation and debridement and with one-stage exchange arthroplasty. CONCLUSION Additional research is needed to define the optimal treatment of PJIs associated with rare pathogens, such as fungi and mycobacteria. There is a need for inexpensive, reliable tests that rapidly detect specific microbial species and antimicrobial susceptibilities. Additional research is also required to define the specific organisms, clinical scenarios, surgical techniques, and antimicrobial regimens that allow for reproducible treatment success with prosthetic retention strategies.",10.2174/1874325001610010615,i7ycpseq,"['BACKGROUND', 'Periprosthetic', 'joint', 'infection', 'PJI', 'is', 'a', 'devastating', 'complication', 'following', 'lower', 'extremity', 'total', 'joint', 'arthroplasty', 'TJA', 'It', 'is', 'a', 'leading', 'cause', 'of', 'morbidity', 'and', 'revision', 'following', 'TJA', 'As', 'such', 'PJI', 'is', 'a', 'significant', 'driver', 'of', 'healthcare', 'costs', 'The', 'prevalence', 'of', 'PJI', 'related', 'to', 'resistant', 'and', 'atypical', 'organisms', 'is', 'increasing', 'and', 'approximately', '10', '30', 'of', 'PJIs', 'are', 'culture', 'negative', 'The', 'purpose', 'of', 'this', 'review', 'is', 'to', 'summarize', 'the', 'current', 'epidemiology', 'diagnostics', 'and', 'management', 'of', 'PJI', 'associated', 'with', 'resistant', 'and', 'atypical', 'pathogens', 'and', 'of', 'culture', 'negative', 'PJIs', 'METHODS', 'The', 'published', 'literature', 'related', 'to', 'the', 'epidemiology', 'diagnosis', 'and', 'management', 'of', 'atypical', 'drug', 'resistant', 'and', 'culture', 'negative', 'PJI', 'is', 'reviewed', 'RESULTS', 'The', 'clinical', 'diagnosis', 'of', 'PJI', 'is', 'often', 'challenging', 'particularly', 'when', 'pathogens', 'are', 'fastidious', 'or', 'when', 'antibiotics', 'have', 'been', 'administered', 'empirically', 'Molecular', 'diagnostic', 'studies', 'such', 'as', 'synovial', 'α', 'defensin', 'may', 'provide', 'rapid', 'accurate', 'identification', 'of', 'PJI', 'even', 'in', 'the', 'setting', 'of', 'concurrent', 'antibiotics', 'administration', 'or', 'systemic', 'inflammatory', 'disease', 'Once', 'PJI', 'is', 'diagnosed', 'two', 'stage', 'exchange', 'arthroplasty', 'remains', 'the', 'gold', 'standard', 'for', 'treating', 'PJI', 'with', 'resistant', 'microorganisms', 'since', 'there', 'is', 'a', 'high', 'rate', 'of', 'treatment', 'failure', 'with', 'irrigation', 'and', 'debridement', 'and', 'with', 'one', 'stage', 'exchange', 'arthroplasty', 'CONCLUSION', 'Additional', 'research', 'is', 'needed', 'to', 'define', 'the', 'optimal', 'treatment', 'of', 'PJIs', 'associated', 'with', 'rare', 'pathogens', 'such', 'as', 'fungi', 'and', 'mycobacteria', 'There', 'is', 'a', 'need', 'for', 'inexpensive', 'reliable', 'tests', 'that', 'rapidly', 'detect', 'specific', 'microbial', 'species', 'and', 'antimicrobial', 'susceptibilities', 'Additional', 'research', 'is', 'also', 'required', 'to', 'define', 'the', 'specific', 'organisms', 'clinical', 'scenarios', 'surgical', 'techniques', 'and', 'antimicrobial', 'regimens', 'that', 'allow', 'for', 'reproducible', 'treatment', 'success', 'with', 'prosthetic', 'retention', 'strategies', '']"
58205,"Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives.",2015,Journal of infection in developing countries,https://doi.org/10.3855/jidc.6197; https://www.ncbi.nlm.nih.gov/pubmed/25989163/,"Humans constantly encounter threats from many infectious, zoonotic, and devastating pathogens. Outbreaks of severe acute respiratory syndrome (SARS), bird flu, and swine flu posing pandemic threats have compelled health agencies to follow global preparedness for combating the emerging deadly pathogens. The outbreak in West Africa of highly contagious Ebola viral disease (EVD) that started in Guinea in December 2013, assumed global proportions to become the largest outbreak of EVD and the most prominent international health concern. With fatality rates of nearly 50%-90%, it has claimed, as of 11 April 2015, 10,619 human lives out of a total of 25,626 cases reported worldwide. Ebola virus (EBOV), a member of Filoviridae family, is associated with severe, often lethal, hemorrhagic fever disease in humans and animals. The animal hosts, including non-human primates and reservoir hosts (fruit bats), play a significant role in transmission and maintenance of EBOV in nature. Although no approved vaccine for the prevention of EVD currently exists, disease control can be greatly enhanced by timely laboratory confirmation through blood tests using enzyme-linked immunosorbent assay (ELISA) and reverse transcription polymerase chain reaction (RT-PCR). Adherence to strict sanitary and hygienic measures, monitoring and surveillance of EBOV, as well as quarantine checks on international trade, transport, and visitors from affected countries are mandatory to prevent and control the spread of EVD. This review describes the salient properties of EBOV and the development of novel diagnostics, vaccines, and control strategies for this emerging disease of high public health concern and international emergency.",10.3855/jidc.6197,2l7f22fl,"['Humans', 'constantly', 'encounter', 'threats', 'from', 'many', 'infectious', 'zoonotic', 'and', 'devastating', 'pathogens', 'Outbreaks', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'bird', 'flu', 'and', 'swine', 'flu', 'posing', 'pandemic', 'threats', 'have', 'compelled', 'health', 'agencies', 'to', 'follow', 'global', 'preparedness', 'for', 'combating', 'the', 'emerging', 'deadly', 'pathogens', 'The', 'outbreak', 'in', 'West', 'Africa', 'of', 'highly', 'contagious', 'Ebola', 'viral', 'disease', 'EVD', 'that', 'started', 'in', 'Guinea', 'in', 'December', '2013', 'assumed', 'global', 'proportions', 'to', 'become', 'the', 'largest', 'outbreak', 'of', 'EVD', 'and', 'the', 'most', 'prominent', 'international', 'health', 'concern', 'With', 'fatality', 'rates', 'of', 'nearly', '50', '90', 'it', 'has', 'claimed', 'as', 'of', '11', 'April', '2015', '10', '619', 'human', 'lives', 'out', 'of', 'a', 'total', 'of', '25', '626', 'cases', 'reported', 'worldwide', 'Ebola', 'virus', 'EBOV', 'a', 'member', 'of', 'Filoviridae', 'family', 'is', 'associated', 'with', 'severe', 'often', 'lethal', 'hemorrhagic', 'fever', 'disease', 'in', 'humans', 'and', 'animals', 'The', 'animal', 'hosts', 'including', 'non', 'human', 'primates', 'and', 'reservoir', 'hosts', 'fruit', 'bats', 'play', 'a', 'significant', 'role', 'in', 'transmission', 'and', 'maintenance', 'of', 'EBOV', 'in', 'nature', 'Although', 'no', 'approved', 'vaccine', 'for', 'the', 'prevention', 'of', 'EVD', 'currently', 'exists', 'disease', 'control', 'can', 'be', 'greatly', 'enhanced', 'by', 'timely', 'laboratory', 'confirmation', 'through', 'blood', 'tests', 'using', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'and', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'Adherence', 'to', 'strict', 'sanitary', 'and', 'hygienic', 'measures', 'monitoring', 'and', 'surveillance', 'of', 'EBOV', 'as', 'well', 'as', 'quarantine', 'checks', 'on', 'international', 'trade', 'transport', 'and', 'visitors', 'from', 'affected', 'countries', 'are', 'mandatory', 'to', 'prevent', 'and', 'control', 'the', 'spread', 'of', 'EVD', 'This', 'review', 'describes', 'the', 'salient', 'properties', 'of', 'EBOV', 'and', 'the', 'development', 'of', 'novel', 'diagnostics', 'vaccines', 'and', 'control', 'strategies', 'for', 'this', 'emerging', 'disease', 'of', 'high', 'public', 'health', 'concern', 'and', 'international', 'emergency', '']"
58249,"The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia.",2014,Journal of medical microbiology,https://doi.org/10.1099/jmm.0.067108-0; https://www.ncbi.nlm.nih.gov/pubmed/24344207/,"Current diagnostics for community-acquired pneumonia (CAP) include testing for a wide range of pathogens, which is costly and not always informative. We compared clinical and laboratory parameters of patients with CAP caused by different groups of pathogens to evaluate the potential for targeted diagnostics and directed treatment. In a prospective study, conducted between April 2008 and April 2009, adult patients with CAP were tested for the presence of a broad range of possible respiratory pathogens using bacterial cultures, PCR, urinary antigen testing and serology. Of 408 patients with CAP, pathogens were detected in 263 patients (64.5%). Streptococcus pneumoniae and influenza A virus were the most frequently identified bacterial and viral pathogens, respectively. Age had a significant effect on the prediction of aetiology (P = 0.054), with an increase in the relative contribution of viruses with advancing age. Multivariate analyses further showed that the presence of cough increased the likelihood of detecting a viral pathogen [odds ratio (OR) 5.536, 95% confidence interval (CI) 2.130-14.390], the presence of immunodeficiency decreased the likelihood of detecting a bacterial pathogen (OR 0.595, 95 % CI 0.246-1.437) and an increase in pneumonia severity index score increased the likelihood of detecting a pathogen in general. Although several variables were independently associated with the detection of a pathogen group, substantial overlap meant there were no reliable clinical predictors to distinguish aetiologies. Therefore, testing for common respiratory pathogens is still necessary to optimize treatment.",10.1099/jmm.0.067108-0,rq37ljed,"['Current', 'diagnostics', 'for', 'community', 'acquired', 'pneumonia', 'CAP', 'include', 'testing', 'for', 'a', 'wide', 'range', 'of', 'pathogens', 'which', 'is', 'costly', 'and', 'not', 'always', 'informative', 'We', 'compared', 'clinical', 'and', 'laboratory', 'parameters', 'of', 'patients', 'with', 'CAP', 'caused', 'by', 'different', 'groups', 'of', 'pathogens', 'to', 'evaluate', 'the', 'potential', 'for', 'targeted', 'diagnostics', 'and', 'directed', 'treatment', 'In', 'a', 'prospective', 'study', 'conducted', 'between', 'April', '2008', 'and', 'April', '2009', 'adult', 'patients', 'with', 'CAP', 'were', 'tested', 'for', 'the', 'presence', 'of', 'a', 'broad', 'range', 'of', 'possible', 'respiratory', 'pathogens', 'using', 'bacterial', 'cultures', 'PCR', 'urinary', 'antigen', 'testing', 'and', 'serology', 'Of', '408', 'patients', 'with', 'CAP', 'pathogens', 'were', 'detected', 'in', '263', 'patients', '64', '5', 'Streptococcus', 'pneumoniae', 'and', 'influenza', 'A', 'virus', 'were', 'the', 'most', 'frequently', 'identified', 'bacterial', 'and', 'viral', 'pathogens', 'respectively', 'Age', 'had', 'a', 'significant', 'effect', 'on', 'the', 'prediction', 'of', 'aetiology', 'P', '0', '054', 'with', 'an', 'increase', 'in', 'the', 'relative', 'contribution', 'of', 'viruses', 'with', 'advancing', 'age', 'Multivariate', 'analyses', 'further', 'showed', 'that', 'the', 'presence', 'of', 'cough', 'increased', 'the', 'likelihood', 'of', 'detecting', 'a', 'viral', 'pathogen', 'odds', 'ratio', 'OR', '5', '536', '95', 'confidence', 'interval', 'CI', '2', '130', '14', '390', 'the', 'presence', 'of', 'immunodeficiency', 'decreased', 'the', 'likelihood', 'of', 'detecting', 'a', 'bacterial', 'pathogen', 'OR', '0', '595', '95', 'CI', '0', '246', '1', '437', 'and', 'an', 'increase', 'in', 'pneumonia', 'severity', 'index', 'score', 'increased', 'the', 'likelihood', 'of', 'detecting', 'a', 'pathogen', 'in', 'general', 'Although', 'several', 'variables', 'were', 'independently', 'associated', 'with', 'the', 'detection', 'of', 'a', 'pathogen', 'group', 'substantial', 'overlap', 'meant', 'there', 'were', 'no', 'reliable', 'clinical', 'predictors', 'to', 'distinguish', 'aetiologies', 'Therefore', 'testing', 'for', 'common', 'respiratory', 'pathogens', 'is', 'still', 'necessary', 'to', 'optimize', 'treatment', '']"
58670,An update on the status of COVID-19: a comprehensive review.,2020-04-01,European review for medical and pharmacological sciences,https://doi.org/10.26355/eurrev_202004_21046; https://www.ncbi.nlm.nih.gov/pubmed/32374000/,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",10.26355/eurrev_202004_21046,irqcpi6g,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
60769,Reducing Uncertainty for Acute Febrile Illness in Resource-Limited Settings: The Current Diagnostic Landscape.,2017,The American journal of tropical medicine and hygiene,https://doi.org/10.4269/ajtmh.16-0667; https://www.ncbi.nlm.nih.gov/pubmed/28719277/,"AbstractDiagnosing the cause of acute febrile illness in resource-limited settings is important-to give the correct antimicrobials to patients who need them, to prevent unnecessary antimicrobial use, to detect emerging infectious diseases early, and to guide vaccine deployment. A variety of approaches are yielding more rapid and accurate tests that can detect more pathogens in a wider variety of settings. After decades of slow progress in diagnostics for acute febrile illness in resource-limited settings, a wave of converging advancements will enable clinicians in resource-limited settings to reduce uncertainty for the diagnosis of acute febrile illness.",10.4269/ajtmh.16-0667,d56mj864,"['AbstractDiagnosing', 'the', 'cause', 'of', 'acute', 'febrile', 'illness', 'in', 'resource', 'limited', 'settings', 'is', 'important', 'to', 'give', 'the', 'correct', 'antimicrobials', 'to', 'patients', 'who', 'need', 'them', 'to', 'prevent', 'unnecessary', 'antimicrobial', 'use', 'to', 'detect', 'emerging', 'infectious', 'diseases', 'early', 'and', 'to', 'guide', 'vaccine', 'deployment', 'A', 'variety', 'of', 'approaches', 'are', 'yielding', 'more', 'rapid', 'and', 'accurate', 'tests', 'that', 'can', 'detect', 'more', 'pathogens', 'in', 'a', 'wider', 'variety', 'of', 'settings', 'After', 'decades', 'of', 'slow', 'progress', 'in', 'diagnostics', 'for', 'acute', 'febrile', 'illness', 'in', 'resource', 'limited', 'settings', 'a', 'wave', 'of', 'converging', 'advancements', 'will', 'enable', 'clinicians', 'in', 'resource', 'limited', 'settings', 'to', 'reduce', 'uncertainty', 'for', 'the', 'diagnosis', 'of', 'acute', 'febrile', 'illness', '']"
61757,Ultrasonographic Detection of Airway Obstruction in a Model of Obstructive Sleep Apnea.,2017,Ultrasound international open,https://doi.org/10.1055/s-0042-124503; https://www.ncbi.nlm.nih.gov/pubmed/28345075/,"Purpose Obstructive sleep apnea (OSA) is a common clinical disorder characterized by repetitive airway obstruction during sleep. The gold standard for diagnosis of OSA, polysomnogram (PSG), cannot anatomically localize obstruction. Precise identification of obstruction has potential to improve outcomes following surgery. Current diagnostic modalities that provide this information require anesthesia, involve ionizing radiation or disrupt sleep. To mitigate these problems, we conceived that ultrasound (US) technology may be adapted (i) to detect, quantify and localize airway obstruction and (ii) for translational application to home-based testing for OSA. Materials and Methods Segmental airway collapse was induced in 4 fresh cadavers by application of negative pressure. Following visualization of airway obstruction, a rotary US probe was used to acquire transcervical images of the airway before and after induction of obstruction. These images (n=800) were analyzed offline using image processing algorithms. Results Our results show that the non-obstructed airway consistently demonstrated the presence of a US air-tissue interface. Importantly, automated detection of the air-tissue interface strongly correlated with manual measurements. The algorithm correctly detected an air-tissue interface in 90% of the US images while incorrectly detecting it in 20% (area under the curve=0.91). Conclusion The non-invasive detection of airway obstruction using US represents a major step in expanding OSA diagnostics beyond PSG. The preliminary data obtained from our model could spur further research in non-invasive localization of obstruction. US offers the benefit of precise localization of the site of obstruction, with potential for improving outcomes in surgical management.",10.1055/s-0042-124503,x21fqgye,"['Purpose', 'Obstructive', 'sleep', 'apnea', 'OSA', 'is', 'a', 'common', 'clinical', 'disorder', 'characterized', 'by', 'repetitive', 'airway', 'obstruction', 'during', 'sleep', 'The', 'gold', 'standard', 'for', 'diagnosis', 'of', 'OSA', 'polysomnogram', 'PSG', 'cannot', 'anatomically', 'localize', 'obstruction', 'Precise', 'identification', 'of', 'obstruction', 'has', 'potential', 'to', 'improve', 'outcomes', 'following', 'surgery', 'Current', 'diagnostic', 'modalities', 'that', 'provide', 'this', 'information', 'require', 'anesthesia', 'involve', 'ionizing', 'radiation', 'or', 'disrupt', 'sleep', 'To', 'mitigate', 'these', 'problems', 'we', 'conceived', 'that', 'ultrasound', 'US', 'technology', 'may', 'be', 'adapted', 'i', 'to', 'detect', 'quantify', 'and', 'localize', 'airway', 'obstruction', 'and', 'ii', 'for', 'translational', 'application', 'to', 'home', 'based', 'testing', 'for', 'OSA', 'Materials', 'and', 'Methods', 'Segmental', 'airway', 'collapse', 'was', 'induced', 'in', '4', 'fresh', 'cadavers', 'by', 'application', 'of', 'negative', 'pressure', 'Following', 'visualization', 'of', 'airway', 'obstruction', 'a', 'rotary', 'US', 'probe', 'was', 'used', 'to', 'acquire', 'transcervical', 'images', 'of', 'the', 'airway', 'before', 'and', 'after', 'induction', 'of', 'obstruction', 'These', 'images', 'n', '800', 'were', 'analyzed', 'offline', 'using', 'image', 'processing', 'algorithms', 'Results', 'Our', 'results', 'show', 'that', 'the', 'non', 'obstructed', 'airway', 'consistently', 'demonstrated', 'the', 'presence', 'of', 'a', 'US', 'air', 'tissue', 'interface', 'Importantly', 'automated', 'detection', 'of', 'the', 'air', 'tissue', 'interface', 'strongly', 'correlated', 'with', 'manual', 'measurements', 'The', 'algorithm', 'correctly', 'detected', 'an', 'air', 'tissue', 'interface', 'in', '90', 'of', 'the', 'US', 'images', 'while', 'incorrectly', 'detecting', 'it', 'in', '20', 'area', 'under', 'the', 'curve', '0', '91', 'Conclusion', 'The', 'non', 'invasive', 'detection', 'of', 'airway', 'obstruction', 'using', 'US', 'represents', 'a', 'major', 'step', 'in', 'expanding', 'OSA', 'diagnostics', 'beyond', 'PSG', 'The', 'preliminary', 'data', 'obtained', 'from', 'our', 'model', 'could', 'spur', 'further', 'research', 'in', 'non', 'invasive', 'localization', 'of', 'obstruction', 'US', 'offers', 'the', 'benefit', 'of', 'precise', 'localization', 'of', 'the', 'site', 'of', 'obstruction', 'with', 'potential', 'for', 'improving', 'outcomes', 'in', 'surgical', 'management', '']"
61914,Point-of-care multiplex PCR promises short turnaround times for microbial testing in hospital-acquired pneumonia--an observational pilot study in critical ill patients.,2015,Annals of clinical microbiology and antimicrobials,https://doi.org/10.1186/s12941-015-0091-3; https://www.ncbi.nlm.nih.gov/pubmed/26071191/,"BACKGROUND The early beginning of an adequate antibiotic therapy is crucial in hospital-acquired pneumonia (HAP), but depends on the results of conventional microbiological diagnostics (cMD). It was the aim of this study to evaluate the performance and turnaround times of a new point-of-care multiplex polymerase chain reaction (mPCR) system for rapid identification of pathogens and antibiotic resistance markers. We assessed the applicability of the system under real-life conditions in critical ill patients with HAP. METHODS We enrolled forty critical ill patients with clinical signs for HAP into an observational study. Two samples of respiratory secretions were collected during one course of aspiration and cMD and mPCR testing (Unyvero, Curetis AG, Holzgerlingen, Germany) were performed immediately. The mPCR device was operated as a point-of-care system at the intensive care unit. We compared turnaround times, results of pathogen identification and results of antibiotic resistance testing of both methods. RESULTS Mean turnaround times (min-max) were 6.5 h (4.7-18.3 h) for multiplex PCR and 71 h (37.2-217.8 h) for conventional microbiology (final cMD results, incomplete results neglected). 60% (n = 24) of the mPCR tests were completely valid. Complete test failure occurred in 10% (n = 4) and partial test failure occurred in 30% (n = 12). We found concordant results in 45% (n = 18) and non-concordant results in 45% (n = 18) of all patients. 55% (n = 16) of the results were concordant in patients with a clinical pulmonary infection score (CPIS) > 5 (n = 29). Concordant results included three cases of multidrug resistant bacteria. MPCR frequently detected antibiotic resistance markers that were not found by cMD. CONCLUSIONS Unyvero allowed point-of-care microbial testing with short turnaround times. The performance of the system was poor. However, an improved system with a more reliable performance and an extended microbial panel could be a useful addition to cMD in intensive care medicine. TRIAL REGISTRATION ClinicalTrials.gov NCT01858974 (registered 16 May 2013).",10.1186/s12941-015-0091-3,npz9a1mw,"['BACKGROUND', 'The', 'early', 'beginning', 'of', 'an', 'adequate', 'antibiotic', 'therapy', 'is', 'crucial', 'in', 'hospital', 'acquired', 'pneumonia', 'HAP', 'but', 'depends', 'on', 'the', 'results', 'of', 'conventional', 'microbiological', 'diagnostics', 'cMD', 'It', 'was', 'the', 'aim', 'of', 'this', 'study', 'to', 'evaluate', 'the', 'performance', 'and', 'turnaround', 'times', 'of', 'a', 'new', 'point', 'of', 'care', 'multiplex', 'polymerase', 'chain', 'reaction', 'mPCR', 'system', 'for', 'rapid', 'identification', 'of', 'pathogens', 'and', 'antibiotic', 'resistance', 'markers', 'We', 'assessed', 'the', 'applicability', 'of', 'the', 'system', 'under', 'real', 'life', 'conditions', 'in', 'critical', 'ill', 'patients', 'with', 'HAP', 'METHODS', 'We', 'enrolled', 'forty', 'critical', 'ill', 'patients', 'with', 'clinical', 'signs', 'for', 'HAP', 'into', 'an', 'observational', 'study', 'Two', 'samples', 'of', 'respiratory', 'secretions', 'were', 'collected', 'during', 'one', 'course', 'of', 'aspiration', 'and', 'cMD', 'and', 'mPCR', 'testing', 'Unyvero', 'Curetis', 'AG', 'Holzgerlingen', 'Germany', 'were', 'performed', 'immediately', 'The', 'mPCR', 'device', 'was', 'operated', 'as', 'a', 'point', 'of', 'care', 'system', 'at', 'the', 'intensive', 'care', 'unit', 'We', 'compared', 'turnaround', 'times', 'results', 'of', 'pathogen', 'identification', 'and', 'results', 'of', 'antibiotic', 'resistance', 'testing', 'of', 'both', 'methods', 'RESULTS', 'Mean', 'turnaround', 'times', 'min', 'max', 'were', '6', '5', 'h', '4', '7', '18', '3', 'h', 'for', 'multiplex', 'PCR', 'and', '71', 'h', '37', '2', '217', '8', 'h', 'for', 'conventional', 'microbiology', 'final', 'cMD', 'results', 'incomplete', 'results', 'neglected', '60', 'n', '24', 'of', 'the', 'mPCR', 'tests', 'were', 'completely', 'valid', 'Complete', 'test', 'failure', 'occurred', 'in', '10', 'n', '4', 'and', 'partial', 'test', 'failure', 'occurred', 'in', '30', 'n', '12', 'We', 'found', 'concordant', 'results', 'in', '45', 'n', '18', 'and', 'non', 'concordant', 'results', 'in', '45', 'n', '18', 'of', 'all', 'patients', '55', 'n', '16', 'of', 'the', 'results', 'were', 'concordant', 'in', 'patients', 'with', 'a', 'clinical', 'pulmonary', 'infection', 'score', 'CPIS', '5', 'n', '29', 'Concordant', 'results', 'included', 'three', 'cases', 'of', 'multidrug', 'resistant', 'bacteria', 'MPCR', 'frequently', 'detected', 'antibiotic', 'resistance', 'markers', 'that', 'were', 'not', 'found', 'by', 'cMD', 'CONCLUSIONS', 'Unyvero', 'allowed', 'point', 'of', 'care', 'microbial', 'testing', 'with', 'short', 'turnaround', 'times', 'The', 'performance', 'of', 'the', 'system', 'was', 'poor', 'However', 'an', 'improved', 'system', 'with', 'a', 'more', 'reliable', 'performance', 'and', 'an', 'extended', 'microbial', 'panel', 'could', 'be', 'a', 'useful', 'addition', 'to', 'cMD', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT01858974', 'registered', '16', 'May', '2013', '']"
62158,The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.,2020-03-19,Clinical chemistry and laboratory medicine,https://doi.org/10.1515/cclm-2020-0240; https://www.ncbi.nlm.nih.gov/pubmed/32191623/,"Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume the relevance of insidious worldwide threat. One obvious question that is now engaging the minds of many scientists and healthcare professionals is whether and eventually how laboratory medicine could efficiently contribute to counteract this and other (future) viral outbreaks. Despite there being evidence that laboratory tests are vital throughout many clinical pathways, there are at least three major areas where in vitro diagnostics can also provide essential contributions to diagnostic reasoning and managed care of patients with suspected or confirmed SARS-CoV-2 infection. These include etiological diagnosis, patient monitoring, as well as epidemiologic surveillance. Nonetheless, some structural and practical aspects may generate substantial hurdles in providing timely and efficient response to this infectious emergency, which basically include inadequate (insufficient) environment and shortage of technical and human resources for facing enhanced volume of tests on many infected patients, some of whom are with severe disease. Some proactive and reactive strategies may hence be identified to confront this serious healthcare challenge, which entail major investments on conventional laboratory resources, reinforcement of regional networks of clinical laboratories, installation of mobile laboratories, as well as being proactive in establishing laboratory emergency plans.",10.1515/cclm-2020-0240,lazqwdn0,"['Coronavirus', 'disease', '2019', 'abbreviated', 'to', 'COVID', '19', 'and', 'sustained', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'latest', 'biological', 'hazard', 'to', 'assume', 'the', 'relevance', 'of', 'insidious', 'worldwide', 'threat', 'One', 'obvious', 'question', 'that', 'is', 'now', 'engaging', 'the', 'minds', 'of', 'many', 'scientists', 'and', 'healthcare', 'professionals', 'is', 'whether', 'and', 'eventually', 'how', 'laboratory', 'medicine', 'could', 'efficiently', 'contribute', 'to', 'counteract', 'this', 'and', 'other', 'future', 'viral', 'outbreaks', 'Despite', 'there', 'being', 'evidence', 'that', 'laboratory', 'tests', 'are', 'vital', 'throughout', 'many', 'clinical', 'pathways', 'there', 'are', 'at', 'least', 'three', 'major', 'areas', 'where', 'in', 'vitro', 'diagnostics', 'can', 'also', 'provide', 'essential', 'contributions', 'to', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'patients', 'with', 'suspected', 'or', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'These', 'include', 'etiological', 'diagnosis', 'patient', 'monitoring', 'as', 'well', 'as', 'epidemiologic', 'surveillance', 'Nonetheless', 'some', 'structural', 'and', 'practical', 'aspects', 'may', 'generate', 'substantial', 'hurdles', 'in', 'providing', 'timely', 'and', 'efficient', 'response', 'to', 'this', 'infectious', 'emergency', 'which', 'basically', 'include', 'inadequate', 'insufficient', 'environment', 'and', 'shortage', 'of', 'technical', 'and', 'human', 'resources', 'for', 'facing', 'enhanced', 'volume', 'of', 'tests', 'on', 'many', 'infected', 'patients', 'some', 'of', 'whom', 'are', 'with', 'severe', 'disease', 'Some', 'proactive', 'and', 'reactive', 'strategies', 'may', 'hence', 'be', 'identified', 'to', 'confront', 'this', 'serious', 'healthcare', 'challenge', 'which', 'entail', 'major', 'investments', 'on', 'conventional', 'laboratory', 'resources', 'reinforcement', 'of', 'regional', 'networks', 'of', 'clinical', 'laboratories', 'installation', 'of', 'mobile', 'laboratories', 'as', 'well', 'as', 'being', 'proactive', 'in', 'establishing', 'laboratory', 'emergency', 'plans', '']"
62349,Transcatheter arterial embolisation in upper gastrointestinal bleeding in a sample of 29 patients in a gastrointestinal referral center in Germany.,2015,Zeitschrift fur Gastroenterologie,https://doi.org/10.1055/s-0034-1399472; https://www.ncbi.nlm.nih.gov/pubmed/26367022/,"OBJECTIVE This is a retrospective analysis of interventional embolisation performed with catheter angiography in 29 patients with upper gastrointestinal bleeding in the setting of a secondary care hospital. PATIENTS, MATERIALS, AND METHODS From April 2007 to February 2013, 29 patients with upper gastrointestinal bleeding underwent endovascular diagnostics and treatment. The diagnosis was established by endoscopy, computed tomography or clinically based on a significant decrease in hemoglobin. Transcatheter arterial embolisation was performed with coils, liquid embolic agents, and particles. The technical and clinical outcomes were assessed by postinterventional endoscopy, hemoglobin concentrations, number of necessary transfusions, or surgical interventions, as well as by post-interventional mortality within 28 days after the procedure. RESULTS Selective angiographic embolisation in upper gastrointestinal bleeding was primarily successful technically and clinically in 22 of 29 patients. In 4/29 cases an angiographic reintervention was performed, which was successful in 3 cases. In 3 cases of primarily technically unsuccessful procedures reintervention was not attempted. No catheterisation-related complications were recorded. Peri-interventional mortality was 31%, but only 2 of these patients died due to uncontrolled massive bleeding, whereas the lethal outcome in the other 7 patients was due to their underlying diseases. CONCLUSION Transcatheter arterial embolisation is an effective and rapid method in the management of upper gastrointestinal bleeding. Radiological endovascular interventions may considerably contribute to reduced mortality in GI bleeding by avoiding a potential surgical procedure following unsuccessful endoscopic treatment. The study underlines the importance of the combination of interventional endoscopy with interventional radiology in secondary care hospitals for patient outcome in complex and complicated upper gastrointestinal bleeding situations.",10.1055/s-0034-1399472,jd574e0r,"['OBJECTIVE', 'This', 'is', 'a', 'retrospective', 'analysis', 'of', 'interventional', 'embolisation', 'performed', 'with', 'catheter', 'angiography', 'in', '29', 'patients', 'with', 'upper', 'gastrointestinal', 'bleeding', 'in', 'the', 'setting', 'of', 'a', 'secondary', 'care', 'hospital', 'PATIENTS', 'MATERIALS', 'AND', 'METHODS', 'From', 'April', '2007', 'to', 'February', '2013', '29', 'patients', 'with', 'upper', 'gastrointestinal', 'bleeding', 'underwent', 'endovascular', 'diagnostics', 'and', 'treatment', 'The', 'diagnosis', 'was', 'established', 'by', 'endoscopy', 'computed', 'tomography', 'or', 'clinically', 'based', 'on', 'a', 'significant', 'decrease', 'in', 'hemoglobin', 'Transcatheter', 'arterial', 'embolisation', 'was', 'performed', 'with', 'coils', 'liquid', 'embolic', 'agents', 'and', 'particles', 'The', 'technical', 'and', 'clinical', 'outcomes', 'were', 'assessed', 'by', 'postinterventional', 'endoscopy', 'hemoglobin', 'concentrations', 'number', 'of', 'necessary', 'transfusions', 'or', 'surgical', 'interventions', 'as', 'well', 'as', 'by', 'post', 'interventional', 'mortality', 'within', '28', 'days', 'after', 'the', 'procedure', 'RESULTS', 'Selective', 'angiographic', 'embolisation', 'in', 'upper', 'gastrointestinal', 'bleeding', 'was', 'primarily', 'successful', 'technically', 'and', 'clinically', 'in', '22', 'of', '29', 'patients', 'In', '4', '29', 'cases', 'an', 'angiographic', 'reintervention', 'was', 'performed', 'which', 'was', 'successful', 'in', '3', 'cases', 'In', '3', 'cases', 'of', 'primarily', 'technically', 'unsuccessful', 'procedures', 'reintervention', 'was', 'not', 'attempted', 'No', 'catheterisation', 'related', 'complications', 'were', 'recorded', 'Peri', 'interventional', 'mortality', 'was', '31', 'but', 'only', '2', 'of', 'these', 'patients', 'died', 'due', 'to', 'uncontrolled', 'massive', 'bleeding', 'whereas', 'the', 'lethal', 'outcome', 'in', 'the', 'other', '7', 'patients', 'was', 'due', 'to', 'their', 'underlying', 'diseases', 'CONCLUSION', 'Transcatheter', 'arterial', 'embolisation', 'is', 'an', 'effective', 'and', 'rapid', 'method', 'in', 'the', 'management', 'of', 'upper', 'gastrointestinal', 'bleeding', 'Radiological', 'endovascular', 'interventions', 'may', 'considerably', 'contribute', 'to', 'reduced', 'mortality', 'in', 'GI', 'bleeding', 'by', 'avoiding', 'a', 'potential', 'surgical', 'procedure', 'following', 'unsuccessful', 'endoscopic', 'treatment', 'The', 'study', 'underlines', 'the', 'importance', 'of', 'the', 'combination', 'of', 'interventional', 'endoscopy', 'with', 'interventional', 'radiology', 'in', 'secondary', 'care', 'hospitals', 'for', 'patient', 'outcome', 'in', 'complex', 'and', 'complicated', 'upper', 'gastrointestinal', 'bleeding', 'situations', '']"
62357,Biosensors as rapid diagnostic tests for tropical diseases.,2010,Critical reviews in clinical laboratory sciences,https://doi.org/10.3109/10408363.2010.518405; https://www.ncbi.nlm.nih.gov/pubmed/21155631/,"Effective diagnosis of infectious pathogens is essential for disease identification and subsequent adequate treatment, to prevent drug resistance and to adopt suitable public health interventions for the prevention and control of epidemic outbreaks. Particular situations under which medical diagnostics operate in tropical environments make the use of new easy-to-use diagnostic tools the preferred (or even unique) option. These diagnostic tests and devices, usually based on biosensing methods, are being increasingly exploited as promising alternatives to classical, ""heavy"" lab instrumentation for clinical diagnosis, allowing simple, inexpensive and point-of-care testing. However, in many developing countries the lack of accessibility and affordability for many commercial diagnostic tests remains a major cause of high disease burden in such regions. We present a comprehensive overview about the problems of conventional medical diagnosis of infectious pathologies in tropical regions, while pointing out new methods and analytical tools for in-the-field and decentralized diagnosis of current major infectious tropical diseases. The review includes not only biosensor-based rapid diagnostic tests approved by regulatory entities and already commercialized, but also those at the early stages of research.",10.3109/10408363.2010.518405,fn4526m0,"['Effective', 'diagnosis', 'of', 'infectious', 'pathogens', 'is', 'essential', 'for', 'disease', 'identification', 'and', 'subsequent', 'adequate', 'treatment', 'to', 'prevent', 'drug', 'resistance', 'and', 'to', 'adopt', 'suitable', 'public', 'health', 'interventions', 'for', 'the', 'prevention', 'and', 'control', 'of', 'epidemic', 'outbreaks', 'Particular', 'situations', 'under', 'which', 'medical', 'diagnostics', 'operate', 'in', 'tropical', 'environments', 'make', 'the', 'use', 'of', 'new', 'easy', 'to', 'use', 'diagnostic', 'tools', 'the', 'preferred', 'or', 'even', 'unique', 'option', 'These', 'diagnostic', 'tests', 'and', 'devices', 'usually', 'based', 'on', 'biosensing', 'methods', 'are', 'being', 'increasingly', 'exploited', 'as', 'promising', 'alternatives', 'to', 'classical', 'heavy', 'lab', 'instrumentation', 'for', 'clinical', 'diagnosis', 'allowing', 'simple', 'inexpensive', 'and', 'point', 'of', 'care', 'testing', 'However', 'in', 'many', 'developing', 'countries', 'the', 'lack', 'of', 'accessibility', 'and', 'affordability', 'for', 'many', 'commercial', 'diagnostic', 'tests', 'remains', 'a', 'major', 'cause', 'of', 'high', 'disease', 'burden', 'in', 'such', 'regions', 'We', 'present', 'a', 'comprehensive', 'overview', 'about', 'the', 'problems', 'of', 'conventional', 'medical', 'diagnosis', 'of', 'infectious', 'pathologies', 'in', 'tropical', 'regions', 'while', 'pointing', 'out', 'new', 'methods', 'and', 'analytical', 'tools', 'for', 'in', 'the', 'field', 'and', 'decentralized', 'diagnosis', 'of', 'current', 'major', 'infectious', 'tropical', 'diseases', 'The', 'review', 'includes', 'not', 'only', 'biosensor', 'based', 'rapid', 'diagnostic', 'tests', 'approved', 'by', 'regulatory', 'entities', 'and', 'already', 'commercialized', 'but', 'also', 'those', 'at', 'the', 'early', 'stages', 'of', 'research', '']"
62445,Dissociated Crossed Speech Areas in a Tumour Patient.,2017,Case reports in neurology,https://doi.org/10.1159/000475882; https://www.ncbi.nlm.nih.gov/pubmed/28626411/,"In the past, the eloquent areas could be deliberately localised by the invasive Wada test. The very rare cases of dissociated crossed speech areas were accidentally found based on the clinical symptomatology. Today functional magnetic resonance imaging (fMRI)-based imaging can be employed to non-invasively localise the eloquent areas in brain tumour patients for therapy planning. A 41-year-old, left-handed man with a low-grade glioma in the left frontal operculum extending to the insular cortex, tension headaches, and anomic aphasia over 5 months underwent a pre-operative speech area localisation fMRI measurement, which revealed the evidence of the transhemispheric disposition, where the dominant Wernicke speech area is located on the left and the Broca's area is strongly lateralised to the right hemisphere. The outcome of the Wada test and the intraoperative cortico-subcortical stimulation mapping were congruent with this finding. After tumour removal, language area function was fully preserved. Upon the occurrence of brain tumours with a risk of impaired speech function, the rare dissociate crossed speech areas disposition may gain a clinically relevant meaning by allowing for more extended tumour removal. Hence, for its identification, diagnostics which take into account both brain hemispheres, such as fMRI, are recommended.",10.1159/000475882,qsrdf03l,"['In', 'the', 'past', 'the', 'eloquent', 'areas', 'could', 'be', 'deliberately', 'localised', 'by', 'the', 'invasive', 'Wada', 'test', 'The', 'very', 'rare', 'cases', 'of', 'dissociated', 'crossed', 'speech', 'areas', 'were', 'accidentally', 'found', 'based', 'on', 'the', 'clinical', 'symptomatology', 'Today', 'functional', 'magnetic', 'resonance', 'imaging', 'fMRI', 'based', 'imaging', 'can', 'be', 'employed', 'to', 'non', 'invasively', 'localise', 'the', 'eloquent', 'areas', 'in', 'brain', 'tumour', 'patients', 'for', 'therapy', 'planning', 'A', '41', 'year', 'old', 'left', 'handed', 'man', 'with', 'a', 'low', 'grade', 'glioma', 'in', 'the', 'left', 'frontal', 'operculum', 'extending', 'to', 'the', 'insular', 'cortex', 'tension', 'headaches', 'and', 'anomic', 'aphasia', 'over', '5', 'months', 'underwent', 'a', 'pre', 'operative', 'speech', 'area', 'localisation', 'fMRI', 'measurement', 'which', 'revealed', 'the', 'evidence', 'of', 'the', 'transhemispheric', 'disposition', 'where', 'the', 'dominant', 'Wernicke', 'speech', 'area', 'is', 'located', 'on', 'the', 'left', 'and', 'the', 'Broca', 's', 'area', 'is', 'strongly', 'lateralised', 'to', 'the', 'right', 'hemisphere', 'The', 'outcome', 'of', 'the', 'Wada', 'test', 'and', 'the', 'intraoperative', 'cortico', 'subcortical', 'stimulation', 'mapping', 'were', 'congruent', 'with', 'this', 'finding', 'After', 'tumour', 'removal', 'language', 'area', 'function', 'was', 'fully', 'preserved', 'Upon', 'the', 'occurrence', 'of', 'brain', 'tumours', 'with', 'a', 'risk', 'of', 'impaired', 'speech', 'function', 'the', 'rare', 'dissociate', 'crossed', 'speech', 'areas', 'disposition', 'may', 'gain', 'a', 'clinically', 'relevant', 'meaning', 'by', 'allowing', 'for', 'more', 'extended', 'tumour', 'removal', 'Hence', 'for', 'its', 'identification', 'diagnostics', 'which', 'take', 'into', 'account', 'both', 'brain', 'hemispheres', 'such', 'as', 'fMRI', 'are', 'recommended', '']"
63597,Dynamic linkage of COVID-19 test results between Public Health England's Second Generation Surveillance System and UK Biobank.,2020-06-18,Microbial genomics,https://doi.org/10.1099/mgen.0.000397; https://www.ncbi.nlm.nih.gov/pubmed/32553051/,"UK Biobank (UKB) is an international health resource enabling research into the genetic and lifestyle determinants of common diseases of middle and older age. It comprises 500 000 participants. Public Health England's Second Generation Surveillance System is a centralized microbiology database covering English clinical diagnostics laboratories that provides national surveillance of legally notifiable infections, bacterial isolations and antimicrobial resistance. We previously developed secure, pseudonymized, individual-level linkage of these systems. In this study, we implemented rapid dynamic linkage, which allows us to provide a regular feed of new COVID-19 (SARS-CoV-2) test results to UKB to facilitate rapid and urgent research into the epidemiological and human genetic risk factors for severe infection in the cohort. Here, we have characterized the first 1352 cases of COVID-19 in UKB participants, of whom 895 met our working definition of severe COVID-19 as inpatients hospitalized on or after 16 March 2020. We found that the incidence of severe COVID-19 among UKB cases was 27.4 % lower than the general population in England, although this difference varied significantly by age and sex. The total number of UKB cases could be estimated as 0.6 % of the publicly announced number of cases in England. We considered how increasing case numbers will affect the power of genome-wide association studies. This new dynamic linkage system has further potential to facilitate the investigation of other infections and the prospective collection of microbiological cultures to create a microbiological biobank (bugbank) for studying the interaction of environment, human and microbial genetics on infection in the UKB cohort.",10.1099/mgen.0.000397,ctu3mrnw,"['UK', 'Biobank', 'UKB', 'is', 'an', 'international', 'health', 'resource', 'enabling', 'research', 'into', 'the', 'genetic', 'and', 'lifestyle', 'determinants', 'of', 'common', 'diseases', 'of', 'middle', 'and', 'older', 'age', 'It', 'comprises', '500', '000', 'participants', 'Public', 'Health', 'England', 's', 'Second', 'Generation', 'Surveillance', 'System', 'is', 'a', 'centralized', 'microbiology', 'database', 'covering', 'English', 'clinical', 'diagnostics', 'laboratories', 'that', 'provides', 'national', 'surveillance', 'of', 'legally', 'notifiable', 'infections', 'bacterial', 'isolations', 'and', 'antimicrobial', 'resistance', 'We', 'previously', 'developed', 'secure', 'pseudonymized', 'individual', 'level', 'linkage', 'of', 'these', 'systems', 'In', 'this', 'study', 'we', 'implemented', 'rapid', 'dynamic', 'linkage', 'which', 'allows', 'us', 'to', 'provide', 'a', 'regular', 'feed', 'of', 'new', 'COVID', '19', 'SARS', 'CoV', '2', 'test', 'results', 'to', 'UKB', 'to', 'facilitate', 'rapid', 'and', 'urgent', 'research', 'into', 'the', 'epidemiological', 'and', 'human', 'genetic', 'risk', 'factors', 'for', 'severe', 'infection', 'in', 'the', 'cohort', 'Here', 'we', 'have', 'characterized', 'the', 'first', '1352', 'cases', 'of', 'COVID', '19', 'in', 'UKB', 'participants', 'of', 'whom', '895', 'met', 'our', 'working', 'definition', 'of', 'severe', 'COVID', '19', 'as', 'inpatients', 'hospitalized', 'on', 'or', 'after', '16', 'March', '2020', 'We', 'found', 'that', 'the', 'incidence', 'of', 'severe', 'COVID', '19', 'among', 'UKB', 'cases', 'was', '27', '4', 'lower', 'than', 'the', 'general', 'population', 'in', 'England', 'although', 'this', 'difference', 'varied', 'significantly', 'by', 'age', 'and', 'sex', 'The', 'total', 'number', 'of', 'UKB', 'cases', 'could', 'be', 'estimated', 'as', '0', '6', 'of', 'the', 'publicly', 'announced', 'number', 'of', 'cases', 'in', 'England', 'We', 'considered', 'how', 'increasing', 'case', 'numbers', 'will', 'affect', 'the', 'power', 'of', 'genome', 'wide', 'association', 'studies', 'This', 'new', 'dynamic', 'linkage', 'system', 'has', 'further', 'potential', 'to', 'facilitate', 'the', 'investigation', 'of', 'other', 'infections', 'and', 'the', 'prospective', 'collection', 'of', 'microbiological', 'cultures', 'to', 'create', 'a', 'microbiological', 'biobank', 'bugbank', 'for', 'studying', 'the', 'interaction', 'of', 'environment', 'human', 'and', 'microbial', 'genetics', 'on', 'infection', 'in', 'the', 'UKB', 'cohort', '']"
63839,Turning the Page: Advancing Paper-Based Microfluidics for Broad Diagnostic Application.,2017,Chemical reviews,https://doi.org/10.1021/acs.chemrev.7b00024; https://www.ncbi.nlm.nih.gov/pubmed/28627178/,"Infectious diseases are a major global health issue. Diagnosis is a critical first step in effectively managing their spread. Paper-based microfluidic diagnostics first emerged in 2007 as a low-cost alternative to conventional laboratory testing, with the goal of improving accessibility to medical diagnostics in developing countries. In this review, we examine the advances in paper-based microfluidic diagnostics for medical diagnosis in the context of global health from 2007 to 2016. The theory of fluid transport in paper is first presented. The next section examines the strategies that have been employed to control fluid and analyte transport in paper-based assays. Tasks such as mixing, timing, and sequential fluid delivery have been achieved in paper and have enabled analytical capabilities comparable to those of conventional laboratory methods. The following section examines paper-based sample processing and analysis. The most impactful advancement here has been the translation of nucleic acid analysis to a paper-based format. Smartphone-based analysis is another exciting development with potential for wide dissemination. The last core section of the review highlights emerging health applications, such as male fertility testing and wearable diagnostics. We conclude the review with the future outlook, remaining challenges, and emerging opportunities.",10.1021/acs.chemrev.7b00024,u9rytelh,"['Infectious', 'diseases', 'are', 'a', 'major', 'global', 'health', 'issue', 'Diagnosis', 'is', 'a', 'critical', 'first', 'step', 'in', 'effectively', 'managing', 'their', 'spread', 'Paper', 'based', 'microfluidic', 'diagnostics', 'first', 'emerged', 'in', '2007', 'as', 'a', 'low', 'cost', 'alternative', 'to', 'conventional', 'laboratory', 'testing', 'with', 'the', 'goal', 'of', 'improving', 'accessibility', 'to', 'medical', 'diagnostics', 'in', 'developing', 'countries', 'In', 'this', 'review', 'we', 'examine', 'the', 'advances', 'in', 'paper', 'based', 'microfluidic', 'diagnostics', 'for', 'medical', 'diagnosis', 'in', 'the', 'context', 'of', 'global', 'health', 'from', '2007', 'to', '2016', 'The', 'theory', 'of', 'fluid', 'transport', 'in', 'paper', 'is', 'first', 'presented', 'The', 'next', 'section', 'examines', 'the', 'strategies', 'that', 'have', 'been', 'employed', 'to', 'control', 'fluid', 'and', 'analyte', 'transport', 'in', 'paper', 'based', 'assays', 'Tasks', 'such', 'as', 'mixing', 'timing', 'and', 'sequential', 'fluid', 'delivery', 'have', 'been', 'achieved', 'in', 'paper', 'and', 'have', 'enabled', 'analytical', 'capabilities', 'comparable', 'to', 'those', 'of', 'conventional', 'laboratory', 'methods', 'The', 'following', 'section', 'examines', 'paper', 'based', 'sample', 'processing', 'and', 'analysis', 'The', 'most', 'impactful', 'advancement', 'here', 'has', 'been', 'the', 'translation', 'of', 'nucleic', 'acid', 'analysis', 'to', 'a', 'paper', 'based', 'format', 'Smartphone', 'based', 'analysis', 'is', 'another', 'exciting', 'development', 'with', 'potential', 'for', 'wide', 'dissemination', 'The', 'last', 'core', 'section', 'of', 'the', 'review', 'highlights', 'emerging', 'health', 'applications', 'such', 'as', 'male', 'fertility', 'testing', 'and', 'wearable', 'diagnostics', 'We', 'conclude', 'the', 'review', 'with', 'the', 'future', 'outlook', 'remaining', 'challenges', 'and', 'emerging', 'opportunities', '']"
64423,The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors.,2012,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",https://doi.org/10.2967/jnumed.111.101675; https://www.ncbi.nlm.nih.gov/pubmed/22984220/,"UNLABELLED In patients with suspected but yet not localized neuroendocrine tumors (NETs), early diagnosis or reliable exclusion is crucial for optimal individual prognosis and therapy. Despite recourse to several imaging modalities, the definite diagnosis of NET can be challenging. Therefore, we tested (68)Ga-DOTATATE PET/CT as a tool for improved diagnosis in a cohort of patients with suspected, nonlocalized NET. METHODS (68)Ga-DOTATATE PET/CT recordings were obtained in 104 consecutive patients meeting at least one of the following criteria: clinical suspicion of NET (n = 70), elevated blood levels of tumor markers (n = 49), and image-based suspicion of NET (n = 53). The presence of NET was validated by histopathology (n = 49) or clinical follow-up of 107 ± 59 wk (n = 55). RESULTS In 36 of 104 patients (35%), NET was histologically verified, most frequently located in the small bowel (10/36), pancreas (8/36), lung (5/36), and stomach (2/36). Twelve patients had tumors of nonneuroendocrine origin, and 7 patients had benign tumors. (68)Ga-DOTATATE PET/CT identified NET in 29 of the 36 cases and excluded the presence of a NET in 61 of the 68 non-NET patients, indicating a sensitivity of 81% and specificity of 90%. The PET/CT gave a false-positive result in 7 patients and a false-negative in another 7 patients, indicating positive and negative predictive values of 81% and 90%, respectively, and an accuracy of 87%. Chromogranin A levels were significantly higher in both PET-positive patients (1,841 vs. 342 ng/mL; P < 0.05) and patients with verified NET (2,214 vs. 524 ng/mL; P < 0.05). CONCLUSION In patients with suspected NETs due to clinical symptoms, elevated levels of tumor markers, or indeterminate tumors suggestive of NET, (68)Ga-DOTATATE PET/CT is highly accurate, thus supporting its use in clinical routine diagnostics.",10.2967/jnumed.111.101675,q48fa7av,"['UNLABELLED', 'In', 'patients', 'with', 'suspected', 'but', 'yet', 'not', 'localized', 'neuroendocrine', 'tumors', 'NETs', 'early', 'diagnosis', 'or', 'reliable', 'exclusion', 'is', 'crucial', 'for', 'optimal', 'individual', 'prognosis', 'and', 'therapy', 'Despite', 'recourse', 'to', 'several', 'imaging', 'modalities', 'the', 'definite', 'diagnosis', 'of', 'NET', 'can', 'be', 'challenging', 'Therefore', 'we', 'tested', '68', 'Ga', 'DOTATATE', 'PET', 'CT', 'as', 'a', 'tool', 'for', 'improved', 'diagnosis', 'in', 'a', 'cohort', 'of', 'patients', 'with', 'suspected', 'nonlocalized', 'NET', 'METHODS', '68', 'Ga', 'DOTATATE', 'PET', 'CT', 'recordings', 'were', 'obtained', 'in', '104', 'consecutive', 'patients', 'meeting', 'at', 'least', 'one', 'of', 'the', 'following', 'criteria', 'clinical', 'suspicion', 'of', 'NET', 'n', '70', 'elevated', 'blood', 'levels', 'of', 'tumor', 'markers', 'n', '49', 'and', 'image', 'based', 'suspicion', 'of', 'NET', 'n', '53', 'The', 'presence', 'of', 'NET', 'was', 'validated', 'by', 'histopathology', 'n', '49', 'or', 'clinical', 'follow', 'up', 'of', '107', '59', 'wk', 'n', '55', 'RESULTS', 'In', '36', 'of', '104', 'patients', '35', 'NET', 'was', 'histologically', 'verified', 'most', 'frequently', 'located', 'in', 'the', 'small', 'bowel', '10', '36', 'pancreas', '8', '36', 'lung', '5', '36', 'and', 'stomach', '2', '36', 'Twelve', 'patients', 'had', 'tumors', 'of', 'nonneuroendocrine', 'origin', 'and', '7', 'patients', 'had', 'benign', 'tumors', '68', 'Ga', 'DOTATATE', 'PET', 'CT', 'identified', 'NET', 'in', '29', 'of', 'the', '36', 'cases', 'and', 'excluded', 'the', 'presence', 'of', 'a', 'NET', 'in', '61', 'of', 'the', '68', 'non', 'NET', 'patients', 'indicating', 'a', 'sensitivity', 'of', '81', 'and', 'specificity', 'of', '90', 'The', 'PET', 'CT', 'gave', 'a', 'false', 'positive', 'result', 'in', '7', 'patients', 'and', 'a', 'false', 'negative', 'in', 'another', '7', 'patients', 'indicating', 'positive', 'and', 'negative', 'predictive', 'values', 'of', '81', 'and', '90', 'respectively', 'and', 'an', 'accuracy', 'of', '87', 'Chromogranin', 'A', 'levels', 'were', 'significantly', 'higher', 'in', 'both', 'PET', 'positive', 'patients', '1', '841', 'vs', '342', 'ng', 'mL', 'P', '0', '05', 'and', 'patients', 'with', 'verified', 'NET', '2', '214', 'vs', '524', 'ng', 'mL', 'P', '0', '05', 'CONCLUSION', 'In', 'patients', 'with', 'suspected', 'NETs', 'due', 'to', 'clinical', 'symptoms', 'elevated', 'levels', 'of', 'tumor', 'markers', 'or', 'indeterminate', 'tumors', 'suggestive', 'of', 'NET', '68', 'Ga', 'DOTATATE', 'PET', 'CT', 'is', 'highly', 'accurate', 'thus', 'supporting', 'its', 'use', 'in', 'clinical', 'routine', 'diagnostics', '']"
65800,Diagnostic strategies for healthcare-associated pneumonia.,2009,Seminars in respiratory and critical care medicine,https://doi.org/10.1055/s-0028-1119807; https://www.ncbi.nlm.nih.gov/pubmed/19199185/,"The first point of a good diagnostic strategy for healthcare-associated pneumonia (HCAP) is correct classification of patients with specific criteria, as suggested by the last American Thoracic Society/ Infectious Diseases Society of America (ATS/IDSA) guidelines. However, clinical practice and recent literature have suggested new risk factors for multidrug-resistant infection (MRI): the presence of permanent indwelling devices, prior antibiotic use in the last 3 months, chronic and advanced pulmonary diseases (chronic obstructive pulmonary disease, bronchiectasis, etc.), history of alcoholism, and immunosuppression. The clinical presentation in HCAP patients is often unusual (mild respiratory symptoms and frequent extrapulmonary manifestations) due to different factors: advanced age, neurological disorders, and multiple chronic comorbidities. Moreover, HCAP commonly presents a worse clinical course than community-acquired pneumonia, a prolonged length of stay, and a mortality rate close to hospital-acquired pneumonia. Chest radiography and routine laboratory markers (including C-reactive protein) are always needed for clinical evaluation and severity assessment. The clinical use of new biomarkers of infection and sepsis (procalcitonin, etc.) is currently being investigated. Extensive microbiological testing to overcome the high prevalence of MRI in HCAP, including urinary antigens for Legionella and Streptococcus pneumoniae; blood cultures; Gram staining and low respiratory tract secretions (sputum, tracheobronchial aspirate, fibrobronchial aspirate, protected specimen brush, bronchoalveolar lavage); and cultures for aerobic, anaerobic, mycobacterial, and fungal pathogens are recommended, whereas the indication for serology tests for respiratory viruses and atypical pathogens is low. By contrast, the new polymerase chain reaction-based techniques for the rapid identification (2 to 4 hours) of microbial pathogens in respiratory samples (nasopharyngeal swab, bronchoalveolar lavage) seem to be the most innovative future perspective in the diagnostics of HCAP.",10.1055/s-0028-1119807,oiwue2k5,"['The', 'first', 'point', 'of', 'a', 'good', 'diagnostic', 'strategy', 'for', 'healthcare', 'associated', 'pneumonia', 'HCAP', 'is', 'correct', 'classification', 'of', 'patients', 'with', 'specific', 'criteria', 'as', 'suggested', 'by', 'the', 'last', 'American', 'Thoracic', 'Society', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'ATS', 'IDSA', 'guidelines', 'However', 'clinical', 'practice', 'and', 'recent', 'literature', 'have', 'suggested', 'new', 'risk', 'factors', 'for', 'multidrug', 'resistant', 'infection', 'MRI', 'the', 'presence', 'of', 'permanent', 'indwelling', 'devices', 'prior', 'antibiotic', 'use', 'in', 'the', 'last', '3', 'months', 'chronic', 'and', 'advanced', 'pulmonary', 'diseases', 'chronic', 'obstructive', 'pulmonary', 'disease', 'bronchiectasis', 'etc', 'history', 'of', 'alcoholism', 'and', 'immunosuppression', 'The', 'clinical', 'presentation', 'in', 'HCAP', 'patients', 'is', 'often', 'unusual', 'mild', 'respiratory', 'symptoms', 'and', 'frequent', 'extrapulmonary', 'manifestations', 'due', 'to', 'different', 'factors', 'advanced', 'age', 'neurological', 'disorders', 'and', 'multiple', 'chronic', 'comorbidities', 'Moreover', 'HCAP', 'commonly', 'presents', 'a', 'worse', 'clinical', 'course', 'than', 'community', 'acquired', 'pneumonia', 'a', 'prolonged', 'length', 'of', 'stay', 'and', 'a', 'mortality', 'rate', 'close', 'to', 'hospital', 'acquired', 'pneumonia', 'Chest', 'radiography', 'and', 'routine', 'laboratory', 'markers', 'including', 'C', 'reactive', 'protein', 'are', 'always', 'needed', 'for', 'clinical', 'evaluation', 'and', 'severity', 'assessment', 'The', 'clinical', 'use', 'of', 'new', 'biomarkers', 'of', 'infection', 'and', 'sepsis', 'procalcitonin', 'etc', 'is', 'currently', 'being', 'investigated', 'Extensive', 'microbiological', 'testing', 'to', 'overcome', 'the', 'high', 'prevalence', 'of', 'MRI', 'in', 'HCAP', 'including', 'urinary', 'antigens', 'for', 'Legionella', 'and', 'Streptococcus', 'pneumoniae', 'blood', 'cultures', 'Gram', 'staining', 'and', 'low', 'respiratory', 'tract', 'secretions', 'sputum', 'tracheobronchial', 'aspirate', 'fibrobronchial', 'aspirate', 'protected', 'specimen', 'brush', 'bronchoalveolar', 'lavage', 'and', 'cultures', 'for', 'aerobic', 'anaerobic', 'mycobacterial', 'and', 'fungal', 'pathogens', 'are', 'recommended', 'whereas', 'the', 'indication', 'for', 'serology', 'tests', 'for', 'respiratory', 'viruses', 'and', 'atypical', 'pathogens', 'is', 'low', 'By', 'contrast', 'the', 'new', 'polymerase', 'chain', 'reaction', 'based', 'techniques', 'for', 'the', 'rapid', 'identification', '2', 'to', '4', 'hours', 'of', 'microbial', 'pathogens', 'in', 'respiratory', 'samples', 'nasopharyngeal', 'swab', 'bronchoalveolar', 'lavage', 'seem', 'to', 'be', 'the', 'most', 'innovative', 'future', 'perspective', 'in', 'the', 'diagnostics', 'of', 'HCAP', '']"
66038,Detection of Emerging Zoonotic Pathogens: An Integrated One Health Approach.,2018,Annual review of animal biosciences,https://doi.org/10.1146/annurev-animal-030117-014628; https://www.ncbi.nlm.nih.gov/pubmed/29144769/,"The emergence of novel zoonotic pathogens is one of the greatest challenges to global health security. The advent of increasingly sophisticated diagnostics tools has revolutionized our capacity to detect and respond to these health threats more rapidly than ever before. Yet, no matter how sophisticated these tools become, the initial identification of emerging infectious diseases begins at the local community level. It is here that the initial human or animal case resides, and it is here that early pathogen detection would have maximum benefit. Unfortunately, many areas at highest risk of zoonotic disease emergence lack sufficient infrastructure capacity to support robust laboratory diagnostic systems. Multiple factors are essential for pathogen detection networks, including an understanding of the complex sociological and ecological factors influencing disease transmission risk, community engagement, surveillance along high-risk human-animal interfaces, and a skilled laboratory workforce. Here we discuss factors relevant to the emerging disease paradigm, recent technical advances in diagnostic methods, and strategies for comprehensive and sustainable approaches to rapid zoonotic disease detection.",10.1146/annurev-animal-030117-014628,rgizxuad,"['The', 'emergence', 'of', 'novel', 'zoonotic', 'pathogens', 'is', 'one', 'of', 'the', 'greatest', 'challenges', 'to', 'global', 'health', 'security', 'The', 'advent', 'of', 'increasingly', 'sophisticated', 'diagnostics', 'tools', 'has', 'revolutionized', 'our', 'capacity', 'to', 'detect', 'and', 'respond', 'to', 'these', 'health', 'threats', 'more', 'rapidly', 'than', 'ever', 'before', 'Yet', 'no', 'matter', 'how', 'sophisticated', 'these', 'tools', 'become', 'the', 'initial', 'identification', 'of', 'emerging', 'infectious', 'diseases', 'begins', 'at', 'the', 'local', 'community', 'level', 'It', 'is', 'here', 'that', 'the', 'initial', 'human', 'or', 'animal', 'case', 'resides', 'and', 'it', 'is', 'here', 'that', 'early', 'pathogen', 'detection', 'would', 'have', 'maximum', 'benefit', 'Unfortunately', 'many', 'areas', 'at', 'highest', 'risk', 'of', 'zoonotic', 'disease', 'emergence', 'lack', 'sufficient', 'infrastructure', 'capacity', 'to', 'support', 'robust', 'laboratory', 'diagnostic', 'systems', 'Multiple', 'factors', 'are', 'essential', 'for', 'pathogen', 'detection', 'networks', 'including', 'an', 'understanding', 'of', 'the', 'complex', 'sociological', 'and', 'ecological', 'factors', 'influencing', 'disease', 'transmission', 'risk', 'community', 'engagement', 'surveillance', 'along', 'high', 'risk', 'human', 'animal', 'interfaces', 'and', 'a', 'skilled', 'laboratory', 'workforce', 'Here', 'we', 'discuss', 'factors', 'relevant', 'to', 'the', 'emerging', 'disease', 'paradigm', 'recent', 'technical', 'advances', 'in', 'diagnostic', 'methods', 'and', 'strategies', 'for', 'comprehensive', 'and', 'sustainable', 'approaches', 'to', 'rapid', 'zoonotic', 'disease', 'detection', '']"
67112,Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection.,2017,Archives of pathology & laboratory medicine,https://doi.org/10.5858/arpa.2016-0539-ra; https://www.ncbi.nlm.nih.gov/pubmed/28169558/,"CONTEXT - Metagenomic sequencing can be used for detection of any pathogens using unbiased, shotgun next-generation sequencing (NGS), without the need for sequence-specific amplification. Proof-of-concept has been demonstrated in infectious disease outbreaks of unknown causes and in patients with suspected infections but negative results for conventional tests. Metagenomic NGS tests hold great promise to improve infectious disease diagnostics, especially in immunocompromised and critically ill patients. OBJECTIVE - To discuss challenges and provide example solutions for validating metagenomic pathogen detection tests in clinical laboratories. A summary of current regulatory requirements, largely based on prior guidance for NGS testing in constitutional genetics and oncology, is provided. DATA SOURCES - Examples from 2 separate validation studies are provided for steps from assay design, and validation of wet bench and bioinformatics protocols, to quality control and assurance. CONCLUSIONS - Although laboratory and data analysis workflows are still complex, metagenomic NGS tests for infectious diseases are increasingly being validated in clinical laboratories. Many parallels exist to NGS tests in other fields. Nevertheless, specimen preparation, rapidly evolving data analysis algorithms, and incomplete reference sequence databases are idiosyncratic to the field of microbiology and often overlooked.",10.5858/arpa.2016-0539-ra,2h0zyugc,"['CONTEXT', 'Metagenomic', 'sequencing', 'can', 'be', 'used', 'for', 'detection', 'of', 'any', 'pathogens', 'using', 'unbiased', 'shotgun', 'next', 'generation', 'sequencing', 'NGS', 'without', 'the', 'need', 'for', 'sequence', 'specific', 'amplification', 'Proof', 'of', 'concept', 'has', 'been', 'demonstrated', 'in', 'infectious', 'disease', 'outbreaks', 'of', 'unknown', 'causes', 'and', 'in', 'patients', 'with', 'suspected', 'infections', 'but', 'negative', 'results', 'for', 'conventional', 'tests', 'Metagenomic', 'NGS', 'tests', 'hold', 'great', 'promise', 'to', 'improve', 'infectious', 'disease', 'diagnostics', 'especially', 'in', 'immunocompromised', 'and', 'critically', 'ill', 'patients', 'OBJECTIVE', 'To', 'discuss', 'challenges', 'and', 'provide', 'example', 'solutions', 'for', 'validating', 'metagenomic', 'pathogen', 'detection', 'tests', 'in', 'clinical', 'laboratories', 'A', 'summary', 'of', 'current', 'regulatory', 'requirements', 'largely', 'based', 'on', 'prior', 'guidance', 'for', 'NGS', 'testing', 'in', 'constitutional', 'genetics', 'and', 'oncology', 'is', 'provided', 'DATA', 'SOURCES', 'Examples', 'from', '2', 'separate', 'validation', 'studies', 'are', 'provided', 'for', 'steps', 'from', 'assay', 'design', 'and', 'validation', 'of', 'wet', 'bench', 'and', 'bioinformatics', 'protocols', 'to', 'quality', 'control', 'and', 'assurance', 'CONCLUSIONS', 'Although', 'laboratory', 'and', 'data', 'analysis', 'workflows', 'are', 'still', 'complex', 'metagenomic', 'NGS', 'tests', 'for', 'infectious', 'diseases', 'are', 'increasingly', 'being', 'validated', 'in', 'clinical', 'laboratories', 'Many', 'parallels', 'exist', 'to', 'NGS', 'tests', 'in', 'other', 'fields', 'Nevertheless', 'specimen', 'preparation', 'rapidly', 'evolving', 'data', 'analysis', 'algorithms', 'and', 'incomplete', 'reference', 'sequence', 'databases', 'are', 'idiosyncratic', 'to', 'the', 'field', 'of', 'microbiology', 'and', 'often', 'overlooked', '']"
68057,Laboratory methods for determining pneumonia etiology in children.,2012,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,https://doi.org/10.1093/cid/cir1073; https://www.ncbi.nlm.nih.gov/pubmed/22403229/,"Laboratory diagnostics are a core component of any pneumonia etiology study. Recent advances in diagnostic technology have introduced newer methods that have greatly improved the ability to identify respiratory pathogens. However, determining the microbial etiology of pneumonia remains a challenge, especially in children. This is largely because of the inconsistent use of assays between studies, difficulties in specimen collection, and problems in interpreting the presence of pathogens as being causally related to the pneumonia event. The laboratory testing strategy for the Pneumonia Etiology Research for Child Health (PERCH) study aims to incorporate a broad range of diagnostic testing that will be standardized across the 7 participating sites. We describe the current status of laboratory diagnostics for pneumonia and the PERCH approach for specimen testing. Pneumonia diagnostics are evolving, and it is also a priority of PERCH to collect and archive specimens for future testing by promising diagnostic methods that are currently under development.",10.1093/cid/cir1073,n76k4nuh,"['Laboratory', 'diagnostics', 'are', 'a', 'core', 'component', 'of', 'any', 'pneumonia', 'etiology', 'study', 'Recent', 'advances', 'in', 'diagnostic', 'technology', 'have', 'introduced', 'newer', 'methods', 'that', 'have', 'greatly', 'improved', 'the', 'ability', 'to', 'identify', 'respiratory', 'pathogens', 'However', 'determining', 'the', 'microbial', 'etiology', 'of', 'pneumonia', 'remains', 'a', 'challenge', 'especially', 'in', 'children', 'This', 'is', 'largely', 'because', 'of', 'the', 'inconsistent', 'use', 'of', 'assays', 'between', 'studies', 'difficulties', 'in', 'specimen', 'collection', 'and', 'problems', 'in', 'interpreting', 'the', 'presence', 'of', 'pathogens', 'as', 'being', 'causally', 'related', 'to', 'the', 'pneumonia', 'event', 'The', 'laboratory', 'testing', 'strategy', 'for', 'the', 'Pneumonia', 'Etiology', 'Research', 'for', 'Child', 'Health', 'PERCH', 'study', 'aims', 'to', 'incorporate', 'a', 'broad', 'range', 'of', 'diagnostic', 'testing', 'that', 'will', 'be', 'standardized', 'across', 'the', '7', 'participating', 'sites', 'We', 'describe', 'the', 'current', 'status', 'of', 'laboratory', 'diagnostics', 'for', 'pneumonia', 'and', 'the', 'PERCH', 'approach', 'for', 'specimen', 'testing', 'Pneumonia', 'diagnostics', 'are', 'evolving', 'and', 'it', 'is', 'also', 'a', 'priority', 'of', 'PERCH', 'to', 'collect', 'and', 'archive', 'specimens', 'for', 'future', 'testing', 'by', 'promising', 'diagnostic', 'methods', 'that', 'are', 'currently', 'under', 'development', '']"
68762,Evaluation and clinical validation of an alcohol-based transport medium for preservation and inactivation of respiratory viruses.,2011,Journal of clinical microbiology,https://doi.org/10.1128/jcm.00327-11; https://www.ncbi.nlm.nih.gov/pubmed/21508158/,"The clinical and public health importance of influenza and other respiratory viruses has accelerated the development of highly sensitive molecular diagnostics, but data are limited regarding preanalytical stages of diagnostic testing. We evaluated CyMol, an alcohol-based transport medium, for its ability to maintain specimen integrity for up to 21 days of storage at various temperatures; for its ability to inactivate virus; and for its compatibility with antigen- or nucleic acid-based diagnostics for respiratory viruses in clinical samples. In mock-infected samples, both universal transport medium (UTM-RT) and CyMol maintained equivalent viral quantities for at least 14 days at room temperature or colder, whereas a dry swab collection maintained viral quantities only if refrigerated or frozen. CyMol inactivated influenza virus within 5 min of sample immersion. UTM-RT- and CyMol-collected nasal swab specimens from 73 symptomatic students attending a campus health clinic were positive for a respiratory virus in 56.2% of subjects by multiplex PCR testing, including influenza A and B viruses, rhinovirus/enteroviruses, coronaviruses, respiratory syncytial virus, parainfluenza viruses, metapneumovirus, and adenovirus. Detection by PCR was equivalent in UTM-RT- and CyMol-collected specimens and in self- and staff-collected swabs. Direct fluorescent antibody (DFA) testing was substantially less sensitive (23.3%) than multiplex PCR, and DFA testing from UTM-RT-collected swabs was more sensitive than that from CyMol-collected swabs. These data indicate that an alcohol-based transport medium such as CyMol preserves respiratory virus integrity, rapidly inactivates viruses, and is compatible with PCR-based respiratory diagnostics.",10.1128/jcm.00327-11,4cgs2kp5,"['The', 'clinical', 'and', 'public', 'health', 'importance', 'of', 'influenza', 'and', 'other', 'respiratory', 'viruses', 'has', 'accelerated', 'the', 'development', 'of', 'highly', 'sensitive', 'molecular', 'diagnostics', 'but', 'data', 'are', 'limited', 'regarding', 'preanalytical', 'stages', 'of', 'diagnostic', 'testing', 'We', 'evaluated', 'CyMol', 'an', 'alcohol', 'based', 'transport', 'medium', 'for', 'its', 'ability', 'to', 'maintain', 'specimen', 'integrity', 'for', 'up', 'to', '21', 'days', 'of', 'storage', 'at', 'various', 'temperatures', 'for', 'its', 'ability', 'to', 'inactivate', 'virus', 'and', 'for', 'its', 'compatibility', 'with', 'antigen', 'or', 'nucleic', 'acid', 'based', 'diagnostics', 'for', 'respiratory', 'viruses', 'in', 'clinical', 'samples', 'In', 'mock', 'infected', 'samples', 'both', 'universal', 'transport', 'medium', 'UTM', 'RT', 'and', 'CyMol', 'maintained', 'equivalent', 'viral', 'quantities', 'for', 'at', 'least', '14', 'days', 'at', 'room', 'temperature', 'or', 'colder', 'whereas', 'a', 'dry', 'swab', 'collection', 'maintained', 'viral', 'quantities', 'only', 'if', 'refrigerated', 'or', 'frozen', 'CyMol', 'inactivated', 'influenza', 'virus', 'within', '5', 'min', 'of', 'sample', 'immersion', 'UTM', 'RT', 'and', 'CyMol', 'collected', 'nasal', 'swab', 'specimens', 'from', '73', 'symptomatic', 'students', 'attending', 'a', 'campus', 'health', 'clinic', 'were', 'positive', 'for', 'a', 'respiratory', 'virus', 'in', '56', '2', 'of', 'subjects', 'by', 'multiplex', 'PCR', 'testing', 'including', 'influenza', 'A', 'and', 'B', 'viruses', 'rhinovirus', 'enteroviruses', 'coronaviruses', 'respiratory', 'syncytial', 'virus', 'parainfluenza', 'viruses', 'metapneumovirus', 'and', 'adenovirus', 'Detection', 'by', 'PCR', 'was', 'equivalent', 'in', 'UTM', 'RT', 'and', 'CyMol', 'collected', 'specimens', 'and', 'in', 'self', 'and', 'staff', 'collected', 'swabs', 'Direct', 'fluorescent', 'antibody', 'DFA', 'testing', 'was', 'substantially', 'less', 'sensitive', '23', '3', 'than', 'multiplex', 'PCR', 'and', 'DFA', 'testing', 'from', 'UTM', 'RT', 'collected', 'swabs', 'was', 'more', 'sensitive', 'than', 'that', 'from', 'CyMol', 'collected', 'swabs', 'These', 'data', 'indicate', 'that', 'an', 'alcohol', 'based', 'transport', 'medium', 'such', 'as', 'CyMol', 'preserves', 'respiratory', 'virus', 'integrity', 'rapidly', 'inactivates', 'viruses', 'and', 'is', 'compatible', 'with', 'PCR', 'based', 'respiratory', 'diagnostics', '']"
69232,Coagulation pattern in critical liver dysfunction.,2013,Current opinion in critical care,https://doi.org/10.1097/mcc.0b013e32835ebb52; https://www.ncbi.nlm.nih.gov/pubmed/23400090/,"PURPOSE OF REVIEW This article reviews the current literature dealing with pathophysiology, diagnostics, bleeding management, and thromboprophylaxis in patients with acute and chronic liver dysfunction. RECENT FINDINGS Routine coagulation tests such as prothrombin time and International Normalized Ratio (INR) are not able to define whether a patient with critical liver dysfunction is hypocoagulable or hypercoagulable and are not able to predict the risk of bleeding in patients with liver dysfunction. Therefore, prophylactic transfusion of fresh frozen plasma and platelets in order to correct laboratory values is not appropriate. Notably, patients with liver dysfunction and increased INR are not 'autoanticoagulated'. In contrast, thrombin generation assays in the presence and absence of thrombomodulin or Protac, a snake venom that activates protein C in a manner similar to thrombomodulin, as well as viscoelastic tests (thrombelastography/thromboelastometry) indicate that patients with liver dysfunction are rather hypercoagulable with the inherent risk of thrombosis. SUMMARY Coagulopathy in patients with critical liver dysfunction is complex and can quickly decompensate to bleeding as well as to thrombosis. Both are associated with worse outcome. Hemostatic interventions should only be performed in case of clinically relevant bleeding and thromboprophylaxis should strongly be considered.",10.1097/mcc.0b013e32835ebb52,tu7hex29,"['PURPOSE', 'OF', 'REVIEW', 'This', 'article', 'reviews', 'the', 'current', 'literature', 'dealing', 'with', 'pathophysiology', 'diagnostics', 'bleeding', 'management', 'and', 'thromboprophylaxis', 'in', 'patients', 'with', 'acute', 'and', 'chronic', 'liver', 'dysfunction', 'RECENT', 'FINDINGS', 'Routine', 'coagulation', 'tests', 'such', 'as', 'prothrombin', 'time', 'and', 'International', 'Normalized', 'Ratio', 'INR', 'are', 'not', 'able', 'to', 'define', 'whether', 'a', 'patient', 'with', 'critical', 'liver', 'dysfunction', 'is', 'hypocoagulable', 'or', 'hypercoagulable', 'and', 'are', 'not', 'able', 'to', 'predict', 'the', 'risk', 'of', 'bleeding', 'in', 'patients', 'with', 'liver', 'dysfunction', 'Therefore', 'prophylactic', 'transfusion', 'of', 'fresh', 'frozen', 'plasma', 'and', 'platelets', 'in', 'order', 'to', 'correct', 'laboratory', 'values', 'is', 'not', 'appropriate', 'Notably', 'patients', 'with', 'liver', 'dysfunction', 'and', 'increased', 'INR', 'are', 'not', 'autoanticoagulated', 'In', 'contrast', 'thrombin', 'generation', 'assays', 'in', 'the', 'presence', 'and', 'absence', 'of', 'thrombomodulin', 'or', 'Protac', 'a', 'snake', 'venom', 'that', 'activates', 'protein', 'C', 'in', 'a', 'manner', 'similar', 'to', 'thrombomodulin', 'as', 'well', 'as', 'viscoelastic', 'tests', 'thrombelastography', 'thromboelastometry', 'indicate', 'that', 'patients', 'with', 'liver', 'dysfunction', 'are', 'rather', 'hypercoagulable', 'with', 'the', 'inherent', 'risk', 'of', 'thrombosis', 'SUMMARY', 'Coagulopathy', 'in', 'patients', 'with', 'critical', 'liver', 'dysfunction', 'is', 'complex', 'and', 'can', 'quickly', 'decompensate', 'to', 'bleeding', 'as', 'well', 'as', 'to', 'thrombosis', 'Both', 'are', 'associated', 'with', 'worse', 'outcome', 'Hemostatic', 'interventions', 'should', 'only', 'be', 'performed', 'in', 'case', 'of', 'clinically', 'relevant', 'bleeding', 'and', 'thromboprophylaxis', 'should', 'strongly', 'be', 'considered', '']"
70300,Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe.,2005,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,https://doi.org/10.2807/esm.10.06.00545-en; https://www.ncbi.nlm.nih.gov/pubmed/29183474/,"The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of ""Imported"" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. A public website is available at http://www.enivd.de.",10.2807/esm.10.06.00545-en,v9qrsy9n,"['The', 'threat', 'posed', 'by', 'emerging', 'and', 're', 'emerging', 'communicable', 'diseases', 'and', 'more', 'recently', 'by', 'the', 'intentional', 'release', 'of', 'infectious', 'agents', 'in', 'a', 'susceptible', 'population', 'has', 'been', 'receiving', 'considerable', 'attention', 'at', 'the', 'national', 'and', 'international', 'levels', 'Public', 'health', 'efforts', 'to', 'strengthen', 'disease', 'detection', 'surveillance', 'and', 'control', 'have', 'been', 'intensified', 'However', 'clinicians', 'and', 'clinical', 'microbiology', 'laboratories', 'play', 'an', 'important', 'role', 'in', 'the', 'early', 'detection', 'of', 'disease', 'the', 'identification', 'of', 'the', 'putative', 'agent', 'and', 'notification', 'of', 'the', 'appropriate', 'authorities', 'To', 'be', 'effective', 'in', 'this', 'role', 'laboratories', 'must', 'be', 'specially', 'prepared', 'to', 'handle', 'viral', 'agents', 'safely', 'and', 'need', 'among', 'other', 'things', 'the', 'appropriate', 'rapid', 'and', 'sensitive', 'diagnostic', 'tests', 'In', '1998', 'the', 'European', 'Network', 'for', 'Diagnostics', 'of', 'Imported', 'Viral', 'Diseases', 'ENIVD', 'was', 'established', 'ENIVD', 'presently', 'comprises', 'as', 'permanent', 'members', '44', 'expert', 'laboratories', 'in', '21', 'European', 'Union', 'EU', 'member', 'states', 'and', '4', 'non', 'EU', 'countries', 'and', 'is', 'one', 'of', 'the', 'networks', 'on', 'infectious', 'diseases', 'funded', 'by', 'the', 'European', 'Commission', 'ENIVD', 'fulfils', 'many', 'of', 'the', 'important', 'tasks', 'required', 'for', 'the', 'surveillance', 'and', 'control', 'of', 'imported', 'rare', 'and', 'emerging', 'viral', 'infections', 'such', 'as', 'the', 'exchange', 'of', 'expertise', 'and', 'the', 'organisation', 'of', 'external', 'quality', 'assurance', 'EQA', 'programmes', 'both', 'of', 'which', 'are', 'needed', 'to', 'improve', 'diagnostics', 'Here', 'we', 'summarise', 'the', 'data', 'generated', 'by', 'recent', 'EQA', 'activities', 'focussed', 'on', 'the', 'diagnostics', 'of', 'infections', 'with', 'hantavirus', 'dengue', 'virus', 'filovirus', 'Lassa', 'virus', 'orthopox', 'virus', 'and', 'the', 'SARS', 'coronavirus', 'SARS', 'CoV', 'These', 'were', 'carried', 'out', 'between', '1999', 'and', '2004', 'and', 'involved', '93', 'laboratories', 'from', '41', 'countries', 'including', 'laboratories', 'from', 'additional', 'countries', 'outside', 'of', 'Europe', 'Particularly', 'the', 'EU', 'candidate', 'countries', 'and', 'Eastern', 'neighbouring', 'countries', 'will', 'be', 'invited', 'to', 'join', 'the', 'network', 'in', 'the', 'near', 'future', 'A', 'public', 'website', 'is', 'available', 'at', 'http', 'www', 'enivd', 'de', '']"
70782,Development and Applications of Portable Biosensors.,2015,Journal of laboratory automation,https://doi.org/10.1177/2211068215581349; https://www.ncbi.nlm.nih.gov/pubmed/25878051/,"The significance of microfluidics-based and microelectromechanical systems-based biosensors has been widely acknowledged, and many reviews have explored their potential applications in clinical diagnostics, personalized medicine, global health, drug discovery, food safety, and forensics. Because health care costs are increasing, there is an increasing need to remotely monitor the health condition of patients by point-of-care-testing. The demand for biosensors for detection of biological warfare agents has increased, and research is focused on ways of producing small portable devices that would allow fast, accurate, and on-site detection. In the past decade, the demand for rapid and accurate on-site detection of plant disease diagnosis has increased due to emerging pathogens with resistance to pesticides, increased human mobility, and regulations limiting the application of toxic chemicals to prevent spread of diseases. The portability of biosensors for on-site diagnosis is limited due to various issues, including sample preparation techniques, fluid-handling techniques, the limited lifetime of biological reagents, device packaging, integrating electronics for data collection/analysis, and the requirement of external accessories and power. Many microfluidic, electronic, and biological design strategies, such as handling liquids in biosensors without pumps/valves, the application of droplet-based microfluidics, paper-based microfluidic devices, and wireless networking capabilities for data transmission, are being explored.",10.1177/2211068215581349,x4aexpbe,"['The', 'significance', 'of', 'microfluidics', 'based', 'and', 'microelectromechanical', 'systems', 'based', 'biosensors', 'has', 'been', 'widely', 'acknowledged', 'and', 'many', 'reviews', 'have', 'explored', 'their', 'potential', 'applications', 'in', 'clinical', 'diagnostics', 'personalized', 'medicine', 'global', 'health', 'drug', 'discovery', 'food', 'safety', 'and', 'forensics', 'Because', 'health', 'care', 'costs', 'are', 'increasing', 'there', 'is', 'an', 'increasing', 'need', 'to', 'remotely', 'monitor', 'the', 'health', 'condition', 'of', 'patients', 'by', 'point', 'of', 'care', 'testing', 'The', 'demand', 'for', 'biosensors', 'for', 'detection', 'of', 'biological', 'warfare', 'agents', 'has', 'increased', 'and', 'research', 'is', 'focused', 'on', 'ways', 'of', 'producing', 'small', 'portable', 'devices', 'that', 'would', 'allow', 'fast', 'accurate', 'and', 'on', 'site', 'detection', 'In', 'the', 'past', 'decade', 'the', 'demand', 'for', 'rapid', 'and', 'accurate', 'on', 'site', 'detection', 'of', 'plant', 'disease', 'diagnosis', 'has', 'increased', 'due', 'to', 'emerging', 'pathogens', 'with', 'resistance', 'to', 'pesticides', 'increased', 'human', 'mobility', 'and', 'regulations', 'limiting', 'the', 'application', 'of', 'toxic', 'chemicals', 'to', 'prevent', 'spread', 'of', 'diseases', 'The', 'portability', 'of', 'biosensors', 'for', 'on', 'site', 'diagnosis', 'is', 'limited', 'due', 'to', 'various', 'issues', 'including', 'sample', 'preparation', 'techniques', 'fluid', 'handling', 'techniques', 'the', 'limited', 'lifetime', 'of', 'biological', 'reagents', 'device', 'packaging', 'integrating', 'electronics', 'for', 'data', 'collection', 'analysis', 'and', 'the', 'requirement', 'of', 'external', 'accessories', 'and', 'power', 'Many', 'microfluidic', 'electronic', 'and', 'biological', 'design', 'strategies', 'such', 'as', 'handling', 'liquids', 'in', 'biosensors', 'without', 'pumps', 'valves', 'the', 'application', 'of', 'droplet', 'based', 'microfluidics', 'paper', 'based', 'microfluidic', 'devices', 'and', 'wireless', 'networking', 'capabilities', 'for', 'data', 'transmission', 'are', 'being', 'explored', '']"
71368,Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan,2020-07-11,,http://medrxiv.org/cgi/content/short/2020.07.10.20150904v1?rss=1,"Serological tests for SARS-CoV-2 coronavirus in pre-COVID-19 samples in Japan showed 1.5%-1.75% positives, and previous surveys might overestimate COVID-19 seroprevalence in several population of Japan. These false negatives could be excluded by combination of different diagnostics to 0.25%.",10.1101/2020.07.10.20150904,hkvh2lc9,"['Serological', 'tests', 'for', 'SARS', 'CoV', '2', 'coronavirus', 'in', 'pre', 'COVID', '19', 'samples', 'in', 'Japan', 'showed', '1', '5', '1', '75', 'positives', 'and', 'previous', 'surveys', 'might', 'overestimate', 'COVID', '19', 'seroprevalence', 'in', 'several', 'population', 'of', 'Japan', 'These', 'false', 'negatives', 'could', 'be', 'excluded', 'by', 'combination', 'of', 'different', 'diagnostics', 'to', '0', '25', '']"
71608,Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays,2020-04-20,,https://doi.org/10.1101/2020.04.15.20066407,"Background: The SARS-CoV-2 pandemic caused >1 million infections during January-March 2020. There is an urgent need for robust antibody detection approaches to support diagnostics, vaccine development, safe individual release from quarantine and population lock-down exit strategies. The early promise of lateral flow immunoassay (LFIA) devices has been questioned following concerns about sensitivity and specificity. Methods: We used a panel of plasma samples designated SARS-CoV-2 positive (from SARS-CoV-2 RT-PCR-positive individuals; n=40) and negative (samples banked in the UK prior to December-2019 (n=142)). We tested plasma for SARS-Cov-2 IgM and IgG antibodies by ELISA and using nine different commercially available LFIA devices. Results: ELISA detected SARS-CoV-2 IgM or IgG in 34/40 individuals with an RT-PCR-confirmed diagnosis of SARS-CoV-2 infection (sensitivity 85%, 95%CI 70-94%), vs 0/50 pre-pandemic controls (specificity 100% [95%CI 93-100%]). IgG levels were detected in 31/31 RT-PCR-positive individuals tested ≥10 days after symptom onset (sensitivity 100%, 95%CI 89-100%). IgG titres rose during the 3 weeks post symptom onset and began to fall by 8 weeks, but remained above the detection threshold. Point estimates for the sensitivity of LFIA devices ranged from 55-70% versus RT-PCR and 65-85% versus ELISA, with specificity 95-100% and 93-100% respectively. Within the limits of the study size, the performance of most LFIA devices was similar. Conclusions: The performance of current LFIA devices is inadequate for most individual patient applications. ELISA can be calibrated to be specific for detecting and quantifying SARS-CoV-2 IgM and IgG and is highly sensitive for IgG from 10 days following symptoms onset.",10.1101/2020.04.15.20066407,5trox1i5,"['Background', 'The', 'SARS', 'CoV', '2', 'pandemic', 'caused', '1', 'million', 'infections', 'during', 'January', 'March', '2020', 'There', 'is', 'an', 'urgent', 'need', 'for', 'robust', 'antibody', 'detection', 'approaches', 'to', 'support', 'diagnostics', 'vaccine', 'development', 'safe', 'individual', 'release', 'from', 'quarantine', 'and', 'population', 'lock', 'down', 'exit', 'strategies', 'The', 'early', 'promise', 'of', 'lateral', 'flow', 'immunoassay', 'LFIA', 'devices', 'has', 'been', 'questioned', 'following', 'concerns', 'about', 'sensitivity', 'and', 'specificity', 'Methods', 'We', 'used', 'a', 'panel', 'of', 'plasma', 'samples', 'designated', 'SARS', 'CoV', '2', 'positive', 'from', 'SARS', 'CoV', '2', 'RT', 'PCR', 'positive', 'individuals', 'n', '40', 'and', 'negative', 'samples', 'banked', 'in', 'the', 'UK', 'prior', 'to', 'December', '2019', 'n', '142', 'We', 'tested', 'plasma', 'for', 'SARS', 'Cov', '2', 'IgM', 'and', 'IgG', 'antibodies', 'by', 'ELISA', 'and', 'using', 'nine', 'different', 'commercially', 'available', 'LFIA', 'devices', 'Results', 'ELISA', 'detected', 'SARS', 'CoV', '2', 'IgM', 'or', 'IgG', 'in', '34', '40', 'individuals', 'with', 'an', 'RT', 'PCR', 'confirmed', 'diagnosis', 'of', 'SARS', 'CoV', '2', 'infection', 'sensitivity', '85', '95', 'CI', '70', '94', 'vs', '0', '50', 'pre', 'pandemic', 'controls', 'specificity', '100', '95', 'CI', '93', '100', 'IgG', 'levels', 'were', 'detected', 'in', '31', '31', 'RT', 'PCR', 'positive', 'individuals', 'tested', '10', 'days', 'after', 'symptom', 'onset', 'sensitivity', '100', '95', 'CI', '89', '100', 'IgG', 'titres', 'rose', 'during', 'the', '3', 'weeks', 'post', 'symptom', 'onset', 'and', 'began', 'to', 'fall', 'by', '8', 'weeks', 'but', 'remained', 'above', 'the', 'detection', 'threshold', 'Point', 'estimates', 'for', 'the', 'sensitivity', 'of', 'LFIA', 'devices', 'ranged', 'from', '55', '70', 'versus', 'RT', 'PCR', 'and', '65', '85', 'versus', 'ELISA', 'with', 'specificity', '95', '100', 'and', '93', '100', 'respectively', 'Within', 'the', 'limits', 'of', 'the', 'study', 'size', 'the', 'performance', 'of', 'most', 'LFIA', 'devices', 'was', 'similar', 'Conclusions', 'The', 'performance', 'of', 'current', 'LFIA', 'devices', 'is', 'inadequate', 'for', 'most', 'individual', 'patient', 'applications', 'ELISA', 'can', 'be', 'calibrated', 'to', 'be', 'specific', 'for', 'detecting', 'and', 'quantifying', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'and', 'is', 'highly', 'sensitive', 'for', 'IgG', 'from', '10', 'days', 'following', 'symptoms', 'onset', '']"
71667,Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment.,2020-04-29,,http://medrxiv.org/cgi/content/short/2020.04.23.20077156v1?rss=1,"The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a comprehensive comparison of serological COVID-19 assays. We show that the assay detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, had optimal characteristics for antibody detection in different stages of disease.",10.1101/2020.04.23.20077156,nxy21x7k,"['The', 'world', 'is', 'entering', 'a', 'new', 'era', 'of', 'the', 'COVID', '19', 'pandemic', 'in', 'which', 'there', 'is', 'an', 'increasing', 'call', 'for', 'reliable', 'antibody', 'testing', 'To', 'support', 'decision', 'making', 'on', 'the', 'deployment', 'of', 'serology', 'for', 'either', 'population', 'screening', 'or', 'diagnostics', 'we', 'present', 'a', 'comprehensive', 'comparison', 'of', 'serological', 'COVID', '19', 'assays', 'We', 'show', 'that', 'the', 'assay', 'detecting', 'total', 'immunoglobulins', 'against', 'the', 'receptor', 'binding', 'domain', 'of', 'SARS', 'CoV', '2', 'had', 'optimal', 'characteristics', 'for', 'antibody', 'detection', 'in', 'different', 'stages', 'of', 'disease', '']"
71868,Molecular detection of SARS-CoV-2 using a reagent-free approach,2020-05-02,,http://medrxiv.org/cgi/content/short/2020.04.28.20083626v1?rss=1,"Shortage of reagents and consumables required for the extraction and molecular detection of SARS-CoV-2 RNA in respiratory samples has led many laboratories to investigate alternative approaches for sample preparation. Fomsgaard et al 2020 recently presented results using heat-processing of respiratory samples prior to RT-qPCR as an economical method enabling an extremely fast streamlining of the processes at virtually no cost. Here, we present our results using this method and highlight some major pitfalls that diagnostics laboratories should be aware of before proceeding with this technique. We first investigated various treatments using different temperatures, incubation times and sample volumes based on the above study to optimise the heat-treatment conditions. Although the initial data confirmed the published results, further investigations revealed unexpected inhibitory properties of some commonly used virus transport media (VTMs) on some commercially available RT-qPCR mixes, emphasising the critical importance of a thorough validation process to determine the most adapted reagents to be used depending on the sample types to be tested. In conclusion, although the method works, with very consistent Ct values and an excellent sensitivity when compared to a conventional RNA extraction method, it is critical to include an internal control to check each sample for potential inhibition.",10.1101/2020.04.28.20083626,ivye1qao,"['Shortage', 'of', 'reagents', 'and', 'consumables', 'required', 'for', 'the', 'extraction', 'and', 'molecular', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'in', 'respiratory', 'samples', 'has', 'led', 'many', 'laboratories', 'to', 'investigate', 'alternative', 'approaches', 'for', 'sample', 'preparation', 'Fomsgaard', 'et', 'al', '2020', 'recently', 'presented', 'results', 'using', 'heat', 'processing', 'of', 'respiratory', 'samples', 'prior', 'to', 'RT', 'qPCR', 'as', 'an', 'economical', 'method', 'enabling', 'an', 'extremely', 'fast', 'streamlining', 'of', 'the', 'processes', 'at', 'virtually', 'no', 'cost', 'Here', 'we', 'present', 'our', 'results', 'using', 'this', 'method', 'and', 'highlight', 'some', 'major', 'pitfalls', 'that', 'diagnostics', 'laboratories', 'should', 'be', 'aware', 'of', 'before', 'proceeding', 'with', 'this', 'technique', 'We', 'first', 'investigated', 'various', 'treatments', 'using', 'different', 'temperatures', 'incubation', 'times', 'and', 'sample', 'volumes', 'based', 'on', 'the', 'above', 'study', 'to', 'optimise', 'the', 'heat', 'treatment', 'conditions', 'Although', 'the', 'initial', 'data', 'confirmed', 'the', 'published', 'results', 'further', 'investigations', 'revealed', 'unexpected', 'inhibitory', 'properties', 'of', 'some', 'commonly', 'used', 'virus', 'transport', 'media', 'VTMs', 'on', 'some', 'commercially', 'available', 'RT', 'qPCR', 'mixes', 'emphasising', 'the', 'critical', 'importance', 'of', 'a', 'thorough', 'validation', 'process', 'to', 'determine', 'the', 'most', 'adapted', 'reagents', 'to', 'be', 'used', 'depending', 'on', 'the', 'sample', 'types', 'to', 'be', 'tested', 'In', 'conclusion', 'although', 'the', 'method', 'works', 'with', 'very', 'consistent', 'Ct', 'values', 'and', 'an', 'excellent', 'sensitivity', 'when', 'compared', 'to', 'a', 'conventional', 'RNA', 'extraction', 'method', 'it', 'is', 'critical', 'to', 'include', 'an', 'internal', 'control', 'to', 'check', 'each', 'sample', 'for', 'potential', 'inhibition', '']"
71934,"COVID-19 Spread in India: Dynamics, Modeling, and Future Projections",2020-06-14,,http://medrxiv.org/cgi/content/short/2020.06.12.20129197v1?rss=1,"COVID-19 is an extremely infectious disease with a relatively large virus incubation period in the affected people who may be asymptomatic. Therefore, to reduce the transmission of this pathogen, several countries have taken many intervention measures. In this paper, we show that the impact of these measures in India is different from several other countries. It is shown that an early lockdown in late March 2020 changed the initial exponential growth curve of COVID-19 to a linear one, but a surge in the number of cases from late April 2020 brought India back to a quadratic trajectory. A regional analysis shows the disparate impact of the intervention in different states. It is further shown that the number of reported infections correlates with the number of tests, and therefore regions with limited diagnostics resources may not have a realistic estimate of the virus spread. This insufficiency of diagnostic test data is also reflected in an increasing positivity rate for India nearly 2.5 months after the lockdown, inconsistent with the trends observed for other geographical regions. Nonetheless, future projections are made using different epidemiological models based on the available data, and a comparative study is presented. In the absence of a reliable estimate of the true number of infections, these projections will have a limited accuracy: with that limitation, the most optimistic prediction suggests a continuing virus transmission through September 2020.",10.1101/2020.06.12.20129197,qk5z84xd,"['COVID', '19', 'is', 'an', 'extremely', 'infectious', 'disease', 'with', 'a', 'relatively', 'large', 'virus', 'incubation', 'period', 'in', 'the', 'affected', 'people', 'who', 'may', 'be', 'asymptomatic', 'Therefore', 'to', 'reduce', 'the', 'transmission', 'of', 'this', 'pathogen', 'several', 'countries', 'have', 'taken', 'many', 'intervention', 'measures', 'In', 'this', 'paper', 'we', 'show', 'that', 'the', 'impact', 'of', 'these', 'measures', 'in', 'India', 'is', 'different', 'from', 'several', 'other', 'countries', 'It', 'is', 'shown', 'that', 'an', 'early', 'lockdown', 'in', 'late', 'March', '2020', 'changed', 'the', 'initial', 'exponential', 'growth', 'curve', 'of', 'COVID', '19', 'to', 'a', 'linear', 'one', 'but', 'a', 'surge', 'in', 'the', 'number', 'of', 'cases', 'from', 'late', 'April', '2020', 'brought', 'India', 'back', 'to', 'a', 'quadratic', 'trajectory', 'A', 'regional', 'analysis', 'shows', 'the', 'disparate', 'impact', 'of', 'the', 'intervention', 'in', 'different', 'states', 'It', 'is', 'further', 'shown', 'that', 'the', 'number', 'of', 'reported', 'infections', 'correlates', 'with', 'the', 'number', 'of', 'tests', 'and', 'therefore', 'regions', 'with', 'limited', 'diagnostics', 'resources', 'may', 'not', 'have', 'a', 'realistic', 'estimate', 'of', 'the', 'virus', 'spread', 'This', 'insufficiency', 'of', 'diagnostic', 'test', 'data', 'is', 'also', 'reflected', 'in', 'an', 'increasing', 'positivity', 'rate', 'for', 'India', 'nearly', '2', '5', 'months', 'after', 'the', 'lockdown', 'inconsistent', 'with', 'the', 'trends', 'observed', 'for', 'other', 'geographical', 'regions', 'Nonetheless', 'future', 'projections', 'are', 'made', 'using', 'different', 'epidemiological', 'models', 'based', 'on', 'the', 'available', 'data', 'and', 'a', 'comparative', 'study', 'is', 'presented', 'In', 'the', 'absence', 'of', 'a', 'reliable', 'estimate', 'of', 'the', 'true', 'number', 'of', 'infections', 'these', 'projections', 'will', 'have', 'a', 'limited', 'accuracy', 'with', 'that', 'limitation', 'the', 'most', 'optimistic', 'prediction', 'suggests', 'a', 'continuing', 'virus', 'transmission', 'through', 'September', '2020', '']"
71965,Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in Colombia,2020-06-04,,http://medrxiv.org/cgi/content/short/2020.06.02.20120782v1?rss=1,"Introduction: SARS-CoV-2 is a new member of the genus Betacoronavirus, responsible for the COVID-19 pandemics. The virus crossed the species barrier and established in the human population due to its ability to exploit the ACE receptor for virus entry, which is present and abundant in several tissues, including the lung and respiratory tract, gastrointestinal tract and hearth. Virus interaction with the cellular receptor is mediated by the surface protein, known as Spike. Another structural protein of major importance in the Nucleocapsid, directly interacting with the viral RNA to form the ribonucleocapsid, considered a multifunctional protein, and being the target of the most molecular diagnostics assays. Objective: To describe the frequency of substitutions in spike and nucleocapsid proteins of SARS-CoV-2 circulating in Colombia and evaluate the frequency of these substitutions in SARS-CoV-2 sequences from other countries of South America. Materials and methods: Samples of 43 patients were included for viral RNA detection by real-time RT-PCR using the Charite-Berlin protocol for the amplification of the SARS-CoV-2 E and RdRp genes. Genome sequences were obtained through the Oxford Nanopore and Illumina MiSeq technologies, following the artic.network ""nCoV-2019 sequencing protocol"". Available genomes were consulted from GISAID, GenBank, and Genome sequence archive (GSA) and a total of 371 genomes sequences from South America were included. The genome sequences were aligned with the Muscle tool using the MEGA X software. Substitution matrices of the Colombian sequences respect to the reference genome (NC_045512) at the nucleotide and amino acid levels were generated for the spike and nucleocapsid gene. Results: substitution D614G in the amino acid sequence of spike protein was found in 86.7% of the Colombian sequences; substitutions G181V and D936Y in 2.3%, respectively. Five substitutions were found in the nucleocapsid protein, with substitution R203K and G204R being the most frequent (13.95 %) in Colombia. The substitutions D614G in Spike and R203K-G204R in nucleocapsid have a frequency of 83% and 28% respectively in sequences from South America. Conclusion: Non-synonymous substitutions were found in the spike and nucleocapsid proteins in Colombian genomes, the most frequent being D614G in Spike and R203K-G204R in nucleocapsid. These substitutions are frequent in the genomes reported for other South American countries. It is necessary to continue with genomic surveillance of the changes in Spike and Nucleocapsid proteins during the SARS-CoV-2 pandemic in Colombia and South America, even more considering that these proteins are the most commonly used antigen in serological tests.",10.1101/2020.06.02.20120782,zb034sbv,"['Introduction', 'SARS', 'CoV', '2', 'is', 'a', 'new', 'member', 'of', 'the', 'genus', 'Betacoronavirus', 'responsible', 'for', 'the', 'COVID', '19', 'pandemics', 'The', 'virus', 'crossed', 'the', 'species', 'barrier', 'and', 'established', 'in', 'the', 'human', 'population', 'due', 'to', 'its', 'ability', 'to', 'exploit', 'the', 'ACE', 'receptor', 'for', 'virus', 'entry', 'which', 'is', 'present', 'and', 'abundant', 'in', 'several', 'tissues', 'including', 'the', 'lung', 'and', 'respiratory', 'tract', 'gastrointestinal', 'tract', 'and', 'hearth', 'Virus', 'interaction', 'with', 'the', 'cellular', 'receptor', 'is', 'mediated', 'by', 'the', 'surface', 'protein', 'known', 'as', 'Spike', 'Another', 'structural', 'protein', 'of', 'major', 'importance', 'in', 'the', 'Nucleocapsid', 'directly', 'interacting', 'with', 'the', 'viral', 'RNA', 'to', 'form', 'the', 'ribonucleocapsid', 'considered', 'a', 'multifunctional', 'protein', 'and', 'being', 'the', 'target', 'of', 'the', 'most', 'molecular', 'diagnostics', 'assays', 'Objective', 'To', 'describe', 'the', 'frequency', 'of', 'substitutions', 'in', 'spike', 'and', 'nucleocapsid', 'proteins', 'of', 'SARS', 'CoV', '2', 'circulating', 'in', 'Colombia', 'and', 'evaluate', 'the', 'frequency', 'of', 'these', 'substitutions', 'in', 'SARS', 'CoV', '2', 'sequences', 'from', 'other', 'countries', 'of', 'South', 'America', 'Materials', 'and', 'methods', 'Samples', 'of', '43', 'patients', 'were', 'included', 'for', 'viral', 'RNA', 'detection', 'by', 'real', 'time', 'RT', 'PCR', 'using', 'the', 'Charite', 'Berlin', 'protocol', 'for', 'the', 'amplification', 'of', 'the', 'SARS', 'CoV', '2', 'E', 'and', 'RdRp', 'genes', 'Genome', 'sequences', 'were', 'obtained', 'through', 'the', 'Oxford', 'Nanopore', 'and', 'Illumina', 'MiSeq', 'technologies', 'following', 'the', 'artic', 'network', 'nCoV', '2019', 'sequencing', 'protocol', 'Available', 'genomes', 'were', 'consulted', 'from', 'GISAID', 'GenBank', 'and', 'Genome', 'sequence', 'archive', 'GSA', 'and', 'a', 'total', 'of', '371', 'genomes', 'sequences', 'from', 'South', 'America', 'were', 'included', 'The', 'genome', 'sequences', 'were', 'aligned', 'with', 'the', 'Muscle', 'tool', 'using', 'the', 'MEGA', 'X', 'software', 'Substitution', 'matrices', 'of', 'the', 'Colombian', 'sequences', 'respect', 'to', 'the', 'reference', 'genome', 'NC', '045512', 'at', 'the', 'nucleotide', 'and', 'amino', 'acid', 'levels', 'were', 'generated', 'for', 'the', 'spike', 'and', 'nucleocapsid', 'gene', 'Results', 'substitution', 'D614G', 'in', 'the', 'amino', 'acid', 'sequence', 'of', 'spike', 'protein', 'was', 'found', 'in', '86', '7', 'of', 'the', 'Colombian', 'sequences', 'substitutions', 'G181V', 'and', 'D936Y', 'in', '2', '3', 'respectively', 'Five', 'substitutions', 'were', 'found', 'in', 'the', 'nucleocapsid', 'protein', 'with', 'substitution', 'R203K', 'and', 'G204R', 'being', 'the', 'most', 'frequent', '13', '95', 'in', 'Colombia', 'The', 'substitutions', 'D614G', 'in', 'Spike', 'and', 'R203K', 'G204R', 'in', 'nucleocapsid', 'have', 'a', 'frequency', 'of', '83', 'and', '28', 'respectively', 'in', 'sequences', 'from', 'South', 'America', 'Conclusion', 'Non', 'synonymous', 'substitutions', 'were', 'found', 'in', 'the', 'spike', 'and', 'nucleocapsid', 'proteins', 'in', 'Colombian', 'genomes', 'the', 'most', 'frequent', 'being', 'D614G', 'in', 'Spike', 'and', 'R203K', 'G204R', 'in', 'nucleocapsid', 'These', 'substitutions', 'are', 'frequent', 'in', 'the', 'genomes', 'reported', 'for', 'other', 'South', 'American', 'countries', 'It', 'is', 'necessary', 'to', 'continue', 'with', 'genomic', 'surveillance', 'of', 'the', 'changes', 'in', 'Spike', 'and', 'Nucleocapsid', 'proteins', 'during', 'the', 'SARS', 'CoV', '2', 'pandemic', 'in', 'Colombia', 'and', 'South', 'America', 'even', 'more', 'considering', 'that', 'these', 'proteins', 'are', 'the', 'most', 'commonly', 'used', 'antigen', 'in', 'serological', 'tests', '']"
71995,Real-time colorimetric LAMP methodology for quantitative nucleic acids detection at the point-of-care,2020-07-24,bioRxiv,https://doi.org/10.1101/2020.07.22.215251,"Most methods applied to nucleic acids’ detection at the point-of-care require either expensive and mostly bench-top instruments or simpler inexpensive systems providing qualitative results. Truly decentralized approaches to reliable, quantitative and affordable diagnostics are still missing. Here, we report the development of real-time quantitative colorimetric LAMP based on a portable and cost-effective device, the use of which requires minimal training. Main advantages of the method are the rapid analysis time (<30min); quantification over a large dynamic range (9 log units); ability to work with crude samples (saliva, tissue); demonstrated low detection limit (1-10 copies); smartphone-operation and fast prototyping (3D-printing). The system’s broad detection capability is demonstrated during infectious diseases-testing for COVID-19 and pharmacogenetics for BRAF V600E mutation testing. Validation studies showed 97.4% and 100% agreement with qRT-PCR for SARS-CoV-2 RNA detection extracted from positive and negative patients’ samples (89), respectively; and 100% agreement with ddPCR and Sanger sequencing for BRAF V600E mutation detection from 12 clinical biopsy samples. The new methodology provides a needed solution for affordable healthcare at the point-of-care, with emphasis on global diagnostics.",10.1101/2020.07.22.215251,e0krtdfy,"['Most', 'methods', 'applied', 'to', 'nucleic', 'acids', 'detection', 'at', 'the', 'point', 'of', 'care', 'require', 'either', 'expensive', 'and', 'mostly', 'bench', 'top', 'instruments', 'or', 'simpler', 'inexpensive', 'systems', 'providing', 'qualitative', 'results', 'Truly', 'decentralized', 'approaches', 'to', 'reliable', 'quantitative', 'and', 'affordable', 'diagnostics', 'are', 'still', 'missing', 'Here', 'we', 'report', 'the', 'development', 'of', 'real', 'time', 'quantitative', 'colorimetric', 'LAMP', 'based', 'on', 'a', 'portable', 'and', 'cost', 'effective', 'device', 'the', 'use', 'of', 'which', 'requires', 'minimal', 'training', 'Main', 'advantages', 'of', 'the', 'method', 'are', 'the', 'rapid', 'analysis', 'time', '30min', 'quantification', 'over', 'a', 'large', 'dynamic', 'range', '9', 'log', 'units', 'ability', 'to', 'work', 'with', 'crude', 'samples', 'saliva', 'tissue', 'demonstrated', 'low', 'detection', 'limit', '1', '10', 'copies', 'smartphone', 'operation', 'and', 'fast', 'prototyping', '3D', 'printing', 'The', 'system', 's', 'broad', 'detection', 'capability', 'is', 'demonstrated', 'during', 'infectious', 'diseases', 'testing', 'for', 'COVID', '19', 'and', 'pharmacogenetics', 'for', 'BRAF', 'V600E', 'mutation', 'testing', 'Validation', 'studies', 'showed', '97', '4', 'and', '100', 'agreement', 'with', 'qRT', 'PCR', 'for', 'SARS', 'CoV', '2', 'RNA', 'detection', 'extracted', 'from', 'positive', 'and', 'negative', 'patients', 'samples', '89', 'respectively', 'and', '100', 'agreement', 'with', 'ddPCR', 'and', 'Sanger', 'sequencing', 'for', 'BRAF', 'V600E', 'mutation', 'detection', 'from', '12', 'clinical', 'biopsy', 'samples', 'The', 'new', 'methodology', 'provides', 'a', 'needed', 'solution', 'for', 'affordable', 'healthcare', 'at', 'the', 'point', 'of', 'care', 'with', 'emphasis', 'on', 'global', 'diagnostics', '']"
72341,"Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration",2020-05-05,,http://medrxiv.org/cgi/content/short/2020.04.29.20082099v1?rss=1,"In January, Mologic, embarked on a product development pathway for COVID-19 diagnostics focusing on ELISA and rapid diagnostic tests (RDTs), with anticipated funding from Wellcome Trust and DFID. 755 clinical samples from known COVID-19 patients and hospital negative controls were tested on Mologics IgG ELISA. The reported sensitivity on 191 SGUL prospectively enrolled patients was 95% on day 7 or more post diagnosis, and 97% 10 days or more post-diagnosis. A specificity panel comprising 564 samples pre-December 2019 were tested to include most common respiratory pathogens, other types of coronavirus, and flaviviruses. Specificity in this panel was 97%. This is the first in a series of Mologic products for COVID-19, which will be deployed for COVID-19 diagnosis, contact tracing and sero-epidemiological studies to estimate disease burden and transmission with a focus on ensuring access, affordability, and availability to lowest resource settings.",10.1101/2020.04.29.20082099,nol2n8fo,"['In', 'January', 'Mologic', 'embarked', 'on', 'a', 'product', 'development', 'pathway', 'for', 'COVID', '19', 'diagnostics', 'focusing', 'on', 'ELISA', 'and', 'rapid', 'diagnostic', 'tests', 'RDTs', 'with', 'anticipated', 'funding', 'from', 'Wellcome', 'Trust', 'and', 'DFID', '755', 'clinical', 'samples', 'from', 'known', 'COVID', '19', 'patients', 'and', 'hospital', 'negative', 'controls', 'were', 'tested', 'on', 'Mologics', 'IgG', 'ELISA', 'The', 'reported', 'sensitivity', 'on', '191', 'SGUL', 'prospectively', 'enrolled', 'patients', 'was', '95', 'on', 'day', '7', 'or', 'more', 'post', 'diagnosis', 'and', '97', '10', 'days', 'or', 'more', 'post', 'diagnosis', 'A', 'specificity', 'panel', 'comprising', '564', 'samples', 'pre', 'December', '2019', 'were', 'tested', 'to', 'include', 'most', 'common', 'respiratory', 'pathogens', 'other', 'types', 'of', 'coronavirus', 'and', 'flaviviruses', 'Specificity', 'in', 'this', 'panel', 'was', '97', 'This', 'is', 'the', 'first', 'in', 'a', 'series', 'of', 'Mologic', 'products', 'for', 'COVID', '19', 'which', 'will', 'be', 'deployed', 'for', 'COVID', '19', 'diagnosis', 'contact', 'tracing', 'and', 'sero', 'epidemiological', 'studies', 'to', 'estimate', 'disease', 'burden', 'and', 'transmission', 'with', 'a', 'focus', 'on', 'ensuring', 'access', 'affordability', 'and', 'availability', 'to', 'lowest', 'resource', 'settings', '']"
72632,"Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products",2020-06-29,,http://medrxiv.org/cgi/content/short/2020.06.25.20140236v1?rss=1,"As the United States prepares to return to work and open up the economy in the midst of the COVID-19 pandemic without an available vaccine or effective therapy, testing and contact tracing are essential to contain and limit the spread of the COVID-19 virus. In response to the urgent public health need for accurate, effective, low-cost, and scalable COVID-19 testing technology, we evaluated and identified diagnostic solutions with potential for use as an at-home product. We conducted a deep horizon scan for antigen and serology-based diagnostics and down-selected to the most promising technologies. A total of 303 candidate products (138 antibody and 44 antigen tests) were identified. Product evaluations were based entirely on company-provided data. 73 serology-based antibody tests passing an initial scoring algorithm based on specificity and sensitivity data were then further evaluated using a second scoring algorithm. This second algorithm included a review of additional technical specifications of the devices, an analysis of supply chain, manufacturing, and distribution capacity of each vendor. 24 potential antibody products met the selection criteria for further direct laboratory evaluation. The performance metrics for selection of these 24 products are currently being evaluated in a Mass General Brigham laboratory. Testing alone might not be sufficient to prevent the spread of a highly contagious disease like COVID-19. Manual contact tracing could complement testing, but it is likely to fail in identifying many individuals who were in contact with a given COVID patient. The proliferation of smartphones in the population has enabled the development of solutions that can provide public health officials with valuable information for rapid and accurate contact tracing. Besides, electronic-based contact tracing solutions can be augmented by symptom self-reports gathered using electronic patient reported outcome (ePRO) platforms and by physiological data collected using wearable sensors. We performed a detailed assessment of 12 ePRO solutions, 27 wearable sensors, and 44 electronic-based contact tracing solutions. These technologies were evaluated using criteria developed to assess their suitability to address the COVID-19 pandemic. We identified a number of solutions that could augment if not provide a more effective alternative to manual contact tracing. Finally, we propose a theoretical framework in which ePRO platforms, wearable sensors, and electronic-based contact tracing solutions would be utilized in combination with molecular and serological tests to identify and isolate COVID-19 cases rapidly.",10.1101/2020.06.25.20140236,hz3z6xkk,"['As', 'the', 'United', 'States', 'prepares', 'to', 'return', 'to', 'work', 'and', 'open', 'up', 'the', 'economy', 'in', 'the', 'midst', 'of', 'the', 'COVID', '19', 'pandemic', 'without', 'an', 'available', 'vaccine', 'or', 'effective', 'therapy', 'testing', 'and', 'contact', 'tracing', 'are', 'essential', 'to', 'contain', 'and', 'limit', 'the', 'spread', 'of', 'the', 'COVID', '19', 'virus', 'In', 'response', 'to', 'the', 'urgent', 'public', 'health', 'need', 'for', 'accurate', 'effective', 'low', 'cost', 'and', 'scalable', 'COVID', '19', 'testing', 'technology', 'we', 'evaluated', 'and', 'identified', 'diagnostic', 'solutions', 'with', 'potential', 'for', 'use', 'as', 'an', 'at', 'home', 'product', 'We', 'conducted', 'a', 'deep', 'horizon', 'scan', 'for', 'antigen', 'and', 'serology', 'based', 'diagnostics', 'and', 'down', 'selected', 'to', 'the', 'most', 'promising', 'technologies', 'A', 'total', 'of', '303', 'candidate', 'products', '138', 'antibody', 'and', '44', 'antigen', 'tests', 'were', 'identified', 'Product', 'evaluations', 'were', 'based', 'entirely', 'on', 'company', 'provided', 'data', '73', 'serology', 'based', 'antibody', 'tests', 'passing', 'an', 'initial', 'scoring', 'algorithm', 'based', 'on', 'specificity', 'and', 'sensitivity', 'data', 'were', 'then', 'further', 'evaluated', 'using', 'a', 'second', 'scoring', 'algorithm', 'This', 'second', 'algorithm', 'included', 'a', 'review', 'of', 'additional', 'technical', 'specifications', 'of', 'the', 'devices', 'an', 'analysis', 'of', 'supply', 'chain', 'manufacturing', 'and', 'distribution', 'capacity', 'of', 'each', 'vendor', '24', 'potential', 'antibody', 'products', 'met', 'the', 'selection', 'criteria', 'for', 'further', 'direct', 'laboratory', 'evaluation', 'The', 'performance', 'metrics', 'for', 'selection', 'of', 'these', '24', 'products', 'are', 'currently', 'being', 'evaluated', 'in', 'a', 'Mass', 'General', 'Brigham', 'laboratory', 'Testing', 'alone', 'might', 'not', 'be', 'sufficient', 'to', 'prevent', 'the', 'spread', 'of', 'a', 'highly', 'contagious', 'disease', 'like', 'COVID', '19', 'Manual', 'contact', 'tracing', 'could', 'complement', 'testing', 'but', 'it', 'is', 'likely', 'to', 'fail', 'in', 'identifying', 'many', 'individuals', 'who', 'were', 'in', 'contact', 'with', 'a', 'given', 'COVID', 'patient', 'The', 'proliferation', 'of', 'smartphones', 'in', 'the', 'population', 'has', 'enabled', 'the', 'development', 'of', 'solutions', 'that', 'can', 'provide', 'public', 'health', 'officials', 'with', 'valuable', 'information', 'for', 'rapid', 'and', 'accurate', 'contact', 'tracing', 'Besides', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'can', 'be', 'augmented', 'by', 'symptom', 'self', 'reports', 'gathered', 'using', 'electronic', 'patient', 'reported', 'outcome', 'ePRO', 'platforms', 'and', 'by', 'physiological', 'data', 'collected', 'using', 'wearable', 'sensors', 'We', 'performed', 'a', 'detailed', 'assessment', 'of', '12', 'ePRO', 'solutions', '27', 'wearable', 'sensors', 'and', '44', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'These', 'technologies', 'were', 'evaluated', 'using', 'criteria', 'developed', 'to', 'assess', 'their', 'suitability', 'to', 'address', 'the', 'COVID', '19', 'pandemic', 'We', 'identified', 'a', 'number', 'of', 'solutions', 'that', 'could', 'augment', 'if', 'not', 'provide', 'a', 'more', 'effective', 'alternative', 'to', 'manual', 'contact', 'tracing', 'Finally', 'we', 'propose', 'a', 'theoretical', 'framework', 'in', 'which', 'ePRO', 'platforms', 'wearable', 'sensors', 'and', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'would', 'be', 'utilized', 'in', 'combination', 'with', 'molecular', 'and', 'serological', 'tests', 'to', 'identify', 'and', 'isolate', 'COVID', '19', 'cases', 'rapidly', '']"
72639,Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context.,2020-04-29,,http://medrxiv.org/cgi/content/short/2020.04.24.20077776v1?rss=1,"Introduction: COVID-19 Ag Respi-Strip, an immunochromatographic (ICT) assay for the rapid detection of SARS-CoV-2 antigen on nasopharyngeal specimen, has been developed to identify positive COVID-19 patients allowing prompt clinical and quarantine decisions. In this Original Research article, we describe the conception, the analytical and clinical performances as well as the risk management of implementing the COVID-19 Ag Respi-Strip in a diagnostic decision algorithm. Materials and Methods: Development of the COVID-19 Ag Respi-Strip resulted in a ready-to-use ICT assay based on a membrane technology with colloidal gold nanoparticles using monoclonal antibodies directed against the SARS-CoV and SARS-CoV-2 highly conserved nucleoprotein antigen. Four hundred observations were recorded for the analytical performance study and thirty tests were analysed for the cross-reactivity study. The clinical performance study was performed in a retrospective multi-centric evaluation on aliquots of 328 nasopharyngeal samples. COVID-19 Ag Respi-Strip results were compared with qRT-PCR as golden standard for COVID-19 diagnostics. Results: In the analytical performance study, the reproducibility showed a between-observer disagreement of 1.7%, a robustness of 98%, an overall satisfying user friendliness and no cross-reactivity with other virus-infected nasopharyngeal samples. In the clinical performance study performed in three different clinical laboratories we found an overall sensitivity and specificity of 57.6% and 99.5% respectively with an accuracy of 82.6%. The cut-off of the assay was found at Ct<22. User-friendliness analysis and risk management assessment through Ishikawa diagram demonstrate that COVID-19 Ag Respi-Strip may be implemented in clinical laboratories according to biosafety recommendations. Conclusion: The COVID-19 Ag Respi-Strip represents a promising rapid SARS-CoV-2 antigen assay for the first-line diagnosis of COVID-19 in 15 minutes. Its role in the proposed diagnostic algorithm is complementary to the currently-used molecular techniques.",10.1101/2020.04.24.20077776,812st0np,"['Introduction', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'an', 'immunochromatographic', 'ICT', 'assay', 'for', 'the', 'rapid', 'detection', 'of', 'SARS', 'CoV', '2', 'antigen', 'on', 'nasopharyngeal', 'specimen', 'has', 'been', 'developed', 'to', 'identify', 'positive', 'COVID', '19', 'patients', 'allowing', 'prompt', 'clinical', 'and', 'quarantine', 'decisions', 'In', 'this', 'Original', 'Research', 'article', 'we', 'describe', 'the', 'conception', 'the', 'analytical', 'and', 'clinical', 'performances', 'as', 'well', 'as', 'the', 'risk', 'management', 'of', 'implementing', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'in', 'a', 'diagnostic', 'decision', 'algorithm', 'Materials', 'and', 'Methods', 'Development', 'of', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'resulted', 'in', 'a', 'ready', 'to', 'use', 'ICT', 'assay', 'based', 'on', 'a', 'membrane', 'technology', 'with', 'colloidal', 'gold', 'nanoparticles', 'using', 'monoclonal', 'antibodies', 'directed', 'against', 'the', 'SARS', 'CoV', 'and', 'SARS', 'CoV', '2', 'highly', 'conserved', 'nucleoprotein', 'antigen', 'Four', 'hundred', 'observations', 'were', 'recorded', 'for', 'the', 'analytical', 'performance', 'study', 'and', 'thirty', 'tests', 'were', 'analysed', 'for', 'the', 'cross', 'reactivity', 'study', 'The', 'clinical', 'performance', 'study', 'was', 'performed', 'in', 'a', 'retrospective', 'multi', 'centric', 'evaluation', 'on', 'aliquots', 'of', '328', 'nasopharyngeal', 'samples', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'results', 'were', 'compared', 'with', 'qRT', 'PCR', 'as', 'golden', 'standard', 'for', 'COVID', '19', 'diagnostics', 'Results', 'In', 'the', 'analytical', 'performance', 'study', 'the', 'reproducibility', 'showed', 'a', 'between', 'observer', 'disagreement', 'of', '1', '7', 'a', 'robustness', 'of', '98', 'an', 'overall', 'satisfying', 'user', 'friendliness', 'and', 'no', 'cross', 'reactivity', 'with', 'other', 'virus', 'infected', 'nasopharyngeal', 'samples', 'In', 'the', 'clinical', 'performance', 'study', 'performed', 'in', 'three', 'different', 'clinical', 'laboratories', 'we', 'found', 'an', 'overall', 'sensitivity', 'and', 'specificity', 'of', '57', '6', 'and', '99', '5', 'respectively', 'with', 'an', 'accuracy', 'of', '82', '6', 'The', 'cut', 'off', 'of', 'the', 'assay', 'was', 'found', 'at', 'Ct', '22', 'User', 'friendliness', 'analysis', 'and', 'risk', 'management', 'assessment', 'through', 'Ishikawa', 'diagram', 'demonstrate', 'that', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'may', 'be', 'implemented', 'in', 'clinical', 'laboratories', 'according', 'to', 'biosafety', 'recommendations', 'Conclusion', 'The', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'represents', 'a', 'promising', 'rapid', 'SARS', 'CoV', '2', 'antigen', 'assay', 'for', 'the', 'first', 'line', 'diagnosis', 'of', 'COVID', '19', 'in', '15', 'minutes', 'Its', 'role', 'in', 'the', 'proposed', 'diagnostic', 'algorithm', 'is', 'complementary', 'to', 'the', 'currently', 'used', 'molecular', 'techniques', '']"
72719,Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting,2020-04-11,,https://doi.org/10.1101/2020.04.07.20056234,"The ongoing SARS-CoV-2 pandemic presents a unique challenge for diagnostic laboratories around the world. Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for urgent cases. In this study we evaluated a SARS-CoV-2 LDT for the NeuMoDx 96 system, a fully automated (sample to result) RT-PCR platform offering random-access capabilities and good clinical performance for SARS-CoV-2 testing.",10.1101/2020.04.07.20056234,rkkhv4mw,"['The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'for', 'diagnostic', 'laboratories', 'around', 'the', 'world', 'Automation', 'of', 'workflows', 'in', 'molecular', 'diagnostics', 'is', 'instrumental', 'for', 'coping', 'with', 'the', 'large', 'number', 'of', 'tests', 'ordered', 'by', 'clinicians', 'as', 'well', 'as', 'providing', 'fast', 'tracked', 'rapid', 'testing', 'for', 'urgent', 'cases', 'In', 'this', 'study', 'we', 'evaluated', 'a', 'SARS', 'CoV', '2', 'LDT', 'for', 'the', 'NeuMoDx', '96', 'system', 'a', 'fully', 'automated', 'sample', 'to', 'result', 'RT', 'PCR', 'platform', 'offering', 'random', 'access', 'capabilities', 'and', 'good', 'clinical', 'performance', 'for', 'SARS', 'CoV', '2', 'testing', '']"
72823,Rapid implementation of SARS-CoV-2 emergency use authorization RT-PCR testing and experience at an academic medical institution,2020-06-08,,http://medrxiv.org/cgi/content/short/2020.06.05.20109637v1?rss=1,"An epidemic caused by an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019 has since rapidly spread internationally, requiring urgent response from the clinical diagnostics community. We present a detailed overview of the clinical validation and implementation of the first laboratory-developed real-time reverse-transcription-PCR (rRT-PCR) test offered in the NewYork-Presbyterian Hospital system following the emergency use authority (EUA) guidance issued by the US Food and Drug Administration. Validation was performed on nasopharyngeal and sputum specimens (n=124) using newly designed dual-target rRT-PCR (altona RealStar SARS-CoV-2 Reagent) for detecting of SARS-CoV-2 in upper respiratory and lower respiratory tract specimens, including bronchoalveolar lavage and tracheal aspirates. Accuracy testing demonstrated excellent assay agreement between expected and observed values. The limit of detection (LOD) was 2.7 and 23.0 gene copies/reaction for nasopharyngeal and sputum specimens, respectively. Retrospective analysis of 1,694 tests from 1,571 patients revealed increased positivity in older patients and males compared to females, and an increasing positivity rate from approximately 20% at the start of testing to 50% at the end of testing three weeks later. Our findings demonstrate that the assay accurately and sensitively identifies SARS-CoV-2 in multiple specimen types in the clinical setting and summarizes clinical data from early in the epidemic in New York City.",10.1101/2020.06.05.20109637,mb784dam,"['An', 'epidemic', 'caused', 'by', 'an', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'in', 'China', 'in', 'December', '2019', 'has', 'since', 'rapidly', 'spread', 'internationally', 'requiring', 'urgent', 'response', 'from', 'the', 'clinical', 'diagnostics', 'community', 'We', 'present', 'a', 'detailed', 'overview', 'of', 'the', 'clinical', 'validation', 'and', 'implementation', 'of', 'the', 'first', 'laboratory', 'developed', 'real', 'time', 'reverse', 'transcription', 'PCR', 'rRT', 'PCR', 'test', 'offered', 'in', 'the', 'NewYork', 'Presbyterian', 'Hospital', 'system', 'following', 'the', 'emergency', 'use', 'authority', 'EUA', 'guidance', 'issued', 'by', 'the', 'US', 'Food', 'and', 'Drug', 'Administration', 'Validation', 'was', 'performed', 'on', 'nasopharyngeal', 'and', 'sputum', 'specimens', 'n', '124', 'using', 'newly', 'designed', 'dual', 'target', 'rRT', 'PCR', 'altona', 'RealStar', 'SARS', 'CoV', '2', 'Reagent', 'for', 'detecting', 'of', 'SARS', 'CoV', '2', 'in', 'upper', 'respiratory', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'including', 'bronchoalveolar', 'lavage', 'and', 'tracheal', 'aspirates', 'Accuracy', 'testing', 'demonstrated', 'excellent', 'assay', 'agreement', 'between', 'expected', 'and', 'observed', 'values', 'The', 'limit', 'of', 'detection', 'LOD', 'was', '2', '7', 'and', '23', '0', 'gene', 'copies', 'reaction', 'for', 'nasopharyngeal', 'and', 'sputum', 'specimens', 'respectively', 'Retrospective', 'analysis', 'of', '1', '694', 'tests', 'from', '1', '571', 'patients', 'revealed', 'increased', 'positivity', 'in', 'older', 'patients', 'and', 'males', 'compared', 'to', 'females', 'and', 'an', 'increasing', 'positivity', 'rate', 'from', 'approximately', '20', 'at', 'the', 'start', 'of', 'testing', 'to', '50', 'at', 'the', 'end', 'of', 'testing', 'three', 'weeks', 'later', 'Our', 'findings', 'demonstrate', 'that', 'the', 'assay', 'accurately', 'and', 'sensitively', 'identifies', 'SARS', 'CoV', '2', 'in', 'multiple', 'specimen', 'types', 'in', 'the', 'clinical', 'setting', 'and', 'summarizes', 'clinical', 'data', 'from', 'early', 'in', 'the', 'epidemic', 'in', 'New', 'York', 'City', '']"
72984,A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19,2020,Cureus,https://doi.org/10.7759/cureus.7708,"Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19 Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms SARS-CoV can be detected in saliva at high titers Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures",10.7759/cureus.7708,awy3aans,"['Saliva', 'is', 'an', 'exocrine', 'secretion', 'produced', 'from', 'the', 'salivary', 'glands', 'and', 'has', 'numerous', 'functions', 'such', 'as', 'cleansing', 'and', 'protection', 'of', 'the', 'oral', 'cavity', 'antimicrobial', 'effects', 'and', 'aids', 'in', 'digestion', 'Due', 'to', 'the', 'speedy', 'development', 'in', 'the', 'field', 'of', 'salivaomics', 'saliva', 'is', 'now', 'well', 'accepted', 'as', 'a', 'pool', 'of', 'biological', 'markers', 'that', 'vary', 'from', 'changes', 'in', 'biochemicals', 'nucleic', 'acids', 'and', 'proteins', 'to', 'the', 'microflora', 'Saliva', 'has', 'an', 'immense', 'potential', 'as', 'a', 'diagnostic', 'fluid', 'and', 'offers', 'an', 'edge', 'over', 'other', 'biological', 'fluids', 'as', 'its', 'collection', 'method', 'does', 'not', 'require', 'invasive', 'procedure', 'economical', 'and', 'is', 'useful', 'for', 'monitoring', 'systemic', 'health', 'Development', 'of', 'sensitive', 'and', 'precise', 'salivary', 'diagnostic', 'tools', 'and', 'the', 'formulation', 'of', 'defined', 'guidelines', 'following', 'meticulous', 'testing', 'will', 'allow', 'salivary', 'diagnostics', 'to', 'be', 'utilised', 'as', 'chair', 'side', 'tests', 'for', 'various', 'oral', 'and', 'systemic', 'diseases', 'in', 'the', 'near', 'future', 'The', 'coronavirus', 'disease', 'Covid', '19', 'pandemic', 'is', 'the', 'biggest', 'challenge', 'and', 'global', 'health', 'crisis', 'for', 'the', 'world', 'since', 'World', 'War', 'Two', 'Rapid', 'and', 'accurate', 'diagnosis', 'of', 'Covid', '19', 'is', 'crucial', 'in', 'controlling', 'the', 'outbreak', 'in', 'the', 'community', 'and', 'in', 'hospitals', 'Nasopharyngeal', 'and', 'oropharyngeal', 'swabs', 'are', 'the', 'recommended', 'specimen', 'types', 'for', 'Covid', '19', 'diagnostic', 'testing', 'The', 'collection', 'of', 'these', 'specimen', 'types', 'requires', 'close', 'contact', 'between', 'healthcare', 'workers', 'and', 'patients', 'and', 'poses', 'a', 'risk', 'of', 'transmission', 'of', 'the', 'virus', 'causes', 'discomfort', 'and', 'may', 'cause', 'bleeding', 'especially', 'in', 'patients', 'with', 'condition', 'such', 'as', 'thrombocytopenia', 'Hence', 'nasopharyngeal', 'or', 'oropharyngeal', 'swabs', 'are', 'not', 'desirable', 'for', 'sequential', 'monitoring', 'of', 'viral', 'load', 'Saliva', 'specimens', 'can', 'be', 'obtained', 'easily', 'as', 'the', 'patient', 'is', 'asked', 'to', 'spit', 'into', 'a', 'sterile', 'bottle', 'The', 'collection', 'of', 'saliva', 'is', 'non', 'invasive', 'and', 'greatly', 'minimizes', 'the', 'exposure', 'of', 'healthcare', 'workers', 'to', 'Covid', '19', 'Saliva', 'has', 'a', 'high', 'consistency', 'rate', 'of', 'greater', 'than', '90', 'with', 'nasopharyngeal', 'specimens', 'in', 'the', 'detection', 'of', 'respiratory', 'viruses', 'including', 'coronaviruses', 'Saliva', 'has', 'also', 'been', 'used', 'in', 'screening', 'respiratory', 'viruses', 'among', 'hospitalized', 'patients', 'without', 'pyrexia', 'or', 'respiratory', 'symptoms', 'SARS', 'CoV', 'can', 'be', 'detected', 'in', 'saliva', 'at', 'high', 'titers', 'Salivary', 'diagnostics', 'is', 'a', 'dynamic', 'field', 'that', 'is', 'being', 'incorporated', 'as', 'part', 'of', 'disease', 'diagnosis', 'clinical', 'monitoring', 'of', 'systemic', 'health', 'and', 'to', 'make', 'significant', 'clinical', 'decisions', 'for', 'patient', 'care', 'More', 'research', 'is', 'required', 'to', 'analyze', 'the', 'potential', 'diagnostic', 'of', 'Covid', '19', 'in', 'saliva', 'to', 'develop', 'rapid', 'chair', 'side', 'tests', 'for', 'the', 'detection', 'of', 'Covid', '19', 'and', 'it', 'is', 'also', 'pivotal', 'to', 'improve', 'and', 'develop', 'successful', 'strategies', 'for', 'prevention', 'especially', 'for', 'dentists', 'and', 'healthcare', 'professionals', 'who', 'are', 'involved', 'in', 'performing', 'aerosol', 'generating', 'procedures']"
73021,The UCSC SARS-CoV-2 Genome Browser,2020-05-04,bioRxiv,https://doi.org/10.1101/2020.05.04.075945,"Background Researchers are generating molecular data pertaining to the SARS-CoV-2 RNA genome and its proteins at an unprecedented rate during the COVID-19 pandemic. As a result, there is a critical need for rapid and continuously updated access to the latest molecular data in a format in which all data can be quickly cross-referenced and compared. We adapted our genome browser visualization tool to the viral genome for this purpose. Molecular data, curated from published studies or from database submissions, are mapped to the viral genome and grouped together into “annotation tracks” where they can be visualized along the linear map of the viral genome sequence and programmatically downloaded in standard format for analysis. Results The UCSC Genome Browser for SARS-CoV-2 (https://genome.ucsc.edu/covid19.html) provides continuously updated access to the mutations in the many thousands of SARS-CoV-2 genomes deposited in GISAID and the international nucleotide sequencing databases, displayed alongside phylogenetic trees. These data are augmented with alignments of bat, pangolin, and other animal and human coronavirus genomes, including per-base evolutionary rate analysis. All available annotations are cross-referenced on the virus genome, including those from major databases (PDB, RFAM, IEDB, UniProt) as well as up-to-date individual results from preprints. Annotated data include predicted and validated immune epitopes, promising antibodies, RT-PCR and sequencing primers, CRISPR guides (from research, diagnostics, vaccines, and therapies), and points of interaction between human and viral genes. As a community resource, any user can add manual annotations which are quality checked and shared publicly on the browser the next day. Conclusions We invite all investigators to contribute additional data and annotations to this resource to accelerate research and development activities globally. Contact us at genome-www@soe.ucsc.edu with data suggestions or requests for support for adding data. Rapid sharing of data will accelerate SARS-CoV-2 research, especially when researchers take time to integrate their data with those from other labs on a widely-used community browser platform with standardized machine-readable data formats, such as the SARS-CoV-2 Genome Browser.",10.1101/2020.05.04.075945,gmk4qo4i,"['Background', 'Researchers', 'are', 'generating', 'molecular', 'data', 'pertaining', 'to', 'the', 'SARS', 'CoV', '2', 'RNA', 'genome', 'and', 'its', 'proteins', 'at', 'an', 'unprecedented', 'rate', 'during', 'the', 'COVID', '19', 'pandemic', 'As', 'a', 'result', 'there', 'is', 'a', 'critical', 'need', 'for', 'rapid', 'and', 'continuously', 'updated', 'access', 'to', 'the', 'latest', 'molecular', 'data', 'in', 'a', 'format', 'in', 'which', 'all', 'data', 'can', 'be', 'quickly', 'cross', 'referenced', 'and', 'compared', 'We', 'adapted', 'our', 'genome', 'browser', 'visualization', 'tool', 'to', 'the', 'viral', 'genome', 'for', 'this', 'purpose', 'Molecular', 'data', 'curated', 'from', 'published', 'studies', 'or', 'from', 'database', 'submissions', 'are', 'mapped', 'to', 'the', 'viral', 'genome', 'and', 'grouped', 'together', 'into', 'annotation', 'tracks', 'where', 'they', 'can', 'be', 'visualized', 'along', 'the', 'linear', 'map', 'of', 'the', 'viral', 'genome', 'sequence', 'and', 'programmatically', 'downloaded', 'in', 'standard', 'format', 'for', 'analysis', 'Results', 'The', 'UCSC', 'Genome', 'Browser', 'for', 'SARS', 'CoV', '2', 'https', 'genome', 'ucsc', 'edu', 'covid19', 'html', 'provides', 'continuously', 'updated', 'access', 'to', 'the', 'mutations', 'in', 'the', 'many', 'thousands', 'of', 'SARS', 'CoV', '2', 'genomes', 'deposited', 'in', 'GISAID', 'and', 'the', 'international', 'nucleotide', 'sequencing', 'databases', 'displayed', 'alongside', 'phylogenetic', 'trees', 'These', 'data', 'are', 'augmented', 'with', 'alignments', 'of', 'bat', 'pangolin', 'and', 'other', 'animal', 'and', 'human', 'coronavirus', 'genomes', 'including', 'per', 'base', 'evolutionary', 'rate', 'analysis', 'All', 'available', 'annotations', 'are', 'cross', 'referenced', 'on', 'the', 'virus', 'genome', 'including', 'those', 'from', 'major', 'databases', 'PDB', 'RFAM', 'IEDB', 'UniProt', 'as', 'well', 'as', 'up', 'to', 'date', 'individual', 'results', 'from', 'preprints', 'Annotated', 'data', 'include', 'predicted', 'and', 'validated', 'immune', 'epitopes', 'promising', 'antibodies', 'RT', 'PCR', 'and', 'sequencing', 'primers', 'CRISPR', 'guides', 'from', 'research', 'diagnostics', 'vaccines', 'and', 'therapies', 'and', 'points', 'of', 'interaction', 'between', 'human', 'and', 'viral', 'genes', 'As', 'a', 'community', 'resource', 'any', 'user', 'can', 'add', 'manual', 'annotations', 'which', 'are', 'quality', 'checked', 'and', 'shared', 'publicly', 'on', 'the', 'browser', 'the', 'next', 'day', 'Conclusions', 'We', 'invite', 'all', 'investigators', 'to', 'contribute', 'additional', 'data', 'and', 'annotations', 'to', 'this', 'resource', 'to', 'accelerate', 'research', 'and', 'development', 'activities', 'globally', 'Contact', 'us', 'at', 'genome', 'www', 'soe', 'ucsc', 'edu', 'with', 'data', 'suggestions', 'or', 'requests', 'for', 'support', 'for', 'adding', 'data', 'Rapid', 'sharing', 'of', 'data', 'will', 'accelerate', 'SARS', 'CoV', '2', 'research', 'especially', 'when', 'researchers', 'take', 'time', 'to', 'integrate', 'their', 'data', 'with', 'those', 'from', 'other', 'labs', 'on', 'a', 'widely', 'used', 'community', 'browser', 'platform', 'with', 'standardized', 'machine', 'readable', 'data', 'formats', 'such', 'as', 'the', 'SARS', 'CoV', '2', 'Genome', 'Browser', '']"
73070,Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent sera,2020-06-17,,http://medrxiv.org/cgi/content/short/2020.06.15.20131672v1?rss=1,"The reliable detection of immunoglobulin G (IgG) or total antibodies directed against the novel severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is important for clinical diagnostics and epidemiological studies. Here, we compare the diagnostic accuracy of six commercially available SARS-CoV-2 IgG (Abbott SARS-CoV-2 IgG; Diasorin Liaison SARS-CoV-2 S1/2 IgG; Epitope EDI Novel Coronavirus COVID-19 IgG ELISA Kit; Euroimmun Anti-SARS-CoV-2 ELISA (IgG); Mikrogen recomWell SARS-CoV-2 IgG) or total SARS-CoV-2 antibody assays (Roche Elecsys Anti-SARS-CoV-2). The test sensitivities were analyzed with a set of 34 sera obtained from 26 patients after PCR-confirmed SARS-CoV-2 infection and varied from 76.9% (Euroimmun) to 96.2% (Abbott). The majority of assay results were confirmed in a laboratory-developed plaque reduction neutralization test and by a SARS-CoV-2 IgG-specific line assay including measurement of generally low IgG avidities (Mikrogen recomLine Coronavirus IgG [Aviditaet], prototype). Moreover, 100 stored sera collected during summer 2018 (N = 50) and winter season 2018/2019 (N = 50) were included to demonstrate test specificities. These varied from 96.0% (DiaSorin) to 100% (Epitope EDI). A subset of sera were retested with a lateral flow test (STANDARD Q COVID-19 IgM/IgG Duo) and a considerably lower sensitivity was noted. Overall, the diagnostic accuracy of the six SARS-CoV-2 IgG/total antibody assays was good and varied from 92.9% (Euroimmun) to 98.4% (Abbott). Due to the different specificities, results of commercially available SARS-CoV-2 antibody tests should be interpreted with caution. A high proportion of antibody-positive patient sera demonstrated neutralizing capacity against SARS-CoV-2.",10.1101/2020.06.15.20131672,tbr2ynx0,"['The', 'reliable', 'detection', 'of', 'immunoglobulin', 'G', 'IgG', 'or', 'total', 'antibodies', 'directed', 'against', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'type', '2', 'SARS', 'CoV', '2', 'is', 'important', 'for', 'clinical', 'diagnostics', 'and', 'epidemiological', 'studies', 'Here', 'we', 'compare', 'the', 'diagnostic', 'accuracy', 'of', 'six', 'commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'Abbott', 'SARS', 'CoV', '2', 'IgG', 'Diasorin', 'Liaison', 'SARS', 'CoV', '2', 'S1', '2', 'IgG', 'Epitope', 'EDI', 'Novel', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Kit', 'Euroimmun', 'Anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Mikrogen', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'or', 'total', 'SARS', 'CoV', '2', 'antibody', 'assays', 'Roche', 'Elecsys', 'Anti', 'SARS', 'CoV', '2', 'The', 'test', 'sensitivities', 'were', 'analyzed', 'with', 'a', 'set', 'of', '34', 'sera', 'obtained', 'from', '26', 'patients', 'after', 'PCR', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'and', 'varied', 'from', '76', '9', 'Euroimmun', 'to', '96', '2', 'Abbott', 'The', 'majority', 'of', 'assay', 'results', 'were', 'confirmed', 'in', 'a', 'laboratory', 'developed', 'plaque', 'reduction', 'neutralization', 'test', 'and', 'by', 'a', 'SARS', 'CoV', '2', 'IgG', 'specific', 'line', 'assay', 'including', 'measurement', 'of', 'generally', 'low', 'IgG', 'avidities', 'Mikrogen', 'recomLine', 'Coronavirus', 'IgG', 'Aviditaet', 'prototype', 'Moreover', '100', 'stored', 'sera', 'collected', 'during', 'summer', '2018', 'N', '50', 'and', 'winter', 'season', '2018', '2019', 'N', '50', 'were', 'included', 'to', 'demonstrate', 'test', 'specificities', 'These', 'varied', 'from', '96', '0', 'DiaSorin', 'to', '100', 'Epitope', 'EDI', 'A', 'subset', 'of', 'sera', 'were', 'retested', 'with', 'a', 'lateral', 'flow', 'test', 'STANDARD', 'Q', 'COVID', '19', 'IgM', 'IgG', 'Duo', 'and', 'a', 'considerably', 'lower', 'sensitivity', 'was', 'noted', 'Overall', 'the', 'diagnostic', 'accuracy', 'of', 'the', 'six', 'SARS', 'CoV', '2', 'IgG', 'total', 'antibody', 'assays', 'was', 'good', 'and', 'varied', 'from', '92', '9', 'Euroimmun', 'to', '98', '4', 'Abbott', 'Due', 'to', 'the', 'different', 'specificities', 'results', 'of', 'commercially', 'available', 'SARS', 'CoV', '2', 'antibody', 'tests', 'should', 'be', 'interpreted', 'with', 'caution', 'A', 'high', 'proportion', 'of', 'antibody', 'positive', 'patient', 'sera', 'demonstrated', 'neutralizing', 'capacity', 'against', 'SARS', 'CoV', '2', '']"
73082,Measuring COVID-19 and Influenza in the Real World via Person-Generated Health Data,2020-05-30,,http://medrxiv.org/cgi/content/short/2020.05.28.20115964v1?rss=1,"Background: Since the beginning of the COVID-19 pandemic data from smartphones and connected sensors has been used to learn about symptoms presentation and management outside the clinic walls. However, reports on the validity of such data are still sparse, especially when it comes to symptom progression and relevance of wearable sensors. Objective: To understand the relevance of Person-GeneratedHealth Data (PGHD) as a means for early detection, monitoring and management of COVID-19 in everyday life. This includes quantifying prevalence and progression of symptoms from self-reports as well as changes in activity and physiological parameters continuously measured from wearable sensors, and contextualizing findings for COVID-19 patients with those from cohorts of flu patients. Design, Setting, and Participants: Retrospective digital cohort study of individuals with a self-reported positive SARS-CoV-2 or influenza test followed over the period 2019-12-02 to2020-04-27. Three cohorts were derived: Patients who self-reported being diagnosed with flu prior to the SARS-CoV-2 pandemic (N=6270, of which 1226 also contributed sensorPGHD); Patients who reported being diagnosed with flu during the SARS-CoV-2 pandemic (N=426, of which 85 also shared sensor PGHD); and patients who reported being diagnosed withCOVID-19 (N=230, of which sensor PGHD was available for 41).The cohorts were derived from a large-scale digital participatory surveillance study designed to track Influenza-like Illness(ILI) incidence and burden over time. Exposures: Self-reported demographic data, comorbidities, and symptoms experienced during a diagnosed ILI episode, including SARS-CoV-2.Physiological and behavioral parameters measured daily from commercial wearable sensors, includingResting Heart Rate (RHR), total step count, and nightly sleep hours. Main Outcomes and Measures: We investigated the percent-age of individuals experiencing symptoms of a given type (e.g.shortness of breath) across demographic groups and over time. We examined illness duration, and care seeking behavior, and how RHR, step count, and nightly sleep hours deviated from expected behavior on healthy days over the course of the infection episode. Results: Self-reported symptoms of COVID-19 present differently from flu. COVID-19 cases tended to last longer than flu(median of 12 vs. 9 days), are uniquely characterized by chest pain/pressure, shortness of breath, and anosmia. The fraction of elevated RHR measurements collected daily from commercial wearable devices rise significantly in the 2 days surrounding ILI symptoms onset, but does not appear to do so in a way specific to COVID-19. Steps lost due to COVID-19 persists for longer. Conclusion and Relevance: PGHD can be a valid source of longitudinal real world data to detect and monitor COVID-19-related symptoms and behaviors at population scale. PGHD may provide continuous, near realtime feedback to intervention effectiveness that otherwise requires waiting for symptoms to develop into contacts with the healthcare system. It has also the potential to increase pre-test probability of other downstream diagnostics. To effectively leverage PGHD for participatory surveillance it is crucial to invest in the creation of trusted, long-term communication channels with individuals through whichdata can be efficiently collected, consented, and contextualized,while protecting the privacy of individuals and ultimately facilitating the transition in and out of care.",10.1101/2020.05.28.20115964,2bz9u8k0,"['Background', 'Since', 'the', 'beginning', 'of', 'the', 'COVID', '19', 'pandemic', 'data', 'from', 'smartphones', 'and', 'connected', 'sensors', 'has', 'been', 'used', 'to', 'learn', 'about', 'symptoms', 'presentation', 'and', 'management', 'outside', 'the', 'clinic', 'walls', 'However', 'reports', 'on', 'the', 'validity', 'of', 'such', 'data', 'are', 'still', 'sparse', 'especially', 'when', 'it', 'comes', 'to', 'symptom', 'progression', 'and', 'relevance', 'of', 'wearable', 'sensors', 'Objective', 'To', 'understand', 'the', 'relevance', 'of', 'Person', 'GeneratedHealth', 'Data', 'PGHD', 'as', 'a', 'means', 'for', 'early', 'detection', 'monitoring', 'and', 'management', 'of', 'COVID', '19', 'in', 'everyday', 'life', 'This', 'includes', 'quantifying', 'prevalence', 'and', 'progression', 'of', 'symptoms', 'from', 'self', 'reports', 'as', 'well', 'as', 'changes', 'in', 'activity', 'and', 'physiological', 'parameters', 'continuously', 'measured', 'from', 'wearable', 'sensors', 'and', 'contextualizing', 'findings', 'for', 'COVID', '19', 'patients', 'with', 'those', 'from', 'cohorts', 'of', 'flu', 'patients', 'Design', 'Setting', 'and', 'Participants', 'Retrospective', 'digital', 'cohort', 'study', 'of', 'individuals', 'with', 'a', 'self', 'reported', 'positive', 'SARS', 'CoV', '2', 'or', 'influenza', 'test', 'followed', 'over', 'the', 'period', '2019', '12', '02', 'to2020', '04', '27', 'Three', 'cohorts', 'were', 'derived', 'Patients', 'who', 'self', 'reported', 'being', 'diagnosed', 'with', 'flu', 'prior', 'to', 'the', 'SARS', 'CoV', '2', 'pandemic', 'N', '6270', 'of', 'which', '1226', 'also', 'contributed', 'sensorPGHD', 'Patients', 'who', 'reported', 'being', 'diagnosed', 'with', 'flu', 'during', 'the', 'SARS', 'CoV', '2', 'pandemic', 'N', '426', 'of', 'which', '85', 'also', 'shared', 'sensor', 'PGHD', 'and', 'patients', 'who', 'reported', 'being', 'diagnosed', 'withCOVID', '19', 'N', '230', 'of', 'which', 'sensor', 'PGHD', 'was', 'available', 'for', '41', 'The', 'cohorts', 'were', 'derived', 'from', 'a', 'large', 'scale', 'digital', 'participatory', 'surveillance', 'study', 'designed', 'to', 'track', 'Influenza', 'like', 'Illness', 'ILI', 'incidence', 'and', 'burden', 'over', 'time', 'Exposures', 'Self', 'reported', 'demographic', 'data', 'comorbidities', 'and', 'symptoms', 'experienced', 'during', 'a', 'diagnosed', 'ILI', 'episode', 'including', 'SARS', 'CoV', '2', 'Physiological', 'and', 'behavioral', 'parameters', 'measured', 'daily', 'from', 'commercial', 'wearable', 'sensors', 'includingResting', 'Heart', 'Rate', 'RHR', 'total', 'step', 'count', 'and', 'nightly', 'sleep', 'hours', 'Main', 'Outcomes', 'and', 'Measures', 'We', 'investigated', 'the', 'percent', 'age', 'of', 'individuals', 'experiencing', 'symptoms', 'of', 'a', 'given', 'type', 'e', 'g', 'shortness', 'of', 'breath', 'across', 'demographic', 'groups', 'and', 'over', 'time', 'We', 'examined', 'illness', 'duration', 'and', 'care', 'seeking', 'behavior', 'and', 'how', 'RHR', 'step', 'count', 'and', 'nightly', 'sleep', 'hours', 'deviated', 'from', 'expected', 'behavior', 'on', 'healthy', 'days', 'over', 'the', 'course', 'of', 'the', 'infection', 'episode', 'Results', 'Self', 'reported', 'symptoms', 'of', 'COVID', '19', 'present', 'differently', 'from', 'flu', 'COVID', '19', 'cases', 'tended', 'to', 'last', 'longer', 'than', 'flu', 'median', 'of', '12', 'vs', '9', 'days', 'are', 'uniquely', 'characterized', 'by', 'chest', 'pain', 'pressure', 'shortness', 'of', 'breath', 'and', 'anosmia', 'The', 'fraction', 'of', 'elevated', 'RHR', 'measurements', 'collected', 'daily', 'from', 'commercial', 'wearable', 'devices', 'rise', 'significantly', 'in', 'the', '2', 'days', 'surrounding', 'ILI', 'symptoms', 'onset', 'but', 'does', 'not', 'appear', 'to', 'do', 'so', 'in', 'a', 'way', 'specific', 'to', 'COVID', '19', 'Steps', 'lost', 'due', 'to', 'COVID', '19', 'persists', 'for', 'longer', 'Conclusion', 'and', 'Relevance', 'PGHD', 'can', 'be', 'a', 'valid', 'source', 'of', 'longitudinal', 'real', 'world', 'data', 'to', 'detect', 'and', 'monitor', 'COVID', '19', 'related', 'symptoms', 'and', 'behaviors', 'at', 'population', 'scale', 'PGHD', 'may', 'provide', 'continuous', 'near', 'realtime', 'feedback', 'to', 'intervention', 'effectiveness', 'that', 'otherwise', 'requires', 'waiting', 'for', 'symptoms', 'to', 'develop', 'into', 'contacts', 'with', 'the', 'healthcare', 'system', 'It', 'has', 'also', 'the', 'potential', 'to', 'increase', 'pre', 'test', 'probability', 'of', 'other', 'downstream', 'diagnostics', 'To', 'effectively', 'leverage', 'PGHD', 'for', 'participatory', 'surveillance', 'it', 'is', 'crucial', 'to', 'invest', 'in', 'the', 'creation', 'of', 'trusted', 'long', 'term', 'communication', 'channels', 'with', 'individuals', 'through', 'whichdata', 'can', 'be', 'efficiently', 'collected', 'consented', 'and', 'contextualized', 'while', 'protecting', 'the', 'privacy', 'of', 'individuals', 'and', 'ultimately', 'facilitating', 'the', 'transition', 'in', 'and', 'out', 'of', 'care', '']"
73274,Suspected sepsis in a 10-week-old infant and SARS-CoV-2 detection in cerebrospinal fluid and pharynx/ 10 Wochen alter Säugling mit Sepsisverdacht und SARS-CoV-2-Nachweis in Liquor und Rachen,2020,Monatsschr. Kinderheilkd.,https://doi.org/10.1007/s00112-020-00942-8,A young male infant was referred to the emergency department with apparent acute sepsis. The laboratory results were compatible with a viral infection except for a slightly elevated procalcitonin level. Due to the clinical severity intravenous antibiotic treatment was started immediately. Cerebrospinal fluid and urine testing initially showed no infection focus but then SARS-CoV‑2 was detected in the lower pharynx and cerebrospinal fluid. The clinical condition of the infant rapidly improved but whether this was due to symptomatic or antibiotic treatment remained unknown. There is still a considerable lack of experience regarding diagnostics and treatment of pediatric SARS-CoV-2 infections.,10.1007/s00112-020-00942-8,m8fl96zb,"['A', 'young', 'male', 'infant', 'was', 'referred', 'to', 'the', 'emergency', 'department', 'with', 'apparent', 'acute', 'sepsis', 'The', 'laboratory', 'results', 'were', 'compatible', 'with', 'a', 'viral', 'infection', 'except', 'for', 'a', 'slightly', 'elevated', 'procalcitonin', 'level', 'Due', 'to', 'the', 'clinical', 'severity', 'intravenous', 'antibiotic', 'treatment', 'was', 'started', 'immediately', 'Cerebrospinal', 'fluid', 'and', 'urine', 'testing', 'initially', 'showed', 'no', 'infection', 'focus', 'but', 'then', 'SARS', 'CoV', '2', 'was', 'detected', 'in', 'the', 'lower', 'pharynx', 'and', 'cerebrospinal', 'fluid', 'The', 'clinical', 'condition', 'of', 'the', 'infant', 'rapidly', 'improved', 'but', 'whether', 'this', 'was', 'due', 'to', 'symptomatic', 'or', 'antibiotic', 'treatment', 'remained', 'unknown', 'There', 'is', 'still', 'a', 'considerable', 'lack', 'of', 'experience', 'regarding', 'diagnostics', 'and', 'treatment', 'of', 'pediatric', 'SARS', 'CoV', '2', 'infections', '']"
73671,Pitfalls in SARS-CoV-2 PCR diagnostics,2020-06-04,bioRxiv,https://doi.org/10.1101/2020.06.03.132357,"To combat the COVID-19 pandemic, millions of PCR tests are performed worldwide. Any deviation of the diagnostic sensitivity and specificity will reduce the predictive values of the test. Here, we report the occurrence of contaminations of commercial primers/probe sets with the SARS-CoV-2 target sequence of the RT-qPCR as an example for pitfalls during PCR diagnostics affecting diagnostic specificity. In several purchased in-house primers/probe sets, quantification cycle values as low as 17 were measured for negative control samples. However, there were also primers/probe sets that displayed very low-level contaminations, which were detected only during thorough internal validation. Hence, it appears imperative to pre-test each batch of reagents extensively before use in routine diagnosis, to avoid false-positive results and low positive predictive value in low-prevalence situations. As such, contaminations may have happened more widely, COVID-19 diagnostic results should be re-assessed retrospectively to validate the epidemiological basis for control measures.",10.1101/2020.06.03.132357,4xf76n6a,"['To', 'combat', 'the', 'COVID', '19', 'pandemic', 'millions', 'of', 'PCR', 'tests', 'are', 'performed', 'worldwide', 'Any', 'deviation', 'of', 'the', 'diagnostic', 'sensitivity', 'and', 'specificity', 'will', 'reduce', 'the', 'predictive', 'values', 'of', 'the', 'test', 'Here', 'we', 'report', 'the', 'occurrence', 'of', 'contaminations', 'of', 'commercial', 'primers', 'probe', 'sets', 'with', 'the', 'SARS', 'CoV', '2', 'target', 'sequence', 'of', 'the', 'RT', 'qPCR', 'as', 'an', 'example', 'for', 'pitfalls', 'during', 'PCR', 'diagnostics', 'affecting', 'diagnostic', 'specificity', 'In', 'several', 'purchased', 'in', 'house', 'primers', 'probe', 'sets', 'quantification', 'cycle', 'values', 'as', 'low', 'as', '17', 'were', 'measured', 'for', 'negative', 'control', 'samples', 'However', 'there', 'were', 'also', 'primers', 'probe', 'sets', 'that', 'displayed', 'very', 'low', 'level', 'contaminations', 'which', 'were', 'detected', 'only', 'during', 'thorough', 'internal', 'validation', 'Hence', 'it', 'appears', 'imperative', 'to', 'pre', 'test', 'each', 'batch', 'of', 'reagents', 'extensively', 'before', 'use', 'in', 'routine', 'diagnosis', 'to', 'avoid', 'false', 'positive', 'results', 'and', 'low', 'positive', 'predictive', 'value', 'in', 'low', 'prevalence', 'situations', 'As', 'such', 'contaminations', 'may', 'have', 'happened', 'more', 'widely', 'COVID', '19', 'diagnostic', 'results', 'should', 'be', 're', 'assessed', 'retrospectively', 'to', 'validate', 'the', 'epidemiological', 'basis', 'for', 'control', 'measures', '']"
74114,Failure of the cobas(R) SARS-CoV-2 (Roche) E-gene assay is associated with a C-to-T transition at position 26340 of the SARS-CoV-2 genome,2020-05-03,,http://medrxiv.org/cgi/content/short/2020.04.28.20083337v1?rss=1,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of RT-PCR tests have been developed to identify SARS-CoV-2, targeting multiple regions in the viral genome. In comparison to other RNA viruses the mutation rate of SARS-CoV-2 is moderate, however given the large number of transmission chains it is prudent to monitor circulating viruses for mutations that might compromise these tests. Here we report the identification of a C-to-T transition at position 26340 of the SARS-CoV-2 genome which is associated with failure of the cobas(R) SARS-CoV-2 E-gene assay. This variant was detected in four health care workers from the same team. Whole genome sequencing of SARS-CoV-2 showed all four to carry genetically identical viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently on three occasions. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect the RT-PCRs used in diagnostics. Additionally, it argues that two regions in the SARS-CoV-2 should be targeted in RT-PCRs to avoid false negatives.",10.1101/2020.04.28.20083337,vd62r8qu,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'RT', 'PCR', 'tests', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'regions', 'in', 'the', 'viral', 'genome', 'In', 'comparison', 'to', 'other', 'RNA', 'viruses', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'however', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'mutations', 'that', 'might', 'compromise', 'these', 'tests', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'T', 'transition', 'at', 'position', '26340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'R', 'SARS', 'CoV', '2', 'E', 'gene', 'assay', 'This', 'variant', 'was', 'detected', 'in', 'four', 'health', 'care', 'workers', 'from', 'the', 'same', 'team', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'four', 'to', 'carry', 'genetically', 'identical', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'on', 'three', 'occasions', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'the', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'in', 'RT', 'PCRs', 'to', 'avoid', 'false', 'negatives', '']"
74274,Optimized qRT-PCR approach for the detection of intra- and extra-cellular SARS-CoV-2 RNAs,2020-04-25,bioRxiv,https://doi.org/10.1101/2020.04.20.052258,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19 which has become a global concern due to its rapid spread. Meanwhile, increased demand in testing has led to shortage of reagents, supplies, and compromised the performance of diagnostic laboratories in many countries. Both the world health organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate interpretation of the test results especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in the diagnostics as well as in research labs using a low cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infection and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",10.1101/2020.04.20.052258,t9jaspf2,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'in', 'testing', 'has', 'led', 'to', 'shortage', 'of', 'reagents', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'world', 'health', 'organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'the', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
74556,A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing,2020-04-10,bioRxiv,https://doi.org/10.1101/2020.04.07.029199,"There is currently an urgent unmet need to increase coronavirus disease 2019 (COVID-19) testing capability to effectively respond to the COVID-19 pandemic. However, the current shortage in RNA extraction reagents as well as limitations in qPCR protocols have resulted in bottlenecks in testing capacity. Herein, we describe a novel molecular diagnostic for COVID-19 based on Sanger sequencing. This assay uses the addition of a frame-shifted spike-in, a modified PCR master mix, and custom Sanger sequencing data analysis to detect and quantify SARS-CoV-2 RNA at a limit of detection comparable to existing qPCR-based assays, at 10-20 genome copy equivalents. Crucially, our assay was able to detect SARS-CoV-2 RNA from viral particles suspended in transport media that was directly added to the PCR master mix, suggesting that RNA extraction can be skipped entirely without any degradation of test performance. Since Sanger sequencing instruments are widespread in clinical laboratories and commonly have built-in liquid handling automation to support up to 3840 samples per instrument per day, the widespread adoption of qSanger COVID-19 diagnostics can unlock more than 1,000,000 tests per day in the US.",10.1101/2020.04.07.029199,eui41zyg,"['There', 'is', 'currently', 'an', 'urgent', 'unmet', 'need', 'to', 'increase', 'coronavirus', 'disease', '2019', 'COVID', '19', 'testing', 'capability', 'to', 'effectively', 'respond', 'to', 'the', 'COVID', '19', 'pandemic', 'However', 'the', 'current', 'shortage', 'in', 'RNA', 'extraction', 'reagents', 'as', 'well', 'as', 'limitations', 'in', 'qPCR', 'protocols', 'have', 'resulted', 'in', 'bottlenecks', 'in', 'testing', 'capacity', 'Herein', 'we', 'describe', 'a', 'novel', 'molecular', 'diagnostic', 'for', 'COVID', '19', 'based', 'on', 'Sanger', 'sequencing', 'This', 'assay', 'uses', 'the', 'addition', 'of', 'a', 'frame', 'shifted', 'spike', 'in', 'a', 'modified', 'PCR', 'master', 'mix', 'and', 'custom', 'Sanger', 'sequencing', 'data', 'analysis', 'to', 'detect', 'and', 'quantify', 'SARS', 'CoV', '2', 'RNA', 'at', 'a', 'limit', 'of', 'detection', 'comparable', 'to', 'existing', 'qPCR', 'based', 'assays', 'at', '10', '20', 'genome', 'copy', 'equivalents', 'Crucially', 'our', 'assay', 'was', 'able', 'to', 'detect', 'SARS', 'CoV', '2', 'RNA', 'from', 'viral', 'particles', 'suspended', 'in', 'transport', 'media', 'that', 'was', 'directly', 'added', 'to', 'the', 'PCR', 'master', 'mix', 'suggesting', 'that', 'RNA', 'extraction', 'can', 'be', 'skipped', 'entirely', 'without', 'any', 'degradation', 'of', 'test', 'performance', 'Since', 'Sanger', 'sequencing', 'instruments', 'are', 'widespread', 'in', 'clinical', 'laboratories', 'and', 'commonly', 'have', 'built', 'in', 'liquid', 'handling', 'automation', 'to', 'support', 'up', 'to', '3840', 'samples', 'per', 'instrument', 'per', 'day', 'the', 'widespread', 'adoption', 'of', 'qSanger', 'COVID', '19', 'diagnostics', 'can', 'unlock', 'more', 'than', '1', '000', '000', 'tests', 'per', 'day', 'in', 'the', 'US', '']"
75563,A CRISPR-based SARS-CoV-2 diagnostic assay that is robust against viral evolution and RNA editing,2020-07-03,bioRxiv,https://doi.org/10.1101/2020.07.03.185850,"Extensive testing is essential to break the transmission of the new coronavirus SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Recently, CRISPR-based diagnostics have emerged as attractive alternatives to quantitative real-time PCR due to their faster turnaround time and their potential to be used in point-of-care testing scenarios. However, existing CRISPR-based assays for COVID-19 have not considered viral genome mutations and RNA editing in human cells. Here, we present the VaNGuard (Variant Nucleotide Guard) test that is not only specific and sensitive for SARS-CoV-2, but can also detect the virus when its genome or transcriptome has evolved or has been edited by deaminases in infected human cells. We show that an engineered AsCas12a enzyme is more tolerant of mismatches than wildtype LbCas12a and that multiplexed Cas12a targeting can overcome the presence of single nucleotide variations. Our assay can be completed in 30 minutes with a dipstick for a rapid point-of-care test.",10.1101/2020.07.03.185850,648r94o8,"['Extensive', 'testing', 'is', 'essential', 'to', 'break', 'the', 'transmission', 'of', 'the', 'new', 'coronavirus', 'SARS', 'CoV', '2', 'which', 'causes', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'Recently', 'CRISPR', 'based', 'diagnostics', 'have', 'emerged', 'as', 'attractive', 'alternatives', 'to', 'quantitative', 'real', 'time', 'PCR', 'due', 'to', 'their', 'faster', 'turnaround', 'time', 'and', 'their', 'potential', 'to', 'be', 'used', 'in', 'point', 'of', 'care', 'testing', 'scenarios', 'However', 'existing', 'CRISPR', 'based', 'assays', 'for', 'COVID', '19', 'have', 'not', 'considered', 'viral', 'genome', 'mutations', 'and', 'RNA', 'editing', 'in', 'human', 'cells', 'Here', 'we', 'present', 'the', 'VaNGuard', 'Variant', 'Nucleotide', 'Guard', 'test', 'that', 'is', 'not', 'only', 'specific', 'and', 'sensitive', 'for', 'SARS', 'CoV', '2', 'but', 'can', 'also', 'detect', 'the', 'virus', 'when', 'its', 'genome', 'or', 'transcriptome', 'has', 'evolved', 'or', 'has', 'been', 'edited', 'by', 'deaminases', 'in', 'infected', 'human', 'cells', 'We', 'show', 'that', 'an', 'engineered', 'AsCas12a', 'enzyme', 'is', 'more', 'tolerant', 'of', 'mismatches', 'than', 'wildtype', 'LbCas12a', 'and', 'that', 'multiplexed', 'Cas12a', 'targeting', 'can', 'overcome', 'the', 'presence', 'of', 'single', 'nucleotide', 'variations', 'Our', 'assay', 'can', 'be', 'completed', 'in', '30', 'minutes', 'with', 'a', 'dipstick', 'for', 'a', 'rapid', 'point', 'of', 'care', 'test', '']"
75721,"Features, Evaluation and Treatment Coronavirus (COVID-19) Discussing the ABCs of Health Security-Antibiotic Resistance, Biothreats, and Coronavirus",2020,StatPearls,https://doi.org/10.1001/jama.2019.21022,"According to the World Health Organization (WHO), viral diseases continue to emerge and represent a serious issue to public health In the last twenty years, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003, and H1N1 influenza in 2009, have been recorded Most recently, the Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 In a timeline that reaches the present day, an epidemic of cases with unexplained low respiratory infections detected in Wuhan, the largest metropolitan area in China's Hubei province, was first reported to the WHO Country Office in China, on December 31, 2019 Published literature can trace the beginning of symptomatic individuals back to the beginning of December 2019 As they were unable to identify the causative agent, these first cases were classified as ""pneumonia of unknown etiology "" The Chinese Center for Disease Control and Prevention (CDC) and local CDCs organized an intensive outbreak investigation program The etiology of this illness is now attributed to a novel virus belonging to the coronavirus (CoV) family, COVID-19 On February 11, 2020, the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, announced that the disease caused by this new CoV was a ""COVID-19,"" which is the acronym of ""coronavirus disease 2019"" In the past twenty years, two additional coronavirus epidemics have occurred SARS-CoV provoked a large-scale epidemic beginning in China and involving two dozen countries with approximately 8000 cases and 800 deaths, and the MERS-CoV that began in Saudi Arabia and has approximately 2,500 cases and 800 deaths and still causes as sporadic cases This new virus seems to be very contagious and has quickly spread globally In a meeting on January 30, 2020, per the International Health Regulations (IHR, 2005), the outbreak was declared by the WHO a Public Health Emergency of International Concern (PHEIC) as it had spread to 18 countries with four countries reporting human-to-human transmission An additional landmark occurred on February 26, 2020, as the first case of the disease, not imported from China, was recorded in the United States Initially, the new virus was called 2019-nCoV Subsequently, the task of experts of the International Committee on Taxonomy of Viruses (ICTV) termed it the SARS-CoV-2 virus as it is very similar to the one that caused the SARS outbreak (SARS-CoVs) The CoVs have become the major pathogens of emerging respiratory disease outbreaks They are a large family of single-stranded RNA viruses (+ssRNA) that can be isolated in different animal species For reasons yet to be explained, these viruses can cross species barriers and can cause, in humans, illness ranging from the common cold to more severe diseases such as MERS and SARS Interestingly, these latter viruses have probably originated from bats and then moving into other mammalian hosts — the Himalayan palm civet for SARS-CoV, and the dromedary camel for MERS-CoV — before jumping to humans The dynamics of SARS-Cov-2 are currently unknown, but there is speculation that it also has an animal origin The potential for these viruses to grow to become a pandemic worldwide seems to be a serious public health risk Concerning COVID-19, the WHO raised the threat to the CoV epidemic to the ""very high"" level, on February 28, 2020 Probably, the effects of the epidemic caused by the new CoV has yet to emerge as the situation is quickly evolving World governments are at work to establish countermeasures to stem possible devastating effects Health organizations coordinate information flows and issues directives and guidelines to best mitigate the impact of the threat At the same time, scientists around the world work tirelessly, and information about the transmission mechanisms, the clinical spectrum of disease, new diagnostics, and prevention and therapeutic strategies are rapidly developing Many uncertainties remain with regard to both the virus-host interaction and the evolution of the epidemic, with specific reference to the times when the epidemic will reach its peak At the moment, the therapeutic strategies to deal with the infection are only supportive, and prevention aimed at reducing transmission in the community is our best weapon Aggressive isolation measures in China have led to a progressive reduction of cases in the last few days In Italy, in geographic regions of the north of the peninsula, political and health authorities are making incredible efforts to contain a shock wave that is severely testing the health system In the midst of the crisis, the authors have chosen to use the ""Statpearls"" platform because, within the PubMed scenario, it represents a unique tool that may allow them to make updates in real-time The aim, therefore, is to collect information and scientific evidence and to provide an overview of the topic that will be continuously updated",10.1001/jama.2019.21022,zzpw375i,"['According', 'to', 'the', 'World', 'Health', 'Organization', 'WHO', 'viral', 'diseases', 'continue', 'to', 'emerge', 'and', 'represent', 'a', 'serious', 'issue', 'to', 'public', 'health', 'In', 'the', 'last', 'twenty', 'years', 'several', 'viral', 'epidemics', 'such', 'as', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'in', '2002', 'to', '2003', 'and', 'H1N1', 'influenza', 'in', '2009', 'have', 'been', 'recorded', 'Most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'first', 'identified', 'in', 'Saudi', 'Arabia', 'in', '2012', 'In', 'a', 'timeline', 'that', 'reaches', 'the', 'present', 'day', 'an', 'epidemic', 'of', 'cases', 'with', 'unexplained', 'low', 'respiratory', 'infections', 'detected', 'in', 'Wuhan', 'the', 'largest', 'metropolitan', 'area', 'in', 'China', 's', 'Hubei', 'province', 'was', 'first', 'reported', 'to', 'the', 'WHO', 'Country', 'Office', 'in', 'China', 'on', 'December', '31', '2019', 'Published', 'literature', 'can', 'trace', 'the', 'beginning', 'of', 'symptomatic', 'individuals', 'back', 'to', 'the', 'beginning', 'of', 'December', '2019', 'As', 'they', 'were', 'unable', 'to', 'identify', 'the', 'causative', 'agent', 'these', 'first', 'cases', 'were', 'classified', 'as', 'pneumonia', 'of', 'unknown', 'etiology', 'The', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'and', 'local', 'CDCs', 'organized', 'an', 'intensive', 'outbreak', 'investigation', 'program', 'The', 'etiology', 'of', 'this', 'illness', 'is', 'now', 'attributed', 'to', 'a', 'novel', 'virus', 'belonging', 'to', 'the', 'coronavirus', 'CoV', 'family', 'COVID', '19', 'On', 'February', '11', '2020', 'the', 'WHO', 'Director', 'General', 'Dr', 'Tedros', 'Adhanom', 'Ghebreyesus', 'announced', 'that', 'the', 'disease', 'caused', 'by', 'this', 'new', 'CoV', 'was', 'a', 'COVID', '19', 'which', 'is', 'the', 'acronym', 'of', 'coronavirus', 'disease', '2019', 'In', 'the', 'past', 'twenty', 'years', 'two', 'additional', 'coronavirus', 'epidemics', 'have', 'occurred', 'SARS', 'CoV', 'provoked', 'a', 'large', 'scale', 'epidemic', 'beginning', 'in', 'China', 'and', 'involving', 'two', 'dozen', 'countries', 'with', 'approximately', '8000', 'cases', 'and', '800', 'deaths', 'and', 'the', 'MERS', 'CoV', 'that', 'began', 'in', 'Saudi', 'Arabia', 'and', 'has', 'approximately', '2', '500', 'cases', 'and', '800', 'deaths', 'and', 'still', 'causes', 'as', 'sporadic', 'cases', 'This', 'new', 'virus', 'seems', 'to', 'be', 'very', 'contagious', 'and', 'has', 'quickly', 'spread', 'globally', 'In', 'a', 'meeting', 'on', 'January', '30', '2020', 'per', 'the', 'International', 'Health', 'Regulations', 'IHR', '2005', 'the', 'outbreak', 'was', 'declared', 'by', 'the', 'WHO', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'PHEIC', 'as', 'it', 'had', 'spread', 'to', '18', 'countries', 'with', 'four', 'countries', 'reporting', 'human', 'to', 'human', 'transmission', 'An', 'additional', 'landmark', 'occurred', 'on', 'February', '26', '2020', 'as', 'the', 'first', 'case', 'of', 'the', 'disease', 'not', 'imported', 'from', 'China', 'was', 'recorded', 'in', 'the', 'United', 'States', 'Initially', 'the', 'new', 'virus', 'was', 'called', '2019', 'nCoV', 'Subsequently', 'the', 'task', 'of', 'experts', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'ICTV', 'termed', 'it', 'the', 'SARS', 'CoV', '2', 'virus', 'as', 'it', 'is', 'very', 'similar', 'to', 'the', 'one', 'that', 'caused', 'the', 'SARS', 'outbreak', 'SARS', 'CoVs', 'The', 'CoVs', 'have', 'become', 'the', 'major', 'pathogens', 'of', 'emerging', 'respiratory', 'disease', 'outbreaks', 'They', 'are', 'a', 'large', 'family', 'of', 'single', 'stranded', 'RNA', 'viruses', 'ssRNA', 'that', 'can', 'be', 'isolated', 'in', 'different', 'animal', 'species', 'For', 'reasons', 'yet', 'to', 'be', 'explained', 'these', 'viruses', 'can', 'cross', 'species', 'barriers', 'and', 'can', 'cause', 'in', 'humans', 'illness', 'ranging', 'from', 'the', 'common', 'cold', 'to', 'more', 'severe', 'diseases', 'such', 'as', 'MERS', 'and', 'SARS', 'Interestingly', 'these', 'latter', 'viruses', 'have', 'probably', 'originated', 'from', 'bats', 'and', 'then', 'moving', 'into', 'other', 'mammalian', 'hosts', 'the', 'Himalayan', 'palm', 'civet', 'for', 'SARS', 'CoV', 'and', 'the', 'dromedary', 'camel', 'for', 'MERS', 'CoV', 'before', 'jumping', 'to', 'humans', 'The', 'dynamics', 'of', 'SARS', 'Cov', '2', 'are', 'currently', 'unknown', 'but', 'there', 'is', 'speculation', 'that', 'it', 'also', 'has', 'an', 'animal', 'origin', 'The', 'potential', 'for', 'these', 'viruses', 'to', 'grow', 'to', 'become', 'a', 'pandemic', 'worldwide', 'seems', 'to', 'be', 'a', 'serious', 'public', 'health', 'risk', 'Concerning', 'COVID', '19', 'the', 'WHO', 'raised', 'the', 'threat', 'to', 'the', 'CoV', 'epidemic', 'to', 'the', 'very', 'high', 'level', 'on', 'February', '28', '2020', 'Probably', 'the', 'effects', 'of', 'the', 'epidemic', 'caused', 'by', 'the', 'new', 'CoV', 'has', 'yet', 'to', 'emerge', 'as', 'the', 'situation', 'is', 'quickly', 'evolving', 'World', 'governments', 'are', 'at', 'work', 'to', 'establish', 'countermeasures', 'to', 'stem', 'possible', 'devastating', 'effects', 'Health', 'organizations', 'coordinate', 'information', 'flows', 'and', 'issues', 'directives', 'and', 'guidelines', 'to', 'best', 'mitigate', 'the', 'impact', 'of', 'the', 'threat', 'At', 'the', 'same', 'time', 'scientists', 'around', 'the', 'world', 'work', 'tirelessly', 'and', 'information', 'about', 'the', 'transmission', 'mechanisms', 'the', 'clinical', 'spectrum', 'of', 'disease', 'new', 'diagnostics', 'and', 'prevention', 'and', 'therapeutic', 'strategies', 'are', 'rapidly', 'developing', 'Many', 'uncertainties', 'remain', 'with', 'regard', 'to', 'both', 'the', 'virus', 'host', 'interaction', 'and', 'the', 'evolution', 'of', 'the', 'epidemic', 'with', 'specific', 'reference', 'to', 'the', 'times', 'when', 'the', 'epidemic', 'will', 'reach', 'its', 'peak', 'At', 'the', 'moment', 'the', 'therapeutic', 'strategies', 'to', 'deal', 'with', 'the', 'infection', 'are', 'only', 'supportive', 'and', 'prevention', 'aimed', 'at', 'reducing', 'transmission', 'in', 'the', 'community', 'is', 'our', 'best', 'weapon', 'Aggressive', 'isolation', 'measures', 'in', 'China', 'have', 'led', 'to', 'a', 'progressive', 'reduction', 'of', 'cases', 'in', 'the', 'last', 'few', 'days', 'In', 'Italy', 'in', 'geographic', 'regions', 'of', 'the', 'north', 'of', 'the', 'peninsula', 'political', 'and', 'health', 'authorities', 'are', 'making', 'incredible', 'efforts', 'to', 'contain', 'a', 'shock', 'wave', 'that', 'is', 'severely', 'testing', 'the', 'health', 'system', 'In', 'the', 'midst', 'of', 'the', 'crisis', 'the', 'authors', 'have', 'chosen', 'to', 'use', 'the', 'Statpearls', 'platform', 'because', 'within', 'the', 'PubMed', 'scenario', 'it', 'represents', 'a', 'unique', 'tool', 'that', 'may', 'allow', 'them', 'to', 'make', 'updates', 'in', 'real', 'time', 'The', 'aim', 'therefore', 'is', 'to', 'collect', 'information', 'and', 'scientific', 'evidence', 'and', 'to', 'provide', 'an', 'overview', 'of', 'the', 'topic', 'that', 'will', 'be', 'continuously', 'updated']"
75728,Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2,2020-06-26,,http://medrxiv.org/cgi/content/short/2020.06.25.20137398v1?rss=1,"The COVID-19 pandemic resulted in lockdowns all over the world thus affecting nearly all aspects of social life and also had a huge impact on global economies. Since vaccines and therapies are still not available for the population, prevention becomes desperately needed. One important aspect for prevention is the identification and subsequent isolation of contagious specimens. The currently used methods for diagnostics are time consuming and also hindered by the limited availability of reagents and reaction costs, thus presenting a bottle neck for prevention of COVID-19 spread. Here, we present a new ultra-fast test method which is ten times faster than conventional diagnostic tests using real time quantitative PCR (RT-qPCR). In addition, this ultra-fast method is easy to handle as well as cost effective. We translated published SARS-CoV-2 testing protocols from the Centers of Disease Control and Prevention (Atlanta, Georgia, USA) and the Charite Berlin (Germany) to the NEXTGENPCR (NGPCR) machine and combined it with a fluorescence-based endpoint measurement. Fluorescence was measured with a commercial blue light scanner. We confirmed the NEXTGENPCR results with commercially available positive controls. In addition, we isolated RNA from SARS-CoV-2 infected patients and achieved similar results to clinical RT-qPCR assays. Here, we could show correlation between the results obtained by NEXTGENPCR and conventional RT-qPCR.",10.1101/2020.06.25.20137398,p8rsagx2,"['The', 'COVID', '19', 'pandemic', 'resulted', 'in', 'lockdowns', 'all', 'over', 'the', 'world', 'thus', 'affecting', 'nearly', 'all', 'aspects', 'of', 'social', 'life', 'and', 'also', 'had', 'a', 'huge', 'impact', 'on', 'global', 'economies', 'Since', 'vaccines', 'and', 'therapies', 'are', 'still', 'not', 'available', 'for', 'the', 'population', 'prevention', 'becomes', 'desperately', 'needed', 'One', 'important', 'aspect', 'for', 'prevention', 'is', 'the', 'identification', 'and', 'subsequent', 'isolation', 'of', 'contagious', 'specimens', 'The', 'currently', 'used', 'methods', 'for', 'diagnostics', 'are', 'time', 'consuming', 'and', 'also', 'hindered', 'by', 'the', 'limited', 'availability', 'of', 'reagents', 'and', 'reaction', 'costs', 'thus', 'presenting', 'a', 'bottle', 'neck', 'for', 'prevention', 'of', 'COVID', '19', 'spread', 'Here', 'we', 'present', 'a', 'new', 'ultra', 'fast', 'test', 'method', 'which', 'is', 'ten', 'times', 'faster', 'than', 'conventional', 'diagnostic', 'tests', 'using', 'real', 'time', 'quantitative', 'PCR', 'RT', 'qPCR', 'In', 'addition', 'this', 'ultra', 'fast', 'method', 'is', 'easy', 'to', 'handle', 'as', 'well', 'as', 'cost', 'effective', 'We', 'translated', 'published', 'SARS', 'CoV', '2', 'testing', 'protocols', 'from', 'the', 'Centers', 'of', 'Disease', 'Control', 'and', 'Prevention', 'Atlanta', 'Georgia', 'USA', 'and', 'the', 'Charite', 'Berlin', 'Germany', 'to', 'the', 'NEXTGENPCR', 'NGPCR', 'machine', 'and', 'combined', 'it', 'with', 'a', 'fluorescence', 'based', 'endpoint', 'measurement', 'Fluorescence', 'was', 'measured', 'with', 'a', 'commercial', 'blue', 'light', 'scanner', 'We', 'confirmed', 'the', 'NEXTGENPCR', 'results', 'with', 'commercially', 'available', 'positive', 'controls', 'In', 'addition', 'we', 'isolated', 'RNA', 'from', 'SARS', 'CoV', '2', 'infected', 'patients', 'and', 'achieved', 'similar', 'results', 'to', 'clinical', 'RT', 'qPCR', 'assays', 'Here', 'we', 'could', 'show', 'correlation', 'between', 'the', 'results', 'obtained', 'by', 'NEXTGENPCR', 'and', 'conventional', 'RT', 'qPCR', '']"
75968,Enhancing Colorimetric LAMP Amplification Speed and Sensitivity with Guanidine Chloride,2020-06-04,bioRxiv,https://doi.org/10.1101/2020.06.03.132894,"Loop-mediated isothermal amplification (LAMP) is a versatile technique for detection of target DNA and RNA, enabling rapid molecular diagnostic assays with minimal equipment. The global SARS-CoV-2 pandemic has presented an urgent need for new and better diagnostic methods, with colorimetric LAMP utilized in numerous studies for SARS-CoV-2 detection. However, the sensitivity of colorimetric LAMP in early reports has been below that of the standard RT-qPCR tests, and we sought to improve performance. Here we report the use of guanidine hydrochloride and combined primer sets to increase speed and sensitivity in colorimetric LAMP, bringing this simple method up to the standards of sophisticated technique and enabling accurate and high-throughput diagnostics.",10.1101/2020.06.03.132894,nm6ogap2,"['Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'a', 'versatile', 'technique', 'for', 'detection', 'of', 'target', 'DNA', 'and', 'RNA', 'enabling', 'rapid', 'molecular', 'diagnostic', 'assays', 'with', 'minimal', 'equipment', 'The', 'global', 'SARS', 'CoV', '2', 'pandemic', 'has', 'presented', 'an', 'urgent', 'need', 'for', 'new', 'and', 'better', 'diagnostic', 'methods', 'with', 'colorimetric', 'LAMP', 'utilized', 'in', 'numerous', 'studies', 'for', 'SARS', 'CoV', '2', 'detection', 'However', 'the', 'sensitivity', 'of', 'colorimetric', 'LAMP', 'in', 'early', 'reports', 'has', 'been', 'below', 'that', 'of', 'the', 'standard', 'RT', 'qPCR', 'tests', 'and', 'we', 'sought', 'to', 'improve', 'performance', 'Here', 'we', 'report', 'the', 'use', 'of', 'guanidine', 'hydrochloride', 'and', 'combined', 'primer', 'sets', 'to', 'increase', 'speed', 'and', 'sensitivity', 'in', 'colorimetric', 'LAMP', 'bringing', 'this', 'simple', 'method', 'up', 'to', 'the', 'standards', 'of', 'sophisticated', 'technique', 'and', 'enabling', 'accurate', 'and', 'high', 'throughput', 'diagnostics', '']"
76045,Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification,2020-05-18,,http://medrxiv.org/cgi/content/short/2020.05.12.20095638v1?rss=1,"Amid the enduring COVID-19 pandemic, there is an urgent need for expanded access to rapid and sensitive SARS-CoV-2 testing worldwide. Here we present a simple clinical workflow that uses a sensitive and highly specific colorimetric reverse-transcription loop-mediated isothermal amplification (RT-LAMP) to detect SARS-CoV-2 and takes forty minutes from sample collection to result. This test requires no specialized equipment and costs a few dollars per sample. Nasopharyngeal samples collected in saline were added either directly (unprocessed) to RT-LAMP reactions or first inactivated by a combined chemical and heat treatment step to inhibit RNases and lyse virions and human cells. The specimens were then amplified with two SARS-CoV-2-specific primer sets and an internal specimen control; the resulting color change was visually interpreted. While direct addition of unprocessed specimens to RT-LAMP reactions could reliably detect samples with abundant SARS-CoV-2, the assay sensitivity markedly increased after the addition of an inactivation step. In 62 clinical samples with a wide range of SARS-CoV-2 nucleic acid concentrations, the assay had 87.5% sensitivity and 100% specificity with a limit of detection at least 25 copies/L, making it an ideal test to rule in infection. To increase sensitivity, samples that tested negative for SARS-CoV-2 by direct sample addition could be reflexed to a purification step, to increase the effective per-reaction sample input volume. In 40 purified samples, the assay yielded a 90% sensitivity and 100% specificity, with a limit of detection comparable to commercially available real-time PCR-based diagnostics that have received Emergency Use Authorization (EUA) from the FDA. This test for SARS-CoV-2 can be performed in a range of settings for a fraction of the price of other available tests, with limited equipment, and without relying on over-burdened supply chains to increase overall testing capacity.",10.1101/2020.05.12.20095638,m7gzgtil,"['Amid', 'the', 'enduring', 'COVID', '19', 'pandemic', 'there', 'is', 'an', 'urgent', 'need', 'for', 'expanded', 'access', 'to', 'rapid', 'and', 'sensitive', 'SARS', 'CoV', '2', 'testing', 'worldwide', 'Here', 'we', 'present', 'a', 'simple', 'clinical', 'workflow', 'that', 'uses', 'a', 'sensitive', 'and', 'highly', 'specific', 'colorimetric', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'to', 'detect', 'SARS', 'CoV', '2', 'and', 'takes', 'forty', 'minutes', 'from', 'sample', 'collection', 'to', 'result', 'This', 'test', 'requires', 'no', 'specialized', 'equipment', 'and', 'costs', 'a', 'few', 'dollars', 'per', 'sample', 'Nasopharyngeal', 'samples', 'collected', 'in', 'saline', 'were', 'added', 'either', 'directly', 'unprocessed', 'to', 'RT', 'LAMP', 'reactions', 'or', 'first', 'inactivated', 'by', 'a', 'combined', 'chemical', 'and', 'heat', 'treatment', 'step', 'to', 'inhibit', 'RNases', 'and', 'lyse', 'virions', 'and', 'human', 'cells', 'The', 'specimens', 'were', 'then', 'amplified', 'with', 'two', 'SARS', 'CoV', '2', 'specific', 'primer', 'sets', 'and', 'an', 'internal', 'specimen', 'control', 'the', 'resulting', 'color', 'change', 'was', 'visually', 'interpreted', 'While', 'direct', 'addition', 'of', 'unprocessed', 'specimens', 'to', 'RT', 'LAMP', 'reactions', 'could', 'reliably', 'detect', 'samples', 'with', 'abundant', 'SARS', 'CoV', '2', 'the', 'assay', 'sensitivity', 'markedly', 'increased', 'after', 'the', 'addition', 'of', 'an', 'inactivation', 'step', 'In', '62', 'clinical', 'samples', 'with', 'a', 'wide', 'range', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'concentrations', 'the', 'assay', 'had', '87', '5', 'sensitivity', 'and', '100', 'specificity', 'with', 'a', 'limit', 'of', 'detection', 'at', 'least', '25', 'copies', 'L', 'making', 'it', 'an', 'ideal', 'test', 'to', 'rule', 'in', 'infection', 'To', 'increase', 'sensitivity', 'samples', 'that', 'tested', 'negative', 'for', 'SARS', 'CoV', '2', 'by', 'direct', 'sample', 'addition', 'could', 'be', 'reflexed', 'to', 'a', 'purification', 'step', 'to', 'increase', 'the', 'effective', 'per', 'reaction', 'sample', 'input', 'volume', 'In', '40', 'purified', 'samples', 'the', 'assay', 'yielded', 'a', '90', 'sensitivity', 'and', '100', 'specificity', 'with', 'a', 'limit', 'of', 'detection', 'comparable', 'to', 'commercially', 'available', 'real', 'time', 'PCR', 'based', 'diagnostics', 'that', 'have', 'received', 'Emergency', 'Use', 'Authorization', 'EUA', 'from', 'the', 'FDA', 'This', 'test', 'for', 'SARS', 'CoV', '2', 'can', 'be', 'performed', 'in', 'a', 'range', 'of', 'settings', 'for', 'a', 'fraction', 'of', 'the', 'price', 'of', 'other', 'available', 'tests', 'with', 'limited', 'equipment', 'and', 'without', 'relying', 'on', 'over', 'burdened', 'supply', 'chains', 'to', 'increase', 'overall', 'testing', 'capacity', '']"
76436,Dog Savior: Immediate Scent-Detection of SARS-COV-2 by Trained Dogs,2020-06-19,bioRxiv,https://doi.org/10.1101/2020.06.17.158105,"Molecular tests for viral diagnostics are essential to confront the COVID-19 pandemic, but their production and distribution cannot satisfy the current high demand. Early identification of infected people and their contacts is the key to being able to isolate them and prevent the dissemination of the pathogen; unfortunately, most countries are unable to do this due to the lack of diagnostic tools. Dogs can identify, with a high rate of precision, unique odors of volatile organic compounds generated during an infection; as a result, dogs can diagnose infectious agents by smelling specimens and, sometimes, the body of an infected individual. We trained six dogs of three different breeds to detect SARS-CoV-2 in respiratory secretions of infected patients and evaluated their performance experimentally, comparing it against the gold standard (rRT-PCR). Here we show that viral detection takes one second per specimen. After scent-interrogating 9,200 samples, our six dogs achieved independently and as a group very high sensitivity, specificity, predictive values, accuracy, and likelihood ratio, with very narrow confidence intervals. The highest metric was the negative predictive value, indicating that with a disease prevalence of 7.6%, 99.9% of the specimens indicated as negative by the dogs did not carry the virus. These findings demonstrate that dogs could be useful to track viral infection in humans, allowing COVID-19 free people to return to work safely.",10.1101/2020.06.17.158105,ywuj9gu7,"['Molecular', 'tests', 'for', 'viral', 'diagnostics', 'are', 'essential', 'to', 'confront', 'the', 'COVID', '19', 'pandemic', 'but', 'their', 'production', 'and', 'distribution', 'cannot', 'satisfy', 'the', 'current', 'high', 'demand', 'Early', 'identification', 'of', 'infected', 'people', 'and', 'their', 'contacts', 'is', 'the', 'key', 'to', 'being', 'able', 'to', 'isolate', 'them', 'and', 'prevent', 'the', 'dissemination', 'of', 'the', 'pathogen', 'unfortunately', 'most', 'countries', 'are', 'unable', 'to', 'do', 'this', 'due', 'to', 'the', 'lack', 'of', 'diagnostic', 'tools', 'Dogs', 'can', 'identify', 'with', 'a', 'high', 'rate', 'of', 'precision', 'unique', 'odors', 'of', 'volatile', 'organic', 'compounds', 'generated', 'during', 'an', 'infection', 'as', 'a', 'result', 'dogs', 'can', 'diagnose', 'infectious', 'agents', 'by', 'smelling', 'specimens', 'and', 'sometimes', 'the', 'body', 'of', 'an', 'infected', 'individual', 'We', 'trained', 'six', 'dogs', 'of', 'three', 'different', 'breeds', 'to', 'detect', 'SARS', 'CoV', '2', 'in', 'respiratory', 'secretions', 'of', 'infected', 'patients', 'and', 'evaluated', 'their', 'performance', 'experimentally', 'comparing', 'it', 'against', 'the', 'gold', 'standard', 'rRT', 'PCR', 'Here', 'we', 'show', 'that', 'viral', 'detection', 'takes', 'one', 'second', 'per', 'specimen', 'After', 'scent', 'interrogating', '9', '200', 'samples', 'our', 'six', 'dogs', 'achieved', 'independently', 'and', 'as', 'a', 'group', 'very', 'high', 'sensitivity', 'specificity', 'predictive', 'values', 'accuracy', 'and', 'likelihood', 'ratio', 'with', 'very', 'narrow', 'confidence', 'intervals', 'The', 'highest', 'metric', 'was', 'the', 'negative', 'predictive', 'value', 'indicating', 'that', 'with', 'a', 'disease', 'prevalence', 'of', '7', '6', '99', '9', 'of', 'the', 'specimens', 'indicated', 'as', 'negative', 'by', 'the', 'dogs', 'did', 'not', 'carry', 'the', 'virus', 'These', 'findings', 'demonstrate', 'that', 'dogs', 'could', 'be', 'useful', 'to', 'track', 'viral', 'infection', 'in', 'humans', 'allowing', 'COVID', '19', 'free', 'people', 'to', 'return', 'to', 'work', 'safely', '']"
76523,Combination of Antibody based rapid diagnostic tests used in an algorithm may improve their performance in SARS CoV-2 diagnosis.,2020-06-29,,http://medrxiv.org/cgi/content/short/2020.06.26.20140806v1?rss=1,"Background: Globally response to the SARS-CoV-2 pandemic is highly limited by diagnostic methods. Currently, World Health Organization (WHO) recommends the use of molecular assays for confirmation of SARS-CoV-2 infection which are highly expensive and require specialized laboratory equipment. This is a limitation in mass testing and in low resource settings. SARS CoV-2 IgG/IgM antibody tests have had poor diagnostic performance that do not guarantee their use in diagnostics. In this study we demonstrate a concept of using a combination of RDTs in an algorithm to improve their performance for diagnostics. Method: Eighty six (86) EDTA whole blood samples were collected from SARS-CoV-2 positive cases admitted at Masaka and Mbarara Regional Referral Hospitals in Uganda. These were categorized from day when confirmed positive as follows; category A (0-3 days, 10 samples), category B (4-7 days, 20 samples), Category C (8-17 days, 11 samples) and Category D (18-28 days, 20 samples). Plasma was prepared, transported to the testing laboratory and stored at -200C prior to testing. A total of 13 RDTS were tested following manufacturers instructions. Data was entered in Microsoft Excel exported to STATA for computation of sensitivity and specificity. We computed for all possible combinations of 2 of the 13 RDTS (13C2) that were evaluated in parallel algorithm. Results: The individual sensitives of the RDTs ranged between 74% and 18% and there was a general increasing trend across the categories with days since PCR confirmation. A total of 78 possible combinations of the RDTs to be used in parallel was computated. The combinations of the 2 RDTS improved the sensitivities to 90%. Discussion: We demonstrate that use of RDTs in combinations can improve their overall sensitivity. This approach when used on a wider range of combination of RDTs may yield combinations that can give sensitivities that are of diagnostics relevance in mass testing and low resource setting.",10.1101/2020.06.26.20140806,bqgm1e1x,"['Background', 'Globally', 'response', 'to', 'the', 'SARS', 'CoV', '2', 'pandemic', 'is', 'highly', 'limited', 'by', 'diagnostic', 'methods', 'Currently', 'World', 'Health', 'Organization', 'WHO', 'recommends', 'the', 'use', 'of', 'molecular', 'assays', 'for', 'confirmation', 'of', 'SARS', 'CoV', '2', 'infection', 'which', 'are', 'highly', 'expensive', 'and', 'require', 'specialized', 'laboratory', 'equipment', 'This', 'is', 'a', 'limitation', 'in', 'mass', 'testing', 'and', 'in', 'low', 'resource', 'settings', 'SARS', 'CoV', '2', 'IgG', 'IgM', 'antibody', 'tests', 'have', 'had', 'poor', 'diagnostic', 'performance', 'that', 'do', 'not', 'guarantee', 'their', 'use', 'in', 'diagnostics', 'In', 'this', 'study', 'we', 'demonstrate', 'a', 'concept', 'of', 'using', 'a', 'combination', 'of', 'RDTs', 'in', 'an', 'algorithm', 'to', 'improve', 'their', 'performance', 'for', 'diagnostics', 'Method', 'Eighty', 'six', '86', 'EDTA', 'whole', 'blood', 'samples', 'were', 'collected', 'from', 'SARS', 'CoV', '2', 'positive', 'cases', 'admitted', 'at', 'Masaka', 'and', 'Mbarara', 'Regional', 'Referral', 'Hospitals', 'in', 'Uganda', 'These', 'were', 'categorized', 'from', 'day', 'when', 'confirmed', 'positive', 'as', 'follows', 'category', 'A', '0', '3', 'days', '10', 'samples', 'category', 'B', '4', '7', 'days', '20', 'samples', 'Category', 'C', '8', '17', 'days', '11', 'samples', 'and', 'Category', 'D', '18', '28', 'days', '20', 'samples', 'Plasma', 'was', 'prepared', 'transported', 'to', 'the', 'testing', 'laboratory', 'and', 'stored', 'at', '200C', 'prior', 'to', 'testing', 'A', 'total', 'of', '13', 'RDTS', 'were', 'tested', 'following', 'manufacturers', 'instructions', 'Data', 'was', 'entered', 'in', 'Microsoft', 'Excel', 'exported', 'to', 'STATA', 'for', 'computation', 'of', 'sensitivity', 'and', 'specificity', 'We', 'computed', 'for', 'all', 'possible', 'combinations', 'of', '2', 'of', 'the', '13', 'RDTS', '13C2', 'that', 'were', 'evaluated', 'in', 'parallel', 'algorithm', 'Results', 'The', 'individual', 'sensitives', 'of', 'the', 'RDTs', 'ranged', 'between', '74', 'and', '18', 'and', 'there', 'was', 'a', 'general', 'increasing', 'trend', 'across', 'the', 'categories', 'with', 'days', 'since', 'PCR', 'confirmation', 'A', 'total', 'of', '78', 'possible', 'combinations', 'of', 'the', 'RDTs', 'to', 'be', 'used', 'in', 'parallel', 'was', 'computated', 'The', 'combinations', 'of', 'the', '2', 'RDTS', 'improved', 'the', 'sensitivities', 'to', '90', 'Discussion', 'We', 'demonstrate', 'that', 'use', 'of', 'RDTs', 'in', 'combinations', 'can', 'improve', 'their', 'overall', 'sensitivity', 'This', 'approach', 'when', 'used', 'on', 'a', 'wider', 'range', 'of', 'combination', 'of', 'RDTs', 'may', 'yield', 'combinations', 'that', 'can', 'give', 'sensitivities', 'that', 'are', 'of', 'diagnostics', 'relevance', 'in', 'mass', 'testing', 'and', 'low', 'resource', 'setting', '']"
76529,A handheld point-of-care system for rapid detection of SARS-CoV-2 in under 20 minutes,2020-06-30,,http://medrxiv.org/cgi/content/short/2020.06.29.20142349v1?rss=1,"The COVID-19 pandemic is a global health emergency characterized by the high rate of transmission and ongoing increase of cases globally. Rapid point-of-care (PoC) diagnostics to detect the causative virus, SARS-CoV-2, are urgently needed to identify and isolate patients, contain its spread and guide clinical management. In this work, we report the development of a rapid PoC diagnostic test (< 20 min) based on reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) and semiconductor technology for the detection of SARS-CoV-2 from extracted RNA samples. The developed LAMP assay was tested on a real-time benchtop instrument (RT-qLAMP) showing a lower limit of detection of 10 RNA copies per reaction. It was validated against 183 clinical samples including 127 positive samples (screened by the CDC RT-qPCR assay). Results showed 90.55% sensitivity and 100% specificity when compared to RT-qPCR and average positive detection times of 15.45 {+/-} 4.43 min. For validating the incorporation of the RT-LAMP assay onto our PoC platform (RT-eLAMP), a subset of samples was tested (n=40), showing average detection times of 12.89 {+/-} 2.59 min for positive samples (n=34), demonstrating a comparable performance to a benchtop commercial instrument. Paired with a smartphone for results visualization and geo-localization, this portable diagnostic platform with secure cloud connectivity will enable real-time case identification and epidemiological surveillance.",10.1101/2020.06.29.20142349,m9l8ntur,"['The', 'COVID', '19', 'pandemic', 'is', 'a', 'global', 'health', 'emergency', 'characterized', 'by', 'the', 'high', 'rate', 'of', 'transmission', 'and', 'ongoing', 'increase', 'of', 'cases', 'globally', 'Rapid', 'point', 'of', 'care', 'PoC', 'diagnostics', 'to', 'detect', 'the', 'causative', 'virus', 'SARS', 'CoV', '2', 'are', 'urgently', 'needed', 'to', 'identify', 'and', 'isolate', 'patients', 'contain', 'its', 'spread', 'and', 'guide', 'clinical', 'management', 'In', 'this', 'work', 'we', 'report', 'the', 'development', 'of', 'a', 'rapid', 'PoC', 'diagnostic', 'test', '20', 'min', 'based', 'on', 'reverse', 'transcriptase', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'and', 'semiconductor', 'technology', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'from', 'extracted', 'RNA', 'samples', 'The', 'developed', 'LAMP', 'assay', 'was', 'tested', 'on', 'a', 'real', 'time', 'benchtop', 'instrument', 'RT', 'qLAMP', 'showing', 'a', 'lower', 'limit', 'of', 'detection', 'of', '10', 'RNA', 'copies', 'per', 'reaction', 'It', 'was', 'validated', 'against', '183', 'clinical', 'samples', 'including', '127', 'positive', 'samples', 'screened', 'by', 'the', 'CDC', 'RT', 'qPCR', 'assay', 'Results', 'showed', '90', '55', 'sensitivity', 'and', '100', 'specificity', 'when', 'compared', 'to', 'RT', 'qPCR', 'and', 'average', 'positive', 'detection', 'times', 'of', '15', '45', '4', '43', 'min', 'For', 'validating', 'the', 'incorporation', 'of', 'the', 'RT', 'LAMP', 'assay', 'onto', 'our', 'PoC', 'platform', 'RT', 'eLAMP', 'a', 'subset', 'of', 'samples', 'was', 'tested', 'n', '40', 'showing', 'average', 'detection', 'times', 'of', '12', '89', '2', '59', 'min', 'for', 'positive', 'samples', 'n', '34', 'demonstrating', 'a', 'comparable', 'performance', 'to', 'a', 'benchtop', 'commercial', 'instrument', 'Paired', 'with', 'a', 'smartphone', 'for', 'results', 'visualization', 'and', 'geo', 'localization', 'this', 'portable', 'diagnostic', 'platform', 'with', 'secure', 'cloud', 'connectivity', 'will', 'enable', 'real', 'time', 'case', 'identification', 'and', 'epidemiological', 'surveillance', '']"
76548,Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic,2020-05-05,,http://medrxiv.org/cgi/content/short/2020.04.29.20085068v1?rss=1,"ABSTRACT Background: Antibody diagnostics play an important role in disease detection and can potentially aid in monitoring of the immune responses to see if an individual has developed immunity. Developing high throughput diagnostics which does not involve handling of infectious material becomes imperative in the case of pandemics such as the recent outbreak of SARS-CoV2. Methods: A protein microarray technology was used to detect the plurality of antibody response to four novel antigens namely S1 glycoprotein, Receptor binding domain (RBD), S2 glycoprotein and Nucleoprotein of the novel coronavirus named SARS-CoV2 using serum samples. A DBS card was additionally used to compare its performance with a venipuncture-based serum separator tube (SST) draw. Results: The three main subclasses of antibodies IgM, IgA and IgG were analyzed to see the variations in immune responses in the affected population and compared to their microbial RT-PCR based NP swab results. The clinical sensitivity and specificity were determined to be 98.1% and 98.6%. In the matrix comparison study, which would enable patients to test without risk of transmitting the virus, DBS matched with higher than 98% accuracy to a venipuncture-based SST collection. Conclusion: Multiplex testing enables higher sensitivity and specificity which is essential while establishing exposure on a population scale. This flexible platform along with a discrete collection methodology would be crucial and broadly useful to scale up testing in current and future pandemics. Minimum sample volume that can be collected using DBS cards can be processed in this multiplex pillar plate format enabling the capacity to provide the reliability of high throughput analyzers while having the ease of collection similar to rapid tests. Keywords: COVID19, SARS-CoV2, Antibody, Multiplex, serology, biomarker, immune modulation, prevalence, high sensitivity, high specificity, Dried blood spot, pandemic, venipuncture",10.1101/2020.04.29.20085068,8uu10t4p,"['ABSTRACT', 'Background', 'Antibody', 'diagnostics', 'play', 'an', 'important', 'role', 'in', 'disease', 'detection', 'and', 'can', 'potentially', 'aid', 'in', 'monitoring', 'of', 'the', 'immune', 'responses', 'to', 'see', 'if', 'an', 'individual', 'has', 'developed', 'immunity', 'Developing', 'high', 'throughput', 'diagnostics', 'which', 'does', 'not', 'involve', 'handling', 'of', 'infectious', 'material', 'becomes', 'imperative', 'in', 'the', 'case', 'of', 'pandemics', 'such', 'as', 'the', 'recent', 'outbreak', 'of', 'SARS', 'CoV2', 'Methods', 'A', 'protein', 'microarray', 'technology', 'was', 'used', 'to', 'detect', 'the', 'plurality', 'of', 'antibody', 'response', 'to', 'four', 'novel', 'antigens', 'namely', 'S1', 'glycoprotein', 'Receptor', 'binding', 'domain', 'RBD', 'S2', 'glycoprotein', 'and', 'Nucleoprotein', 'of', 'the', 'novel', 'coronavirus', 'named', 'SARS', 'CoV2', 'using', 'serum', 'samples', 'A', 'DBS', 'card', 'was', 'additionally', 'used', 'to', 'compare', 'its', 'performance', 'with', 'a', 'venipuncture', 'based', 'serum', 'separator', 'tube', 'SST', 'draw', 'Results', 'The', 'three', 'main', 'subclasses', 'of', 'antibodies', 'IgM', 'IgA', 'and', 'IgG', 'were', 'analyzed', 'to', 'see', 'the', 'variations', 'in', 'immune', 'responses', 'in', 'the', 'affected', 'population', 'and', 'compared', 'to', 'their', 'microbial', 'RT', 'PCR', 'based', 'NP', 'swab', 'results', 'The', 'clinical', 'sensitivity', 'and', 'specificity', 'were', 'determined', 'to', 'be', '98', '1', 'and', '98', '6', 'In', 'the', 'matrix', 'comparison', 'study', 'which', 'would', 'enable', 'patients', 'to', 'test', 'without', 'risk', 'of', 'transmitting', 'the', 'virus', 'DBS', 'matched', 'with', 'higher', 'than', '98', 'accuracy', 'to', 'a', 'venipuncture', 'based', 'SST', 'collection', 'Conclusion', 'Multiplex', 'testing', 'enables', 'higher', 'sensitivity', 'and', 'specificity', 'which', 'is', 'essential', 'while', 'establishing', 'exposure', 'on', 'a', 'population', 'scale', 'This', 'flexible', 'platform', 'along', 'with', 'a', 'discrete', 'collection', 'methodology', 'would', 'be', 'crucial', 'and', 'broadly', 'useful', 'to', 'scale', 'up', 'testing', 'in', 'current', 'and', 'future', 'pandemics', 'Minimum', 'sample', 'volume', 'that', 'can', 'be', 'collected', 'using', 'DBS', 'cards', 'can', 'be', 'processed', 'in', 'this', 'multiplex', 'pillar', 'plate', 'format', 'enabling', 'the', 'capacity', 'to', 'provide', 'the', 'reliability', 'of', 'high', 'throughput', 'analyzers', 'while', 'having', 'the', 'ease', 'of', 'collection', 'similar', 'to', 'rapid', 'tests', 'Keywords', 'COVID19', 'SARS', 'CoV2', 'Antibody', 'Multiplex', 'serology', 'biomarker', 'immune', 'modulation', 'prevalence', 'high', 'sensitivity', 'high', 'specificity', 'Dried', 'blood', 'spot', 'pandemic', 'venipuncture']"
76565,Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs,2020-04-22,,http://medrxiv.org/cgi/content/short/2020.04.16.20067835v1?rss=1,"Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR detection of SARS-CoV-2 from nasopharyngeal swabs. Low sensitivity, exposure risks to healthcare workers, and global shortages of swabs and personal protective equipment, however, necessitate the validation of new diagnostic approaches. Saliva is a promising candidate for SARS-CoV-2 diagnostics because (1) collection is minimally invasive and can reliably be self-administered and (2) saliva has exhibited comparable sensitivity to nasopharyngeal swabs in detection of other respiratory pathogens, including endemic human coronaviruses, in previous studies. To validate the use of saliva for SARS-CoV-2 detection, we tested nasopharyngeal and saliva samples from confirmed COVID-19 patients and self-collected samples from healthcare workers on COVID-19 wards. When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection. Furthermore, we report less variability in self-sample collection of saliva. Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large-scale SARS-CoV-2 testing.",10.1101/2020.04.16.20067835,lt7qsxxh,"['Rapid', 'and', 'accurate', 'SARS', 'CoV', '2', 'diagnostic', 'testing', 'is', 'essential', 'for', 'controlling', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'The', 'current', 'gold', 'standard', 'for', 'COVID', '19', 'diagnosis', 'is', 'real', 'time', 'RT', 'PCR', 'detection', 'of', 'SARS', 'CoV', '2', 'from', 'nasopharyngeal', 'swabs', 'Low', 'sensitivity', 'exposure', 'risks', 'to', 'healthcare', 'workers', 'and', 'global', 'shortages', 'of', 'swabs', 'and', 'personal', 'protective', 'equipment', 'however', 'necessitate', 'the', 'validation', 'of', 'new', 'diagnostic', 'approaches', 'Saliva', 'is', 'a', 'promising', 'candidate', 'for', 'SARS', 'CoV', '2', 'diagnostics', 'because', '1', 'collection', 'is', 'minimally', 'invasive', 'and', 'can', 'reliably', 'be', 'self', 'administered', 'and', '2', 'saliva', 'has', 'exhibited', 'comparable', 'sensitivity', 'to', 'nasopharyngeal', 'swabs', 'in', 'detection', 'of', 'other', 'respiratory', 'pathogens', 'including', 'endemic', 'human', 'coronaviruses', 'in', 'previous', 'studies', 'To', 'validate', 'the', 'use', 'of', 'saliva', 'for', 'SARS', 'CoV', '2', 'detection', 'we', 'tested', 'nasopharyngeal', 'and', 'saliva', 'samples', 'from', 'confirmed', 'COVID', '19', 'patients', 'and', 'self', 'collected', 'samples', 'from', 'healthcare', 'workers', 'on', 'COVID', '19', 'wards', 'When', 'we', 'compared', 'SARS', 'CoV', '2', 'detection', 'from', 'patient', 'matched', 'nasopharyngeal', 'and', 'saliva', 'samples', 'we', 'found', 'that', 'saliva', 'yielded', 'greater', 'detection', 'sensitivity', 'and', 'consistency', 'throughout', 'the', 'course', 'of', 'infection', 'Furthermore', 'we', 'report', 'less', 'variability', 'in', 'self', 'sample', 'collection', 'of', 'saliva', 'Taken', 'together', 'our', 'findings', 'demonstrate', 'that', 'saliva', 'is', 'a', 'viable', 'and', 'more', 'sensitive', 'alternative', 'to', 'nasopharyngeal', 'swabs', 'and', 'could', 'enable', 'at', 'home', 'self', 'administered', 'sample', 'collection', 'for', 'accurate', 'large', 'scale', 'SARS', 'CoV', '2', 'testing', '']"
76774,Saliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community setting,2020-05-15,,http://medrxiv.org/cgi/content/short/2020.05.11.20092338v1?rss=1,"The use of saliva collection for SARS-CoV-2 diagnostics in the ambulatory setting provides several advantages when compared to nasopharyngeal swabs (NPS), including ease of self-collection and reduced use of personal protective equipment (PPE). In addition saliva collection could be advantageous in advising if a convalescent patient is able to return to work after a period of self-quarantine. We investigated the utility of saliva collection in the community setting at Renown Health in a prospective Diagnostic Cohort of 88 patients and in a Convalescent Cohort of 24 patients. In the Diagnostic Cohort, we find that saliva collection has reduced sensitivity (~15% less) relative than NPS. And in our convalescent cohort of patients greater than 8 days and less than 21 days from first symptom, we find that saliva has ~ 50% sensitivity relative to NPS. Our results suggest that rigorous studies in the intended populations should be performed before large-scale screening using saliva as the test matrix is initiated.",10.1101/2020.05.11.20092338,yx8lsfdv,"['The', 'use', 'of', 'saliva', 'collection', 'for', 'SARS', 'CoV', '2', 'diagnostics', 'in', 'the', 'ambulatory', 'setting', 'provides', 'several', 'advantages', 'when', 'compared', 'to', 'nasopharyngeal', 'swabs', 'NPS', 'including', 'ease', 'of', 'self', 'collection', 'and', 'reduced', 'use', 'of', 'personal', 'protective', 'equipment', 'PPE', 'In', 'addition', 'saliva', 'collection', 'could', 'be', 'advantageous', 'in', 'advising', 'if', 'a', 'convalescent', 'patient', 'is', 'able', 'to', 'return', 'to', 'work', 'after', 'a', 'period', 'of', 'self', 'quarantine', 'We', 'investigated', 'the', 'utility', 'of', 'saliva', 'collection', 'in', 'the', 'community', 'setting', 'at', 'Renown', 'Health', 'in', 'a', 'prospective', 'Diagnostic', 'Cohort', 'of', '88', 'patients', 'and', 'in', 'a', 'Convalescent', 'Cohort', 'of', '24', 'patients', 'In', 'the', 'Diagnostic', 'Cohort', 'we', 'find', 'that', 'saliva', 'collection', 'has', 'reduced', 'sensitivity', '15', 'less', 'relative', 'than', 'NPS', 'And', 'in', 'our', 'convalescent', 'cohort', 'of', 'patients', 'greater', 'than', '8', 'days', 'and', 'less', 'than', '21', 'days', 'from', 'first', 'symptom', 'we', 'find', 'that', 'saliva', 'has', '50', 'sensitivity', 'relative', 'to', 'NPS', 'Our', 'results', 'suggest', 'that', 'rigorous', 'studies', 'in', 'the', 'intended', 'populations', 'should', 'be', 'performed', 'before', 'large', 'scale', 'screening', 'using', 'saliva', 'as', 'the', 'test', 'matrix', 'is', 'initiated', '']"
77081,DeepRC: Immune repertoire classification with attention-based deep massive multiple instance learning,2020-04-14,bioRxiv,https://doi.org/10.1101/2020.04.12.038158,"High-throughput immunosequencing allows re-constructing the immune repertoire of an individual, which is an exceptional opportunity for new immunotherapies, immunodiagnostics, and vaccine design. Such immune repertoires are shaped by past and current immune events, for example infection and disease, and thus record an individual’s state of health. Consequently, immune repertoire sequencing data may enable the prediction of health and disease using machine learning. However, finding the connections between an individual’s repertoire and the individual’s disease class, with potentially hundreds of thousands to millions of short sequences per individual, poses a difficult and unique challenge for machine learning methods. In this work, we present our method DeepRC that combines a Deep Learning architecture with attention-based multiple instance learning. To validate that DeepRC accurately predicts an individual’s disease class based on its immune repertoire and determines the associated class-specific sequence motifs, we applied DeepRC in four large-scale experiments encompassing ground-truth simulated as well as real-world virus infection data. We demonstrate that DeepRC out-performs all tested methods with respect to predictive performance and enables the extraction of those sequence motifs that are connected to a given disease class.",10.1101/2020.04.12.038158,4stnx8dw,"['High', 'throughput', 'immunosequencing', 'allows', 're', 'constructing', 'the', 'immune', 'repertoire', 'of', 'an', 'individual', 'which', 'is', 'an', 'exceptional', 'opportunity', 'for', 'new', 'immunotherapies', 'immunodiagnostics', 'and', 'vaccine', 'design', 'Such', 'immune', 'repertoires', 'are', 'shaped', 'by', 'past', 'and', 'current', 'immune', 'events', 'for', 'example', 'infection', 'and', 'disease', 'and', 'thus', 'record', 'an', 'individual', 's', 'state', 'of', 'health', 'Consequently', 'immune', 'repertoire', 'sequencing', 'data', 'may', 'enable', 'the', 'prediction', 'of', 'health', 'and', 'disease', 'using', 'machine', 'learning', 'However', 'finding', 'the', 'connections', 'between', 'an', 'individual', 's', 'repertoire', 'and', 'the', 'individual', 's', 'disease', 'class', 'with', 'potentially', 'hundreds', 'of', 'thousands', 'to', 'millions', 'of', 'short', 'sequences', 'per', 'individual', 'poses', 'a', 'difficult', 'and', 'unique', 'challenge', 'for', 'machine', 'learning', 'methods', 'In', 'this', 'work', 'we', 'present', 'our', 'method', 'DeepRC', 'that', 'combines', 'a', 'Deep', 'Learning', 'architecture', 'with', 'attention', 'based', 'multiple', 'instance', 'learning', 'To', 'validate', 'that', 'DeepRC', 'accurately', 'predicts', 'an', 'individual', 's', 'disease', 'class', 'based', 'on', 'its', 'immune', 'repertoire', 'and', 'determines', 'the', 'associated', 'class', 'specific', 'sequence', 'motifs', 'we', 'applied', 'DeepRC', 'in', 'four', 'large', 'scale', 'experiments', 'encompassing', 'ground', 'truth', 'simulated', 'as', 'well', 'as', 'real', 'world', 'virus', 'infection', 'data', 'We', 'demonstrate', 'that', 'DeepRC', 'out', 'performs', 'all', 'tested', 'methods', 'with', 'respect', 'to', 'predictive', 'performance', 'and', 'enables', 'the', 'extraction', 'of', 'those', 'sequence', 'motifs', 'that', 'are', 'connected', 'to', 'a', 'given', 'disease', 'class', '']"
77228,A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds,2020-06-05,bioRxiv,https://doi.org/10.1101/2020.06.05.135806,"The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most pressing medical and socioeconomic challenge. Constituting important correlates of protection, determination of virus-neutralizing antibodies (NAbs) is indispensable for convalescent plasma selection, vaccine candidate evaluation, and immunity certificates. In contrast to standard serology ELISAs, plaque reduction neutralization tests (PRNTs) are laborious, time-consuming, expensive, and restricted to specialized laboratories. To replace microscopic counting-based SARS-CoV-2 PRNTs by a novel assay exempt from genetically modified viruses, which are inapplicable in most diagnostics departments, we established a simple, rapid, and automated SARS-CoV-2 neutralization assay employing an in-cell ELISA (icELISA) approach. After optimization of various parameters such as virus-specific antibodies, cell lines, virus doses, and duration of infection, SARS-CoV-2-infected cells became amenable as direct antigen source for quantitative icELISA. Using commercially available nucleocapsid protein-specific antibodies, viral infection could easily be quantified in human and highly permissive Vero E6 cells by icELISA. Antiviral agents such as human sera containing NAbs or antiviral interferons dose-dependently reduced the SARS-CoV-2-specific signal. Applying increased infectious doses, the icNT was superior to PRNT in discriminating convalescent sera with high from those with intermediate neutralizing capacities. The SARS-CoV-2 icELISA test allows rapid (<48h in total, read-out in seconds) and automated quantification of virus infection in cell culture to evaluate the efficacy of NAbs as well as antiviral drugs, using reagents and equipment present in most routine diagnostics departments. We propose the icELISA and the icNT for COVID-19 research and diagnostics.",10.1101/2020.06.05.135806,grs1zpag,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'currently', 'the', 'most', 'pressing', 'medical', 'and', 'socioeconomic', 'challenge', 'Constituting', 'important', 'correlates', 'of', 'protection', 'determination', 'of', 'virus', 'neutralizing', 'antibodies', 'NAbs', 'is', 'indispensable', 'for', 'convalescent', 'plasma', 'selection', 'vaccine', 'candidate', 'evaluation', 'and', 'immunity', 'certificates', 'In', 'contrast', 'to', 'standard', 'serology', 'ELISAs', 'plaque', 'reduction', 'neutralization', 'tests', 'PRNTs', 'are', 'laborious', 'time', 'consuming', 'expensive', 'and', 'restricted', 'to', 'specialized', 'laboratories', 'To', 'replace', 'microscopic', 'counting', 'based', 'SARS', 'CoV', '2', 'PRNTs', 'by', 'a', 'novel', 'assay', 'exempt', 'from', 'genetically', 'modified', 'viruses', 'which', 'are', 'inapplicable', 'in', 'most', 'diagnostics', 'departments', 'we', 'established', 'a', 'simple', 'rapid', 'and', 'automated', 'SARS', 'CoV', '2', 'neutralization', 'assay', 'employing', 'an', 'in', 'cell', 'ELISA', 'icELISA', 'approach', 'After', 'optimization', 'of', 'various', 'parameters', 'such', 'as', 'virus', 'specific', 'antibodies', 'cell', 'lines', 'virus', 'doses', 'and', 'duration', 'of', 'infection', 'SARS', 'CoV', '2', 'infected', 'cells', 'became', 'amenable', 'as', 'direct', 'antigen', 'source', 'for', 'quantitative', 'icELISA', 'Using', 'commercially', 'available', 'nucleocapsid', 'protein', 'specific', 'antibodies', 'viral', 'infection', 'could', 'easily', 'be', 'quantified', 'in', 'human', 'and', 'highly', 'permissive', 'Vero', 'E6', 'cells', 'by', 'icELISA', 'Antiviral', 'agents', 'such', 'as', 'human', 'sera', 'containing', 'NAbs', 'or', 'antiviral', 'interferons', 'dose', 'dependently', 'reduced', 'the', 'SARS', 'CoV', '2', 'specific', 'signal', 'Applying', 'increased', 'infectious', 'doses', 'the', 'icNT', 'was', 'superior', 'to', 'PRNT', 'in', 'discriminating', 'convalescent', 'sera', 'with', 'high', 'from', 'those', 'with', 'intermediate', 'neutralizing', 'capacities', 'The', 'SARS', 'CoV', '2', 'icELISA', 'test', 'allows', 'rapid', '48h', 'in', 'total', 'read', 'out', 'in', 'seconds', 'and', 'automated', 'quantification', 'of', 'virus', 'infection', 'in', 'cell', 'culture', 'to', 'evaluate', 'the', 'efficacy', 'of', 'NAbs', 'as', 'well', 'as', 'antiviral', 'drugs', 'using', 'reagents', 'and', 'equipment', 'present', 'in', 'most', 'routine', 'diagnostics', 'departments', 'We', 'propose', 'the', 'icELISA', 'and', 'the', 'icNT', 'for', 'COVID', '19', 'research', 'and', 'diagnostics', '']"
77421,A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry,2020-07-29,,http://medrxiv.org/cgi/content/short/2020.07.27.20161836v1?rss=1,"In the last few months, there has been a global catastrophic outbreak of severe acute respiratory syndrome disease caused by the novel corona virus SARS-CoV-2 affecting millions of people worldwide. Early diagnosis and isolation is key to contain the rapid spread of the virus. Towards this goal, we report a simple, sensitive and rapid method to detect the virus using a targeted mass spectrometric approach, which can directly detect the presence of virus from naso-oropharyngeal swabs. Using a multiple reaction monitoring we can detect the presence of two peptides specific to SARS-CoV-2 in a 2.3 minute gradient run with 100% specificity and 90.4 % sensitivity when compared to RT-PCR. Importantly, we further show that these peptides could be detected even in the patients who have recovered from the symptoms and have tested negative for the virus by RT-PCR highlighting the sensitivity of the technique. This method has the translational potential of in terms of the rapid diagnostics of symptomatic and asymptomatic COVID-19 and can augment current methods available for diagnosis of SARS-CoV-2.",10.1101/2020.07.27.20161836,h1ovifuq,"['In', 'the', 'last', 'few', 'months', 'there', 'has', 'been', 'a', 'global', 'catastrophic', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'disease', 'caused', 'by', 'the', 'novel', 'corona', 'virus', 'SARS', 'CoV', '2', 'affecting', 'millions', 'of', 'people', 'worldwide', 'Early', 'diagnosis', 'and', 'isolation', 'is', 'key', 'to', 'contain', 'the', 'rapid', 'spread', 'of', 'the', 'virus', 'Towards', 'this', 'goal', 'we', 'report', 'a', 'simple', 'sensitive', 'and', 'rapid', 'method', 'to', 'detect', 'the', 'virus', 'using', 'a', 'targeted', 'mass', 'spectrometric', 'approach', 'which', 'can', 'directly', 'detect', 'the', 'presence', 'of', 'virus', 'from', 'naso', 'oropharyngeal', 'swabs', 'Using', 'a', 'multiple', 'reaction', 'monitoring', 'we', 'can', 'detect', 'the', 'presence', 'of', 'two', 'peptides', 'specific', 'to', 'SARS', 'CoV', '2', 'in', 'a', '2', '3', 'minute', 'gradient', 'run', 'with', '100', 'specificity', 'and', '90', '4', 'sensitivity', 'when', 'compared', 'to', 'RT', 'PCR', 'Importantly', 'we', 'further', 'show', 'that', 'these', 'peptides', 'could', 'be', 'detected', 'even', 'in', 'the', 'patients', 'who', 'have', 'recovered', 'from', 'the', 'symptoms', 'and', 'have', 'tested', 'negative', 'for', 'the', 'virus', 'by', 'RT', 'PCR', 'highlighting', 'the', 'sensitivity', 'of', 'the', 'technique', 'This', 'method', 'has', 'the', 'translational', 'potential', 'of', 'in', 'terms', 'of', 'the', 'rapid', 'diagnostics', 'of', 'symptomatic', 'and', 'asymptomatic', 'COVID', '19', 'and', 'can', 'augment', 'current', 'methods', 'available', 'for', 'diagnosis', 'of', 'SARS', 'CoV', '2', '']"
77611,BioLaboro: A bioinformatics system for detecting molecular assay signature erosion and designing new assays in response to emerging and reemerging pathogens,2020-04-10,bioRxiv,https://doi.org/10.1101/2020.04.08.031963,"Background Emerging and reemerging infectious diseases such as the novel Coronavirus disease, COVID-19 and Ebola pose a significant threat to global society and test the public health community’s preparedness to rapidly respond to an outbreak with effective diagnostics and therapeutics. Recent advances in next generation sequencing technologies enable rapid generation of pathogen genome sequence data, within 24 hours of obtaining a sample in some instances. With these data, one can quickly evaluate the effectiveness of existing diagnostics and therapeutics using in silico approaches. The propensity of some viruses to rapidly accumulate mutations can lead to the failure of molecular detection assays creating the need for redesigned or newly designed assays. Results Here we describe a bioinformatics system named BioLaboro to identify signature regions in a given pathogen genome, design PCR assays targeting those regions, and then test the PCR assays in silico to determine their sensitivity and specificity. We demonstrate BioLaboro with two use cases: Bombali Ebolavirus (BOMV) and the novel Coronavirus 2019 (SARS-CoV-2). For the BOMV, we analyzed 30 currently available real-time reverse transcription-PCR assays against the three available complete genome sequences of BOMV. Only two met our in silico criteria for successful detection and neither had perfect matches to the primer/probe sequences. We designed five new primer sets against BOMV signatures and all had true positive hits to the three BOMV genomes and no false positive hits to any other sequence. Four assays are closely clustered in the nucleoprotein gene and one is located in the glycoprotein gene. Similarly, for the SARS-CoV-2, we designed five highly specific primer sets that hit all 145 whole genomes (available as of February 28, 2020) and none of the near neighbors. Conclusions Here we applied BioLaboro in two real-world use cases to demonstrate its capability; 1) to identify signature regions, 2) to assess the efficacy of existing PCR assays to detect pathogens as they evolve over time, and 3) to design new assays with perfect in silico detection accuracy, all within hours, for further development and deployment. BioLaboro is designed with a user-friendly graphical user interface for biologists with limited bioinformatics experience.",10.1101/2020.04.08.031963,eifrg2fe,"['Background', 'Emerging', 'and', 'reemerging', 'infectious', 'diseases', 'such', 'as', 'the', 'novel', 'Coronavirus', 'disease', 'COVID', '19', 'and', 'Ebola', 'pose', 'a', 'significant', 'threat', 'to', 'global', 'society', 'and', 'test', 'the', 'public', 'health', 'community', 's', 'preparedness', 'to', 'rapidly', 'respond', 'to', 'an', 'outbreak', 'with', 'effective', 'diagnostics', 'and', 'therapeutics', 'Recent', 'advances', 'in', 'next', 'generation', 'sequencing', 'technologies', 'enable', 'rapid', 'generation', 'of', 'pathogen', 'genome', 'sequence', 'data', 'within', '24', 'hours', 'of', 'obtaining', 'a', 'sample', 'in', 'some', 'instances', 'With', 'these', 'data', 'one', 'can', 'quickly', 'evaluate', 'the', 'effectiveness', 'of', 'existing', 'diagnostics', 'and', 'therapeutics', 'using', 'in', 'silico', 'approaches', 'The', 'propensity', 'of', 'some', 'viruses', 'to', 'rapidly', 'accumulate', 'mutations', 'can', 'lead', 'to', 'the', 'failure', 'of', 'molecular', 'detection', 'assays', 'creating', 'the', 'need', 'for', 'redesigned', 'or', 'newly', 'designed', 'assays', 'Results', 'Here', 'we', 'describe', 'a', 'bioinformatics', 'system', 'named', 'BioLaboro', 'to', 'identify', 'signature', 'regions', 'in', 'a', 'given', 'pathogen', 'genome', 'design', 'PCR', 'assays', 'targeting', 'those', 'regions', 'and', 'then', 'test', 'the', 'PCR', 'assays', 'in', 'silico', 'to', 'determine', 'their', 'sensitivity', 'and', 'specificity', 'We', 'demonstrate', 'BioLaboro', 'with', 'two', 'use', 'cases', 'Bombali', 'Ebolavirus', 'BOMV', 'and', 'the', 'novel', 'Coronavirus', '2019', 'SARS', 'CoV', '2', 'For', 'the', 'BOMV', 'we', 'analyzed', '30', 'currently', 'available', 'real', 'time', 'reverse', 'transcription', 'PCR', 'assays', 'against', 'the', 'three', 'available', 'complete', 'genome', 'sequences', 'of', 'BOMV', 'Only', 'two', 'met', 'our', 'in', 'silico', 'criteria', 'for', 'successful', 'detection', 'and', 'neither', 'had', 'perfect', 'matches', 'to', 'the', 'primer', 'probe', 'sequences', 'We', 'designed', 'five', 'new', 'primer', 'sets', 'against', 'BOMV', 'signatures', 'and', 'all', 'had', 'true', 'positive', 'hits', 'to', 'the', 'three', 'BOMV', 'genomes', 'and', 'no', 'false', 'positive', 'hits', 'to', 'any', 'other', 'sequence', 'Four', 'assays', 'are', 'closely', 'clustered', 'in', 'the', 'nucleoprotein', 'gene', 'and', 'one', 'is', 'located', 'in', 'the', 'glycoprotein', 'gene', 'Similarly', 'for', 'the', 'SARS', 'CoV', '2', 'we', 'designed', 'five', 'highly', 'specific', 'primer', 'sets', 'that', 'hit', 'all', '145', 'whole', 'genomes', 'available', 'as', 'of', 'February', '28', '2020', 'and', 'none', 'of', 'the', 'near', 'neighbors', 'Conclusions', 'Here', 'we', 'applied', 'BioLaboro', 'in', 'two', 'real', 'world', 'use', 'cases', 'to', 'demonstrate', 'its', 'capability', '1', 'to', 'identify', 'signature', 'regions', '2', 'to', 'assess', 'the', 'efficacy', 'of', 'existing', 'PCR', 'assays', 'to', 'detect', 'pathogens', 'as', 'they', 'evolve', 'over', 'time', 'and', '3', 'to', 'design', 'new', 'assays', 'with', 'perfect', 'in', 'silico', 'detection', 'accuracy', 'all', 'within', 'hours', 'for', 'further', 'development', 'and', 'deployment', 'BioLaboro', 'is', 'designed', 'with', 'a', 'user', 'friendly', 'graphical', 'user', 'interface', 'for', 'biologists', 'with', 'limited', 'bioinformatics', 'experience', '']"
77844,Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3,2020-06-02,,http://medrxiv.org/cgi/content/short/2020.06.02.20119875v1?rss=1,"Novel coronavirus SARS-CoV-2 outbreaks have rapidly spread to multiple countries, highlighting the urgent necessity for fast, sensitive, and specific diagnostic tools for virus surveillance. Here, the previously unknown collateral single-stranded DNA cleavage we observed with type I CRISPR-Cas3 highlights its potential for development as a Cas3-mediated rapid (within 40 min), low-cost, instrument-free detection method for SARS-CoV-2. This Cas3-based assay is comparable with Cas12- and real-time reverse-transcriptase PCR-based assays in its speed and sensitivity, but offers greater specificity for single-base-pair discrimination while negating the need for highly trained operators. These findings support the use of CRISPR diagnostics for point-of-care testing in patients with suspected SARS-CoV-2 infections.",10.1101/2020.06.02.20119875,mqvp28h1,"['Novel', 'coronavirus', 'SARS', 'CoV', '2', 'outbreaks', 'have', 'rapidly', 'spread', 'to', 'multiple', 'countries', 'highlighting', 'the', 'urgent', 'necessity', 'for', 'fast', 'sensitive', 'and', 'specific', 'diagnostic', 'tools', 'for', 'virus', 'surveillance', 'Here', 'the', 'previously', 'unknown', 'collateral', 'single', 'stranded', 'DNA', 'cleavage', 'we', 'observed', 'with', 'type', 'I', 'CRISPR', 'Cas3', 'highlights', 'its', 'potential', 'for', 'development', 'as', 'a', 'Cas3', 'mediated', 'rapid', 'within', '40', 'min', 'low', 'cost', 'instrument', 'free', 'detection', 'method', 'for', 'SARS', 'CoV', '2', 'This', 'Cas3', 'based', 'assay', 'is', 'comparable', 'with', 'Cas12', 'and', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'based', 'assays', 'in', 'its', 'speed', 'and', 'sensitivity', 'but', 'offers', 'greater', 'specificity', 'for', 'single', 'base', 'pair', 'discrimination', 'while', 'negating', 'the', 'need', 'for', 'highly', 'trained', 'operators', 'These', 'findings', 'support', 'the', 'use', 'of', 'CRISPR', 'diagnostics', 'for', 'point', 'of', 'care', 'testing', 'in', 'patients', 'with', 'suspected', 'SARS', 'CoV', '2', 'infections', '']"
78440,Laboratory validation of an RNA/DNA hybrid tagmentation based mNGS workflow on SARS-CoV-2 and other respiratory RNA viruses detection,2020-05-14,,http://medrxiv.org/cgi/content/short/2020.05.12.20099754v1?rss=1,"Background: Acute respiratory infection caused by RNA viruses is still one of the main diseases all over the world such as SARS CoV 2 and Influenza A virus. mNGS was a powerful tool for ethological diagnosis. But there were some challenges during mNGS implementation in clinical settings such as time consuming manipulation and lack of comprehensive analytical validation. Methods: We set up CATCH that was a mNGS method based on RNA and DNA hybrid tagmentation via Tn5 transposon. Seven respiratory RNA viruses and three subtypes of Influenza A virus had been used to test capabilities of CATCH on detection and quantification. Analytical performance of SARS CoV 2 and Influenza A virus had been determined with reference standards. We compared accuracy of CATCH with quantitative real time PCR by using clinical 98 samples from 64 COVID19 patients. Results: We minimized the library preparation process to 3 hours and handling time to 35 minutes. Duplicate filtered RPM of 7 respiratory viruses and 3 Influenza A virus subtypes were highly correlated with viral concentration. LOD of SARS CoV 2 was 39.2 copies/test and of Influenza A virus was 278.1 copies/mL. Comparing with quantitative real time PCR, the overall accuracy of CATCH was 91.4%. Sensitivity was 84.5% and specificity was 100%. Meanwhile, there were significant difference of microbial profile in oropharyngeal swabs among critical, moderate patients and healthy controls. Conclusion: Although further optimization is needed before CATCH can be rolled out as a routine diagnostic test, we highlight the potential impact of it advancing molecular diagnostics for respiratory pathogens.",10.1101/2020.05.12.20099754,cw5pqroz,"['Background', 'Acute', 'respiratory', 'infection', 'caused', 'by', 'RNA', 'viruses', 'is', 'still', 'one', 'of', 'the', 'main', 'diseases', 'all', 'over', 'the', 'world', 'such', 'as', 'SARS', 'CoV', '2', 'and', 'Influenza', 'A', 'virus', 'mNGS', 'was', 'a', 'powerful', 'tool', 'for', 'ethological', 'diagnosis', 'But', 'there', 'were', 'some', 'challenges', 'during', 'mNGS', 'implementation', 'in', 'clinical', 'settings', 'such', 'as', 'time', 'consuming', 'manipulation', 'and', 'lack', 'of', 'comprehensive', 'analytical', 'validation', 'Methods', 'We', 'set', 'up', 'CATCH', 'that', 'was', 'a', 'mNGS', 'method', 'based', 'on', 'RNA', 'and', 'DNA', 'hybrid', 'tagmentation', 'via', 'Tn5', 'transposon', 'Seven', 'respiratory', 'RNA', 'viruses', 'and', 'three', 'subtypes', 'of', 'Influenza', 'A', 'virus', 'had', 'been', 'used', 'to', 'test', 'capabilities', 'of', 'CATCH', 'on', 'detection', 'and', 'quantification', 'Analytical', 'performance', 'of', 'SARS', 'CoV', '2', 'and', 'Influenza', 'A', 'virus', 'had', 'been', 'determined', 'with', 'reference', 'standards', 'We', 'compared', 'accuracy', 'of', 'CATCH', 'with', 'quantitative', 'real', 'time', 'PCR', 'by', 'using', 'clinical', '98', 'samples', 'from', '64', 'COVID19', 'patients', 'Results', 'We', 'minimized', 'the', 'library', 'preparation', 'process', 'to', '3', 'hours', 'and', 'handling', 'time', 'to', '35', 'minutes', 'Duplicate', 'filtered', 'RPM', 'of', '7', 'respiratory', 'viruses', 'and', '3', 'Influenza', 'A', 'virus', 'subtypes', 'were', 'highly', 'correlated', 'with', 'viral', 'concentration', 'LOD', 'of', 'SARS', 'CoV', '2', 'was', '39', '2', 'copies', 'test', 'and', 'of', 'Influenza', 'A', 'virus', 'was', '278', '1', 'copies', 'mL', 'Comparing', 'with', 'quantitative', 'real', 'time', 'PCR', 'the', 'overall', 'accuracy', 'of', 'CATCH', 'was', '91', '4', 'Sensitivity', 'was', '84', '5', 'and', 'specificity', 'was', '100', 'Meanwhile', 'there', 'were', 'significant', 'difference', 'of', 'microbial', 'profile', 'in', 'oropharyngeal', 'swabs', 'among', 'critical', 'moderate', 'patients', 'and', 'healthy', 'controls', 'Conclusion', 'Although', 'further', 'optimization', 'is', 'needed', 'before', 'CATCH', 'can', 'be', 'rolled', 'out', 'as', 'a', 'routine', 'diagnostic', 'test', 'we', 'highlight', 'the', 'potential', 'impact', 'of', 'it', 'advancing', 'molecular', 'diagnostics', 'for', 'respiratory', 'pathogens', '']"
78488,Pushing beyond specifications: Evaluation of linearity and clinical performance of a fully automated SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations,2020-05-30,,http://medrxiv.org/cgi/content/short/2020.05.28.20115469v1?rss=1,"Background: The ongoing SARS-CoV-2 pandemic presents a unique challenge to diagnostic laboratories. There are preliminary studies correlating qRT-PCR results from different materials to clinical outcomes, yet, comparability is limited due to the plethora of different assays used for diagnostics. In this study we evaluate clinical performance and linear range for the SARS-CoV-2 IVD (cobas6800/8800 system, a fully automated sample-to-result platform) in different clinically relevant matrix materials outside official specifications. Methods: Assay performance was assessed in human plasma, BAL/BL and transport medium following chemical inactivation. For analytical evaluation, respective matrix materials were spiked with SARS-CoV-2 RNA in ten-fold dilution series. The efficacy of chemical inactivation by guanidine hydrochloride solution was confirmed in cell culture infectivity experiments. For correlation, a total of 235 predetermined clinical samples including respiratory swabs, plasma and BAL/BL were subjected to the SARS-CoV-2 IVD test and results were compared. Results: The SARS-CoV-2 IVD showed excellent linearity over five to seven log steps depending on matrix material. Chemical inactivation resulted in a reduction in plaque forming units of at least 3.5 log steps, while having no significant impact on assay performance. Inter-run consistency from three different testing sites demonstrated excellent comparability of RT-PCR results (maximum deviation was 1.53 CT). Clinical evaluation for respiratory swabs showed very good agreement with the comparator assay (Positive agreement 95.7%, negative agreement 98.9%). Conclusion: The SARS-CoV-2 IVD test for the cobas6800/8800 systems offers excellent linear range and inter-run consistency for quantification of SARS-CoV-2 RNA in different matrices outside official specifications.",10.1101/2020.05.28.20115469,c9dwvhk3,"['Background', 'The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'to', 'diagnostic', 'laboratories', 'There', 'are', 'preliminary', 'studies', 'correlating', 'qRT', 'PCR', 'results', 'from', 'different', 'materials', 'to', 'clinical', 'outcomes', 'yet', 'comparability', 'is', 'limited', 'due', 'to', 'the', 'plethora', 'of', 'different', 'assays', 'used', 'for', 'diagnostics', 'In', 'this', 'study', 'we', 'evaluate', 'clinical', 'performance', 'and', 'linear', 'range', 'for', 'the', 'SARS', 'CoV', '2', 'IVD', 'cobas6800', '8800', 'system', 'a', 'fully', 'automated', 'sample', 'to', 'result', 'platform', 'in', 'different', 'clinically', 'relevant', 'matrix', 'materials', 'outside', 'official', 'specifications', 'Methods', 'Assay', 'performance', 'was', 'assessed', 'in', 'human', 'plasma', 'BAL', 'BL', 'and', 'transport', 'medium', 'following', 'chemical', 'inactivation', 'For', 'analytical', 'evaluation', 'respective', 'matrix', 'materials', 'were', 'spiked', 'with', 'SARS', 'CoV', '2', 'RNA', 'in', 'ten', 'fold', 'dilution', 'series', 'The', 'efficacy', 'of', 'chemical', 'inactivation', 'by', 'guanidine', 'hydrochloride', 'solution', 'was', 'confirmed', 'in', 'cell', 'culture', 'infectivity', 'experiments', 'For', 'correlation', 'a', 'total', 'of', '235', 'predetermined', 'clinical', 'samples', 'including', 'respiratory', 'swabs', 'plasma', 'and', 'BAL', 'BL', 'were', 'subjected', 'to', 'the', 'SARS', 'CoV', '2', 'IVD', 'test', 'and', 'results', 'were', 'compared', 'Results', 'The', 'SARS', 'CoV', '2', 'IVD', 'showed', 'excellent', 'linearity', 'over', 'five', 'to', 'seven', 'log', 'steps', 'depending', 'on', 'matrix', 'material', 'Chemical', 'inactivation', 'resulted', 'in', 'a', 'reduction', 'in', 'plaque', 'forming', 'units', 'of', 'at', 'least', '3', '5', 'log', 'steps', 'while', 'having', 'no', 'significant', 'impact', 'on', 'assay', 'performance', 'Inter', 'run', 'consistency', 'from', 'three', 'different', 'testing', 'sites', 'demonstrated', 'excellent', 'comparability', 'of', 'RT', 'PCR', 'results', 'maximum', 'deviation', 'was', '1', '53', 'CT', 'Clinical', 'evaluation', 'for', 'respiratory', 'swabs', 'showed', 'very', 'good', 'agreement', 'with', 'the', 'comparator', 'assay', 'Positive', 'agreement', '95', '7', 'negative', 'agreement', '98', '9', 'Conclusion', 'The', 'SARS', 'CoV', '2', 'IVD', 'test', 'for', 'the', 'cobas6800', '8800', 'systems', 'offers', 'excellent', 'linear', 'range', 'and', 'inter', 'run', 'consistency', 'for', 'quantification', 'of', 'SARS', 'CoV', '2', 'RNA', 'in', 'different', 'matrices', 'outside', 'official', 'specifications', '']"
78547,Global Status of COVID-19 Diagnosis: An Overview,2020,Journal of Pure and Applied Microbiology,https://doi.org/10.22207/jpam.14.spl1.25,"Since the beginning of the New Year 2020, countries around the world are stumbling due to the coronavirus disease (COVID-19) pandemic Better approaches of diagnostics and medical facilities have helped some countries recover early Previous exposures to epidemics have imparted lessons to handle such a pandemic with a high level of preparedness The World Health Organization (WHO) and national health authorities are taking great efforts via efficient and impactful interventions to contain the virus Diagnostic tests such as reverse transcription-polymerase chain reaction are increasingly being used to confirm the diagnosis because testing biological samples for the presence of the virus is the definitive method to identify the disease, analyze the risk for transmission, and determine whether someone has been cured or not It is also important to screen asymptomatic individuals to get the exact overview of the virus spread Antibody detection plays a pivotal role in diagnosis;however, using it at the wrong time yields negative results and conveys dissenting opinion about the tests Although the scaling up of testing has been significant, overall testing has been limited by the availability of diagnostics Rapid diagnoses and discontinuation of transmission are keys to ending this pandemic Diagnostics manufacturers are developing test kits and distributing them to different countries Therefore, more than 500 commercial test kits for molecular- and immunoassays, most with Emergency Use Authorization, are now becoming available in the market In this review, we discuss the importance of diagnostics, approaches of different countries toward the epidemic, global testing situation, and lessons to countries at the start of the epidemic for better preparedness",10.22207/jpam.14.spl1.25,tn1jzpbx,"['Since', 'the', 'beginning', 'of', 'the', 'New', 'Year', '2020', 'countries', 'around', 'the', 'world', 'are', 'stumbling', 'due', 'to', 'the', 'coronavirus', 'disease', 'COVID', '19', 'pandemic', 'Better', 'approaches', 'of', 'diagnostics', 'and', 'medical', 'facilities', 'have', 'helped', 'some', 'countries', 'recover', 'early', 'Previous', 'exposures', 'to', 'epidemics', 'have', 'imparted', 'lessons', 'to', 'handle', 'such', 'a', 'pandemic', 'with', 'a', 'high', 'level', 'of', 'preparedness', 'The', 'World', 'Health', 'Organization', 'WHO', 'and', 'national', 'health', 'authorities', 'are', 'taking', 'great', 'efforts', 'via', 'efficient', 'and', 'impactful', 'interventions', 'to', 'contain', 'the', 'virus', 'Diagnostic', 'tests', 'such', 'as', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'are', 'increasingly', 'being', 'used', 'to', 'confirm', 'the', 'diagnosis', 'because', 'testing', 'biological', 'samples', 'for', 'the', 'presence', 'of', 'the', 'virus', 'is', 'the', 'definitive', 'method', 'to', 'identify', 'the', 'disease', 'analyze', 'the', 'risk', 'for', 'transmission', 'and', 'determine', 'whether', 'someone', 'has', 'been', 'cured', 'or', 'not', 'It', 'is', 'also', 'important', 'to', 'screen', 'asymptomatic', 'individuals', 'to', 'get', 'the', 'exact', 'overview', 'of', 'the', 'virus', 'spread', 'Antibody', 'detection', 'plays', 'a', 'pivotal', 'role', 'in', 'diagnosis', 'however', 'using', 'it', 'at', 'the', 'wrong', 'time', 'yields', 'negative', 'results', 'and', 'conveys', 'dissenting', 'opinion', 'about', 'the', 'tests', 'Although', 'the', 'scaling', 'up', 'of', 'testing', 'has', 'been', 'significant', 'overall', 'testing', 'has', 'been', 'limited', 'by', 'the', 'availability', 'of', 'diagnostics', 'Rapid', 'diagnoses', 'and', 'discontinuation', 'of', 'transmission', 'are', 'keys', 'to', 'ending', 'this', 'pandemic', 'Diagnostics', 'manufacturers', 'are', 'developing', 'test', 'kits', 'and', 'distributing', 'them', 'to', 'different', 'countries', 'Therefore', 'more', 'than', '500', 'commercial', 'test', 'kits', 'for', 'molecular', 'and', 'immunoassays', 'most', 'with', 'Emergency', 'Use', 'Authorization', 'are', 'now', 'becoming', 'available', 'in', 'the', 'market', 'In', 'this', 'review', 'we', 'discuss', 'the', 'importance', 'of', 'diagnostics', 'approaches', 'of', 'different', 'countries', 'toward', 'the', 'epidemic', 'global', 'testing', 'situation', 'and', 'lessons', 'to', 'countries', 'at', 'the', 'start', 'of', 'the', 'epidemic', 'for', 'better', 'preparedness']"
78806,Evaluation of commercial qPCR kits for detection of SARS-CoV-2 in pooled samples,2020-05-28,bioRxiv,https://doi.org/10.1101/2020.05.28.120667,"Due to the current pandemic, global shortage of reagents has drawn interest in developing alternatives to increase the number coronavirus tests. One such alternative is sample pooling. Here we compared commercial kits that are used in COVID-19 diagnostics, in terms of sensitivity and feasibility for use in pooling. We showed that pooling of up to 60 samples did not affect the efficiency of the kits. Also, the RNA dependent RNA polymerase (RdRp) is a more suitable target in pooled samples than the Envelope (E) protein. This approach could provide an easy method of screening large number of samples and help adjust different government regulations.",10.1101/2020.05.28.120667,72gmj59l,"['Due', 'to', 'the', 'current', 'pandemic', 'global', 'shortage', 'of', 'reagents', 'has', 'drawn', 'interest', 'in', 'developing', 'alternatives', 'to', 'increase', 'the', 'number', 'coronavirus', 'tests', 'One', 'such', 'alternative', 'is', 'sample', 'pooling', 'Here', 'we', 'compared', 'commercial', 'kits', 'that', 'are', 'used', 'in', 'COVID', '19', 'diagnostics', 'in', 'terms', 'of', 'sensitivity', 'and', 'feasibility', 'for', 'use', 'in', 'pooling', 'We', 'showed', 'that', 'pooling', 'of', 'up', 'to', '60', 'samples', 'did', 'not', 'affect', 'the', 'efficiency', 'of', 'the', 'kits', 'Also', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'is', 'a', 'more', 'suitable', 'target', 'in', 'pooled', 'samples', 'than', 'the', 'Envelope', 'E', 'protein', 'This', 'approach', 'could', 'provide', 'an', 'easy', 'method', 'of', 'screening', 'large', 'number', 'of', 'samples', 'and', 'help', 'adjust', 'different', 'government', 'regulations', '']"
79288,COVID-MATCH65 - A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2,2020-07-02,,http://medrxiv.org/cgi/content/short/2020.06.30.20143818v1?rss=1,"Due to the ongoing COVID-19 pandemic and increased pressure on testing resources, understanding the clinical and epidemiological features closely associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is vital at point of care to enable risk stratification. We demonstrate that an internally derived and validated clinical decision rule, COVID-MATCH65, has a high sensitivity (92.6%) and NPV (99.5%) for SARS-CoV-2 and could be used to aid COVID-19 risk-assessment and resource allocation for SARS-CoV-2 diagnostics.",10.1101/2020.06.30.20143818,8bfafpe0,"['Due', 'to', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'and', 'increased', 'pressure', 'on', 'testing', 'resources', 'understanding', 'the', 'clinical', 'and', 'epidemiological', 'features', 'closely', 'associated', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'vital', 'at', 'point', 'of', 'care', 'to', 'enable', 'risk', 'stratification', 'We', 'demonstrate', 'that', 'an', 'internally', 'derived', 'and', 'validated', 'clinical', 'decision', 'rule', 'COVID', 'MATCH65', 'has', 'a', 'high', 'sensitivity', '92', '6', 'and', 'NPV', '99', '5', 'for', 'SARS', 'CoV', '2', 'and', 'could', 'be', 'used', 'to', 'aid', 'COVID', '19', 'risk', 'assessment', 'and', 'resource', 'allocation', 'for', 'SARS', 'CoV', '2', 'diagnostics', '']"
79357,A simplified SARS-CoV-2 detection protocol for research laboratories,2020-07-14,,http://medrxiv.org/cgi/content/short/2020.07.11.20150912v1?rss=1,"Widespread testing is required to limit the current public health crisis caused by the COVID-19 pandemic. Multiple tests protocols have been authorized by the food and drugs administration under an emergency use authorization (EUA). The majority of these protocols are based on the gold-standard RT-qPCR test pioneered by the U.S. Centers for Disease Control and Prevention. However, there is still a widespread lack of testing in the US and many of the clinical diagnostics protocols require extensive human labor and materials, such as RNA extraction kits, that could face supply shortages and present biosafety concerns. Given the need to develop alternative reagents and approaches to allow nucleic-acid testing in the face of heightened demand and potential shortages, we have developed a simplified SARS-CoV-2 testing protocol adapted for its use in laboratory research with minimal molecular biology equipment and expertise. The protocol requires minimal BSL1 biosafety level precautions and facilities.",10.1101/2020.07.11.20150912,d0nuoomk,"['Widespread', 'testing', 'is', 'required', 'to', 'limit', 'the', 'current', 'public', 'health', 'crisis', 'caused', 'by', 'the', 'COVID', '19', 'pandemic', 'Multiple', 'tests', 'protocols', 'have', 'been', 'authorized', 'by', 'the', 'food', 'and', 'drugs', 'administration', 'under', 'an', 'emergency', 'use', 'authorization', 'EUA', 'The', 'majority', 'of', 'these', 'protocols', 'are', 'based', 'on', 'the', 'gold', 'standard', 'RT', 'qPCR', 'test', 'pioneered', 'by', 'the', 'U', 'S', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'However', 'there', 'is', 'still', 'a', 'widespread', 'lack', 'of', 'testing', 'in', 'the', 'US', 'and', 'many', 'of', 'the', 'clinical', 'diagnostics', 'protocols', 'require', 'extensive', 'human', 'labor', 'and', 'materials', 'such', 'as', 'RNA', 'extraction', 'kits', 'that', 'could', 'face', 'supply', 'shortages', 'and', 'present', 'biosafety', 'concerns', 'Given', 'the', 'need', 'to', 'develop', 'alternative', 'reagents', 'and', 'approaches', 'to', 'allow', 'nucleic', 'acid', 'testing', 'in', 'the', 'face', 'of', 'heightened', 'demand', 'and', 'potential', 'shortages', 'we', 'have', 'developed', 'a', 'simplified', 'SARS', 'CoV', '2', 'testing', 'protocol', 'adapted', 'for', 'its', 'use', 'in', 'laboratory', 'research', 'with', 'minimal', 'molecular', 'biology', 'equipment', 'and', 'expertise', 'The', 'protocol', 'requires', 'minimal', 'BSL1', 'biosafety', 'level', 'precautions', 'and', 'facilities', '']"
79364,"A new role for Biofoundries in rapid prototyping, development, and validation of automated clinical diagnostic tests for SARS-CoV-2",2020-05-06,,http://medrxiv.org/cgi/content/short/2020.05.02.20088344v1?rss=1,"The SARS-CoV-2 pandemic has shown how the rapid rise in demand for patient and community sample testing, required for tracing and containing a highly infectious disease, has quickly overwhelmed testing capability globally. With most diagnostic infrastructure dependent on specialised instruments, their exclusive reagent supplies quickly become bottlenecks in times of peak demand, creating an urgent need for novel approaches to boost testing capacity. We address this challenge by refocusing the full synthetic biology stack available at the London Biofoundry onto the development of alternative patient sample testing pipelines. We present a reagent-agnostic automated SARS-CoV-2 testing platform that can be quickly deployed and scaled, and that accepts a diverse range of reagents. Using an in-house-generated, open-source, MS2-virus-like-particle-SARS-CoV-2 standard, we validate RNA extraction and RT-qPCR workflows as well as two novel detection assays based on CRISPR-Cas and Loop-mediated isothermal Amplification (LAMP) approaches. In collaboration with an NHS diagnostic testing lab, we report the performance of the overall workflow and benchmark SARS-CoV-2 detection in patient samples via RT-qPCR, CRISPR-Cas, and LAMP against clinical test sets. The validated RNA extraction and RT-qPCR platform has been installed in NHS diagnostic labs and now contributes to increased patient sample processing in the UK while we continue to refine and develop novel high-throughput diagnostic methods. Finally, our workflows and protocols can be quickly implemented and adapted by members of the Global Biofoundry Alliance and the wider scientific and medical diagnostics community.",10.1101/2020.05.02.20088344,9h7kulwn,"['The', 'SARS', 'CoV', '2', 'pandemic', 'has', 'shown', 'how', 'the', 'rapid', 'rise', 'in', 'demand', 'for', 'patient', 'and', 'community', 'sample', 'testing', 'required', 'for', 'tracing', 'and', 'containing', 'a', 'highly', 'infectious', 'disease', 'has', 'quickly', 'overwhelmed', 'testing', 'capability', 'globally', 'With', 'most', 'diagnostic', 'infrastructure', 'dependent', 'on', 'specialised', 'instruments', 'their', 'exclusive', 'reagent', 'supplies', 'quickly', 'become', 'bottlenecks', 'in', 'times', 'of', 'peak', 'demand', 'creating', 'an', 'urgent', 'need', 'for', 'novel', 'approaches', 'to', 'boost', 'testing', 'capacity', 'We', 'address', 'this', 'challenge', 'by', 'refocusing', 'the', 'full', 'synthetic', 'biology', 'stack', 'available', 'at', 'the', 'London', 'Biofoundry', 'onto', 'the', 'development', 'of', 'alternative', 'patient', 'sample', 'testing', 'pipelines', 'We', 'present', 'a', 'reagent', 'agnostic', 'automated', 'SARS', 'CoV', '2', 'testing', 'platform', 'that', 'can', 'be', 'quickly', 'deployed', 'and', 'scaled', 'and', 'that', 'accepts', 'a', 'diverse', 'range', 'of', 'reagents', 'Using', 'an', 'in', 'house', 'generated', 'open', 'source', 'MS2', 'virus', 'like', 'particle', 'SARS', 'CoV', '2', 'standard', 'we', 'validate', 'RNA', 'extraction', 'and', 'RT', 'qPCR', 'workflows', 'as', 'well', 'as', 'two', 'novel', 'detection', 'assays', 'based', 'on', 'CRISPR', 'Cas', 'and', 'Loop', 'mediated', 'isothermal', 'Amplification', 'LAMP', 'approaches', 'In', 'collaboration', 'with', 'an', 'NHS', 'diagnostic', 'testing', 'lab', 'we', 'report', 'the', 'performance', 'of', 'the', 'overall', 'workflow', 'and', 'benchmark', 'SARS', 'CoV', '2', 'detection', 'in', 'patient', 'samples', 'via', 'RT', 'qPCR', 'CRISPR', 'Cas', 'and', 'LAMP', 'against', 'clinical', 'test', 'sets', 'The', 'validated', 'RNA', 'extraction', 'and', 'RT', 'qPCR', 'platform', 'has', 'been', 'installed', 'in', 'NHS', 'diagnostic', 'labs', 'and', 'now', 'contributes', 'to', 'increased', 'patient', 'sample', 'processing', 'in', 'the', 'UK', 'while', 'we', 'continue', 'to', 'refine', 'and', 'develop', 'novel', 'high', 'throughput', 'diagnostic', 'methods', 'Finally', 'our', 'workflows', 'and', 'protocols', 'can', 'be', 'quickly', 'implemented', 'and', 'adapted', 'by', 'members', 'of', 'the', 'Global', 'Biofoundry', 'Alliance', 'and', 'the', 'wider', 'scientific', 'and', 'medical', 'diagnostics', 'community', '']"
79524,Next-generation diagnostics: virus capture facilitates a sensitive viral diagnosis for epizootic and zoonotic pathogens including SARS-CoV-2,2020-07-01,bioRxiv,https://doi.org/10.1101/2020.06.30.181446,"Background The detection of pathogens in clinical and environmental samples using high-throughput sequencing (HTS) is often hampered by large amounts of background information, which is especially true for viruses with small genomes. Enormous sequencing depth can be necessary to compile sufficient information for identification of a certain pathogen. Generic HTS combining with in-solution capture enrichment can markedly increase the sensitivity for virus detection in complex diagnostic samples. Methods A virus panel based on the principle of biotinylated RNA-baits was developed for specific capture enrichment of epizootic and zoonotic viruses (VirBaits). The VirBaits set was supplemented by a SARS-CoV-2 predesigned bait set for testing recent SARS-CoV-2 positive samples. Libraries generated from complex samples were sequenced via generic HTS and afterwards enriched with the VirBaits set. For validation, an internal proficiency test for emerging epizootic and zoonotic viruses (African swine fever virus, Ebolavirus, Marburgvirus, Nipah henipavirus, Rift Valley fever virus) was conducted. Results The VirBaits set consists of 177,471 RNA-baits (80-mer) based on about 18,800 complete viral genomes targeting 35 epizootic and zoonotic viruses. In all tested samples, viruses with both DNA and RNA genomes were clearly enriched ranging from about 10-fold to 10,000-fold for viruses including distantly related viruses with at least 72% overall identity to viruses represented in the bait set. Viruses showing a lower overall identity (38% and 46%) to them were not enriched but could nonetheless be detected based on capturing conserved genome regions. The internal proficiency test supports the improved virus detection using the combination of HTS plus targeted enrichment but also point to the risk of carryover between samples. Conclusions The VirBaits approach showed a high diagnostic performance, also for distantly related viruses. The bait set is modular and expandable according to the favored diagnostics, health sector or research question. The risk of carryover needs to be taken into consideration. The application of the RNA-baits principle turned out to be user-friendly, and even non-experts (without sophisticated bioinformatics skills) can easily use the VirBait workflow. The rapid extension of the established VirBaits set adapted to actual outbreak events is possible without any problems as shown for SARS-CoV-2.",10.1101/2020.06.30.181446,72v12ftb,"['Background', 'The', 'detection', 'of', 'pathogens', 'in', 'clinical', 'and', 'environmental', 'samples', 'using', 'high', 'throughput', 'sequencing', 'HTS', 'is', 'often', 'hampered', 'by', 'large', 'amounts', 'of', 'background', 'information', 'which', 'is', 'especially', 'true', 'for', 'viruses', 'with', 'small', 'genomes', 'Enormous', 'sequencing', 'depth', 'can', 'be', 'necessary', 'to', 'compile', 'sufficient', 'information', 'for', 'identification', 'of', 'a', 'certain', 'pathogen', 'Generic', 'HTS', 'combining', 'with', 'in', 'solution', 'capture', 'enrichment', 'can', 'markedly', 'increase', 'the', 'sensitivity', 'for', 'virus', 'detection', 'in', 'complex', 'diagnostic', 'samples', 'Methods', 'A', 'virus', 'panel', 'based', 'on', 'the', 'principle', 'of', 'biotinylated', 'RNA', 'baits', 'was', 'developed', 'for', 'specific', 'capture', 'enrichment', 'of', 'epizootic', 'and', 'zoonotic', 'viruses', 'VirBaits', 'The', 'VirBaits', 'set', 'was', 'supplemented', 'by', 'a', 'SARS', 'CoV', '2', 'predesigned', 'bait', 'set', 'for', 'testing', 'recent', 'SARS', 'CoV', '2', 'positive', 'samples', 'Libraries', 'generated', 'from', 'complex', 'samples', 'were', 'sequenced', 'via', 'generic', 'HTS', 'and', 'afterwards', 'enriched', 'with', 'the', 'VirBaits', 'set', 'For', 'validation', 'an', 'internal', 'proficiency', 'test', 'for', 'emerging', 'epizootic', 'and', 'zoonotic', 'viruses', 'African', 'swine', 'fever', 'virus', 'Ebolavirus', 'Marburgvirus', 'Nipah', 'henipavirus', 'Rift', 'Valley', 'fever', 'virus', 'was', 'conducted', 'Results', 'The', 'VirBaits', 'set', 'consists', 'of', '177', '471', 'RNA', 'baits', '80', 'mer', 'based', 'on', 'about', '18', '800', 'complete', 'viral', 'genomes', 'targeting', '35', 'epizootic', 'and', 'zoonotic', 'viruses', 'In', 'all', 'tested', 'samples', 'viruses', 'with', 'both', 'DNA', 'and', 'RNA', 'genomes', 'were', 'clearly', 'enriched', 'ranging', 'from', 'about', '10', 'fold', 'to', '10', '000', 'fold', 'for', 'viruses', 'including', 'distantly', 'related', 'viruses', 'with', 'at', 'least', '72', 'overall', 'identity', 'to', 'viruses', 'represented', 'in', 'the', 'bait', 'set', 'Viruses', 'showing', 'a', 'lower', 'overall', 'identity', '38', 'and', '46', 'to', 'them', 'were', 'not', 'enriched', 'but', 'could', 'nonetheless', 'be', 'detected', 'based', 'on', 'capturing', 'conserved', 'genome', 'regions', 'The', 'internal', 'proficiency', 'test', 'supports', 'the', 'improved', 'virus', 'detection', 'using', 'the', 'combination', 'of', 'HTS', 'plus', 'targeted', 'enrichment', 'but', 'also', 'point', 'to', 'the', 'risk', 'of', 'carryover', 'between', 'samples', 'Conclusions', 'The', 'VirBaits', 'approach', 'showed', 'a', 'high', 'diagnostic', 'performance', 'also', 'for', 'distantly', 'related', 'viruses', 'The', 'bait', 'set', 'is', 'modular', 'and', 'expandable', 'according', 'to', 'the', 'favored', 'diagnostics', 'health', 'sector', 'or', 'research', 'question', 'The', 'risk', 'of', 'carryover', 'needs', 'to', 'be', 'taken', 'into', 'consideration', 'The', 'application', 'of', 'the', 'RNA', 'baits', 'principle', 'turned', 'out', 'to', 'be', 'user', 'friendly', 'and', 'even', 'non', 'experts', 'without', 'sophisticated', 'bioinformatics', 'skills', 'can', 'easily', 'use', 'the', 'VirBait', 'workflow', 'The', 'rapid', 'extension', 'of', 'the', 'established', 'VirBaits', 'set', 'adapted', 'to', 'actual', 'outbreak', 'events', 'is', 'possible', 'without', 'any', 'problems', 'as', 'shown', 'for', 'SARS', 'CoV', '2', '']"
79610,Development and clinical application of a rapid and sensitive loop-mediated isothermalamplification test for SARS-CoV-2 infection,2020-05-23,,http://medrxiv.org/cgi/content/short/2020.05.20.20108530v1?rss=1,"Background The outbreak of SARS-CoV-2 urgently requires sensitive and convenient COVID-19 diagnostics to assure the containment and timely treatment of patients. We aimed to develop and validate a novel reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay to detect SARS-CoV-2 in both qualified laboratories and point-of-care settings. Methods Patients with suspected COVID-19 and close contacts between Jan 26 and April 8, 2020, were recruited from two hospitals. Respiratory samples were collected and tested with LAMP and the results were compared with those obtained by RT-qPCR. The inconsistent samples between these two methods were subjected to next-generation sequencing for confirmation. In addition, we tested the RT-LAMP on an asymptomatic COVID-19 carrier and patients with other respiratory viral infections. Results We finally collected a cohort of 129 cases (329 nasopharyngeal swabs) and the independent cohort of 76 patients (152 nasopharyngeal swabs and sputum samples). RT-LAMP was validated to be accurate (overall sensitivity and specificity: 88.89% and 99.00%; positive and negative predictive values: 94.74% and 97.78%) and diagnostically useful (positive and negative likelihood ratios: 88.89 and 0.11). RT-LAMP showed an increased sensitivity (88.89% vs 81.48%) and high consistency (kappa 0.92) compared with RT-qPCR for SARS-CoV-2 screening while requiring only constant temperature heating and visual inspection. The median time required for RT-LAMP was less than 1 h from sample to result. Further analyses indicated that RT-LAMP was feasible for asymptomatic patients and did not cross-react with other respiratory pathogen infections. Conclusion The RT-LAMP assay offers a rapid, sensitive and straightforward detection for SARS-CoV-2 infection, which could aid the expansion of COVID-19 testing in the public domain and hospitals.",10.1101/2020.05.20.20108530,mjr6u7ak,"['Background', 'The', 'outbreak', 'of', 'SARS', 'CoV', '2', 'urgently', 'requires', 'sensitive', 'and', 'convenient', 'COVID', '19', 'diagnostics', 'to', 'assure', 'the', 'containment', 'and', 'timely', 'treatment', 'of', 'patients', 'We', 'aimed', 'to', 'develop', 'and', 'validate', 'a', 'novel', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'to', 'detect', 'SARS', 'CoV', '2', 'in', 'both', 'qualified', 'laboratories', 'and', 'point', 'of', 'care', 'settings', 'Methods', 'Patients', 'with', 'suspected', 'COVID', '19', 'and', 'close', 'contacts', 'between', 'Jan', '26', 'and', 'April', '8', '2020', 'were', 'recruited', 'from', 'two', 'hospitals', 'Respiratory', 'samples', 'were', 'collected', 'and', 'tested', 'with', 'LAMP', 'and', 'the', 'results', 'were', 'compared', 'with', 'those', 'obtained', 'by', 'RT', 'qPCR', 'The', 'inconsistent', 'samples', 'between', 'these', 'two', 'methods', 'were', 'subjected', 'to', 'next', 'generation', 'sequencing', 'for', 'confirmation', 'In', 'addition', 'we', 'tested', 'the', 'RT', 'LAMP', 'on', 'an', 'asymptomatic', 'COVID', '19', 'carrier', 'and', 'patients', 'with', 'other', 'respiratory', 'viral', 'infections', 'Results', 'We', 'finally', 'collected', 'a', 'cohort', 'of', '129', 'cases', '329', 'nasopharyngeal', 'swabs', 'and', 'the', 'independent', 'cohort', 'of', '76', 'patients', '152', 'nasopharyngeal', 'swabs', 'and', 'sputum', 'samples', 'RT', 'LAMP', 'was', 'validated', 'to', 'be', 'accurate', 'overall', 'sensitivity', 'and', 'specificity', '88', '89', 'and', '99', '00', 'positive', 'and', 'negative', 'predictive', 'values', '94', '74', 'and', '97', '78', 'and', 'diagnostically', 'useful', 'positive', 'and', 'negative', 'likelihood', 'ratios', '88', '89', 'and', '0', '11', 'RT', 'LAMP', 'showed', 'an', 'increased', 'sensitivity', '88', '89', 'vs', '81', '48', 'and', 'high', 'consistency', 'kappa', '0', '92', 'compared', 'with', 'RT', 'qPCR', 'for', 'SARS', 'CoV', '2', 'screening', 'while', 'requiring', 'only', 'constant', 'temperature', 'heating', 'and', 'visual', 'inspection', 'The', 'median', 'time', 'required', 'for', 'RT', 'LAMP', 'was', 'less', 'than', '1', 'h', 'from', 'sample', 'to', 'result', 'Further', 'analyses', 'indicated', 'that', 'RT', 'LAMP', 'was', 'feasible', 'for', 'asymptomatic', 'patients', 'and', 'did', 'not', 'cross', 'react', 'with', 'other', 'respiratory', 'pathogen', 'infections', 'Conclusion', 'The', 'RT', 'LAMP', 'assay', 'offers', 'a', 'rapid', 'sensitive', 'and', 'straightforward', 'detection', 'for', 'SARS', 'CoV', '2', 'infection', 'which', 'could', 'aid', 'the', 'expansion', 'of', 'COVID', '19', 'testing', 'in', 'the', 'public', 'domain', 'and', 'hospitals', '']"
79831,Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples,2020-03-31,,https://doi.org/10.1101/2020.03.30.20043513,"We report a laboratory-based surveillance for SARS-CoV-2 using minipools of respiratory samples submitted for routine diagnostics. We tested a total of 70 minipools resembling 700 samples shortly before the upsurge of cases in Germany. We identified one SARS-CoV-2 positive patient. Our approach proved its concept, is easily adaptable and resource-saving.",10.1101/2020.03.30.20043513,dekhm53p,"['We', 'report', 'a', 'laboratory', 'based', 'surveillance', 'for', 'SARS', 'CoV', '2', 'using', 'minipools', 'of', 'respiratory', 'samples', 'submitted', 'for', 'routine', 'diagnostics', 'We', 'tested', 'a', 'total', 'of', '70', 'minipools', 'resembling', '700', 'samples', 'shortly', 'before', 'the', 'upsurge', 'of', 'cases', 'in', 'Germany', 'We', 'identified', 'one', 'SARS', 'CoV', '2', 'positive', 'patient', 'Our', 'approach', 'proved', 'its', 'concept', 'is', 'easily', 'adaptable', 'and', 'resource', 'saving', '']"
80025,Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation,2020-05-22,,http://medrxiv.org/cgi/content/short/2020.05.18.20101618v1?rss=1,"There is an urgent need for reliable high-throughput serological assays for the management of the ongoing COVID-19 pandemic. Preferably, the performance of serological tests for a novel virus should be determined with clinical specimens against a gold standard, i.e. virus neutralisation. We evaluated specificity and sensitivity of six commercial immunoassays for the detection of SARS-CoV-2 IgG, IgA and IgM antibodies, including four automated assays [Abbott SARS-COV-2 IgG (CE marked), Diasorin Liaison SARS-CoV-2 S1/S2 IgG (research use only), and Euroimmun SARS-CoV-2 IgG and IgA (CE marked)], and two rapid lateral flow (immunocromatographic) tests [Acro Biotech 2019-nCoV IgG/IgM (CE marked) and Xiamen Biotime Biotechnology SARS-CoV-2 IgG/IgM (CE marked)] in comparison with a microneutralisation test (MNT). Two specimen panels from serum samples sent to Helsinki University Hospital Laboratory (HUSLAB) were compiled: the patient panel included sera from PCR confirmed COVID-19 patients, and the negative panel included sera sent for screening of autoimmune diseases and respiratory virus antibodies in 2018 and 2019. The MNT was carried out for all COVID-19 samples (70 serum samples, 62 individuals) and for 53 samples from the negative panel. Forty-one out of 62 COVID-19 patients showed neutralising antibodies with median of 11 days (range 3-51) after onset of symptoms. The specificity and sensitivity values of the commercial tests against MNT, respectively, were as follows: 95.1%/80.5% (Abbott Architect SARS-CoV-2 IgG), 94.9%/43.8% (Diasorin Liaison SARS-CoV-2 IgG), 68.3%/87.8% (Euroimmun SARS-CoV-2 IgA), 86.6%/70.7% (Euroimmun SARS-CoV-2 IgG), 74.4%/56.1% (Acro 2019-nCoV IgG), 69.5%/46.3% (Acro 2019-nCoV IgM), 97.5%/71.9% (Xiamen Biotime SARS-CoV-2 IgG), and 88.8%/81.3% (Xiamen Biotime SARS-CoV-2 IgM). This study shows variable performance values. Laboratories should carefully consider their testing process, such as a two-tier approach, in order to optimize the overall performance of SARS-CoV-2 serodiagnostics.",10.1101/2020.05.18.20101618,hb2bpyag,"['There', 'is', 'an', 'urgent', 'need', 'for', 'reliable', 'high', 'throughput', 'serological', 'assays', 'for', 'the', 'management', 'of', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'Preferably', 'the', 'performance', 'of', 'serological', 'tests', 'for', 'a', 'novel', 'virus', 'should', 'be', 'determined', 'with', 'clinical', 'specimens', 'against', 'a', 'gold', 'standard', 'i', 'e', 'virus', 'neutralisation', 'We', 'evaluated', 'specificity', 'and', 'sensitivity', 'of', 'six', 'commercial', 'immunoassays', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'IgG', 'IgA', 'and', 'IgM', 'antibodies', 'including', 'four', 'automated', 'assays', 'Abbott', 'SARS', 'COV', '2', 'IgG', 'CE', 'marked', 'Diasorin', 'Liaison', 'SARS', 'CoV', '2', 'S1', 'S2', 'IgG', 'research', 'use', 'only', 'and', 'Euroimmun', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', 'CE', 'marked', 'and', 'two', 'rapid', 'lateral', 'flow', 'immunocromatographic', 'tests', 'Acro', 'Biotech', '2019', 'nCoV', 'IgG', 'IgM', 'CE', 'marked', 'and', 'Xiamen', 'Biotime', 'Biotechnology', 'SARS', 'CoV', '2', 'IgG', 'IgM', 'CE', 'marked', 'in', 'comparison', 'with', 'a', 'microneutralisation', 'test', 'MNT', 'Two', 'specimen', 'panels', 'from', 'serum', 'samples', 'sent', 'to', 'Helsinki', 'University', 'Hospital', 'Laboratory', 'HUSLAB', 'were', 'compiled', 'the', 'patient', 'panel', 'included', 'sera', 'from', 'PCR', 'confirmed', 'COVID', '19', 'patients', 'and', 'the', 'negative', 'panel', 'included', 'sera', 'sent', 'for', 'screening', 'of', 'autoimmune', 'diseases', 'and', 'respiratory', 'virus', 'antibodies', 'in', '2018', 'and', '2019', 'The', 'MNT', 'was', 'carried', 'out', 'for', 'all', 'COVID', '19', 'samples', '70', 'serum', 'samples', '62', 'individuals', 'and', 'for', '53', 'samples', 'from', 'the', 'negative', 'panel', 'Forty', 'one', 'out', 'of', '62', 'COVID', '19', 'patients', 'showed', 'neutralising', 'antibodies', 'with', 'median', 'of', '11', 'days', 'range', '3', '51', 'after', 'onset', 'of', 'symptoms', 'The', 'specificity', 'and', 'sensitivity', 'values', 'of', 'the', 'commercial', 'tests', 'against', 'MNT', 'respectively', 'were', 'as', 'follows', '95', '1', '80', '5', 'Abbott', 'Architect', 'SARS', 'CoV', '2', 'IgG', '94', '9', '43', '8', 'Diasorin', 'Liaison', 'SARS', 'CoV', '2', 'IgG', '68', '3', '87', '8', 'Euroimmun', 'SARS', 'CoV', '2', 'IgA', '86', '6', '70', '7', 'Euroimmun', 'SARS', 'CoV', '2', 'IgG', '74', '4', '56', '1', 'Acro', '2019', 'nCoV', 'IgG', '69', '5', '46', '3', 'Acro', '2019', 'nCoV', 'IgM', '97', '5', '71', '9', 'Xiamen', 'Biotime', 'SARS', 'CoV', '2', 'IgG', 'and', '88', '8', '81', '3', 'Xiamen', 'Biotime', 'SARS', 'CoV', '2', 'IgM', 'This', 'study', 'shows', 'variable', 'performance', 'values', 'Laboratories', 'should', 'carefully', 'consider', 'their', 'testing', 'process', 'such', 'as', 'a', 'two', 'tier', 'approach', 'in', 'order', 'to', 'optimize', 'the', 'overall', 'performance', 'of', 'SARS', 'CoV', '2', 'serodiagnostics', '']"
80192,Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mapping,2020-05-22,bioRxiv,https://doi.org/10.1101/2020.05.21.109298,"The newly emergent SARS-CoV-2 coronavirus is closely related to SARS-CoV which emerged in 2002. Studies on coronaviruses in general, and SARS in particular, have identified the virus spike protein (S) as being central to virus tropism, to the generation of a protective antibody response and to the unambiguous detection of past infections. As a result of this centrality SARS-CoV-2 S protein has a role in many aspects of research from vaccines to diagnostic tests. We describe a number of recombinant forms of SARS-CoV-2 S expressed in commonly available expression systems and their preliminary use in diagnostics and epitope mapping. These sources may find use in the current and future analysis of the virus and the Covid-19 disease it causes.",10.1101/2020.05.21.109298,e20gtx0z,"['The', 'newly', 'emergent', 'SARS', 'CoV', '2', 'coronavirus', 'is', 'closely', 'related', 'to', 'SARS', 'CoV', 'which', 'emerged', 'in', '2002', 'Studies', 'on', 'coronaviruses', 'in', 'general', 'and', 'SARS', 'in', 'particular', 'have', 'identified', 'the', 'virus', 'spike', 'protein', 'S', 'as', 'being', 'central', 'to', 'virus', 'tropism', 'to', 'the', 'generation', 'of', 'a', 'protective', 'antibody', 'response', 'and', 'to', 'the', 'unambiguous', 'detection', 'of', 'past', 'infections', 'As', 'a', 'result', 'of', 'this', 'centrality', 'SARS', 'CoV', '2', 'S', 'protein', 'has', 'a', 'role', 'in', 'many', 'aspects', 'of', 'research', 'from', 'vaccines', 'to', 'diagnostic', 'tests', 'We', 'describe', 'a', 'number', 'of', 'recombinant', 'forms', 'of', 'SARS', 'CoV', '2', 'S', 'expressed', 'in', 'commonly', 'available', 'expression', 'systems', 'and', 'their', 'preliminary', 'use', 'in', 'diagnostics', 'and', 'epitope', 'mapping', 'These', 'sources', 'may', 'find', 'use', 'in', 'the', 'current', 'and', 'future', 'analysis', 'of', 'the', 'virus', 'and', 'the', 'Covid', '19', 'disease', 'it', 'causes', '']"
80253,Pharma mobilizes to combat the coronavirus,2020,C&amp;EN Global Enterprise,https://doi.org/10.1021/cen-09805-buscon4,"The World Health Organization has declared the fast-moving coronavirus outbreak in China a “public health emergency of international concern,” a measure that can spur coordinated global efforts to combat it With infections steadily rising, major drug companies are mobilizing to develop diagnostics, vaccines, and possible treatments for the virus, 2019-nCoV According to WHO, as of Jan 30 more than 7,800 people worldwide are confirmed to have been infected by the virus, and another 12,000-plus cases are suspected Almost all of the cases are in China, where 170 people have died Although smaller biotech firms were among the first to publicly respond to the outbreak, big pharma firms say they have been quietly working on tests and treatments for several weeks Roche has sent the first commercial diagnostic to China, and Johnson & Johnson says it is using the same technologies deployed for the rapid development of an Ebola vaccine to( )",10.1021/cen-09805-buscon4,0tetqt33,"['The', 'World', 'Health', 'Organization', 'has', 'declared', 'the', 'fast', 'moving', 'coronavirus', 'outbreak', 'in', 'China', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'a', 'measure', 'that', 'can', 'spur', 'coordinated', 'global', 'efforts', 'to', 'combat', 'it', 'With', 'infections', 'steadily', 'rising', 'major', 'drug', 'companies', 'are', 'mobilizing', 'to', 'develop', 'diagnostics', 'vaccines', 'and', 'possible', 'treatments', 'for', 'the', 'virus', '2019', 'nCoV', 'According', 'to', 'WHO', 'as', 'of', 'Jan', '30', 'more', 'than', '7', '800', 'people', 'worldwide', 'are', 'confirmed', 'to', 'have', 'been', 'infected', 'by', 'the', 'virus', 'and', 'another', '12', '000', 'plus', 'cases', 'are', 'suspected', 'Almost', 'all', 'of', 'the', 'cases', 'are', 'in', 'China', 'where', '170', 'people', 'have', 'died', 'Although', 'smaller', 'biotech', 'firms', 'were', 'among', 'the', 'first', 'to', 'publicly', 'respond', 'to', 'the', 'outbreak', 'big', 'pharma', 'firms', 'say', 'they', 'have', 'been', 'quietly', 'working', 'on', 'tests', 'and', 'treatments', 'for', 'several', 'weeks', 'Roche', 'has', 'sent', 'the', 'first', 'commercial', 'diagnostic', 'to', 'China', 'and', 'Johnson', 'Johnson', 'says', 'it', 'is', 'using', 'the', 'same', 'technologies', 'deployed', 'for', 'the', 'rapid', 'development', 'of', 'an', 'Ebola', 'vaccine', 'to', '']"
80322,Rapid Single Cell Evaluation of Human Disease and Disorder Targets Using REVEAL: SingleCell™,2020-06-25,bioRxiv,https://doi.org/10.1101/2020.06.24.169730,"Single-cell (sc) sequencing performs unbiased profiling of individual cells and enables evaluation of less prevalent cellular populations, often missed using bulk sequencing. However, the scale and the complexity of the sc datasets poses a great challenge in its utility and this problem is further exacerbated when working with larger datasets typically generated by consortium efforts. As the scale of single cell datasets continues to increase exponentially, there is an unmet technological need to develop database platforms that can evaluate key biological hypothesis by querying extensive single-cell datasets. Large single-cell datasets like human cell atlas and COVID-19 cell atlas (collection of annotated sc datasets from various human organs) are excellent resources for profiling target genes involved in human diseases and disorders ranging from oncology, auto-immunity, as well as infectious diseases like COVID-19 caused by SARS-CoV-2 virus. SARS-CoV-2 infections have led to a worldwide pandemic with massive loss of lives, infections exceeding 7 million cases. The virus uses ACE2 and TMPRSS2 as key viral entry associated proteins expressed in human cells for infections. Evaluating the expression profile of key genes in large single-cell datasets can facilitate testing for diagnostics, therapeutics and vaccine targets; as the world struggles to cope with the on-going spread of COVID-19 infections. In this manuscript we describe, REVEAL: SingleCell which enables storage, retrieval and rapid query of single-cell datasets inclusive of millions of cells. The analytical database described here enables selecting and analyzing cells across multiple studies. Cells can be selected using individual metadata tags, more complex hierarchical ontology filtering, and gene expression threshold ranges, including co-expression of multiple genes. The tags on selected cells can be further evaluated for testing biological hypothesis. One such example includes identifying the most prevalent cell type annotation tag on returned cells. We used REVEAL: SingleCell to evaluate expression of key SARS-CoV-2 entry associated genes, and queried the current database (2.2 Million cells, 32 projects) to obtain the results in <60 seconds. We highlighted cells expressing COVID-19 associated genes are expressed on multiple tissue types, thus in part explains the multi-organ involvement in infected patients observed worldwide during the on-going COVID-19 pandemic.",10.1101/2020.06.24.169730,1ul6dszs,"['Single', 'cell', 'sc', 'sequencing', 'performs', 'unbiased', 'profiling', 'of', 'individual', 'cells', 'and', 'enables', 'evaluation', 'of', 'less', 'prevalent', 'cellular', 'populations', 'often', 'missed', 'using', 'bulk', 'sequencing', 'However', 'the', 'scale', 'and', 'the', 'complexity', 'of', 'the', 'sc', 'datasets', 'poses', 'a', 'great', 'challenge', 'in', 'its', 'utility', 'and', 'this', 'problem', 'is', 'further', 'exacerbated', 'when', 'working', 'with', 'larger', 'datasets', 'typically', 'generated', 'by', 'consortium', 'efforts', 'As', 'the', 'scale', 'of', 'single', 'cell', 'datasets', 'continues', 'to', 'increase', 'exponentially', 'there', 'is', 'an', 'unmet', 'technological', 'need', 'to', 'develop', 'database', 'platforms', 'that', 'can', 'evaluate', 'key', 'biological', 'hypothesis', 'by', 'querying', 'extensive', 'single', 'cell', 'datasets', 'Large', 'single', 'cell', 'datasets', 'like', 'human', 'cell', 'atlas', 'and', 'COVID', '19', 'cell', 'atlas', 'collection', 'of', 'annotated', 'sc', 'datasets', 'from', 'various', 'human', 'organs', 'are', 'excellent', 'resources', 'for', 'profiling', 'target', 'genes', 'involved', 'in', 'human', 'diseases', 'and', 'disorders', 'ranging', 'from', 'oncology', 'auto', 'immunity', 'as', 'well', 'as', 'infectious', 'diseases', 'like', 'COVID', '19', 'caused', 'by', 'SARS', 'CoV', '2', 'virus', 'SARS', 'CoV', '2', 'infections', 'have', 'led', 'to', 'a', 'worldwide', 'pandemic', 'with', 'massive', 'loss', 'of', 'lives', 'infections', 'exceeding', '7', 'million', 'cases', 'The', 'virus', 'uses', 'ACE2', 'and', 'TMPRSS2', 'as', 'key', 'viral', 'entry', 'associated', 'proteins', 'expressed', 'in', 'human', 'cells', 'for', 'infections', 'Evaluating', 'the', 'expression', 'profile', 'of', 'key', 'genes', 'in', 'large', 'single', 'cell', 'datasets', 'can', 'facilitate', 'testing', 'for', 'diagnostics', 'therapeutics', 'and', 'vaccine', 'targets', 'as', 'the', 'world', 'struggles', 'to', 'cope', 'with', 'the', 'on', 'going', 'spread', 'of', 'COVID', '19', 'infections', 'In', 'this', 'manuscript', 'we', 'describe', 'REVEAL', 'SingleCell', 'which', 'enables', 'storage', 'retrieval', 'and', 'rapid', 'query', 'of', 'single', 'cell', 'datasets', 'inclusive', 'of', 'millions', 'of', 'cells', 'The', 'analytical', 'database', 'described', 'here', 'enables', 'selecting', 'and', 'analyzing', 'cells', 'across', 'multiple', 'studies', 'Cells', 'can', 'be', 'selected', 'using', 'individual', 'metadata', 'tags', 'more', 'complex', 'hierarchical', 'ontology', 'filtering', 'and', 'gene', 'expression', 'threshold', 'ranges', 'including', 'co', 'expression', 'of', 'multiple', 'genes', 'The', 'tags', 'on', 'selected', 'cells', 'can', 'be', 'further', 'evaluated', 'for', 'testing', 'biological', 'hypothesis', 'One', 'such', 'example', 'includes', 'identifying', 'the', 'most', 'prevalent', 'cell', 'type', 'annotation', 'tag', 'on', 'returned', 'cells', 'We', 'used', 'REVEAL', 'SingleCell', 'to', 'evaluate', 'expression', 'of', 'key', 'SARS', 'CoV', '2', 'entry', 'associated', 'genes', 'and', 'queried', 'the', 'current', 'database', '2', '2', 'Million', 'cells', '32', 'projects', 'to', 'obtain', 'the', 'results', 'in', '60', 'seconds', 'We', 'highlighted', 'cells', 'expressing', 'COVID', '19', 'associated', 'genes', 'are', 'expressed', 'on', 'multiple', 'tissue', 'types', 'thus', 'in', 'part', 'explains', 'the', 'multi', 'organ', 'involvement', 'in', 'infected', 'patients', 'observed', 'worldwide', 'during', 'the', 'on', 'going', 'COVID', '19', 'pandemic', '']"
80526,Real-time RT-PCR diagnostics of virus causing COVID-19,2020,Farmakoekonomika,https://doi.org/10.17749/2070-4909.2020.13.1.52-63,"Aim: the study was aimed to develop a reagent kit for the real-time RT-PCR diagnostics of virus causing COVID-19 Materials and Methods Three target sites were chosen in the genome SARS-CoV-2 The testing included 220 samples, 48 artificially created positive samples (made from patients' biomaterial) and 172 clinical samples (scrapes from nasal and pharyngeal cavities, bronchoalveolar lavage, expectoration, endotracheal/nasopharyngeal aspirate, feces, post-mortem material), obtained from two medical centers Preliminary, the obtained biomaterial was analyzed with a reagent kit of comparison The evaluation was performed with a confidential interval CI 95% The calculation of CI for the sensitivity and specificity was made based on the distribution of χ2 Results The authors developed a technology of novel coronavirus infection (COVID-19) real-time RT-PCR diagnostics for the application in practical healthcare and proposed the variants of testing at all the stages (preanalytical, analytical, and post-analytical, including automated results processing) The proposed reagent kit meets the requirements of the World Health Organization and the Ministry of Healthcare of the Russian Federation The study results demonstrated high sensitivity and specificity The sensitivity was 100% (95% CI) 95 6-100%;the specificity was 100% (95% CI) 96 7-100% Conclusion The proposed reagent kit was registered in the RF as a medical product;the registration certificate No RZN 2020/9948 dated 01 04 2020 The application of the reagent kit in network laboratories will provide patients with access to testing for the virus causing COVID-19 and contribute to quick differential diagnostics, improvement of pandemic control, and accurate statistics on the spread of the virus",10.17749/2070-4909.2020.13.1.52-63,5wqirhd1,"['Aim', 'the', 'study', 'was', 'aimed', 'to', 'develop', 'a', 'reagent', 'kit', 'for', 'the', 'real', 'time', 'RT', 'PCR', 'diagnostics', 'of', 'virus', 'causing', 'COVID', '19', 'Materials', 'and', 'Methods', 'Three', 'target', 'sites', 'were', 'chosen', 'in', 'the', 'genome', 'SARS', 'CoV', '2', 'The', 'testing', 'included', '220', 'samples', '48', 'artificially', 'created', 'positive', 'samples', 'made', 'from', 'patients', 'biomaterial', 'and', '172', 'clinical', 'samples', 'scrapes', 'from', 'nasal', 'and', 'pharyngeal', 'cavities', 'bronchoalveolar', 'lavage', 'expectoration', 'endotracheal', 'nasopharyngeal', 'aspirate', 'feces', 'post', 'mortem', 'material', 'obtained', 'from', 'two', 'medical', 'centers', 'Preliminary', 'the', 'obtained', 'biomaterial', 'was', 'analyzed', 'with', 'a', 'reagent', 'kit', 'of', 'comparison', 'The', 'evaluation', 'was', 'performed', 'with', 'a', 'confidential', 'interval', 'CI', '95', 'The', 'calculation', 'of', 'CI', 'for', 'the', 'sensitivity', 'and', 'specificity', 'was', 'made', 'based', 'on', 'the', 'distribution', 'of', 'χ2', 'Results', 'The', 'authors', 'developed', 'a', 'technology', 'of', 'novel', 'coronavirus', 'infection', 'COVID', '19', 'real', 'time', 'RT', 'PCR', 'diagnostics', 'for', 'the', 'application', 'in', 'practical', 'healthcare', 'and', 'proposed', 'the', 'variants', 'of', 'testing', 'at', 'all', 'the', 'stages', 'preanalytical', 'analytical', 'and', 'post', 'analytical', 'including', 'automated', 'results', 'processing', 'The', 'proposed', 'reagent', 'kit', 'meets', 'the', 'requirements', 'of', 'the', 'World', 'Health', 'Organization', 'and', 'the', 'Ministry', 'of', 'Healthcare', 'of', 'the', 'Russian', 'Federation', 'The', 'study', 'results', 'demonstrated', 'high', 'sensitivity', 'and', 'specificity', 'The', 'sensitivity', 'was', '100', '95', 'CI', '95', '6', '100', 'the', 'specificity', 'was', '100', '95', 'CI', '96', '7', '100', 'Conclusion', 'The', 'proposed', 'reagent', 'kit', 'was', 'registered', 'in', 'the', 'RF', 'as', 'a', 'medical', 'product', 'the', 'registration', 'certificate', 'No', 'RZN', '2020', '9948', 'dated', '01', '04', '2020', 'The', 'application', 'of', 'the', 'reagent', 'kit', 'in', 'network', 'laboratories', 'will', 'provide', 'patients', 'with', 'access', 'to', 'testing', 'for', 'the', 'virus', 'causing', 'COVID', '19', 'and', 'contribute', 'to', 'quick', 'differential', 'diagnostics', 'improvement', 'of', 'pandemic', 'control', 'and', 'accurate', 'statistics', 'on', 'the', 'spread', 'of', 'the', 'virus']"
80540,Scaling diagnostics in times of COVID-19: Rapid prototyping of 3D-printed water circulators for Loop-mediated Isothermal Amplification (LAMP) and detection of SARS-CoV-2 virus,2020-04-14,,https://doi.org/10.1101/2020.04.09.20058651,"By the first week of April 2020, more than 1,500,000 positive cases of COVID-19 and more than 50,000 deaths had been officially reported worldwide. While developed countries such as the USA, Italy, England, France, Spain, and Germany struggle to mitigate the propagation of SARS-CoV-2, the COVID-19 pandemic arrived in Latin America, India, and Africa -territories in which the mounted infrastructure for diagnosis is greatly underdeveloped. An actual epidemic emergency does not provide the required timeframe for testing new diagnostic strategies; therefore, the first line of response must be based on commercially and readily available resources. Here, we demonstrate the combined use of a three-dimensional (3D)-printed incubation chamber for commercial Eppendorf PCR tubes, and a colorimetric embodiment of a loop-mediated isothermal amplification (LAMP) reaction scheme for the detection of SARS-CoV-2 nucleic acids. We used this strategy to detect and amplify SARS-CoV-2 DNA sequences using a set of in-house designed initiators that target regions encoding the N protein. We were able to detect and amplify SARS-CoV-2 nucleic acids in the range of ~625 to 2 X 105 DNA copies by this straightforward method. The accuracy and simplicity of this diagnostics strategy may provide a cost-efficient and reliable alternative for use during the COVID-19 pandemics, particularly in underdeveloped regions were the availability of RT-qPCR instruments may be limited. Moreover, the portability, ease of use, and reproducibility of this strategy make it a reliable alternative for deployment of point-of-care SARS-CoV-2 detection efforts during the pandemics.",10.1101/2020.04.09.20058651,cr2myr9p,"['By', 'the', 'first', 'week', 'of', 'April', '2020', 'more', 'than', '1', '500', '000', 'positive', 'cases', 'of', 'COVID', '19', 'and', 'more', 'than', '50', '000', 'deaths', 'had', 'been', 'officially', 'reported', 'worldwide', 'While', 'developed', 'countries', 'such', 'as', 'the', 'USA', 'Italy', 'England', 'France', 'Spain', 'and', 'Germany', 'struggle', 'to', 'mitigate', 'the', 'propagation', 'of', 'SARS', 'CoV', '2', 'the', 'COVID', '19', 'pandemic', 'arrived', 'in', 'Latin', 'America', 'India', 'and', 'Africa', 'territories', 'in', 'which', 'the', 'mounted', 'infrastructure', 'for', 'diagnosis', 'is', 'greatly', 'underdeveloped', 'An', 'actual', 'epidemic', 'emergency', 'does', 'not', 'provide', 'the', 'required', 'timeframe', 'for', 'testing', 'new', 'diagnostic', 'strategies', 'therefore', 'the', 'first', 'line', 'of', 'response', 'must', 'be', 'based', 'on', 'commercially', 'and', 'readily', 'available', 'resources', 'Here', 'we', 'demonstrate', 'the', 'combined', 'use', 'of', 'a', 'three', 'dimensional', '3D', 'printed', 'incubation', 'chamber', 'for', 'commercial', 'Eppendorf', 'PCR', 'tubes', 'and', 'a', 'colorimetric', 'embodiment', 'of', 'a', 'loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'reaction', 'scheme', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'We', 'used', 'this', 'strategy', 'to', 'detect', 'and', 'amplify', 'SARS', 'CoV', '2', 'DNA', 'sequences', 'using', 'a', 'set', 'of', 'in', 'house', 'designed', 'initiators', 'that', 'target', 'regions', 'encoding', 'the', 'N', 'protein', 'We', 'were', 'able', 'to', 'detect', 'and', 'amplify', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'the', 'range', 'of', '625', 'to', '2', 'X', '105', 'DNA', 'copies', 'by', 'this', 'straightforward', 'method', 'The', 'accuracy', 'and', 'simplicity', 'of', 'this', 'diagnostics', 'strategy', 'may', 'provide', 'a', 'cost', 'efficient', 'and', 'reliable', 'alternative', 'for', 'use', 'during', 'the', 'COVID', '19', 'pandemics', 'particularly', 'in', 'underdeveloped', 'regions', 'were', 'the', 'availability', 'of', 'RT', 'qPCR', 'instruments', 'may', 'be', 'limited', 'Moreover', 'the', 'portability', 'ease', 'of', 'use', 'and', 'reproducibility', 'of', 'this', 'strategy', 'make', 'it', 'a', 'reliable', 'alternative', 'for', 'deployment', 'of', 'point', 'of', 'care', 'SARS', 'CoV', '2', 'detection', 'efforts', 'during', 'the', 'pandemics', '']"
80628,Companies are racing to develop COVID-19 tests for the US. Will the tests help?,2020,C&amp;EN Global Enterprise,https://doi.org/10.1021/cen-09814-cover3,"These speed bumps are some of the reasons why many industry watchers and public health officials are praising the development of a 5 min bedside, or point-of-care, test produced by Abbott Laboratories Approved in late March, the test relies on PCR but uses a different method of copying genetic material, allowing it to be done at a constant temperature and quickly Other companies that use this method, called isothermal amplification, for infectious disease diagnostics have developed specialized enzymes that can copy viral RNA without the temperature cycling used in more traditional PCR It’s not clear exactly how Abbott is employing isothermal amplification, but the company says the test can be done in a small, portable machine that many hospitals already use to diagnose other infectious diseases Abbott says this test and another, more traditional PCR diagnostic it developed can perform up to 5 million COVID-19 tests per month total",10.1021/cen-09814-cover3,hboafe4u,"['These', 'speed', 'bumps', 'are', 'some', 'of', 'the', 'reasons', 'why', 'many', 'industry', 'watchers', 'and', 'public', 'health', 'officials', 'are', 'praising', 'the', 'development', 'of', 'a', '5', 'min', 'bedside', 'or', 'point', 'of', 'care', 'test', 'produced', 'by', 'Abbott', 'Laboratories', 'Approved', 'in', 'late', 'March', 'the', 'test', 'relies', 'on', 'PCR', 'but', 'uses', 'a', 'different', 'method', 'of', 'copying', 'genetic', 'material', 'allowing', 'it', 'to', 'be', 'done', 'at', 'a', 'constant', 'temperature', 'and', 'quickly', 'Other', 'companies', 'that', 'use', 'this', 'method', 'called', 'isothermal', 'amplification', 'for', 'infectious', 'disease', 'diagnostics', 'have', 'developed', 'specialized', 'enzymes', 'that', 'can', 'copy', 'viral', 'RNA', 'without', 'the', 'temperature', 'cycling', 'used', 'in', 'more', 'traditional', 'PCR', 'It', 's', 'not', 'clear', 'exactly', 'how', 'Abbott', 'is', 'employing', 'isothermal', 'amplification', 'but', 'the', 'company', 'says', 'the', 'test', 'can', 'be', 'done', 'in', 'a', 'small', 'portable', 'machine', 'that', 'many', 'hospitals', 'already', 'use', 'to', 'diagnose', 'other', 'infectious', 'diseases', 'Abbott', 'says', 'this', 'test', 'and', 'another', 'more', 'traditional', 'PCR', 'diagnostic', 'it', 'developed', 'can', 'perform', 'up', 'to', '5', 'million', 'COVID', '19', 'tests', 'per', 'month', 'total']"
81011,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens,2020-04-22,,http://medrxiv.org/cgi/content/short/2020.04.17.20069864v1?rss=1,"The novel human coronavirus SARS-CoV-2 was first discovered in the city of Wuhan, Hubei province, China, causing an outbreak of pneumonia in January 2020. As of April 10, 2020, the virus has rapidly disseminated to over 200 countries and territories, causing more than 1.6 million confirmed cases of COVID-19 and 97,000 deaths worldwide. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Further, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients. This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.",10.1101/2020.04.17.20069864,2bf3xzni,"['The', 'novel', 'human', 'coronavirus', 'SARS', 'CoV', '2', 'was', 'first', 'discovered', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'causing', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'January', '2020', 'As', 'of', 'April', '10', '2020', 'the', 'virus', 'has', 'rapidly', 'disseminated', 'to', 'over', '200', 'countries', 'and', 'territories', 'causing', 'more', 'than', '1', '6', 'million', 'confirmed', 'cases', 'of', 'COVID', '19', 'and', '97', '000', 'deaths', 'worldwide', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'non', 'specific', 'and', 'symptoms', 'overlap', 'with', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Further', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'have', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'Emergency', 'Use', 'Authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
81053,Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-qPCR,2020-04-17,,https://doi.org/10.1101/2020.04.17.20067348,"Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The most widely used method of COVID-19 diagnostics is a reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay, detecting the presence of SARS-CoV-2 RNA in patient samples, typically from nasopharyngeal swabs. The RNA extraction is a major bottleneck in current COVID-19 testing, in terms of turn-around, logistics, component availability and cost, which delays or completely precludes COVID-19 diagnostics in many settings. Efforts to simplify the current methods are important, as increased diagnostic availability and efficiency is expected to benefit patient care and infection control. Here, we describe methods to circumvent RNA extraction in COVID-19 testing by performing RT-qPCR directly on heat-inactivated subject samples as well as samples lysed with readily available detergents. Our data, including cross-comparisons with clinically diagnosed patient samples, suggest that direct RT-qPCR is a viable option to extraction-based COVID-19 diagnostics. We argue that significant savings in terms of time and cost can be achieved by embracing RNA-extraction-free protocols, that feeds directly into the established PCR-based testing pipeline. This could aid the expansion of COVID-19 testing.",10.1101/2020.04.17.20067348,jeufhpkq,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'The', 'most', 'widely', 'used', 'method', 'of', 'COVID', '19', 'diagnostics', 'is', 'a', 'reverse', 'transcription', 'quantitative', 'polymerase', 'chain', 'reaction', 'RT', 'qPCR', 'assay', 'detecting', 'the', 'presence', 'of', 'SARS', 'CoV', '2', 'RNA', 'in', 'patient', 'samples', 'typically', 'from', 'nasopharyngeal', 'swabs', 'The', 'RNA', 'extraction', 'is', 'a', 'major', 'bottleneck', 'in', 'current', 'COVID', '19', 'testing', 'in', 'terms', 'of', 'turn', 'around', 'logistics', 'component', 'availability', 'and', 'cost', 'which', 'delays', 'or', 'completely', 'precludes', 'COVID', '19', 'diagnostics', 'in', 'many', 'settings', 'Efforts', 'to', 'simplify', 'the', 'current', 'methods', 'are', 'important', 'as', 'increased', 'diagnostic', 'availability', 'and', 'efficiency', 'is', 'expected', 'to', 'benefit', 'patient', 'care', 'and', 'infection', 'control', 'Here', 'we', 'describe', 'methods', 'to', 'circumvent', 'RNA', 'extraction', 'in', 'COVID', '19', 'testing', 'by', 'performing', 'RT', 'qPCR', 'directly', 'on', 'heat', 'inactivated', 'subject', 'samples', 'as', 'well', 'as', 'samples', 'lysed', 'with', 'readily', 'available', 'detergents', 'Our', 'data', 'including', 'cross', 'comparisons', 'with', 'clinically', 'diagnosed', 'patient', 'samples', 'suggest', 'that', 'direct', 'RT', 'qPCR', 'is', 'a', 'viable', 'option', 'to', 'extraction', 'based', 'COVID', '19', 'diagnostics', 'We', 'argue', 'that', 'significant', 'savings', 'in', 'terms', 'of', 'time', 'and', 'cost', 'can', 'be', 'achieved', 'by', 'embracing', 'RNA', 'extraction', 'free', 'protocols', 'that', 'feeds', 'directly', 'into', 'the', 'established', 'PCR', 'based', 'testing', 'pipeline', 'This', 'could', 'aid', 'the', 'expansion', 'of', 'COVID', '19', 'testing', '']"
81237,Serological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnostics,2020-05-11,,http://medrxiv.org/cgi/content/short/2020.05.07.20093963v1?rss=1,"Background The antibody response generated following infection with SARS-CoV-2 is expected to decline over time. This may cause individuals with confirmed SARS-CoV-2 infection to test negative according to serological diagnostic tests in the months and years following symptom onset. Methods A multiplex serological assay was developed to measure IgG and IgM antibody responses to four SARS-CoV-2 Spike (S) antigens: spike trimeric ectodomain (Stri), its receptor-binding domain (RBD), spike subunit 1 (S1), and spike subunit 2 (S2). Antibody responses were measured in serum samples from patients in French hospitals with RT-qPCR confirmed infection (n = 259), and negative control serum samples collected before the start of the SARS-CoV-2 epidemic in 2019 (n = 335). The multiplex antibody data was used to train a random forests algorithm for classifying individuals with previous SARS-CoV-2 infection. A mathematical model of antibody kinetics informed by prior information from other coronaviruses was used to estimate time-varying antibody responses and assess the potential sensitivity and classification performance of serological diagnostics during the first year following symptom onset. Results IgG antibody responses to one S antigen identified individuals with previous RT-qPCR confirmed SARS-CoV-2 infection with 90.3% sensitivity (95% confidence interval (CI); 86.1%, 93.4%) and 99.1% specificity (95% CI; 97.4%, 99.7%). Using a serological signature of IgG to four antigens, it was possible to identify infected individuals with 96.1% sensitivity (95% CI; 93.0%, 97.9%) and 99.1% specificity (95% CI; 97.4%, 99.7%). Antibody responses to SARS-CoV-2 increase rapidly 1-2 weeks after symptom onset, with antibody responses predicted to peak within 2-4 weeks. Informed by prior data from other coronaviruses, one year following symptom onset antibody responses are predicted to decay by approximately 60% from the peak response. Depending on the selection of sero-positivity cutoff, we estimate that the sensitivity of serological diagnostics may reduce to 56%-97% after six months, and to 49%-93% after one year. Conclusion Serological signatures based on antibody responses to multiple antigens can provide more accurate and robust serological classification of individuals with previous SARS-CoV-2 infection. Changes in antibody levels over time may cause reductions in the sensitivity of serological diagnostics leading to an underestimation of sero-prevalence. It is essential that data continue to be collected to evaluate this potential risk.",10.1101/2020.05.07.20093963,gqjyusjw,"['Background', 'The', 'antibody', 'response', 'generated', 'following', 'infection', 'with', 'SARS', 'CoV', '2', 'is', 'expected', 'to', 'decline', 'over', 'time', 'This', 'may', 'cause', 'individuals', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'to', 'test', 'negative', 'according', 'to', 'serological', 'diagnostic', 'tests', 'in', 'the', 'months', 'and', 'years', 'following', 'symptom', 'onset', 'Methods', 'A', 'multiplex', 'serological', 'assay', 'was', 'developed', 'to', 'measure', 'IgG', 'and', 'IgM', 'antibody', 'responses', 'to', 'four', 'SARS', 'CoV', '2', 'Spike', 'S', 'antigens', 'spike', 'trimeric', 'ectodomain', 'Stri', 'its', 'receptor', 'binding', 'domain', 'RBD', 'spike', 'subunit', '1', 'S1', 'and', 'spike', 'subunit', '2', 'S2', 'Antibody', 'responses', 'were', 'measured', 'in', 'serum', 'samples', 'from', 'patients', 'in', 'French', 'hospitals', 'with', 'RT', 'qPCR', 'confirmed', 'infection', 'n', '259', 'and', 'negative', 'control', 'serum', 'samples', 'collected', 'before', 'the', 'start', 'of', 'the', 'SARS', 'CoV', '2', 'epidemic', 'in', '2019', 'n', '335', 'The', 'multiplex', 'antibody', 'data', 'was', 'used', 'to', 'train', 'a', 'random', 'forests', 'algorithm', 'for', 'classifying', 'individuals', 'with', 'previous', 'SARS', 'CoV', '2', 'infection', 'A', 'mathematical', 'model', 'of', 'antibody', 'kinetics', 'informed', 'by', 'prior', 'information', 'from', 'other', 'coronaviruses', 'was', 'used', 'to', 'estimate', 'time', 'varying', 'antibody', 'responses', 'and', 'assess', 'the', 'potential', 'sensitivity', 'and', 'classification', 'performance', 'of', 'serological', 'diagnostics', 'during', 'the', 'first', 'year', 'following', 'symptom', 'onset', 'Results', 'IgG', 'antibody', 'responses', 'to', 'one', 'S', 'antigen', 'identified', 'individuals', 'with', 'previous', 'RT', 'qPCR', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'with', '90', '3', 'sensitivity', '95', 'confidence', 'interval', 'CI', '86', '1', '93', '4', 'and', '99', '1', 'specificity', '95', 'CI', '97', '4', '99', '7', 'Using', 'a', 'serological', 'signature', 'of', 'IgG', 'to', 'four', 'antigens', 'it', 'was', 'possible', 'to', 'identify', 'infected', 'individuals', 'with', '96', '1', 'sensitivity', '95', 'CI', '93', '0', '97', '9', 'and', '99', '1', 'specificity', '95', 'CI', '97', '4', '99', '7', 'Antibody', 'responses', 'to', 'SARS', 'CoV', '2', 'increase', 'rapidly', '1', '2', 'weeks', 'after', 'symptom', 'onset', 'with', 'antibody', 'responses', 'predicted', 'to', 'peak', 'within', '2', '4', 'weeks', 'Informed', 'by', 'prior', 'data', 'from', 'other', 'coronaviruses', 'one', 'year', 'following', 'symptom', 'onset', 'antibody', 'responses', 'are', 'predicted', 'to', 'decay', 'by', 'approximately', '60', 'from', 'the', 'peak', 'response', 'Depending', 'on', 'the', 'selection', 'of', 'sero', 'positivity', 'cutoff', 'we', 'estimate', 'that', 'the', 'sensitivity', 'of', 'serological', 'diagnostics', 'may', 'reduce', 'to', '56', '97', 'after', 'six', 'months', 'and', 'to', '49', '93', 'after', 'one', 'year', 'Conclusion', 'Serological', 'signatures', 'based', 'on', 'antibody', 'responses', 'to', 'multiple', 'antigens', 'can', 'provide', 'more', 'accurate', 'and', 'robust', 'serological', 'classification', 'of', 'individuals', 'with', 'previous', 'SARS', 'CoV', '2', 'infection', 'Changes', 'in', 'antibody', 'levels', 'over', 'time', 'may', 'cause', 'reductions', 'in', 'the', 'sensitivity', 'of', 'serological', 'diagnostics', 'leading', 'to', 'an', 'underestimation', 'of', 'sero', 'prevalence', 'It', 'is', 'essential', 'that', 'data', 'continue', 'to', 'be', 'collected', 'to', 'evaluate', 'this', 'potential', 'risk', '']"
81453,Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-CoV-2 virus detection,2020-04-07,,https://doi.org/10.1101/2020.04.03.20052860,"The COVID-19 pandemic has crudely demonstrated the value of massive and rapid diagnostics. By the first week of April, more than 900,000 positive cases of COVID-19 have been reported worldwide, although this number could be greatly underestimated. In the case of an epidemic emergency, the first line of response should be based on commercially available and validated resources. Here, we demonstrate the combined use of the miniPCR, a commercial compact and portable PCR device recently available on the market, and a commercial well-plate reader as a diagnostic system for detecting SARS-CoV-2 nucleic acids. We used the miniPCR to detect and amplify SARS-CoV-2 DNA sequences using the sets of initiators recommended by the World Health Organization for targeting three different regions that encode for the N protein. Prior to amplification, samples were combined with a DNA intercalating reagent (i.e., EvaGreen Dye). Sample fluorescence after amplification was then read using a commercial 96-well plate reader. This straightforward method allows the detection and amplification of SARS-CoV-2 nucleic acids in the range of ~625 to 2 x 105 DNA copies. The accuracy and simplicity of this diagnostics strategy may provide a cost-efficient and reliable alternative for COVID-19 pandemic testing, particularly in underdeveloped regions where RT-qPCR instrument availability may be limited. The portability, ease of use, and reproducibility of the miniPCR makes it a reliable alternative for deployment in point-of-care SARS-CoV-2 detection efforts during pandemics.",10.1101/2020.04.03.20052860,avo5jfaj,"['The', 'COVID', '19', 'pandemic', 'has', 'crudely', 'demonstrated', 'the', 'value', 'of', 'massive', 'and', 'rapid', 'diagnostics', 'By', 'the', 'first', 'week', 'of', 'April', 'more', 'than', '900', '000', 'positive', 'cases', 'of', 'COVID', '19', 'have', 'been', 'reported', 'worldwide', 'although', 'this', 'number', 'could', 'be', 'greatly', 'underestimated', 'In', 'the', 'case', 'of', 'an', 'epidemic', 'emergency', 'the', 'first', 'line', 'of', 'response', 'should', 'be', 'based', 'on', 'commercially', 'available', 'and', 'validated', 'resources', 'Here', 'we', 'demonstrate', 'the', 'combined', 'use', 'of', 'the', 'miniPCR', 'a', 'commercial', 'compact', 'and', 'portable', 'PCR', 'device', 'recently', 'available', 'on', 'the', 'market', 'and', 'a', 'commercial', 'well', 'plate', 'reader', 'as', 'a', 'diagnostic', 'system', 'for', 'detecting', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'We', 'used', 'the', 'miniPCR', 'to', 'detect', 'and', 'amplify', 'SARS', 'CoV', '2', 'DNA', 'sequences', 'using', 'the', 'sets', 'of', 'initiators', 'recommended', 'by', 'the', 'World', 'Health', 'Organization', 'for', 'targeting', 'three', 'different', 'regions', 'that', 'encode', 'for', 'the', 'N', 'protein', 'Prior', 'to', 'amplification', 'samples', 'were', 'combined', 'with', 'a', 'DNA', 'intercalating', 'reagent', 'i', 'e', 'EvaGreen', 'Dye', 'Sample', 'fluorescence', 'after', 'amplification', 'was', 'then', 'read', 'using', 'a', 'commercial', '96', 'well', 'plate', 'reader', 'This', 'straightforward', 'method', 'allows', 'the', 'detection', 'and', 'amplification', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'the', 'range', 'of', '625', 'to', '2', 'x', '105', 'DNA', 'copies', 'The', 'accuracy', 'and', 'simplicity', 'of', 'this', 'diagnostics', 'strategy', 'may', 'provide', 'a', 'cost', 'efficient', 'and', 'reliable', 'alternative', 'for', 'COVID', '19', 'pandemic', 'testing', 'particularly', 'in', 'underdeveloped', 'regions', 'where', 'RT', 'qPCR', 'instrument', 'availability', 'may', 'be', 'limited', 'The', 'portability', 'ease', 'of', 'use', 'and', 'reproducibility', 'of', 'the', 'miniPCR', 'makes', 'it', 'a', 'reliable', 'alternative', 'for', 'deployment', 'in', 'point', 'of', 'care', 'SARS', 'CoV', '2', 'detection', 'efforts', 'during', 'pandemics', '']"
81458,Detection of SARS-CoV-2 RNA by multiplex RT-qPCR,2020-06-17,bioRxiv,https://doi.org/10.1101/2020.06.16.155887,"The current RT-qPCR assay recommended for SARS-CoV-2 testing in the United States requires analysis of three genomic targets per sample: two viral and one host. To simplify testing and reduce the volume of required reagents, we developed a multiplex RT-qPCR assay to detect SARS-CoV-2 in a single reaction. We used existing N1, N2, and RP primer and probe sets by the CDC, but substituted fluorophores to allow multiplexing of the assay. The cycle threshold (Ct) values of our multiplex RT-qPCR were comparable to those obtained by the singleplex assay adapted for research purposes. Low copies (>500 copies / reaction) of SARS-CoV-2 RNA were consistently detected by the multiplex RT-qPCR. Our novel multiplex RT-qPCR improves upon current singleplex diagnostics by saving reagents, costs, time and labor.",10.1101/2020.06.16.155887,y9frjzzu,"['The', 'current', 'RT', 'qPCR', 'assay', 'recommended', 'for', 'SARS', 'CoV', '2', 'testing', 'in', 'the', 'United', 'States', 'requires', 'analysis', 'of', 'three', 'genomic', 'targets', 'per', 'sample', 'two', 'viral', 'and', 'one', 'host', 'To', 'simplify', 'testing', 'and', 'reduce', 'the', 'volume', 'of', 'required', 'reagents', 'we', 'developed', 'a', 'multiplex', 'RT', 'qPCR', 'assay', 'to', 'detect', 'SARS', 'CoV', '2', 'in', 'a', 'single', 'reaction', 'We', 'used', 'existing', 'N1', 'N2', 'and', 'RP', 'primer', 'and', 'probe', 'sets', 'by', 'the', 'CDC', 'but', 'substituted', 'fluorophores', 'to', 'allow', 'multiplexing', 'of', 'the', 'assay', 'The', 'cycle', 'threshold', 'Ct', 'values', 'of', 'our', 'multiplex', 'RT', 'qPCR', 'were', 'comparable', 'to', 'those', 'obtained', 'by', 'the', 'singleplex', 'assay', 'adapted', 'for', 'research', 'purposes', 'Low', 'copies', '500', 'copies', 'reaction', 'of', 'SARS', 'CoV', '2', 'RNA', 'were', 'consistently', 'detected', 'by', 'the', 'multiplex', 'RT', 'qPCR', 'Our', 'novel', 'multiplex', 'RT', 'qPCR', 'improves', 'upon', 'current', 'singleplex', 'diagnostics', 'by', 'saving', 'reagents', 'costs', 'time', 'and', 'labor', '']"
81941,Production systems for recombinant antibodies.,2008,Frontiers in bioscience : a journal and virtual library,https://www.ncbi.nlm.nih.gov/pubmed/18508530/,"Recombinant antibodies are the fastest growing class of therapeutic proteins. Furthermore, antibodies are key detection reagents in research and diagnostics. The increasing demand for antibodies with regards to amount and quality resulted in the development of a variety of recombinant production systems employing gram-negative and gram-positive bacteria, yeast and filamentous fungi, insect cell lines as well as mammalian cell lines. More recently, antibodies were also successfully produced in transgenic plants and animals. Currently, the production of recombinant antibodies for therapy is performed in mammalian cell lines to reduce the risk of immunogenicity caused by non-human post-translational modifications, in particular glycosylation. However, novel strategies already allow human-like glycosylation patterns in yeast, insect cell lines and transgenic plants. Furthermore, therapeutic strategies not requiring glycosylation of the Fc portion have been conceived, most prominently using bispecific antibodies or scFv fusion proteins, which can be produced in bacteria. Here, we review all current antibody production systems considering their advantages and limitations with respect to intended applications.",,a6ewlox0,"['Recombinant', 'antibodies', 'are', 'the', 'fastest', 'growing', 'class', 'of', 'therapeutic', 'proteins', 'Furthermore', 'antibodies', 'are', 'key', 'detection', 'reagents', 'in', 'research', 'and', 'diagnostics', 'The', 'increasing', 'demand', 'for', 'antibodies', 'with', 'regards', 'to', 'amount', 'and', 'quality', 'resulted', 'in', 'the', 'development', 'of', 'a', 'variety', 'of', 'recombinant', 'production', 'systems', 'employing', 'gram', 'negative', 'and', 'gram', 'positive', 'bacteria', 'yeast', 'and', 'filamentous', 'fungi', 'insect', 'cell', 'lines', 'as', 'well', 'as', 'mammalian', 'cell', 'lines', 'More', 'recently', 'antibodies', 'were', 'also', 'successfully', 'produced', 'in', 'transgenic', 'plants', 'and', 'animals', 'Currently', 'the', 'production', 'of', 'recombinant', 'antibodies', 'for', 'therapy', 'is', 'performed', 'in', 'mammalian', 'cell', 'lines', 'to', 'reduce', 'the', 'risk', 'of', 'immunogenicity', 'caused', 'by', 'non', 'human', 'post', 'translational', 'modifications', 'in', 'particular', 'glycosylation', 'However', 'novel', 'strategies', 'already', 'allow', 'human', 'like', 'glycosylation', 'patterns', 'in', 'yeast', 'insect', 'cell', 'lines', 'and', 'transgenic', 'plants', 'Furthermore', 'therapeutic', 'strategies', 'not', 'requiring', 'glycosylation', 'of', 'the', 'Fc', 'portion', 'have', 'been', 'conceived', 'most', 'prominently', 'using', 'bispecific', 'antibodies', 'or', 'scFv', 'fusion', 'proteins', 'which', 'can', 'be', 'produced', 'in', 'bacteria', 'Here', 'we', 'review', 'all', 'current', 'antibody', 'production', 'systems', 'considering', 'their', 'advantages', 'and', 'limitations', 'with', 'respect', 'to', 'intended', 'applications', '']"
82568,A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions?,2006,Bulletin of the World Health Organization,https://www.ncbi.nlm.nih.gov/pubmed/16710543/,"In genetic diagnostics, the emergence of a so-called ""patent thicket"" is imminent. Such an overlapping set of patent rights may have restrictive effects on further research and development of diagnostic tests, and the provision of clinical diagnostic services. Currently, two models that may facilitate access to and use of patented genetic inventions are attracting much debate in various national and international fora: patent pools and clearing houses. In this article, we explore the concept of clearing houses. Several types of clearing houses are identified. First, we describe and discuss two types that would provide access to information on the patented inventions: the information clearing house and the technology exchange clearing house. Second, three types of clearing houses are analysed that not only offer access to information but also provide an instrument to facilitate the use of the patented inventions: the open access clearing house, the standardized licences clearing house and the royalty collection clearing house. A royalty collection clearing house for genetic diagnostic testing would be the most comprehensive as it would serve several functions: identifying patents and patent claims essential to diagnostic testing, matching licensees with licensors, developing and supplying standardized licences, collecting royalties, monitoring whether users respect licensing conditions, and providing dispute resolution services such as mediation and arbitration. In this way, it might function as an effective model for users to facilitate access to and use of the patented inventions. However, it remains to be seen whether patent holders with a strong patent portfolio will be convinced by the advantages of the royalty collection clearing house and be willing to participate.",,9zffv8o9,"['In', 'genetic', 'diagnostics', 'the', 'emergence', 'of', 'a', 'so', 'called', 'patent', 'thicket', 'is', 'imminent', 'Such', 'an', 'overlapping', 'set', 'of', 'patent', 'rights', 'may', 'have', 'restrictive', 'effects', 'on', 'further', 'research', 'and', 'development', 'of', 'diagnostic', 'tests', 'and', 'the', 'provision', 'of', 'clinical', 'diagnostic', 'services', 'Currently', 'two', 'models', 'that', 'may', 'facilitate', 'access', 'to', 'and', 'use', 'of', 'patented', 'genetic', 'inventions', 'are', 'attracting', 'much', 'debate', 'in', 'various', 'national', 'and', 'international', 'fora', 'patent', 'pools', 'and', 'clearing', 'houses', 'In', 'this', 'article', 'we', 'explore', 'the', 'concept', 'of', 'clearing', 'houses', 'Several', 'types', 'of', 'clearing', 'houses', 'are', 'identified', 'First', 'we', 'describe', 'and', 'discuss', 'two', 'types', 'that', 'would', 'provide', 'access', 'to', 'information', 'on', 'the', 'patented', 'inventions', 'the', 'information', 'clearing', 'house', 'and', 'the', 'technology', 'exchange', 'clearing', 'house', 'Second', 'three', 'types', 'of', 'clearing', 'houses', 'are', 'analysed', 'that', 'not', 'only', 'offer', 'access', 'to', 'information', 'but', 'also', 'provide', 'an', 'instrument', 'to', 'facilitate', 'the', 'use', 'of', 'the', 'patented', 'inventions', 'the', 'open', 'access', 'clearing', 'house', 'the', 'standardized', 'licences', 'clearing', 'house', 'and', 'the', 'royalty', 'collection', 'clearing', 'house', 'A', 'royalty', 'collection', 'clearing', 'house', 'for', 'genetic', 'diagnostic', 'testing', 'would', 'be', 'the', 'most', 'comprehensive', 'as', 'it', 'would', 'serve', 'several', 'functions', 'identifying', 'patents', 'and', 'patent', 'claims', 'essential', 'to', 'diagnostic', 'testing', 'matching', 'licensees', 'with', 'licensors', 'developing', 'and', 'supplying', 'standardized', 'licences', 'collecting', 'royalties', 'monitoring', 'whether', 'users', 'respect', 'licensing', 'conditions', 'and', 'providing', 'dispute', 'resolution', 'services', 'such', 'as', 'mediation', 'and', 'arbitration', 'In', 'this', 'way', 'it', 'might', 'function', 'as', 'an', 'effective', 'model', 'for', 'users', 'to', 'facilitate', 'access', 'to', 'and', 'use', 'of', 'the', 'patented', 'inventions', 'However', 'it', 'remains', 'to', 'be', 'seen', 'whether', 'patent', 'holders', 'with', 'a', 'strong', 'patent', 'portfolio', 'will', 'be', 'convinced', 'by', 'the', 'advantages', 'of', 'the', 'royalty', 'collection', 'clearing', 'house', 'and', 'be', 'willing', 'to', 'participate', '']"
82654,Nucleocapsid protein-based enzyme-linked immunosorbent assay for detection and differentiation of antibodies against European and North American porcine reproductive and respiratory syndrome virus.,2002,Clinical and diagnostic laboratory immunology,https://www.ncbi.nlm.nih.gov/pubmed/12414748/,"Two types of porcine reproductive and respiratory syndrome virus (PRRSV) have been reported, the European type (EU PRRSV) and the North American type (US PRRSV). We developed a dual enzyme-linked immunosorbent assay (ELISA) for the simultaneous detection and differentiation of serum antibodies directed against either of the two PRRSV types. This tandem PRRS ELISA is based on affinity-purified recombinant nucleocapsid protein expressed in Escherichia coli. Sensitivity and specificity were assessed by using the IDEXX HerdChek PRRS ELISA and the indirect immunofluorescence assay as reference tests. A total of 1571 sera originating from the United States, Europe, and two PRRS-free countries, i.e., Switzerland and New Zealand, were used for validation of the tandem PRRS ELISA. The new test performed at least as well as the reference tests in regard to sensitivity (0.94 for the US PRRS ELISA and 0.93 for the EU PRRS ELISA) and specificity (0.96 for the US PRRS ELISA and 0.99 for the EU PRRS ELISA). Positive sera were correctly differentiated in 582 of 591 cases, indicating a high differentiation capability of this dual ELISA. The robustness and repeatability of the test were assessed and found to be appropriate for diagnostic applications. Taken together, the data indicate that the tandem PRRS ELISA described here is the first differentiation ELISA for PRRSV serology based on recombinant antigen. It is convenient with respect to antigen production, and it is reliable, economical, and highly sensitive and specific. Thus, it is considered to be a powerful tool for routine diagnostics, epidemiological surveys, and outbreak investigations.",,lr9gb0sb,"['Two', 'types', 'of', 'porcine', 'reproductive', 'and', 'respiratory', 'syndrome', 'virus', 'PRRSV', 'have', 'been', 'reported', 'the', 'European', 'type', 'EU', 'PRRSV', 'and', 'the', 'North', 'American', 'type', 'US', 'PRRSV', 'We', 'developed', 'a', 'dual', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'for', 'the', 'simultaneous', 'detection', 'and', 'differentiation', 'of', 'serum', 'antibodies', 'directed', 'against', 'either', 'of', 'the', 'two', 'PRRSV', 'types', 'This', 'tandem', 'PRRS', 'ELISA', 'is', 'based', 'on', 'affinity', 'purified', 'recombinant', 'nucleocapsid', 'protein', 'expressed', 'in', 'Escherichia', 'coli', 'Sensitivity', 'and', 'specificity', 'were', 'assessed', 'by', 'using', 'the', 'IDEXX', 'HerdChek', 'PRRS', 'ELISA', 'and', 'the', 'indirect', 'immunofluorescence', 'assay', 'as', 'reference', 'tests', 'A', 'total', 'of', '1571', 'sera', 'originating', 'from', 'the', 'United', 'States', 'Europe', 'and', 'two', 'PRRS', 'free', 'countries', 'i', 'e', 'Switzerland', 'and', 'New', 'Zealand', 'were', 'used', 'for', 'validation', 'of', 'the', 'tandem', 'PRRS', 'ELISA', 'The', 'new', 'test', 'performed', 'at', 'least', 'as', 'well', 'as', 'the', 'reference', 'tests', 'in', 'regard', 'to', 'sensitivity', '0', '94', 'for', 'the', 'US', 'PRRS', 'ELISA', 'and', '0', '93', 'for', 'the', 'EU', 'PRRS', 'ELISA', 'and', 'specificity', '0', '96', 'for', 'the', 'US', 'PRRS', 'ELISA', 'and', '0', '99', 'for', 'the', 'EU', 'PRRS', 'ELISA', 'Positive', 'sera', 'were', 'correctly', 'differentiated', 'in', '582', 'of', '591', 'cases', 'indicating', 'a', 'high', 'differentiation', 'capability', 'of', 'this', 'dual', 'ELISA', 'The', 'robustness', 'and', 'repeatability', 'of', 'the', 'test', 'were', 'assessed', 'and', 'found', 'to', 'be', 'appropriate', 'for', 'diagnostic', 'applications', 'Taken', 'together', 'the', 'data', 'indicate', 'that', 'the', 'tandem', 'PRRS', 'ELISA', 'described', 'here', 'is', 'the', 'first', 'differentiation', 'ELISA', 'for', 'PRRSV', 'serology', 'based', 'on', 'recombinant', 'antigen', 'It', 'is', 'convenient', 'with', 'respect', 'to', 'antigen', 'production', 'and', 'it', 'is', 'reliable', 'economical', 'and', 'highly', 'sensitive', 'and', 'specific', 'Thus', 'it', 'is', 'considered', 'to', 'be', 'a', 'powerful', 'tool', 'for', 'routine', 'diagnostics', 'epidemiological', 'surveys', 'and', 'outbreak', 'investigations', '']"
82843,Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).,2008,"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",https://www.ncbi.nlm.nih.gov/pubmed/19203466/,"PURPOSE The large number of deaths in a short period of time due to the spread of severe acute respiratory syndrome (SARS) infection led to the unparalleled collaborative efforts world wide to determine and characterize the new coronavirus (SARS-CoV). The full genome sequence was determined within weeks of the first outbreak by the Canadian group with international collaboration. As per the World Health Organization (WHO), the continual lack of a rapid laboratory test to aid the early diagnosis of suspected cases of SARS makes this area a priority for future research. To prevent deaths in the future, early diagnosis and therapy of this infectious disease is of paramount importance. METHODS This review describes the specific molecular targets for diagnostics and therapeutics of viral infection. RESULTS The three major diagnostic methods available for SARS includes viral RNA detection by reverse transcription polymerase chain reaction (RT-PCR), virus induced antibodies by immunofluorescence assay (IFA) or by enzyme linked immunosorbant assay (ELISA) of nucleocapsid protein (NP). The spike glycoprotein of SARS-CoV is the major inducer of neutralizing antibodies. The receptor binding domain (RBD) in the S1 region of the spike glycoprotein contains multiple conformational epitopes that induces highly potent neutralizing antibodies. The genetically engineered attenuated form of the virus or viral vector vaccine encoding for the SARS-CoV spike glycoprotein has been shown to elicit protective immunity in vaccinated animals. CONCLUSION NP is the preferred target for routine detection of SARS-CoV infection by ELISA which is an economical method compared to other methods. The RBD of the spike glycoprotein is both a functional domain for cell receptor binding and also a major neutralizing determinant of SARS-CoV. The progress in evaluating a therapeutic or vaccine would depend on the avail ability of clinically relevant animal model.",,qxiyo47f,"['PURPOSE', 'The', 'large', 'number', 'of', 'deaths', 'in', 'a', 'short', 'period', 'of', 'time', 'due', 'to', 'the', 'spread', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'infection', 'led', 'to', 'the', 'unparalleled', 'collaborative', 'efforts', 'world', 'wide', 'to', 'determine', 'and', 'characterize', 'the', 'new', 'coronavirus', 'SARS', 'CoV', 'The', 'full', 'genome', 'sequence', 'was', 'determined', 'within', 'weeks', 'of', 'the', 'first', 'outbreak', 'by', 'the', 'Canadian', 'group', 'with', 'international', 'collaboration', 'As', 'per', 'the', 'World', 'Health', 'Organization', 'WHO', 'the', 'continual', 'lack', 'of', 'a', 'rapid', 'laboratory', 'test', 'to', 'aid', 'the', 'early', 'diagnosis', 'of', 'suspected', 'cases', 'of', 'SARS', 'makes', 'this', 'area', 'a', 'priority', 'for', 'future', 'research', 'To', 'prevent', 'deaths', 'in', 'the', 'future', 'early', 'diagnosis', 'and', 'therapy', 'of', 'this', 'infectious', 'disease', 'is', 'of', 'paramount', 'importance', 'METHODS', 'This', 'review', 'describes', 'the', 'specific', 'molecular', 'targets', 'for', 'diagnostics', 'and', 'therapeutics', 'of', 'viral', 'infection', 'RESULTS', 'The', 'three', 'major', 'diagnostic', 'methods', 'available', 'for', 'SARS', 'includes', 'viral', 'RNA', 'detection', 'by', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'virus', 'induced', 'antibodies', 'by', 'immunofluorescence', 'assay', 'IFA', 'or', 'by', 'enzyme', 'linked', 'immunosorbant', 'assay', 'ELISA', 'of', 'nucleocapsid', 'protein', 'NP', 'The', 'spike', 'glycoprotein', 'of', 'SARS', 'CoV', 'is', 'the', 'major', 'inducer', 'of', 'neutralizing', 'antibodies', 'The', 'receptor', 'binding', 'domain', 'RBD', 'in', 'the', 'S1', 'region', 'of', 'the', 'spike', 'glycoprotein', 'contains', 'multiple', 'conformational', 'epitopes', 'that', 'induces', 'highly', 'potent', 'neutralizing', 'antibodies', 'The', 'genetically', 'engineered', 'attenuated', 'form', 'of', 'the', 'virus', 'or', 'viral', 'vector', 'vaccine', 'encoding', 'for', 'the', 'SARS', 'CoV', 'spike', 'glycoprotein', 'has', 'been', 'shown', 'to', 'elicit', 'protective', 'immunity', 'in', 'vaccinated', 'animals', 'CONCLUSION', 'NP', 'is', 'the', 'preferred', 'target', 'for', 'routine', 'detection', 'of', 'SARS', 'CoV', 'infection', 'by', 'ELISA', 'which', 'is', 'an', 'economical', 'method', 'compared', 'to', 'other', 'methods', 'The', 'RBD', 'of', 'the', 'spike', 'glycoprotein', 'is', 'both', 'a', 'functional', 'domain', 'for', 'cell', 'receptor', 'binding', 'and', 'also', 'a', 'major', 'neutralizing', 'determinant', 'of', 'SARS', 'CoV', 'The', 'progress', 'in', 'evaluating', 'a', 'therapeutic', 'or', 'vaccine', 'would', 'depend', 'on', 'the', 'avail', 'ability', 'of', 'clinically', 'relevant', 'animal', 'model', '']"
83140,Recent advances in diagnostic technology: applications in autoimmune and infectious diseases.,2008,Clinical and experimental rheumatology,https://www.ncbi.nlm.nih.gov/pubmed/18570756/,"Biomarkers are used ubiquitously as indicators of biological health. The development of genomic and proteomic multiplex technologies have enormously amplified biomarker discovery and application to diagnostic and therapeutic decisions in clinical practice. New technologies are now available that simultaneously identify a wide spectrum of biomarkers and save time and costs. Multiplexed assays can be coupled to other disease specific indicators (i.e., cytokines, single nucleotide polymorphisms) in order to get more powerful information. However, there is an urgent need for validation/standardization of the new assays before they are adopted into clinical diagnostics. It is worthy to note a new assay, T cell interferon gamma release (TIGRAs), which has recently been introduced in the diagnosis of latent tuberculosis infection. It seems to perform better than tuberculin skin test in patients with inflammatory rheumatic diseases. In this review, we focus on advantages and limits of novel approaches to the detection of autoantibody profiles in autoimmune diseases or pathogen signatures in microbiology.",,e102oa18,"['Biomarkers', 'are', 'used', 'ubiquitously', 'as', 'indicators', 'of', 'biological', 'health', 'The', 'development', 'of', 'genomic', 'and', 'proteomic', 'multiplex', 'technologies', 'have', 'enormously', 'amplified', 'biomarker', 'discovery', 'and', 'application', 'to', 'diagnostic', 'and', 'therapeutic', 'decisions', 'in', 'clinical', 'practice', 'New', 'technologies', 'are', 'now', 'available', 'that', 'simultaneously', 'identify', 'a', 'wide', 'spectrum', 'of', 'biomarkers', 'and', 'save', 'time', 'and', 'costs', 'Multiplexed', 'assays', 'can', 'be', 'coupled', 'to', 'other', 'disease', 'specific', 'indicators', 'i', 'e', 'cytokines', 'single', 'nucleotide', 'polymorphisms', 'in', 'order', 'to', 'get', 'more', 'powerful', 'information', 'However', 'there', 'is', 'an', 'urgent', 'need', 'for', 'validation', 'standardization', 'of', 'the', 'new', 'assays', 'before', 'they', 'are', 'adopted', 'into', 'clinical', 'diagnostics', 'It', 'is', 'worthy', 'to', 'note', 'a', 'new', 'assay', 'T', 'cell', 'interferon', 'gamma', 'release', 'TIGRAs', 'which', 'has', 'recently', 'been', 'introduced', 'in', 'the', 'diagnosis', 'of', 'latent', 'tuberculosis', 'infection', 'It', 'seems', 'to', 'perform', 'better', 'than', 'tuberculin', 'skin', 'test', 'in', 'patients', 'with', 'inflammatory', 'rheumatic', 'diseases', 'In', 'this', 'review', 'we', 'focus', 'on', 'advantages', 'and', 'limits', 'of', 'novel', 'approaches', 'to', 'the', 'detection', 'of', 'autoantibody', 'profiles', 'in', 'autoimmune', 'diseases', 'or', 'pathogen', 'signatures', 'in', 'microbiology', '']"
83245,Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories.,2008,"Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc",https://www.ncbi.nlm.nih.gov/pubmed/18599844/,"This document is the consensus of the American Association of Veterinary Laboratory Diagnosticians (AAVLD) Subcommittee on Standardization of Immunohistochemistry on a set of guidelines for immunohistochemistry (IHC) testing in veterinary laboratories. Immunohistochemistry is a powerful ancillary methodology frequently used in many veterinary laboratories for both diagnostic and research purposes. However, neither standardization nor validation of IHC tests has been completely achieved in veterinary medicine. This document addresses both issues. Topics covered include antibody selection, fixation, antigen retrieval, antibody incubation, antibody dilutions, tissue and reagent controls, buffers, and detection systems. The validation of an IHC test is addressed for both infectious diseases and neoplastic processes. In addition, storage and handling of IHC reagents, interpretation, quality control and assurance, and troubleshooting are also discussed. Proper standardization and validation of IHC will improve the quality of diagnostics in veterinary laboratories.",,k87llmw8,"['This', 'document', 'is', 'the', 'consensus', 'of', 'the', 'American', 'Association', 'of', 'Veterinary', 'Laboratory', 'Diagnosticians', 'AAVLD', 'Subcommittee', 'on', 'Standardization', 'of', 'Immunohistochemistry', 'on', 'a', 'set', 'of', 'guidelines', 'for', 'immunohistochemistry', 'IHC', 'testing', 'in', 'veterinary', 'laboratories', 'Immunohistochemistry', 'is', 'a', 'powerful', 'ancillary', 'methodology', 'frequently', 'used', 'in', 'many', 'veterinary', 'laboratories', 'for', 'both', 'diagnostic', 'and', 'research', 'purposes', 'However', 'neither', 'standardization', 'nor', 'validation', 'of', 'IHC', 'tests', 'has', 'been', 'completely', 'achieved', 'in', 'veterinary', 'medicine', 'This', 'document', 'addresses', 'both', 'issues', 'Topics', 'covered', 'include', 'antibody', 'selection', 'fixation', 'antigen', 'retrieval', 'antibody', 'incubation', 'antibody', 'dilutions', 'tissue', 'and', 'reagent', 'controls', 'buffers', 'and', 'detection', 'systems', 'The', 'validation', 'of', 'an', 'IHC', 'test', 'is', 'addressed', 'for', 'both', 'infectious', 'diseases', 'and', 'neoplastic', 'processes', 'In', 'addition', 'storage', 'and', 'handling', 'of', 'IHC', 'reagents', 'interpretation', 'quality', 'control', 'and', 'assurance', 'and', 'troubleshooting', 'are', 'also', 'discussed', 'Proper', 'standardization', 'and', 'validation', 'of', 'IHC', 'will', 'improve', 'the', 'quality', 'of', 'diagnostics', 'in', 'veterinary', 'laboratories', '']"
83431,Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe.,2005,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,https://www.ncbi.nlm.nih.gov/pubmed/16077216/,"The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of 'Imported' Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. A public website is available at http://www.enivd.de.",,9x79p8m8,"['The', 'threat', 'posed', 'by', 'emerging', 'and', 're', 'emerging', 'communicable', 'diseases', 'and', 'more', 'recently', 'by', 'the', 'intentional', 'release', 'of', 'infectious', 'agents', 'in', 'a', 'susceptible', 'population', 'has', 'been', 'receiving', 'considerable', 'attention', 'at', 'the', 'national', 'and', 'international', 'levels', 'Public', 'health', 'efforts', 'to', 'strengthen', 'disease', 'detection', 'surveillance', 'and', 'control', 'have', 'been', 'intensified', 'However', 'clinicians', 'and', 'clinical', 'microbiology', 'laboratories', 'play', 'an', 'important', 'role', 'in', 'the', 'early', 'detection', 'of', 'disease', 'the', 'identification', 'of', 'the', 'putative', 'agent', 'and', 'notification', 'of', 'the', 'appropriate', 'authorities', 'To', 'be', 'effective', 'in', 'this', 'role', 'laboratories', 'must', 'be', 'specially', 'prepared', 'to', 'handle', 'viral', 'agents', 'safely', 'and', 'need', 'among', 'other', 'things', 'the', 'appropriate', 'rapid', 'and', 'sensitive', 'diagnostic', 'tests', 'In', '1998', 'the', 'European', 'Network', 'for', 'Diagnostics', 'of', 'Imported', 'Viral', 'Diseases', 'ENIVD', 'was', 'established', 'ENIVD', 'presently', 'comprises', 'as', 'permanent', 'members', '44', 'expert', 'laboratories', 'in', '21', 'European', 'Union', 'EU', 'member', 'states', 'and', '4', 'non', 'EU', 'countries', 'and', 'is', 'one', 'of', 'the', 'networks', 'on', 'infectious', 'diseases', 'funded', 'by', 'the', 'European', 'Commission', 'ENIVD', 'fulfils', 'many', 'of', 'the', 'important', 'tasks', 'required', 'for', 'the', 'surveillance', 'and', 'control', 'of', 'imported', 'rare', 'and', 'emerging', 'viral', 'infections', 'such', 'as', 'the', 'exchange', 'of', 'expertise', 'and', 'the', 'organisation', 'of', 'external', 'quality', 'assurance', 'EQA', 'programmes', 'both', 'of', 'which', 'are', 'needed', 'to', 'improve', 'diagnostics', 'Here', 'we', 'summarise', 'the', 'data', 'generated', 'by', 'recent', 'EQA', 'activities', 'focussed', 'on', 'the', 'diagnostics', 'of', 'infections', 'with', 'hantavirus', 'dengue', 'virus', 'filovirus', 'Lassa', 'virus', 'orthopox', 'virus', 'and', 'the', 'SARS', 'coronavirus', 'SARS', 'CoV', 'These', 'were', 'carried', 'out', 'between', '1999', 'and', '2004', 'and', 'involved', '93', 'laboratories', 'from', '41', 'countries', 'including', 'laboratories', 'from', 'additional', 'countries', 'outside', 'of', 'Europe', 'Particularly', 'the', 'EU', 'candidate', 'countries', 'and', 'Eastern', 'neighbouring', 'countries', 'will', 'be', 'invited', 'to', 'join', 'the', 'network', 'in', 'the', 'near', 'future', 'A', 'public', 'website', 'is', 'available', 'at', 'http', 'www', 'enivd', 'de', '']"
84351,Factors associated with length of hospital stay in children with respiratory disease.,2010,Hong Kong medical journal = Xianggang yi xue za zhi,https://www.ncbi.nlm.nih.gov/pubmed/21135420/,"OBJECTIVES To explore factors associated with length of stay, and secondarily to explore the potential of enhanced diagnostics to address respiratory disease burden in children. DESIGN Prospective study. SETTING A university teaching hospital in Hong Kong. PATIENTS Data from 475 children with respiratory tract symptoms or fever admitted to Prince of Wales Hospital, Hong Kong from November 2005 to April 2007. MAIN OUTCOME MEASURES Aetiological diagnoses based on enhanced diagnostics and their association with clinical information. RESULTS Data from 469 subjects showed that major presentations were fever (84%), cough (72%), and runny nose (64%). The median length of stay was longest (3 days) for adenovirus, metapneumovirus and mycoplasma infections, while children with negative aetiological results had a median length of stay of 2 days. Fever duration during admission (P<0.001), the highest recorded temperature during admission (P < 0.001), use of antibiotics during admission (P<0.001), ear pain before admission (P = 0.019), and high white cell counts (P = 0.021) were associated with increased length of stay (univariate analysis). Identifying an aetiological agent did not affect length of stay. Comparison of children with a positive immunofluorescence test result (rapidly available) with those in whom the test was negative though a positive multiplex polymerase chain reaction ensued (result not available to clinicians) also showed no association with length of stay. CONCLUSION Although rapid enhanced diagnostics may not have a major influence on length of stay, these data form an integral part of enhanced sentinel surveillance systems.",,9ay2tf56,"['OBJECTIVES', 'To', 'explore', 'factors', 'associated', 'with', 'length', 'of', 'stay', 'and', 'secondarily', 'to', 'explore', 'the', 'potential', 'of', 'enhanced', 'diagnostics', 'to', 'address', 'respiratory', 'disease', 'burden', 'in', 'children', 'DESIGN', 'Prospective', 'study', 'SETTING', 'A', 'university', 'teaching', 'hospital', 'in', 'Hong', 'Kong', 'PATIENTS', 'Data', 'from', '475', 'children', 'with', 'respiratory', 'tract', 'symptoms', 'or', 'fever', 'admitted', 'to', 'Prince', 'of', 'Wales', 'Hospital', 'Hong', 'Kong', 'from', 'November', '2005', 'to', 'April', '2007', 'MAIN', 'OUTCOME', 'MEASURES', 'Aetiological', 'diagnoses', 'based', 'on', 'enhanced', 'diagnostics', 'and', 'their', 'association', 'with', 'clinical', 'information', 'RESULTS', 'Data', 'from', '469', 'subjects', 'showed', 'that', 'major', 'presentations', 'were', 'fever', '84', 'cough', '72', 'and', 'runny', 'nose', '64', 'The', 'median', 'length', 'of', 'stay', 'was', 'longest', '3', 'days', 'for', 'adenovirus', 'metapneumovirus', 'and', 'mycoplasma', 'infections', 'while', 'children', 'with', 'negative', 'aetiological', 'results', 'had', 'a', 'median', 'length', 'of', 'stay', 'of', '2', 'days', 'Fever', 'duration', 'during', 'admission', 'P', '0', '001', 'the', 'highest', 'recorded', 'temperature', 'during', 'admission', 'P', '0', '001', 'use', 'of', 'antibiotics', 'during', 'admission', 'P', '0', '001', 'ear', 'pain', 'before', 'admission', 'P', '0', '019', 'and', 'high', 'white', 'cell', 'counts', 'P', '0', '021', 'were', 'associated', 'with', 'increased', 'length', 'of', 'stay', 'univariate', 'analysis', 'Identifying', 'an', 'aetiological', 'agent', 'did', 'not', 'affect', 'length', 'of', 'stay', 'Comparison', 'of', 'children', 'with', 'a', 'positive', 'immunofluorescence', 'test', 'result', 'rapidly', 'available', 'with', 'those', 'in', 'whom', 'the', 'test', 'was', 'negative', 'though', 'a', 'positive', 'multiplex', 'polymerase', 'chain', 'reaction', 'ensued', 'result', 'not', 'available', 'to', 'clinicians', 'also', 'showed', 'no', 'association', 'with', 'length', 'of', 'stay', 'CONCLUSION', 'Although', 'rapid', 'enhanced', 'diagnostics', 'may', 'not', 'have', 'a', 'major', 'influence', 'on', 'length', 'of', 'stay', 'these', 'data', 'form', 'an', 'integral', 'part', 'of', 'enhanced', 'sentinel', 'surveillance', 'systems', '']"
84976,"Laboratory test descriptions for bovine respiratory disease diagnosis and their strengths and weaknesses: gold standards for diagnosis, do they exist?",2012,The Canadian veterinary journal = La revue veterinaire canadienne,https://www.ncbi.nlm.nih.gov/pubmed/23277642/,"The diagnosis of bovine respiratory diseases (BRD) poses significant challenges to the clinician as there are numerous infectious etiologies, operating singly or most often in combination. Clinical signs alone may not be diagnostic and the diagnostic laboratory is often used to assist the clinician. Recently many molecular-based tests have been taken from the research laboratory to the veterinary diagnostic laboratory. This review describes the ""traditional tests"" and several ""molecular tests"" and discusses the benefits and limitations of the tests and their interpretation. Clinicians should consult with their diagnostic laboratory regarding the interpretation of the test results. The rate of development and use of molecular diagnostic tests have outpaced validation, standardization, and standards for interpretation relative to their use in BRD diagnostics.",,e82pjjuu,"['The', 'diagnosis', 'of', 'bovine', 'respiratory', 'diseases', 'BRD', 'poses', 'significant', 'challenges', 'to', 'the', 'clinician', 'as', 'there', 'are', 'numerous', 'infectious', 'etiologies', 'operating', 'singly', 'or', 'most', 'often', 'in', 'combination', 'Clinical', 'signs', 'alone', 'may', 'not', 'be', 'diagnostic', 'and', 'the', 'diagnostic', 'laboratory', 'is', 'often', 'used', 'to', 'assist', 'the', 'clinician', 'Recently', 'many', 'molecular', 'based', 'tests', 'have', 'been', 'taken', 'from', 'the', 'research', 'laboratory', 'to', 'the', 'veterinary', 'diagnostic', 'laboratory', 'This', 'review', 'describes', 'the', 'traditional', 'tests', 'and', 'several', 'molecular', 'tests', 'and', 'discusses', 'the', 'benefits', 'and', 'limitations', 'of', 'the', 'tests', 'and', 'their', 'interpretation', 'Clinicians', 'should', 'consult', 'with', 'their', 'diagnostic', 'laboratory', 'regarding', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'The', 'rate', 'of', 'development', 'and', 'use', 'of', 'molecular', 'diagnostic', 'tests', 'have', 'outpaced', 'validation', 'standardization', 'and', 'standards', 'for', 'interpretation', 'relative', 'to', 'their', 'use', 'in', 'BRD', 'diagnostics', '']"
85807,Evaluation of a multiplexed PCR assay for detection of respiratory viral pathogens in a public health laboratory setting.,2007,Journal of clinical microbiology,https://www.ncbi.nlm.nih.gov/pubmed/17928425/,"There are numerous viral and bacterial causes of respiratory disease. To enable rapid and sensitive detection of even the most prevalent causes, there is a need for more-simplified testing systems that enable researchers and clinicians to perform multiplexed molecular diagnostics quickly and easily. To this end, a new multiplexed molecular test called the MultiCode-PLx respiratory virus panel (PLx-RVP) was developed and then implemented in a public health laboratory setting. A total of 687 respiratory samples were analyzed for the presence of 17 viruses that commonly cause respiratory disease. As a comparator, the samples were also tested using a standard testing algorithm that included the use of a real-time influenza virus A and B reverse transcription-PCR test and routine viral culture identification. The standard testing algorithm identified 503 (73%) samples as positive and 184 as negative. Analyzing the same 687 samples, the PLx-RVP assay detected one or more targets in 528 (77%) samples and found 159 samples negative for all targets. There were 25 discordant results between the two systems; 14 samples were positive for viruses not routinely tested for by the Wisconsin State Laboratory of Hygiene, and 13 of these were confirmed by real-time PCR. When the results of the standard testing algorithm were considered ""true positives,"" the PLx-RVP assay showed an overall sensitivity of 99% and an overall specificity of 87%. In total, the PLx-RVP assay detected an additional 40 viral infections, of which 11 were mixed infections.",,0k4f3hcs,"['There', 'are', 'numerous', 'viral', 'and', 'bacterial', 'causes', 'of', 'respiratory', 'disease', 'To', 'enable', 'rapid', 'and', 'sensitive', 'detection', 'of', 'even', 'the', 'most', 'prevalent', 'causes', 'there', 'is', 'a', 'need', 'for', 'more', 'simplified', 'testing', 'systems', 'that', 'enable', 'researchers', 'and', 'clinicians', 'to', 'perform', 'multiplexed', 'molecular', 'diagnostics', 'quickly', 'and', 'easily', 'To', 'this', 'end', 'a', 'new', 'multiplexed', 'molecular', 'test', 'called', 'the', 'MultiCode', 'PLx', 'respiratory', 'virus', 'panel', 'PLx', 'RVP', 'was', 'developed', 'and', 'then', 'implemented', 'in', 'a', 'public', 'health', 'laboratory', 'setting', 'A', 'total', 'of', '687', 'respiratory', 'samples', 'were', 'analyzed', 'for', 'the', 'presence', 'of', '17', 'viruses', 'that', 'commonly', 'cause', 'respiratory', 'disease', 'As', 'a', 'comparator', 'the', 'samples', 'were', 'also', 'tested', 'using', 'a', 'standard', 'testing', 'algorithm', 'that', 'included', 'the', 'use', 'of', 'a', 'real', 'time', 'influenza', 'virus', 'A', 'and', 'B', 'reverse', 'transcription', 'PCR', 'test', 'and', 'routine', 'viral', 'culture', 'identification', 'The', 'standard', 'testing', 'algorithm', 'identified', '503', '73', 'samples', 'as', 'positive', 'and', '184', 'as', 'negative', 'Analyzing', 'the', 'same', '687', 'samples', 'the', 'PLx', 'RVP', 'assay', 'detected', 'one', 'or', 'more', 'targets', 'in', '528', '77', 'samples', 'and', 'found', '159', 'samples', 'negative', 'for', 'all', 'targets', 'There', 'were', '25', 'discordant', 'results', 'between', 'the', 'two', 'systems', '14', 'samples', 'were', 'positive', 'for', 'viruses', 'not', 'routinely', 'tested', 'for', 'by', 'the', 'Wisconsin', 'State', 'Laboratory', 'of', 'Hygiene', 'and', '13', 'of', 'these', 'were', 'confirmed', 'by', 'real', 'time', 'PCR', 'When', 'the', 'results', 'of', 'the', 'standard', 'testing', 'algorithm', 'were', 'considered', 'true', 'positives', 'the', 'PLx', 'RVP', 'assay', 'showed', 'an', 'overall', 'sensitivity', 'of', '99', 'and', 'an', 'overall', 'specificity', 'of', '87', 'In', 'total', 'the', 'PLx', 'RVP', 'assay', 'detected', 'an', 'additional', '40', 'viral', 'infections', 'of', 'which', '11', 'were', 'mixed', 'infections', '']"
86313,Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.,2004,Journal of clinical microbiology,https://www.ncbi.nlm.nih.gov/pubmed/15243082/,"The severe acute respiratory syndrome coronavirus (SARS-CoV) is the causative agent of the recent outbreak of severe acute respiratory syndrome. VeroE6 cells, fetal rhesus monkey kidney cells, and human peripheral blood mononuclear cells were the only cells known to be susceptible to SARS-CoV. We developed a multiplex reverse transcription-PCR assay to analyze the susceptibility of cells derived from a variety of tissues and species to SARS-CoV. Additionally, productive infection was determined by titration of cellular supernatants. Cells derived from three species of monkey were susceptible to SARS-CoV. However, the levels of SARS-CoV produced differed by 4 log(10). Mink lung epithelial cells (Mv1Lu) and R-Mix, a mixed monolayer of human lung-derived cells (A549) and mink lung-derived cells (Mv1Lu), are used by diagnostic laboratories to detect respiratory viruses (e.g., influenza virus); they were also infected with SARS-CoV, indicating that the practices of diagnostic laboratories should be examined to ensure appropriate biosafety precautions. Mv1Lu cells produce little SARS-CoV compared to that produced by VeroE6 cells, which indicates that they are a safer alternative for SARS-CoV diagnostics. Evaluation of cells permissive to other coronaviruses indicated that these cell types are not infected by SARS-CoV, providing additional evidence that SARS-CoV binds an alternative receptor. Analysis of human cells derived from lung, kidney, liver, and intestine led to the discovery that human cell lines were productively infected by SARS-CoV. This study identifies new cell lines that may be used for SARS-CoV diagnostics and/or basic research. Our data and other in vivo studies indicate that SARS-CoV has a wide host range, suggesting that the cellular receptor(s) utilized by SARS-CoV is highly conserved and is expressed by a variety of tissues.",,j5ogel6y,"['The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'is', 'the', 'causative', 'agent', 'of', 'the', 'recent', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'VeroE6', 'cells', 'fetal', 'rhesus', 'monkey', 'kidney', 'cells', 'and', 'human', 'peripheral', 'blood', 'mononuclear', 'cells', 'were', 'the', 'only', 'cells', 'known', 'to', 'be', 'susceptible', 'to', 'SARS', 'CoV', 'We', 'developed', 'a', 'multiplex', 'reverse', 'transcription', 'PCR', 'assay', 'to', 'analyze', 'the', 'susceptibility', 'of', 'cells', 'derived', 'from', 'a', 'variety', 'of', 'tissues', 'and', 'species', 'to', 'SARS', 'CoV', 'Additionally', 'productive', 'infection', 'was', 'determined', 'by', 'titration', 'of', 'cellular', 'supernatants', 'Cells', 'derived', 'from', 'three', 'species', 'of', 'monkey', 'were', 'susceptible', 'to', 'SARS', 'CoV', 'However', 'the', 'levels', 'of', 'SARS', 'CoV', 'produced', 'differed', 'by', '4', 'log', '10', 'Mink', 'lung', 'epithelial', 'cells', 'Mv1Lu', 'and', 'R', 'Mix', 'a', 'mixed', 'monolayer', 'of', 'human', 'lung', 'derived', 'cells', 'A549', 'and', 'mink', 'lung', 'derived', 'cells', 'Mv1Lu', 'are', 'used', 'by', 'diagnostic', 'laboratories', 'to', 'detect', 'respiratory', 'viruses', 'e', 'g', 'influenza', 'virus', 'they', 'were', 'also', 'infected', 'with', 'SARS', 'CoV', 'indicating', 'that', 'the', 'practices', 'of', 'diagnostic', 'laboratories', 'should', 'be', 'examined', 'to', 'ensure', 'appropriate', 'biosafety', 'precautions', 'Mv1Lu', 'cells', 'produce', 'little', 'SARS', 'CoV', 'compared', 'to', 'that', 'produced', 'by', 'VeroE6', 'cells', 'which', 'indicates', 'that', 'they', 'are', 'a', 'safer', 'alternative', 'for', 'SARS', 'CoV', 'diagnostics', 'Evaluation', 'of', 'cells', 'permissive', 'to', 'other', 'coronaviruses', 'indicated', 'that', 'these', 'cell', 'types', 'are', 'not', 'infected', 'by', 'SARS', 'CoV', 'providing', 'additional', 'evidence', 'that', 'SARS', 'CoV', 'binds', 'an', 'alternative', 'receptor', 'Analysis', 'of', 'human', 'cells', 'derived', 'from', 'lung', 'kidney', 'liver', 'and', 'intestine', 'led', 'to', 'the', 'discovery', 'that', 'human', 'cell', 'lines', 'were', 'productively', 'infected', 'by', 'SARS', 'CoV', 'This', 'study', 'identifies', 'new', 'cell', 'lines', 'that', 'may', 'be', 'used', 'for', 'SARS', 'CoV', 'diagnostics', 'and', 'or', 'basic', 'research', 'Our', 'data', 'and', 'other', 'in', 'vivo', 'studies', 'indicate', 'that', 'SARS', 'CoV', 'has', 'a', 'wide', 'host', 'range', 'suggesting', 'that', 'the', 'cellular', 'receptor', 's', 'utilized', 'by', 'SARS', 'CoV', 'is', 'highly', 'conserved', 'and', 'is', 'expressed', 'by', 'a', 'variety', 'of', 'tissues', '']"
86712,The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.,2004,The Clinical biochemist. Reviews,https://www.ncbi.nlm.nih.gov/pubmed/18458711/,"The 2003 pandemic of Severe Acute Respiratory Syndrome (SARS) profiled the ability of modern diagnostic microbiology and molecular biology to identify, isolate and characterize, within weeks, a previously unknown viral infectious pathogen. The culprit, SARS coronavirus (SARS-CoV), was detected in patient specimens by traditional cell culture using an unusual cell line for respiratory viruses, Vero E6, and by reverse transcriptase polymerase chain reaction (RT-PCR) targeting the polymerase 1 B region of the genome. In addition, serologic assays were rapidly developed, and the genome of this large virus was sequenced within one month of its spread to North America. At the present time, diagnostics have progressed to the point that RT-PCR has a sensitivity approaching 80% within the first few days of onset of illness, while serology has a sensitivity close to 100% on convalescent sera taken >21 days after illness onset. Viral culture remains a method confined to biosafety level III laboratories. The specificity of RT-PCR and serology remains to be conclusively defined, but in most studies to date seems to be >90%. Serologic cross-reactivity with human coronaviruses causing the common cold may be a problem with some serologic assays. The early development of SARS-CoV diagnostics is now being replaced by refinement and optimization of these assays. Although at the present time we do not have a test that will definitively rule in or rule out SARS at the time of initial presentation of a patient with a respiratory infection, modifications of existing assays will hopefully result in our ability to make this diagnosis with a high degree of accuracy in the future.",,ycch15k8,"['The', '2003', 'pandemic', 'of', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'SARS', 'profiled', 'the', 'ability', 'of', 'modern', 'diagnostic', 'microbiology', 'and', 'molecular', 'biology', 'to', 'identify', 'isolate', 'and', 'characterize', 'within', 'weeks', 'a', 'previously', 'unknown', 'viral', 'infectious', 'pathogen', 'The', 'culprit', 'SARS', 'coronavirus', 'SARS', 'CoV', 'was', 'detected', 'in', 'patient', 'specimens', 'by', 'traditional', 'cell', 'culture', 'using', 'an', 'unusual', 'cell', 'line', 'for', 'respiratory', 'viruses', 'Vero', 'E6', 'and', 'by', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'targeting', 'the', 'polymerase', '1', 'B', 'region', 'of', 'the', 'genome', 'In', 'addition', 'serologic', 'assays', 'were', 'rapidly', 'developed', 'and', 'the', 'genome', 'of', 'this', 'large', 'virus', 'was', 'sequenced', 'within', 'one', 'month', 'of', 'its', 'spread', 'to', 'North', 'America', 'At', 'the', 'present', 'time', 'diagnostics', 'have', 'progressed', 'to', 'the', 'point', 'that', 'RT', 'PCR', 'has', 'a', 'sensitivity', 'approaching', '80', 'within', 'the', 'first', 'few', 'days', 'of', 'onset', 'of', 'illness', 'while', 'serology', 'has', 'a', 'sensitivity', 'close', 'to', '100', 'on', 'convalescent', 'sera', 'taken', '21', 'days', 'after', 'illness', 'onset', 'Viral', 'culture', 'remains', 'a', 'method', 'confined', 'to', 'biosafety', 'level', 'III', 'laboratories', 'The', 'specificity', 'of', 'RT', 'PCR', 'and', 'serology', 'remains', 'to', 'be', 'conclusively', 'defined', 'but', 'in', 'most', 'studies', 'to', 'date', 'seems', 'to', 'be', '90', 'Serologic', 'cross', 'reactivity', 'with', 'human', 'coronaviruses', 'causing', 'the', 'common', 'cold', 'may', 'be', 'a', 'problem', 'with', 'some', 'serologic', 'assays', 'The', 'early', 'development', 'of', 'SARS', 'CoV', 'diagnostics', 'is', 'now', 'being', 'replaced', 'by', 'refinement', 'and', 'optimization', 'of', 'these', 'assays', 'Although', 'at', 'the', 'present', 'time', 'we', 'do', 'not', 'have', 'a', 'test', 'that', 'will', 'definitively', 'rule', 'in', 'or', 'rule', 'out', 'SARS', 'at', 'the', 'time', 'of', 'initial', 'presentation', 'of', 'a', 'patient', 'with', 'a', 'respiratory', 'infection', 'modifications', 'of', 'existing', 'assays', 'will', 'hopefully', 'result', 'in', 'our', 'ability', 'to', 'make', 'this', 'diagnosis', 'with', 'a', 'high', 'degree', 'of', 'accuracy', 'in', 'the', 'future', '']"
87135,Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.,2006,Expert review of molecular diagnostics,https://www.ncbi.nlm.nih.gov/pubmed/16706745/,"The molecular diagnosis of infectious diseases is currently going through a revolution sustained by the regulatory approval of amplification tests that have been shown to be equivalent or superior to existing gold standard methods. The recent approval of a microarray system for the pharmacogenomic profiling of cytochrome P450-mediated drug metabolism is paving the way to novel, rapid, sensitive, robust and economical microfabricated systems for point-of-care diagnostics, which are utilized closer and closer to the patient's bedside. These systems will enable the multiparametric genetic evaluation of several medical conditions, including infectious diseases. This forecoming revolution will position molecular theranostics in a broader integrated view of personalized medicine, which exploits genetic information from microbes and human hosts to optimize patient management and disease treatment.",,wfkrafu4,"['The', 'molecular', 'diagnosis', 'of', 'infectious', 'diseases', 'is', 'currently', 'going', 'through', 'a', 'revolution', 'sustained', 'by', 'the', 'regulatory', 'approval', 'of', 'amplification', 'tests', 'that', 'have', 'been', 'shown', 'to', 'be', 'equivalent', 'or', 'superior', 'to', 'existing', 'gold', 'standard', 'methods', 'The', 'recent', 'approval', 'of', 'a', 'microarray', 'system', 'for', 'the', 'pharmacogenomic', 'profiling', 'of', 'cytochrome', 'P450', 'mediated', 'drug', 'metabolism', 'is', 'paving', 'the', 'way', 'to', 'novel', 'rapid', 'sensitive', 'robust', 'and', 'economical', 'microfabricated', 'systems', 'for', 'point', 'of', 'care', 'diagnostics', 'which', 'are', 'utilized', 'closer', 'and', 'closer', 'to', 'the', 'patient', 's', 'bedside', 'These', 'systems', 'will', 'enable', 'the', 'multiparametric', 'genetic', 'evaluation', 'of', 'several', 'medical', 'conditions', 'including', 'infectious', 'diseases', 'This', 'forecoming', 'revolution', 'will', 'position', 'molecular', 'theranostics', 'in', 'a', 'broader', 'integrated', 'view', 'of', 'personalized', 'medicine', 'which', 'exploits', 'genetic', 'information', 'from', 'microbes', 'and', 'human', 'hosts', 'to', 'optimize', 'patient', 'management', 'and', 'disease', 'treatment', '']"
88005,[Rapid point-of-care serology testing for sars-cov-2].,2020-05-27,Lakartidningen,https://www.ncbi.nlm.nih.gov/pubmed/32463475/,"Increasing evidence indicates immunity against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) after covid-19, but it remains unclear for how long the protection remains. Serology testing seems to have a higher sensitivity than molecular diagnostics from 8 days after onset of symtoms, and should be part of risk assessment and epidemiological studies of COVID-19. The performance of commercial serological point-of-care (POC) lateral flow tests are highly manufacturer-dependant. Low sensitivity increases the risk of false negative results and could result in unnecessary quarantine of test persons with developed antibodies. Low specificity increases the risk of false positive results and could lead to false assumptions of immunity. Carefully selected serological POC tests for sars-cov-2 can be used in large scale testing but should only be used by licensed medical staff able to understand their limitations and interpret the results.",,91872v0l,"['Increasing', 'evidence', 'indicates', 'immunity', 'against', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'after', 'covid', '19', 'but', 'it', 'remains', 'unclear', 'for', 'how', 'long', 'the', 'protection', 'remains', 'Serology', 'testing', 'seems', 'to', 'have', 'a', 'higher', 'sensitivity', 'than', 'molecular', 'diagnostics', 'from', '8', 'days', 'after', 'onset', 'of', 'symtoms', 'and', 'should', 'be', 'part', 'of', 'risk', 'assessment', 'and', 'epidemiological', 'studies', 'of', 'COVID', '19', 'The', 'performance', 'of', 'commercial', 'serological', 'point', 'of', 'care', 'POC', 'lateral', 'flow', 'tests', 'are', 'highly', 'manufacturer', 'dependant', 'Low', 'sensitivity', 'increases', 'the', 'risk', 'of', 'false', 'negative', 'results', 'and', 'could', 'result', 'in', 'unnecessary', 'quarantine', 'of', 'test', 'persons', 'with', 'developed', 'antibodies', 'Low', 'specificity', 'increases', 'the', 'risk', 'of', 'false', 'positive', 'results', 'and', 'could', 'lead', 'to', 'false', 'assumptions', 'of', 'immunity', 'Carefully', 'selected', 'serological', 'POC', 'tests', 'for', 'sars', 'cov', '2', 'can', 'be', 'used', 'in', 'large', 'scale', 'testing', 'but', 'should', 'only', 'be', 'used', 'by', 'licensed', 'medical', 'staff', 'able', 'to', 'understand', 'their', 'limitations', 'and', 'interpret', 'the', 'results', '']"
89429,Using a resequencing microarray as a multiple respiratory pathogen detection assay.,2007,Journal of clinical microbiology,https://www.ncbi.nlm.nih.gov/pubmed/17135438/,"Simultaneous testing for detection of infectious pathogens that cause similar symptoms (e.g., acute respiratory infections) is invaluable for patient treatment, outbreak prevention, and efficient use of antibiotic and antiviral agents. In addition, such testing may provide information regarding possible coinfections or induced secondary infections, such as virally induced bacterial infections. Furthermore, in many cases, detection of a pathogen requires more than genus/species-level resolution, since harmful agents (e.g., avian influenza virus) are grouped with other, relatively benign common agents, and for every pathogen, finer resolution is useful to allow tracking of the location and nature of mutations leading to strain variations. In this study, a previously developed resequencing microarray that has been demonstrated to have these capabilities was further developed to provide individual detection sensitivity ranging from 10(1) to 10(3) genomic copies for more than 26 respiratory pathogens while still retaining the ability to detect and differentiate between close genetic neighbors. In addition, the study demonstrated that this system allows unambiguous and reproducible sequence-based strain identification of the mixed pathogens. Successful proof-of-concept experiments using clinical specimens show that this approach is potentially very useful for both diagnostics and epidemic surveillance.",,z7ux4bhd,"['Simultaneous', 'testing', 'for', 'detection', 'of', 'infectious', 'pathogens', 'that', 'cause', 'similar', 'symptoms', 'e', 'g', 'acute', 'respiratory', 'infections', 'is', 'invaluable', 'for', 'patient', 'treatment', 'outbreak', 'prevention', 'and', 'efficient', 'use', 'of', 'antibiotic', 'and', 'antiviral', 'agents', 'In', 'addition', 'such', 'testing', 'may', 'provide', 'information', 'regarding', 'possible', 'coinfections', 'or', 'induced', 'secondary', 'infections', 'such', 'as', 'virally', 'induced', 'bacterial', 'infections', 'Furthermore', 'in', 'many', 'cases', 'detection', 'of', 'a', 'pathogen', 'requires', 'more', 'than', 'genus', 'species', 'level', 'resolution', 'since', 'harmful', 'agents', 'e', 'g', 'avian', 'influenza', 'virus', 'are', 'grouped', 'with', 'other', 'relatively', 'benign', 'common', 'agents', 'and', 'for', 'every', 'pathogen', 'finer', 'resolution', 'is', 'useful', 'to', 'allow', 'tracking', 'of', 'the', 'location', 'and', 'nature', 'of', 'mutations', 'leading', 'to', 'strain', 'variations', 'In', 'this', 'study', 'a', 'previously', 'developed', 'resequencing', 'microarray', 'that', 'has', 'been', 'demonstrated', 'to', 'have', 'these', 'capabilities', 'was', 'further', 'developed', 'to', 'provide', 'individual', 'detection', 'sensitivity', 'ranging', 'from', '10', '1', 'to', '10', '3', 'genomic', 'copies', 'for', 'more', 'than', '26', 'respiratory', 'pathogens', 'while', 'still', 'retaining', 'the', 'ability', 'to', 'detect', 'and', 'differentiate', 'between', 'close', 'genetic', 'neighbors', 'In', 'addition', 'the', 'study', 'demonstrated', 'that', 'this', 'system', 'allows', 'unambiguous', 'and', 'reproducible', 'sequence', 'based', 'strain', 'identification', 'of', 'the', 'mixed', 'pathogens', 'Successful', 'proof', 'of', 'concept', 'experiments', 'using', 'clinical', 'specimens', 'show', 'that', 'this', 'approach', 'is', 'potentially', 'very', 'useful', 'for', 'both', 'diagnostics', 'and', 'epidemic', 'surveillance', '']"
90318,Historical Data Analysis of Hospital Discharges Related to the Amerithrax Attack in Florida.,2016,Perspectives in health information management,https://www.ncbi.nlm.nih.gov/pubmed/27843420/,"Interrupted time-series analysis (ITSA) can be used to identify, quantify, and evaluate the magnitude and direction of an event on the basis of time-series data. This study evaluates the impact of the bioterrorist anthrax attacks (""Amerithrax"") on hospital inpatient discharges in the metropolitan statistical area of Palm Beach, Broward, and Miami-Dade counties in the fourth quarter of 2001. Three statistical methods-standardized incidence ratio (SIR), segmented regression, and an autoregressive integrated moving average (ARIMA)-were used to determine whether Amerithrax influenced inpatient utilization. The SIR found a non-statistically significant 2 percent decrease in hospital discharges. Although the segmented regression test found a slight increase in the discharge rate during the fourth quarter, it was also not statistically significant; therefore, it could not be attributed to Amerithrax. Segmented regression diagnostics preparing for ARIMA indicated that the quarterly data time frame was not serially correlated and violated one of the assumptions for the use of the ARIMA method and therefore could not properly evaluate the impact on the time-series data. Lack of data granularity of the time frames hindered the successful evaluation of the impact by the three analytic methods. This study demonstrates that the granularity of the data points is as important as the number of data points in a time series. ITSA is important for the ability to evaluate the impact that any hazard may have on inpatient utilization. Knowledge of hospital utilization patterns during disasters offer healthcare and civic professionals valuable information to plan, respond, mitigate, and evaluate any outcomes stemming from biothreats.",,gsphs7j8,"['Interrupted', 'time', 'series', 'analysis', 'ITSA', 'can', 'be', 'used', 'to', 'identify', 'quantify', 'and', 'evaluate', 'the', 'magnitude', 'and', 'direction', 'of', 'an', 'event', 'on', 'the', 'basis', 'of', 'time', 'series', 'data', 'This', 'study', 'evaluates', 'the', 'impact', 'of', 'the', 'bioterrorist', 'anthrax', 'attacks', 'Amerithrax', 'on', 'hospital', 'inpatient', 'discharges', 'in', 'the', 'metropolitan', 'statistical', 'area', 'of', 'Palm', 'Beach', 'Broward', 'and', 'Miami', 'Dade', 'counties', 'in', 'the', 'fourth', 'quarter', 'of', '2001', 'Three', 'statistical', 'methods', 'standardized', 'incidence', 'ratio', 'SIR', 'segmented', 'regression', 'and', 'an', 'autoregressive', 'integrated', 'moving', 'average', 'ARIMA', 'were', 'used', 'to', 'determine', 'whether', 'Amerithrax', 'influenced', 'inpatient', 'utilization', 'The', 'SIR', 'found', 'a', 'non', 'statistically', 'significant', '2', 'percent', 'decrease', 'in', 'hospital', 'discharges', 'Although', 'the', 'segmented', 'regression', 'test', 'found', 'a', 'slight', 'increase', 'in', 'the', 'discharge', 'rate', 'during', 'the', 'fourth', 'quarter', 'it', 'was', 'also', 'not', 'statistically', 'significant', 'therefore', 'it', 'could', 'not', 'be', 'attributed', 'to', 'Amerithrax', 'Segmented', 'regression', 'diagnostics', 'preparing', 'for', 'ARIMA', 'indicated', 'that', 'the', 'quarterly', 'data', 'time', 'frame', 'was', 'not', 'serially', 'correlated', 'and', 'violated', 'one', 'of', 'the', 'assumptions', 'for', 'the', 'use', 'of', 'the', 'ARIMA', 'method', 'and', 'therefore', 'could', 'not', 'properly', 'evaluate', 'the', 'impact', 'on', 'the', 'time', 'series', 'data', 'Lack', 'of', 'data', 'granularity', 'of', 'the', 'time', 'frames', 'hindered', 'the', 'successful', 'evaluation', 'of', 'the', 'impact', 'by', 'the', 'three', 'analytic', 'methods', 'This', 'study', 'demonstrates', 'that', 'the', 'granularity', 'of', 'the', 'data', 'points', 'is', 'as', 'important', 'as', 'the', 'number', 'of', 'data', 'points', 'in', 'a', 'time', 'series', 'ITSA', 'is', 'important', 'for', 'the', 'ability', 'to', 'evaluate', 'the', 'impact', 'that', 'any', 'hazard', 'may', 'have', 'on', 'inpatient', 'utilization', 'Knowledge', 'of', 'hospital', 'utilization', 'patterns', 'during', 'disasters', 'offer', 'healthcare', 'and', 'civic', 'professionals', 'valuable', 'information', 'to', 'plan', 'respond', 'mitigate', 'and', 'evaluate', 'any', 'outcomes', 'stemming', 'from', 'biothreats', '']"
90813,COVID 19 diagnostic multiplicity and its role in community surveillance and control.,2020-06-01,Le infezioni in medicina,https://www.ncbi.nlm.nih.gov/pubmed/32532934/,"Diagnosis of persons exposed to/infected with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is central to controlling the global pandemic of COVID-19. Currently, several diagnostic modalities are available for COVID-19, each with its own pros and cons. Although there is a global consensus to increase the testing capacity, it is also essential to prudently utilize these tests to control the pandemic. In this paper, we have reviewed the current array of diagnostics for SARS-CoV-2, highlighted the gaps in current diagnostic modalities, and their role in community surveillance and control of the pandemic. The different modalities of COVID-19 diagnosis discussed are: clinical and radiological, molecular based (laboratory based and point-of-care), Immunoassay based (ELISA, rapid antigen and antibody detection tests) and digital diagnostics (artificial intelligence based algorithms). The role of rapid antigen/antibody detection tests in community surveillance has also been described here. These tests can be used to identify asymptomatic persons exposed to the virus and in community based seroprevalence surveys to assess the epidemiology of spread of the virus. However, there are few concerns about the accuracy of these tests which needs to evaluated beforehand.",,846t2t8g,"['Diagnosis', 'of', 'persons', 'exposed', 'to', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'central', 'to', 'controlling', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'Currently', 'several', 'diagnostic', 'modalities', 'are', 'available', 'for', 'COVID', '19', 'each', 'with', 'its', 'own', 'pros', 'and', 'cons', 'Although', 'there', 'is', 'a', 'global', 'consensus', 'to', 'increase', 'the', 'testing', 'capacity', 'it', 'is', 'also', 'essential', 'to', 'prudently', 'utilize', 'these', 'tests', 'to', 'control', 'the', 'pandemic', 'In', 'this', 'paper', 'we', 'have', 'reviewed', 'the', 'current', 'array', 'of', 'diagnostics', 'for', 'SARS', 'CoV', '2', 'highlighted', 'the', 'gaps', 'in', 'current', 'diagnostic', 'modalities', 'and', 'their', 'role', 'in', 'community', 'surveillance', 'and', 'control', 'of', 'the', 'pandemic', 'The', 'different', 'modalities', 'of', 'COVID', '19', 'diagnosis', 'discussed', 'are', 'clinical', 'and', 'radiological', 'molecular', 'based', 'laboratory', 'based', 'and', 'point', 'of', 'care', 'Immunoassay', 'based', 'ELISA', 'rapid', 'antigen', 'and', 'antibody', 'detection', 'tests', 'and', 'digital', 'diagnostics', 'artificial', 'intelligence', 'based', 'algorithms', 'The', 'role', 'of', 'rapid', 'antigen', 'antibody', 'detection', 'tests', 'in', 'community', 'surveillance', 'has', 'also', 'been', 'described', 'here', 'These', 'tests', 'can', 'be', 'used', 'to', 'identify', 'asymptomatic', 'persons', 'exposed', 'to', 'the', 'virus', 'and', 'in', 'community', 'based', 'seroprevalence', 'surveys', 'to', 'assess', 'the', 'epidemiology', 'of', 'spread', 'of', 'the', 'virus', 'However', 'there', 'are', 'few', 'concerns', 'about', 'the', 'accuracy', 'of', 'these', 'tests', 'which', 'needs', 'to', 'evaluated', 'beforehand', '']"
91015,Advances in the laboratory diagnosis of viral respiratory disease.,2004,The Pediatric infectious disease journal,https://www.ncbi.nlm.nih.gov/pubmed/14730264/,"BACKGROUND In recent years significant advances in the laboratory diagnostics available to detect respiratory viral infections have been achieved. METHODS This article presents the types of diagnostic methods currently available to the practitioner, as well as those on the horizon. The article covers tissue culture, serology and direct examination as well as some rapid diagnostic techniques and molecular assays, previewing developing new technology. CONCLUSIONS Laboratory diagnosis will likely be clinically useful in some but not all cases of viral infection. As new diagnostic methods become widely available, it is increasingly important to develop guidelines for laboratory testing when viral illness is suspected.",,1c1oe7tg,"['BACKGROUND', 'In', 'recent', 'years', 'significant', 'advances', 'in', 'the', 'laboratory', 'diagnostics', 'available', 'to', 'detect', 'respiratory', 'viral', 'infections', 'have', 'been', 'achieved', 'METHODS', 'This', 'article', 'presents', 'the', 'types', 'of', 'diagnostic', 'methods', 'currently', 'available', 'to', 'the', 'practitioner', 'as', 'well', 'as', 'those', 'on', 'the', 'horizon', 'The', 'article', 'covers', 'tissue', 'culture', 'serology', 'and', 'direct', 'examination', 'as', 'well', 'as', 'some', 'rapid', 'diagnostic', 'techniques', 'and', 'molecular', 'assays', 'previewing', 'developing', 'new', 'technology', 'CONCLUSIONS', 'Laboratory', 'diagnosis', 'will', 'likely', 'be', 'clinically', 'useful', 'in', 'some', 'but', 'not', 'all', 'cases', 'of', 'viral', 'infection', 'As', 'new', 'diagnostic', 'methods', 'become', 'widely', 'available', 'it', 'is', 'increasingly', 'important', 'to', 'develop', 'guidelines', 'for', 'laboratory', 'testing', 'when', 'viral', 'illness', 'is', 'suspected', '']"
91125,National laboratory surveillance of viral agents of gastroenteritis in Brazil.,1993,Bulletin of the Pan American Health Organization,https://www.ncbi.nlm.nih.gov/pubmed/8220517/,"In 1984 an enzyme immunoassay for rotavirus and adenovirus developed in the Virology Department of the Oswaldo Cruz Foundation was distributed to laboratories in 14 Brazilian states as part of a project to survey viral agents in fecal specimens from children with diarrhea. The ensuing surveillance continued for 3 to 5 years, and in 1991 the results obtained by all laboratories that tested 300 or more fecal specimens were reviewed at a workshop held in Belém. These results showed that rotavirus had been detected in 13% to 20% of the specimens tested, with positive specimens appearing to peak in the May to September ""winter"" or dry season in Brazil's central and southern states but not in the more tropical northern areas. Adenovirus, detected in 0.7% to 5.5% of the specimens tested for it, showed no seasonal variations. Many other viral agents known to cause gastroenteritis (e.g., astrovirus, small round-structured viruses, calcivirus, and group C rotavirus) were detected at centers that used electron microscopy. Picobirnavirus, a novel agent not yet associated with gastroenteritis in humans, was found by polyacrylamide gel electrophoresis in specimens from a number of centers using this technique. Vaccines to prevent rotavirus that are currently under development would be of great use in Brazil, where rotavirus is the most common cause of childhood diarrhea. Improved diagnostics will be required to assess the importance of the other viral agents.",,7jj1lyso,"['In', '1984', 'an', 'enzyme', 'immunoassay', 'for', 'rotavirus', 'and', 'adenovirus', 'developed', 'in', 'the', 'Virology', 'Department', 'of', 'the', 'Oswaldo', 'Cruz', 'Foundation', 'was', 'distributed', 'to', 'laboratories', 'in', '14', 'Brazilian', 'states', 'as', 'part', 'of', 'a', 'project', 'to', 'survey', 'viral', 'agents', 'in', 'fecal', 'specimens', 'from', 'children', 'with', 'diarrhea', 'The', 'ensuing', 'surveillance', 'continued', 'for', '3', 'to', '5', 'years', 'and', 'in', '1991', 'the', 'results', 'obtained', 'by', 'all', 'laboratories', 'that', 'tested', '300', 'or', 'more', 'fecal', 'specimens', 'were', 'reviewed', 'at', 'a', 'workshop', 'held', 'in', 'Belém', 'These', 'results', 'showed', 'that', 'rotavirus', 'had', 'been', 'detected', 'in', '13', 'to', '20', 'of', 'the', 'specimens', 'tested', 'with', 'positive', 'specimens', 'appearing', 'to', 'peak', 'in', 'the', 'May', 'to', 'September', 'winter', 'or', 'dry', 'season', 'in', 'Brazil', 's', 'central', 'and', 'southern', 'states', 'but', 'not', 'in', 'the', 'more', 'tropical', 'northern', 'areas', 'Adenovirus', 'detected', 'in', '0', '7', 'to', '5', '5', 'of', 'the', 'specimens', 'tested', 'for', 'it', 'showed', 'no', 'seasonal', 'variations', 'Many', 'other', 'viral', 'agents', 'known', 'to', 'cause', 'gastroenteritis', 'e', 'g', 'astrovirus', 'small', 'round', 'structured', 'viruses', 'calcivirus', 'and', 'group', 'C', 'rotavirus', 'were', 'detected', 'at', 'centers', 'that', 'used', 'electron', 'microscopy', 'Picobirnavirus', 'a', 'novel', 'agent', 'not', 'yet', 'associated', 'with', 'gastroenteritis', 'in', 'humans', 'was', 'found', 'by', 'polyacrylamide', 'gel', 'electrophoresis', 'in', 'specimens', 'from', 'a', 'number', 'of', 'centers', 'using', 'this', 'technique', 'Vaccines', 'to', 'prevent', 'rotavirus', 'that', 'are', 'currently', 'under', 'development', 'would', 'be', 'of', 'great', 'use', 'in', 'Brazil', 'where', 'rotavirus', 'is', 'the', 'most', 'common', 'cause', 'of', 'childhood', 'diarrhea', 'Improved', 'diagnostics', 'will', 'be', 'required', 'to', 'assess', 'the', 'importance', 'of', 'the', 'other', 'viral', 'agents', '']"
92286,Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis.,2005,Clinical science,https://www.ncbi.nlm.nih.gov/pubmed/16171460/,"qRT-PCR (real-time reverse transcription-PCR) has become the benchmark for the detection and quantification of RNA targets and is being utilized increasingly in novel clinical diagnostic assays. Quantitative results obtained by this technology are not only more informative than qualitative data, but simplify assay standardization and quality management. qRT-PCR assays are most established for the detection of viral load and therapy monitoring, and the development of SARS (severe acute respiratory syndrome)-associated coronavirus qRT-PCR assays provide a textbook example of the value of this technology for clinical diagnostics. The widespread use of qRT-PCR assays for diagnosis and the detection of disease-specific prognostic markers in leukaemia patients provide further examples of their usefulness. Their value for the detection of disease-associated mRNA expressed by circulating tumour cells in patients with solid malignancies is far less apparent, and the clinical significance of results obtained from such tests remains unclear. This is because of conceptual reservations as well as technical limitations that can interfere with the diagnostic specificity of qRT-PCR assays. Therefore, although it is evident that qRT-PCR assay has become a useful and important technology in the clinical diagnostic laboratory, it must be used appropriately and it is essential to be aware of its limitations if it is to fulfil its potential.",,z1d8i5em,"['qRT', 'PCR', 'real', 'time', 'reverse', 'transcription', 'PCR', 'has', 'become', 'the', 'benchmark', 'for', 'the', 'detection', 'and', 'quantification', 'of', 'RNA', 'targets', 'and', 'is', 'being', 'utilized', 'increasingly', 'in', 'novel', 'clinical', 'diagnostic', 'assays', 'Quantitative', 'results', 'obtained', 'by', 'this', 'technology', 'are', 'not', 'only', 'more', 'informative', 'than', 'qualitative', 'data', 'but', 'simplify', 'assay', 'standardization', 'and', 'quality', 'management', 'qRT', 'PCR', 'assays', 'are', 'most', 'established', 'for', 'the', 'detection', 'of', 'viral', 'load', 'and', 'therapy', 'monitoring', 'and', 'the', 'development', 'of', 'SARS', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'qRT', 'PCR', 'assays', 'provide', 'a', 'textbook', 'example', 'of', 'the', 'value', 'of', 'this', 'technology', 'for', 'clinical', 'diagnostics', 'The', 'widespread', 'use', 'of', 'qRT', 'PCR', 'assays', 'for', 'diagnosis', 'and', 'the', 'detection', 'of', 'disease', 'specific', 'prognostic', 'markers', 'in', 'leukaemia', 'patients', 'provide', 'further', 'examples', 'of', 'their', 'usefulness', 'Their', 'value', 'for', 'the', 'detection', 'of', 'disease', 'associated', 'mRNA', 'expressed', 'by', 'circulating', 'tumour', 'cells', 'in', 'patients', 'with', 'solid', 'malignancies', 'is', 'far', 'less', 'apparent', 'and', 'the', 'clinical', 'significance', 'of', 'results', 'obtained', 'from', 'such', 'tests', 'remains', 'unclear', 'This', 'is', 'because', 'of', 'conceptual', 'reservations', 'as', 'well', 'as', 'technical', 'limitations', 'that', 'can', 'interfere', 'with', 'the', 'diagnostic', 'specificity', 'of', 'qRT', 'PCR', 'assays', 'Therefore', 'although', 'it', 'is', 'evident', 'that', 'qRT', 'PCR', 'assay', 'has', 'become', 'a', 'useful', 'and', 'important', 'technology', 'in', 'the', 'clinical', 'diagnostic', 'laboratory', 'it', 'must', 'be', 'used', 'appropriately', 'and', 'it', 'is', 'essential', 'to', 'be', 'aware', 'of', 'its', 'limitations', 'if', 'it', 'is', 'to', 'fulfil', 'its', 'potential', '']"
92797,"Fast, ultrasensitive virus detection using a Young interferometer sensor.",2007,Nano letters,https://www.ncbi.nlm.nih.gov/pubmed/17298006/,"We report the application of an integrated optical Young interferometer sensor for ultrasensitive, real-time, direct detection of viruses. We have validated the sensor by detecting herpes simplex virus type 1 (HSV-1), but the principle is generally applicable. Detection of HSV-1 virus particles was performed by applying the virus sample onto a sensor surface coated with a specific antibody against HSV-1. The performance of the sensor was tested by monitoring virus samples at clinically relevant concentrations. We show that the Young interferometer sensor can specifically and sensitively detect HSV-1 at very low concentrations (850 particles/mL). We have further demonstrated that the sensor can specifically detect HSV-1 suspended in serum. Extrapolation of the results indicates that the sensitivity of the sensor approaches the detection of a single virus particle binding, yielding a sensor of unprecedented sensitivity with wide applications for viral diagnostics.",,teyzripb,"['We', 'report', 'the', 'application', 'of', 'an', 'integrated', 'optical', 'Young', 'interferometer', 'sensor', 'for', 'ultrasensitive', 'real', 'time', 'direct', 'detection', 'of', 'viruses', 'We', 'have', 'validated', 'the', 'sensor', 'by', 'detecting', 'herpes', 'simplex', 'virus', 'type', '1', 'HSV', '1', 'but', 'the', 'principle', 'is', 'generally', 'applicable', 'Detection', 'of', 'HSV', '1', 'virus', 'particles', 'was', 'performed', 'by', 'applying', 'the', 'virus', 'sample', 'onto', 'a', 'sensor', 'surface', 'coated', 'with', 'a', 'specific', 'antibody', 'against', 'HSV', '1', 'The', 'performance', 'of', 'the', 'sensor', 'was', 'tested', 'by', 'monitoring', 'virus', 'samples', 'at', 'clinically', 'relevant', 'concentrations', 'We', 'show', 'that', 'the', 'Young', 'interferometer', 'sensor', 'can', 'specifically', 'and', 'sensitively', 'detect', 'HSV', '1', 'at', 'very', 'low', 'concentrations', '850', 'particles', 'mL', 'We', 'have', 'further', 'demonstrated', 'that', 'the', 'sensor', 'can', 'specifically', 'detect', 'HSV', '1', 'suspended', 'in', 'serum', 'Extrapolation', 'of', 'the', 'results', 'indicates', 'that', 'the', 'sensitivity', 'of', 'the', 'sensor', 'approaches', 'the', 'detection', 'of', 'a', 'single', 'virus', 'particle', 'binding', 'yielding', 'a', 'sensor', 'of', 'unprecedented', 'sensitivity', 'with', 'wide', 'applications', 'for', 'viral', 'diagnostics', '']"
93097,"Features, Evaluation and Treatment Coronavirus (COVID-19)",2020,StatPearls,,"According to the World Health Organization (WHO), viral diseases continue to emerge and represent a serious issue to public health In the last twenty years, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003, and H1N1 influenza in 2009, have been recorded Most recently, the Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 In a timeline that reaches the present day, an epidemic of cases with unexplained low respiratory infections detected in Wuhan, the largest metropolitan area in China's Hubei province, was first reported to the WHO Country Office in China, on December 31, 2019 Published literature can trace the beginning of symptomatic individuals back to the beginning of December 2019 As they were unable to identify the causative agent, these first cases were classified as ""pneumonia of unknown etiology "" The Chinese Center for Disease Control and Prevention (CDC) and local CDCs organized an intensive outbreak investigation program The etiology of this illness is now attributed to a novel virus belonging to the coronavirus (CoV) family, COVID-19 On February 11, 2020, the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, announced that the disease caused by this new CoV was a ""COVID-19,"" which is the acronym of ""coronavirus disease 2019"" In the past twenty years, two additional coronavirus epidemics have occurred SARS-CoV provoked a large-scale epidemic beginning in China and involving two dozen countries with approximately 8000 cases and 800 deaths, and the MERS-CoV that began in Saudi Arabia and has approximately 2,500 cases and 800 deaths and still causes as sporadic cases This new virus seems to be very contagious and has quickly spread globally In a meeting on January 30, 2020, per the International Health Regulations (IHR, 2005), the outbreak was declared by the WHO a Public Health Emergency of International Concern (PHEIC) as it had spread to 18 countries with four countries reporting human-to-human transmission An additional landmark occurred on February 26, 2020, as the first case of the disease, not imported from China, was recorded in the United States Initially, the new virus was called 2019-nCoV Subsequently, the task of experts of the International Committee on Taxonomy of Viruses (ICTV) termed it the SARS-CoV-2 virus as it is very similar to the one that caused the SARS outbreak (SARS-CoVs) The CoVs have become the major pathogens of emerging respiratory disease outbreaks They are a large family of single-stranded RNA viruses (+ssRNA) that can be isolated in different animal species For reasons yet to be explained, these viruses can cross species barriers and can cause, in humans, illness ranging from the common cold to more severe diseases such as MERS and SARS Interestingly, these latter viruses have probably originated from bats and then moving into other mammalian hosts — the Himalayan palm civet for SARS-CoV, and the dromedary camel for MERS-CoV — before jumping to humans The dynamics of SARS-Cov-2 are currently unknown, but there is speculation that it also has an animal origin The potential for these viruses to grow to become a pandemic worldwide seems to be a serious public health risk Concerning COVID-19, the WHO raised the threat to the CoV epidemic to the ""very high"" level, on February 28, 2020 Probably, the effects of the epidemic caused by the new CoV has yet to emerge as the situation is quickly evolving World governments are at work to establish countermeasures to stem possible devastating effects Health organizations coordinate information flows and issues directives and guidelines to best mitigate the impact of the threat At the same time, scientists around the world work tirelessly, and information about the transmission mechanisms, the clinical spectrum of disease, new diagnostics, and prevention and therapeutic strategies are rapidly developing Many uncertainties remain with regard to both the virus-host interac ion and the evolution of the epidemic, with specific reference to the times when the epidemic will reach its peak At the moment, the therapeutic strategies to deal with the infection are only supportive, and prevention aimed at reducing transmission in the community is our best weapon Aggressive isolation measures in China have led to a progressive reduction of cases in the last few days In Italy, in geographic regions of the north of the peninsula, political and health authorities are making incredible efforts to contain a shock wave that is severely testing the health system In the midst of the crisis, the authors have chosen to use the ""Statpearls"" platform because, within the PubMed scenario, it represents a unique tool that may allow them to make updates in real-time The aim, therefore, is to collect information and scientific evidence and to provide an overview of the topic that will be continuously updated",,n4v4n8d1,"['According', 'to', 'the', 'World', 'Health', 'Organization', 'WHO', 'viral', 'diseases', 'continue', 'to', 'emerge', 'and', 'represent', 'a', 'serious', 'issue', 'to', 'public', 'health', 'In', 'the', 'last', 'twenty', 'years', 'several', 'viral', 'epidemics', 'such', 'as', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'in', '2002', 'to', '2003', 'and', 'H1N1', 'influenza', 'in', '2009', 'have', 'been', 'recorded', 'Most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'first', 'identified', 'in', 'Saudi', 'Arabia', 'in', '2012', 'In', 'a', 'timeline', 'that', 'reaches', 'the', 'present', 'day', 'an', 'epidemic', 'of', 'cases', 'with', 'unexplained', 'low', 'respiratory', 'infections', 'detected', 'in', 'Wuhan', 'the', 'largest', 'metropolitan', 'area', 'in', 'China', 's', 'Hubei', 'province', 'was', 'first', 'reported', 'to', 'the', 'WHO', 'Country', 'Office', 'in', 'China', 'on', 'December', '31', '2019', 'Published', 'literature', 'can', 'trace', 'the', 'beginning', 'of', 'symptomatic', 'individuals', 'back', 'to', 'the', 'beginning', 'of', 'December', '2019', 'As', 'they', 'were', 'unable', 'to', 'identify', 'the', 'causative', 'agent', 'these', 'first', 'cases', 'were', 'classified', 'as', 'pneumonia', 'of', 'unknown', 'etiology', 'The', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'and', 'local', 'CDCs', 'organized', 'an', 'intensive', 'outbreak', 'investigation', 'program', 'The', 'etiology', 'of', 'this', 'illness', 'is', 'now', 'attributed', 'to', 'a', 'novel', 'virus', 'belonging', 'to', 'the', 'coronavirus', 'CoV', 'family', 'COVID', '19', 'On', 'February', '11', '2020', 'the', 'WHO', 'Director', 'General', 'Dr', 'Tedros', 'Adhanom', 'Ghebreyesus', 'announced', 'that', 'the', 'disease', 'caused', 'by', 'this', 'new', 'CoV', 'was', 'a', 'COVID', '19', 'which', 'is', 'the', 'acronym', 'of', 'coronavirus', 'disease', '2019', 'In', 'the', 'past', 'twenty', 'years', 'two', 'additional', 'coronavirus', 'epidemics', 'have', 'occurred', 'SARS', 'CoV', 'provoked', 'a', 'large', 'scale', 'epidemic', 'beginning', 'in', 'China', 'and', 'involving', 'two', 'dozen', 'countries', 'with', 'approximately', '8000', 'cases', 'and', '800', 'deaths', 'and', 'the', 'MERS', 'CoV', 'that', 'began', 'in', 'Saudi', 'Arabia', 'and', 'has', 'approximately', '2', '500', 'cases', 'and', '800', 'deaths', 'and', 'still', 'causes', 'as', 'sporadic', 'cases', 'This', 'new', 'virus', 'seems', 'to', 'be', 'very', 'contagious', 'and', 'has', 'quickly', 'spread', 'globally', 'In', 'a', 'meeting', 'on', 'January', '30', '2020', 'per', 'the', 'International', 'Health', 'Regulations', 'IHR', '2005', 'the', 'outbreak', 'was', 'declared', 'by', 'the', 'WHO', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'PHEIC', 'as', 'it', 'had', 'spread', 'to', '18', 'countries', 'with', 'four', 'countries', 'reporting', 'human', 'to', 'human', 'transmission', 'An', 'additional', 'landmark', 'occurred', 'on', 'February', '26', '2020', 'as', 'the', 'first', 'case', 'of', 'the', 'disease', 'not', 'imported', 'from', 'China', 'was', 'recorded', 'in', 'the', 'United', 'States', 'Initially', 'the', 'new', 'virus', 'was', 'called', '2019', 'nCoV', 'Subsequently', 'the', 'task', 'of', 'experts', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'ICTV', 'termed', 'it', 'the', 'SARS', 'CoV', '2', 'virus', 'as', 'it', 'is', 'very', 'similar', 'to', 'the', 'one', 'that', 'caused', 'the', 'SARS', 'outbreak', 'SARS', 'CoVs', 'The', 'CoVs', 'have', 'become', 'the', 'major', 'pathogens', 'of', 'emerging', 'respiratory', 'disease', 'outbreaks', 'They', 'are', 'a', 'large', 'family', 'of', 'single', 'stranded', 'RNA', 'viruses', 'ssRNA', 'that', 'can', 'be', 'isolated', 'in', 'different', 'animal', 'species', 'For', 'reasons', 'yet', 'to', 'be', 'explained', 'these', 'viruses', 'can', 'cross', 'species', 'barriers', 'and', 'can', 'cause', 'in', 'humans', 'illness', 'ranging', 'from', 'the', 'common', 'cold', 'to', 'more', 'severe', 'diseases', 'such', 'as', 'MERS', 'and', 'SARS', 'Interestingly', 'these', 'latter', 'viruses', 'have', 'probably', 'originated', 'from', 'bats', 'and', 'then', 'moving', 'into', 'other', 'mammalian', 'hosts', 'the', 'Himalayan', 'palm', 'civet', 'for', 'SARS', 'CoV', 'and', 'the', 'dromedary', 'camel', 'for', 'MERS', 'CoV', 'before', 'jumping', 'to', 'humans', 'The', 'dynamics', 'of', 'SARS', 'Cov', '2', 'are', 'currently', 'unknown', 'but', 'there', 'is', 'speculation', 'that', 'it', 'also', 'has', 'an', 'animal', 'origin', 'The', 'potential', 'for', 'these', 'viruses', 'to', 'grow', 'to', 'become', 'a', 'pandemic', 'worldwide', 'seems', 'to', 'be', 'a', 'serious', 'public', 'health', 'risk', 'Concerning', 'COVID', '19', 'the', 'WHO', 'raised', 'the', 'threat', 'to', 'the', 'CoV', 'epidemic', 'to', 'the', 'very', 'high', 'level', 'on', 'February', '28', '2020', 'Probably', 'the', 'effects', 'of', 'the', 'epidemic', 'caused', 'by', 'the', 'new', 'CoV', 'has', 'yet', 'to', 'emerge', 'as', 'the', 'situation', 'is', 'quickly', 'evolving', 'World', 'governments', 'are', 'at', 'work', 'to', 'establish', 'countermeasures', 'to', 'stem', 'possible', 'devastating', 'effects', 'Health', 'organizations', 'coordinate', 'information', 'flows', 'and', 'issues', 'directives', 'and', 'guidelines', 'to', 'best', 'mitigate', 'the', 'impact', 'of', 'the', 'threat', 'At', 'the', 'same', 'time', 'scientists', 'around', 'the', 'world', 'work', 'tirelessly', 'and', 'information', 'about', 'the', 'transmission', 'mechanisms', 'the', 'clinical', 'spectrum', 'of', 'disease', 'new', 'diagnostics', 'and', 'prevention', 'and', 'therapeutic', 'strategies', 'are', 'rapidly', 'developing', 'Many', 'uncertainties', 'remain', 'with', 'regard', 'to', 'both', 'the', 'virus', 'host', 'interac', 'ion', 'and', 'the', 'evolution', 'of', 'the', 'epidemic', 'with', 'specific', 'reference', 'to', 'the', 'times', 'when', 'the', 'epidemic', 'will', 'reach', 'its', 'peak', 'At', 'the', 'moment', 'the', 'therapeutic', 'strategies', 'to', 'deal', 'with', 'the', 'infection', 'are', 'only', 'supportive', 'and', 'prevention', 'aimed', 'at', 'reducing', 'transmission', 'in', 'the', 'community', 'is', 'our', 'best', 'weapon', 'Aggressive', 'isolation', 'measures', 'in', 'China', 'have', 'led', 'to', 'a', 'progressive', 'reduction', 'of', 'cases', 'in', 'the', 'last', 'few', 'days', 'In', 'Italy', 'in', 'geographic', 'regions', 'of', 'the', 'north', 'of', 'the', 'peninsula', 'political', 'and', 'health', 'authorities', 'are', 'making', 'incredible', 'efforts', 'to', 'contain', 'a', 'shock', 'wave', 'that', 'is', 'severely', 'testing', 'the', 'health', 'system', 'In', 'the', 'midst', 'of', 'the', 'crisis', 'the', 'authors', 'have', 'chosen', 'to', 'use', 'the', 'Statpearls', 'platform', 'because', 'within', 'the', 'PubMed', 'scenario', 'it', 'represents', 'a', 'unique', 'tool', 'that', 'may', 'allow', 'them', 'to', 'make', 'updates', 'in', 'real', 'time', 'The', 'aim', 'therefore', 'is', 'to', 'collect', 'information', 'and', 'scientific', 'evidence', 'and', 'to', 'provide', 'an', 'overview', 'of', 'the', 'topic', 'that', 'will', 'be', 'continuously', 'updated']"
93219,Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma,2020,Clin Chim Acta,,"BACKGROUND: Besides SARS-CoV-2 RT-PCR testing, serological testing is emerging as additional option in COVID-19 diagnostics. Aim of this study was to evaluate novel immunoassays for detection of SARS-CoV-2 antibodies in human plasma. METHODS: Using EDITM Novel Coronavirus COVID-19 Enzyme Linked Immunosorbent Assays (ELISAs), we measured SARS-CoV-2 IgM and IgG antibodies in 64 SARS-CoV-2 RT-PCR confirmed COVID-19 patients with serial blood samples (n = 104) collected at different time points from symptom onset. Blood samples from 200 healthy blood donors and 256 intensive care unit (ICU) patients collected before the COVID-19 outbreak were also used. RESULTS: The positivity rates in the COVID-19 patients were 5.9% for IgM and 2.9% for IgG &#8804; 5 days after symptom onset; Between day 5 and day 10 the positivity rates were 37.1% for IgM and 37.1% for IgG and rose to 76.4% for IgM and 82.4% for IgG after > 10-15 days. After 15-22 days the ""true"" positivity rates were 94.4% for IgM and 100% for IgG. The ""false"" positivity rates were 0.5% for IgM and 1.0% for IgG in the healthy blood donors, 1.6% for IgM and 1.2% for IgG in ICU patients. CONCLUSIONS: This study shows high ""true"" vs. low ""false"" positivity rates for the EDITM SARS-CoV-2 IgM and IgG ELISAs.",,zvj00qjj,"['BACKGROUND', 'Besides', 'SARS', 'CoV', '2', 'RT', 'PCR', 'testing', 'serological', 'testing', 'is', 'emerging', 'as', 'additional', 'option', 'in', 'COVID', '19', 'diagnostics', 'Aim', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'novel', 'immunoassays', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'antibodies', 'in', 'human', 'plasma', 'METHODS', 'Using', 'EDITM', 'Novel', 'Coronavirus', 'COVID', '19', 'Enzyme', 'Linked', 'Immunosorbent', 'Assays', 'ELISAs', 'we', 'measured', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'in', '64', 'SARS', 'CoV', '2', 'RT', 'PCR', 'confirmed', 'COVID', '19', 'patients', 'with', 'serial', 'blood', 'samples', 'n', '104', 'collected', 'at', 'different', 'time', 'points', 'from', 'symptom', 'onset', 'Blood', 'samples', 'from', '200', 'healthy', 'blood', 'donors', 'and', '256', 'intensive', 'care', 'unit', 'ICU', 'patients', 'collected', 'before', 'the', 'COVID', '19', 'outbreak', 'were', 'also', 'used', 'RESULTS', 'The', 'positivity', 'rates', 'in', 'the', 'COVID', '19', 'patients', 'were', '5', '9', 'for', 'IgM', 'and', '2', '9', 'for', 'IgG', '8804', '5', 'days', 'after', 'symptom', 'onset', 'Between', 'day', '5', 'and', 'day', '10', 'the', 'positivity', 'rates', 'were', '37', '1', 'for', 'IgM', 'and', '37', '1', 'for', 'IgG', 'and', 'rose', 'to', '76', '4', 'for', 'IgM', 'and', '82', '4', 'for', 'IgG', 'after', '10', '15', 'days', 'After', '15', '22', 'days', 'the', 'true', 'positivity', 'rates', 'were', '94', '4', 'for', 'IgM', 'and', '100', 'for', 'IgG', 'The', 'false', 'positivity', 'rates', 'were', '0', '5', 'for', 'IgM', 'and', '1', '0', 'for', 'IgG', 'in', 'the', 'healthy', 'blood', 'donors', '1', '6', 'for', 'IgM', 'and', '1', '2', 'for', 'IgG', 'in', 'ICU', 'patients', 'CONCLUSIONS', 'This', 'study', 'shows', 'high', 'true', 'vs', 'low', 'false', 'positivity', 'rates', 'for', 'the', 'EDITM', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'ELISAs', '']"
93260,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,vn5boexq,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93261,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,x065xgd3,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93262,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,zxr52une,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93520,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois",2020,Curr. opin. rheumatol,,"BACKGROUND: Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM: Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY: In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW: Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",,m7y37ue6,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
93521,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois",2020,Curr. opin. rheumatol,,"BACKGROUND: Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM: Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY: In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW: Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",,llf0iqop,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
95608,Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience,2020,J. med. virol,,"A pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading throughout the world. Though molecular diagnostic tests are the gold standard for COVID-19, serological testing is emerging as a potential surveillance tool, in addition to its complementary role in COVID-19 diagnostics. Indubitably quantitative serological testing provides greater advantages than qualitative tests but today there is still little known about serological diagnostics and what the most appropriate role quantitative tests might play. Sixty-one COVID-19 patients and 64 patients from a control group were tested by iFlash1800 CLIA analyzer for anti-SARS CoV-2 antibodies IgM and IgG. All COVID-19 patients were hospitalized in San Giovanni di Dio Hospital (Florence, Italy) and had a positive oro/nasopharyngeal swab reverse-transcription polymerase chain reaction result. The highest sensitivity with a very good specificity performance was reached at a cutoff value of 10.0 AU/mL for IgM and of 7.1 for IgG antibodies, hence near to the manufacturer's cutoff values of 10 AU/mL for both isotypes. The receiver operating characteristic curves showed area under the curve values of 0.918 and 0.980 for anti-SARS CoV-2 antibodies IgM and IgG, respectively. iFlash1800 CLIA analyzer has shown highly accurate results for the anti-SARS-CoV-2 antibodies profile and can be considered an excellent tool for COVID-19 diagnostics.",,1dbeh8q7,"['A', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'spreading', 'throughout', 'the', 'world', 'Though', 'molecular', 'diagnostic', 'tests', 'are', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'serological', 'testing', 'is', 'emerging', 'as', 'a', 'potential', 'surveillance', 'tool', 'in', 'addition', 'to', 'its', 'complementary', 'role', 'in', 'COVID', '19', 'diagnostics', 'Indubitably', 'quantitative', 'serological', 'testing', 'provides', 'greater', 'advantages', 'than', 'qualitative', 'tests', 'but', 'today', 'there', 'is', 'still', 'little', 'known', 'about', 'serological', 'diagnostics', 'and', 'what', 'the', 'most', 'appropriate', 'role', 'quantitative', 'tests', 'might', 'play', 'Sixty', 'one', 'COVID', '19', 'patients', 'and', '64', 'patients', 'from', 'a', 'control', 'group', 'were', 'tested', 'by', 'iFlash1800', 'CLIA', 'analyzer', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'All', 'COVID', '19', 'patients', 'were', 'hospitalized', 'in', 'San', 'Giovanni', 'di', 'Dio', 'Hospital', 'Florence', 'Italy', 'and', 'had', 'a', 'positive', 'oro', 'nasopharyngeal', 'swab', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'result', 'The', 'highest', 'sensitivity', 'with', 'a', 'very', 'good', 'specificity', 'performance', 'was', 'reached', 'at', 'a', 'cutoff', 'value', 'of', '10', '0', 'AU', 'mL', 'for', 'IgM', 'and', 'of', '7', '1', 'for', 'IgG', 'antibodies', 'hence', 'near', 'to', 'the', 'manufacturer', 's', 'cutoff', 'values', 'of', '10', 'AU', 'mL', 'for', 'both', 'isotypes', 'The', 'receiver', 'operating', 'characteristic', 'curves', 'showed', 'area', 'under', 'the', 'curve', 'values', 'of', '0', '918', 'and', '0', '980', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'respectively', 'iFlash1800', 'CLIA', 'analyzer', 'has', 'shown', 'highly', 'accurate', 'results', 'for', 'the', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'profile', 'and', 'can', 'be', 'considered', 'an', 'excellent', 'tool', 'for', 'COVID', '19', 'diagnostics', '']"
98529,Current laboratory diagnostics of coronavirus disease 2019 (COVID-19),2020,Acta Biomed,,"Laboratory medicine provides an almost irreplaceable contribution to the diagnostic reasoning and managed care of most human pathologies. The novel coronavirus disease 2019 (COVID-19) is not an exception to this paradigm. Although the relatively recent emergence does not allow to draw definitive conclusions on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, some standpoints can be conveyed. First and foremost, it seems now clear that we will be living together with this virus for quite a long time, so that our vigilance and responsiveness against the emergence of new local outbreaks shall be maintained at the highest possible levels. The etiological diagnosis of COVID-19 is, and will remain for the foreseeable future, deeply based on direct identification of viral RNA by means of molecular biology techniques in biological materials, especially upper and lower respiratory tract specimens. Whether other materials, such as blood, urine, stools, saliva and throat washing, will become valid alternatives has not been unequivocally defined so far. As concerns serological testing, promising information can be garnered from preliminary investigations, showing that the vast majority of COVID-19 patients seem to develop a sustained immune response against the virus, characterized especially by emergence of anti-SARS-CoV-2 IgG and IgA, 1 to 2 weeks after the onset of fever and/or respiratory symptoms. Whether these antibodies will have persistent neutralizing activity against the virus is still to be elucidated on individual and general basis. The availability of rapid tests for detecting either viral antigens or anti-SARS-CoV-2 antibodies are a potentially viable opportunity for purposes of epidemiologic surveillance, though more information is needed on accuracy and reliability of these portable immunoassays.",,3y47oszt,"['Laboratory', 'medicine', 'provides', 'an', 'almost', 'irreplaceable', 'contribution', 'to', 'the', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'most', 'human', 'pathologies', 'The', 'novel', 'coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'not', 'an', 'exception', 'to', 'this', 'paradigm', 'Although', 'the', 'relatively', 'recent', 'emergence', 'does', 'not', 'allow', 'to', 'draw', 'definitive', 'conclusions', 'on', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'diagnostics', 'some', 'standpoints', 'can', 'be', 'conveyed', 'First', 'and', 'foremost', 'it', 'seems', 'now', 'clear', 'that', 'we', 'will', 'be', 'living', 'together', 'with', 'this', 'virus', 'for', 'quite', 'a', 'long', 'time', 'so', 'that', 'our', 'vigilance', 'and', 'responsiveness', 'against', 'the', 'emergence', 'of', 'new', 'local', 'outbreaks', 'shall', 'be', 'maintained', 'at', 'the', 'highest', 'possible', 'levels', 'The', 'etiological', 'diagnosis', 'of', 'COVID', '19', 'is', 'and', 'will', 'remain', 'for', 'the', 'foreseeable', 'future', 'deeply', 'based', 'on', 'direct', 'identification', 'of', 'viral', 'RNA', 'by', 'means', 'of', 'molecular', 'biology', 'techniques', 'in', 'biological', 'materials', 'especially', 'upper', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'Whether', 'other', 'materials', 'such', 'as', 'blood', 'urine', 'stools', 'saliva', 'and', 'throat', 'washing', 'will', 'become', 'valid', 'alternatives', 'has', 'not', 'been', 'unequivocally', 'defined', 'so', 'far', 'As', 'concerns', 'serological', 'testing', 'promising', 'information', 'can', 'be', 'garnered', 'from', 'preliminary', 'investigations', 'showing', 'that', 'the', 'vast', 'majority', 'of', 'COVID', '19', 'patients', 'seem', 'to', 'develop', 'a', 'sustained', 'immune', 'response', 'against', 'the', 'virus', 'characterized', 'especially', 'by', 'emergence', 'of', 'anti', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', '1', 'to', '2', 'weeks', 'after', 'the', 'onset', 'of', 'fever', 'and', 'or', 'respiratory', 'symptoms', 'Whether', 'these', 'antibodies', 'will', 'have', 'persistent', 'neutralizing', 'activity', 'against', 'the', 'virus', 'is', 'still', 'to', 'be', 'elucidated', 'on', 'individual', 'and', 'general', 'basis', 'The', 'availability', 'of', 'rapid', 'tests', 'for', 'detecting', 'either', 'viral', 'antigens', 'or', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'are', 'a', 'potentially', 'viable', 'opportunity', 'for', 'purposes', 'of', 'epidemiologic', 'surveillance', 'though', 'more', 'information', 'is', 'needed', 'on', 'accuracy', 'and', 'reliability', 'of', 'these', 'portable', 'immunoassays', '']"
98530,Current laboratory diagnostics of coronavirus disease 2019 (COVID-19),2020,Acta Biomed,,"Laboratory medicine provides an almost irreplaceable contribution to the diagnostic reasoning and managed care of most human pathologies. The novel coronavirus disease 2019 (COVID-19) is not an exception to this paradigm. Although the relatively recent emergence does not allow to draw definitive conclusions on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, some standpoints can be conveyed. First and foremost, it seems now clear that we will be living together with this virus for quite a long time, so that our vigilance and responsiveness against the emergence of new local outbreaks shall be maintained at the highest possible levels. The etiological diagnosis of COVID-19 is, and will remain for the foreseeable future, deeply based on direct identification of viral RNA by means of molecular biology techniques in biological materials, especially upper and lower respiratory tract specimens. Whether other materials, such as blood, urine, stools, saliva and throat washing, will become valid alternatives has not been unequivocally defined so far. As concerns serological testing, promising information can be garnered from preliminary investigations, showing that the vast majority of COVID-19 patients seem to develop a sustained immune response against the virus, characterized especially by emergence of anti-SARS-CoV-2 IgG and IgA, 1 to 2 weeks after the onset of fever and/or respiratory symptoms. Whether these antibodies will have persistent neutralizing activity against the virus is still to be elucidated on individual and general basis. The availability of rapid tests for detecting either viral antigens or anti-SARS-CoV-2 antibodies are a potentially viable opportunity for purposes of epidemiologic surveillance, though more information is needed on accuracy and reliability of these portable immunoassays.",,40tgyur8,"['Laboratory', 'medicine', 'provides', 'an', 'almost', 'irreplaceable', 'contribution', 'to', 'the', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'most', 'human', 'pathologies', 'The', 'novel', 'coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'not', 'an', 'exception', 'to', 'this', 'paradigm', 'Although', 'the', 'relatively', 'recent', 'emergence', 'does', 'not', 'allow', 'to', 'draw', 'definitive', 'conclusions', 'on', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'diagnostics', 'some', 'standpoints', 'can', 'be', 'conveyed', 'First', 'and', 'foremost', 'it', 'seems', 'now', 'clear', 'that', 'we', 'will', 'be', 'living', 'together', 'with', 'this', 'virus', 'for', 'quite', 'a', 'long', 'time', 'so', 'that', 'our', 'vigilance', 'and', 'responsiveness', 'against', 'the', 'emergence', 'of', 'new', 'local', 'outbreaks', 'shall', 'be', 'maintained', 'at', 'the', 'highest', 'possible', 'levels', 'The', 'etiological', 'diagnosis', 'of', 'COVID', '19', 'is', 'and', 'will', 'remain', 'for', 'the', 'foreseeable', 'future', 'deeply', 'based', 'on', 'direct', 'identification', 'of', 'viral', 'RNA', 'by', 'means', 'of', 'molecular', 'biology', 'techniques', 'in', 'biological', 'materials', 'especially', 'upper', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'Whether', 'other', 'materials', 'such', 'as', 'blood', 'urine', 'stools', 'saliva', 'and', 'throat', 'washing', 'will', 'become', 'valid', 'alternatives', 'has', 'not', 'been', 'unequivocally', 'defined', 'so', 'far', 'As', 'concerns', 'serological', 'testing', 'promising', 'information', 'can', 'be', 'garnered', 'from', 'preliminary', 'investigations', 'showing', 'that', 'the', 'vast', 'majority', 'of', 'COVID', '19', 'patients', 'seem', 'to', 'develop', 'a', 'sustained', 'immune', 'response', 'against', 'the', 'virus', 'characterized', 'especially', 'by', 'emergence', 'of', 'anti', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', '1', 'to', '2', 'weeks', 'after', 'the', 'onset', 'of', 'fever', 'and', 'or', 'respiratory', 'symptoms', 'Whether', 'these', 'antibodies', 'will', 'have', 'persistent', 'neutralizing', 'activity', 'against', 'the', 'virus', 'is', 'still', 'to', 'be', 'elucidated', 'on', 'individual', 'and', 'general', 'basis', 'The', 'availability', 'of', 'rapid', 'tests', 'for', 'detecting', 'either', 'viral', 'antigens', 'or', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'are', 'a', 'potentially', 'viable', 'opportunity', 'for', 'purposes', 'of', 'epidemiologic', 'surveillance', 'though', 'more', 'information', 'is', 'needed', 'on', 'accuracy', 'and', 'reliability', 'of', 'these', 'portable', 'immunoassays', '']"
99644,Traumatic stress in the age of COVID-19: A call to close critical gaps and adapt to new realities,2020,Psychol Trauma,,"THE ISSUE: Coronavirus-19 (COVID-19) is transforming every aspect of our lives. Identified in late 2019, COVID-19 quickly became characterized as a global pandemic by March of 2020. Given the rapid acceleration of transmission, and the lack of preparedness to prevent and treat this virus, the negative impacts of COVID-19 are rippling through every facet of society. Although large numbers of people throughout the world will show resilience to the profound loss, stress, and fear associated with COVID-19, the virus will likely exacerbate existing mental health disorders and contribute to the onset of new stress-related disorders for many. RECOMMENDATIONS: The field of traumatic stress should address the serious needs that will emerge now and well into the future. However, we propose that these efforts may be limited, in part, by ongoing gaps that exist within our research and clinical care. In particular, we suggest that COVID-19 requires us to prioritize and mobilize as a research and clinical community around several key areas: (a) diagnostics, (b) prevention, (c) public outreach and communication, (d) working with medical staff and mainstreaming into nonmental health services, and (e) COVID-19-specific trauma research. As members of our community begin to rapidly develop and test interventions for COVID-19-related distress, we hope that those in positions of leadership in the field of traumatic stress consider limits of our current approaches, and invest the intellectual and financial resources urgently needed in order to innovate, forge partnerships, and develop the technologies to support those in greatest need. (PsycInfo Database Record (c) 2020 APA, all rights reserved).",,oahh6qkq,"['THE', 'ISSUE', 'Coronavirus', '19', 'COVID', '19', 'is', 'transforming', 'every', 'aspect', 'of', 'our', 'lives', 'Identified', 'in', 'late', '2019', 'COVID', '19', 'quickly', 'became', 'characterized', 'as', 'a', 'global', 'pandemic', 'by', 'March', 'of', '2020', 'Given', 'the', 'rapid', 'acceleration', 'of', 'transmission', 'and', 'the', 'lack', 'of', 'preparedness', 'to', 'prevent', 'and', 'treat', 'this', 'virus', 'the', 'negative', 'impacts', 'of', 'COVID', '19', 'are', 'rippling', 'through', 'every', 'facet', 'of', 'society', 'Although', 'large', 'numbers', 'of', 'people', 'throughout', 'the', 'world', 'will', 'show', 'resilience', 'to', 'the', 'profound', 'loss', 'stress', 'and', 'fear', 'associated', 'with', 'COVID', '19', 'the', 'virus', 'will', 'likely', 'exacerbate', 'existing', 'mental', 'health', 'disorders', 'and', 'contribute', 'to', 'the', 'onset', 'of', 'new', 'stress', 'related', 'disorders', 'for', 'many', 'RECOMMENDATIONS', 'The', 'field', 'of', 'traumatic', 'stress', 'should', 'address', 'the', 'serious', 'needs', 'that', 'will', 'emerge', 'now', 'and', 'well', 'into', 'the', 'future', 'However', 'we', 'propose', 'that', 'these', 'efforts', 'may', 'be', 'limited', 'in', 'part', 'by', 'ongoing', 'gaps', 'that', 'exist', 'within', 'our', 'research', 'and', 'clinical', 'care', 'In', 'particular', 'we', 'suggest', 'that', 'COVID', '19', 'requires', 'us', 'to', 'prioritize', 'and', 'mobilize', 'as', 'a', 'research', 'and', 'clinical', 'community', 'around', 'several', 'key', 'areas', 'a', 'diagnostics', 'b', 'prevention', 'c', 'public', 'outreach', 'and', 'communication', 'd', 'working', 'with', 'medical', 'staff', 'and', 'mainstreaming', 'into', 'nonmental', 'health', 'services', 'and', 'e', 'COVID', '19', 'specific', 'trauma', 'research', 'As', 'members', 'of', 'our', 'community', 'begin', 'to', 'rapidly', 'develop', 'and', 'test', 'interventions', 'for', 'COVID', '19', 'related', 'distress', 'we', 'hope', 'that', 'those', 'in', 'positions', 'of', 'leadership', 'in', 'the', 'field', 'of', 'traumatic', 'stress', 'consider', 'limits', 'of', 'our', 'current', 'approaches', 'and', 'invest', 'the', 'intellectual', 'and', 'financial', 'resources', 'urgently', 'needed', 'in', 'order', 'to', 'innovate', 'forge', 'partnerships', 'and', 'develop', 'the', 'technologies', 'to', 'support', 'those', 'in', 'greatest', 'need', 'PsycInfo', 'Database', 'Record', 'c', '2020', 'APA', 'all', 'rights', 'reserved', '']"
99645,Traumatic stress in the age of COVID-19: A call to close critical gaps and adapt to new realities,2020,Psychol Trauma,,"THE ISSUE: Coronavirus-19 (COVID-19) is transforming every aspect of our lives. Identified in late 2019, COVID-19 quickly became characterized as a global pandemic by March of 2020. Given the rapid acceleration of transmission, and the lack of preparedness to prevent and treat this virus, the negative impacts of COVID-19 are rippling through every facet of society. Although large numbers of people throughout the world will show resilience to the profound loss, stress, and fear associated with COVID-19, the virus will likely exacerbate existing mental health disorders and contribute to the onset of new stress-related disorders for many. RECOMMENDATIONS: The field of traumatic stress should address the serious needs that will emerge now and well into the future. However, we propose that these efforts may be limited, in part, by ongoing gaps that exist within our research and clinical care. In particular, we suggest that COVID-19 requires us to prioritize and mobilize as a research and clinical community around several key areas: (a) diagnostics, (b) prevention, (c) public outreach and communication, (d) working with medical staff and mainstreaming into nonmental health services, and (e) COVID-19-specific trauma research. As members of our community begin to rapidly develop and test interventions for COVID-19-related distress, we hope that those in positions of leadership in the field of traumatic stress consider limits of our current approaches, and invest the intellectual and financial resources urgently needed in order to innovate, forge partnerships, and develop the technologies to support those in greatest need. (PsycInfo Database Record (c) 2020 APA, all rights reserved).",,puuxjekp,"['THE', 'ISSUE', 'Coronavirus', '19', 'COVID', '19', 'is', 'transforming', 'every', 'aspect', 'of', 'our', 'lives', 'Identified', 'in', 'late', '2019', 'COVID', '19', 'quickly', 'became', 'characterized', 'as', 'a', 'global', 'pandemic', 'by', 'March', 'of', '2020', 'Given', 'the', 'rapid', 'acceleration', 'of', 'transmission', 'and', 'the', 'lack', 'of', 'preparedness', 'to', 'prevent', 'and', 'treat', 'this', 'virus', 'the', 'negative', 'impacts', 'of', 'COVID', '19', 'are', 'rippling', 'through', 'every', 'facet', 'of', 'society', 'Although', 'large', 'numbers', 'of', 'people', 'throughout', 'the', 'world', 'will', 'show', 'resilience', 'to', 'the', 'profound', 'loss', 'stress', 'and', 'fear', 'associated', 'with', 'COVID', '19', 'the', 'virus', 'will', 'likely', 'exacerbate', 'existing', 'mental', 'health', 'disorders', 'and', 'contribute', 'to', 'the', 'onset', 'of', 'new', 'stress', 'related', 'disorders', 'for', 'many', 'RECOMMENDATIONS', 'The', 'field', 'of', 'traumatic', 'stress', 'should', 'address', 'the', 'serious', 'needs', 'that', 'will', 'emerge', 'now', 'and', 'well', 'into', 'the', 'future', 'However', 'we', 'propose', 'that', 'these', 'efforts', 'may', 'be', 'limited', 'in', 'part', 'by', 'ongoing', 'gaps', 'that', 'exist', 'within', 'our', 'research', 'and', 'clinical', 'care', 'In', 'particular', 'we', 'suggest', 'that', 'COVID', '19', 'requires', 'us', 'to', 'prioritize', 'and', 'mobilize', 'as', 'a', 'research', 'and', 'clinical', 'community', 'around', 'several', 'key', 'areas', 'a', 'diagnostics', 'b', 'prevention', 'c', 'public', 'outreach', 'and', 'communication', 'd', 'working', 'with', 'medical', 'staff', 'and', 'mainstreaming', 'into', 'nonmental', 'health', 'services', 'and', 'e', 'COVID', '19', 'specific', 'trauma', 'research', 'As', 'members', 'of', 'our', 'community', 'begin', 'to', 'rapidly', 'develop', 'and', 'test', 'interventions', 'for', 'COVID', '19', 'related', 'distress', 'we', 'hope', 'that', 'those', 'in', 'positions', 'of', 'leadership', 'in', 'the', 'field', 'of', 'traumatic', 'stress', 'consider', 'limits', 'of', 'our', 'current', 'approaches', 'and', 'invest', 'the', 'intellectual', 'and', 'financial', 'resources', 'urgently', 'needed', 'in', 'order', 'to', 'innovate', 'forge', 'partnerships', 'and', 'develop', 'the', 'technologies', 'to', 'support', 'those', 'in', 'greatest', 'need', 'PsycInfo', 'Database', 'Record', 'c', '2020', 'APA', 'all', 'rights', 'reserved', '']"
99675,SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America,2020,J. assist. reprod. genet,,"The incorporation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing into patient care algorithms has been proposed to mitigate risk. However, the two main professional societies for human reproduction (ESHRE and ASRM) appear divergent on their clinical utility and whether they should be adopted. In this opinion paper, we review the currently available tests and discuss the strengths and weaknesses of the proposed clinical care pathways. Nucleic acid amplification tests are the cornerstone of SARS-CoV-2 testing but test results are largely influenced by viral load, sample site, specimen collection method, and specimen shipment technique, such that a negative result in a symptomatic patient cannot be relied upon. Serological assays for SARS-CoV-2 antibodies exhibit a temporal increase in sensitivity and specificity after symptom onset irrespective of the assay used, with sensitivity estimates ranging from 0 to 50% with the first 3 days of symptoms, to 83 to 88% at 10 days, increasing to almost 100% at &#8805; 14 days. These inherent constraints in diagnostics would suggest that at present there is inadequate evidence to utilize SARS-CoV-2 testing to stratify fertility patients and reliably inform clinical decision-making. The failure to appreciate the characteristics and limitations of the diagnostic tests may lead to disastrous consequences for the patient and the multidisciplinary team looking after them.",,z1ad5uc2,"['The', 'incorporation', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'testing', 'into', 'patient', 'care', 'algorithms', 'has', 'been', 'proposed', 'to', 'mitigate', 'risk', 'However', 'the', 'two', 'main', 'professional', 'societies', 'for', 'human', 'reproduction', 'ESHRE', 'and', 'ASRM', 'appear', 'divergent', 'on', 'their', 'clinical', 'utility', 'and', 'whether', 'they', 'should', 'be', 'adopted', 'In', 'this', 'opinion', 'paper', 'we', 'review', 'the', 'currently', 'available', 'tests', 'and', 'discuss', 'the', 'strengths', 'and', 'weaknesses', 'of', 'the', 'proposed', 'clinical', 'care', 'pathways', 'Nucleic', 'acid', 'amplification', 'tests', 'are', 'the', 'cornerstone', 'of', 'SARS', 'CoV', '2', 'testing', 'but', 'test', 'results', 'are', 'largely', 'influenced', 'by', 'viral', 'load', 'sample', 'site', 'specimen', 'collection', 'method', 'and', 'specimen', 'shipment', 'technique', 'such', 'that', 'a', 'negative', 'result', 'in', 'a', 'symptomatic', 'patient', 'cannot', 'be', 'relied', 'upon', 'Serological', 'assays', 'for', 'SARS', 'CoV', '2', 'antibodies', 'exhibit', 'a', 'temporal', 'increase', 'in', 'sensitivity', 'and', 'specificity', 'after', 'symptom', 'onset', 'irrespective', 'of', 'the', 'assay', 'used', 'with', 'sensitivity', 'estimates', 'ranging', 'from', '0', 'to', '50', 'with', 'the', 'first', '3', 'days', 'of', 'symptoms', 'to', '83', 'to', '88', 'at', '10', 'days', 'increasing', 'to', 'almost', '100', 'at', '8805', '14', 'days', 'These', 'inherent', 'constraints', 'in', 'diagnostics', 'would', 'suggest', 'that', 'at', 'present', 'there', 'is', 'inadequate', 'evidence', 'to', 'utilize', 'SARS', 'CoV', '2', 'testing', 'to', 'stratify', 'fertility', 'patients', 'and', 'reliably', 'inform', 'clinical', 'decision', 'making', 'The', 'failure', 'to', 'appreciate', 'the', 'characteristics', 'and', 'limitations', 'of', 'the', 'diagnostic', 'tests', 'may', 'lead', 'to', 'disastrous', 'consequences', 'for', 'the', 'patient', 'and', 'the', 'multidisciplinary', 'team', 'looking', 'after', 'them', '']"
100123,The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection,2020,Swiss Med Wkly,,"We present the case of an oncology patient admitted to our hospital during the current COVID-19 pandemic with clinical and radiological features strongly suggestive of interstitial pneumonia. Multiple laboratory tests were negative for SARS-CoV-2 (polymerase chain reaction testing of nasopharyngeal swabs, and of induced sputum and stool samples, investigation of serum immunoglobulins G and M). In the setting of an immunocompromised status due to recent chemotherapy cycles for lung adenocarcinoma and prolonged corticosteroid therapy (due to frequent exacerbations of chronic obstructive pulmonary disease in recent months), we actively searched for the pathological agent and found it to be Pneumocystis jirovecii. The patient started specific antibiotic treatment but finally had a negative outcome due to the progression of the lung adenocarcinoma. The importance of differential diagnostics in clinical practice should be a given, especially during times of pandemic. The novel coronavirus infection introduced new guidelines for and approaches to the investigation of immunocompromised patients, so it is especially important not to forget the basis of differential diagnosis, to and adopt a thorough approach when assessing these complex patients. We want to stress the importance of thorough investigation to avoid misdiagnosis of atypical pathogens in the current setting of SARS-CoV-2 pandemic.",,lp79phjd,"['We', 'present', 'the', 'case', 'of', 'an', 'oncology', 'patient', 'admitted', 'to', 'our', 'hospital', 'during', 'the', 'current', 'COVID', '19', 'pandemic', 'with', 'clinical', 'and', 'radiological', 'features', 'strongly', 'suggestive', 'of', 'interstitial', 'pneumonia', 'Multiple', 'laboratory', 'tests', 'were', 'negative', 'for', 'SARS', 'CoV', '2', 'polymerase', 'chain', 'reaction', 'testing', 'of', 'nasopharyngeal', 'swabs', 'and', 'of', 'induced', 'sputum', 'and', 'stool', 'samples', 'investigation', 'of', 'serum', 'immunoglobulins', 'G', 'and', 'M', 'In', 'the', 'setting', 'of', 'an', 'immunocompromised', 'status', 'due', 'to', 'recent', 'chemotherapy', 'cycles', 'for', 'lung', 'adenocarcinoma', 'and', 'prolonged', 'corticosteroid', 'therapy', 'due', 'to', 'frequent', 'exacerbations', 'of', 'chronic', 'obstructive', 'pulmonary', 'disease', 'in', 'recent', 'months', 'we', 'actively', 'searched', 'for', 'the', 'pathological', 'agent', 'and', 'found', 'it', 'to', 'be', 'Pneumocystis', 'jirovecii', 'The', 'patient', 'started', 'specific', 'antibiotic', 'treatment', 'but', 'finally', 'had', 'a', 'negative', 'outcome', 'due', 'to', 'the', 'progression', 'of', 'the', 'lung', 'adenocarcinoma', 'The', 'importance', 'of', 'differential', 'diagnostics', 'in', 'clinical', 'practice', 'should', 'be', 'a', 'given', 'especially', 'during', 'times', 'of', 'pandemic', 'The', 'novel', 'coronavirus', 'infection', 'introduced', 'new', 'guidelines', 'for', 'and', 'approaches', 'to', 'the', 'investigation', 'of', 'immunocompromised', 'patients', 'so', 'it', 'is', 'especially', 'important', 'not', 'to', 'forget', 'the', 'basis', 'of', 'differential', 'diagnosis', 'to', 'and', 'adopt', 'a', 'thorough', 'approach', 'when', 'assessing', 'these', 'complex', 'patients', 'We', 'want', 'to', 'stress', 'the', 'importance', 'of', 'thorough', 'investigation', 'to', 'avoid', 'misdiagnosis', 'of', 'atypical', 'pathogens', 'in', 'the', 'current', 'setting', 'of', 'SARS', 'CoV', '2', 'pandemic', '']"
102034,SARS-CoV-2 diagnostic diary: from rumors to the first case. Early reports of molecular tests from the military research and diagnostic institute of Rio de Janeiro,2020,Mem Inst Oswaldo Cruz,,"Corona virus disease (COVID-19) presents a serious threat to global health. A historical timeline of early molecular diagnostics from government alert (January 22) (D) was presented. After in silico analysis, Brazilian Army Institute of Biology (IBEx-RJ) tested samples in house using real-time reverse transcriptase polymerase chain reaction (RT-PCR) (fast mode) based on Centers for Disease Control and Prevention (CDC) recommendations. First cases from Brazil, Rio de Janeiro, IBEx, and diagnosis team were reported in D36, D44, D66, and D74 respectively. Therefore, after 1300 tests, we recommend N1/N2 primer sets (CDC) for preliminary and Charité protocol confirmation in case of positive results. Moreover, every professional should be tested before starting work, in addition to weekly tests for everyone involved.",,fzf8tefr,"['Corona', 'virus', 'disease', 'COVID', '19', 'presents', 'a', 'serious', 'threat', 'to', 'global', 'health', 'A', 'historical', 'timeline', 'of', 'early', 'molecular', 'diagnostics', 'from', 'government', 'alert', 'January', '22', 'D', 'was', 'presented', 'After', 'in', 'silico', 'analysis', 'Brazilian', 'Army', 'Institute', 'of', 'Biology', 'IBEx', 'RJ', 'tested', 'samples', 'in', 'house', 'using', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'fast', 'mode', 'based', 'on', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommendations', 'First', 'cases', 'from', 'Brazil', 'Rio', 'de', 'Janeiro', 'IBEx', 'and', 'diagnosis', 'team', 'were', 'reported', 'in', 'D36', 'D44', 'D66', 'and', 'D74', 'respectively', 'Therefore', 'after', '1300', 'tests', 'we', 'recommend', 'N1', 'N2', 'primer', 'sets', 'CDC', 'for', 'preliminary', 'and', 'Charité', 'protocol', 'confirmation', 'in', 'case', 'of', 'positive', 'results', 'Moreover', 'every', 'professional', 'should', 'be', 'tested', 'before', 'starting', 'work', 'in', 'addition', 'to', 'weekly', 'tests', 'for', 'everyone', 'involved', '']"
102294,Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests,2020,J Clin Virol,,"The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has been followed by the rapid development of antibody tests. To assess the utility of the tests for clinical use and seroepidemiologic studies, we examined the sensitivity of commercial antibody tests from Roche, Abbott, Novatec, Virotech Siemens, Euroimmun, and Mediagnost in a prospective diagnostic study. The tests were evaluated with 73 sera from SARS CoV-2 RNA positive individuals with mild to moderate disease or asymptomatic infection. Sera were obtained at 2-3 weeks (Nâ¯=â¯25) or > 4 weeks (Nâ¯=â¯48) after symptom onset and viral RNA test. The overall sensitivity of the tests ranged from 64.4-93.2%. The most sensitive assays recognized 95.8-100 % of the sera obtained after 4 weeks or later. Sera drawn at 2-3 weeks were recognized with lower sensitivity indicating that the optimal time point for serologic testing is later than 3 weeks after onset of the disease. Nucleoprotein- and glycoproteinbased assays had similar sensitivity indicating that tests with both antigens are suitable for serological diagnostics. Breakdown of the test results showed that nucleoprotein- and glycoprotein-based tests of comparable sensitivity reacted with different sets of sera. The observation indicates that a combination of nucleoprotein- and glycoprotein-based tests would increase the percentage of positive results.",,57fkrkiz,"['The', 'emergence', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'followed', 'by', 'the', 'rapid', 'development', 'of', 'antibody', 'tests', 'To', 'assess', 'the', 'utility', 'of', 'the', 'tests', 'for', 'clinical', 'use', 'and', 'seroepidemiologic', 'studies', 'we', 'examined', 'the', 'sensitivity', 'of', 'commercial', 'antibody', 'tests', 'from', 'Roche', 'Abbott', 'Novatec', 'Virotech', 'Siemens', 'Euroimmun', 'and', 'Mediagnost', 'in', 'a', 'prospective', 'diagnostic', 'study', 'The', 'tests', 'were', 'evaluated', 'with', '73', 'sera', 'from', 'SARS', 'CoV', '2', 'RNA', 'positive', 'individuals', 'with', 'mild', 'to', 'moderate', 'disease', 'or', 'asymptomatic', 'infection', 'Sera', 'were', 'obtained', 'at', '2', '3', 'weeks', 'Nâ', 'â', '25', 'or', '4', 'weeks', 'Nâ', 'â', '48', 'after', 'symptom', 'onset', 'and', 'viral', 'RNA', 'test', 'The', 'overall', 'sensitivity', 'of', 'the', 'tests', 'ranged', 'from', '64', '4', '93', '2', 'The', 'most', 'sensitive', 'assays', 'recognized', '95', '8', '100', 'of', 'the', 'sera', 'obtained', 'after', '4', 'weeks', 'or', 'later', 'Sera', 'drawn', 'at', '2', '3', 'weeks', 'were', 'recognized', 'with', 'lower', 'sensitivity', 'indicating', 'that', 'the', 'optimal', 'time', 'point', 'for', 'serologic', 'testing', 'is', 'later', 'than', '3', 'weeks', 'after', 'onset', 'of', 'the', 'disease', 'Nucleoprotein', 'and', 'glycoproteinbased', 'assays', 'had', 'similar', 'sensitivity', 'indicating', 'that', 'tests', 'with', 'both', 'antigens', 'are', 'suitable', 'for', 'serological', 'diagnostics', 'Breakdown', 'of', 'the', 'test', 'results', 'showed', 'that', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'of', 'comparable', 'sensitivity', 'reacted', 'with', 'different', 'sets', 'of', 'sera', 'The', 'observation', 'indicates', 'that', 'a', 'combination', 'of', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'would', 'increase', 'the', 'percentage', 'of', 'positive', 'results', '']"
102425,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020,Bioinformatics,,"SUMMARY: Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present the Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS)-related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2000 sequences per submission and the analysis of a new whole-genome sequence will take approximately 1 min. The tool has been tested and validated with hundreds of whole genomes from 10 coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY AND IMPLEMENTATION: https://www.genomedetective.com/app/typingtool/cov. CONTACT: koen@emweb.be or deoliveira@ukzn.ac.za. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",,88hswyln,"['SUMMARY', 'Genome', 'detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'the', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', '1', 'min', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', '10', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'AND', 'IMPLEMENTATION', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'CONTACT', 'koen', 'emweb', 'be', 'or', 'deoliveira', 'ukzn', 'ac', 'za', 'SUPPLEMENTARY', 'INFORMATION', 'Supplementary', 'data', 'are', 'available', 'at', 'Bioinformatics', 'online', '']"
102426,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020,Bioinformatics,,"SUMMARY: Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present the Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS)-related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2000 sequences per submission and the analysis of a new whole-genome sequence will take approximately 1 min. The tool has been tested and validated with hundreds of whole genomes from 10 coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY AND IMPLEMENTATION: https://www.genomedetective.com/app/typingtool/cov. CONTACT: koen@emweb.be or deoliveira@ukzn.ac.za. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",,xgpxa84g,"['SUMMARY', 'Genome', 'detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'the', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', '1', 'min', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', '10', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'AND', 'IMPLEMENTATION', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'CONTACT', 'koen', 'emweb', 'be', 'or', 'deoliveira', 'ukzn', 'ac', 'za', 'SUPPLEMENTARY', 'INFORMATION', 'Supplementary', 'data', 'are', 'available', 'at', 'Bioinformatics', 'online', '']"
102539,Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis,2020,Biosens Bioelectron,,"Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-throughput operation that can preferably utilize existing equipment to facilitate broad, large-scale screening efforts. We have developed a CRISPR-based assay that can meet all these criteria. This assay utilizes a custom CRISPR Cas12a/gRNA complex and a fluorescent probe to detect target amplicons produced by standard RT-PCR or isothermal recombinase polymerase amplification (RPA), to allow sensitive detection at sites not equipped with real-time PCR systems required for qPCR diagnostics. We found this approach allowed sensitive and robust detection of SARS-CoV-2 positive samples, with a sample-to-answer time of ~50 min, and a limit of detection of 2 copies per sample. CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved quantitative RT-PCR (RT-qPCR) assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the RT-qPCR assay exhibited multiple invalid or inconclusive results. Our assay also demonstrated greater analytical sensitivity and more robust diagnostic performance than other recently reported CRISPR-based assays. Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts.",,pfb0ozy6,"['Recent', 'research', 'suggests', 'that', 'SARS', 'CoV', '2', 'infected', 'individuals', 'can', 'be', 'highly', 'infectious', 'while', 'asymptomatic', 'or', 'pre', 'symptomatic', 'and', 'that', 'an', 'infected', 'person', 'may', 'infect', '5', '6', 'other', 'individuals', 'on', 'average', 'This', 'situation', 'highlights', 'the', 'need', 'for', 'rapid', 'sensitive', 'SARS', 'CoV', '2', 'diagnostic', 'assays', 'capable', 'of', 'high', 'throughput', 'operation', 'that', 'can', 'preferably', 'utilize', 'existing', 'equipment', 'to', 'facilitate', 'broad', 'large', 'scale', 'screening', 'efforts', 'We', 'have', 'developed', 'a', 'CRISPR', 'based', 'assay', 'that', 'can', 'meet', 'all', 'these', 'criteria', 'This', 'assay', 'utilizes', 'a', 'custom', 'CRISPR', 'Cas12a', 'gRNA', 'complex', 'and', 'a', 'fluorescent', 'probe', 'to', 'detect', 'target', 'amplicons', 'produced', 'by', 'standard', 'RT', 'PCR', 'or', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'to', 'allow', 'sensitive', 'detection', 'at', 'sites', 'not', 'equipped', 'with', 'real', 'time', 'PCR', 'systems', 'required', 'for', 'qPCR', 'diagnostics', 'We', 'found', 'this', 'approach', 'allowed', 'sensitive', 'and', 'robust', 'detection', 'of', 'SARS', 'CoV', '2', 'positive', 'samples', 'with', 'a', 'sample', 'to', 'answer', 'time', 'of', '50', 'min', 'and', 'a', 'limit', 'of', 'detection', 'of', '2', 'copies', 'per', 'sample', 'CRISPR', 'assay', 'diagnostic', 'results', 'obtained', 'nasal', 'swab', 'samples', 'of', 'individuals', 'with', 'suspected', 'COVID', '19', 'cases', 'were', 'comparable', 'to', 'paired', 'results', 'from', 'a', 'CDC', 'approved', 'quantitative', 'RT', 'PCR', 'RT', 'qPCR', 'assay', 'performed', 'in', 'a', 'state', 'testing', 'lab', 'and', 'superior', 'to', 'those', 'produced', 'by', 'same', 'assay', 'in', 'a', 'clinical', 'lab', 'where', 'the', 'RT', 'qPCR', 'assay', 'exhibited', 'multiple', 'invalid', 'or', 'inconclusive', 'results', 'Our', 'assay', 'also', 'demonstrated', 'greater', 'analytical', 'sensitivity', 'and', 'more', 'robust', 'diagnostic', 'performance', 'than', 'other', 'recently', 'reported', 'CRISPR', 'based', 'assays', 'Based', 'on', 'these', 'findings', 'we', 'believe', 'that', 'a', 'CRISPR', 'based', 'fluorescent', 'application', 'has', 'potential', 'to', 'improve', 'current', 'COVID', '19', 'screening', 'efforts', '']"
102540,Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis,2020,Biosens Bioelectron,,"Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-throughput operation that can preferably utilize existing equipment to facilitate broad, large-scale screening efforts. We have developed a CRISPR-based assay that can meet all these criteria. This assay utilizes a custom CRISPR Cas12a/gRNA complex and a fluorescent probe to detect target amplicons produced by standard RT-PCR or isothermal recombinase polymerase amplification (RPA), to allow sensitive detection at sites not equipped with real-time PCR systems required for qPCR diagnostics. We found this approach allowed sensitive and robust detection of SARS-CoV-2 positive samples, with a sample-to-answer time of ~50 min, and a limit of detection of 2 copies per sample. CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved quantitative RT-PCR (RT-qPCR) assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the RT-qPCR assay exhibited multiple invalid or inconclusive results. Our assay also demonstrated greater analytical sensitivity and more robust diagnostic performance than other recently reported CRISPR-based assays. Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts.",,b5izy2tn,"['Recent', 'research', 'suggests', 'that', 'SARS', 'CoV', '2', 'infected', 'individuals', 'can', 'be', 'highly', 'infectious', 'while', 'asymptomatic', 'or', 'pre', 'symptomatic', 'and', 'that', 'an', 'infected', 'person', 'may', 'infect', '5', '6', 'other', 'individuals', 'on', 'average', 'This', 'situation', 'highlights', 'the', 'need', 'for', 'rapid', 'sensitive', 'SARS', 'CoV', '2', 'diagnostic', 'assays', 'capable', 'of', 'high', 'throughput', 'operation', 'that', 'can', 'preferably', 'utilize', 'existing', 'equipment', 'to', 'facilitate', 'broad', 'large', 'scale', 'screening', 'efforts', 'We', 'have', 'developed', 'a', 'CRISPR', 'based', 'assay', 'that', 'can', 'meet', 'all', 'these', 'criteria', 'This', 'assay', 'utilizes', 'a', 'custom', 'CRISPR', 'Cas12a', 'gRNA', 'complex', 'and', 'a', 'fluorescent', 'probe', 'to', 'detect', 'target', 'amplicons', 'produced', 'by', 'standard', 'RT', 'PCR', 'or', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'to', 'allow', 'sensitive', 'detection', 'at', 'sites', 'not', 'equipped', 'with', 'real', 'time', 'PCR', 'systems', 'required', 'for', 'qPCR', 'diagnostics', 'We', 'found', 'this', 'approach', 'allowed', 'sensitive', 'and', 'robust', 'detection', 'of', 'SARS', 'CoV', '2', 'positive', 'samples', 'with', 'a', 'sample', 'to', 'answer', 'time', 'of', '50', 'min', 'and', 'a', 'limit', 'of', 'detection', 'of', '2', 'copies', 'per', 'sample', 'CRISPR', 'assay', 'diagnostic', 'results', 'obtained', 'nasal', 'swab', 'samples', 'of', 'individuals', 'with', 'suspected', 'COVID', '19', 'cases', 'were', 'comparable', 'to', 'paired', 'results', 'from', 'a', 'CDC', 'approved', 'quantitative', 'RT', 'PCR', 'RT', 'qPCR', 'assay', 'performed', 'in', 'a', 'state', 'testing', 'lab', 'and', 'superior', 'to', 'those', 'produced', 'by', 'same', 'assay', 'in', 'a', 'clinical', 'lab', 'where', 'the', 'RT', 'qPCR', 'assay', 'exhibited', 'multiple', 'invalid', 'or', 'inconclusive', 'results', 'Our', 'assay', 'also', 'demonstrated', 'greater', 'analytical', 'sensitivity', 'and', 'more', 'robust', 'diagnostic', 'performance', 'than', 'other', 'recently', 'reported', 'CRISPR', 'based', 'assays', 'Based', 'on', 'these', 'findings', 'we', 'believe', 'that', 'a', 'CRISPR', 'based', 'fluorescent', 'application', 'has', 'potential', 'to', 'improve', 'current', 'COVID', '19', 'screening', 'efforts', '']"
104446,Pitfalls in SARS-CoV-2 PCR diagnostics,2020,,,"To combat the COVID-19 pandemic, millions of PCR tests are performed worldwide. Any deviation of the diagnostic sensitivity and specificity will reduce the predictive values of the test. Here, we report the occurrence of contaminations of commercial primers/probe sets with the SARS-CoV-2 target sequence of the RT-qPCR as an example for pitfalls during PCR diagnostics affecting diagnostic specificity. In several purchased in-house primers/probe sets, quantification cycle values as low as 17 were measured for negative control samples. However, there were also primers/probe sets that displayed very low-level contaminations, which were detected only during thorough internal validation. Hence, it appears imperative to pre-test each batch of reagents extensively before use in routine diagnosis, to avoid false-positive results and low positive predictive value in low-prevalence situations. As such, contaminations may have happened more widely, and COVID-19 diagnostic results should be re-assessed retrospectively to validate the epidemiological basis for control measures.",,zoqcr7gd,"['To', 'combat', 'the', 'COVID', '19', 'pandemic', 'millions', 'of', 'PCR', 'tests', 'are', 'performed', 'worldwide', 'Any', 'deviation', 'of', 'the', 'diagnostic', 'sensitivity', 'and', 'specificity', 'will', 'reduce', 'the', 'predictive', 'values', 'of', 'the', 'test', 'Here', 'we', 'report', 'the', 'occurrence', 'of', 'contaminations', 'of', 'commercial', 'primers', 'probe', 'sets', 'with', 'the', 'SARS', 'CoV', '2', 'target', 'sequence', 'of', 'the', 'RT', 'qPCR', 'as', 'an', 'example', 'for', 'pitfalls', 'during', 'PCR', 'diagnostics', 'affecting', 'diagnostic', 'specificity', 'In', 'several', 'purchased', 'in', 'house', 'primers', 'probe', 'sets', 'quantification', 'cycle', 'values', 'as', 'low', 'as', '17', 'were', 'measured', 'for', 'negative', 'control', 'samples', 'However', 'there', 'were', 'also', 'primers', 'probe', 'sets', 'that', 'displayed', 'very', 'low', 'level', 'contaminations', 'which', 'were', 'detected', 'only', 'during', 'thorough', 'internal', 'validation', 'Hence', 'it', 'appears', 'imperative', 'to', 'pre', 'test', 'each', 'batch', 'of', 'reagents', 'extensively', 'before', 'use', 'in', 'routine', 'diagnosis', 'to', 'avoid', 'false', 'positive', 'results', 'and', 'low', 'positive', 'predictive', 'value', 'in', 'low', 'prevalence', 'situations', 'As', 'such', 'contaminations', 'may', 'have', 'happened', 'more', 'widely', 'and', 'COVID', '19', 'diagnostic', 'results', 'should', 'be', 're', 'assessed', 'retrospectively', 'to', 'validate', 'the', 'epidemiological', 'basis', 'for', 'control', 'measures', '']"
104699,"Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines",2020,Biomed. j. (Mumbai.Online),,"The coronavirus disease 2019 (COVID-19) pandemic caused by a novel coronavirus, SARS-CoV-2, has infected more than 4.9 million individuals and resulted in over 300,000 deaths globally. The rapid spread of the virus and the precipitously increasing numbers of cases necessitate the urgent development of accurate diagnostic methods, effective treatments, and vaccines. Here, we review the progress of developing diagnostic methods, therapies, and vaccines for SARS-CoV-2 with a focus on current clinical trials and their challenges. For diagnosis, nucleic acid amplification tests remain the mainstay diagnostics for laboratory confirmation of SARS-CoV-2 infection, while serological antibody tests are used to aid contact tracing, epidemiological, and vaccine evaluation studies. Viral isolation is not recommended for routine diagnostic procedures due to safety concerns. Currently, no single effective drug or specific vaccine is available against SARS-CoV-2. Some candidate drugs targeting different levels and stages of human responses against COVID-19 such as cell membrane fusion, RNA-dependent RNA polymerase, viral protease inhibitor, interleukin 6 blocker, and convalescent plasma may improve the clinical outcomes of critical COVID-19 patients. Other supportive care measures for critical patients are still necessary. Advances in genetic sequencing and other technological developments have sped up the establishment of a variety of vaccine platforms. Accordingly, numerous vaccines are under development. Vaccine candidates against SARS-CoV-2 are mainly based upon the viral spike protein due to its vital role in viral infectivity, and most of these candidates have recently moved into clinical trials. Before the efficacy of such vaccines in humans is demonstrated, strong international coordination and collaboration among studies, pharmaceutical companies, regulators, and governments are needed to limit further damage due the emerging SARS-CoV-2 virus.",,2vevp0fg,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'infected', 'more', 'than', '4', '9', 'million', 'individuals', 'and', 'resulted', 'in', 'over', '300', '000', 'deaths', 'globally', 'The', 'rapid', 'spread', 'of', 'the', 'virus', 'and', 'the', 'precipitously', 'increasing', 'numbers', 'of', 'cases', 'necessitate', 'the', 'urgent', 'development', 'of', 'accurate', 'diagnostic', 'methods', 'effective', 'treatments', 'and', 'vaccines', 'Here', 'we', 'review', 'the', 'progress', 'of', 'developing', 'diagnostic', 'methods', 'therapies', 'and', 'vaccines', 'for', 'SARS', 'CoV', '2', 'with', 'a', 'focus', 'on', 'current', 'clinical', 'trials', 'and', 'their', 'challenges', 'For', 'diagnosis', 'nucleic', 'acid', 'amplification', 'tests', 'remain', 'the', 'mainstay', 'diagnostics', 'for', 'laboratory', 'confirmation', 'of', 'SARS', 'CoV', '2', 'infection', 'while', 'serological', 'antibody', 'tests', 'are', 'used', 'to', 'aid', 'contact', 'tracing', 'epidemiological', 'and', 'vaccine', 'evaluation', 'studies', 'Viral', 'isolation', 'is', 'not', 'recommended', 'for', 'routine', 'diagnostic', 'procedures', 'due', 'to', 'safety', 'concerns', 'Currently', 'no', 'single', 'effective', 'drug', 'or', 'specific', 'vaccine', 'is', 'available', 'against', 'SARS', 'CoV', '2', 'Some', 'candidate', 'drugs', 'targeting', 'different', 'levels', 'and', 'stages', 'of', 'human', 'responses', 'against', 'COVID', '19', 'such', 'as', 'cell', 'membrane', 'fusion', 'RNA', 'dependent', 'RNA', 'polymerase', 'viral', 'protease', 'inhibitor', 'interleukin', '6', 'blocker', 'and', 'convalescent', 'plasma', 'may', 'improve', 'the', 'clinical', 'outcomes', 'of', 'critical', 'COVID', '19', 'patients', 'Other', 'supportive', 'care', 'measures', 'for', 'critical', 'patients', 'are', 'still', 'necessary', 'Advances', 'in', 'genetic', 'sequencing', 'and', 'other', 'technological', 'developments', 'have', 'sped', 'up', 'the', 'establishment', 'of', 'a', 'variety', 'of', 'vaccine', 'platforms', 'Accordingly', 'numerous', 'vaccines', 'are', 'under', 'development', 'Vaccine', 'candidates', 'against', 'SARS', 'CoV', '2', 'are', 'mainly', 'based', 'upon', 'the', 'viral', 'spike', 'protein', 'due', 'to', 'its', 'vital', 'role', 'in', 'viral', 'infectivity', 'and', 'most', 'of', 'these', 'candidates', 'have', 'recently', 'moved', 'into', 'clinical', 'trials', 'Before', 'the', 'efficacy', 'of', 'such', 'vaccines', 'in', 'humans', 'is', 'demonstrated', 'strong', 'international', 'coordination', 'and', 'collaboration', 'among', 'studies', 'pharmaceutical', 'companies', 'regulators', 'and', 'governments', 'are', 'needed', 'to', 'limit', 'further', 'damage', 'due', 'the', 'emerging', 'SARS', 'CoV', '2', 'virus', '']"
105644,"Clinical display, diagnostics and genetic implication of novel Coronavirus (COVID-19) epidemic",2020,Eur Rev Med Pharmacol Sci,,"COVID-19 pandemic can cause irreparable damage to the involved society. This study aimed to provide a summary of the up-to-dated clinical display, diagnostics, molecular and genetic implications for COVID-19 infected patients. In this review, 73 research articles published before 25 March 2020 were analyzed to better understand the clinical characteristics of patients and to introduce the available serological, hematology and molecular diagnostic methods. Apart from articles extracted from PubMed and Google Scholar, WHO (https://www.who.int/), NHC (National Health Commission of the People's Republic of China (http://www.nhc.gov.cn/), NICE (National Institute for Health and Clinical Excellence, https://www.nice.org.uk/), CDC (Centers for Disease Control and Prevention, https://www.cdc.gov/), and National Administration of Traditional Chinese Medicine (http://www.satcm.gov.cn/) were also accessed to search for eligible studies. Papers published between January 1, 2020, and 25 March 2020 were searched in English and the terms ""2019-nCoV, Covid-19, Clinical Characteristics OR manifestation, method of detection, COVID-19 Genome and molecular test"" were used. As the pandemic continues to evolve, there have been reports about the possibility of asymptomatic transmission of this newly emerged pneumonia virus. We highlighted the role of HLA haplotype in virus infection as HLA typing will provide susceptibility information for personalized prevention, diagnosis, and treatment in future studies. All the data in this article will assist researchers and clinicians to develop their clinical views regarding infected patients and to emphasize the origin of SARS-CoV-2 for diagnostics.",,nz95gp0s,"['COVID', '19', 'pandemic', 'can', 'cause', 'irreparable', 'damage', 'to', 'the', 'involved', 'society', 'This', 'study', 'aimed', 'to', 'provide', 'a', 'summary', 'of', 'the', 'up', 'to', 'dated', 'clinical', 'display', 'diagnostics', 'molecular', 'and', 'genetic', 'implications', 'for', 'COVID', '19', 'infected', 'patients', 'In', 'this', 'review', '73', 'research', 'articles', 'published', 'before', '25', 'March', '2020', 'were', 'analyzed', 'to', 'better', 'understand', 'the', 'clinical', 'characteristics', 'of', 'patients', 'and', 'to', 'introduce', 'the', 'available', 'serological', 'hematology', 'and', 'molecular', 'diagnostic', 'methods', 'Apart', 'from', 'articles', 'extracted', 'from', 'PubMed', 'and', 'Google', 'Scholar', 'WHO', 'https', 'www', 'who', 'int', 'NHC', 'National', 'Health', 'Commission', 'of', 'the', 'People', 's', 'Republic', 'of', 'China', 'http', 'www', 'nhc', 'gov', 'cn', 'NICE', 'National', 'Institute', 'for', 'Health', 'and', 'Clinical', 'Excellence', 'https', 'www', 'nice', 'org', 'uk', 'CDC', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'https', 'www', 'cdc', 'gov', 'and', 'National', 'Administration', 'of', 'Traditional', 'Chinese', 'Medicine', 'http', 'www', 'satcm', 'gov', 'cn', 'were', 'also', 'accessed', 'to', 'search', 'for', 'eligible', 'studies', 'Papers', 'published', 'between', 'January', '1', '2020', 'and', '25', 'March', '2020', 'were', 'searched', 'in', 'English', 'and', 'the', 'terms', '2019', 'nCoV', 'Covid', '19', 'Clinical', 'Characteristics', 'OR', 'manifestation', 'method', 'of', 'detection', 'COVID', '19', 'Genome', 'and', 'molecular', 'test', 'were', 'used', 'As', 'the', 'pandemic', 'continues', 'to', 'evolve', 'there', 'have', 'been', 'reports', 'about', 'the', 'possibility', 'of', 'asymptomatic', 'transmission', 'of', 'this', 'newly', 'emerged', 'pneumonia', 'virus', 'We', 'highlighted', 'the', 'role', 'of', 'HLA', 'haplotype', 'in', 'virus', 'infection', 'as', 'HLA', 'typing', 'will', 'provide', 'susceptibility', 'information', 'for', 'personalized', 'prevention', 'diagnosis', 'and', 'treatment', 'in', 'future', 'studies', 'All', 'the', 'data', 'in', 'this', 'article', 'will', 'assist', 'researchers', 'and', 'clinicians', 'to', 'develop', 'their', 'clinical', 'views', 'regarding', 'infected', 'patients', 'and', 'to', 'emphasize', 'the', 'origin', 'of', 'SARS', 'CoV', '2', 'for', 'diagnostics', '']"
105645,"Clinical display, diagnostics and genetic implication of novel Coronavirus (COVID-19) epidemic",2020,Eur Rev Med Pharmacol Sci,,"COVID-19 pandemic can cause irreparable damage to the involved society. This study aimed to provide a summary of the up-to-dated clinical display, diagnostics, molecular and genetic implications for COVID-19 infected patients. In this review, 73 research articles published before 25 March 2020 were analyzed to better understand the clinical characteristics of patients and to introduce the available serological, hematology and molecular diagnostic methods. Apart from articles extracted from PubMed and Google Scholar, WHO (https://www.who.int/), NHC (National Health Commission of the People's Republic of China (http://www.nhc.gov.cn/), NICE (National Institute for Health and Clinical Excellence, https://www.nice.org.uk/), CDC (Centers for Disease Control and Prevention, https://www.cdc.gov/), and National Administration of Traditional Chinese Medicine (http://www.satcm.gov.cn/) were also accessed to search for eligible studies. Papers published between January 1, 2020, and 25 March 2020 were searched in English and the terms ""2019-nCoV, Covid-19, Clinical Characteristics OR manifestation, method of detection, COVID-19 Genome and molecular test"" were used. As the pandemic continues to evolve, there have been reports about the possibility of asymptomatic transmission of this newly emerged pneumonia virus. We highlighted the role of HLA haplotype in virus infection as HLA typing will provide susceptibility information for personalized prevention, diagnosis, and treatment in future studies. All the data in this article will assist researchers and clinicians to develop their clinical views regarding infected patients and to emphasize the origin of SARS-CoV-2 for diagnostics.",,29skis2m,"['COVID', '19', 'pandemic', 'can', 'cause', 'irreparable', 'damage', 'to', 'the', 'involved', 'society', 'This', 'study', 'aimed', 'to', 'provide', 'a', 'summary', 'of', 'the', 'up', 'to', 'dated', 'clinical', 'display', 'diagnostics', 'molecular', 'and', 'genetic', 'implications', 'for', 'COVID', '19', 'infected', 'patients', 'In', 'this', 'review', '73', 'research', 'articles', 'published', 'before', '25', 'March', '2020', 'were', 'analyzed', 'to', 'better', 'understand', 'the', 'clinical', 'characteristics', 'of', 'patients', 'and', 'to', 'introduce', 'the', 'available', 'serological', 'hematology', 'and', 'molecular', 'diagnostic', 'methods', 'Apart', 'from', 'articles', 'extracted', 'from', 'PubMed', 'and', 'Google', 'Scholar', 'WHO', 'https', 'www', 'who', 'int', 'NHC', 'National', 'Health', 'Commission', 'of', 'the', 'People', 's', 'Republic', 'of', 'China', 'http', 'www', 'nhc', 'gov', 'cn', 'NICE', 'National', 'Institute', 'for', 'Health', 'and', 'Clinical', 'Excellence', 'https', 'www', 'nice', 'org', 'uk', 'CDC', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'https', 'www', 'cdc', 'gov', 'and', 'National', 'Administration', 'of', 'Traditional', 'Chinese', 'Medicine', 'http', 'www', 'satcm', 'gov', 'cn', 'were', 'also', 'accessed', 'to', 'search', 'for', 'eligible', 'studies', 'Papers', 'published', 'between', 'January', '1', '2020', 'and', '25', 'March', '2020', 'were', 'searched', 'in', 'English', 'and', 'the', 'terms', '2019', 'nCoV', 'Covid', '19', 'Clinical', 'Characteristics', 'OR', 'manifestation', 'method', 'of', 'detection', 'COVID', '19', 'Genome', 'and', 'molecular', 'test', 'were', 'used', 'As', 'the', 'pandemic', 'continues', 'to', 'evolve', 'there', 'have', 'been', 'reports', 'about', 'the', 'possibility', 'of', 'asymptomatic', 'transmission', 'of', 'this', 'newly', 'emerged', 'pneumonia', 'virus', 'We', 'highlighted', 'the', 'role', 'of', 'HLA', 'haplotype', 'in', 'virus', 'infection', 'as', 'HLA', 'typing', 'will', 'provide', 'susceptibility', 'information', 'for', 'personalized', 'prevention', 'diagnosis', 'and', 'treatment', 'in', 'future', 'studies', 'All', 'the', 'data', 'in', 'this', 'article', 'will', 'assist', 'researchers', 'and', 'clinicians', 'to', 'develop', 'their', 'clinical', 'views', 'regarding', 'infected', 'patients', 'and', 'to', 'emphasize', 'the', 'origin', 'of', 'SARS', 'CoV', '2', 'for', 'diagnostics', '']"
106203,COVID-19 pandemic-a focused review for clinicians,2020,Clin Microbiol Infect,,"BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019, and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. OBJECTIVES: Here we provide an update for clinicians on the recent developments in the virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. SOURCES: We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. CONTENT: We describe the virological characteristics of SARS-CoV-2 and the clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. IMPLICATIONS: The key challenge in managing COVID-19 remains patient density. However, accurate diagnosis as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",,f33f0868,"['BACKGROUND', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'OBJECTIVES', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'in', 'the', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'SOURCES', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'CONTENT', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'the', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'IMPLICATIONS', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'patient', 'density', 'However', 'accurate', 'diagnosis', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
106232,SARS-CoV-2 antibody testing-questions to be asked,2020,J Allergy Clin Immunol,,"Severe acute respiratory syndrome coronavirus 2 infection and development of coronavirus disease 2019 presents a major health care challenge of global dimensions. Laboratory diagnostics of infected patients, and the assessment of immunity against severe acute respiratory syndrome coronavirus 2, presents a major cornerstone in handling the pandemic. Currently, there is an increase in demand for antibody testing and a large number of tests are already marketed or are in the late stage of development. However, the interpretation of test results depends on many variables and factors, including sensitivity, specificity, potential cross-reactivity and cross-protectivity, the diagnostic value of antibodies of different isotypes, and the use of antibody testing in identification of acutely ill patients or in epidemiological settings. In this article, the recently established COVID-19 Task Force of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) addresses these issues on the basis of currently available data sets in this rapidly moving field.",,laobflfb,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'infection', 'and', 'development', 'of', 'coronavirus', 'disease', '2019', 'presents', 'a', 'major', 'health', 'care', 'challenge', 'of', 'global', 'dimensions', 'Laboratory', 'diagnostics', 'of', 'infected', 'patients', 'and', 'the', 'assessment', 'of', 'immunity', 'against', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'presents', 'a', 'major', 'cornerstone', 'in', 'handling', 'the', 'pandemic', 'Currently', 'there', 'is', 'an', 'increase', 'in', 'demand', 'for', 'antibody', 'testing', 'and', 'a', 'large', 'number', 'of', 'tests', 'are', 'already', 'marketed', 'or', 'are', 'in', 'the', 'late', 'stage', 'of', 'development', 'However', 'the', 'interpretation', 'of', 'test', 'results', 'depends', 'on', 'many', 'variables', 'and', 'factors', 'including', 'sensitivity', 'specificity', 'potential', 'cross', 'reactivity', 'and', 'cross', 'protectivity', 'the', 'diagnostic', 'value', 'of', 'antibodies', 'of', 'different', 'isotypes', 'and', 'the', 'use', 'of', 'antibody', 'testing', 'in', 'identification', 'of', 'acutely', 'ill', 'patients', 'or', 'in', 'epidemiological', 'settings', 'In', 'this', 'article', 'the', 'recently', 'established', 'COVID', '19', 'Task', 'Force', 'of', 'the', 'German', 'Society', 'for', 'Clinical', 'Chemistry', 'and', 'Laboratory', 'Medicine', 'DGKL', 'addresses', 'these', 'issues', 'on', 'the', 'basis', 'of', 'currently', 'available', 'data', 'sets', 'in', 'this', 'rapidly', 'moving', 'field', '']"
107264,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020,,,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",,d08pnq1u,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
107265,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020,,,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",,2svdhayy,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
108046,Enhancing colorimetric loop-mediated isothermal amplification speed and sensitivity with guanidine chloride,2020,Biotechniques,,"Loop-mediated isothermal amplification (LAMP) is a versatile technique for detection of target DNA and RNA, enabling rapid molecular diagnostic assays with minimal equipment. The global SARS-CoV-2 pandemic has presented an urgent need for new and better diagnostic methods, with colorimetric LAMP utilized in numerous studies for SARS-CoV-2 detection. However, the sensitivity of colorimetric LAMP in early reports has been below that of the standard RT-qPCR tests, and we sought to improve performance. Here we report the use of guanidine hydrochloride and combined primer sets to increase speed and sensitivity in colorimetric LAMP, bringing this simple method up to the standards of sophisticated techniques and enabling accurate, high-throughput diagnostics.",,rxt90elc,"['Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'a', 'versatile', 'technique', 'for', 'detection', 'of', 'target', 'DNA', 'and', 'RNA', 'enabling', 'rapid', 'molecular', 'diagnostic', 'assays', 'with', 'minimal', 'equipment', 'The', 'global', 'SARS', 'CoV', '2', 'pandemic', 'has', 'presented', 'an', 'urgent', 'need', 'for', 'new', 'and', 'better', 'diagnostic', 'methods', 'with', 'colorimetric', 'LAMP', 'utilized', 'in', 'numerous', 'studies', 'for', 'SARS', 'CoV', '2', 'detection', 'However', 'the', 'sensitivity', 'of', 'colorimetric', 'LAMP', 'in', 'early', 'reports', 'has', 'been', 'below', 'that', 'of', 'the', 'standard', 'RT', 'qPCR', 'tests', 'and', 'we', 'sought', 'to', 'improve', 'performance', 'Here', 'we', 'report', 'the', 'use', 'of', 'guanidine', 'hydrochloride', 'and', 'combined', 'primer', 'sets', 'to', 'increase', 'speed', 'and', 'sensitivity', 'in', 'colorimetric', 'LAMP', 'bringing', 'this', 'simple', 'method', 'up', 'to', 'the', 'standards', 'of', 'sophisticated', 'techniques', 'and', 'enabling', 'accurate', 'high', 'throughput', 'diagnostics', '']"
109228,Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination,2020,Emerg Infect Dis,,"The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries.",,xa5iy0ra,"['The', 'emergence', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'created', 'an', 'exceptional', 'situation', 'in', 'which', 'numerous', 'laboratories', 'in', 'Europe', 'simultaneously', 'implemented', 'SARS', 'CoV', '2', 'diagnostics', 'These', 'laboratories', 'reported', 'in', 'February', '2020', 'that', 'commercial', 'primer', 'and', 'probe', 'batches', 'for', 'SARS', 'CoV', '2', 'detection', 'were', 'contaminated', 'with', 'synthetic', 'control', 'material', 'causing', 'delays', 'of', 'regional', 'testing', 'roll', 'out', 'in', 'various', 'countries', '']"
109581,Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?,2020,Cell Immunol,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a severe acute respiratory syndrome that is called COVID-19. Clinical manifestations of COVID-19 include diarrhea, pneumonia, lymphopenia, exhausted lymphocytes, and pro-inflammatory cytokine production. Immunology is part of the process of clinical evolution, but there are some questions around immunity-based protection: (1) why some infected people have only mild symptoms of the disease or are asymptomatic; (2) why delayed and weak antibody responses are associated with severe outcomes; and (3) why positivity in molecular tests does not represent protective antibody IgG. Perhaps T cell responses may be the key to solving those questions. SARS-CoV-2-specific memory T cells persist in peripheral blood and may be capable of providing effective information about protective immunity. The T cells studies can be helpful in elucidating the pathways for development of vaccines, therapies, and diagnostics for COVID-19 and for filling these immunology knowledge gaps.",,rs79r7kc,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'induces', 'a', 'severe', 'acute', 'respiratory', 'syndrome', 'that', 'is', 'called', 'COVID', '19', 'Clinical', 'manifestations', 'of', 'COVID', '19', 'include', 'diarrhea', 'pneumonia', 'lymphopenia', 'exhausted', 'lymphocytes', 'and', 'pro', 'inflammatory', 'cytokine', 'production', 'Immunology', 'is', 'part', 'of', 'the', 'process', 'of', 'clinical', 'evolution', 'but', 'there', 'are', 'some', 'questions', 'around', 'immunity', 'based', 'protection', '1', 'why', 'some', 'infected', 'people', 'have', 'only', 'mild', 'symptoms', 'of', 'the', 'disease', 'or', 'are', 'asymptomatic', '2', 'why', 'delayed', 'and', 'weak', 'antibody', 'responses', 'are', 'associated', 'with', 'severe', 'outcomes', 'and', '3', 'why', 'positivity', 'in', 'molecular', 'tests', 'does', 'not', 'represent', 'protective', 'antibody', 'IgG', 'Perhaps', 'T', 'cell', 'responses', 'may', 'be', 'the', 'key', 'to', 'solving', 'those', 'questions', 'SARS', 'CoV', '2', 'specific', 'memory', 'T', 'cells', 'persist', 'in', 'peripheral', 'blood', 'and', 'may', 'be', 'capable', 'of', 'providing', 'effective', 'information', 'about', 'protective', 'immunity', 'The', 'T', 'cells', 'studies', 'can', 'be', 'helpful', 'in', 'elucidating', 'the', 'pathways', 'for', 'development', 'of', 'vaccines', 'therapies', 'and', 'diagnostics', 'for', 'COVID', '19', 'and', 'for', 'filling', 'these', 'immunology', 'knowledge', 'gaps', '']"
109624,Trends and Innovations in Biosensors for COVID-19 Mass Testing,2020,Chembiochem,,"Fast and widespread diagnosis is crucial to fighting against the outbreak of COVID-19. This work surveys the landscape of available and emerging biosensor technologies for COVID-19 testing. Molecular diagnostic assays based on quantitative reverse transcription polymerase chain reaction are used in most clinical laboratories. However, the COVID-19 pandemic has overwhelmed testing capacity and motivated the development of fast point-of-care tests and the adoption of isothermal DNA amplification. Antigenic and serological rapid tests based on lateral-flow immunoassays suffer from low sensitivity. Advanced digital systems enhance performance at the expense of speed and the need for large equipment. Emerging technologies, including CRISPR gene-editing tools, benefit from high sensitivity and specificity of molecular diagnostics and the easy use of lateral-flow assays. DNA sequencing and sample pooling strategies are highlighted to bring out the full capacity of the available biosensor technologies and accelerate mass testing.",,d5d10lwr,"['Fast', 'and', 'widespread', 'diagnosis', 'is', 'crucial', 'to', 'fighting', 'against', 'the', 'outbreak', 'of', 'COVID', '19', 'This', 'work', 'surveys', 'the', 'landscape', 'of', 'available', 'and', 'emerging', 'biosensor', 'technologies', 'for', 'COVID', '19', 'testing', 'Molecular', 'diagnostic', 'assays', 'based', 'on', 'quantitative', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'are', 'used', 'in', 'most', 'clinical', 'laboratories', 'However', 'the', 'COVID', '19', 'pandemic', 'has', 'overwhelmed', 'testing', 'capacity', 'and', 'motivated', 'the', 'development', 'of', 'fast', 'point', 'of', 'care', 'tests', 'and', 'the', 'adoption', 'of', 'isothermal', 'DNA', 'amplification', 'Antigenic', 'and', 'serological', 'rapid', 'tests', 'based', 'on', 'lateral', 'flow', 'immunoassays', 'suffer', 'from', 'low', 'sensitivity', 'Advanced', 'digital', 'systems', 'enhance', 'performance', 'at', 'the', 'expense', 'of', 'speed', 'and', 'the', 'need', 'for', 'large', 'equipment', 'Emerging', 'technologies', 'including', 'CRISPR', 'gene', 'editing', 'tools', 'benefit', 'from', 'high', 'sensitivity', 'and', 'specificity', 'of', 'molecular', 'diagnostics', 'and', 'the', 'easy', 'use', 'of', 'lateral', 'flow', 'assays', 'DNA', 'sequencing', 'and', 'sample', 'pooling', 'strategies', 'are', 'highlighted', 'to', 'bring', 'out', 'the', 'full', 'capacity', 'of', 'the', 'available', 'biosensor', 'technologies', 'and', 'accelerate', 'mass', 'testing', '']"
110168,Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG,2020,J Clin Virol,,"BACKGROUND: Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). STUDY DESIGN: Our study is the first to compare four new commercially available assays using 75 sera from patients tested positive or negative by SARS-CoV-2 PCR: the anti SARS-CoV-2 ELISA (IgG) (Euroimmun, Germany), the EDI New Coronavirus COVID-19 IgG ELISA, (Epitope diagnostics (EDI), USA), the recomWell SARS-CoV-2 IgG ELISA (Mikrogen, Germany), and the SARS-CoV-2 Virachip IgG (Viramed, Germany). RESULTS: We found a sensitivity of 86.4 %, 100 %, 86.4 %, and 77.3 % and a specificity of 96,2 %, 88,7 %, 100 %, and 100 % for the Euroimmun assay, the EDI assay, the Mikrogen assay, and the Viramed assay, respectively. CONCLUSIONS: Commercially available SARS-CoV-2 IgG assays have a sufficient specificity and sensitivity for identifying individuals with past SARS-CoV-2 infection.",,7e79o2gy,"['BACKGROUND', 'Facing', 'the', 'ongoing', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'there', 'is', 'an', 'urgent', 'need', 'for', 'serological', 'assays', 'identifying', 'individuals', 'with', 'past', 'coronavirus', 'disease', '2019', 'COVID', '19', 'STUDY', 'DESIGN', 'Our', 'study', 'is', 'the', 'first', 'to', 'compare', 'four', 'new', 'commercially', 'available', 'assays', 'using', '75', 'sera', 'from', 'patients', 'tested', 'positive', 'or', 'negative', 'by', 'SARS', 'CoV', '2', 'PCR', 'the', 'anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Euroimmun', 'Germany', 'the', 'EDI', 'New', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Epitope', 'diagnostics', 'EDI', 'USA', 'the', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'ELISA', 'Mikrogen', 'Germany', 'and', 'the', 'SARS', 'CoV', '2', 'Virachip', 'IgG', 'Viramed', 'Germany', 'RESULTS', 'We', 'found', 'a', 'sensitivity', 'of', '86', '4', '100', '86', '4', 'and', '77', '3', 'and', 'a', 'specificity', 'of', '96', '2', '88', '7', '100', 'and', '100', 'for', 'the', 'Euroimmun', 'assay', 'the', 'EDI', 'assay', 'the', 'Mikrogen', 'assay', 'and', 'the', 'Viramed', 'assay', 'respectively', 'CONCLUSIONS', 'Commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'assays', 'have', 'a', 'sufficient', 'specificity', 'and', 'sensitivity', 'for', 'identifying', 'individuals', 'with', 'past', 'SARS', 'CoV', '2', 'infection', '']"
110169,Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG,2020,J Clin Virol,,"BACKGROUND: Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). STUDY DESIGN: Our study is the first to compare four new commercially available assays using 75 sera from patients tested positive or negative by SARS-CoV-2 PCR: the anti SARS-CoV-2 ELISA (IgG) (Euroimmun, Germany), the EDI New Coronavirus COVID-19 IgG ELISA, (Epitope diagnostics (EDI), USA), the recomWell SARS-CoV-2 IgG ELISA (Mikrogen, Germany), and the SARS-CoV-2 Virachip IgG (Viramed, Germany). RESULTS: We found a sensitivity of 86.4 %, 100 %, 86.4 %, and 77.3 % and a specificity of 96,2 %, 88,7 %, 100 %, and 100 % for the Euroimmun assay, the EDI assay, the Mikrogen assay, and the Viramed assay, respectively. CONCLUSIONS: Commercially available SARS-CoV-2 IgG assays have a sufficient specificity and sensitivity for identifying individuals with past SARS-CoV-2 infection.",,856mfbkb,"['BACKGROUND', 'Facing', 'the', 'ongoing', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'there', 'is', 'an', 'urgent', 'need', 'for', 'serological', 'assays', 'identifying', 'individuals', 'with', 'past', 'coronavirus', 'disease', '2019', 'COVID', '19', 'STUDY', 'DESIGN', 'Our', 'study', 'is', 'the', 'first', 'to', 'compare', 'four', 'new', 'commercially', 'available', 'assays', 'using', '75', 'sera', 'from', 'patients', 'tested', 'positive', 'or', 'negative', 'by', 'SARS', 'CoV', '2', 'PCR', 'the', 'anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Euroimmun', 'Germany', 'the', 'EDI', 'New', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Epitope', 'diagnostics', 'EDI', 'USA', 'the', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'ELISA', 'Mikrogen', 'Germany', 'and', 'the', 'SARS', 'CoV', '2', 'Virachip', 'IgG', 'Viramed', 'Germany', 'RESULTS', 'We', 'found', 'a', 'sensitivity', 'of', '86', '4', '100', '86', '4', 'and', '77', '3', 'and', 'a', 'specificity', 'of', '96', '2', '88', '7', '100', 'and', '100', 'for', 'the', 'Euroimmun', 'assay', 'the', 'EDI', 'assay', 'the', 'Mikrogen', 'assay', 'and', 'the', 'Viramed', 'assay', 'respectively', 'CONCLUSIONS', 'Commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'assays', 'have', 'a', 'sufficient', 'specificity', 'and', 'sensitivity', 'for', 'identifying', 'individuals', 'with', 'past', 'SARS', 'CoV', '2', 'infection', '']"
111023,Technologies to Optimize the Care of Severe COVID-19 Patients for Health Care Providers Challenged by Limited Resources,2020,Anesth Analg,,"Health care systems are belligerently responding to the new coronavirus disease 2019 (COVID-19). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a specific condition, whose distinctive features are severe hypoxemia associated with (>50% of cases) normal respiratory system compliance. When a patient requires intubation and invasive ventilation, the outcome is poor, and the length of stay in the intensive care unit (ICU) is usually 2 or 3 weeks. In this article, the authors review several technological devices, which could support health care providers at the bedside to optimize the care for COVID-19 patients who are sedated, paralyzed, and ventilated. Particular attention is provided to the use of videolaryngoscopes (VL) because these can assist anesthetists to perform a successful intubation outside the ICU while protecting health care providers from this viral infection. Authors will also review processed electroencephalographic (EEG) monitors which are used to better titrate sedation and the train-of-four monitors which are utilized to better administer neuromuscular blocking agents in the view of sparing limited pharmacological resources. COVID-19 can rapidly exhaust human and technological resources too within the ICU. This review features a series of technological advancements that can significantly improve the care of patients requiring isolation. The working conditions in isolation could cause gaps or barriers in communication, fatigue, and poor documentation of provided care. The available technology has several advantages including (a) facilitating appropriate paperless documentation and communication between all health care givers working in isolation rooms or large isolation areas; (b) testing patients and staff at the bedside using smart point-of-care diagnostics (SPOCD) to confirm COVID-19 infection; (c) allowing diagnostics and treatment at the bedside through point-of-care ultrasound (POCUS) and thromboelastography (TEG); (d) adapting the use of anesthetic machines and the use of volatile anesthetics. Implementing technologies for safeguarding health care providers as well as monitoring the limited pharmacological resources are paramount. Only by leveraging new technologies, it will be possible to sustain and support health care systems during the expected long course of this pandemic.",,9lromyuz,"['Health', 'care', 'systems', 'are', 'belligerently', 'responding', 'to', 'the', 'new', 'coronavirus', 'disease', '2019', 'COVID', '19', 'The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'specific', 'condition', 'whose', 'distinctive', 'features', 'are', 'severe', 'hypoxemia', 'associated', 'with', '50', 'of', 'cases', 'normal', 'respiratory', 'system', 'compliance', 'When', 'a', 'patient', 'requires', 'intubation', 'and', 'invasive', 'ventilation', 'the', 'outcome', 'is', 'poor', 'and', 'the', 'length', 'of', 'stay', 'in', 'the', 'intensive', 'care', 'unit', 'ICU', 'is', 'usually', '2', 'or', '3', 'weeks', 'In', 'this', 'article', 'the', 'authors', 'review', 'several', 'technological', 'devices', 'which', 'could', 'support', 'health', 'care', 'providers', 'at', 'the', 'bedside', 'to', 'optimize', 'the', 'care', 'for', 'COVID', '19', 'patients', 'who', 'are', 'sedated', 'paralyzed', 'and', 'ventilated', 'Particular', 'attention', 'is', 'provided', 'to', 'the', 'use', 'of', 'videolaryngoscopes', 'VL', 'because', 'these', 'can', 'assist', 'anesthetists', 'to', 'perform', 'a', 'successful', 'intubation', 'outside', 'the', 'ICU', 'while', 'protecting', 'health', 'care', 'providers', 'from', 'this', 'viral', 'infection', 'Authors', 'will', 'also', 'review', 'processed', 'electroencephalographic', 'EEG', 'monitors', 'which', 'are', 'used', 'to', 'better', 'titrate', 'sedation', 'and', 'the', 'train', 'of', 'four', 'monitors', 'which', 'are', 'utilized', 'to', 'better', 'administer', 'neuromuscular', 'blocking', 'agents', 'in', 'the', 'view', 'of', 'sparing', 'limited', 'pharmacological', 'resources', 'COVID', '19', 'can', 'rapidly', 'exhaust', 'human', 'and', 'technological', 'resources', 'too', 'within', 'the', 'ICU', 'This', 'review', 'features', 'a', 'series', 'of', 'technological', 'advancements', 'that', 'can', 'significantly', 'improve', 'the', 'care', 'of', 'patients', 'requiring', 'isolation', 'The', 'working', 'conditions', 'in', 'isolation', 'could', 'cause', 'gaps', 'or', 'barriers', 'in', 'communication', 'fatigue', 'and', 'poor', 'documentation', 'of', 'provided', 'care', 'The', 'available', 'technology', 'has', 'several', 'advantages', 'including', 'a', 'facilitating', 'appropriate', 'paperless', 'documentation', 'and', 'communication', 'between', 'all', 'health', 'care', 'givers', 'working', 'in', 'isolation', 'rooms', 'or', 'large', 'isolation', 'areas', 'b', 'testing', 'patients', 'and', 'staff', 'at', 'the', 'bedside', 'using', 'smart', 'point', 'of', 'care', 'diagnostics', 'SPOCD', 'to', 'confirm', 'COVID', '19', 'infection', 'c', 'allowing', 'diagnostics', 'and', 'treatment', 'at', 'the', 'bedside', 'through', 'point', 'of', 'care', 'ultrasound', 'POCUS', 'and', 'thromboelastography', 'TEG', 'd', 'adapting', 'the', 'use', 'of', 'anesthetic', 'machines', 'and', 'the', 'use', 'of', 'volatile', 'anesthetics', 'Implementing', 'technologies', 'for', 'safeguarding', 'health', 'care', 'providers', 'as', 'well', 'as', 'monitoring', 'the', 'limited', 'pharmacological', 'resources', 'are', 'paramount', 'Only', 'by', 'leveraging', 'new', 'technologies', 'it', 'will', 'be', 'possible', 'to', 'sustain', 'and', 'support', 'health', 'care', 'systems', 'during', 'the', 'expected', 'long', 'course', 'of', 'this', 'pandemic', '']"
111024,Technologies to optimize the care of severe COVID-19 patients for healthcare providers challenged by limited resources,2020,,,"Healthcare systems are belligerently responding to the new Coronavirus Disease 2019 (COVID-19). The severe acute respiratory syndrome (SARS co-V2) is a specific condition, whose distinctive features are severe hypoxemia associated with (>50% of cases) normal respiratory system compliance. When a patient requires intubation and invasive ventilation the outcome is poor and the length of stay in the intensive care unit (ICU) is usually two or three weeks. In this manuscript, authors will review several technological devices, which could support healthcare providers at the bedside to optimise the care for COVID-19 patients who are sedated, paralysed and ventilated. Particular attention is provided to the use of video-laryngoscopes (VL) because these can assist anaesthetists to perform a successful intubation outside the ICU while protecting healthcare providers from this viral infection. Authors will also review processed electroencephalographic (EEG) monitors which are used to better titrate sedation and the train of four monitors which are utilised to better titrate neuromuscular blocking agents in the view of sparing limited pharmacological resources. COVID-19 can rapidly exhaust human and technological resources too within the ICU. This review features a series of technological advancements that can significantly improve the care of patients requiring isolation. The working conditions in isolation could cause gaps or barriers in communication, fatigue and poor documentation of provided care. The available technology has several advantages including: a) facilitating appropriate paperless documentation and communication between all healthcare givers working in isolation rooms or large isolation areas; b) testing patients and staff at the bedside using smart point of care diagnostics (SPOCD) to confirm COVID-19 infection; c) allowing diagnostics and treatment at the bedside through point of care ultrasound (POCUS) and Thromboelastography (TEG); d) adapting the use of anaesthetic machines and the use of volatile anaesthetics. Implementing technologies for safeguarding healthcare providers as well as monitoring the limited pharmacological resources is paramount. Only by leveraging new technologies it will be possible to sustain and support healthcare systems during the expected long course of this pandemic.",,gfq7u8n3,"['Healthcare', 'systems', 'are', 'belligerently', 'responding', 'to', 'the', 'new', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'The', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'co', 'V2', 'is', 'a', 'specific', 'condition', 'whose', 'distinctive', 'features', 'are', 'severe', 'hypoxemia', 'associated', 'with', '50', 'of', 'cases', 'normal', 'respiratory', 'system', 'compliance', 'When', 'a', 'patient', 'requires', 'intubation', 'and', 'invasive', 'ventilation', 'the', 'outcome', 'is', 'poor', 'and', 'the', 'length', 'of', 'stay', 'in', 'the', 'intensive', 'care', 'unit', 'ICU', 'is', 'usually', 'two', 'or', 'three', 'weeks', 'In', 'this', 'manuscript', 'authors', 'will', 'review', 'several', 'technological', 'devices', 'which', 'could', 'support', 'healthcare', 'providers', 'at', 'the', 'bedside', 'to', 'optimise', 'the', 'care', 'for', 'COVID', '19', 'patients', 'who', 'are', 'sedated', 'paralysed', 'and', 'ventilated', 'Particular', 'attention', 'is', 'provided', 'to', 'the', 'use', 'of', 'video', 'laryngoscopes', 'VL', 'because', 'these', 'can', 'assist', 'anaesthetists', 'to', 'perform', 'a', 'successful', 'intubation', 'outside', 'the', 'ICU', 'while', 'protecting', 'healthcare', 'providers', 'from', 'this', 'viral', 'infection', 'Authors', 'will', 'also', 'review', 'processed', 'electroencephalographic', 'EEG', 'monitors', 'which', 'are', 'used', 'to', 'better', 'titrate', 'sedation', 'and', 'the', 'train', 'of', 'four', 'monitors', 'which', 'are', 'utilised', 'to', 'better', 'titrate', 'neuromuscular', 'blocking', 'agents', 'in', 'the', 'view', 'of', 'sparing', 'limited', 'pharmacological', 'resources', 'COVID', '19', 'can', 'rapidly', 'exhaust', 'human', 'and', 'technological', 'resources', 'too', 'within', 'the', 'ICU', 'This', 'review', 'features', 'a', 'series', 'of', 'technological', 'advancements', 'that', 'can', 'significantly', 'improve', 'the', 'care', 'of', 'patients', 'requiring', 'isolation', 'The', 'working', 'conditions', 'in', 'isolation', 'could', 'cause', 'gaps', 'or', 'barriers', 'in', 'communication', 'fatigue', 'and', 'poor', 'documentation', 'of', 'provided', 'care', 'The', 'available', 'technology', 'has', 'several', 'advantages', 'including', 'a', 'facilitating', 'appropriate', 'paperless', 'documentation', 'and', 'communication', 'between', 'all', 'healthcare', 'givers', 'working', 'in', 'isolation', 'rooms', 'or', 'large', 'isolation', 'areas', 'b', 'testing', 'patients', 'and', 'staff', 'at', 'the', 'bedside', 'using', 'smart', 'point', 'of', 'care', 'diagnostics', 'SPOCD', 'to', 'confirm', 'COVID', '19', 'infection', 'c', 'allowing', 'diagnostics', 'and', 'treatment', 'at', 'the', 'bedside', 'through', 'point', 'of', 'care', 'ultrasound', 'POCUS', 'and', 'Thromboelastography', 'TEG', 'd', 'adapting', 'the', 'use', 'of', 'anaesthetic', 'machines', 'and', 'the', 'use', 'of', 'volatile', 'anaesthetics', 'Implementing', 'technologies', 'for', 'safeguarding', 'healthcare', 'providers', 'as', 'well', 'as', 'monitoring', 'the', 'limited', 'pharmacological', 'resources', 'is', 'paramount', 'Only', 'by', 'leveraging', 'new', 'technologies', 'it', 'will', 'be', 'possible', 'to', 'sustain', 'and', 'support', 'healthcare', 'systems', 'during', 'the', 'expected', 'long', 'course', 'of', 'this', 'pandemic', '']"
112936,Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2,2020,Emerg Microbes Infect,,"The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 102 RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30â min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities.",,77jpm4o0,"['The', 'previous', 'outbreaks', 'of', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'have', 'led', 'researchers', 'to', 'study', 'the', 'role', 'of', 'diagnostics', 'in', 'impediment', 'of', 'further', 'spread', 'and', 'transmission', 'With', 'the', 'recent', 'emergence', 'of', 'the', 'novel', 'SARS', 'CoV', '2', 'the', 'availability', 'of', 'rapid', 'sensitive', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'essential', 'for', 'disease', 'control', 'Hence', 'we', 'have', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'for', 'the', 'specific', 'detection', 'of', 'SARS', 'CoV', '2', 'The', 'primer', 'sets', 'for', 'RT', 'LAMP', 'assay', 'were', 'designed', 'to', 'target', 'the', 'nucleocapsid', 'gene', 'of', 'the', 'viral', 'RNA', 'and', 'displayed', 'a', 'detection', 'limit', 'of', '102', 'RNA', 'copies', 'close', 'to', 'that', 'of', 'qRT', 'PCR', 'Notably', 'the', 'assay', 'has', 'exhibited', 'a', 'rapid', 'detection', 'span', 'of', '30â', 'min', 'combined', 'with', 'the', 'colorimetric', 'visualization', 'This', 'test', 'can', 'detect', 'specifically', 'viral', 'RNAs', 'of', 'the', 'SARS', 'CoV', '2', 'with', 'no', 'cross', 'reactivity', 'to', 'related', 'coronaviruses', 'such', 'as', 'HCoV', '229E', 'HCoV', 'NL63', 'HCoV', 'OC43', 'and', 'MERS', 'CoV', 'as', 'well', 'as', 'human', 'infectious', 'influenza', 'viruses', 'type', 'B', 'H1N1pdm', 'H3N2', 'H5N1', 'H5N6', 'H5N8', 'and', 'H7N9', 'and', 'other', 'respiratory', 'disease', 'causing', 'viruses', 'RSVA', 'RSVB', 'ADV', 'PIV', 'MPV', 'and', 'HRV', 'Furthermore', 'the', 'developed', 'RT', 'LAMP', 'assay', 'has', 'been', 'evaluated', 'using', 'specimens', 'collected', 'from', 'COVID', '19', 'patients', 'that', 'exhibited', 'high', 'agreement', 'to', 'the', 'qRT', 'PCR', 'Our', 'RT', 'LAMP', 'assay', 'is', 'simple', 'to', 'perform', 'less', 'expensive', 'time', 'efficient', 'and', 'can', 'be', 'used', 'in', 'clinical', 'laboratories', 'for', 'preliminary', 'detection', 'of', 'SARS', 'CoV', '2', 'in', 'suspected', 'patients', 'In', 'addition', 'to', 'the', 'high', 'sensitivity', 'and', 'specificity', 'this', 'isothermal', 'amplification', 'conjugated', 'with', 'a', 'single', 'tube', 'colorimetric', 'detection', 'method', 'may', 'contribute', 'to', 'the', 'public', 'health', 'responses', 'and', 'disease', 'control', 'especially', 'in', 'the', 'areas', 'with', 'limited', 'laboratory', 'capacities', '']"
113122,COVID-19 diagnostics in context,2020,Sci. transl. med,,"The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.",,rk8pract,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'has', 'highlighted', 'the', 'need', 'for', 'different', 'types', 'of', 'diagnostics', 'comparative', 'validation', 'of', 'new', 'tests', 'faster', 'approval', 'by', 'federal', 'agencies', 'and', 'rapid', 'production', 'of', 'test', 'kits', 'to', 'meet', 'global', 'demands', 'In', 'this', 'Perspective', 'we', 'discuss', 'the', 'utility', 'and', 'challenges', 'of', 'current', 'diagnostics', 'for', 'COVID', '19', '']"
113123,COVID-19 diagnostics in context,2020,Sci. transl. med,,"The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.",,qgeiani2,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'has', 'highlighted', 'the', 'need', 'for', 'different', 'types', 'of', 'diagnostics', 'comparative', 'validation', 'of', 'new', 'tests', 'faster', 'approval', 'by', 'federal', 'agencies', 'and', 'rapid', 'production', 'of', 'test', 'kits', 'to', 'meet', 'global', 'demands', 'In', 'this', 'Perspective', 'we', 'discuss', 'the', 'utility', 'and', 'challenges', 'of', 'current', 'diagnostics', 'for', 'COVID', '19', '']"
113701,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020,Science,,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",,2b5hue2r,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
113702,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020,Science,,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",,sb297tzj,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
114213,Serology testing in the COVID-19 pandemic response,2020,Lancet infect. dis,,"The collapse of global cooperation and a failure of international solidarity have led to many low-income and middle-income countries being denied access to molecular diagnostics in the COVID-19 pandemic response. Yet the scarcity of knowledge on the dynamics of the immune response to infection has led to hesitation on recommending the use of rapid immunodiagnostic tests, even though rapid serology tests are commercially available and scalable. On the basis of our knowledge and understanding of viral infectivity and host response, we urge countries without the capacity to do molecular testing at scale to research the use of serology tests to triage symptomatic patients in community settings, to test contacts of confirmed cases, and in situational analysis and surveillance. The WHO R&D Blue Print expert group identified eight priorities for research and development, of which the highest is to mobilise research on rapid point-of-care diagnostics for use at the community level. This research should inform control programmes of the required performance and utility of rapid serology tests, which, when applied specifically for appropriate public health measures to then be put in place, can make a huge difference.",,rrxloui4,"['The', 'collapse', 'of', 'global', 'cooperation', 'and', 'a', 'failure', 'of', 'international', 'solidarity', 'have', 'led', 'to', 'many', 'low', 'income', 'and', 'middle', 'income', 'countries', 'being', 'denied', 'access', 'to', 'molecular', 'diagnostics', 'in', 'the', 'COVID', '19', 'pandemic', 'response', 'Yet', 'the', 'scarcity', 'of', 'knowledge', 'on', 'the', 'dynamics', 'of', 'the', 'immune', 'response', 'to', 'infection', 'has', 'led', 'to', 'hesitation', 'on', 'recommending', 'the', 'use', 'of', 'rapid', 'immunodiagnostic', 'tests', 'even', 'though', 'rapid', 'serology', 'tests', 'are', 'commercially', 'available', 'and', 'scalable', 'On', 'the', 'basis', 'of', 'our', 'knowledge', 'and', 'understanding', 'of', 'viral', 'infectivity', 'and', 'host', 'response', 'we', 'urge', 'countries', 'without', 'the', 'capacity', 'to', 'do', 'molecular', 'testing', 'at', 'scale', 'to', 'research', 'the', 'use', 'of', 'serology', 'tests', 'to', 'triage', 'symptomatic', 'patients', 'in', 'community', 'settings', 'to', 'test', 'contacts', 'of', 'confirmed', 'cases', 'and', 'in', 'situational', 'analysis', 'and', 'surveillance', 'The', 'WHO', 'R', 'D', 'Blue', 'Print', 'expert', 'group', 'identified', 'eight', 'priorities', 'for', 'research', 'and', 'development', 'of', 'which', 'the', 'highest', 'is', 'to', 'mobilise', 'research', 'on', 'rapid', 'point', 'of', 'care', 'diagnostics', 'for', 'use', 'at', 'the', 'community', 'level', 'This', 'research', 'should', 'inform', 'control', 'programmes', 'of', 'the', 'required', 'performance', 'and', 'utility', 'of', 'rapid', 'serology', 'tests', 'which', 'when', 'applied', 'specifically', 'for', 'appropriate', 'public', 'health', 'measures', 'to', 'then', 'be', 'put', 'in', 'place', 'can', 'make', 'a', 'huge', 'difference', '']"
115076,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020,J Clin Virol,,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",,l0cm3mae,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
115077,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020,J Clin Virol,,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",,4nq2ok89,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
115078,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020,J Clin Virol,,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",,ltvpbxp4,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
115157,Assessment of the Angolan (CHERRT) Mobile Laboratory Curriculum for Disaster and Pandemic Response,2020,West J Emerg Med,,"INTRODUCTION: As of April 5, 2020, the World Health Organization reported over one million confirmed cases and more than 62,000 confirmed coronavirus (COVID-19) deaths affecting 204 countries/regions. The lack of COVID-19 testing capacity threatens the ability of both the United States (US) and low middle income countries (LMIC) to respond to this growing threat, The purpose of this study was to assess the effectiveness through participant self-assessment of a rapid response team (RRT) mobile laboratory curriculum METHODS: We conducted a pre and post survey for the purpose of a process improvement assessment in Angola, involving 32 individuals. The survey was performed before and after a 14-day training workshop held in Luanda, Angola, in December 2019. A paired t-test was used to identify any significant change on six 7-point Likert scale questions with &#945;< 0.05 (95% confidence interval). RESULTS: All six of the questions - 1) ""I feel confident managing a real laboratory sample test for Ebola or other highly contagious sample;"" 2) ""I feel safe working in the lab environment during a real scenario;"" 3) ""I feel as if I can appropriately manage a potentially highly contagious laboratory sample;"" 4)""I feel that I can interpret a positive or negative sample during a suspected contagious outbreak;"" 5) ""I understand basic Biobubble/mobile laboratory concepts and procedures;"" and 6) ""I understand polymerase chain reaction (PCR) principles"" - showed statistical significant change pre and post training. Additionally, the final two questions - ""I can more effectively perform my role/position because of the training I received during this course;"" and ""This training was valuable"" - received high scores on the Likert scale. CONCLUSION: This Angolan RRT mobile laboratory training curriculum provides the nation of Angola with the confidence to rapidly respond and test at the national level a highly infectious contagion in the region and perform on-scene diagnostics. This mobile RRT laboratory provides a mobile and rapid diagnostic resource when epidemic/pandemic resource allocation may need to be prioritized based on confirmed disease prevalence.",,63cznc3h,"['INTRODUCTION', 'As', 'of', 'April', '5', '2020', 'the', 'World', 'Health', 'Organization', 'reported', 'over', 'one', 'million', 'confirmed', 'cases', 'and', 'more', 'than', '62', '000', 'confirmed', 'coronavirus', 'COVID', '19', 'deaths', 'affecting', '204', 'countries', 'regions', 'The', 'lack', 'of', 'COVID', '19', 'testing', 'capacity', 'threatens', 'the', 'ability', 'of', 'both', 'the', 'United', 'States', 'US', 'and', 'low', 'middle', 'income', 'countries', 'LMIC', 'to', 'respond', 'to', 'this', 'growing', 'threat', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'assess', 'the', 'effectiveness', 'through', 'participant', 'self', 'assessment', 'of', 'a', 'rapid', 'response', 'team', 'RRT', 'mobile', 'laboratory', 'curriculum', 'METHODS', 'We', 'conducted', 'a', 'pre', 'and', 'post', 'survey', 'for', 'the', 'purpose', 'of', 'a', 'process', 'improvement', 'assessment', 'in', 'Angola', 'involving', '32', 'individuals', 'The', 'survey', 'was', 'performed', 'before', 'and', 'after', 'a', '14', 'day', 'training', 'workshop', 'held', 'in', 'Luanda', 'Angola', 'in', 'December', '2019', 'A', 'paired', 't', 'test', 'was', 'used', 'to', 'identify', 'any', 'significant', 'change', 'on', 'six', '7', 'point', 'Likert', 'scale', 'questions', 'with', '945', '0', '05', '95', 'confidence', 'interval', 'RESULTS', 'All', 'six', 'of', 'the', 'questions', '1', 'I', 'feel', 'confident', 'managing', 'a', 'real', 'laboratory', 'sample', 'test', 'for', 'Ebola', 'or', 'other', 'highly', 'contagious', 'sample', '2', 'I', 'feel', 'safe', 'working', 'in', 'the', 'lab', 'environment', 'during', 'a', 'real', 'scenario', '3', 'I', 'feel', 'as', 'if', 'I', 'can', 'appropriately', 'manage', 'a', 'potentially', 'highly', 'contagious', 'laboratory', 'sample', '4', 'I', 'feel', 'that', 'I', 'can', 'interpret', 'a', 'positive', 'or', 'negative', 'sample', 'during', 'a', 'suspected', 'contagious', 'outbreak', '5', 'I', 'understand', 'basic', 'Biobubble', 'mobile', 'laboratory', 'concepts', 'and', 'procedures', 'and', '6', 'I', 'understand', 'polymerase', 'chain', 'reaction', 'PCR', 'principles', 'showed', 'statistical', 'significant', 'change', 'pre', 'and', 'post', 'training', 'Additionally', 'the', 'final', 'two', 'questions', 'I', 'can', 'more', 'effectively', 'perform', 'my', 'role', 'position', 'because', 'of', 'the', 'training', 'I', 'received', 'during', 'this', 'course', 'and', 'This', 'training', 'was', 'valuable', 'received', 'high', 'scores', 'on', 'the', 'Likert', 'scale', 'CONCLUSION', 'This', 'Angolan', 'RRT', 'mobile', 'laboratory', 'training', 'curriculum', 'provides', 'the', 'nation', 'of', 'Angola', 'with', 'the', 'confidence', 'to', 'rapidly', 'respond', 'and', 'test', 'at', 'the', 'national', 'level', 'a', 'highly', 'infectious', 'contagion', 'in', 'the', 'region', 'and', 'perform', 'on', 'scene', 'diagnostics', 'This', 'mobile', 'RRT', 'laboratory', 'provides', 'a', 'mobile', 'and', 'rapid', 'diagnostic', 'resource', 'when', 'epidemic', 'pandemic', 'resource', 'allocation', 'may', 'need', 'to', 'be', 'prioritized', 'based', 'on', 'confirmed', 'disease', 'prevalence', '']"
115158,Assessment of the Angolan (CHERRT) Mobile Laboratory Curriculum for Disaster and Pandemic Response,2020,West J Emerg Med,,"INTRODUCTION: As of April 5, 2020, the World Health Organization reported over one million confirmed cases and more than 62,000 confirmed coronavirus (COVID-19) deaths affecting 204 countries/regions. The lack of COVID-19 testing capacity threatens the ability of both the United States (US) and low middle income countries (LMIC) to respond to this growing threat, The purpose of this study was to assess the effectiveness through participant self-assessment of a rapid response team (RRT) mobile laboratory curriculum METHODS: We conducted a pre and post survey for the purpose of a process improvement assessment in Angola, involving 32 individuals. The survey was performed before and after a 14-day training workshop held in Luanda, Angola, in December 2019. A paired t-test was used to identify any significant change on six 7-point Likert scale questions with &#945;< 0.05 (95% confidence interval). RESULTS: All six of the questions - 1) ""I feel confident managing a real laboratory sample test for Ebola or other highly contagious sample;"" 2) ""I feel safe working in the lab environment during a real scenario;"" 3) ""I feel as if I can appropriately manage a potentially highly contagious laboratory sample;"" 4)""I feel that I can interpret a positive or negative sample during a suspected contagious outbreak;"" 5) ""I understand basic Biobubble/mobile laboratory concepts and procedures;"" and 6) ""I understand polymerase chain reaction (PCR) principles"" - showed statistical significant change pre and post training. Additionally, the final two questions - ""I can more effectively perform my role/position because of the training I received during this course;"" and ""This training was valuable"" - received high scores on the Likert scale. CONCLUSION: This Angolan RRT mobile laboratory training curriculum provides the nation of Angola with the confidence to rapidly respond and test at the national level a highly infectious contagion in the region and perform on-scene diagnostics. This mobile RRT laboratory provides a mobile and rapid diagnostic resource when epidemic/pandemic resource allocation may need to be prioritized based on confirmed disease prevalence.",,c8gvrfd7,"['INTRODUCTION', 'As', 'of', 'April', '5', '2020', 'the', 'World', 'Health', 'Organization', 'reported', 'over', 'one', 'million', 'confirmed', 'cases', 'and', 'more', 'than', '62', '000', 'confirmed', 'coronavirus', 'COVID', '19', 'deaths', 'affecting', '204', 'countries', 'regions', 'The', 'lack', 'of', 'COVID', '19', 'testing', 'capacity', 'threatens', 'the', 'ability', 'of', 'both', 'the', 'United', 'States', 'US', 'and', 'low', 'middle', 'income', 'countries', 'LMIC', 'to', 'respond', 'to', 'this', 'growing', 'threat', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'assess', 'the', 'effectiveness', 'through', 'participant', 'self', 'assessment', 'of', 'a', 'rapid', 'response', 'team', 'RRT', 'mobile', 'laboratory', 'curriculum', 'METHODS', 'We', 'conducted', 'a', 'pre', 'and', 'post', 'survey', 'for', 'the', 'purpose', 'of', 'a', 'process', 'improvement', 'assessment', 'in', 'Angola', 'involving', '32', 'individuals', 'The', 'survey', 'was', 'performed', 'before', 'and', 'after', 'a', '14', 'day', 'training', 'workshop', 'held', 'in', 'Luanda', 'Angola', 'in', 'December', '2019', 'A', 'paired', 't', 'test', 'was', 'used', 'to', 'identify', 'any', 'significant', 'change', 'on', 'six', '7', 'point', 'Likert', 'scale', 'questions', 'with', '945', '0', '05', '95', 'confidence', 'interval', 'RESULTS', 'All', 'six', 'of', 'the', 'questions', '1', 'I', 'feel', 'confident', 'managing', 'a', 'real', 'laboratory', 'sample', 'test', 'for', 'Ebola', 'or', 'other', 'highly', 'contagious', 'sample', '2', 'I', 'feel', 'safe', 'working', 'in', 'the', 'lab', 'environment', 'during', 'a', 'real', 'scenario', '3', 'I', 'feel', 'as', 'if', 'I', 'can', 'appropriately', 'manage', 'a', 'potentially', 'highly', 'contagious', 'laboratory', 'sample', '4', 'I', 'feel', 'that', 'I', 'can', 'interpret', 'a', 'positive', 'or', 'negative', 'sample', 'during', 'a', 'suspected', 'contagious', 'outbreak', '5', 'I', 'understand', 'basic', 'Biobubble', 'mobile', 'laboratory', 'concepts', 'and', 'procedures', 'and', '6', 'I', 'understand', 'polymerase', 'chain', 'reaction', 'PCR', 'principles', 'showed', 'statistical', 'significant', 'change', 'pre', 'and', 'post', 'training', 'Additionally', 'the', 'final', 'two', 'questions', 'I', 'can', 'more', 'effectively', 'perform', 'my', 'role', 'position', 'because', 'of', 'the', 'training', 'I', 'received', 'during', 'this', 'course', 'and', 'This', 'training', 'was', 'valuable', 'received', 'high', 'scores', 'on', 'the', 'Likert', 'scale', 'CONCLUSION', 'This', 'Angolan', 'RRT', 'mobile', 'laboratory', 'training', 'curriculum', 'provides', 'the', 'nation', 'of', 'Angola', 'with', 'the', 'confidence', 'to', 'rapidly', 'respond', 'and', 'test', 'at', 'the', 'national', 'level', 'a', 'highly', 'infectious', 'contagion', 'in', 'the', 'region', 'and', 'perform', 'on', 'scene', 'diagnostics', 'This', 'mobile', 'RRT', 'laboratory', 'provides', 'a', 'mobile', 'and', 'rapid', 'diagnostic', 'resource', 'when', 'epidemic', 'pandemic', 'resource', 'allocation', 'may', 'need', 'to', 'be', 'prioritized', 'based', 'on', 'confirmed', 'disease', 'prevalence', '']"
115219,"A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay",2020,J. clin. microbiol,,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas® SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas® SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.",,uwrps3x3,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'qRT', 'PCR', 'assays', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'positions', 'in', 'the', 'viral', 'genome', 'While', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'variants', 'that', 'might', 'compromise', 'these', 'assays', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'U', 'transition', 'at', 'position', '26', '340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'SARS', 'CoV', '2', 'E', 'gene', 'qRT', 'PCR', 'in', 'eight', 'patients', 'As', 'the', 'cobas', 'SARS', 'CoV', '2', 'assay', 'targets', 'two', 'positions', 'in', 'the', 'genome', 'the', 'individuals', 'carrying', 'this', 'variant', 'were', 'still', 'called', 'as', 'SARS', 'CoV', '2', 'positive', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'to', 'carry', 'closely', 'related', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'at', 'least', 'four', 'times', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'to', 'avoid', 'false', 'negatives', '']"
116642,Impact of COVID-19 Pandemic on Laboratory Utilization,2020,,,"BACKGROUND: Coronavirus Disease 2019 (COVID-19) was formally characterized as a pandemic on March 11, 2020. Since that time, the COVID-19 pandemic has led to unprecedented demand for healthcare resources. The purpose of this study was to identify changes in laboratory test utilization in the setting of increasing local incidence of COVID-19. METHODS: We performed a retrospective assessment of laboratory test order and specimen container utilization at a single, urban tertiary care medical center. Data were extracted from the laboratory information system database over a 10-week period, spanning the primordial inflection of COVID-19 incidence in our region. Total testing volumes were calculated during the first and last two-weeks of the observation period and used as reference points to examine the absolute and relative differences in test order volume between the pre-pandemic and COVID-19 surge periods. RESULTS: Between February 2, 2020 and April 11, 2020, there were 873,397 tests ordered and final verified. The in-house SARS-CoV-2 PCR positivity rate for admitted patients in the last week of the observation period was 30.8%. Significant increases in workload were observed in the send-out laboratory section and for COVID-19 diagnosis (PCR) and management-related testing. Otherwise, there was a net decrease in overall demand across nearly all laboratory sections. Increases in testing were noted for tests related to COVID-19 management. Viral transport media and citrated blue top containers demonstrated increases in utilization. CONCLUSION: Increasing local incidence of COVID-19 had a profound impact on laboratory operations. While volume increases were seen for laboratory tests related to COVID-19 diagnostics and management, including some with limited evidence to support their use, overall testing volumes decreased substantially. During events such as COVID-19, monitoring of such patterns can help inform laboratory management, staffing, and test stewardship recommendations for managing resource and supply availability.",,au5rc9x6,"['BACKGROUND', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'was', 'formally', 'characterized', 'as', 'a', 'pandemic', 'on', 'March', '11', '2020', 'Since', 'that', 'time', 'the', 'COVID', '19', 'pandemic', 'has', 'led', 'to', 'unprecedented', 'demand', 'for', 'healthcare', 'resources', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'identify', 'changes', 'in', 'laboratory', 'test', 'utilization', 'in', 'the', 'setting', 'of', 'increasing', 'local', 'incidence', 'of', 'COVID', '19', 'METHODS', 'We', 'performed', 'a', 'retrospective', 'assessment', 'of', 'laboratory', 'test', 'order', 'and', 'specimen', 'container', 'utilization', 'at', 'a', 'single', 'urban', 'tertiary', 'care', 'medical', 'center', 'Data', 'were', 'extracted', 'from', 'the', 'laboratory', 'information', 'system', 'database', 'over', 'a', '10', 'week', 'period', 'spanning', 'the', 'primordial', 'inflection', 'of', 'COVID', '19', 'incidence', 'in', 'our', 'region', 'Total', 'testing', 'volumes', 'were', 'calculated', 'during', 'the', 'first', 'and', 'last', 'two', 'weeks', 'of', 'the', 'observation', 'period', 'and', 'used', 'as', 'reference', 'points', 'to', 'examine', 'the', 'absolute', 'and', 'relative', 'differences', 'in', 'test', 'order', 'volume', 'between', 'the', 'pre', 'pandemic', 'and', 'COVID', '19', 'surge', 'periods', 'RESULTS', 'Between', 'February', '2', '2020', 'and', 'April', '11', '2020', 'there', 'were', '873', '397', 'tests', 'ordered', 'and', 'final', 'verified', 'The', 'in', 'house', 'SARS', 'CoV', '2', 'PCR', 'positivity', 'rate', 'for', 'admitted', 'patients', 'in', 'the', 'last', 'week', 'of', 'the', 'observation', 'period', 'was', '30', '8', 'Significant', 'increases', 'in', 'workload', 'were', 'observed', 'in', 'the', 'send', 'out', 'laboratory', 'section', 'and', 'for', 'COVID', '19', 'diagnosis', 'PCR', 'and', 'management', 'related', 'testing', 'Otherwise', 'there', 'was', 'a', 'net', 'decrease', 'in', 'overall', 'demand', 'across', 'nearly', 'all', 'laboratory', 'sections', 'Increases', 'in', 'testing', 'were', 'noted', 'for', 'tests', 'related', 'to', 'COVID', '19', 'management', 'Viral', 'transport', 'media', 'and', 'citrated', 'blue', 'top', 'containers', 'demonstrated', 'increases', 'in', 'utilization', 'CONCLUSION', 'Increasing', 'local', 'incidence', 'of', 'COVID', '19', 'had', 'a', 'profound', 'impact', 'on', 'laboratory', 'operations', 'While', 'volume', 'increases', 'were', 'seen', 'for', 'laboratory', 'tests', 'related', 'to', 'COVID', '19', 'diagnostics', 'and', 'management', 'including', 'some', 'with', 'limited', 'evidence', 'to', 'support', 'their', 'use', 'overall', 'testing', 'volumes', 'decreased', 'substantially', 'During', 'events', 'such', 'as', 'COVID', '19', 'monitoring', 'of', 'such', 'patterns', 'can', 'help', 'inform', 'laboratory', 'management', 'staffing', 'and', 'test', 'stewardship', 'recommendations', 'for', 'managing', 'resource', 'and', 'supply', 'availability', '']"
116783,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management,2020,IEEE reviews in biomedical engineering (Online),,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",,kawhus2f,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
116784,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management,2020,,,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",,ye44fr72,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
116949,Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts,2020,J Dent Res,,"Orofacial clefts and their management impose a substantial burden on patients, on their families, and on the health system. Under the current standard of care, affected patients are subjected to a lifelong journey of corrective surgeries and multidisciplinary management to replace bone and soft tissues, as well as restore esthetics and physiologic functions while restoring self-esteem and psychological health. Hence, a better understanding of the dynamic interplay of molecular signaling pathways at critical phases of palate development is necessary to pioneer novel prenatal interventions. Such pathways include transforming growth factor-ß (Tgfß), sonic hedgehog (Shh), wingless-integrated site (Wnt)/ß-catenin, bone morphogenetic protein (Bmp), and fibroblast growth factor (Fgf) and its associated receptors, among others. Here, we summarize commonly used surgical methods used to correct cleft defects postnatally. We also review the advances made in prenatal diagnostics of clefts through imaging and genomics and the various in utero surgical corrections that have been attempted thus far. An overview of how key mediators of signaling that drive palatogenesis are emphasized in the context of the framework and rationale for the development and testing of therapeutics in animal model systems and in humans is provided. The pros and cons of in utero therapies that can potentially restore molecular homeostasis needed for the proper growth and fusion of palatal shelves are presented. The theme advanced throughout this review is the need to develop preclinical molecular therapies that could ultimately be translated into human trials that can correct orofacial clefts at earlier stages of development.",,p0ak6cnt,"['Orofacial', 'clefts', 'and', 'their', 'management', 'impose', 'a', 'substantial', 'burden', 'on', 'patients', 'on', 'their', 'families', 'and', 'on', 'the', 'health', 'system', 'Under', 'the', 'current', 'standard', 'of', 'care', 'affected', 'patients', 'are', 'subjected', 'to', 'a', 'lifelong', 'journey', 'of', 'corrective', 'surgeries', 'and', 'multidisciplinary', 'management', 'to', 'replace', 'bone', 'and', 'soft', 'tissues', 'as', 'well', 'as', 'restore', 'esthetics', 'and', 'physiologic', 'functions', 'while', 'restoring', 'self', 'esteem', 'and', 'psychological', 'health', 'Hence', 'a', 'better', 'understanding', 'of', 'the', 'dynamic', 'interplay', 'of', 'molecular', 'signaling', 'pathways', 'at', 'critical', 'phases', 'of', 'palate', 'development', 'is', 'necessary', 'to', 'pioneer', 'novel', 'prenatal', 'interventions', 'Such', 'pathways', 'include', 'transforming', 'growth', 'factor', 'ß', 'Tgfß', 'sonic', 'hedgehog', 'Shh', 'wingless', 'integrated', 'site', 'Wnt', 'ß', 'catenin', 'bone', 'morphogenetic', 'protein', 'Bmp', 'and', 'fibroblast', 'growth', 'factor', 'Fgf', 'and', 'its', 'associated', 'receptors', 'among', 'others', 'Here', 'we', 'summarize', 'commonly', 'used', 'surgical', 'methods', 'used', 'to', 'correct', 'cleft', 'defects', 'postnatally', 'We', 'also', 'review', 'the', 'advances', 'made', 'in', 'prenatal', 'diagnostics', 'of', 'clefts', 'through', 'imaging', 'and', 'genomics', 'and', 'the', 'various', 'in', 'utero', 'surgical', 'corrections', 'that', 'have', 'been', 'attempted', 'thus', 'far', 'An', 'overview', 'of', 'how', 'key', 'mediators', 'of', 'signaling', 'that', 'drive', 'palatogenesis', 'are', 'emphasized', 'in', 'the', 'context', 'of', 'the', 'framework', 'and', 'rationale', 'for', 'the', 'development', 'and', 'testing', 'of', 'therapeutics', 'in', 'animal', 'model', 'systems', 'and', 'in', 'humans', 'is', 'provided', 'The', 'pros', 'and', 'cons', 'of', 'in', 'utero', 'therapies', 'that', 'can', 'potentially', 'restore', 'molecular', 'homeostasis', 'needed', 'for', 'the', 'proper', 'growth', 'and', 'fusion', 'of', 'palatal', 'shelves', 'are', 'presented', 'The', 'theme', 'advanced', 'throughout', 'this', 'review', 'is', 'the', 'need', 'to', 'develop', 'preclinical', 'molecular', 'therapies', 'that', 'could', 'ultimately', 'be', 'translated', 'into', 'human', 'trials', 'that', 'can', 'correct', 'orofacial', 'clefts', 'at', 'earlier', 'stages', 'of', 'development', '']"
117369,"COVID-19: Progress in diagnostics, therapy and vaccination",2020,Theranostics,,"Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.",,l5uf8y58,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'recently', 'become', 'a', 'pandemic', 'As', 'the', 'sudden', 'emergence', 'and', 'rapid', 'spread', 'of', 'SARS', 'CoV', '2', 'is', 'endangering', 'global', 'health', 'and', 'the', 'economy', 'the', 'development', 'of', 'strategies', 'to', 'contain', 'the', 'virus', 's', 'spread', 'are', 'urgently', 'needed', 'At', 'present', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'SARS', 'CoV', '2', 'are', 'available', 'for', 'use', 'to', 'initiate', 'appropriate', 'treatment', 'faster', 'and', 'to', 'limit', 'further', 'spread', 'of', 'the', 'virus', 'Several', 'drugs', 'have', 'demonstrated', 'in', 'vitro', 'activity', 'against', 'SARS', 'CoV', '2', 'or', 'potential', 'clinical', 'benefits', 'In', 'addition', 'institutions', 'and', 'companies', 'worldwide', 'are', 'working', 'tirelessly', 'to', 'develop', 'treatments', 'and', 'vaccines', 'against', 'COVID', '19', 'However', 'no', 'drug', 'or', 'vaccine', 'has', 'yet', 'been', 'specifically', 'approved', 'for', 'COVID', '19', 'Given', 'the', 'urgency', 'of', 'the', 'outbreak', 'we', 'focus', 'here', 'on', 'recent', 'advances', 'in', 'the', 'diagnostics', 'treatment', 'and', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'infection', 'helping', 'to', 'guide', 'strategies', 'to', 'address', 'the', 'current', 'COVID', '19', 'pandemic', '']"
119302,Rapid point-of-care serology testing for sars-cov-2/ Snabbtest for covid-19-antikroppar bor utforas av utbildad personal,2020,Lakartidningen,,"Increasing evidence indicates immunity against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) after covid-19, but it remains unclear for how long the protection remains Serology testing seems to have a higher sensitivity than molecular diagnostics from 8 days after onset of symtoms, and should be part of risk assessment and epidemiological studies of COVID-19 The performance of commercial serological point-of-care (POC) lateral flow tests are highly manufacturer-dependant Low sensitivity increases the risk of false negative results and could result in unnecessary quarantine of test persons with developed antibodies Low specificity increases the risk of false positive results and could lead to false assumptions of immunity Carefully selected serological POC tests for sars-cov-2 can be used in large scale testing but should only be used by licensed medical staff able to understand their limitations and interpret the results",,m60w5dnl,"['Increasing', 'evidence', 'indicates', 'immunity', 'against', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'after', 'covid', '19', 'but', 'it', 'remains', 'unclear', 'for', 'how', 'long', 'the', 'protection', 'remains', 'Serology', 'testing', 'seems', 'to', 'have', 'a', 'higher', 'sensitivity', 'than', 'molecular', 'diagnostics', 'from', '8', 'days', 'after', 'onset', 'of', 'symtoms', 'and', 'should', 'be', 'part', 'of', 'risk', 'assessment', 'and', 'epidemiological', 'studies', 'of', 'COVID', '19', 'The', 'performance', 'of', 'commercial', 'serological', 'point', 'of', 'care', 'POC', 'lateral', 'flow', 'tests', 'are', 'highly', 'manufacturer', 'dependant', 'Low', 'sensitivity', 'increases', 'the', 'risk', 'of', 'false', 'negative', 'results', 'and', 'could', 'result', 'in', 'unnecessary', 'quarantine', 'of', 'test', 'persons', 'with', 'developed', 'antibodies', 'Low', 'specificity', 'increases', 'the', 'risk', 'of', 'false', 'positive', 'results', 'and', 'could', 'lead', 'to', 'false', 'assumptions', 'of', 'immunity', 'Carefully', 'selected', 'serological', 'POC', 'tests', 'for', 'sars', 'cov', '2', 'can', 'be', 'used', 'in', 'large', 'scale', 'testing', 'but', 'should', 'only', 'be', 'used', 'by', 'licensed', 'medical', 'staff', 'able', 'to', 'understand', 'their', 'limitations', 'and', 'interpret', 'the', 'results']"
122423,Leveraging open hardware to alleviate the burden of COVID-19 on global health systems,2020,PLoS Biol,,"With the current rapid spread of COVID-19, global health systems are increasingly overburdened by the sheer number of people that need diagnosis, isolation and treatment. Shortcomings are evident across the board, from staffing, facilities for rapid and reliable testing to availability of hospital beds and key medical-grade equipment. The scale and breadth of the problem calls for an equally substantive response not only from frontline workers such as medical staff and scientists, but from skilled members of the public who have the time, facilities and knowledge to meaningfully contribute to a consolidated global response. Here, we summarise community-driven approaches based on Free and Open Source scientific and medical Hardware (FOSH) as well as personal protective equipment (PPE) currently being developed and deployed to support the global response for COVID-19 prevention, patient treatment and diagnostics.",,ubd5bisd,"['With', 'the', 'current', 'rapid', 'spread', 'of', 'COVID', '19', 'global', 'health', 'systems', 'are', 'increasingly', 'overburdened', 'by', 'the', 'sheer', 'number', 'of', 'people', 'that', 'need', 'diagnosis', 'isolation', 'and', 'treatment', 'Shortcomings', 'are', 'evident', 'across', 'the', 'board', 'from', 'staffing', 'facilities', 'for', 'rapid', 'and', 'reliable', 'testing', 'to', 'availability', 'of', 'hospital', 'beds', 'and', 'key', 'medical', 'grade', 'equipment', 'The', 'scale', 'and', 'breadth', 'of', 'the', 'problem', 'calls', 'for', 'an', 'equally', 'substantive', 'response', 'not', 'only', 'from', 'frontline', 'workers', 'such', 'as', 'medical', 'staff', 'and', 'scientists', 'but', 'from', 'skilled', 'members', 'of', 'the', 'public', 'who', 'have', 'the', 'time', 'facilities', 'and', 'knowledge', 'to', 'meaningfully', 'contribute', 'to', 'a', 'consolidated', 'global', 'response', 'Here', 'we', 'summarise', 'community', 'driven', 'approaches', 'based', 'on', 'Free', 'and', 'Open', 'Source', 'scientific', 'and', 'medical', 'Hardware', 'FOSH', 'as', 'well', 'as', 'personal', 'protective', 'equipment', 'PPE', 'currently', 'being', 'developed', 'and', 'deployed', 'to', 'support', 'the', 'global', 'response', 'for', 'COVID', '19', 'prevention', 'patient', 'treatment', 'and', 'diagnostics', '']"
123445,CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia,2020,J Drug Target,,"Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarise current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis.",,5uv9kaxf,"['Emerging', 'infectious', 'diseases', 'the', 'persistent', 'potential', 'for', 'destabilising', 'pandemics', 'remain', 'a', 'global', 'threat', 'leading', 'to', 'excessive', 'morbidity', 'and', 'mortality', 'The', 'current', 'outbreak', 'of', 'pneumonia', 'caused', 'by', '2019', 'novel', 'coronavirus', 'COVID', '19', 'illustrated', 'difficulties', 'in', 'lack', 'of', 'effective', 'drugs', 'for', 'treatment', 'Accurate', 'and', 'rapid', 'diagnostic', 'tools', 'are', 'essential', 'for', 'early', 'recognition', 'and', 'treatment', 'of', 'infectious', 'diseases', 'allowing', 'timely', 'implementation', 'of', 'infection', 'control', 'improved', 'clinical', 'care', 'and', 'other', 'public', 'health', 'measures', 'to', 'stop', 'the', 'spread', 'of', 'the', 'disease', 'CRISPR', 'Cas', 'technology', 'speed', 'up', 'the', 'development', 'of', 'infectious', 'disease', 'diagnostics', 'with', 'high', 'rapid', 'and', 'accurate', 'In', 'this', 'review', 'we', 'summarise', 'current', 'advance', 'regarding', 'diverse', 'CRISPR', 'Cas', 'systems', 'including', 'CRISPR', 'Cas9', 'CRISPR', 'Cas12', 'and', 'CRISPR', 'Cas13', 'in', 'the', 'development', 'of', 'fast', 'accurate', 'and', 'portable', 'diagnostic', 'tests', 'and', 'highlight', 'the', 'potential', 'of', 'CRISPR', 'Cas13', 'in', 'COVID', '19', 'Pneumonia', 'and', 'other', 'emerging', 'infectious', 'diseases', 'diagnosis', '']"
124164,Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting,2020,J Clin Virol,,"BACKGROUND: The ongoing SARS-CoV-2 pandemic presents a unique challenge for diagnostic laboratories around the world. Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for highly urgent cases. In this study we evaluated a SARS-CoV-2 LDT for the NeuMoDx 96 system, a fully automated device performing extraction and real-time PCR. METHODS: A publicly available SARS-CoV-2 RT-PCR assay was adapted for the automated system. Analytical performance was evaluated using in-vitro transcribed RNA and clinical performance was compared to the cobas 6800-based reference assay within the lab. RESULTS: The Envelope (E) Gene-LDT displayed good analytical performance with an LoD of 95.55 cp/mL and no false positives during evaluation of cross-reactivity. A total of 176 patient samples were tested with both the E-Gene-LDT and the reference assay. Positive and negative agreement were 100 % and 99.2 % respectively. Invalid-rate was 6.3 %. CONCLUSION: The E-Gene-LDT showed analytical and clinical performance comparable to the cobas6800-based reference assay. Due to its random-access workflow concept and rapid time-to-result of about 80 min, the system is very well suited for providing fast-tracked SARS-CoV-2 diagnostics for urgent clinical samples in the hospital setting.",,v5gtgh0o,"['BACKGROUND', 'The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'for', 'diagnostic', 'laboratories', 'around', 'the', 'world', 'Automation', 'of', 'workflows', 'in', 'molecular', 'diagnostics', 'is', 'instrumental', 'for', 'coping', 'with', 'the', 'large', 'number', 'of', 'tests', 'ordered', 'by', 'clinicians', 'as', 'well', 'as', 'providing', 'fast', 'tracked', 'rapid', 'testing', 'for', 'highly', 'urgent', 'cases', 'In', 'this', 'study', 'we', 'evaluated', 'a', 'SARS', 'CoV', '2', 'LDT', 'for', 'the', 'NeuMoDx', '96', 'system', 'a', 'fully', 'automated', 'device', 'performing', 'extraction', 'and', 'real', 'time', 'PCR', 'METHODS', 'A', 'publicly', 'available', 'SARS', 'CoV', '2', 'RT', 'PCR', 'assay', 'was', 'adapted', 'for', 'the', 'automated', 'system', 'Analytical', 'performance', 'was', 'evaluated', 'using', 'in', 'vitro', 'transcribed', 'RNA', 'and', 'clinical', 'performance', 'was', 'compared', 'to', 'the', 'cobas', '6800', 'based', 'reference', 'assay', 'within', 'the', 'lab', 'RESULTS', 'The', 'Envelope', 'E', 'Gene', 'LDT', 'displayed', 'good', 'analytical', 'performance', 'with', 'an', 'LoD', 'of', '95', '55', 'cp', 'mL', 'and', 'no', 'false', 'positives', 'during', 'evaluation', 'of', 'cross', 'reactivity', 'A', 'total', 'of', '176', 'patient', 'samples', 'were', 'tested', 'with', 'both', 'the', 'E', 'Gene', 'LDT', 'and', 'the', 'reference', 'assay', 'Positive', 'and', 'negative', 'agreement', 'were', '100', 'and', '99', '2', 'respectively', 'Invalid', 'rate', 'was', '6', '3', 'CONCLUSION', 'The', 'E', 'Gene', 'LDT', 'showed', 'analytical', 'and', 'clinical', 'performance', 'comparable', 'to', 'the', 'cobas6800', 'based', 'reference', 'assay', 'Due', 'to', 'its', 'random', 'access', 'workflow', 'concept', 'and', 'rapid', 'time', 'to', 'result', 'of', 'about', '80', 'min', 'the', 'system', 'is', 'very', 'well', 'suited', 'for', 'providing', 'fast', 'tracked', 'SARS', 'CoV', '2', 'diagnostics', 'for', 'urgent', 'clinical', 'samples', 'in', 'the', 'hospital', 'setting', '']"
127362,An update on the status of COVID-19: a comprehensive review,2020,Eur Rev Med Pharmacol Sci,,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",,limug35b,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
127363,An update on the status of COVID-19: a comprehensive review,2020,Eur Rev Med Pharmacol Sci,,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",,gj8ng7xg,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
127400,An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment,2020,Nat Commun,,"The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a detailed comparison of serological COVID-19 assays. We show that among the selected assays there is a wide diversity in assay performance in different scenarios and when correlated to virus neutralizing antibodies. The Wantai ELISA detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, has the best overall characteristics to detect functional antibodies in different stages and severity of disease, including the potential to set a cut-off indicating the presence of protective antibodies. The large variety of available serological assays requires proper assay validation before deciding on deployment of assays for specific applications.",,cv2dg9tg,"['The', 'world', 'is', 'entering', 'a', 'new', 'era', 'of', 'the', 'COVID', '19', 'pandemic', 'in', 'which', 'there', 'is', 'an', 'increasing', 'call', 'for', 'reliable', 'antibody', 'testing', 'To', 'support', 'decision', 'making', 'on', 'the', 'deployment', 'of', 'serology', 'for', 'either', 'population', 'screening', 'or', 'diagnostics', 'we', 'present', 'a', 'detailed', 'comparison', 'of', 'serological', 'COVID', '19', 'assays', 'We', 'show', 'that', 'among', 'the', 'selected', 'assays', 'there', 'is', 'a', 'wide', 'diversity', 'in', 'assay', 'performance', 'in', 'different', 'scenarios', 'and', 'when', 'correlated', 'to', 'virus', 'neutralizing', 'antibodies', 'The', 'Wantai', 'ELISA', 'detecting', 'total', 'immunoglobulins', 'against', 'the', 'receptor', 'binding', 'domain', 'of', 'SARS', 'CoV', '2', 'has', 'the', 'best', 'overall', 'characteristics', 'to', 'detect', 'functional', 'antibodies', 'in', 'different', 'stages', 'and', 'severity', 'of', 'disease', 'including', 'the', 'potential', 'to', 'set', 'a', 'cut', 'off', 'indicating', 'the', 'presence', 'of', 'protective', 'antibodies', 'The', 'large', 'variety', 'of', 'available', 'serological', 'assays', 'requires', 'proper', 'assay', 'validation', 'before', 'deciding', 'on', 'deployment', 'of', 'assays', 'for', 'specific', 'applications', '']"
129250,Recent advances in lab-on-a-chip technologies for viral diagnosis,2020,Biosens Bioelectron,,"The global risk of viral disease outbreaks emphasizes the need for rapid, accurate, and sensitive detection techniques to speed up diagnostics allowing early intervention. An emerging field of microfluidics also known as the lab-on-a-chip (LOC) or micro total analysis system includes a wide range of diagnostic devices. This review briefly covers both conventional and microfluidics-based techniques for rapid viral detection. We first describe conventional detection methods such as cell culturing, immunofluorescence or enzyme-linked immunosorbent assay (ELISA), or reverse transcription polymerase chain reaction (RT-PCR). These methods often have limited speed, sensitivity, or specificity and are performed with typically bulky equipment. Here, we discuss some of the LOC technologies that can overcome these demerits, highlighting the latest advances in LOC devices for viral disease diagnosis. We also discuss the fabrication of LOC systems to produce devices for performing either individual steps or virus detection in samples with the sample to answer method. The complete system consists of sample preparation, and ELISA and RT-PCR for viral-antibody and nucleic acid detection, respectively. Finally, we formulate our opinions on these areas for the future development of LOC systems for viral diagnostics.",,u9s272m5,"['The', 'global', 'risk', 'of', 'viral', 'disease', 'outbreaks', 'emphasizes', 'the', 'need', 'for', 'rapid', 'accurate', 'and', 'sensitive', 'detection', 'techniques', 'to', 'speed', 'up', 'diagnostics', 'allowing', 'early', 'intervention', 'An', 'emerging', 'field', 'of', 'microfluidics', 'also', 'known', 'as', 'the', 'lab', 'on', 'a', 'chip', 'LOC', 'or', 'micro', 'total', 'analysis', 'system', 'includes', 'a', 'wide', 'range', 'of', 'diagnostic', 'devices', 'This', 'review', 'briefly', 'covers', 'both', 'conventional', 'and', 'microfluidics', 'based', 'techniques', 'for', 'rapid', 'viral', 'detection', 'We', 'first', 'describe', 'conventional', 'detection', 'methods', 'such', 'as', 'cell', 'culturing', 'immunofluorescence', 'or', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'or', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'These', 'methods', 'often', 'have', 'limited', 'speed', 'sensitivity', 'or', 'specificity', 'and', 'are', 'performed', 'with', 'typically', 'bulky', 'equipment', 'Here', 'we', 'discuss', 'some', 'of', 'the', 'LOC', 'technologies', 'that', 'can', 'overcome', 'these', 'demerits', 'highlighting', 'the', 'latest', 'advances', 'in', 'LOC', 'devices', 'for', 'viral', 'disease', 'diagnosis', 'We', 'also', 'discuss', 'the', 'fabrication', 'of', 'LOC', 'systems', 'to', 'produce', 'devices', 'for', 'performing', 'either', 'individual', 'steps', 'or', 'virus', 'detection', 'in', 'samples', 'with', 'the', 'sample', 'to', 'answer', 'method', 'The', 'complete', 'system', 'consists', 'of', 'sample', 'preparation', 'and', 'ELISA', 'and', 'RT', 'PCR', 'for', 'viral', 'antibody', 'and', 'nucleic', 'acid', 'detection', 'respectively', 'Finally', 'we', 'formulate', 'our', 'opinions', 'on', 'these', 'areas', 'for', 'the', 'future', 'development', 'of', 'LOC', 'systems', 'for', 'viral', 'diagnostics', '']"
131260,The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks,2020,Clin Chem Lab Med,,"Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume the relevance of insidious worldwide threat. One obvious question that is now engaging the minds of many scientists and healthcare professionals is whether and eventually how laboratory medicine could efficiently contribute to counteract this and other (future) viral outbreaks. Despite there being evidence that laboratory tests are vital throughout many clinical pathways, there are at least three major areas where in vitro diagnostics can also provide essential contributions to diagnostic reasoning and managed care of patients with suspected or confirmed SARS-CoV-2 infection. These include etiological diagnosis, patient monitoring, as well as epidemiologic surveillance. Nonetheless, some structural and practical aspects may generate substantial hurdles in providing timely and efficient response to this infectious emergency, which basically include inadequate (insufficient) environment and shortage of technical and human resources for facing enhanced volume of tests on many infected patients, some of whom are with severe disease. Some proactive and reactive strategies may hence be identified to confront this serious healthcare challenge, which entail major investments on conventional laboratory resources, reinforcement of regional networks of clinical laboratories, installation of mobile laboratories, as well as being proactive in establishing laboratory emergency plans.",,2uaicw30,"['Coronavirus', 'disease', '2019', 'abbreviated', 'to', 'COVID', '19', 'and', 'sustained', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'latest', 'biological', 'hazard', 'to', 'assume', 'the', 'relevance', 'of', 'insidious', 'worldwide', 'threat', 'One', 'obvious', 'question', 'that', 'is', 'now', 'engaging', 'the', 'minds', 'of', 'many', 'scientists', 'and', 'healthcare', 'professionals', 'is', 'whether', 'and', 'eventually', 'how', 'laboratory', 'medicine', 'could', 'efficiently', 'contribute', 'to', 'counteract', 'this', 'and', 'other', 'future', 'viral', 'outbreaks', 'Despite', 'there', 'being', 'evidence', 'that', 'laboratory', 'tests', 'are', 'vital', 'throughout', 'many', 'clinical', 'pathways', 'there', 'are', 'at', 'least', 'three', 'major', 'areas', 'where', 'in', 'vitro', 'diagnostics', 'can', 'also', 'provide', 'essential', 'contributions', 'to', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'patients', 'with', 'suspected', 'or', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'These', 'include', 'etiological', 'diagnosis', 'patient', 'monitoring', 'as', 'well', 'as', 'epidemiologic', 'surveillance', 'Nonetheless', 'some', 'structural', 'and', 'practical', 'aspects', 'may', 'generate', 'substantial', 'hurdles', 'in', 'providing', 'timely', 'and', 'efficient', 'response', 'to', 'this', 'infectious', 'emergency', 'which', 'basically', 'include', 'inadequate', 'insufficient', 'environment', 'and', 'shortage', 'of', 'technical', 'and', 'human', 'resources', 'for', 'facing', 'enhanced', 'volume', 'of', 'tests', 'on', 'many', 'infected', 'patients', 'some', 'of', 'whom', 'are', 'with', 'severe', 'disease', 'Some', 'proactive', 'and', 'reactive', 'strategies', 'may', 'hence', 'be', 'identified', 'to', 'confront', 'this', 'serious', 'healthcare', 'challenge', 'which', 'entail', 'major', 'investments', 'on', 'conventional', 'laboratory', 'resources', 'reinforcement', 'of', 'regional', 'networks', 'of', 'clinical', 'laboratories', 'installation', 'of', 'mobile', 'laboratories', 'as', 'well', 'as', 'being', 'proactive', 'in', 'establishing', 'laboratory', 'emergency', 'plans', '']"
131334,Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature,2020,Allergol. immunopatol,,"Coronavirus disease 2019 (COVID-19) named by the WHO as a result of the global public health emergency. COVID-19 is caused by a new coronavirus named as novel coronavirus (2019-nCOV). From the first case reported in December 2019 it is now a pandemic situation and a major public health emergency. The COVID-19 transmission rate is very high, infecting two to three persons on average with contact to an already infected person. There is a need for the health system, specially in developing countries such as in Pakistan, to combat such a novel disease by rapid, accurate, and high quality diagnostic testing in order to screen suspected cases and also surveillance of the disease. A rapid, accurate and low-cost diagnostic point-of-care device is needed for timely diagnosis of COVID-19 and is essential to combat such outbreaks for compelling preventive measures against the disease spread. This review is to highlight the importance of point-of-care diagnostics device for robust and accurate diagnosis of COVID-19 in physician offices and other urgent healthcare-type settings and encourage academics and stake holders towards advancement in order to control outbreaks and develop the public health surveillance system.",,yvsv8ns2,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'named', 'by', 'the', 'WHO', 'as', 'a', 'result', 'of', 'the', 'global', 'public', 'health', 'emergency', 'COVID', '19', 'is', 'caused', 'by', 'a', 'new', 'coronavirus', 'named', 'as', 'novel', 'coronavirus', '2019', 'nCOV', 'From', 'the', 'first', 'case', 'reported', 'in', 'December', '2019', 'it', 'is', 'now', 'a', 'pandemic', 'situation', 'and', 'a', 'major', 'public', 'health', 'emergency', 'The', 'COVID', '19', 'transmission', 'rate', 'is', 'very', 'high', 'infecting', 'two', 'to', 'three', 'persons', 'on', 'average', 'with', 'contact', 'to', 'an', 'already', 'infected', 'person', 'There', 'is', 'a', 'need', 'for', 'the', 'health', 'system', 'specially', 'in', 'developing', 'countries', 'such', 'as', 'in', 'Pakistan', 'to', 'combat', 'such', 'a', 'novel', 'disease', 'by', 'rapid', 'accurate', 'and', 'high', 'quality', 'diagnostic', 'testing', 'in', 'order', 'to', 'screen', 'suspected', 'cases', 'and', 'also', 'surveillance', 'of', 'the', 'disease', 'A', 'rapid', 'accurate', 'and', 'low', 'cost', 'diagnostic', 'point', 'of', 'care', 'device', 'is', 'needed', 'for', 'timely', 'diagnosis', 'of', 'COVID', '19', 'and', 'is', 'essential', 'to', 'combat', 'such', 'outbreaks', 'for', 'compelling', 'preventive', 'measures', 'against', 'the', 'disease', 'spread', 'This', 'review', 'is', 'to', 'highlight', 'the', 'importance', 'of', 'point', 'of', 'care', 'diagnostics', 'device', 'for', 'robust', 'and', 'accurate', 'diagnosis', 'of', 'COVID', '19', 'in', 'physician', 'offices', 'and', 'other', 'urgent', 'healthcare', 'type', 'settings', 'and', 'encourage', 'academics', 'and', 'stake', 'holders', 'towards', 'advancement', 'in', 'order', 'to', 'control', 'outbreaks', 'and', 'develop', 'the', 'public', 'health', 'surveillance', 'system', '']"
132062,COVID 19 diagnostic multiplicity and its role in community surveillance and control,2020,Le infezioni in medicina,,"Diagnosis of persons exposed to/infected with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is central to controlling the global pandemic of COVID-19 Currently, several diagnostic modalities are available for COVID-19, each with its own pros and cons Although there is a global consensus to increase the testing capacity, it is also essential to prudently utilize these tests to control the pandemic In this paper, we have reviewed the current array of diagnostics for SARS-CoV-2, highlighted the gaps in current diagnostic modalities, and their role in community surveillance and control of the pandemic The different modalities of COVID-19 diagnosis discussed are: clinical and radiological, molecular based (laboratory based and point-of-care), Immunoassay based (ELISA, rapid antigen and antibody detection tests) and digital diagnostics (artificial intelligence based algorithms) The role of rapid antigen/antibody detection tests in community surveillance has also been described here These tests can be used to identify asymptomatic persons exposed to the virus and in community based seroprevalence surveys to assess the epidemiology of spread of the virus However, there are few concerns about the accuracy of these tests which needs to evaluated beforehand",,kuk0scmr,"['Diagnosis', 'of', 'persons', 'exposed', 'to', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'central', 'to', 'controlling', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'Currently', 'several', 'diagnostic', 'modalities', 'are', 'available', 'for', 'COVID', '19', 'each', 'with', 'its', 'own', 'pros', 'and', 'cons', 'Although', 'there', 'is', 'a', 'global', 'consensus', 'to', 'increase', 'the', 'testing', 'capacity', 'it', 'is', 'also', 'essential', 'to', 'prudently', 'utilize', 'these', 'tests', 'to', 'control', 'the', 'pandemic', 'In', 'this', 'paper', 'we', 'have', 'reviewed', 'the', 'current', 'array', 'of', 'diagnostics', 'for', 'SARS', 'CoV', '2', 'highlighted', 'the', 'gaps', 'in', 'current', 'diagnostic', 'modalities', 'and', 'their', 'role', 'in', 'community', 'surveillance', 'and', 'control', 'of', 'the', 'pandemic', 'The', 'different', 'modalities', 'of', 'COVID', '19', 'diagnosis', 'discussed', 'are', 'clinical', 'and', 'radiological', 'molecular', 'based', 'laboratory', 'based', 'and', 'point', 'of', 'care', 'Immunoassay', 'based', 'ELISA', 'rapid', 'antigen', 'and', 'antibody', 'detection', 'tests', 'and', 'digital', 'diagnostics', 'artificial', 'intelligence', 'based', 'algorithms', 'The', 'role', 'of', 'rapid', 'antigen', 'antibody', 'detection', 'tests', 'in', 'community', 'surveillance', 'has', 'also', 'been', 'described', 'here', 'These', 'tests', 'can', 'be', 'used', 'to', 'identify', 'asymptomatic', 'persons', 'exposed', 'to', 'the', 'virus', 'and', 'in', 'community', 'based', 'seroprevalence', 'surveys', 'to', 'assess', 'the', 'epidemiology', 'of', 'spread', 'of', 'the', 'virus', 'However', 'there', 'are', 'few', 'concerns', 'about', 'the', 'accuracy', 'of', 'these', 'tests', 'which', 'needs', 'to', 'evaluated', 'beforehand']"
132393,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020,Clin. infect. dis,,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA's goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",,gp4i8xhv,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
132394,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020,Clin. infect. dis,,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA's goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",,pcc40byf,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
132395,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020,Clin. infect. dis,,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA's goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",,gsp5tm1f,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
132892,Dynamic linkage of COVID-19 test results between Public Health England's Second Generation Surveillance System and UK Biobank,2020,Microb. genom,,"UK Biobank (UKB) is an international health resource enabling research into the genetic and lifestyle determinants of common diseases of middle and older age. It comprises 500â000 participants. Public Health England's Second Generation Surveillance System is a centralized microbiology database covering English clinical diagnostics laboratories that provides national surveillance of legally notifiable infections, bacterial isolations and antimicrobial resistance. We previously developed secure, pseudonymized, individual-level linkage of these systems. In this study, we implemented rapid dynamic linkage, which allows us to provide a regular feed of new COVID-19 (SARS-CoV-2) test results to UKB to facilitate rapid and urgent research into the epidemiological and human genetic risk factors for severe infection in the cohort. Here, we have characterized the first 1352 cases of COVID-19 in UKB participants, of whom 895 met our working definition of severe COVID-19 as inpatients hospitalized on or after 16 March 2020. We found that the incidence of severe COVID-19 among UKB cases was 27.4â% lower than the general population in England, although this difference varied significantly by age and sex. The total number of UKB cases could be estimated as 0.6â% of the publicly announced number of cases in England. We considered how increasing case numbers will affect the power of genome-wide association studies. This new dynamic linkage system has further potential to facilitate the investigation of other infections and the prospective collection of microbiological cultures to create a microbiological biobank (bugbank) for studying the interaction of environment, human and microbial genetics on infection in the UKB cohort.",,b7o9n6cz,"['UK', 'Biobank', 'UKB', 'is', 'an', 'international', 'health', 'resource', 'enabling', 'research', 'into', 'the', 'genetic', 'and', 'lifestyle', 'determinants', 'of', 'common', 'diseases', 'of', 'middle', 'and', 'older', 'age', 'It', 'comprises', '500â', '000', 'participants', 'Public', 'Health', 'England', 's', 'Second', 'Generation', 'Surveillance', 'System', 'is', 'a', 'centralized', 'microbiology', 'database', 'covering', 'English', 'clinical', 'diagnostics', 'laboratories', 'that', 'provides', 'national', 'surveillance', 'of', 'legally', 'notifiable', 'infections', 'bacterial', 'isolations', 'and', 'antimicrobial', 'resistance', 'We', 'previously', 'developed', 'secure', 'pseudonymized', 'individual', 'level', 'linkage', 'of', 'these', 'systems', 'In', 'this', 'study', 'we', 'implemented', 'rapid', 'dynamic', 'linkage', 'which', 'allows', 'us', 'to', 'provide', 'a', 'regular', 'feed', 'of', 'new', 'COVID', '19', 'SARS', 'CoV', '2', 'test', 'results', 'to', 'UKB', 'to', 'facilitate', 'rapid', 'and', 'urgent', 'research', 'into', 'the', 'epidemiological', 'and', 'human', 'genetic', 'risk', 'factors', 'for', 'severe', 'infection', 'in', 'the', 'cohort', 'Here', 'we', 'have', 'characterized', 'the', 'first', '1352', 'cases', 'of', 'COVID', '19', 'in', 'UKB', 'participants', 'of', 'whom', '895', 'met', 'our', 'working', 'definition', 'of', 'severe', 'COVID', '19', 'as', 'inpatients', 'hospitalized', 'on', 'or', 'after', '16', 'March', '2020', 'We', 'found', 'that', 'the', 'incidence', 'of', 'severe', 'COVID', '19', 'among', 'UKB', 'cases', 'was', '27', '4â', 'lower', 'than', 'the', 'general', 'population', 'in', 'England', 'although', 'this', 'difference', 'varied', 'significantly', 'by', 'age', 'and', 'sex', 'The', 'total', 'number', 'of', 'UKB', 'cases', 'could', 'be', 'estimated', 'as', '0', '6â', 'of', 'the', 'publicly', 'announced', 'number', 'of', 'cases', 'in', 'England', 'We', 'considered', 'how', 'increasing', 'case', 'numbers', 'will', 'affect', 'the', 'power', 'of', 'genome', 'wide', 'association', 'studies', 'This', 'new', 'dynamic', 'linkage', 'system', 'has', 'further', 'potential', 'to', 'facilitate', 'the', 'investigation', 'of', 'other', 'infections', 'and', 'the', 'prospective', 'collection', 'of', 'microbiological', 'cultures', 'to', 'create', 'a', 'microbiological', 'biobank', 'bugbank', 'for', 'studying', 'the', 'interaction', 'of', 'environment', 'human', 'and', 'microbial', 'genetics', 'on', 'infection', 'in', 'the', 'UKB', 'cohort', '']"
132893,Dynamic linkage of COVID-19 test results between Public Health England's Second Generation Surveillance System and UK Biobank,2020,Microb. genom,,"UK Biobank (UKB) is an international health resource enabling research into the genetic and lifestyle determinants of common diseases of middle and older age. It comprises 500â000 participants. Public Health England's Second Generation Surveillance System is a centralized microbiology database covering English clinical diagnostics laboratories that provides national surveillance of legally notifiable infections, bacterial isolations and antimicrobial resistance. We previously developed secure, pseudonymized, individual-level linkage of these systems. In this study, we implemented rapid dynamic linkage, which allows us to provide a regular feed of new COVID-19 (SARS-CoV-2) test results to UKB to facilitate rapid and urgent research into the epidemiological and human genetic risk factors for severe infection in the cohort. Here, we have characterized the first 1352 cases of COVID-19 in UKB participants, of whom 895 met our working definition of severe COVID-19 as inpatients hospitalized on or after 16 March 2020. We found that the incidence of severe COVID-19 among UKB cases was 27.4â% lower than the general population in England, although this difference varied significantly by age and sex. The total number of UKB cases could be estimated as 0.6â% of the publicly announced number of cases in England. We considered how increasing case numbers will affect the power of genome-wide association studies. This new dynamic linkage system has further potential to facilitate the investigation of other infections and the prospective collection of microbiological cultures to create a microbiological biobank (bugbank) for studying the interaction of environment, human and microbial genetics on infection in the UKB cohort.",,9ekyw7j6,"['UK', 'Biobank', 'UKB', 'is', 'an', 'international', 'health', 'resource', 'enabling', 'research', 'into', 'the', 'genetic', 'and', 'lifestyle', 'determinants', 'of', 'common', 'diseases', 'of', 'middle', 'and', 'older', 'age', 'It', 'comprises', '500â', '000', 'participants', 'Public', 'Health', 'England', 's', 'Second', 'Generation', 'Surveillance', 'System', 'is', 'a', 'centralized', 'microbiology', 'database', 'covering', 'English', 'clinical', 'diagnostics', 'laboratories', 'that', 'provides', 'national', 'surveillance', 'of', 'legally', 'notifiable', 'infections', 'bacterial', 'isolations', 'and', 'antimicrobial', 'resistance', 'We', 'previously', 'developed', 'secure', 'pseudonymized', 'individual', 'level', 'linkage', 'of', 'these', 'systems', 'In', 'this', 'study', 'we', 'implemented', 'rapid', 'dynamic', 'linkage', 'which', 'allows', 'us', 'to', 'provide', 'a', 'regular', 'feed', 'of', 'new', 'COVID', '19', 'SARS', 'CoV', '2', 'test', 'results', 'to', 'UKB', 'to', 'facilitate', 'rapid', 'and', 'urgent', 'research', 'into', 'the', 'epidemiological', 'and', 'human', 'genetic', 'risk', 'factors', 'for', 'severe', 'infection', 'in', 'the', 'cohort', 'Here', 'we', 'have', 'characterized', 'the', 'first', '1352', 'cases', 'of', 'COVID', '19', 'in', 'UKB', 'participants', 'of', 'whom', '895', 'met', 'our', 'working', 'definition', 'of', 'severe', 'COVID', '19', 'as', 'inpatients', 'hospitalized', 'on', 'or', 'after', '16', 'March', '2020', 'We', 'found', 'that', 'the', 'incidence', 'of', 'severe', 'COVID', '19', 'among', 'UKB', 'cases', 'was', '27', '4â', 'lower', 'than', 'the', 'general', 'population', 'in', 'England', 'although', 'this', 'difference', 'varied', 'significantly', 'by', 'age', 'and', 'sex', 'The', 'total', 'number', 'of', 'UKB', 'cases', 'could', 'be', 'estimated', 'as', '0', '6â', 'of', 'the', 'publicly', 'announced', 'number', 'of', 'cases', 'in', 'England', 'We', 'considered', 'how', 'increasing', 'case', 'numbers', 'will', 'affect', 'the', 'power', 'of', 'genome', 'wide', 'association', 'studies', 'This', 'new', 'dynamic', 'linkage', 'system', 'has', 'further', 'potential', 'to', 'facilitate', 'the', 'investigation', 'of', 'other', 'infections', 'and', 'the', 'prospective', 'collection', 'of', 'microbiological', 'cultures', 'to', 'create', 'a', 'microbiological', 'biobank', 'bugbank', 'for', 'studying', 'the', 'interaction', 'of', 'environment', 'human', 'and', 'microbial', 'genetics', 'on', 'infection', 'in', 'the', 'UKB', 'cohort', '']"
133633,COVID-19 Clinical Diagnostics and Testing Technology,2020,Pharmacotherapy,,"Given the global nature of the COVID-19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS-CoV-2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID-19 diagnostics on the horizon. Antibody response against SARS-CoV-2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",,afcd4wc9,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
133754,Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation,2020,J Clin Virol,,"There is an urgent need for reliable high-throughput serological assays for the management of the ongoing COVID-19 pandemic. Preferably, the performance of serological tests for a novel virus should be determined with clinical specimens against a gold standard, i.e. virus neutralisation. We compared the performance of six commercial immunoassays for the detection of SARS-COV-2 IgG, IgA and IgM antibodies, including four automated assays [Abbott SARS-COV-2 IgG (CE marked), Diasorin Liaison® SARS-COV-2 S1/S2 IgG (research use only, RUO), and Euroimmun SARS-COV-2 IgG and IgA (CE marked)], and two rapid lateral flow (immunocromatographic) tests [Acro Biotech 2019-nCoV IgG/IgM (CE marked) and Xiamen Biotime Biotechnology SARS-COV-2 IgG/IgM (CE marked)] with a microneutralisation test (MNT). Two specimen panels from serum samples sent to Helsinki University Hospital Laboratory (HUSLAB) were compiled: the patient panel (N=70) included sera from PCR confirmed COVID-19 patients, and the negative panel (N=81) included sera sent for screening of autoimmune diseases and respiratory virus antibodies in 2018 and 2019. The MNT was carried out for all COVID-19 samples (70 serum samples, 62 individuals) and for 53 samples from the negative panel. Forty-one out of 62 COVID-19 patients showed neutralising antibodies.The specificity and sensitivity values of the commercial tests against MNT, respectively, were as follows: 95.1 %/80.5 % (Abbott Architect SARS-CoV-2 IgG), 94.9 %/43.8 % (Diasorin Liaison SARS-CoV-2 IgG; RUO), 68.3 %/87.8 % (Euroimmun SARS-CoV-2 IgA), 86.6 %/70.7 % (Euroimmun SARS-CoV-2 IgG), 74.4 %/56.1 % (Acro 2019-nCoV IgG), 69.5 %/46.3 % (Acro 2019-nCoV IgM), 97.5 %/71.9 % (Xiamen Biotime SARS-CoV-2 IgG), and 88.8 %/81.3 % (Xiamen Biotime SARS-CoV-2 IgM). This study shows variable performance values. Laboratories should carefully consider their testing process, such as a two-tier approach, in order to optimize the overall performance of SARS- CoV-2 serodiagnostics.",,4n7ax0gg,"['There', 'is', 'an', 'urgent', 'need', 'for', 'reliable', 'high', 'throughput', 'serological', 'assays', 'for', 'the', 'management', 'of', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'Preferably', 'the', 'performance', 'of', 'serological', 'tests', 'for', 'a', 'novel', 'virus', 'should', 'be', 'determined', 'with', 'clinical', 'specimens', 'against', 'a', 'gold', 'standard', 'i', 'e', 'virus', 'neutralisation', 'We', 'compared', 'the', 'performance', 'of', 'six', 'commercial', 'immunoassays', 'for', 'the', 'detection', 'of', 'SARS', 'COV', '2', 'IgG', 'IgA', 'and', 'IgM', 'antibodies', 'including', 'four', 'automated', 'assays', 'Abbott', 'SARS', 'COV', '2', 'IgG', 'CE', 'marked', 'Diasorin', 'Liaison', 'SARS', 'COV', '2', 'S1', 'S2', 'IgG', 'research', 'use', 'only', 'RUO', 'and', 'Euroimmun', 'SARS', 'COV', '2', 'IgG', 'and', 'IgA', 'CE', 'marked', 'and', 'two', 'rapid', 'lateral', 'flow', 'immunocromatographic', 'tests', 'Acro', 'Biotech', '2019', 'nCoV', 'IgG', 'IgM', 'CE', 'marked', 'and', 'Xiamen', 'Biotime', 'Biotechnology', 'SARS', 'COV', '2', 'IgG', 'IgM', 'CE', 'marked', 'with', 'a', 'microneutralisation', 'test', 'MNT', 'Two', 'specimen', 'panels', 'from', 'serum', 'samples', 'sent', 'to', 'Helsinki', 'University', 'Hospital', 'Laboratory', 'HUSLAB', 'were', 'compiled', 'the', 'patient', 'panel', 'N', '70', 'included', 'sera', 'from', 'PCR', 'confirmed', 'COVID', '19', 'patients', 'and', 'the', 'negative', 'panel', 'N', '81', 'included', 'sera', 'sent', 'for', 'screening', 'of', 'autoimmune', 'diseases', 'and', 'respiratory', 'virus', 'antibodies', 'in', '2018', 'and', '2019', 'The', 'MNT', 'was', 'carried', 'out', 'for', 'all', 'COVID', '19', 'samples', '70', 'serum', 'samples', '62', 'individuals', 'and', 'for', '53', 'samples', 'from', 'the', 'negative', 'panel', 'Forty', 'one', 'out', 'of', '62', 'COVID', '19', 'patients', 'showed', 'neutralising', 'antibodies', 'The', 'specificity', 'and', 'sensitivity', 'values', 'of', 'the', 'commercial', 'tests', 'against', 'MNT', 'respectively', 'were', 'as', 'follows', '95', '1', '80', '5', 'Abbott', 'Architect', 'SARS', 'CoV', '2', 'IgG', '94', '9', '43', '8', 'Diasorin', 'Liaison', 'SARS', 'CoV', '2', 'IgG', 'RUO', '68', '3', '87', '8', 'Euroimmun', 'SARS', 'CoV', '2', 'IgA', '86', '6', '70', '7', 'Euroimmun', 'SARS', 'CoV', '2', 'IgG', '74', '4', '56', '1', 'Acro', '2019', 'nCoV', 'IgG', '69', '5', '46', '3', 'Acro', '2019', 'nCoV', 'IgM', '97', '5', '71', '9', 'Xiamen', 'Biotime', 'SARS', 'CoV', '2', 'IgG', 'and', '88', '8', '81', '3', 'Xiamen', 'Biotime', 'SARS', 'CoV', '2', 'IgM', 'This', 'study', 'shows', 'variable', 'performance', 'values', 'Laboratories', 'should', 'carefully', 'consider', 'their', 'testing', 'process', 'such', 'as', 'a', 'two', 'tier', 'approach', 'in', 'order', 'to', 'optimize', 'the', 'overall', 'performance', 'of', 'SARS', 'CoV', '2', 'serodiagnostics', '']"
133861,"The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors",2020,,,"Our work concerns the actual problem of spread of SARS- CoV-2 outbreak which requires fast and correct as possible answer. In current scenario, the need of rapid answer put away the imperative of proper methodology. We focus on the serogical immunoassay for diagnosis of Covid-19 as an important weapon not only for diagnostic purpose, but also for epidemiologic one. The right equilibrium between high speed, low cost and accuracy is obtained with easy-to-use decentralized point-of-care test as the colloidal gold-based immunochromatographic strip assay which detects IgM and IgG antibodies directed against SARS-CoV-2. As our aim is to evaluate the efficacy of Covid-19 rapid tests and of serological assays in real-life settings, we designed a research protocol aimed to establish how to use correctly these diagnostics, taking into account the different possible clinical and epidemiological scenarios.",,xaw3t7tf,"['Our', 'work', 'concerns', 'the', 'actual', 'problem', 'of', 'spread', 'of', 'SARS', 'CoV', '2', 'outbreak', 'which', 'requires', 'fast', 'and', 'correct', 'as', 'possible', 'answer', 'In', 'current', 'scenario', 'the', 'need', 'of', 'rapid', 'answer', 'put', 'away', 'the', 'imperative', 'of', 'proper', 'methodology', 'We', 'focus', 'on', 'the', 'serogical', 'immunoassay', 'for', 'diagnosis', 'of', 'Covid', '19', 'as', 'an', 'important', 'weapon', 'not', 'only', 'for', 'diagnostic', 'purpose', 'but', 'also', 'for', 'epidemiologic', 'one', 'The', 'right', 'equilibrium', 'between', 'high', 'speed', 'low', 'cost', 'and', 'accuracy', 'is', 'obtained', 'with', 'easy', 'to', 'use', 'decentralized', 'point', 'of', 'care', 'test', 'as', 'the', 'colloidal', 'gold', 'based', 'immunochromatographic', 'strip', 'assay', 'which', 'detects', 'IgM', 'and', 'IgG', 'antibodies', 'directed', 'against', 'SARS', 'CoV', '2', 'As', 'our', 'aim', 'is', 'to', 'evaluate', 'the', 'efficacy', 'of', 'Covid', '19', 'rapid', 'tests', 'and', 'of', 'serological', 'assays', 'in', 'real', 'life', 'settings', 'we', 'designed', 'a', 'research', 'protocol', 'aimed', 'to', 'establish', 'how', 'to', 'use', 'correctly', 'these', 'diagnostics', 'taking', 'into', 'account', 'the', 'different', 'possible', 'clinical', 'and', 'epidemiological', 'scenarios', '']"
137306,COVID-19: An update on diagnostic and therapeutic approaches,2020,BMB reports,,"The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused severe panic among people worldwide COVID-19 has created havoc, and scientists and physicians are urged to test the efficiency and safety of drugs used to treat this disease In such a pandemic situation, various steps have been taken by government to control and prevent the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) This pandemic situation has forced scientists to rework strategies to combat infectious diseases through drugs, treatment, and control measures COVID-19 treatment requires both limiting viral multiplication and neutralizing tissue damage induced by inappropriate immune reaction Currently, various diagnostic kits to test for COVID-19 are available, and repurposing therapeutics for COVID-19 has shown to be clinically effective As the global demand for diagnostics and therapeutics continues to rise, it is essential to rapidly develop various algorithms to successfully identify and contain the virus This review discusses the updates on specimens/samples, recent efficient diagnostics, and therapeutic approaches to control the disease and repurposed drugs mainly focusing on chloroquine/hydroxychloroquine and convalescent plasma (CP) More research is required for further understanding of the influence of diagnostics and therapeutic approaches to developing vaccines and drugs for COVID-19",,0ikvdwkz,"['The', 'unexpected', 'pandemic', 'set', 'off', 'by', 'the', 'novel', 'coronavirus', '2019', 'COVID', '19', 'has', 'caused', 'severe', 'panic', 'among', 'people', 'worldwide', 'COVID', '19', 'has', 'created', 'havoc', 'and', 'scientists', 'and', 'physicians', 'are', 'urged', 'to', 'test', 'the', 'efficiency', 'and', 'safety', 'of', 'drugs', 'used', 'to', 'treat', 'this', 'disease', 'In', 'such', 'a', 'pandemic', 'situation', 'various', 'steps', 'have', 'been', 'taken', 'by', 'government', 'to', 'control', 'and', 'prevent', 'the', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'This', 'pandemic', 'situation', 'has', 'forced', 'scientists', 'to', 'rework', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'through', 'drugs', 'treatment', 'and', 'control', 'measures', 'COVID', '19', 'treatment', 'requires', 'both', 'limiting', 'viral', 'multiplication', 'and', 'neutralizing', 'tissue', 'damage', 'induced', 'by', 'inappropriate', 'immune', 'reaction', 'Currently', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'COVID', '19', 'are', 'available', 'and', 'repurposing', 'therapeutics', 'for', 'COVID', '19', 'has', 'shown', 'to', 'be', 'clinically', 'effective', 'As', 'the', 'global', 'demand', 'for', 'diagnostics', 'and', 'therapeutics', 'continues', 'to', 'rise', 'it', 'is', 'essential', 'to', 'rapidly', 'develop', 'various', 'algorithms', 'to', 'successfully', 'identify', 'and', 'contain', 'the', 'virus', 'This', 'review', 'discusses', 'the', 'updates', 'on', 'specimens', 'samples', 'recent', 'efficient', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'control', 'the', 'disease', 'and', 'repurposed', 'drugs', 'mainly', 'focusing', 'on', 'chloroquine', 'hydroxychloroquine', 'and', 'convalescent', 'plasma', 'CP', 'More', 'research', 'is', 'required', 'for', 'further', 'understanding', 'of', 'the', 'influence', 'of', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'developing', 'vaccines', 'and', 'drugs', 'for', 'COVID', '19']"
138433,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens,2020,J. clin. microbiol,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly nonspecific, and symptoms overlap those of other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19-positive patients. In the present study, we evaluated the analytical sensitivity and clinical performance of the following four SARS-CoV-2 molecular diagnostic assays granted emergency use authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (modified CDC) assay, the Simplexa COVID-19 Direct (Diasorin Molecular) assay, GenMark ePlex SARS-CoV-2 (GenMark) assay, and the Hologic Panther Fusion SARS-CoV-2 (Hologic) assay. This information is crucial for both laboratories and clinical teams as decisions on which testing platform to implement are made.",,mg2xl68q,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'the', 'novel', 'human', 'coronavirus', 'that', 'causes', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'first', 'discovered', 'in', 'December', '2019', 'as', 'the', 'cause', 'of', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'nonspecific', 'and', 'symptoms', 'overlap', 'those', 'of', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Furthermore', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'the', 'following', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'emergency', 'use', 'authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'the', 'New', 'York', 'SARS', 'CoV', '2', 'Real', 'time', 'Reverse', 'Transcriptase', 'RT', 'PCR', 'Diagnostic', 'Panel', 'modified', 'CDC', 'assay', 'the', 'Simplexa', 'COVID', '19', 'Direct', 'Diasorin', 'Molecular', 'assay', 'GenMark', 'ePlex', 'SARS', 'CoV', '2', 'GenMark', 'assay', 'and', 'the', 'Hologic', 'Panther', 'Fusion', 'SARS', 'CoV', '2', 'Hologic', 'assay', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
138434,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens,2020,J. clin. microbiol,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (Modified CDC), the Simplexa COVID-19 Direct (Diasorin Molecular), GenMark ePlex SARS-CoV-2 assay (GenMark) and the Hologic Panther Fusion® SARS-CoV-2 assay (Hologic). This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.",,78yzkodj,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'the', 'novel', 'human', 'coronavirus', 'that', 'causes', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'first', 'discovered', 'in', 'December', '2019', 'as', 'the', 'cause', 'of', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'non', 'specific', 'and', 'symptoms', 'overlap', 'with', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Furthermore', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'have', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'Emergency', 'Use', 'Authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'the', 'New', 'York', 'SARS', 'CoV', '2', 'Real', 'time', 'Reverse', 'Transcriptase', 'RT', 'PCR', 'Diagnostic', 'Panel', 'Modified', 'CDC', 'the', 'Simplexa', 'COVID', '19', 'Direct', 'Diasorin', 'Molecular', 'GenMark', 'ePlex', 'SARS', 'CoV', '2', 'assay', 'GenMark', 'and', 'the', 'Hologic', 'Panther', 'Fusion', 'SARS', 'CoV', '2', 'assay', 'Hologic', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
138444,Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review,2020,Ann Intern Med,,"Diagnostic testing to identify persons infected with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction-based assays performed in a laboratory on respiratory specimens are the reference standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging. Although excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, important gaps remain in screening asymptomatic persons in the incubation phase, as well as in the accurate determination of live viral shedding during convalescence to inform decisions to end isolation. Many affluent countries have encountered challenges in test delivery and specimen collection that have inhibited rapid increases in testing capacity. These challenges may be even greater in low-resource settings. Urgent clinical and public health needs currently drive an unprecedented global effort to increase testing capacity for SARS-CoV-2 infection. Here, the authors review the current array of tests for SARS-CoV-2, highlight gaps in current diagnostic capacity, and propose potential solutions.",,wnt1v675,"['Diagnostic', 'testing', 'to', 'identify', 'persons', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'infection', 'is', 'central', 'to', 'control', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'that', 'began', 'in', 'late', '2019', 'In', 'a', 'few', 'countries', 'the', 'use', 'of', 'diagnostic', 'testing', 'on', 'a', 'massive', 'scale', 'has', 'been', 'a', 'cornerstone', 'of', 'successful', 'containment', 'strategies', 'In', 'contrast', 'the', 'United', 'States', 'hampered', 'by', 'limited', 'testing', 'capacity', 'has', 'prioritized', 'testing', 'for', 'specific', 'groups', 'of', 'persons', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'based', 'assays', 'performed', 'in', 'a', 'laboratory', 'on', 'respiratory', 'specimens', 'are', 'the', 'reference', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'Although', 'excellent', 'tools', 'exist', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'in', 'well', 'equipped', 'laboratories', 'important', 'gaps', 'remain', 'in', 'screening', 'asymptomatic', 'persons', 'in', 'the', 'incubation', 'phase', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'to', 'end', 'isolation', 'Many', 'affluent', 'countries', 'have', 'encountered', 'challenges', 'in', 'test', 'delivery', 'and', 'specimen', 'collection', 'that', 'have', 'inhibited', 'rapid', 'increases', 'in', 'testing', 'capacity', 'These', 'challenges', 'may', 'be', 'even', 'greater', 'in', 'low', 'resource', 'settings', 'Urgent', 'clinical', 'and', 'public', 'health', 'needs', 'currently', 'drive', 'an', 'unprecedented', 'global', 'effort', 'to', 'increase', 'testing', 'capacity', 'for', 'SARS', 'CoV', '2', 'infection', 'Here', 'the', 'authors', 'review', 'the', 'current', 'array', 'of', 'tests', 'for', 'SARS', 'CoV', '2', 'highlight', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'propose', 'potential', 'solutions', '']"
140799,"Virus detections among patients with severe acute respiratory illness, Northern Vietnam",2020,PLoS One,,"Severe acute respiratory illness (SARI) is a major cause of death and morbidity in low- and middle-income countries, however, the etiologic agents are often undetermined due to the lack of molecular diagnostics in hospitals and clinics. To examine evidence for select viral infections among patients with SARI in northern Vietnam, we studied 348 nasopharyngeal samples from military and civilian patients admitted to 4 hospitals in the greater Hanoi area from 2017-2019. Initial screening for human respiratory viral pathogens was performed in Hanoi, Vietnam at the National Institute of Hygiene and Epidemiology (NIHE) or the Military Institute of Preventative Medicine (MIPM), and an aliquot was shipped to Duke-NUS Medical School in Singapore for validation. Patient demographics were recorded and used to epidemiologically describe the infections. Among military and civilian cases of SARI, 184 (52.9%) tested positive for one or more respiratory viruses. Influenza A virus was the most prevalent virus detected (64.7%), followed by influenza B virus (29.3%), enterovirus (3.8%), adenovirus (1.1%), and coronavirus (1.1%). Risk factor analyses demonstrated an increased risk of influenza A virus detection among military hospital patients (adjusted OR, 2.0; 95% CI, 1.2-3.2), and an increased risk of influenza B virus detection among patients enrolled in year 2017 (adjusted OR, 7.9; 95% CI, 2.7-22.9). As influenza A and B viruses were commonly associated with SARI and are treatable, SARI patients entering these hospitals would benefit if the hospitals were able to adapt onsite molecular diagnostics.",,y97ax058,"['Severe', 'acute', 'respiratory', 'illness', 'SARI', 'is', 'a', 'major', 'cause', 'of', 'death', 'and', 'morbidity', 'in', 'low', 'and', 'middle', 'income', 'countries', 'however', 'the', 'etiologic', 'agents', 'are', 'often', 'undetermined', 'due', 'to', 'the', 'lack', 'of', 'molecular', 'diagnostics', 'in', 'hospitals', 'and', 'clinics', 'To', 'examine', 'evidence', 'for', 'select', 'viral', 'infections', 'among', 'patients', 'with', 'SARI', 'in', 'northern', 'Vietnam', 'we', 'studied', '348', 'nasopharyngeal', 'samples', 'from', 'military', 'and', 'civilian', 'patients', 'admitted', 'to', '4', 'hospitals', 'in', 'the', 'greater', 'Hanoi', 'area', 'from', '2017', '2019', 'Initial', 'screening', 'for', 'human', 'respiratory', 'viral', 'pathogens', 'was', 'performed', 'in', 'Hanoi', 'Vietnam', 'at', 'the', 'National', 'Institute', 'of', 'Hygiene', 'and', 'Epidemiology', 'NIHE', 'or', 'the', 'Military', 'Institute', 'of', 'Preventative', 'Medicine', 'MIPM', 'and', 'an', 'aliquot', 'was', 'shipped', 'to', 'Duke', 'NUS', 'Medical', 'School', 'in', 'Singapore', 'for', 'validation', 'Patient', 'demographics', 'were', 'recorded', 'and', 'used', 'to', 'epidemiologically', 'describe', 'the', 'infections', 'Among', 'military', 'and', 'civilian', 'cases', 'of', 'SARI', '184', '52', '9', 'tested', 'positive', 'for', 'one', 'or', 'more', 'respiratory', 'viruses', 'Influenza', 'A', 'virus', 'was', 'the', 'most', 'prevalent', 'virus', 'detected', '64', '7', 'followed', 'by', 'influenza', 'B', 'virus', '29', '3', 'enterovirus', '3', '8', 'adenovirus', '1', '1', 'and', 'coronavirus', '1', '1', 'Risk', 'factor', 'analyses', 'demonstrated', 'an', 'increased', 'risk', 'of', 'influenza', 'A', 'virus', 'detection', 'among', 'military', 'hospital', 'patients', 'adjusted', 'OR', '2', '0', '95', 'CI', '1', '2', '3', '2', 'and', 'an', 'increased', 'risk', 'of', 'influenza', 'B', 'virus', 'detection', 'among', 'patients', 'enrolled', 'in', 'year', '2017', 'adjusted', 'OR', '7', '9', '95', 'CI', '2', '7', '22', '9', 'As', 'influenza', 'A', 'and', 'B', 'viruses', 'were', 'commonly', 'associated', 'with', 'SARI', 'and', 'are', 'treatable', 'SARI', 'patients', 'entering', 'these', 'hospitals', 'would', 'benefit', 'if', 'the', 'hospitals', 'were', 'able', 'to', 'adapt', 'onsite', 'molecular', 'diagnostics', '']"
141010,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020,,,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",,m95bmi9t,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
141349,Recombinase Polymerase Amplification for Diagnostic Applications,2016-07-01,Clin Chem,https://www.ncbi.nlm.nih.gov/pubmed/27160000/; https://doi.org/10.1373/clinchem.2015.245829,"BACKGROUND: First introduced in 2006, recombinase polymerase amplification (RPA) has stirred great interest, as evidenced by 75 publications as of October 2015, with 56 of them just in the last 2 years. The widespread adoption of this isothermal molecular tool in many diagnostic fields represents an affordable (approximately 4.3 USD per test), simple (few and easy hands-on steps), fast (results within 5–20 min), and sensitive (single target copy number detected) method for the identification of pathogens and the detection of single nucleotide polymorphisms in human cancers and genetically modified organisms. CONTENT: This review summarizes the current knowledge on RPA. The molecular diagnostics of various RNA/DNA pathogens is discussed while highlighting recent applications in clinical settings with focus on point-of-care (POC) bioassays and on automated fluidic platforms. The strengths and limitations of this isothermal method are also addressed. SUMMARY: RPA is becoming a molecular tool of choice for the rapid, specific, and cost-effective identification of pathogens. Owing to minimal sample-preparation requirements, low operation temperature (25–42 °C), and commercial availability of freeze-dried reagents, this method has been applied outside laboratory settings, in remote areas, and interestingly, onboard automated sample-to-answer microfluidic devices. RPA is undoubtedly a promising isothermal molecular technique for clinical microbiology laboratories and emergence response in clinical settings.",10.1373/clinchem.2015.245829,xk4w0iz5,"['BACKGROUND', 'First', 'introduced', 'in', '2006', 'recombinase', 'polymerase', 'amplification', 'RPA', 'has', 'stirred', 'great', 'interest', 'as', 'evidenced', 'by', '75', 'publications', 'as', 'of', 'October', '2015', 'with', '56', 'of', 'them', 'just', 'in', 'the', 'last', '2', 'years', 'The', 'widespread', 'adoption', 'of', 'this', 'isothermal', 'molecular', 'tool', 'in', 'many', 'diagnostic', 'fields', 'represents', 'an', 'affordable', 'approximately', '4', '3', 'USD', 'per', 'test', 'simple', 'few', 'and', 'easy', 'hands', 'on', 'steps', 'fast', 'results', 'within', '5', '20', 'min', 'and', 'sensitive', 'single', 'target', 'copy', 'number', 'detected', 'method', 'for', 'the', 'identification', 'of', 'pathogens', 'and', 'the', 'detection', 'of', 'single', 'nucleotide', 'polymorphisms', 'in', 'human', 'cancers', 'and', 'genetically', 'modified', 'organisms', 'CONTENT', 'This', 'review', 'summarizes', 'the', 'current', 'knowledge', 'on', 'RPA', 'The', 'molecular', 'diagnostics', 'of', 'various', 'RNA', 'DNA', 'pathogens', 'is', 'discussed', 'while', 'highlighting', 'recent', 'applications', 'in', 'clinical', 'settings', 'with', 'focus', 'on', 'point', 'of', 'care', 'POC', 'bioassays', 'and', 'on', 'automated', 'fluidic', 'platforms', 'The', 'strengths', 'and', 'limitations', 'of', 'this', 'isothermal', 'method', 'are', 'also', 'addressed', 'SUMMARY', 'RPA', 'is', 'becoming', 'a', 'molecular', 'tool', 'of', 'choice', 'for', 'the', 'rapid', 'specific', 'and', 'cost', 'effective', 'identification', 'of', 'pathogens', 'Owing', 'to', 'minimal', 'sample', 'preparation', 'requirements', 'low', 'operation', 'temperature', '25', '42', 'C', 'and', 'commercial', 'availability', 'of', 'freeze', 'dried', 'reagents', 'this', 'method', 'has', 'been', 'applied', 'outside', 'laboratory', 'settings', 'in', 'remote', 'areas', 'and', 'interestingly', 'onboard', 'automated', 'sample', 'to', 'answer', 'microfluidic', 'devices', 'RPA', 'is', 'undoubtedly', 'a', 'promising', 'isothermal', 'molecular', 'technique', 'for', 'clinical', 'microbiology', 'laboratories', 'and', 'emergence', 'response', 'in', 'clinical', 'settings', '']"
141361,"Social determinants, ethical issues and future challenge of tuberculosis in a pluralistic society: the example of Israel",2020-04-30,J Prev Med Hyg,https://www.ncbi.nlm.nih.gov/pubmed/32529102/; https://doi.org/10.15167/2421-4248/jpmh2020.61.1s1.1443,"Tuberculosis is a very serious respiratory infectious disease, caused by the bacillus Mycobacterium tuberculosis, which generates a relevant societal and clinical burden. It has always represented a permanent concern and a public health challenge over the course of human history, because of its severe epidemiological, and economic-financial implications. The present review aims at over-viewing the impact of tuberculosis on the Israeli healthcare system, its temporal trend and evolution, stratified according to ethnicities and minorities, the need of establishing new facilities and implementing screening techniques, public health strategies and diagnostic tests, following massive immigration waves from countries characterized by a high incidence rate of tuberculosis during the fifties-sixties until the nineties, and the policies implemented by the Israeli government in the control, management and treatment of tuberculosis, as well as the role played by Israeli prominent scientists in discovering new druggable targets and finding bioactive compounds and bio-molecules in the fight against tuberculosis. Israel represents a unique, living laboratory in which features of developed and developing countries mix together. This country as a case-study of immigrant, pluralistic society underlines the importance of adopting a culturally-sensitive community intervention approach. The understanding of the subtle interplay between race/ethnic host and pathogen factors, including the role of gene variations and polymorphisms can pave the way for a personalized treatment and management of tuberculosis patients, contributing to the development of new tools for targeted tuberculosis therapeutics, immunodiagnostics and vaccination products.",10.15167/2421-4248/jpmh2020.61.1s1.1443,yy3v8sos,"['Tuberculosis', 'is', 'a', 'very', 'serious', 'respiratory', 'infectious', 'disease', 'caused', 'by', 'the', 'bacillus', 'Mycobacterium', 'tuberculosis', 'which', 'generates', 'a', 'relevant', 'societal', 'and', 'clinical', 'burden', 'It', 'has', 'always', 'represented', 'a', 'permanent', 'concern', 'and', 'a', 'public', 'health', 'challenge', 'over', 'the', 'course', 'of', 'human', 'history', 'because', 'of', 'its', 'severe', 'epidemiological', 'and', 'economic', 'financial', 'implications', 'The', 'present', 'review', 'aims', 'at', 'over', 'viewing', 'the', 'impact', 'of', 'tuberculosis', 'on', 'the', 'Israeli', 'healthcare', 'system', 'its', 'temporal', 'trend', 'and', 'evolution', 'stratified', 'according', 'to', 'ethnicities', 'and', 'minorities', 'the', 'need', 'of', 'establishing', 'new', 'facilities', 'and', 'implementing', 'screening', 'techniques', 'public', 'health', 'strategies', 'and', 'diagnostic', 'tests', 'following', 'massive', 'immigration', 'waves', 'from', 'countries', 'characterized', 'by', 'a', 'high', 'incidence', 'rate', 'of', 'tuberculosis', 'during', 'the', 'fifties', 'sixties', 'until', 'the', 'nineties', 'and', 'the', 'policies', 'implemented', 'by', 'the', 'Israeli', 'government', 'in', 'the', 'control', 'management', 'and', 'treatment', 'of', 'tuberculosis', 'as', 'well', 'as', 'the', 'role', 'played', 'by', 'Israeli', 'prominent', 'scientists', 'in', 'discovering', 'new', 'druggable', 'targets', 'and', 'finding', 'bioactive', 'compounds', 'and', 'bio', 'molecules', 'in', 'the', 'fight', 'against', 'tuberculosis', 'Israel', 'represents', 'a', 'unique', 'living', 'laboratory', 'in', 'which', 'features', 'of', 'developed', 'and', 'developing', 'countries', 'mix', 'together', 'This', 'country', 'as', 'a', 'case', 'study', 'of', 'immigrant', 'pluralistic', 'society', 'underlines', 'the', 'importance', 'of', 'adopting', 'a', 'culturally', 'sensitive', 'community', 'intervention', 'approach', 'The', 'understanding', 'of', 'the', 'subtle', 'interplay', 'between', 'race', 'ethnic', 'host', 'and', 'pathogen', 'factors', 'including', 'the', 'role', 'of', 'gene', 'variations', 'and', 'polymorphisms', 'can', 'pave', 'the', 'way', 'for', 'a', 'personalized', 'treatment', 'and', 'management', 'of', 'tuberculosis', 'patients', 'contributing', 'to', 'the', 'development', 'of', 'new', 'tools', 'for', 'targeted', 'tuberculosis', 'therapeutics', 'immunodiagnostics', 'and', 'vaccination', 'products', '']"
141621,Rapid in situ hybridization technique for the detection of ribonucleic acids in tissues using radiolabelled and fluorescein-labelled riboprobes,1997-08-31,Molecular and Cellular Probes,https://www.sciencedirect.com/science/article/pii/S0890850897901146; https://www.ncbi.nlm.nih.gov/pubmed/9281413/; https://api.elsevier.com/content/article/pii/S0890850897901146,"Abstract In situhybridization (ISH) is a useful diagnostic and research tool, but is also time consuming. This study was conducted to determine if a rate enhancement hybridization (REH) buffer, developed for membrane hybridization, could be used to decrease hybridization time for ISH. Tissue from swine with an enteric disease produced by a swine coronavirus, transmissible gastroenteritis virus (TGEV), was used as a model to standardize hybridization conditions for a rapid ISH technique. Small intestinal sections from pigs experimentally and naturally infected with TGEV were hybridized for various times at 52°C and 70°C with a radiolabelled or a fluorescein-labelled RNA probe in a standard hybridization or a REH buffer. Viral RNA was detected in intestines from as early as 30 min of hybridization by using both buffers with the radiolabelled probe; however, the signal was stronger with the REH buffer. With the fluorescein-labelled probe, viral RNA was detected in virus-infected cells of the intestines after 30 min of hybridization by using the REH buffer. Signal intensity was greater with the REH buffer than with the standard hybridization buffer when compared at each hybridization time and hybridization temperature using both radiolabelled and fluorescein-labelled probes. With the REH buffer, hybridization signal intensity was greater at 70°C than at 52°C for both probes. The best results were obtained when small intestinal sections were hybridized at 70°C for 2 h using a radiolabelled or a fluorescein-labelled probe diluted in the REH buffer. The fluorescein-labelled RNA probe with REH buffer resulted in a minimal non-specific signal when compared with the radiolabelled probe. These studies demonstrated that the REH buffer can be used to decrease the time of ISH for the detection of viral RNA. This rapid ISH technique should have broad applications in the utilization of probe technology in diagnostics and research for the detection of target ribonucleic acidsin situ",10.1006/mcpr.1997.0114,hsspggp8,"['Abstract', 'In', 'situhybridization', 'ISH', 'is', 'a', 'useful', 'diagnostic', 'and', 'research', 'tool', 'but', 'is', 'also', 'time', 'consuming', 'This', 'study', 'was', 'conducted', 'to', 'determine', 'if', 'a', 'rate', 'enhancement', 'hybridization', 'REH', 'buffer', 'developed', 'for', 'membrane', 'hybridization', 'could', 'be', 'used', 'to', 'decrease', 'hybridization', 'time', 'for', 'ISH', 'Tissue', 'from', 'swine', 'with', 'an', 'enteric', 'disease', 'produced', 'by', 'a', 'swine', 'coronavirus', 'transmissible', 'gastroenteritis', 'virus', 'TGEV', 'was', 'used', 'as', 'a', 'model', 'to', 'standardize', 'hybridization', 'conditions', 'for', 'a', 'rapid', 'ISH', 'technique', 'Small', 'intestinal', 'sections', 'from', 'pigs', 'experimentally', 'and', 'naturally', 'infected', 'with', 'TGEV', 'were', 'hybridized', 'for', 'various', 'times', 'at', '52', 'C', 'and', '70', 'C', 'with', 'a', 'radiolabelled', 'or', 'a', 'fluorescein', 'labelled', 'RNA', 'probe', 'in', 'a', 'standard', 'hybridization', 'or', 'a', 'REH', 'buffer', 'Viral', 'RNA', 'was', 'detected', 'in', 'intestines', 'from', 'as', 'early', 'as', '30', 'min', 'of', 'hybridization', 'by', 'using', 'both', 'buffers', 'with', 'the', 'radiolabelled', 'probe', 'however', 'the', 'signal', 'was', 'stronger', 'with', 'the', 'REH', 'buffer', 'With', 'the', 'fluorescein', 'labelled', 'probe', 'viral', 'RNA', 'was', 'detected', 'in', 'virus', 'infected', 'cells', 'of', 'the', 'intestines', 'after', '30', 'min', 'of', 'hybridization', 'by', 'using', 'the', 'REH', 'buffer', 'Signal', 'intensity', 'was', 'greater', 'with', 'the', 'REH', 'buffer', 'than', 'with', 'the', 'standard', 'hybridization', 'buffer', 'when', 'compared', 'at', 'each', 'hybridization', 'time', 'and', 'hybridization', 'temperature', 'using', 'both', 'radiolabelled', 'and', 'fluorescein', 'labelled', 'probes', 'With', 'the', 'REH', 'buffer', 'hybridization', 'signal', 'intensity', 'was', 'greater', 'at', '70', 'C', 'than', 'at', '52', 'C', 'for', 'both', 'probes', 'The', 'best', 'results', 'were', 'obtained', 'when', 'small', 'intestinal', 'sections', 'were', 'hybridized', 'at', '70', 'C', 'for', '2', 'h', 'using', 'a', 'radiolabelled', 'or', 'a', 'fluorescein', 'labelled', 'probe', 'diluted', 'in', 'the', 'REH', 'buffer', 'The', 'fluorescein', 'labelled', 'RNA', 'probe', 'with', 'REH', 'buffer', 'resulted', 'in', 'a', 'minimal', 'non', 'specific', 'signal', 'when', 'compared', 'with', 'the', 'radiolabelled', 'probe', 'These', 'studies', 'demonstrated', 'that', 'the', 'REH', 'buffer', 'can', 'be', 'used', 'to', 'decrease', 'the', 'time', 'of', 'ISH', 'for', 'the', 'detection', 'of', 'viral', 'RNA', 'This', 'rapid', 'ISH', 'technique', 'should', 'have', 'broad', 'applications', 'in', 'the', 'utilization', 'of', 'probe', 'technology', 'in', 'diagnostics', 'and', 'research', 'for', 'the', 'detection', 'of', 'target', 'ribonucleic', 'acidsin', 'situ']"
141823,"MERS: Progress on the global response, remaining challenges and the way forward",2018-11-30,Antiviral Research,https://www.ncbi.nlm.nih.gov/pubmed/30236531/; https://doi.org/10.1016/j.antiviral.2018.09.002; https://api.elsevier.com/content/article/pii/S0166354218305308; https://www.sciencedirect.com/science/article/pii/S0166354218305308,"Abstract This article summarizes progress in research on Middle East Respiratory Syndrome (MERS) since a FAO-OIE-WHO Global Technical Meeting held at WHO Headquarters in Geneva on 25–27 September 2017. The meeting reviewed the latest scientific findings and identified and prioritized the global activities necessary to prevent, manage and control the disease. Critical needs for research and technical guidance identified during the meeting have been used to update the WHO R&D MERS-CoV Roadmap for diagnostics, therapeutics and vaccines and a broader public health research agenda. Since the 2017 meeting, progress has been made on several key actions in animal populations, at the animal/human interface and in human populations. This report also summarizes the latest scientific studies on MERS since 2017, including data from more than 50 research studies examining the presence of MERS-CoV infection in dromedary camels.",10.1016/j.antiviral.2018.09.002,d5l60cgc,"['Abstract', 'This', 'article', 'summarizes', 'progress', 'in', 'research', 'on', 'Middle', 'East', 'Respiratory', 'Syndrome', 'MERS', 'since', 'a', 'FAO', 'OIE', 'WHO', 'Global', 'Technical', 'Meeting', 'held', 'at', 'WHO', 'Headquarters', 'in', 'Geneva', 'on', '25', '27', 'September', '2017', 'The', 'meeting', 'reviewed', 'the', 'latest', 'scientific', 'findings', 'and', 'identified', 'and', 'prioritized', 'the', 'global', 'activities', 'necessary', 'to', 'prevent', 'manage', 'and', 'control', 'the', 'disease', 'Critical', 'needs', 'for', 'research', 'and', 'technical', 'guidance', 'identified', 'during', 'the', 'meeting', 'have', 'been', 'used', 'to', 'update', 'the', 'WHO', 'R', 'D', 'MERS', 'CoV', 'Roadmap', 'for', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'and', 'a', 'broader', 'public', 'health', 'research', 'agenda', 'Since', 'the', '2017', 'meeting', 'progress', 'has', 'been', 'made', 'on', 'several', 'key', 'actions', 'in', 'animal', 'populations', 'at', 'the', 'animal', 'human', 'interface', 'and', 'in', 'human', 'populations', 'This', 'report', 'also', 'summarizes', 'the', 'latest', 'scientific', 'studies', 'on', 'MERS', 'since', '2017', 'including', 'data', 'from', 'more', 'than', '50', 'research', 'studies', 'examining', 'the', 'presence', 'of', 'MERS', 'CoV', 'infection', 'in', 'dromedary', 'camels', '']"
142629,ARMAX modelling of international tourism demand,2009-05-31,Mathematics and Computers in Simulation,https://www.ncbi.nlm.nih.gov/pubmed/32288116/; https://doi.org/10.1016/j.matcom.2008.08.010; https://api.elsevier.com/content/article/pii/S0378475408002930; https://www.sciencedirect.com/science/article/pii/S0378475408002930,"Abstract Box–Jenkins (1970) models are often used to capture the autoregressive moving average of past observations of tourist arrivals from Japan to Taiwan and New Zealand. However, other explanatory variables, such as real income in the origin country, have also affected the demand for international travel. The purpose of this paper is to use the ARMAX model to investigate the dynamic relationship between tourism demand and real income of Japan, and to compare the findings with the single-equation model. Unit root tests and diagnostics are performed before estimating the income elasticity of travel demand by Japan for New Zealand and Taiwan based on seasonally unadjusted quarterly data for 1980(1) to 2004(2). The empirical results of the ARMAX model support the economic theory that the demand for international travel is positively related to income of the origin country.",10.1016/j.matcom.2008.08.010,ffk0ifwy,"['Abstract', 'Box', 'Jenkins', '1970', 'models', 'are', 'often', 'used', 'to', 'capture', 'the', 'autoregressive', 'moving', 'average', 'of', 'past', 'observations', 'of', 'tourist', 'arrivals', 'from', 'Japan', 'to', 'Taiwan', 'and', 'New', 'Zealand', 'However', 'other', 'explanatory', 'variables', 'such', 'as', 'real', 'income', 'in', 'the', 'origin', 'country', 'have', 'also', 'affected', 'the', 'demand', 'for', 'international', 'travel', 'The', 'purpose', 'of', 'this', 'paper', 'is', 'to', 'use', 'the', 'ARMAX', 'model', 'to', 'investigate', 'the', 'dynamic', 'relationship', 'between', 'tourism', 'demand', 'and', 'real', 'income', 'of', 'Japan', 'and', 'to', 'compare', 'the', 'findings', 'with', 'the', 'single', 'equation', 'model', 'Unit', 'root', 'tests', 'and', 'diagnostics', 'are', 'performed', 'before', 'estimating', 'the', 'income', 'elasticity', 'of', 'travel', 'demand', 'by', 'Japan', 'for', 'New', 'Zealand', 'and', 'Taiwan', 'based', 'on', 'seasonally', 'unadjusted', 'quarterly', 'data', 'for', '1980', '1', 'to', '2004', '2', 'The', 'empirical', 'results', 'of', 'the', 'ARMAX', 'model', 'support', 'the', 'economic', 'theory', 'that', 'the', 'demand', 'for', 'international', 'travel', 'is', 'positively', 'related', 'to', 'income', 'of', 'the', 'origin', 'country', '']"
142834,Emerging Advances in Rapid Diagnostics of Respiratory Infections,2010-09-30,Infectious Disease Clinics of North America,https://api.elsevier.com/content/article/pii/S0891552010000334; https://www.ncbi.nlm.nih.gov/pubmed/20674804/; https://doi.org/10.1016/j.idc.2010.04.006; https://www.sciencedirect.com/science/article/pii/S0891552010000334,"Recent developments in rapid diagnostics for respiratory infections have mostly occurred in the areas of antigen and nucleic acid detection. Nucleic acid amplification tests have improved the ability to identify respiratory viruses in clinical specimens and have played pivotal roles in the rapid characterization of new viral pathogens. Antigen-detection assays in immunochromatographic or similar formats are most easily developed as near-patient tests, although they have been developed commercially only for a limited range of respiratory pathogens. New approaches for respiratory pathogen detection are needed, and breath analysis is an exciting area with enormous potential.",10.1016/j.idc.2010.04.006,bjksz4hf,"['Recent', 'developments', 'in', 'rapid', 'diagnostics', 'for', 'respiratory', 'infections', 'have', 'mostly', 'occurred', 'in', 'the', 'areas', 'of', 'antigen', 'and', 'nucleic', 'acid', 'detection', 'Nucleic', 'acid', 'amplification', 'tests', 'have', 'improved', 'the', 'ability', 'to', 'identify', 'respiratory', 'viruses', 'in', 'clinical', 'specimens', 'and', 'have', 'played', 'pivotal', 'roles', 'in', 'the', 'rapid', 'characterization', 'of', 'new', 'viral', 'pathogens', 'Antigen', 'detection', 'assays', 'in', 'immunochromatographic', 'or', 'similar', 'formats', 'are', 'most', 'easily', 'developed', 'as', 'near', 'patient', 'tests', 'although', 'they', 'have', 'been', 'developed', 'commercially', 'only', 'for', 'a', 'limited', 'range', 'of', 'respiratory', 'pathogens', 'New', 'approaches', 'for', 'respiratory', 'pathogen', 'detection', 'are', 'needed', 'and', 'breath', 'analysis', 'is', 'an', 'exciting', 'area', 'with', 'enormous', 'potential', '']"
142853,"Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies",2019-10-01,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/30689772/; https://doi.org/10.1093/cid/ciz056,"We systematically reviewed available evidence from Embase, Medline, and the Cochrane Library on diagnostic accuracy and clinical impact of commercially available rapid (results <3 hours) molecular diagnostics for respiratory viruses as compared to conventional molecular tests. Quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies criteria for diagnostic test accuracy (DTA) studies, and the Cochrane Risk of Bias Assessment and Risk of Bias in Nonrandomized Studies of Interventions criteria for randomized and observational impact studies, respectively. Sixty-three DTA reports (56 studies) were meta-analyzed with a pooled sensitivity of 90.9% (95% confidence interval [CI], 88.7%–93.1%) and specificity of 96.1% (95% CI, 94.2%–97.9%) for the detection of either influenza virus (n = 29), respiratory syncytial virus (RSV) (n = 1), influenza virus and RSV (n = 19), or a viral panel including influenza virus and RSV (n = 14). The 15 included impact studies (5 randomized) were very heterogeneous and results were therefore inconclusive. However, we suggest that implementation of rapid diagnostics in hospital care settings should be considered.",10.1093/cid/ciz056,n95hz6jq,"['We', 'systematically', 'reviewed', 'available', 'evidence', 'from', 'Embase', 'Medline', 'and', 'the', 'Cochrane', 'Library', 'on', 'diagnostic', 'accuracy', 'and', 'clinical', 'impact', 'of', 'commercially', 'available', 'rapid', 'results', '3', 'hours', 'molecular', 'diagnostics', 'for', 'respiratory', 'viruses', 'as', 'compared', 'to', 'conventional', 'molecular', 'tests', 'Quality', 'of', 'included', 'studies', 'was', 'assessed', 'using', 'the', 'Quality', 'Assessment', 'of', 'Diagnostic', 'Accuracy', 'Studies', 'criteria', 'for', 'diagnostic', 'test', 'accuracy', 'DTA', 'studies', 'and', 'the', 'Cochrane', 'Risk', 'of', 'Bias', 'Assessment', 'and', 'Risk', 'of', 'Bias', 'in', 'Nonrandomized', 'Studies', 'of', 'Interventions', 'criteria', 'for', 'randomized', 'and', 'observational', 'impact', 'studies', 'respectively', 'Sixty', 'three', 'DTA', 'reports', '56', 'studies', 'were', 'meta', 'analyzed', 'with', 'a', 'pooled', 'sensitivity', 'of', '90', '9', '95', 'confidence', 'interval', 'CI', '88', '7', '93', '1', 'and', 'specificity', 'of', '96', '1', '95', 'CI', '94', '2', '97', '9', 'for', 'the', 'detection', 'of', 'either', 'influenza', 'virus', 'n', '29', 'respiratory', 'syncytial', 'virus', 'RSV', 'n', '1', 'influenza', 'virus', 'and', 'RSV', 'n', '19', 'or', 'a', 'viral', 'panel', 'including', 'influenza', 'virus', 'and', 'RSV', 'n', '14', 'The', '15', 'included', 'impact', 'studies', '5', 'randomized', 'were', 'very', 'heterogeneous', 'and', 'results', 'were', 'therefore', 'inconclusive', 'However', 'we', 'suggest', 'that', 'implementation', 'of', 'rapid', 'diagnostics', 'in', 'hospital', 'care', 'settings', 'should', 'be', 'considered', '']"
143069,"Surveillance for respiratory syncytial virus and parainfluenza virus among patients hospitalized with pneumonia in Sarawak, Malaysia",2018-08-15,PLoS One,https://doi.org/10.1371/journal.pone.0202147; https://www.ncbi.nlm.nih.gov/pubmed/30110367/,"BACKGROUND: Respiratory syncytial virus (RSV) and parainfluenza virus (PIV) are frequent causes of pneumonia and death among children at Sibu and Kapit Hospitals in Sarawak, Malaysia. OBJECTIVES: To determine the prevalence and risk factors for RSV subtypes A and B and PIV types 1–4 among patients hospitalized with pneumonia. METHODS: In a cross-sectional, pilot study nasopharyngeal swabs were studied with real-time reverse transcription polymerase chain reaction assays. Concurrently, we helped Sibu and Kapit Hospitals adapt their first molecular diagnostics for RSV and PIV. RESULTS: Of 129 specimens collected (June to July 2017), 39 tested positive for RSV-A (30.2%), two were positive for RSV B (1.6%), one was positive for PIV-3 (0.8%) and one was positive for PIV-4 (0.8%). No samples were positive for PIV-1 or PIV-2. Of the 39 RSV-A positive specimens, 46.2% were collected from children under one year of age and only 5.1% were from patients over the age of 18. A multivariable analysis found the odds of children <1 year of age testing positive for RSV-A were 32.7 (95% CI: 3.9, 276.2) times larger than >18 years of age, and the odds of patients hospitalized at Kapit Hospital testing positive for RSV-A were 3.2 (95% CI: 1.3, 7.8) times larger than patients hospitalized at Sibu Hospital. CONCLUSION: This study found an unusually high prevalence of RSV-A among pneumonia patients admitted to the two hospitals. Subsequently, Sibu Hospital adapted the molecular assays with the goal of providing more directed care for such pneumonia patients.",10.1371/journal.pone.0202147,3n7f5c0t,"['BACKGROUND', 'Respiratory', 'syncytial', 'virus', 'RSV', 'and', 'parainfluenza', 'virus', 'PIV', 'are', 'frequent', 'causes', 'of', 'pneumonia', 'and', 'death', 'among', 'children', 'at', 'Sibu', 'and', 'Kapit', 'Hospitals', 'in', 'Sarawak', 'Malaysia', 'OBJECTIVES', 'To', 'determine', 'the', 'prevalence', 'and', 'risk', 'factors', 'for', 'RSV', 'subtypes', 'A', 'and', 'B', 'and', 'PIV', 'types', '1', '4', 'among', 'patients', 'hospitalized', 'with', 'pneumonia', 'METHODS', 'In', 'a', 'cross', 'sectional', 'pilot', 'study', 'nasopharyngeal', 'swabs', 'were', 'studied', 'with', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'assays', 'Concurrently', 'we', 'helped', 'Sibu', 'and', 'Kapit', 'Hospitals', 'adapt', 'their', 'first', 'molecular', 'diagnostics', 'for', 'RSV', 'and', 'PIV', 'RESULTS', 'Of', '129', 'specimens', 'collected', 'June', 'to', 'July', '2017', '39', 'tested', 'positive', 'for', 'RSV', 'A', '30', '2', 'two', 'were', 'positive', 'for', 'RSV', 'B', '1', '6', 'one', 'was', 'positive', 'for', 'PIV', '3', '0', '8', 'and', 'one', 'was', 'positive', 'for', 'PIV', '4', '0', '8', 'No', 'samples', 'were', 'positive', 'for', 'PIV', '1', 'or', 'PIV', '2', 'Of', 'the', '39', 'RSV', 'A', 'positive', 'specimens', '46', '2', 'were', 'collected', 'from', 'children', 'under', 'one', 'year', 'of', 'age', 'and', 'only', '5', '1', 'were', 'from', 'patients', 'over', 'the', 'age', 'of', '18', 'A', 'multivariable', 'analysis', 'found', 'the', 'odds', 'of', 'children', '1', 'year', 'of', 'age', 'testing', 'positive', 'for', 'RSV', 'A', 'were', '32', '7', '95', 'CI', '3', '9', '276', '2', 'times', 'larger', 'than', '18', 'years', 'of', 'age', 'and', 'the', 'odds', 'of', 'patients', 'hospitalized', 'at', 'Kapit', 'Hospital', 'testing', 'positive', 'for', 'RSV', 'A', 'were', '3', '2', '95', 'CI', '1', '3', '7', '8', 'times', 'larger', 'than', 'patients', 'hospitalized', 'at', 'Sibu', 'Hospital', 'CONCLUSION', 'This', 'study', 'found', 'an', 'unusually', 'high', 'prevalence', 'of', 'RSV', 'A', 'among', 'pneumonia', 'patients', 'admitted', 'to', 'the', 'two', 'hospitals', 'Subsequently', 'Sibu', 'Hospital', 'adapted', 'the', 'molecular', 'assays', 'with', 'the', 'goal', 'of', 'providing', 'more', 'directed', 'care', 'for', 'such', 'pneumonia', 'patients', '']"
143255,Feline Coronavirus in Multicat Environments,2011-11-30,Veterinary Clinics of North America: Small Animal Practice,https://www.sciencedirect.com/science/article/pii/S0195561611001422; https://doi.org/10.1016/j.cvsm.2011.08.004; https://www.ncbi.nlm.nih.gov/pubmed/22041208/; https://api.elsevier.com/content/article/pii/S0195561611001422,"Feline infectious peritonitis (FIP), a fatal disease in cats worldwide, is caused by FCoV infection, which commonly occurs in multicat environments. The enteric FCoV, referred to as feline enteric virus (FECV), is considered a mostly benign biotype infecting the gut, whereas the FIP virus biotype is considered the highly pathogenic etiologic agent for FIP. Current laboratory tests are unable to distinguish between virus biotypes of FCoV. FECV is highly contagious and easily spreads in multicat environments; therefore, the challenges to animal shelters are tremendous. This review summarizes interdisciplinary current knowledge in regard to virology, immunology, pathology, diagnostics, and treatment options in the context of multicat environments.",10.1016/j.cvsm.2011.08.004,xi1wd8b5,"['Feline', 'infectious', 'peritonitis', 'FIP', 'a', 'fatal', 'disease', 'in', 'cats', 'worldwide', 'is', 'caused', 'by', 'FCoV', 'infection', 'which', 'commonly', 'occurs', 'in', 'multicat', 'environments', 'The', 'enteric', 'FCoV', 'referred', 'to', 'as', 'feline', 'enteric', 'virus', 'FECV', 'is', 'considered', 'a', 'mostly', 'benign', 'biotype', 'infecting', 'the', 'gut', 'whereas', 'the', 'FIP', 'virus', 'biotype', 'is', 'considered', 'the', 'highly', 'pathogenic', 'etiologic', 'agent', 'for', 'FIP', 'Current', 'laboratory', 'tests', 'are', 'unable', 'to', 'distinguish', 'between', 'virus', 'biotypes', 'of', 'FCoV', 'FECV', 'is', 'highly', 'contagious', 'and', 'easily', 'spreads', 'in', 'multicat', 'environments', 'therefore', 'the', 'challenges', 'to', 'animal', 'shelters', 'are', 'tremendous', 'This', 'review', 'summarizes', 'interdisciplinary', 'current', 'knowledge', 'in', 'regard', 'to', 'virology', 'immunology', 'pathology', 'diagnostics', 'and', 'treatment', 'options', 'in', 'the', 'context', 'of', 'multicat', 'environments', '']"
143322,CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia,2020-05-26,J Drug Target,https://doi.org/10.1080/1061186x.2020.1769637; https://www.ncbi.nlm.nih.gov/pubmed/32401064/,"Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarise current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis.",10.1080/1061186x.2020.1769637,q52mia0e,"['Emerging', 'infectious', 'diseases', 'the', 'persistent', 'potential', 'for', 'destabilising', 'pandemics', 'remain', 'a', 'global', 'threat', 'leading', 'to', 'excessive', 'morbidity', 'and', 'mortality', 'The', 'current', 'outbreak', 'of', 'pneumonia', 'caused', 'by', '2019', 'novel', 'coronavirus', 'COVID', '19', 'illustrated', 'difficulties', 'in', 'lack', 'of', 'effective', 'drugs', 'for', 'treatment', 'Accurate', 'and', 'rapid', 'diagnostic', 'tools', 'are', 'essential', 'for', 'early', 'recognition', 'and', 'treatment', 'of', 'infectious', 'diseases', 'allowing', 'timely', 'implementation', 'of', 'infection', 'control', 'improved', 'clinical', 'care', 'and', 'other', 'public', 'health', 'measures', 'to', 'stop', 'the', 'spread', 'of', 'the', 'disease', 'CRISPR', 'Cas', 'technology', 'speed', 'up', 'the', 'development', 'of', 'infectious', 'disease', 'diagnostics', 'with', 'high', 'rapid', 'and', 'accurate', 'In', 'this', 'review', 'we', 'summarise', 'current', 'advance', 'regarding', 'diverse', 'CRISPR', 'Cas', 'systems', 'including', 'CRISPR', 'Cas9', 'CRISPR', 'Cas12', 'and', 'CRISPR', 'Cas13', 'in', 'the', 'development', 'of', 'fast', 'accurate', 'and', 'portable', 'diagnostic', 'tests', 'and', 'highlight', 'the', 'potential', 'of', 'CRISPR', 'Cas13', 'in', 'COVID', '19', 'Pneumonia', 'and', 'other', 'emerging', 'infectious', 'diseases', 'diagnosis', '']"
143444,More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients,2019-07-31,Journal of Clinical Virology,https://api.elsevier.com/content/article/pii/S1386653219300770; https://www.ncbi.nlm.nih.gov/pubmed/30999234/; https://doi.org/10.1016/j.jcv.2019.04.003; https://www.sciencedirect.com/science/article/pii/S1386653219300770,"Abstract Background Immunocompromised adults are more vulnerable to a complicated course of viral respiratory tract infections (RTI). Objectives Provide evidence on the effect of implementation of rapid molecular diagnostics for viruses on use of in-hospital isolation facilities, oseltamivir and antibiotic usage, and other clinical outcomes in immunocompromised patients. Study design A before-after study during two consecutive respiratory viral seasons, including immunocompromised adult patients presenting at a tertiary care emergency department with clinical suspicion of RTI. During the first season (2016/2017), respiratory viruses were detected using inhouse real-time PCR. The second season (2017/2018), we implemented a diagnostic flowchart including a rapid molecular test for 15 respiratory viruses (FilmArray®). We assessed the effect of this implementation on need for isolation, antivirals and empirical antibiotics. Results We included 192 immunocompromised adult patients during the first and 378 during the second season. Respiratory viral testing was performed in 135 patients (70%) during the first and 284 (75%) during the second season (p = 0.218) of which 213 (75%) using the rapid test. After implementation, use of in-hospital isolation facilities was reduced (adjusted odds ratio 0.35, 95%CI 0.19-0.64). Furthermore, adequate use of oseltamivir improved, with fewer prescriptions in influenza negative patients (0.15, 95%CI 0.08-0.28) and more in influenza positive patients (11.13, 95%CI 1.75–70.86). No effect was observed on empirical antibiotic use, hospital admissions, length of hospital stay or safety outcomes. Conclusions Implementation of rapid molecular testing for respiratory viruses in adult immunocompromised patients results in more adequate use of oseltamivir and in-hospital isolation facilities without compromising safety.",10.1016/j.jcv.2019.04.003,3cwh5yh7,"['Abstract', 'Background', 'Immunocompromised', 'adults', 'are', 'more', 'vulnerable', 'to', 'a', 'complicated', 'course', 'of', 'viral', 'respiratory', 'tract', 'infections', 'RTI', 'Objectives', 'Provide', 'evidence', 'on', 'the', 'effect', 'of', 'implementation', 'of', 'rapid', 'molecular', 'diagnostics', 'for', 'viruses', 'on', 'use', 'of', 'in', 'hospital', 'isolation', 'facilities', 'oseltamivir', 'and', 'antibiotic', 'usage', 'and', 'other', 'clinical', 'outcomes', 'in', 'immunocompromised', 'patients', 'Study', 'design', 'A', 'before', 'after', 'study', 'during', 'two', 'consecutive', 'respiratory', 'viral', 'seasons', 'including', 'immunocompromised', 'adult', 'patients', 'presenting', 'at', 'a', 'tertiary', 'care', 'emergency', 'department', 'with', 'clinical', 'suspicion', 'of', 'RTI', 'During', 'the', 'first', 'season', '2016', '2017', 'respiratory', 'viruses', 'were', 'detected', 'using', 'inhouse', 'real', 'time', 'PCR', 'The', 'second', 'season', '2017', '2018', 'we', 'implemented', 'a', 'diagnostic', 'flowchart', 'including', 'a', 'rapid', 'molecular', 'test', 'for', '15', 'respiratory', 'viruses', 'FilmArray', 'We', 'assessed', 'the', 'effect', 'of', 'this', 'implementation', 'on', 'need', 'for', 'isolation', 'antivirals', 'and', 'empirical', 'antibiotics', 'Results', 'We', 'included', '192', 'immunocompromised', 'adult', 'patients', 'during', 'the', 'first', 'and', '378', 'during', 'the', 'second', 'season', 'Respiratory', 'viral', 'testing', 'was', 'performed', 'in', '135', 'patients', '70', 'during', 'the', 'first', 'and', '284', '75', 'during', 'the', 'second', 'season', 'p', '0', '218', 'of', 'which', '213', '75', 'using', 'the', 'rapid', 'test', 'After', 'implementation', 'use', 'of', 'in', 'hospital', 'isolation', 'facilities', 'was', 'reduced', 'adjusted', 'odds', 'ratio', '0', '35', '95', 'CI', '0', '19', '0', '64', 'Furthermore', 'adequate', 'use', 'of', 'oseltamivir', 'improved', 'with', 'fewer', 'prescriptions', 'in', 'influenza', 'negative', 'patients', '0', '15', '95', 'CI', '0', '08', '0', '28', 'and', 'more', 'in', 'influenza', 'positive', 'patients', '11', '13', '95', 'CI', '1', '75', '70', '86', 'No', 'effect', 'was', 'observed', 'on', 'empirical', 'antibiotic', 'use', 'hospital', 'admissions', 'length', 'of', 'hospital', 'stay', 'or', 'safety', 'outcomes', 'Conclusions', 'Implementation', 'of', 'rapid', 'molecular', 'testing', 'for', 'respiratory', 'viruses', 'in', 'adult', 'immunocompromised', 'patients', 'results', 'in', 'more', 'adequate', 'use', 'of', 'oseltamivir', 'and', 'in', 'hospital', 'isolation', 'facilities', 'without', 'compromising', 'safety', '']"
144036,New Developments in Rapid Diagnostic Testing for Children,2018-03-31,Infectious Disease Clinics of North America,https://doi.org/10.1016/j.idc.2017.11.006; https://www.ncbi.nlm.nih.gov/pubmed/29269192/; https://api.elsevier.com/content/article/pii/S0891552017301113; https://www.sciencedirect.com/science/article/pii/S0891552017301113,"The advent of new diagnostics assays for Group A Streptococcus, influenza, and respiratory syncytial virus now provide rapid results with increased sensitivity and specificity. Molecular testing is no longer confined to the walls of the laboratory, but moving to the patient in the form of point-of-care tests. In addition, multiplex syndromic panels are allowing broad testing of pathogens associated with a single clinical presentation. This article focuses specifically on rapid diagnostic tests for pathogens most affecting children. Rapid and accurate pathogen detection in children may result in decreased time to optimal antimicrobial treatment and improved patient outcomes.",10.1016/j.idc.2017.11.006,hzahejqk,"['The', 'advent', 'of', 'new', 'diagnostics', 'assays', 'for', 'Group', 'A', 'Streptococcus', 'influenza', 'and', 'respiratory', 'syncytial', 'virus', 'now', 'provide', 'rapid', 'results', 'with', 'increased', 'sensitivity', 'and', 'specificity', 'Molecular', 'testing', 'is', 'no', 'longer', 'confined', 'to', 'the', 'walls', 'of', 'the', 'laboratory', 'but', 'moving', 'to', 'the', 'patient', 'in', 'the', 'form', 'of', 'point', 'of', 'care', 'tests', 'In', 'addition', 'multiplex', 'syndromic', 'panels', 'are', 'allowing', 'broad', 'testing', 'of', 'pathogens', 'associated', 'with', 'a', 'single', 'clinical', 'presentation', 'This', 'article', 'focuses', 'specifically', 'on', 'rapid', 'diagnostic', 'tests', 'for', 'pathogens', 'most', 'affecting', 'children', 'Rapid', 'and', 'accurate', 'pathogen', 'detection', 'in', 'children', 'may', 'result', 'in', 'decreased', 'time', 'to', 'optimal', 'antimicrobial', 'treatment', 'and', 'improved', 'patient', 'outcomes', '']"
144221,Erythrocytes Reveal Complement Activation in Patients with COVID-19,2020-05-22,medRxiv : the preprint server for health sciences,https://doi.org/10.1101/2020.05.20.20104398; https://www.ncbi.nlm.nih.gov/pubmed/32511554/; http://medrxiv.org/cgi/content/short/2020.05.20.20104398v1?rss=1,"COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-organ failure characterized by respiratory insufficiency, arrhythmias, thromboembolic complications and shock. The mortality of patients hospitalized with COVID-19 is unacceptably high and new strategies are urgently needed to rapidly identify and treat patients at risk for organ failure. Clinical epidemiologic studies demonstrate that vulnerability to organ failure is greatest after viral clearance from the upper airway, which suggests that dysregulation of the host immune response is a critical mediator of clinical deterioration and death. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. A potential therapeutic strategy warranting investigation is to inhibit complement, with case reports of successful treatment of COVID-19 with inhibitors of complement. However, this approach requires careful balance between the host protective and potential injurious effects of complement activation, and biomarkers to identify the optimal timing and candidates for therapy are lacking. Here we report the presence of complement activation products on circulating erythrocytes from hospitalized COVID-19 patients using flow cytometry. These findings suggest that novel erythrocyte-based diagnostics provide a method to identify patients with dysregulated complement activation.",10.1101/2020.05.20.20104398,4ua67ztd,"['COVID', '19', 'the', 'disease', 'caused', 'by', 'the', 'SARS', 'CoV', '2', 'virus', 'can', 'progress', 'to', 'multi', 'organ', 'failure', 'characterized', 'by', 'respiratory', 'insufficiency', 'arrhythmias', 'thromboembolic', 'complications', 'and', 'shock', 'The', 'mortality', 'of', 'patients', 'hospitalized', 'with', 'COVID', '19', 'is', 'unacceptably', 'high', 'and', 'new', 'strategies', 'are', 'urgently', 'needed', 'to', 'rapidly', 'identify', 'and', 'treat', 'patients', 'at', 'risk', 'for', 'organ', 'failure', 'Clinical', 'epidemiologic', 'studies', 'demonstrate', 'that', 'vulnerability', 'to', 'organ', 'failure', 'is', 'greatest', 'after', 'viral', 'clearance', 'from', 'the', 'upper', 'airway', 'which', 'suggests', 'that', 'dysregulation', 'of', 'the', 'host', 'immune', 'response', 'is', 'a', 'critical', 'mediator', 'of', 'clinical', 'deterioration', 'and', 'death', 'Autopsy', 'and', 'pre', 'clinical', 'evidence', 'implicate', 'aberrant', 'complement', 'activation', 'in', 'endothelial', 'injury', 'and', 'organ', 'failure', 'A', 'potential', 'therapeutic', 'strategy', 'warranting', 'investigation', 'is', 'to', 'inhibit', 'complement', 'with', 'case', 'reports', 'of', 'successful', 'treatment', 'of', 'COVID', '19', 'with', 'inhibitors', 'of', 'complement', 'However', 'this', 'approach', 'requires', 'careful', 'balance', 'between', 'the', 'host', 'protective', 'and', 'potential', 'injurious', 'effects', 'of', 'complement', 'activation', 'and', 'biomarkers', 'to', 'identify', 'the', 'optimal', 'timing', 'and', 'candidates', 'for', 'therapy', 'are', 'lacking', 'Here', 'we', 'report', 'the', 'presence', 'of', 'complement', 'activation', 'products', 'on', 'circulating', 'erythrocytes', 'from', 'hospitalized', 'COVID', '19', 'patients', 'using', 'flow', 'cytometry', 'These', 'findings', 'suggest', 'that', 'novel', 'erythrocyte', 'based', 'diagnostics', 'provide', 'a', 'method', 'to', 'identify', 'patients', 'with', 'dysregulated', 'complement', 'activation', '']"
144227,Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections,2019-07-31,Clinical Microbiology and Infection,https://www.sciencedirect.com/science/article/pii/S1198743X18307213; https://www.ncbi.nlm.nih.gov/pubmed/30391583/; https://api.elsevier.com/content/article/pii/S1198743X18307213; https://doi.org/10.1016/j.cmi.2018.10.016,"Abstract Objectives Highly pathogenic viruses such as EBOV are a threat to routine laboratory workers. Inactivation procedures with Triton X-100 0.1% and/or heat are currently recommended, but have unknown effects on the accuracy of serological testing. Furthermore, virus inactivation by Triton X-100 0.1% was shown to be ineffective in serum. This study aimed to demonstrate virus inactivation in serum by Triton X-100 1% and maintained accuracy of serological testing. Methods A panel of 19 serological tests was run on patient serum samples after treatment with Triton X-100 1%, 0.1%, and 0.1% + heat inactivation at 60°C for 1 h. Mean differences between measurements (bias) were calculated applying the Bland–Altman method. To determine effectiveness of virus inactivation, herpes simplex virus 1 (HSV-1) was spiked into medium containing 90% or 1% serum, and treated with Triton X-100 0.1% or 1%. Infectious titres were then determined on Vero cells. Results Serological measurements showed good agreement between controls and samples treated with Triton X-100 0.1% and 1%, with an estimated bias of 0.6 ± 9.2% (n = 258) and –0.1 ± 18.6% (n = 174), respectively. Discordant qualitative results were rare. Conversely, heat inactivation alone and combined with Triton X-100 0.1% triggered a bias of 17.5 ± 66.4% (n = 200) and 37.9 ± 79.8% (n = 160), respectively. Triton X-100 1% completely inactivated HSV-1 in 1% and 90% serum while Triton X-100 0.1% failed to do so in 90% serum. Conclusions Unlike heat inactivation, Triton X-100 1% enabled accurate serological testing and completely inactivated HSV-1 in serum. This simple method could allow safe routine serological diagnostics in high-risk patients.",10.1016/j.cmi.2018.10.016,e58jd3ac,"['Abstract', 'Objectives', 'Highly', 'pathogenic', 'viruses', 'such', 'as', 'EBOV', 'are', 'a', 'threat', 'to', 'routine', 'laboratory', 'workers', 'Inactivation', 'procedures', 'with', 'Triton', 'X', '100', '0', '1', 'and', 'or', 'heat', 'are', 'currently', 'recommended', 'but', 'have', 'unknown', 'effects', 'on', 'the', 'accuracy', 'of', 'serological', 'testing', 'Furthermore', 'virus', 'inactivation', 'by', 'Triton', 'X', '100', '0', '1', 'was', 'shown', 'to', 'be', 'ineffective', 'in', 'serum', 'This', 'study', 'aimed', 'to', 'demonstrate', 'virus', 'inactivation', 'in', 'serum', 'by', 'Triton', 'X', '100', '1', 'and', 'maintained', 'accuracy', 'of', 'serological', 'testing', 'Methods', 'A', 'panel', 'of', '19', 'serological', 'tests', 'was', 'run', 'on', 'patient', 'serum', 'samples', 'after', 'treatment', 'with', 'Triton', 'X', '100', '1', '0', '1', 'and', '0', '1', 'heat', 'inactivation', 'at', '60', 'C', 'for', '1', 'h', 'Mean', 'differences', 'between', 'measurements', 'bias', 'were', 'calculated', 'applying', 'the', 'Bland', 'Altman', 'method', 'To', 'determine', 'effectiveness', 'of', 'virus', 'inactivation', 'herpes', 'simplex', 'virus', '1', 'HSV', '1', 'was', 'spiked', 'into', 'medium', 'containing', '90', 'or', '1', 'serum', 'and', 'treated', 'with', 'Triton', 'X', '100', '0', '1', 'or', '1', 'Infectious', 'titres', 'were', 'then', 'determined', 'on', 'Vero', 'cells', 'Results', 'Serological', 'measurements', 'showed', 'good', 'agreement', 'between', 'controls', 'and', 'samples', 'treated', 'with', 'Triton', 'X', '100', '0', '1', 'and', '1', 'with', 'an', 'estimated', 'bias', 'of', '0', '6', '9', '2', 'n', '258', 'and', '0', '1', '18', '6', 'n', '174', 'respectively', 'Discordant', 'qualitative', 'results', 'were', 'rare', 'Conversely', 'heat', 'inactivation', 'alone', 'and', 'combined', 'with', 'Triton', 'X', '100', '0', '1', 'triggered', 'a', 'bias', 'of', '17', '5', '66', '4', 'n', '200', 'and', '37', '9', '79', '8', 'n', '160', 'respectively', 'Triton', 'X', '100', '1', 'completely', 'inactivated', 'HSV', '1', 'in', '1', 'and', '90', 'serum', 'while', 'Triton', 'X', '100', '0', '1', 'failed', 'to', 'do', 'so', 'in', '90', 'serum', 'Conclusions', 'Unlike', 'heat', 'inactivation', 'Triton', 'X', '100', '1', 'enabled', 'accurate', 'serological', 'testing', 'and', 'completely', 'inactivated', 'HSV', '1', 'in', 'serum', 'This', 'simple', 'method', 'could', 'allow', 'safe', 'routine', 'serological', 'diagnostics', 'in', 'high', 'risk', 'patients', '']"
144723,Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection,2020-05-27,J Clin Virol,https://api.elsevier.com/content/article/pii/S1386653220302183; https://www.sciencedirect.com/science/article/pii/S1386653220302183?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32516739/; https://doi.org/10.1016/j.jcv.2020.104476,"BACKGROUND: Rapid and sensitive diagnostic assays for SARS-CoV-2 detection are required for prompt patient management and infection control. The analytical and clinical performances of LightMix® Modular SARS and Wuhan CoV E-gene kit, a widely used commercial assay for SARS-CoV-2 detection, have not been well studied. OBJECTIVE: To evaluate the performance characteristics of the LightMix® E-gene kit in comparison with well-validated in-house developed tests. STUDY DESIGN: Serial dilutions of SARS-CoV-2 culture isolate extracts were used for analytical sensitivity evaluation. A total of 289 clinical specimens from 186 patients with suspected COVID-19 and 8 proficiency testing (PT) samples were used to evaluate the diagnostic performance of the LightMix® E-gene kit against in-house developed COVID-19-RdRp/Hel and COVID-19-N RT-PCR assays. RESULTS: The LightMix® E-gene kit had a limit-of-detection of 1.8 × 10(-1) TCID(50)/mL, which was one log(10) lower than those of the two in-house RT-PCR assays. The LightMix® E-gene kit (149/289 [51.6%]) had higher diagnostic sensitivity than the in-house assays (144/289 [49.8%] for RdRp/Hel and 146/289 [50.5%] for N). All three assays gave correct results for all the PT samples. Cycle threshold (Cp) values of the LightMix® E-gene kit and in-house assays showed excellent correlation. Reproducibility of the Cp values was satisfactory with intra- and inter-assay coefficient of variation values <5%. Importantly, the LightMix® E-gene kit, when used as a stand-alone assay, was equally sensitive as testing algorithms using multiple SARS-CoV-2 assays. CONCLUSIONS: The LightMix® E-gene kit is a rapid and sensitive assay for SARS-CoV-2 diagnostics, with fewer verification requirements compared to laboratory-developed tests",10.1016/j.jcv.2020.104476,i8u0j87l,"['BACKGROUND', 'Rapid', 'and', 'sensitive', 'diagnostic', 'assays', 'for', 'SARS', 'CoV', '2', 'detection', 'are', 'required', 'for', 'prompt', 'patient', 'management', 'and', 'infection', 'control', 'The', 'analytical', 'and', 'clinical', 'performances', 'of', 'LightMix', 'Modular', 'SARS', 'and', 'Wuhan', 'CoV', 'E', 'gene', 'kit', 'a', 'widely', 'used', 'commercial', 'assay', 'for', 'SARS', 'CoV', '2', 'detection', 'have', 'not', 'been', 'well', 'studied', 'OBJECTIVE', 'To', 'evaluate', 'the', 'performance', 'characteristics', 'of', 'the', 'LightMix', 'E', 'gene', 'kit', 'in', 'comparison', 'with', 'well', 'validated', 'in', 'house', 'developed', 'tests', 'STUDY', 'DESIGN', 'Serial', 'dilutions', 'of', 'SARS', 'CoV', '2', 'culture', 'isolate', 'extracts', 'were', 'used', 'for', 'analytical', 'sensitivity', 'evaluation', 'A', 'total', 'of', '289', 'clinical', 'specimens', 'from', '186', 'patients', 'with', 'suspected', 'COVID', '19', 'and', '8', 'proficiency', 'testing', 'PT', 'samples', 'were', 'used', 'to', 'evaluate', 'the', 'diagnostic', 'performance', 'of', 'the', 'LightMix', 'E', 'gene', 'kit', 'against', 'in', 'house', 'developed', 'COVID', '19', 'RdRp', 'Hel', 'and', 'COVID', '19', 'N', 'RT', 'PCR', 'assays', 'RESULTS', 'The', 'LightMix', 'E', 'gene', 'kit', 'had', 'a', 'limit', 'of', 'detection', 'of', '1', '8', '10', '1', 'TCID', '50', 'mL', 'which', 'was', 'one', 'log', '10', 'lower', 'than', 'those', 'of', 'the', 'two', 'in', 'house', 'RT', 'PCR', 'assays', 'The', 'LightMix', 'E', 'gene', 'kit', '149', '289', '51', '6', 'had', 'higher', 'diagnostic', 'sensitivity', 'than', 'the', 'in', 'house', 'assays', '144', '289', '49', '8', 'for', 'RdRp', 'Hel', 'and', '146', '289', '50', '5', 'for', 'N', 'All', 'three', 'assays', 'gave', 'correct', 'results', 'for', 'all', 'the', 'PT', 'samples', 'Cycle', 'threshold', 'Cp', 'values', 'of', 'the', 'LightMix', 'E', 'gene', 'kit', 'and', 'in', 'house', 'assays', 'showed', 'excellent', 'correlation', 'Reproducibility', 'of', 'the', 'Cp', 'values', 'was', 'satisfactory', 'with', 'intra', 'and', 'inter', 'assay', 'coefficient', 'of', 'variation', 'values', '5', 'Importantly', 'the', 'LightMix', 'E', 'gene', 'kit', 'when', 'used', 'as', 'a', 'stand', 'alone', 'assay', 'was', 'equally', 'sensitive', 'as', 'testing', 'algorithms', 'using', 'multiple', 'SARS', 'CoV', '2', 'assays', 'CONCLUSIONS', 'The', 'LightMix', 'E', 'gene', 'kit', 'is', 'a', 'rapid', 'and', 'sensitive', 'assay', 'for', 'SARS', 'CoV', '2', 'diagnostics', 'with', 'fewer', 'verification', 'requirements', 'compared', 'to', 'laboratory', 'developed', 'tests']"
144861,Gastrointestinal Disease in Guinea Pigs and Rabbits,2013-05-31,Veterinary Clinics of North America: Exotic Animal Practice,https://www.sciencedirect.com/science/article/pii/S1094919413000030; https://api.elsevier.com/content/article/pii/S1094919413000030; https://doi.org/10.1016/j.cvex.2013.01.002; https://www.ncbi.nlm.nih.gov/pubmed/23642870/,"This article reviews diagnosis and management of gastrointestinal diseases in guinea pigs and rabbits. The review includes established causes of gastrointestinal disease in these species. The authors highlight syndromes that may be considered emerging or less-recognized causes of gastrointestinal stasis, including gastric dilation and volvulus in guinea pigs and lead toxicity, colonic entrapment, and liver torsion in rabbits. Practitioners should recommend initial diagnostics, including radiographs and blood work on guinea pigs and rabbits presenting with nonspecific signs of gastrointestinal stasis, to better determine possible cause and make the best treatment recommendations.",10.1016/j.cvex.2013.01.002,ocqmn8dw,"['This', 'article', 'reviews', 'diagnosis', 'and', 'management', 'of', 'gastrointestinal', 'diseases', 'in', 'guinea', 'pigs', 'and', 'rabbits', 'The', 'review', 'includes', 'established', 'causes', 'of', 'gastrointestinal', 'disease', 'in', 'these', 'species', 'The', 'authors', 'highlight', 'syndromes', 'that', 'may', 'be', 'considered', 'emerging', 'or', 'less', 'recognized', 'causes', 'of', 'gastrointestinal', 'stasis', 'including', 'gastric', 'dilation', 'and', 'volvulus', 'in', 'guinea', 'pigs', 'and', 'lead', 'toxicity', 'colonic', 'entrapment', 'and', 'liver', 'torsion', 'in', 'rabbits', 'Practitioners', 'should', 'recommend', 'initial', 'diagnostics', 'including', 'radiographs', 'and', 'blood', 'work', 'on', 'guinea', 'pigs', 'and', 'rabbits', 'presenting', 'with', 'nonspecific', 'signs', 'of', 'gastrointestinal', 'stasis', 'to', 'better', 'determine', 'possible', 'cause', 'and', 'make', 'the', 'best', 'treatment', 'recommendations', '']"
144890,Recognizing flu-like symptoms from videos,2014-09-12,BMC Bioinformatics,https://doi.org/10.1186/1471-2105-15-300; https://www.ncbi.nlm.nih.gov/pubmed/25217118/,"BACKGROUND: Vision-based surveillance and monitoring is a potential alternative for early detection of respiratory disease outbreaks in urban areas complementing molecular diagnostics and hospital and doctor visit-based alert systems. Visible actions representing typical flu-like symptoms include sneeze and cough that are associated with changing patterns of hand to head distances, among others. The technical difficulties lie in the high complexity and large variation of those actions as well as numerous similar background actions such as scratching head, cell phone use, eating, drinking and so on. RESULTS: In this paper, we make a first attempt at the challenging problem of recognizing flu-like symptoms from videos. Since there was no related dataset available, we created a new public health dataset for action recognition that includes two major flu-like symptom related actions (sneeze and cough) and a number of background actions. We also developed a suitable novel algorithm by introducing two types of Action Matching Kernels, where both types aim to integrate two aspects of local features, namely the space-time layout and the Bag-of-Words representations. In particular, we show that the Pyramid Match Kernel and Spatial Pyramid Matching are both special cases of our proposed kernels. Besides experimenting on standard testbed, the proposed algorithm is evaluated also on the new sneeze and cough set. Empirically, we observe that our approach achieves competitive performance compared to the state-of-the-arts, while recognition on the new public health dataset is shown to be a non-trivial task even with simple single person unobstructed view. CONCLUSIONS: Our sneeze and cough video dataset and newly developed action recognition algorithm is the first of its kind and aims to kick-start the field of action recognition of flu-like symptoms from videos. It will be challenging but necessary in future developments to consider more complex real-life scenario of detecting these actions simultaneously from multiple persons in possibly crowded environments.",10.1186/1471-2105-15-300,gm1e9j80,"['BACKGROUND', 'Vision', 'based', 'surveillance', 'and', 'monitoring', 'is', 'a', 'potential', 'alternative', 'for', 'early', 'detection', 'of', 'respiratory', 'disease', 'outbreaks', 'in', 'urban', 'areas', 'complementing', 'molecular', 'diagnostics', 'and', 'hospital', 'and', 'doctor', 'visit', 'based', 'alert', 'systems', 'Visible', 'actions', 'representing', 'typical', 'flu', 'like', 'symptoms', 'include', 'sneeze', 'and', 'cough', 'that', 'are', 'associated', 'with', 'changing', 'patterns', 'of', 'hand', 'to', 'head', 'distances', 'among', 'others', 'The', 'technical', 'difficulties', 'lie', 'in', 'the', 'high', 'complexity', 'and', 'large', 'variation', 'of', 'those', 'actions', 'as', 'well', 'as', 'numerous', 'similar', 'background', 'actions', 'such', 'as', 'scratching', 'head', 'cell', 'phone', 'use', 'eating', 'drinking', 'and', 'so', 'on', 'RESULTS', 'In', 'this', 'paper', 'we', 'make', 'a', 'first', 'attempt', 'at', 'the', 'challenging', 'problem', 'of', 'recognizing', 'flu', 'like', 'symptoms', 'from', 'videos', 'Since', 'there', 'was', 'no', 'related', 'dataset', 'available', 'we', 'created', 'a', 'new', 'public', 'health', 'dataset', 'for', 'action', 'recognition', 'that', 'includes', 'two', 'major', 'flu', 'like', 'symptom', 'related', 'actions', 'sneeze', 'and', 'cough', 'and', 'a', 'number', 'of', 'background', 'actions', 'We', 'also', 'developed', 'a', 'suitable', 'novel', 'algorithm', 'by', 'introducing', 'two', 'types', 'of', 'Action', 'Matching', 'Kernels', 'where', 'both', 'types', 'aim', 'to', 'integrate', 'two', 'aspects', 'of', 'local', 'features', 'namely', 'the', 'space', 'time', 'layout', 'and', 'the', 'Bag', 'of', 'Words', 'representations', 'In', 'particular', 'we', 'show', 'that', 'the', 'Pyramid', 'Match', 'Kernel', 'and', 'Spatial', 'Pyramid', 'Matching', 'are', 'both', 'special', 'cases', 'of', 'our', 'proposed', 'kernels', 'Besides', 'experimenting', 'on', 'standard', 'testbed', 'the', 'proposed', 'algorithm', 'is', 'evaluated', 'also', 'on', 'the', 'new', 'sneeze', 'and', 'cough', 'set', 'Empirically', 'we', 'observe', 'that', 'our', 'approach', 'achieves', 'competitive', 'performance', 'compared', 'to', 'the', 'state', 'of', 'the', 'arts', 'while', 'recognition', 'on', 'the', 'new', 'public', 'health', 'dataset', 'is', 'shown', 'to', 'be', 'a', 'non', 'trivial', 'task', 'even', 'with', 'simple', 'single', 'person', 'unobstructed', 'view', 'CONCLUSIONS', 'Our', 'sneeze', 'and', 'cough', 'video', 'dataset', 'and', 'newly', 'developed', 'action', 'recognition', 'algorithm', 'is', 'the', 'first', 'of', 'its', 'kind', 'and', 'aims', 'to', 'kick', 'start', 'the', 'field', 'of', 'action', 'recognition', 'of', 'flu', 'like', 'symptoms', 'from', 'videos', 'It', 'will', 'be', 'challenging', 'but', 'necessary', 'in', 'future', 'developments', 'to', 'consider', 'more', 'complex', 'real', 'life', 'scenario', 'of', 'detecting', 'these', 'actions', 'simultaneously', 'from', 'multiple', 'persons', 'in', 'possibly', 'crowded', 'environments', '']"
145049,Evaluation of Two Dry Commercial Therapeutic Diets for the Management of Feline Chronic Gastroenteropathy,2017-05-10,Front Vet Sci,https://doi.org/10.3389/fvets.2017.00069; https://www.ncbi.nlm.nih.gov/pubmed/28540291/,"Management of feline chronic gastroenteropathies has included intervention with both veterinary therapeutic formulas designed to manage non-specific gastrointestinal disorders and those designed with limited novel or hydrolyzed ingredients for management of food-responsive enteropathies and steroid-responsive enteropathies (inflammatory bowel disease). There have been few studies evaluating the use of dietary intervention for the management of feline chronic gastroenteropathy. This prospective, multi-center study evaluated the use of two commercially available feline veterinary therapeutic dry diets designed to manage non-specific gastrointestinal disorders in 28 cats with a history of chronic vomiting and/or diarrhea. The majority of cats enrolled in the study had a history of vomiting (n = 25), with a smaller number having a history of concurrent diarrhea (n = 2) or diarrhea alone (n = 3). Cats were excluded if diagnostic tests identified any systemic or infectious disease that could be associated with the clinical signs of vomiting or diarrhea, and if they were panhypoproteinemic, hypoalbuminemic, hypocobalaminemic, or had a Spec fPL ≥5.4 µg/L. Cats were randomized to one of two veterinary therapeutic diets for 4 weeks. Feeding of both therapeutic diets resulted in a numeric reduction in the number of vomiting episodes over the 4-week period, but no significant differences were seen between dietary interventions. When looking within dietary groups, significant differences were seen in cats fed Diet A with reductions of 69.1, 73.3, and 63.2% (p values of 0.008, 0.003, and 0.029) in weeks 2, 3, and 4, respectively, when compared to week 0. The probability of vomiting also showed significant reductions in cats fed Diet A between weeks 0 and 2, 3, and 4, with odds ratios of 0.008, 0.005, and 0.005, respectively (p values of 0.038, 0.23, and 0.23). Results of this study demonstrate that a veterinary therapeutic gastrointestinal formula can be effective in the management of feline chronic vomiting. Cats that fail to respond to this dietary approach after a 2- to 4-week trial may benefit from a limited novel or hydrolyzed ingredient formula and may require additional diagnostics to better characterize the underlying disease.",10.3389/fvets.2017.00069,eeljt0ur,"['Management', 'of', 'feline', 'chronic', 'gastroenteropathies', 'has', 'included', 'intervention', 'with', 'both', 'veterinary', 'therapeutic', 'formulas', 'designed', 'to', 'manage', 'non', 'specific', 'gastrointestinal', 'disorders', 'and', 'those', 'designed', 'with', 'limited', 'novel', 'or', 'hydrolyzed', 'ingredients', 'for', 'management', 'of', 'food', 'responsive', 'enteropathies', 'and', 'steroid', 'responsive', 'enteropathies', 'inflammatory', 'bowel', 'disease', 'There', 'have', 'been', 'few', 'studies', 'evaluating', 'the', 'use', 'of', 'dietary', 'intervention', 'for', 'the', 'management', 'of', 'feline', 'chronic', 'gastroenteropathy', 'This', 'prospective', 'multi', 'center', 'study', 'evaluated', 'the', 'use', 'of', 'two', 'commercially', 'available', 'feline', 'veterinary', 'therapeutic', 'dry', 'diets', 'designed', 'to', 'manage', 'non', 'specific', 'gastrointestinal', 'disorders', 'in', '28', 'cats', 'with', 'a', 'history', 'of', 'chronic', 'vomiting', 'and', 'or', 'diarrhea', 'The', 'majority', 'of', 'cats', 'enrolled', 'in', 'the', 'study', 'had', 'a', 'history', 'of', 'vomiting', 'n', '25', 'with', 'a', 'smaller', 'number', 'having', 'a', 'history', 'of', 'concurrent', 'diarrhea', 'n', '2', 'or', 'diarrhea', 'alone', 'n', '3', 'Cats', 'were', 'excluded', 'if', 'diagnostic', 'tests', 'identified', 'any', 'systemic', 'or', 'infectious', 'disease', 'that', 'could', 'be', 'associated', 'with', 'the', 'clinical', 'signs', 'of', 'vomiting', 'or', 'diarrhea', 'and', 'if', 'they', 'were', 'panhypoproteinemic', 'hypoalbuminemic', 'hypocobalaminemic', 'or', 'had', 'a', 'Spec', 'fPL', '5', '4', 'µg', 'L', 'Cats', 'were', 'randomized', 'to', 'one', 'of', 'two', 'veterinary', 'therapeutic', 'diets', 'for', '4', 'weeks', 'Feeding', 'of', 'both', 'therapeutic', 'diets', 'resulted', 'in', 'a', 'numeric', 'reduction', 'in', 'the', 'number', 'of', 'vomiting', 'episodes', 'over', 'the', '4', 'week', 'period', 'but', 'no', 'significant', 'differences', 'were', 'seen', 'between', 'dietary', 'interventions', 'When', 'looking', 'within', 'dietary', 'groups', 'significant', 'differences', 'were', 'seen', 'in', 'cats', 'fed', 'Diet', 'A', 'with', 'reductions', 'of', '69', '1', '73', '3', 'and', '63', '2', 'p', 'values', 'of', '0', '008', '0', '003', 'and', '0', '029', 'in', 'weeks', '2', '3', 'and', '4', 'respectively', 'when', 'compared', 'to', 'week', '0', 'The', 'probability', 'of', 'vomiting', 'also', 'showed', 'significant', 'reductions', 'in', 'cats', 'fed', 'Diet', 'A', 'between', 'weeks', '0', 'and', '2', '3', 'and', '4', 'with', 'odds', 'ratios', 'of', '0', '008', '0', '005', 'and', '0', '005', 'respectively', 'p', 'values', 'of', '0', '038', '0', '23', 'and', '0', '23', 'Results', 'of', 'this', 'study', 'demonstrate', 'that', 'a', 'veterinary', 'therapeutic', 'gastrointestinal', 'formula', 'can', 'be', 'effective', 'in', 'the', 'management', 'of', 'feline', 'chronic', 'vomiting', 'Cats', 'that', 'fail', 'to', 'respond', 'to', 'this', 'dietary', 'approach', 'after', 'a', '2', 'to', '4', 'week', 'trial', 'may', 'benefit', 'from', 'a', 'limited', 'novel', 'or', 'hydrolyzed', 'ingredient', 'formula', 'and', 'may', 'require', 'additional', 'diagnostics', 'to', 'better', 'characterize', 'the', 'underlying', 'disease', '']"
145107,2009 H1N1 Influenza: A Twenty-First Century Pandemic With Roots in the Early Twentieth Century,2015-12-16,Am J Med Sci,https://www.ncbi.nlm.nih.gov/pubmed/20697263/; https://api.elsevier.com/content/article/pii/S0002962915314993; https://www.sciencedirect.com/science/article/pii/S0002962915314993; https://doi.org/10.1097/maj.0b013e3181e937b0,"A swine-origin H1N1 triple-reassortant influenza A virus found to be a distant relative of the 1918 “Spanish flu” virus emerged in April 2009 to give rise to the first influenza pandemic of the 21st century. Although disease was generally mild and similar to seasonal influenza, severe manifestations including respiratory failure were noted in some, particularly those with underlying conditions such as asthma, pregnancy and immunosuppression. Children and younger adults accounted for most cases, hospitalizations and deaths. A reverse transcriptase-polymerase chain reaction assay was superior to antigen-based rapid tests for diagnosis. All 2009 H1N1 pandemic influenza strains were susceptible to 1 or more neuraminidase inhibitors. Monovalent, unadjuvanted 2009 H1N1 vaccines were licensed in the United States in September 2009 and initially targeted to younger individuals, pregnant women, caretakers of infants and healthcare providers. The 2009 H1N1 pandemic highlights the need for modernization of influenza vaccines, improved diagnostics and more rigorous evaluation of mitigation strategies.",10.1097/maj.0b013e3181e937b0,24knxh4m,"['A', 'swine', 'origin', 'H1N1', 'triple', 'reassortant', 'influenza', 'A', 'virus', 'found', 'to', 'be', 'a', 'distant', 'relative', 'of', 'the', '1918', 'Spanish', 'flu', 'virus', 'emerged', 'in', 'April', '2009', 'to', 'give', 'rise', 'to', 'the', 'first', 'influenza', 'pandemic', 'of', 'the', '21st', 'century', 'Although', 'disease', 'was', 'generally', 'mild', 'and', 'similar', 'to', 'seasonal', 'influenza', 'severe', 'manifestations', 'including', 'respiratory', 'failure', 'were', 'noted', 'in', 'some', 'particularly', 'those', 'with', 'underlying', 'conditions', 'such', 'as', 'asthma', 'pregnancy', 'and', 'immunosuppression', 'Children', 'and', 'younger', 'adults', 'accounted', 'for', 'most', 'cases', 'hospitalizations', 'and', 'deaths', 'A', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'assay', 'was', 'superior', 'to', 'antigen', 'based', 'rapid', 'tests', 'for', 'diagnosis', 'All', '2009', 'H1N1', 'pandemic', 'influenza', 'strains', 'were', 'susceptible', 'to', '1', 'or', 'more', 'neuraminidase', 'inhibitors', 'Monovalent', 'unadjuvanted', '2009', 'H1N1', 'vaccines', 'were', 'licensed', 'in', 'the', 'United', 'States', 'in', 'September', '2009', 'and', 'initially', 'targeted', 'to', 'younger', 'individuals', 'pregnant', 'women', 'caretakers', 'of', 'infants', 'and', 'healthcare', 'providers', 'The', '2009', 'H1N1', 'pandemic', 'highlights', 'the', 'need', 'for', 'modernization', 'of', 'influenza', 'vaccines', 'improved', 'diagnostics', 'and', 'more', 'rigorous', 'evaluation', 'of', 'mitigation', 'strategies', '']"
145353,Evaluation of ViroCyt(®) Virus Counter for Rapid Filovirus Quantitation,2015-02-20,Viruses,https://doi.org/10.3390/v7030857; https://www.ncbi.nlm.nih.gov/pubmed/25710889/,"Development and evaluation of medical countermeasures for diagnostics, vaccines, and therapeutics requires production of standardized, reproducible, and well characterized virus preparations. For filoviruses this includes plaque assay for quantitation of infectious virus, transmission electron microscopy (TEM) for morphology and quantitation of virus particles, and real-time reverse transcription PCR for quantitation of viral RNA (qRT-PCR). The ViroCyt(®) Virus Counter (VC) 2100 (ViroCyt, Boulder, CO, USA) is a flow-based instrument capable of quantifying virus particles in solution. Using a proprietary combination of fluorescent dyes that stain both nucleic acid and protein in a single 30 min step, rapid, reproducible, and cost-effective quantification of filovirus particles was demonstrated. Using a seed stock of Ebola virus variant Kikwit, the linear range of the instrument was determined to be 2.8E+06 to 1.0E+09 virus particles per mL with coefficient of variation ranging from 9.4% to 31.5% for samples tested in triplicate. VC particle counts for various filovirus stocks were within one log of TEM particle counts. A linear relationship was established between the plaque assay, qRT-PCR, and the VC. VC results significantly correlated with both plaque assay and qRT-PCR. These results demonstrated that the VC is an easy, fast, and consistent method to quantify filoviruses in stock preparations.",10.3390/v7030857,ic3r2g7s,"['Development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'for', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'requires', 'production', 'of', 'standardized', 'reproducible', 'and', 'well', 'characterized', 'virus', 'preparations', 'For', 'filoviruses', 'this', 'includes', 'plaque', 'assay', 'for', 'quantitation', 'of', 'infectious', 'virus', 'transmission', 'electron', 'microscopy', 'TEM', 'for', 'morphology', 'and', 'quantitation', 'of', 'virus', 'particles', 'and', 'real', 'time', 'reverse', 'transcription', 'PCR', 'for', 'quantitation', 'of', 'viral', 'RNA', 'qRT', 'PCR', 'The', 'ViroCyt', 'Virus', 'Counter', 'VC', '2100', 'ViroCyt', 'Boulder', 'CO', 'USA', 'is', 'a', 'flow', 'based', 'instrument', 'capable', 'of', 'quantifying', 'virus', 'particles', 'in', 'solution', 'Using', 'a', 'proprietary', 'combination', 'of', 'fluorescent', 'dyes', 'that', 'stain', 'both', 'nucleic', 'acid', 'and', 'protein', 'in', 'a', 'single', '30', 'min', 'step', 'rapid', 'reproducible', 'and', 'cost', 'effective', 'quantification', 'of', 'filovirus', 'particles', 'was', 'demonstrated', 'Using', 'a', 'seed', 'stock', 'of', 'Ebola', 'virus', 'variant', 'Kikwit', 'the', 'linear', 'range', 'of', 'the', 'instrument', 'was', 'determined', 'to', 'be', '2', '8E', '06', 'to', '1', '0E', '09', 'virus', 'particles', 'per', 'mL', 'with', 'coefficient', 'of', 'variation', 'ranging', 'from', '9', '4', 'to', '31', '5', 'for', 'samples', 'tested', 'in', 'triplicate', 'VC', 'particle', 'counts', 'for', 'various', 'filovirus', 'stocks', 'were', 'within', 'one', 'log', 'of', 'TEM', 'particle', 'counts', 'A', 'linear', 'relationship', 'was', 'established', 'between', 'the', 'plaque', 'assay', 'qRT', 'PCR', 'and', 'the', 'VC', 'VC', 'results', 'significantly', 'correlated', 'with', 'both', 'plaque', 'assay', 'and', 'qRT', 'PCR', 'These', 'results', 'demonstrated', 'that', 'the', 'VC', 'is', 'an', 'easy', 'fast', 'and', 'consistent', 'method', 'to', 'quantify', 'filoviruses', 'in', 'stock', 'preparations', '']"
145806,A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents,2006-08-31,Journal of Virological Methods,https://www.sciencedirect.com/science/article/pii/S0166093406001054; https://api.elsevier.com/content/article/pii/S0166093406001054; https://www.ncbi.nlm.nih.gov/pubmed/16677717/,"Abstract Medical and veterinary diagnostic and public health laboratories world-wide are increasingly being called upon to introduce molecular diagnostic tests for both endemic and exotic diseases. This demand has accelerated following increasing terrorism fears. Ironically these same concerns have lead to tightening of both import and export controls preventing many laboratories, particularly those outside of the United States, from gaining access to positive control material. This in turn has prevented many laboratories from introducing much needed molecular diagnostic tests. We describe here a generic approach for preparing synthetic DNA or RNA control material for use in either TaqMan or conventional PCR assays. The production of synthetic controls using this approach does not require cloning or special equipment or facilities beyond that found in any laboratory performing molecular diagnostics. The approach significantly reduces the possibility of contamination or erroneously reporting false-positive reactions due to contamination from positive control material. Synthetic controls produced using this approach have been employed in all molecular diagnostic tests performed in our laboratory and are used irrespective of whether we possess the organism or not.",10.1016/j.jviromet.2006.03.007,38k97qi0,"['Abstract', 'Medical', 'and', 'veterinary', 'diagnostic', 'and', 'public', 'health', 'laboratories', 'world', 'wide', 'are', 'increasingly', 'being', 'called', 'upon', 'to', 'introduce', 'molecular', 'diagnostic', 'tests', 'for', 'both', 'endemic', 'and', 'exotic', 'diseases', 'This', 'demand', 'has', 'accelerated', 'following', 'increasing', 'terrorism', 'fears', 'Ironically', 'these', 'same', 'concerns', 'have', 'lead', 'to', 'tightening', 'of', 'both', 'import', 'and', 'export', 'controls', 'preventing', 'many', 'laboratories', 'particularly', 'those', 'outside', 'of', 'the', 'United', 'States', 'from', 'gaining', 'access', 'to', 'positive', 'control', 'material', 'This', 'in', 'turn', 'has', 'prevented', 'many', 'laboratories', 'from', 'introducing', 'much', 'needed', 'molecular', 'diagnostic', 'tests', 'We', 'describe', 'here', 'a', 'generic', 'approach', 'for', 'preparing', 'synthetic', 'DNA', 'or', 'RNA', 'control', 'material', 'for', 'use', 'in', 'either', 'TaqMan', 'or', 'conventional', 'PCR', 'assays', 'The', 'production', 'of', 'synthetic', 'controls', 'using', 'this', 'approach', 'does', 'not', 'require', 'cloning', 'or', 'special', 'equipment', 'or', 'facilities', 'beyond', 'that', 'found', 'in', 'any', 'laboratory', 'performing', 'molecular', 'diagnostics', 'The', 'approach', 'significantly', 'reduces', 'the', 'possibility', 'of', 'contamination', 'or', 'erroneously', 'reporting', 'false', 'positive', 'reactions', 'due', 'to', 'contamination', 'from', 'positive', 'control', 'material', 'Synthetic', 'controls', 'produced', 'using', 'this', 'approach', 'have', 'been', 'employed', 'in', 'all', 'molecular', 'diagnostic', 'tests', 'performed', 'in', 'our', 'laboratory', 'and', 'are', 'used', 'irrespective', 'of', 'whether', 'we', 'possess', 'the', 'organism', 'or', 'not', '']"
145971,"PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings",2004-06-30,The Lancet Infectious Diseases,https://www.ncbi.nlm.nih.gov/pubmed/15172342/; https://api.elsevier.com/content/article/pii/S1473309904010448; https://www.sciencedirect.com/science/article/pii/S1473309904010448,"Summary Molecular diagnostics are revolutionising the clinical practice of infectious disease. Their effects will be significant in acute-care settings where timely and accurate diagnostic tools are critical for patient treatment decisions and outcomes. PCR is the most well-developed molecular technique up to now, and has a wide range of already fulfilled, and potential, clinical applications, including specific or broad-spectrum pathogen detection, evaluation of emerging novel infections, surveillance, early detection of biothreat agents, and antimicrobial resistance profiling. PCR-based methods may also be cost effective relative to traditional testing procedures. Further advancement of technology is needed to improve automation, optimise detection sensitivity and specificity, and expand the capacity to detect multiple targets simultaneously (multiplexing). This review provides an up-to-date look at the general principles, diagnostic value, and limitations of the most current PCR-based platforms as they evolve from bench to bedside.",10.1016/s1473-3099(04)01044-8,amu616mu,"['Summary', 'Molecular', 'diagnostics', 'are', 'revolutionising', 'the', 'clinical', 'practice', 'of', 'infectious', 'disease', 'Their', 'effects', 'will', 'be', 'significant', 'in', 'acute', 'care', 'settings', 'where', 'timely', 'and', 'accurate', 'diagnostic', 'tools', 'are', 'critical', 'for', 'patient', 'treatment', 'decisions', 'and', 'outcomes', 'PCR', 'is', 'the', 'most', 'well', 'developed', 'molecular', 'technique', 'up', 'to', 'now', 'and', 'has', 'a', 'wide', 'range', 'of', 'already', 'fulfilled', 'and', 'potential', 'clinical', 'applications', 'including', 'specific', 'or', 'broad', 'spectrum', 'pathogen', 'detection', 'evaluation', 'of', 'emerging', 'novel', 'infections', 'surveillance', 'early', 'detection', 'of', 'biothreat', 'agents', 'and', 'antimicrobial', 'resistance', 'profiling', 'PCR', 'based', 'methods', 'may', 'also', 'be', 'cost', 'effective', 'relative', 'to', 'traditional', 'testing', 'procedures', 'Further', 'advancement', 'of', 'technology', 'is', 'needed', 'to', 'improve', 'automation', 'optimise', 'detection', 'sensitivity', 'and', 'specificity', 'and', 'expand', 'the', 'capacity', 'to', 'detect', 'multiple', 'targets', 'simultaneously', 'multiplexing', 'This', 'review', 'provides', 'an', 'up', 'to', 'date', 'look', 'at', 'the', 'general', 'principles', 'diagnostic', 'value', 'and', 'limitations', 'of', 'the', 'most', 'current', 'PCR', 'based', 'platforms', 'as', 'they', 'evolve', 'from', 'bench', 'to', 'bedside', '']"
146615,Comparison of four multiplex PCR assays for the detection of viral pathogens in respiratory specimens,2013-08-31,Journal of Virological Methods,https://doi.org/10.1016/j.jviromet.2013.04.005; https://www.sciencedirect.com/science/article/pii/S0166093413001092; https://api.elsevier.com/content/article/pii/S0166093413001092; https://www.ncbi.nlm.nih.gov/pubmed/23583489/,"Abstract Multiplex PCR has become the test of choice for the detection of multiple respiratory viruses in clinical specimens. However, there are few direct comparisons of different PCR assays. This study compares 4 different multiplex PCR assays for the recovery of common respiratory viruses. We tested 213 respiratory specimens using four different multiplex PCR assays: the xTAG respiratory viral panel fast (Abbott Molecular Laboratories), Fast-track Respiratory Pathogen assay (Fast-track Diagnostics), Easyplex respiratory pathogen 12 kit (Ausdiagnostics), and an in-house multiplex real-time PCR assay. The performance of the four assays was very similar, with 93–100% agreement for all comparisons. Other issues, such as through-put, technical requirements and cost, are likely to be as important for making a decision about which of these assays to use given their comparative performance.",10.1016/j.jviromet.2013.04.005,bf6hu6es,"['Abstract', 'Multiplex', 'PCR', 'has', 'become', 'the', 'test', 'of', 'choice', 'for', 'the', 'detection', 'of', 'multiple', 'respiratory', 'viruses', 'in', 'clinical', 'specimens', 'However', 'there', 'are', 'few', 'direct', 'comparisons', 'of', 'different', 'PCR', 'assays', 'This', 'study', 'compares', '4', 'different', 'multiplex', 'PCR', 'assays', 'for', 'the', 'recovery', 'of', 'common', 'respiratory', 'viruses', 'We', 'tested', '213', 'respiratory', 'specimens', 'using', 'four', 'different', 'multiplex', 'PCR', 'assays', 'the', 'xTAG', 'respiratory', 'viral', 'panel', 'fast', 'Abbott', 'Molecular', 'Laboratories', 'Fast', 'track', 'Respiratory', 'Pathogen', 'assay', 'Fast', 'track', 'Diagnostics', 'Easyplex', 'respiratory', 'pathogen', '12', 'kit', 'Ausdiagnostics', 'and', 'an', 'in', 'house', 'multiplex', 'real', 'time', 'PCR', 'assay', 'The', 'performance', 'of', 'the', 'four', 'assays', 'was', 'very', 'similar', 'with', '93', '100', 'agreement', 'for', 'all', 'comparisons', 'Other', 'issues', 'such', 'as', 'through', 'put', 'technical', 'requirements', 'and', 'cost', 'are', 'likely', 'to', 'be', 'as', 'important', 'for', 'making', 'a', 'decision', 'about', 'which', 'of', 'these', 'assays', 'to', 'use', 'given', 'their', 'comparative', 'performance', '']"
146672,A practical review of alternatives to the steady pressurisation method for determining building airtightness,2020-10-31,Renewable and Sustainable Energy Reviews,https://www.sciencedirect.com/science/article/pii/S1364032120303403; https://api.elsevier.com/content/article/pii/S1364032120303403,"Abstract As an important indicator of construction quality and envelope integrity of buildings, airtightness is responsible for a considerable amount of energy losses associated with infiltration. It is crucial to understand building airtightness during construction and retrofitting to achieve a suitable envelope airtightness which is essential for obtaining a desirable building energy efficiency, durability and indoor environment. As a convenient means of measurement, the current steady pressurisation method has long been accepted as a standard testing method for measuring building airtightness. It offers an intuitive and robust approach for measuring building airtightness and performing building diagnostics. However, it also has some shortcomings that are mainly related to its high pressure measurement, requirement for skilful operation, long test duration and change to the building envelope. Efforts have been made by manufacturers and researchers to further improve its accuracy and practicality with much progress achieved. Work has also been done to develop alternative methods that can overcome some of the issues. This paper provides a practical review on the incumbent methodology and efforts that have been made over the past decades in research and development of other methods to achieve a similar purpose. It compares them in relation to aspects that are considered important in achieving an accurate, quick and practical measurement of building airtightness and the finding shows other methods such as acoustic and unsteady technique have their own advantages over the steady pressurisation method but also add some of their own restrictions, which therefore makes them suited for different applications.",10.1016/j.rser.2020.110049,ow7gzpyd,"['Abstract', 'As', 'an', 'important', 'indicator', 'of', 'construction', 'quality', 'and', 'envelope', 'integrity', 'of', 'buildings', 'airtightness', 'is', 'responsible', 'for', 'a', 'considerable', 'amount', 'of', 'energy', 'losses', 'associated', 'with', 'infiltration', 'It', 'is', 'crucial', 'to', 'understand', 'building', 'airtightness', 'during', 'construction', 'and', 'retrofitting', 'to', 'achieve', 'a', 'suitable', 'envelope', 'airtightness', 'which', 'is', 'essential', 'for', 'obtaining', 'a', 'desirable', 'building', 'energy', 'efficiency', 'durability', 'and', 'indoor', 'environment', 'As', 'a', 'convenient', 'means', 'of', 'measurement', 'the', 'current', 'steady', 'pressurisation', 'method', 'has', 'long', 'been', 'accepted', 'as', 'a', 'standard', 'testing', 'method', 'for', 'measuring', 'building', 'airtightness', 'It', 'offers', 'an', 'intuitive', 'and', 'robust', 'approach', 'for', 'measuring', 'building', 'airtightness', 'and', 'performing', 'building', 'diagnostics', 'However', 'it', 'also', 'has', 'some', 'shortcomings', 'that', 'are', 'mainly', 'related', 'to', 'its', 'high', 'pressure', 'measurement', 'requirement', 'for', 'skilful', 'operation', 'long', 'test', 'duration', 'and', 'change', 'to', 'the', 'building', 'envelope', 'Efforts', 'have', 'been', 'made', 'by', 'manufacturers', 'and', 'researchers', 'to', 'further', 'improve', 'its', 'accuracy', 'and', 'practicality', 'with', 'much', 'progress', 'achieved', 'Work', 'has', 'also', 'been', 'done', 'to', 'develop', 'alternative', 'methods', 'that', 'can', 'overcome', 'some', 'of', 'the', 'issues', 'This', 'paper', 'provides', 'a', 'practical', 'review', 'on', 'the', 'incumbent', 'methodology', 'and', 'efforts', 'that', 'have', 'been', 'made', 'over', 'the', 'past', 'decades', 'in', 'research', 'and', 'development', 'of', 'other', 'methods', 'to', 'achieve', 'a', 'similar', 'purpose', 'It', 'compares', 'them', 'in', 'relation', 'to', 'aspects', 'that', 'are', 'considered', 'important', 'in', 'achieving', 'an', 'accurate', 'quick', 'and', 'practical', 'measurement', 'of', 'building', 'airtightness', 'and', 'the', 'finding', 'shows', 'other', 'methods', 'such', 'as', 'acoustic', 'and', 'unsteady', 'technique', 'have', 'their', 'own', 'advantages', 'over', 'the', 'steady', 'pressurisation', 'method', 'but', 'also', 'add', 'some', 'of', 'their', 'own', 'restrictions', 'which', 'therefore', 'makes', 'them', 'suited', 'for', 'different', 'applications', '']"
146758,"Clinical presentation, diagnostic findings, and outcome of adult horses with equine coronavirus infection at a veterinary teaching hospital: 33 cases (2012–2018)",2019-06-30,The Veterinary Journal,https://www.ncbi.nlm.nih.gov/pubmed/31113572/; https://api.elsevier.com/content/article/pii/S1090023318303289; https://www.sciencedirect.com/science/article/pii/S1090023318303289; https://doi.org/10.1016/j.tvjl.2019.05.001,"Abstract Equine coronavirus (ECoV) is a recently described enteric virus with worldwide outbreaks; however, there are little data available on clinical presentation, diagnosis, and outcome. The study objective was to document case management of ECoV in adult horses presented to a referral hospital and compare to a cohort of horses that tested negative for ECoV. A retrospective case series was performed based on positive real-time quantitative PCR results for ECoV on faeces from horses treated at the UC Davis Veterinary Medical Teaching Hospital from 1 March 2012 to 31 March 2018. Horses negative for ECoV were matched to the ECoV-positive group as controls. Data collected included signalment, history, exam findings, diagnostics, treatment, and follow-up. Thirty-three horses (median age, 11 years; range, 2–37 years) tested ECoV-positive, including three horses with co-infections. Presenting complaints for ECoV-infected horses included historic fevers (n = 25/30; 83%), anorexia (n = 14/30; 47%), and colic (n = 13/30; 43%). ECoV-positive horses had significantly lower white blood cell (median, 3.0 × 109/L; range, 0.68–16.2 × 109/L), neutrophil (median, 1.26 × 109/L; range, 0.15–14.4 × 109/L), and lymphocyte (median, 0.86 × 109/L; range, 0.42–3.47 × 109/L) counts than ECoV-negative horses. Electrolyte and metabolic derangements and scant faeces were common. Twenty-seven horses were hospitalised for a median of 5 days (range, 0.5–14 days), with 26/27 (96%) horses surviving to discharge. ECoV infection should be a differential diagnosis for adult horses with fever, colic, anorexia, and leukopenia. The disease has a low mortality rate, but horses may require intensive care to resolve severe leukopenia, systemic inflammation, and metabolic disturbances.",10.1016/j.tvjl.2019.05.001,pcvq2e9q,"['Abstract', 'Equine', 'coronavirus', 'ECoV', 'is', 'a', 'recently', 'described', 'enteric', 'virus', 'with', 'worldwide', 'outbreaks', 'however', 'there', 'are', 'little', 'data', 'available', 'on', 'clinical', 'presentation', 'diagnosis', 'and', 'outcome', 'The', 'study', 'objective', 'was', 'to', 'document', 'case', 'management', 'of', 'ECoV', 'in', 'adult', 'horses', 'presented', 'to', 'a', 'referral', 'hospital', 'and', 'compare', 'to', 'a', 'cohort', 'of', 'horses', 'that', 'tested', 'negative', 'for', 'ECoV', 'A', 'retrospective', 'case', 'series', 'was', 'performed', 'based', 'on', 'positive', 'real', 'time', 'quantitative', 'PCR', 'results', 'for', 'ECoV', 'on', 'faeces', 'from', 'horses', 'treated', 'at', 'the', 'UC', 'Davis', 'Veterinary', 'Medical', 'Teaching', 'Hospital', 'from', '1', 'March', '2012', 'to', '31', 'March', '2018', 'Horses', 'negative', 'for', 'ECoV', 'were', 'matched', 'to', 'the', 'ECoV', 'positive', 'group', 'as', 'controls', 'Data', 'collected', 'included', 'signalment', 'history', 'exam', 'findings', 'diagnostics', 'treatment', 'and', 'follow', 'up', 'Thirty', 'three', 'horses', 'median', 'age', '11', 'years', 'range', '2', '37', 'years', 'tested', 'ECoV', 'positive', 'including', 'three', 'horses', 'with', 'co', 'infections', 'Presenting', 'complaints', 'for', 'ECoV', 'infected', 'horses', 'included', 'historic', 'fevers', 'n', '25', '30', '83', 'anorexia', 'n', '14', '30', '47', 'and', 'colic', 'n', '13', '30', '43', 'ECoV', 'positive', 'horses', 'had', 'significantly', 'lower', 'white', 'blood', 'cell', 'median', '3', '0', '109', 'L', 'range', '0', '68', '16', '2', '109', 'L', 'neutrophil', 'median', '1', '26', '109', 'L', 'range', '0', '15', '14', '4', '109', 'L', 'and', 'lymphocyte', 'median', '0', '86', '109', 'L', 'range', '0', '42', '3', '47', '109', 'L', 'counts', 'than', 'ECoV', 'negative', 'horses', 'Electrolyte', 'and', 'metabolic', 'derangements', 'and', 'scant', 'faeces', 'were', 'common', 'Twenty', 'seven', 'horses', 'were', 'hospitalised', 'for', 'a', 'median', 'of', '5', 'days', 'range', '0', '5', '14', 'days', 'with', '26', '27', '96', 'horses', 'surviving', 'to', 'discharge', 'ECoV', 'infection', 'should', 'be', 'a', 'differential', 'diagnosis', 'for', 'adult', 'horses', 'with', 'fever', 'colic', 'anorexia', 'and', 'leukopenia', 'The', 'disease', 'has', 'a', 'low', 'mortality', 'rate', 'but', 'horses', 'may', 'require', 'intensive', 'care', 'to', 'resolve', 'severe', 'leukopenia', 'systemic', 'inflammation', 'and', 'metabolic', 'disturbances', '']"
146829,SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America,2020-07-17,J Assist Reprod Genet,https://doi.org/10.1007/s10815-020-01887-3; https://www.ncbi.nlm.nih.gov/pubmed/32681280/,"The incorporation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing into patient care algorithms has been proposed to mitigate risk. However, the two main professional societies for human reproduction (ESHRE and ASRM) appear divergent on their clinical utility and whether they should be adopted. In this opinion paper, we review the currently available tests and discuss the strengths and weaknesses of the proposed clinical care pathways. Nucleic acid amplification tests are the cornerstone of SARS-CoV-2 testing but test results are largely influenced by viral load, sample site, specimen collection method, and specimen shipment technique, such that a negative result in a symptomatic patient cannot be relied upon. Serological assays for SARS-CoV-2 antibodies exhibit a temporal increase in sensitivity and specificity after symptom onset irrespective of the assay used, with sensitivity estimates ranging from 0 to 50% with the first 3 days of symptoms, to 83 to 88% at 10 days, increasing to almost 100% at ≥ 14 days. These inherent constraints in diagnostics would suggest that at present there is inadequate evidence to utilize SARS-CoV-2 testing to stratify fertility patients and reliably inform clinical decision-making. The failure to appreciate the characteristics and limitations of the diagnostic tests may lead to disastrous consequences for the patient and the multidisciplinary team looking after them.",10.1007/s10815-020-01887-3,qwuivy99,"['The', 'incorporation', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'testing', 'into', 'patient', 'care', 'algorithms', 'has', 'been', 'proposed', 'to', 'mitigate', 'risk', 'However', 'the', 'two', 'main', 'professional', 'societies', 'for', 'human', 'reproduction', 'ESHRE', 'and', 'ASRM', 'appear', 'divergent', 'on', 'their', 'clinical', 'utility', 'and', 'whether', 'they', 'should', 'be', 'adopted', 'In', 'this', 'opinion', 'paper', 'we', 'review', 'the', 'currently', 'available', 'tests', 'and', 'discuss', 'the', 'strengths', 'and', 'weaknesses', 'of', 'the', 'proposed', 'clinical', 'care', 'pathways', 'Nucleic', 'acid', 'amplification', 'tests', 'are', 'the', 'cornerstone', 'of', 'SARS', 'CoV', '2', 'testing', 'but', 'test', 'results', 'are', 'largely', 'influenced', 'by', 'viral', 'load', 'sample', 'site', 'specimen', 'collection', 'method', 'and', 'specimen', 'shipment', 'technique', 'such', 'that', 'a', 'negative', 'result', 'in', 'a', 'symptomatic', 'patient', 'cannot', 'be', 'relied', 'upon', 'Serological', 'assays', 'for', 'SARS', 'CoV', '2', 'antibodies', 'exhibit', 'a', 'temporal', 'increase', 'in', 'sensitivity', 'and', 'specificity', 'after', 'symptom', 'onset', 'irrespective', 'of', 'the', 'assay', 'used', 'with', 'sensitivity', 'estimates', 'ranging', 'from', '0', 'to', '50', 'with', 'the', 'first', '3', 'days', 'of', 'symptoms', 'to', '83', 'to', '88', 'at', '10', 'days', 'increasing', 'to', 'almost', '100', 'at', '14', 'days', 'These', 'inherent', 'constraints', 'in', 'diagnostics', 'would', 'suggest', 'that', 'at', 'present', 'there', 'is', 'inadequate', 'evidence', 'to', 'utilize', 'SARS', 'CoV', '2', 'testing', 'to', 'stratify', 'fertility', 'patients', 'and', 'reliably', 'inform', 'clinical', 'decision', 'making', 'The', 'failure', 'to', 'appreciate', 'the', 'characteristics', 'and', 'limitations', 'of', 'the', 'diagnostic', 'tests', 'may', 'lead', 'to', 'disastrous', 'consequences', 'for', 'the', 'patient', 'and', 'the', 'multidisciplinary', 'team', 'looking', 'after', 'them', '']"
146836,Ultra-sensitive and high-throughput CRISPR-Powered COVID-19 diagnosis,2020-05-23,Biosens Bioelectron,https://doi.org/10.1016/j.bios.2020.112316; https://www.ncbi.nlm.nih.gov/pubmed/32553350/; https://www.sciencedirect.com/science/article/pii/S0956566320303110?v=s5; https://api.elsevier.com/content/article/pii/S0956566320303110,"Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-throughput operation that can preferably utilize existing equipment to facilitate broad, large-scale screening efforts. We have developed a CRISPR-based assay that can meet all these criteria. This assay utilizes a custom CRISPR Cas12a/gRNA complex and a fluorescent probe to amplify target amplicons produced by standard RT-PCR or isothermal recombinase polymerase amplification (RPA), to allow sensitive detection at sites not equipped with real-time PCR systems required for qPCR diagnostics. We found this approach allowed sensitive and robust detection of SARS-CoV-2 positive samples, with a sample-to-answer time of ∼50 min, and a limit of detection of 2 copies per sample. CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved qPCR assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the qPCR assay exhibited multiple invalid or inconclusive results. Our assay also demonstrated greater analytical sensitivity and more robust diagnostic performance than other recently reported CRISPR-based assays. Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts.",10.1016/j.bios.2020.112316,rhtpajoq,"['Recent', 'research', 'suggests', 'that', 'SARS', 'CoV', '2', 'infected', 'individuals', 'can', 'be', 'highly', 'infectious', 'while', 'asymptomatic', 'or', 'pre', 'symptomatic', 'and', 'that', 'an', 'infected', 'person', 'may', 'infect', '5', '6', 'other', 'individuals', 'on', 'average', 'This', 'situation', 'highlights', 'the', 'need', 'for', 'rapid', 'sensitive', 'SARS', 'CoV', '2', 'diagnostic', 'assays', 'capable', 'of', 'high', 'throughput', 'operation', 'that', 'can', 'preferably', 'utilize', 'existing', 'equipment', 'to', 'facilitate', 'broad', 'large', 'scale', 'screening', 'efforts', 'We', 'have', 'developed', 'a', 'CRISPR', 'based', 'assay', 'that', 'can', 'meet', 'all', 'these', 'criteria', 'This', 'assay', 'utilizes', 'a', 'custom', 'CRISPR', 'Cas12a', 'gRNA', 'complex', 'and', 'a', 'fluorescent', 'probe', 'to', 'amplify', 'target', 'amplicons', 'produced', 'by', 'standard', 'RT', 'PCR', 'or', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'to', 'allow', 'sensitive', 'detection', 'at', 'sites', 'not', 'equipped', 'with', 'real', 'time', 'PCR', 'systems', 'required', 'for', 'qPCR', 'diagnostics', 'We', 'found', 'this', 'approach', 'allowed', 'sensitive', 'and', 'robust', 'detection', 'of', 'SARS', 'CoV', '2', 'positive', 'samples', 'with', 'a', 'sample', 'to', 'answer', 'time', 'of', '50', 'min', 'and', 'a', 'limit', 'of', 'detection', 'of', '2', 'copies', 'per', 'sample', 'CRISPR', 'assay', 'diagnostic', 'results', 'obtained', 'nasal', 'swab', 'samples', 'of', 'individuals', 'with', 'suspected', 'COVID', '19', 'cases', 'were', 'comparable', 'to', 'paired', 'results', 'from', 'a', 'CDC', 'approved', 'qPCR', 'assay', 'performed', 'in', 'a', 'state', 'testing', 'lab', 'and', 'superior', 'to', 'those', 'produced', 'by', 'same', 'assay', 'in', 'a', 'clinical', 'lab', 'where', 'the', 'qPCR', 'assay', 'exhibited', 'multiple', 'invalid', 'or', 'inconclusive', 'results', 'Our', 'assay', 'also', 'demonstrated', 'greater', 'analytical', 'sensitivity', 'and', 'more', 'robust', 'diagnostic', 'performance', 'than', 'other', 'recently', 'reported', 'CRISPR', 'based', 'assays', 'Based', 'on', 'these', 'findings', 'we', 'believe', 'that', 'a', 'CRISPR', 'based', 'fluorescent', 'application', 'has', 'potential', 'to', 'improve', 'current', 'COVID', '19', 'screening', 'efforts', '']"
146845,An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment,2020-07-06,Nat Commun,https://www.ncbi.nlm.nih.gov/pubmed/32632160/; https://doi.org/10.1038/s41467-020-17317-y,"The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a detailed comparison of serological COVID-19 assays. We show that among the selected assays there is a wide diversity in assay performance in different scenarios and when correlated to virus neutralizing antibodies. The Wantai ELISA detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, has the best overall characteristics to detect functional antibodies in different stages and severity of disease, including the potential to set a cut-off indicating the presence of protective antibodies. The large variety of available serological assays requires proper assay validation before deciding on deployment of assays for specific applications.",10.1038/s41467-020-17317-y,jeedo5mc,"['The', 'world', 'is', 'entering', 'a', 'new', 'era', 'of', 'the', 'COVID', '19', 'pandemic', 'in', 'which', 'there', 'is', 'an', 'increasing', 'call', 'for', 'reliable', 'antibody', 'testing', 'To', 'support', 'decision', 'making', 'on', 'the', 'deployment', 'of', 'serology', 'for', 'either', 'population', 'screening', 'or', 'diagnostics', 'we', 'present', 'a', 'detailed', 'comparison', 'of', 'serological', 'COVID', '19', 'assays', 'We', 'show', 'that', 'among', 'the', 'selected', 'assays', 'there', 'is', 'a', 'wide', 'diversity', 'in', 'assay', 'performance', 'in', 'different', 'scenarios', 'and', 'when', 'correlated', 'to', 'virus', 'neutralizing', 'antibodies', 'The', 'Wantai', 'ELISA', 'detecting', 'total', 'immunoglobulins', 'against', 'the', 'receptor', 'binding', 'domain', 'of', 'SARS', 'CoV', '2', 'has', 'the', 'best', 'overall', 'characteristics', 'to', 'detect', 'functional', 'antibodies', 'in', 'different', 'stages', 'and', 'severity', 'of', 'disease', 'including', 'the', 'potential', 'to', 'set', 'a', 'cut', 'off', 'indicating', 'the', 'presence', 'of', 'protective', 'antibodies', 'The', 'large', 'variety', 'of', 'available', 'serological', 'assays', 'requires', 'proper', 'assay', 'validation', 'before', 'deciding', 'on', 'deployment', 'of', 'assays', 'for', 'specific', 'applications', '']"
147180,Evaluation of a two-stage testing algorithm for the diagnosis of respiratory viral infections,2018-08-31,Diagnostic Microbiology and Infectious Disease,https://api.elsevier.com/content/article/pii/S0732889318300853; https://www.sciencedirect.com/science/article/pii/S0732889318300853; https://www.ncbi.nlm.nih.gov/pubmed/29636246/; https://doi.org/10.1016/j.diagmicrobio.2018.03.007,"Abstract New on-demand multiplex molecular respiratory viral diagnostics offer superior performance although can be expensive and some platforms cannot process multiple specimens simultaneously. We performed a retrospective study reviewing results of patients tested for respiratory viruses following introduction of a two-stage testing algorithm incorporating an initial screen with Sofia® immunoassay then secondary Biofire Filmarray®, and compared to a period when only Filmarray® was used. Of 2976 testing episodes, 1814 underwent initial Sofia® then follow-up FilmArray®. A diagnosis of influenza was made by Sofia® in 282 patients, and by FilmArray® in an additional 163 (median time to result 1.12hours versus 3.46hours, P <0.001). Significantly more patients received their diagnosis within 90minutes in winter despite testing more samples (11.1% versus 3.4%, P <0.001), and approximately $36,000 was saved. An algorithmic approach to respiratory viral diagnosis can combine the advantages of accuracy and speed and be cost saving.",10.1016/j.diagmicrobio.2018.03.007,7paar9wg,"['Abstract', 'New', 'on', 'demand', 'multiplex', 'molecular', 'respiratory', 'viral', 'diagnostics', 'offer', 'superior', 'performance', 'although', 'can', 'be', 'expensive', 'and', 'some', 'platforms', 'cannot', 'process', 'multiple', 'specimens', 'simultaneously', 'We', 'performed', 'a', 'retrospective', 'study', 'reviewing', 'results', 'of', 'patients', 'tested', 'for', 'respiratory', 'viruses', 'following', 'introduction', 'of', 'a', 'two', 'stage', 'testing', 'algorithm', 'incorporating', 'an', 'initial', 'screen', 'with', 'Sofia', 'immunoassay', 'then', 'secondary', 'Biofire', 'Filmarray', 'and', 'compared', 'to', 'a', 'period', 'when', 'only', 'Filmarray', 'was', 'used', 'Of', '2976', 'testing', 'episodes', '1814', 'underwent', 'initial', 'Sofia', 'then', 'follow', 'up', 'FilmArray', 'A', 'diagnosis', 'of', 'influenza', 'was', 'made', 'by', 'Sofia', 'in', '282', 'patients', 'and', 'by', 'FilmArray', 'in', 'an', 'additional', '163', 'median', 'time', 'to', 'result', '1', '12hours', 'versus', '3', '46hours', 'P', '0', '001', 'Significantly', 'more', 'patients', 'received', 'their', 'diagnosis', 'within', '90minutes', 'in', 'winter', 'despite', 'testing', 'more', 'samples', '11', '1', 'versus', '3', '4', 'P', '0', '001', 'and', 'approximately', '36', '000', 'was', 'saved', 'An', 'algorithmic', 'approach', 'to', 'respiratory', 'viral', 'diagnosis', 'can', 'combine', 'the', 'advantages', 'of', 'accuracy', 'and', 'speed', 'and', 'be', 'cost', 'saving', '']"
147753,"Point-Of-Care Testing Curriculum and Accreditation for Public Health—Enabling Preparedness, Response, and Higher Standards of Care at Points of Need",2019-01-29,Front Public Health,https://www.ncbi.nlm.nih.gov/pubmed/30761282/; https://doi.org/10.3389/fpubh.2018.00385,"Objectives: To develop awareness of benefits of point-of-care testing (POCT) education in schools of public health, to identify learning objectives for teaching POCT, to enable public health professionals and emergency responders to perform evidence-based diagnosis and triage effectively and efficiently at points of need, and to better improve future standards of care for public health practice, including in limited-resource settings and crisis situations. Methods: We surveyed all U.S. schools of public health, colleges of public health, and public health schools accredited by the Council on Education in Public Health (CEPH). We included accredited public health programs, so that all states offering public health education were represented. We analyzed survey data, public health books, and board certification guidelines. We used PubMed to identify public health curriculum papers, and assessed 2019 CEPH accreditation requirements. We merged POCT knowledge bases to design a new curriculum for teaching public health students and practitioners the principles and practice of POCT. Results: Public health curricula, certification requirements, and textbooks generally do not include POCT instruction. Only one book, Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience, and one online course on public health preparedness address POCT and public health intervention issues. The topic, POC HIV/HCV ED testing, appeared in one course and POC diagnostics in local clinics, in another. Papers on public health curriculum have not incorporated POCT. No curriculum addresses POCT in isolation units during quarantine, despite evidence that recent Ebola virus disease cases in the U.S. and elsewhere proved unequivocally the need for POCT. The modular learning objectives identified in this paper were customized for public health students. Public health graduates can use boot camps, online credentialing, and self-study to acquire POCT skills. Conclusions: Enhancing accreditation requirements, academic training, board certification, and field experience will generate public health healthcare professionals who will rely upon evidence-based medical decision making at points of care, including during crises when time is of the essence. A POCT-enabled public health workforce can help prevent and stop outbreaks. Public health-based medical professionals urgently need the skills necessary to perform POCT and prepare America and other nations for threats portending significant adverse medical, economic, social, and cultural impact.",10.3389/fpubh.2018.00385,fvb6w11l,"['Objectives', 'To', 'develop', 'awareness', 'of', 'benefits', 'of', 'point', 'of', 'care', 'testing', 'POCT', 'education', 'in', 'schools', 'of', 'public', 'health', 'to', 'identify', 'learning', 'objectives', 'for', 'teaching', 'POCT', 'to', 'enable', 'public', 'health', 'professionals', 'and', 'emergency', 'responders', 'to', 'perform', 'evidence', 'based', 'diagnosis', 'and', 'triage', 'effectively', 'and', 'efficiently', 'at', 'points', 'of', 'need', 'and', 'to', 'better', 'improve', 'future', 'standards', 'of', 'care', 'for', 'public', 'health', 'practice', 'including', 'in', 'limited', 'resource', 'settings', 'and', 'crisis', 'situations', 'Methods', 'We', 'surveyed', 'all', 'U', 'S', 'schools', 'of', 'public', 'health', 'colleges', 'of', 'public', 'health', 'and', 'public', 'health', 'schools', 'accredited', 'by', 'the', 'Council', 'on', 'Education', 'in', 'Public', 'Health', 'CEPH', 'We', 'included', 'accredited', 'public', 'health', 'programs', 'so', 'that', 'all', 'states', 'offering', 'public', 'health', 'education', 'were', 'represented', 'We', 'analyzed', 'survey', 'data', 'public', 'health', 'books', 'and', 'board', 'certification', 'guidelines', 'We', 'used', 'PubMed', 'to', 'identify', 'public', 'health', 'curriculum', 'papers', 'and', 'assessed', '2019', 'CEPH', 'accreditation', 'requirements', 'We', 'merged', 'POCT', 'knowledge', 'bases', 'to', 'design', 'a', 'new', 'curriculum', 'for', 'teaching', 'public', 'health', 'students', 'and', 'practitioners', 'the', 'principles', 'and', 'practice', 'of', 'POCT', 'Results', 'Public', 'health', 'curricula', 'certification', 'requirements', 'and', 'textbooks', 'generally', 'do', 'not', 'include', 'POCT', 'instruction', 'Only', 'one', 'book', 'Global', 'Point', 'of', 'Care', 'Strategies', 'for', 'Disasters', 'Emergencies', 'and', 'Public', 'Health', 'Resilience', 'and', 'one', 'online', 'course', 'on', 'public', 'health', 'preparedness', 'address', 'POCT', 'and', 'public', 'health', 'intervention', 'issues', 'The', 'topic', 'POC', 'HIV', 'HCV', 'ED', 'testing', 'appeared', 'in', 'one', 'course', 'and', 'POC', 'diagnostics', 'in', 'local', 'clinics', 'in', 'another', 'Papers', 'on', 'public', 'health', 'curriculum', 'have', 'not', 'incorporated', 'POCT', 'No', 'curriculum', 'addresses', 'POCT', 'in', 'isolation', 'units', 'during', 'quarantine', 'despite', 'evidence', 'that', 'recent', 'Ebola', 'virus', 'disease', 'cases', 'in', 'the', 'U', 'S', 'and', 'elsewhere', 'proved', 'unequivocally', 'the', 'need', 'for', 'POCT', 'The', 'modular', 'learning', 'objectives', 'identified', 'in', 'this', 'paper', 'were', 'customized', 'for', 'public', 'health', 'students', 'Public', 'health', 'graduates', 'can', 'use', 'boot', 'camps', 'online', 'credentialing', 'and', 'self', 'study', 'to', 'acquire', 'POCT', 'skills', 'Conclusions', 'Enhancing', 'accreditation', 'requirements', 'academic', 'training', 'board', 'certification', 'and', 'field', 'experience', 'will', 'generate', 'public', 'health', 'healthcare', 'professionals', 'who', 'will', 'rely', 'upon', 'evidence', 'based', 'medical', 'decision', 'making', 'at', 'points', 'of', 'care', 'including', 'during', 'crises', 'when', 'time', 'is', 'of', 'the', 'essence', 'A', 'POCT', 'enabled', 'public', 'health', 'workforce', 'can', 'help', 'prevent', 'and', 'stop', 'outbreaks', 'Public', 'health', 'based', 'medical', 'professionals', 'urgently', 'need', 'the', 'skills', 'necessary', 'to', 'perform', 'POCT', 'and', 'prepare', 'America', 'and', 'other', 'nations', 'for', 'threats', 'portending', 'significant', 'adverse', 'medical', 'economic', 'social', 'and', 'cultural', 'impact', '']"
148094,Clinical decision making in the emergency department setting using rapid PCR: Results of the CLADE study group,2018-05-31,Journal of Clinical Virology,https://www.ncbi.nlm.nih.gov/pubmed/29494950/; https://api.elsevier.com/content/article/pii/S1386653218300465; https://www.sciencedirect.com/science/article/pii/S1386653218300465; https://doi.org/10.1016/j.jcv.2018.02.013,"Abstract Background Emergency Departments (ED) are challenged during influenza season by patients who present acutely during sporadic ED visits. ED management is largely empiric, often occurring without reliable diagnostics needed for targeted therapies, safe outpatient discharge, or hospital admissions. Objective To evaluate the impact of the influenza diagnosis on physician decision making during ED visits using the Cobas Liat® influenza A + B assay. Study design Prospective study assessing the impact of rapid (<30 min), reverse-transcriptase polymerase chain reaction (RT-PCR) influenza testing on physician decision making in the ED. Physician responses established pre-and post-diagnosis management courses which required confirmation via secondary documentation in the medical record. Changes in physician decision making were analyzed across four clinical touchpoints: (i) admission/discharge status, (ii) medical procedures, (iii) antiviral and antibiotic prescribing, and (iv) laboratory studies. Results An influenza diagnosis changed patient management courses, relative to empiric, pre-diagnosis plans, in in 61% of the cases resulting in cost savings of $49,420-to-$42,270 over 143 patients and 104 days during influenza season resulting in a cost savings of $200.40/ED visit. Evaluation over 2000 ED patient visits projects cost savings > $578,000 due to deferred admissions, and reduction in antiviral prescribing. Sensitivity of ED-based influenza testing using the Cobas Liat® assay was equivalent to centralized lab testing at 98.8% sensitivity and 98.5% specificity respectively. Conclusion Providing rapid, RT-PCR influenza testing to ED settings is actionable and used to guide patient care decisions. Understanding the cascade of events linked to the influenza diagnosis in the ED provides overall cost savings which offset the cost of providing ED-based testing.",10.1016/j.jcv.2018.02.013,v5qb41c1,"['Abstract', 'Background', 'Emergency', 'Departments', 'ED', 'are', 'challenged', 'during', 'influenza', 'season', 'by', 'patients', 'who', 'present', 'acutely', 'during', 'sporadic', 'ED', 'visits', 'ED', 'management', 'is', 'largely', 'empiric', 'often', 'occurring', 'without', 'reliable', 'diagnostics', 'needed', 'for', 'targeted', 'therapies', 'safe', 'outpatient', 'discharge', 'or', 'hospital', 'admissions', 'Objective', 'To', 'evaluate', 'the', 'impact', 'of', 'the', 'influenza', 'diagnosis', 'on', 'physician', 'decision', 'making', 'during', 'ED', 'visits', 'using', 'the', 'Cobas', 'Liat', 'influenza', 'A', 'B', 'assay', 'Study', 'design', 'Prospective', 'study', 'assessing', 'the', 'impact', 'of', 'rapid', '30', 'min', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'influenza', 'testing', 'on', 'physician', 'decision', 'making', 'in', 'the', 'ED', 'Physician', 'responses', 'established', 'pre', 'and', 'post', 'diagnosis', 'management', 'courses', 'which', 'required', 'confirmation', 'via', 'secondary', 'documentation', 'in', 'the', 'medical', 'record', 'Changes', 'in', 'physician', 'decision', 'making', 'were', 'analyzed', 'across', 'four', 'clinical', 'touchpoints', 'i', 'admission', 'discharge', 'status', 'ii', 'medical', 'procedures', 'iii', 'antiviral', 'and', 'antibiotic', 'prescribing', 'and', 'iv', 'laboratory', 'studies', 'Results', 'An', 'influenza', 'diagnosis', 'changed', 'patient', 'management', 'courses', 'relative', 'to', 'empiric', 'pre', 'diagnosis', 'plans', 'in', 'in', '61', 'of', 'the', 'cases', 'resulting', 'in', 'cost', 'savings', 'of', '49', '420', 'to', '42', '270', 'over', '143', 'patients', 'and', '104', 'days', 'during', 'influenza', 'season', 'resulting', 'in', 'a', 'cost', 'savings', 'of', '200', '40', 'ED', 'visit', 'Evaluation', 'over', '2000', 'ED', 'patient', 'visits', 'projects', 'cost', 'savings', '578', '000', 'due', 'to', 'deferred', 'admissions', 'and', 'reduction', 'in', 'antiviral', 'prescribing', 'Sensitivity', 'of', 'ED', 'based', 'influenza', 'testing', 'using', 'the', 'Cobas', 'Liat', 'assay', 'was', 'equivalent', 'to', 'centralized', 'lab', 'testing', 'at', '98', '8', 'sensitivity', 'and', '98', '5', 'specificity', 'respectively', 'Conclusion', 'Providing', 'rapid', 'RT', 'PCR', 'influenza', 'testing', 'to', 'ED', 'settings', 'is', 'actionable', 'and', 'used', 'to', 'guide', 'patient', 'care', 'decisions', 'Understanding', 'the', 'cascade', 'of', 'events', 'linked', 'to', 'the', 'influenza', 'diagnosis', 'in', 'the', 'ED', 'provides', 'overall', 'cost', 'savings', 'which', 'offset', 'the', 'cost', 'of', 'providing', 'ED', 'based', 'testing', '']"
148114,Diagnostic Techniques: Serological and Molecular Approaches☆,2015-12-31,Reference Module in Biomedical Sciences,https://api.elsevier.com/content/article/pii/B9780128012383025587; https://www.sciencedirect.com/science/article/pii/B9780128012383025587,"Abstract Virus laboratory diagnostics has an increasingly important role in modern patient care. Virological methods are needed to investigate the etiology of acute viral infection or the reactivation of a latent infection, as well as to follow virus load in antiviral treatments. Serological assays are also used for screening of blood products for the risk of certain chronic infections, evaluation of the immune status, and need for prophylactic treatments in connection with organ transplantations. For diagnostic purposes the following approaches can be used: demonstration of presence of infectious virus or its structural components directly from a patient's specimens or investigation of specific antibody response in serum specimens. Amplification techniques, most commonly polymerase chain reaction (PCR) is currently the workhorse of nucleic acid testing for the detection and quantitation of virus genomes. Virus isolation is used to demonstrate infectious virus in a patient's specimens, whereas virus antigens are investigated by antigen detection assays. Serological diagnosis is based on either the demonstration of the presence of virus-specific IgM antibodies or a significant increase in the levels and/or avidity of specific IgG antibodies. Immunoassays are the most commonly used serological assays. Point-of-care tests (POC tests), for antigens, antibodies, and also nucleic acids are also becoming more and more common in diagnostic use. In order to reach the best diagnostic efficiency for each patient it is important to select the most suitable method using the right sample collected at the right time.",10.1016/b978-0-12-801238-3.02558-7,2u16otbf,"['Abstract', 'Virus', 'laboratory', 'diagnostics', 'has', 'an', 'increasingly', 'important', 'role', 'in', 'modern', 'patient', 'care', 'Virological', 'methods', 'are', 'needed', 'to', 'investigate', 'the', 'etiology', 'of', 'acute', 'viral', 'infection', 'or', 'the', 'reactivation', 'of', 'a', 'latent', 'infection', 'as', 'well', 'as', 'to', 'follow', 'virus', 'load', 'in', 'antiviral', 'treatments', 'Serological', 'assays', 'are', 'also', 'used', 'for', 'screening', 'of', 'blood', 'products', 'for', 'the', 'risk', 'of', 'certain', 'chronic', 'infections', 'evaluation', 'of', 'the', 'immune', 'status', 'and', 'need', 'for', 'prophylactic', 'treatments', 'in', 'connection', 'with', 'organ', 'transplantations', 'For', 'diagnostic', 'purposes', 'the', 'following', 'approaches', 'can', 'be', 'used', 'demonstration', 'of', 'presence', 'of', 'infectious', 'virus', 'or', 'its', 'structural', 'components', 'directly', 'from', 'a', 'patient', 's', 'specimens', 'or', 'investigation', 'of', 'specific', 'antibody', 'response', 'in', 'serum', 'specimens', 'Amplification', 'techniques', 'most', 'commonly', 'polymerase', 'chain', 'reaction', 'PCR', 'is', 'currently', 'the', 'workhorse', 'of', 'nucleic', 'acid', 'testing', 'for', 'the', 'detection', 'and', 'quantitation', 'of', 'virus', 'genomes', 'Virus', 'isolation', 'is', 'used', 'to', 'demonstrate', 'infectious', 'virus', 'in', 'a', 'patient', 's', 'specimens', 'whereas', 'virus', 'antigens', 'are', 'investigated', 'by', 'antigen', 'detection', 'assays', 'Serological', 'diagnosis', 'is', 'based', 'on', 'either', 'the', 'demonstration', 'of', 'the', 'presence', 'of', 'virus', 'specific', 'IgM', 'antibodies', 'or', 'a', 'significant', 'increase', 'in', 'the', 'levels', 'and', 'or', 'avidity', 'of', 'specific', 'IgG', 'antibodies', 'Immunoassays', 'are', 'the', 'most', 'commonly', 'used', 'serological', 'assays', 'Point', 'of', 'care', 'tests', 'POC', 'tests', 'for', 'antigens', 'antibodies', 'and', 'also', 'nucleic', 'acids', 'are', 'also', 'becoming', 'more', 'and', 'more', 'common', 'in', 'diagnostic', 'use', 'In', 'order', 'to', 'reach', 'the', 'best', 'diagnostic', 'efficiency', 'for', 'each', 'patient', 'it', 'is', 'important', 'to', 'select', 'the', 'most', 'suitable', 'method', 'using', 'the', 'right', 'sample', 'collected', 'at', 'the', 'right', 'time', '']"
149075,Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies,2012-09-27,Med Clin North Am,https://www.ncbi.nlm.nih.gov/pubmed/23102477/; https://doi.org/10.1016/j.mcna.2012.08.005; https://api.elsevier.com/content/article/pii/S0025712512001538; https://www.sciencedirect.com/science/article/pii/S0025712512001538,"Clinical laboratories have traditionally relied on time-consuming phenotypic methods such as culture, serology, and biochemical tests for detection, identification, and characterization of microbial pathogens. Real-time polymerase chain reaction technology can now identify many pathogenic organisms that constitute infectious disease emergencies in normal and immune-compromised hosts. Use of this molecular technology for the accurate diagnosis of infectious disease agents by clinical laboratories reduces the time to diagnosis for many pathogens. This article is designed such that the clinician evaluating a patient with severe acute illness can reference the most relevant molecular diagnostics available pertinent to the predominant organ system involved.",10.1016/j.mcna.2012.08.005,jw8hqei0,"['Clinical', 'laboratories', 'have', 'traditionally', 'relied', 'on', 'time', 'consuming', 'phenotypic', 'methods', 'such', 'as', 'culture', 'serology', 'and', 'biochemical', 'tests', 'for', 'detection', 'identification', 'and', 'characterization', 'of', 'microbial', 'pathogens', 'Real', 'time', 'polymerase', 'chain', 'reaction', 'technology', 'can', 'now', 'identify', 'many', 'pathogenic', 'organisms', 'that', 'constitute', 'infectious', 'disease', 'emergencies', 'in', 'normal', 'and', 'immune', 'compromised', 'hosts', 'Use', 'of', 'this', 'molecular', 'technology', 'for', 'the', 'accurate', 'diagnosis', 'of', 'infectious', 'disease', 'agents', 'by', 'clinical', 'laboratories', 'reduces', 'the', 'time', 'to', 'diagnosis', 'for', 'many', 'pathogens', 'This', 'article', 'is', 'designed', 'such', 'that', 'the', 'clinician', 'evaluating', 'a', 'patient', 'with', 'severe', 'acute', 'illness', 'can', 'reference', 'the', 'most', 'relevant', 'molecular', 'diagnostics', 'available', 'pertinent', 'to', 'the', 'predominant', 'organ', 'system', 'involved', '']"
149337,Molecular Diagnosis of Diarrhea: Current Status and Future Potential,2011-11-26,Curr Infect Dis Rep,https://www.ncbi.nlm.nih.gov/pubmed/22116640/; https://doi.org/10.1007/s11908-011-0223-7,"Determining the microbiologic etiology of enteric infection remains an elusive goal. Conventional approaches, including culture, microscopy, and antigen-based tests have significant limitations such as limit of detection and the need for multiple procedures. Molecular diagnostics, especially PCR based tests, are rapidly changing research and practice in infectious diseases. Diarrheal disease, with its broad range of potential infectious etiologies, is well suited for multiplex molecular testing. This review highlights examples of currently employed molecular tests, as well as ways in which these tests can be applied in the future. The absence of a gold standard for the microbiologic cause of diarrhea means that the clinical significance of detected organisms may not always be clear. Conventional wisdom is that there should be one main pathogen causing diarrhea, however our thinking is challenged by increased detection of mixed infections. Thus, the successful incorporation of molecular diagnostics for diarrheal disease into practice will require both a careful understanding of the technical aspects and research to define their clinical utility.",10.1007/s11908-011-0223-7,tlpncdox,"['Determining', 'the', 'microbiologic', 'etiology', 'of', 'enteric', 'infection', 'remains', 'an', 'elusive', 'goal', 'Conventional', 'approaches', 'including', 'culture', 'microscopy', 'and', 'antigen', 'based', 'tests', 'have', 'significant', 'limitations', 'such', 'as', 'limit', 'of', 'detection', 'and', 'the', 'need', 'for', 'multiple', 'procedures', 'Molecular', 'diagnostics', 'especially', 'PCR', 'based', 'tests', 'are', 'rapidly', 'changing', 'research', 'and', 'practice', 'in', 'infectious', 'diseases', 'Diarrheal', 'disease', 'with', 'its', 'broad', 'range', 'of', 'potential', 'infectious', 'etiologies', 'is', 'well', 'suited', 'for', 'multiplex', 'molecular', 'testing', 'This', 'review', 'highlights', 'examples', 'of', 'currently', 'employed', 'molecular', 'tests', 'as', 'well', 'as', 'ways', 'in', 'which', 'these', 'tests', 'can', 'be', 'applied', 'in', 'the', 'future', 'The', 'absence', 'of', 'a', 'gold', 'standard', 'for', 'the', 'microbiologic', 'cause', 'of', 'diarrhea', 'means', 'that', 'the', 'clinical', 'significance', 'of', 'detected', 'organisms', 'may', 'not', 'always', 'be', 'clear', 'Conventional', 'wisdom', 'is', 'that', 'there', 'should', 'be', 'one', 'main', 'pathogen', 'causing', 'diarrhea', 'however', 'our', 'thinking', 'is', 'challenged', 'by', 'increased', 'detection', 'of', 'mixed', 'infections', 'Thus', 'the', 'successful', 'incorporation', 'of', 'molecular', 'diagnostics', 'for', 'diarrheal', 'disease', 'into', 'practice', 'will', 'require', 'both', 'a', 'careful', 'understanding', 'of', 'the', 'technical', 'aspects', 'and', 'research', 'to', 'define', 'their', 'clinical', 'utility', '']"
149384,Probable primary polydipsia in a domestic shorthair cat,2015-12-01,JFMS Open Rep,https://doi.org/10.1177/2055116915615370; https://www.ncbi.nlm.nih.gov/pubmed/28491395/,"CASE SUMMARY: A 10-month-old neutered male domestic shorthair cat presented with a 4 month history of polyuria and polydipsia. After a thorough diagnostic work-up the only abnormal findings were hyposthenuria and an elevated random plasma osmolality level. Trial therapy with the oral and ophthalmic forms of desmopressin failed to concentrate urine. A modified water deprivation test confirmed the ability to concentrate urine above a urine specific gravity (USG) of 1.035. After transitioning the cat to a higher sodium diet and instituting several enrichment changes to the cat’s environment, average water consumption and urine output levels decreased to almost normal levels and USG increased from 1.006 to 1.022. These findings provide strong evidence that primary polydipsia was the underlying etiology of the cat’s condition. RELEVANCE AND NOVEL INFORMATION: This case report exemplifies the challenges faced when a cat presents for polyuria and polydipsia without an obvious cause identified on routine diagnostics. To our knowledge, this is the first report of primary polydipsia in a cat.",10.1177/2055116915615370,acr04xkz,"['CASE', 'SUMMARY', 'A', '10', 'month', 'old', 'neutered', 'male', 'domestic', 'shorthair', 'cat', 'presented', 'with', 'a', '4', 'month', 'history', 'of', 'polyuria', 'and', 'polydipsia', 'After', 'a', 'thorough', 'diagnostic', 'work', 'up', 'the', 'only', 'abnormal', 'findings', 'were', 'hyposthenuria', 'and', 'an', 'elevated', 'random', 'plasma', 'osmolality', 'level', 'Trial', 'therapy', 'with', 'the', 'oral', 'and', 'ophthalmic', 'forms', 'of', 'desmopressin', 'failed', 'to', 'concentrate', 'urine', 'A', 'modified', 'water', 'deprivation', 'test', 'confirmed', 'the', 'ability', 'to', 'concentrate', 'urine', 'above', 'a', 'urine', 'specific', 'gravity', 'USG', 'of', '1', '035', 'After', 'transitioning', 'the', 'cat', 'to', 'a', 'higher', 'sodium', 'diet', 'and', 'instituting', 'several', 'enrichment', 'changes', 'to', 'the', 'cat', 's', 'environment', 'average', 'water', 'consumption', 'and', 'urine', 'output', 'levels', 'decreased', 'to', 'almost', 'normal', 'levels', 'and', 'USG', 'increased', 'from', '1', '006', 'to', '1', '022', 'These', 'findings', 'provide', 'strong', 'evidence', 'that', 'primary', 'polydipsia', 'was', 'the', 'underlying', 'etiology', 'of', 'the', 'cat', 's', 'condition', 'RELEVANCE', 'AND', 'NOVEL', 'INFORMATION', 'This', 'case', 'report', 'exemplifies', 'the', 'challenges', 'faced', 'when', 'a', 'cat', 'presents', 'for', 'polyuria', 'and', 'polydipsia', 'without', 'an', 'obvious', 'cause', 'identified', 'on', 'routine', 'diagnostics', 'To', 'our', 'knowledge', 'this', 'is', 'the', 'first', 'report', 'of', 'primary', 'polydipsia', 'in', 'a', 'cat', '']"
150211,Lethal Outcome of Leptospirosis in Southern Russia: Characterization of Leptospira Interrogans Isolated from a Deсeased Teenager,2020-06-14,Int J Environ Res Public Health,https://www.ncbi.nlm.nih.gov/pubmed/32545855/; https://doi.org/10.3390/ijerph17124238,"This article describes a lethal case of leptospirosis that occurred in Southern Russia. The Leptospira strain was isolated and characterized using a microscopic agglutination test, MALDI-TOF mass spectrometry, targeted PCR, and high-throughput sequencing. We show that molecular and mass-spectrometry methods can be an alternative to conventional methods of leptospirosis diagnostics and Leptospira study, which require highly qualified staff and can be performed only at specialized laboratories. We also report the first whole genome of L. interrogans isolated in Russia.",10.3390/ijerph17124238,xdqje83t,"['This', 'article', 'describes', 'a', 'lethal', 'case', 'of', 'leptospirosis', 'that', 'occurred', 'in', 'Southern', 'Russia', 'The', 'Leptospira', 'strain', 'was', 'isolated', 'and', 'characterized', 'using', 'a', 'microscopic', 'agglutination', 'test', 'MALDI', 'TOF', 'mass', 'spectrometry', 'targeted', 'PCR', 'and', 'high', 'throughput', 'sequencing', 'We', 'show', 'that', 'molecular', 'and', 'mass', 'spectrometry', 'methods', 'can', 'be', 'an', 'alternative', 'to', 'conventional', 'methods', 'of', 'leptospirosis', 'diagnostics', 'and', 'Leptospira', 'study', 'which', 'require', 'highly', 'qualified', 'staff', 'and', 'can', 'be', 'performed', 'only', 'at', 'specialized', 'laboratories', 'We', 'also', 'report', 'the', 'first', 'whole', 'genome', 'of', 'L', 'interrogans', 'isolated', 'in', 'Russia', '']"
151054,PCR diagnostics: In silico validation by an automated tool using freely available software programs,2019-08-31,Journal of Virological Methods,https://doi.org/10.1016/j.jviromet.2019.05.002; https://api.elsevier.com/content/article/pii/S0166093419301247; https://www.ncbi.nlm.nih.gov/pubmed/31095975/; https://www.sciencedirect.com/science/article/pii/S0166093419301247,"Abstract PCR diagnostics are often the first line of laboratory diagnostics and are regularly designed to either differentiate between or detect all pathogen variants of a family, genus or species. The ideal PCR test detects all variants of the target pathogen, including newly discovered and emerging variants, while closely related pathogens and their variants should not be detected. This is challenging as pathogens show a high degree of genetic variation due to genetic drift, adaptation and evolution. Therefore, frequent re-evaluation of PCR diagnostics is needed to monitor its usefulness. Validation of PCR diagnostics recognizes three stages, in silico, in vitro and in vivo validation. In vitro and in vivo testing are usually costly, labour intensive and imply a risk of handling dangerous pathogens. In silico validation reduces this burden. In silico validation checks primers and probes by comparing their sequences with available nucleotide sequences. In recent years the amount of available sequences has dramatically increased by high throughput and deep sequencing projects. This makes in silico validation more informative, but also more computing intensive. To facilitate validation of PCR tests, a software tool named PCRv was developed. PCRv consists of a user friendly graphical user interface and coordinates the use of the software programs ClustalW and SSEARCH in order to perform in silico validation of PCR tests of different formats. Use of internal control sequences makes the analysis compliant to laboratory quality control systems. Finally, PCRv generates a validation report that includes an overview as well as a list of detailed results. In-house developed, published and OIE-recommended PCR tests were easily (re-) evaluated by use of PCRv. To demonstrate the power of PCRv, in silico validation of several PCR tests are shown and discussed.",10.1016/j.jviromet.2019.05.002,ajzk86rq,"['Abstract', 'PCR', 'diagnostics', 'are', 'often', 'the', 'first', 'line', 'of', 'laboratory', 'diagnostics', 'and', 'are', 'regularly', 'designed', 'to', 'either', 'differentiate', 'between', 'or', 'detect', 'all', 'pathogen', 'variants', 'of', 'a', 'family', 'genus', 'or', 'species', 'The', 'ideal', 'PCR', 'test', 'detects', 'all', 'variants', 'of', 'the', 'target', 'pathogen', 'including', 'newly', 'discovered', 'and', 'emerging', 'variants', 'while', 'closely', 'related', 'pathogens', 'and', 'their', 'variants', 'should', 'not', 'be', 'detected', 'This', 'is', 'challenging', 'as', 'pathogens', 'show', 'a', 'high', 'degree', 'of', 'genetic', 'variation', 'due', 'to', 'genetic', 'drift', 'adaptation', 'and', 'evolution', 'Therefore', 'frequent', 're', 'evaluation', 'of', 'PCR', 'diagnostics', 'is', 'needed', 'to', 'monitor', 'its', 'usefulness', 'Validation', 'of', 'PCR', 'diagnostics', 'recognizes', 'three', 'stages', 'in', 'silico', 'in', 'vitro', 'and', 'in', 'vivo', 'validation', 'In', 'vitro', 'and', 'in', 'vivo', 'testing', 'are', 'usually', 'costly', 'labour', 'intensive', 'and', 'imply', 'a', 'risk', 'of', 'handling', 'dangerous', 'pathogens', 'In', 'silico', 'validation', 'reduces', 'this', 'burden', 'In', 'silico', 'validation', 'checks', 'primers', 'and', 'probes', 'by', 'comparing', 'their', 'sequences', 'with', 'available', 'nucleotide', 'sequences', 'In', 'recent', 'years', 'the', 'amount', 'of', 'available', 'sequences', 'has', 'dramatically', 'increased', 'by', 'high', 'throughput', 'and', 'deep', 'sequencing', 'projects', 'This', 'makes', 'in', 'silico', 'validation', 'more', 'informative', 'but', 'also', 'more', 'computing', 'intensive', 'To', 'facilitate', 'validation', 'of', 'PCR', 'tests', 'a', 'software', 'tool', 'named', 'PCRv', 'was', 'developed', 'PCRv', 'consists', 'of', 'a', 'user', 'friendly', 'graphical', 'user', 'interface', 'and', 'coordinates', 'the', 'use', 'of', 'the', 'software', 'programs', 'ClustalW', 'and', 'SSEARCH', 'in', 'order', 'to', 'perform', 'in', 'silico', 'validation', 'of', 'PCR', 'tests', 'of', 'different', 'formats', 'Use', 'of', 'internal', 'control', 'sequences', 'makes', 'the', 'analysis', 'compliant', 'to', 'laboratory', 'quality', 'control', 'systems', 'Finally', 'PCRv', 'generates', 'a', 'validation', 'report', 'that', 'includes', 'an', 'overview', 'as', 'well', 'as', 'a', 'list', 'of', 'detailed', 'results', 'In', 'house', 'developed', 'published', 'and', 'OIE', 'recommended', 'PCR', 'tests', 'were', 'easily', 're', 'evaluated', 'by', 'use', 'of', 'PCRv', 'To', 'demonstrate', 'the', 'power', 'of', 'PCRv', 'in', 'silico', 'validation', 'of', 'several', 'PCR', 'tests', 'are', 'shown', 'and', 'discussed', '']"
151210,Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics,2020-06-26,Diagnostics (Basel),https://doi.org/10.3390/diagnostics10060434; https://www.ncbi.nlm.nih.gov/pubmed/32604919/,"Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material of SARS-CoV-2 that causes COVID-19 in specimens, or specific anti-viral antibodies in blood/serum. Due to the current pandemic situation, a development of point-of-care diagnostics (POCD) allows us to substantially accelerate taking clinical decisions and implement strategic planning at the national level of preventative measures. This review summarizes and compares the available POCD and those currently under development, including quantitative reverse transcription PCR (RT-qPCR), serology immunoassays (SIAs) and protein microarray method (PMM) designed for standard and rapid COVID-19 diagnosis.",10.3390/diagnostics10060434,tb1zsuw4,"['Validated', 'and', 'accurate', 'laboratory', 'testing', 'for', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'Coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'crucial', 'part', 'of', 'the', 'timely', 'management', 'of', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'disease', 'supporting', 'the', 'clinical', 'decision', 'making', 'process', 'for', 'infection', 'control', 'at', 'the', 'healthcare', 'level', 'and', 'detecting', 'asymptomatic', 'cases', 'This', 'would', 'facilitate', 'an', 'appropriate', 'treatment', 'a', 'prompt', 'isolation', 'and', 'consequently', 'deceleration', 'of', 'the', 'pandemic', 'Various', 'laboratory', 'tests', 'can', 'identify', 'the', 'genetic', 'material', 'of', 'SARS', 'CoV', '2', 'that', 'causes', 'COVID', '19', 'in', 'specimens', 'or', 'specific', 'anti', 'viral', 'antibodies', 'in', 'blood', 'serum', 'Due', 'to', 'the', 'current', 'pandemic', 'situation', 'a', 'development', 'of', 'point', 'of', 'care', 'diagnostics', 'POCD', 'allows', 'us', 'to', 'substantially', 'accelerate', 'taking', 'clinical', 'decisions', 'and', 'implement', 'strategic', 'planning', 'at', 'the', 'national', 'level', 'of', 'preventative', 'measures', 'This', 'review', 'summarizes', 'and', 'compares', 'the', 'available', 'POCD', 'and', 'those', 'currently', 'under', 'development', 'including', 'quantitative', 'reverse', 'transcription', 'PCR', 'RT', 'qPCR', 'serology', 'immunoassays', 'SIAs', 'and', 'protein', 'microarray', 'method', 'PMM', 'designed', 'for', 'standard', 'and', 'rapid', 'COVID', '19', 'diagnosis', '']"
151542,COVID-19: an update on diagnostic and therapeutic approaches,2020-04-30,BMB Rep,https://www.ncbi.nlm.nih.gov/pubmed/32336317/,"The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused severe panic among people worldwide. COVID-19 has created havoc, and scientists and physicians are urged to test the efficiency and safety of drugs used to treat this disease. In such a pandemic situation, various steps have been taken by the government to control and prevent the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). This pandemic situation has forced scientists to rework strategies to combat infectious diseases through drugs, treatment, and control measures. COVID-19 treatment requires both limiting viral multiplication and neutralizing tissue damage induced by an inappropriate immune reaction. Currently, various diagnostic kits to test for COVID-19 are available, and repurposing therapeutics for COVID-19 has shown to be clinically effective. As the global demand for diagnostics and therapeutics continues to rise, it is essential to rapidly develop various algorithms to successfully identify and contain the virus. This review discusses the updates on specimens/samples, recent efficient diagnostics, and therapeutic approaches to control the disease and repurposed drugs mainly focusing on chloroquine/hydroxychloroquine and convalescent plasma (CP). More research is required for further understanding of the influence of diagnostics and therapeutic approaches to develop vaccines and drugs for COVID-19.",10.5483/bmbrep.2020.53.4.080,bisheysk,"['The', 'unexpected', 'pandemic', 'set', 'off', 'by', 'the', 'novel', 'coronavirus', '2019', 'COVID', '19', 'has', 'caused', 'severe', 'panic', 'among', 'people', 'worldwide', 'COVID', '19', 'has', 'created', 'havoc', 'and', 'scientists', 'and', 'physicians', 'are', 'urged', 'to', 'test', 'the', 'efficiency', 'and', 'safety', 'of', 'drugs', 'used', 'to', 'treat', 'this', 'disease', 'In', 'such', 'a', 'pandemic', 'situation', 'various', 'steps', 'have', 'been', 'taken', 'by', 'the', 'government', 'to', 'control', 'and', 'prevent', 'the', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'This', 'pandemic', 'situation', 'has', 'forced', 'scientists', 'to', 'rework', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'through', 'drugs', 'treatment', 'and', 'control', 'measures', 'COVID', '19', 'treatment', 'requires', 'both', 'limiting', 'viral', 'multiplication', 'and', 'neutralizing', 'tissue', 'damage', 'induced', 'by', 'an', 'inappropriate', 'immune', 'reaction', 'Currently', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'COVID', '19', 'are', 'available', 'and', 'repurposing', 'therapeutics', 'for', 'COVID', '19', 'has', 'shown', 'to', 'be', 'clinically', 'effective', 'As', 'the', 'global', 'demand', 'for', 'diagnostics', 'and', 'therapeutics', 'continues', 'to', 'rise', 'it', 'is', 'essential', 'to', 'rapidly', 'develop', 'various', 'algorithms', 'to', 'successfully', 'identify', 'and', 'contain', 'the', 'virus', 'This', 'review', 'discusses', 'the', 'updates', 'on', 'specimens', 'samples', 'recent', 'efficient', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'control', 'the', 'disease', 'and', 'repurposed', 'drugs', 'mainly', 'focusing', 'on', 'chloroquine', 'hydroxychloroquine', 'and', 'convalescent', 'plasma', 'CP', 'More', 'research', 'is', 'required', 'for', 'further', 'understanding', 'of', 'the', 'influence', 'of', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'develop', 'vaccines', 'and', 'drugs', 'for', 'COVID', '19', '']"
151789,Improving Evidence Based Bronchiolitis Care,2018-03-31,Clinical Pediatric Emergency Medicine,https://api.elsevier.com/content/article/pii/S152284011830003X; https://www.sciencedirect.com/science/article/pii/S152284011830003X; https://doi.org/10.1016/j.cpem.2018.02.003; https://www.ncbi.nlm.nih.gov/pubmed/32288646/,"Abstract Bronchiolitis is the number one cause of hospitalization in infants during the first year of life. Clinical guidelines recommend primarily supportive care and discourage use of pharmacotherapies and diagnostics. However, there continues to be widespread use of non-recommended therapies and variation in the use of therapeutic interventions among hospitals in the United States. Here we review evidence-based management of this common disease in order to optimize resource utilization, decrease healthcare costs, and decrease unnecessary hospitalization. Current evidence does not support the routine use of chest radiographs, viral testing or laboratory evaluation in children with bronchiolitis. In addition, routine administration of bronchodilators, including albuterol and nebulized epinephrine, corticosteroids and hypertonic saline are not recommended for infants and children with bronchiolitis. Intravenous or nasogastric hydration and nutritional support, supplemental oxygen, and respiratory support are recommended. Standardization of bronchiolitis care with evidence based institutional clinical pathways spanning ED to inpatient care can help optimize resource utilization while simultaneously improving care of bronchiolitis and reducing hospital length of stays and costs.",10.1016/j.cpem.2018.02.003,59iwx6ws,"['Abstract', 'Bronchiolitis', 'is', 'the', 'number', 'one', 'cause', 'of', 'hospitalization', 'in', 'infants', 'during', 'the', 'first', 'year', 'of', 'life', 'Clinical', 'guidelines', 'recommend', 'primarily', 'supportive', 'care', 'and', 'discourage', 'use', 'of', 'pharmacotherapies', 'and', 'diagnostics', 'However', 'there', 'continues', 'to', 'be', 'widespread', 'use', 'of', 'non', 'recommended', 'therapies', 'and', 'variation', 'in', 'the', 'use', 'of', 'therapeutic', 'interventions', 'among', 'hospitals', 'in', 'the', 'United', 'States', 'Here', 'we', 'review', 'evidence', 'based', 'management', 'of', 'this', 'common', 'disease', 'in', 'order', 'to', 'optimize', 'resource', 'utilization', 'decrease', 'healthcare', 'costs', 'and', 'decrease', 'unnecessary', 'hospitalization', 'Current', 'evidence', 'does', 'not', 'support', 'the', 'routine', 'use', 'of', 'chest', 'radiographs', 'viral', 'testing', 'or', 'laboratory', 'evaluation', 'in', 'children', 'with', 'bronchiolitis', 'In', 'addition', 'routine', 'administration', 'of', 'bronchodilators', 'including', 'albuterol', 'and', 'nebulized', 'epinephrine', 'corticosteroids', 'and', 'hypertonic', 'saline', 'are', 'not', 'recommended', 'for', 'infants', 'and', 'children', 'with', 'bronchiolitis', 'Intravenous', 'or', 'nasogastric', 'hydration', 'and', 'nutritional', 'support', 'supplemental', 'oxygen', 'and', 'respiratory', 'support', 'are', 'recommended', 'Standardization', 'of', 'bronchiolitis', 'care', 'with', 'evidence', 'based', 'institutional', 'clinical', 'pathways', 'spanning', 'ED', 'to', 'inpatient', 'care', 'can', 'help', 'optimize', 'resource', 'utilization', 'while', 'simultaneously', 'improving', 'care', 'of', 'bronchiolitis', 'and', 'reducing', 'hospital', 'length', 'of', 'stays', 'and', 'costs', '']"
151850,Integrated Blood Barcode Chips,2008-11-16,Nat Biotechnol,https://www.ncbi.nlm.nih.gov/pubmed/19029914/; https://doi.org/10.1038/nbt.1507,"Blood comprises the largest version of the human proteome1. Changes of plasma protein profiles can reflect physiological or pathological conditions associated with many human diseases, making blood the most important fluid for clinical diagnostics2-4. Nevertheless, only a handful of plasma proteins are utilized in routine clinical tests. This is due to a host of reasons, including the intrinsic complexity of the plasma proteome1, the heterogeneity of human diseases and the fast kinetics associated with protein degradation in sampled blood5. Simple technologies that can sensitively sample large numbers of proteins over broad concentration ranges, from small amounts of blood, and within minutes of sample collection, would assist in solving these problems. Herein, we report on an integrated microfluidic system, called the Integrated Blood Barcode Chip (IBBC). It enables on-chip blood separation and the rapid measurement of a panel of plasma proteins from small quantities of blood samples including a fingerprick of whole blood. This platform holds potential for inexpensive, non-invasive, and informative clinical diagnoses, particularly, for point-of-care.",10.1038/nbt.1507,5agqknvu,"['Blood', 'comprises', 'the', 'largest', 'version', 'of', 'the', 'human', 'proteome1', 'Changes', 'of', 'plasma', 'protein', 'profiles', 'can', 'reflect', 'physiological', 'or', 'pathological', 'conditions', 'associated', 'with', 'many', 'human', 'diseases', 'making', 'blood', 'the', 'most', 'important', 'fluid', 'for', 'clinical', 'diagnostics2', '4', 'Nevertheless', 'only', 'a', 'handful', 'of', 'plasma', 'proteins', 'are', 'utilized', 'in', 'routine', 'clinical', 'tests', 'This', 'is', 'due', 'to', 'a', 'host', 'of', 'reasons', 'including', 'the', 'intrinsic', 'complexity', 'of', 'the', 'plasma', 'proteome1', 'the', 'heterogeneity', 'of', 'human', 'diseases', 'and', 'the', 'fast', 'kinetics', 'associated', 'with', 'protein', 'degradation', 'in', 'sampled', 'blood5', 'Simple', 'technologies', 'that', 'can', 'sensitively', 'sample', 'large', 'numbers', 'of', 'proteins', 'over', 'broad', 'concentration', 'ranges', 'from', 'small', 'amounts', 'of', 'blood', 'and', 'within', 'minutes', 'of', 'sample', 'collection', 'would', 'assist', 'in', 'solving', 'these', 'problems', 'Herein', 'we', 'report', 'on', 'an', 'integrated', 'microfluidic', 'system', 'called', 'the', 'Integrated', 'Blood', 'Barcode', 'Chip', 'IBBC', 'It', 'enables', 'on', 'chip', 'blood', 'separation', 'and', 'the', 'rapid', 'measurement', 'of', 'a', 'panel', 'of', 'plasma', 'proteins', 'from', 'small', 'quantities', 'of', 'blood', 'samples', 'including', 'a', 'fingerprick', 'of', 'whole', 'blood', 'This', 'platform', 'holds', 'potential', 'for', 'inexpensive', 'non', 'invasive', 'and', 'informative', 'clinical', 'diagnoses', 'particularly', 'for', 'point', 'of', 'care', '']"
152105,Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context,2020-05-08,Front Med (Lausanne),https://www.ncbi.nlm.nih.gov/pubmed/32574326/; https://doi.org/10.3389/fmed.2020.00225,"Introduction: COVID-19 Ag Respi-Strip, an immunochromatographic (ICT) assay for the rapid detection of SARS-CoV-2 antigen on nasopharyngeal specimen, has been developed to identify positive COVID-19 patients allowing prompt clinical and quarantine decisions. In this original research article, we describe the conception, the analytical and clinical performances as well as the risk management of implementing the COVID-19 Ag Respi-Strip in a diagnostic decision algorithm. Materials and Methods: Development of the COVID-19 Ag Respi-Strip resulted in a ready-to-use ICT assay based on a membrane technology with colloidal gold nanoparticles using monoclonal antibodies directed against the SARS-CoV and SARS-CoV-2 highly conserved nucleoprotein antigen. Four hundred observations were recorded for the analytical performance study and thirty tests were analyzed for the cross-reactivity study. The clinical performance study was performed in a retrospective multi-centric evaluation on aliquots of 328 nasopharyngeal samples. COVID-19 Ag Respi-Strip results were compared with qRT-PCR as golden standard for COVID-19 diagnostics. Results: In the analytical performance study, the reproducibility showed a between-observer disagreement of 1.7%, a robustness of 98%, an overall satisfying user friendliness and no cross-reactivity with other virus-infected nasopharyngeal samples. In the clinical performance study performed in three different clinical laboratories during the ascendant phase of the epidemiological curve, we found an overall sensitivity and specificity of 57.6 and 99.5%, respectively with an accuracy of 82.6%. The cut-off of the ICT was found at CT <22. User-friendliness analysis and risk management assessment through Ishikawa diagram demonstrate that COVID-19 Ag Respi-Strip may be implemented in clinical laboratories according to biosafety recommendations. Conclusion: The COVID-19 Ag Respi-Strip represents a promising rapid SARS-CoV-2 antigen assay for the first-line diagnosis of COVID-19 in 15 min at the peak of the pandemic. Its role in the proposed diagnostic algorithm is complementary to the currently-used molecular techniques.",10.3389/fmed.2020.00225,w3yoxhsg,"['Introduction', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'an', 'immunochromatographic', 'ICT', 'assay', 'for', 'the', 'rapid', 'detection', 'of', 'SARS', 'CoV', '2', 'antigen', 'on', 'nasopharyngeal', 'specimen', 'has', 'been', 'developed', 'to', 'identify', 'positive', 'COVID', '19', 'patients', 'allowing', 'prompt', 'clinical', 'and', 'quarantine', 'decisions', 'In', 'this', 'original', 'research', 'article', 'we', 'describe', 'the', 'conception', 'the', 'analytical', 'and', 'clinical', 'performances', 'as', 'well', 'as', 'the', 'risk', 'management', 'of', 'implementing', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'in', 'a', 'diagnostic', 'decision', 'algorithm', 'Materials', 'and', 'Methods', 'Development', 'of', 'the', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'resulted', 'in', 'a', 'ready', 'to', 'use', 'ICT', 'assay', 'based', 'on', 'a', 'membrane', 'technology', 'with', 'colloidal', 'gold', 'nanoparticles', 'using', 'monoclonal', 'antibodies', 'directed', 'against', 'the', 'SARS', 'CoV', 'and', 'SARS', 'CoV', '2', 'highly', 'conserved', 'nucleoprotein', 'antigen', 'Four', 'hundred', 'observations', 'were', 'recorded', 'for', 'the', 'analytical', 'performance', 'study', 'and', 'thirty', 'tests', 'were', 'analyzed', 'for', 'the', 'cross', 'reactivity', 'study', 'The', 'clinical', 'performance', 'study', 'was', 'performed', 'in', 'a', 'retrospective', 'multi', 'centric', 'evaluation', 'on', 'aliquots', 'of', '328', 'nasopharyngeal', 'samples', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'results', 'were', 'compared', 'with', 'qRT', 'PCR', 'as', 'golden', 'standard', 'for', 'COVID', '19', 'diagnostics', 'Results', 'In', 'the', 'analytical', 'performance', 'study', 'the', 'reproducibility', 'showed', 'a', 'between', 'observer', 'disagreement', 'of', '1', '7', 'a', 'robustness', 'of', '98', 'an', 'overall', 'satisfying', 'user', 'friendliness', 'and', 'no', 'cross', 'reactivity', 'with', 'other', 'virus', 'infected', 'nasopharyngeal', 'samples', 'In', 'the', 'clinical', 'performance', 'study', 'performed', 'in', 'three', 'different', 'clinical', 'laboratories', 'during', 'the', 'ascendant', 'phase', 'of', 'the', 'epidemiological', 'curve', 'we', 'found', 'an', 'overall', 'sensitivity', 'and', 'specificity', 'of', '57', '6', 'and', '99', '5', 'respectively', 'with', 'an', 'accuracy', 'of', '82', '6', 'The', 'cut', 'off', 'of', 'the', 'ICT', 'was', 'found', 'at', 'CT', '22', 'User', 'friendliness', 'analysis', 'and', 'risk', 'management', 'assessment', 'through', 'Ishikawa', 'diagram', 'demonstrate', 'that', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'may', 'be', 'implemented', 'in', 'clinical', 'laboratories', 'according', 'to', 'biosafety', 'recommendations', 'Conclusion', 'The', 'COVID', '19', 'Ag', 'Respi', 'Strip', 'represents', 'a', 'promising', 'rapid', 'SARS', 'CoV', '2', 'antigen', 'assay', 'for', 'the', 'first', 'line', 'diagnosis', 'of', 'COVID', '19', 'in', '15', 'min', 'at', 'the', 'peak', 'of', 'the', 'pandemic', 'Its', 'role', 'in', 'the', 'proposed', 'diagnostic', 'algorithm', 'is', 'complementary', 'to', 'the', 'currently', 'used', 'molecular', 'techniques', '']"
152320,IoT PCR for pandemic disease detection and its spread monitoring,2020-01-15,Sensors and Actuators B: Chemical,https://doi.org/10.1016/j.snb.2019.127098; https://www.sciencedirect.com/science/article/pii/S0925400519312973; https://www.ncbi.nlm.nih.gov/pubmed/32288256/; https://api.elsevier.com/content/article/pii/S0925400519312973,"Abstract During infectious disease outbreaks, the centers for disease control need to monitor particular areas. Considerable effort has been invested in the development of portable, user-friendly, and cost-effective systems for point-of-care (POC) diagnostics, which could also create an Internet of Things (IoT) for healthcare via a global network. However, at present IoT based on a functional POC instrument is not available. Here we show a fast, user-friendly, and affordable IoT system based on a miniaturized polymerase chain reaction device. We demonstrated the system’s capability by amplification of complementary deoxyribonucleic acid (cDNA) of the dengue fever virus. The resulting data were then automatically uploaded via a Bluetooth interface to an Android-based smartphone and then wirelessly sent to a global network, instantly making the test results available anywhere in the world. The IoT system presented here could become an essential tool for healthcare centers to tackle infectious disease outbreaks identified either by DNA or ribonucleic acid.",10.1016/j.snb.2019.127098,ityhcak7,"['Abstract', 'During', 'infectious', 'disease', 'outbreaks', 'the', 'centers', 'for', 'disease', 'control', 'need', 'to', 'monitor', 'particular', 'areas', 'Considerable', 'effort', 'has', 'been', 'invested', 'in', 'the', 'development', 'of', 'portable', 'user', 'friendly', 'and', 'cost', 'effective', 'systems', 'for', 'point', 'of', 'care', 'POC', 'diagnostics', 'which', 'could', 'also', 'create', 'an', 'Internet', 'of', 'Things', 'IoT', 'for', 'healthcare', 'via', 'a', 'global', 'network', 'However', 'at', 'present', 'IoT', 'based', 'on', 'a', 'functional', 'POC', 'instrument', 'is', 'not', 'available', 'Here', 'we', 'show', 'a', 'fast', 'user', 'friendly', 'and', 'affordable', 'IoT', 'system', 'based', 'on', 'a', 'miniaturized', 'polymerase', 'chain', 'reaction', 'device', 'We', 'demonstrated', 'the', 'system', 's', 'capability', 'by', 'amplification', 'of', 'complementary', 'deoxyribonucleic', 'acid', 'cDNA', 'of', 'the', 'dengue', 'fever', 'virus', 'The', 'resulting', 'data', 'were', 'then', 'automatically', 'uploaded', 'via', 'a', 'Bluetooth', 'interface', 'to', 'an', 'Android', 'based', 'smartphone', 'and', 'then', 'wirelessly', 'sent', 'to', 'a', 'global', 'network', 'instantly', 'making', 'the', 'test', 'results', 'available', 'anywhere', 'in', 'the', 'world', 'The', 'IoT', 'system', 'presented', 'here', 'could', 'become', 'an', 'essential', 'tool', 'for', 'healthcare', 'centers', 'to', 'tackle', 'infectious', 'disease', 'outbreaks', 'identified', 'either', 'by', 'DNA', 'or', 'ribonucleic', 'acid', '']"
152829,COVSACK: an innovative portable isolated and safe COVID-19 sample collection kiosk with automatic disinfection,2020-07-05,Trans Indian Natl,https://doi.org/10.1007/s41403-020-00139-1,"The Corona VIrus Disease 2019 (COVID-19) is one of the significant medical disaster that changed the life of humankind in the 21st century. The deadly virus is transmittable from infected person, through his nasal droplets, to surrounding people among whom, the healthcare personnel are the utmost affected. The present article brings out an innovative chamber, which is used for collection of throat, or nasal swabs/samples for diagnosis of COVID-19 suspected persons. The chamber, called COVid SAmple Collection Kiosk (COVSACK), eliminates the transmission of the deadly virus to the health care personnel while collecting the sample. The kiosk is designed based on CFD simulations for effective spread of disinfectant in fine droplet form, built with a lightweight composite that is sustainable in extreme weather conditions and the kiosk can be easily sanitized within 3 min after sample collection. The chamber is first positioned in ESI Hospital, Hyderabad, and other hospitals and diagnostics centres across India, extensively being used for testing the COVID-19 patients at a faster rate, with a drastic reduction in use of personal protection equipment (PPE). This technological innovation, to certain extent, has changed the way the testing of COVID-19 patients carried out in the country.",10.1007/s41403-020-00139-1,68jypaaw,"['The', 'Corona', 'VIrus', 'Disease', '2019', 'COVID', '19', 'is', 'one', 'of', 'the', 'significant', 'medical', 'disaster', 'that', 'changed', 'the', 'life', 'of', 'humankind', 'in', 'the', '21st', 'century', 'The', 'deadly', 'virus', 'is', 'transmittable', 'from', 'infected', 'person', 'through', 'his', 'nasal', 'droplets', 'to', 'surrounding', 'people', 'among', 'whom', 'the', 'healthcare', 'personnel', 'are', 'the', 'utmost', 'affected', 'The', 'present', 'article', 'brings', 'out', 'an', 'innovative', 'chamber', 'which', 'is', 'used', 'for', 'collection', 'of', 'throat', 'or', 'nasal', 'swabs', 'samples', 'for', 'diagnosis', 'of', 'COVID', '19', 'suspected', 'persons', 'The', 'chamber', 'called', 'COVid', 'SAmple', 'Collection', 'Kiosk', 'COVSACK', 'eliminates', 'the', 'transmission', 'of', 'the', 'deadly', 'virus', 'to', 'the', 'health', 'care', 'personnel', 'while', 'collecting', 'the', 'sample', 'The', 'kiosk', 'is', 'designed', 'based', 'on', 'CFD', 'simulations', 'for', 'effective', 'spread', 'of', 'disinfectant', 'in', 'fine', 'droplet', 'form', 'built', 'with', 'a', 'lightweight', 'composite', 'that', 'is', 'sustainable', 'in', 'extreme', 'weather', 'conditions', 'and', 'the', 'kiosk', 'can', 'be', 'easily', 'sanitized', 'within', '3', 'min', 'after', 'sample', 'collection', 'The', 'chamber', 'is', 'first', 'positioned', 'in', 'ESI', 'Hospital', 'Hyderabad', 'and', 'other', 'hospitals', 'and', 'diagnostics', 'centres', 'across', 'India', 'extensively', 'being', 'used', 'for', 'testing', 'the', 'COVID', '19', 'patients', 'at', 'a', 'faster', 'rate', 'with', 'a', 'drastic', 'reduction', 'in', 'use', 'of', 'personal', 'protection', 'equipment', 'PPE', 'This', 'technological', 'innovation', 'to', 'certain', 'extent', 'has', 'changed', 'the', 'way', 'the', 'testing', 'of', 'COVID', '19', 'patients', 'carried', 'out', 'in', 'the', 'country', '']"
152846,Networking of Public Health Microbiology Laboratories Bolsters Europe’s Defenses against Infectious Diseases,2018-02-26,Front Public Health,https://doi.org/10.3389/fpubh.2018.00046; https://www.ncbi.nlm.nih.gov/pubmed/29535998/,"In an era of global health threats caused by epidemics of infectious diseases and rising multidrug resistance, microbiology laboratories provide essential scientific evidence for risk assessment, prevention, and control. Microbiology has been at the core of European infectious disease surveillance networks for decades. Since 2010, these networks have been coordinated by the European Centre for Disease Prevention and Control (ECDC). Activities delivered in these networks include harmonization of laboratory diagnostic, antimicrobial susceptibility and molecular typing methods, multicentre method validation, technical capacity mapping, training of laboratory staff, and continuing quality assessment of laboratory testing. Cooperation among the European laboratory networks in the past 7 years has proved successful in strengthening epidemic preparedness by enabling adaptive capabilities for rapid detection of emerging pathogens across Europe. In partnership with food safety authorities, international public health agencies and learned societies, ECDC-supported laboratory networks have also progressed harmonization of routinely used antimicrobial susceptibility and molecular typing methods, thereby significantly advancing the quality, comparability and precision of microbiological information gathered by ECDC for surveillance for zoonotic diseases and multidrug-resistant pathogens in Europe. ECDC continues to act as a catalyst for sustaining continuous practice improvements and strengthening wider access to laboratory capacity across the European Union. Key priorities include optimization and broader use of rapid diagnostics, further integration of whole-genome sequencing in surveillance and electronic linkage of laboratory and public health systems. This article highlights some of the network contributions to public health in Europe and the role that ECDC plays managing these networks.",10.3389/fpubh.2018.00046,hq8dg87u,"['In', 'an', 'era', 'of', 'global', 'health', 'threats', 'caused', 'by', 'epidemics', 'of', 'infectious', 'diseases', 'and', 'rising', 'multidrug', 'resistance', 'microbiology', 'laboratories', 'provide', 'essential', 'scientific', 'evidence', 'for', 'risk', 'assessment', 'prevention', 'and', 'control', 'Microbiology', 'has', 'been', 'at', 'the', 'core', 'of', 'European', 'infectious', 'disease', 'surveillance', 'networks', 'for', 'decades', 'Since', '2010', 'these', 'networks', 'have', 'been', 'coordinated', 'by', 'the', 'European', 'Centre', 'for', 'Disease', 'Prevention', 'and', 'Control', 'ECDC', 'Activities', 'delivered', 'in', 'these', 'networks', 'include', 'harmonization', 'of', 'laboratory', 'diagnostic', 'antimicrobial', 'susceptibility', 'and', 'molecular', 'typing', 'methods', 'multicentre', 'method', 'validation', 'technical', 'capacity', 'mapping', 'training', 'of', 'laboratory', 'staff', 'and', 'continuing', 'quality', 'assessment', 'of', 'laboratory', 'testing', 'Cooperation', 'among', 'the', 'European', 'laboratory', 'networks', 'in', 'the', 'past', '7', 'years', 'has', 'proved', 'successful', 'in', 'strengthening', 'epidemic', 'preparedness', 'by', 'enabling', 'adaptive', 'capabilities', 'for', 'rapid', 'detection', 'of', 'emerging', 'pathogens', 'across', 'Europe', 'In', 'partnership', 'with', 'food', 'safety', 'authorities', 'international', 'public', 'health', 'agencies', 'and', 'learned', 'societies', 'ECDC', 'supported', 'laboratory', 'networks', 'have', 'also', 'progressed', 'harmonization', 'of', 'routinely', 'used', 'antimicrobial', 'susceptibility', 'and', 'molecular', 'typing', 'methods', 'thereby', 'significantly', 'advancing', 'the', 'quality', 'comparability', 'and', 'precision', 'of', 'microbiological', 'information', 'gathered', 'by', 'ECDC', 'for', 'surveillance', 'for', 'zoonotic', 'diseases', 'and', 'multidrug', 'resistant', 'pathogens', 'in', 'Europe', 'ECDC', 'continues', 'to', 'act', 'as', 'a', 'catalyst', 'for', 'sustaining', 'continuous', 'practice', 'improvements', 'and', 'strengthening', 'wider', 'access', 'to', 'laboratory', 'capacity', 'across', 'the', 'European', 'Union', 'Key', 'priorities', 'include', 'optimization', 'and', 'broader', 'use', 'of', 'rapid', 'diagnostics', 'further', 'integration', 'of', 'whole', 'genome', 'sequencing', 'in', 'surveillance', 'and', 'electronic', 'linkage', 'of', 'laboratory', 'and', 'public', 'health', 'systems', 'This', 'article', 'highlights', 'some', 'of', 'the', 'network', 'contributions', 'to', 'public', 'health', 'in', 'Europe', 'and', 'the', 'role', 'that', 'ECDC', 'plays', 'managing', 'these', 'networks', '']"
152922,How recent advances in molecular tests could impact the diagnosis of pneumonia,2016-03-07,Expert Rev Mol Diagn,https://doi.org/10.1586/14737159.2016.1156536; https://www.ncbi.nlm.nih.gov/pubmed/26891612/,"Molecular diagnostic tests have been the single major development in pneumonia diagnostics over recent years. Nucleic acid detection tests (NATs) have greatly improved the ability to detect respiratory viruses and bacterial pathogens that do not normally colonize the respiratory tract. In contrast, NATs do not yet have an established role for diagnosing pneumonia caused by bacteria that commonly colonize the nasopharynx due to difficulties discriminating between pathogens and coincidental carriage strains. New approaches are needed to distinguish infection from colonization, such as through use of quantitative methods and identification of discriminating cut-off levels. The recent realization that the lung microbiome exists has provided new insights into the pathogenesis of pneumonia involving the interaction between multiple microorganisms. New developments in molecular diagnostics must account for this new paradigm.",10.1586/14737159.2016.1156536,4ivqlsgt,"['Molecular', 'diagnostic', 'tests', 'have', 'been', 'the', 'single', 'major', 'development', 'in', 'pneumonia', 'diagnostics', 'over', 'recent', 'years', 'Nucleic', 'acid', 'detection', 'tests', 'NATs', 'have', 'greatly', 'improved', 'the', 'ability', 'to', 'detect', 'respiratory', 'viruses', 'and', 'bacterial', 'pathogens', 'that', 'do', 'not', 'normally', 'colonize', 'the', 'respiratory', 'tract', 'In', 'contrast', 'NATs', 'do', 'not', 'yet', 'have', 'an', 'established', 'role', 'for', 'diagnosing', 'pneumonia', 'caused', 'by', 'bacteria', 'that', 'commonly', 'colonize', 'the', 'nasopharynx', 'due', 'to', 'difficulties', 'discriminating', 'between', 'pathogens', 'and', 'coincidental', 'carriage', 'strains', 'New', 'approaches', 'are', 'needed', 'to', 'distinguish', 'infection', 'from', 'colonization', 'such', 'as', 'through', 'use', 'of', 'quantitative', 'methods', 'and', 'identification', 'of', 'discriminating', 'cut', 'off', 'levels', 'The', 'recent', 'realization', 'that', 'the', 'lung', 'microbiome', 'exists', 'has', 'provided', 'new', 'insights', 'into', 'the', 'pathogenesis', 'of', 'pneumonia', 'involving', 'the', 'interaction', 'between', 'multiple', 'microorganisms', 'New', 'developments', 'in', 'molecular', 'diagnostics', 'must', 'account', 'for', 'this', 'new', 'paradigm', '']"
153044,A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses,2006-01-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653205001435; https://www.ncbi.nlm.nih.gov/pubmed/16019258/; https://api.elsevier.com/content/article/pii/S1386653205001435,"Abstract Objectives To assess the quality of molecular detection of respiratory viruses in clinical diagnostic laboratories. Study design Respiratory virus proficiency panels were produced from diluted stocks of respiratory viruses provided and tested by four reference laboratories. The panels consisted of strong positive, positive, low positive and negative samples for influenza viruses A and B, respiratory syncytial virus, parainfluenza viruses 1 and 3, adenovirus serotypes 4 and 7, human rhinovirus serotypes 16, 72 and 90, human coronaviruses OC43 and 229E. The panels were sent to 17 participants; results and information on methodology was collected. Results All laboratories returned results, of which five submitted complete data sets. So, for analysis all results were combined. Samples were correctly identified by participants in 93.75%, 76.75% and 47.03% for the high positive, positive and low positive samples, respectively. One false positive was reported for all data sets (1.1%). The overall score for all assays using different methodologies was 78.8%. Laboratory performance was not dependant on methodology as all in-house methodologies could achieve optimal results, but dependant on careful optimisation and procedures specific to the laboratory. Conclusions The first proficiency panel showed that in general all participants performed well. Although, it also highlights areas for improvement for all participants in order to generate robust results for use in clinical diagnostics.",10.1016/j.jcv.2005.05.005,h7uwl0pb,"['Abstract', 'Objectives', 'To', 'assess', 'the', 'quality', 'of', 'molecular', 'detection', 'of', 'respiratory', 'viruses', 'in', 'clinical', 'diagnostic', 'laboratories', 'Study', 'design', 'Respiratory', 'virus', 'proficiency', 'panels', 'were', 'produced', 'from', 'diluted', 'stocks', 'of', 'respiratory', 'viruses', 'provided', 'and', 'tested', 'by', 'four', 'reference', 'laboratories', 'The', 'panels', 'consisted', 'of', 'strong', 'positive', 'positive', 'low', 'positive', 'and', 'negative', 'samples', 'for', 'influenza', 'viruses', 'A', 'and', 'B', 'respiratory', 'syncytial', 'virus', 'parainfluenza', 'viruses', '1', 'and', '3', 'adenovirus', 'serotypes', '4', 'and', '7', 'human', 'rhinovirus', 'serotypes', '16', '72', 'and', '90', 'human', 'coronaviruses', 'OC43', 'and', '229E', 'The', 'panels', 'were', 'sent', 'to', '17', 'participants', 'results', 'and', 'information', 'on', 'methodology', 'was', 'collected', 'Results', 'All', 'laboratories', 'returned', 'results', 'of', 'which', 'five', 'submitted', 'complete', 'data', 'sets', 'So', 'for', 'analysis', 'all', 'results', 'were', 'combined', 'Samples', 'were', 'correctly', 'identified', 'by', 'participants', 'in', '93', '75', '76', '75', 'and', '47', '03', 'for', 'the', 'high', 'positive', 'positive', 'and', 'low', 'positive', 'samples', 'respectively', 'One', 'false', 'positive', 'was', 'reported', 'for', 'all', 'data', 'sets', '1', '1', 'The', 'overall', 'score', 'for', 'all', 'assays', 'using', 'different', 'methodologies', 'was', '78', '8', 'Laboratory', 'performance', 'was', 'not', 'dependant', 'on', 'methodology', 'as', 'all', 'in', 'house', 'methodologies', 'could', 'achieve', 'optimal', 'results', 'but', 'dependant', 'on', 'careful', 'optimisation', 'and', 'procedures', 'specific', 'to', 'the', 'laboratory', 'Conclusions', 'The', 'first', 'proficiency', 'panel', 'showed', 'that', 'in', 'general', 'all', 'participants', 'performed', 'well', 'Although', 'it', 'also', 'highlights', 'areas', 'for', 'improvement', 'for', 'all', 'participants', 'in', 'order', 'to', 'generate', 'robust', 'results', 'for', 'use', 'in', 'clinical', 'diagnostics', '']"
153784,COVID-19 pandemic – A focused review for clinicians,2020-04-25,Clin Microbiol Infect,https://www.ncbi.nlm.nih.gov/pubmed/32344166/; https://www.sciencedirect.com/science/article/pii/S1198743X20302317?v=s5; https://api.elsevier.com/content/article/pii/S1198743X20302317; https://doi.org/10.1016/j.cmi.2020.04.023,"Abstract Background The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019 and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. Objectives Here we provide an update for clinicians on the recent developments about virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. Sources We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. Content We describe the virological characteristics of SARS-CoV-2 and clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. Implications The key challenge in managing COVID-19 remains the patient density. However, accurate diagnoses as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",10.1016/j.cmi.2020.04.023,x64tii2t,"['Abstract', 'Background', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'Objectives', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'about', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'Sources', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'Content', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'Implications', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'the', 'patient', 'density', 'However', 'accurate', 'diagnoses', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
153793,"Etiology of Childhood Pneumonia: What We Know, and What We Need to Know!: Based on 5th Dr. IC Verma Excellence Oration Award",2017-09-25,Indian J Pediatr,https://www.ncbi.nlm.nih.gov/pubmed/28944408/; https://doi.org/10.1007/s12098-017-2486-y,"Childhood community acquired pneumonia continues to be an important clinical problem at the individual, institutional and community levels. Determination of microbial etiology is critical to develop evidence-based management (therapeutic and prophylactic) decisions. For decades, the approach to this relied on culture of lung aspirate specimens obtained from children with radiographically confirmed pneumonia, before administering antibiotics. Such studies revealed the major bacteria associated with pneumonia, prompting the World Health Organization to develop a highly sensitive clinical definition of pneumonia and advocate empiric antibiotic therapy; in order to save lives (focusing on community settings lacking resources for diagnostic tests). However, it spawned research studies conducted in/from/by institutions enrolling children with the relatively non-specific WHO definition of pneumonia. Specificity got further compromised by abandoning lung aspiration and using naso/oro pharyngeal specimens; even in children who had received antibiotics. This led to the recovery of viruses more often than bacteria. The use of highly sensitive molecular based diagnostics (especially PCR) facilitated the detection of multiple organisms (bacteria, viruses, atypical organisms and even fungal species); making it difficult to attribute etiology in individual cases. This challenge was sought to be addressed through the multi-site PERCH Study (Pneumonia Etiology Research for Child Health), designed as a case-control study to conclusively determine the etiology of pneumonia. However, despite a slew of publications, the answer to the central question of etiology has not emerged so far. Since none of the PERCH Study sites was located in India, the Community Acquired Pneumonia Etiology Study (CAPES) was conducted at Chandigarh. This turned out to be the largest single-centre pneumonia etiology study, and generated a wealth of data. This article summarizes the current challenges in pneumonia etiology research; outlines the key observations from the PERCH and CAPES projects, as well as other important studies; and suggests a way forward for pneumonia etiology research in the current era.",10.1007/s12098-017-2486-y,yep6sjhj,"['Childhood', 'community', 'acquired', 'pneumonia', 'continues', 'to', 'be', 'an', 'important', 'clinical', 'problem', 'at', 'the', 'individual', 'institutional', 'and', 'community', 'levels', 'Determination', 'of', 'microbial', 'etiology', 'is', 'critical', 'to', 'develop', 'evidence', 'based', 'management', 'therapeutic', 'and', 'prophylactic', 'decisions', 'For', 'decades', 'the', 'approach', 'to', 'this', 'relied', 'on', 'culture', 'of', 'lung', 'aspirate', 'specimens', 'obtained', 'from', 'children', 'with', 'radiographically', 'confirmed', 'pneumonia', 'before', 'administering', 'antibiotics', 'Such', 'studies', 'revealed', 'the', 'major', 'bacteria', 'associated', 'with', 'pneumonia', 'prompting', 'the', 'World', 'Health', 'Organization', 'to', 'develop', 'a', 'highly', 'sensitive', 'clinical', 'definition', 'of', 'pneumonia', 'and', 'advocate', 'empiric', 'antibiotic', 'therapy', 'in', 'order', 'to', 'save', 'lives', 'focusing', 'on', 'community', 'settings', 'lacking', 'resources', 'for', 'diagnostic', 'tests', 'However', 'it', 'spawned', 'research', 'studies', 'conducted', 'in', 'from', 'by', 'institutions', 'enrolling', 'children', 'with', 'the', 'relatively', 'non', 'specific', 'WHO', 'definition', 'of', 'pneumonia', 'Specificity', 'got', 'further', 'compromised', 'by', 'abandoning', 'lung', 'aspiration', 'and', 'using', 'naso', 'oro', 'pharyngeal', 'specimens', 'even', 'in', 'children', 'who', 'had', 'received', 'antibiotics', 'This', 'led', 'to', 'the', 'recovery', 'of', 'viruses', 'more', 'often', 'than', 'bacteria', 'The', 'use', 'of', 'highly', 'sensitive', 'molecular', 'based', 'diagnostics', 'especially', 'PCR', 'facilitated', 'the', 'detection', 'of', 'multiple', 'organisms', 'bacteria', 'viruses', 'atypical', 'organisms', 'and', 'even', 'fungal', 'species', 'making', 'it', 'difficult', 'to', 'attribute', 'etiology', 'in', 'individual', 'cases', 'This', 'challenge', 'was', 'sought', 'to', 'be', 'addressed', 'through', 'the', 'multi', 'site', 'PERCH', 'Study', 'Pneumonia', 'Etiology', 'Research', 'for', 'Child', 'Health', 'designed', 'as', 'a', 'case', 'control', 'study', 'to', 'conclusively', 'determine', 'the', 'etiology', 'of', 'pneumonia', 'However', 'despite', 'a', 'slew', 'of', 'publications', 'the', 'answer', 'to', 'the', 'central', 'question', 'of', 'etiology', 'has', 'not', 'emerged', 'so', 'far', 'Since', 'none', 'of', 'the', 'PERCH', 'Study', 'sites', 'was', 'located', 'in', 'India', 'the', 'Community', 'Acquired', 'Pneumonia', 'Etiology', 'Study', 'CAPES', 'was', 'conducted', 'at', 'Chandigarh', 'This', 'turned', 'out', 'to', 'be', 'the', 'largest', 'single', 'centre', 'pneumonia', 'etiology', 'study', 'and', 'generated', 'a', 'wealth', 'of', 'data', 'This', 'article', 'summarizes', 'the', 'current', 'challenges', 'in', 'pneumonia', 'etiology', 'research', 'outlines', 'the', 'key', 'observations', 'from', 'the', 'PERCH', 'and', 'CAPES', 'projects', 'as', 'well', 'as', 'other', 'important', 'studies', 'and', 'suggests', 'a', 'way', 'forward', 'for', 'pneumonia', 'etiology', 'research', 'in', 'the', 'current', 'era', '']"
153954,Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning,2019-07-31,Antibodies (Basel),https://doi.org/10.3390/antib8030042; https://www.ncbi.nlm.nih.gov/pubmed/31544848/,"Since its first report in the Middle East in 2012, the Middle East respiratory syndrome-coronavirus (MERS-CoV) has become a global concern due to the high morbidity and mortality of individuals infected with the virus. Although the majority of MERS-CoV cases have been reported in Saudi Arabia, the overall risk in areas outside the Middle East remains significant as inside Saudi Arabia. Additional pandemics of MERS-CoV are expected, and thus novel tools and reagents for therapy and diagnosis are urgently needed. Here, we used phage display to develop novel monoclonal antibodies (mAbs) that target MERS-CoV. A human Fab phage display library was panned against the S2 subunit of the MERS-CoV spike protein (MERS-S2P), yielding three unique Fabs (S2A3, S2A6, and S2D5). The Fabs had moderate apparent affinities (Half maximal effective concentration (EC(50) = 123–421 nM) for MERS-S2P, showed no cross-reactivity to spike proteins from other CoVs, and were non-aggregating and thermostable (T(m) = 61.5–80.4 °C). Reformatting the Fabs into IgGs (Immunoglobulin Gs) greatly increased their apparent affinities (K(D) = 0.17–1.2 nM), presumably due to the effects of avidity. These apparent affinities were notably higher than that of a previously reported anti-MERS-CoV S2 reference mAb (K(D) = 8.7 nM). Furthermore, two of the three mAbs (S2A3 and S2D5) bound only MERS-CoV (Erasmus Medical Center (EMC)) and not other CoVs, reflecting their high binding specificity. However, the mAbs lacked MERS-CoV neutralizing activity. Given their high affinity, specificity, and desirable stabilities, we anticipate that these anti-MERS-CoV mAbs would be suitable reagents for developing antibody-based diagnostics in laboratory or hospital settings for point-of-care testing.",10.3390/antib8030042,1zcxw6yu,"['Since', 'its', 'first', 'report', 'in', 'the', 'Middle', 'East', 'in', '2012', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'the', 'high', 'morbidity', 'and', 'mortality', 'of', 'individuals', 'infected', 'with', 'the', 'virus', 'Although', 'the', 'majority', 'of', 'MERS', 'CoV', 'cases', 'have', 'been', 'reported', 'in', 'Saudi', 'Arabia', 'the', 'overall', 'risk', 'in', 'areas', 'outside', 'the', 'Middle', 'East', 'remains', 'significant', 'as', 'inside', 'Saudi', 'Arabia', 'Additional', 'pandemics', 'of', 'MERS', 'CoV', 'are', 'expected', 'and', 'thus', 'novel', 'tools', 'and', 'reagents', 'for', 'therapy', 'and', 'diagnosis', 'are', 'urgently', 'needed', 'Here', 'we', 'used', 'phage', 'display', 'to', 'develop', 'novel', 'monoclonal', 'antibodies', 'mAbs', 'that', 'target', 'MERS', 'CoV', 'A', 'human', 'Fab', 'phage', 'display', 'library', 'was', 'panned', 'against', 'the', 'S2', 'subunit', 'of', 'the', 'MERS', 'CoV', 'spike', 'protein', 'MERS', 'S2P', 'yielding', 'three', 'unique', 'Fabs', 'S2A3', 'S2A6', 'and', 'S2D5', 'The', 'Fabs', 'had', 'moderate', 'apparent', 'affinities', 'Half', 'maximal', 'effective', 'concentration', 'EC', '50', '123', '421', 'nM', 'for', 'MERS', 'S2P', 'showed', 'no', 'cross', 'reactivity', 'to', 'spike', 'proteins', 'from', 'other', 'CoVs', 'and', 'were', 'non', 'aggregating', 'and', 'thermostable', 'T', 'm', '61', '5', '80', '4', 'C', 'Reformatting', 'the', 'Fabs', 'into', 'IgGs', 'Immunoglobulin', 'Gs', 'greatly', 'increased', 'their', 'apparent', 'affinities', 'K', 'D', '0', '17', '1', '2', 'nM', 'presumably', 'due', 'to', 'the', 'effects', 'of', 'avidity', 'These', 'apparent', 'affinities', 'were', 'notably', 'higher', 'than', 'that', 'of', 'a', 'previously', 'reported', 'anti', 'MERS', 'CoV', 'S2', 'reference', 'mAb', 'K', 'D', '8', '7', 'nM', 'Furthermore', 'two', 'of', 'the', 'three', 'mAbs', 'S2A3', 'and', 'S2D5', 'bound', 'only', 'MERS', 'CoV', 'Erasmus', 'Medical', 'Center', 'EMC', 'and', 'not', 'other', 'CoVs', 'reflecting', 'their', 'high', 'binding', 'specificity', 'However', 'the', 'mAbs', 'lacked', 'MERS', 'CoV', 'neutralizing', 'activity', 'Given', 'their', 'high', 'affinity', 'specificity', 'and', 'desirable', 'stabilities', 'we', 'anticipate', 'that', 'these', 'anti', 'MERS', 'CoV', 'mAbs', 'would', 'be', 'suitable', 'reagents', 'for', 'developing', 'antibody', 'based', 'diagnostics', 'in', 'laboratory', 'or', 'hospital', 'settings', 'for', 'point', 'of', 'care', 'testing', '']"
154483,SAROTUP: Scanner and Reporter of Target-Unrelated Peptides,2010-03-21,J Biomed Biotechnol,https://doi.org/10.1155/2010/101932; https://www.ncbi.nlm.nih.gov/pubmed/20339521/,"As epitope mimics, mimotopes have been widely utilized in the study of epitope prediction and the development of new diagnostics, therapeutics, and vaccines. Screening the random peptide libraries constructed with phage display or any other surface display technologies provides an efficient and convenient approach to acquire mimotopes. However, target-unrelated peptides creep into mimotopes from time to time through binding to contaminants or other components of the screening system. In this study, we present SAROTUP, a free web tool for scanning, reporting and excluding possible target-unrelated peptides from real mimotopes. Preliminary tests show that SAROTUP is efficient and capable of improving the accuracy of mimotope-based epitope mapping. It is also helpful for the development of mimotope-based diagnostics, therapeutics, and vaccines.",10.1155/2010/101932,hi7z3nob,"['As', 'epitope', 'mimics', 'mimotopes', 'have', 'been', 'widely', 'utilized', 'in', 'the', 'study', 'of', 'epitope', 'prediction', 'and', 'the', 'development', 'of', 'new', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Screening', 'the', 'random', 'peptide', 'libraries', 'constructed', 'with', 'phage', 'display', 'or', 'any', 'other', 'surface', 'display', 'technologies', 'provides', 'an', 'efficient', 'and', 'convenient', 'approach', 'to', 'acquire', 'mimotopes', 'However', 'target', 'unrelated', 'peptides', 'creep', 'into', 'mimotopes', 'from', 'time', 'to', 'time', 'through', 'binding', 'to', 'contaminants', 'or', 'other', 'components', 'of', 'the', 'screening', 'system', 'In', 'this', 'study', 'we', 'present', 'SAROTUP', 'a', 'free', 'web', 'tool', 'for', 'scanning', 'reporting', 'and', 'excluding', 'possible', 'target', 'unrelated', 'peptides', 'from', 'real', 'mimotopes', 'Preliminary', 'tests', 'show', 'that', 'SAROTUP', 'is', 'efficient', 'and', 'capable', 'of', 'improving', 'the', 'accuracy', 'of', 'mimotope', 'based', 'epitope', 'mapping', 'It', 'is', 'also', 'helpful', 'for', 'the', 'development', 'of', 'mimotope', 'based', 'diagnostics', 'therapeutics', 'and', 'vaccines', '']"
154518,"Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012–2015",2017-09-13,PLoS Negl Trop Dis,https://www.ncbi.nlm.nih.gov/pubmed/28902845/; https://doi.org/10.1371/journal.pntd.0005859,"Identifying etiologies of acute febrile illnesses (AFI) is challenging due to non-specific presentation and limited availability of diagnostics. Prospective AFI studies provide a methodology to describe the syndrome by age and etiology, findings that can be used to develop case definitions and multiplexed diagnostics to optimize management. We conducted a 3-year prospective AFI study in Puerto Rico. Patients with fever ≤7 days were offered enrollment, and clinical data and specimens were collected at enrollment and upon discharge or follow-up. Blood and oro-nasopharyngeal specimens were tested by RT-PCR and immunodiagnostic methods for infection with dengue viruses (DENV) 1–4, chikungunya virus (CHIKV), influenza A and B viruses (FLU A/B), 12 other respiratory viruses (ORV), enterovirus, Leptospira spp., and Burkholderia pseudomallei. Clinical presentation and laboratory findings of participants infected with DENV were compared to those infected with CHIKV, FLU A/B, and ORV. Clinical predictors of laboratory-positive dengue compared to all other AFI etiologies were determined by age and day post-illness onset (DPO) at presentation. Of 8,996 participants enrolled from May 7, 2012 through May 6, 2015, more than half (54.8%, 4,930) had a pathogen detected. Pathogens most frequently detected were CHIKV (1,635, 18.2%), FLU A/B (1,074, 11.9%), DENV 1–4 (970, 10.8%), and ORV (904, 10.3%). Participants with DENV infection presented later and a higher proportion were hospitalized than those with other diagnoses (46.7% versus 27.3% with ORV, 18.8% with FLU A/B, and 11.2% with CHIKV). Predictors of dengue in participants presenting <3 DPO included leukopenia, thrombocytopenia, headache, eye pain, nausea, and dizziness, while negative predictors were irritability and rhinorrhea. Predictors of dengue in participants presenting 3–5 DPO were leukopenia, thrombocytopenia, facial/neck erythema, nausea, eye pain, signs of poor circulation, and diarrhea; presence of rhinorrhea, cough, and red conjunctiva predicted non-dengue AFI. By enrolling febrile patients at clinical presentation, we identified unbiased predictors of laboratory-positive dengue as compared to other common causes of AFI. These findings can be used to assist in early identification of dengue patients, as well as direct anticipatory guidance and timely initiation of correct clinical management.",10.1371/journal.pntd.0005859,ded5t1ai,"['Identifying', 'etiologies', 'of', 'acute', 'febrile', 'illnesses', 'AFI', 'is', 'challenging', 'due', 'to', 'non', 'specific', 'presentation', 'and', 'limited', 'availability', 'of', 'diagnostics', 'Prospective', 'AFI', 'studies', 'provide', 'a', 'methodology', 'to', 'describe', 'the', 'syndrome', 'by', 'age', 'and', 'etiology', 'findings', 'that', 'can', 'be', 'used', 'to', 'develop', 'case', 'definitions', 'and', 'multiplexed', 'diagnostics', 'to', 'optimize', 'management', 'We', 'conducted', 'a', '3', 'year', 'prospective', 'AFI', 'study', 'in', 'Puerto', 'Rico', 'Patients', 'with', 'fever', '7', 'days', 'were', 'offered', 'enrollment', 'and', 'clinical', 'data', 'and', 'specimens', 'were', 'collected', 'at', 'enrollment', 'and', 'upon', 'discharge', 'or', 'follow', 'up', 'Blood', 'and', 'oro', 'nasopharyngeal', 'specimens', 'were', 'tested', 'by', 'RT', 'PCR', 'and', 'immunodiagnostic', 'methods', 'for', 'infection', 'with', 'dengue', 'viruses', 'DENV', '1', '4', 'chikungunya', 'virus', 'CHIKV', 'influenza', 'A', 'and', 'B', 'viruses', 'FLU', 'A', 'B', '12', 'other', 'respiratory', 'viruses', 'ORV', 'enterovirus', 'Leptospira', 'spp', 'and', 'Burkholderia', 'pseudomallei', 'Clinical', 'presentation', 'and', 'laboratory', 'findings', 'of', 'participants', 'infected', 'with', 'DENV', 'were', 'compared', 'to', 'those', 'infected', 'with', 'CHIKV', 'FLU', 'A', 'B', 'and', 'ORV', 'Clinical', 'predictors', 'of', 'laboratory', 'positive', 'dengue', 'compared', 'to', 'all', 'other', 'AFI', 'etiologies', 'were', 'determined', 'by', 'age', 'and', 'day', 'post', 'illness', 'onset', 'DPO', 'at', 'presentation', 'Of', '8', '996', 'participants', 'enrolled', 'from', 'May', '7', '2012', 'through', 'May', '6', '2015', 'more', 'than', 'half', '54', '8', '4', '930', 'had', 'a', 'pathogen', 'detected', 'Pathogens', 'most', 'frequently', 'detected', 'were', 'CHIKV', '1', '635', '18', '2', 'FLU', 'A', 'B', '1', '074', '11', '9', 'DENV', '1', '4', '970', '10', '8', 'and', 'ORV', '904', '10', '3', 'Participants', 'with', 'DENV', 'infection', 'presented', 'later', 'and', 'a', 'higher', 'proportion', 'were', 'hospitalized', 'than', 'those', 'with', 'other', 'diagnoses', '46', '7', 'versus', '27', '3', 'with', 'ORV', '18', '8', 'with', 'FLU', 'A', 'B', 'and', '11', '2', 'with', 'CHIKV', 'Predictors', 'of', 'dengue', 'in', 'participants', 'presenting', '3', 'DPO', 'included', 'leukopenia', 'thrombocytopenia', 'headache', 'eye', 'pain', 'nausea', 'and', 'dizziness', 'while', 'negative', 'predictors', 'were', 'irritability', 'and', 'rhinorrhea', 'Predictors', 'of', 'dengue', 'in', 'participants', 'presenting', '3', '5', 'DPO', 'were', 'leukopenia', 'thrombocytopenia', 'facial', 'neck', 'erythema', 'nausea', 'eye', 'pain', 'signs', 'of', 'poor', 'circulation', 'and', 'diarrhea', 'presence', 'of', 'rhinorrhea', 'cough', 'and', 'red', 'conjunctiva', 'predicted', 'non', 'dengue', 'AFI', 'By', 'enrolling', 'febrile', 'patients', 'at', 'clinical', 'presentation', 'we', 'identified', 'unbiased', 'predictors', 'of', 'laboratory', 'positive', 'dengue', 'as', 'compared', 'to', 'other', 'common', 'causes', 'of', 'AFI', 'These', 'findings', 'can', 'be', 'used', 'to', 'assist', 'in', 'early', 'identification', 'of', 'dengue', 'patients', 'as', 'well', 'as', 'direct', 'anticipatory', 'guidance', 'and', 'timely', 'initiation', 'of', 'correct', 'clinical', 'management', '']"
154534,Multiplex real-time PCR for detection of respiratory tract infections,2008-01-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653207003940; https://www.ncbi.nlm.nih.gov/pubmed/18093871/; https://api.elsevier.com/content/article/pii/S1386653207003940,"Abstract Background Broad diagnostics of respiratory infection by molecular assays has not yet won acceptance due to technical difficulties and high costs. Objectives To evaluate clinical applicability of multiplex real-time PCR. Study design An assay targeting influenza virus A (IfA) and B (IfB), parainfluenza 1-3 (PIV), human metapneumovirus (MPV), respiratory syncytial virus (RSV), rhinovirus (RV), enterovirus (EV), adenovirus (AdV), human coronaviruses (229E, OC43, NL63), M. pneumoniae and Ch. pneumoniae was developed and run daily on consecutive clinical nasopharyngeal swab samples. Results An etiology was identified in 48% of the 954 samples, with IfA in 25%, RV in 20%, MPV in 10% and M. pneumoniae in 10% of the positive. By a rational procedure costs could be reduced and the customer price set relatively low (€33 per sample). Conclusion Streamlined testing and cost limitation is achievable and probably critical for implementation of a broad molecular diagnostics of respiratory infections.",10.1016/j.jcv.2007.10.029,f2ct57em,"['Abstract', 'Background', 'Broad', 'diagnostics', 'of', 'respiratory', 'infection', 'by', 'molecular', 'assays', 'has', 'not', 'yet', 'won', 'acceptance', 'due', 'to', 'technical', 'difficulties', 'and', 'high', 'costs', 'Objectives', 'To', 'evaluate', 'clinical', 'applicability', 'of', 'multiplex', 'real', 'time', 'PCR', 'Study', 'design', 'An', 'assay', 'targeting', 'influenza', 'virus', 'A', 'IfA', 'and', 'B', 'IfB', 'parainfluenza', '1', '3', 'PIV', 'human', 'metapneumovirus', 'MPV', 'respiratory', 'syncytial', 'virus', 'RSV', 'rhinovirus', 'RV', 'enterovirus', 'EV', 'adenovirus', 'AdV', 'human', 'coronaviruses', '229E', 'OC43', 'NL63', 'M', 'pneumoniae', 'and', 'Ch', 'pneumoniae', 'was', 'developed', 'and', 'run', 'daily', 'on', 'consecutive', 'clinical', 'nasopharyngeal', 'swab', 'samples', 'Results', 'An', 'etiology', 'was', 'identified', 'in', '48', 'of', 'the', '954', 'samples', 'with', 'IfA', 'in', '25', 'RV', 'in', '20', 'MPV', 'in', '10', 'and', 'M', 'pneumoniae', 'in', '10', 'of', 'the', 'positive', 'By', 'a', 'rational', 'procedure', 'costs', 'could', 'be', 'reduced', 'and', 'the', 'customer', 'price', 'set', 'relatively', 'low', '33', 'per', 'sample', 'Conclusion', 'Streamlined', 'testing', 'and', 'cost', 'limitation', 'is', 'achievable', 'and', 'probably', 'critical', 'for', 'implementation', 'of', 'a', 'broad', 'molecular', 'diagnostics', 'of', 'respiratory', 'infections', '']"
154549,Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation,2020-02-15,bioRxiv,https://doi.org/10.1101/2020.02.11.944462; https://www.ncbi.nlm.nih.gov/pubmed/32511295/,"The outbreak of a novel betacoronavirus (2019-nCov) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for urgently needed vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure (MCM) development we determined a 3.5 Å-resolution cryo-EM structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also show biophysical and structural evidence that the 2019-nCoV S binds ACE2 with higher affinity than SARS-CoV S. Additionally we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to nCoV-2019 S, suggesting antibody cross-reactivity may be limited between the two virus RBDs. The atomic-resolution structure of 2019-nCoV S should enable rapid development and evaluation of MCMs to address the ongoing public health crisis.",10.1101/2020.02.11.944462,prqeufwg,"['The', 'outbreak', 'of', 'a', 'novel', 'betacoronavirus', '2019', 'nCov', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'urgently', 'needed', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'MCM', 'development', 'we', 'determined', 'a', '3', '5', 'Å', 'resolution', 'cryo', 'EM', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'show', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'binds', 'ACE2', 'with', 'higher', 'affinity', 'than', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', 'nCoV', '2019', 'S', 'suggesting', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'virus', 'RBDs', 'The', 'atomic', 'resolution', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'rapid', 'development', 'and', 'evaluation', 'of', 'MCMs', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
155026,Future Veterinary Diagnostics,2010-09-19,J Exot Pet Med,https://api.elsevier.com/content/article/pii/S1557506310000558; https://doi.org/10.1053/j.jepm.2010.05.006; https://www.sciencedirect.com/science/article/pii/S1557506310000558; https://www.ncbi.nlm.nih.gov/pubmed/32288673/,"The development of rapid, accurate, and sensitive diagnostic methods for detecting pathogens is the basis for treating, controlling, and eradicating infectious diseases of veterinary importance. Scientific and technological advancements have revolutionized the field of veterinary diagnostics. Genome sequencing has allowed efficient, sensitive, and specific diagnostic assays to be developed based on the detection of nucleic acids. The integration of advances in biochemistry, proteomics, engineering, and medicine offers enormous potential for the rapid and accurate diagnosis of viral, microbial, genetic, and metabolic disease. In the future, polymerase chain reaction assays, microarray testing, genomic analysis, and metabolic profiling will be accomplished in a rapid, portable, sensitive, and cost-efficient manner.",10.1053/j.jepm.2010.05.006,o976nab9,"['The', 'development', 'of', 'rapid', 'accurate', 'and', 'sensitive', 'diagnostic', 'methods', 'for', 'detecting', 'pathogens', 'is', 'the', 'basis', 'for', 'treating', 'controlling', 'and', 'eradicating', 'infectious', 'diseases', 'of', 'veterinary', 'importance', 'Scientific', 'and', 'technological', 'advancements', 'have', 'revolutionized', 'the', 'field', 'of', 'veterinary', 'diagnostics', 'Genome', 'sequencing', 'has', 'allowed', 'efficient', 'sensitive', 'and', 'specific', 'diagnostic', 'assays', 'to', 'be', 'developed', 'based', 'on', 'the', 'detection', 'of', 'nucleic', 'acids', 'The', 'integration', 'of', 'advances', 'in', 'biochemistry', 'proteomics', 'engineering', 'and', 'medicine', 'offers', 'enormous', 'potential', 'for', 'the', 'rapid', 'and', 'accurate', 'diagnosis', 'of', 'viral', 'microbial', 'genetic', 'and', 'metabolic', 'disease', 'In', 'the', 'future', 'polymerase', 'chain', 'reaction', 'assays', 'microarray', 'testing', 'genomic', 'analysis', 'and', 'metabolic', 'profiling', 'will', 'be', 'accomplished', 'in', 'a', 'rapid', 'portable', 'sensitive', 'and', 'cost', 'efficient', 'manner', '']"
155069,Identification of a Novel Linear B-Cell Epitope on the Nucleocapsid Protein of Porcine Deltacoronavirus,2020-01-19,Int J Mol Sci,https://www.ncbi.nlm.nih.gov/pubmed/31963776/; https://doi.org/10.3390/ijms21020648,"Porcine deltacoronavirus (PDCoV), first identified in 2012, is a swine enteropathogen now found in many countries. The nucleocapsid (N) protein, a core component of PDCoV, is essential for virus replication and is a significant candidate in the development of diagnostics for PDCoV. In this study, monoclonal antibodies (mAbs) were generated and tested for reactivity with three truncations of the full protein (N1, N2, N3) that contained partial overlaps; of the five monoclonals chosen tested, each reacted with only the N3 truncation. The antibody designated 4E88 had highest binding affinity with the N protein and was chosen for in-depth examination. The 4E88 epitope was located to amino acids 308-AKPKQQKKPKK-318 by testing the 4E88 monoclonal for reactivity with a series of N3 truncations, then the minimal epitope, 309-KPKQQKKPK-317 (designated EP-4E88), was pinpointed by testing the 4E88 monoclonal for reactivity with a series of synthetic peptides of this region. Homology analysis showed that the EP-4E88 sequence is highly conserved among PDCoV strains, and also shares high similarity with sparrow coronavirus (HKU17), Asian leopard cat coronavirus (ALCCoV), quail coronavirus (UAE-HKU30), and sparrow deltacoronavirus (SpDCoV). Of note, the PDCoV EP-4E88 sequence shared very low similarity (<22.2%) with other porcine coronaviruses (PEDV, TGEV, PRCV, SADS-CoV, PHEV), demonstrating that it is an epitope that can be used for distinguishing PDCoV and other porcine coronavirus. 3D structural analysis revealed that amino acids of EP-4E88 were in close proximity and may be exposed on the surface of the N protein.",10.3390/ijms21020648,2r101v54,"['Porcine', 'deltacoronavirus', 'PDCoV', 'first', 'identified', 'in', '2012', 'is', 'a', 'swine', 'enteropathogen', 'now', 'found', 'in', 'many', 'countries', 'The', 'nucleocapsid', 'N', 'protein', 'a', 'core', 'component', 'of', 'PDCoV', 'is', 'essential', 'for', 'virus', 'replication', 'and', 'is', 'a', 'significant', 'candidate', 'in', 'the', 'development', 'of', 'diagnostics', 'for', 'PDCoV', 'In', 'this', 'study', 'monoclonal', 'antibodies', 'mAbs', 'were', 'generated', 'and', 'tested', 'for', 'reactivity', 'with', 'three', 'truncations', 'of', 'the', 'full', 'protein', 'N1', 'N2', 'N3', 'that', 'contained', 'partial', 'overlaps', 'of', 'the', 'five', 'monoclonals', 'chosen', 'tested', 'each', 'reacted', 'with', 'only', 'the', 'N3', 'truncation', 'The', 'antibody', 'designated', '4E88', 'had', 'highest', 'binding', 'affinity', 'with', 'the', 'N', 'protein', 'and', 'was', 'chosen', 'for', 'in', 'depth', 'examination', 'The', '4E88', 'epitope', 'was', 'located', 'to', 'amino', 'acids', '308', 'AKPKQQKKPKK', '318', 'by', 'testing', 'the', '4E88', 'monoclonal', 'for', 'reactivity', 'with', 'a', 'series', 'of', 'N3', 'truncations', 'then', 'the', 'minimal', 'epitope', '309', 'KPKQQKKPK', '317', 'designated', 'EP', '4E88', 'was', 'pinpointed', 'by', 'testing', 'the', '4E88', 'monoclonal', 'for', 'reactivity', 'with', 'a', 'series', 'of', 'synthetic', 'peptides', 'of', 'this', 'region', 'Homology', 'analysis', 'showed', 'that', 'the', 'EP', '4E88', 'sequence', 'is', 'highly', 'conserved', 'among', 'PDCoV', 'strains', 'and', 'also', 'shares', 'high', 'similarity', 'with', 'sparrow', 'coronavirus', 'HKU17', 'Asian', 'leopard', 'cat', 'coronavirus', 'ALCCoV', 'quail', 'coronavirus', 'UAE', 'HKU30', 'and', 'sparrow', 'deltacoronavirus', 'SpDCoV', 'Of', 'note', 'the', 'PDCoV', 'EP', '4E88', 'sequence', 'shared', 'very', 'low', 'similarity', '22', '2', 'with', 'other', 'porcine', 'coronaviruses', 'PEDV', 'TGEV', 'PRCV', 'SADS', 'CoV', 'PHEV', 'demonstrating', 'that', 'it', 'is', 'an', 'epitope', 'that', 'can', 'be', 'used', 'for', 'distinguishing', 'PDCoV', 'and', 'other', 'porcine', 'coronavirus', '3D', 'structural', 'analysis', 'revealed', 'that', 'amino', 'acids', 'of', 'EP', '4E88', 'were', 'in', 'close', 'proximity', 'and', 'may', 'be', 'exposed', 'on', 'the', 'surface', 'of', 'the', 'N', 'protein', '']"
155161,Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe,2017-10-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653217302172; https://www.ncbi.nlm.nih.gov/pubmed/28837859/; https://api.elsevier.com/content/article/pii/S1386653217302172; https://doi.org/10.1016/j.jcv.2017.07.019,"Abstract Community-acquired pneumonia (CAP) is an important respiratory disease and the fifth leading cause of mortality in Europe. The development of molecular diagnostic tests has highlighted the contributions of respiratory viruses to the aetiology of CAP, suggesting the incidence of viral pneumonia may have been previously underestimated. We performed a systematic review and meta-analysis to describe the overall identification of respiratory viruses in adult patients with CAP in Europe, following PRISMA guidelines (PROSPERO; CRD42016037233). We searched EMBASE, MEDLINE, CINAHL, WHOLIS, COCHRANE library and grey literature sources for relevant studies, and screened these against protocol eligibility criteria. Two researchers performed data extraction and risk of bias assessments, independently, using a piloted form. Results were synthesised narratively, and random effects meta-analyses performed to calculate pooled estimates of effect; heterogeneity was quantified using I2. Twenty-eight studies met inclusion criteria of which 21 were included in the primary meta-analysis. The pooled proportion of patients with identified respiratory viruses was 22.0% (95% CI: 18.0%–27.0%), rising to 29.0% (25.0%–34.0%) in studies where polymerase chain reaction (PCR) diagnostics were performed. Influenza virus was the most frequently detected virus in 9% (7%–12%) of adults with CAP. Respiratory viruses make a substantial contribution to the aetiology of CAP in adult patients in Europe; one or more respiratory viruses are detected in about one quarter of all cases.",10.1016/j.jcv.2017.07.019,b6mlolpx,"['Abstract', 'Community', 'acquired', 'pneumonia', 'CAP', 'is', 'an', 'important', 'respiratory', 'disease', 'and', 'the', 'fifth', 'leading', 'cause', 'of', 'mortality', 'in', 'Europe', 'The', 'development', 'of', 'molecular', 'diagnostic', 'tests', 'has', 'highlighted', 'the', 'contributions', 'of', 'respiratory', 'viruses', 'to', 'the', 'aetiology', 'of', 'CAP', 'suggesting', 'the', 'incidence', 'of', 'viral', 'pneumonia', 'may', 'have', 'been', 'previously', 'underestimated', 'We', 'performed', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'to', 'describe', 'the', 'overall', 'identification', 'of', 'respiratory', 'viruses', 'in', 'adult', 'patients', 'with', 'CAP', 'in', 'Europe', 'following', 'PRISMA', 'guidelines', 'PROSPERO', 'CRD42016037233', 'We', 'searched', 'EMBASE', 'MEDLINE', 'CINAHL', 'WHOLIS', 'COCHRANE', 'library', 'and', 'grey', 'literature', 'sources', 'for', 'relevant', 'studies', 'and', 'screened', 'these', 'against', 'protocol', 'eligibility', 'criteria', 'Two', 'researchers', 'performed', 'data', 'extraction', 'and', 'risk', 'of', 'bias', 'assessments', 'independently', 'using', 'a', 'piloted', 'form', 'Results', 'were', 'synthesised', 'narratively', 'and', 'random', 'effects', 'meta', 'analyses', 'performed', 'to', 'calculate', 'pooled', 'estimates', 'of', 'effect', 'heterogeneity', 'was', 'quantified', 'using', 'I2', 'Twenty', 'eight', 'studies', 'met', 'inclusion', 'criteria', 'of', 'which', '21', 'were', 'included', 'in', 'the', 'primary', 'meta', 'analysis', 'The', 'pooled', 'proportion', 'of', 'patients', 'with', 'identified', 'respiratory', 'viruses', 'was', '22', '0', '95', 'CI', '18', '0', '27', '0', 'rising', 'to', '29', '0', '25', '0', '34', '0', 'in', 'studies', 'where', 'polymerase', 'chain', 'reaction', 'PCR', 'diagnostics', 'were', 'performed', 'Influenza', 'virus', 'was', 'the', 'most', 'frequently', 'detected', 'virus', 'in', '9', '7', '12', 'of', 'adults', 'with', 'CAP', 'Respiratory', 'viruses', 'make', 'a', 'substantial', 'contribution', 'to', 'the', 'aetiology', 'of', 'CAP', 'in', 'adult', 'patients', 'in', 'Europe', 'one', 'or', 'more', 'respiratory', 'viruses', 'are', 'detected', 'in', 'about', 'one', 'quarter', 'of', 'all', 'cases', '']"
155422,"The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors",2020-06-22,Int J Mol Sci,https://doi.org/10.3390/ijms21124446; https://www.ncbi.nlm.nih.gov/pubmed/32580529/,"Our work concerns the actual problem of spread of SARS- CoV-2 outbreak which requires fast and correct as possible answer. In current scenario, the need of rapid answer put away the imperative of proper methodology. We focus on the serogical immunoassay for diagnosis of Covid-19 as an important weapon not only for diagnostic purpose, but also for epidemiologic one. The right equilibrium between high speed, low cost and accuracy is obtained with easy-to-use decentralized point-of-care test as the colloidal gold-based immunochromatographic strip assay which detects IgM and IgG antibodies directed against SARS-CoV-2. As our aim is to evaluate the efficacy of Covid-19 rapid tests and of serological assays in real-life settings, we designed a research protocol aimed to establish how to use correctly these diagnostics, taking into account the different possible clinical and epidemiological scenarios.",10.3390/ijms21124446,zt3w9vy3,"['Our', 'work', 'concerns', 'the', 'actual', 'problem', 'of', 'spread', 'of', 'SARS', 'CoV', '2', 'outbreak', 'which', 'requires', 'fast', 'and', 'correct', 'as', 'possible', 'answer', 'In', 'current', 'scenario', 'the', 'need', 'of', 'rapid', 'answer', 'put', 'away', 'the', 'imperative', 'of', 'proper', 'methodology', 'We', 'focus', 'on', 'the', 'serogical', 'immunoassay', 'for', 'diagnosis', 'of', 'Covid', '19', 'as', 'an', 'important', 'weapon', 'not', 'only', 'for', 'diagnostic', 'purpose', 'but', 'also', 'for', 'epidemiologic', 'one', 'The', 'right', 'equilibrium', 'between', 'high', 'speed', 'low', 'cost', 'and', 'accuracy', 'is', 'obtained', 'with', 'easy', 'to', 'use', 'decentralized', 'point', 'of', 'care', 'test', 'as', 'the', 'colloidal', 'gold', 'based', 'immunochromatographic', 'strip', 'assay', 'which', 'detects', 'IgM', 'and', 'IgG', 'antibodies', 'directed', 'against', 'SARS', 'CoV', '2', 'As', 'our', 'aim', 'is', 'to', 'evaluate', 'the', 'efficacy', 'of', 'Covid', '19', 'rapid', 'tests', 'and', 'of', 'serological', 'assays', 'in', 'real', 'life', 'settings', 'we', 'designed', 'a', 'research', 'protocol', 'aimed', 'to', 'establish', 'how', 'to', 'use', 'correctly', 'these', 'diagnostics', 'taking', 'into', 'account', 'the', 'different', 'possible', 'clinical', 'and', 'epidemiological', 'scenarios', '']"
155557,"Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions",2020-05-01,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32511352/; https://doi.org/10.1101/2020.04.20.048066,"The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused thousands of deaths worldwide, including >18,000 in New York City (NYC) alone. The sudden emergence of this pandemic has highlighted a pressing clinical need for rapid, scalable diagnostics that can detect infection, interrogate strain evolution, and identify novel patient biomarkers. To address these challenges, we designed a fast (30-minute) colorimetric test (LAMP) for SARS-CoV-2 infection from naso/oropharyngeal swabs, plus a large-scale shotgun metatranscriptomics platform (total-RNA-seq) for host, bacterial, and viral profiling. We applied both technologies across 857 SARS-CoV-2 clinical specimens and 86 NYC subway samples, providing a broad molecular portrait of the COVID-19 NYC outbreak. Our results define new features of SARS-CoV-2 evolution, nominate a novel, NYC-enriched viral subclade, reveal specific host responses in interferon, ACE, hematological, and olfaction pathways, and examine risks associated with use of ACE inhibitors and angiotensin receptor blockers. Together, these findings have immediate applications to SARS-CoV-2 diagnostics, public health, and new therapeutic targets.",10.1101/2020.04.20.048066,kyoa5gsf,"['The', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'Coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'caused', 'thousands', 'of', 'deaths', 'worldwide', 'including', '18', '000', 'in', 'New', 'York', 'City', 'NYC', 'alone', 'The', 'sudden', 'emergence', 'of', 'this', 'pandemic', 'has', 'highlighted', 'a', 'pressing', 'clinical', 'need', 'for', 'rapid', 'scalable', 'diagnostics', 'that', 'can', 'detect', 'infection', 'interrogate', 'strain', 'evolution', 'and', 'identify', 'novel', 'patient', 'biomarkers', 'To', 'address', 'these', 'challenges', 'we', 'designed', 'a', 'fast', '30', 'minute', 'colorimetric', 'test', 'LAMP', 'for', 'SARS', 'CoV', '2', 'infection', 'from', 'naso', 'oropharyngeal', 'swabs', 'plus', 'a', 'large', 'scale', 'shotgun', 'metatranscriptomics', 'platform', 'total', 'RNA', 'seq', 'for', 'host', 'bacterial', 'and', 'viral', 'profiling', 'We', 'applied', 'both', 'technologies', 'across', '857', 'SARS', 'CoV', '2', 'clinical', 'specimens', 'and', '86', 'NYC', 'subway', 'samples', 'providing', 'a', 'broad', 'molecular', 'portrait', 'of', 'the', 'COVID', '19', 'NYC', 'outbreak', 'Our', 'results', 'define', 'new', 'features', 'of', 'SARS', 'CoV', '2', 'evolution', 'nominate', 'a', 'novel', 'NYC', 'enriched', 'viral', 'subclade', 'reveal', 'specific', 'host', 'responses', 'in', 'interferon', 'ACE', 'hematological', 'and', 'olfaction', 'pathways', 'and', 'examine', 'risks', 'associated', 'with', 'use', 'of', 'ACE', 'inhibitors', 'and', 'angiotensin', 'receptor', 'blockers', 'Together', 'these', 'findings', 'have', 'immediate', 'applications', 'to', 'SARS', 'CoV', '2', 'diagnostics', 'public', 'health', 'and', 'new', 'therapeutic', 'targets', '']"
155678,Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics,2018-12-04,Chem Rev,https://www.ncbi.nlm.nih.gov/pubmed/30511833/; https://doi.org/10.1021/acs.chemrev.8b00136,"[Image: see text] Infectious diseases claim millions of lives each year. Robust and accurate diagnostics are essential tools for identifying those who are at risk and in need of treatment in low-resource settings. Inorganic complexes and metal-based nanomaterials continue to drive the development of diagnostic platforms and strategies that enable infectious disease detection in low-resource settings. In this review, we highlight works from the past 20 years in which inorganic chemistry and nanotechnology were implemented in each of the core components that make up a diagnostic test. First, we present how inorganic biomarkers and their properties are leveraged for infectious disease detection. In the following section, we detail metal-based technologies that have been employed for sample preparation and biomarker isolation from sample matrices. We then describe how inorganic- and nanomaterial-based probes have been utilized in point-of-care diagnostics for signal generation. The following section discusses instrumentation for signal readout in resource-limited settings. Next, we highlight the detection of nucleic acids at the point of care as an emerging application of inorganic chemistry. Lastly, we consider the challenges that remain for translation of the aforementioned diagnostic platforms to low-resource settings.",10.1021/acs.chemrev.8b00136,dc90ecfe,"['', 'Image', 'see', 'text', 'Infectious', 'diseases', 'claim', 'millions', 'of', 'lives', 'each', 'year', 'Robust', 'and', 'accurate', 'diagnostics', 'are', 'essential', 'tools', 'for', 'identifying', 'those', 'who', 'are', 'at', 'risk', 'and', 'in', 'need', 'of', 'treatment', 'in', 'low', 'resource', 'settings', 'Inorganic', 'complexes', 'and', 'metal', 'based', 'nanomaterials', 'continue', 'to', 'drive', 'the', 'development', 'of', 'diagnostic', 'platforms', 'and', 'strategies', 'that', 'enable', 'infectious', 'disease', 'detection', 'in', 'low', 'resource', 'settings', 'In', 'this', 'review', 'we', 'highlight', 'works', 'from', 'the', 'past', '20', 'years', 'in', 'which', 'inorganic', 'chemistry', 'and', 'nanotechnology', 'were', 'implemented', 'in', 'each', 'of', 'the', 'core', 'components', 'that', 'make', 'up', 'a', 'diagnostic', 'test', 'First', 'we', 'present', 'how', 'inorganic', 'biomarkers', 'and', 'their', 'properties', 'are', 'leveraged', 'for', 'infectious', 'disease', 'detection', 'In', 'the', 'following', 'section', 'we', 'detail', 'metal', 'based', 'technologies', 'that', 'have', 'been', 'employed', 'for', 'sample', 'preparation', 'and', 'biomarker', 'isolation', 'from', 'sample', 'matrices', 'We', 'then', 'describe', 'how', 'inorganic', 'and', 'nanomaterial', 'based', 'probes', 'have', 'been', 'utilized', 'in', 'point', 'of', 'care', 'diagnostics', 'for', 'signal', 'generation', 'The', 'following', 'section', 'discusses', 'instrumentation', 'for', 'signal', 'readout', 'in', 'resource', 'limited', 'settings', 'Next', 'we', 'highlight', 'the', 'detection', 'of', 'nucleic', 'acids', 'at', 'the', 'point', 'of', 'care', 'as', 'an', 'emerging', 'application', 'of', 'inorganic', 'chemistry', 'Lastly', 'we', 'consider', 'the', 'challenges', 'that', 'remain', 'for', 'translation', 'of', 'the', 'aforementioned', 'diagnostic', 'platforms', 'to', 'low', 'resource', 'settings', '']"
155812,Leveraging open hardware to alleviate the burden of COVID-19 on global health systems,2020-04-24,PLoS Biol,https://doi.org/10.1371/journal.pbio.3000730; https://www.ncbi.nlm.nih.gov/pubmed/32330124/,"With the current rapid spread of COVID-19, global health systems are increasingly overburdened by the sheer number of people that need diagnosis, isolation and treatment. Shortcomings are evident across the board, from staffing, facilities for rapid and reliable testing to availability of hospital beds and key medical-grade equipment. The scale and breadth of the problem calls for an equally substantive response not only from frontline workers such as medical staff and scientists, but from skilled members of the public who have the time, facilities and knowledge to meaningfully contribute to a consolidated global response. Here, we summarise community-driven approaches based on Free and Open Source scientific and medical Hardware (FOSH) as well as personal protective equipment (PPE) currently being developed and deployed to support the global response for COVID-19 prevention, patient treatment and diagnostics.",10.1371/journal.pbio.3000730,wxqly479,"['With', 'the', 'current', 'rapid', 'spread', 'of', 'COVID', '19', 'global', 'health', 'systems', 'are', 'increasingly', 'overburdened', 'by', 'the', 'sheer', 'number', 'of', 'people', 'that', 'need', 'diagnosis', 'isolation', 'and', 'treatment', 'Shortcomings', 'are', 'evident', 'across', 'the', 'board', 'from', 'staffing', 'facilities', 'for', 'rapid', 'and', 'reliable', 'testing', 'to', 'availability', 'of', 'hospital', 'beds', 'and', 'key', 'medical', 'grade', 'equipment', 'The', 'scale', 'and', 'breadth', 'of', 'the', 'problem', 'calls', 'for', 'an', 'equally', 'substantive', 'response', 'not', 'only', 'from', 'frontline', 'workers', 'such', 'as', 'medical', 'staff', 'and', 'scientists', 'but', 'from', 'skilled', 'members', 'of', 'the', 'public', 'who', 'have', 'the', 'time', 'facilities', 'and', 'knowledge', 'to', 'meaningfully', 'contribute', 'to', 'a', 'consolidated', 'global', 'response', 'Here', 'we', 'summarise', 'community', 'driven', 'approaches', 'based', 'on', 'Free', 'and', 'Open', 'Source', 'scientific', 'and', 'medical', 'Hardware', 'FOSH', 'as', 'well', 'as', 'personal', 'protective', 'equipment', 'PPE', 'currently', 'being', 'developed', 'and', 'deployed', 'to', 'support', 'the', 'global', 'response', 'for', 'COVID', '19', 'prevention', 'patient', 'treatment', 'and', 'diagnostics', '']"
155849,Cross sectional and longitudinal surveys of canine enteric coronavirus infection in kennelled dogs: A molecular marker for biosecurity,2012-04-21,Infect Genet Evol,https://doi.org/10.1016/j.meegid.2012.04.010; https://api.elsevier.com/content/article/pii/S1567134812001426; https://www.sciencedirect.com/science/article/pii/S1567134812001426; https://www.ncbi.nlm.nih.gov/pubmed/22543007/,"Previous studies have suggested that kennelled dogs are more likely to test positive for CECoV than household pets. Here we describe both cross sectional and longitudinal studies in two rescue kennels and two boarding kennels, together with molecular diagnostics, to provide a new insight into the epidemiology of CECoV. Prevalence of CECoV in the cross sectional studies tended to be higher in the rescue kennels (13.8% and 33.3%) than the boarding kennels (5.3% and 13.5%). In each kennel, type I CECoV was more prevalent than type 2 CECoV. The mean quantity of type I detected was equivalent to 6.3 × 10(8) gc/gm (range = 5 × 10(6), 8.5 × 10(11)), compared to 1.3 × 10(8) gc/gm (range = 3 × 10(6), 2.4 × 10(10)) for type II. In one rescue shelter where dogs were followed longitudinally, infection was significantly associated with accommodation block as well as the length of stay (increased risk of CECoV per week in residence of ×1.9). Of those animals sampled on two or more occasions, none tested positive on arrival, and 54.5% later shed CECoV, suggesting that infection may have been acquired within the kennel. Shedding patterns and sequence analysis suggested both types I and II CECoV were maintained in this population by a combination of introductions into the shelter and within-shelter transmission. The findings suggest that some kennel environments may be important in maintaining CECoV infection in the population. We also propose that the diversity of viruses like CECoV in these populations may provide a novel surrogate marker for the success of biosecurity.",10.1016/j.meegid.2012.04.010,slyzg73q,"['Previous', 'studies', 'have', 'suggested', 'that', 'kennelled', 'dogs', 'are', 'more', 'likely', 'to', 'test', 'positive', 'for', 'CECoV', 'than', 'household', 'pets', 'Here', 'we', 'describe', 'both', 'cross', 'sectional', 'and', 'longitudinal', 'studies', 'in', 'two', 'rescue', 'kennels', 'and', 'two', 'boarding', 'kennels', 'together', 'with', 'molecular', 'diagnostics', 'to', 'provide', 'a', 'new', 'insight', 'into', 'the', 'epidemiology', 'of', 'CECoV', 'Prevalence', 'of', 'CECoV', 'in', 'the', 'cross', 'sectional', 'studies', 'tended', 'to', 'be', 'higher', 'in', 'the', 'rescue', 'kennels', '13', '8', 'and', '33', '3', 'than', 'the', 'boarding', 'kennels', '5', '3', 'and', '13', '5', 'In', 'each', 'kennel', 'type', 'I', 'CECoV', 'was', 'more', 'prevalent', 'than', 'type', '2', 'CECoV', 'The', 'mean', 'quantity', 'of', 'type', 'I', 'detected', 'was', 'equivalent', 'to', '6', '3', '10', '8', 'gc', 'gm', 'range', '5', '10', '6', '8', '5', '10', '11', 'compared', 'to', '1', '3', '10', '8', 'gc', 'gm', 'range', '3', '10', '6', '2', '4', '10', '10', 'for', 'type', 'II', 'In', 'one', 'rescue', 'shelter', 'where', 'dogs', 'were', 'followed', 'longitudinally', 'infection', 'was', 'significantly', 'associated', 'with', 'accommodation', 'block', 'as', 'well', 'as', 'the', 'length', 'of', 'stay', 'increased', 'risk', 'of', 'CECoV', 'per', 'week', 'in', 'residence', 'of', '1', '9', 'Of', 'those', 'animals', 'sampled', 'on', 'two', 'or', 'more', 'occasions', 'none', 'tested', 'positive', 'on', 'arrival', 'and', '54', '5', 'later', 'shed', 'CECoV', 'suggesting', 'that', 'infection', 'may', 'have', 'been', 'acquired', 'within', 'the', 'kennel', 'Shedding', 'patterns', 'and', 'sequence', 'analysis', 'suggested', 'both', 'types', 'I', 'and', 'II', 'CECoV', 'were', 'maintained', 'in', 'this', 'population', 'by', 'a', 'combination', 'of', 'introductions', 'into', 'the', 'shelter', 'and', 'within', 'shelter', 'transmission', 'The', 'findings', 'suggest', 'that', 'some', 'kennel', 'environments', 'may', 'be', 'important', 'in', 'maintaining', 'CECoV', 'infection', 'in', 'the', 'population', 'We', 'also', 'propose', 'that', 'the', 'diversity', 'of', 'viruses', 'like', 'CECoV', 'in', 'these', 'populations', 'may', 'provide', 'a', 'novel', 'surrogate', 'marker', 'for', 'the', 'success', 'of', 'biosecurity', '']"
155862,"Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19",2020-05-06,medRxiv,http://medrxiv.org/cgi/content/short/2020.05.02.20082461v1?rss=1; https://doi.org/10.1101/2020.05.02.20082461; https://www.ncbi.nlm.nih.gov/pubmed/32511488/,"BACKGROUND: Emerging data on the clinical presentation, diagnostics, and outcomes of patients with COVID-19 have largely been presented as case series. Few studies have compared these clinical features and outcomes of COVID-19 to other acute respiratory illnesses. METHODS: We examined all patients presenting to an emergency department in San Francisco, California between February 3 and March 31, 2020 with an acute respiratory illness who were tested for SARS-CoV-2. We determined COVID-19 status by PCR and metagenomic next generation sequencing (mNGS). We compared demographics, comorbidities, symptoms, vital signs, and laboratory results including viral diagnostics using PCR and mNGS. Among those hospitalized, we determined differences in treatment (antibiotics, antivirals, respiratory support) and outcomes (ICU admission, ICU interventions, acute respiratory distress syndrome, cardiac injury). FINDINGS: In a cohort of 316 patients, 33 (10%) tested positive for SARS-CoV-2; 31 patients, all without COVID-19, tested positive for another respiratory virus (16%). Among patients with additional viral testing, no co-infections with SARS-CoV-2 were identified by PCR or mNGS. Patients with COVID-19 reported longer symptoms duration (median 7 vs. 3 days), and were more likely to report fever (82% vs. 44%), fatigue (85% vs. 50%), and myalgias (61% vs 27%); p<0.001 for all comparisons. Lymphopenia (55% vs 34%, p=0.018) and bilateral opacities on initial chest radiograph (55% vs. 24%, p=0.001) were more common in patients with COVID-19. Patients with COVID-19 were more often hospitalized (79% vs. 56%, p=0.014). Of 186 hospitalized patients, patients with COVID-19 had longer hospitalizations (median 10.7d vs. 4.7d, p<0.001) and were more likely to develop ARDS (23% vs. 3%, p<0.001). Most comorbidities, home medications, signs and symptoms, vital signs, laboratory results, treatment, and outcomes did not differ by COVID-19 status. INTERPRETATION: While we found differences in clinical features of COVID-19 compared to other acute respiratory illnesses, there was significant overlap in presentation and comorbidities. Patients with COVID-19 were more likely to be admitted to the hospital, have longer hospitalizations and develop ARDS, and were unlikely to have co-existent viral infections. These findings enhance understanding of the clinical characteristics of COVID-19 in comparison to other acute respiratory illnesses.",10.1101/2020.05.02.20082461,jgwqqer5,"['BACKGROUND', 'Emerging', 'data', 'on', 'the', 'clinical', 'presentation', 'diagnostics', 'and', 'outcomes', 'of', 'patients', 'with', 'COVID', '19', 'have', 'largely', 'been', 'presented', 'as', 'case', 'series', 'Few', 'studies', 'have', 'compared', 'these', 'clinical', 'features', 'and', 'outcomes', 'of', 'COVID', '19', 'to', 'other', 'acute', 'respiratory', 'illnesses', 'METHODS', 'We', 'examined', 'all', 'patients', 'presenting', 'to', 'an', 'emergency', 'department', 'in', 'San', 'Francisco', 'California', 'between', 'February', '3', 'and', 'March', '31', '2020', 'with', 'an', 'acute', 'respiratory', 'illness', 'who', 'were', 'tested', 'for', 'SARS', 'CoV', '2', 'We', 'determined', 'COVID', '19', 'status', 'by', 'PCR', 'and', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'We', 'compared', 'demographics', 'comorbidities', 'symptoms', 'vital', 'signs', 'and', 'laboratory', 'results', 'including', 'viral', 'diagnostics', 'using', 'PCR', 'and', 'mNGS', 'Among', 'those', 'hospitalized', 'we', 'determined', 'differences', 'in', 'treatment', 'antibiotics', 'antivirals', 'respiratory', 'support', 'and', 'outcomes', 'ICU', 'admission', 'ICU', 'interventions', 'acute', 'respiratory', 'distress', 'syndrome', 'cardiac', 'injury', 'FINDINGS', 'In', 'a', 'cohort', 'of', '316', 'patients', '33', '10', 'tested', 'positive', 'for', 'SARS', 'CoV', '2', '31', 'patients', 'all', 'without', 'COVID', '19', 'tested', 'positive', 'for', 'another', 'respiratory', 'virus', '16', 'Among', 'patients', 'with', 'additional', 'viral', 'testing', 'no', 'co', 'infections', 'with', 'SARS', 'CoV', '2', 'were', 'identified', 'by', 'PCR', 'or', 'mNGS', 'Patients', 'with', 'COVID', '19', 'reported', 'longer', 'symptoms', 'duration', 'median', '7', 'vs', '3', 'days', 'and', 'were', 'more', 'likely', 'to', 'report', 'fever', '82', 'vs', '44', 'fatigue', '85', 'vs', '50', 'and', 'myalgias', '61', 'vs', '27', 'p', '0', '001', 'for', 'all', 'comparisons', 'Lymphopenia', '55', 'vs', '34', 'p', '0', '018', 'and', 'bilateral', 'opacities', 'on', 'initial', 'chest', 'radiograph', '55', 'vs', '24', 'p', '0', '001', 'were', 'more', 'common', 'in', 'patients', 'with', 'COVID', '19', 'Patients', 'with', 'COVID', '19', 'were', 'more', 'often', 'hospitalized', '79', 'vs', '56', 'p', '0', '014', 'Of', '186', 'hospitalized', 'patients', 'patients', 'with', 'COVID', '19', 'had', 'longer', 'hospitalizations', 'median', '10', '7d', 'vs', '4', '7d', 'p', '0', '001', 'and', 'were', 'more', 'likely', 'to', 'develop', 'ARDS', '23', 'vs', '3', 'p', '0', '001', 'Most', 'comorbidities', 'home', 'medications', 'signs', 'and', 'symptoms', 'vital', 'signs', 'laboratory', 'results', 'treatment', 'and', 'outcomes', 'did', 'not', 'differ', 'by', 'COVID', '19', 'status', 'INTERPRETATION', 'While', 'we', 'found', 'differences', 'in', 'clinical', 'features', 'of', 'COVID', '19', 'compared', 'to', 'other', 'acute', 'respiratory', 'illnesses', 'there', 'was', 'significant', 'overlap', 'in', 'presentation', 'and', 'comorbidities', 'Patients', 'with', 'COVID', '19', 'were', 'more', 'likely', 'to', 'be', 'admitted', 'to', 'the', 'hospital', 'have', 'longer', 'hospitalizations', 'and', 'develop', 'ARDS', 'and', 'were', 'unlikely', 'to', 'have', 'co', 'existent', 'viral', 'infections', 'These', 'findings', 'enhance', 'understanding', 'of', 'the', 'clinical', 'characteristics', 'of', 'COVID', '19', 'in', 'comparison', 'to', 'other', 'acute', 'respiratory', 'illnesses', '']"
156228,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020-03-13,Science,https://www.ncbi.nlm.nih.gov/pubmed/32075877/; https://doi.org/10.1126/science.abb2507,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo–electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",10.1126/science.abb2507,vp96izcs,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
156642,History and Future of Nucleic Acid Amplification Technology Blood Donor Testing,2019-01-01,Transfusion Medicine and Hemotherapy,https://www.ncbi.nlm.nih.gov/pubmed/31191192/; https://doi.org/10.1159/000496749,"The introduction of blood donor screening by virus nucleic acid amplification technology (NAT) in the mid to late 1990s was driven by the so-called AIDS and hepatitis C virus (HCV) epidemic, with thousands of recipients of infected blood products and components. Plasma fractionators were the first to introduce NAT testing besides pathogen reduction procedures, to reduce the virus transmission risk through their products. To achieve a similar safety standard, NAT was then also introduced for labile blood components. German transfusion centres were the first to start in-house NAT testing of their donations in pools of up to 96 samples for HCV, hepatitis B virus (HBV), and human immunodeficiency virus-1 (HIV-1). Years later the diagnostics industry provided commercial HCV and HIV-1 and later HBV NAT tests on automated platforms. NAT tests for HIV-2, hepatitis A virus, and Parvovirus B19 followed, again driven by transfusion centres with their in-house tests. When severe acute respiratory syndrome corona virus (SARS-CoV) and West Nile Virus emerged it was the NAT that enabled the manufacturers and transfusion centres to instantly introduce sensitive and specific screening tests. Subsequent automation including sample preparation has significantly reduced the costs and complexity of the procedure and made it affordable to middle income countries as well. Currently more than 60 million donations per year are NAT tested worldwide and the remaining residual risk of virus transmission by blood components and products could be reduced to almost zero. Automation rendered possible the reduction of pool size in conjunction with increased throughput and sensitivity. Thus, antibody and antigen testing may be dispensable in the long run, particularly in the combination of NAT testing with pathogen reduction. There are new technologies on the horizon like digital droplet PCR, next-generation sequencing, lab-on-a-chip, and digital antigen assays, which are comparably sensitive. However, each of these has limitations, either in throughput, costs, automation, time to result, specificity, or the need for NAT as an integral part of the technology. Thus, NAT is still the shortest and most efficient means to the result. Donor screening NAT also contributed significantly to our knowledge on how fast viruses replicate, and on the respective diagnostic window. In conjunction with animal and patient studies, we have learned more about the minimal infectious dose and the epidemics in the donor population.",10.1159/000496749,q23zf9mj,"['The', 'introduction', 'of', 'blood', 'donor', 'screening', 'by', 'virus', 'nucleic', 'acid', 'amplification', 'technology', 'NAT', 'in', 'the', 'mid', 'to', 'late', '1990s', 'was', 'driven', 'by', 'the', 'so', 'called', 'AIDS', 'and', 'hepatitis', 'C', 'virus', 'HCV', 'epidemic', 'with', 'thousands', 'of', 'recipients', 'of', 'infected', 'blood', 'products', 'and', 'components', 'Plasma', 'fractionators', 'were', 'the', 'first', 'to', 'introduce', 'NAT', 'testing', 'besides', 'pathogen', 'reduction', 'procedures', 'to', 'reduce', 'the', 'virus', 'transmission', 'risk', 'through', 'their', 'products', 'To', 'achieve', 'a', 'similar', 'safety', 'standard', 'NAT', 'was', 'then', 'also', 'introduced', 'for', 'labile', 'blood', 'components', 'German', 'transfusion', 'centres', 'were', 'the', 'first', 'to', 'start', 'in', 'house', 'NAT', 'testing', 'of', 'their', 'donations', 'in', 'pools', 'of', 'up', 'to', '96', 'samples', 'for', 'HCV', 'hepatitis', 'B', 'virus', 'HBV', 'and', 'human', 'immunodeficiency', 'virus', '1', 'HIV', '1', 'Years', 'later', 'the', 'diagnostics', 'industry', 'provided', 'commercial', 'HCV', 'and', 'HIV', '1', 'and', 'later', 'HBV', 'NAT', 'tests', 'on', 'automated', 'platforms', 'NAT', 'tests', 'for', 'HIV', '2', 'hepatitis', 'A', 'virus', 'and', 'Parvovirus', 'B19', 'followed', 'again', 'driven', 'by', 'transfusion', 'centres', 'with', 'their', 'in', 'house', 'tests', 'When', 'severe', 'acute', 'respiratory', 'syndrome', 'corona', 'virus', 'SARS', 'CoV', 'and', 'West', 'Nile', 'Virus', 'emerged', 'it', 'was', 'the', 'NAT', 'that', 'enabled', 'the', 'manufacturers', 'and', 'transfusion', 'centres', 'to', 'instantly', 'introduce', 'sensitive', 'and', 'specific', 'screening', 'tests', 'Subsequent', 'automation', 'including', 'sample', 'preparation', 'has', 'significantly', 'reduced', 'the', 'costs', 'and', 'complexity', 'of', 'the', 'procedure', 'and', 'made', 'it', 'affordable', 'to', 'middle', 'income', 'countries', 'as', 'well', 'Currently', 'more', 'than', '60', 'million', 'donations', 'per', 'year', 'are', 'NAT', 'tested', 'worldwide', 'and', 'the', 'remaining', 'residual', 'risk', 'of', 'virus', 'transmission', 'by', 'blood', 'components', 'and', 'products', 'could', 'be', 'reduced', 'to', 'almost', 'zero', 'Automation', 'rendered', 'possible', 'the', 'reduction', 'of', 'pool', 'size', 'in', 'conjunction', 'with', 'increased', 'throughput', 'and', 'sensitivity', 'Thus', 'antibody', 'and', 'antigen', 'testing', 'may', 'be', 'dispensable', 'in', 'the', 'long', 'run', 'particularly', 'in', 'the', 'combination', 'of', 'NAT', 'testing', 'with', 'pathogen', 'reduction', 'There', 'are', 'new', 'technologies', 'on', 'the', 'horizon', 'like', 'digital', 'droplet', 'PCR', 'next', 'generation', 'sequencing', 'lab', 'on', 'a', 'chip', 'and', 'digital', 'antigen', 'assays', 'which', 'are', 'comparably', 'sensitive', 'However', 'each', 'of', 'these', 'has', 'limitations', 'either', 'in', 'throughput', 'costs', 'automation', 'time', 'to', 'result', 'specificity', 'or', 'the', 'need', 'for', 'NAT', 'as', 'an', 'integral', 'part', 'of', 'the', 'technology', 'Thus', 'NAT', 'is', 'still', 'the', 'shortest', 'and', 'most', 'efficient', 'means', 'to', 'the', 'result', 'Donor', 'screening', 'NAT', 'also', 'contributed', 'significantly', 'to', 'our', 'knowledge', 'on', 'how', 'fast', 'viruses', 'replicate', 'and', 'on', 'the', 'respective', 'diagnostic', 'window', 'In', 'conjunction', 'with', 'animal', 'and', 'patient', 'studies', 'we', 'have', 'learned', 'more', 'about', 'the', 'minimal', 'infectious', 'dose', 'and', 'the', 'epidemics', 'in', 'the', 'donor', 'population', '']"
157005,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020-06-20,Int J Mol Sci,https://www.ncbi.nlm.nih.gov/pubmed/32575728/; https://doi.org/10.3390/ijms21124396,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",10.3390/ijms21124396,d65njv7b,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
157246,Unexplained diarrhoea in HIV-1 infected individuals,2014-01-13,BMC Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/24410947/; https://doi.org/10.1186/1471-2334-14-22,"BACKGROUND: Gastrointestinal symptoms, in particular diarrhoea, are common in non-treated HIV-1 infected individuals. Although various enteric pathogens have been implicated, the aetiology of diarrhoea remains unexplained in a large proportion of HIV-1 infected patients. Our aim is to identify the cause of diarrhoea for patients that remain negative in routine diagnostics. METHODS: In this study stool samples of 196 HIV-1 infected persons, including 29 persons with diarrhoea, were examined for enteropathogens and HIV-1. A search for unknown and unexpected viruses was performed using virus discovery cDNA-AFLP combined with Roche-454 sequencing (VIDISCA-454). RESULTS: HIV-1 RNA was detected in stool of 19 patients with diarrhoea (66%) compared to 75 patients (45%) without diarrhoea. In 19 of the 29 diarrhoea cases a known enteropathogen could be identified (66%). Next to these known causative agents, a range of recently identified viruses was identified via VIDISCA-454: cosavirus, Aichi virus, human gyrovirus, and non-A non-B hepatitis virus. Moreover, a novel virus was detected which was named immunodeficiency-associated stool virus (IASvirus). However, PCR based screening for these viruses showed that none of these novel viruses was associated with diarrhoea. Notably, among the 34% enteropathogen-negative cases, HIV-1 RNA shedding in stool was more frequently observed (80%) compared to enteropathogen-positive cases (47%), indicating that HIV-1 itself is the most likely candidate to be involved in diarrhoea. CONCLUSION: Unexplained diarrhoea in HIV-1 infected patients is probably not caused by recently described or previously unknown pathogens, but it is more likely that HIV-1 itself plays a role in intestinal mucosal abnormalities which leads to diarrhoea.",10.1186/1471-2334-14-22,0e9l19kp,"['BACKGROUND', 'Gastrointestinal', 'symptoms', 'in', 'particular', 'diarrhoea', 'are', 'common', 'in', 'non', 'treated', 'HIV', '1', 'infected', 'individuals', 'Although', 'various', 'enteric', 'pathogens', 'have', 'been', 'implicated', 'the', 'aetiology', 'of', 'diarrhoea', 'remains', 'unexplained', 'in', 'a', 'large', 'proportion', 'of', 'HIV', '1', 'infected', 'patients', 'Our', 'aim', 'is', 'to', 'identify', 'the', 'cause', 'of', 'diarrhoea', 'for', 'patients', 'that', 'remain', 'negative', 'in', 'routine', 'diagnostics', 'METHODS', 'In', 'this', 'study', 'stool', 'samples', 'of', '196', 'HIV', '1', 'infected', 'persons', 'including', '29', 'persons', 'with', 'diarrhoea', 'were', 'examined', 'for', 'enteropathogens', 'and', 'HIV', '1', 'A', 'search', 'for', 'unknown', 'and', 'unexpected', 'viruses', 'was', 'performed', 'using', 'virus', 'discovery', 'cDNA', 'AFLP', 'combined', 'with', 'Roche', '454', 'sequencing', 'VIDISCA', '454', 'RESULTS', 'HIV', '1', 'RNA', 'was', 'detected', 'in', 'stool', 'of', '19', 'patients', 'with', 'diarrhoea', '66', 'compared', 'to', '75', 'patients', '45', 'without', 'diarrhoea', 'In', '19', 'of', 'the', '29', 'diarrhoea', 'cases', 'a', 'known', 'enteropathogen', 'could', 'be', 'identified', '66', 'Next', 'to', 'these', 'known', 'causative', 'agents', 'a', 'range', 'of', 'recently', 'identified', 'viruses', 'was', 'identified', 'via', 'VIDISCA', '454', 'cosavirus', 'Aichi', 'virus', 'human', 'gyrovirus', 'and', 'non', 'A', 'non', 'B', 'hepatitis', 'virus', 'Moreover', 'a', 'novel', 'virus', 'was', 'detected', 'which', 'was', 'named', 'immunodeficiency', 'associated', 'stool', 'virus', 'IASvirus', 'However', 'PCR', 'based', 'screening', 'for', 'these', 'viruses', 'showed', 'that', 'none', 'of', 'these', 'novel', 'viruses', 'was', 'associated', 'with', 'diarrhoea', 'Notably', 'among', 'the', '34', 'enteropathogen', 'negative', 'cases', 'HIV', '1', 'RNA', 'shedding', 'in', 'stool', 'was', 'more', 'frequently', 'observed', '80', 'compared', 'to', 'enteropathogen', 'positive', 'cases', '47', 'indicating', 'that', 'HIV', '1', 'itself', 'is', 'the', 'most', 'likely', 'candidate', 'to', 'be', 'involved', 'in', 'diarrhoea', 'CONCLUSION', 'Unexplained', 'diarrhoea', 'in', 'HIV', '1', 'infected', 'patients', 'is', 'probably', 'not', 'caused', 'by', 'recently', 'described', 'or', 'previously', 'unknown', 'pathogens', 'but', 'it', 'is', 'more', 'likely', 'that', 'HIV', '1', 'itself', 'plays', 'a', 'role', 'in', 'intestinal', 'mucosal', 'abnormalities', 'which', 'leads', 'to', 'diarrhoea', '']"
157709,Co-Infections with Influenza and Other Respiratory Viruses,2012-06-29,Respiratory Regulation - The Molecular Approach,https://www.ncbi.nlm.nih.gov/pubmed/22836647/; https://doi.org/10.1007/978-94-007-4549-0_36,"Clinicians often do not consider the presence of more than one viral etiologic agent in respiratory infection, and in many cases they order diagnostics for influenza viruses or recently even only for A(H1N1)2009 virus. However, in a substantial number of patients with a respiratory tract disease, co-infection with various viral pathogens has been confirmed. Although the association between the occurrence of co-infection and substantially higher severity of disease is still unclear, a rapid and proper diagnostics of wide spectrum of viral respiratory pathogens reveals an accurate picture of the disease and is essential for appropriate therapeutic management and control of infection. In the present study we reported five cases of multiple respiratory infection in hospitalized immunosuppressed patients: two double infections with influenza virus (IV) type A/respiratory syncytial virus (RSV) type A and IV type A/coronavirus (CoV) OC43, one infection with four viruses – IV type A/RSV type A and B/CoV OC43, and two cases of mixed infections caused by five viral agents – IV type A and B/RSV type A and B/ parainfluenza type 3 or CoV OC43. Each patient had an underlying chronic disease and received immunosuppressive treatment. Despite a low number of tested specimens, our study shows that the inclusions of multiplex PCR methods for diagnostics of respiratory tract infections and the extension of diagnostic strategies by clinicians to detect viruses other than influenza are very important and make a contribution to identifying the true rate of co-infections and their correlation with the clinical symptoms and severity of disease.",10.1007/978-94-007-4549-0_36,zb8gphr9,"['Clinicians', 'often', 'do', 'not', 'consider', 'the', 'presence', 'of', 'more', 'than', 'one', 'viral', 'etiologic', 'agent', 'in', 'respiratory', 'infection', 'and', 'in', 'many', 'cases', 'they', 'order', 'diagnostics', 'for', 'influenza', 'viruses', 'or', 'recently', 'even', 'only', 'for', 'A', 'H1N1', '2009', 'virus', 'However', 'in', 'a', 'substantial', 'number', 'of', 'patients', 'with', 'a', 'respiratory', 'tract', 'disease', 'co', 'infection', 'with', 'various', 'viral', 'pathogens', 'has', 'been', 'confirmed', 'Although', 'the', 'association', 'between', 'the', 'occurrence', 'of', 'co', 'infection', 'and', 'substantially', 'higher', 'severity', 'of', 'disease', 'is', 'still', 'unclear', 'a', 'rapid', 'and', 'proper', 'diagnostics', 'of', 'wide', 'spectrum', 'of', 'viral', 'respiratory', 'pathogens', 'reveals', 'an', 'accurate', 'picture', 'of', 'the', 'disease', 'and', 'is', 'essential', 'for', 'appropriate', 'therapeutic', 'management', 'and', 'control', 'of', 'infection', 'In', 'the', 'present', 'study', 'we', 'reported', 'five', 'cases', 'of', 'multiple', 'respiratory', 'infection', 'in', 'hospitalized', 'immunosuppressed', 'patients', 'two', 'double', 'infections', 'with', 'influenza', 'virus', 'IV', 'type', 'A', 'respiratory', 'syncytial', 'virus', 'RSV', 'type', 'A', 'and', 'IV', 'type', 'A', 'coronavirus', 'CoV', 'OC43', 'one', 'infection', 'with', 'four', 'viruses', 'IV', 'type', 'A', 'RSV', 'type', 'A', 'and', 'B', 'CoV', 'OC43', 'and', 'two', 'cases', 'of', 'mixed', 'infections', 'caused', 'by', 'five', 'viral', 'agents', 'IV', 'type', 'A', 'and', 'B', 'RSV', 'type', 'A', 'and', 'B', 'parainfluenza', 'type', '3', 'or', 'CoV', 'OC43', 'Each', 'patient', 'had', 'an', 'underlying', 'chronic', 'disease', 'and', 'received', 'immunosuppressive', 'treatment', 'Despite', 'a', 'low', 'number', 'of', 'tested', 'specimens', 'our', 'study', 'shows', 'that', 'the', 'inclusions', 'of', 'multiplex', 'PCR', 'methods', 'for', 'diagnostics', 'of', 'respiratory', 'tract', 'infections', 'and', 'the', 'extension', 'of', 'diagnostic', 'strategies', 'by', 'clinicians', 'to', 'detect', 'viruses', 'other', 'than', 'influenza', 'are', 'very', 'important', 'and', 'make', 'a', 'contribution', 'to', 'identifying', 'the', 'true', 'rate', 'of', 'co', 'infections', 'and', 'their', 'correlation', 'with', 'the', 'clinical', 'symptoms', 'and', 'severity', 'of', 'disease', '']"
157758,Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma,2020-06-08,Clin Chim Acta,https://www.sciencedirect.com/science/article/pii/S0009898120302588?v=s5; https://doi.org/10.1016/j.cca.2020.05.047; https://api.elsevier.com/content/article/pii/S0009898120302588; https://www.ncbi.nlm.nih.gov/pubmed/32526218/,"BACKGROUND: Besides SARS-CoV-2 RT-PCR testing, serological testing is emerging as additional option in COVID-19 diagnostics. Aim of this study was to evaluate novel immunoassays for detection of SARS-CoV-2 antibodies in human plasma. METHODS: Using EDI(TM) Novel Coronavirus COVID-19 Enzyme Linked Immunosorbent Assays (ELISAs), we measured SARS-CoV-2 IgM and IgG antibodies in 64 SARS-CoV-2 RT-PCR confirmed COVID-19 patients with serial blood samples (n=104) collected at different time points from symptom onset. Blood samples from 200 healthy blood donors and 256 intensive care unit (ICU) patients collected before the COVID-19 outbreak were also used. RESULTS: The positivity rates in the COVID-19 patients were 5.9% for IgM and 2.9% for IgG ≤5 days after symptom onset; Between day 5 and day 10 the positivity rates were 37.1% for IgM and 37.1% for IgG and rose to 76.4% for IgM and 82.4% for IgG after >10-15 days. After 15-22 days the “true” positivity rates were 94.4% for IgM and 100% for IgG. The “false” positivity rates were 0.5% for IgM and 1.0% for IgG in the healthy blood donors, 1.6% for IgM and 1.2% for IgG in ICU patients. CONCLUSIONS: This study shows high “true” vs. low “false” positivity rates for the EDI(TM) SARS-CoV-2 IgM and IgG ELISAs.",10.1016/j.cca.2020.05.047,uqg2xkie,"['BACKGROUND', 'Besides', 'SARS', 'CoV', '2', 'RT', 'PCR', 'testing', 'serological', 'testing', 'is', 'emerging', 'as', 'additional', 'option', 'in', 'COVID', '19', 'diagnostics', 'Aim', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'novel', 'immunoassays', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'antibodies', 'in', 'human', 'plasma', 'METHODS', 'Using', 'EDI', 'TM', 'Novel', 'Coronavirus', 'COVID', '19', 'Enzyme', 'Linked', 'Immunosorbent', 'Assays', 'ELISAs', 'we', 'measured', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'in', '64', 'SARS', 'CoV', '2', 'RT', 'PCR', 'confirmed', 'COVID', '19', 'patients', 'with', 'serial', 'blood', 'samples', 'n', '104', 'collected', 'at', 'different', 'time', 'points', 'from', 'symptom', 'onset', 'Blood', 'samples', 'from', '200', 'healthy', 'blood', 'donors', 'and', '256', 'intensive', 'care', 'unit', 'ICU', 'patients', 'collected', 'before', 'the', 'COVID', '19', 'outbreak', 'were', 'also', 'used', 'RESULTS', 'The', 'positivity', 'rates', 'in', 'the', 'COVID', '19', 'patients', 'were', '5', '9', 'for', 'IgM', 'and', '2', '9', 'for', 'IgG', '5', 'days', 'after', 'symptom', 'onset', 'Between', 'day', '5', 'and', 'day', '10', 'the', 'positivity', 'rates', 'were', '37', '1', 'for', 'IgM', 'and', '37', '1', 'for', 'IgG', 'and', 'rose', 'to', '76', '4', 'for', 'IgM', 'and', '82', '4', 'for', 'IgG', 'after', '10', '15', 'days', 'After', '15', '22', 'days', 'the', 'true', 'positivity', 'rates', 'were', '94', '4', 'for', 'IgM', 'and', '100', 'for', 'IgG', 'The', 'false', 'positivity', 'rates', 'were', '0', '5', 'for', 'IgM', 'and', '1', '0', 'for', 'IgG', 'in', 'the', 'healthy', 'blood', 'donors', '1', '6', 'for', 'IgM', 'and', '1', '2', 'for', 'IgG', 'in', 'ICU', 'patients', 'CONCLUSIONS', 'This', 'study', 'shows', 'high', 'true', 'vs', 'low', 'false', 'positivity', 'rates', 'for', 'the', 'EDI', 'TM', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'ELISAs', '']"
157769,Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG,2020-04-29,J Clin Virol,https://doi.org/10.1016/j.jcv.2020.104394; https://api.elsevier.com/content/article/pii/S1386653220301360; https://www.ncbi.nlm.nih.gov/pubmed/32416599/; https://www.sciencedirect.com/science/article/pii/S1386653220301360?v=s5,"Abstract Background Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). Study Design Our study is the first to compare four new commercially available assays using 75 sera from patients tested positive or negative by SARS-CoV-2 PCR: the anti SARS-CoV-2 ELISA (IgG) (Euroimmun, Germany), the EDI New Coronavirus COVID-19 IgG ELISA, (Epitope diagnostics (EDI), USA), the recomWell SARS-CoV-2 IgG ELISA (Mikrogen, Germany), and the SARS-CoV-2 Virachip IgG (Viramed, Germany). Results We found a sensitivity of 86.4%, 100%, 86.4%, and 77.3% and a specificity of 96,2%, 88,7%, 100%, and 100% for the Euroimmun assay, the EDI assay, the Mikrogen assay, and the Viramed assay, respectively. Conclusions Commercially available SARS-CoV-2 IgG assays have a sufficient specificity and sensitivity for identifying individuals with past SARS-CoV-2 infection.",10.1016/j.jcv.2020.104394,peq6kyyz,"['Abstract', 'Background', 'Facing', 'the', 'ongoing', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'there', 'is', 'an', 'urgent', 'need', 'for', 'serological', 'assays', 'identifying', 'individuals', 'with', 'past', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Study', 'Design', 'Our', 'study', 'is', 'the', 'first', 'to', 'compare', 'four', 'new', 'commercially', 'available', 'assays', 'using', '75', 'sera', 'from', 'patients', 'tested', 'positive', 'or', 'negative', 'by', 'SARS', 'CoV', '2', 'PCR', 'the', 'anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Euroimmun', 'Germany', 'the', 'EDI', 'New', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Epitope', 'diagnostics', 'EDI', 'USA', 'the', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'ELISA', 'Mikrogen', 'Germany', 'and', 'the', 'SARS', 'CoV', '2', 'Virachip', 'IgG', 'Viramed', 'Germany', 'Results', 'We', 'found', 'a', 'sensitivity', 'of', '86', '4', '100', '86', '4', 'and', '77', '3', 'and', 'a', 'specificity', 'of', '96', '2', '88', '7', '100', 'and', '100', 'for', 'the', 'Euroimmun', 'assay', 'the', 'EDI', 'assay', 'the', 'Mikrogen', 'assay', 'and', 'the', 'Viramed', 'assay', 'respectively', 'Conclusions', 'Commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'assays', 'have', 'a', 'sufficient', 'specificity', 'and', 'sensitivity', 'for', 'identifying', 'individuals', 'with', 'past', 'SARS', 'CoV', '2', 'infection', '']"
157851,Respiratory virus surveillance and outbreak investigation,2007-10-31,Journal of Clinical Virology,https://api.elsevier.com/content/article/pii/S1386653207700069; https://www.sciencedirect.com/science/article/pii/S1386653207700069; https://doi.org/10.1016/s1386-6532(07)70006-9; https://www.ncbi.nlm.nih.gov/pubmed/18162251/,"Abstract Sensitive, rapid detection of respiratory viruses is needed for surveillance and for investigation of epidemiologically linked cases. The utility of rapid antigen-based methods for detection of common respiratory viruses and to confirm the cause of outbreaks is well established. However, nucleic acid amplification tests (NATs) offer some benefits above antigen or culture-based procedures, with the main advantages being sensitivity and range of pathogens detectable. It is important to understand how changes in our testing methodology alter respiratory virus detection and information for epidemiological studies. For viruses such as influenza A, influenza B and respiratory syncytial virus, NATs offer enhanced sensitivity above antigen assays but still identify the seasonal peaks important for predicting disease and managing time-sensitive prophylaxis. For other viruses, such as rhinoviruses, coronaviruses, human bocavirus and parainfluenza virus type 4, culture and antigen-based procedures are not available and/or lack sensitivity. Thus such targets would be missed if NATs were not included in testing for surveillance and outbreak investigation. As more respiratory viruses are identified there is a need to expand surveillance and further evaluate new technologies and automation beyond currently-available diagnostics to address detection of a broad range of potential pathogens.",10.1016/s1386-6532(07)70006-9,zgltws0c,"['Abstract', 'Sensitive', 'rapid', 'detection', 'of', 'respiratory', 'viruses', 'is', 'needed', 'for', 'surveillance', 'and', 'for', 'investigation', 'of', 'epidemiologically', 'linked', 'cases', 'The', 'utility', 'of', 'rapid', 'antigen', 'based', 'methods', 'for', 'detection', 'of', 'common', 'respiratory', 'viruses', 'and', 'to', 'confirm', 'the', 'cause', 'of', 'outbreaks', 'is', 'well', 'established', 'However', 'nucleic', 'acid', 'amplification', 'tests', 'NATs', 'offer', 'some', 'benefits', 'above', 'antigen', 'or', 'culture', 'based', 'procedures', 'with', 'the', 'main', 'advantages', 'being', 'sensitivity', 'and', 'range', 'of', 'pathogens', 'detectable', 'It', 'is', 'important', 'to', 'understand', 'how', 'changes', 'in', 'our', 'testing', 'methodology', 'alter', 'respiratory', 'virus', 'detection', 'and', 'information', 'for', 'epidemiological', 'studies', 'For', 'viruses', 'such', 'as', 'influenza', 'A', 'influenza', 'B', 'and', 'respiratory', 'syncytial', 'virus', 'NATs', 'offer', 'enhanced', 'sensitivity', 'above', 'antigen', 'assays', 'but', 'still', 'identify', 'the', 'seasonal', 'peaks', 'important', 'for', 'predicting', 'disease', 'and', 'managing', 'time', 'sensitive', 'prophylaxis', 'For', 'other', 'viruses', 'such', 'as', 'rhinoviruses', 'coronaviruses', 'human', 'bocavirus', 'and', 'parainfluenza', 'virus', 'type', '4', 'culture', 'and', 'antigen', 'based', 'procedures', 'are', 'not', 'available', 'and', 'or', 'lack', 'sensitivity', 'Thus', 'such', 'targets', 'would', 'be', 'missed', 'if', 'NATs', 'were', 'not', 'included', 'in', 'testing', 'for', 'surveillance', 'and', 'outbreak', 'investigation', 'As', 'more', 'respiratory', 'viruses', 'are', 'identified', 'there', 'is', 'a', 'need', 'to', 'expand', 'surveillance', 'and', 'further', 'evaluate', 'new', 'technologies', 'and', 'automation', 'beyond', 'currently', 'available', 'diagnostics', 'to', 'address', 'detection', 'of', 'a', 'broad', 'range', 'of', 'potential', 'pathogens', '']"
158521,Identification and characterization of unrecognized viruses in stool samples of non-polio acute flaccid paralysis children by simplified VIDISCA,2014-08-12,Virol J,https://doi.org/10.1186/1743-422x-11-146; https://www.ncbi.nlm.nih.gov/pubmed/25112200/,"BACKGROUND: The use of sequence independent methods combined with next generation sequencing for identification purposes in clinical samples appears promising and exciting results have been achieved to understand unexplained infections. One sequence independent method, Virus Discovery based on cDNA Amplified Fragment Length Polymorphism (VIDISCA) is capable of identifying viruses that would have remained unidentified in standard diagnostics or cell cultures. METHODS: VIDISCA is normally combined with next generation sequencing, however, we set up a simplified VIDISCA which can be used in case next generation sequencing is not possible. Stool samples of 10 patients with unexplained acute flaccid paralysis showing cytopathic effect in rhabdomyosarcoma cells and/or mouse cells were used to test the efficiency of this method. To further characterize the viruses, VIDISCA-positive samples were amplified and sequenced with gene specific primers. RESULTS: Simplified VIDISCA detected seven viruses (70%) and the proportion of eukaryotic viral sequences from each sample ranged from 8.3 to 45.8%. Human enterovirus EV-B97, EV-B100, echovirus-9 and echovirus-21, human parechovirus type-3, human astrovirus probably a type-3/5 recombinant, and tetnovirus-1 were identified. Phylogenetic analysis based on the VP1 region demonstrated that the human enteroviruses are more divergent isolates circulating in the community. CONCLUSION: Our data support that a simplified VIDISCA protocol can efficiently identify unrecognized viruses grown in cell culture with low cost, limited time without need of advanced technical expertise. Also complex data interpretation is avoided thus the method can be used as a powerful diagnostic tool in limited resources. Redesigning the routine diagnostics might lead to additional detection of previously undiagnosed viruses in clinical samples of patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-422X-11-146) contains supplementary material, which is available to authorized users.",10.1186/1743-422x-11-146,b9shffb3,"['BACKGROUND', 'The', 'use', 'of', 'sequence', 'independent', 'methods', 'combined', 'with', 'next', 'generation', 'sequencing', 'for', 'identification', 'purposes', 'in', 'clinical', 'samples', 'appears', 'promising', 'and', 'exciting', 'results', 'have', 'been', 'achieved', 'to', 'understand', 'unexplained', 'infections', 'One', 'sequence', 'independent', 'method', 'Virus', 'Discovery', 'based', 'on', 'cDNA', 'Amplified', 'Fragment', 'Length', 'Polymorphism', 'VIDISCA', 'is', 'capable', 'of', 'identifying', 'viruses', 'that', 'would', 'have', 'remained', 'unidentified', 'in', 'standard', 'diagnostics', 'or', 'cell', 'cultures', 'METHODS', 'VIDISCA', 'is', 'normally', 'combined', 'with', 'next', 'generation', 'sequencing', 'however', 'we', 'set', 'up', 'a', 'simplified', 'VIDISCA', 'which', 'can', 'be', 'used', 'in', 'case', 'next', 'generation', 'sequencing', 'is', 'not', 'possible', 'Stool', 'samples', 'of', '10', 'patients', 'with', 'unexplained', 'acute', 'flaccid', 'paralysis', 'showing', 'cytopathic', 'effect', 'in', 'rhabdomyosarcoma', 'cells', 'and', 'or', 'mouse', 'cells', 'were', 'used', 'to', 'test', 'the', 'efficiency', 'of', 'this', 'method', 'To', 'further', 'characterize', 'the', 'viruses', 'VIDISCA', 'positive', 'samples', 'were', 'amplified', 'and', 'sequenced', 'with', 'gene', 'specific', 'primers', 'RESULTS', 'Simplified', 'VIDISCA', 'detected', 'seven', 'viruses', '70', 'and', 'the', 'proportion', 'of', 'eukaryotic', 'viral', 'sequences', 'from', 'each', 'sample', 'ranged', 'from', '8', '3', 'to', '45', '8', 'Human', 'enterovirus', 'EV', 'B97', 'EV', 'B100', 'echovirus', '9', 'and', 'echovirus', '21', 'human', 'parechovirus', 'type', '3', 'human', 'astrovirus', 'probably', 'a', 'type', '3', '5', 'recombinant', 'and', 'tetnovirus', '1', 'were', 'identified', 'Phylogenetic', 'analysis', 'based', 'on', 'the', 'VP1', 'region', 'demonstrated', 'that', 'the', 'human', 'enteroviruses', 'are', 'more', 'divergent', 'isolates', 'circulating', 'in', 'the', 'community', 'CONCLUSION', 'Our', 'data', 'support', 'that', 'a', 'simplified', 'VIDISCA', 'protocol', 'can', 'efficiently', 'identify', 'unrecognized', 'viruses', 'grown', 'in', 'cell', 'culture', 'with', 'low', 'cost', 'limited', 'time', 'without', 'need', 'of', 'advanced', 'technical', 'expertise', 'Also', 'complex', 'data', 'interpretation', 'is', 'avoided', 'thus', 'the', 'method', 'can', 'be', 'used', 'as', 'a', 'powerful', 'diagnostic', 'tool', 'in', 'limited', 'resources', 'Redesigning', 'the', 'routine', 'diagnostics', 'might', 'lead', 'to', 'additional', 'detection', 'of', 'previously', 'undiagnosed', 'viruses', 'in', 'clinical', 'samples', 'of', 'patients', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1186', '1743', '422X', '11', '146', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
158588,Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?,2020-04-28,Cell Immunol,https://doi.org/10.1016/j.cellimm.2020.104114; https://www.ncbi.nlm.nih.gov/pubmed/32361409/; https://www.sciencedirect.com/science/article/pii/S0008874920302501?v=s5; https://api.elsevier.com/content/article/pii/S0008874920302501,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a severe acute respiratory syndrome that is called COVID-19. Clinical manifestations of COVID-19 include diarrhea, pneumonia, lymphopenia, exhausted lymphocytes, and pro-inflammatory cytokine production. Immunology is part of the process of clinical evolution, but there are some questions around immunity-based protection: (1) why some infected people have only mild symptoms of the disease or are asymptomatic; (2) why delayed and weak antibody responses are associated with severe outcomes; and (3) why positivity in molecular tests does not represent protective antibody IgG. Perhaps T cell responses may be the key to solving those questions. SARS-CoV-2-specific memory T cells persist in peripheral blood and may be capable of providing effective information about protective immunity. The T cells studies can be helpful in elucidating the pathways for development of vaccines, therapies, and diagnostics for COVID-19 and for filling these immunology knowledge gaps.",10.1016/j.cellimm.2020.104114,rsz7ch2a,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'induces', 'a', 'severe', 'acute', 'respiratory', 'syndrome', 'that', 'is', 'called', 'COVID', '19', 'Clinical', 'manifestations', 'of', 'COVID', '19', 'include', 'diarrhea', 'pneumonia', 'lymphopenia', 'exhausted', 'lymphocytes', 'and', 'pro', 'inflammatory', 'cytokine', 'production', 'Immunology', 'is', 'part', 'of', 'the', 'process', 'of', 'clinical', 'evolution', 'but', 'there', 'are', 'some', 'questions', 'around', 'immunity', 'based', 'protection', '1', 'why', 'some', 'infected', 'people', 'have', 'only', 'mild', 'symptoms', 'of', 'the', 'disease', 'or', 'are', 'asymptomatic', '2', 'why', 'delayed', 'and', 'weak', 'antibody', 'responses', 'are', 'associated', 'with', 'severe', 'outcomes', 'and', '3', 'why', 'positivity', 'in', 'molecular', 'tests', 'does', 'not', 'represent', 'protective', 'antibody', 'IgG', 'Perhaps', 'T', 'cell', 'responses', 'may', 'be', 'the', 'key', 'to', 'solving', 'those', 'questions', 'SARS', 'CoV', '2', 'specific', 'memory', 'T', 'cells', 'persist', 'in', 'peripheral', 'blood', 'and', 'may', 'be', 'capable', 'of', 'providing', 'effective', 'information', 'about', 'protective', 'immunity', 'The', 'T', 'cells', 'studies', 'can', 'be', 'helpful', 'in', 'elucidating', 'the', 'pathways', 'for', 'development', 'of', 'vaccines', 'therapies', 'and', 'diagnostics', 'for', 'COVID', '19', 'and', 'for', 'filling', 'these', 'immunology', 'knowledge', 'gaps', '']"
158643,"Better Tests, Better Care: Improved Diagnostics for Infectious Diseases",2013-11-06,Clinical Infectious Diseases,https://www.ncbi.nlm.nih.gov/pubmed/24200831/; https://academic.oup.com/cid/article-pdf/57/suppl_3/S139/20911343/cit578.pdf; https://doi.org/10.1093/cid/cit578,"In this IDSA policy paper, we review the current diagnostic landscape, including unmet needs and emerging technologies, and assess the challenges to the development and clinical integration of improved tests. To fulfill the promise of emerging diagnostics, IDSA presents recommendations that address a host of identified barriers. Achieving these goals will require the engagement and coordination of a number of stakeholders, including Congress, funding and regulatory bodies, public health agencies, the diagnostics industry, healthcare systems, professional societies, and individual clinicians.",10.1093/cid/cit578,6x3l453f,"['In', 'this', 'IDSA', 'policy', 'paper', 'we', 'review', 'the', 'current', 'diagnostic', 'landscape', 'including', 'unmet', 'needs', 'and', 'emerging', 'technologies', 'and', 'assess', 'the', 'challenges', 'to', 'the', 'development', 'and', 'clinical', 'integration', 'of', 'improved', 'tests', 'To', 'fulfill', 'the', 'promise', 'of', 'emerging', 'diagnostics', 'IDSA', 'presents', 'recommendations', 'that', 'address', 'a', 'host', 'of', 'identified', 'barriers', 'Achieving', 'these', 'goals', 'will', 'require', 'the', 'engagement', 'and', 'coordination', 'of', 'a', 'number', 'of', 'stakeholders', 'including', 'Congress', 'funding', 'and', 'regulatory', 'bodies', 'public', 'health', 'agencies', 'the', 'diagnostics', 'industry', 'healthcare', 'systems', 'professional', 'societies', 'and', 'individual', 'clinicians', '']"
159192,Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children,2016-12-07,Clinical Infectious Diseases,https://doi.org/10.1093/cid/ciw756; https://www.ncbi.nlm.nih.gov/pubmed/27927871/; https://academic.oup.com/cid/article-pdf/64/4/443/13803872/ciw756.pdf,"BACKGROUND: Molecular diagnostics enable sensitive detection of respiratory viruses, but their clinical significance remains unclear in pediatric lower respiratory tract infection (LRTI). We aimed to determine whether viral coinfections increased life-threatening disease in a large cohort. METHODS: Molecular testing was performed for respiratory viruses in nasopharyngeal aspirates collected from children aged <5 years within 24 hours of hospital admission during sentinel surveillance for severe acute respiratory illness (SARI) hospitalization conducted in South Africa during February 2009–December 2013. The primary outcome was life-threatening disease, defined as mechanical ventilation, intensive care unit admission, or death. RESULTS: Of 2322 HIV-uninfected children with respiratory syncytial virus (RSV)–associated LRTI, 1330 (57.3%) had RSV monoinfection, 38 (1.6%) had life-threatening disease, 575 (24.8%) had rhinovirus, 347 (14.9%) had adenovirus (ADV), and 30 (1.3%) had influenza virus. RSV and any other viral coinfection was not associated with severe disease (odds ratio [OR], 1.4; 95% confidence interval [CI], OR, 0.74; 95% CI, .39–1.4), ADV coinfection had increased odds of life-threatening disease (adjusted OR, 3.4; 95% CI, 1.6–7.2; P = .001), and influenza coinfection had increased odds of life-threatening disease and prolonged length of stay (adjusted OR, 2.1; 95% CI, 1.0–4.5; P = .05) compared with RSV monoinfection. CONCLUSIONS: RSV coinfection with any respiratory virus is not associated with more severe disease when compared to RSV alone in this study. However, increased life-threatening disease in RSV-ADV and RSV-influenza coinfection warrants further study.",10.1093/cid/ciw756,i61aeuww,"['BACKGROUND', 'Molecular', 'diagnostics', 'enable', 'sensitive', 'detection', 'of', 'respiratory', 'viruses', 'but', 'their', 'clinical', 'significance', 'remains', 'unclear', 'in', 'pediatric', 'lower', 'respiratory', 'tract', 'infection', 'LRTI', 'We', 'aimed', 'to', 'determine', 'whether', 'viral', 'coinfections', 'increased', 'life', 'threatening', 'disease', 'in', 'a', 'large', 'cohort', 'METHODS', 'Molecular', 'testing', 'was', 'performed', 'for', 'respiratory', 'viruses', 'in', 'nasopharyngeal', 'aspirates', 'collected', 'from', 'children', 'aged', '5', 'years', 'within', '24', 'hours', 'of', 'hospital', 'admission', 'during', 'sentinel', 'surveillance', 'for', 'severe', 'acute', 'respiratory', 'illness', 'SARI', 'hospitalization', 'conducted', 'in', 'South', 'Africa', 'during', 'February', '2009', 'December', '2013', 'The', 'primary', 'outcome', 'was', 'life', 'threatening', 'disease', 'defined', 'as', 'mechanical', 'ventilation', 'intensive', 'care', 'unit', 'admission', 'or', 'death', 'RESULTS', 'Of', '2322', 'HIV', 'uninfected', 'children', 'with', 'respiratory', 'syncytial', 'virus', 'RSV', 'associated', 'LRTI', '1330', '57', '3', 'had', 'RSV', 'monoinfection', '38', '1', '6', 'had', 'life', 'threatening', 'disease', '575', '24', '8', 'had', 'rhinovirus', '347', '14', '9', 'had', 'adenovirus', 'ADV', 'and', '30', '1', '3', 'had', 'influenza', 'virus', 'RSV', 'and', 'any', 'other', 'viral', 'coinfection', 'was', 'not', 'associated', 'with', 'severe', 'disease', 'odds', 'ratio', 'OR', '1', '4', '95', 'confidence', 'interval', 'CI', 'OR', '0', '74', '95', 'CI', '39', '1', '4', 'ADV', 'coinfection', 'had', 'increased', 'odds', 'of', 'life', 'threatening', 'disease', 'adjusted', 'OR', '3', '4', '95', 'CI', '1', '6', '7', '2', 'P', '001', 'and', 'influenza', 'coinfection', 'had', 'increased', 'odds', 'of', 'life', 'threatening', 'disease', 'and', 'prolonged', 'length', 'of', 'stay', 'adjusted', 'OR', '2', '1', '95', 'CI', '1', '0', '4', '5', 'P', '05', 'compared', 'with', 'RSV', 'monoinfection', 'CONCLUSIONS', 'RSV', 'coinfection', 'with', 'any', 'respiratory', 'virus', 'is', 'not', 'associated', 'with', 'more', 'severe', 'disease', 'when', 'compared', 'to', 'RSV', 'alone', 'in', 'this', 'study', 'However', 'increased', 'life', 'threatening', 'disease', 'in', 'RSV', 'ADV', 'and', 'RSV', 'influenza', 'coinfection', 'warrants', 'further', 'study', '']"
159254,Current Trends in Diagnostics of Viral Infections of Unknown Etiology,2020-02-14,Viruses,https://doi.org/10.3390/v12020211; https://www.ncbi.nlm.nih.gov/pubmed/32074965/,"Viruses are evolving at an alarming rate, spreading and inconspicuously adapting to cutting-edge therapies. Therefore, the search for rapid, informative and reliable diagnostic methods is becoming urgent as ever. Conventional clinical tests (PCR, serology, etc.) are being continually optimized, yet provide very limited data. Could high throughput sequencing (HTS) become the future gold standard in molecular diagnostics of viral infections? Compared to conventional clinical tests, HTS is universal and more precise at profiling pathogens. Nevertheless, it has not yet been widely accepted as a diagnostic tool, owing primarily to its high cost and the complexity of sample preparation and data analysis. Those obstacles must be tackled to integrate HTS into daily clinical practice. For this, three objectives are to be achieved: (1) designing and assessing universal protocols for library preparation, (2) assembling purpose-specific pipelines, and (3) building computational infrastructure to suit the needs and financial abilities of modern healthcare centers. Data harvested with HTS could not only augment diagnostics and help to choose the correct therapy, but also facilitate research in epidemiology, genetics and virology. This information, in turn, could significantly aid clinicians in battling viral infections.",10.3390/v12020211,u2n8so5w,"['Viruses', 'are', 'evolving', 'at', 'an', 'alarming', 'rate', 'spreading', 'and', 'inconspicuously', 'adapting', 'to', 'cutting', 'edge', 'therapies', 'Therefore', 'the', 'search', 'for', 'rapid', 'informative', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'becoming', 'urgent', 'as', 'ever', 'Conventional', 'clinical', 'tests', 'PCR', 'serology', 'etc', 'are', 'being', 'continually', 'optimized', 'yet', 'provide', 'very', 'limited', 'data', 'Could', 'high', 'throughput', 'sequencing', 'HTS', 'become', 'the', 'future', 'gold', 'standard', 'in', 'molecular', 'diagnostics', 'of', 'viral', 'infections', 'Compared', 'to', 'conventional', 'clinical', 'tests', 'HTS', 'is', 'universal', 'and', 'more', 'precise', 'at', 'profiling', 'pathogens', 'Nevertheless', 'it', 'has', 'not', 'yet', 'been', 'widely', 'accepted', 'as', 'a', 'diagnostic', 'tool', 'owing', 'primarily', 'to', 'its', 'high', 'cost', 'and', 'the', 'complexity', 'of', 'sample', 'preparation', 'and', 'data', 'analysis', 'Those', 'obstacles', 'must', 'be', 'tackled', 'to', 'integrate', 'HTS', 'into', 'daily', 'clinical', 'practice', 'For', 'this', 'three', 'objectives', 'are', 'to', 'be', 'achieved', '1', 'designing', 'and', 'assessing', 'universal', 'protocols', 'for', 'library', 'preparation', '2', 'assembling', 'purpose', 'specific', 'pipelines', 'and', '3', 'building', 'computational', 'infrastructure', 'to', 'suit', 'the', 'needs', 'and', 'financial', 'abilities', 'of', 'modern', 'healthcare', 'centers', 'Data', 'harvested', 'with', 'HTS', 'could', 'not', 'only', 'augment', 'diagnostics', 'and', 'help', 'to', 'choose', 'the', 'correct', 'therapy', 'but', 'also', 'facilitate', 'research', 'in', 'epidemiology', 'genetics', 'and', 'virology', 'This', 'information', 'in', 'turn', 'could', 'significantly', 'aid', 'clinicians', 'in', 'battling', 'viral', 'infections', '']"
159717,Biosensors and rapid diagnostic tests on the frontier between analytical and clinical chemistry for biomolecular diagnosis of dengue disease: A review,2011-02-14,Anal Chim Acta,https://doi.org/10.1016/j.aca.2010.12.011; https://api.elsevier.com/content/article/pii/S0003267010015321; https://www.sciencedirect.com/science/article/pii/S0003267010015321; https://www.ncbi.nlm.nih.gov/pubmed/21241843/,"The past decades have witnessed enormous technological improvements towards the development of simple, cost-effective and accurate rapid diagnostic tests for detection and identification of infectious pathogens. Among them is dengue virus, the etiologic agent of the mosquito-borne dengue disease, one of the most important emerging infectious pathologies of nowadays. Dengue fever may cause potentially deadly hemorrhagic symptoms and is endemic in the tropical and sub-tropical world, being also a serious threat to temperate countries in the developed world. Effective diagnostics for dengue should be able to discriminate among the four antigenically related dengue serotypes and fulfill the requirements for successful decentralized (point-of-care) testing in the harsh environmental conditions found in most tropical regions. The accurate identification of circulating serotypes is crucial for the successful implementation of vector control programs based on reliable epidemiological predictions. This paper briefly summarizes the limitations of the main conventional techniques for biomolecular diagnosis of dengue disease and critically reviews some of the most relevant biosensors and rapid diagnostic tests developed, implemented and reported so far for point-of-care testing of dengue infections. The invaluable contributions of microfluidics and nanotechnology encompass the whole paper, while evaluation concerns of rapid diagnostic tests and foreseen technological improvements in this field are also overviewed for the diagnosis of dengue and other infectious and tropical diseases as well.",10.1016/j.aca.2010.12.011,uutap3da,"['The', 'past', 'decades', 'have', 'witnessed', 'enormous', 'technological', 'improvements', 'towards', 'the', 'development', 'of', 'simple', 'cost', 'effective', 'and', 'accurate', 'rapid', 'diagnostic', 'tests', 'for', 'detection', 'and', 'identification', 'of', 'infectious', 'pathogens', 'Among', 'them', 'is', 'dengue', 'virus', 'the', 'etiologic', 'agent', 'of', 'the', 'mosquito', 'borne', 'dengue', 'disease', 'one', 'of', 'the', 'most', 'important', 'emerging', 'infectious', 'pathologies', 'of', 'nowadays', 'Dengue', 'fever', 'may', 'cause', 'potentially', 'deadly', 'hemorrhagic', 'symptoms', 'and', 'is', 'endemic', 'in', 'the', 'tropical', 'and', 'sub', 'tropical', 'world', 'being', 'also', 'a', 'serious', 'threat', 'to', 'temperate', 'countries', 'in', 'the', 'developed', 'world', 'Effective', 'diagnostics', 'for', 'dengue', 'should', 'be', 'able', 'to', 'discriminate', 'among', 'the', 'four', 'antigenically', 'related', 'dengue', 'serotypes', 'and', 'fulfill', 'the', 'requirements', 'for', 'successful', 'decentralized', 'point', 'of', 'care', 'testing', 'in', 'the', 'harsh', 'environmental', 'conditions', 'found', 'in', 'most', 'tropical', 'regions', 'The', 'accurate', 'identification', 'of', 'circulating', 'serotypes', 'is', 'crucial', 'for', 'the', 'successful', 'implementation', 'of', 'vector', 'control', 'programs', 'based', 'on', 'reliable', 'epidemiological', 'predictions', 'This', 'paper', 'briefly', 'summarizes', 'the', 'limitations', 'of', 'the', 'main', 'conventional', 'techniques', 'for', 'biomolecular', 'diagnosis', 'of', 'dengue', 'disease', 'and', 'critically', 'reviews', 'some', 'of', 'the', 'most', 'relevant', 'biosensors', 'and', 'rapid', 'diagnostic', 'tests', 'developed', 'implemented', 'and', 'reported', 'so', 'far', 'for', 'point', 'of', 'care', 'testing', 'of', 'dengue', 'infections', 'The', 'invaluable', 'contributions', 'of', 'microfluidics', 'and', 'nanotechnology', 'encompass', 'the', 'whole', 'paper', 'while', 'evaluation', 'concerns', 'of', 'rapid', 'diagnostic', 'tests', 'and', 'foreseen', 'technological', 'improvements', 'in', 'this', 'field', 'are', 'also', 'overviewed', 'for', 'the', 'diagnosis', 'of', 'dengue', 'and', 'other', 'infectious', 'and', 'tropical', 'diseases', 'as', 'well', '']"
159817,Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting,2020-04-28,J Clin Virol,https://www.sciencedirect.com/science/article/pii/S1386653220301323?v=s5; https://api.elsevier.com/content/article/pii/S1386653220301323; https://www.ncbi.nlm.nih.gov/pubmed/32388471/; https://doi.org/10.1016/j.jcv.2020.104390,"Abstract Background The ongoing SARS-CoV-2 pandemic presents a unique challenge for diagnostic laboratories around the world. Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for highly urgent cases. In this study we evaluated a SARS-CoV-2 LDT for the NeuMoDx 96 system, a fully automated device performing extraction and real-time PCR. Methods A publicly available SARS-CoV-2 RT-PCR assay was adapted for the automated system. Analytical performance was evaluated using in-vitro transcribed RNA and clinical performance was compared to the cobas 6800-based reference assay within the lab. Results The Envelope (E) Gene-LDT displayed good analytical performance with an LoD of 95.55 cp/ml and no false positives during evaluation of cross-reactivity. A total of 176 patient samples were tested with both the E-Gene-LDT and the reference assay. Positive and negative agreement were 100% and 99.2% respectively. Invalid-rate was 6.3%. Conclusion The E-Gene-LDT showed analytical and clinical performance comparable to the cobas6800-based reference assay. Due to its random-access workflow concept and rapid time-to-result of about 80 minutes, the system is very well suited for providing fast-tracked SARS-CoV-2 diagnostics for urgent clinical samples in the hospital setting.",10.1016/j.jcv.2020.104390,hzn6k9ru,"['Abstract', 'Background', 'The', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'presents', 'a', 'unique', 'challenge', 'for', 'diagnostic', 'laboratories', 'around', 'the', 'world', 'Automation', 'of', 'workflows', 'in', 'molecular', 'diagnostics', 'is', 'instrumental', 'for', 'coping', 'with', 'the', 'large', 'number', 'of', 'tests', 'ordered', 'by', 'clinicians', 'as', 'well', 'as', 'providing', 'fast', 'tracked', 'rapid', 'testing', 'for', 'highly', 'urgent', 'cases', 'In', 'this', 'study', 'we', 'evaluated', 'a', 'SARS', 'CoV', '2', 'LDT', 'for', 'the', 'NeuMoDx', '96', 'system', 'a', 'fully', 'automated', 'device', 'performing', 'extraction', 'and', 'real', 'time', 'PCR', 'Methods', 'A', 'publicly', 'available', 'SARS', 'CoV', '2', 'RT', 'PCR', 'assay', 'was', 'adapted', 'for', 'the', 'automated', 'system', 'Analytical', 'performance', 'was', 'evaluated', 'using', 'in', 'vitro', 'transcribed', 'RNA', 'and', 'clinical', 'performance', 'was', 'compared', 'to', 'the', 'cobas', '6800', 'based', 'reference', 'assay', 'within', 'the', 'lab', 'Results', 'The', 'Envelope', 'E', 'Gene', 'LDT', 'displayed', 'good', 'analytical', 'performance', 'with', 'an', 'LoD', 'of', '95', '55', 'cp', 'ml', 'and', 'no', 'false', 'positives', 'during', 'evaluation', 'of', 'cross', 'reactivity', 'A', 'total', 'of', '176', 'patient', 'samples', 'were', 'tested', 'with', 'both', 'the', 'E', 'Gene', 'LDT', 'and', 'the', 'reference', 'assay', 'Positive', 'and', 'negative', 'agreement', 'were', '100', 'and', '99', '2', 'respectively', 'Invalid', 'rate', 'was', '6', '3', 'Conclusion', 'The', 'E', 'Gene', 'LDT', 'showed', 'analytical', 'and', 'clinical', 'performance', 'comparable', 'to', 'the', 'cobas6800', 'based', 'reference', 'assay', 'Due', 'to', 'its', 'random', 'access', 'workflow', 'concept', 'and', 'rapid', 'time', 'to', 'result', 'of', 'about', '80', 'minutes', 'the', 'system', 'is', 'very', 'well', 'suited', 'for', 'providing', 'fast', 'tracked', 'SARS', 'CoV', '2', 'diagnostics', 'for', 'urgent', 'clinical', 'samples', 'in', 'the', 'hospital', 'setting', '']"
160092,Diagnostic Techniques: Serological and Molecular Approaches,2008-07-30,Encyclopedia of Virology,https://api.elsevier.com/content/article/pii/B9780123744104005859; https://www.sciencedirect.com/science/article/pii/B9780123744104005859,"Virus laboratory diagnostics has an increasingly important role in modern patient care. Virological methods are needed to investigate the etiology of acute viral infection or the reactivation of a latent infection, as well as to follow virus load in antiviral treatments. Serological assays are also used for screening of blood products for the risk of certain chronic infections, evaluation of the immune status, and need for prophylatic treatments in connection with organ transplantations. For diagnostic purposes the following approaches can be used: demonstration of presence of infectious virus or its structural components directly from a patient's specimens or investigation of specific antibody response in serum specimes. Virus isolation is used to demonstrate infectious virus in a patient's specimens, whereas nucleic acid amplification techniques, like polymerase chain reaction (PCR), are widely used to detect virus nucleic acids. Virus antigens are investigated by antigen detection assays. Serological diagnosis is based on either the demonstration of the presence of virus-specific IgM antibodies or a significant increase in the levels of specific IgG antibodies. Immunoassays are the most commonly used serological assays. Point-of-care tests (POC tests), both for antigens and antibodies, are also becoming more and more common in diagnostic use. In order to reach the best diagnostic efficiency for each patient it is important to select the most suitable method using the right sample collected at the right time.",10.1016/b978-012374410-4.00585-9,jg0br2ro,"['Virus', 'laboratory', 'diagnostics', 'has', 'an', 'increasingly', 'important', 'role', 'in', 'modern', 'patient', 'care', 'Virological', 'methods', 'are', 'needed', 'to', 'investigate', 'the', 'etiology', 'of', 'acute', 'viral', 'infection', 'or', 'the', 'reactivation', 'of', 'a', 'latent', 'infection', 'as', 'well', 'as', 'to', 'follow', 'virus', 'load', 'in', 'antiviral', 'treatments', 'Serological', 'assays', 'are', 'also', 'used', 'for', 'screening', 'of', 'blood', 'products', 'for', 'the', 'risk', 'of', 'certain', 'chronic', 'infections', 'evaluation', 'of', 'the', 'immune', 'status', 'and', 'need', 'for', 'prophylatic', 'treatments', 'in', 'connection', 'with', 'organ', 'transplantations', 'For', 'diagnostic', 'purposes', 'the', 'following', 'approaches', 'can', 'be', 'used', 'demonstration', 'of', 'presence', 'of', 'infectious', 'virus', 'or', 'its', 'structural', 'components', 'directly', 'from', 'a', 'patient', 's', 'specimens', 'or', 'investigation', 'of', 'specific', 'antibody', 'response', 'in', 'serum', 'specimes', 'Virus', 'isolation', 'is', 'used', 'to', 'demonstrate', 'infectious', 'virus', 'in', 'a', 'patient', 's', 'specimens', 'whereas', 'nucleic', 'acid', 'amplification', 'techniques', 'like', 'polymerase', 'chain', 'reaction', 'PCR', 'are', 'widely', 'used', 'to', 'detect', 'virus', 'nucleic', 'acids', 'Virus', 'antigens', 'are', 'investigated', 'by', 'antigen', 'detection', 'assays', 'Serological', 'diagnosis', 'is', 'based', 'on', 'either', 'the', 'demonstration', 'of', 'the', 'presence', 'of', 'virus', 'specific', 'IgM', 'antibodies', 'or', 'a', 'significant', 'increase', 'in', 'the', 'levels', 'of', 'specific', 'IgG', 'antibodies', 'Immunoassays', 'are', 'the', 'most', 'commonly', 'used', 'serological', 'assays', 'Point', 'of', 'care', 'tests', 'POC', 'tests', 'both', 'for', 'antigens', 'and', 'antibodies', 'are', 'also', 'becoming', 'more', 'and', 'more', 'common', 'in', 'diagnostic', 'use', 'In', 'order', 'to', 'reach', 'the', 'best', 'diagnostic', 'efficiency', 'for', 'each', 'patient', 'it', 'is', 'important', 'to', 'select', 'the', 'most', 'suitable', 'method', 'using', 'the', 'right', 'sample', 'collected', 'at', 'the', 'right', 'time', '']"
160222,Diagnostic accuracy of an automated chemiluminescent immunoassay for anti‐SARS‐CoV‐2 IgM and IgG antibodies: an Italian experience,2020-05-10,J Med Virol,https://www.ncbi.nlm.nih.gov/pubmed/32330291/; https://doi.org/10.1002/jmv.25932,"A pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been spreading throughout the world. Though molecular diagnostic tests are the gold standard for COVID‐19, serological testing is emerging as a potential surveillance tool, in addition to its complementary role in COVID‐19 diagnostics. Indubitably quantitative serological testing provides greater advantages than qualitative tests but today there is still little known about serological diagnostics and what the most appropriate role quantitative tests might play. Sixty‐one COVID‐19 patients and 64 patients from a control group were tested by iFlash1800 CLIA analyzer for anti‐SARS CoV‐2 antibodies IgM and IgG. All COVID‐19 patients were hospitalized in San Giovanni di Dio Hospital (Florence, Italy) and had a positive oro/nasopharyngeal swab reverse‐transcription polymerase chain reaction result. The highest sensitivity with a very good specificity performance was reached at a cutoff value of 10.0 AU/mL for IgM and of 7.1 for IgG antibodies, hence near to the manufacturer's cutoff values of 10 AU/mL for both isotypes. The receiver operating characteristic curves showed area under the curve values of 0.918 and 0.980 for anti‐SARS CoV‐2 antibodies IgM and IgG, respectively. iFlash1800 CLIA analyzer has shown highly accurate results for the anti‐SARS‐CoV‐2 antibodies profile and can be considered an excellent tool for COVID‐19 diagnostics.",10.1002/jmv.25932,px4fe7mn,"['A', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'spreading', 'throughout', 'the', 'world', 'Though', 'molecular', 'diagnostic', 'tests', 'are', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'serological', 'testing', 'is', 'emerging', 'as', 'a', 'potential', 'surveillance', 'tool', 'in', 'addition', 'to', 'its', 'complementary', 'role', 'in', 'COVID', '19', 'diagnostics', 'Indubitably', 'quantitative', 'serological', 'testing', 'provides', 'greater', 'advantages', 'than', 'qualitative', 'tests', 'but', 'today', 'there', 'is', 'still', 'little', 'known', 'about', 'serological', 'diagnostics', 'and', 'what', 'the', 'most', 'appropriate', 'role', 'quantitative', 'tests', 'might', 'play', 'Sixty', 'one', 'COVID', '19', 'patients', 'and', '64', 'patients', 'from', 'a', 'control', 'group', 'were', 'tested', 'by', 'iFlash1800', 'CLIA', 'analyzer', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'All', 'COVID', '19', 'patients', 'were', 'hospitalized', 'in', 'San', 'Giovanni', 'di', 'Dio', 'Hospital', 'Florence', 'Italy', 'and', 'had', 'a', 'positive', 'oro', 'nasopharyngeal', 'swab', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'result', 'The', 'highest', 'sensitivity', 'with', 'a', 'very', 'good', 'specificity', 'performance', 'was', 'reached', 'at', 'a', 'cutoff', 'value', 'of', '10', '0', 'AU', 'mL', 'for', 'IgM', 'and', 'of', '7', '1', 'for', 'IgG', 'antibodies', 'hence', 'near', 'to', 'the', 'manufacturer', 's', 'cutoff', 'values', 'of', '10', 'AU', 'mL', 'for', 'both', 'isotypes', 'The', 'receiver', 'operating', 'characteristic', 'curves', 'showed', 'area', 'under', 'the', 'curve', 'values', 'of', '0', '918', 'and', '0', '980', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'respectively', 'iFlash1800', 'CLIA', 'analyzer', 'has', 'shown', 'highly', 'accurate', 'results', 'for', 'the', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'profile', 'and', 'can', 'be', 'considered', 'an', 'excellent', 'tool', 'for', 'COVID', '19', 'diagnostics', '']"
160366,SARS-CoV-2 Antibody Testing – Questions to be asked,2020-05-29,J Allergy Clin Immunol,https://www.ncbi.nlm.nih.gov/pubmed/32479758/; https://api.elsevier.com/content/article/pii/S0091674920307399; https://doi.org/10.1016/j.jaci.2020.05.020; https://www.sciencedirect.com/science/article/pii/S0091674920307399?v=s5,"ABSTRACT SARS-CoV-2 infection and development of COVID-19 disease presents a major healthcare challenge of global dimensions. Laboratory diagnostics of infected patients, and the assessment of immunity against the SARS-CoV-2 virus presents a major cornerstone in handling the pandemic. Currently there is an increase in demand of antibody testing and a large number of tests are already marketed or in the late stage of development. However, the interpretation of test results depends on many variables and factors, including sensitivity, specificity, potential cross-reactivity and cross-protectivity; the diagnostic value of antibodies of different isotypes, the use of antibody testing in identification of acutely ill patients or in epidemiological settings. In this article the recently established COVID-19 Task Force of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) addresses these issues based on the currently available datasets in this rapidly moving field.",10.1016/j.jaci.2020.05.020,tveeq4fj,"['ABSTRACT', 'SARS', 'CoV', '2', 'infection', 'and', 'development', 'of', 'COVID', '19', 'disease', 'presents', 'a', 'major', 'healthcare', 'challenge', 'of', 'global', 'dimensions', 'Laboratory', 'diagnostics', 'of', 'infected', 'patients', 'and', 'the', 'assessment', 'of', 'immunity', 'against', 'the', 'SARS', 'CoV', '2', 'virus', 'presents', 'a', 'major', 'cornerstone', 'in', 'handling', 'the', 'pandemic', 'Currently', 'there', 'is', 'an', 'increase', 'in', 'demand', 'of', 'antibody', 'testing', 'and', 'a', 'large', 'number', 'of', 'tests', 'are', 'already', 'marketed', 'or', 'in', 'the', 'late', 'stage', 'of', 'development', 'However', 'the', 'interpretation', 'of', 'test', 'results', 'depends', 'on', 'many', 'variables', 'and', 'factors', 'including', 'sensitivity', 'specificity', 'potential', 'cross', 'reactivity', 'and', 'cross', 'protectivity', 'the', 'diagnostic', 'value', 'of', 'antibodies', 'of', 'different', 'isotypes', 'the', 'use', 'of', 'antibody', 'testing', 'in', 'identification', 'of', 'acutely', 'ill', 'patients', 'or', 'in', 'epidemiological', 'settings', 'In', 'this', 'article', 'the', 'recently', 'established', 'COVID', '19', 'Task', 'Force', 'of', 'the', 'German', 'Society', 'for', 'Clinical', 'Chemistry', 'and', 'Laboratory', 'Medicine', 'DGKL', 'addresses', 'these', 'issues', 'based', 'on', 'the', 'currently', 'available', 'datasets', 'in', 'this', 'rapidly', 'moving', 'field', '']"
160414,RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice,2019-03-22,Clin Transplant,https://doi.org/10.1111/ctr.13511; https://www.ncbi.nlm.nih.gov/pubmed/30817023/,"These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of RNA respiratory viral infections in the pre‐ and post‐transplant period. Viruses reviewed include influenza, respiratory syncytial virus (RSV), parainfluenza, rhinovirus, human metapneumovirus (hMPV), and coronavirus. Diagnosis is by nucleic acid testing due to improved sensitivity, specificity, broad range of detection of viral pathogens, automatization, and turnaround time. Respiratory viral infections may be associated with acute rejection and chronic lung allograft dysfunction in lung transplant recipients. The cornerstone of influenza prevention is annual vaccination and in some cases antiviral prophylaxis. Treatment with neuraminidase inhibitors and other antivirals is reviewed. Prevention of RSV is limited to prophylaxis with palivizumab in select children. Therapy of RSV upper or lower tract disease is controversial but may include oral or aerosolized ribavirin in some populations. There are no approved vaccines or licensed antivirals for parainfluenza, rhinovirus, hMPV, and coronavirus. Potential management strategies for these viruses are given. Future studies should include prospective trials using contemporary molecular diagnostics to understand the true epidemiology, clinical spectrum, and long‐term consequences of respiratory viruses as well as to define preventative and therapeutic measures.",10.1111/ctr.13511,6musyeez,"['These', 'updated', 'guidelines', 'from', 'the', 'Infectious', 'Diseases', 'Community', 'of', 'Practice', 'of', 'the', 'American', 'Society', 'of', 'Transplantation', 'review', 'the', 'diagnosis', 'prevention', 'and', 'management', 'of', 'RNA', 'respiratory', 'viral', 'infections', 'in', 'the', 'pre', 'and', 'post', 'transplant', 'period', 'Viruses', 'reviewed', 'include', 'influenza', 'respiratory', 'syncytial', 'virus', 'RSV', 'parainfluenza', 'rhinovirus', 'human', 'metapneumovirus', 'hMPV', 'and', 'coronavirus', 'Diagnosis', 'is', 'by', 'nucleic', 'acid', 'testing', 'due', 'to', 'improved', 'sensitivity', 'specificity', 'broad', 'range', 'of', 'detection', 'of', 'viral', 'pathogens', 'automatization', 'and', 'turnaround', 'time', 'Respiratory', 'viral', 'infections', 'may', 'be', 'associated', 'with', 'acute', 'rejection', 'and', 'chronic', 'lung', 'allograft', 'dysfunction', 'in', 'lung', 'transplant', 'recipients', 'The', 'cornerstone', 'of', 'influenza', 'prevention', 'is', 'annual', 'vaccination', 'and', 'in', 'some', 'cases', 'antiviral', 'prophylaxis', 'Treatment', 'with', 'neuraminidase', 'inhibitors', 'and', 'other', 'antivirals', 'is', 'reviewed', 'Prevention', 'of', 'RSV', 'is', 'limited', 'to', 'prophylaxis', 'with', 'palivizumab', 'in', 'select', 'children', 'Therapy', 'of', 'RSV', 'upper', 'or', 'lower', 'tract', 'disease', 'is', 'controversial', 'but', 'may', 'include', 'oral', 'or', 'aerosolized', 'ribavirin', 'in', 'some', 'populations', 'There', 'are', 'no', 'approved', 'vaccines', 'or', 'licensed', 'antivirals', 'for', 'parainfluenza', 'rhinovirus', 'hMPV', 'and', 'coronavirus', 'Potential', 'management', 'strategies', 'for', 'these', 'viruses', 'are', 'given', 'Future', 'studies', 'should', 'include', 'prospective', 'trials', 'using', 'contemporary', 'molecular', 'diagnostics', 'to', 'understand', 'the', 'true', 'epidemiology', 'clinical', 'spectrum', 'and', 'long', 'term', 'consequences', 'of', 'respiratory', 'viruses', 'as', 'well', 'as', 'to', 'define', 'preventative', 'and', 'therapeutic', 'measures', '']"
160810,NTD Diagnostics for Disease Elimination: A Review,2020-06-05,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32517108/; https://doi.org/10.3390/diagnostics10060375,"Neglected Tropical Diseases (NTDs) marked out for disease elimination provide a lens through which to explore the changing status of diagnosis in global health. This paper reports on the findings of a scoping review, which set out to explore the main debates around diagnosis for the elimination of NTDs, including the multiple roles diagnostic technologies are being ascribed and the ideal characteristics of tests. It also attempts to summarise the state of diagnosis for three NTDs with elimination goals. The review places special emphasis on point-of-care testing in acknowledgement of the remote and underserved areas where NTDs proliferate. Early NTD campaigns were largely focused on attack phase planning, whereby a similar set of interventions could be transplanted anywhere. Now, with elimination goals in sight, strategies must be tailored to local settings if they are to attain and sustain success. Diagnostic data helps with local adaptation and is increasingly used for programmatic decision-making. The review finds that elimination goals reframe whom diagnosis is for and the myriad roles diagnostics can play. The exigencies of elimination also serve to highlight deficiencies in the current diagnostic arsenal and development pipeline for many NTDs. Moving forward, a guiding framework is needed to drive research and stimulate investment in diagnosis to support NTD goals.",10.3390/diagnostics10060375,u6mu11nl,"['Neglected', 'Tropical', 'Diseases', 'NTDs', 'marked', 'out', 'for', 'disease', 'elimination', 'provide', 'a', 'lens', 'through', 'which', 'to', 'explore', 'the', 'changing', 'status', 'of', 'diagnosis', 'in', 'global', 'health', 'This', 'paper', 'reports', 'on', 'the', 'findings', 'of', 'a', 'scoping', 'review', 'which', 'set', 'out', 'to', 'explore', 'the', 'main', 'debates', 'around', 'diagnosis', 'for', 'the', 'elimination', 'of', 'NTDs', 'including', 'the', 'multiple', 'roles', 'diagnostic', 'technologies', 'are', 'being', 'ascribed', 'and', 'the', 'ideal', 'characteristics', 'of', 'tests', 'It', 'also', 'attempts', 'to', 'summarise', 'the', 'state', 'of', 'diagnosis', 'for', 'three', 'NTDs', 'with', 'elimination', 'goals', 'The', 'review', 'places', 'special', 'emphasis', 'on', 'point', 'of', 'care', 'testing', 'in', 'acknowledgement', 'of', 'the', 'remote', 'and', 'underserved', 'areas', 'where', 'NTDs', 'proliferate', 'Early', 'NTD', 'campaigns', 'were', 'largely', 'focused', 'on', 'attack', 'phase', 'planning', 'whereby', 'a', 'similar', 'set', 'of', 'interventions', 'could', 'be', 'transplanted', 'anywhere', 'Now', 'with', 'elimination', 'goals', 'in', 'sight', 'strategies', 'must', 'be', 'tailored', 'to', 'local', 'settings', 'if', 'they', 'are', 'to', 'attain', 'and', 'sustain', 'success', 'Diagnostic', 'data', 'helps', 'with', 'local', 'adaptation', 'and', 'is', 'increasingly', 'used', 'for', 'programmatic', 'decision', 'making', 'The', 'review', 'finds', 'that', 'elimination', 'goals', 'reframe', 'whom', 'diagnosis', 'is', 'for', 'and', 'the', 'myriad', 'roles', 'diagnostics', 'can', 'play', 'The', 'exigencies', 'of', 'elimination', 'also', 'serve', 'to', 'highlight', 'deficiencies', 'in', 'the', 'current', 'diagnostic', 'arsenal', 'and', 'development', 'pipeline', 'for', 'many', 'NTDs', 'Moving', 'forward', 'a', 'guiding', 'framework', 'is', 'needed', 'to', 'drive', 'research', 'and', 'stimulate', 'investment', 'in', 'diagnosis', 'to', 'support', 'NTD', 'goals', '']"
160918,Retrospective Validation of a Metagenomic Sequencing Protocol for Combined Detection of RNA and DNA Viruses Using Respiratory Samples from Pediatric Patients,2019-12-16,J Mol Diagn,https://www.ncbi.nlm.nih.gov/pubmed/31837435/; https://www.sciencedirect.com/science/article/pii/S1525157819304325; https://doi.org/10.1016/j.jmoldx.2019.10.007; https://api.elsevier.com/content/article/pii/S1525157819304325,"Viruses are the main cause of respiratory tract infections. Metagenomic next-generation sequencing (mNGS) enables unbiased detection of all potential pathogens. To apply mNGS in viral diagnostics, sensitive and simultaneous detection of RNA and DNA viruses is needed. Herein, were studied the performance of an in-house mNGS protocol for routine diagnostics of viral respiratory infections with potential for automated pan-pathogen detection. The sequencing protocol and bioinformatics analysis were designed and optimized, including exogenous internal controls. Subsequently, the protocol was retrospectively validated using 25 clinical respiratory samples. The developed protocol using Illumina NextSeq 500 sequencing showed high repeatability. Use of the National Center for Biotechnology Information’s RefSeq database as opposed to the National Center for Biotechnology Information’s nucleotide database led to enhanced specificity of classification of viral pathogens. A correlation was established between read counts and PCR cycle threshold value. Sensitivity of mNGS, compared with PCR, varied up to 83%, with specificity of 94%, dependent on the cutoff for defining positive mNGS results. Viral pathogens only detected by mNGS, not present in the routine diagnostic workflow, were influenza C, KI polyomavirus, cytomegalovirus, and enterovirus. Sensitivity and analytical specificity of this mNGS protocol were comparable to PCR and higher when considering off-PCR target viral pathogens. One single test detected all potential viral pathogens and simultaneously obtained detailed information on detected viruses.",10.1016/j.jmoldx.2019.10.007,dw1sfzqx,"['Viruses', 'are', 'the', 'main', 'cause', 'of', 'respiratory', 'tract', 'infections', 'Metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'enables', 'unbiased', 'detection', 'of', 'all', 'potential', 'pathogens', 'To', 'apply', 'mNGS', 'in', 'viral', 'diagnostics', 'sensitive', 'and', 'simultaneous', 'detection', 'of', 'RNA', 'and', 'DNA', 'viruses', 'is', 'needed', 'Herein', 'were', 'studied', 'the', 'performance', 'of', 'an', 'in', 'house', 'mNGS', 'protocol', 'for', 'routine', 'diagnostics', 'of', 'viral', 'respiratory', 'infections', 'with', 'potential', 'for', 'automated', 'pan', 'pathogen', 'detection', 'The', 'sequencing', 'protocol', 'and', 'bioinformatics', 'analysis', 'were', 'designed', 'and', 'optimized', 'including', 'exogenous', 'internal', 'controls', 'Subsequently', 'the', 'protocol', 'was', 'retrospectively', 'validated', 'using', '25', 'clinical', 'respiratory', 'samples', 'The', 'developed', 'protocol', 'using', 'Illumina', 'NextSeq', '500', 'sequencing', 'showed', 'high', 'repeatability', 'Use', 'of', 'the', 'National', 'Center', 'for', 'Biotechnology', 'Information', 's', 'RefSeq', 'database', 'as', 'opposed', 'to', 'the', 'National', 'Center', 'for', 'Biotechnology', 'Information', 's', 'nucleotide', 'database', 'led', 'to', 'enhanced', 'specificity', 'of', 'classification', 'of', 'viral', 'pathogens', 'A', 'correlation', 'was', 'established', 'between', 'read', 'counts', 'and', 'PCR', 'cycle', 'threshold', 'value', 'Sensitivity', 'of', 'mNGS', 'compared', 'with', 'PCR', 'varied', 'up', 'to', '83', 'with', 'specificity', 'of', '94', 'dependent', 'on', 'the', 'cutoff', 'for', 'defining', 'positive', 'mNGS', 'results', 'Viral', 'pathogens', 'only', 'detected', 'by', 'mNGS', 'not', 'present', 'in', 'the', 'routine', 'diagnostic', 'workflow', 'were', 'influenza', 'C', 'KI', 'polyomavirus', 'cytomegalovirus', 'and', 'enterovirus', 'Sensitivity', 'and', 'analytical', 'specificity', 'of', 'this', 'mNGS', 'protocol', 'were', 'comparable', 'to', 'PCR', 'and', 'higher', 'when', 'considering', 'off', 'PCR', 'target', 'viral', 'pathogens', 'One', 'single', 'test', 'detected', 'all', 'potential', 'viral', 'pathogens', 'and', 'simultaneously', 'obtained', 'detailed', 'information', 'on', 'detected', 'viruses', '']"
161087,The use of next generation sequencing in the diagnosis and typing of respiratory infections,2015-08-31,Journal of Clinical Virology,https://doi.org/10.1016/j.jcv.2015.06.082; https://www.ncbi.nlm.nih.gov/pubmed/26209388/; https://api.elsevier.com/content/article/pii/S138665321500267X; https://www.sciencedirect.com/science/article/pii/S138665321500267X,"Abstract Background Molecular assays are the gold standard methods used to diagnose viral respiratory pathogens. Pitfalls associated with this technique include limits to the number of targeted pathogens, the requirement for continuous monitoring to ensure sensitivity/specificity is maintained and the need to evolve to include emerging pathogens. Introducing target independent next generation sequencing (NGS) could resolve these issues and revolutionise respiratory viral diagnostics. Objectives To compare the sensitivity and specificity of target independent NGS against the current standard diagnostic test. Study design Diagnostic RT-PCR of clinical samples was carried out in parallel with target independent NGS. NGS sequences were analyzed to determine the proportion with viral origin and consensus sequences were used to establish viral genotypes and serotypes where applicable. Results 89 nasopharyngeal swabs were tested. A viral pathogen was detected in 43% of samples by NGS and 54% by RT-PCR. All NGS viral detections were confirmed by RT-PCR. Conclusions Target independent NGS can detect viral pathogens in clinical samples. Where viruses were detected by RT-PCR alone the Ct value was higher than those detected by both assays, suggesting an NGS detection cut-off – Ct=32. The sensitivity and specificity of NGS compared with RT-PCR was 78% and 80% respectively. This is lower than current diagnostic assays but NGS provided full genome sequences in some cases, allowing determination of viral subtype and serotype. Sequencing technology is improving rapidly and it is likely that within a short period of time sequencing depth will increase in-turn improving test sensitivity.",10.1016/j.jcv.2015.06.082,q7jp224a,"['Abstract', 'Background', 'Molecular', 'assays', 'are', 'the', 'gold', 'standard', 'methods', 'used', 'to', 'diagnose', 'viral', 'respiratory', 'pathogens', 'Pitfalls', 'associated', 'with', 'this', 'technique', 'include', 'limits', 'to', 'the', 'number', 'of', 'targeted', 'pathogens', 'the', 'requirement', 'for', 'continuous', 'monitoring', 'to', 'ensure', 'sensitivity', 'specificity', 'is', 'maintained', 'and', 'the', 'need', 'to', 'evolve', 'to', 'include', 'emerging', 'pathogens', 'Introducing', 'target', 'independent', 'next', 'generation', 'sequencing', 'NGS', 'could', 'resolve', 'these', 'issues', 'and', 'revolutionise', 'respiratory', 'viral', 'diagnostics', 'Objectives', 'To', 'compare', 'the', 'sensitivity', 'and', 'specificity', 'of', 'target', 'independent', 'NGS', 'against', 'the', 'current', 'standard', 'diagnostic', 'test', 'Study', 'design', 'Diagnostic', 'RT', 'PCR', 'of', 'clinical', 'samples', 'was', 'carried', 'out', 'in', 'parallel', 'with', 'target', 'independent', 'NGS', 'NGS', 'sequences', 'were', 'analyzed', 'to', 'determine', 'the', 'proportion', 'with', 'viral', 'origin', 'and', 'consensus', 'sequences', 'were', 'used', 'to', 'establish', 'viral', 'genotypes', 'and', 'serotypes', 'where', 'applicable', 'Results', '89', 'nasopharyngeal', 'swabs', 'were', 'tested', 'A', 'viral', 'pathogen', 'was', 'detected', 'in', '43', 'of', 'samples', 'by', 'NGS', 'and', '54', 'by', 'RT', 'PCR', 'All', 'NGS', 'viral', 'detections', 'were', 'confirmed', 'by', 'RT', 'PCR', 'Conclusions', 'Target', 'independent', 'NGS', 'can', 'detect', 'viral', 'pathogens', 'in', 'clinical', 'samples', 'Where', 'viruses', 'were', 'detected', 'by', 'RT', 'PCR', 'alone', 'the', 'Ct', 'value', 'was', 'higher', 'than', 'those', 'detected', 'by', 'both', 'assays', 'suggesting', 'an', 'NGS', 'detection', 'cut', 'off', 'Ct', '32', 'The', 'sensitivity', 'and', 'specificity', 'of', 'NGS', 'compared', 'with', 'RT', 'PCR', 'was', '78', 'and', '80', 'respectively', 'This', 'is', 'lower', 'than', 'current', 'diagnostic', 'assays', 'but', 'NGS', 'provided', 'full', 'genome', 'sequences', 'in', 'some', 'cases', 'allowing', 'determination', 'of', 'viral', 'subtype', 'and', 'serotype', 'Sequencing', 'technology', 'is', 'improving', 'rapidly', 'and', 'it', 'is', 'likely', 'that', 'within', 'a', 'short', 'period', 'of', 'time', 'sequencing', 'depth', 'will', 'increase', 'in', 'turn', 'improving', 'test', 'sensitivity', '']"
161443,Chapter 5 Clinical Applications of Quantitative Real-Time PCR in Virology,2015-12-31,Methods in Microbiology,https://www.sciencedirect.com/science/article/pii/S0580951715000069; https://api.elsevier.com/content/article/pii/S0580951715000069,"Abstract Since the invention of the polymerase chain reaction (PCR) and discovery of Taq polymerase, PCR has become a staple in both research and clinical molecular laboratories. As clinical and diagnostic needs have evolved over the last few decades, demanding greater levels of sensitivity and accuracy, so too has PCR performance. Through optimisation, the present-day uses of real-time PCR and quantitative real-time PCR are enumerable. The technique, combined with adoption of automated processes and reduced sample volume requirements, makes it an ideal method in a broad range of clinical applications, especially in virology. Complementing serologic testing by detecting infections within the pre-seroconversion window period and infections with immunovariant viruses, real-time PCR provides a highly valuable tool for screening, diagnosing, or monitoring diseases, as well as evaluating medical and therapeutic decision points that allows for more timely predictions of therapeutic failures than traditional methods and, lastly, assessing cure rates following targeted therapies. All of these serve vital roles in the continuum of care to enhance patient management. Beyond this, quantitative real-time PCR facilitates advancements in the quality of diagnostics by driving consensus management guidelines following standardisation to improve patient outcomes, pushing for disease eradication with assays offering progressively lower limits of detection, and rapidly meeting medical needs in cases of emerging epidemic crises involving new pathogens that may result in significant health threats.",10.1016/bs.mim.2015.04.005,b1wlr3t7,"['Abstract', 'Since', 'the', 'invention', 'of', 'the', 'polymerase', 'chain', 'reaction', 'PCR', 'and', 'discovery', 'of', 'Taq', 'polymerase', 'PCR', 'has', 'become', 'a', 'staple', 'in', 'both', 'research', 'and', 'clinical', 'molecular', 'laboratories', 'As', 'clinical', 'and', 'diagnostic', 'needs', 'have', 'evolved', 'over', 'the', 'last', 'few', 'decades', 'demanding', 'greater', 'levels', 'of', 'sensitivity', 'and', 'accuracy', 'so', 'too', 'has', 'PCR', 'performance', 'Through', 'optimisation', 'the', 'present', 'day', 'uses', 'of', 'real', 'time', 'PCR', 'and', 'quantitative', 'real', 'time', 'PCR', 'are', 'enumerable', 'The', 'technique', 'combined', 'with', 'adoption', 'of', 'automated', 'processes', 'and', 'reduced', 'sample', 'volume', 'requirements', 'makes', 'it', 'an', 'ideal', 'method', 'in', 'a', 'broad', 'range', 'of', 'clinical', 'applications', 'especially', 'in', 'virology', 'Complementing', 'serologic', 'testing', 'by', 'detecting', 'infections', 'within', 'the', 'pre', 'seroconversion', 'window', 'period', 'and', 'infections', 'with', 'immunovariant', 'viruses', 'real', 'time', 'PCR', 'provides', 'a', 'highly', 'valuable', 'tool', 'for', 'screening', 'diagnosing', 'or', 'monitoring', 'diseases', 'as', 'well', 'as', 'evaluating', 'medical', 'and', 'therapeutic', 'decision', 'points', 'that', 'allows', 'for', 'more', 'timely', 'predictions', 'of', 'therapeutic', 'failures', 'than', 'traditional', 'methods', 'and', 'lastly', 'assessing', 'cure', 'rates', 'following', 'targeted', 'therapies', 'All', 'of', 'these', 'serve', 'vital', 'roles', 'in', 'the', 'continuum', 'of', 'care', 'to', 'enhance', 'patient', 'management', 'Beyond', 'this', 'quantitative', 'real', 'time', 'PCR', 'facilitates', 'advancements', 'in', 'the', 'quality', 'of', 'diagnostics', 'by', 'driving', 'consensus', 'management', 'guidelines', 'following', 'standardisation', 'to', 'improve', 'patient', 'outcomes', 'pushing', 'for', 'disease', 'eradication', 'with', 'assays', 'offering', 'progressively', 'lower', 'limits', 'of', 'detection', 'and', 'rapidly', 'meeting', 'medical', 'needs', 'in', 'cases', 'of', 'emerging', 'epidemic', 'crises', 'involving', 'new', 'pathogens', 'that', 'may', 'result', 'in', 'significant', 'health', 'threats', '']"
161763,SARS-CoV-2-Pandemie und ihre Auswirkungen auf Orthopädie und Unfallchirurgie: „Booster“ für die Telemedizin,2020-05-14,Knie J.,https://doi.org/10.1007/s43205-020-00062-z,"With the outbreak of the COVID-19 pandemic, interest in telemedical care options has grown. Today’s telemedicine options relate not only to the area of diagnostics, but also to the monitoring of therapy courses and rehabilitation measures. Due to the current resource constraints, many orthopedic surgeons and trauma surgeons have been forced to set up video consultations, although standards for orthopedic video consultations have so far been insufficiently developed. In order to maximize the efficiency of virtual orthopedics, patients should be prepared for the virtual visit (checklist with specific instructions on camera positioning, body positioning, adjustment and clothing, testing of audiovisual skills). Classic diagnostic measures such as anamnesis, inspection and assessment of radiological findings are possible in the video consultation. One major disadvantage is, that there is no possibility for a functional examination (stability of the knee joint, shoulder tests). Although initial controlled scientific studies have shown that telemedical diagnostics are not inferior to conventional diagnostics, there are still no validated examination protocols and methods. Postoperative monitoring of rehabilitation measures can, for example, be made easier by the use of sensors. With modern sensors, inexpensive detection of joint mobility and joint position is now possible and is already used in the area of rehabilitation after reconstruction of the anterior cruciate ligament. Here too, further research is certainly necessary to validate these methods. We believe that the current pandemic offers opportunities to further expand the possibilities of telemedicine for orthopedics and trauma surgery in order to continue to use it in the future (e.g. in the care of patients from abroad or in sparsely populated areas, care of professional athletes).",10.1007/s43205-020-00062-z,q4gozwtv,"['With', 'the', 'outbreak', 'of', 'the', 'COVID', '19', 'pandemic', 'interest', 'in', 'telemedical', 'care', 'options', 'has', 'grown', 'Today', 's', 'telemedicine', 'options', 'relate', 'not', 'only', 'to', 'the', 'area', 'of', 'diagnostics', 'but', 'also', 'to', 'the', 'monitoring', 'of', 'therapy', 'courses', 'and', 'rehabilitation', 'measures', 'Due', 'to', 'the', 'current', 'resource', 'constraints', 'many', 'orthopedic', 'surgeons', 'and', 'trauma', 'surgeons', 'have', 'been', 'forced', 'to', 'set', 'up', 'video', 'consultations', 'although', 'standards', 'for', 'orthopedic', 'video', 'consultations', 'have', 'so', 'far', 'been', 'insufficiently', 'developed', 'In', 'order', 'to', 'maximize', 'the', 'efficiency', 'of', 'virtual', 'orthopedics', 'patients', 'should', 'be', 'prepared', 'for', 'the', 'virtual', 'visit', 'checklist', 'with', 'specific', 'instructions', 'on', 'camera', 'positioning', 'body', 'positioning', 'adjustment', 'and', 'clothing', 'testing', 'of', 'audiovisual', 'skills', 'Classic', 'diagnostic', 'measures', 'such', 'as', 'anamnesis', 'inspection', 'and', 'assessment', 'of', 'radiological', 'findings', 'are', 'possible', 'in', 'the', 'video', 'consultation', 'One', 'major', 'disadvantage', 'is', 'that', 'there', 'is', 'no', 'possibility', 'for', 'a', 'functional', 'examination', 'stability', 'of', 'the', 'knee', 'joint', 'shoulder', 'tests', 'Although', 'initial', 'controlled', 'scientific', 'studies', 'have', 'shown', 'that', 'telemedical', 'diagnostics', 'are', 'not', 'inferior', 'to', 'conventional', 'diagnostics', 'there', 'are', 'still', 'no', 'validated', 'examination', 'protocols', 'and', 'methods', 'Postoperative', 'monitoring', 'of', 'rehabilitation', 'measures', 'can', 'for', 'example', 'be', 'made', 'easier', 'by', 'the', 'use', 'of', 'sensors', 'With', 'modern', 'sensors', 'inexpensive', 'detection', 'of', 'joint', 'mobility', 'and', 'joint', 'position', 'is', 'now', 'possible', 'and', 'is', 'already', 'used', 'in', 'the', 'area', 'of', 'rehabilitation', 'after', 'reconstruction', 'of', 'the', 'anterior', 'cruciate', 'ligament', 'Here', 'too', 'further', 'research', 'is', 'certainly', 'necessary', 'to', 'validate', 'these', 'methods', 'We', 'believe', 'that', 'the', 'current', 'pandemic', 'offers', 'opportunities', 'to', 'further', 'expand', 'the', 'possibilities', 'of', 'telemedicine', 'for', 'orthopedics', 'and', 'trauma', 'surgery', 'in', 'order', 'to', 'continue', 'to', 'use', 'it', 'in', 'the', 'future', 'e', 'g', 'in', 'the', 'care', 'of', 'patients', 'from', 'abroad', 'or', 'in', 'sparsely', 'populated', 'areas', 'care', 'of', 'professional', 'athletes', '']"
161902,Nucleic acid-based diagnostics for infectious diseases in public health affairs,2012-06-03,Front Med,https://www.ncbi.nlm.nih.gov/pubmed/22660977/; https://doi.org/10.1007/s11684-012-0195-5,"Infectious diseases, mostly caused by bacteria and viruses but also a result of fungal and parasitic infection, have been one of the most important public health concerns throughout human history. The first step in combating these pathogens is to get a timely and accurate diagnosis at an affordable cost. Many kinds of diagnostics have been developed, such as pathogen culture, biochemical tests and serological tests, to help detect and fight against the causative agents of diseases. However, these diagnostic tests are generally unsatisfactory because they are not particularly sensitive and specific and are unable to deliver speedy results. Nucleic acid-based diagnostics, detecting pathogens through the identification of their genomic sequences, have shown promise to overcome the above limitations and become more widely adopted in clinical tests. Here we review some of the most popular nucleic acid-based diagnostics and focus on their adaptability and applicability to routine clinical usage. We also compare and contrast the characteristics of different types of nucleic acid-based diagnostics.",10.1007/s11684-012-0195-5,5vt9orsg,"['Infectious', 'diseases', 'mostly', 'caused', 'by', 'bacteria', 'and', 'viruses', 'but', 'also', 'a', 'result', 'of', 'fungal', 'and', 'parasitic', 'infection', 'have', 'been', 'one', 'of', 'the', 'most', 'important', 'public', 'health', 'concerns', 'throughout', 'human', 'history', 'The', 'first', 'step', 'in', 'combating', 'these', 'pathogens', 'is', 'to', 'get', 'a', 'timely', 'and', 'accurate', 'diagnosis', 'at', 'an', 'affordable', 'cost', 'Many', 'kinds', 'of', 'diagnostics', 'have', 'been', 'developed', 'such', 'as', 'pathogen', 'culture', 'biochemical', 'tests', 'and', 'serological', 'tests', 'to', 'help', 'detect', 'and', 'fight', 'against', 'the', 'causative', 'agents', 'of', 'diseases', 'However', 'these', 'diagnostic', 'tests', 'are', 'generally', 'unsatisfactory', 'because', 'they', 'are', 'not', 'particularly', 'sensitive', 'and', 'specific', 'and', 'are', 'unable', 'to', 'deliver', 'speedy', 'results', 'Nucleic', 'acid', 'based', 'diagnostics', 'detecting', 'pathogens', 'through', 'the', 'identification', 'of', 'their', 'genomic', 'sequences', 'have', 'shown', 'promise', 'to', 'overcome', 'the', 'above', 'limitations', 'and', 'become', 'more', 'widely', 'adopted', 'in', 'clinical', 'tests', 'Here', 'we', 'review', 'some', 'of', 'the', 'most', 'popular', 'nucleic', 'acid', 'based', 'diagnostics', 'and', 'focus', 'on', 'their', 'adaptability', 'and', 'applicability', 'to', 'routine', 'clinical', 'usage', 'We', 'also', 'compare', 'and', 'contrast', 'the', 'characteristics', 'of', 'different', 'types', 'of', 'nucleic', 'acid', 'based', 'diagnostics', '']"
162222,Difficulty with mumps diagnosis: What is the contribution of mumps mimickers?,2009-12-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653209004624; https://doi.org/10.1016/j.jcv.2009.09.024; https://api.elsevier.com/content/article/pii/S1386653209004624; https://www.ncbi.nlm.nih.gov/pubmed/19828368/,"Abstract Background Mumps is a vaccine preventable disease that typically presents with unilateral or bilateral parotitis. In February 2007, mumps re-emerged in university students in Nova Scotia. Despite highly sensitive methods for mumps virus detection, only 14% (298/2082) of cases during the peak of the outbreak were laboratory confirmed. Objectives Due to the low positivity rate, this study investigated whether infection with other viral pathogens caused mumps-like presentations during the outbreak. Study design 148 buccal specimens from patients who presented with unilateral or bilateral parotitis but had negative laboratory tests for mumps virus were tested for Epstein-Barr virus (EBV) and cytomegalovirus (CMV) by quantitative PCR and 21 different viral markers using the Luminex xTAG Respiratory Virus Panel (RVP). Companion sera to each buccal specimen were available for EBV and CMV serology to differentiate acute infection from reactivation. Results No correlation was observed since viral pathogens were detected in both the parotitis and non-parotitis groups. Conclusion Although there was co-circulation of other viral pathogens during the mumps outbreak, no difference was observed in the prevalence between patients who presented with or without parotitis. The low positivity rate for specimens submitted for mumps diagnostics was likely the result of increased Public Health messaging and physician inexperience in recognizing mumps infection, suggesting the clinical acumen for mumps diagnosis based solely on clinical presentation is low.",10.1016/j.jcv.2009.09.024,ion8wr2l,"['Abstract', 'Background', 'Mumps', 'is', 'a', 'vaccine', 'preventable', 'disease', 'that', 'typically', 'presents', 'with', 'unilateral', 'or', 'bilateral', 'parotitis', 'In', 'February', '2007', 'mumps', 're', 'emerged', 'in', 'university', 'students', 'in', 'Nova', 'Scotia', 'Despite', 'highly', 'sensitive', 'methods', 'for', 'mumps', 'virus', 'detection', 'only', '14', '298', '2082', 'of', 'cases', 'during', 'the', 'peak', 'of', 'the', 'outbreak', 'were', 'laboratory', 'confirmed', 'Objectives', 'Due', 'to', 'the', 'low', 'positivity', 'rate', 'this', 'study', 'investigated', 'whether', 'infection', 'with', 'other', 'viral', 'pathogens', 'caused', 'mumps', 'like', 'presentations', 'during', 'the', 'outbreak', 'Study', 'design', '148', 'buccal', 'specimens', 'from', 'patients', 'who', 'presented', 'with', 'unilateral', 'or', 'bilateral', 'parotitis', 'but', 'had', 'negative', 'laboratory', 'tests', 'for', 'mumps', 'virus', 'were', 'tested', 'for', 'Epstein', 'Barr', 'virus', 'EBV', 'and', 'cytomegalovirus', 'CMV', 'by', 'quantitative', 'PCR', 'and', '21', 'different', 'viral', 'markers', 'using', 'the', 'Luminex', 'xTAG', 'Respiratory', 'Virus', 'Panel', 'RVP', 'Companion', 'sera', 'to', 'each', 'buccal', 'specimen', 'were', 'available', 'for', 'EBV', 'and', 'CMV', 'serology', 'to', 'differentiate', 'acute', 'infection', 'from', 'reactivation', 'Results', 'No', 'correlation', 'was', 'observed', 'since', 'viral', 'pathogens', 'were', 'detected', 'in', 'both', 'the', 'parotitis', 'and', 'non', 'parotitis', 'groups', 'Conclusion', 'Although', 'there', 'was', 'co', 'circulation', 'of', 'other', 'viral', 'pathogens', 'during', 'the', 'mumps', 'outbreak', 'no', 'difference', 'was', 'observed', 'in', 'the', 'prevalence', 'between', 'patients', 'who', 'presented', 'with', 'or', 'without', 'parotitis', 'The', 'low', 'positivity', 'rate', 'for', 'specimens', 'submitted', 'for', 'mumps', 'diagnostics', 'was', 'likely', 'the', 'result', 'of', 'increased', 'Public', 'Health', 'messaging', 'and', 'physician', 'inexperience', 'in', 'recognizing', 'mumps', 'infection', 'suggesting', 'the', 'clinical', 'acumen', 'for', 'mumps', 'diagnosis', 'based', 'solely', 'on', 'clinical', 'presentation', 'is', 'low', '']"
162420,CRISPR/cas systems redefine nucleic acid detection: Principles and methods,2020-07-08,Biosens Bioelectron,https://api.elsevier.com/content/article/pii/S0956566320304243; https://www.sciencedirect.com/science/article/pii/S0956566320304243?v=s5,"Methods that enable rapid, sensitive and specific analyses of nucleic acid sequences have positive effects on precise disease diagnostics and effective clinical treatments by providing direct insight into clinically relevant genetic information. Thus far, many CRISPR/Cas systems have been repurposed for diagnostic functions and are revolutionizing the accessibility of robust diagnostic tools due to their high flexibility, sensitivity and specificity. As RNA-guided targeted recognition effectors, Cas9 variants have been utilized for a variety of diagnostic applications, including biosensing assays, imaging assays and target enrichment for next-generation sequencing (NGS), thereby enabling the development of flexible and cost-effective tests. In addition, the ensuing discovery of Cas proteins (Cas12 and Cas13) with collateral cleavage activities has facilitated the development of numerous diagnostic tools for rapid and portable detection, and these tools have great potential for point-of-care settings. However, representative reviews proposed on this topic are mainly confined to classical biosensing applications; thus, a comprehensive and systematic description of this fast-developing field is required. In this review, based on the detection principle, we provide a detailed classification and comprehensive discussion of recent works that harness these CRISPR-based diagnostic tools from a new perspective. Furthermore, current challenges and future perspectives of CRISPR-based diagnostics are outlined.",10.1016/j.bios.2020.112430,nd7ub2u3,"['Methods', 'that', 'enable', 'rapid', 'sensitive', 'and', 'specific', 'analyses', 'of', 'nucleic', 'acid', 'sequences', 'have', 'positive', 'effects', 'on', 'precise', 'disease', 'diagnostics', 'and', 'effective', 'clinical', 'treatments', 'by', 'providing', 'direct', 'insight', 'into', 'clinically', 'relevant', 'genetic', 'information', 'Thus', 'far', 'many', 'CRISPR', 'Cas', 'systems', 'have', 'been', 'repurposed', 'for', 'diagnostic', 'functions', 'and', 'are', 'revolutionizing', 'the', 'accessibility', 'of', 'robust', 'diagnostic', 'tools', 'due', 'to', 'their', 'high', 'flexibility', 'sensitivity', 'and', 'specificity', 'As', 'RNA', 'guided', 'targeted', 'recognition', 'effectors', 'Cas9', 'variants', 'have', 'been', 'utilized', 'for', 'a', 'variety', 'of', 'diagnostic', 'applications', 'including', 'biosensing', 'assays', 'imaging', 'assays', 'and', 'target', 'enrichment', 'for', 'next', 'generation', 'sequencing', 'NGS', 'thereby', 'enabling', 'the', 'development', 'of', 'flexible', 'and', 'cost', 'effective', 'tests', 'In', 'addition', 'the', 'ensuing', 'discovery', 'of', 'Cas', 'proteins', 'Cas12', 'and', 'Cas13', 'with', 'collateral', 'cleavage', 'activities', 'has', 'facilitated', 'the', 'development', 'of', 'numerous', 'diagnostic', 'tools', 'for', 'rapid', 'and', 'portable', 'detection', 'and', 'these', 'tools', 'have', 'great', 'potential', 'for', 'point', 'of', 'care', 'settings', 'However', 'representative', 'reviews', 'proposed', 'on', 'this', 'topic', 'are', 'mainly', 'confined', 'to', 'classical', 'biosensing', 'applications', 'thus', 'a', 'comprehensive', 'and', 'systematic', 'description', 'of', 'this', 'fast', 'developing', 'field', 'is', 'required', 'In', 'this', 'review', 'based', 'on', 'the', 'detection', 'principle', 'we', 'provide', 'a', 'detailed', 'classification', 'and', 'comprehensive', 'discussion', 'of', 'recent', 'works', 'that', 'harness', 'these', 'CRISPR', 'based', 'diagnostic', 'tools', 'from', 'a', 'new', 'perspective', 'Furthermore', 'current', 'challenges', 'and', 'future', 'perspectives', 'of', 'CRISPR', 'based', 'diagnostics', 'are', 'outlined', '']"
162435,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020-02-02,bioRxiv,https://doi.org/10.1101/2020.01.31.928796; https://www.ncbi.nlm.nih.gov/pubmed/32511309/,"Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify novel coronavirus (2019-nCoV) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for 2019-nCoV. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines.",10.1101/2020.01.31.928796,gxstlzuk,"['Genome', 'Detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'The', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'novel', 'coronavirus', '2019', 'nCoV', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2', '000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', 'one', 'minute', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', 'ten', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', '2019', 'nCoV', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', '']"
163390,"REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes",2018-12-13,Nat Microbiol,https://www.ncbi.nlm.nih.gov/pubmed/30546093/; https://doi.org/10.1038/s41564-018-0295-3,"Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes.",10.1038/s41564-018-0295-3,xhpv783y,"['Lack', 'of', 'access', 'to', 'quality', 'diagnostics', 'remains', 'a', 'major', 'contributor', 'to', 'health', 'burden', 'in', 'resource', 'limited', 'settings', 'It', 'has', 'been', 'more', 'than', '10', 'years', 'since', 'ASSURED', 'affordable', 'sensitive', 'specific', 'user', 'friendly', 'rapid', 'equipment', 'free', 'delivered', 'was', 'coined', 'to', 'describe', 'the', 'ideal', 'test', 'to', 'meet', 'the', 'needs', 'of', 'the', 'developing', 'world', 'Since', 'its', 'initial', 'publication', 'technological', 'innovations', 'have', 'led', 'to', 'the', 'development', 'of', 'diagnostics', 'that', 'address', 'the', 'ASSURED', 'criteria', 'but', 'challenges', 'remain', 'From', 'this', 'perspective', 'we', 'assess', 'factors', 'contributing', 'to', 'the', 'success', 'and', 'failure', 'of', 'ASSURED', 'diagnostics', 'lessons', 'learnt', 'in', 'the', 'implementation', 'of', 'ASSURED', 'tests', 'over', 'the', 'past', 'decade', 'and', 'highlight', 'additional', 'conditions', 'that', 'should', 'be', 'considered', 'in', 'addressing', 'point', 'of', 'care', 'needs', 'With', 'rapid', 'advances', 'in', 'digital', 'technology', 'and', 'mobile', 'health', 'm', 'health', 'future', 'diagnostics', 'should', 'incorporate', 'these', 'elements', 'to', 'give', 'us', 'REASSURED', 'diagnostic', 'systems', 'that', 'can', 'inform', 'disease', 'control', 'strategies', 'in', 'real', 'time', 'strengthen', 'the', 'efficiency', 'of', 'health', 'care', 'systems', 'and', 'improve', 'patient', 'outcomes', '']"
163465,Magnetic Lateral Flow Immunoassays,2020-05-08,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32397264/; https://doi.org/10.3390/diagnostics10050288,"A new generation of magnetic lateral flow immunoassays is emerging as powerful tool for diagnostics. They rely on the use of magnetic nanoparticles (MNP) as detecting label, replacing conventional gold or latex beads. MNPs can be sensed and quantified by means of external devices, allowing the development of immunochromatographic tests with a quantitative capability. Moreover, they have an added advantage because they can be used for immunomagnetic separation (IMS), with improvements in selectivity and sensitivity. In this paper, we have reviewed the current knowledge on magnetic-lateral flow immunoassay (LFIA), coupled with both research and commercially available instruments. The work in the literature has been classified in two categories: optical and magnetic sensing. We have analysed the type of magnetic nanoparticles used in each case, their size, coating, crystal structure and the functional groups for their conjugation with biomolecules. We have also taken into account the analytical characteristics and the type of transduction. Magnetic LFIA have been used for the determination of biomarkers, pathogens, toxins, allergens and drugs. Nanocomposites have been developed as alternative to MNP with the purpose of sensitivity enhancement. Moreover, IMS in combination with other detection principles could also improve sensitivity and limit of detection. The critical analysis in this review could have an impact for the future development of magnetic LFIA in fields requiring both rapid separation and quantification.",10.3390/diagnostics10050288,lyw3en42,"['A', 'new', 'generation', 'of', 'magnetic', 'lateral', 'flow', 'immunoassays', 'is', 'emerging', 'as', 'powerful', 'tool', 'for', 'diagnostics', 'They', 'rely', 'on', 'the', 'use', 'of', 'magnetic', 'nanoparticles', 'MNP', 'as', 'detecting', 'label', 'replacing', 'conventional', 'gold', 'or', 'latex', 'beads', 'MNPs', 'can', 'be', 'sensed', 'and', 'quantified', 'by', 'means', 'of', 'external', 'devices', 'allowing', 'the', 'development', 'of', 'immunochromatographic', 'tests', 'with', 'a', 'quantitative', 'capability', 'Moreover', 'they', 'have', 'an', 'added', 'advantage', 'because', 'they', 'can', 'be', 'used', 'for', 'immunomagnetic', 'separation', 'IMS', 'with', 'improvements', 'in', 'selectivity', 'and', 'sensitivity', 'In', 'this', 'paper', 'we', 'have', 'reviewed', 'the', 'current', 'knowledge', 'on', 'magnetic', 'lateral', 'flow', 'immunoassay', 'LFIA', 'coupled', 'with', 'both', 'research', 'and', 'commercially', 'available', 'instruments', 'The', 'work', 'in', 'the', 'literature', 'has', 'been', 'classified', 'in', 'two', 'categories', 'optical', 'and', 'magnetic', 'sensing', 'We', 'have', 'analysed', 'the', 'type', 'of', 'magnetic', 'nanoparticles', 'used', 'in', 'each', 'case', 'their', 'size', 'coating', 'crystal', 'structure', 'and', 'the', 'functional', 'groups', 'for', 'their', 'conjugation', 'with', 'biomolecules', 'We', 'have', 'also', 'taken', 'into', 'account', 'the', 'analytical', 'characteristics', 'and', 'the', 'type', 'of', 'transduction', 'Magnetic', 'LFIA', 'have', 'been', 'used', 'for', 'the', 'determination', 'of', 'biomarkers', 'pathogens', 'toxins', 'allergens', 'and', 'drugs', 'Nanocomposites', 'have', 'been', 'developed', 'as', 'alternative', 'to', 'MNP', 'with', 'the', 'purpose', 'of', 'sensitivity', 'enhancement', 'Moreover', 'IMS', 'in', 'combination', 'with', 'other', 'detection', 'principles', 'could', 'also', 'improve', 'sensitivity', 'and', 'limit', 'of', 'detection', 'The', 'critical', 'analysis', 'in', 'this', 'review', 'could', 'have', 'an', 'impact', 'for', 'the', 'future', 'development', 'of', 'magnetic', 'LFIA', 'in', 'fields', 'requiring', 'both', 'rapid', 'separation', 'and', 'quantification', '']"
163652,"Laboratory Surge Response to Pandemic (H1N1) 2009 Outbreak, New York City Metropolitan Area, USA",2010-01-31,Emerg Infect Dis,https://doi.org/10.3201/eid1601.091167; https://www.ncbi.nlm.nih.gov/pubmed/20031036/,"The North Shore–Long Island Jewish Health System Laboratories serve 15 hospitals and affiliated regional physician practices in the New York City metropolitan area, with virus testing performed at a central reference laboratory. The influenza A pandemic (H1N1) 2009 outbreak began in this area on April 24, 2009, and within weeks respiratory virus testing increased 7.5 times. In response, laboratory and client service workforces were increased, physical plant build-out was completed, testing paradigms were converted from routine screening tests and viral culture to a high-capacity molecular assay for respiratory viruses, laboratory information system interfaces were built, and same-day epidemiologic reports were produced. Daily review by leadership of data from emergency rooms, hospital facilities, and the Health System Laboratories enabled real-time management of unfolding events. The ability of System laboratories to rapidly increase to high-volume comprehensive diagnostics, including influenza A subtyping, provided key epidemiologic information for local and state public health departments.",10.3201/eid1601.091167,94cdafua,"['The', 'North', 'Shore', 'Long', 'Island', 'Jewish', 'Health', 'System', 'Laboratories', 'serve', '15', 'hospitals', 'and', 'affiliated', 'regional', 'physician', 'practices', 'in', 'the', 'New', 'York', 'City', 'metropolitan', 'area', 'with', 'virus', 'testing', 'performed', 'at', 'a', 'central', 'reference', 'laboratory', 'The', 'influenza', 'A', 'pandemic', 'H1N1', '2009', 'outbreak', 'began', 'in', 'this', 'area', 'on', 'April', '24', '2009', 'and', 'within', 'weeks', 'respiratory', 'virus', 'testing', 'increased', '7', '5', 'times', 'In', 'response', 'laboratory', 'and', 'client', 'service', 'workforces', 'were', 'increased', 'physical', 'plant', 'build', 'out', 'was', 'completed', 'testing', 'paradigms', 'were', 'converted', 'from', 'routine', 'screening', 'tests', 'and', 'viral', 'culture', 'to', 'a', 'high', 'capacity', 'molecular', 'assay', 'for', 'respiratory', 'viruses', 'laboratory', 'information', 'system', 'interfaces', 'were', 'built', 'and', 'same', 'day', 'epidemiologic', 'reports', 'were', 'produced', 'Daily', 'review', 'by', 'leadership', 'of', 'data', 'from', 'emergency', 'rooms', 'hospital', 'facilities', 'and', 'the', 'Health', 'System', 'Laboratories', 'enabled', 'real', 'time', 'management', 'of', 'unfolding', 'events', 'The', 'ability', 'of', 'System', 'laboratories', 'to', 'rapidly', 'increase', 'to', 'high', 'volume', 'comprehensive', 'diagnostics', 'including', 'influenza', 'A', 'subtyping', 'provided', 'key', 'epidemiologic', 'information', 'for', 'local', 'and', 'state', 'public', 'health', 'departments', '']"
163850,Antibody response of definitive hosts against antigens of two life stages of the neuropathogenic schistosome Trichobilharzia regenti,2015-07-28,Parasit Vectors,https://www.ncbi.nlm.nih.gov/pubmed/26216102/; https://doi.org/10.1186/s13071-015-1007-y,"BACKGROUND: The nasal avian schistosome Trichobilharzia regenti spends part of its intravertebrate period of life within the central nervous system. Migration of the parasites can be accompanied by neuromotor disorders or paralysis in natural definitive hosts (ducks) and even in laboratory mammals. Cercariae are also able to penetrate human skin and induce cercarial dermatitis. While the cellular and antibody responses against cercariae and migrating schistosomula have been investigated in mice, little is known about immune reactions in birds. This study first describes the dynamics of antibody response in infected ducks and identifies frequently recognized antigens that may serve as diagnostic markers of infection by T. regenti. METHODS: Groups of 35 domestic ducks and 10 mallards were exposed to different doses of T. regenti cercariae. Sera were collected at predefined time intervals and tested by ELISA for the presence of specific anti-cercarial IgY and IgM. Antigens recognized by the antibodies were identified on Western blots of cercariae and schistosomula. The applicability in immunodiagnostics was statistically evaluated by expression of specificity and sensitivity values for individual antigens. RESULTS: In ELISA, the levels of anti-cercarial IgM peaked on day 15 pi. Increased production of IgY associated with the later phases of infection was observed in most individuals around 20 dpi and culminated 30 dpi. The time course of antibody response did not differ among experimental groups, variations were only observed in the levels of specific IgY which depended rather on the age of ducks at the time of infection than on the infectious dose. On Western blots, 40 cercarial and 7 schistosomular antigens were recognized by IgY from infected ducks. Among them, 4 cercarial antigens of 50, 47, 32 and 19 kDa provided the most sensitive and specific reactions. CONCLUSIONS: Antigens of cercariae and schistosomula elicited distinct antibody response in ducks, which correlated positively with the age of animals at the time of infection. Several antigens originating in cercariae and fewer in schistosomula were recognized by IgY with diverse sensitivity and specificity; only a few seemed to be common to both stages. Four of them were considered as the most promising candidates for immunodiagnostics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-015-1007-y) contains supplementary material, which is available to authorized users.",10.1186/s13071-015-1007-y,d2505w2z,"['BACKGROUND', 'The', 'nasal', 'avian', 'schistosome', 'Trichobilharzia', 'regenti', 'spends', 'part', 'of', 'its', 'intravertebrate', 'period', 'of', 'life', 'within', 'the', 'central', 'nervous', 'system', 'Migration', 'of', 'the', 'parasites', 'can', 'be', 'accompanied', 'by', 'neuromotor', 'disorders', 'or', 'paralysis', 'in', 'natural', 'definitive', 'hosts', 'ducks', 'and', 'even', 'in', 'laboratory', 'mammals', 'Cercariae', 'are', 'also', 'able', 'to', 'penetrate', 'human', 'skin', 'and', 'induce', 'cercarial', 'dermatitis', 'While', 'the', 'cellular', 'and', 'antibody', 'responses', 'against', 'cercariae', 'and', 'migrating', 'schistosomula', 'have', 'been', 'investigated', 'in', 'mice', 'little', 'is', 'known', 'about', 'immune', 'reactions', 'in', 'birds', 'This', 'study', 'first', 'describes', 'the', 'dynamics', 'of', 'antibody', 'response', 'in', 'infected', 'ducks', 'and', 'identifies', 'frequently', 'recognized', 'antigens', 'that', 'may', 'serve', 'as', 'diagnostic', 'markers', 'of', 'infection', 'by', 'T', 'regenti', 'METHODS', 'Groups', 'of', '35', 'domestic', 'ducks', 'and', '10', 'mallards', 'were', 'exposed', 'to', 'different', 'doses', 'of', 'T', 'regenti', 'cercariae', 'Sera', 'were', 'collected', 'at', 'predefined', 'time', 'intervals', 'and', 'tested', 'by', 'ELISA', 'for', 'the', 'presence', 'of', 'specific', 'anti', 'cercarial', 'IgY', 'and', 'IgM', 'Antigens', 'recognized', 'by', 'the', 'antibodies', 'were', 'identified', 'on', 'Western', 'blots', 'of', 'cercariae', 'and', 'schistosomula', 'The', 'applicability', 'in', 'immunodiagnostics', 'was', 'statistically', 'evaluated', 'by', 'expression', 'of', 'specificity', 'and', 'sensitivity', 'values', 'for', 'individual', 'antigens', 'RESULTS', 'In', 'ELISA', 'the', 'levels', 'of', 'anti', 'cercarial', 'IgM', 'peaked', 'on', 'day', '15', 'pi', 'Increased', 'production', 'of', 'IgY', 'associated', 'with', 'the', 'later', 'phases', 'of', 'infection', 'was', 'observed', 'in', 'most', 'individuals', 'around', '20', 'dpi', 'and', 'culminated', '30', 'dpi', 'The', 'time', 'course', 'of', 'antibody', 'response', 'did', 'not', 'differ', 'among', 'experimental', 'groups', 'variations', 'were', 'only', 'observed', 'in', 'the', 'levels', 'of', 'specific', 'IgY', 'which', 'depended', 'rather', 'on', 'the', 'age', 'of', 'ducks', 'at', 'the', 'time', 'of', 'infection', 'than', 'on', 'the', 'infectious', 'dose', 'On', 'Western', 'blots', '40', 'cercarial', 'and', '7', 'schistosomular', 'antigens', 'were', 'recognized', 'by', 'IgY', 'from', 'infected', 'ducks', 'Among', 'them', '4', 'cercarial', 'antigens', 'of', '50', '47', '32', 'and', '19', 'kDa', 'provided', 'the', 'most', 'sensitive', 'and', 'specific', 'reactions', 'CONCLUSIONS', 'Antigens', 'of', 'cercariae', 'and', 'schistosomula', 'elicited', 'distinct', 'antibody', 'response', 'in', 'ducks', 'which', 'correlated', 'positively', 'with', 'the', 'age', 'of', 'animals', 'at', 'the', 'time', 'of', 'infection', 'Several', 'antigens', 'originating', 'in', 'cercariae', 'and', 'fewer', 'in', 'schistosomula', 'were', 'recognized', 'by', 'IgY', 'with', 'diverse', 'sensitivity', 'and', 'specificity', 'only', 'a', 'few', 'seemed', 'to', 'be', 'common', 'to', 'both', 'stages', 'Four', 'of', 'them', 'were', 'considered', 'as', 'the', 'most', 'promising', 'candidates', 'for', 'immunodiagnostics', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1186', 's13071', '015', '1007', 'y', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
164112,Molecular detection and point-of-care testing in Ebola virus disease and other threats: a new global public health framework to stop outbreaks,2015-09-14,Expert Rev Mol Diagn,https://doi.org/10.1586/14737159.2015.1079776; https://www.ncbi.nlm.nih.gov/pubmed/26367243/,"Ultrahigh sensitivity and specificity assays that detect Ebola virus disease or other highly contagious and deadly diseases quickly and successfully upstream in Spatial Care Paths™ can stop outbreaks from escalating into devastating epidemics ravaging communities locally and countries globally. Even had the WHO and CDC responded more quickly and not misjudged the dissemination of Ebola in West Africa and other world regions, mobile rapid diagnostics were, and still are, not readily available for immediate and definitive diagnosis, a stunning strategic flaw that needs correcting worldwide. This article strategizes point-of-care testing for diagnosis, triage, monitoring, recovery and stopping outbreaks in the USA and other countries; reviews Ebola molecular diagnostics, summarizes USA FDA emergency use authorizations and documents why they should not be stop-gaps; and reduces community risk from internal and external infectious disease threats by enabling public health at points of need.",10.1586/14737159.2015.1079776,3wsihzhk,"['Ultrahigh', 'sensitivity', 'and', 'specificity', 'assays', 'that', 'detect', 'Ebola', 'virus', 'disease', 'or', 'other', 'highly', 'contagious', 'and', 'deadly', 'diseases', 'quickly', 'and', 'successfully', 'upstream', 'in', 'Spatial', 'Care', 'Paths', 'can', 'stop', 'outbreaks', 'from', 'escalating', 'into', 'devastating', 'epidemics', 'ravaging', 'communities', 'locally', 'and', 'countries', 'globally', 'Even', 'had', 'the', 'WHO', 'and', 'CDC', 'responded', 'more', 'quickly', 'and', 'not', 'misjudged', 'the', 'dissemination', 'of', 'Ebola', 'in', 'West', 'Africa', 'and', 'other', 'world', 'regions', 'mobile', 'rapid', 'diagnostics', 'were', 'and', 'still', 'are', 'not', 'readily', 'available', 'for', 'immediate', 'and', 'definitive', 'diagnosis', 'a', 'stunning', 'strategic', 'flaw', 'that', 'needs', 'correcting', 'worldwide', 'This', 'article', 'strategizes', 'point', 'of', 'care', 'testing', 'for', 'diagnosis', 'triage', 'monitoring', 'recovery', 'and', 'stopping', 'outbreaks', 'in', 'the', 'USA', 'and', 'other', 'countries', 'reviews', 'Ebola', 'molecular', 'diagnostics', 'summarizes', 'USA', 'FDA', 'emergency', 'use', 'authorizations', 'and', 'documents', 'why', 'they', 'should', 'not', 'be', 'stop', 'gaps', 'and', 'reduces', 'community', 'risk', 'from', 'internal', 'and', 'external', 'infectious', 'disease', 'threats', 'by', 'enabling', 'public', 'health', 'at', 'points', 'of', 'need', '']"
164417,Prevalence of antibodies against transmissible gastroenteritis virus (TGEV) in Hungary,2018-11-02,Vet Anim Sci,https://doi.org/10.1016/j.vas.2018.11.003; https://www.sciencedirect.com/science/article/pii/S2451943X18300620; https://www.ncbi.nlm.nih.gov/pubmed/32289094/; https://api.elsevier.com/content/article/pii/S2451943X18300620,"Transmissible gastroenteritis (TGE) is a highly contagious enteric disease of swine, which became infrequent with the appearance of porcine respiratory coronavirus (PRCV). TGE was last reported in Hungary in 2013 and the virus has not been found since, therefore a serological survey was planned to estimate the level of protection against it. 908 sera of sows from 93 farms were selected together with 174 archive samples from one farm covering a wider age group. All samples were screened with an indirect immunofluorescence (IF) test with a positive result of 15.42% and 17.82%, respectively. All IF-positive samples were examined with a commercial ELISA, revealing seropositivity against PRCV in almost all cases. These findings should serve as a recommendation to not omit TGE from the diagnostics of diarrhoea in swine.",10.1016/j.vas.2018.11.003,4xhcamks,"['Transmissible', 'gastroenteritis', 'TGE', 'is', 'a', 'highly', 'contagious', 'enteric', 'disease', 'of', 'swine', 'which', 'became', 'infrequent', 'with', 'the', 'appearance', 'of', 'porcine', 'respiratory', 'coronavirus', 'PRCV', 'TGE', 'was', 'last', 'reported', 'in', 'Hungary', 'in', '2013', 'and', 'the', 'virus', 'has', 'not', 'been', 'found', 'since', 'therefore', 'a', 'serological', 'survey', 'was', 'planned', 'to', 'estimate', 'the', 'level', 'of', 'protection', 'against', 'it', '908', 'sera', 'of', 'sows', 'from', '93', 'farms', 'were', 'selected', 'together', 'with', '174', 'archive', 'samples', 'from', 'one', 'farm', 'covering', 'a', 'wider', 'age', 'group', 'All', 'samples', 'were', 'screened', 'with', 'an', 'indirect', 'immunofluorescence', 'IF', 'test', 'with', 'a', 'positive', 'result', 'of', '15', '42', 'and', '17', '82', 'respectively', 'All', 'IF', 'positive', 'samples', 'were', 'examined', 'with', 'a', 'commercial', 'ELISA', 'revealing', 'seropositivity', 'against', 'PRCV', 'in', 'almost', 'all', 'cases', 'These', 'findings', 'should', 'serve', 'as', 'a', 'recommendation', 'to', 'not', 'omit', 'TGE', 'from', 'the', 'diagnostics', 'of', 'diarrhoea', 'in', 'swine', '']"
164925,"Cryptosporidium Infection: Epidemiology, Pathogenesis, and Differential Diagnosis",2019-10-22,Eur J Microbiol Immunol (Bp),https://www.ncbi.nlm.nih.gov/pubmed/31934363/; https://doi.org/10.1556/1886.2019.00019,"Cryptosporidium is a protozoan that infects a wide variety of vertebrates, including humans, causing acute gastroenteritis. The disease manifests with abdominal pain and diarrhea similar to that of choleric infection. In the immunocompromised hosts, the parasite causes prolonged infections that can also be fatal. For this reason, cryptosporidiosis is considered one of riskiest opportunistic infections for patients with acquired immunodeficiency syndrome. The best way to control the infection in these patients is setting up sensitive and specific diagnostic tests for epidemiological surveillance and morbidity reduction. Here, we summarized the general aspects of Cryptosporidium infection focusing on available diagnostic tools used for the diagnosis of cryptosporidiosis. Molecular methods currently available for its detection and progress in the development of new diagnostics for cryptosporidiosis are also discussed.",10.1556/1886.2019.00019,9qj8d2f7,"['Cryptosporidium', 'is', 'a', 'protozoan', 'that', 'infects', 'a', 'wide', 'variety', 'of', 'vertebrates', 'including', 'humans', 'causing', 'acute', 'gastroenteritis', 'The', 'disease', 'manifests', 'with', 'abdominal', 'pain', 'and', 'diarrhea', 'similar', 'to', 'that', 'of', 'choleric', 'infection', 'In', 'the', 'immunocompromised', 'hosts', 'the', 'parasite', 'causes', 'prolonged', 'infections', 'that', 'can', 'also', 'be', 'fatal', 'For', 'this', 'reason', 'cryptosporidiosis', 'is', 'considered', 'one', 'of', 'riskiest', 'opportunistic', 'infections', 'for', 'patients', 'with', 'acquired', 'immunodeficiency', 'syndrome', 'The', 'best', 'way', 'to', 'control', 'the', 'infection', 'in', 'these', 'patients', 'is', 'setting', 'up', 'sensitive', 'and', 'specific', 'diagnostic', 'tests', 'for', 'epidemiological', 'surveillance', 'and', 'morbidity', 'reduction', 'Here', 'we', 'summarized', 'the', 'general', 'aspects', 'of', 'Cryptosporidium', 'infection', 'focusing', 'on', 'available', 'diagnostic', 'tools', 'used', 'for', 'the', 'diagnosis', 'of', 'cryptosporidiosis', 'Molecular', 'methods', 'currently', 'available', 'for', 'its', 'detection', 'and', 'progress', 'in', 'the', 'development', 'of', 'new', 'diagnostics', 'for', 'cryptosporidiosis', 'are', 'also', 'discussed', '']"
165348,Metagenomic Sequencing Detects Respiratory Pathogens in Hematopoietic Cellular Transplant Patients,2017-01-24,bioRxiv,https://doi.org/10.1101/102798,"Current microbiologic diagnostics often fail to identify the etiology of lower respiratory tract infections (LRTI) in hematopoietic cellular transplant recipients (HCT), which precludes the implementation of targeted therapies. To address the need for improved LRTI diagnostics, we evaluated the utility of metagenomic next generation sequencing (mNGS) of bronchoalveolar lavage (BAL) to detect microbial pathogens in HCT patients with acute respiratory illnesses. We enrolled 22 post-HCT adults ages 19-69 years with acute respiratory illnesses who underwent BAL at the University of Michigan between January 2012 and May 2013. mNGS was performed on BAL fluid to detect microbes and simultaneously assess the host transcriptional response. Results were compared against conventional microbiologic assays. mNGS demonstrated 100% sensitivity for detecting respiratory microbes (human metapneumovirus, respiratory syncytial virus, Stenotrophomonas maltophilia, human herpesvirus 6 and cytomegalovirus) when compared to standard testing. Previously unrecognized LRTI pathogens were identified in six patients for whom standard testing was negative (human coronavirus 229E, human rhinovirus A, Corynebacterium propinquum and Streptococcus mitis); findings were confirmed by independent PCR and 16S rRNA sequencing. Relative to patients without infection, patients with infection had increased expression of immunity related genes (p=0.022) and significantly lower diversity of their respiratory microbiome (p=0.017). Compared to conventional diagnostics, mNGS enhanced detection of pathogens in BAL fluid from HCT patients. Furthermore, our results suggest that combining unbiased microbial pathogen detection with assessment of host gene biomarkers of immune response may hold promise for enhancing the diagnosis of post-HCT respiratory infections.",10.1101/102798,km0b1z64,"['Current', 'microbiologic', 'diagnostics', 'often', 'fail', 'to', 'identify', 'the', 'etiology', 'of', 'lower', 'respiratory', 'tract', 'infections', 'LRTI', 'in', 'hematopoietic', 'cellular', 'transplant', 'recipients', 'HCT', 'which', 'precludes', 'the', 'implementation', 'of', 'targeted', 'therapies', 'To', 'address', 'the', 'need', 'for', 'improved', 'LRTI', 'diagnostics', 'we', 'evaluated', 'the', 'utility', 'of', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'of', 'bronchoalveolar', 'lavage', 'BAL', 'to', 'detect', 'microbial', 'pathogens', 'in', 'HCT', 'patients', 'with', 'acute', 'respiratory', 'illnesses', 'We', 'enrolled', '22', 'post', 'HCT', 'adults', 'ages', '19', '69', 'years', 'with', 'acute', 'respiratory', 'illnesses', 'who', 'underwent', 'BAL', 'at', 'the', 'University', 'of', 'Michigan', 'between', 'January', '2012', 'and', 'May', '2013', 'mNGS', 'was', 'performed', 'on', 'BAL', 'fluid', 'to', 'detect', 'microbes', 'and', 'simultaneously', 'assess', 'the', 'host', 'transcriptional', 'response', 'Results', 'were', 'compared', 'against', 'conventional', 'microbiologic', 'assays', 'mNGS', 'demonstrated', '100', 'sensitivity', 'for', 'detecting', 'respiratory', 'microbes', 'human', 'metapneumovirus', 'respiratory', 'syncytial', 'virus', 'Stenotrophomonas', 'maltophilia', 'human', 'herpesvirus', '6', 'and', 'cytomegalovirus', 'when', 'compared', 'to', 'standard', 'testing', 'Previously', 'unrecognized', 'LRTI', 'pathogens', 'were', 'identified', 'in', 'six', 'patients', 'for', 'whom', 'standard', 'testing', 'was', 'negative', 'human', 'coronavirus', '229E', 'human', 'rhinovirus', 'A', 'Corynebacterium', 'propinquum', 'and', 'Streptococcus', 'mitis', 'findings', 'were', 'confirmed', 'by', 'independent', 'PCR', 'and', '16S', 'rRNA', 'sequencing', 'Relative', 'to', 'patients', 'without', 'infection', 'patients', 'with', 'infection', 'had', 'increased', 'expression', 'of', 'immunity', 'related', 'genes', 'p', '0', '022', 'and', 'significantly', 'lower', 'diversity', 'of', 'their', 'respiratory', 'microbiome', 'p', '0', '017', 'Compared', 'to', 'conventional', 'diagnostics', 'mNGS', 'enhanced', 'detection', 'of', 'pathogens', 'in', 'BAL', 'fluid', 'from', 'HCT', 'patients', 'Furthermore', 'our', 'results', 'suggest', 'that', 'combining', 'unbiased', 'microbial', 'pathogen', 'detection', 'with', 'assessment', 'of', 'host', 'gene', 'biomarkers', 'of', 'immune', 'response', 'may', 'hold', 'promise', 'for', 'enhancing', 'the', 'diagnosis', 'of', 'post', 'HCT', 'respiratory', 'infections', '']"
165429,Nanobioimaging and sensing of infectious diseases,2010-03-18,Advanced Drug Delivery Reviews,https://www.ncbi.nlm.nih.gov/pubmed/19931579/; https://api.elsevier.com/content/article/pii/S0169409X0900355X; https://www.sciencedirect.com/science/article/pii/S0169409X0900355X; https://doi.org/10.1016/j.addr.2009.11.014,"Abstract New methods to identify trace amount of infectious pathogens rapidly, accurately and with high sensitivity are in constant demand to prevent epidemics and loss of lives. Early detection of these pathogens to prevent, treat and contain the spread of infections is crucial. Therefore, there is a need and urgency for sensitive, specific, accurate, easy-to-use diagnostic tests. Versatile biofunctionalized engineered nanomaterials are proving to be promising in meeting these needs in diagnosing the pathogens in food, blood and clinical samples. The unique optical and magnetic properties of the nanoscale materials have been put to use for the diagnostics. In this review, we focus on the developments of the fluorescent nanoparticles, metallic nanostructures and superparamagnetic nanoparticles for bioimaging and detection of infectious microorganisms. The various nanodiagnostic assays developed to image, detect and capture infectious virus and bacteria in solutions, food or biological samples in vitro and in vivo are presented and their relevance to developing countries is discussed.",10.1016/j.addr.2009.11.014,hzs6y5lo,"['Abstract', 'New', 'methods', 'to', 'identify', 'trace', 'amount', 'of', 'infectious', 'pathogens', 'rapidly', 'accurately', 'and', 'with', 'high', 'sensitivity', 'are', 'in', 'constant', 'demand', 'to', 'prevent', 'epidemics', 'and', 'loss', 'of', 'lives', 'Early', 'detection', 'of', 'these', 'pathogens', 'to', 'prevent', 'treat', 'and', 'contain', 'the', 'spread', 'of', 'infections', 'is', 'crucial', 'Therefore', 'there', 'is', 'a', 'need', 'and', 'urgency', 'for', 'sensitive', 'specific', 'accurate', 'easy', 'to', 'use', 'diagnostic', 'tests', 'Versatile', 'biofunctionalized', 'engineered', 'nanomaterials', 'are', 'proving', 'to', 'be', 'promising', 'in', 'meeting', 'these', 'needs', 'in', 'diagnosing', 'the', 'pathogens', 'in', 'food', 'blood', 'and', 'clinical', 'samples', 'The', 'unique', 'optical', 'and', 'magnetic', 'properties', 'of', 'the', 'nanoscale', 'materials', 'have', 'been', 'put', 'to', 'use', 'for', 'the', 'diagnostics', 'In', 'this', 'review', 'we', 'focus', 'on', 'the', 'developments', 'of', 'the', 'fluorescent', 'nanoparticles', 'metallic', 'nanostructures', 'and', 'superparamagnetic', 'nanoparticles', 'for', 'bioimaging', 'and', 'detection', 'of', 'infectious', 'microorganisms', 'The', 'various', 'nanodiagnostic', 'assays', 'developed', 'to', 'image', 'detect', 'and', 'capture', 'infectious', 'virus', 'and', 'bacteria', 'in', 'solutions', 'food', 'or', 'biological', 'samples', 'in', 'vitro', 'and', 'in', 'vivo', 'are', 'presented', 'and', 'their', 'relevance', 'to', 'developing', 'countries', 'is', 'discussed', '']"
165438,Emerging Pathogens: Challenges and Successes of Molecular Diagnostics,2008-05-01,The Journal of Molecular Diagnostics,https://www.ncbi.nlm.nih.gov/pubmed/18403608/; https://api.elsevier.com/content/article/pii/S1525157810601493; https://doi.org/10.2353/jmoldx.2008.070063; http://europepmc.org/articles/pmc2329782?pdf=render; https://www.sciencedirect.com/science/article/pii/S1525157810601493,"More than 50 emerging and reemerging pathogens have been identified during the last 40 years. Until 1992 when the Institute of Medicine issued a report that defined emerging infectious diseases, medicine had been complacent about such infectious diseases despite the alarm bells of infections with human immunodeficiency virus. Molecular tools have proven useful in discovering and characterizing emerging viruses and bacteria such as Sin Nombre virus (hantaviral pulmonary syndrome), hepatitis C virus, Bartonella henselae (cat scratch disease, bacillary angiomatosis), and Anaplasma phagocytophilum (human granulocytotropic anaplasmosis). The feasibility of applying molecular diagnostics to dangerous, fastidious, and uncultivated agents for which conventional tests do not yield timely diagnoses has achieved proof of concept for many agents, but widespread use of cost-effective, validated commercial assays has yet to occur. This review presents representative emerging viral respiratory infections, hemorrhagic fevers, and hepatitides, as well as bacterial and parasitic zoonotic, gastrointestinal, and pulmonary infections. Agent characteristics, epidemiology, clinical manifestations, and diagnostic methods are tabulated for another 22 emerging viruses and five emerging bacteria. The ongoing challenge to the field of molecular diagnostics is to apply contemporary knowledge to facilitate agent diagnosis as well as to further discoveries of novel pathogens.",10.2353/jmoldx.2008.070063,ijdl4toy,"['More', 'than', '50', 'emerging', 'and', 'reemerging', 'pathogens', 'have', 'been', 'identified', 'during', 'the', 'last', '40', 'years', 'Until', '1992', 'when', 'the', 'Institute', 'of', 'Medicine', 'issued', 'a', 'report', 'that', 'defined', 'emerging', 'infectious', 'diseases', 'medicine', 'had', 'been', 'complacent', 'about', 'such', 'infectious', 'diseases', 'despite', 'the', 'alarm', 'bells', 'of', 'infections', 'with', 'human', 'immunodeficiency', 'virus', 'Molecular', 'tools', 'have', 'proven', 'useful', 'in', 'discovering', 'and', 'characterizing', 'emerging', 'viruses', 'and', 'bacteria', 'such', 'as', 'Sin', 'Nombre', 'virus', 'hantaviral', 'pulmonary', 'syndrome', 'hepatitis', 'C', 'virus', 'Bartonella', 'henselae', 'cat', 'scratch', 'disease', 'bacillary', 'angiomatosis', 'and', 'Anaplasma', 'phagocytophilum', 'human', 'granulocytotropic', 'anaplasmosis', 'The', 'feasibility', 'of', 'applying', 'molecular', 'diagnostics', 'to', 'dangerous', 'fastidious', 'and', 'uncultivated', 'agents', 'for', 'which', 'conventional', 'tests', 'do', 'not', 'yield', 'timely', 'diagnoses', 'has', 'achieved', 'proof', 'of', 'concept', 'for', 'many', 'agents', 'but', 'widespread', 'use', 'of', 'cost', 'effective', 'validated', 'commercial', 'assays', 'has', 'yet', 'to', 'occur', 'This', 'review', 'presents', 'representative', 'emerging', 'viral', 'respiratory', 'infections', 'hemorrhagic', 'fevers', 'and', 'hepatitides', 'as', 'well', 'as', 'bacterial', 'and', 'parasitic', 'zoonotic', 'gastrointestinal', 'and', 'pulmonary', 'infections', 'Agent', 'characteristics', 'epidemiology', 'clinical', 'manifestations', 'and', 'diagnostic', 'methods', 'are', 'tabulated', 'for', 'another', '22', 'emerging', 'viruses', 'and', 'five', 'emerging', 'bacteria', 'The', 'ongoing', 'challenge', 'to', 'the', 'field', 'of', 'molecular', 'diagnostics', 'is', 'to', 'apply', 'contemporary', 'knowledge', 'to', 'facilitate', 'agent', 'diagnosis', 'as', 'well', 'as', 'to', 'further', 'discoveries', 'of', 'novel', 'pathogens', '']"
165464,Mechanisms of viral impact on asthma exacerbations,2004-02-29,Journal of Allergy and Clinical Immunology,https://api.elsevier.com/content/article/pii/S0091674904004245; https://www.sciencedirect.com/science/article/pii/S0091674904004245,"Abstract Rationale Respiratory viruses are a frequent cause of wheezing in infants and children. 60 - 85% of asthma exacerbations in children and up to 50% of asthma exacerbations in adults are attributed to respiratory viruses. Previous studies investigated the role of rhinoviruses, RS-viruses and adenoviruses in development of asthma exacerbations in children hospitalized in the clinic of the Institute of Immunology (Moscow, Russia). Rhinovirus was the most frequently detected – 33 samples (24.8% of all tested samples), adenovirus – 5 samples (3.8%), RSV– 4 samples (3.0%), and mixed infections (rhinovirus and RSV) – 1 sample (0.7%). Among positive samples rhinovirus accounted for 76.7%, adenovirus - 11.6%, RSV - 9.3%, and mixed infection - 2.3%. Methods Primers for PCR diagnostics of Parainfluenza viruses of 1, 2 and 3 type and coronaviruses OC43 and 229E were developed. Investigation of HLA-alleles and genotypes was conducted in patients with virus-induced bronchial asthma to reveal HLA-associated markers of susceptibility to viral-induced asthma. Results An increased frequency of HLA-DRB1∗13 specificity and reduced frequencies of HLA-DRB1∗04 and HLA-DRB1∗11 specificities were noted in the viral-induced asthmatics compared to the healthy control group. A minimal increase of HLA-DRB1 homozygotes - 21% was also noted in comparison with the control group - 14%. Conclusions Investigation of HLA-haplotype in patients with viral-induced outbreaks of asthma via HLA-genotyping may reveal more evident associations between HLA-haplotypes and individual respiratory viral infections.",10.1016/j.jaci.2004.01.419,d7nj2cdm,"['Abstract', 'Rationale', 'Respiratory', 'viruses', 'are', 'a', 'frequent', 'cause', 'of', 'wheezing', 'in', 'infants', 'and', 'children', '60', '85', 'of', 'asthma', 'exacerbations', 'in', 'children', 'and', 'up', 'to', '50', 'of', 'asthma', 'exacerbations', 'in', 'adults', 'are', 'attributed', 'to', 'respiratory', 'viruses', 'Previous', 'studies', 'investigated', 'the', 'role', 'of', 'rhinoviruses', 'RS', 'viruses', 'and', 'adenoviruses', 'in', 'development', 'of', 'asthma', 'exacerbations', 'in', 'children', 'hospitalized', 'in', 'the', 'clinic', 'of', 'the', 'Institute', 'of', 'Immunology', 'Moscow', 'Russia', 'Rhinovirus', 'was', 'the', 'most', 'frequently', 'detected', '33', 'samples', '24', '8', 'of', 'all', 'tested', 'samples', 'adenovirus', '5', 'samples', '3', '8', 'RSV', '4', 'samples', '3', '0', 'and', 'mixed', 'infections', 'rhinovirus', 'and', 'RSV', '1', 'sample', '0', '7', 'Among', 'positive', 'samples', 'rhinovirus', 'accounted', 'for', '76', '7', 'adenovirus', '11', '6', 'RSV', '9', '3', 'and', 'mixed', 'infection', '2', '3', 'Methods', 'Primers', 'for', 'PCR', 'diagnostics', 'of', 'Parainfluenza', 'viruses', 'of', '1', '2', 'and', '3', 'type', 'and', 'coronaviruses', 'OC43', 'and', '229E', 'were', 'developed', 'Investigation', 'of', 'HLA', 'alleles', 'and', 'genotypes', 'was', 'conducted', 'in', 'patients', 'with', 'virus', 'induced', 'bronchial', 'asthma', 'to', 'reveal', 'HLA', 'associated', 'markers', 'of', 'susceptibility', 'to', 'viral', 'induced', 'asthma', 'Results', 'An', 'increased', 'frequency', 'of', 'HLA', 'DRB1', '13', 'specificity', 'and', 'reduced', 'frequencies', 'of', 'HLA', 'DRB1', '04', 'and', 'HLA', 'DRB1', '11', 'specificities', 'were', 'noted', 'in', 'the', 'viral', 'induced', 'asthmatics', 'compared', 'to', 'the', 'healthy', 'control', 'group', 'A', 'minimal', 'increase', 'of', 'HLA', 'DRB1', 'homozygotes', '21', 'was', 'also', 'noted', 'in', 'comparison', 'with', 'the', 'control', 'group', '14', 'Conclusions', 'Investigation', 'of', 'HLA', 'haplotype', 'in', 'patients', 'with', 'viral', 'induced', 'outbreaks', 'of', 'asthma', 'via', 'HLA', 'genotyping', 'may', 'reveal', 'more', 'evident', 'associations', 'between', 'HLA', 'haplotypes', 'and', 'individual', 'respiratory', 'viral', 'infections', '']"
166361,Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana,2020-04-16,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32316233/; https://doi.org/10.3390/diagnostics10040229,"Background: Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency screening test is essential for malaria treatment, control, and elimination programs. G6PD deficient individuals are at high risk of severe hemolysis when given anti-malarial drugs such as primaquine, quinine, other sulphonamide-containing medicines, and chloroquine, which has recently been shown to be potent for the treatment of coronavirus disease (COVID-19). We evaluated the geographical accessibility to POC testing for G6PD deficiency in Ghana, a malaria-endemic country. Methods: We obtained the geographic information of 100 randomly sampled clinics previously included in a cross-sectional survey. We also obtained the geolocated data of all public hospitals providing G6PD deficiency testing services in the region. Using ArcGIS 10.5, we quantified geographical access to G6PD deficiency screening test and identified clinics as well as visualize locations with poor access for targeted improvement. The travel time was estimated using an assumed speed of 20 km per hour. Findings: Of the 100 clinics, 58% were Community-based Health Planning and Services facilities, and 42% were sub-district health centers. The majority (92%) were Ghana Health Service facilities, and the remaining 8% were Christian Health Association of Ghana facilities. Access to G6PD deficiency screening test was varied across the districts, and G6PD deficiency screening test was available in all eight public hospitals. This implies that the health facility-to-population ratio for G6PD deficiency testing service was approximately 1:159,210 (8/1,273,677) population. The spatial analysis quantified the current mean distance to a G6PD deficiency testing service from all locations in the region to be 34 ± 14 km, and travel time (68 ± 27 min). The estimated mean distance from a clinic to a district hospital for G6PD deficiency testing services was 15 ± 11 km, and travel time (46 ± 33 min). Conclusion: Access to POC testing for G6PD deficiency in Ghana was poor. Given the challenges associated with G6PD deficiency, it would be essential to improve access to G6PD deficiency POC testing to facilitate administration of sulphadoxine-pyrimethamine to pregnant women, full implementation of the malaria control program in Ghana, and treatment of COVID-19 patients with chloroquine in malaria-endemic countries. To enable the World Health Organization include appropriate G6PD POC diagnostic tests in its list of essential in-vitro diagnostics for use in resource-limited settings, we recommend a wider evaluation of available POC diagnostic tests for G6PD deficiency, particularly in malaria-endemic countries.",10.3390/diagnostics10040229,0i8nkpjf,"['Background', 'Glucose', '6', 'Phosphate', 'Dehydrogenase', 'G6PD', 'deficiency', 'screening', 'test', 'is', 'essential', 'for', 'malaria', 'treatment', 'control', 'and', 'elimination', 'programs', 'G6PD', 'deficient', 'individuals', 'are', 'at', 'high', 'risk', 'of', 'severe', 'hemolysis', 'when', 'given', 'anti', 'malarial', 'drugs', 'such', 'as', 'primaquine', 'quinine', 'other', 'sulphonamide', 'containing', 'medicines', 'and', 'chloroquine', 'which', 'has', 'recently', 'been', 'shown', 'to', 'be', 'potent', 'for', 'the', 'treatment', 'of', 'coronavirus', 'disease', 'COVID', '19', 'We', 'evaluated', 'the', 'geographical', 'accessibility', 'to', 'POC', 'testing', 'for', 'G6PD', 'deficiency', 'in', 'Ghana', 'a', 'malaria', 'endemic', 'country', 'Methods', 'We', 'obtained', 'the', 'geographic', 'information', 'of', '100', 'randomly', 'sampled', 'clinics', 'previously', 'included', 'in', 'a', 'cross', 'sectional', 'survey', 'We', 'also', 'obtained', 'the', 'geolocated', 'data', 'of', 'all', 'public', 'hospitals', 'providing', 'G6PD', 'deficiency', 'testing', 'services', 'in', 'the', 'region', 'Using', 'ArcGIS', '10', '5', 'we', 'quantified', 'geographical', 'access', 'to', 'G6PD', 'deficiency', 'screening', 'test', 'and', 'identified', 'clinics', 'as', 'well', 'as', 'visualize', 'locations', 'with', 'poor', 'access', 'for', 'targeted', 'improvement', 'The', 'travel', 'time', 'was', 'estimated', 'using', 'an', 'assumed', 'speed', 'of', '20', 'km', 'per', 'hour', 'Findings', 'Of', 'the', '100', 'clinics', '58', 'were', 'Community', 'based', 'Health', 'Planning', 'and', 'Services', 'facilities', 'and', '42', 'were', 'sub', 'district', 'health', 'centers', 'The', 'majority', '92', 'were', 'Ghana', 'Health', 'Service', 'facilities', 'and', 'the', 'remaining', '8', 'were', 'Christian', 'Health', 'Association', 'of', 'Ghana', 'facilities', 'Access', 'to', 'G6PD', 'deficiency', 'screening', 'test', 'was', 'varied', 'across', 'the', 'districts', 'and', 'G6PD', 'deficiency', 'screening', 'test', 'was', 'available', 'in', 'all', 'eight', 'public', 'hospitals', 'This', 'implies', 'that', 'the', 'health', 'facility', 'to', 'population', 'ratio', 'for', 'G6PD', 'deficiency', 'testing', 'service', 'was', 'approximately', '1', '159', '210', '8', '1', '273', '677', 'population', 'The', 'spatial', 'analysis', 'quantified', 'the', 'current', 'mean', 'distance', 'to', 'a', 'G6PD', 'deficiency', 'testing', 'service', 'from', 'all', 'locations', 'in', 'the', 'region', 'to', 'be', '34', '14', 'km', 'and', 'travel', 'time', '68', '27', 'min', 'The', 'estimated', 'mean', 'distance', 'from', 'a', 'clinic', 'to', 'a', 'district', 'hospital', 'for', 'G6PD', 'deficiency', 'testing', 'services', 'was', '15', '11', 'km', 'and', 'travel', 'time', '46', '33', 'min', 'Conclusion', 'Access', 'to', 'POC', 'testing', 'for', 'G6PD', 'deficiency', 'in', 'Ghana', 'was', 'poor', 'Given', 'the', 'challenges', 'associated', 'with', 'G6PD', 'deficiency', 'it', 'would', 'be', 'essential', 'to', 'improve', 'access', 'to', 'G6PD', 'deficiency', 'POC', 'testing', 'to', 'facilitate', 'administration', 'of', 'sulphadoxine', 'pyrimethamine', 'to', 'pregnant', 'women', 'full', 'implementation', 'of', 'the', 'malaria', 'control', 'program', 'in', 'Ghana', 'and', 'treatment', 'of', 'COVID', '19', 'patients', 'with', 'chloroquine', 'in', 'malaria', 'endemic', 'countries', 'To', 'enable', 'the', 'World', 'Health', 'Organization', 'include', 'appropriate', 'G6PD', 'POC', 'diagnostic', 'tests', 'in', 'its', 'list', 'of', 'essential', 'in', 'vitro', 'diagnostics', 'for', 'use', 'in', 'resource', 'limited', 'settings', 'we', 'recommend', 'a', 'wider', 'evaluation', 'of', 'available', 'POC', 'diagnostic', 'tests', 'for', 'G6PD', 'deficiency', 'particularly', 'in', 'malaria', 'endemic', 'countries', '']"
166396,"Human bocavirus, coronavirus, and polyomavirus detected among patients hospitalised with severe acute respiratory illness in South Africa, 2012 to 2013",2018-07-18,Health Sci Rep,https://www.ncbi.nlm.nih.gov/pubmed/30623094/; https://doi.org/10.1002/hsr2.59,"AIM: To investigate the prevalence of human bocavirus (hBoV), human coronaviruses (hCoV), and human polyomaviruses (hPyV) among patients with severe acute respiratory illness (SARI), in South Africa. METHODS: The study included 680 South African patients randomly selected in age‐defined categories from hospitalised patients enrolled through SARI surveillance during 2012 to 2013. A multiplex reverse transcription real‐time polymerase chain reaction assay was used to detect hBoV; hCoV‐OC43, hCoV‐229E, hCoV‐NL63, and hCoV‐HKU1; and Washington University hPyV (hPyV‐WU) and Karolinska Insitute hPyV (hPyV‐KI), in respiratory tract specimens collected from patients with SARI. All respiratory specimens from patients enrolled through SARI surveillance were also routinely tested by multiplex reverse transcription real‐time polymerase chain reaction for adenovirus; enterovirus; human metapneumovirus; parainfluenza virus types 1, 2, and 3; respiratory syncytial virus; rhinovirus; influenza A, and influenza B. RESULTS: Human bocavirus, hCoV‐229E, and hPyV‐WU were detected in 3.7% (25/680), 4.1% (28/680), and 4.1% (28/680) of respiratory specimens, respectively. All other viruses were detected in <2% of specimens. Rhinovirus was the most common coinfecting virus (21.4%‐60.7%), followed by adenovirus (21.4%‐39.3%), and respiratory syncytial virus (10.7%‐24.0%). Testing for the additional viruses (hBoV, hCoV, and hPyV) decreased the number of specimens that initially tested negative by 2.9% (20/680). CONCLUSION: Inclusion of laboratory tests for hBoV, hCoV‐229E, and hPyV‐WU in differential testing algorithms for surveillance and diagnostics for suspected cases of respiratory illness of unknown cause may improve our understanding of the etiology of SARI, especially in a country like South Africa with a high number of immune compromised persons.",10.1002/hsr2.59,nx5a9bq9,"['AIM', 'To', 'investigate', 'the', 'prevalence', 'of', 'human', 'bocavirus', 'hBoV', 'human', 'coronaviruses', 'hCoV', 'and', 'human', 'polyomaviruses', 'hPyV', 'among', 'patients', 'with', 'severe', 'acute', 'respiratory', 'illness', 'SARI', 'in', 'South', 'Africa', 'METHODS', 'The', 'study', 'included', '680', 'South', 'African', 'patients', 'randomly', 'selected', 'in', 'age', 'defined', 'categories', 'from', 'hospitalised', 'patients', 'enrolled', 'through', 'SARI', 'surveillance', 'during', '2012', 'to', '2013', 'A', 'multiplex', 'reverse', 'transcription', 'real', 'time', 'polymerase', 'chain', 'reaction', 'assay', 'was', 'used', 'to', 'detect', 'hBoV', 'hCoV', 'OC43', 'hCoV', '229E', 'hCoV', 'NL63', 'and', 'hCoV', 'HKU1', 'and', 'Washington', 'University', 'hPyV', 'hPyV', 'WU', 'and', 'Karolinska', 'Insitute', 'hPyV', 'hPyV', 'KI', 'in', 'respiratory', 'tract', 'specimens', 'collected', 'from', 'patients', 'with', 'SARI', 'All', 'respiratory', 'specimens', 'from', 'patients', 'enrolled', 'through', 'SARI', 'surveillance', 'were', 'also', 'routinely', 'tested', 'by', 'multiplex', 'reverse', 'transcription', 'real', 'time', 'polymerase', 'chain', 'reaction', 'for', 'adenovirus', 'enterovirus', 'human', 'metapneumovirus', 'parainfluenza', 'virus', 'types', '1', '2', 'and', '3', 'respiratory', 'syncytial', 'virus', 'rhinovirus', 'influenza', 'A', 'and', 'influenza', 'B', 'RESULTS', 'Human', 'bocavirus', 'hCoV', '229E', 'and', 'hPyV', 'WU', 'were', 'detected', 'in', '3', '7', '25', '680', '4', '1', '28', '680', 'and', '4', '1', '28', '680', 'of', 'respiratory', 'specimens', 'respectively', 'All', 'other', 'viruses', 'were', 'detected', 'in', '2', 'of', 'specimens', 'Rhinovirus', 'was', 'the', 'most', 'common', 'coinfecting', 'virus', '21', '4', '60', '7', 'followed', 'by', 'adenovirus', '21', '4', '39', '3', 'and', 'respiratory', 'syncytial', 'virus', '10', '7', '24', '0', 'Testing', 'for', 'the', 'additional', 'viruses', 'hBoV', 'hCoV', 'and', 'hPyV', 'decreased', 'the', 'number', 'of', 'specimens', 'that', 'initially', 'tested', 'negative', 'by', '2', '9', '20', '680', 'CONCLUSION', 'Inclusion', 'of', 'laboratory', 'tests', 'for', 'hBoV', 'hCoV', '229E', 'and', 'hPyV', 'WU', 'in', 'differential', 'testing', 'algorithms', 'for', 'surveillance', 'and', 'diagnostics', 'for', 'suspected', 'cases', 'of', 'respiratory', 'illness', 'of', 'unknown', 'cause', 'may', 'improve', 'our', 'understanding', 'of', 'the', 'etiology', 'of', 'SARI', 'especially', 'in', 'a', 'country', 'like', 'South', 'Africa', 'with', 'a', 'high', 'number', 'of', 'immune', 'compromised', 'persons', '']"
166617,Intervention strategies for emerging respiratory virus infections: policy and public health considerations,2013-03-08,Curr Opin Virol,https://www.ncbi.nlm.nih.gov/pubmed/23477831/; https://www.sciencedirect.com/science/article/pii/S1879625713000242; https://doi.org/10.1016/j.coviro.2013.02.004; https://api.elsevier.com/content/article/pii/S1879625713000242,"Respiratory viruses have emerged and re-emerged in humans for hundreds of years. In the recent past avian and animal influenza viruses have caused human disease ranging from conjunctivitis to respiratory illnesses, including the 2009–10 A(H1N1)pdm09 pandemic. Coronaviruses, human metapneumovirus (hMPV) and enteroviruses have also impacted humans globally. Since the likely public health impacts are common, plans and policies for intervention strategies can be developed, encompassing early detection through surveillance and diagnostics, as well as treatment and prevention through clinical and non-clinical interventions. The global comprehensiveness of these varies according to differing resources, competing health priorities and the causative agent, yet, irrespective of this, activities must be proportional to the threat. Pandemics and severe epidemics enable policies to be tested and gaps identified.",10.1016/j.coviro.2013.02.004,u8pjg6op,"['Respiratory', 'viruses', 'have', 'emerged', 'and', 're', 'emerged', 'in', 'humans', 'for', 'hundreds', 'of', 'years', 'In', 'the', 'recent', 'past', 'avian', 'and', 'animal', 'influenza', 'viruses', 'have', 'caused', 'human', 'disease', 'ranging', 'from', 'conjunctivitis', 'to', 'respiratory', 'illnesses', 'including', 'the', '2009', '10', 'A', 'H1N1', 'pdm09', 'pandemic', 'Coronaviruses', 'human', 'metapneumovirus', 'hMPV', 'and', 'enteroviruses', 'have', 'also', 'impacted', 'humans', 'globally', 'Since', 'the', 'likely', 'public', 'health', 'impacts', 'are', 'common', 'plans', 'and', 'policies', 'for', 'intervention', 'strategies', 'can', 'be', 'developed', 'encompassing', 'early', 'detection', 'through', 'surveillance', 'and', 'diagnostics', 'as', 'well', 'as', 'treatment', 'and', 'prevention', 'through', 'clinical', 'and', 'non', 'clinical', 'interventions', 'The', 'global', 'comprehensiveness', 'of', 'these', 'varies', 'according', 'to', 'differing', 'resources', 'competing', 'health', 'priorities', 'and', 'the', 'causative', 'agent', 'yet', 'irrespective', 'of', 'this', 'activities', 'must', 'be', 'proportional', 'to', 'the', 'threat', 'Pandemics', 'and', 'severe', 'epidemics', 'enable', 'policies', 'to', 'be', 'tested', 'and', 'gaps', 'identified', '']"
167221,Rapid Isothermal Amplification and Portable Detection System for SARS-CoV-2,2020-05-21,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32511358/; https://doi.org/10.1101/2020.05.21.108381,"The COVID-19 pandemic provides an urgent example where a gap exists between availability of state-of-the-art diagnostics and current needs. As assay details and primer sequences become widely known, many laboratories could perform diagnostic tests using methods such as RT-PCR or isothermal RT-LAMP amplification. A key advantage of RT-LAMP based approaches compared to RT-PCR is that RT-LAMP is known to be robust in detecting targets from unprocessed samples. In addition, RT-LAMP assays are performed at a constant temperature enabling speed, simplicity, and point-of-use testing. Here, we provide the details of an RT-LAMP isothermal assay for the detection of SARS-CoV-2 virus with performance comparable to currently approved tests using RT-PCR. We characterize the assay by introducing swabs in virus spiked synthetic nasal fluids, moving the swab to viral transport medium (VTM), and using a volume of that VTM for performing the amplification without an RNA extraction kit. The assay has a Limit-of-Detection (LOD) of 50 RNA copies/μL in the VTM solution within 20 minutes, and LOD of 5000 RNA copies/μL in the nasal solution. Additionally, we show the utility of this assay for real-time point-of-use testing by demonstrating detection of SARS-CoV-2 virus in less than 40 minutes using an additively manufactured cartridge and a smartphone-based reader. Finally, we explore the speed and cost advantages by comparing the required resources and workflows with RT-PCR. This work could accelerate the development and availability of SARS-CoV-2 diagnostics by proving alternatives to conventional laboratory benchtop tests.",10.1101/2020.05.21.108381,6epdh88j,"['The', 'COVID', '19', 'pandemic', 'provides', 'an', 'urgent', 'example', 'where', 'a', 'gap', 'exists', 'between', 'availability', 'of', 'state', 'of', 'the', 'art', 'diagnostics', 'and', 'current', 'needs', 'As', 'assay', 'details', 'and', 'primer', 'sequences', 'become', 'widely', 'known', 'many', 'laboratories', 'could', 'perform', 'diagnostic', 'tests', 'using', 'methods', 'such', 'as', 'RT', 'PCR', 'or', 'isothermal', 'RT', 'LAMP', 'amplification', 'A', 'key', 'advantage', 'of', 'RT', 'LAMP', 'based', 'approaches', 'compared', 'to', 'RT', 'PCR', 'is', 'that', 'RT', 'LAMP', 'is', 'known', 'to', 'be', 'robust', 'in', 'detecting', 'targets', 'from', 'unprocessed', 'samples', 'In', 'addition', 'RT', 'LAMP', 'assays', 'are', 'performed', 'at', 'a', 'constant', 'temperature', 'enabling', 'speed', 'simplicity', 'and', 'point', 'of', 'use', 'testing', 'Here', 'we', 'provide', 'the', 'details', 'of', 'an', 'RT', 'LAMP', 'isothermal', 'assay', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'virus', 'with', 'performance', 'comparable', 'to', 'currently', 'approved', 'tests', 'using', 'RT', 'PCR', 'We', 'characterize', 'the', 'assay', 'by', 'introducing', 'swabs', 'in', 'virus', 'spiked', 'synthetic', 'nasal', 'fluids', 'moving', 'the', 'swab', 'to', 'viral', 'transport', 'medium', 'VTM', 'and', 'using', 'a', 'volume', 'of', 'that', 'VTM', 'for', 'performing', 'the', 'amplification', 'without', 'an', 'RNA', 'extraction', 'kit', 'The', 'assay', 'has', 'a', 'Limit', 'of', 'Detection', 'LOD', 'of', '50', 'RNA', 'copies', 'μL', 'in', 'the', 'VTM', 'solution', 'within', '20', 'minutes', 'and', 'LOD', 'of', '5000', 'RNA', 'copies', 'μL', 'in', 'the', 'nasal', 'solution', 'Additionally', 'we', 'show', 'the', 'utility', 'of', 'this', 'assay', 'for', 'real', 'time', 'point', 'of', 'use', 'testing', 'by', 'demonstrating', 'detection', 'of', 'SARS', 'CoV', '2', 'virus', 'in', 'less', 'than', '40', 'minutes', 'using', 'an', 'additively', 'manufactured', 'cartridge', 'and', 'a', 'smartphone', 'based', 'reader', 'Finally', 'we', 'explore', 'the', 'speed', 'and', 'cost', 'advantages', 'by', 'comparing', 'the', 'required', 'resources', 'and', 'workflows', 'with', 'RT', 'PCR', 'This', 'work', 'could', 'accelerate', 'the', 'development', 'and', 'availability', 'of', 'SARS', 'CoV', '2', 'diagnostics', 'by', 'proving', 'alternatives', 'to', 'conventional', 'laboratory', 'benchtop', 'tests', '']"
167324,Pathogenicity and pathogenesis of a United States porcine deltacoronavirus cell culture isolate in 5-day-old neonatal piglets,2015-08-31,Virology,https://doi.org/10.1016/j.virol.2015.03.024; https://www.sciencedirect.com/science/article/pii/S0042682215001609; https://api.elsevier.com/content/article/pii/S0042682215001609; https://www.ncbi.nlm.nih.gov/pubmed/25817405/,"Abstract Porcine deltacoronavirus (PDCoV) was first identified in Hong Kong in 2009–2010 and reported in United States swine for the first time in February 2014. However, diagnostic tools other than polymerase chain reaction for PDCoV detection were lacking and Koch׳s postulates had not been fulfilled to confirm the pathogenic potential of PDCoV. In the present study, PDCoV peptide-specific rabbit antisera were developed and used in immunofluorescence and immunohistochemistry assays to assist PDCoV diagnostics. The pathogenicity and pathogenesis of PDCoV was investigated following orogastric inoculation of 5-day-old piglets with a plaque-purified PDCoV cell culture isolate (3×104 TCID50 per pig). The PDCoV-inoculated piglets developed mild to moderate diarrhea, shed increasing amount of virus in rectal swabs from 2 to 7 days post inoculation, and developed macroscopic and microscopic lesions in small intestines with viral antigen confirmed by immunohistochemistry staining. This study experimentally confirmed PDCoV pathogenicity and characterized PDCoV pathogenesis in neonatal piglets.",10.1016/j.virol.2015.03.024,p5kjnfyf,"['Abstract', 'Porcine', 'deltacoronavirus', 'PDCoV', 'was', 'first', 'identified', 'in', 'Hong', 'Kong', 'in', '2009', '2010', 'and', 'reported', 'in', 'United', 'States', 'swine', 'for', 'the', 'first', 'time', 'in', 'February', '2014', 'However', 'diagnostic', 'tools', 'other', 'than', 'polymerase', 'chain', 'reaction', 'for', 'PDCoV', 'detection', 'were', 'lacking', 'and', 'Koch', 's', 'postulates', 'had', 'not', 'been', 'fulfilled', 'to', 'confirm', 'the', 'pathogenic', 'potential', 'of', 'PDCoV', 'In', 'the', 'present', 'study', 'PDCoV', 'peptide', 'specific', 'rabbit', 'antisera', 'were', 'developed', 'and', 'used', 'in', 'immunofluorescence', 'and', 'immunohistochemistry', 'assays', 'to', 'assist', 'PDCoV', 'diagnostics', 'The', 'pathogenicity', 'and', 'pathogenesis', 'of', 'PDCoV', 'was', 'investigated', 'following', 'orogastric', 'inoculation', 'of', '5', 'day', 'old', 'piglets', 'with', 'a', 'plaque', 'purified', 'PDCoV', 'cell', 'culture', 'isolate', '3', '104', 'TCID50', 'per', 'pig', 'The', 'PDCoV', 'inoculated', 'piglets', 'developed', 'mild', 'to', 'moderate', 'diarrhea', 'shed', 'increasing', 'amount', 'of', 'virus', 'in', 'rectal', 'swabs', 'from', '2', 'to', '7', 'days', 'post', 'inoculation', 'and', 'developed', 'macroscopic', 'and', 'microscopic', 'lesions', 'in', 'small', 'intestines', 'with', 'viral', 'antigen', 'confirmed', 'by', 'immunohistochemistry', 'staining', 'This', 'study', 'experimentally', 'confirmed', 'PDCoV', 'pathogenicity', 'and', 'characterized', 'PDCoV', 'pathogenesis', 'in', 'neonatal', 'piglets', '']"
167580,Enhancing preparation for large Nipah outbreaks beyond Bangladesh: Preventing a tragedy like Ebola in West Africa,2018-07-31,International Journal of Infectious Diseases,https://api.elsevier.com/content/article/pii/S1201971218344254; https://doi.org/10.1016/j.ijid.2018.05.015; https://www.sciencedirect.com/science/article/pii/S1201971218344254; https://www.ncbi.nlm.nih.gov/pubmed/29879523/,"Abstract The Nipah virus has been transmitted from person-to-person via close contact in non-urban parts of India (including Kerala May 2018), Bangladesh, and the Philippines. It can cause encephalitis and pneumonia, and has a high case fatality rate. Nipah is a One Health zoonotic infectious disease linked to fruit bats, and sometimes pigs or horses. We advocate anticipating and preparing for urban and larger rural outbreaks of Nipah. Immediate enhanced preparations would include standardized guidance on infection prevention and control, and personal protective equipment, from the World Health Organization (WHO) on their OpenWHO website and 2018 “Managing Epidemics” handbook, along with adding best clinical practices by experts in countries with multiple outbreaks such as Bangladesh and India. Longer-term enhanced preparations include accelerating development of field diagnostics, antiviral drugs, immune-based therapies, and vaccines. WHO-coordinated multi-partner protocols to test investigational treatments, diagnostics, and vaccines are needed, by analogy to such protocols for Ebola during the unanticipated pan-epidemic in Guinea, Liberia, and Sierra Leone. Anticipating and preparing now for urban and rural Nipah outbreaks in nations with no experience with Nipah will help avoid the potential for what the United Nations 2016 report on Ebola in West Africa called a “preventable tragedy”.",10.1016/j.ijid.2018.05.015,se5xtmul,"['Abstract', 'The', 'Nipah', 'virus', 'has', 'been', 'transmitted', 'from', 'person', 'to', 'person', 'via', 'close', 'contact', 'in', 'non', 'urban', 'parts', 'of', 'India', 'including', 'Kerala', 'May', '2018', 'Bangladesh', 'and', 'the', 'Philippines', 'It', 'can', 'cause', 'encephalitis', 'and', 'pneumonia', 'and', 'has', 'a', 'high', 'case', 'fatality', 'rate', 'Nipah', 'is', 'a', 'One', 'Health', 'zoonotic', 'infectious', 'disease', 'linked', 'to', 'fruit', 'bats', 'and', 'sometimes', 'pigs', 'or', 'horses', 'We', 'advocate', 'anticipating', 'and', 'preparing', 'for', 'urban', 'and', 'larger', 'rural', 'outbreaks', 'of', 'Nipah', 'Immediate', 'enhanced', 'preparations', 'would', 'include', 'standardized', 'guidance', 'on', 'infection', 'prevention', 'and', 'control', 'and', 'personal', 'protective', 'equipment', 'from', 'the', 'World', 'Health', 'Organization', 'WHO', 'on', 'their', 'OpenWHO', 'website', 'and', '2018', 'Managing', 'Epidemics', 'handbook', 'along', 'with', 'adding', 'best', 'clinical', 'practices', 'by', 'experts', 'in', 'countries', 'with', 'multiple', 'outbreaks', 'such', 'as', 'Bangladesh', 'and', 'India', 'Longer', 'term', 'enhanced', 'preparations', 'include', 'accelerating', 'development', 'of', 'field', 'diagnostics', 'antiviral', 'drugs', 'immune', 'based', 'therapies', 'and', 'vaccines', 'WHO', 'coordinated', 'multi', 'partner', 'protocols', 'to', 'test', 'investigational', 'treatments', 'diagnostics', 'and', 'vaccines', 'are', 'needed', 'by', 'analogy', 'to', 'such', 'protocols', 'for', 'Ebola', 'during', 'the', 'unanticipated', 'pan', 'epidemic', 'in', 'Guinea', 'Liberia', 'and', 'Sierra', 'Leone', 'Anticipating', 'and', 'preparing', 'now', 'for', 'urban', 'and', 'rural', 'Nipah', 'outbreaks', 'in', 'nations', 'with', 'no', 'experience', 'with', 'Nipah', 'will', 'help', 'avoid', 'the', 'potential', 'for', 'what', 'the', 'United', 'Nations', '2016', 'report', 'on', 'Ebola', 'in', 'West', 'Africa', 'called', 'a', 'preventable', 'tragedy', '']"
168319,The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic,2017-02-28,J Microbiol,https://doi.org/10.1007/s12275-017-7026-y; https://www.ncbi.nlm.nih.gov/pubmed/28243939/,"Rapidly emerging infectious disease outbreaks place a great strain on laboratories to develop and implement sensitive and specific diagnostic tests for patient management and infection control in a timely manner. Furthermore, laboratories also play a role in real-time zoonotic, environmental, and epidemiological investigations to identify the ultimate source of the epidemic, facilitating measures to eventually control the outbreak. Each assay modality has unique pros and cons; therefore, incorporation of a battery of tests using traditional culture-based, molecular and serological diagnostics into diagnostic algorithms is often required. As such, laboratories face challenges in assay development, test evaluation, and subsequent quality assurance. In this review, we describe the different testing modalities available for the ongoing Middle East respiratory syndrome (MERS) epidemic including cell culture, nucleic acid amplification, antigen detection, and antibody detection assays. Applications of such tests in both acute clinical and epidemiological investigation settings are highlighted. Using the MERS epidemic as an example, we illustrate the various challenges faced by laboratories in test development and implementation in the setting of a rapidly emerging infectious disease. Future directions in the diagnosis of MERS and other emerging infectious disease investigations are also highlighted.",10.1007/s12275-017-7026-y,i0i5p4k7,"['Rapidly', 'emerging', 'infectious', 'disease', 'outbreaks', 'place', 'a', 'great', 'strain', 'on', 'laboratories', 'to', 'develop', 'and', 'implement', 'sensitive', 'and', 'specific', 'diagnostic', 'tests', 'for', 'patient', 'management', 'and', 'infection', 'control', 'in', 'a', 'timely', 'manner', 'Furthermore', 'laboratories', 'also', 'play', 'a', 'role', 'in', 'real', 'time', 'zoonotic', 'environmental', 'and', 'epidemiological', 'investigations', 'to', 'identify', 'the', 'ultimate', 'source', 'of', 'the', 'epidemic', 'facilitating', 'measures', 'to', 'eventually', 'control', 'the', 'outbreak', 'Each', 'assay', 'modality', 'has', 'unique', 'pros', 'and', 'cons', 'therefore', 'incorporation', 'of', 'a', 'battery', 'of', 'tests', 'using', 'traditional', 'culture', 'based', 'molecular', 'and', 'serological', 'diagnostics', 'into', 'diagnostic', 'algorithms', 'is', 'often', 'required', 'As', 'such', 'laboratories', 'face', 'challenges', 'in', 'assay', 'development', 'test', 'evaluation', 'and', 'subsequent', 'quality', 'assurance', 'In', 'this', 'review', 'we', 'describe', 'the', 'different', 'testing', 'modalities', 'available', 'for', 'the', 'ongoing', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'epidemic', 'including', 'cell', 'culture', 'nucleic', 'acid', 'amplification', 'antigen', 'detection', 'and', 'antibody', 'detection', 'assays', 'Applications', 'of', 'such', 'tests', 'in', 'both', 'acute', 'clinical', 'and', 'epidemiological', 'investigation', 'settings', 'are', 'highlighted', 'Using', 'the', 'MERS', 'epidemic', 'as', 'an', 'example', 'we', 'illustrate', 'the', 'various', 'challenges', 'faced', 'by', 'laboratories', 'in', 'test', 'development', 'and', 'implementation', 'in', 'the', 'setting', 'of', 'a', 'rapidly', 'emerging', 'infectious', 'disease', 'Future', 'directions', 'in', 'the', 'diagnosis', 'of', 'MERS', 'and', 'other', 'emerging', 'infectious', 'disease', 'investigations', 'are', 'also', 'highlighted', '']"
168601,Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE): protocol for a multisite prospective observational study of the causes of fever in Africa and Asia,2020-07-21,BMJ Open,https://doi.org/10.1136/bmjopen-2019-035632; https://www.ncbi.nlm.nih.gov/pubmed/32699131/,"INTRODUCTION: Fever commonly leads to healthcare seeking and hospital admission in sub-Saharan Africa and Asia. There is only limited guidance for clinicians managing non-malarial fevers, which often results in inappropriate treatment for patients. Furthermore, there is little evidence for estimates of disease burden, or to guide empirical therapy, control measures, resource allocation, prioritisation of clinical diagnostics or antimicrobial stewardship. The Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE) study seeks to address these information gaps. METHODS AND ANALYSIS: FIEBRE investigates febrile illness in paediatric and adult outpatients and inpatients using standardised clinical, laboratory and social science protocols over a minimum 12-month period at five sites in sub-Saharan Africa and Southeastern and Southern Asia. Patients presenting with fever are enrolled and provide clinical data, pharyngeal swabs and a venous blood sample; selected participants also provide a urine sample. Laboratory assessments target infections that are treatable and/or preventable. Selected point-of-care tests, as well as blood and urine cultures and antimicrobial susceptibility testing, are performed on site. On day 28, patients provide a second venous blood sample for serology and information on clinical outcome. Further diagnostic assays are performed at international reference laboratories. Blood and pharyngeal samples from matched community controls enable calculation of AFs, and surveys of treatment seeking allow estimation of the incidence of common infections. Additional assays detect markers that may differentiate bacterial from non-bacterial causes of illness and/or prognosticate illness severity. Social science research on antimicrobial use will inform future recommendations for fever case management. Residual samples from participants are stored for future use. ETHICS AND DISSEMINATION: Ethics approval was obtained from all relevant institutional and national committees; written informed consent is obtained from all participants or parents/guardians. Final results will be shared with participating communities, and in open-access journals and other scientific fora. Study documents are available online (https://doi.org/10.17037/PUBS.04652739).",10.1136/bmjopen-2019-035632,g7vxhpx2,"['INTRODUCTION', 'Fever', 'commonly', 'leads', 'to', 'healthcare', 'seeking', 'and', 'hospital', 'admission', 'in', 'sub', 'Saharan', 'Africa', 'and', 'Asia', 'There', 'is', 'only', 'limited', 'guidance', 'for', 'clinicians', 'managing', 'non', 'malarial', 'fevers', 'which', 'often', 'results', 'in', 'inappropriate', 'treatment', 'for', 'patients', 'Furthermore', 'there', 'is', 'little', 'evidence', 'for', 'estimates', 'of', 'disease', 'burden', 'or', 'to', 'guide', 'empirical', 'therapy', 'control', 'measures', 'resource', 'allocation', 'prioritisation', 'of', 'clinical', 'diagnostics', 'or', 'antimicrobial', 'stewardship', 'The', 'Febrile', 'Illness', 'Evaluation', 'in', 'a', 'Broad', 'Range', 'of', 'Endemicities', 'FIEBRE', 'study', 'seeks', 'to', 'address', 'these', 'information', 'gaps', 'METHODS', 'AND', 'ANALYSIS', 'FIEBRE', 'investigates', 'febrile', 'illness', 'in', 'paediatric', 'and', 'adult', 'outpatients', 'and', 'inpatients', 'using', 'standardised', 'clinical', 'laboratory', 'and', 'social', 'science', 'protocols', 'over', 'a', 'minimum', '12', 'month', 'period', 'at', 'five', 'sites', 'in', 'sub', 'Saharan', 'Africa', 'and', 'Southeastern', 'and', 'Southern', 'Asia', 'Patients', 'presenting', 'with', 'fever', 'are', 'enrolled', 'and', 'provide', 'clinical', 'data', 'pharyngeal', 'swabs', 'and', 'a', 'venous', 'blood', 'sample', 'selected', 'participants', 'also', 'provide', 'a', 'urine', 'sample', 'Laboratory', 'assessments', 'target', 'infections', 'that', 'are', 'treatable', 'and', 'or', 'preventable', 'Selected', 'point', 'of', 'care', 'tests', 'as', 'well', 'as', 'blood', 'and', 'urine', 'cultures', 'and', 'antimicrobial', 'susceptibility', 'testing', 'are', 'performed', 'on', 'site', 'On', 'day', '28', 'patients', 'provide', 'a', 'second', 'venous', 'blood', 'sample', 'for', 'serology', 'and', 'information', 'on', 'clinical', 'outcome', 'Further', 'diagnostic', 'assays', 'are', 'performed', 'at', 'international', 'reference', 'laboratories', 'Blood', 'and', 'pharyngeal', 'samples', 'from', 'matched', 'community', 'controls', 'enable', 'calculation', 'of', 'AFs', 'and', 'surveys', 'of', 'treatment', 'seeking', 'allow', 'estimation', 'of', 'the', 'incidence', 'of', 'common', 'infections', 'Additional', 'assays', 'detect', 'markers', 'that', 'may', 'differentiate', 'bacterial', 'from', 'non', 'bacterial', 'causes', 'of', 'illness', 'and', 'or', 'prognosticate', 'illness', 'severity', 'Social', 'science', 'research', 'on', 'antimicrobial', 'use', 'will', 'inform', 'future', 'recommendations', 'for', 'fever', 'case', 'management', 'Residual', 'samples', 'from', 'participants', 'are', 'stored', 'for', 'future', 'use', 'ETHICS', 'AND', 'DISSEMINATION', 'Ethics', 'approval', 'was', 'obtained', 'from', 'all', 'relevant', 'institutional', 'and', 'national', 'committees', 'written', 'informed', 'consent', 'is', 'obtained', 'from', 'all', 'participants', 'or', 'parents', 'guardians', 'Final', 'results', 'will', 'be', 'shared', 'with', 'participating', 'communities', 'and', 'in', 'open', 'access', 'journals', 'and', 'other', 'scientific', 'fora', 'Study', 'documents', 'are', 'available', 'online', 'https', 'doi', 'org', '10', '17037', 'PUBS', '04652739', '']"
168962,Scanning the horizon: emerging hospital-wide technologies and their impact on critical care,2005-01-13,Crit Care,https://www.ncbi.nlm.nih.gov/pubmed/15693973/,"This commentary represents a selective survey of developments relevant to critical care. Selected themes include advances in point-of-care diagnostic testing, glucose control, novel microbiological diagnostics and infection control measures, and developments in information technology that have implications for intensive care. The latter encompasses an early example of an artificially intelligent clinical decision support mechanism, the introduction of a national health care information technology programme (UK NPfIT) and its implications, and exotic threats to patient safety due to emergent behaviour in complex information systems.",10.1186/cc3046,xiv9vxdp,"['This', 'commentary', 'represents', 'a', 'selective', 'survey', 'of', 'developments', 'relevant', 'to', 'critical', 'care', 'Selected', 'themes', 'include', 'advances', 'in', 'point', 'of', 'care', 'diagnostic', 'testing', 'glucose', 'control', 'novel', 'microbiological', 'diagnostics', 'and', 'infection', 'control', 'measures', 'and', 'developments', 'in', 'information', 'technology', 'that', 'have', 'implications', 'for', 'intensive', 'care', 'The', 'latter', 'encompasses', 'an', 'early', 'example', 'of', 'an', 'artificially', 'intelligent', 'clinical', 'decision', 'support', 'mechanism', 'the', 'introduction', 'of', 'a', 'national', 'health', 'care', 'information', 'technology', 'programme', 'UK', 'NPfIT', 'and', 'its', 'implications', 'and', 'exotic', 'threats', 'to', 'patient', 'safety', 'due', 'to', 'emergent', 'behaviour', 'in', 'complex', 'information', 'systems', '']"
169372,Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review,2020-04-13,Ann Intern Med,https://doi.org/10.7326/m20-1301; https://www.ncbi.nlm.nih.gov/pubmed/32282894/,"Diagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laboratory on respiratory specimens are the reference standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging. Although excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, important gaps remain in screening asymptomatic persons in the incubation phase, as well as in the accurate determination of live viral shedding during convalescence to inform decisions to end isolation. Many affluent countries have encountered challenges in test delivery and specimen collection that have inhibited rapid increases in testing capacity. These challenges may be even greater in low-resource settings. Urgent clinical and public health needs currently drive an unprecedented global effort to increase testing capacity for SARS–CoV-2 infection. Here, the authors review the current array of tests for SARS–CoV-2, highlight gaps in current diagnostic capacity, and propose potential solutions.",10.7326/m20-1301,ho5n7n90,"['Diagnostic', 'testing', 'to', 'identify', 'persons', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'infection', 'is', 'central', 'to', 'control', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'that', 'began', 'in', 'late', '2019', 'In', 'a', 'few', 'countries', 'the', 'use', 'of', 'diagnostic', 'testing', 'on', 'a', 'massive', 'scale', 'has', 'been', 'a', 'cornerstone', 'of', 'successful', 'containment', 'strategies', 'In', 'contrast', 'the', 'United', 'States', 'hampered', 'by', 'limited', 'testing', 'capacity', 'has', 'prioritized', 'testing', 'for', 'specific', 'groups', 'of', 'persons', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'based', 'assays', 'performed', 'in', 'a', 'laboratory', 'on', 'respiratory', 'specimens', 'are', 'the', 'reference', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'Although', 'excellent', 'tools', 'exist', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'in', 'well', 'equipped', 'laboratories', 'important', 'gaps', 'remain', 'in', 'screening', 'asymptomatic', 'persons', 'in', 'the', 'incubation', 'phase', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'to', 'end', 'isolation', 'Many', 'affluent', 'countries', 'have', 'encountered', 'challenges', 'in', 'test', 'delivery', 'and', 'specimen', 'collection', 'that', 'have', 'inhibited', 'rapid', 'increases', 'in', 'testing', 'capacity', 'These', 'challenges', 'may', 'be', 'even', 'greater', 'in', 'low', 'resource', 'settings', 'Urgent', 'clinical', 'and', 'public', 'health', 'needs', 'currently', 'drive', 'an', 'unprecedented', 'global', 'effort', 'to', 'increase', 'testing', 'capacity', 'for', 'SARS', 'CoV', '2', 'infection', 'Here', 'the', 'authors', 'review', 'the', 'current', 'array', 'of', 'tests', 'for', 'SARS', 'CoV', '2', 'highlight', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'propose', 'potential', 'solutions', '']"
169633,Multicenter evaluation of the QIAstat Respiratory Panel—A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections,2020-03-12,PLoS One,https://www.ncbi.nlm.nih.gov/pubmed/32163484/; https://doi.org/10.1371/journal.pone.0230183,"Acute respiratory tract infections (ARTI), including the common cold, pharyngitis, sinusitis, otitis media, bronchiolitis and pneumonia are the most common diagnoses among patients seeking medical care in western countries, and account for most antibiotic prescriptions. While a confirmed and fast ARTI diagnosis is key for antibiotic prescribing, empiric antimicrobial treatment remains common, because viral symptoms are often clinically similar and difficult to distinguish from those caused by bacteria. As a result, inappropriate antibiotic prescriptions are high and in certain settings likely higher than the commonly estimated 30%. The QIAstat Respiratory Panel(®) assay (QIAstat RP) is a multiplexed in vitro diagnostics test for the rapid simultaneous detection of 21 pathogens directly from respiratory samples, including human mastadenovirus A-G, primate bocaparvovirus 1+2, human coronavirus (HKU1, NL63, OC43, 229E), human metapneumovirus A/B, rhinovirus/enterovirus, influenza A virus (no subtype, subtype H1, H1N1/2009, H3), influenza B virus, human respirovirus 1+3, human orthorubulavirus 2+4, human orthopneumovirus, Bordetella pertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila. We describe the first multicenter study of 445 respiratory samples, collected through the 2016–2017 and 2018 respiratory seasons, with performance compared against BioFire FilmArray RP v1.7 and discrepancy testing by Seegene Allplex RP. The QIAstat RP demonstrated a positive percentage of agreement of 98.0% (95% CI: 96.0–99.1%) and a negative percentage agreement of 99.8% (95% CI: 99.6–99.9%). With use of this comprehensive and rapid test, improved patient outcomes and antimicrobial stewardship may potentially be achieved.",10.1371/journal.pone.0230183,wezrs7gc,"['Acute', 'respiratory', 'tract', 'infections', 'ARTI', 'including', 'the', 'common', 'cold', 'pharyngitis', 'sinusitis', 'otitis', 'media', 'bronchiolitis', 'and', 'pneumonia', 'are', 'the', 'most', 'common', 'diagnoses', 'among', 'patients', 'seeking', 'medical', 'care', 'in', 'western', 'countries', 'and', 'account', 'for', 'most', 'antibiotic', 'prescriptions', 'While', 'a', 'confirmed', 'and', 'fast', 'ARTI', 'diagnosis', 'is', 'key', 'for', 'antibiotic', 'prescribing', 'empiric', 'antimicrobial', 'treatment', 'remains', 'common', 'because', 'viral', 'symptoms', 'are', 'often', 'clinically', 'similar', 'and', 'difficult', 'to', 'distinguish', 'from', 'those', 'caused', 'by', 'bacteria', 'As', 'a', 'result', 'inappropriate', 'antibiotic', 'prescriptions', 'are', 'high', 'and', 'in', 'certain', 'settings', 'likely', 'higher', 'than', 'the', 'commonly', 'estimated', '30', 'The', 'QIAstat', 'Respiratory', 'Panel', 'assay', 'QIAstat', 'RP', 'is', 'a', 'multiplexed', 'in', 'vitro', 'diagnostics', 'test', 'for', 'the', 'rapid', 'simultaneous', 'detection', 'of', '21', 'pathogens', 'directly', 'from', 'respiratory', 'samples', 'including', 'human', 'mastadenovirus', 'A', 'G', 'primate', 'bocaparvovirus', '1', '2', 'human', 'coronavirus', 'HKU1', 'NL63', 'OC43', '229E', 'human', 'metapneumovirus', 'A', 'B', 'rhinovirus', 'enterovirus', 'influenza', 'A', 'virus', 'no', 'subtype', 'subtype', 'H1', 'H1N1', '2009', 'H3', 'influenza', 'B', 'virus', 'human', 'respirovirus', '1', '3', 'human', 'orthorubulavirus', '2', '4', 'human', 'orthopneumovirus', 'Bordetella', 'pertussis', 'Chlamydia', 'pneumoniae', 'Mycoplasma', 'pneumoniae', 'and', 'Legionella', 'pneumophila', 'We', 'describe', 'the', 'first', 'multicenter', 'study', 'of', '445', 'respiratory', 'samples', 'collected', 'through', 'the', '2016', '2017', 'and', '2018', 'respiratory', 'seasons', 'with', 'performance', 'compared', 'against', 'BioFire', 'FilmArray', 'RP', 'v1', '7', 'and', 'discrepancy', 'testing', 'by', 'Seegene', 'Allplex', 'RP', 'The', 'QIAstat', 'RP', 'demonstrated', 'a', 'positive', 'percentage', 'of', 'agreement', 'of', '98', '0', '95', 'CI', '96', '0', '99', '1', 'and', 'a', 'negative', 'percentage', 'agreement', 'of', '99', '8', '95', 'CI', '99', '6', '99', '9', 'With', 'use', 'of', 'this', 'comprehensive', 'and', 'rapid', 'test', 'improved', 'patient', 'outcomes', 'and', 'antimicrobial', 'stewardship', 'may', 'potentially', 'be', 'achieved', '']"
169779,Nonparametric methods for the analysis of single-color pathogen microarrays,2010-06-28,BMC Bioinformatics,https://doi.org/10.1186/1471-2105-11-354; https://www.ncbi.nlm.nih.gov/pubmed/20584331/,"BACKGROUND: The analysis of oligonucleotide microarray data in pathogen surveillance and discovery is a challenging task. Target template concentration, nucleic acid integrity, and host nucleic acid composition can each have a profound effect on signal distribution. Exploratory analysis of fluorescent signal distribution in clinical samples has revealed deviations from normality, suggesting that distribution-free approaches should be applied. RESULTS: Positive predictive value and false positive rates were examined to assess the utility of three well-established nonparametric methods for the analysis of viral array hybridization data: (1) Mann-Whitney U, (2) the Spearman correlation coefficient and (3) the chi-square test. Of the three tests, the chi-square proved most useful. CONCLUSIONS: The acceptance of microarray use for routine clinical diagnostics will require that the technology be accompanied by simple yet reliable analytic methods. We report that our implementation of the chi-square test yielded a combination of low false positive rates and a high degree of predictive accuracy.",10.1186/1471-2105-11-354,l09c8ise,"['BACKGROUND', 'The', 'analysis', 'of', 'oligonucleotide', 'microarray', 'data', 'in', 'pathogen', 'surveillance', 'and', 'discovery', 'is', 'a', 'challenging', 'task', 'Target', 'template', 'concentration', 'nucleic', 'acid', 'integrity', 'and', 'host', 'nucleic', 'acid', 'composition', 'can', 'each', 'have', 'a', 'profound', 'effect', 'on', 'signal', 'distribution', 'Exploratory', 'analysis', 'of', 'fluorescent', 'signal', 'distribution', 'in', 'clinical', 'samples', 'has', 'revealed', 'deviations', 'from', 'normality', 'suggesting', 'that', 'distribution', 'free', 'approaches', 'should', 'be', 'applied', 'RESULTS', 'Positive', 'predictive', 'value', 'and', 'false', 'positive', 'rates', 'were', 'examined', 'to', 'assess', 'the', 'utility', 'of', 'three', 'well', 'established', 'nonparametric', 'methods', 'for', 'the', 'analysis', 'of', 'viral', 'array', 'hybridization', 'data', '1', 'Mann', 'Whitney', 'U', '2', 'the', 'Spearman', 'correlation', 'coefficient', 'and', '3', 'the', 'chi', 'square', 'test', 'Of', 'the', 'three', 'tests', 'the', 'chi', 'square', 'proved', 'most', 'useful', 'CONCLUSIONS', 'The', 'acceptance', 'of', 'microarray', 'use', 'for', 'routine', 'clinical', 'diagnostics', 'will', 'require', 'that', 'the', 'technology', 'be', 'accompanied', 'by', 'simple', 'yet', 'reliable', 'analytic', 'methods', 'We', 'report', 'that', 'our', 'implementation', 'of', 'the', 'chi', 'square', 'test', 'yielded', 'a', 'combination', 'of', 'low', 'false', 'positive', 'rates', 'and', 'a', 'high', 'degree', 'of', 'predictive', 'accuracy', '']"
169815,Pitfalls in SARS‐CoV‐2 PCR diagnostics,2020-06-14,Transbound Emerg Dis,https://www.ncbi.nlm.nih.gov/pubmed/32536002/; https://doi.org/10.1111/tbed.13684,"To combat the COVID‐19 pandemic, millions of PCR tests are performed worldwide. Any deviation of the diagnostic sensitivity and specificity will reduce the predictive values of the test. Here, we report the occurrence of contaminations of commercial primers/probe sets with the SARS‐CoV‐2 target sequence of the RT‐qPCR as an example for pitfalls during PCR diagnostics affecting diagnostic specificity. In several purchased in‐house primers/probe sets, quantification cycle values as low as 17 were measured for negative control samples. However, there were also primers/probe sets that displayed very low‐level contaminations, which were detected only during thorough internal validation. Hence, it appears imperative to pre‐test each batch of reagents extensively before use in routine diagnosis, to avoid false‐positive results and low positive predictive value in low‐prevalence situations. As such, contaminations may have happened more widely, COVID‐19 diagnostic results should be re‐assessed retrospectively to validate the epidemiological basis for control measures.",10.1111/tbed.13684,xg3fit4m,"['To', 'combat', 'the', 'COVID', '19', 'pandemic', 'millions', 'of', 'PCR', 'tests', 'are', 'performed', 'worldwide', 'Any', 'deviation', 'of', 'the', 'diagnostic', 'sensitivity', 'and', 'specificity', 'will', 'reduce', 'the', 'predictive', 'values', 'of', 'the', 'test', 'Here', 'we', 'report', 'the', 'occurrence', 'of', 'contaminations', 'of', 'commercial', 'primers', 'probe', 'sets', 'with', 'the', 'SARS', 'CoV', '2', 'target', 'sequence', 'of', 'the', 'RT', 'qPCR', 'as', 'an', 'example', 'for', 'pitfalls', 'during', 'PCR', 'diagnostics', 'affecting', 'diagnostic', 'specificity', 'In', 'several', 'purchased', 'in', 'house', 'primers', 'probe', 'sets', 'quantification', 'cycle', 'values', 'as', 'low', 'as', '17', 'were', 'measured', 'for', 'negative', 'control', 'samples', 'However', 'there', 'were', 'also', 'primers', 'probe', 'sets', 'that', 'displayed', 'very', 'low', 'level', 'contaminations', 'which', 'were', 'detected', 'only', 'during', 'thorough', 'internal', 'validation', 'Hence', 'it', 'appears', 'imperative', 'to', 'pre', 'test', 'each', 'batch', 'of', 'reagents', 'extensively', 'before', 'use', 'in', 'routine', 'diagnosis', 'to', 'avoid', 'false', 'positive', 'results', 'and', 'low', 'positive', 'predictive', 'value', 'in', 'low', 'prevalence', 'situations', 'As', 'such', 'contaminations', 'may', 'have', 'happened', 'more', 'widely', 'COVID', '19', 'diagnostic', 'results', 'should', 'be', 're', 'assessed', 'retrospectively', 'to', 'validate', 'the', 'epidemiological', 'basis', 'for', 'control', 'measures', '']"
170144,An update on feline infectious peritonitis: Diagnostics and therapeutics,2014-08-31,The Veterinary Journal,https://www.ncbi.nlm.nih.gov/pubmed/24857253/; https://doi.org/10.1016/j.tvjl.2014.04.016; https://api.elsevier.com/content/article/pii/S1090023314001774; https://www.sciencedirect.com/science/article/pii/S1090023314001774,"Abstract This review is concerned with what has been learned about feline infectious peritonitis (FIP) diagnostics and therapeutics since the publication of an extensive overview of literature covering the period 1963–2009. Although progress has been made in both areas, obtaining a definitive diagnosis of FIP remains a problem for those veterinarians and/or cat owners who require absolute certainty. This review will cover both indirect and direct diagnostic tests for the disease and will emphasize their limitations, as well as their specificity and sensitivity. There is still no effective treatment for FIP, although there are both claims that such therapies exist and glimmers of hope coming from new therapies that are under research. FIP has also been identified in wild felids and FIP-like disease is now a growing problem among pet ferrets.",10.1016/j.tvjl.2014.04.016,j3yb3k57,"['Abstract', 'This', 'review', 'is', 'concerned', 'with', 'what', 'has', 'been', 'learned', 'about', 'feline', 'infectious', 'peritonitis', 'FIP', 'diagnostics', 'and', 'therapeutics', 'since', 'the', 'publication', 'of', 'an', 'extensive', 'overview', 'of', 'literature', 'covering', 'the', 'period', '1963', '2009', 'Although', 'progress', 'has', 'been', 'made', 'in', 'both', 'areas', 'obtaining', 'a', 'definitive', 'diagnosis', 'of', 'FIP', 'remains', 'a', 'problem', 'for', 'those', 'veterinarians', 'and', 'or', 'cat', 'owners', 'who', 'require', 'absolute', 'certainty', 'This', 'review', 'will', 'cover', 'both', 'indirect', 'and', 'direct', 'diagnostic', 'tests', 'for', 'the', 'disease', 'and', 'will', 'emphasize', 'their', 'limitations', 'as', 'well', 'as', 'their', 'specificity', 'and', 'sensitivity', 'There', 'is', 'still', 'no', 'effective', 'treatment', 'for', 'FIP', 'although', 'there', 'are', 'both', 'claims', 'that', 'such', 'therapies', 'exist', 'and', 'glimmers', 'of', 'hope', 'coming', 'from', 'new', 'therapies', 'that', 'are', 'under', 'research', 'FIP', 'has', 'also', 'been', 'identified', 'in', 'wild', 'felids', 'and', 'FIP', 'like', 'disease', 'is', 'now', 'a', 'growing', 'problem', 'among', 'pet', 'ferrets', '']"
170349,PCR testing for Paediatric Acute Respiratory Tract Infections,2014-08-04,Paediatr Respir Rev,https://doi.org/10.1016/j.prrv.2014.07.002; https://www.sciencedirect.com/science/article/pii/S1526054214000803; https://api.elsevier.com/content/article/pii/S1526054214000803; https://www.ncbi.nlm.nih.gov/pubmed/25164571/,"Acute respiratory tract infection (ARI) is a frequently occurring disease in children. It is a clinical diagnosis for which no internationally accepted diagnostic test is available. The majority of ARI is viral in origin, though diagnostic tests for viruses were rarely performed in the past. In the past 2 decades, new molecular techniques have been introduced in many hospitals. They are capable of generating a high yield of viral and bacterial diagnoses, but their impact upon clinical practices is still questionable. In this paper, we discuss the difficulties of diagnosing ARI in children, the indications for conventional and new diagnostics and their implications.",10.1016/j.prrv.2014.07.002,5m1727m1,"['Acute', 'respiratory', 'tract', 'infection', 'ARI', 'is', 'a', 'frequently', 'occurring', 'disease', 'in', 'children', 'It', 'is', 'a', 'clinical', 'diagnosis', 'for', 'which', 'no', 'internationally', 'accepted', 'diagnostic', 'test', 'is', 'available', 'The', 'majority', 'of', 'ARI', 'is', 'viral', 'in', 'origin', 'though', 'diagnostic', 'tests', 'for', 'viruses', 'were', 'rarely', 'performed', 'in', 'the', 'past', 'In', 'the', 'past', '2', 'decades', 'new', 'molecular', 'techniques', 'have', 'been', 'introduced', 'in', 'many', 'hospitals', 'They', 'are', 'capable', 'of', 'generating', 'a', 'high', 'yield', 'of', 'viral', 'and', 'bacterial', 'diagnoses', 'but', 'their', 'impact', 'upon', 'clinical', 'practices', 'is', 'still', 'questionable', 'In', 'this', 'paper', 'we', 'discuss', 'the', 'difficulties', 'of', 'diagnosing', 'ARI', 'in', 'children', 'the', 'indications', 'for', 'conventional', 'and', 'new', 'diagnostics', 'and', 'their', 'implications', '']"
170517,"Discussing the ABCs of Health Security-Antibiotic Resistance, Biothreats, and Coronavirus.",2020-02-19,JAMA,https://www.ncbi.nlm.nih.gov/pubmed/32074261/; https://doi.org/10.1001/jama.2019.21022,"According to the World Health Organization (WHO), viral diseases continue to emerge and represent a serious issue to public health In the last twenty years, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003, and H1N1 influenza in 2009, have been recorded Most recently, the Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 In a timeline that reaches the present day, an epidemic of cases with unexplained low respiratory infections detected in Wuhan, the largest metropolitan area in China's Hubei province, was first reported to the WHO Country Office in China, on December 31, 2019 Published literature can trace the beginning of symptomatic individuals back to the beginning of December 2019 As they were unable to identify the causative agent, these first cases were classified as ""pneumonia of unknown etiology "" The Chinese Center for Disease Control and Prevention (CDC) and local CDCs organized an intensive outbreak investigation program The etiology of this illness is now attributed to a novel virus belonging to the coronavirus (CoV) family, COVID-19 On February 11, 2020, the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, announced that the disease caused by this new CoV was a ""COVID-19,"" which is the acronym of ""coronavirus disease 2019"" In the past twenty years, two additional coronavirus epidemics have occurred SARS-CoV provoked a large-scale epidemic beginning in China and involving two dozen countries with approximately 8000 cases and 800 deaths, and the MERS-CoV that began in Saudi Arabia and has approximately 2,500 cases and 800 deaths and still causes as sporadic cases This new virus seems to be very contagious and has quickly spread globally In a meeting on January 30, 2020, per the International Health Regulations (IHR, 2005), the outbreak was declared by the WHO a Public Health Emergency of International Concern (PHEIC) as it had spread to 18 countries with four countries reporting human-to-human transmission An additional landmark occurred on February 26, 2020, as the first case of the disease, not imported from China, was recorded in the United States Initially, the new virus was called 2019-nCoV Subsequently, the task of experts of the International Committee on Taxonomy of Viruses (ICTV) termed it the SARS-CoV-2 virus as it is very similar to the one that caused the SARS outbreak (SARS-CoVs) The CoVs have become the major pathogens of emerging respiratory disease outbreaks They are a large family of single-stranded RNA viruses (+ssRNA) that can be isolated in different animal species For reasons yet to be explained, these viruses can cross species barriers and can cause, in humans, illness ranging from the common cold to more severe diseases such as MERS and SARS Interestingly, these latter viruses have probably originated from bats and then moving into other mammalian hosts — the Himalayan palm civet for SARS-CoV, and the dromedary camel for MERS-CoV — before jumping to humans The dynamics of SARS-Cov-2 are currently unknown, but there is speculation that it also has an animal origin The potential for these viruses to grow to become a pandemic worldwide seems to be a serious public health risk Concerning COVID-19, the WHO raised the threat to the CoV epidemic to the ""very high"" level, on February 28, 2020 Probably, the effects of the epidemic caused by the new CoV has yet to emerge as the situation is quickly evolving World governments are at work to establish countermeasures to stem possible devastating effects Health organizations coordinate information flows and issues directives and guidelines to best mitigate the impact of the threat At the same time, scientists around the world work tirelessly, and information about the transmission mechanisms, the clinical spectrum of disease, new diagnostics, and prevention and therapeutic strategies are rapidly developing Many uncertainties remain with regard to both the virus-host interaction and the evolution of the epidemic, with specific reference to the times when the epidemic will reach its peak At the moment, the therapeutic strategies to deal with the infection are only supportive, and prevention aimed at reducing transmission in the community is our best weapon Aggressive isolation measures in China have led to a progressive reduction of cases in the last few days In Italy, in geographic regions of the north of the peninsula, political and health authorities are making incredible efforts to contain a shock wave that is severely testing the health system In the midst of the crisis, the authors have chosen to use the ""Statpearls"" platform because, within the PubMed scenario, it represents a unique tool that may allow them to make updates in real-time The aim, therefore, is to collect information and scientific evidence and to provide an overview of the topic that will be continuously updated",10.1001/jama.2019.21022,zzpw375i,"['According', 'to', 'the', 'World', 'Health', 'Organization', 'WHO', 'viral', 'diseases', 'continue', 'to', 'emerge', 'and', 'represent', 'a', 'serious', 'issue', 'to', 'public', 'health', 'In', 'the', 'last', 'twenty', 'years', 'several', 'viral', 'epidemics', 'such', 'as', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'in', '2002', 'to', '2003', 'and', 'H1N1', 'influenza', 'in', '2009', 'have', 'been', 'recorded', 'Most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'first', 'identified', 'in', 'Saudi', 'Arabia', 'in', '2012', 'In', 'a', 'timeline', 'that', 'reaches', 'the', 'present', 'day', 'an', 'epidemic', 'of', 'cases', 'with', 'unexplained', 'low', 'respiratory', 'infections', 'detected', 'in', 'Wuhan', 'the', 'largest', 'metropolitan', 'area', 'in', 'China', 's', 'Hubei', 'province', 'was', 'first', 'reported', 'to', 'the', 'WHO', 'Country', 'Office', 'in', 'China', 'on', 'December', '31', '2019', 'Published', 'literature', 'can', 'trace', 'the', 'beginning', 'of', 'symptomatic', 'individuals', 'back', 'to', 'the', 'beginning', 'of', 'December', '2019', 'As', 'they', 'were', 'unable', 'to', 'identify', 'the', 'causative', 'agent', 'these', 'first', 'cases', 'were', 'classified', 'as', 'pneumonia', 'of', 'unknown', 'etiology', 'The', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'and', 'local', 'CDCs', 'organized', 'an', 'intensive', 'outbreak', 'investigation', 'program', 'The', 'etiology', 'of', 'this', 'illness', 'is', 'now', 'attributed', 'to', 'a', 'novel', 'virus', 'belonging', 'to', 'the', 'coronavirus', 'CoV', 'family', 'COVID', '19', 'On', 'February', '11', '2020', 'the', 'WHO', 'Director', 'General', 'Dr', 'Tedros', 'Adhanom', 'Ghebreyesus', 'announced', 'that', 'the', 'disease', 'caused', 'by', 'this', 'new', 'CoV', 'was', 'a', 'COVID', '19', 'which', 'is', 'the', 'acronym', 'of', 'coronavirus', 'disease', '2019', 'In', 'the', 'past', 'twenty', 'years', 'two', 'additional', 'coronavirus', 'epidemics', 'have', 'occurred', 'SARS', 'CoV', 'provoked', 'a', 'large', 'scale', 'epidemic', 'beginning', 'in', 'China', 'and', 'involving', 'two', 'dozen', 'countries', 'with', 'approximately', '8000', 'cases', 'and', '800', 'deaths', 'and', 'the', 'MERS', 'CoV', 'that', 'began', 'in', 'Saudi', 'Arabia', 'and', 'has', 'approximately', '2', '500', 'cases', 'and', '800', 'deaths', 'and', 'still', 'causes', 'as', 'sporadic', 'cases', 'This', 'new', 'virus', 'seems', 'to', 'be', 'very', 'contagious', 'and', 'has', 'quickly', 'spread', 'globally', 'In', 'a', 'meeting', 'on', 'January', '30', '2020', 'per', 'the', 'International', 'Health', 'Regulations', 'IHR', '2005', 'the', 'outbreak', 'was', 'declared', 'by', 'the', 'WHO', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'PHEIC', 'as', 'it', 'had', 'spread', 'to', '18', 'countries', 'with', 'four', 'countries', 'reporting', 'human', 'to', 'human', 'transmission', 'An', 'additional', 'landmark', 'occurred', 'on', 'February', '26', '2020', 'as', 'the', 'first', 'case', 'of', 'the', 'disease', 'not', 'imported', 'from', 'China', 'was', 'recorded', 'in', 'the', 'United', 'States', 'Initially', 'the', 'new', 'virus', 'was', 'called', '2019', 'nCoV', 'Subsequently', 'the', 'task', 'of', 'experts', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'ICTV', 'termed', 'it', 'the', 'SARS', 'CoV', '2', 'virus', 'as', 'it', 'is', 'very', 'similar', 'to', 'the', 'one', 'that', 'caused', 'the', 'SARS', 'outbreak', 'SARS', 'CoVs', 'The', 'CoVs', 'have', 'become', 'the', 'major', 'pathogens', 'of', 'emerging', 'respiratory', 'disease', 'outbreaks', 'They', 'are', 'a', 'large', 'family', 'of', 'single', 'stranded', 'RNA', 'viruses', 'ssRNA', 'that', 'can', 'be', 'isolated', 'in', 'different', 'animal', 'species', 'For', 'reasons', 'yet', 'to', 'be', 'explained', 'these', 'viruses', 'can', 'cross', 'species', 'barriers', 'and', 'can', 'cause', 'in', 'humans', 'illness', 'ranging', 'from', 'the', 'common', 'cold', 'to', 'more', 'severe', 'diseases', 'such', 'as', 'MERS', 'and', 'SARS', 'Interestingly', 'these', 'latter', 'viruses', 'have', 'probably', 'originated', 'from', 'bats', 'and', 'then', 'moving', 'into', 'other', 'mammalian', 'hosts', 'the', 'Himalayan', 'palm', 'civet', 'for', 'SARS', 'CoV', 'and', 'the', 'dromedary', 'camel', 'for', 'MERS', 'CoV', 'before', 'jumping', 'to', 'humans', 'The', 'dynamics', 'of', 'SARS', 'Cov', '2', 'are', 'currently', 'unknown', 'but', 'there', 'is', 'speculation', 'that', 'it', 'also', 'has', 'an', 'animal', 'origin', 'The', 'potential', 'for', 'these', 'viruses', 'to', 'grow', 'to', 'become', 'a', 'pandemic', 'worldwide', 'seems', 'to', 'be', 'a', 'serious', 'public', 'health', 'risk', 'Concerning', 'COVID', '19', 'the', 'WHO', 'raised', 'the', 'threat', 'to', 'the', 'CoV', 'epidemic', 'to', 'the', 'very', 'high', 'level', 'on', 'February', '28', '2020', 'Probably', 'the', 'effects', 'of', 'the', 'epidemic', 'caused', 'by', 'the', 'new', 'CoV', 'has', 'yet', 'to', 'emerge', 'as', 'the', 'situation', 'is', 'quickly', 'evolving', 'World', 'governments', 'are', 'at', 'work', 'to', 'establish', 'countermeasures', 'to', 'stem', 'possible', 'devastating', 'effects', 'Health', 'organizations', 'coordinate', 'information', 'flows', 'and', 'issues', 'directives', 'and', 'guidelines', 'to', 'best', 'mitigate', 'the', 'impact', 'of', 'the', 'threat', 'At', 'the', 'same', 'time', 'scientists', 'around', 'the', 'world', 'work', 'tirelessly', 'and', 'information', 'about', 'the', 'transmission', 'mechanisms', 'the', 'clinical', 'spectrum', 'of', 'disease', 'new', 'diagnostics', 'and', 'prevention', 'and', 'therapeutic', 'strategies', 'are', 'rapidly', 'developing', 'Many', 'uncertainties', 'remain', 'with', 'regard', 'to', 'both', 'the', 'virus', 'host', 'interaction', 'and', 'the', 'evolution', 'of', 'the', 'epidemic', 'with', 'specific', 'reference', 'to', 'the', 'times', 'when', 'the', 'epidemic', 'will', 'reach', 'its', 'peak', 'At', 'the', 'moment', 'the', 'therapeutic', 'strategies', 'to', 'deal', 'with', 'the', 'infection', 'are', 'only', 'supportive', 'and', 'prevention', 'aimed', 'at', 'reducing', 'transmission', 'in', 'the', 'community', 'is', 'our', 'best', 'weapon', 'Aggressive', 'isolation', 'measures', 'in', 'China', 'have', 'led', 'to', 'a', 'progressive', 'reduction', 'of', 'cases', 'in', 'the', 'last', 'few', 'days', 'In', 'Italy', 'in', 'geographic', 'regions', 'of', 'the', 'north', 'of', 'the', 'peninsula', 'political', 'and', 'health', 'authorities', 'are', 'making', 'incredible', 'efforts', 'to', 'contain', 'a', 'shock', 'wave', 'that', 'is', 'severely', 'testing', 'the', 'health', 'system', 'In', 'the', 'midst', 'of', 'the', 'crisis', 'the', 'authors', 'have', 'chosen', 'to', 'use', 'the', 'Statpearls', 'platform', 'because', 'within', 'the', 'PubMed', 'scenario', 'it', 'represents', 'a', 'unique', 'tool', 'that', 'may', 'allow', 'them', 'to', 'make', 'updates', 'in', 'real', 'time', 'The', 'aim', 'therefore', 'is', 'to', 'collect', 'information', 'and', 'scientific', 'evidence', 'and', 'to', 'provide', 'an', 'overview', 'of', 'the', 'topic', 'that', 'will', 'be', 'continuously', 'updated']"
170563,Current applications and future trends of molecular diagnostics in clinical bacteriology,2009-04-18,Anal Bioanal Chem,https://www.ncbi.nlm.nih.gov/pubmed/19377839/; https://doi.org/10.1007/s00216-009-2779-8,"Molecular diagnostics of infectious diseases, in particular, nucleic-acid-based methods, are the fastest growing field in clinical laboratory diagnostics. These applications are stepwise replacing or complementing culture-based, biochemical, and immunological assays in microbiology laboratories. The first-generation nucleic acid assays were monoparametric such as conventional tests, determining only a single parameter. Improvements and new approaches in technology now open the possibility for the development of multiparameter assays using microarrays, multiplex nucleic acid amplification techniques, or mass spectrometry, while the introduction of closed-tube systems has resulted in rapid microbial diagnostics with a subsequently reduced contamination risk. Whereas the first assays were focused on the detection and identification of microbial pathogens, these new technologies paved the way for the parallel determination of multiple antibiotic resistance determinants or to perform microbial epidemiology and surveillance on a genetic level.",10.1007/s00216-009-2779-8,sxh2nqre,"['Molecular', 'diagnostics', 'of', 'infectious', 'diseases', 'in', 'particular', 'nucleic', 'acid', 'based', 'methods', 'are', 'the', 'fastest', 'growing', 'field', 'in', 'clinical', 'laboratory', 'diagnostics', 'These', 'applications', 'are', 'stepwise', 'replacing', 'or', 'complementing', 'culture', 'based', 'biochemical', 'and', 'immunological', 'assays', 'in', 'microbiology', 'laboratories', 'The', 'first', 'generation', 'nucleic', 'acid', 'assays', 'were', 'monoparametric', 'such', 'as', 'conventional', 'tests', 'determining', 'only', 'a', 'single', 'parameter', 'Improvements', 'and', 'new', 'approaches', 'in', 'technology', 'now', 'open', 'the', 'possibility', 'for', 'the', 'development', 'of', 'multiparameter', 'assays', 'using', 'microarrays', 'multiplex', 'nucleic', 'acid', 'amplification', 'techniques', 'or', 'mass', 'spectrometry', 'while', 'the', 'introduction', 'of', 'closed', 'tube', 'systems', 'has', 'resulted', 'in', 'rapid', 'microbial', 'diagnostics', 'with', 'a', 'subsequently', 'reduced', 'contamination', 'risk', 'Whereas', 'the', 'first', 'assays', 'were', 'focused', 'on', 'the', 'detection', 'and', 'identification', 'of', 'microbial', 'pathogens', 'these', 'new', 'technologies', 'paved', 'the', 'way', 'for', 'the', 'parallel', 'determination', 'of', 'multiple', 'antibiotic', 'resistance', 'determinants', 'or', 'to', 'perform', 'microbial', 'epidemiology', 'and', 'surveillance', 'on', 'a', 'genetic', 'level', '']"
171019,Importance of diagnostics in epidemic and pandemic preparedness,2019-01-29,BMJ Glob Health,https://www.ncbi.nlm.nih.gov/pubmed/30815287/; https://doi.org/10.1136/bmjgh-2018-001179,"Diagnostics are fundamental for successful outbreak containment. In this supplement, ‘Diagnostic preparedness for WHO Blueprint pathogens’, we describe specific diagnostic challenges presented by selected priority pathogens most likely to cause future epidemics. Some challenges to diagnostic preparedness are common to all outbreak situations, as highlighted by recent outbreaks of Ebola, Zika and yellow fever. In this article, we review these overarching challenges and explore potential solutions. Challenges include fragmented and unreliable funding pathways, limited access to specimens and reagents, inadequate diagnostic testing capacity at both national and community levels of healthcare and lack of incentives for companies to develop and manufacture diagnostics for priority pathogens during non-outbreak periods. Addressing these challenges in an efficient and effective way will require multiple stakeholders—public and private—coordinated in implementing a holistic approach to diagnostics preparedness. All require strengthening of healthcare system diagnostic capacity (including surveillance and education of healthcare workers), establishment of sustainable financing and market strategies and integration of diagnostics with existing mechanisms. Identifying overlaps in diagnostic development needs across different priority pathogens would allow more timely and cost-effective use of resources than a pathogen by pathogen approach; target product profiles for diagnostics should be refined accordingly. We recommend the establishment of a global forum to bring together representatives from all key stakeholders required for the response to develop a coordinated implementation plan. In addition, we should explore if and how existing mechanisms to address challenges to the vaccines sector, such as Coalition for Epidemic Preparedness Innovations and Gavi, could be expanded to cover diagnostics.",10.1136/bmjgh-2018-001179,mcyeyl4s,"['Diagnostics', 'are', 'fundamental', 'for', 'successful', 'outbreak', 'containment', 'In', 'this', 'supplement', 'Diagnostic', 'preparedness', 'for', 'WHO', 'Blueprint', 'pathogens', 'we', 'describe', 'specific', 'diagnostic', 'challenges', 'presented', 'by', 'selected', 'priority', 'pathogens', 'most', 'likely', 'to', 'cause', 'future', 'epidemics', 'Some', 'challenges', 'to', 'diagnostic', 'preparedness', 'are', 'common', 'to', 'all', 'outbreak', 'situations', 'as', 'highlighted', 'by', 'recent', 'outbreaks', 'of', 'Ebola', 'Zika', 'and', 'yellow', 'fever', 'In', 'this', 'article', 'we', 'review', 'these', 'overarching', 'challenges', 'and', 'explore', 'potential', 'solutions', 'Challenges', 'include', 'fragmented', 'and', 'unreliable', 'funding', 'pathways', 'limited', 'access', 'to', 'specimens', 'and', 'reagents', 'inadequate', 'diagnostic', 'testing', 'capacity', 'at', 'both', 'national', 'and', 'community', 'levels', 'of', 'healthcare', 'and', 'lack', 'of', 'incentives', 'for', 'companies', 'to', 'develop', 'and', 'manufacture', 'diagnostics', 'for', 'priority', 'pathogens', 'during', 'non', 'outbreak', 'periods', 'Addressing', 'these', 'challenges', 'in', 'an', 'efficient', 'and', 'effective', 'way', 'will', 'require', 'multiple', 'stakeholders', 'public', 'and', 'private', 'coordinated', 'in', 'implementing', 'a', 'holistic', 'approach', 'to', 'diagnostics', 'preparedness', 'All', 'require', 'strengthening', 'of', 'healthcare', 'system', 'diagnostic', 'capacity', 'including', 'surveillance', 'and', 'education', 'of', 'healthcare', 'workers', 'establishment', 'of', 'sustainable', 'financing', 'and', 'market', 'strategies', 'and', 'integration', 'of', 'diagnostics', 'with', 'existing', 'mechanisms', 'Identifying', 'overlaps', 'in', 'diagnostic', 'development', 'needs', 'across', 'different', 'priority', 'pathogens', 'would', 'allow', 'more', 'timely', 'and', 'cost', 'effective', 'use', 'of', 'resources', 'than', 'a', 'pathogen', 'by', 'pathogen', 'approach', 'target', 'product', 'profiles', 'for', 'diagnostics', 'should', 'be', 'refined', 'accordingly', 'We', 'recommend', 'the', 'establishment', 'of', 'a', 'global', 'forum', 'to', 'bring', 'together', 'representatives', 'from', 'all', 'key', 'stakeholders', 'required', 'for', 'the', 'response', 'to', 'develop', 'a', 'coordinated', 'implementation', 'plan', 'In', 'addition', 'we', 'should', 'explore', 'if', 'and', 'how', 'existing', 'mechanisms', 'to', 'address', 'challenges', 'to', 'the', 'vaccines', 'sector', 'such', 'as', 'Coalition', 'for', 'Epidemic', 'Preparedness', 'Innovations', 'and', 'Gavi', 'could', 'be', 'expanded', 'to', 'cover', 'diagnostics', '']"
171228,"Clinical Epidemiology of Bocavirus, Rhinovirus, Two Polyomaviruses and Four Coronaviruses in HIV-Infected and HIV-Uninfected South African Children",2014-02-03,PLoS One,https://doi.org/10.1371/journal.pone.0086448; https://www.ncbi.nlm.nih.gov/pubmed/24498274/,"BACKGROUND: Advances in molecular diagnostics have implicated newly-discovered respiratory viruses in the pathogenesis of pneumonia. We aimed to determine the prevalence and clinical characteristics of human bocavirus (hBoV), human rhinovirus (hRV), polyomavirus-WU (WUPyV) and –KI (KIPyV) and human coronaviruses (CoV)-OC43, -NL63, -HKU1 and -229E among children hospitalized with lower respiratory tract infections (LRTI). METHODS: Multiplex real-time reverse-transcriptase polymerase chain reaction was undertaken on archived nasopharyngeal aspirates from HIV-infected and –uninfected children (<2 years age) hospitalized for LRTI, who had been previously investigated for respiratory syncytial virus, human metapneumovirus, parainfluenza I–III, adenovirus and influenza A/B. RESULTS: At least one of these viruses were identified in 274 (53.0%) of 517 and in 509 (54.0%) of 943 LRTI-episodes in HIV-infected and -uninfected children, respectively. Human rhinovirus was the most prevalent in HIV-infected (31.7%) and –uninfected children (32.0%), followed by CoV-OC43 (12.2%) and hBoV (9.5%) in HIV-infected; and by hBoV (13.3%) and WUPyV (11.9%) in HIV-uninfected children. Polyomavirus-KI (8.9% vs. 4.8%; p = 0.002) and CoV-OC43 (12.2% vs. 3.6%; p<0.001) were more prevalent in HIV-infected than –uninfected children. Combined with previously-tested viruses, respiratory viruses were identified in 60.9% of HIV-infected and 78.3% of HIV-uninfected children. The newly tested viruses were detected at high frequency in association with other respiratory viruses, including previously-investigated viruses (22.8% in HIV-infected and 28.5% in HIV–uninfected children). CONCLUSIONS: We established that combined with previously-investigated viruses, at least one respiratory virus was identified in the majority of HIV-infected and HIV-uninfected children hospitalized for LRTI. The high frequency of viral co-infections illustrates the complexities in attributing causality to specific viruses in the aetiology of LRTI and may indicate a synergetic role of viral co-infections in the pathogenesis of childhood LRTI.",10.1371/journal.pone.0086448,f9sdt7ax,"['BACKGROUND', 'Advances', 'in', 'molecular', 'diagnostics', 'have', 'implicated', 'newly', 'discovered', 'respiratory', 'viruses', 'in', 'the', 'pathogenesis', 'of', 'pneumonia', 'We', 'aimed', 'to', 'determine', 'the', 'prevalence', 'and', 'clinical', 'characteristics', 'of', 'human', 'bocavirus', 'hBoV', 'human', 'rhinovirus', 'hRV', 'polyomavirus', 'WU', 'WUPyV', 'and', 'KI', 'KIPyV', 'and', 'human', 'coronaviruses', 'CoV', 'OC43', 'NL63', 'HKU1', 'and', '229E', 'among', 'children', 'hospitalized', 'with', 'lower', 'respiratory', 'tract', 'infections', 'LRTI', 'METHODS', 'Multiplex', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'was', 'undertaken', 'on', 'archived', 'nasopharyngeal', 'aspirates', 'from', 'HIV', 'infected', 'and', 'uninfected', 'children', '2', 'years', 'age', 'hospitalized', 'for', 'LRTI', 'who', 'had', 'been', 'previously', 'investigated', 'for', 'respiratory', 'syncytial', 'virus', 'human', 'metapneumovirus', 'parainfluenza', 'I', 'III', 'adenovirus', 'and', 'influenza', 'A', 'B', 'RESULTS', 'At', 'least', 'one', 'of', 'these', 'viruses', 'were', 'identified', 'in', '274', '53', '0', 'of', '517', 'and', 'in', '509', '54', '0', 'of', '943', 'LRTI', 'episodes', 'in', 'HIV', 'infected', 'and', 'uninfected', 'children', 'respectively', 'Human', 'rhinovirus', 'was', 'the', 'most', 'prevalent', 'in', 'HIV', 'infected', '31', '7', 'and', 'uninfected', 'children', '32', '0', 'followed', 'by', 'CoV', 'OC43', '12', '2', 'and', 'hBoV', '9', '5', 'in', 'HIV', 'infected', 'and', 'by', 'hBoV', '13', '3', 'and', 'WUPyV', '11', '9', 'in', 'HIV', 'uninfected', 'children', 'Polyomavirus', 'KI', '8', '9', 'vs', '4', '8', 'p', '0', '002', 'and', 'CoV', 'OC43', '12', '2', 'vs', '3', '6', 'p', '0', '001', 'were', 'more', 'prevalent', 'in', 'HIV', 'infected', 'than', 'uninfected', 'children', 'Combined', 'with', 'previously', 'tested', 'viruses', 'respiratory', 'viruses', 'were', 'identified', 'in', '60', '9', 'of', 'HIV', 'infected', 'and', '78', '3', 'of', 'HIV', 'uninfected', 'children', 'The', 'newly', 'tested', 'viruses', 'were', 'detected', 'at', 'high', 'frequency', 'in', 'association', 'with', 'other', 'respiratory', 'viruses', 'including', 'previously', 'investigated', 'viruses', '22', '8', 'in', 'HIV', 'infected', 'and', '28', '5', 'in', 'HIV', 'uninfected', 'children', 'CONCLUSIONS', 'We', 'established', 'that', 'combined', 'with', 'previously', 'investigated', 'viruses', 'at', 'least', 'one', 'respiratory', 'virus', 'was', 'identified', 'in', 'the', 'majority', 'of', 'HIV', 'infected', 'and', 'HIV', 'uninfected', 'children', 'hospitalized', 'for', 'LRTI', 'The', 'high', 'frequency', 'of', 'viral', 'co', 'infections', 'illustrates', 'the', 'complexities', 'in', 'attributing', 'causality', 'to', 'specific', 'viruses', 'in', 'the', 'aetiology', 'of', 'LRTI', 'and', 'may', 'indicate', 'a', 'synergetic', 'role', 'of', 'viral', 'co', 'infections', 'in', 'the', 'pathogenesis', 'of', 'childhood', 'LRTI', '']"
171526,Mathematical model to reduce loop mediated isothermal amplification (LAMP) false‐positive diagnosis,2019-06-26,Electrophoresis,https://doi.org/10.1002/elps.201900167; https://www.ncbi.nlm.nih.gov/pubmed/31206723/,"Loop mediated isothermal amplification (LAMP) is a nucleic acid amplification technique performed under isothermal conditions. The output of this amplification technique includes multiple different sizes of deoxyribonucleic acid (DNA) structures which are identified by a banding pattern on gel electrophoresis plots. Although this is a specific amplification technique, the complexity of the primer design and amplification still lead to the issue of obtaining false‐positive results, especially when a positive reading is determined solely by whether there is any banding pattern in the gel electrophoresis plot. Here, we first performed extensive LAMP experiments and evaluated the DNA structures using microchip electrophoresis. We then developed a mathematical model derived from the various components that make up an entire LAMP structure to predict the full LAMP structure size in base pairs. This model can be implemented by users to make predictions for specific, DNA size dependent, banding patterns on their gel electrophoresis plots. Each prediction is specific to the target sequence and primers used and therefore reduces incorrect diagnosis errors through identifying true‐positive and false‐positive results. This model was accurately tested with multiple primer sets in house and was also translatable to different DNA and RNA types in previously published literature. The mathematical model can ultimately be used to reduce false‐positive LAMP diagnosis errors for applications ranging from tuberculosis diagnostics to E. coli to numerous other infectious diseases.",10.1002/elps.201900167,bk4v53oz,"['Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'a', 'nucleic', 'acid', 'amplification', 'technique', 'performed', 'under', 'isothermal', 'conditions', 'The', 'output', 'of', 'this', 'amplification', 'technique', 'includes', 'multiple', 'different', 'sizes', 'of', 'deoxyribonucleic', 'acid', 'DNA', 'structures', 'which', 'are', 'identified', 'by', 'a', 'banding', 'pattern', 'on', 'gel', 'electrophoresis', 'plots', 'Although', 'this', 'is', 'a', 'specific', 'amplification', 'technique', 'the', 'complexity', 'of', 'the', 'primer', 'design', 'and', 'amplification', 'still', 'lead', 'to', 'the', 'issue', 'of', 'obtaining', 'false', 'positive', 'results', 'especially', 'when', 'a', 'positive', 'reading', 'is', 'determined', 'solely', 'by', 'whether', 'there', 'is', 'any', 'banding', 'pattern', 'in', 'the', 'gel', 'electrophoresis', 'plot', 'Here', 'we', 'first', 'performed', 'extensive', 'LAMP', 'experiments', 'and', 'evaluated', 'the', 'DNA', 'structures', 'using', 'microchip', 'electrophoresis', 'We', 'then', 'developed', 'a', 'mathematical', 'model', 'derived', 'from', 'the', 'various', 'components', 'that', 'make', 'up', 'an', 'entire', 'LAMP', 'structure', 'to', 'predict', 'the', 'full', 'LAMP', 'structure', 'size', 'in', 'base', 'pairs', 'This', 'model', 'can', 'be', 'implemented', 'by', 'users', 'to', 'make', 'predictions', 'for', 'specific', 'DNA', 'size', 'dependent', 'banding', 'patterns', 'on', 'their', 'gel', 'electrophoresis', 'plots', 'Each', 'prediction', 'is', 'specific', 'to', 'the', 'target', 'sequence', 'and', 'primers', 'used', 'and', 'therefore', 'reduces', 'incorrect', 'diagnosis', 'errors', 'through', 'identifying', 'true', 'positive', 'and', 'false', 'positive', 'results', 'This', 'model', 'was', 'accurately', 'tested', 'with', 'multiple', 'primer', 'sets', 'in', 'house', 'and', 'was', 'also', 'translatable', 'to', 'different', 'DNA', 'and', 'RNA', 'types', 'in', 'previously', 'published', 'literature', 'The', 'mathematical', 'model', 'can', 'ultimately', 'be', 'used', 'to', 'reduce', 'false', 'positive', 'LAMP', 'diagnosis', 'errors', 'for', 'applications', 'ranging', 'from', 'tuberculosis', 'diagnostics', 'to', 'E', 'coli', 'to', 'numerous', 'other', 'infectious', 'diseases', '']"
172366,Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection,2017-05-23,PLoS One,https://doi.org/10.1371/journal.pone.0177340; https://www.ncbi.nlm.nih.gov/pubmed/28542207/,"BACKGROUND: Lung transplant patients are a vulnerable group of immunosuppressed patients that are prone to frequent respiratory infections. We studied 60 episodes of respiratory symptoms in 71 lung transplant patients. Almost half of these episodes were of unknown infectious etiology despite extensive routine diagnostic testing. METHODS: We re-analyzed respiratory samples of all episodes with undetermined etiology in order to detect potential viral pathogens missed/not accounted for in routine diagnostics. Respiratory samples were enriched for viruses by filtration and nuclease digestion, whole nucleic acids extracted and randomly amplified before high throughput metagenomic virus sequencing. Viruses were identified by a bioinformatic pipeline and confirmed and quantified using specific real-time PCR. RESULTS: In completion of routine diagnostics, we identified and confirmed a viral etiology of infection by our metagenomic approach in four patients (three Rhinovirus A, one Rhinovirus B infection) despite initial negative results in specific multiplex PCR. Notably, the majority of samples were also positive for Torque teno virus (TTV) and Human Herpesvirus 7 (HHV-7). While TTV viral loads increased with immunosuppression in both throat swabs and blood samples, HHV-7 remained at low levels throughout the observation period and was restricted to the respiratory tract. CONCLUSION: This study highlights the potential of metagenomic sequencing for virus diagnostics in cases with previously unknown etiology of infection and in complex diagnostic situations such as in immunocompromised hosts.",10.1371/journal.pone.0177340,7ta9wj23,"['BACKGROUND', 'Lung', 'transplant', 'patients', 'are', 'a', 'vulnerable', 'group', 'of', 'immunosuppressed', 'patients', 'that', 'are', 'prone', 'to', 'frequent', 'respiratory', 'infections', 'We', 'studied', '60', 'episodes', 'of', 'respiratory', 'symptoms', 'in', '71', 'lung', 'transplant', 'patients', 'Almost', 'half', 'of', 'these', 'episodes', 'were', 'of', 'unknown', 'infectious', 'etiology', 'despite', 'extensive', 'routine', 'diagnostic', 'testing', 'METHODS', 'We', 're', 'analyzed', 'respiratory', 'samples', 'of', 'all', 'episodes', 'with', 'undetermined', 'etiology', 'in', 'order', 'to', 'detect', 'potential', 'viral', 'pathogens', 'missed', 'not', 'accounted', 'for', 'in', 'routine', 'diagnostics', 'Respiratory', 'samples', 'were', 'enriched', 'for', 'viruses', 'by', 'filtration', 'and', 'nuclease', 'digestion', 'whole', 'nucleic', 'acids', 'extracted', 'and', 'randomly', 'amplified', 'before', 'high', 'throughput', 'metagenomic', 'virus', 'sequencing', 'Viruses', 'were', 'identified', 'by', 'a', 'bioinformatic', 'pipeline', 'and', 'confirmed', 'and', 'quantified', 'using', 'specific', 'real', 'time', 'PCR', 'RESULTS', 'In', 'completion', 'of', 'routine', 'diagnostics', 'we', 'identified', 'and', 'confirmed', 'a', 'viral', 'etiology', 'of', 'infection', 'by', 'our', 'metagenomic', 'approach', 'in', 'four', 'patients', 'three', 'Rhinovirus', 'A', 'one', 'Rhinovirus', 'B', 'infection', 'despite', 'initial', 'negative', 'results', 'in', 'specific', 'multiplex', 'PCR', 'Notably', 'the', 'majority', 'of', 'samples', 'were', 'also', 'positive', 'for', 'Torque', 'teno', 'virus', 'TTV', 'and', 'Human', 'Herpesvirus', '7', 'HHV', '7', 'While', 'TTV', 'viral', 'loads', 'increased', 'with', 'immunosuppression', 'in', 'both', 'throat', 'swabs', 'and', 'blood', 'samples', 'HHV', '7', 'remained', 'at', 'low', 'levels', 'throughout', 'the', 'observation', 'period', 'and', 'was', 'restricted', 'to', 'the', 'respiratory', 'tract', 'CONCLUSION', 'This', 'study', 'highlights', 'the', 'potential', 'of', 'metagenomic', 'sequencing', 'for', 'virus', 'diagnostics', 'in', 'cases', 'with', 'previously', 'unknown', 'etiology', 'of', 'infection', 'and', 'in', 'complex', 'diagnostic', 'situations', 'such', 'as', 'in', 'immunocompromised', 'hosts', '']"
172753,"Taxonomy, Classification and Nomenclature of Viruses",2008-07-30,Encyclopedia of Virology,https://api.elsevier.com/content/article/pii/B9780123744104005094; https://www.sciencedirect.com/science/article/pii/B9780123744104005094,"Virus taxonomy is a man-made field of science aiming at helping the classification of viral entities and at using the same nomenclature for the description of these entities in their biological and physical properties. Taxonomy at the interface of conceptual and physical matters is by essence very controversial, but it is important for many purposes from virus diagnostics to virus evolution. Virus taxonomy, which officially began in 1966 under the activity of 43 virologists who created the International Committee on Taxonomy of Viruses (ICTV), has made tremendous progress in the last 40 years to classify today about 6000 virus entities into more than 2000 species, themselves classified into 287 genera, 73 families, and 3 orders, as attested by the Eighth Report of the ICTV. Virus nomenclature has also progressed in parallel to virus taxonomy, and although virologists still debate about the best way to write virus species names, undoubtedly virus taxonomy and nomenclature are now in a very advanced state. However, major challenges are ahead for virologists with the exponential increase in virus genome sequencing which will be beyond 1 million sequences by 2010 and the virologists have to face that challenge with organization and creativity, in order to offer to the virological community the best and most useful virus taxonomy and nomenclature.",10.1016/b978-012374410-4.00509-4,o6m5wz1z,"['Virus', 'taxonomy', 'is', 'a', 'man', 'made', 'field', 'of', 'science', 'aiming', 'at', 'helping', 'the', 'classification', 'of', 'viral', 'entities', 'and', 'at', 'using', 'the', 'same', 'nomenclature', 'for', 'the', 'description', 'of', 'these', 'entities', 'in', 'their', 'biological', 'and', 'physical', 'properties', 'Taxonomy', 'at', 'the', 'interface', 'of', 'conceptual', 'and', 'physical', 'matters', 'is', 'by', 'essence', 'very', 'controversial', 'but', 'it', 'is', 'important', 'for', 'many', 'purposes', 'from', 'virus', 'diagnostics', 'to', 'virus', 'evolution', 'Virus', 'taxonomy', 'which', 'officially', 'began', 'in', '1966', 'under', 'the', 'activity', 'of', '43', 'virologists', 'who', 'created', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'ICTV', 'has', 'made', 'tremendous', 'progress', 'in', 'the', 'last', '40', 'years', 'to', 'classify', 'today', 'about', '6000', 'virus', 'entities', 'into', 'more', 'than', '2000', 'species', 'themselves', 'classified', 'into', '287', 'genera', '73', 'families', 'and', '3', 'orders', 'as', 'attested', 'by', 'the', 'Eighth', 'Report', 'of', 'the', 'ICTV', 'Virus', 'nomenclature', 'has', 'also', 'progressed', 'in', 'parallel', 'to', 'virus', 'taxonomy', 'and', 'although', 'virologists', 'still', 'debate', 'about', 'the', 'best', 'way', 'to', 'write', 'virus', 'species', 'names', 'undoubtedly', 'virus', 'taxonomy', 'and', 'nomenclature', 'are', 'now', 'in', 'a', 'very', 'advanced', 'state', 'However', 'major', 'challenges', 'are', 'ahead', 'for', 'virologists', 'with', 'the', 'exponential', 'increase', 'in', 'virus', 'genome', 'sequencing', 'which', 'will', 'be', 'beyond', '1', 'million', 'sequences', 'by', '2010', 'and', 'the', 'virologists', 'have', 'to', 'face', 'that', 'challenge', 'with', 'organization', 'and', 'creativity', 'in', 'order', 'to', 'offer', 'to', 'the', 'virological', 'community', 'the', 'best', 'and', 'most', 'useful', 'virus', 'taxonomy', 'and', 'nomenclature', '']"
173292,Loop-mediated isothermal amplification (LAMP): recent progress in research and development,2013-03-29,J Infect Chemother,https://doi.org/10.1007/s10156-013-0590-0; https://api.elsevier.com/content/article/pii/S1341321X13701223; https://www.sciencedirect.com/science/article/pii/S1341321X13701223; https://www.ncbi.nlm.nih.gov/pubmed/23539453/,"Loop-mediated isothermal amplification (LAMP) is an established technology that continues to attract the attention of researchers in many fields. Research and development efforts on LAMP technology in recent years have focused on two major areas; first, the study of its clinical application as an approved in vitro diagnostics tool in Japan and certain other countries; and second, research aimed at further simplifying the LAMP test process. This review provides an overview of the status of LAMP on these two topics by summarizing research work conducted, in the main, after our previous review article.",10.1007/s10156-013-0590-0,8gbuoas6,"['Loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'is', 'an', 'established', 'technology', 'that', 'continues', 'to', 'attract', 'the', 'attention', 'of', 'researchers', 'in', 'many', 'fields', 'Research', 'and', 'development', 'efforts', 'on', 'LAMP', 'technology', 'in', 'recent', 'years', 'have', 'focused', 'on', 'two', 'major', 'areas', 'first', 'the', 'study', 'of', 'its', 'clinical', 'application', 'as', 'an', 'approved', 'in', 'vitro', 'diagnostics', 'tool', 'in', 'Japan', 'and', 'certain', 'other', 'countries', 'and', 'second', 'research', 'aimed', 'at', 'further', 'simplifying', 'the', 'LAMP', 'test', 'process', 'This', 'review', 'provides', 'an', 'overview', 'of', 'the', 'status', 'of', 'LAMP', 'on', 'these', 'two', 'topics', 'by', 'summarizing', 'research', 'work', 'conducted', 'in', 'the', 'main', 'after', 'our', 'previous', 'review', 'article', '']"
173399,Molecular and diagnostic clinical virology in real time,2014-12-12,Clin Microbiol Infect,https://www.ncbi.nlm.nih.gov/pubmed/14706081/,"During the last decade, the application of both qualitative and quantitative nucleic acid detection techniques has had a major impact on diagnostics in clinical virology. Both signal and target amplification-based systems are currently used routinely in most if not all virology laboratories. However, commercial assays are only available for a very limited number of targets, and this has resulted in the development and introduction of assays developed in-house for most viral targets. With improved and automated nucleic acid sample isolation techniques, as well as real-time detection methods, a new generation of assays for most clinically important viruses is being developed. These technological improvements also make it possible to generate results with a very short turnaround time. As an example of a more individual-patient disease-management concept, we have introduced in our clinical setting the quantitative detection of Epstein–Barr virus (EBV) in T-cell-depleted allogeneic stem cell transplant patients. This has enabled us to develop models for pre-emptive anti-B-cell immunotherapy for EBV reactivation, and for reducing not only the incidence of EBV lymphoproliferative disease (EBV-LPD), but the virus-related mortality. It is now also feasible to introduce molecular testing for those viruses that can easily be detected using classical virological methods, such as culture techniques or antigen detection. Prospective studies are needed to evaluate the clinical importance of the additional positive samples detected. It should, however, be clear that a complete exchange of technology is unlikely to occur, and that complementary methods should stay operational, making possible the discovery of new viruses. Furthermore, the ability to characterise viruses more easily by sequencing opens new possibilities for epidemiological studies. There is also an urgent need, with regard to molecular diagnostic methods, for the introduction and use of standardised materials and participation in international quality control programmes. Finally, with the introduction of a universal internal control throughout the whole procedure, the accuracy of the results generated is warranted.",10.1111/j.1469-0691.2004.00699.x,oscbagdq,"['During', 'the', 'last', 'decade', 'the', 'application', 'of', 'both', 'qualitative', 'and', 'quantitative', 'nucleic', 'acid', 'detection', 'techniques', 'has', 'had', 'a', 'major', 'impact', 'on', 'diagnostics', 'in', 'clinical', 'virology', 'Both', 'signal', 'and', 'target', 'amplification', 'based', 'systems', 'are', 'currently', 'used', 'routinely', 'in', 'most', 'if', 'not', 'all', 'virology', 'laboratories', 'However', 'commercial', 'assays', 'are', 'only', 'available', 'for', 'a', 'very', 'limited', 'number', 'of', 'targets', 'and', 'this', 'has', 'resulted', 'in', 'the', 'development', 'and', 'introduction', 'of', 'assays', 'developed', 'in', 'house', 'for', 'most', 'viral', 'targets', 'With', 'improved', 'and', 'automated', 'nucleic', 'acid', 'sample', 'isolation', 'techniques', 'as', 'well', 'as', 'real', 'time', 'detection', 'methods', 'a', 'new', 'generation', 'of', 'assays', 'for', 'most', 'clinically', 'important', 'viruses', 'is', 'being', 'developed', 'These', 'technological', 'improvements', 'also', 'make', 'it', 'possible', 'to', 'generate', 'results', 'with', 'a', 'very', 'short', 'turnaround', 'time', 'As', 'an', 'example', 'of', 'a', 'more', 'individual', 'patient', 'disease', 'management', 'concept', 'we', 'have', 'introduced', 'in', 'our', 'clinical', 'setting', 'the', 'quantitative', 'detection', 'of', 'Epstein', 'Barr', 'virus', 'EBV', 'in', 'T', 'cell', 'depleted', 'allogeneic', 'stem', 'cell', 'transplant', 'patients', 'This', 'has', 'enabled', 'us', 'to', 'develop', 'models', 'for', 'pre', 'emptive', 'anti', 'B', 'cell', 'immunotherapy', 'for', 'EBV', 'reactivation', 'and', 'for', 'reducing', 'not', 'only', 'the', 'incidence', 'of', 'EBV', 'lymphoproliferative', 'disease', 'EBV', 'LPD', 'but', 'the', 'virus', 'related', 'mortality', 'It', 'is', 'now', 'also', 'feasible', 'to', 'introduce', 'molecular', 'testing', 'for', 'those', 'viruses', 'that', 'can', 'easily', 'be', 'detected', 'using', 'classical', 'virological', 'methods', 'such', 'as', 'culture', 'techniques', 'or', 'antigen', 'detection', 'Prospective', 'studies', 'are', 'needed', 'to', 'evaluate', 'the', 'clinical', 'importance', 'of', 'the', 'additional', 'positive', 'samples', 'detected', 'It', 'should', 'however', 'be', 'clear', 'that', 'a', 'complete', 'exchange', 'of', 'technology', 'is', 'unlikely', 'to', 'occur', 'and', 'that', 'complementary', 'methods', 'should', 'stay', 'operational', 'making', 'possible', 'the', 'discovery', 'of', 'new', 'viruses', 'Furthermore', 'the', 'ability', 'to', 'characterise', 'viruses', 'more', 'easily', 'by', 'sequencing', 'opens', 'new', 'possibilities', 'for', 'epidemiological', 'studies', 'There', 'is', 'also', 'an', 'urgent', 'need', 'with', 'regard', 'to', 'molecular', 'diagnostic', 'methods', 'for', 'the', 'introduction', 'and', 'use', 'of', 'standardised', 'materials', 'and', 'participation', 'in', 'international', 'quality', 'control', 'programmes', 'Finally', 'with', 'the', 'introduction', 'of', 'a', 'universal', 'internal', 'control', 'throughout', 'the', 'whole', 'procedure', 'the', 'accuracy', 'of', 'the', 'results', 'generated', 'is', 'warranted', '']"
173456,"Virus detections among patients with severe acute respiratory illness, Northern Vietnam",2020-05-12,PLoS One,https://doi.org/10.1371/journal.pone.0233117; https://www.ncbi.nlm.nih.gov/pubmed/32396550/,"Severe acute respiratory illness (SARI) is a major cause of death and morbidity in low- and middle-income countries, however, the etiologic agents are often undetermined due to the lack of molecular diagnostics in hospitals and clinics. To examine evidence for select viral infections among patients with SARI in northern Vietnam, we studied 348 nasopharyngeal samples from military and civilian patients admitted to 4 hospitals in the greater Hanoi area from 2017–2019. Initial screening for human respiratory viral pathogens was performed in Hanoi, Vietnam at the National Institute of Hygiene and Epidemiology (NIHE) or the Military Institute of Preventative Medicine (MIPM), and an aliquot was shipped to Duke-NUS Medical School in Singapore for validation. Patient demographics were recorded and used to epidemiologically describe the infections. Among military and civilian cases of SARI, 184 (52.9%) tested positive for one or more respiratory viruses. Influenza A virus was the most prevalent virus detected (64.7%), followed by influenza B virus (29.3%), enterovirus (3.8%), adenovirus (1.1%), and coronavirus (1.1%). Risk factor analyses demonstrated an increased risk of influenza A virus detection among military hospital patients (adjusted OR, 2.0; 95% CI, 1.2–3.2), and an increased risk of influenza B virus detection among patients enrolled in year 2017 (adjusted OR, 7.9; 95% CI, 2.7–22.9). As influenza A and B viruses were commonly associated with SARI and are treatable, SARI patients entering these hospitals would benefit if the hospitals were able to adapt onsite molecular diagnostics.",10.1371/journal.pone.0233117,4b0mshqa,"['Severe', 'acute', 'respiratory', 'illness', 'SARI', 'is', 'a', 'major', 'cause', 'of', 'death', 'and', 'morbidity', 'in', 'low', 'and', 'middle', 'income', 'countries', 'however', 'the', 'etiologic', 'agents', 'are', 'often', 'undetermined', 'due', 'to', 'the', 'lack', 'of', 'molecular', 'diagnostics', 'in', 'hospitals', 'and', 'clinics', 'To', 'examine', 'evidence', 'for', 'select', 'viral', 'infections', 'among', 'patients', 'with', 'SARI', 'in', 'northern', 'Vietnam', 'we', 'studied', '348', 'nasopharyngeal', 'samples', 'from', 'military', 'and', 'civilian', 'patients', 'admitted', 'to', '4', 'hospitals', 'in', 'the', 'greater', 'Hanoi', 'area', 'from', '2017', '2019', 'Initial', 'screening', 'for', 'human', 'respiratory', 'viral', 'pathogens', 'was', 'performed', 'in', 'Hanoi', 'Vietnam', 'at', 'the', 'National', 'Institute', 'of', 'Hygiene', 'and', 'Epidemiology', 'NIHE', 'or', 'the', 'Military', 'Institute', 'of', 'Preventative', 'Medicine', 'MIPM', 'and', 'an', 'aliquot', 'was', 'shipped', 'to', 'Duke', 'NUS', 'Medical', 'School', 'in', 'Singapore', 'for', 'validation', 'Patient', 'demographics', 'were', 'recorded', 'and', 'used', 'to', 'epidemiologically', 'describe', 'the', 'infections', 'Among', 'military', 'and', 'civilian', 'cases', 'of', 'SARI', '184', '52', '9', 'tested', 'positive', 'for', 'one', 'or', 'more', 'respiratory', 'viruses', 'Influenza', 'A', 'virus', 'was', 'the', 'most', 'prevalent', 'virus', 'detected', '64', '7', 'followed', 'by', 'influenza', 'B', 'virus', '29', '3', 'enterovirus', '3', '8', 'adenovirus', '1', '1', 'and', 'coronavirus', '1', '1', 'Risk', 'factor', 'analyses', 'demonstrated', 'an', 'increased', 'risk', 'of', 'influenza', 'A', 'virus', 'detection', 'among', 'military', 'hospital', 'patients', 'adjusted', 'OR', '2', '0', '95', 'CI', '1', '2', '3', '2', 'and', 'an', 'increased', 'risk', 'of', 'influenza', 'B', 'virus', 'detection', 'among', 'patients', 'enrolled', 'in', 'year', '2017', 'adjusted', 'OR', '7', '9', '95', 'CI', '2', '7', '22', '9', 'As', 'influenza', 'A', 'and', 'B', 'viruses', 'were', 'commonly', 'associated', 'with', 'SARI', 'and', 'are', 'treatable', 'SARI', 'patients', 'entering', 'these', 'hospitals', 'would', 'benefit', 'if', 'the', 'hospitals', 'were', 'able', 'to', 'adapt', 'onsite', 'molecular', 'diagnostics', '']"
174015,"Comparison of the Biofire FilmArray Respiratory Panel, Seegene AnyplexII RV16, and Argene for the detection of respiratory viruses",2018-09-30,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653218301690; https://api.elsevier.com/content/article/pii/S1386653218301690; https://doi.org/10.1016/j.jcv.2018.07.002; https://www.ncbi.nlm.nih.gov/pubmed/30007137/,"Abstract Background Respiratory infections are common reasons for hospital admission, and are associated with enormous economic burden due to significant morbidity and mortality. The wide spectrum of microbial agents underlying the pathology renders the diagnosis of respiratory infections challenging. Molecular diagnostics offer an advantage to the current serological and culture-based methods in terms of sensitivity, coverage, hands-on time, and time to results. Objectives This study aimed to compare the clinical performance of three commercial kits for respiratory viral detection. Study design The performance of FilmArray Respiratory Panel, AnyplexII RV16, and Argene was compared using clinical respiratory samples (n = 224, comprising 189 nasopharyngeal swabs in Universal Transport Medium (UTM) and 35 endotracheal aspirates), based on common overlapping targets across the platforms. Influenza A “equivocal” and “no-subtype” samples by FilmArray were further compared to a laboratory-developed Influenza A/B test. Results and Conclusions The overall performance of all three platforms appeared to be comparable with regards to sensitivities (95.8–97.9%) and specificities (96.1–98.0%), detection of coinfections, and distinguishment of influenza from non-influenza cases. “Equivocal” and “no-subtype” samples by FilmArray mostly represented weak Influenza A by laboratory-developed test. Lower respiratory tract samples had comparable final-run success-rates and discordant-rates as compared to UTM. Coronavirus HKU1, which was not targeted by AnyplexII RV16, were detected as OC43. The expected test volume would be the main determinant for the selection of platform. Among the platforms, the FilmArray is the most automated but is of the lowest-throughput and has the highest reagent cost.",10.1016/j.jcv.2018.07.002,q9ij2skz,"['Abstract', 'Background', 'Respiratory', 'infections', 'are', 'common', 'reasons', 'for', 'hospital', 'admission', 'and', 'are', 'associated', 'with', 'enormous', 'economic', 'burden', 'due', 'to', 'significant', 'morbidity', 'and', 'mortality', 'The', 'wide', 'spectrum', 'of', 'microbial', 'agents', 'underlying', 'the', 'pathology', 'renders', 'the', 'diagnosis', 'of', 'respiratory', 'infections', 'challenging', 'Molecular', 'diagnostics', 'offer', 'an', 'advantage', 'to', 'the', 'current', 'serological', 'and', 'culture', 'based', 'methods', 'in', 'terms', 'of', 'sensitivity', 'coverage', 'hands', 'on', 'time', 'and', 'time', 'to', 'results', 'Objectives', 'This', 'study', 'aimed', 'to', 'compare', 'the', 'clinical', 'performance', 'of', 'three', 'commercial', 'kits', 'for', 'respiratory', 'viral', 'detection', 'Study', 'design', 'The', 'performance', 'of', 'FilmArray', 'Respiratory', 'Panel', 'AnyplexII', 'RV16', 'and', 'Argene', 'was', 'compared', 'using', 'clinical', 'respiratory', 'samples', 'n', '224', 'comprising', '189', 'nasopharyngeal', 'swabs', 'in', 'Universal', 'Transport', 'Medium', 'UTM', 'and', '35', 'endotracheal', 'aspirates', 'based', 'on', 'common', 'overlapping', 'targets', 'across', 'the', 'platforms', 'Influenza', 'A', 'equivocal', 'and', 'no', 'subtype', 'samples', 'by', 'FilmArray', 'were', 'further', 'compared', 'to', 'a', 'laboratory', 'developed', 'Influenza', 'A', 'B', 'test', 'Results', 'and', 'Conclusions', 'The', 'overall', 'performance', 'of', 'all', 'three', 'platforms', 'appeared', 'to', 'be', 'comparable', 'with', 'regards', 'to', 'sensitivities', '95', '8', '97', '9', 'and', 'specificities', '96', '1', '98', '0', 'detection', 'of', 'coinfections', 'and', 'distinguishment', 'of', 'influenza', 'from', 'non', 'influenza', 'cases', 'Equivocal', 'and', 'no', 'subtype', 'samples', 'by', 'FilmArray', 'mostly', 'represented', 'weak', 'Influenza', 'A', 'by', 'laboratory', 'developed', 'test', 'Lower', 'respiratory', 'tract', 'samples', 'had', 'comparable', 'final', 'run', 'success', 'rates', 'and', 'discordant', 'rates', 'as', 'compared', 'to', 'UTM', 'Coronavirus', 'HKU1', 'which', 'was', 'not', 'targeted', 'by', 'AnyplexII', 'RV16', 'were', 'detected', 'as', 'OC43', 'The', 'expected', 'test', 'volume', 'would', 'be', 'the', 'main', 'determinant', 'for', 'the', 'selection', 'of', 'platform', 'Among', 'the', 'platforms', 'the', 'FilmArray', 'is', 'the', 'most', 'automated', 'but', 'is', 'of', 'the', 'lowest', 'throughput', 'and', 'has', 'the', 'highest', 'reagent', 'cost', '']"
174139,Assessment of the Angolan (CHERRT) Mobile Laboratory Curriculum for Disaster and Pandemic Response,2020-04-13,West J Emerg Med,https://www.ncbi.nlm.nih.gov/pubmed/32302277/; https://doi.org/10.5811/westjem.2020.4.47385,"INTRODUCTION: As of April 5, 2020, the World Health Organization reported over one million confirmed cases and more than 62,000 confirmed coronavirus (COVID-19) deaths affecting 204 countries/regions. The lack of COVID-19 testing capacity threatens the ability of both the United States (US) and low middle income countries (LMIC) to respond to this growing threat, The purpose of this study was to assess the effectiveness through participant self-assessment of a rapid response team (RRT) mobile laboratory curriculum METHODS: We conducted a pre and post survey for the purpose of a process improvement assessment in Angola, involving 32 individuals. The survey was performed before and after a 14-day training workshop held in Luanda, Angola, in December 2019. A paired t-test was used to identify any significant change on six 7-point Likert scale questions with α< 0.05 (95% confidence interval). RESULTS: All six of the questions – 1) “I feel confident managing a real laboratory sample test for Ebola or other highly contagious sample;” 2) “I feel safe working in the lab environment during a real scenario;” 3) “I feel as if I can appropriately manage a potentially highly contagious laboratory sample;” 4)“I feel that I can interpret a positive or negative sample during a suspected contagious outbreak;” 5) “I understand basic Biobubble/mobile laboratory concepts and procedures;” and 6) “I understand polymerase chain reaction (PCR) principles” – showed statistical significant change pre and post training. Additionally, the final two questions – “I can more effectively perform my role/position because of the training I received during this course;” and “This training was valuable” – received high scores on the Likert scale. CONCLUSION: This Angolan RRT mobile laboratory training curriculum provides the nation of Angola with the confidence to rapidly respond and test at the national level a highly infectious contagion in the region and perform on-scene diagnostics. This mobile RRT laboratory provides a mobile and rapid diagnostic resource when epidemic/pandemic resource allocation may need to be prioritized based on confirmed disease prevalence.",10.5811/westjem.2020.4.47385,qmavade5,"['INTRODUCTION', 'As', 'of', 'April', '5', '2020', 'the', 'World', 'Health', 'Organization', 'reported', 'over', 'one', 'million', 'confirmed', 'cases', 'and', 'more', 'than', '62', '000', 'confirmed', 'coronavirus', 'COVID', '19', 'deaths', 'affecting', '204', 'countries', 'regions', 'The', 'lack', 'of', 'COVID', '19', 'testing', 'capacity', 'threatens', 'the', 'ability', 'of', 'both', 'the', 'United', 'States', 'US', 'and', 'low', 'middle', 'income', 'countries', 'LMIC', 'to', 'respond', 'to', 'this', 'growing', 'threat', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'assess', 'the', 'effectiveness', 'through', 'participant', 'self', 'assessment', 'of', 'a', 'rapid', 'response', 'team', 'RRT', 'mobile', 'laboratory', 'curriculum', 'METHODS', 'We', 'conducted', 'a', 'pre', 'and', 'post', 'survey', 'for', 'the', 'purpose', 'of', 'a', 'process', 'improvement', 'assessment', 'in', 'Angola', 'involving', '32', 'individuals', 'The', 'survey', 'was', 'performed', 'before', 'and', 'after', 'a', '14', 'day', 'training', 'workshop', 'held', 'in', 'Luanda', 'Angola', 'in', 'December', '2019', 'A', 'paired', 't', 'test', 'was', 'used', 'to', 'identify', 'any', 'significant', 'change', 'on', 'six', '7', 'point', 'Likert', 'scale', 'questions', 'with', 'α', '0', '05', '95', 'confidence', 'interval', 'RESULTS', 'All', 'six', 'of', 'the', 'questions', '1', 'I', 'feel', 'confident', 'managing', 'a', 'real', 'laboratory', 'sample', 'test', 'for', 'Ebola', 'or', 'other', 'highly', 'contagious', 'sample', '2', 'I', 'feel', 'safe', 'working', 'in', 'the', 'lab', 'environment', 'during', 'a', 'real', 'scenario', '3', 'I', 'feel', 'as', 'if', 'I', 'can', 'appropriately', 'manage', 'a', 'potentially', 'highly', 'contagious', 'laboratory', 'sample', '4', 'I', 'feel', 'that', 'I', 'can', 'interpret', 'a', 'positive', 'or', 'negative', 'sample', 'during', 'a', 'suspected', 'contagious', 'outbreak', '5', 'I', 'understand', 'basic', 'Biobubble', 'mobile', 'laboratory', 'concepts', 'and', 'procedures', 'and', '6', 'I', 'understand', 'polymerase', 'chain', 'reaction', 'PCR', 'principles', 'showed', 'statistical', 'significant', 'change', 'pre', 'and', 'post', 'training', 'Additionally', 'the', 'final', 'two', 'questions', 'I', 'can', 'more', 'effectively', 'perform', 'my', 'role', 'position', 'because', 'of', 'the', 'training', 'I', 'received', 'during', 'this', 'course', 'and', 'This', 'training', 'was', 'valuable', 'received', 'high', 'scores', 'on', 'the', 'Likert', 'scale', 'CONCLUSION', 'This', 'Angolan', 'RRT', 'mobile', 'laboratory', 'training', 'curriculum', 'provides', 'the', 'nation', 'of', 'Angola', 'with', 'the', 'confidence', 'to', 'rapidly', 'respond', 'and', 'test', 'at', 'the', 'national', 'level', 'a', 'highly', 'infectious', 'contagion', 'in', 'the', 'region', 'and', 'perform', 'on', 'scene', 'diagnostics', 'This', 'mobile', 'RRT', 'laboratory', 'provides', 'a', 'mobile', 'and', 'rapid', 'diagnostic', 'resource', 'when', 'epidemic', 'pandemic', 'resource', 'allocation', 'may', 'need', 'to', 'be', 'prioritized', 'based', 'on', 'confirmed', 'disease', 'prevalence', '']"
174374,Viral Lower Respiratory Tract Infection in the Elderly: A Prospective In-Hospital Study,2003-11-06,Eur J Clin Microbiol Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/14605944/,"The objective of this prospective study was to evaluate the clinical and laboratory parameters distinguishing viral from nonviral lower respiratory tract infection in elderly patients and to determine the yield of virological diagnostics in elderly patients with lower respiratory tract infection. The study was conducted in a 184-bed geriatric department in a university hospital during 4 winter months. All consecutive elderly persons admitted with a lower respiratory tract infection were included in the study. Clinical and laboratory parameters, a nasopharyngeal swab, and serological results for respiratory viruses were obtained for all participants. Available blood and sputum cultures were analysed. A total of 165 elderly persons (mean age, 82±6.8 years) were hospitalised with a lower respiratory tract infection. Familial flu-like illness (OR, 4.25; 95%CI, 1.4–13), better functionality (OR, 4; 95%CI, 1.3–14.15), and leucocyte count <10(10)/l (OR, 3; 95%CI, 1.3–7.1) were predictive for viral lower respiratory tract infection. Sixty (36.5%) definite diagnoses (positive blood culture, viral culture, or serological test) and seven (4.2%) probable diagnoses (positive sputum culture) were obtained. An early diagnosis (within 72 h) was possible in 38 (23%) and a late diagnosis in 29 (17.6%) participants. A nasopharyngeal swab contributed in 60.5% of the cases to an early diagnosis. Viral culture identified half (22/43) of the lower respiratory tract infections caused by influenza but only one of six lower respiratory tract infections caused by respiratory syncytial virus. In conclusion, a history of flu-like illness in family members and a total leucocyte count within normal limits makes a viral cause more likely in elderly people hospitalised with a lower respiratory tract infection during winter. Viral culture and rapid antigen detection are insensitive in elderly patients hospitalised with a lower respiratory tract infection.",10.1007/s10096-003-1042-z,vi6zbb0g,"['The', 'objective', 'of', 'this', 'prospective', 'study', 'was', 'to', 'evaluate', 'the', 'clinical', 'and', 'laboratory', 'parameters', 'distinguishing', 'viral', 'from', 'nonviral', 'lower', 'respiratory', 'tract', 'infection', 'in', 'elderly', 'patients', 'and', 'to', 'determine', 'the', 'yield', 'of', 'virological', 'diagnostics', 'in', 'elderly', 'patients', 'with', 'lower', 'respiratory', 'tract', 'infection', 'The', 'study', 'was', 'conducted', 'in', 'a', '184', 'bed', 'geriatric', 'department', 'in', 'a', 'university', 'hospital', 'during', '4', 'winter', 'months', 'All', 'consecutive', 'elderly', 'persons', 'admitted', 'with', 'a', 'lower', 'respiratory', 'tract', 'infection', 'were', 'included', 'in', 'the', 'study', 'Clinical', 'and', 'laboratory', 'parameters', 'a', 'nasopharyngeal', 'swab', 'and', 'serological', 'results', 'for', 'respiratory', 'viruses', 'were', 'obtained', 'for', 'all', 'participants', 'Available', 'blood', 'and', 'sputum', 'cultures', 'were', 'analysed', 'A', 'total', 'of', '165', 'elderly', 'persons', 'mean', 'age', '82', '6', '8', 'years', 'were', 'hospitalised', 'with', 'a', 'lower', 'respiratory', 'tract', 'infection', 'Familial', 'flu', 'like', 'illness', 'OR', '4', '25', '95', 'CI', '1', '4', '13', 'better', 'functionality', 'OR', '4', '95', 'CI', '1', '3', '14', '15', 'and', 'leucocyte', 'count', '10', '10', 'l', 'OR', '3', '95', 'CI', '1', '3', '7', '1', 'were', 'predictive', 'for', 'viral', 'lower', 'respiratory', 'tract', 'infection', 'Sixty', '36', '5', 'definite', 'diagnoses', 'positive', 'blood', 'culture', 'viral', 'culture', 'or', 'serological', 'test', 'and', 'seven', '4', '2', 'probable', 'diagnoses', 'positive', 'sputum', 'culture', 'were', 'obtained', 'An', 'early', 'diagnosis', 'within', '72', 'h', 'was', 'possible', 'in', '38', '23', 'and', 'a', 'late', 'diagnosis', 'in', '29', '17', '6', 'participants', 'A', 'nasopharyngeal', 'swab', 'contributed', 'in', '60', '5', 'of', 'the', 'cases', 'to', 'an', 'early', 'diagnosis', 'Viral', 'culture', 'identified', 'half', '22', '43', 'of', 'the', 'lower', 'respiratory', 'tract', 'infections', 'caused', 'by', 'influenza', 'but', 'only', 'one', 'of', 'six', 'lower', 'respiratory', 'tract', 'infections', 'caused', 'by', 'respiratory', 'syncytial', 'virus', 'In', 'conclusion', 'a', 'history', 'of', 'flu', 'like', 'illness', 'in', 'family', 'members', 'and', 'a', 'total', 'leucocyte', 'count', 'within', 'normal', 'limits', 'makes', 'a', 'viral', 'cause', 'more', 'likely', 'in', 'elderly', 'people', 'hospitalised', 'with', 'a', 'lower', 'respiratory', 'tract', 'infection', 'during', 'winter', 'Viral', 'culture', 'and', 'rapid', 'antigen', 'detection', 'are', 'insensitive', 'in', 'elderly', 'patients', 'hospitalised', 'with', 'a', 'lower', 'respiratory', 'tract', 'infection', '']"
174681,Home Self-Collection of Nasal Swabs for Diagnosis of Acute Respiratory Virus Infections in Children With Cystic Fibrosis,2013-07-14,Journal of the Pediatric Infectious Diseases Society,https://doi.org/10.1093/jpids/pit039; https://www.ncbi.nlm.nih.gov/pubmed/24363931/; http://europepmc.org/articles/pmc3869469?pdf=render,"BACKGROUND: Understanding the importance of respiratory viruses in children with cystic fibrosis (CF) has been limited because of challenges using clinic- or hospital-based diagnostic testing. We conducted a pilot study to assess feasibility of home self- (or parent-) collection of nasal swabs (NS). METHODS: Cystic fibrosis patients aged 6–18 years with new respiratory illness participated. In clinic, a deep nasal flocked swab was collected by research staff and compared with an anterior foam NS obtained after instillation of saline spray. At home, up to 2 self-collections of paired foam NS (with and without saline) were collected and mailed for real-time polymerase chain reaction (PCR) testing. RESULTS: Paired swabs were collected from 28 patients: 18 sets in clinic (deep nasal vs saline foam NS) and 43 sets at home (saline vs dry foam NS) with 9 (50%) and 35 (81%) virus detections, respectively. Home-collected NS were obtained closer to illness onset, with a mean difference in symptom days of −2.3 between home and clinic collections (95% confidence interval [CI] −3.5, −1.2; P < .001). Rhinovirus comprised 73% of virus detections; the difference in mean PCR cycle threshold values for rhinovirus between swabs collected at home versus clinic was −3.8 (95% CI −6.8, −0.9; P = .014), indicating significantly higher viral load for home-collected swabs. CONCLUSIONS: Home-collected foam NS had a higher positivity rate compared with clinic-collected swabs, likely because collection was closer to illness onset. Home self-collection is feasible and well tolerated for timely respiratory virus diagnosis and provides a novel approach for clinical diagnostics and surveillance of respiratory virus infections among CF patients.",10.1093/jpids/pit039,t0asknzu,"['BACKGROUND', 'Understanding', 'the', 'importance', 'of', 'respiratory', 'viruses', 'in', 'children', 'with', 'cystic', 'fibrosis', 'CF', 'has', 'been', 'limited', 'because', 'of', 'challenges', 'using', 'clinic', 'or', 'hospital', 'based', 'diagnostic', 'testing', 'We', 'conducted', 'a', 'pilot', 'study', 'to', 'assess', 'feasibility', 'of', 'home', 'self', 'or', 'parent', 'collection', 'of', 'nasal', 'swabs', 'NS', 'METHODS', 'Cystic', 'fibrosis', 'patients', 'aged', '6', '18', 'years', 'with', 'new', 'respiratory', 'illness', 'participated', 'In', 'clinic', 'a', 'deep', 'nasal', 'flocked', 'swab', 'was', 'collected', 'by', 'research', 'staff', 'and', 'compared', 'with', 'an', 'anterior', 'foam', 'NS', 'obtained', 'after', 'instillation', 'of', 'saline', 'spray', 'At', 'home', 'up', 'to', '2', 'self', 'collections', 'of', 'paired', 'foam', 'NS', 'with', 'and', 'without', 'saline', 'were', 'collected', 'and', 'mailed', 'for', 'real', 'time', 'polymerase', 'chain', 'reaction', 'PCR', 'testing', 'RESULTS', 'Paired', 'swabs', 'were', 'collected', 'from', '28', 'patients', '18', 'sets', 'in', 'clinic', 'deep', 'nasal', 'vs', 'saline', 'foam', 'NS', 'and', '43', 'sets', 'at', 'home', 'saline', 'vs', 'dry', 'foam', 'NS', 'with', '9', '50', 'and', '35', '81', 'virus', 'detections', 'respectively', 'Home', 'collected', 'NS', 'were', 'obtained', 'closer', 'to', 'illness', 'onset', 'with', 'a', 'mean', 'difference', 'in', 'symptom', 'days', 'of', '2', '3', 'between', 'home', 'and', 'clinic', 'collections', '95', 'confidence', 'interval', 'CI', '3', '5', '1', '2', 'P', '001', 'Rhinovirus', 'comprised', '73', 'of', 'virus', 'detections', 'the', 'difference', 'in', 'mean', 'PCR', 'cycle', 'threshold', 'values', 'for', 'rhinovirus', 'between', 'swabs', 'collected', 'at', 'home', 'versus', 'clinic', 'was', '3', '8', '95', 'CI', '6', '8', '0', '9', 'P', '014', 'indicating', 'significantly', 'higher', 'viral', 'load', 'for', 'home', 'collected', 'swabs', 'CONCLUSIONS', 'Home', 'collected', 'foam', 'NS', 'had', 'a', 'higher', 'positivity', 'rate', 'compared', 'with', 'clinic', 'collected', 'swabs', 'likely', 'because', 'collection', 'was', 'closer', 'to', 'illness', 'onset', 'Home', 'self', 'collection', 'is', 'feasible', 'and', 'well', 'tolerated', 'for', 'timely', 'respiratory', 'virus', 'diagnosis', 'and', 'provides', 'a', 'novel', 'approach', 'for', 'clinical', 'diagnostics', 'and', 'surveillance', 'of', 'respiratory', 'virus', 'infections', 'among', 'CF', 'patients', '']"
174805,Cutting-Edge Infectious Disease Diagnostics with CRISPR,2018-06-13,Cell Host Microbe,https://www.sciencedirect.com/science/article/pii/S1931312818302701; https://www.ncbi.nlm.nih.gov/pubmed/29902435/; https://api.elsevier.com/content/article/pii/S1931312818302701; https://doi.org/10.1016/j.chom.2018.05.016,"Three recent Science articles (Chen et al., 2018, Gootenberg et al., 2018, Myhrvold et al., 2018) describe the use of CRISPR-Cas technology to develop point-of-care diagnostics that directly detect viruses from clinical samples. These tests could radically transform approaches to diagnosing infectious diseases at the bedside and in the field.",10.1016/j.chom.2018.05.016,pwq5gir9,"['Three', 'recent', 'Science', 'articles', 'Chen', 'et', 'al', '2018', 'Gootenberg', 'et', 'al', '2018', 'Myhrvold', 'et', 'al', '2018', 'describe', 'the', 'use', 'of', 'CRISPR', 'Cas', 'technology', 'to', 'develop', 'point', 'of', 'care', 'diagnostics', 'that', 'directly', 'detect', 'viruses', 'from', 'clinical', 'samples', 'These', 'tests', 'could', 'radically', 'transform', 'approaches', 'to', 'diagnosing', 'infectious', 'diseases', 'at', 'the', 'bedside', 'and', 'in', 'the', 'field', '']"
175091,Evaluation of Commercial qPCR Kits for Detection of SARS-CoV-2 in Pooled Samples.,2020-07-11,Diagnostics,https://www.ncbi.nlm.nih.gov/pubmed/32664511/; https://doi.org/10.3390/diagnostics10070472,"Due to the current pandemic, a global shortage of reagents has drawn interest in developing alternatives to increase the number of coronavirus tests. One such alternative is sample pooling. We compared commercial kits that are used in COVID-19 diagnostics in terms of their sensitivity and feasibility for use in pooling. In this preliminary study, we showed that pooling of up to 80 samples did not affect the efficacy of the kits. Additionally, the RNA-dependent RNA polymerase (RdRp) gene is a more suitable target in pooled samples than the envelope (E) gene. This approach could provide an easy method of screening a large number of samples and help adjust different governmental regulations.",10.3390/diagnostics10070472,rz88g3ze,"['Due', 'to', 'the', 'current', 'pandemic', 'a', 'global', 'shortage', 'of', 'reagents', 'has', 'drawn', 'interest', 'in', 'developing', 'alternatives', 'to', 'increase', 'the', 'number', 'of', 'coronavirus', 'tests', 'One', 'such', 'alternative', 'is', 'sample', 'pooling', 'We', 'compared', 'commercial', 'kits', 'that', 'are', 'used', 'in', 'COVID', '19', 'diagnostics', 'in', 'terms', 'of', 'their', 'sensitivity', 'and', 'feasibility', 'for', 'use', 'in', 'pooling', 'In', 'this', 'preliminary', 'study', 'we', 'showed', 'that', 'pooling', 'of', 'up', 'to', '80', 'samples', 'did', 'not', 'affect', 'the', 'efficacy', 'of', 'the', 'kits', 'Additionally', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'gene', 'is', 'a', 'more', 'suitable', 'target', 'in', 'pooled', 'samples', 'than', 'the', 'envelope', 'E', 'gene', 'This', 'approach', 'could', 'provide', 'an', 'easy', 'method', 'of', 'screening', 'a', 'large', 'number', 'of', 'samples', 'and', 'help', 'adjust', 'different', 'governmental', 'regulations', '']"
175777,Development and Laboratory Evaluation of a Real-Time PCR Assay for Detecting Viruses and Bacteria of Relevance for Community-Acquired Pneumonia,2015-03-13,J Mol Diagn,https://api.elsevier.com/content/article/pii/S1525157815000422; https://doi.org/10.1016/j.jmoldx.2015.01.005; https://www.sciencedirect.com/science/article/pii/S1525157815000422; https://www.ncbi.nlm.nih.gov/pubmed/25772704/,"Community-acquired pneumonia may present with similar clinical symptoms, regardless of viral or bacterial cause. Diagnostic assays are needed to rapidly discriminate between causes, because this will guide decisions on appropriate treatment. Therefore, a quantitative real-time PCR (qPCR) assay with duplex reactions targeting eight bacteria and six viruses was developed. Technical performance was examined with linear plasmids. Upper and lower respiratory tract specimens were used to compare the qPCR assay with standard microbiological methods. The limit of detection was 5 to 20 DNA template copies with approximately 1000-fold differences in concentrations of the two competing templates. SDs for positive controls were <5%. The use of the qPCR assay resulted in 113 positive identifications in 94 respiratory specimens compared with 38 by using standard diagnostics. Diagnostic accuracy of the qPCR assay varied between 60% positive agreement with standard tests for Streptococcus pneumoniae and 100% for Mycoplasma pneumoniae, Moraxella catarrhalis, and Staphylococcus aureus. Negative percentage of agreement was >95% for M. pneumoniae, Streptococcus pyogenes, respiratory syncytial virus, and influenza A virus; whereas it was only 56% for Haemophilus influenzae. Multiple microbial agents were identified in 19 of 44 sputum and 19 of 50 nasopharynx specimens. We conclude that in parallel qPCR detection of the targeted respiratory bacteria and viruses is feasible. The results indicate good technical performance of the assay in clinical specimens.",10.1016/j.jmoldx.2015.01.005,1gu0a6cb,"['Community', 'acquired', 'pneumonia', 'may', 'present', 'with', 'similar', 'clinical', 'symptoms', 'regardless', 'of', 'viral', 'or', 'bacterial', 'cause', 'Diagnostic', 'assays', 'are', 'needed', 'to', 'rapidly', 'discriminate', 'between', 'causes', 'because', 'this', 'will', 'guide', 'decisions', 'on', 'appropriate', 'treatment', 'Therefore', 'a', 'quantitative', 'real', 'time', 'PCR', 'qPCR', 'assay', 'with', 'duplex', 'reactions', 'targeting', 'eight', 'bacteria', 'and', 'six', 'viruses', 'was', 'developed', 'Technical', 'performance', 'was', 'examined', 'with', 'linear', 'plasmids', 'Upper', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'were', 'used', 'to', 'compare', 'the', 'qPCR', 'assay', 'with', 'standard', 'microbiological', 'methods', 'The', 'limit', 'of', 'detection', 'was', '5', 'to', '20', 'DNA', 'template', 'copies', 'with', 'approximately', '1000', 'fold', 'differences', 'in', 'concentrations', 'of', 'the', 'two', 'competing', 'templates', 'SDs', 'for', 'positive', 'controls', 'were', '5', 'The', 'use', 'of', 'the', 'qPCR', 'assay', 'resulted', 'in', '113', 'positive', 'identifications', 'in', '94', 'respiratory', 'specimens', 'compared', 'with', '38', 'by', 'using', 'standard', 'diagnostics', 'Diagnostic', 'accuracy', 'of', 'the', 'qPCR', 'assay', 'varied', 'between', '60', 'positive', 'agreement', 'with', 'standard', 'tests', 'for', 'Streptococcus', 'pneumoniae', 'and', '100', 'for', 'Mycoplasma', 'pneumoniae', 'Moraxella', 'catarrhalis', 'and', 'Staphylococcus', 'aureus', 'Negative', 'percentage', 'of', 'agreement', 'was', '95', 'for', 'M', 'pneumoniae', 'Streptococcus', 'pyogenes', 'respiratory', 'syncytial', 'virus', 'and', 'influenza', 'A', 'virus', 'whereas', 'it', 'was', 'only', '56', 'for', 'Haemophilus', 'influenzae', 'Multiple', 'microbial', 'agents', 'were', 'identified', 'in', '19', 'of', '44', 'sputum', 'and', '19', 'of', '50', 'nasopharynx', 'specimens', 'We', 'conclude', 'that', 'in', 'parallel', 'qPCR', 'detection', 'of', 'the', 'targeted', 'respiratory', 'bacteria', 'and', 'viruses', 'is', 'feasible', 'The', 'results', 'indicate', 'good', 'technical', 'performance', 'of', 'the', 'assay', 'in', 'clinical', 'specimens', '']"
175868,Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation,2020-06-15,J Clin Virol,https://www.ncbi.nlm.nih.gov/pubmed/32563180/; https://api.elsevier.com/content/article/pii/S1386653220302547; https://doi.org/10.1016/j.jcv.2020.104512; https://www.sciencedirect.com/science/article/pii/S1386653220302547?v=s5,"There is an urgent need for reliable high-throughput serological assays for the management of the ongoing COVID-19 pandemic. Preferably, the performance of serological tests for a novel virus should be determined with clinical specimens against a gold standard, i.e. virus neutralisation. We compared the performance of six commercial immunoassays for the detection of SARS-CoV-2 IgG, IgA and IgM antibodies, including four automated assays [Abbott SARS-COV-2 IgG (CE marked), Diasorin Liaison® SARS-CoV-2 S1/S2 IgG (research use only, RUO), and Euroimmun SARS-CoV-2 IgG and IgA (CE marked)], and two rapid lateral flow (immunocromatographic) tests [Acro Biotech 2019-nCoV IgG/IgM (CE marked) and Xiamen Biotime Biotechnology SARS-CoV-2 IgG/IgM (CE marked)] with a microneutralisation test (MNT). Two specimen panels from serum samples sent to Helsinki University Hospital Laboratory (HUSLAB) were compiled: the patient panel (N=70) included sera from PCR confirmed COVID-19 patients, and the negative panel (N=81) included sera sent for screening of autoimmune diseases and respiratory virus antibodies in 2018 and 2019. The MNT was carried out for all COVID-19 samples (70 serum samples, 62 individuals) and for 53 samples from the negative panel. Forty-one out of 62 COVID-19 patients showed neutralising antibodies.The specificity and sensitivity values of the commercial tests against MNT, respectively, were as follows: 95.1%/80.5% (Abbott Architect SARS-CoV-2 IgG), 94.9%/43.8% (Diasorin Liaison SARS-CoV-2 IgG; RUO), 68.3%/87.8% (Euroimmun SARS-CoV-2 IgA), 86.6%/70.7% (Euroimmun SARS-CoV-2 IgG), 74.4%/56.1% (Acro 2019-nCoV IgG), 69.5%/46.3% (Acro 2019-nCoV IgM), 97.5%/71.9% (Xiamen Biotime SARS-CoV-2 IgG), and 88.8%/81.3% (Xiamen Biotime SARS-CoV-2 IgM). This study shows variable performance values. Laboratories should carefully consider their testing process, such as a two-tier approach, in order to optimize the overall performance of SARS- CoV-2 serodiagnostics.",10.1016/j.jcv.2020.104512,hc7gagnq,"['There', 'is', 'an', 'urgent', 'need', 'for', 'reliable', 'high', 'throughput', 'serological', 'assays', 'for', 'the', 'management', 'of', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'Preferably', 'the', 'performance', 'of', 'serological', 'tests', 'for', 'a', 'novel', 'virus', 'should', 'be', 'determined', 'with', 'clinical', 'specimens', 'against', 'a', 'gold', 'standard', 'i', 'e', 'virus', 'neutralisation', 'We', 'compared', 'the', 'performance', 'of', 'six', 'commercial', 'immunoassays', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'IgG', 'IgA', 'and', 'IgM', 'antibodies', 'including', 'four', 'automated', 'assays', 'Abbott', 'SARS', 'COV', '2', 'IgG', 'CE', 'marked', 'Diasorin', 'Liaison', 'SARS', 'CoV', '2', 'S1', 'S2', 'IgG', 'research', 'use', 'only', 'RUO', 'and', 'Euroimmun', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', 'CE', 'marked', 'and', 'two', 'rapid', 'lateral', 'flow', 'immunocromatographic', 'tests', 'Acro', 'Biotech', '2019', 'nCoV', 'IgG', 'IgM', 'CE', 'marked', 'and', 'Xiamen', 'Biotime', 'Biotechnology', 'SARS', 'CoV', '2', 'IgG', 'IgM', 'CE', 'marked', 'with', 'a', 'microneutralisation', 'test', 'MNT', 'Two', 'specimen', 'panels', 'from', 'serum', 'samples', 'sent', 'to', 'Helsinki', 'University', 'Hospital', 'Laboratory', 'HUSLAB', 'were', 'compiled', 'the', 'patient', 'panel', 'N', '70', 'included', 'sera', 'from', 'PCR', 'confirmed', 'COVID', '19', 'patients', 'and', 'the', 'negative', 'panel', 'N', '81', 'included', 'sera', 'sent', 'for', 'screening', 'of', 'autoimmune', 'diseases', 'and', 'respiratory', 'virus', 'antibodies', 'in', '2018', 'and', '2019', 'The', 'MNT', 'was', 'carried', 'out', 'for', 'all', 'COVID', '19', 'samples', '70', 'serum', 'samples', '62', 'individuals', 'and', 'for', '53', 'samples', 'from', 'the', 'negative', 'panel', 'Forty', 'one', 'out', 'of', '62', 'COVID', '19', 'patients', 'showed', 'neutralising', 'antibodies', 'The', 'specificity', 'and', 'sensitivity', 'values', 'of', 'the', 'commercial', 'tests', 'against', 'MNT', 'respectively', 'were', 'as', 'follows', '95', '1', '80', '5', 'Abbott', 'Architect', 'SARS', 'CoV', '2', 'IgG', '94', '9', '43', '8', 'Diasorin', 'Liaison', 'SARS', 'CoV', '2', 'IgG', 'RUO', '68', '3', '87', '8', 'Euroimmun', 'SARS', 'CoV', '2', 'IgA', '86', '6', '70', '7', 'Euroimmun', 'SARS', 'CoV', '2', 'IgG', '74', '4', '56', '1', 'Acro', '2019', 'nCoV', 'IgG', '69', '5', '46', '3', 'Acro', '2019', 'nCoV', 'IgM', '97', '5', '71', '9', 'Xiamen', 'Biotime', 'SARS', 'CoV', '2', 'IgG', 'and', '88', '8', '81', '3', 'Xiamen', 'Biotime', 'SARS', 'CoV', '2', 'IgM', 'This', 'study', 'shows', 'variable', 'performance', 'values', 'Laboratories', 'should', 'carefully', 'consider', 'their', 'testing', 'process', 'such', 'as', 'a', 'two', 'tier', 'approach', 'in', 'order', 'to', 'optimize', 'the', 'overall', 'performance', 'of', 'SARS', 'CoV', '2', 'serodiagnostics', '']"
176138,A novel method to produce armored double-stranded DNA by encapsulation of MS2 viral capsids,2015-05-19,Appl Microbiol Biotechnol,https://www.ncbi.nlm.nih.gov/pubmed/25981999/; https://doi.org/10.1007/s00253-015-6664-4,"With the rapid development of molecular diagnostic techniques, there is a growing need for quality controls and standards with favorable properties to monitor the entire detection process. In this study, we describe a novel method to produce armored hepatitis B virus (HBV) and human papillomavirus (HPV) DNA for use in nucleic acid tests, which was confirmed to be stable, homogeneous, noninfectious, nuclease resistant, and safe for shipping. We demonstrated that MS2 bacteriophage could successfully package double-stranded DNA of 1.3-, 3-, 3.5-, and 6.5-kb length into viral capsids with high reassembly efficiency. This is the first application of RNA bacteriophage MS2 as a platform to encapsulate double-stranded DNA, forming virus-like particles (VLPs) which were indistinguishable from native MS2 capsids in size and morphology. Moreover, by analyzing the interaction mechanism of pac site and the MS2 coat protein (CP), we found that in addition to the recognized initiation signal TR-RNA, TR-DNA can also trigger spontaneous reassembly of CP dimers, providing a more convenient and feasible method of assembly. In conclusion, this straightforward and reliable manufacturing approach makes armored DNA an ideal control and standard for use in clinical laboratory tests and diagnostics, possessing prospects for broad application, especially providing a new platform for the production of quality controls for DNA viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00253-015-6664-4) contains supplementary material, which is available to authorized users.",10.1007/s00253-015-6664-4,ou2cilvp,"['With', 'the', 'rapid', 'development', 'of', 'molecular', 'diagnostic', 'techniques', 'there', 'is', 'a', 'growing', 'need', 'for', 'quality', 'controls', 'and', 'standards', 'with', 'favorable', 'properties', 'to', 'monitor', 'the', 'entire', 'detection', 'process', 'In', 'this', 'study', 'we', 'describe', 'a', 'novel', 'method', 'to', 'produce', 'armored', 'hepatitis', 'B', 'virus', 'HBV', 'and', 'human', 'papillomavirus', 'HPV', 'DNA', 'for', 'use', 'in', 'nucleic', 'acid', 'tests', 'which', 'was', 'confirmed', 'to', 'be', 'stable', 'homogeneous', 'noninfectious', 'nuclease', 'resistant', 'and', 'safe', 'for', 'shipping', 'We', 'demonstrated', 'that', 'MS2', 'bacteriophage', 'could', 'successfully', 'package', 'double', 'stranded', 'DNA', 'of', '1', '3', '3', '3', '5', 'and', '6', '5', 'kb', 'length', 'into', 'viral', 'capsids', 'with', 'high', 'reassembly', 'efficiency', 'This', 'is', 'the', 'first', 'application', 'of', 'RNA', 'bacteriophage', 'MS2', 'as', 'a', 'platform', 'to', 'encapsulate', 'double', 'stranded', 'DNA', 'forming', 'virus', 'like', 'particles', 'VLPs', 'which', 'were', 'indistinguishable', 'from', 'native', 'MS2', 'capsids', 'in', 'size', 'and', 'morphology', 'Moreover', 'by', 'analyzing', 'the', 'interaction', 'mechanism', 'of', 'pac', 'site', 'and', 'the', 'MS2', 'coat', 'protein', 'CP', 'we', 'found', 'that', 'in', 'addition', 'to', 'the', 'recognized', 'initiation', 'signal', 'TR', 'RNA', 'TR', 'DNA', 'can', 'also', 'trigger', 'spontaneous', 'reassembly', 'of', 'CP', 'dimers', 'providing', 'a', 'more', 'convenient', 'and', 'feasible', 'method', 'of', 'assembly', 'In', 'conclusion', 'this', 'straightforward', 'and', 'reliable', 'manufacturing', 'approach', 'makes', 'armored', 'DNA', 'an', 'ideal', 'control', 'and', 'standard', 'for', 'use', 'in', 'clinical', 'laboratory', 'tests', 'and', 'diagnostics', 'possessing', 'prospects', 'for', 'broad', 'application', 'especially', 'providing', 'a', 'new', 'platform', 'for', 'the', 'production', 'of', 'quality', 'controls', 'for', 'DNA', 'viruses', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1007', 's00253', '015', '6664', '4', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
176293,A Rapid and Low-Cost PCR Thermal Cycler for Infectious Disease Diagnostics,2016-02-12,PLoS One,https://www.ncbi.nlm.nih.gov/pubmed/26872358/; https://doi.org/10.1371/journal.pone.0149150,"The ability to make rapid diagnosis of infectious diseases broadly available in a portable, low-cost format would mark a great step forward in global health. Many molecular diagnostic assays are developed based on using thermal cyclers to carry out polymerase chain reaction (PCR) and reverse-transcription PCR for DNA and RNA amplification and detection, respectively. Unfortunately, most commercial thermal cyclers are expensive and need continuous electrical power supply, so they are not suitable for uses in low-resource settings. We have previously reported a low-cost and simple approach to amplify DNA using vacuum insulated stainless steel thermoses food cans, which we have named it thermos thermal cycler or TTC. Here, we describe the use of an improved set up to enable the detection of viral RNA targets by reverse-transcription PCR (RT-PCR), thus expanding the TTC’s ability to identify highly infectious, RNA virus-based diseases in low resource settings. The TTC was successful in demonstrating high-speed and sensitive detection of DNA or RNA targets of sexually transmitted diseases, HIV/AIDS, Ebola hemorrhagic fever, and dengue fever. Our innovative TTC costs less than $200 to build and has a capacity of at least eight tubes. In terms of speed, the TTC’s performance exceeded that of commercial thermal cyclers tested. When coupled with low-cost endpoint detection technologies such as nucleic acid lateral-flow assay or a cell-phone-based fluorescence detector, the TTC will increase the availability of on-site molecular diagnostics in low-resource settings.",10.1371/journal.pone.0149150,pt4jsr6d,"['The', 'ability', 'to', 'make', 'rapid', 'diagnosis', 'of', 'infectious', 'diseases', 'broadly', 'available', 'in', 'a', 'portable', 'low', 'cost', 'format', 'would', 'mark', 'a', 'great', 'step', 'forward', 'in', 'global', 'health', 'Many', 'molecular', 'diagnostic', 'assays', 'are', 'developed', 'based', 'on', 'using', 'thermal', 'cyclers', 'to', 'carry', 'out', 'polymerase', 'chain', 'reaction', 'PCR', 'and', 'reverse', 'transcription', 'PCR', 'for', 'DNA', 'and', 'RNA', 'amplification', 'and', 'detection', 'respectively', 'Unfortunately', 'most', 'commercial', 'thermal', 'cyclers', 'are', 'expensive', 'and', 'need', 'continuous', 'electrical', 'power', 'supply', 'so', 'they', 'are', 'not', 'suitable', 'for', 'uses', 'in', 'low', 'resource', 'settings', 'We', 'have', 'previously', 'reported', 'a', 'low', 'cost', 'and', 'simple', 'approach', 'to', 'amplify', 'DNA', 'using', 'vacuum', 'insulated', 'stainless', 'steel', 'thermoses', 'food', 'cans', 'which', 'we', 'have', 'named', 'it', 'thermos', 'thermal', 'cycler', 'or', 'TTC', 'Here', 'we', 'describe', 'the', 'use', 'of', 'an', 'improved', 'set', 'up', 'to', 'enable', 'the', 'detection', 'of', 'viral', 'RNA', 'targets', 'by', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'thus', 'expanding', 'the', 'TTC', 's', 'ability', 'to', 'identify', 'highly', 'infectious', 'RNA', 'virus', 'based', 'diseases', 'in', 'low', 'resource', 'settings', 'The', 'TTC', 'was', 'successful', 'in', 'demonstrating', 'high', 'speed', 'and', 'sensitive', 'detection', 'of', 'DNA', 'or', 'RNA', 'targets', 'of', 'sexually', 'transmitted', 'diseases', 'HIV', 'AIDS', 'Ebola', 'hemorrhagic', 'fever', 'and', 'dengue', 'fever', 'Our', 'innovative', 'TTC', 'costs', 'less', 'than', '200', 'to', 'build', 'and', 'has', 'a', 'capacity', 'of', 'at', 'least', 'eight', 'tubes', 'In', 'terms', 'of', 'speed', 'the', 'TTC', 's', 'performance', 'exceeded', 'that', 'of', 'commercial', 'thermal', 'cyclers', 'tested', 'When', 'coupled', 'with', 'low', 'cost', 'endpoint', 'detection', 'technologies', 'such', 'as', 'nucleic', 'acid', 'lateral', 'flow', 'assay', 'or', 'a', 'cell', 'phone', 'based', 'fluorescence', 'detector', 'the', 'TTC', 'will', 'increase', 'the', 'availability', 'of', 'on', 'site', 'molecular', 'diagnostics', 'in', 'low', 'resource', 'settings', '']"
177294,A novel enterovirus and parechovirus multiplex one-step real-time PCR-validation and clinical experience,2013-11-30,Journal of Virological Methods,https://doi.org/10.1016/j.jviromet.2013.06.038; https://www.sciencedirect.com/science/article/pii/S0166093413002528; https://api.elsevier.com/content/article/pii/S0166093413002528; https://www.ncbi.nlm.nih.gov/pubmed/23845901/,"Abstract As the number of new enteroviruses and human parechoviruses seems ever growing, the necessity for updated diagnostics is relevant. We have updated an enterovirus assay and combined it with a previously published assay for human parechovirus resulting in a multiplex one-step RT-PCR assay. The multiplex assay was validated by analysing the sensitivity and specificity of the assay compared to the respective monoplex assays, and a good concordance was found. Furthermore, the enterovirus assay was able to detect 42 reference strains from all 4 species, and an additional 9 genotypes during panel testing and routine usage. During 15 months of routine use, from October 2008 to December 2009, we received and analysed 2187 samples (stool samples, cerebrospinal fluids, blood samples, respiratory samples and autopsy samples) were tested, from 1546 patients and detected enteroviruses and parechoviruses in 171 (8%) and 66 (3%) of the samples, respectively. 180 of the positive samples could be genotyped by PCR and sequencing and the most common genotypes found were human parechovirus type 3, echovirus 9, enterovirus 71, Coxsackievirus A16, and echovirus 25. During 2009 in Denmark, both enterovirus and human parechovirus type 3 had a similar seasonal pattern with a peak during the summer and autumn. Human parechovirus type 3 was almost invariably found in children less than 4 months of age. In conclusion, a multiplex assay was developed allowing simultaneous detection of 2 viruses, which can cause similar clinical symptoms.",10.1016/j.jviromet.2013.06.038,rldr8om0,"['Abstract', 'As', 'the', 'number', 'of', 'new', 'enteroviruses', 'and', 'human', 'parechoviruses', 'seems', 'ever', 'growing', 'the', 'necessity', 'for', 'updated', 'diagnostics', 'is', 'relevant', 'We', 'have', 'updated', 'an', 'enterovirus', 'assay', 'and', 'combined', 'it', 'with', 'a', 'previously', 'published', 'assay', 'for', 'human', 'parechovirus', 'resulting', 'in', 'a', 'multiplex', 'one', 'step', 'RT', 'PCR', 'assay', 'The', 'multiplex', 'assay', 'was', 'validated', 'by', 'analysing', 'the', 'sensitivity', 'and', 'specificity', 'of', 'the', 'assay', 'compared', 'to', 'the', 'respective', 'monoplex', 'assays', 'and', 'a', 'good', 'concordance', 'was', 'found', 'Furthermore', 'the', 'enterovirus', 'assay', 'was', 'able', 'to', 'detect', '42', 'reference', 'strains', 'from', 'all', '4', 'species', 'and', 'an', 'additional', '9', 'genotypes', 'during', 'panel', 'testing', 'and', 'routine', 'usage', 'During', '15', 'months', 'of', 'routine', 'use', 'from', 'October', '2008', 'to', 'December', '2009', 'we', 'received', 'and', 'analysed', '2187', 'samples', 'stool', 'samples', 'cerebrospinal', 'fluids', 'blood', 'samples', 'respiratory', 'samples', 'and', 'autopsy', 'samples', 'were', 'tested', 'from', '1546', 'patients', 'and', 'detected', 'enteroviruses', 'and', 'parechoviruses', 'in', '171', '8', 'and', '66', '3', 'of', 'the', 'samples', 'respectively', '180', 'of', 'the', 'positive', 'samples', 'could', 'be', 'genotyped', 'by', 'PCR', 'and', 'sequencing', 'and', 'the', 'most', 'common', 'genotypes', 'found', 'were', 'human', 'parechovirus', 'type', '3', 'echovirus', '9', 'enterovirus', '71', 'Coxsackievirus', 'A16', 'and', 'echovirus', '25', 'During', '2009', 'in', 'Denmark', 'both', 'enterovirus', 'and', 'human', 'parechovirus', 'type', '3', 'had', 'a', 'similar', 'seasonal', 'pattern', 'with', 'a', 'peak', 'during', 'the', 'summer', 'and', 'autumn', 'Human', 'parechovirus', 'type', '3', 'was', 'almost', 'invariably', 'found', 'in', 'children', 'less', 'than', '4', 'months', 'of', 'age', 'In', 'conclusion', 'a', 'multiplex', 'assay', 'was', 'developed', 'allowing', 'simultaneous', 'detection', 'of', '2', 'viruses', 'which', 'can', 'cause', 'similar', 'clinical', 'symptoms', '']"
177418,Towards Detection and Diagnosis of Ebola Virus Disease at Point-of-Care,2016-01-01,Biosensors and Bioelectronics,https://api.elsevier.com/content/article/pii/S0956566315303651; https://doi.org/10.1016/j.bios.2015.08.040; https://www.ncbi.nlm.nih.gov/pubmed/26319169/; http://europepmc.org/articles/pmc4601610?pdf=render; https://www.sciencedirect.com/science/article/pii/S0956566315303651,"Ebola outbreak-2014 (mainly Zaire strain related Ebola virus) has been declared most widely spread deadly persistent epidemic due to unavailability of rapid diagnostic, detection, and therapeutics. Ebola virus disease (EVD), a severe viral hemorrhagic fever syndrome caused by Ebola virus (EBOV) is transmitted by direct contact with the body fluids of infected person and objects contaminated with virus or infected animals. World Health Organization (WHO) has declared EVD epidemic as public health emergency of international concern with severe global economic burden. At fatal EBOV infection stage, patients usually die before the antibody response. Currently, rapid blood tests to diagnose EBOV infection include the antigen or antibodies capture using ELISA and RNA detection using RT/Q-PCR within 3–10 days after the onset of symptoms. Moreover, few nanotechnology-based colorimetric and paper-based immunoassay methods have been recently reported to detect Ebola virus. Unfortunately, these methods are limited to laboratory only. As state-of-the art (SoA) diagnostics time to confirm Ebola infection, varies from 6 hours to about 3 days, it causes delay in therapeutic approaches. Thus developing a cost-effective, rapid, sensitive, and selective sensor to detect EVD at point-of-care (POC) is certainly worth exploring to establish rapid diagnostics to decide therapeutics. This review highlights SoA of Ebola diagnostics and also a call to develop rapid, selective and sensitive POC detection of EBOV for global health care. We propose that adopting miniaturized electrochemical EBOV immunosensing can detect virus level at pM concentration within ~40 minute compared to 3 days of ELISA test at nM levels.",10.1016/j.bios.2015.08.040,yrqcyboo,"['Ebola', 'outbreak', '2014', 'mainly', 'Zaire', 'strain', 'related', 'Ebola', 'virus', 'has', 'been', 'declared', 'most', 'widely', 'spread', 'deadly', 'persistent', 'epidemic', 'due', 'to', 'unavailability', 'of', 'rapid', 'diagnostic', 'detection', 'and', 'therapeutics', 'Ebola', 'virus', 'disease', 'EVD', 'a', 'severe', 'viral', 'hemorrhagic', 'fever', 'syndrome', 'caused', 'by', 'Ebola', 'virus', 'EBOV', 'is', 'transmitted', 'by', 'direct', 'contact', 'with', 'the', 'body', 'fluids', 'of', 'infected', 'person', 'and', 'objects', 'contaminated', 'with', 'virus', 'or', 'infected', 'animals', 'World', 'Health', 'Organization', 'WHO', 'has', 'declared', 'EVD', 'epidemic', 'as', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'with', 'severe', 'global', 'economic', 'burden', 'At', 'fatal', 'EBOV', 'infection', 'stage', 'patients', 'usually', 'die', 'before', 'the', 'antibody', 'response', 'Currently', 'rapid', 'blood', 'tests', 'to', 'diagnose', 'EBOV', 'infection', 'include', 'the', 'antigen', 'or', 'antibodies', 'capture', 'using', 'ELISA', 'and', 'RNA', 'detection', 'using', 'RT', 'Q', 'PCR', 'within', '3', '10', 'days', 'after', 'the', 'onset', 'of', 'symptoms', 'Moreover', 'few', 'nanotechnology', 'based', 'colorimetric', 'and', 'paper', 'based', 'immunoassay', 'methods', 'have', 'been', 'recently', 'reported', 'to', 'detect', 'Ebola', 'virus', 'Unfortunately', 'these', 'methods', 'are', 'limited', 'to', 'laboratory', 'only', 'As', 'state', 'of', 'the', 'art', 'SoA', 'diagnostics', 'time', 'to', 'confirm', 'Ebola', 'infection', 'varies', 'from', '6', 'hours', 'to', 'about', '3', 'days', 'it', 'causes', 'delay', 'in', 'therapeutic', 'approaches', 'Thus', 'developing', 'a', 'cost', 'effective', 'rapid', 'sensitive', 'and', 'selective', 'sensor', 'to', 'detect', 'EVD', 'at', 'point', 'of', 'care', 'POC', 'is', 'certainly', 'worth', 'exploring', 'to', 'establish', 'rapid', 'diagnostics', 'to', 'decide', 'therapeutics', 'This', 'review', 'highlights', 'SoA', 'of', 'Ebola', 'diagnostics', 'and', 'also', 'a', 'call', 'to', 'develop', 'rapid', 'selective', 'and', 'sensitive', 'POC', 'detection', 'of', 'EBOV', 'for', 'global', 'health', 'care', 'We', 'propose', 'that', 'adopting', 'miniaturized', 'electrochemical', 'EBOV', 'immunosensing', 'can', 'detect', 'virus', 'level', 'at', 'pM', 'concentration', 'within', '40', 'minute', 'compared', 'to', '3', 'days', 'of', 'ELISA', 'test', 'at', 'nM', 'levels', '']"
177579,Immunochromatographic test for detection of adenovirus from respiratory samples: Is it a real solution for pediatric emergency department?,2014-01-31,Journal of Virological Methods,https://doi.org/10.1016/j.jviromet.2013.09.002; https://api.elsevier.com/content/article/pii/S0166093413003893; https://www.ncbi.nlm.nih.gov/pubmed/24096271/; https://www.sciencedirect.com/science/article/pii/S0166093413003893,"Abstract Rapid diagnosis of adenoviral respiratory infections is required in order to decide optimal treatment strategies. The adenovirus antigen immunochromatography Adeno Respiratory Card Letitest (Leti diagnostics, Barcelona, Spain), was evaluated versus the shell-vial culture and multiplex PCR (Clart Pneumovir Version 3.0, Genomica, Madrid, Spain), in nasopharyngeal washes and oropharyngeal swabs specimens from subjects with respiratory tract infections. Between April 2011 and November 2012, 224 patients were included. The IC Adeno Respiratory Card Letitest was positive for 77.9% (74 of 95) of patients diagnosed at bedside. Using multiplex-PCR as the reference standard, the overall sensitivity was 77.9% and the specificity was 73.6%. Taking shell-viral culture as the reference method, the Adeno Respiratory Card Letitest (Leti diagnostics, Barcelona, Spain) sensitivity and specificity values were 80.0% and 60.9%, respectively. Using RT-PCR (Clart Pneumovir Version 3.0, Genomica, Madrid, Spain) as the reference standard, the viral culture sensitivity was 53.2% and the specificity was 100%. The Adeno Respiratory Card Letitest (Leti diagnostics, Barcelona, Spain) assay could be a simple and rapid method for antigenic detection of adenovirus in pediatric respiratory samples although it would be necessary to improve the specificity and sensitivity of the test.",10.1016/j.jviromet.2013.09.002,0oos87b1,"['Abstract', 'Rapid', 'diagnosis', 'of', 'adenoviral', 'respiratory', 'infections', 'is', 'required', 'in', 'order', 'to', 'decide', 'optimal', 'treatment', 'strategies', 'The', 'adenovirus', 'antigen', 'immunochromatography', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'Leti', 'diagnostics', 'Barcelona', 'Spain', 'was', 'evaluated', 'versus', 'the', 'shell', 'vial', 'culture', 'and', 'multiplex', 'PCR', 'Clart', 'Pneumovir', 'Version', '3', '0', 'Genomica', 'Madrid', 'Spain', 'in', 'nasopharyngeal', 'washes', 'and', 'oropharyngeal', 'swabs', 'specimens', 'from', 'subjects', 'with', 'respiratory', 'tract', 'infections', 'Between', 'April', '2011', 'and', 'November', '2012', '224', 'patients', 'were', 'included', 'The', 'IC', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'was', 'positive', 'for', '77', '9', '74', 'of', '95', 'of', 'patients', 'diagnosed', 'at', 'bedside', 'Using', 'multiplex', 'PCR', 'as', 'the', 'reference', 'standard', 'the', 'overall', 'sensitivity', 'was', '77', '9', 'and', 'the', 'specificity', 'was', '73', '6', 'Taking', 'shell', 'viral', 'culture', 'as', 'the', 'reference', 'method', 'the', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'Leti', 'diagnostics', 'Barcelona', 'Spain', 'sensitivity', 'and', 'specificity', 'values', 'were', '80', '0', 'and', '60', '9', 'respectively', 'Using', 'RT', 'PCR', 'Clart', 'Pneumovir', 'Version', '3', '0', 'Genomica', 'Madrid', 'Spain', 'as', 'the', 'reference', 'standard', 'the', 'viral', 'culture', 'sensitivity', 'was', '53', '2', 'and', 'the', 'specificity', 'was', '100', 'The', 'Adeno', 'Respiratory', 'Card', 'Letitest', 'Leti', 'diagnostics', 'Barcelona', 'Spain', 'assay', 'could', 'be', 'a', 'simple', 'and', 'rapid', 'method', 'for', 'antigenic', 'detection', 'of', 'adenovirus', 'in', 'pediatric', 'respiratory', 'samples', 'although', 'it', 'would', 'be', 'necessary', 'to', 'improve', 'the', 'specificity', 'and', 'sensitivity', 'of', 'the', 'test', '']"
177883,Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses,2017-10-31,Molecular and Cellular Probes,https://www.sciencedirect.com/science/article/pii/S0890850817300658; https://doi.org/10.1016/j.mcp.2017.06.005; https://www.ncbi.nlm.nih.gov/pubmed/28652020/; https://api.elsevier.com/content/article/pii/S0890850817300658,"Abstract Influenza and other acute respiratory infections are of great concern for public health, causing excessive morbidity and mortality throughout the world. Influenza virus A(H2N2), which caused a pandemic of so called “Asian flu” in 1957 was expelled from the human population by the new pandemic virus subtype H3N2 in 1968, however, influenza A(H2) viruses continue to circulate in wild birds and poultry. The lack of immunity in human population and the continued circulation of influenza A(H2) among animals makes emergence of a new pandemic virus possible. One of the basic techniques of molecular diagnostics of infectious diseases is the realtime polymerase chain reaction (PCR). The aim of this work was to design oligonucleotide primers and probes for the rapid detection of influenza A virus subtype H2 by realtime reverse transcription - polymerase chain reaction (rRT-PCR). Analysis of 539 sequences of influenza A(H2N2) virus hemagglutinin gene from GISAID EpiFlu database revealed conservative regions suitable for use as binding sites for primers and probes. 191 probes were designed and 2 sets of primers and probes (H2-1 and H2-2) were selected for further experimental evaluation. Detection limit of RT-PCR system was 50 copies of DNA per 25 μl reaction when 10-fold dilutions of pCI-neo-H2 plasmid used as template. Analytical specificity of selected sets of primers and probes were tested on wide range of influenza strains and non-influenza respiratory viruses. H2-2 set found to have insufficient specificity detecting seasonal influenza A(H1N1) viruses and was excluded from further analysis. Analytical sensitivity was further tested on vaccine strain A/17/California/66/395 (H2N2) and A/Japan/305/1957 (H2N2), limit of detection for primers-probe set H2-1 was 3.2 (CI95%: 3.07–3.48) lg EID50/ml. Designed primers and probes for the realtime RT-PCR universal detection of influenza A(H2) viruses could be used in clinical trials of vaccines against influenza A(H2) and screening for H2 in cases of unsubtypeable influenza A in humans.",10.1016/j.mcp.2017.06.005,ozv0zp7r,"['Abstract', 'Influenza', 'and', 'other', 'acute', 'respiratory', 'infections', 'are', 'of', 'great', 'concern', 'for', 'public', 'health', 'causing', 'excessive', 'morbidity', 'and', 'mortality', 'throughout', 'the', 'world', 'Influenza', 'virus', 'A', 'H2N2', 'which', 'caused', 'a', 'pandemic', 'of', 'so', 'called', 'Asian', 'flu', 'in', '1957', 'was', 'expelled', 'from', 'the', 'human', 'population', 'by', 'the', 'new', 'pandemic', 'virus', 'subtype', 'H3N2', 'in', '1968', 'however', 'influenza', 'A', 'H2', 'viruses', 'continue', 'to', 'circulate', 'in', 'wild', 'birds', 'and', 'poultry', 'The', 'lack', 'of', 'immunity', 'in', 'human', 'population', 'and', 'the', 'continued', 'circulation', 'of', 'influenza', 'A', 'H2', 'among', 'animals', 'makes', 'emergence', 'of', 'a', 'new', 'pandemic', 'virus', 'possible', 'One', 'of', 'the', 'basic', 'techniques', 'of', 'molecular', 'diagnostics', 'of', 'infectious', 'diseases', 'is', 'the', 'realtime', 'polymerase', 'chain', 'reaction', 'PCR', 'The', 'aim', 'of', 'this', 'work', 'was', 'to', 'design', 'oligonucleotide', 'primers', 'and', 'probes', 'for', 'the', 'rapid', 'detection', 'of', 'influenza', 'A', 'virus', 'subtype', 'H2', 'by', 'realtime', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'Analysis', 'of', '539', 'sequences', 'of', 'influenza', 'A', 'H2N2', 'virus', 'hemagglutinin', 'gene', 'from', 'GISAID', 'EpiFlu', 'database', 'revealed', 'conservative', 'regions', 'suitable', 'for', 'use', 'as', 'binding', 'sites', 'for', 'primers', 'and', 'probes', '191', 'probes', 'were', 'designed', 'and', '2', 'sets', 'of', 'primers', 'and', 'probes', 'H2', '1', 'and', 'H2', '2', 'were', 'selected', 'for', 'further', 'experimental', 'evaluation', 'Detection', 'limit', 'of', 'RT', 'PCR', 'system', 'was', '50', 'copies', 'of', 'DNA', 'per', '25', 'μl', 'reaction', 'when', '10', 'fold', 'dilutions', 'of', 'pCI', 'neo', 'H2', 'plasmid', 'used', 'as', 'template', 'Analytical', 'specificity', 'of', 'selected', 'sets', 'of', 'primers', 'and', 'probes', 'were', 'tested', 'on', 'wide', 'range', 'of', 'influenza', 'strains', 'and', 'non', 'influenza', 'respiratory', 'viruses', 'H2', '2', 'set', 'found', 'to', 'have', 'insufficient', 'specificity', 'detecting', 'seasonal', 'influenza', 'A', 'H1N1', 'viruses', 'and', 'was', 'excluded', 'from', 'further', 'analysis', 'Analytical', 'sensitivity', 'was', 'further', 'tested', 'on', 'vaccine', 'strain', 'A', '17', 'California', '66', '395', 'H2N2', 'and', 'A', 'Japan', '305', '1957', 'H2N2', 'limit', 'of', 'detection', 'for', 'primers', 'probe', 'set', 'H2', '1', 'was', '3', '2', 'CI95', '3', '07', '3', '48', 'lg', 'EID50', 'ml', 'Designed', 'primers', 'and', 'probes', 'for', 'the', 'realtime', 'RT', 'PCR', 'universal', 'detection', 'of', 'influenza', 'A', 'H2', 'viruses', 'could', 'be', 'used', 'in', 'clinical', 'trials', 'of', 'vaccines', 'against', 'influenza', 'A', 'H2', 'and', 'screening', 'for', 'H2', 'in', 'cases', 'of', 'unsubtypeable', 'influenza', 'A', 'in', 'humans', '']"
177963,FDA Perspectives on Diagnostic Device Clinical Studies for Respiratory Infections,2011-05-01,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/21460289/; https://doi.org/10.1093/cid/cir056,"Two pathways are described for submission to FDA for clearance of a diagnostic device: a Premarket Application (PMA), which can lead to approval of a diagnostic device, and a Premarket Notification, which can lead to clearance. The latter is often called a 510(k), named for the statute providing for this path. Recent FDA clearance of molecular-based multiplex panels represents the beginning of a new era for the diagnosis of respiratory infections. The ability to test for multiple pathogens simultaneously, accompanied by the increasing availability of molecular-based assays for newly recognized respiratory pathogens will likely have a major impact on patient care, drug development, and public health epidemiology. We provide a general overview of how FDA evaluates new diagnostics for respiratory tract infections and the agency’s expectations for sponsors developing new tests in this area.",10.1093/cid/cir056,uijwq8gx,"['Two', 'pathways', 'are', 'described', 'for', 'submission', 'to', 'FDA', 'for', 'clearance', 'of', 'a', 'diagnostic', 'device', 'a', 'Premarket', 'Application', 'PMA', 'which', 'can', 'lead', 'to', 'approval', 'of', 'a', 'diagnostic', 'device', 'and', 'a', 'Premarket', 'Notification', 'which', 'can', 'lead', 'to', 'clearance', 'The', 'latter', 'is', 'often', 'called', 'a', '510', 'k', 'named', 'for', 'the', 'statute', 'providing', 'for', 'this', 'path', 'Recent', 'FDA', 'clearance', 'of', 'molecular', 'based', 'multiplex', 'panels', 'represents', 'the', 'beginning', 'of', 'a', 'new', 'era', 'for', 'the', 'diagnosis', 'of', 'respiratory', 'infections', 'The', 'ability', 'to', 'test', 'for', 'multiple', 'pathogens', 'simultaneously', 'accompanied', 'by', 'the', 'increasing', 'availability', 'of', 'molecular', 'based', 'assays', 'for', 'newly', 'recognized', 'respiratory', 'pathogens', 'will', 'likely', 'have', 'a', 'major', 'impact', 'on', 'patient', 'care', 'drug', 'development', 'and', 'public', 'health', 'epidemiology', 'We', 'provide', 'a', 'general', 'overview', 'of', 'how', 'FDA', 'evaluates', 'new', 'diagnostics', 'for', 'respiratory', 'tract', 'infections', 'and', 'the', 'agency', 's', 'expectations', 'for', 'sponsors', 'developing', 'new', 'tests', 'in', 'this', 'area', '']"
178044,Development and Implementation of Multiplex TaqMan Array Cards for Specimen Testing at Child Health and Mortality Prevention Surveillance Site Laboratories,2019-10-15,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/31598666/; https://doi.org/10.1093/cid/ciz571,"Child Health and Mortality Prevention Surveillance (CHAMPS) laboratories are employing a variety of laboratory methods to identify infectious agents contributing to deaths of children <5 years old and stillbirths in sub-Saharan Africa and South Asia. In support of this long-term objective, our team developed TaqMan Array Cards (TACs) for testing postmortem specimens (blood, cerebrospinal fluid, lung tissue, respiratory tract swabs, and rectal swabs) for >100 real-time polymerase chain reaction (PCR) targets in total (30–45 per card depending on configuration). Multipathogen panels were configured by syndrome and customized to include pathogens of significance in young children within the regions where CHAMPS is conducted, including bacteria (57 targets covering 30 genera), viruses (48 targets covering 40 viruses), parasites (8 targets covering 8 organisms), and fungi (3 targets covering 3 organisms). The development and application of multiplex real-time PCR reactions to the TAC microfluidic platform increased the number of targets in each panel while maintaining assay efficiency and replicates for heightened sensitivity. These advances represent a substantial improvement in the utility of this technology for infectious disease diagnostics and surveillance. We optimized all aspects of the CHAMPS molecular laboratory testing workflow including nucleic acid extraction, quality assurance, and data management to ensure comprehensive molecular testing of specimens and high-quality data. Here we describe the development and implementation of multiplex TACs and associated laboratory protocols for specimen processing, testing, and data management at CHAMPS site laboratories.",10.1093/cid/ciz571,8zfss1ox,"['Child', 'Health', 'and', 'Mortality', 'Prevention', 'Surveillance', 'CHAMPS', 'laboratories', 'are', 'employing', 'a', 'variety', 'of', 'laboratory', 'methods', 'to', 'identify', 'infectious', 'agents', 'contributing', 'to', 'deaths', 'of', 'children', '5', 'years', 'old', 'and', 'stillbirths', 'in', 'sub', 'Saharan', 'Africa', 'and', 'South', 'Asia', 'In', 'support', 'of', 'this', 'long', 'term', 'objective', 'our', 'team', 'developed', 'TaqMan', 'Array', 'Cards', 'TACs', 'for', 'testing', 'postmortem', 'specimens', 'blood', 'cerebrospinal', 'fluid', 'lung', 'tissue', 'respiratory', 'tract', 'swabs', 'and', 'rectal', 'swabs', 'for', '100', 'real', 'time', 'polymerase', 'chain', 'reaction', 'PCR', 'targets', 'in', 'total', '30', '45', 'per', 'card', 'depending', 'on', 'configuration', 'Multipathogen', 'panels', 'were', 'configured', 'by', 'syndrome', 'and', 'customized', 'to', 'include', 'pathogens', 'of', 'significance', 'in', 'young', 'children', 'within', 'the', 'regions', 'where', 'CHAMPS', 'is', 'conducted', 'including', 'bacteria', '57', 'targets', 'covering', '30', 'genera', 'viruses', '48', 'targets', 'covering', '40', 'viruses', 'parasites', '8', 'targets', 'covering', '8', 'organisms', 'and', 'fungi', '3', 'targets', 'covering', '3', 'organisms', 'The', 'development', 'and', 'application', 'of', 'multiplex', 'real', 'time', 'PCR', 'reactions', 'to', 'the', 'TAC', 'microfluidic', 'platform', 'increased', 'the', 'number', 'of', 'targets', 'in', 'each', 'panel', 'while', 'maintaining', 'assay', 'efficiency', 'and', 'replicates', 'for', 'heightened', 'sensitivity', 'These', 'advances', 'represent', 'a', 'substantial', 'improvement', 'in', 'the', 'utility', 'of', 'this', 'technology', 'for', 'infectious', 'disease', 'diagnostics', 'and', 'surveillance', 'We', 'optimized', 'all', 'aspects', 'of', 'the', 'CHAMPS', 'molecular', 'laboratory', 'testing', 'workflow', 'including', 'nucleic', 'acid', 'extraction', 'quality', 'assurance', 'and', 'data', 'management', 'to', 'ensure', 'comprehensive', 'molecular', 'testing', 'of', 'specimens', 'and', 'high', 'quality', 'data', 'Here', 'we', 'describe', 'the', 'development', 'and', 'implementation', 'of', 'multiplex', 'TACs', 'and', 'associated', 'laboratory', 'protocols', 'for', 'specimen', 'processing', 'testing', 'and', 'data', 'management', 'at', 'CHAMPS', 'site', 'laboratories', '']"
178095,Integrated Polymerase Chain Reaction Technologies (Sample-to-Answer Technologies),2016-11-04,Molecular Diagnostics,https://www.sciencedirect.com/science/article/pii/B9780128029718000055; https://api.elsevier.com/content/article/pii/B9780128029718000055,"The tools available for both infectious disease diagnostics and human identity testing have benefitted from major technological advances in the automation of nucleic acid purification, amplification, and detection methods. The seamless integration of these processes into a fully automated microscale format has led to the development of rapid, user-friendly sample-to-answer assay systems. The application of these systems for human identity testing allows for DNA profiles to be generated in a field-forward environment where they can be used to generate investigative leads in crimes or other actionable intelligence. When used for infectious disease diagnostics, the sensitivity and specificity of these assay systems meets or exceeds that of more conventional strategies for the detection of respiratory, gastrointestinal, nervous system, and sexually transmitted pathogens. The anticipated medical benefits of this technology include shorter hospital stays, the elimination of unnecessary or ineffectual treatment, improved patient outcomes, and an overall quantifiable reduction in healthcare costs.",10.1016/b978-0-12-802971-8.00005-5,x821kf2c,"['The', 'tools', 'available', 'for', 'both', 'infectious', 'disease', 'diagnostics', 'and', 'human', 'identity', 'testing', 'have', 'benefitted', 'from', 'major', 'technological', 'advances', 'in', 'the', 'automation', 'of', 'nucleic', 'acid', 'purification', 'amplification', 'and', 'detection', 'methods', 'The', 'seamless', 'integration', 'of', 'these', 'processes', 'into', 'a', 'fully', 'automated', 'microscale', 'format', 'has', 'led', 'to', 'the', 'development', 'of', 'rapid', 'user', 'friendly', 'sample', 'to', 'answer', 'assay', 'systems', 'The', 'application', 'of', 'these', 'systems', 'for', 'human', 'identity', 'testing', 'allows', 'for', 'DNA', 'profiles', 'to', 'be', 'generated', 'in', 'a', 'field', 'forward', 'environment', 'where', 'they', 'can', 'be', 'used', 'to', 'generate', 'investigative', 'leads', 'in', 'crimes', 'or', 'other', 'actionable', 'intelligence', 'When', 'used', 'for', 'infectious', 'disease', 'diagnostics', 'the', 'sensitivity', 'and', 'specificity', 'of', 'these', 'assay', 'systems', 'meets', 'or', 'exceeds', 'that', 'of', 'more', 'conventional', 'strategies', 'for', 'the', 'detection', 'of', 'respiratory', 'gastrointestinal', 'nervous', 'system', 'and', 'sexually', 'transmitted', 'pathogens', 'The', 'anticipated', 'medical', 'benefits', 'of', 'this', 'technology', 'include', 'shorter', 'hospital', 'stays', 'the', 'elimination', 'of', 'unnecessary', 'or', 'ineffectual', 'treatment', 'improved', 'patient', 'outcomes', 'and', 'an', 'overall', 'quantifiable', 'reduction', 'in', 'healthcare', 'costs', '']"
178117,Performance evaluation of the Panther Fusion® respiratory tract panel,2020-02-29,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653219302628; https://api.elsevier.com/content/article/pii/S1386653219302628; https://doi.org/10.1016/j.jcv.2019.104232; https://www.ncbi.nlm.nih.gov/pubmed/31869661/,"Abstract Background Respiratory tract infections are among the most common infections during winter season. Rapid diagnostics is required for clinical decision making regarding isolation of patients and appropriate therapy. Objectives The aim of this study was to evaluate the analytical and clinical performance characteristics of the Panther Fusion® respiratory panel using published laboratory-developed real-time PCR assays (LDT). Study design Analytical sensitivity of Panther Fusion® Flu A/B/RSV was assessed by testing dilutions of cell culture isolates. Clinical performance assessment included the complete Panther Fusion® respiratory panel (Flu-A/B/RSV, PIV 1-4 and AdV/hMPV/RV) and consisted of a retrospective and a prospective study-arm. The retrospective evaluation included 201, stored (−80 °C) samples collected between February 2006 and January 2017. Prospective evaluation was performed on 1045 unselected pretreated respiratory tract samples from patients presented to our hospital between November 2017 and May 2018. Results Analytical sensitivity was generally slightly lower for the Panther Fusion® assays. Clinical specificity and sensitivity was between 96 %–100 % and 71.9 %–100 %, respectively. Discrepant results were found in 146 samples of which 88 samples tested LDT positive / Panther Fusion® negative and 58 samples were LDT negative / Panther Fusion® positive. A total of ten discrepant samples with Ct-values <30 were sequenced to confirm the presence of 7 RV-C not-detected by LDT and 1 RV-A and 2 ADV-2 not detected by Panther Fusion®. Conclusions The Panther Fusion® provides a random-access system with continuous loading and much shorter sample-to-answer times compared to LDT, albeit with a slightly less clinical sensitivity compared to the LDT.",10.1016/j.jcv.2019.104232,zqwgha36,"['Abstract', 'Background', 'Respiratory', 'tract', 'infections', 'are', 'among', 'the', 'most', 'common', 'infections', 'during', 'winter', 'season', 'Rapid', 'diagnostics', 'is', 'required', 'for', 'clinical', 'decision', 'making', 'regarding', 'isolation', 'of', 'patients', 'and', 'appropriate', 'therapy', 'Objectives', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'the', 'analytical', 'and', 'clinical', 'performance', 'characteristics', 'of', 'the', 'Panther', 'Fusion', 'respiratory', 'panel', 'using', 'published', 'laboratory', 'developed', 'real', 'time', 'PCR', 'assays', 'LDT', 'Study', 'design', 'Analytical', 'sensitivity', 'of', 'Panther', 'Fusion', 'Flu', 'A', 'B', 'RSV', 'was', 'assessed', 'by', 'testing', 'dilutions', 'of', 'cell', 'culture', 'isolates', 'Clinical', 'performance', 'assessment', 'included', 'the', 'complete', 'Panther', 'Fusion', 'respiratory', 'panel', 'Flu', 'A', 'B', 'RSV', 'PIV', '1', '4', 'and', 'AdV', 'hMPV', 'RV', 'and', 'consisted', 'of', 'a', 'retrospective', 'and', 'a', 'prospective', 'study', 'arm', 'The', 'retrospective', 'evaluation', 'included', '201', 'stored', '80', 'C', 'samples', 'collected', 'between', 'February', '2006', 'and', 'January', '2017', 'Prospective', 'evaluation', 'was', 'performed', 'on', '1045', 'unselected', 'pretreated', 'respiratory', 'tract', 'samples', 'from', 'patients', 'presented', 'to', 'our', 'hospital', 'between', 'November', '2017', 'and', 'May', '2018', 'Results', 'Analytical', 'sensitivity', 'was', 'generally', 'slightly', 'lower', 'for', 'the', 'Panther', 'Fusion', 'assays', 'Clinical', 'specificity', 'and', 'sensitivity', 'was', 'between', '96', '100', 'and', '71', '9', '100', 'respectively', 'Discrepant', 'results', 'were', 'found', 'in', '146', 'samples', 'of', 'which', '88', 'samples', 'tested', 'LDT', 'positive', 'Panther', 'Fusion', 'negative', 'and', '58', 'samples', 'were', 'LDT', 'negative', 'Panther', 'Fusion', 'positive', 'A', 'total', 'of', 'ten', 'discrepant', 'samples', 'with', 'Ct', 'values', '30', 'were', 'sequenced', 'to', 'confirm', 'the', 'presence', 'of', '7', 'RV', 'C', 'not', 'detected', 'by', 'LDT', 'and', '1', 'RV', 'A', 'and', '2', 'ADV', '2', 'not', 'detected', 'by', 'Panther', 'Fusion', 'Conclusions', 'The', 'Panther', 'Fusion', 'provides', 'a', 'random', 'access', 'system', 'with', 'continuous', 'loading', 'and', 'much', 'shorter', 'sample', 'to', 'answer', 'times', 'compared', 'to', 'LDT', 'albeit', 'with', 'a', 'slightly', 'less', 'clinical', 'sensitivity', 'compared', 'to', 'the', 'LDT', '']"
178643,"Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities",2020-07-26,Biosens Bioelectron,https://www.sciencedirect.com/science/article/pii/S0956566320304395?v=s5; https://api.elsevier.com/content/article/pii/S0956566320304395,"With the trend of moving genomic test from (medical) laboratories to on-site testing, there is a need for nucleic acid based diagnostic tools combining the sensitivity, specificity and flexibility of established genomic diagnostics with the ease, cost effectiveness and speed of isothermal amplification methods. A promising new genomic sensing method is Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated nuclease (Cas)-based sensing. In this method Cas effector proteins are used as highly specific sequence recognition elements that can be combined with many different read-out methods for on-site point-of-care testing. This review covers the technical aspects of integrating CRISPR/Cas technology in miniaturized sensors for analysis on-site. We start with a short introduction to CRISPR/Cas systems and the different effector proteins and continue with reviewing the recent developments of integrating CRISPR sensing in miniaturized sensors for point-of-care applications. Finally, we discuss the challenges of point-of-care CRISPR sensing and describe future research perspectives.",10.1016/j.bios.2020.112445,muy75w79,"['With', 'the', 'trend', 'of', 'moving', 'genomic', 'test', 'from', 'medical', 'laboratories', 'to', 'on', 'site', 'testing', 'there', 'is', 'a', 'need', 'for', 'nucleic', 'acid', 'based', 'diagnostic', 'tools', 'combining', 'the', 'sensitivity', 'specificity', 'and', 'flexibility', 'of', 'established', 'genomic', 'diagnostics', 'with', 'the', 'ease', 'cost', 'effectiveness', 'and', 'speed', 'of', 'isothermal', 'amplification', 'methods', 'A', 'promising', 'new', 'genomic', 'sensing', 'method', 'is', 'Clustered', 'Regularly', 'Interspaced', 'Short', 'Palindromic', 'Repeats', 'CRISPR', 'associated', 'nuclease', 'Cas', 'based', 'sensing', 'In', 'this', 'method', 'Cas', 'effector', 'proteins', 'are', 'used', 'as', 'highly', 'specific', 'sequence', 'recognition', 'elements', 'that', 'can', 'be', 'combined', 'with', 'many', 'different', 'read', 'out', 'methods', 'for', 'on', 'site', 'point', 'of', 'care', 'testing', 'This', 'review', 'covers', 'the', 'technical', 'aspects', 'of', 'integrating', 'CRISPR', 'Cas', 'technology', 'in', 'miniaturized', 'sensors', 'for', 'analysis', 'on', 'site', 'We', 'start', 'with', 'a', 'short', 'introduction', 'to', 'CRISPR', 'Cas', 'systems', 'and', 'the', 'different', 'effector', 'proteins', 'and', 'continue', 'with', 'reviewing', 'the', 'recent', 'developments', 'of', 'integrating', 'CRISPR', 'sensing', 'in', 'miniaturized', 'sensors', 'for', 'point', 'of', 'care', 'applications', 'Finally', 'we', 'discuss', 'the', 'challenges', 'of', 'point', 'of', 'care', 'CRISPR', 'sensing', 'and', 'describe', 'future', 'research', 'perspectives', '']"
178785,An enhanced isothermal amplification assay for viral detection,2020-05-29,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32577657/; https://doi.org/10.1101/2020.05.28.118059,"Rapid, inexpensive, robust diagnostics are essential to control the spread of infectious diseases. Current state of the art diagnostics are highly sensitive and specific, but slow, and require expensive equipment. We developed a molecular diagnostic test for SARS-CoV-2, FIND (Fast Isothermal Nucleic acid Detection), based on an enhanced isothermal recombinase polymerase amplification reaction. FIND has a detection limit on patient samples close to that of RT-qPCR, requires minimal instrumentation, and is highly scalable and cheap. It can be performed in high throughput, does not cross-react with other common coronaviruses, avoids bottlenecks caused by the current worldwide shortage of RNA isolation kits, and takes ~45 minutes from sample collection to results. FIND can be adapted to future novel viruses in days once sequence is available. One sentence summary Sensitive, specific, rapid, scalable, enhanced isothermal amplification method for detecting SARS-CoV-2 from patient samples.",10.1101/2020.05.28.118059,k2ihqdq5,"['Rapid', 'inexpensive', 'robust', 'diagnostics', 'are', 'essential', 'to', 'control', 'the', 'spread', 'of', 'infectious', 'diseases', 'Current', 'state', 'of', 'the', 'art', 'diagnostics', 'are', 'highly', 'sensitive', 'and', 'specific', 'but', 'slow', 'and', 'require', 'expensive', 'equipment', 'We', 'developed', 'a', 'molecular', 'diagnostic', 'test', 'for', 'SARS', 'CoV', '2', 'FIND', 'Fast', 'Isothermal', 'Nucleic', 'acid', 'Detection', 'based', 'on', 'an', 'enhanced', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'reaction', 'FIND', 'has', 'a', 'detection', 'limit', 'on', 'patient', 'samples', 'close', 'to', 'that', 'of', 'RT', 'qPCR', 'requires', 'minimal', 'instrumentation', 'and', 'is', 'highly', 'scalable', 'and', 'cheap', 'It', 'can', 'be', 'performed', 'in', 'high', 'throughput', 'does', 'not', 'cross', 'react', 'with', 'other', 'common', 'coronaviruses', 'avoids', 'bottlenecks', 'caused', 'by', 'the', 'current', 'worldwide', 'shortage', 'of', 'RNA', 'isolation', 'kits', 'and', 'takes', '45', 'minutes', 'from', 'sample', 'collection', 'to', 'results', 'FIND', 'can', 'be', 'adapted', 'to', 'future', 'novel', 'viruses', 'in', 'days', 'once', 'sequence', 'is', 'available', 'One', 'sentence', 'summary', 'Sensitive', 'specific', 'rapid', 'scalable', 'enhanced', 'isothermal', 'amplification', 'method', 'for', 'detecting', 'SARS', 'CoV', '2', 'from', 'patient', 'samples', '']"
179286,Appropriate Use and Future Directions of Molecular Diagnostic Testing,2020-02-06,Curr Infect Dis Rep,https://doi.org/10.1007/s11908-020-0714-5; https://www.ncbi.nlm.nih.gov/pubmed/32030534/,"PURPOSE OF REVIEW: Major technologic advances in two main areas of molecular infectious disease diagnostics have resulted in accelerated adoption or ordering, outpacing implementation, and clinical utility studies. Physicians must understand the limitations to and appropriate utilization of these technologies in order to provide cost-effective and well-informed care for their patients. RECENT FINDINGS: Rapid molecular testing and, to a lesser degree, clinical metagenomics are now being routinely used in clinical practice. While these tests allow for a breadth of interrogation not possible with conventional microbiology, they pose new challenges for diagnostic and antimicrobial stewardship programs. This review will summarize the most recent literature on these two categories of technologic advances and discuss the few studies that have looked at utilization and stewardship approaches. This review also highlights the future directions for both of these technologies. SUMMARY: The appropriate utilization of rapid molecular testing and clinical metagenomics has not been well established. More studies are needed to assess their prospective impacts on patient management and antimicrobial stewardship efforts as the future state of infectious disease diagnostics will see continued expansion of these technologic advances.",10.1007/s11908-020-0714-5,ekok0mp5,"['PURPOSE', 'OF', 'REVIEW', 'Major', 'technologic', 'advances', 'in', 'two', 'main', 'areas', 'of', 'molecular', 'infectious', 'disease', 'diagnostics', 'have', 'resulted', 'in', 'accelerated', 'adoption', 'or', 'ordering', 'outpacing', 'implementation', 'and', 'clinical', 'utility', 'studies', 'Physicians', 'must', 'understand', 'the', 'limitations', 'to', 'and', 'appropriate', 'utilization', 'of', 'these', 'technologies', 'in', 'order', 'to', 'provide', 'cost', 'effective', 'and', 'well', 'informed', 'care', 'for', 'their', 'patients', 'RECENT', 'FINDINGS', 'Rapid', 'molecular', 'testing', 'and', 'to', 'a', 'lesser', 'degree', 'clinical', 'metagenomics', 'are', 'now', 'being', 'routinely', 'used', 'in', 'clinical', 'practice', 'While', 'these', 'tests', 'allow', 'for', 'a', 'breadth', 'of', 'interrogation', 'not', 'possible', 'with', 'conventional', 'microbiology', 'they', 'pose', 'new', 'challenges', 'for', 'diagnostic', 'and', 'antimicrobial', 'stewardship', 'programs', 'This', 'review', 'will', 'summarize', 'the', 'most', 'recent', 'literature', 'on', 'these', 'two', 'categories', 'of', 'technologic', 'advances', 'and', 'discuss', 'the', 'few', 'studies', 'that', 'have', 'looked', 'at', 'utilization', 'and', 'stewardship', 'approaches', 'This', 'review', 'also', 'highlights', 'the', 'future', 'directions', 'for', 'both', 'of', 'these', 'technologies', 'SUMMARY', 'The', 'appropriate', 'utilization', 'of', 'rapid', 'molecular', 'testing', 'and', 'clinical', 'metagenomics', 'has', 'not', 'been', 'well', 'established', 'More', 'studies', 'are', 'needed', 'to', 'assess', 'their', 'prospective', 'impacts', 'on', 'patient', 'management', 'and', 'antimicrobial', 'stewardship', 'efforts', 'as', 'the', 'future', 'state', 'of', 'infectious', 'disease', 'diagnostics', 'will', 'see', 'continued', 'expansion', 'of', 'these', 'technologic', 'advances', '']"
179793,A Sensitive Assay for Virus Discovery in Respiratory Clinical Samples,2011-01-24,PLoS One,https://doi.org/10.1371/journal.pone.0016118; https://www.ncbi.nlm.nih.gov/pubmed/21283679/,"In 5–40% of respiratory infections in children, the diagnostics remain negative, suggesting that the patients might be infected with a yet unknown pathogen. Virus discovery cDNA-AFLP (VIDISCA) is a virus discovery method based on recognition of restriction enzyme cleavage sites, ligation of adaptors and subsequent amplification by PCR. However, direct discovery of unknown pathogens in nasopharyngeal swabs is difficult due to the high concentration of ribosomal RNA (rRNA) that acts as competitor. In the current study we optimized VIDISCA by adjusting the reverse transcription enzymes and decreasing rRNA amplification in the reverse transcription, using hexamer oligonucleotides that do not anneal to rRNA. Residual cDNA synthesis on rRNA templates was further reduced with oligonucleotides that anneal to rRNA but can not be extended due to 3′-dideoxy-C6-modification. With these modifications >90% reduction of rRNA amplification was established. Further improvement of the VIDISCA sensitivity was obtained by high throughput sequencing (VIDISCA-454). Eighteen nasopharyngeal swabs were analysed, all containing known respiratory viruses. We could identify the proper virus in the majority of samples tested (11/18). The median load in the VIDISCA-454 positive samples was 7.2 E5 viral genome copies/ml (ranging from 1.4 E3–7.7 E6). Our results show that optimization of VIDISCA and subsequent high-throughput-sequencing enhances sensitivity drastically and provides the opportunity to perform virus discovery directly in patient material.",10.1371/journal.pone.0016118,mduxxe5y,"['In', '5', '40', 'of', 'respiratory', 'infections', 'in', 'children', 'the', 'diagnostics', 'remain', 'negative', 'suggesting', 'that', 'the', 'patients', 'might', 'be', 'infected', 'with', 'a', 'yet', 'unknown', 'pathogen', 'Virus', 'discovery', 'cDNA', 'AFLP', 'VIDISCA', 'is', 'a', 'virus', 'discovery', 'method', 'based', 'on', 'recognition', 'of', 'restriction', 'enzyme', 'cleavage', 'sites', 'ligation', 'of', 'adaptors', 'and', 'subsequent', 'amplification', 'by', 'PCR', 'However', 'direct', 'discovery', 'of', 'unknown', 'pathogens', 'in', 'nasopharyngeal', 'swabs', 'is', 'difficult', 'due', 'to', 'the', 'high', 'concentration', 'of', 'ribosomal', 'RNA', 'rRNA', 'that', 'acts', 'as', 'competitor', 'In', 'the', 'current', 'study', 'we', 'optimized', 'VIDISCA', 'by', 'adjusting', 'the', 'reverse', 'transcription', 'enzymes', 'and', 'decreasing', 'rRNA', 'amplification', 'in', 'the', 'reverse', 'transcription', 'using', 'hexamer', 'oligonucleotides', 'that', 'do', 'not', 'anneal', 'to', 'rRNA', 'Residual', 'cDNA', 'synthesis', 'on', 'rRNA', 'templates', 'was', 'further', 'reduced', 'with', 'oligonucleotides', 'that', 'anneal', 'to', 'rRNA', 'but', 'can', 'not', 'be', 'extended', 'due', 'to', '3', 'dideoxy', 'C6', 'modification', 'With', 'these', 'modifications', '90', 'reduction', 'of', 'rRNA', 'amplification', 'was', 'established', 'Further', 'improvement', 'of', 'the', 'VIDISCA', 'sensitivity', 'was', 'obtained', 'by', 'high', 'throughput', 'sequencing', 'VIDISCA', '454', 'Eighteen', 'nasopharyngeal', 'swabs', 'were', 'analysed', 'all', 'containing', 'known', 'respiratory', 'viruses', 'We', 'could', 'identify', 'the', 'proper', 'virus', 'in', 'the', 'majority', 'of', 'samples', 'tested', '11', '18', 'The', 'median', 'load', 'in', 'the', 'VIDISCA', '454', 'positive', 'samples', 'was', '7', '2', 'E5', 'viral', 'genome', 'copies', 'ml', 'ranging', 'from', '1', '4', 'E3', '7', '7', 'E6', 'Our', 'results', 'show', 'that', 'optimization', 'of', 'VIDISCA', 'and', 'subsequent', 'high', 'throughput', 'sequencing', 'enhances', 'sensitivity', 'drastically', 'and', 'provides', 'the', 'opportunity', 'to', 'perform', 'virus', 'discovery', 'directly', 'in', 'patient', 'material', '']"
180028,Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2,2020-04-14,Infect Ecol Epidemiol,https://www.ncbi.nlm.nih.gov/pubmed/32363011/; https://doi.org/10.1080/20008686.2020.1754538,"COVID-19 is the most rapidly growing pandemic in modern time, and the need for serological testing is most urgent. Although the diagnostics of acute patients by RT-PCR is both efficient and specific, we are also crucially in need of serological tools for investigating antibody responses and assessing individual and potential herd immunity. We evaluated a commercially available test developed for rapid (within 15 minutes) detection of SARS-CoV-2-specific IgM and IgG by 29 PCR-confirmed COVID-19 cases and 124 negative controls. The results revealed a sensitivity of 69% and 93.1% for IgM and IgG, respectively, based solely on PCR-positivity due to the absence of a serological gold standard. The assay specificities were shown to be 100% for IgM and 99.2% for IgG. This indicates that the test is suitable for assessing previous virus exposure, although negative results may be unreliable during the first weeks after infection. More detailed studies on antibody responses during and post infection are urgently needed.",10.1080/20008686.2020.1754538,knc0ruou,"['COVID', '19', 'is', 'the', 'most', 'rapidly', 'growing', 'pandemic', 'in', 'modern', 'time', 'and', 'the', 'need', 'for', 'serological', 'testing', 'is', 'most', 'urgent', 'Although', 'the', 'diagnostics', 'of', 'acute', 'patients', 'by', 'RT', 'PCR', 'is', 'both', 'efficient', 'and', 'specific', 'we', 'are', 'also', 'crucially', 'in', 'need', 'of', 'serological', 'tools', 'for', 'investigating', 'antibody', 'responses', 'and', 'assessing', 'individual', 'and', 'potential', 'herd', 'immunity', 'We', 'evaluated', 'a', 'commercially', 'available', 'test', 'developed', 'for', 'rapid', 'within', '15', 'minutes', 'detection', 'of', 'SARS', 'CoV', '2', 'specific', 'IgM', 'and', 'IgG', 'by', '29', 'PCR', 'confirmed', 'COVID', '19', 'cases', 'and', '124', 'negative', 'controls', 'The', 'results', 'revealed', 'a', 'sensitivity', 'of', '69', 'and', '93', '1', 'for', 'IgM', 'and', 'IgG', 'respectively', 'based', 'solely', 'on', 'PCR', 'positivity', 'due', 'to', 'the', 'absence', 'of', 'a', 'serological', 'gold', 'standard', 'The', 'assay', 'specificities', 'were', 'shown', 'to', 'be', '100', 'for', 'IgM', 'and', '99', '2', 'for', 'IgG', 'This', 'indicates', 'that', 'the', 'test', 'is', 'suitable', 'for', 'assessing', 'previous', 'virus', 'exposure', 'although', 'negative', 'results', 'may', 'be', 'unreliable', 'during', 'the', 'first', 'weeks', 'after', 'infection', 'More', 'detailed', 'studies', 'on', 'antibody', 'responses', 'during', 'and', 'post', 'infection', 'are', 'urgently', 'needed', '']"
180098,Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2,2020-05-18,Emerg Microbes Infect,https://www.ncbi.nlm.nih.gov/pubmed/32306853/; https://doi.org/10.1080/22221751.2020.1756698,"The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 10(2) RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30 min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities.",10.1080/22221751.2020.1756698,sdde8bgd,"['The', 'previous', 'outbreaks', 'of', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'have', 'led', 'researchers', 'to', 'study', 'the', 'role', 'of', 'diagnostics', 'in', 'impediment', 'of', 'further', 'spread', 'and', 'transmission', 'With', 'the', 'recent', 'emergence', 'of', 'the', 'novel', 'SARS', 'CoV', '2', 'the', 'availability', 'of', 'rapid', 'sensitive', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'essential', 'for', 'disease', 'control', 'Hence', 'we', 'have', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'for', 'the', 'specific', 'detection', 'of', 'SARS', 'CoV', '2', 'The', 'primer', 'sets', 'for', 'RT', 'LAMP', 'assay', 'were', 'designed', 'to', 'target', 'the', 'nucleocapsid', 'gene', 'of', 'the', 'viral', 'RNA', 'and', 'displayed', 'a', 'detection', 'limit', 'of', '10', '2', 'RNA', 'copies', 'close', 'to', 'that', 'of', 'qRT', 'PCR', 'Notably', 'the', 'assay', 'has', 'exhibited', 'a', 'rapid', 'detection', 'span', 'of', '30', 'min', 'combined', 'with', 'the', 'colorimetric', 'visualization', 'This', 'test', 'can', 'detect', 'specifically', 'viral', 'RNAs', 'of', 'the', 'SARS', 'CoV', '2', 'with', 'no', 'cross', 'reactivity', 'to', 'related', 'coronaviruses', 'such', 'as', 'HCoV', '229E', 'HCoV', 'NL63', 'HCoV', 'OC43', 'and', 'MERS', 'CoV', 'as', 'well', 'as', 'human', 'infectious', 'influenza', 'viruses', 'type', 'B', 'H1N1pdm', 'H3N2', 'H5N1', 'H5N6', 'H5N8', 'and', 'H7N9', 'and', 'other', 'respiratory', 'disease', 'causing', 'viruses', 'RSVA', 'RSVB', 'ADV', 'PIV', 'MPV', 'and', 'HRV', 'Furthermore', 'the', 'developed', 'RT', 'LAMP', 'assay', 'has', 'been', 'evaluated', 'using', 'specimens', 'collected', 'from', 'COVID', '19', 'patients', 'that', 'exhibited', 'high', 'agreement', 'to', 'the', 'qRT', 'PCR', 'Our', 'RT', 'LAMP', 'assay', 'is', 'simple', 'to', 'perform', 'less', 'expensive', 'time', 'efficient', 'and', 'can', 'be', 'used', 'in', 'clinical', 'laboratories', 'for', 'preliminary', 'detection', 'of', 'SARS', 'CoV', '2', 'in', 'suspected', 'patients', 'In', 'addition', 'to', 'the', 'high', 'sensitivity', 'and', 'specificity', 'this', 'isothermal', 'amplification', 'conjugated', 'with', 'a', 'single', 'tube', 'colorimetric', 'detection', 'method', 'may', 'contribute', 'to', 'the', 'public', 'health', 'responses', 'and', 'disease', 'control', 'especially', 'in', 'the', 'areas', 'with', 'limited', 'laboratory', 'capacities', '']"
180818,Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients,2020-07-17,J Clin Virol,https://api.elsevier.com/content/article/pii/S1386653220302912; https://doi.org/10.1016/j.jcv.2020.104549; https://www.sciencedirect.com/science/article/pii/S1386653220302912?v=s5,"BACKGROUND: The global market for SARS-CoV-2-immunoassays is becoming ever more crowded with antibody-tests of various formats, targets and technologies, careful evaluation is crucial for understanding the implications of individual test results. Here, we evaluate the clinical performance of five automated immunoassays on a set of clinical samples. METHODS: Serum/plasma samples of 75 confirmed COVID-19 patients and 320 pre-pandemic serum samples of healthy blood donors were subjected to two IgG and three total antibody SARS-CoV-2-immunoassays. All test setups were automated workflows. RESULTS: Positivity of assays (onset of symptoms > 10 days) ranged between 68.4% and 81.6% (Diasorin 68.4%, Euroimmun 70.3%, Siemens 73.7%, Roche 79.0% and Wantai 81.6%). All examined assays demonstrated high specificity of >99% (Euroimmun, Diasorin: 99.1%, Wantai: 99.4%) but only two reached levels above 99.5% (Roche: 99.7%, Siemens 100%). Interestingly, there was no overlap in false positive results between the assays. The strongest correlation of quantitative results was observed between the Diasorin and Euroimmun IgG tests (r(2) = 0.76). Overall, we observed no difference in the distribution of test results between female and male patients (p-values: 0.18-0.87). A significant difference between severely versus critically ill patients was demonstrated for the Euroimmun, Diasorin, Wantai and Siemens assays (p-values < 0.041). CONCLUSION: All assays showed good clinical performance. Our data confirm that orthogonal test strategies as recommended by the CDC can enhance clinical specificity. However, the suboptimal rates of test positivity found at time of hospitalization in this cohort underline the importance of molecular diagnostics to rule out/confirm active infection with SARS-CoV-2.",10.1016/j.jcv.2020.104549,x91mgnqm,"['BACKGROUND', 'The', 'global', 'market', 'for', 'SARS', 'CoV', '2', 'immunoassays', 'is', 'becoming', 'ever', 'more', 'crowded', 'with', 'antibody', 'tests', 'of', 'various', 'formats', 'targets', 'and', 'technologies', 'careful', 'evaluation', 'is', 'crucial', 'for', 'understanding', 'the', 'implications', 'of', 'individual', 'test', 'results', 'Here', 'we', 'evaluate', 'the', 'clinical', 'performance', 'of', 'five', 'automated', 'immunoassays', 'on', 'a', 'set', 'of', 'clinical', 'samples', 'METHODS', 'Serum', 'plasma', 'samples', 'of', '75', 'confirmed', 'COVID', '19', 'patients', 'and', '320', 'pre', 'pandemic', 'serum', 'samples', 'of', 'healthy', 'blood', 'donors', 'were', 'subjected', 'to', 'two', 'IgG', 'and', 'three', 'total', 'antibody', 'SARS', 'CoV', '2', 'immunoassays', 'All', 'test', 'setups', 'were', 'automated', 'workflows', 'RESULTS', 'Positivity', 'of', 'assays', 'onset', 'of', 'symptoms', '10', 'days', 'ranged', 'between', '68', '4', 'and', '81', '6', 'Diasorin', '68', '4', 'Euroimmun', '70', '3', 'Siemens', '73', '7', 'Roche', '79', '0', 'and', 'Wantai', '81', '6', 'All', 'examined', 'assays', 'demonstrated', 'high', 'specificity', 'of', '99', 'Euroimmun', 'Diasorin', '99', '1', 'Wantai', '99', '4', 'but', 'only', 'two', 'reached', 'levels', 'above', '99', '5', 'Roche', '99', '7', 'Siemens', '100', 'Interestingly', 'there', 'was', 'no', 'overlap', 'in', 'false', 'positive', 'results', 'between', 'the', 'assays', 'The', 'strongest', 'correlation', 'of', 'quantitative', 'results', 'was', 'observed', 'between', 'the', 'Diasorin', 'and', 'Euroimmun', 'IgG', 'tests', 'r', '2', '0', '76', 'Overall', 'we', 'observed', 'no', 'difference', 'in', 'the', 'distribution', 'of', 'test', 'results', 'between', 'female', 'and', 'male', 'patients', 'p', 'values', '0', '18', '0', '87', 'A', 'significant', 'difference', 'between', 'severely', 'versus', 'critically', 'ill', 'patients', 'was', 'demonstrated', 'for', 'the', 'Euroimmun', 'Diasorin', 'Wantai', 'and', 'Siemens', 'assays', 'p', 'values', '0', '041', 'CONCLUSION', 'All', 'assays', 'showed', 'good', 'clinical', 'performance', 'Our', 'data', 'confirm', 'that', 'orthogonal', 'test', 'strategies', 'as', 'recommended', 'by', 'the', 'CDC', 'can', 'enhance', 'clinical', 'specificity', 'However', 'the', 'suboptimal', 'rates', 'of', 'test', 'positivity', 'found', 'at', 'time', 'of', 'hospitalization', 'in', 'this', 'cohort', 'underline', 'the', 'importance', 'of', 'molecular', 'diagnostics', 'to', 'rule', 'out', 'confirm', 'active', 'infection', 'with', 'SARS', 'CoV', '2', '']"
180949,Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian?,2020-05-12,ACS Pharmacol Transl Sci,https://doi.org/10.1021/acsptsci.0c00027; https://www.ncbi.nlm.nih.gov/pubmed/32551433/,"[Image: see text] This is a narrative review on the potential of rapid and point-of-care microbiological testing in pneumonia patients, focusing particularly on hospital-acquired and ventilator-associated pneumonia, which have substantial mortality and diverse microbiology. This work is written from a United Kingdom perspective, but much of it is generalizable internationally. In a world where antimicrobial resistance is a major international threat, the use of rapid molecular diagnostics has great potential to improve both the management of pneumonia patients and the stewardship of antibiotics. Rapid tests potentially can distinguish patients with bacterial versus viral infection and can swiftly identify bacterial pathogens and their resistances. We seek to answer the question: “Can such tests be used as an antibiotic guardian?” Their availability at the bedside rather than in the laboratory should best ensure that results are swiftly used to optimize patient management but will raise new challenges, not the least with respect to maintaining quality control and microbiology/infection control input. A further challenge lies in assessing the degree of trust that treating clinicians will place in these molecular diagnostic tests, particularly when early de-escalation of antibiotic therapy is indicated.",10.1021/acsptsci.0c00027,245z0a6q,"['', 'Image', 'see', 'text', 'This', 'is', 'a', 'narrative', 'review', 'on', 'the', 'potential', 'of', 'rapid', 'and', 'point', 'of', 'care', 'microbiological', 'testing', 'in', 'pneumonia', 'patients', 'focusing', 'particularly', 'on', 'hospital', 'acquired', 'and', 'ventilator', 'associated', 'pneumonia', 'which', 'have', 'substantial', 'mortality', 'and', 'diverse', 'microbiology', 'This', 'work', 'is', 'written', 'from', 'a', 'United', 'Kingdom', 'perspective', 'but', 'much', 'of', 'it', 'is', 'generalizable', 'internationally', 'In', 'a', 'world', 'where', 'antimicrobial', 'resistance', 'is', 'a', 'major', 'international', 'threat', 'the', 'use', 'of', 'rapid', 'molecular', 'diagnostics', 'has', 'great', 'potential', 'to', 'improve', 'both', 'the', 'management', 'of', 'pneumonia', 'patients', 'and', 'the', 'stewardship', 'of', 'antibiotics', 'Rapid', 'tests', 'potentially', 'can', 'distinguish', 'patients', 'with', 'bacterial', 'versus', 'viral', 'infection', 'and', 'can', 'swiftly', 'identify', 'bacterial', 'pathogens', 'and', 'their', 'resistances', 'We', 'seek', 'to', 'answer', 'the', 'question', 'Can', 'such', 'tests', 'be', 'used', 'as', 'an', 'antibiotic', 'guardian', 'Their', 'availability', 'at', 'the', 'bedside', 'rather', 'than', 'in', 'the', 'laboratory', 'should', 'best', 'ensure', 'that', 'results', 'are', 'swiftly', 'used', 'to', 'optimize', 'patient', 'management', 'but', 'will', 'raise', 'new', 'challenges', 'not', 'the', 'least', 'with', 'respect', 'to', 'maintaining', 'quality', 'control', 'and', 'microbiology', 'infection', 'control', 'input', 'A', 'further', 'challenge', 'lies', 'in', 'assessing', 'the', 'degree', 'of', 'trust', 'that', 'treating', 'clinicians', 'will', 'place', 'in', 'these', 'molecular', 'diagnostic', 'tests', 'particularly', 'when', 'early', 'de', 'escalation', 'of', 'antibiotic', 'therapy', 'is', 'indicated', '']"
181209,"All lesions great and small, part 2. Diagnostic cytology in veterinary medicine",2014-02-19,Diagn Cytopathol,https://www.ncbi.nlm.nih.gov/pubmed/24554415/; https://doi.org/10.1002/dc.23090,"This is the second in a two‐part review of diagnostic cytopathology in veterinary medicine. As in human medicine, cytopathology is a minimally invasive, rapid, and cost‐effective diagnostic modality with broad utilization. In this second part, the diagnostic applications of cytology in respiratory, gastrointestinal, genitourinary, endocrine, ocular, and central nervous system tissues are discussed with a section describing fluid analysis in veterinary medicine. As noted in the previous manuscript, which characterized the cytology of the skin/subcutis, musculoskeletal, and lymphoid tissues, the interpretation of veterinary cytology samples must be undertaken with extensive knowledge of the breadth of animal species, including familiarity with the frequency and clinical progression of diseases, both of which can be influenced by species, breed, and husbandry conditions. Similar to part one, this review focuses on the most common domestic companion animal species (dog, cat, and horse) and highlights lesions that are either unique to veterinary species or have relevant correlates in people. The cytologic features and biological behavior of similar lesions are compared, and selected mechanisms of disease and ancillary diagnostics are reviewed when appropriate. Supporting figures illustrate a subset of lesions. While not an exhaustive archive of veterinary cytology, the goal is to give cytopathologists working in human medicine a general impression of correlates and unique entities in veterinary practice. Diagn. Cytopathol. 2014;42:544–552. © 2014 Wiley Periodicals, Inc.",10.1002/dc.23090,aal5fjmp,"['This', 'is', 'the', 'second', 'in', 'a', 'two', 'part', 'review', 'of', 'diagnostic', 'cytopathology', 'in', 'veterinary', 'medicine', 'As', 'in', 'human', 'medicine', 'cytopathology', 'is', 'a', 'minimally', 'invasive', 'rapid', 'and', 'cost', 'effective', 'diagnostic', 'modality', 'with', 'broad', 'utilization', 'In', 'this', 'second', 'part', 'the', 'diagnostic', 'applications', 'of', 'cytology', 'in', 'respiratory', 'gastrointestinal', 'genitourinary', 'endocrine', 'ocular', 'and', 'central', 'nervous', 'system', 'tissues', 'are', 'discussed', 'with', 'a', 'section', 'describing', 'fluid', 'analysis', 'in', 'veterinary', 'medicine', 'As', 'noted', 'in', 'the', 'previous', 'manuscript', 'which', 'characterized', 'the', 'cytology', 'of', 'the', 'skin', 'subcutis', 'musculoskeletal', 'and', 'lymphoid', 'tissues', 'the', 'interpretation', 'of', 'veterinary', 'cytology', 'samples', 'must', 'be', 'undertaken', 'with', 'extensive', 'knowledge', 'of', 'the', 'breadth', 'of', 'animal', 'species', 'including', 'familiarity', 'with', 'the', 'frequency', 'and', 'clinical', 'progression', 'of', 'diseases', 'both', 'of', 'which', 'can', 'be', 'influenced', 'by', 'species', 'breed', 'and', 'husbandry', 'conditions', 'Similar', 'to', 'part', 'one', 'this', 'review', 'focuses', 'on', 'the', 'most', 'common', 'domestic', 'companion', 'animal', 'species', 'dog', 'cat', 'and', 'horse', 'and', 'highlights', 'lesions', 'that', 'are', 'either', 'unique', 'to', 'veterinary', 'species', 'or', 'have', 'relevant', 'correlates', 'in', 'people', 'The', 'cytologic', 'features', 'and', 'biological', 'behavior', 'of', 'similar', 'lesions', 'are', 'compared', 'and', 'selected', 'mechanisms', 'of', 'disease', 'and', 'ancillary', 'diagnostics', 'are', 'reviewed', 'when', 'appropriate', 'Supporting', 'figures', 'illustrate', 'a', 'subset', 'of', 'lesions', 'While', 'not', 'an', 'exhaustive', 'archive', 'of', 'veterinary', 'cytology', 'the', 'goal', 'is', 'to', 'give', 'cytopathologists', 'working', 'in', 'human', 'medicine', 'a', 'general', 'impression', 'of', 'correlates', 'and', 'unique', 'entities', 'in', 'veterinary', 'practice', 'Diagn', 'Cytopathol', '2014', '42', '544', '552', '2014', 'Wiley', 'Periodicals', 'Inc', '']"
181424,Chapter 11 Solid and Suspension Microarrays for Microbial Diagnostics,2015-12-31,Methods in Microbiology,https://api.elsevier.com/content/article/pii/S0580951715000033; https://www.sciencedirect.com/science/article/pii/S0580951715000033,"Abstract Advancements in molecular technologies have provided new platforms that are being increasingly adopted for use in the clinical microbiology laboratory. Among these, microarray methods are particularly well suited for diagnostics as they allow multiplexing, or the ability to test for multiple targets simultaneously from the same specimen. Microarray technologies commonly used for the detection and identification of microbial targets include solid-state microarrays, electronic microarrays and bead suspension microarrays. Microarray methods have been applied to microbial detection, genotyping and antimicrobial resistance gene detection. Microarrays can offer a panel approach to diagnose specific patient presentations, such as respiratory or gastrointestinal infections, and can discriminate isolates by genotype for tracking epidemiology and outbreak investigations. And, as more information has become available on specific genes and pathways involved in antimicrobial resistance, we are beginning to be able to predict susceptibility patterns based on sequence detection for particular organisms. With further advances in automated microarray processing methods and genotype–phenotype prediction algorithms, these tests will become even more useful as an adjunct or replacement for conventional antimicrobial susceptibility testing, allowing for more rapid selection of targeted therapy for infectious diseases.",10.1016/bs.mim.2015.04.002,ycztzrat,"['Abstract', 'Advancements', 'in', 'molecular', 'technologies', 'have', 'provided', 'new', 'platforms', 'that', 'are', 'being', 'increasingly', 'adopted', 'for', 'use', 'in', 'the', 'clinical', 'microbiology', 'laboratory', 'Among', 'these', 'microarray', 'methods', 'are', 'particularly', 'well', 'suited', 'for', 'diagnostics', 'as', 'they', 'allow', 'multiplexing', 'or', 'the', 'ability', 'to', 'test', 'for', 'multiple', 'targets', 'simultaneously', 'from', 'the', 'same', 'specimen', 'Microarray', 'technologies', 'commonly', 'used', 'for', 'the', 'detection', 'and', 'identification', 'of', 'microbial', 'targets', 'include', 'solid', 'state', 'microarrays', 'electronic', 'microarrays', 'and', 'bead', 'suspension', 'microarrays', 'Microarray', 'methods', 'have', 'been', 'applied', 'to', 'microbial', 'detection', 'genotyping', 'and', 'antimicrobial', 'resistance', 'gene', 'detection', 'Microarrays', 'can', 'offer', 'a', 'panel', 'approach', 'to', 'diagnose', 'specific', 'patient', 'presentations', 'such', 'as', 'respiratory', 'or', 'gastrointestinal', 'infections', 'and', 'can', 'discriminate', 'isolates', 'by', 'genotype', 'for', 'tracking', 'epidemiology', 'and', 'outbreak', 'investigations', 'And', 'as', 'more', 'information', 'has', 'become', 'available', 'on', 'specific', 'genes', 'and', 'pathways', 'involved', 'in', 'antimicrobial', 'resistance', 'we', 'are', 'beginning', 'to', 'be', 'able', 'to', 'predict', 'susceptibility', 'patterns', 'based', 'on', 'sequence', 'detection', 'for', 'particular', 'organisms', 'With', 'further', 'advances', 'in', 'automated', 'microarray', 'processing', 'methods', 'and', 'genotype', 'phenotype', 'prediction', 'algorithms', 'these', 'tests', 'will', 'become', 'even', 'more', 'useful', 'as', 'an', 'adjunct', 'or', 'replacement', 'for', 'conventional', 'antimicrobial', 'susceptibility', 'testing', 'allowing', 'for', 'more', 'rapid', 'selection', 'of', 'targeted', 'therapy', 'for', 'infectious', 'diseases', '']"
181617,"Selected veterinary concerns of geriatric rats, mice, hamsters and gerbils",2020-04-22,Vet Clin North Am Exot Anim Pract,https://www.sciencedirect.com/science/article/pii/S1094919420300293?v=s5; https://doi.org/10.1016/j.cvex.2020.04.001; https://api.elsevier.com/content/article/pii/S1094919420300293; https://www.ncbi.nlm.nih.gov/pubmed/32409159/,"Improved husbandry and better knowledge of exotic pets have led to a gradual increase in the lifespan of pets such as rats, mice, hamsters, and gerbils. Much of the information we have on these senior patients is derived from the laboratory animal studies and anecdotal practitioner information. While the small size of some of the patients makes blood collection problematic for hematology and organ function testing, the advent of polymerase chain reaction (PCR) testing and other molecular diagnostics is allowing the practitioner testing of specific etiologies with the very small biologic samples available. Both radiology and ultrasonography are also very valuable diagnostic modalities.",10.1016/j.cvex.2020.04.001,vots26mm,"['Improved', 'husbandry', 'and', 'better', 'knowledge', 'of', 'exotic', 'pets', 'have', 'led', 'to', 'a', 'gradual', 'increase', 'in', 'the', 'lifespan', 'of', 'pets', 'such', 'as', 'rats', 'mice', 'hamsters', 'and', 'gerbils', 'Much', 'of', 'the', 'information', 'we', 'have', 'on', 'these', 'senior', 'patients', 'is', 'derived', 'from', 'the', 'laboratory', 'animal', 'studies', 'and', 'anecdotal', 'practitioner', 'information', 'While', 'the', 'small', 'size', 'of', 'some', 'of', 'the', 'patients', 'makes', 'blood', 'collection', 'problematic', 'for', 'hematology', 'and', 'organ', 'function', 'testing', 'the', 'advent', 'of', 'polymerase', 'chain', 'reaction', 'PCR', 'testing', 'and', 'other', 'molecular', 'diagnostics', 'is', 'allowing', 'the', 'practitioner', 'testing', 'of', 'specific', 'etiologies', 'with', 'the', 'very', 'small', 'biologic', 'samples', 'available', 'Both', 'radiology', 'and', 'ultrasonography', 'are', 'also', 'very', 'valuable', 'diagnostic', 'modalities', '']"
182816,The role of interleukin-12 in the heavy metal-elicited immunomodulation: relevance of various evaluation methods,2008-11-06,J Occup Med Toxicol,https://www.ncbi.nlm.nih.gov/pubmed/18990205/; https://doi.org/10.1186/1745-6673-3-25,"BACKGROUND: Increasing evidence exists that heavy metals modulate T helper cell (Th) responses and thereby elicit various pathological manifestation. Interleukin (IL)-12, a crucial innate cytokine, was found to be regulated by such xenobiotic agents. This study aimed at testing whether IL-12 profiles may be indicative of heavy metals-induced immunomodulation. METHODS: Human immunocompetent cells, activated either by monoclonal antibodies or heat-killed Salmonella enterica, were cultured in the absence or presence of cadmium (Cd) acetate or mercuric (Hg) chloride. In vivo experiments were set up where BALB/c mice were exposed to sub-lethal doses of Cd or Hg salts for 3 or 5 weeks. Cytotoxicity was assessed by MTT-reduction assay. Modulation of cytokine profiles was evaluated by enzyme-linked immunosorbent assay (ELISA), cytometric bead-based array (CBA) and real-time polymerase chain reaction (RT-PCR); the relevance of these methods of cytokine quantification was explored. RESULTS: Modulation of IL-12 profiles in Cd- or Hg-exposed human PBMC was dose-dependent and significantly related to IFN-γ levels as well as to the Th1- or Th2-polarized responses. Similarly, skewing the Th1/Th2 ratios in vivo correlated significantly with up- or down-regulation of IL-12 levels in both cases of investigated metals. CONCLUSION: It can be inferred that: (i) IL-12 profiles alone may represent a relevant indicator of heavy metal-induced immune modulation; (ii) evaluating cytokine profiles by CBA is relevant and can adequately replace other methods such as ELISA and RT-PCR in basic research as well as in immune diagnostics; and (iii) targeting IL-12 in therapeutic approaches may be promising to modify Th1/Th2-associated immune disorders.",10.1186/1745-6673-3-25,j74a3j5w,"['BACKGROUND', 'Increasing', 'evidence', 'exists', 'that', 'heavy', 'metals', 'modulate', 'T', 'helper', 'cell', 'Th', 'responses', 'and', 'thereby', 'elicit', 'various', 'pathological', 'manifestation', 'Interleukin', 'IL', '12', 'a', 'crucial', 'innate', 'cytokine', 'was', 'found', 'to', 'be', 'regulated', 'by', 'such', 'xenobiotic', 'agents', 'This', 'study', 'aimed', 'at', 'testing', 'whether', 'IL', '12', 'profiles', 'may', 'be', 'indicative', 'of', 'heavy', 'metals', 'induced', 'immunomodulation', 'METHODS', 'Human', 'immunocompetent', 'cells', 'activated', 'either', 'by', 'monoclonal', 'antibodies', 'or', 'heat', 'killed', 'Salmonella', 'enterica', 'were', 'cultured', 'in', 'the', 'absence', 'or', 'presence', 'of', 'cadmium', 'Cd', 'acetate', 'or', 'mercuric', 'Hg', 'chloride', 'In', 'vivo', 'experiments', 'were', 'set', 'up', 'where', 'BALB', 'c', 'mice', 'were', 'exposed', 'to', 'sub', 'lethal', 'doses', 'of', 'Cd', 'or', 'Hg', 'salts', 'for', '3', 'or', '5', 'weeks', 'Cytotoxicity', 'was', 'assessed', 'by', 'MTT', 'reduction', 'assay', 'Modulation', 'of', 'cytokine', 'profiles', 'was', 'evaluated', 'by', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'cytometric', 'bead', 'based', 'array', 'CBA', 'and', 'real', 'time', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'the', 'relevance', 'of', 'these', 'methods', 'of', 'cytokine', 'quantification', 'was', 'explored', 'RESULTS', 'Modulation', 'of', 'IL', '12', 'profiles', 'in', 'Cd', 'or', 'Hg', 'exposed', 'human', 'PBMC', 'was', 'dose', 'dependent', 'and', 'significantly', 'related', 'to', 'IFN', 'γ', 'levels', 'as', 'well', 'as', 'to', 'the', 'Th1', 'or', 'Th2', 'polarized', 'responses', 'Similarly', 'skewing', 'the', 'Th1', 'Th2', 'ratios', 'in', 'vivo', 'correlated', 'significantly', 'with', 'up', 'or', 'down', 'regulation', 'of', 'IL', '12', 'levels', 'in', 'both', 'cases', 'of', 'investigated', 'metals', 'CONCLUSION', 'It', 'can', 'be', 'inferred', 'that', 'i', 'IL', '12', 'profiles', 'alone', 'may', 'represent', 'a', 'relevant', 'indicator', 'of', 'heavy', 'metal', 'induced', 'immune', 'modulation', 'ii', 'evaluating', 'cytokine', 'profiles', 'by', 'CBA', 'is', 'relevant', 'and', 'can', 'adequately', 'replace', 'other', 'methods', 'such', 'as', 'ELISA', 'and', 'RT', 'PCR', 'in', 'basic', 'research', 'as', 'well', 'as', 'in', 'immune', 'diagnostics', 'and', 'iii', 'targeting', 'IL', '12', 'in', 'therapeutic', 'approaches', 'may', 'be', 'promising', 'to', 'modify', 'Th1', 'Th2', 'associated', 'immune', 'disorders', '']"
183023,"COVID-19: Progress in diagnostics, therapy and vaccination",2020-06-19,Theranostics,https://doi.org/10.7150/thno.47987; https://www.ncbi.nlm.nih.gov/pubmed/32685022/,"Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.",10.7150/thno.47987,q7d0ysbo,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'recently', 'become', 'a', 'pandemic', 'As', 'the', 'sudden', 'emergence', 'and', 'rapid', 'spread', 'of', 'SARS', 'CoV', '2', 'is', 'endangering', 'global', 'health', 'and', 'the', 'economy', 'the', 'development', 'of', 'strategies', 'to', 'contain', 'the', 'virus', 's', 'spread', 'are', 'urgently', 'needed', 'At', 'present', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'SARS', 'CoV', '2', 'are', 'available', 'for', 'use', 'to', 'initiate', 'appropriate', 'treatment', 'faster', 'and', 'to', 'limit', 'further', 'spread', 'of', 'the', 'virus', 'Several', 'drugs', 'have', 'demonstrated', 'in', 'vitro', 'activity', 'against', 'SARS', 'CoV', '2', 'or', 'potential', 'clinical', 'benefits', 'In', 'addition', 'institutions', 'and', 'companies', 'worldwide', 'are', 'working', 'tirelessly', 'to', 'develop', 'treatments', 'and', 'vaccines', 'against', 'COVID', '19', 'However', 'no', 'drug', 'or', 'vaccine', 'has', 'yet', 'been', 'specifically', 'approved', 'for', 'COVID', '19', 'Given', 'the', 'urgency', 'of', 'the', 'outbreak', 'we', 'focus', 'here', 'on', 'recent', 'advances', 'in', 'the', 'diagnostics', 'treatment', 'and', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'infection', 'helping', 'to', 'guide', 'strategies', 'to', 'address', 'the', 'current', 'COVID', '19', 'pandemic', '']"
183339,"Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017",2019-04-11,PeerJ,https://doi.org/10.7717/peerj.6748; https://www.ncbi.nlm.nih.gov/pubmed/30997293/,"Children and adults residing in densely populated urban centers around the world are at risk of seasonal influenza-like illness caused by respiratory viruses such as influenza virus, human metapneumovirus (hMPV), and respiratory syncytial virus (RSV). In a large metropolitan of Thailand’s capital city Bangkok, most respiratory infections are rarely confirmed by molecular diagnostics. We therefore examined the frequency of RSV, hMPV, and influenza virus in 8,842 patients who presented influenza-like illness and sought medical care at a large hospital in Bangkok between 2016 and 2017. Using a multiplex real-time reverse-transcription polymerase chain reaction (RT-PCR), 30.5% (2,699/8,842) of nasopharyngeal (NP) swab samples tested positive for one or more of these viruses. Influenza virus comprised 17.3% (1,528/8,842), of which the majority were influenza A/H3N2. Such infection was most prevalent among adults and the elderly. RSV was identified in 11.4% (1,011/8,842) and were mostly ON1 and BA9 genotypes. Of the hMPV-positive samples (3.6%, 318/8,842), genotypes A2, B1, and B2 were detected. A small number of individuals experienced co-infections (1.8%, 155/8,842), most commonly between RSV and influenza A/H3N2. RSV and hMPV co-infections were also found, but mainly in young children. Viral respiratory tract infection peaked locally in the rainy season (June to September). These findings support the utility of rapid nucleic acid testing of RSV, hMPV, and influenza virus in patients with ILI.",10.7717/peerj.6748,vt706f26,"['Children', 'and', 'adults', 'residing', 'in', 'densely', 'populated', 'urban', 'centers', 'around', 'the', 'world', 'are', 'at', 'risk', 'of', 'seasonal', 'influenza', 'like', 'illness', 'caused', 'by', 'respiratory', 'viruses', 'such', 'as', 'influenza', 'virus', 'human', 'metapneumovirus', 'hMPV', 'and', 'respiratory', 'syncytial', 'virus', 'RSV', 'In', 'a', 'large', 'metropolitan', 'of', 'Thailand', 's', 'capital', 'city', 'Bangkok', 'most', 'respiratory', 'infections', 'are', 'rarely', 'confirmed', 'by', 'molecular', 'diagnostics', 'We', 'therefore', 'examined', 'the', 'frequency', 'of', 'RSV', 'hMPV', 'and', 'influenza', 'virus', 'in', '8', '842', 'patients', 'who', 'presented', 'influenza', 'like', 'illness', 'and', 'sought', 'medical', 'care', 'at', 'a', 'large', 'hospital', 'in', 'Bangkok', 'between', '2016', 'and', '2017', 'Using', 'a', 'multiplex', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', '30', '5', '2', '699', '8', '842', 'of', 'nasopharyngeal', 'NP', 'swab', 'samples', 'tested', 'positive', 'for', 'one', 'or', 'more', 'of', 'these', 'viruses', 'Influenza', 'virus', 'comprised', '17', '3', '1', '528', '8', '842', 'of', 'which', 'the', 'majority', 'were', 'influenza', 'A', 'H3N2', 'Such', 'infection', 'was', 'most', 'prevalent', 'among', 'adults', 'and', 'the', 'elderly', 'RSV', 'was', 'identified', 'in', '11', '4', '1', '011', '8', '842', 'and', 'were', 'mostly', 'ON1', 'and', 'BA9', 'genotypes', 'Of', 'the', 'hMPV', 'positive', 'samples', '3', '6', '318', '8', '842', 'genotypes', 'A2', 'B1', 'and', 'B2', 'were', 'detected', 'A', 'small', 'number', 'of', 'individuals', 'experienced', 'co', 'infections', '1', '8', '155', '8', '842', 'most', 'commonly', 'between', 'RSV', 'and', 'influenza', 'A', 'H3N2', 'RSV', 'and', 'hMPV', 'co', 'infections', 'were', 'also', 'found', 'but', 'mainly', 'in', 'young', 'children', 'Viral', 'respiratory', 'tract', 'infection', 'peaked', 'locally', 'in', 'the', 'rainy', 'season', 'June', 'to', 'September', 'These', 'findings', 'support', 'the', 'utility', 'of', 'rapid', 'nucleic', 'acid', 'testing', 'of', 'RSV', 'hMPV', 'and', 'influenza', 'virus', 'in', 'patients', 'with', 'ILI', '']"
183520,Die Virologie von SARS-CoV-2,2020-07-23,Internist (Berl),https://doi.org/10.1007/s00108-020-00853-6; https://www.ncbi.nlm.nih.gov/pubmed/32705298/,"The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has far reaching effects on society, the economy and medical treatment. It is all the more important to understand the characteristics of the virus and to utilize them diagnostically, therapeutically and epidemiologically. This article firstly elucidates the medical importance of coronaviruses in general. Then angiotensin-converting enzyme 2 (ACE2) as the binding site of SARS-CoV‑2 and the possible influence on the disease susceptibility are explained. The gold standard for detection of an active SARS-CoV‑2 infection is the direct detection of the pathogen with nucleic acid amplification techniques. At the onset of symptoms, a swab of the upper airway is especially suitable due to the high viral burden. At a later stage direct detection can be achieved in samples from the lower airway or a stool or anal swab. Antigen or antibody tests cannot replace the direct detection of the pathogen; however, the detection of immunoglobulin G antibodies are of special interest for epidemiological questions (seroconversion time of sometimes several weeks). The plaque reduction neutralization test exclusively detects antibodies which neutralize viruses but the procedure is complicated. In addition, the importance of these antibodies with respect to immunity against a second infection is uncertain. Thanks to modern techniques thousands of SARS-CoV‑2 sequences are already available, which show a genomic variability. The D614G mutation in the S spikes seems to cause a higher infectiosity. Mutations can impair the diagnostics and treatment, which makes monitoring necessary.",10.1007/s00108-020-00853-6,4rx9ii1j,"['The', 'new', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'far', 'reaching', 'effects', 'on', 'society', 'the', 'economy', 'and', 'medical', 'treatment', 'It', 'is', 'all', 'the', 'more', 'important', 'to', 'understand', 'the', 'characteristics', 'of', 'the', 'virus', 'and', 'to', 'utilize', 'them', 'diagnostically', 'therapeutically', 'and', 'epidemiologically', 'This', 'article', 'firstly', 'elucidates', 'the', 'medical', 'importance', 'of', 'coronaviruses', 'in', 'general', 'Then', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'as', 'the', 'binding', 'site', 'of', 'SARS', 'CoV', '2', 'and', 'the', 'possible', 'influence', 'on', 'the', 'disease', 'susceptibility', 'are', 'explained', 'The', 'gold', 'standard', 'for', 'detection', 'of', 'an', 'active', 'SARS', 'CoV', '2', 'infection', 'is', 'the', 'direct', 'detection', 'of', 'the', 'pathogen', 'with', 'nucleic', 'acid', 'amplification', 'techniques', 'At', 'the', 'onset', 'of', 'symptoms', 'a', 'swab', 'of', 'the', 'upper', 'airway', 'is', 'especially', 'suitable', 'due', 'to', 'the', 'high', 'viral', 'burden', 'At', 'a', 'later', 'stage', 'direct', 'detection', 'can', 'be', 'achieved', 'in', 'samples', 'from', 'the', 'lower', 'airway', 'or', 'a', 'stool', 'or', 'anal', 'swab', 'Antigen', 'or', 'antibody', 'tests', 'cannot', 'replace', 'the', 'direct', 'detection', 'of', 'the', 'pathogen', 'however', 'the', 'detection', 'of', 'immunoglobulin', 'G', 'antibodies', 'are', 'of', 'special', 'interest', 'for', 'epidemiological', 'questions', 'seroconversion', 'time', 'of', 'sometimes', 'several', 'weeks', 'The', 'plaque', 'reduction', 'neutralization', 'test', 'exclusively', 'detects', 'antibodies', 'which', 'neutralize', 'viruses', 'but', 'the', 'procedure', 'is', 'complicated', 'In', 'addition', 'the', 'importance', 'of', 'these', 'antibodies', 'with', 'respect', 'to', 'immunity', 'against', 'a', 'second', 'infection', 'is', 'uncertain', 'Thanks', 'to', 'modern', 'techniques', 'thousands', 'of', 'SARS', 'CoV', '2', 'sequences', 'are', 'already', 'available', 'which', 'show', 'a', 'genomic', 'variability', 'The', 'D614G', 'mutation', 'in', 'the', 'S', 'spikes', 'seems', 'to', 'cause', 'a', 'higher', 'infectiosity', 'Mutations', 'can', 'impair', 'the', 'diagnostics', 'and', 'treatment', 'which', 'makes', 'monitoring', 'necessary', '']"
183706,Verification and diagnostic evaluation of the RealStar(®) Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0,2019-07-02,Future microbiology,https://www.ncbi.nlm.nih.gov/pubmed/31271059/; https://doi.org/10.2217/fmb-2019-0067,"AIM: We report the diagnostic evaluation of a confirmatory reverse transcription-PCR (RT-PCR) kit targeting the Middle East respiratory syndrome coronavirus (MERS-CoV) N gene. MATERIAL & METHODS: 33 patient samples from two collections sites in Riyadh, Saudi Arabia, which were pre-characterized via real-time RT-PCR targeting MERS-CoV orf1a and upE, and were tested using the MERS-CoV N gene, as a confirmatory assay. This diagnostic procedure follows a two-step diagnostics scheme, recommended by the WHO. RESULTS: 18/33 samples tested positive, 11/33 tested negative for MERS-CoV RNA and 2/33 showed uncertain results. CONCLUSION: The results suggest, that the RealStar(®) MERS-CoV (N gene) RT-PCR kit 1.0 can be considered a suitable and reliable confirmatory assay in combination with the RealStar MERS-CoV RT-PCR kit 1.0 according to the diagnostic scheme recommended by WHO.",10.2217/fmb-2019-0067,qj45jefm,"['AIM', 'We', 'report', 'the', 'diagnostic', 'evaluation', 'of', 'a', 'confirmatory', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'kit', 'targeting', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'N', 'gene', 'MATERIAL', 'METHODS', '33', 'patient', 'samples', 'from', 'two', 'collections', 'sites', 'in', 'Riyadh', 'Saudi', 'Arabia', 'which', 'were', 'pre', 'characterized', 'via', 'real', 'time', 'RT', 'PCR', 'targeting', 'MERS', 'CoV', 'orf1a', 'and', 'upE', 'and', 'were', 'tested', 'using', 'the', 'MERS', 'CoV', 'N', 'gene', 'as', 'a', 'confirmatory', 'assay', 'This', 'diagnostic', 'procedure', 'follows', 'a', 'two', 'step', 'diagnostics', 'scheme', 'recommended', 'by', 'the', 'WHO', 'RESULTS', '18', '33', 'samples', 'tested', 'positive', '11', '33', 'tested', 'negative', 'for', 'MERS', 'CoV', 'RNA', 'and', '2', '33', 'showed', 'uncertain', 'results', 'CONCLUSION', 'The', 'results', 'suggest', 'that', 'the', 'RealStar', 'MERS', 'CoV', 'N', 'gene', 'RT', 'PCR', 'kit', '1', '0', 'can', 'be', 'considered', 'a', 'suitable', 'and', 'reliable', 'confirmatory', 'assay', 'in', 'combination', 'with', 'the', 'RealStar', 'MERS', 'CoV', 'RT', 'PCR', 'kit', '1', '0', 'according', 'to', 'the', 'diagnostic', 'scheme', 'recommended', 'by', 'WHO', '']"
183780,"Fighting COVID-19: a quick review of diagnoses, therapies, and vaccines",2020-05-30,Biomed J,https://www.sciencedirect.com/science/article/pii/S2319417020300858?v=s5; https://doi.org/10.1016/j.bj.2020.05.021; https://api.elsevier.com/content/article/pii/S2319417020300858; https://www.ncbi.nlm.nih.gov/pubmed/32532623/,"The COVID-19 pandemic caused by a novel coronavirus, SARS-CoV-2, has infected more than 4.9 million individuals and resulted in over 300,000 deaths globally. The rapid spread of the virus and the precipitously increasing numbers of cases necessitate the urgent development of accurate diagnostic methods, effective treatments, and vaccines. Here, we review the progress of developing diagnostic methods, therapies, and vaccines for SARS-CoV-2 with a focus on current clinical trials and their challenges. For diagnosis, nucleic acid amplification tests remain the mainstay diagnostics for laboratory confirmation of SARS-CoV-2 infection, while serological antibody tests are used to aid contact tracing, epidemiological, and vaccine evaluation studies. Viral isolation is not recommended for routine diagnostic procedures due to safety concerns. Currently, no single effective drug or specific vaccine is available against SARS-CoV-2. Some candidate drugs targeting different levels and stages of human responses against COVID-19 such as cell membrane fusion, RNA-dependent RNA polymerase, viral protease inhibitor, interleukin 6 blocker, and convalescent plasma may improve the clinical outcomes of critical COVID-19 patients. Other supportive care measures for critical patients are still necessary. Advances in genetic sequencing and other technological developments have sped up the establishment of a variety of vaccine platforms. Accordingly, numerous vaccines are under development. Vaccine candidates against SARS-CoV-2 are mainly based upon the viral spike protein due to its vital role in viral infectivity, and most of these candidates have recently moved into clinical trials. Before the efficacy of such vaccines in humans is demonstrated, strong international coordination and collaboration among studies, pharmaceutical companies, regulators, and governments are needed to limit further damage due the emerging SARS-CoV-2 virus.",10.1016/j.bj.2020.05.021,0g7a9s5z,"['The', 'COVID', '19', 'pandemic', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'infected', 'more', 'than', '4', '9', 'million', 'individuals', 'and', 'resulted', 'in', 'over', '300', '000', 'deaths', 'globally', 'The', 'rapid', 'spread', 'of', 'the', 'virus', 'and', 'the', 'precipitously', 'increasing', 'numbers', 'of', 'cases', 'necessitate', 'the', 'urgent', 'development', 'of', 'accurate', 'diagnostic', 'methods', 'effective', 'treatments', 'and', 'vaccines', 'Here', 'we', 'review', 'the', 'progress', 'of', 'developing', 'diagnostic', 'methods', 'therapies', 'and', 'vaccines', 'for', 'SARS', 'CoV', '2', 'with', 'a', 'focus', 'on', 'current', 'clinical', 'trials', 'and', 'their', 'challenges', 'For', 'diagnosis', 'nucleic', 'acid', 'amplification', 'tests', 'remain', 'the', 'mainstay', 'diagnostics', 'for', 'laboratory', 'confirmation', 'of', 'SARS', 'CoV', '2', 'infection', 'while', 'serological', 'antibody', 'tests', 'are', 'used', 'to', 'aid', 'contact', 'tracing', 'epidemiological', 'and', 'vaccine', 'evaluation', 'studies', 'Viral', 'isolation', 'is', 'not', 'recommended', 'for', 'routine', 'diagnostic', 'procedures', 'due', 'to', 'safety', 'concerns', 'Currently', 'no', 'single', 'effective', 'drug', 'or', 'specific', 'vaccine', 'is', 'available', 'against', 'SARS', 'CoV', '2', 'Some', 'candidate', 'drugs', 'targeting', 'different', 'levels', 'and', 'stages', 'of', 'human', 'responses', 'against', 'COVID', '19', 'such', 'as', 'cell', 'membrane', 'fusion', 'RNA', 'dependent', 'RNA', 'polymerase', 'viral', 'protease', 'inhibitor', 'interleukin', '6', 'blocker', 'and', 'convalescent', 'plasma', 'may', 'improve', 'the', 'clinical', 'outcomes', 'of', 'critical', 'COVID', '19', 'patients', 'Other', 'supportive', 'care', 'measures', 'for', 'critical', 'patients', 'are', 'still', 'necessary', 'Advances', 'in', 'genetic', 'sequencing', 'and', 'other', 'technological', 'developments', 'have', 'sped', 'up', 'the', 'establishment', 'of', 'a', 'variety', 'of', 'vaccine', 'platforms', 'Accordingly', 'numerous', 'vaccines', 'are', 'under', 'development', 'Vaccine', 'candidates', 'against', 'SARS', 'CoV', '2', 'are', 'mainly', 'based', 'upon', 'the', 'viral', 'spike', 'protein', 'due', 'to', 'its', 'vital', 'role', 'in', 'viral', 'infectivity', 'and', 'most', 'of', 'these', 'candidates', 'have', 'recently', 'moved', 'into', 'clinical', 'trials', 'Before', 'the', 'efficacy', 'of', 'such', 'vaccines', 'in', 'humans', 'is', 'demonstrated', 'strong', 'international', 'coordination', 'and', 'collaboration', 'among', 'studies', 'pharmaceutical', 'companies', 'regulators', 'and', 'governments', 'are', 'needed', 'to', 'limit', 'further', 'damage', 'due', 'the', 'emerging', 'SARS', 'CoV', '2', 'virus', '']"
184092,Serology testing in the COVID-19 pandemic response,2020-07-17,Lancet Infect Dis,https://api.elsevier.com/content/article/pii/S147330992030517X; https://www.sciencedirect.com/science/article/pii/S147330992030517X; https://www.ncbi.nlm.nih.gov/pubmed/32687805/; https://doi.org/10.1016/s1473-3099(20)30517-x,"The collapse of global cooperation and a failure of international solidarity have led to many low-income and middle-income countries being denied access to molecular diagnostics in the COVID-19 pandemic response. Yet the scarcity of knowledge on the dynamics of the immune response to infection has led to hesitation on recommending the use of rapid immunodiagnostic tests, even though rapid serology tests are commercially available and scalable. On the basis of our knowledge and understanding of viral infectivity and host response, we urge countries without the capacity to do molecular testing at scale to research the use of serology tests to triage symptomatic patients in community settings, to test contacts of confirmed cases, and in situational analysis and surveillance. The WHO R&D Blue Print expert group identified eight priorities for research and development, of which the highest is to mobilise research on rapid point-of-care diagnostics for use at the community level. This research should inform control programmes of the required performance and utility of rapid serology tests, which, when applied specifically for appropriate public health measures to then be put in place, can make a huge difference.",10.1016/s1473-3099(20)30517-x,ru2iw0py,"['The', 'collapse', 'of', 'global', 'cooperation', 'and', 'a', 'failure', 'of', 'international', 'solidarity', 'have', 'led', 'to', 'many', 'low', 'income', 'and', 'middle', 'income', 'countries', 'being', 'denied', 'access', 'to', 'molecular', 'diagnostics', 'in', 'the', 'COVID', '19', 'pandemic', 'response', 'Yet', 'the', 'scarcity', 'of', 'knowledge', 'on', 'the', 'dynamics', 'of', 'the', 'immune', 'response', 'to', 'infection', 'has', 'led', 'to', 'hesitation', 'on', 'recommending', 'the', 'use', 'of', 'rapid', 'immunodiagnostic', 'tests', 'even', 'though', 'rapid', 'serology', 'tests', 'are', 'commercially', 'available', 'and', 'scalable', 'On', 'the', 'basis', 'of', 'our', 'knowledge', 'and', 'understanding', 'of', 'viral', 'infectivity', 'and', 'host', 'response', 'we', 'urge', 'countries', 'without', 'the', 'capacity', 'to', 'do', 'molecular', 'testing', 'at', 'scale', 'to', 'research', 'the', 'use', 'of', 'serology', 'tests', 'to', 'triage', 'symptomatic', 'patients', 'in', 'community', 'settings', 'to', 'test', 'contacts', 'of', 'confirmed', 'cases', 'and', 'in', 'situational', 'analysis', 'and', 'surveillance', 'The', 'WHO', 'R', 'D', 'Blue', 'Print', 'expert', 'group', 'identified', 'eight', 'priorities', 'for', 'research', 'and', 'development', 'of', 'which', 'the', 'highest', 'is', 'to', 'mobilise', 'research', 'on', 'rapid', 'point', 'of', 'care', 'diagnostics', 'for', 'use', 'at', 'the', 'community', 'level', 'This', 'research', 'should', 'inform', 'control', 'programmes', 'of', 'the', 'required', 'performance', 'and', 'utility', 'of', 'rapid', 'serology', 'tests', 'which', 'when', 'applied', 'specifically', 'for', 'appropriate', 'public', 'health', 'measures', 'to', 'then', 'be', 'put', 'in', 'place', 'can', 'make', 'a', 'huge', 'difference', '']"
184140,Find the right sample: A study on the versatility of saliva and urine samples for the diagnosis of emerging viruses,2018-12-29,BMC Infect Dis,https://doi.org/10.1186/s12879-018-3611-x; https://www.ncbi.nlm.nih.gov/pubmed/30594124/,"BACKGROUND: The emergence of different viral infections during the last decades like dengue, West Nile, SARS, chikungunya, MERS-CoV, Ebola, Zika and Yellow Fever raised some questions on quickness and reliability of laboratory diagnostic tests for verification of suspected cases. Since sampling of blood requires medically trained personal and comprises some risks for the patient as well as for the health care personal, the sampling by non-invasive methods (e.g. saliva and/ or urine) might be a very valuable alternative for investigating a diseased patient. MAIN BODY: To analyse the usefulness of alternative non­invasive samples for the diagnosis of emerging infectious viral diseases, a literature search was performed on PubMed for alternative sampling for these viral infections. In total, 711 papers of potential relevance were found, of which we have included 128 in this review. CONCLUSIONS: Considering the experience using non-invasive sampling for the diagnostic of emerging viral diseases, it seems important to perform an investigation using alternative samples for routine diagnostics. Moreover, during an outbreak situation, evaluation of appropriate sampling and further processing for laboratory analysis on various diagnostic platforms are very crucial. This will help to achieve optimal diagnostic results for a good and reliable case identification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3611-x) contains supplementary material, which is available to authorized users.",10.1186/s12879-018-3611-x,nq7fb544,"['BACKGROUND', 'The', 'emergence', 'of', 'different', 'viral', 'infections', 'during', 'the', 'last', 'decades', 'like', 'dengue', 'West', 'Nile', 'SARS', 'chikungunya', 'MERS', 'CoV', 'Ebola', 'Zika', 'and', 'Yellow', 'Fever', 'raised', 'some', 'questions', 'on', 'quickness', 'and', 'reliability', 'of', 'laboratory', 'diagnostic', 'tests', 'for', 'verification', 'of', 'suspected', 'cases', 'Since', 'sampling', 'of', 'blood', 'requires', 'medically', 'trained', 'personal', 'and', 'comprises', 'some', 'risks', 'for', 'the', 'patient', 'as', 'well', 'as', 'for', 'the', 'health', 'care', 'personal', 'the', 'sampling', 'by', 'non', 'invasive', 'methods', 'e', 'g', 'saliva', 'and', 'or', 'urine', 'might', 'be', 'a', 'very', 'valuable', 'alternative', 'for', 'investigating', 'a', 'diseased', 'patient', 'MAIN', 'BODY', 'To', 'analyse', 'the', 'usefulness', 'of', 'alternative', 'non', 'invasive', 'samples', 'for', 'the', 'diagnosis', 'of', 'emerging', 'infectious', 'viral', 'diseases', 'a', 'literature', 'search', 'was', 'performed', 'on', 'PubMed', 'for', 'alternative', 'sampling', 'for', 'these', 'viral', 'infections', 'In', 'total', '711', 'papers', 'of', 'potential', 'relevance', 'were', 'found', 'of', 'which', 'we', 'have', 'included', '128', 'in', 'this', 'review', 'CONCLUSIONS', 'Considering', 'the', 'experience', 'using', 'non', 'invasive', 'sampling', 'for', 'the', 'diagnostic', 'of', 'emerging', 'viral', 'diseases', 'it', 'seems', 'important', 'to', 'perform', 'an', 'investigation', 'using', 'alternative', 'samples', 'for', 'routine', 'diagnostics', 'Moreover', 'during', 'an', 'outbreak', 'situation', 'evaluation', 'of', 'appropriate', 'sampling', 'and', 'further', 'processing', 'for', 'laboratory', 'analysis', 'on', 'various', 'diagnostic', 'platforms', 'are', 'very', 'crucial', 'This', 'will', 'help', 'to', 'achieve', 'optimal', 'diagnostic', 'results', 'for', 'a', 'good', 'and', 'reliable', 'case', 'identification', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', '10', '1186', 's12879', '018', '3611', 'x', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
185355,Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay,2006-03-02,BMC Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/16512903/,"BACKGROUND: Continuous outbreaks of the highly pathogenic H5N1 avian influenza A in Asia has resulted in an urgent effort to improve current diagnostics to aid containment of the virus and lower the threat of a influenza pandemic. We report here the development of a PCR-based assay that is highly specific for the H5N1 avian influenza A virus. METHODS: A one-step reverse-transcription PCR assay was developed to detect the H5N1 avian influenza A virus. The specificity of the assay was shown by testing sub-types of influenza A virus and other viral and bacterial pathogens; and on field samples. RESULTS: Validation on 145 field specimens from Vietnam and Malaysia showed that the assay was specific without cross reactivity to a number of other infuenza strains as well as human respiratory related pathogens. Detection was 100% from allantoic fluid in H5N1 positive samples, suggesting it to be a reliable sampling source for accurate detection. CONCLUSION: The assay developed from this study indicates that the primers are specific for the H5N1 influenza virus. As shown by the field tested results, this assay would be highly useful as a diagnostic tool to help identify and control influenza epidemics.",10.1186/1471-2334-6-40,vip4jtlv,"['BACKGROUND', 'Continuous', 'outbreaks', 'of', 'the', 'highly', 'pathogenic', 'H5N1', 'avian', 'influenza', 'A', 'in', 'Asia', 'has', 'resulted', 'in', 'an', 'urgent', 'effort', 'to', 'improve', 'current', 'diagnostics', 'to', 'aid', 'containment', 'of', 'the', 'virus', 'and', 'lower', 'the', 'threat', 'of', 'a', 'influenza', 'pandemic', 'We', 'report', 'here', 'the', 'development', 'of', 'a', 'PCR', 'based', 'assay', 'that', 'is', 'highly', 'specific', 'for', 'the', 'H5N1', 'avian', 'influenza', 'A', 'virus', 'METHODS', 'A', 'one', 'step', 'reverse', 'transcription', 'PCR', 'assay', 'was', 'developed', 'to', 'detect', 'the', 'H5N1', 'avian', 'influenza', 'A', 'virus', 'The', 'specificity', 'of', 'the', 'assay', 'was', 'shown', 'by', 'testing', 'sub', 'types', 'of', 'influenza', 'A', 'virus', 'and', 'other', 'viral', 'and', 'bacterial', 'pathogens', 'and', 'on', 'field', 'samples', 'RESULTS', 'Validation', 'on', '145', 'field', 'specimens', 'from', 'Vietnam', 'and', 'Malaysia', 'showed', 'that', 'the', 'assay', 'was', 'specific', 'without', 'cross', 'reactivity', 'to', 'a', 'number', 'of', 'other', 'infuenza', 'strains', 'as', 'well', 'as', 'human', 'respiratory', 'related', 'pathogens', 'Detection', 'was', '100', 'from', 'allantoic', 'fluid', 'in', 'H5N1', 'positive', 'samples', 'suggesting', 'it', 'to', 'be', 'a', 'reliable', 'sampling', 'source', 'for', 'accurate', 'detection', 'CONCLUSION', 'The', 'assay', 'developed', 'from', 'this', 'study', 'indicates', 'that', 'the', 'primers', 'are', 'specific', 'for', 'the', 'H5N1', 'influenza', 'virus', 'As', 'shown', 'by', 'the', 'field', 'tested', 'results', 'this', 'assay', 'would', 'be', 'highly', 'useful', 'as', 'a', 'diagnostic', 'tool', 'to', 'help', 'identify', 'and', 'control', 'influenza', 'epidemics', '']"
185395,Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature,2020-07-01,Allergol Immunopathol (Madr),https://www.ncbi.nlm.nih.gov/pubmed/32636083/; https://doi.org/10.1016/j.aller.2020.06.001; https://www.sciencedirect.com/science/article/pii/S0301054620301051?v=s5; https://api.elsevier.com/content/article/pii/S0301054620301051,"Coronavirus disease 2019 (COVID-19) named by the WHO as a result of the global public health emergency. COVID-19 is caused by a new coronavirus named as novel coronavirus (2019-nCOV). From the first case reported in December 2019 it is now a pandemic situation and a major public health emergency. The COVID-19 transmission rate is very high, infecting two to three persons on average with contact to an already infected person. There is a need for the health system, specially in developing countries such as in Pakistan, to combat such a novel disease by rapid, accurate, and high quality diagnostic testing in order to screen suspected cases and also surveillance of the disease. A rapid, accurate and low-cost diagnostic point-of-care device is needed for timely diagnosis of COVID-19 and is essential to combat such outbreaks for compelling preventive measures against the disease spread. This review is to highlight the importance of point-of-care diagnostics device for robust and accurate diagnosis of COVID-19 in physician offices and other urgent healthcare-type settings and encourage academics and stake holders towards advancement in order to control outbreaks and develop the public health surveillance system.",10.1016/j.aller.2020.06.001,cmm63mr2,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'named', 'by', 'the', 'WHO', 'as', 'a', 'result', 'of', 'the', 'global', 'public', 'health', 'emergency', 'COVID', '19', 'is', 'caused', 'by', 'a', 'new', 'coronavirus', 'named', 'as', 'novel', 'coronavirus', '2019', 'nCOV', 'From', 'the', 'first', 'case', 'reported', 'in', 'December', '2019', 'it', 'is', 'now', 'a', 'pandemic', 'situation', 'and', 'a', 'major', 'public', 'health', 'emergency', 'The', 'COVID', '19', 'transmission', 'rate', 'is', 'very', 'high', 'infecting', 'two', 'to', 'three', 'persons', 'on', 'average', 'with', 'contact', 'to', 'an', 'already', 'infected', 'person', 'There', 'is', 'a', 'need', 'for', 'the', 'health', 'system', 'specially', 'in', 'developing', 'countries', 'such', 'as', 'in', 'Pakistan', 'to', 'combat', 'such', 'a', 'novel', 'disease', 'by', 'rapid', 'accurate', 'and', 'high', 'quality', 'diagnostic', 'testing', 'in', 'order', 'to', 'screen', 'suspected', 'cases', 'and', 'also', 'surveillance', 'of', 'the', 'disease', 'A', 'rapid', 'accurate', 'and', 'low', 'cost', 'diagnostic', 'point', 'of', 'care', 'device', 'is', 'needed', 'for', 'timely', 'diagnosis', 'of', 'COVID', '19', 'and', 'is', 'essential', 'to', 'combat', 'such', 'outbreaks', 'for', 'compelling', 'preventive', 'measures', 'against', 'the', 'disease', 'spread', 'This', 'review', 'is', 'to', 'highlight', 'the', 'importance', 'of', 'point', 'of', 'care', 'diagnostics', 'device', 'for', 'robust', 'and', 'accurate', 'diagnosis', 'of', 'COVID', '19', 'in', 'physician', 'offices', 'and', 'other', 'urgent', 'healthcare', 'type', 'settings', 'and', 'encourage', 'academics', 'and', 'stake', 'holders', 'towards', 'advancement', 'in', 'order', 'to', 'control', 'outbreaks', 'and', 'develop', 'the', 'public', 'health', 'surveillance', 'system', '']"
185952,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020-02-26,J Clin Med,https://doi.org/10.3390/jcm9030623; https://www.ncbi.nlm.nih.gov/pubmed/32110875/,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",10.3390/jcm9030623,8gncbgot,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
186344,SARS-CoV-2 diagnostic diary: from rumors to the first case. Early reports of molecular tests from the military research and diagnostic institute of Rio de Janeiro,2020-07-13,Mem Inst Oswaldo Cruz,https://doi.org/10.1590/0074-02760200200; https://www.ncbi.nlm.nih.gov/pubmed/32667461/,"Corona virus disease (COVID-19) presents a serious threat to global health. A historical timeline of early molecular diagnostics from government alert (January 22) (D) was presented. After in silico analysis, Brazilian Army Institute of Biology (IBEx-RJ) tested samples in house using real-time reverse transcriptase polymerase chain reaction (RT-PCR) (fast mode) based on Centers for Disease Control and Prevention (CDC) recommendations. First cases from Brazil, Rio de Janeiro, IBEx, and diagnosis team were reported in D36, D44, D66, and D74 respectively. Therefore, after 1300 tests, we recommend N1/N2 primer sets (CDC) for preliminary and Charité protocol confirmation in case of positive results. Moreover, every professional should be tested before starting work, in addition to weekly tests for everyone involved.",10.1590/0074-02760200200,13s3ozv5,"['Corona', 'virus', 'disease', 'COVID', '19', 'presents', 'a', 'serious', 'threat', 'to', 'global', 'health', 'A', 'historical', 'timeline', 'of', 'early', 'molecular', 'diagnostics', 'from', 'government', 'alert', 'January', '22', 'D', 'was', 'presented', 'After', 'in', 'silico', 'analysis', 'Brazilian', 'Army', 'Institute', 'of', 'Biology', 'IBEx', 'RJ', 'tested', 'samples', 'in', 'house', 'using', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'fast', 'mode', 'based', 'on', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommendations', 'First', 'cases', 'from', 'Brazil', 'Rio', 'de', 'Janeiro', 'IBEx', 'and', 'diagnosis', 'team', 'were', 'reported', 'in', 'D36', 'D44', 'D66', 'and', 'D74', 'respectively', 'Therefore', 'after', '1300', 'tests', 'we', 'recommend', 'N1', 'N2', 'primer', 'sets', 'CDC', 'for', 'preliminary', 'and', 'Charité', 'protocol', 'confirmation', 'in', 'case', 'of', 'positive', 'results', 'Moreover', 'every', 'professional', 'should', 'be', 'tested', 'before', 'starting', 'work', 'in', 'addition', 'to', 'weekly', 'tests', 'for', 'everyone', 'involved', '']"
186363,Recent advances in lab-on-a-chip technologies for viral diagnosis,2020-04-01,Biosensors and Bioelectronics,https://api.elsevier.com/content/article/pii/S0956566320300385; https://www.ncbi.nlm.nih.gov/pubmed/31999560/; https://doi.org/10.1016/j.bios.2020.112041; https://www.sciencedirect.com/science/article/pii/S0956566320300385,"Abstract The global risk of viral disease outbreaks emphasizes the need for rapid, accurate, and sensitive detection techniques to speed up diagnostics allowing early intervention. An emerging field of microfluidics also known as the lab-on-a-chip (LOC) or micro total analysis system includes a wide range of diagnostic devices. This review briefly covers both conventional and microfluidics-based techniques for rapid viral detection. We first describe conventional detection methods such as cell culturing, immunofluorescence or enzyme-linked immunosorbent assay (ELISA), or reverse transcription polymerase chain reaction (RT-PCR). These methods often have limited speed, sensitivity, or specificity and are performed with typically bulky equipment. Here, we discuss some of the LOC technologies that can overcome these demerits, highlighting the latest advances in LOC devices for viral disease diagnosis. We also discuss the fabrication of LOC systems to produce devices for performing either individual steps or virus detection in samples with the sample to answer method. The complete system consists of sample preparation, and ELISA and RT-PCR for viral-antibody and nucleic acid detection, respectively. Finally, we formulate our opinions on these areas for the future development of LOC systems for viral diagnostics.",10.1016/j.bios.2020.112041,zwbn44gz,"['Abstract', 'The', 'global', 'risk', 'of', 'viral', 'disease', 'outbreaks', 'emphasizes', 'the', 'need', 'for', 'rapid', 'accurate', 'and', 'sensitive', 'detection', 'techniques', 'to', 'speed', 'up', 'diagnostics', 'allowing', 'early', 'intervention', 'An', 'emerging', 'field', 'of', 'microfluidics', 'also', 'known', 'as', 'the', 'lab', 'on', 'a', 'chip', 'LOC', 'or', 'micro', 'total', 'analysis', 'system', 'includes', 'a', 'wide', 'range', 'of', 'diagnostic', 'devices', 'This', 'review', 'briefly', 'covers', 'both', 'conventional', 'and', 'microfluidics', 'based', 'techniques', 'for', 'rapid', 'viral', 'detection', 'We', 'first', 'describe', 'conventional', 'detection', 'methods', 'such', 'as', 'cell', 'culturing', 'immunofluorescence', 'or', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'or', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'These', 'methods', 'often', 'have', 'limited', 'speed', 'sensitivity', 'or', 'specificity', 'and', 'are', 'performed', 'with', 'typically', 'bulky', 'equipment', 'Here', 'we', 'discuss', 'some', 'of', 'the', 'LOC', 'technologies', 'that', 'can', 'overcome', 'these', 'demerits', 'highlighting', 'the', 'latest', 'advances', 'in', 'LOC', 'devices', 'for', 'viral', 'disease', 'diagnosis', 'We', 'also', 'discuss', 'the', 'fabrication', 'of', 'LOC', 'systems', 'to', 'produce', 'devices', 'for', 'performing', 'either', 'individual', 'steps', 'or', 'virus', 'detection', 'in', 'samples', 'with', 'the', 'sample', 'to', 'answer', 'method', 'The', 'complete', 'system', 'consists', 'of', 'sample', 'preparation', 'and', 'ELISA', 'and', 'RT', 'PCR', 'for', 'viral', 'antibody', 'and', 'nucleic', 'acid', 'detection', 'respectively', 'Finally', 'we', 'formulate', 'our', 'opinions', 'on', 'these', 'areas', 'for', 'the', 'future', 'development', 'of', 'LOC', 'systems', 'for', 'viral', 'diagnostics', '']"
186446,CHAPTER 4 Keeping Track of Viruses,2005-12-31,Microbial Forensics,https://api.elsevier.com/content/article/pii/B978012088483450007X; https://www.sciencedirect.com/science/article/pii/B978012088483450007X,"Publisher Summary This chapter introduces basic concepts of virology and exemplifies the usage of current technology for identifying and tracking viral pathogens. Virus structure, lifestyle, replication strategies, classication, the varied modes of transmission, infection, and disease manifestations are focussed upon in the chapter. Viruses are extremely simple “life” forms without metabolic capacity, organelles, translational machinery, or autonomous replicative potential; the essential elements of a virus are consequently minimal. A virus enters the host through any opportunistic opening of the body—; such as minute breaks in the skin barrier or mucosal linings of the eye, nose, etc. Antibodies produced during an infection often have the ability to bind the virus and reduce infectivity. An immediate question to solve during a virus outbreak is the mechanism by which the virus spreads. Viruses frequently infect animal or insect vectors that serve to pass the virus to humans. By identifying the virus through sequence analysis, a hypothetical reservoir can be predicted by the placement of the sequence on the phylogenetic tree‥ The varied modes of transmission, infection, and disease manifestations as they relate to the different diagnostic methods for virus identification are highlighted. Examples of naturally emerging viruses; such as Sin Nombre, Nipah, West Nile conclude the chapter. New technologies that allow the creation of manmade or “engineered” viruses, new frontiers in viral diagnostics, and a few thoughts on the future of virology are also presented. The global eradication of smallpox ranks as one of humankind's greatest accomplishments yet many viral challenges remain. HIV, hepatitis B and C, influenza, dengue, rotavirus, and many other viral diseases continue to affect tens of millions.",10.1016/b978-012088483-4/50007-x,qma1lsuw,"['Publisher', 'Summary', 'This', 'chapter', 'introduces', 'basic', 'concepts', 'of', 'virology', 'and', 'exemplifies', 'the', 'usage', 'of', 'current', 'technology', 'for', 'identifying', 'and', 'tracking', 'viral', 'pathogens', 'Virus', 'structure', 'lifestyle', 'replication', 'strategies', 'classication', 'the', 'varied', 'modes', 'of', 'transmission', 'infection', 'and', 'disease', 'manifestations', 'are', 'focussed', 'upon', 'in', 'the', 'chapter', 'Viruses', 'are', 'extremely', 'simple', 'life', 'forms', 'without', 'metabolic', 'capacity', 'organelles', 'translational', 'machinery', 'or', 'autonomous', 'replicative', 'potential', 'the', 'essential', 'elements', 'of', 'a', 'virus', 'are', 'consequently', 'minimal', 'A', 'virus', 'enters', 'the', 'host', 'through', 'any', 'opportunistic', 'opening', 'of', 'the', 'body', 'such', 'as', 'minute', 'breaks', 'in', 'the', 'skin', 'barrier', 'or', 'mucosal', 'linings', 'of', 'the', 'eye', 'nose', 'etc', 'Antibodies', 'produced', 'during', 'an', 'infection', 'often', 'have', 'the', 'ability', 'to', 'bind', 'the', 'virus', 'and', 'reduce', 'infectivity', 'An', 'immediate', 'question', 'to', 'solve', 'during', 'a', 'virus', 'outbreak', 'is', 'the', 'mechanism', 'by', 'which', 'the', 'virus', 'spreads', 'Viruses', 'frequently', 'infect', 'animal', 'or', 'insect', 'vectors', 'that', 'serve', 'to', 'pass', 'the', 'virus', 'to', 'humans', 'By', 'identifying', 'the', 'virus', 'through', 'sequence', 'analysis', 'a', 'hypothetical', 'reservoir', 'can', 'be', 'predicted', 'by', 'the', 'placement', 'of', 'the', 'sequence', 'on', 'the', 'phylogenetic', 'tree', 'The', 'varied', 'modes', 'of', 'transmission', 'infection', 'and', 'disease', 'manifestations', 'as', 'they', 'relate', 'to', 'the', 'different', 'diagnostic', 'methods', 'for', 'virus', 'identification', 'are', 'highlighted', 'Examples', 'of', 'naturally', 'emerging', 'viruses', 'such', 'as', 'Sin', 'Nombre', 'Nipah', 'West', 'Nile', 'conclude', 'the', 'chapter', 'New', 'technologies', 'that', 'allow', 'the', 'creation', 'of', 'manmade', 'or', 'engineered', 'viruses', 'new', 'frontiers', 'in', 'viral', 'diagnostics', 'and', 'a', 'few', 'thoughts', 'on', 'the', 'future', 'of', 'virology', 'are', 'also', 'presented', 'The', 'global', 'eradication', 'of', 'smallpox', 'ranks', 'as', 'one', 'of', 'humankind', 's', 'greatest', 'accomplishments', 'yet', 'many', 'viral', 'challenges', 'remain', 'HIV', 'hepatitis', 'B', 'and', 'C', 'influenza', 'dengue', 'rotavirus', 'and', 'many', 'other', 'viral', 'diseases', 'continue', 'to', 'affect', 'tens', 'of', 'millions', '']"
187149,Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic,2020-05-11,J Clin Virol,https://www.ncbi.nlm.nih.gov/pubmed/32417674/; https://www.sciencedirect.com/science/article/pii/S1386653220301682?v=s5; https://api.elsevier.com/content/article/pii/S1386653220301682; https://doi.org/10.1016/j.jcv.2020.104426,"BACKGROUND: With the outbreak of SARS-CoV-2, rapid diagnostics are paramount to contain the current pandemic. The routinely used realtime RT-PCR is sensitive, specific and able to process large batches of samples. However, turnaround time is long and in cases where fast obtained results are critical, molecular point of care tests (POCT) can be an alternative. Here we report on a multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 point-of-care test. STUDY DESIGN: The Xpert Xpress SARS-CoV-2 assay was evaluated against the routine in-house real-time RT-PCR assays in three medical microbiology laboratories in The Netherlands. A sensitivity and specificity panel was tested consisting of a dilution series of SARS-CoV-2 and ten samples containing SARS-CoV-2 and a range of other seasonal respiratory viruses. Additionally, 58 samples of patients positive for SARS-CoV-2 with different viral loads and 30 tested negative samples in all three Dutch laboratories using an in-house RT-PCR, were evaluated using Cepheids Xpert Xpress SARS-CoV-2 cartridges. RESULTS: Xpert Xpress SARS-CoV-2 point of care test showed equal performance compared to routine in-house testing with a limit of detection (LOD) of 8.26 copies/mL. Other seasonal respiratory viruses were not detected. In clinical samples Xpert Xpress SARS-CoV-2 reaches an agreement of 100 % compared to all in-house RT-PCRs CONCLUSION: Cepheids GeneXpert Xpert Xpress SARS-CoV-2 is a valuable addition for laboratories in situations where rapid and accurate diagnostics are of the essence.",10.1016/j.jcv.2020.104426,shdg4l3r,"['BACKGROUND', 'With', 'the', 'outbreak', 'of', 'SARS', 'CoV', '2', 'rapid', 'diagnostics', 'are', 'paramount', 'to', 'contain', 'the', 'current', 'pandemic', 'The', 'routinely', 'used', 'realtime', 'RT', 'PCR', 'is', 'sensitive', 'specific', 'and', 'able', 'to', 'process', 'large', 'batches', 'of', 'samples', 'However', 'turnaround', 'time', 'is', 'long', 'and', 'in', 'cases', 'where', 'fast', 'obtained', 'results', 'are', 'critical', 'molecular', 'point', 'of', 'care', 'tests', 'POCT', 'can', 'be', 'an', 'alternative', 'Here', 'we', 'report', 'on', 'a', 'multicenter', 'evaluation', 'of', 'the', 'Cepheid', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'STUDY', 'DESIGN', 'The', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'assay', 'was', 'evaluated', 'against', 'the', 'routine', 'in', 'house', 'real', 'time', 'RT', 'PCR', 'assays', 'in', 'three', 'medical', 'microbiology', 'laboratories', 'in', 'The', 'Netherlands', 'A', 'sensitivity', 'and', 'specificity', 'panel', 'was', 'tested', 'consisting', 'of', 'a', 'dilution', 'series', 'of', 'SARS', 'CoV', '2', 'and', 'ten', 'samples', 'containing', 'SARS', 'CoV', '2', 'and', 'a', 'range', 'of', 'other', 'seasonal', 'respiratory', 'viruses', 'Additionally', '58', 'samples', 'of', 'patients', 'positive', 'for', 'SARS', 'CoV', '2', 'with', 'different', 'viral', 'loads', 'and', '30', 'tested', 'negative', 'samples', 'in', 'all', 'three', 'Dutch', 'laboratories', 'using', 'an', 'in', 'house', 'RT', 'PCR', 'were', 'evaluated', 'using', 'Cepheids', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'cartridges', 'RESULTS', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'point', 'of', 'care', 'test', 'showed', 'equal', 'performance', 'compared', 'to', 'routine', 'in', 'house', 'testing', 'with', 'a', 'limit', 'of', 'detection', 'LOD', 'of', '8', '26', 'copies', 'mL', 'Other', 'seasonal', 'respiratory', 'viruses', 'were', 'not', 'detected', 'In', 'clinical', 'samples', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'reaches', 'an', 'agreement', 'of', '100', 'compared', 'to', 'all', 'in', 'house', 'RT', 'PCRs', 'CONCLUSION', 'Cepheids', 'GeneXpert', 'Xpert', 'Xpress', 'SARS', 'CoV', '2', 'is', 'a', 'valuable', 'addition', 'for', 'laboratories', 'in', 'situations', 'where', 'rapid', 'and', 'accurate', 'diagnostics', 'are', 'of', 'the', 'essence', '']"
187553,"Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs",2016-08-24,Emerg Microbes Infect,https://www.ncbi.nlm.nih.gov/pubmed/27553173/; https://doi.org/10.1038/emi.2016.99,"Zika virus (ZIKV) is unique among human-pathogenic flaviviruses by its association with congenital anomalies and trans-placental and sexual human-to-human transmission. Although the pathogenesis of ZIKV-associated neurological complications has been reported in recent studies, key questions on the pathogenesis of the other clinical manifestations, non-vector-borne transmission and potential animal reservoirs of ZIKV remain unanswered. We systematically characterized the differential cell line susceptibility of 18 human and 15 nonhuman cell lines to two ZIKV isolates (human and primate) and dengue virus type 2 (DENV-2). Productive ZIKV replication (⩾2 log increase in viral load, ZIKV nonstructural protein-1 (NS1) protein expression and cytopathic effects (CPE)) was found in the placental (JEG-3), neuronal (SF268), muscle (RD), retinal (ARPE19), pulmonary (Hep-2 and HFL), colonic (Caco-2),and hepatic (Huh-7) cell lines. These findings helped to explain the trans-placental transmission and other clinical manifestations of ZIKV. Notably, the prostatic (LNCaP), testicular (833KE) and renal (HEK) cell lines showed increased ZIKV load and/or NS1 protein expression without inducing CPE, suggesting their potential roles in sexual transmission with persistent viral replication at these anatomical sites. Comparatively, none of the placental and genital tract cell lines allowed efficient DENV-2 replication. Among the nonhuman cell lines, nonhuman primate (Vero and LLC-MK2), pig (PK-15), rabbit (RK-13), hamster (BHK21) and chicken (DF-1) cell lines supported productive ZIKV replication. These animal species may be important reservoirs and/or potential animal models for ZIKV. The findings in our study help to explain the viral shedding pattern, transmission and pathogenesis of the rapidly disseminating ZIKV, and are useful for optimizing laboratory diagnostics and studies on the pathogenesis and counter-measures of ZIKV.",10.1038/emi.2016.99,g29kbgha,"['Zika', 'virus', 'ZIKV', 'is', 'unique', 'among', 'human', 'pathogenic', 'flaviviruses', 'by', 'its', 'association', 'with', 'congenital', 'anomalies', 'and', 'trans', 'placental', 'and', 'sexual', 'human', 'to', 'human', 'transmission', 'Although', 'the', 'pathogenesis', 'of', 'ZIKV', 'associated', 'neurological', 'complications', 'has', 'been', 'reported', 'in', 'recent', 'studies', 'key', 'questions', 'on', 'the', 'pathogenesis', 'of', 'the', 'other', 'clinical', 'manifestations', 'non', 'vector', 'borne', 'transmission', 'and', 'potential', 'animal', 'reservoirs', 'of', 'ZIKV', 'remain', 'unanswered', 'We', 'systematically', 'characterized', 'the', 'differential', 'cell', 'line', 'susceptibility', 'of', '18', 'human', 'and', '15', 'nonhuman', 'cell', 'lines', 'to', 'two', 'ZIKV', 'isolates', 'human', 'and', 'primate', 'and', 'dengue', 'virus', 'type', '2', 'DENV', '2', 'Productive', 'ZIKV', 'replication', '2', 'log', 'increase', 'in', 'viral', 'load', 'ZIKV', 'nonstructural', 'protein', '1', 'NS1', 'protein', 'expression', 'and', 'cytopathic', 'effects', 'CPE', 'was', 'found', 'in', 'the', 'placental', 'JEG', '3', 'neuronal', 'SF268', 'muscle', 'RD', 'retinal', 'ARPE19', 'pulmonary', 'Hep', '2', 'and', 'HFL', 'colonic', 'Caco', '2', 'and', 'hepatic', 'Huh', '7', 'cell', 'lines', 'These', 'findings', 'helped', 'to', 'explain', 'the', 'trans', 'placental', 'transmission', 'and', 'other', 'clinical', 'manifestations', 'of', 'ZIKV', 'Notably', 'the', 'prostatic', 'LNCaP', 'testicular', '833KE', 'and', 'renal', 'HEK', 'cell', 'lines', 'showed', 'increased', 'ZIKV', 'load', 'and', 'or', 'NS1', 'protein', 'expression', 'without', 'inducing', 'CPE', 'suggesting', 'their', 'potential', 'roles', 'in', 'sexual', 'transmission', 'with', 'persistent', 'viral', 'replication', 'at', 'these', 'anatomical', 'sites', 'Comparatively', 'none', 'of', 'the', 'placental', 'and', 'genital', 'tract', 'cell', 'lines', 'allowed', 'efficient', 'DENV', '2', 'replication', 'Among', 'the', 'nonhuman', 'cell', 'lines', 'nonhuman', 'primate', 'Vero', 'and', 'LLC', 'MK2', 'pig', 'PK', '15', 'rabbit', 'RK', '13', 'hamster', 'BHK21', 'and', 'chicken', 'DF', '1', 'cell', 'lines', 'supported', 'productive', 'ZIKV', 'replication', 'These', 'animal', 'species', 'may', 'be', 'important', 'reservoirs', 'and', 'or', 'potential', 'animal', 'models', 'for', 'ZIKV', 'The', 'findings', 'in', 'our', 'study', 'help', 'to', 'explain', 'the', 'viral', 'shedding', 'pattern', 'transmission', 'and', 'pathogenesis', 'of', 'the', 'rapidly', 'disseminating', 'ZIKV', 'and', 'are', 'useful', 'for', 'optimizing', 'laboratory', 'diagnostics', 'and', 'studies', 'on', 'the', 'pathogenesis', 'and', 'counter', 'measures', 'of', 'ZIKV', '']"
187787,"Mycobacterium tuberculosis pili (MTP), a putative biomarker for a tuberculosis diagnostic test",2014-05-31,Tuberculosis,https://api.elsevier.com/content/article/pii/S1472979214000304; https://www.sciencedirect.com/science/article/pii/S1472979214000304; https://www.ncbi.nlm.nih.gov/pubmed/24721207/; https://doi.org/10.1016/j.tube.2014.03.004,"Summary Novel biomarkers are urgently needed for point of care TB diagnostics. In this study, we investigated the potential of the pilin subunit protein encoded by the mtp gene as a diagnostic biomarker. BLAST analysis of the mtp gene on published genome databases, and amplicon sequencing were performed in Mycobacterium tuberculosis Complex (MTBC) strains and other organisms. The protein secondary structure of the amino acid sequences of non-tuberculous Mycobacteria that partially aligned with the mtp sequence was analysed with PredictProtein software. The mtp gene and corresponding amino acid sequence of MTBC were 100% homologous with H37Rv, in contrast to the partial alignment of the non-tuberculous Mycobacteria. The mtp gene was present in all 91 clinical isolates of MTBC. Except for 2 strains with point mutations, the sequence was 100% conserved among the clinical strains. The mtp gene could not be amplified in all non-tuberculous Mycobacteria and respiratory organisms. The predicted MTP protein structure of Mycobacterium avium, Mycobacterium ulcerans and Mycobacterium abscessus differed significantly from that of the M. tuberculosis, which was similar to Mycobacterium marinum. The absence of the mtp gene in non-tuberculous Mycobacteria and other respiratory bacteria suggests that its encoded product, the pilin subunit protein of M. tuberculosis may be a suitable marker for a point of care TB test.",10.1016/j.tube.2014.03.004,j6wdclpu,"['Summary', 'Novel', 'biomarkers', 'are', 'urgently', 'needed', 'for', 'point', 'of', 'care', 'TB', 'diagnostics', 'In', 'this', 'study', 'we', 'investigated', 'the', 'potential', 'of', 'the', 'pilin', 'subunit', 'protein', 'encoded', 'by', 'the', 'mtp', 'gene', 'as', 'a', 'diagnostic', 'biomarker', 'BLAST', 'analysis', 'of', 'the', 'mtp', 'gene', 'on', 'published', 'genome', 'databases', 'and', 'amplicon', 'sequencing', 'were', 'performed', 'in', 'Mycobacterium', 'tuberculosis', 'Complex', 'MTBC', 'strains', 'and', 'other', 'organisms', 'The', 'protein', 'secondary', 'structure', 'of', 'the', 'amino', 'acid', 'sequences', 'of', 'non', 'tuberculous', 'Mycobacteria', 'that', 'partially', 'aligned', 'with', 'the', 'mtp', 'sequence', 'was', 'analysed', 'with', 'PredictProtein', 'software', 'The', 'mtp', 'gene', 'and', 'corresponding', 'amino', 'acid', 'sequence', 'of', 'MTBC', 'were', '100', 'homologous', 'with', 'H37Rv', 'in', 'contrast', 'to', 'the', 'partial', 'alignment', 'of', 'the', 'non', 'tuberculous', 'Mycobacteria', 'The', 'mtp', 'gene', 'was', 'present', 'in', 'all', '91', 'clinical', 'isolates', 'of', 'MTBC', 'Except', 'for', '2', 'strains', 'with', 'point', 'mutations', 'the', 'sequence', 'was', '100', 'conserved', 'among', 'the', 'clinical', 'strains', 'The', 'mtp', 'gene', 'could', 'not', 'be', 'amplified', 'in', 'all', 'non', 'tuberculous', 'Mycobacteria', 'and', 'respiratory', 'organisms', 'The', 'predicted', 'MTP', 'protein', 'structure', 'of', 'Mycobacterium', 'avium', 'Mycobacterium', 'ulcerans', 'and', 'Mycobacterium', 'abscessus', 'differed', 'significantly', 'from', 'that', 'of', 'the', 'M', 'tuberculosis', 'which', 'was', 'similar', 'to', 'Mycobacterium', 'marinum', 'The', 'absence', 'of', 'the', 'mtp', 'gene', 'in', 'non', 'tuberculous', 'Mycobacteria', 'and', 'other', 'respiratory', 'bacteria', 'suggests', 'that', 'its', 'encoded', 'product', 'the', 'pilin', 'subunit', 'protein', 'of', 'M', 'tuberculosis', 'may', 'be', 'a', 'suitable', 'marker', 'for', 'a', 'point', 'of', 'care', 'TB', 'test', '']"
187878,Re-imagining the future of diagnosis of Neglected Tropical Diseases,2017-02-21,Comput Struct Biotechnol J,https://api.elsevier.com/content/article/pii/S2001037016301015; https://www.ncbi.nlm.nih.gov/pubmed/28352456/; https://www.sciencedirect.com/science/article/pii/S2001037016301015; https://doi.org/10.1016/j.csbj.2017.02.003,"Neglected Tropical Diseases (NTDs) affect an estimated 1 billion people in 149 countries. The World Health Organization (WHO) prioritised 17 NTDs for control and elimination by 2020 and defined a Road Map to help countries reach these goals. Improved diagnostics for NTDs are essential for guiding treatment strategies at different thresholds of control, interruption of transmission, elimination and post-elimination surveillance. While substantial progress has been made in the last decade with chemotherapy, the same cannot be said of diagnostics, largely due to the perceived lack of a commercially viable market for NTD diagnostics. New sample in-answer out nucleic acid amplification technologies that can be performed at the point-of-care offer improved performance over current technologies and the potential to test for multiple pathogens using a single specimen. Finding commonalities for different NTDs in terms of geographic overlap, sentinel populations and treatment strategy will allow NTD programs to leverage these innovations to build cost-effective multiplex surveillance platforms. Connectivity solutions linking data from diagnostic laboratories and POC test readers/devices provide opportunities for automated surveillance systems to make health systems more efficient, improving patient outcomes and assessing impact of interventions in real time. New models of public–private product development partnerships are critical in leveraging diagnostic innovation in other priority area for better diagnosis, control and elimination of NTDs.",10.1016/j.csbj.2017.02.003,5lusy98x,"['Neglected', 'Tropical', 'Diseases', 'NTDs', 'affect', 'an', 'estimated', '1', 'billion', 'people', 'in', '149', 'countries', 'The', 'World', 'Health', 'Organization', 'WHO', 'prioritised', '17', 'NTDs', 'for', 'control', 'and', 'elimination', 'by', '2020', 'and', 'defined', 'a', 'Road', 'Map', 'to', 'help', 'countries', 'reach', 'these', 'goals', 'Improved', 'diagnostics', 'for', 'NTDs', 'are', 'essential', 'for', 'guiding', 'treatment', 'strategies', 'at', 'different', 'thresholds', 'of', 'control', 'interruption', 'of', 'transmission', 'elimination', 'and', 'post', 'elimination', 'surveillance', 'While', 'substantial', 'progress', 'has', 'been', 'made', 'in', 'the', 'last', 'decade', 'with', 'chemotherapy', 'the', 'same', 'cannot', 'be', 'said', 'of', 'diagnostics', 'largely', 'due', 'to', 'the', 'perceived', 'lack', 'of', 'a', 'commercially', 'viable', 'market', 'for', 'NTD', 'diagnostics', 'New', 'sample', 'in', 'answer', 'out', 'nucleic', 'acid', 'amplification', 'technologies', 'that', 'can', 'be', 'performed', 'at', 'the', 'point', 'of', 'care', 'offer', 'improved', 'performance', 'over', 'current', 'technologies', 'and', 'the', 'potential', 'to', 'test', 'for', 'multiple', 'pathogens', 'using', 'a', 'single', 'specimen', 'Finding', 'commonalities', 'for', 'different', 'NTDs', 'in', 'terms', 'of', 'geographic', 'overlap', 'sentinel', 'populations', 'and', 'treatment', 'strategy', 'will', 'allow', 'NTD', 'programs', 'to', 'leverage', 'these', 'innovations', 'to', 'build', 'cost', 'effective', 'multiplex', 'surveillance', 'platforms', 'Connectivity', 'solutions', 'linking', 'data', 'from', 'diagnostic', 'laboratories', 'and', 'POC', 'test', 'readers', 'devices', 'provide', 'opportunities', 'for', 'automated', 'surveillance', 'systems', 'to', 'make', 'health', 'systems', 'more', 'efficient', 'improving', 'patient', 'outcomes', 'and', 'assessing', 'impact', 'of', 'interventions', 'in', 'real', 'time', 'New', 'models', 'of', 'public', 'private', 'product', 'development', 'partnerships', 'are', 'critical', 'in', 'leveraging', 'diagnostic', 'innovation', 'in', 'other', 'priority', 'area', 'for', 'better', 'diagnosis', 'control', 'and', 'elimination', 'of', 'NTDs', '']"
188194,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020-06-16,Clin Infect Dis,https://doi.org/10.1093/cid/ciaa760; https://www.ncbi.nlm.nih.gov/pubmed/32556191/,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA’s goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",10.1093/cid/ciaa760,q2716lda,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
189098,Technologies to Optimize the Care of Severe Coronavirus Disease 2019 Patients for Health Care Providers Challenged by Limited Resources,2020-05-26,Anesth Analg,https://www.ncbi.nlm.nih.gov/pubmed/32433248/; https://doi.org/10.1213/ane.0000000000004985,"Health care systems are belligerently responding to the new Coronavirus Disease 2019 (COVID-19). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a specific condition, whose distinctive features are severe hypoxemia associated with (>50% of cases) normal respiratory system compliance.(1) When a patient requires intubation and invasive ventilation, the outcome is poor,(2–4) and the length of stay in the intensive care unit (ICU) is usually 2or 3 weeks.(2) In this article, theauthors review several technological devices, which could support health care providers at the bedside to optimizethe care for COVID-19 patients who are sedated, paralyzed, and ventilated. Particular attention is provided to the use of videolaryngoscopes (VL) because these can assist anesthetists to perform a successful intubation outside the ICU while protecting health care providers from this viral infection. Authors will also review processed electroencephalographic (EEG) monitors which are used to better titrate sedation and the train-of-four monitors which are utilizedto better titrate neuromuscular blocking agents in the view of sparing limited pharmacological resources. COVID-19 can rapidly exhaust human and technological resources too within the ICU. This review features a series of technological advancements that can significantly improve the care of patients requiring isolation. The working conditions in isolation could cause gaps or barriers in communication, fatigue, and poor documentation of provided care. The available technology has several advantages including (a) facilitating appropriate paperless documentation and communication between all health care givers working in isolation rooms or large isolation areas; (b) testing patients and staff at the bedside using smart point-of-care diagnostics (SPOCD) to confirm COVID-19 infection; (c) allowing diagnostics and treatment at the bedside through point-of-care ultrasound (POCUS) and thromboelastography(TEG); (d) adapting the use of anesthetic machines and the use of volatile anesthetics. Implementing technologies for safeguarding health care providers as well as monitoring the limited pharmacological resources are paramount. Only by leveraging new technologies, it will be possible to sustain and support health care systems during the expected long course of this pandemic.",10.1213/ane.0000000000004985,2lp3fead,"['Health', 'care', 'systems', 'are', 'belligerently', 'responding', 'to', 'the', 'new', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'specific', 'condition', 'whose', 'distinctive', 'features', 'are', 'severe', 'hypoxemia', 'associated', 'with', '50', 'of', 'cases', 'normal', 'respiratory', 'system', 'compliance', '1', 'When', 'a', 'patient', 'requires', 'intubation', 'and', 'invasive', 'ventilation', 'the', 'outcome', 'is', 'poor', '2', '4', 'and', 'the', 'length', 'of', 'stay', 'in', 'the', 'intensive', 'care', 'unit', 'ICU', 'is', 'usually', '2or', '3', 'weeks', '2', 'In', 'this', 'article', 'theauthors', 'review', 'several', 'technological', 'devices', 'which', 'could', 'support', 'health', 'care', 'providers', 'at', 'the', 'bedside', 'to', 'optimizethe', 'care', 'for', 'COVID', '19', 'patients', 'who', 'are', 'sedated', 'paralyzed', 'and', 'ventilated', 'Particular', 'attention', 'is', 'provided', 'to', 'the', 'use', 'of', 'videolaryngoscopes', 'VL', 'because', 'these', 'can', 'assist', 'anesthetists', 'to', 'perform', 'a', 'successful', 'intubation', 'outside', 'the', 'ICU', 'while', 'protecting', 'health', 'care', 'providers', 'from', 'this', 'viral', 'infection', 'Authors', 'will', 'also', 'review', 'processed', 'electroencephalographic', 'EEG', 'monitors', 'which', 'are', 'used', 'to', 'better', 'titrate', 'sedation', 'and', 'the', 'train', 'of', 'four', 'monitors', 'which', 'are', 'utilizedto', 'better', 'titrate', 'neuromuscular', 'blocking', 'agents', 'in', 'the', 'view', 'of', 'sparing', 'limited', 'pharmacological', 'resources', 'COVID', '19', 'can', 'rapidly', 'exhaust', 'human', 'and', 'technological', 'resources', 'too', 'within', 'the', 'ICU', 'This', 'review', 'features', 'a', 'series', 'of', 'technological', 'advancements', 'that', 'can', 'significantly', 'improve', 'the', 'care', 'of', 'patients', 'requiring', 'isolation', 'The', 'working', 'conditions', 'in', 'isolation', 'could', 'cause', 'gaps', 'or', 'barriers', 'in', 'communication', 'fatigue', 'and', 'poor', 'documentation', 'of', 'provided', 'care', 'The', 'available', 'technology', 'has', 'several', 'advantages', 'including', 'a', 'facilitating', 'appropriate', 'paperless', 'documentation', 'and', 'communication', 'between', 'all', 'health', 'care', 'givers', 'working', 'in', 'isolation', 'rooms', 'or', 'large', 'isolation', 'areas', 'b', 'testing', 'patients', 'and', 'staff', 'at', 'the', 'bedside', 'using', 'smart', 'point', 'of', 'care', 'diagnostics', 'SPOCD', 'to', 'confirm', 'COVID', '19', 'infection', 'c', 'allowing', 'diagnostics', 'and', 'treatment', 'at', 'the', 'bedside', 'through', 'point', 'of', 'care', 'ultrasound', 'POCUS', 'and', 'thromboelastography', 'TEG', 'd', 'adapting', 'the', 'use', 'of', 'anesthetic', 'machines', 'and', 'the', 'use', 'of', 'volatile', 'anesthetics', 'Implementing', 'technologies', 'for', 'safeguarding', 'health', 'care', 'providers', 'as', 'well', 'as', 'monitoring', 'the', 'limited', 'pharmacological', 'resources', 'are', 'paramount', 'Only', 'by', 'leveraging', 'new', 'technologies', 'it', 'will', 'be', 'possible', 'to', 'sustain', 'and', 'support', 'health', 'care', 'systems', 'during', 'the', 'expected', 'long', 'course', 'of', 'this', 'pandemic', '']"
189192,Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders,2018-08-17,Orphanet J Rare Dis,https://doi.org/10.1186/s13023-018-0864-9; https://www.ncbi.nlm.nih.gov/pubmed/30115091/,"BACKGROUND: The telomere biology disorders (TBDs) include a range of multisystem diseases characterized by mucocutaneous symptoms and bone marrow failure. In dyskeratosis congenita (DKC), the clinical features of TBDs stem from the depletion of crucial stem cell populations in highly proliferative tissues, resulting from abnormal telomerase function. Due to the wide spectrum of clinical presentations and lack of a conclusive laboratory test it may be challenging to reach a clinical diagnosis, especially if patients lack the pathognomonic clinical features of TBDs. METHODS: Clinical sequencing was performed on a cohort of patients presenting with variable immune phenotypes lacking molecular diagnoses. Hypothesis-free whole-exome sequencing (WES) was selected in the absence of compelling diagnostic hints in patients with variable immunological and haematological conditions. RESULTS: In four patients belonging to three families, we have detected five novel variants in known TBD-causing genes (DKC1, TERT and RTEL1). In addition to the molecular findings, they all presented shortened blood cell telomeres. These findings are consistent with the displayed TBD phenotypes, addressing towards the molecular diagnosis and subsequent clinical follow-up of the patients. CONCLUSIONS: Our results strongly support the utility of WES-based approaches for routine genetic diagnostics of TBD patients with heterogeneous or atypical clinical presentation who otherwise might remain undiagnosed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-018-0864-9) contains supplementary material, which is available to authorized users.",10.1186/s13023-018-0864-9,uqwo9w4e,"['BACKGROUND', 'The', 'telomere', 'biology', 'disorders', 'TBDs', 'include', 'a', 'range', 'of', 'multisystem', 'diseases', 'characterized', 'by', 'mucocutaneous', 'symptoms', 'and', 'bone', 'marrow', 'failure', 'In', 'dyskeratosis', 'congenita', 'DKC', 'the', 'clinical', 'features', 'of', 'TBDs', 'stem', 'from', 'the', 'depletion', 'of', 'crucial', 'stem', 'cell', 'populations', 'in', 'highly', 'proliferative', 'tissues', 'resulting', 'from', 'abnormal', 'telomerase', 'function', 'Due', 'to', 'the', 'wide', 'spectrum', 'of', 'clinical', 'presentations', 'and', 'lack', 'of', 'a', 'conclusive', 'laboratory', 'test', 'it', 'may', 'be', 'challenging', 'to', 'reach', 'a', 'clinical', 'diagnosis', 'especially', 'if', 'patients', 'lack', 'the', 'pathognomonic', 'clinical', 'features', 'of', 'TBDs', 'METHODS', 'Clinical', 'sequencing', 'was', 'performed', 'on', 'a', 'cohort', 'of', 'patients', 'presenting', 'with', 'variable', 'immune', 'phenotypes', 'lacking', 'molecular', 'diagnoses', 'Hypothesis', 'free', 'whole', 'exome', 'sequencing', 'WES', 'was', 'selected', 'in', 'the', 'absence', 'of', 'compelling', 'diagnostic', 'hints', 'in', 'patients', 'with', 'variable', 'immunological', 'and', 'haematological', 'conditions', 'RESULTS', 'In', 'four', 'patients', 'belonging', 'to', 'three', 'families', 'we', 'have', 'detected', 'five', 'novel', 'variants', 'in', 'known', 'TBD', 'causing', 'genes', 'DKC1', 'TERT', 'and', 'RTEL1', 'In', 'addition', 'to', 'the', 'molecular', 'findings', 'they', 'all', 'presented', 'shortened', 'blood', 'cell', 'telomeres', 'These', 'findings', 'are', 'consistent', 'with', 'the', 'displayed', 'TBD', 'phenotypes', 'addressing', 'towards', 'the', 'molecular', 'diagnosis', 'and', 'subsequent', 'clinical', 'follow', 'up', 'of', 'the', 'patients', 'CONCLUSIONS', 'Our', 'results', 'strongly', 'support', 'the', 'utility', 'of', 'WES', 'based', 'approaches', 'for', 'routine', 'genetic', 'diagnostics', 'of', 'TBD', 'patients', 'with', 'heterogeneous', 'or', 'atypical', 'clinical', 'presentation', 'who', 'otherwise', 'might', 'remain', 'undiagnosed', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', '10', '1186', 's13023', '018', '0864', '9', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
190044,Impact of molecular point‐of‐care testing on clinical management and in‐hospital costs of patients suspected of influenza or RSV infection: a modeling study,2019-04-14,J Med Virol,https://www.ncbi.nlm.nih.gov/pubmed/30950066/; https://doi.org/10.1002/jmv.25479,"BACKGROUND: At hospital admission, patients suspected of infection with influenza or respiratory syncytial virus (RSV) are placed in isolation, pending the outcome of diagnostics. In a significant number, isolated care proves unnecessary. We investigated the potential impact of molecular point‐of‐care (POC) diagnostics on patient management and in‐hospital costs. METHOD: Prospective collection of data on resource utilization within the hospital from consecutive patients 18 years or older presenting at our university medical center with symptoms of respiratory tract infection from December 2016 to April 2017. A cost analysis was conducted using Markov modeling comparing the actual course of events (on the basis of routine diagnostic tests) with two hypothetical scenarios: when POC would impact time to diagnosis only (scenario 1) or on discharge from the hospital, too (scenario 2). RESULTS: A total of 283 patients were included, of whom 217 (76.7%) were admitted. Influenza and RSV were detected in 31% and 7% of the patients, respectively. Fifty‐four percent of patients tested negative, of which 79% were kept in isolated care waiting for test results, with a median duration of 24 hours. Median length of stay was 6.0 days. Mean total in‐hospital costs per patient were € 5243. Introducing POC would lower mean costs per patient to € 4904 (scenario 1) and € 4206 (scenario 2). At the hospital level, this would result in a total cost reduction of € 95 937 to € 293 471 in a single influenza season. CONCLUSIONS: Introducing POC testing for patients presenting with symptoms of viral respiratory tract infection can reduce time‐to‐diagnosis, hospital stay and, thereby, in‐hospital costs.",10.1002/jmv.25479,6n4nmf96,"['BACKGROUND', 'At', 'hospital', 'admission', 'patients', 'suspected', 'of', 'infection', 'with', 'influenza', 'or', 'respiratory', 'syncytial', 'virus', 'RSV', 'are', 'placed', 'in', 'isolation', 'pending', 'the', 'outcome', 'of', 'diagnostics', 'In', 'a', 'significant', 'number', 'isolated', 'care', 'proves', 'unnecessary', 'We', 'investigated', 'the', 'potential', 'impact', 'of', 'molecular', 'point', 'of', 'care', 'POC', 'diagnostics', 'on', 'patient', 'management', 'and', 'in', 'hospital', 'costs', 'METHOD', 'Prospective', 'collection', 'of', 'data', 'on', 'resource', 'utilization', 'within', 'the', 'hospital', 'from', 'consecutive', 'patients', '18', 'years', 'or', 'older', 'presenting', 'at', 'our', 'university', 'medical', 'center', 'with', 'symptoms', 'of', 'respiratory', 'tract', 'infection', 'from', 'December', '2016', 'to', 'April', '2017', 'A', 'cost', 'analysis', 'was', 'conducted', 'using', 'Markov', 'modeling', 'comparing', 'the', 'actual', 'course', 'of', 'events', 'on', 'the', 'basis', 'of', 'routine', 'diagnostic', 'tests', 'with', 'two', 'hypothetical', 'scenarios', 'when', 'POC', 'would', 'impact', 'time', 'to', 'diagnosis', 'only', 'scenario', '1', 'or', 'on', 'discharge', 'from', 'the', 'hospital', 'too', 'scenario', '2', 'RESULTS', 'A', 'total', 'of', '283', 'patients', 'were', 'included', 'of', 'whom', '217', '76', '7', 'were', 'admitted', 'Influenza', 'and', 'RSV', 'were', 'detected', 'in', '31', 'and', '7', 'of', 'the', 'patients', 'respectively', 'Fifty', 'four', 'percent', 'of', 'patients', 'tested', 'negative', 'of', 'which', '79', 'were', 'kept', 'in', 'isolated', 'care', 'waiting', 'for', 'test', 'results', 'with', 'a', 'median', 'duration', 'of', '24', 'hours', 'Median', 'length', 'of', 'stay', 'was', '6', '0', 'days', 'Mean', 'total', 'in', 'hospital', 'costs', 'per', 'patient', 'were', '5243', 'Introducing', 'POC', 'would', 'lower', 'mean', 'costs', 'per', 'patient', 'to', '4904', 'scenario', '1', 'and', '4206', 'scenario', '2', 'At', 'the', 'hospital', 'level', 'this', 'would', 'result', 'in', 'a', 'total', 'cost', 'reduction', 'of', '95', '937', 'to', '293', '471', 'in', 'a', 'single', 'influenza', 'season', 'CONCLUSIONS', 'Introducing', 'POC', 'testing', 'for', 'patients', 'presenting', 'with', 'symptoms', 'of', 'viral', 'respiratory', 'tract', 'infection', 'can', 'reduce', 'time', 'to', 'diagnosis', 'hospital', 'stay', 'and', 'thereby', 'in', 'hospital', 'costs', '']"
191056,"Life beyond PCR: alternative target amplification technologies for the diagnosis of infectious diseases, part I 1 1 Editor's Note: Part II of this article will be published in the September 1 issue of CMN (vol. 26, no. 17).",2004-08-15,Clinical Microbiology Newsletter,https://api.elsevier.com/content/article/pii/S0196439904000297; https://doi.org/10.1016/j.clinmicnews.2004.08.001; https://www.ncbi.nlm.nih.gov/pubmed/32287673/; https://www.sciencedirect.com/science/article/pii/S0196439904000297,"Abstract Non-PCR-based target amplification technologies, including transcription-mediated amplification (TMA), nucleic acid sequence-based amplification (NASBA), and strand displacement amplification (SDA), are currently the basis for a broad range of clinical infectious-disease molecular diagnostics. These amplification technologies are very sensitive and specific and can be used in combination with traditional end-point or “real-time” detection formats. For several nucleic acid targets, TMA, NASBA, and SDA have certain advantages over PCR-based applications. This two-part article will review the molecular basis of each technology and how the technology has been applied to clinical diagnostic systems. The articles will describe the current testing platforms available, U.S. Food and Drug Administration (FDA)- and non-FDA-approved assays, and availability of analyte-specific reagents. In addition, an open-platform system is described that utilizes standardized reagents and methods and allows the user to develop in-house protocols. Finally, applications for the future are discussed.",10.1016/j.clinmicnews.2004.08.001,j33pov9p,"['Abstract', 'Non', 'PCR', 'based', 'target', 'amplification', 'technologies', 'including', 'transcription', 'mediated', 'amplification', 'TMA', 'nucleic', 'acid', 'sequence', 'based', 'amplification', 'NASBA', 'and', 'strand', 'displacement', 'amplification', 'SDA', 'are', 'currently', 'the', 'basis', 'for', 'a', 'broad', 'range', 'of', 'clinical', 'infectious', 'disease', 'molecular', 'diagnostics', 'These', 'amplification', 'technologies', 'are', 'very', 'sensitive', 'and', 'specific', 'and', 'can', 'be', 'used', 'in', 'combination', 'with', 'traditional', 'end', 'point', 'or', 'real', 'time', 'detection', 'formats', 'For', 'several', 'nucleic', 'acid', 'targets', 'TMA', 'NASBA', 'and', 'SDA', 'have', 'certain', 'advantages', 'over', 'PCR', 'based', 'applications', 'This', 'two', 'part', 'article', 'will', 'review', 'the', 'molecular', 'basis', 'of', 'each', 'technology', 'and', 'how', 'the', 'technology', 'has', 'been', 'applied', 'to', 'clinical', 'diagnostic', 'systems', 'The', 'articles', 'will', 'describe', 'the', 'current', 'testing', 'platforms', 'available', 'U', 'S', 'Food', 'and', 'Drug', 'Administration', 'FDA', 'and', 'non', 'FDA', 'approved', 'assays', 'and', 'availability', 'of', 'analyte', 'specific', 'reagents', 'In', 'addition', 'an', 'open', 'platform', 'system', 'is', 'described', 'that', 'utilizes', 'standardized', 'reagents', 'and', 'methods', 'and', 'allows', 'the', 'user', 'to', 'develop', 'in', 'house', 'protocols', 'Finally', 'applications', 'for', 'the', 'future', 'are', 'discussed', '']"
191454,Conventional and molecular diagnostic testing for the acute neurologic patient,2010-02-08,J Vet Emerg Crit Care (San Antonio),https://doi.org/10.1111/j.1476-4431.2009.00495.x; https://www.ncbi.nlm.nih.gov/pubmed/20230434/,"Objective – The aim of this review is to describe and evaluate both conventional and molecular diagnostic testing utilized in dogs and cats with acute neurologic diseases. Various types of polymerase chain reaction (PCR) are explored along with novel molecular diagnostic testing that ultimately may prove useful in the critical care setting. Data Sources – PUBMED was searched to obtain relevant references material using keywords: ‘canine OR feline meningitis AND meningoencephalitis,’‘feline infectious peritonitis,’‘canine distemper,’‘canine OR feline AND toxoplasma,’‘canine neospora,’‘canine OR feline AND rickettsia,’‘granulomatous meningoencephalitis,’‘steroid responsive meningitis arteritis,’‘necrotizing encephalitis,’‘novel neurodiagnostics,’‘canine OR feline AND CNS borrelia,’‘canine OR feline AND CNS bartonella,’‘canine OR feline AND CNS fungal,’‘nested OR multiplex OR degenerate OR consensus OR CODEHOP AND PCR.’ Research findings from the authors' laboratory and current veterinary textbooks also were utilized. Human Data Synthesis – Molecular diagnostic testing including conventional, real‐time, and consensus and degenerate PCR and microarray analysis are utilized routinely for the antemortem diagnosis of infectious meningoencephalitis (ME) in humans. Recently, PCR using consensus degenerate hybrid primers (CODEHOP) has been used to identify and characterize a number of novel human viruses. Veterinary Data Synthesis – Molecular diagnostic testing such as conventional and real‐time PCR aid in the diagnosis of several important central nervous system infectious agents including canine distemper virus, Toxoplasma gondii, Neospora caninum, rickettsial species, and others. Recently, broadly reactive consensus and degenerate PCR reactions have been applied to canine ME including assays for rickettsial organisms, Borrelia spp. and Bartonella spp., and various viral families. Conclusions – In the acute neurologic patient, there are several key infectious diseases that can be pursued by a combination of conventional and molecular diagnostic testing. It is important that the clinician understands the utility, as well as the limitations, of the various neurodiagnostic tests that are available.",10.1111/j.1476-4431.2009.00495.x,iwc1wdew,"['Objective', 'The', 'aim', 'of', 'this', 'review', 'is', 'to', 'describe', 'and', 'evaluate', 'both', 'conventional', 'and', 'molecular', 'diagnostic', 'testing', 'utilized', 'in', 'dogs', 'and', 'cats', 'with', 'acute', 'neurologic', 'diseases', 'Various', 'types', 'of', 'polymerase', 'chain', 'reaction', 'PCR', 'are', 'explored', 'along', 'with', 'novel', 'molecular', 'diagnostic', 'testing', 'that', 'ultimately', 'may', 'prove', 'useful', 'in', 'the', 'critical', 'care', 'setting', 'Data', 'Sources', 'PUBMED', 'was', 'searched', 'to', 'obtain', 'relevant', 'references', 'material', 'using', 'keywords', 'canine', 'OR', 'feline', 'meningitis', 'AND', 'meningoencephalitis', 'feline', 'infectious', 'peritonitis', 'canine', 'distemper', 'canine', 'OR', 'feline', 'AND', 'toxoplasma', 'canine', 'neospora', 'canine', 'OR', 'feline', 'AND', 'rickettsia', 'granulomatous', 'meningoencephalitis', 'steroid', 'responsive', 'meningitis', 'arteritis', 'necrotizing', 'encephalitis', 'novel', 'neurodiagnostics', 'canine', 'OR', 'feline', 'AND', 'CNS', 'borrelia', 'canine', 'OR', 'feline', 'AND', 'CNS', 'bartonella', 'canine', 'OR', 'feline', 'AND', 'CNS', 'fungal', 'nested', 'OR', 'multiplex', 'OR', 'degenerate', 'OR', 'consensus', 'OR', 'CODEHOP', 'AND', 'PCR', 'Research', 'findings', 'from', 'the', 'authors', 'laboratory', 'and', 'current', 'veterinary', 'textbooks', 'also', 'were', 'utilized', 'Human', 'Data', 'Synthesis', 'Molecular', 'diagnostic', 'testing', 'including', 'conventional', 'real', 'time', 'and', 'consensus', 'and', 'degenerate', 'PCR', 'and', 'microarray', 'analysis', 'are', 'utilized', 'routinely', 'for', 'the', 'antemortem', 'diagnosis', 'of', 'infectious', 'meningoencephalitis', 'ME', 'in', 'humans', 'Recently', 'PCR', 'using', 'consensus', 'degenerate', 'hybrid', 'primers', 'CODEHOP', 'has', 'been', 'used', 'to', 'identify', 'and', 'characterize', 'a', 'number', 'of', 'novel', 'human', 'viruses', 'Veterinary', 'Data', 'Synthesis', 'Molecular', 'diagnostic', 'testing', 'such', 'as', 'conventional', 'and', 'real', 'time', 'PCR', 'aid', 'in', 'the', 'diagnosis', 'of', 'several', 'important', 'central', 'nervous', 'system', 'infectious', 'agents', 'including', 'canine', 'distemper', 'virus', 'Toxoplasma', 'gondii', 'Neospora', 'caninum', 'rickettsial', 'species', 'and', 'others', 'Recently', 'broadly', 'reactive', 'consensus', 'and', 'degenerate', 'PCR', 'reactions', 'have', 'been', 'applied', 'to', 'canine', 'ME', 'including', 'assays', 'for', 'rickettsial', 'organisms', 'Borrelia', 'spp', 'and', 'Bartonella', 'spp', 'and', 'various', 'viral', 'families', 'Conclusions', 'In', 'the', 'acute', 'neurologic', 'patient', 'there', 'are', 'several', 'key', 'infectious', 'diseases', 'that', 'can', 'be', 'pursued', 'by', 'a', 'combination', 'of', 'conventional', 'and', 'molecular', 'diagnostic', 'testing', 'It', 'is', 'important', 'that', 'the', 'clinician', 'understands', 'the', 'utility', 'as', 'well', 'as', 'the', 'limitations', 'of', 'the', 'various', 'neurodiagnostic', 'tests', 'that', 'are', 'available', '']"
191904,Evaluation of Patients with Community‐Acquired Pneumonia Caused by Zoonotic Pathogens in an Area with a High Density of Animal Farms,2015-07-27,Zoonoses Public Health,https://doi.org/10.1111/zph.12218; https://www.ncbi.nlm.nih.gov/pubmed/26214299/,"Intensive animal farming could potentially lead to outbreaks of infectious diseases. Clinicians are at the forefront of detecting unusual diseases, but the lack of specificity of zoonotic disease symptoms makes this a challenging task. We evaluated patients with community‐acquired pneumonia (CAP) with known and unknown aetiology in an area with a high livestock density and a potential association with animal farms in the proximity. Between 2008 and 2009, a period coinciding with a large Q fever outbreak in the Netherlands, patients with CAP were tested for the presence of possible respiratory pathogens. The presence and number of farm animals within 1 km of the patients' home address were assessed using geographic information system (GIS) and were compared between cases and age‐matched control subjects. Of 408 patients with CAP, pathogens were detected in 275 (67.4%) patients. The presence of sheep and the number of goats were associated with CAP caused by Coxiella burnetii in a multiple logistic regression model (P < 0.05). CAP with unknown aetiology was not associated with the presence of animal farms (P > 0.10). The use of GIS in combination with aetiology of CAP could be potentially used to target diagnostics and to identify outbreaks of rare zoonotic disease.",10.1111/zph.12218,elwfiima,"['Intensive', 'animal', 'farming', 'could', 'potentially', 'lead', 'to', 'outbreaks', 'of', 'infectious', 'diseases', 'Clinicians', 'are', 'at', 'the', 'forefront', 'of', 'detecting', 'unusual', 'diseases', 'but', 'the', 'lack', 'of', 'specificity', 'of', 'zoonotic', 'disease', 'symptoms', 'makes', 'this', 'a', 'challenging', 'task', 'We', 'evaluated', 'patients', 'with', 'community', 'acquired', 'pneumonia', 'CAP', 'with', 'known', 'and', 'unknown', 'aetiology', 'in', 'an', 'area', 'with', 'a', 'high', 'livestock', 'density', 'and', 'a', 'potential', 'association', 'with', 'animal', 'farms', 'in', 'the', 'proximity', 'Between', '2008', 'and', '2009', 'a', 'period', 'coinciding', 'with', 'a', 'large', 'Q', 'fever', 'outbreak', 'in', 'the', 'Netherlands', 'patients', 'with', 'CAP', 'were', 'tested', 'for', 'the', 'presence', 'of', 'possible', 'respiratory', 'pathogens', 'The', 'presence', 'and', 'number', 'of', 'farm', 'animals', 'within', '1', 'km', 'of', 'the', 'patients', 'home', 'address', 'were', 'assessed', 'using', 'geographic', 'information', 'system', 'GIS', 'and', 'were', 'compared', 'between', 'cases', 'and', 'age', 'matched', 'control', 'subjects', 'Of', '408', 'patients', 'with', 'CAP', 'pathogens', 'were', 'detected', 'in', '275', '67', '4', 'patients', 'The', 'presence', 'of', 'sheep', 'and', 'the', 'number', 'of', 'goats', 'were', 'associated', 'with', 'CAP', 'caused', 'by', 'Coxiella', 'burnetii', 'in', 'a', 'multiple', 'logistic', 'regression', 'model', 'P', '0', '05', 'CAP', 'with', 'unknown', 'aetiology', 'was', 'not', 'associated', 'with', 'the', 'presence', 'of', 'animal', 'farms', 'P', '0', '10', 'The', 'use', 'of', 'GIS', 'in', 'combination', 'with', 'aetiology', 'of', 'CAP', 'could', 'be', 'potentially', 'used', 'to', 'target', 'diagnostics', 'and', 'to', 'identify', 'outbreaks', 'of', 'rare', 'zoonotic', 'disease', '']"
192071,Searching for the elusive typhoid diagnostic,2010-03-05,BMC Infect Dis,https://doi.org/10.1186/1471-2334-10-45; https://www.ncbi.nlm.nih.gov/pubmed/20205702/,"Typhoid (enteric) fever is still a common disease in many developing countries but current diagnostic tests are inadequate. Studies on pathogenesis and genomics have provided new insight into the organisms that cause enteric fever. Better understanding of the microorganisms explains, in part, why our current typhoid methodologies are limited in their diagnostic information and why developing new strategies may be a considerable challenge. Here we discuss the current position of typhoid diagnostics, highlight the need for technological improvements and suggest potential ways of advancing this area.",10.1186/1471-2334-10-45,ipg1vwmv,"['Typhoid', 'enteric', 'fever', 'is', 'still', 'a', 'common', 'disease', 'in', 'many', 'developing', 'countries', 'but', 'current', 'diagnostic', 'tests', 'are', 'inadequate', 'Studies', 'on', 'pathogenesis', 'and', 'genomics', 'have', 'provided', 'new', 'insight', 'into', 'the', 'organisms', 'that', 'cause', 'enteric', 'fever', 'Better', 'understanding', 'of', 'the', 'microorganisms', 'explains', 'in', 'part', 'why', 'our', 'current', 'typhoid', 'methodologies', 'are', 'limited', 'in', 'their', 'diagnostic', 'information', 'and', 'why', 'developing', 'new', 'strategies', 'may', 'be', 'a', 'considerable', 'challenge', 'Here', 'we', 'discuss', 'the', 'current', 'position', 'of', 'typhoid', 'diagnostics', 'highlight', 'the', 'need', 'for', 'technological', 'improvements', 'and', 'suggest', 'potential', 'ways', 'of', 'advancing', 'this', 'area', '']"
192327,Seasonality and prevalence of respiratory pathogens detected by multiplex PCR at a tertiary care medical center,2013-07-24,Arch Virol,https://www.ncbi.nlm.nih.gov/pubmed/23881085/; https://doi.org/10.1007/s00705-013-1794-4,"Respiratory tract infections (RTIs) are a leading cause of mortality and morbidity. Seasonality has been reported for many viruses, including influenza virus, respiratory syncytial virus (RSV), and the recently described human metapneumovirus (hMPV). We hypothesize that the availability of rapid, multiplex PCR diagnostics will provide better clinical care and new insights into the etiology and clinical spectrum of RTIs. We conducted a retrospective analysis of the incidence of respiratory pathogens at a 500-bed adult and 154-bed pediatric hospital tertiary care center. A total of 939 specimens from patients with an age range of 5 days to 91 years (median, 2 years) were tested by a multiplex respiratory pathogen PCR from November 14, 2011 to November 13, 2012. Sixty-five percent of specimens were positive for at least one pathogen. As the age of the patient increased, the positivity rate for the PCR decreased proportionately. Rhinoviruses/enteroviruses (Rhino/Entero) were the most prevalent (34.3 %) followed by RSV (19.2 %) and hMPV (6.2 %). Twelve percent of the positive samples were positive for multiple analytes, with Rhino/Entero and RSV being the most common combination. The peak months were September and May for Rhino/Entero infections, January for RSV and February for coronavirus. hMPV peaked 2 months after RSV, as has been observed recently in other studies. Multiplex PCR provides rapid diagnostic information that can be used to make knowledgeable clinical decisions and potentially reduce the use of antibiotics. Active respiratory PCR surveillance could also predict seasonal respiratory epidemics to allow for adequate planning of additional infection control measures.",10.1007/s00705-013-1794-4,0evqo01m,"['Respiratory', 'tract', 'infections', 'RTIs', 'are', 'a', 'leading', 'cause', 'of', 'mortality', 'and', 'morbidity', 'Seasonality', 'has', 'been', 'reported', 'for', 'many', 'viruses', 'including', 'influenza', 'virus', 'respiratory', 'syncytial', 'virus', 'RSV', 'and', 'the', 'recently', 'described', 'human', 'metapneumovirus', 'hMPV', 'We', 'hypothesize', 'that', 'the', 'availability', 'of', 'rapid', 'multiplex', 'PCR', 'diagnostics', 'will', 'provide', 'better', 'clinical', 'care', 'and', 'new', 'insights', 'into', 'the', 'etiology', 'and', 'clinical', 'spectrum', 'of', 'RTIs', 'We', 'conducted', 'a', 'retrospective', 'analysis', 'of', 'the', 'incidence', 'of', 'respiratory', 'pathogens', 'at', 'a', '500', 'bed', 'adult', 'and', '154', 'bed', 'pediatric', 'hospital', 'tertiary', 'care', 'center', 'A', 'total', 'of', '939', 'specimens', 'from', 'patients', 'with', 'an', 'age', 'range', 'of', '5', 'days', 'to', '91', 'years', 'median', '2', 'years', 'were', 'tested', 'by', 'a', 'multiplex', 'respiratory', 'pathogen', 'PCR', 'from', 'November', '14', '2011', 'to', 'November', '13', '2012', 'Sixty', 'five', 'percent', 'of', 'specimens', 'were', 'positive', 'for', 'at', 'least', 'one', 'pathogen', 'As', 'the', 'age', 'of', 'the', 'patient', 'increased', 'the', 'positivity', 'rate', 'for', 'the', 'PCR', 'decreased', 'proportionately', 'Rhinoviruses', 'enteroviruses', 'Rhino', 'Entero', 'were', 'the', 'most', 'prevalent', '34', '3', 'followed', 'by', 'RSV', '19', '2', 'and', 'hMPV', '6', '2', 'Twelve', 'percent', 'of', 'the', 'positive', 'samples', 'were', 'positive', 'for', 'multiple', 'analytes', 'with', 'Rhino', 'Entero', 'and', 'RSV', 'being', 'the', 'most', 'common', 'combination', 'The', 'peak', 'months', 'were', 'September', 'and', 'May', 'for', 'Rhino', 'Entero', 'infections', 'January', 'for', 'RSV', 'and', 'February', 'for', 'coronavirus', 'hMPV', 'peaked', '2', 'months', 'after', 'RSV', 'as', 'has', 'been', 'observed', 'recently', 'in', 'other', 'studies', 'Multiplex', 'PCR', 'provides', 'rapid', 'diagnostic', 'information', 'that', 'can', 'be', 'used', 'to', 'make', 'knowledgeable', 'clinical', 'decisions', 'and', 'potentially', 'reduce', 'the', 'use', 'of', 'antibiotics', 'Active', 'respiratory', 'PCR', 'surveillance', 'could', 'also', 'predict', 'seasonal', 'respiratory', 'epidemics', 'to', 'allow', 'for', 'adequate', 'planning', 'of', 'additional', 'infection', 'control', 'measures', '']"
193077,Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samples,2017-08-08,Microbiome,https://www.ncbi.nlm.nih.gov/pubmed/28789678/; https://doi.org/10.1186/s40168-017-0317-z,"BACKGROUND: Sequence-specific PCR is the most common approach for virus identification in diagnostic laboratories. However, as specific PCR only detects pre-defined targets, novel virus strains or viruses not included in routine test panels will be missed. Recently, advances in high-throughput sequencing allow for virus-sequence-independent identification of entire virus populations in clinical samples, yet standardized protocols are needed to allow broad application in clinical diagnostics. Here, we describe a comprehensive sample preparation protocol for high-throughput metagenomic virus sequencing using random amplification of total nucleic acids from clinical samples. RESULTS: In order to optimize metagenomic sequencing for application in virus diagnostics, we tested different enrichment and amplification procedures on plasma samples spiked with RNA and DNA viruses. A protocol including filtration, nuclease digestion, and random amplification of RNA and DNA in separate reactions provided the best results, allowing reliable recovery of viral genomes and a good correlation of the relative number of sequencing reads with the virus input. We further validated our method by sequencing a multiplexed viral pathogen reagent containing a range of human viruses from different virus families. Our method proved successful in detecting the majority of the included viruses with high read numbers and compared well to other protocols in the field validated against the same reference reagent. Our sequencing protocol does work not only with plasma but also with other clinical samples such as urine and throat swabs. CONCLUSIONS: The workflow for virus metagenomic sequencing that we established proved successful in detecting a variety of viruses in different clinical samples. Our protocol supplements existing virus-specific detection strategies providing opportunities to identify atypical and novel viruses commonly not accounted for in routine diagnostic panels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-017-0317-z) contains supplementary material, which is available to authorized users.",10.1186/s40168-017-0317-z,3jxyipbn,"['BACKGROUND', 'Sequence', 'specific', 'PCR', 'is', 'the', 'most', 'common', 'approach', 'for', 'virus', 'identification', 'in', 'diagnostic', 'laboratories', 'However', 'as', 'specific', 'PCR', 'only', 'detects', 'pre', 'defined', 'targets', 'novel', 'virus', 'strains', 'or', 'viruses', 'not', 'included', 'in', 'routine', 'test', 'panels', 'will', 'be', 'missed', 'Recently', 'advances', 'in', 'high', 'throughput', 'sequencing', 'allow', 'for', 'virus', 'sequence', 'independent', 'identification', 'of', 'entire', 'virus', 'populations', 'in', 'clinical', 'samples', 'yet', 'standardized', 'protocols', 'are', 'needed', 'to', 'allow', 'broad', 'application', 'in', 'clinical', 'diagnostics', 'Here', 'we', 'describe', 'a', 'comprehensive', 'sample', 'preparation', 'protocol', 'for', 'high', 'throughput', 'metagenomic', 'virus', 'sequencing', 'using', 'random', 'amplification', 'of', 'total', 'nucleic', 'acids', 'from', 'clinical', 'samples', 'RESULTS', 'In', 'order', 'to', 'optimize', 'metagenomic', 'sequencing', 'for', 'application', 'in', 'virus', 'diagnostics', 'we', 'tested', 'different', 'enrichment', 'and', 'amplification', 'procedures', 'on', 'plasma', 'samples', 'spiked', 'with', 'RNA', 'and', 'DNA', 'viruses', 'A', 'protocol', 'including', 'filtration', 'nuclease', 'digestion', 'and', 'random', 'amplification', 'of', 'RNA', 'and', 'DNA', 'in', 'separate', 'reactions', 'provided', 'the', 'best', 'results', 'allowing', 'reliable', 'recovery', 'of', 'viral', 'genomes', 'and', 'a', 'good', 'correlation', 'of', 'the', 'relative', 'number', 'of', 'sequencing', 'reads', 'with', 'the', 'virus', 'input', 'We', 'further', 'validated', 'our', 'method', 'by', 'sequencing', 'a', 'multiplexed', 'viral', 'pathogen', 'reagent', 'containing', 'a', 'range', 'of', 'human', 'viruses', 'from', 'different', 'virus', 'families', 'Our', 'method', 'proved', 'successful', 'in', 'detecting', 'the', 'majority', 'of', 'the', 'included', 'viruses', 'with', 'high', 'read', 'numbers', 'and', 'compared', 'well', 'to', 'other', 'protocols', 'in', 'the', 'field', 'validated', 'against', 'the', 'same', 'reference', 'reagent', 'Our', 'sequencing', 'protocol', 'does', 'work', 'not', 'only', 'with', 'plasma', 'but', 'also', 'with', 'other', 'clinical', 'samples', 'such', 'as', 'urine', 'and', 'throat', 'swabs', 'CONCLUSIONS', 'The', 'workflow', 'for', 'virus', 'metagenomic', 'sequencing', 'that', 'we', 'established', 'proved', 'successful', 'in', 'detecting', 'a', 'variety', 'of', 'viruses', 'in', 'different', 'clinical', 'samples', 'Our', 'protocol', 'supplements', 'existing', 'virus', 'specific', 'detection', 'strategies', 'providing', 'opportunities', 'to', 'identify', 'atypical', 'and', 'novel', 'viruses', 'commonly', 'not', 'accounted', 'for', 'in', 'routine', 'diagnostic', 'panels', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1186', 's40168', '017', '0317', 'z', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
193407,Point-of-care diagnostics for respiratory viral infections,2017-12-26,Expert Rev Mol Diagn,https://www.ncbi.nlm.nih.gov/pubmed/29251007/; https://doi.org/10.1080/14737159.2018.1419065,"Introduction: Successful treatment outcomes for viral respiratory tract infections presenting from primary health care to quaternary hospitals will only be achieved with rapid, sensitive and specific identification of pathogens to allow effective pathogen-specific antiviral therapy and infection control measures. Areas covered: This review aims to explore the different point-of-care tests currently available to diagnose viral respiratory tract infections, discuss the advantages and limitations of point-of-care testing, and provide insights into the future of point-of-care tests. The following databases were searched: Medline (January 1996 to 30 September 2017) and Embase (1988 to 30 September 2017), using the following keywords: ‘point of care’, ‘respiratory virus’, ‘influenza’, ‘RSV’, ‘diagnostics’, ‘nucleic acid test’ and ‘PCR’. Expert commentary: Viral respiratory tract infections cause significant morbidity and mortality worldwide, and point-of-care tests are facilitating the rapid identification of the pathogen responsible given the similarities in clinical presentation.",10.1080/14737159.2018.1419065,tk1q4wkp,"['Introduction', 'Successful', 'treatment', 'outcomes', 'for', 'viral', 'respiratory', 'tract', 'infections', 'presenting', 'from', 'primary', 'health', 'care', 'to', 'quaternary', 'hospitals', 'will', 'only', 'be', 'achieved', 'with', 'rapid', 'sensitive', 'and', 'specific', 'identification', 'of', 'pathogens', 'to', 'allow', 'effective', 'pathogen', 'specific', 'antiviral', 'therapy', 'and', 'infection', 'control', 'measures', 'Areas', 'covered', 'This', 'review', 'aims', 'to', 'explore', 'the', 'different', 'point', 'of', 'care', 'tests', 'currently', 'available', 'to', 'diagnose', 'viral', 'respiratory', 'tract', 'infections', 'discuss', 'the', 'advantages', 'and', 'limitations', 'of', 'point', 'of', 'care', 'testing', 'and', 'provide', 'insights', 'into', 'the', 'future', 'of', 'point', 'of', 'care', 'tests', 'The', 'following', 'databases', 'were', 'searched', 'Medline', 'January', '1996', 'to', '30', 'September', '2017', 'and', 'Embase', '1988', 'to', '30', 'September', '2017', 'using', 'the', 'following', 'keywords', 'point', 'of', 'care', 'respiratory', 'virus', 'influenza', 'RSV', 'diagnostics', 'nucleic', 'acid', 'test', 'and', 'PCR', 'Expert', 'commentary', 'Viral', 'respiratory', 'tract', 'infections', 'cause', 'significant', 'morbidity', 'and', 'mortality', 'worldwide', 'and', 'point', 'of', 'care', 'tests', 'are', 'facilitating', 'the', 'rapid', 'identification', 'of', 'the', 'pathogen', 'responsible', 'given', 'the', 'similarities', 'in', 'clinical', 'presentation', '']"
193555,Continuous Invasion by Respiratory Viruses Observed in Rural Households During a Respiratory Syncytial Virus Seasonal Outbreak in Coastal Kenya,2018-11-15,Clin Infect Dis,https://doi.org/10.1093/cid/ciy313; https://www.ncbi.nlm.nih.gov/pubmed/29668861/,"BACKGROUND: Households are high-intensity close-contact environments favorable for transmission of respiratory viruses, yet little is known for low-income settings. METHODS: Active surveillance was completed on 47 households in rural coastal Kenya over 6 months during a respiratory syncytial virus (RSV) season. Nasopharyngeal swabs (NPSs) were taken from 483 household members twice weekly irrespective of symptoms. Using molecular diagnostics, NPSs from 6 households were screened for 15 respiratory viruses and the remainder of households only for the most frequent viruses observed: rhinovirus (RV), human coronavirus (HCoV; comprising strains 229E, OC43, and NL63), adenovirus (AdV), and RSV (A and B). RESULTS: Of 16928 NPSs tested for the common viruses, 4259 (25.2%) were positive for ≥1 target; 596 (13.8%) had coinfections. Detection frequencies were 10.5% RV (1780), 7.5% HCoV (1274), 7.3% AdV (1232), and 3.2% RSV (537). On average, each household and individual had 6 and 3 different viruses detected over the study period, respectively. Rhinovirus and HCoV were detected in all the 47 households while AdV and RSV were detected in 45 (95.7%) and 40 (85.1%) households, respectively. The individual risk of infection over the 6-month period was 93.4%, 80.1%, 71.6%, 61.5%, and 37.1% for any virus, RV, HCoV, AdV, and RSV, respectively. NPSs collected during symptomatic days and from younger age groups had higher prevalence of virus detection relative to respective counterparts. RSV was underrepresented in households relative to hospital admission data. CONCLUSIONS: In this household setting, respiratory virus infections and associated illness are ubiquitous. Future studies should address the health and economic implications of these observations.",10.1093/cid/ciy313,u3wyyks1,"['BACKGROUND', 'Households', 'are', 'high', 'intensity', 'close', 'contact', 'environments', 'favorable', 'for', 'transmission', 'of', 'respiratory', 'viruses', 'yet', 'little', 'is', 'known', 'for', 'low', 'income', 'settings', 'METHODS', 'Active', 'surveillance', 'was', 'completed', 'on', '47', 'households', 'in', 'rural', 'coastal', 'Kenya', 'over', '6', 'months', 'during', 'a', 'respiratory', 'syncytial', 'virus', 'RSV', 'season', 'Nasopharyngeal', 'swabs', 'NPSs', 'were', 'taken', 'from', '483', 'household', 'members', 'twice', 'weekly', 'irrespective', 'of', 'symptoms', 'Using', 'molecular', 'diagnostics', 'NPSs', 'from', '6', 'households', 'were', 'screened', 'for', '15', 'respiratory', 'viruses', 'and', 'the', 'remainder', 'of', 'households', 'only', 'for', 'the', 'most', 'frequent', 'viruses', 'observed', 'rhinovirus', 'RV', 'human', 'coronavirus', 'HCoV', 'comprising', 'strains', '229E', 'OC43', 'and', 'NL63', 'adenovirus', 'AdV', 'and', 'RSV', 'A', 'and', 'B', 'RESULTS', 'Of', '16928', 'NPSs', 'tested', 'for', 'the', 'common', 'viruses', '4259', '25', '2', 'were', 'positive', 'for', '1', 'target', '596', '13', '8', 'had', 'coinfections', 'Detection', 'frequencies', 'were', '10', '5', 'RV', '1780', '7', '5', 'HCoV', '1274', '7', '3', 'AdV', '1232', 'and', '3', '2', 'RSV', '537', 'On', 'average', 'each', 'household', 'and', 'individual', 'had', '6', 'and', '3', 'different', 'viruses', 'detected', 'over', 'the', 'study', 'period', 'respectively', 'Rhinovirus', 'and', 'HCoV', 'were', 'detected', 'in', 'all', 'the', '47', 'households', 'while', 'AdV', 'and', 'RSV', 'were', 'detected', 'in', '45', '95', '7', 'and', '40', '85', '1', 'households', 'respectively', 'The', 'individual', 'risk', 'of', 'infection', 'over', 'the', '6', 'month', 'period', 'was', '93', '4', '80', '1', '71', '6', '61', '5', 'and', '37', '1', 'for', 'any', 'virus', 'RV', 'HCoV', 'AdV', 'and', 'RSV', 'respectively', 'NPSs', 'collected', 'during', 'symptomatic', 'days', 'and', 'from', 'younger', 'age', 'groups', 'had', 'higher', 'prevalence', 'of', 'virus', 'detection', 'relative', 'to', 'respective', 'counterparts', 'RSV', 'was', 'underrepresented', 'in', 'households', 'relative', 'to', 'hospital', 'admission', 'data', 'CONCLUSIONS', 'In', 'this', 'household', 'setting', 'respiratory', 'virus', 'infections', 'and', 'associated', 'illness', 'are', 'ubiquitous', 'Future', 'studies', 'should', 'address', 'the', 'health', 'and', 'economic', 'implications', 'of', 'these', 'observations', '']"
193681,Diagnostic microbiologique : du diagnostic par étiologie au diagnostic par syndrome,2009-02-28,Antibiotiques,https://www.sciencedirect.com/science/article/pii/S129455010800109X; https://api.elsevier.com/content/article/pii/S129455010800109X,"Résumé Objectifs Depuis les dix dernières années, l’introduction de la biologie moléculaire et l’automatisation ont radicalement changé les pratiques dans les laboratoires de microbiologie clinique. L’amélioration de la communication entre les microbiologistes et les cliniciens ainsi que les évolutions technologiques telles que la standardisation et le développement de tests diagnostics plus rapides ont conduit à une réorganisation des laboratoires de microbiologie. Méthodes Jusqu’à présent la prescription des examens ciblait un diagnostic étiologique précis, actuellement l’évolution se fait vers le diagnostic par syndrome incluant un panel de tests regroupant les étiologies responsables d’un syndrome donné y compris les pathogènes émergents. Résultats et conclusions Dans cette revue, nous avons résumé les développements technologiques les plus récents en matière de diagnostic microbiologique adapté au diagnostic par syndrome incluant les stratégies de diagnostic exhaustif, les DNA microarray et les microarray antigéniques. Summary Objectives Over the past decade, the introduction of techniques of molecular biology and the automation have undergone important changes in the practice of clinical microbiological laboratories. Methods Commonly, physician prescriptions are etiology driven for emerging infectious agent. The improving in test standardization and rapidity and the best communication between physician and clinical microbiologist lead to profound changes in microbiology laboratories. Results and conclusion The present review summarizes the recent development in multiplexed microbiological technology adapted to syndrome driven diagnosis, including sampling strategy, DNA microarray and antigenic microarray.",10.1016/j.antib.2008.10.002,sgtw5lxt,"['Résumé', 'Objectifs', 'Depuis', 'les', 'dix', 'dernières', 'années', 'l', 'introduction', 'de', 'la', 'biologie', 'moléculaire', 'et', 'l', 'automatisation', 'ont', 'radicalement', 'changé', 'les', 'pratiques', 'dans', 'les', 'laboratoires', 'de', 'microbiologie', 'clinique', 'L', 'amélioration', 'de', 'la', 'communication', 'entre', 'les', 'microbiologistes', 'et', 'les', 'cliniciens', 'ainsi', 'que', 'les', 'évolutions', 'technologiques', 'telles', 'que', 'la', 'standardisation', 'et', 'le', 'développement', 'de', 'tests', 'diagnostics', 'plus', 'rapides', 'ont', 'conduit', 'à', 'une', 'réorganisation', 'des', 'laboratoires', 'de', 'microbiologie', 'Méthodes', 'Jusqu', 'à', 'présent', 'la', 'prescription', 'des', 'examens', 'ciblait', 'un', 'diagnostic', 'étiologique', 'précis', 'actuellement', 'l', 'évolution', 'se', 'fait', 'vers', 'le', 'diagnostic', 'par', 'syndrome', 'incluant', 'un', 'panel', 'de', 'tests', 'regroupant', 'les', 'étiologies', 'responsables', 'd', 'un', 'syndrome', 'donné', 'y', 'compris', 'les', 'pathogènes', 'émergents', 'Résultats', 'et', 'conclusions', 'Dans', 'cette', 'revue', 'nous', 'avons', 'résumé', 'les', 'développements', 'technologiques', 'les', 'plus', 'récents', 'en', 'matière', 'de', 'diagnostic', 'microbiologique', 'adapté', 'au', 'diagnostic', 'par', 'syndrome', 'incluant', 'les', 'stratégies', 'de', 'diagnostic', 'exhaustif', 'les', 'DNA', 'microarray', 'et', 'les', 'microarray', 'antigéniques', 'Summary', 'Objectives', 'Over', 'the', 'past', 'decade', 'the', 'introduction', 'of', 'techniques', 'of', 'molecular', 'biology', 'and', 'the', 'automation', 'have', 'undergone', 'important', 'changes', 'in', 'the', 'practice', 'of', 'clinical', 'microbiological', 'laboratories', 'Methods', 'Commonly', 'physician', 'prescriptions', 'are', 'etiology', 'driven', 'for', 'emerging', 'infectious', 'agent', 'The', 'improving', 'in', 'test', 'standardization', 'and', 'rapidity', 'and', 'the', 'best', 'communication', 'between', 'physician', 'and', 'clinical', 'microbiologist', 'lead', 'to', 'profound', 'changes', 'in', 'microbiology', 'laboratories', 'Results', 'and', 'conclusion', 'The', 'present', 'review', 'summarizes', 'the', 'recent', 'development', 'in', 'multiplexed', 'microbiological', 'technology', 'adapted', 'to', 'syndrome', 'driven', 'diagnosis', 'including', 'sampling', 'strategy', 'DNA', 'microarray', 'and', 'antigenic', 'microarray', '']"
193727,The Diagnosis of Viral Respiratory Disease in Older Adults,2010-02-01,Clinical Infectious Diseases,https://doi.org/10.1086/650486; https://www.ncbi.nlm.nih.gov/pubmed/20121411/; https://academic.oup.com/cid/article-pdf/50/5/747/932198/50-5-747.pdf,"Viral respiratory disease in older adults has been increasingly recognized as a significant cause of hospitalizations and death. Unfortunately, the recognition and diagnosis of infection due to many viral respiratory pathogens in older adults can be elusive due to atypical clinical presentations and the insensitivity of current laboratory diagnostic tests in this population. For influenza diagnosis, rapid antigen tests followed by viral culture if negative, can be useful in older adults as long as clinicians are mindful of test limitations. Although specific, rapid antigen tests are insensitive in this population. Erroneous negative results may lead to delays in timely administration of antiviral treatment and institution of appropriate isolation precautions. The increasing availability of new rapid and sensitive molecular diagnostics such as polymerase chain reaction testing, should provide more accurate and timely diagnoses of viral respiratory infections in older adults in the near future.",10.1086/650486,qdgqif5j,"['Viral', 'respiratory', 'disease', 'in', 'older', 'adults', 'has', 'been', 'increasingly', 'recognized', 'as', 'a', 'significant', 'cause', 'of', 'hospitalizations', 'and', 'death', 'Unfortunately', 'the', 'recognition', 'and', 'diagnosis', 'of', 'infection', 'due', 'to', 'many', 'viral', 'respiratory', 'pathogens', 'in', 'older', 'adults', 'can', 'be', 'elusive', 'due', 'to', 'atypical', 'clinical', 'presentations', 'and', 'the', 'insensitivity', 'of', 'current', 'laboratory', 'diagnostic', 'tests', 'in', 'this', 'population', 'For', 'influenza', 'diagnosis', 'rapid', 'antigen', 'tests', 'followed', 'by', 'viral', 'culture', 'if', 'negative', 'can', 'be', 'useful', 'in', 'older', 'adults', 'as', 'long', 'as', 'clinicians', 'are', 'mindful', 'of', 'test', 'limitations', 'Although', 'specific', 'rapid', 'antigen', 'tests', 'are', 'insensitive', 'in', 'this', 'population', 'Erroneous', 'negative', 'results', 'may', 'lead', 'to', 'delays', 'in', 'timely', 'administration', 'of', 'antiviral', 'treatment', 'and', 'institution', 'of', 'appropriate', 'isolation', 'precautions', 'The', 'increasing', 'availability', 'of', 'new', 'rapid', 'and', 'sensitive', 'molecular', 'diagnostics', 'such', 'as', 'polymerase', 'chain', 'reaction', 'testing', 'should', 'provide', 'more', 'accurate', 'and', 'timely', 'diagnoses', 'of', 'viral', 'respiratory', 'infections', 'in', 'older', 'adults', 'in', 'the', 'near', 'future', '']"
194654,Enrichment of Viral Nucleic Acids by Solution Hybrid Selection with Genus Specific Oligonucleotides,2017-08-29,Sci Rep,https://www.ncbi.nlm.nih.gov/pubmed/28852181/; https://doi.org/10.1038/s41598-017-10342-w,"Despite recent advances, our knowledge of potential and rare human pathogens is far from exhaustive. Current molecular diagnostic tools mainly rely on the specific amplification of marker sequences and may overlook infections caused by unknown and rare pathogens. Using high-throughput sequencing (HTS) can solve this problem; but, due to the extremely low fraction of pathogen genetic material in clinical samples, its application is only cost-effective in special, rather than routine, cases. In this study, we present a method for the semi-specific enrichment of viral conservative sequences in a HTS library by hybridization in solution with genus-specific degenerate biotinylated oligonucleotides. Nucleic acids of the test viruses (yellow fever virus and Japanese encephalitis virus) were enriched by solution hybrid selection using pan-flavivirus oligonucleotides. Moreover, enterovirus (family: Picornaviridae, genus: Enterovirus) sequences were successfully enriched using foot-and-mouth disease virus (family: Picornaviridae, genus: Aphthovirus) oligonucleotide. The enrichment factor relative to the background nucleic acid was about 1,000-fold. As hybridization has less stringent oligonucleotide match requirements than PCR, few oligonucleotides are sufficient to cover the potential sequence variation in the whole genus and may even enrich nucleic acids of viruses of other related genera. Efficient enrichment of viral sequences makes its use in diagnostics cost-efficient.",10.1038/s41598-017-10342-w,8pm9hy9u,"['Despite', 'recent', 'advances', 'our', 'knowledge', 'of', 'potential', 'and', 'rare', 'human', 'pathogens', 'is', 'far', 'from', 'exhaustive', 'Current', 'molecular', 'diagnostic', 'tools', 'mainly', 'rely', 'on', 'the', 'specific', 'amplification', 'of', 'marker', 'sequences', 'and', 'may', 'overlook', 'infections', 'caused', 'by', 'unknown', 'and', 'rare', 'pathogens', 'Using', 'high', 'throughput', 'sequencing', 'HTS', 'can', 'solve', 'this', 'problem', 'but', 'due', 'to', 'the', 'extremely', 'low', 'fraction', 'of', 'pathogen', 'genetic', 'material', 'in', 'clinical', 'samples', 'its', 'application', 'is', 'only', 'cost', 'effective', 'in', 'special', 'rather', 'than', 'routine', 'cases', 'In', 'this', 'study', 'we', 'present', 'a', 'method', 'for', 'the', 'semi', 'specific', 'enrichment', 'of', 'viral', 'conservative', 'sequences', 'in', 'a', 'HTS', 'library', 'by', 'hybridization', 'in', 'solution', 'with', 'genus', 'specific', 'degenerate', 'biotinylated', 'oligonucleotides', 'Nucleic', 'acids', 'of', 'the', 'test', 'viruses', 'yellow', 'fever', 'virus', 'and', 'Japanese', 'encephalitis', 'virus', 'were', 'enriched', 'by', 'solution', 'hybrid', 'selection', 'using', 'pan', 'flavivirus', 'oligonucleotides', 'Moreover', 'enterovirus', 'family', 'Picornaviridae', 'genus', 'Enterovirus', 'sequences', 'were', 'successfully', 'enriched', 'using', 'foot', 'and', 'mouth', 'disease', 'virus', 'family', 'Picornaviridae', 'genus', 'Aphthovirus', 'oligonucleotide', 'The', 'enrichment', 'factor', 'relative', 'to', 'the', 'background', 'nucleic', 'acid', 'was', 'about', '1', '000', 'fold', 'As', 'hybridization', 'has', 'less', 'stringent', 'oligonucleotide', 'match', 'requirements', 'than', 'PCR', 'few', 'oligonucleotides', 'are', 'sufficient', 'to', 'cover', 'the', 'potential', 'sequence', 'variation', 'in', 'the', 'whole', 'genus', 'and', 'may', 'even', 'enrich', 'nucleic', 'acids', 'of', 'viruses', 'of', 'other', 'related', 'genera', 'Efficient', 'enrichment', 'of', 'viral', 'sequences', 'makes', 'its', 'use', 'in', 'diagnostics', 'cost', 'efficient', '']"
195444,Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art,2018-10-18,Front Microbiol,https://doi.org/10.3389/fmicb.2018.02478; https://www.ncbi.nlm.nih.gov/pubmed/30405553/,"In the pediatric population, respiratory infections are the most common cause of physician visits. Although many respiratory illnesses are self-limiting viral infections that resolve with time and supportive care, it can be critical to identify the causative pathogen at an early stage of the disease in order to implement effective antimicrobial therapy and infection control. Over the last few years, diagnostics for respiratory infections have evolved substantially, with the development of novel assays and the availability of updated tests for newer strains of pathogens. Newer laboratory methods are rapid, highly sensitive and specific, and are gradually replacing the conventional gold standards, although the clinical utility of these assays is still under evaluation. This article reviews the current laboratory methods available for testing for respiratory pathogens and discusses the advantages and disadvantages of each approach.",10.3389/fmicb.2018.02478,avjw4kx1,"['In', 'the', 'pediatric', 'population', 'respiratory', 'infections', 'are', 'the', 'most', 'common', 'cause', 'of', 'physician', 'visits', 'Although', 'many', 'respiratory', 'illnesses', 'are', 'self', 'limiting', 'viral', 'infections', 'that', 'resolve', 'with', 'time', 'and', 'supportive', 'care', 'it', 'can', 'be', 'critical', 'to', 'identify', 'the', 'causative', 'pathogen', 'at', 'an', 'early', 'stage', 'of', 'the', 'disease', 'in', 'order', 'to', 'implement', 'effective', 'antimicrobial', 'therapy', 'and', 'infection', 'control', 'Over', 'the', 'last', 'few', 'years', 'diagnostics', 'for', 'respiratory', 'infections', 'have', 'evolved', 'substantially', 'with', 'the', 'development', 'of', 'novel', 'assays', 'and', 'the', 'availability', 'of', 'updated', 'tests', 'for', 'newer', 'strains', 'of', 'pathogens', 'Newer', 'laboratory', 'methods', 'are', 'rapid', 'highly', 'sensitive', 'and', 'specific', 'and', 'are', 'gradually', 'replacing', 'the', 'conventional', 'gold', 'standards', 'although', 'the', 'clinical', 'utility', 'of', 'these', 'assays', 'is', 'still', 'under', 'evaluation', 'This', 'article', 'reviews', 'the', 'current', 'laboratory', 'methods', 'available', 'for', 'testing', 'for', 'respiratory', 'pathogens', 'and', 'discusses', 'the', 'advantages', 'and', 'disadvantages', 'of', 'each', 'approach', '']"
195542,Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example,2011-08-16,Virol J,https://www.ncbi.nlm.nih.gov/pubmed/21843374/; https://doi.org/10.1186/1743-422x-8-405,"BACKGROUND: Positive controls are an integral component of any sensitive molecular diagnostic tool, but this can be affected, if several mutations are being screened in a scenario of a pandemic or newly emerging disease where it can be difficult to acquire all the necessary positive controls from the host. This work describes the development of a synthetic oligo-cassette for positive controls for accurate and highly sensitive diagnosis of several mutations relevant to influenza virus drug resistance. RESULTS: Using influenza antiviral drug resistance mutations as an example by employing the utility of synthetic paired long oligonucleotides containing complementary sequences at their 3' ends and utilizing the formation of oligonucleotide dimers and DNA polymerization, we generated ~170bp dsDNA containing several known specific neuraminidase inhibitor (NAI) resistance mutations. These templates were further cloned and successfully applied as positive controls in downstream assays. CONCLUSION: This approach significantly improved the development of diagnosis of resistance mutations in terms of time, accuracy, efficiency and sensitivity, which are paramount to monitoring the emergence and spread of antiviral drug resistant influenza strains. Thus, this may have a significantly broader application in molecular diagnostics along with its application in rapid molecular testing of all relevant mutations in an event of pandemic.",10.1186/1743-422x-8-405,r7m7gfi4,"['BACKGROUND', 'Positive', 'controls', 'are', 'an', 'integral', 'component', 'of', 'any', 'sensitive', 'molecular', 'diagnostic', 'tool', 'but', 'this', 'can', 'be', 'affected', 'if', 'several', 'mutations', 'are', 'being', 'screened', 'in', 'a', 'scenario', 'of', 'a', 'pandemic', 'or', 'newly', 'emerging', 'disease', 'where', 'it', 'can', 'be', 'difficult', 'to', 'acquire', 'all', 'the', 'necessary', 'positive', 'controls', 'from', 'the', 'host', 'This', 'work', 'describes', 'the', 'development', 'of', 'a', 'synthetic', 'oligo', 'cassette', 'for', 'positive', 'controls', 'for', 'accurate', 'and', 'highly', 'sensitive', 'diagnosis', 'of', 'several', 'mutations', 'relevant', 'to', 'influenza', 'virus', 'drug', 'resistance', 'RESULTS', 'Using', 'influenza', 'antiviral', 'drug', 'resistance', 'mutations', 'as', 'an', 'example', 'by', 'employing', 'the', 'utility', 'of', 'synthetic', 'paired', 'long', 'oligonucleotides', 'containing', 'complementary', 'sequences', 'at', 'their', '3', 'ends', 'and', 'utilizing', 'the', 'formation', 'of', 'oligonucleotide', 'dimers', 'and', 'DNA', 'polymerization', 'we', 'generated', '170bp', 'dsDNA', 'containing', 'several', 'known', 'specific', 'neuraminidase', 'inhibitor', 'NAI', 'resistance', 'mutations', 'These', 'templates', 'were', 'further', 'cloned', 'and', 'successfully', 'applied', 'as', 'positive', 'controls', 'in', 'downstream', 'assays', 'CONCLUSION', 'This', 'approach', 'significantly', 'improved', 'the', 'development', 'of', 'diagnosis', 'of', 'resistance', 'mutations', 'in', 'terms', 'of', 'time', 'accuracy', 'efficiency', 'and', 'sensitivity', 'which', 'are', 'paramount', 'to', 'monitoring', 'the', 'emergence', 'and', 'spread', 'of', 'antiviral', 'drug', 'resistant', 'influenza', 'strains', 'Thus', 'this', 'may', 'have', 'a', 'significantly', 'broader', 'application', 'in', 'molecular', 'diagnostics', 'along', 'with', 'its', 'application', 'in', 'rapid', 'molecular', 'testing', 'of', 'all', 'relevant', 'mutations', 'in', 'an', 'event', 'of', 'pandemic', '']"
195716,Navigating the Diagnostics of COVID-19,2020-07-25,SN Compr Clin Med,https://doi.org/10.1007/s42399-020-00408-8,"The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Hubei province, China, in December 2019 and has spread worldwide at an alarming rate. With over eight million individuals infected and exceeding 400,000 deaths globally, the necessity to develop fast and efficient diagnostic methods is of high importance. This paper reports on currently available diagnostic screening methods for patients infected with SARS-CoV-2 to guide frontline healthcare workers involved with the diagnosis of 2019 novel coronavirus disease (COVID-19) patient. An electronic literature search was performed for peer-reviewed articles published from January 1, 2020, until June 19, 2020. Published articles were then reviewed and included based on the applicability to the topic. The preferred diagnostic approach is the reverse transcription (RT) of the virus’ ribonucleic acid (RNA) followed by polymerase chain reaction (PCR) amplification (RT-PCR). However, this method has been proven to be time-consuming. In improving the speed and efficiency of diagnostics, newer rapid diagnostic serological tests are in development for testing SARS-CoV-2, each with its unique advantages and disadvantages. They could potentially be used as triage tests to rapidly identify patients who are very likely to have COVID-19 in combination with other accurate diagnostic methods, such as diagnostic imaging. A combination of the disease history, clinical manifestations, laboratory diagnostic testing, and diagnostic imaging is crucial for making an accurate and useful diagnosis for COVID-19. Hopefully, the continuous development and use of rapid diagnostic tests and the implementation of public health measures will help control the spread of the disease.",10.1007/s42399-020-00408-8,bqibelvc,"['The', 'recent', 'outbreak', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'began', 'in', 'Hubei', 'province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'worldwide', 'at', 'an', 'alarming', 'rate', 'With', 'over', 'eight', 'million', 'individuals', 'infected', 'and', 'exceeding', '400', '000', 'deaths', 'globally', 'the', 'necessity', 'to', 'develop', 'fast', 'and', 'efficient', 'diagnostic', 'methods', 'is', 'of', 'high', 'importance', 'This', 'paper', 'reports', 'on', 'currently', 'available', 'diagnostic', 'screening', 'methods', 'for', 'patients', 'infected', 'with', 'SARS', 'CoV', '2', 'to', 'guide', 'frontline', 'healthcare', 'workers', 'involved', 'with', 'the', 'diagnosis', 'of', '2019', 'novel', 'coronavirus', 'disease', 'COVID', '19', 'patient', 'An', 'electronic', 'literature', 'search', 'was', 'performed', 'for', 'peer', 'reviewed', 'articles', 'published', 'from', 'January', '1', '2020', 'until', 'June', '19', '2020', 'Published', 'articles', 'were', 'then', 'reviewed', 'and', 'included', 'based', 'on', 'the', 'applicability', 'to', 'the', 'topic', 'The', 'preferred', 'diagnostic', 'approach', 'is', 'the', 'reverse', 'transcription', 'RT', 'of', 'the', 'virus', 'ribonucleic', 'acid', 'RNA', 'followed', 'by', 'polymerase', 'chain', 'reaction', 'PCR', 'amplification', 'RT', 'PCR', 'However', 'this', 'method', 'has', 'been', 'proven', 'to', 'be', 'time', 'consuming', 'In', 'improving', 'the', 'speed', 'and', 'efficiency', 'of', 'diagnostics', 'newer', 'rapid', 'diagnostic', 'serological', 'tests', 'are', 'in', 'development', 'for', 'testing', 'SARS', 'CoV', '2', 'each', 'with', 'its', 'unique', 'advantages', 'and', 'disadvantages', 'They', 'could', 'potentially', 'be', 'used', 'as', 'triage', 'tests', 'to', 'rapidly', 'identify', 'patients', 'who', 'are', 'very', 'likely', 'to', 'have', 'COVID', '19', 'in', 'combination', 'with', 'other', 'accurate', 'diagnostic', 'methods', 'such', 'as', 'diagnostic', 'imaging', 'A', 'combination', 'of', 'the', 'disease', 'history', 'clinical', 'manifestations', 'laboratory', 'diagnostic', 'testing', 'and', 'diagnostic', 'imaging', 'is', 'crucial', 'for', 'making', 'an', 'accurate', 'and', 'useful', 'diagnosis', 'for', 'COVID', '19', 'Hopefully', 'the', 'continuous', 'development', 'and', 'use', 'of', 'rapid', 'diagnostic', 'tests', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'will', 'help', 'control', 'the', 'spread', 'of', 'the', 'disease', '']"
196123,Overview of the CSIRO Australian Animal Health Laboratory,2016-04-24,J Infect Public Health,https://www.sciencedirect.com/science/article/pii/S1876034116300247; https://www.ncbi.nlm.nih.gov/pubmed/27118215/; https://api.elsevier.com/content/article/pii/S1876034116300247; https://doi.org/10.1016/j.jiph.2016.04.007,"Emerging infectious diseases arising from livestock and wildlife pose serious threats to global human health, as shown by a series of continuous outbreaks involving highly pathogenic influenza, SARS, Ebola and MERS. The risk of pandemics and bioterrorism threats is ever present and growing, but our ability to combat them is limited by the lack of available vaccines, therapeutics and rapid diagnostics. The use of high bio-containment facilities, such as the CSIRO Australian Animal Health Laboratory, plays a key role studying these dangerous pathogens and facilitates the development of countermeasures. To combat diseases like MERS, we must take a holistic approach that involves the development of early biomarkers of infection, a suite of treatment options (vaccines, anti-viral drugs and antibody therapeutics) and appropriate animal models to test the safety and efficacy of candidate treatments.",10.1016/j.jiph.2016.04.007,13adnvav,"['Emerging', 'infectious', 'diseases', 'arising', 'from', 'livestock', 'and', 'wildlife', 'pose', 'serious', 'threats', 'to', 'global', 'human', 'health', 'as', 'shown', 'by', 'a', 'series', 'of', 'continuous', 'outbreaks', 'involving', 'highly', 'pathogenic', 'influenza', 'SARS', 'Ebola', 'and', 'MERS', 'The', 'risk', 'of', 'pandemics', 'and', 'bioterrorism', 'threats', 'is', 'ever', 'present', 'and', 'growing', 'but', 'our', 'ability', 'to', 'combat', 'them', 'is', 'limited', 'by', 'the', 'lack', 'of', 'available', 'vaccines', 'therapeutics', 'and', 'rapid', 'diagnostics', 'The', 'use', 'of', 'high', 'bio', 'containment', 'facilities', 'such', 'as', 'the', 'CSIRO', 'Australian', 'Animal', 'Health', 'Laboratory', 'plays', 'a', 'key', 'role', 'studying', 'these', 'dangerous', 'pathogens', 'and', 'facilitates', 'the', 'development', 'of', 'countermeasures', 'To', 'combat', 'diseases', 'like', 'MERS', 'we', 'must', 'take', 'a', 'holistic', 'approach', 'that', 'involves', 'the', 'development', 'of', 'early', 'biomarkers', 'of', 'infection', 'a', 'suite', 'of', 'treatment', 'options', 'vaccines', 'anti', 'viral', 'drugs', 'and', 'antibody', 'therapeutics', 'and', 'appropriate', 'animal', 'models', 'to', 'test', 'the', 'safety', 'and', 'efficacy', 'of', 'candidate', 'treatments', '']"
196755,Molecular diagnosis of respiratory viruses,2015-04-30,Pathology,https://api.elsevier.com/content/article/pii/S0031302516301313; https://www.ncbi.nlm.nih.gov/pubmed/25764205/; https://www.sciencedirect.com/science/article/pii/S0031302516301313; https://doi.org/10.1097/pat.0000000000000240,"Summary The increasing availability of nucleic acid amplification tests since the 1980s has revolutionised our understanding of the pathogenesis, epidemiology, clinical and laboratory aspects of known and novel viral respiratory pathogens. High-throughput, multiplex polymerase chain reaction is the most commonly used qualitative detection method, but utilisation of newer techniques such as next-generation sequencing will become more common following significant cost reductions. Rapid and readily accessible isothermal amplification platforms have also allowed molecular diagnostics to be used in a ‘point-of-care’ format. This review focuses on the current applications and limitations of molecular diagnosis for respiratory viruses.",10.1097/pat.0000000000000240,3yaqeirk,"['Summary', 'The', 'increasing', 'availability', 'of', 'nucleic', 'acid', 'amplification', 'tests', 'since', 'the', '1980s', 'has', 'revolutionised', 'our', 'understanding', 'of', 'the', 'pathogenesis', 'epidemiology', 'clinical', 'and', 'laboratory', 'aspects', 'of', 'known', 'and', 'novel', 'viral', 'respiratory', 'pathogens', 'High', 'throughput', 'multiplex', 'polymerase', 'chain', 'reaction', 'is', 'the', 'most', 'commonly', 'used', 'qualitative', 'detection', 'method', 'but', 'utilisation', 'of', 'newer', 'techniques', 'such', 'as', 'next', 'generation', 'sequencing', 'will', 'become', 'more', 'common', 'following', 'significant', 'cost', 'reductions', 'Rapid', 'and', 'readily', 'accessible', 'isothermal', 'amplification', 'platforms', 'have', 'also', 'allowed', 'molecular', 'diagnostics', 'to', 'be', 'used', 'in', 'a', 'point', 'of', 'care', 'format', 'This', 'review', 'focuses', 'on', 'the', 'current', 'applications', 'and', 'limitations', 'of', 'molecular', 'diagnosis', 'for', 'respiratory', 'viruses', '']"
197005,"Distinguishing patients with laboratory-confirmed chikungunya from dengue and other acute febrile illnesses, Puerto Rico, 2012–2015",2019-07-22,PLoS Negl Trop Dis,https://doi.org/10.1371/journal.pntd.0007562; https://www.ncbi.nlm.nih.gov/pubmed/31329598/,"Chikungunya, a mosquito-borne viral, acute febrile illness (AFI) is associated with polyarthralgia and polyarthritis. Differentiation from other AFI is difficult due to the non-specific presentation and limited availability of diagnostics. This 3-year study identified independent clinical predictors by day post-illness onset (DPO) at presentation and age-group that distinguish chikungunya cases from two groups: other AFI and dengue. Specimens collected from participants with fever ≤7 days were tested for chikungunya, dengue viruses 1–4, and 20 other pathogens. Of 8,996 participants, 18.2% had chikungunya, and 10.8% had dengue. Chikungunya cases were more likely than other groups to be older, report a chronic condition, and present <3 DPO. Regardless of timing of presentation, significant positive predictors for chikungunya versus other AFI were: joint pain, muscle, bone or back pain, skin rash, and red conjunctiva; with dengue as the comparator, red swollen joints (arthritis), joint pain, skin rash, any bleeding, and irritability were predictors. Chikungunya cases were less likely than AFI and dengue to present with thrombocytopenia, signs of poor circulation, diarrhea, headache, and cough. Among participants presenting <3 DPO, predictors for chikungunya versus other AFI included: joint pain, skin rash, and muscle, bone or back pain, and absence of thrombocytopenia, poor circulation and respiratory or gastrointestinal symptoms; when the comparator was dengue, joint pain and arthritis, and absence of thrombocytopenia, leukopenia, and nausea were early predictors. Among all groups presenting 3–5 DPO, pruritic skin became a predictor for chikungunya, joint, muscle, bone or back pain were no longer predictive, while arthritis became predictive in all age-groups. Absence of thrombocytopenia was a significant predictor regardless of DPO or comparison group. This study identified robust clinical indicators such as joint pain, skin rash and absence of thrombocytopenia that can allow early identification of and accurate differentiation between patients with chikungunya and other common causes of AFI.",10.1371/journal.pntd.0007562,vindspai,"['Chikungunya', 'a', 'mosquito', 'borne', 'viral', 'acute', 'febrile', 'illness', 'AFI', 'is', 'associated', 'with', 'polyarthralgia', 'and', 'polyarthritis', 'Differentiation', 'from', 'other', 'AFI', 'is', 'difficult', 'due', 'to', 'the', 'non', 'specific', 'presentation', 'and', 'limited', 'availability', 'of', 'diagnostics', 'This', '3', 'year', 'study', 'identified', 'independent', 'clinical', 'predictors', 'by', 'day', 'post', 'illness', 'onset', 'DPO', 'at', 'presentation', 'and', 'age', 'group', 'that', 'distinguish', 'chikungunya', 'cases', 'from', 'two', 'groups', 'other', 'AFI', 'and', 'dengue', 'Specimens', 'collected', 'from', 'participants', 'with', 'fever', '7', 'days', 'were', 'tested', 'for', 'chikungunya', 'dengue', 'viruses', '1', '4', 'and', '20', 'other', 'pathogens', 'Of', '8', '996', 'participants', '18', '2', 'had', 'chikungunya', 'and', '10', '8', 'had', 'dengue', 'Chikungunya', 'cases', 'were', 'more', 'likely', 'than', 'other', 'groups', 'to', 'be', 'older', 'report', 'a', 'chronic', 'condition', 'and', 'present', '3', 'DPO', 'Regardless', 'of', 'timing', 'of', 'presentation', 'significant', 'positive', 'predictors', 'for', 'chikungunya', 'versus', 'other', 'AFI', 'were', 'joint', 'pain', 'muscle', 'bone', 'or', 'back', 'pain', 'skin', 'rash', 'and', 'red', 'conjunctiva', 'with', 'dengue', 'as', 'the', 'comparator', 'red', 'swollen', 'joints', 'arthritis', 'joint', 'pain', 'skin', 'rash', 'any', 'bleeding', 'and', 'irritability', 'were', 'predictors', 'Chikungunya', 'cases', 'were', 'less', 'likely', 'than', 'AFI', 'and', 'dengue', 'to', 'present', 'with', 'thrombocytopenia', 'signs', 'of', 'poor', 'circulation', 'diarrhea', 'headache', 'and', 'cough', 'Among', 'participants', 'presenting', '3', 'DPO', 'predictors', 'for', 'chikungunya', 'versus', 'other', 'AFI', 'included', 'joint', 'pain', 'skin', 'rash', 'and', 'muscle', 'bone', 'or', 'back', 'pain', 'and', 'absence', 'of', 'thrombocytopenia', 'poor', 'circulation', 'and', 'respiratory', 'or', 'gastrointestinal', 'symptoms', 'when', 'the', 'comparator', 'was', 'dengue', 'joint', 'pain', 'and', 'arthritis', 'and', 'absence', 'of', 'thrombocytopenia', 'leukopenia', 'and', 'nausea', 'were', 'early', 'predictors', 'Among', 'all', 'groups', 'presenting', '3', '5', 'DPO', 'pruritic', 'skin', 'became', 'a', 'predictor', 'for', 'chikungunya', 'joint', 'muscle', 'bone', 'or', 'back', 'pain', 'were', 'no', 'longer', 'predictive', 'while', 'arthritis', 'became', 'predictive', 'in', 'all', 'age', 'groups', 'Absence', 'of', 'thrombocytopenia', 'was', 'a', 'significant', 'predictor', 'regardless', 'of', 'DPO', 'or', 'comparison', 'group', 'This', 'study', 'identified', 'robust', 'clinical', 'indicators', 'such', 'as', 'joint', 'pain', 'skin', 'rash', 'and', 'absence', 'of', 'thrombocytopenia', 'that', 'can', 'allow', 'early', 'identification', 'of', 'and', 'accurate', 'differentiation', 'between', 'patients', 'with', 'chikungunya', 'and', 'other', 'common', 'causes', 'of', 'AFI', '']"
197100,Molecular Detection of Multiple Respiratory Viruses,2010-01-29,Molecular Diagnostics,https://api.elsevier.com/content/article/pii/B9780123694287000240; https://www.sciencedirect.com/science/article/pii/B9780123694287000240,"This chapter discusses the molecular detection of multiple respiratory viruses. Respiratory infections are very common. They are responsible for significant morbidity and mortality and are costly in terms of lost time from work, inappropriate use of antibiotics, and lengthy hospital stays. Laboratory detection of causative agents can influence treatment and allow appropriate infection control measures, potentially saving time and money, promoting quicker recovery for the patient, and lowering the risk of nosocomial transmission of the organism. Molecular testing may be the most sensitive method of detecting respiratory viruses. These methods have been shown to detect multiple viruses in a single sample more often than any of the other methods described and, in addition, can detect viruses that are difficult or impossible to grow. The detection of nonviable organisms may provide additional insight into disease but provides its own challenges in terms of determining clinical significance of positive results. Like many areas of clinical medicine and microbiology, the increasing use of molecular diagnostics for detection of respiratory viruses raises many new questions for the laboratory and the clinical diagnostician, but also promises many benefits as these methods become increasingly available for routine use.",10.1016/b978-0-12-369428-7.00024-0,jc732n8d,"['This', 'chapter', 'discusses', 'the', 'molecular', 'detection', 'of', 'multiple', 'respiratory', 'viruses', 'Respiratory', 'infections', 'are', 'very', 'common', 'They', 'are', 'responsible', 'for', 'significant', 'morbidity', 'and', 'mortality', 'and', 'are', 'costly', 'in', 'terms', 'of', 'lost', 'time', 'from', 'work', 'inappropriate', 'use', 'of', 'antibiotics', 'and', 'lengthy', 'hospital', 'stays', 'Laboratory', 'detection', 'of', 'causative', 'agents', 'can', 'influence', 'treatment', 'and', 'allow', 'appropriate', 'infection', 'control', 'measures', 'potentially', 'saving', 'time', 'and', 'money', 'promoting', 'quicker', 'recovery', 'for', 'the', 'patient', 'and', 'lowering', 'the', 'risk', 'of', 'nosocomial', 'transmission', 'of', 'the', 'organism', 'Molecular', 'testing', 'may', 'be', 'the', 'most', 'sensitive', 'method', 'of', 'detecting', 'respiratory', 'viruses', 'These', 'methods', 'have', 'been', 'shown', 'to', 'detect', 'multiple', 'viruses', 'in', 'a', 'single', 'sample', 'more', 'often', 'than', 'any', 'of', 'the', 'other', 'methods', 'described', 'and', 'in', 'addition', 'can', 'detect', 'viruses', 'that', 'are', 'difficult', 'or', 'impossible', 'to', 'grow', 'The', 'detection', 'of', 'nonviable', 'organisms', 'may', 'provide', 'additional', 'insight', 'into', 'disease', 'but', 'provides', 'its', 'own', 'challenges', 'in', 'terms', 'of', 'determining', 'clinical', 'significance', 'of', 'positive', 'results', 'Like', 'many', 'areas', 'of', 'clinical', 'medicine', 'and', 'microbiology', 'the', 'increasing', 'use', 'of', 'molecular', 'diagnostics', 'for', 'detection', 'of', 'respiratory', 'viruses', 'raises', 'many', 'new', 'questions', 'for', 'the', 'laboratory', 'and', 'the', 'clinical', 'diagnostician', 'but', 'also', 'promises', 'many', 'benefits', 'as', 'these', 'methods', 'become', 'increasingly', 'available', 'for', 'routine', 'use', '']"
198074,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020-02-28,Bioinformatics,https://doi.org/10.1093/bioinformatics/btaa145; https://www.ncbi.nlm.nih.gov/pubmed/32108862/,"SUMMARY: Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS) related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY: https://www.genomedetective.com/app/typingtool/cov SUPPLEMENTARY INFORMATION:",10.1093/bioinformatics/btaa145,st5idleq,"['SUMMARY', 'Genome', 'Detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'The', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2', '000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', 'one', 'minute', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', 'ten', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'SUPPLEMENTARY', 'INFORMATION', '']"
198094,Evaluation of the Luminex xTAG Respiratory Viral Panel FAST v2 assay for detection of multiple respiratory viral pathogens in nasal and throat swabs in Vietnam,2018-04-30,Wellcome Open Res,https://doi.org/10.12688/wellcomeopenres.12429.2; https://www.ncbi.nlm.nih.gov/pubmed/29503874/,"Background: Acute respiratory infections (ARI) are among the leading causes of hospitalization in children ≤5 years old. Rapid diagnostics of viral pathogens is essential to avoid unnecessary antibiotic treatment, thereby slowing down antibiotic-resistance. We evaluated the diagnostic performance of the Luminex xTAG Respiratory Viral Panel FAST v2 against viral specific PCR as reference assays for ARI in Vietnam. Methods: Four hundred and forty two nose and throat swabs were collected in viral transport medium, and were tested with Luminex xTAG Respiratory Viral Panel FAST v2. Multiplex RT-PCR and single RT-PCR were used as references. Results: Overall, sensitivity of the Luminex against reference assays was 91.8%, 95% CI 88.1-94.7 (270/294), whilst 112/6336 (1.8%, 95% CI, 1.4-2.1) of pathogens were detected by the Luminex, but not by reference assays. Frequency of pathogens detected by Luminex and reference assays was 379 and 292, respectively. The diagnostic yield was 66.7% (295/442, 95%CI 62.1-71.1%) for the Luminex assay and 54.1% (239/442, 95% CI, 49.3-58.8%) for reference assays. The Luminex kit had higher yields for all viruses except influenza B virus, respiratory syncytial virus, and human bocavirus. High agreements between both methods [mean (range): 0.91 (0.83-1.00)] were found for 10/15 viral agents. Conclusions: The Luminex assay is a high throughput multiplex platform for rapid detection of common viral pathogens causing ARI. Although the current high cost may prevent Luminex assays from being widely used, especially in limited resource settings where ARI are felt most, its introduction in clinical diagnostics may help reduce unnecessary use of antibiotic prescription.",10.12688/wellcomeopenres.12429.2,5lcfxjkc,"['Background', 'Acute', 'respiratory', 'infections', 'ARI', 'are', 'among', 'the', 'leading', 'causes', 'of', 'hospitalization', 'in', 'children', '5', 'years', 'old', 'Rapid', 'diagnostics', 'of', 'viral', 'pathogens', 'is', 'essential', 'to', 'avoid', 'unnecessary', 'antibiotic', 'treatment', 'thereby', 'slowing', 'down', 'antibiotic', 'resistance', 'We', 'evaluated', 'the', 'diagnostic', 'performance', 'of', 'the', 'Luminex', 'xTAG', 'Respiratory', 'Viral', 'Panel', 'FAST', 'v2', 'against', 'viral', 'specific', 'PCR', 'as', 'reference', 'assays', 'for', 'ARI', 'in', 'Vietnam', 'Methods', 'Four', 'hundred', 'and', 'forty', 'two', 'nose', 'and', 'throat', 'swabs', 'were', 'collected', 'in', 'viral', 'transport', 'medium', 'and', 'were', 'tested', 'with', 'Luminex', 'xTAG', 'Respiratory', 'Viral', 'Panel', 'FAST', 'v2', 'Multiplex', 'RT', 'PCR', 'and', 'single', 'RT', 'PCR', 'were', 'used', 'as', 'references', 'Results', 'Overall', 'sensitivity', 'of', 'the', 'Luminex', 'against', 'reference', 'assays', 'was', '91', '8', '95', 'CI', '88', '1', '94', '7', '270', '294', 'whilst', '112', '6336', '1', '8', '95', 'CI', '1', '4', '2', '1', 'of', 'pathogens', 'were', 'detected', 'by', 'the', 'Luminex', 'but', 'not', 'by', 'reference', 'assays', 'Frequency', 'of', 'pathogens', 'detected', 'by', 'Luminex', 'and', 'reference', 'assays', 'was', '379', 'and', '292', 'respectively', 'The', 'diagnostic', 'yield', 'was', '66', '7', '295', '442', '95', 'CI', '62', '1', '71', '1', 'for', 'the', 'Luminex', 'assay', 'and', '54', '1', '239', '442', '95', 'CI', '49', '3', '58', '8', 'for', 'reference', 'assays', 'The', 'Luminex', 'kit', 'had', 'higher', 'yields', 'for', 'all', 'viruses', 'except', 'influenza', 'B', 'virus', 'respiratory', 'syncytial', 'virus', 'and', 'human', 'bocavirus', 'High', 'agreements', 'between', 'both', 'methods', 'mean', 'range', '0', '91', '0', '83', '1', '00', 'were', 'found', 'for', '10', '15', 'viral', 'agents', 'Conclusions', 'The', 'Luminex', 'assay', 'is', 'a', 'high', 'throughput', 'multiplex', 'platform', 'for', 'rapid', 'detection', 'of', 'common', 'viral', 'pathogens', 'causing', 'ARI', 'Although', 'the', 'current', 'high', 'cost', 'may', 'prevent', 'Luminex', 'assays', 'from', 'being', 'widely', 'used', 'especially', 'in', 'limited', 'resource', 'settings', 'where', 'ARI', 'are', 'felt', 'most', 'its', 'introduction', 'in', 'clinical', 'diagnostics', 'may', 'help', 'reduce', 'unnecessary', 'use', 'of', 'antibiotic', 'prescription', '']"
198235,Metagenomic Sequencing for Combined Detection of RNA and DNA Viruses in Respiratory Samples from Paediatric Patients,2018-12-10,bioRxiv,https://doi.org/10.1101/492835,"Introduction Viruses are the main cause of respiratory tract infections. Metagenomic next-generation sequencing (mNGS) enables the unbiased detection of all potential pathogens in a clinical sample, including variants and even unknown pathogens. To apply mNGS in viral diagnostics, there is a need for sensitive and simultaneous detection of RNA and DNA viruses. In this study, the performance of an in-house mNGS protocol for routine diagnostics of viral respiratory infections, with single tube DNA and RNA sample-pre-treatment and potential for automated pan-pathogen detection was studied. Materials and Methods The sequencing protocol and bioinformatics analysis was designed and optimized including the optimal concentration of the spike-in internal controls equine arteritis virus (EAV) and phocine-herpes virus-1 (PhHV-1).The whole genome of PhHV-1 was sequenced and added to the NCBI database. Subsequently, the protocol was retrospectively validated using a selection of 25 respiratory samples with in total 29 positive and 346 negative PCR results, previously sent to the lab for routine diagnostics. Results The results demonstrated that our protocol using Illumina Nextseq 500 sequencing with 10 million reads showed high repeatability. The NCBI RefSeq database as opposed to the NCBI nucleotide database led to enhanced specificity of virus classification. A correlation was established between read counts and PCR cycle threshold value, demonstrating the semi-quantitative nature of viral detection by mNGS. The results as obtained by mNGS appeared condordant with PCR based diagnostics in 25 out of the 29 (86%) respiratory viruses positive by PCR and in 315 of 346 (91%) PCR-negative results. Viral pathogens only detected by mNGS, not present in the routine diagnostic workflow were influenza C, KI polyomavirus, and cytomegalovirus. Conclusions Sensitivity and analytical specificity of this mNGS protocol was comparable with PCR and higher when considering off-PCR target viral pathogens. All potential viral pathogens were detected in one single test, while it simultaneously obtained detailed information on detected viruses.",10.1101/492835,vtc6d2wr,"['Introduction', 'Viruses', 'are', 'the', 'main', 'cause', 'of', 'respiratory', 'tract', 'infections', 'Metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'enables', 'the', 'unbiased', 'detection', 'of', 'all', 'potential', 'pathogens', 'in', 'a', 'clinical', 'sample', 'including', 'variants', 'and', 'even', 'unknown', 'pathogens', 'To', 'apply', 'mNGS', 'in', 'viral', 'diagnostics', 'there', 'is', 'a', 'need', 'for', 'sensitive', 'and', 'simultaneous', 'detection', 'of', 'RNA', 'and', 'DNA', 'viruses', 'In', 'this', 'study', 'the', 'performance', 'of', 'an', 'in', 'house', 'mNGS', 'protocol', 'for', 'routine', 'diagnostics', 'of', 'viral', 'respiratory', 'infections', 'with', 'single', 'tube', 'DNA', 'and', 'RNA', 'sample', 'pre', 'treatment', 'and', 'potential', 'for', 'automated', 'pan', 'pathogen', 'detection', 'was', 'studied', 'Materials', 'and', 'Methods', 'The', 'sequencing', 'protocol', 'and', 'bioinformatics', 'analysis', 'was', 'designed', 'and', 'optimized', 'including', 'the', 'optimal', 'concentration', 'of', 'the', 'spike', 'in', 'internal', 'controls', 'equine', 'arteritis', 'virus', 'EAV', 'and', 'phocine', 'herpes', 'virus', '1', 'PhHV', '1', 'The', 'whole', 'genome', 'of', 'PhHV', '1', 'was', 'sequenced', 'and', 'added', 'to', 'the', 'NCBI', 'database', 'Subsequently', 'the', 'protocol', 'was', 'retrospectively', 'validated', 'using', 'a', 'selection', 'of', '25', 'respiratory', 'samples', 'with', 'in', 'total', '29', 'positive', 'and', '346', 'negative', 'PCR', 'results', 'previously', 'sent', 'to', 'the', 'lab', 'for', 'routine', 'diagnostics', 'Results', 'The', 'results', 'demonstrated', 'that', 'our', 'protocol', 'using', 'Illumina', 'Nextseq', '500', 'sequencing', 'with', '10', 'million', 'reads', 'showed', 'high', 'repeatability', 'The', 'NCBI', 'RefSeq', 'database', 'as', 'opposed', 'to', 'the', 'NCBI', 'nucleotide', 'database', 'led', 'to', 'enhanced', 'specificity', 'of', 'virus', 'classification', 'A', 'correlation', 'was', 'established', 'between', 'read', 'counts', 'and', 'PCR', 'cycle', 'threshold', 'value', 'demonstrating', 'the', 'semi', 'quantitative', 'nature', 'of', 'viral', 'detection', 'by', 'mNGS', 'The', 'results', 'as', 'obtained', 'by', 'mNGS', 'appeared', 'condordant', 'with', 'PCR', 'based', 'diagnostics', 'in', '25', 'out', 'of', 'the', '29', '86', 'respiratory', 'viruses', 'positive', 'by', 'PCR', 'and', 'in', '315', 'of', '346', '91', 'PCR', 'negative', 'results', 'Viral', 'pathogens', 'only', 'detected', 'by', 'mNGS', 'not', 'present', 'in', 'the', 'routine', 'diagnostic', 'workflow', 'were', 'influenza', 'C', 'KI', 'polyomavirus', 'and', 'cytomegalovirus', 'Conclusions', 'Sensitivity', 'and', 'analytical', 'specificity', 'of', 'this', 'mNGS', 'protocol', 'was', 'comparable', 'with', 'PCR', 'and', 'higher', 'when', 'considering', 'off', 'PCR', 'target', 'viral', 'pathogens', 'All', 'potential', 'viral', 'pathogens', 'were', 'detected', 'in', 'one', 'single', 'test', 'while', 'it', 'simultaneously', 'obtained', 'detailed', 'information', 'on', 'detected', 'viruses', '']"
199029,Production of Recombinant N Protein of Infectious Bronchitis Virus Using the Baculovirus Expression System and Its Assessment as a Diagnostic Antigen,2018-07-09,Appl Biochem Biotechnol,https://doi.org/10.1007/s12010-018-2815-2; https://www.ncbi.nlm.nih.gov/pubmed/29987628/,"The avian coronavirus-infectious bronchitis virus (AvCoV-IBV) is recognized as an important avian pathogen, and new viral variants are a continuous threat to the poultry industry worldwide. Sensitive diagnostics and efficacious vaccines are necessary to combat IBV infections in chickens. The aim of this study was to produce recombinant N protein of IBV in the baculovirus system to use in ELISA diagnostic tests in order to enable the assessment of the sero-prevalence and risk of IBV infections in chickens in Turkey. For this, the gene encoding the N protein of the Beaudette strain of IBV was expressed using a recombinant baculovirus expression system. The recombinant N protein was purified using Ni-NTA affinity chromatography. An estimated 50-kDa recombinant protein corresponding to the expected molecular weight of IBV N including the 6xHis tag was detected using an anti-His monoclonal antibody. Specific immunoreactivity of the recombinant protein was confirmed by Western blot using antiserum obtained from vaccinated and naturally infected chicken from Turkey as well as using a monoclonal antibody raised against the N protein of the IBV Massachusetts strain. The results obtained with the in-house ELISA had high agreement with a commercial ELISA. Immunoreactivity analysis using antisera in Western blotting and the in-house ELISA suggests that the recombinant IBV N protein could be broadly cross-reactive with antisera produced against different IBV strains. We conclude that the recombinant baculovirus expressed IBV N protein could serve as a useful diagnostic antigen for detection of IBV infections in chickens by ELISA.",10.1007/s12010-018-2815-2,qnbgywgy,"['The', 'avian', 'coronavirus', 'infectious', 'bronchitis', 'virus', 'AvCoV', 'IBV', 'is', 'recognized', 'as', 'an', 'important', 'avian', 'pathogen', 'and', 'new', 'viral', 'variants', 'are', 'a', 'continuous', 'threat', 'to', 'the', 'poultry', 'industry', 'worldwide', 'Sensitive', 'diagnostics', 'and', 'efficacious', 'vaccines', 'are', 'necessary', 'to', 'combat', 'IBV', 'infections', 'in', 'chickens', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'produce', 'recombinant', 'N', 'protein', 'of', 'IBV', 'in', 'the', 'baculovirus', 'system', 'to', 'use', 'in', 'ELISA', 'diagnostic', 'tests', 'in', 'order', 'to', 'enable', 'the', 'assessment', 'of', 'the', 'sero', 'prevalence', 'and', 'risk', 'of', 'IBV', 'infections', 'in', 'chickens', 'in', 'Turkey', 'For', 'this', 'the', 'gene', 'encoding', 'the', 'N', 'protein', 'of', 'the', 'Beaudette', 'strain', 'of', 'IBV', 'was', 'expressed', 'using', 'a', 'recombinant', 'baculovirus', 'expression', 'system', 'The', 'recombinant', 'N', 'protein', 'was', 'purified', 'using', 'Ni', 'NTA', 'affinity', 'chromatography', 'An', 'estimated', '50', 'kDa', 'recombinant', 'protein', 'corresponding', 'to', 'the', 'expected', 'molecular', 'weight', 'of', 'IBV', 'N', 'including', 'the', '6xHis', 'tag', 'was', 'detected', 'using', 'an', 'anti', 'His', 'monoclonal', 'antibody', 'Specific', 'immunoreactivity', 'of', 'the', 'recombinant', 'protein', 'was', 'confirmed', 'by', 'Western', 'blot', 'using', 'antiserum', 'obtained', 'from', 'vaccinated', 'and', 'naturally', 'infected', 'chicken', 'from', 'Turkey', 'as', 'well', 'as', 'using', 'a', 'monoclonal', 'antibody', 'raised', 'against', 'the', 'N', 'protein', 'of', 'the', 'IBV', 'Massachusetts', 'strain', 'The', 'results', 'obtained', 'with', 'the', 'in', 'house', 'ELISA', 'had', 'high', 'agreement', 'with', 'a', 'commercial', 'ELISA', 'Immunoreactivity', 'analysis', 'using', 'antisera', 'in', 'Western', 'blotting', 'and', 'the', 'in', 'house', 'ELISA', 'suggests', 'that', 'the', 'recombinant', 'IBV', 'N', 'protein', 'could', 'be', 'broadly', 'cross', 'reactive', 'with', 'antisera', 'produced', 'against', 'different', 'IBV', 'strains', 'We', 'conclude', 'that', 'the', 'recombinant', 'baculovirus', 'expressed', 'IBV', 'N', 'protein', 'could', 'serve', 'as', 'a', 'useful', 'diagnostic', 'antigen', 'for', 'detection', 'of', 'IBV', 'infections', 'in', 'chickens', 'by', 'ELISA', '']"
199355,COVID‐19 Clinical Diagnostics and Testing Technology,2020-07-08,Pharmacotherapy,https://doi.org/10.1002/phar.2439; https://www.ncbi.nlm.nih.gov/pubmed/32643218/,"Given the global nature of the COVID‐19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS‐CoV‐2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID‐19 diagnostics on the horizon. Antibody response against SARS‐CoV‐2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",10.1002/phar.2439,5mf1r24m,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
199606,Loop‐mediated isothermal amplification: an emerging technology for detection of fish and shellfish pathogens,2005-11-22,J Fish Dis,https://www.ncbi.nlm.nih.gov/pubmed/16302951/,"Fish and shellfish diseases are a constant threat to the sustainability and economic viability of aquaculture. Early diagnosis plays a vital role in management of fish and shellfish diseases. Traditionally, various biochemical and serological tests have been used for fish disease diagnosis. However, the time and expertise required for such diagnoses makes it difficult for aquaculturists to easily adopt them under production conditions. Polymerase chain reaction and probe‐based nucleic acid detection have become increasingly popular in fish and shellfish diagnostics. Recently, a novel technique called loop‐mediated isothermal amplification (LAMP) has been developed, which is highly sensitive and rapid. LAMP has been used for the detection of bacterial, viral, fungal and parasitic diseases in both animal and plants. In aquaculture, LAMP‐based detection of pathogens like Edwardsiella tarda, E. ictaluri, Nocardia seriolae, Tetracapsuloides bryosalmonae, white spot syndrome virus and infectious haematopoietic necrosis virus have been reported. In this review, the application of LAMP for the detection of aquaculture‐associated pathogens is discussed.",10.1111/j.1365-2761.2005.00670.x,2226jnfl,"['Fish', 'and', 'shellfish', 'diseases', 'are', 'a', 'constant', 'threat', 'to', 'the', 'sustainability', 'and', 'economic', 'viability', 'of', 'aquaculture', 'Early', 'diagnosis', 'plays', 'a', 'vital', 'role', 'in', 'management', 'of', 'fish', 'and', 'shellfish', 'diseases', 'Traditionally', 'various', 'biochemical', 'and', 'serological', 'tests', 'have', 'been', 'used', 'for', 'fish', 'disease', 'diagnosis', 'However', 'the', 'time', 'and', 'expertise', 'required', 'for', 'such', 'diagnoses', 'makes', 'it', 'difficult', 'for', 'aquaculturists', 'to', 'easily', 'adopt', 'them', 'under', 'production', 'conditions', 'Polymerase', 'chain', 'reaction', 'and', 'probe', 'based', 'nucleic', 'acid', 'detection', 'have', 'become', 'increasingly', 'popular', 'in', 'fish', 'and', 'shellfish', 'diagnostics', 'Recently', 'a', 'novel', 'technique', 'called', 'loop', 'mediated', 'isothermal', 'amplification', 'LAMP', 'has', 'been', 'developed', 'which', 'is', 'highly', 'sensitive', 'and', 'rapid', 'LAMP', 'has', 'been', 'used', 'for', 'the', 'detection', 'of', 'bacterial', 'viral', 'fungal', 'and', 'parasitic', 'diseases', 'in', 'both', 'animal', 'and', 'plants', 'In', 'aquaculture', 'LAMP', 'based', 'detection', 'of', 'pathogens', 'like', 'Edwardsiella', 'tarda', 'E', 'ictaluri', 'Nocardia', 'seriolae', 'Tetracapsuloides', 'bryosalmonae', 'white', 'spot', 'syndrome', 'virus', 'and', 'infectious', 'haematopoietic', 'necrosis', 'virus', 'have', 'been', 'reported', 'In', 'this', 'review', 'the', 'application', 'of', 'LAMP', 'for', 'the', 'detection', 'of', 'aquaculture', 'associated', 'pathogens', 'is', 'discussed', '']"
199639,A Decentralized Molecular Diagnostic Testing Plan for Pandemic Influenza in the Ontario Public Health Laboratory System,2008-09-01,Canadian Journal of Public Health,https://www.ncbi.nlm.nih.gov/pubmed/19009922/,"The Ontario Public Health Laboratories system (OPHL) is in the midst of a six-year plan to implement molecular tools for pandemic influenza diagnostics in one central and three regional public health laboratories. This plan has been formulated as a consequence of: 1) experiences gained through severe acute respiratory syndrome (SARS), and comments of the members of the Expert Panel on SARS and Infectious Disease Control (i.e., the Walker report); 2) a review of pandemic preparedness literature; 3) historical and epidemiologic discussions about previous pandemics; and 4) suggestions made by various pandemic working committees. The OPHL plan includes: 1) an aggressive restructuring of the overall molecular microbiology testing capacity of the OPHL; 2) the ability to shift influenza testing of samples between designated OPHL laboratories; and 3) the development of screening tools for pandemic influenza diagnostic tests. The authors believe that investing in increased molecular testing capacity for regional laboratories outside the greater Toronto area will be beneficial to the OPHL system whether or not an influenza pandemic occurs. Well-trained technologists and microbiologists, and the introduction of new technologies, will facilitate the development of a wide variety of molecular tests for other infectious diseases at public health laboratories geographically distant from Toronto, thus enhancing overall laboratory testing capacity in the province of Ontario.",10.1007/bf03405247,wq7p3116,"['The', 'Ontario', 'Public', 'Health', 'Laboratories', 'system', 'OPHL', 'is', 'in', 'the', 'midst', 'of', 'a', 'six', 'year', 'plan', 'to', 'implement', 'molecular', 'tools', 'for', 'pandemic', 'influenza', 'diagnostics', 'in', 'one', 'central', 'and', 'three', 'regional', 'public', 'health', 'laboratories', 'This', 'plan', 'has', 'been', 'formulated', 'as', 'a', 'consequence', 'of', '1', 'experiences', 'gained', 'through', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'comments', 'of', 'the', 'members', 'of', 'the', 'Expert', 'Panel', 'on', 'SARS', 'and', 'Infectious', 'Disease', 'Control', 'i', 'e', 'the', 'Walker', 'report', '2', 'a', 'review', 'of', 'pandemic', 'preparedness', 'literature', '3', 'historical', 'and', 'epidemiologic', 'discussions', 'about', 'previous', 'pandemics', 'and', '4', 'suggestions', 'made', 'by', 'various', 'pandemic', 'working', 'committees', 'The', 'OPHL', 'plan', 'includes', '1', 'an', 'aggressive', 'restructuring', 'of', 'the', 'overall', 'molecular', 'microbiology', 'testing', 'capacity', 'of', 'the', 'OPHL', '2', 'the', 'ability', 'to', 'shift', 'influenza', 'testing', 'of', 'samples', 'between', 'designated', 'OPHL', 'laboratories', 'and', '3', 'the', 'development', 'of', 'screening', 'tools', 'for', 'pandemic', 'influenza', 'diagnostic', 'tests', 'The', 'authors', 'believe', 'that', 'investing', 'in', 'increased', 'molecular', 'testing', 'capacity', 'for', 'regional', 'laboratories', 'outside', 'the', 'greater', 'Toronto', 'area', 'will', 'be', 'beneficial', 'to', 'the', 'OPHL', 'system', 'whether', 'or', 'not', 'an', 'influenza', 'pandemic', 'occurs', 'Well', 'trained', 'technologists', 'and', 'microbiologists', 'and', 'the', 'introduction', 'of', 'new', 'technologies', 'will', 'facilitate', 'the', 'development', 'of', 'a', 'wide', 'variety', 'of', 'molecular', 'tests', 'for', 'other', 'infectious', 'diseases', 'at', 'public', 'health', 'laboratories', 'geographically', 'distant', 'from', 'Toronto', 'thus', 'enhancing', 'overall', 'laboratory', 'testing', 'capacity', 'in', 'the', 'province', 'of', 'Ontario', '']"
199740,A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19,2020-04-17,Cureus,https://doi.org/10.7759/cureus.7708; https://www.ncbi.nlm.nih.gov/pubmed/32313785/,"Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion. Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora. Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health. Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future. The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two. Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals. Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing. The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia. Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load. Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle. The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19. Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses. Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms. SARS-CoV can be detected in saliva at high titers. Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care. More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures.",10.7759/cureus.7708,awy3aans,"['Saliva', 'is', 'an', 'exocrine', 'secretion', 'produced', 'from', 'the', 'salivary', 'glands', 'and', 'has', 'numerous', 'functions', 'such', 'as', 'cleansing', 'and', 'protection', 'of', 'the', 'oral', 'cavity', 'antimicrobial', 'effects', 'and', 'aids', 'in', 'digestion', 'Due', 'to', 'the', 'speedy', 'development', 'in', 'the', 'field', 'of', 'salivaomics', 'saliva', 'is', 'now', 'well', 'accepted', 'as', 'a', 'pool', 'of', 'biological', 'markers', 'that', 'vary', 'from', 'changes', 'in', 'biochemicals', 'nucleic', 'acids', 'and', 'proteins', 'to', 'the', 'microflora', 'Saliva', 'has', 'an', 'immense', 'potential', 'as', 'a', 'diagnostic', 'fluid', 'and', 'offers', 'an', 'edge', 'over', 'other', 'biological', 'fluids', 'as', 'its', 'collection', 'method', 'does', 'not', 'require', 'invasive', 'procedure', 'economical', 'and', 'is', 'useful', 'for', 'monitoring', 'systemic', 'health', 'Development', 'of', 'sensitive', 'and', 'precise', 'salivary', 'diagnostic', 'tools', 'and', 'the', 'formulation', 'of', 'defined', 'guidelines', 'following', 'meticulous', 'testing', 'will', 'allow', 'salivary', 'diagnostics', 'to', 'be', 'utilised', 'as', 'chair', 'side', 'tests', 'for', 'various', 'oral', 'and', 'systemic', 'diseases', 'in', 'the', 'near', 'future', 'The', 'coronavirus', 'disease', 'Covid', '19', 'pandemic', 'is', 'the', 'biggest', 'challenge', 'and', 'global', 'health', 'crisis', 'for', 'the', 'world', 'since', 'World', 'War', 'Two', 'Rapid', 'and', 'accurate', 'diagnosis', 'of', 'Covid', '19', 'is', 'crucial', 'in', 'controlling', 'the', 'outbreak', 'in', 'the', 'community', 'and', 'in', 'hospitals', 'Nasopharyngeal', 'and', 'oropharyngeal', 'swabs', 'are', 'the', 'recommended', 'specimen', 'types', 'for', 'Covid', '19', 'diagnostic', 'testing', 'The', 'collection', 'of', 'these', 'specimen', 'types', 'requires', 'close', 'contact', 'between', 'healthcare', 'workers', 'and', 'patients', 'and', 'poses', 'a', 'risk', 'of', 'transmission', 'of', 'the', 'virus', 'causes', 'discomfort', 'and', 'may', 'cause', 'bleeding', 'especially', 'in', 'patients', 'with', 'condition', 'such', 'as', 'thrombocytopenia', 'Hence', 'nasopharyngeal', 'or', 'oropharyngeal', 'swabs', 'are', 'not', 'desirable', 'for', 'sequential', 'monitoring', 'of', 'viral', 'load', 'Saliva', 'specimens', 'can', 'be', 'obtained', 'easily', 'as', 'the', 'patient', 'is', 'asked', 'to', 'spit', 'into', 'a', 'sterile', 'bottle', 'The', 'collection', 'of', 'saliva', 'is', 'non', 'invasive', 'and', 'greatly', 'minimizes', 'the', 'exposure', 'of', 'healthcare', 'workers', 'to', 'Covid', '19', 'Saliva', 'has', 'a', 'high', 'consistency', 'rate', 'of', 'greater', 'than', '90', 'with', 'nasopharyngeal', 'specimens', 'in', 'the', 'detection', 'of', 'respiratory', 'viruses', 'including', 'coronaviruses', 'Saliva', 'has', 'also', 'been', 'used', 'in', 'screening', 'respiratory', 'viruses', 'among', 'hospitalized', 'patients', 'without', 'pyrexia', 'or', 'respiratory', 'symptoms', 'SARS', 'CoV', 'can', 'be', 'detected', 'in', 'saliva', 'at', 'high', 'titers', 'Salivary', 'diagnostics', 'is', 'a', 'dynamic', 'field', 'that', 'is', 'being', 'incorporated', 'as', 'part', 'of', 'disease', 'diagnosis', 'clinical', 'monitoring', 'of', 'systemic', 'health', 'and', 'to', 'make', 'significant', 'clinical', 'decisions', 'for', 'patient', 'care', 'More', 'research', 'is', 'required', 'to', 'analyze', 'the', 'potential', 'diagnostic', 'of', 'Covid', '19', 'in', 'saliva', 'to', 'develop', 'rapid', 'chair', 'side', 'tests', 'for', 'the', 'detection', 'of', 'Covid', '19', 'and', 'it', 'is', 'also', 'pivotal', 'to', 'improve', 'and', 'develop', 'successful', 'strategies', 'for', 'prevention', 'especially', 'for', 'dentists', 'and', 'healthcare', 'professionals', 'who', 'are', 'involved', 'in', 'performing', 'aerosol', 'generating', 'procedures', '']"
200295,Microarrays for Pathogen Detection and Analysis,2011-09-19,Brief Funct Genomics,https://www.ncbi.nlm.nih.gov/pubmed/21930658/; https://doi.org/10.1093/bfgp/elr027,"DNA microarrays have emerged as a viable platform for detection of pathogenic organisms in clinical and environmental samples. These microbial detection arrays occupy a middle ground between low cost, narrowly focused assays such as multiplex PCR and more expensive, broad-spectrum technologies like high-throughput sequencing. While pathogen detection arrays have been used primarily in a research context, several groups are aggressively working to develop arrays for clinical diagnostics, food safety testing, environmental monitoring and biodefense. Statistical algorithms that can analyze data from microbial detection arrays and provide easily interpretable results are absolutely required in order for these efforts to succeed. In this article, we will review the most promising array designs and analysis algorithms that have been developed to date, comparing their strengths and weaknesses for pathogen detection and discovery.",10.1093/bfgp/elr027,9ntgqyhw,"['DNA', 'microarrays', 'have', 'emerged', 'as', 'a', 'viable', 'platform', 'for', 'detection', 'of', 'pathogenic', 'organisms', 'in', 'clinical', 'and', 'environmental', 'samples', 'These', 'microbial', 'detection', 'arrays', 'occupy', 'a', 'middle', 'ground', 'between', 'low', 'cost', 'narrowly', 'focused', 'assays', 'such', 'as', 'multiplex', 'PCR', 'and', 'more', 'expensive', 'broad', 'spectrum', 'technologies', 'like', 'high', 'throughput', 'sequencing', 'While', 'pathogen', 'detection', 'arrays', 'have', 'been', 'used', 'primarily', 'in', 'a', 'research', 'context', 'several', 'groups', 'are', 'aggressively', 'working', 'to', 'develop', 'arrays', 'for', 'clinical', 'diagnostics', 'food', 'safety', 'testing', 'environmental', 'monitoring', 'and', 'biodefense', 'Statistical', 'algorithms', 'that', 'can', 'analyze', 'data', 'from', 'microbial', 'detection', 'arrays', 'and', 'provide', 'easily', 'interpretable', 'results', 'are', 'absolutely', 'required', 'in', 'order', 'for', 'these', 'efforts', 'to', 'succeed', 'In', 'this', 'article', 'we', 'will', 'review', 'the', 'most', 'promising', 'array', 'designs', 'and', 'analysis', 'algorithms', 'that', 'have', 'been', 'developed', 'to', 'date', 'comparing', 'their', 'strengths', 'and', 'weaknesses', 'for', 'pathogen', 'detection', 'and', 'discovery', '']"
200471,Rapid detection of infectious bovine Rhinotracheitis virus using recombinase polymerase amplification assays,2017-12-13,BMC Vet Res,https://www.ncbi.nlm.nih.gov/pubmed/29237466/; https://doi.org/10.1186/s12917-017-1284-0,"BACKGROUND: Infectious bovine rhinotracheitis virus (IBRV) is a major pathogen in cattle and has led to significant economic losses to the dairy industry worldwide, and therefore a more optimal method for the rapid diagnosis of IBRV infection is highly needed. In this study, we described the development of a lateral flow dipstrip (LFD) of isothermal recombinase polymerase amplification (RPA) method for rapid detection of IBRV. METHODS: Distinct regions were selected as a candidate target for designing the LFD-RPA primers and probes. The analytical sensitivity of the RPA assay was determined using ten-fold serially diluted IBRV DNA. The specificity of the assay was assessed with other viral pathogens of cattle with similar clinic and other herpesviruses. The clinical performance was evaluated by testing 106 acute-phase high fever clinical specimens. RESULTS: RPA primers and probe were designed to target the specific conserved UL52 region fragment of IBRV. The detection could be completed at a constant temperature of 38 °C for 25 min, and the amplification products were easily visualized on a simple LFD. The detection limit of this assay was 5 copies per reaction of IBRV DNA and there was no cross-reactivity with other viruses causing bovine gastrointestinal and respiratory infections or other herpesviruses. The assay performance on acute-phase high fever clinical samples collected from cattle with no vaccine against IBRV, which were suspected to be infected with IBRV, was validated by detecting 24 fecal, 36 blood, 38 nasal swab and 8 tissue specimens, and compared with SYBR Green I based real-time PCR. The coincidence between IBRV LFD-RPA and real-time PCR was 100%. CONCLUSION: IBRV LFD-RPA was fast and much easier to serve as an alternative to the common measures used for IBRV diagnosis, as there is reduction in the use of instruments for identification of the infected animals. In addition, this assay may be the potential candidate to be used as point-of-care diagnostics in the field.",10.1186/s12917-017-1284-0,bgrgzfoo,"['BACKGROUND', 'Infectious', 'bovine', 'rhinotracheitis', 'virus', 'IBRV', 'is', 'a', 'major', 'pathogen', 'in', 'cattle', 'and', 'has', 'led', 'to', 'significant', 'economic', 'losses', 'to', 'the', 'dairy', 'industry', 'worldwide', 'and', 'therefore', 'a', 'more', 'optimal', 'method', 'for', 'the', 'rapid', 'diagnosis', 'of', 'IBRV', 'infection', 'is', 'highly', 'needed', 'In', 'this', 'study', 'we', 'described', 'the', 'development', 'of', 'a', 'lateral', 'flow', 'dipstrip', 'LFD', 'of', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'RPA', 'method', 'for', 'rapid', 'detection', 'of', 'IBRV', 'METHODS', 'Distinct', 'regions', 'were', 'selected', 'as', 'a', 'candidate', 'target', 'for', 'designing', 'the', 'LFD', 'RPA', 'primers', 'and', 'probes', 'The', 'analytical', 'sensitivity', 'of', 'the', 'RPA', 'assay', 'was', 'determined', 'using', 'ten', 'fold', 'serially', 'diluted', 'IBRV', 'DNA', 'The', 'specificity', 'of', 'the', 'assay', 'was', 'assessed', 'with', 'other', 'viral', 'pathogens', 'of', 'cattle', 'with', 'similar', 'clinic', 'and', 'other', 'herpesviruses', 'The', 'clinical', 'performance', 'was', 'evaluated', 'by', 'testing', '106', 'acute', 'phase', 'high', 'fever', 'clinical', 'specimens', 'RESULTS', 'RPA', 'primers', 'and', 'probe', 'were', 'designed', 'to', 'target', 'the', 'specific', 'conserved', 'UL52', 'region', 'fragment', 'of', 'IBRV', 'The', 'detection', 'could', 'be', 'completed', 'at', 'a', 'constant', 'temperature', 'of', '38', 'C', 'for', '25', 'min', 'and', 'the', 'amplification', 'products', 'were', 'easily', 'visualized', 'on', 'a', 'simple', 'LFD', 'The', 'detection', 'limit', 'of', 'this', 'assay', 'was', '5', 'copies', 'per', 'reaction', 'of', 'IBRV', 'DNA', 'and', 'there', 'was', 'no', 'cross', 'reactivity', 'with', 'other', 'viruses', 'causing', 'bovine', 'gastrointestinal', 'and', 'respiratory', 'infections', 'or', 'other', 'herpesviruses', 'The', 'assay', 'performance', 'on', 'acute', 'phase', 'high', 'fever', 'clinical', 'samples', 'collected', 'from', 'cattle', 'with', 'no', 'vaccine', 'against', 'IBRV', 'which', 'were', 'suspected', 'to', 'be', 'infected', 'with', 'IBRV', 'was', 'validated', 'by', 'detecting', '24', 'fecal', '36', 'blood', '38', 'nasal', 'swab', 'and', '8', 'tissue', 'specimens', 'and', 'compared', 'with', 'SYBR', 'Green', 'I', 'based', 'real', 'time', 'PCR', 'The', 'coincidence', 'between', 'IBRV', 'LFD', 'RPA', 'and', 'real', 'time', 'PCR', 'was', '100', 'CONCLUSION', 'IBRV', 'LFD', 'RPA', 'was', 'fast', 'and', 'much', 'easier', 'to', 'serve', 'as', 'an', 'alternative', 'to', 'the', 'common', 'measures', 'used', 'for', 'IBRV', 'diagnosis', 'as', 'there', 'is', 'reduction', 'in', 'the', 'use', 'of', 'instruments', 'for', 'identification', 'of', 'the', 'infected', 'animals', 'In', 'addition', 'this', 'assay', 'may', 'be', 'the', 'potential', 'candidate', 'to', 'be', 'used', 'as', 'point', 'of', 'care', 'diagnostics', 'in', 'the', 'field', '']"
200830,Identification of Upper Respiratory Tract Pathogens Using Electrochemical Detection on an Oligonucleotide Microarray,2007-09-26,PLoS One,https://www.ncbi.nlm.nih.gov/pubmed/17895966/,"Bacterial and viral upper respiratory infections (URI) produce highly variable clinical symptoms that cannot be used to identify the etiologic agent. Proper treatment, however, depends on correct identification of the pathogen involved as antibiotics provide little or no benefit with viral infections. Here we describe a rapid and sensitive genotyping assay and microarray for URI identification using standard amplification and hybridization techniques, with electrochemical detection (ECD) on a semiconductor-based oligonucleotide microarray. The assay was developed to detect four bacterial pathogens (Bordetella pertussis, Streptococcus pyogenes, Chlamydia pneumoniae and Mycoplasma pneumoniae) and 9 viral pathogens (adenovirus 4, coronavirus OC43, 229E and HK, influenza A and B, parainfluinza types 1, 2, and 3 and respiratory syncytial virus. This new platform forms the basis for a fully automated diagnostics system that is very flexible and can be customized to suit different or additional pathogens. Multiple probes on a flexible platform allow one to test probes empirically and then select highly reactive probes for further iterative evaluation. Because ECD uses an enzymatic reaction to create electrical signals that can be read directly from the array, there is no need for image analysis or for expensive and delicate optical scanning equipment. We show assay sensitivity and specificity that are excellent for a multiplexed format.",10.1371/journal.pone.0000924,yzmt1e0l,"['Bacterial', 'and', 'viral', 'upper', 'respiratory', 'infections', 'URI', 'produce', 'highly', 'variable', 'clinical', 'symptoms', 'that', 'cannot', 'be', 'used', 'to', 'identify', 'the', 'etiologic', 'agent', 'Proper', 'treatment', 'however', 'depends', 'on', 'correct', 'identification', 'of', 'the', 'pathogen', 'involved', 'as', 'antibiotics', 'provide', 'little', 'or', 'no', 'benefit', 'with', 'viral', 'infections', 'Here', 'we', 'describe', 'a', 'rapid', 'and', 'sensitive', 'genotyping', 'assay', 'and', 'microarray', 'for', 'URI', 'identification', 'using', 'standard', 'amplification', 'and', 'hybridization', 'techniques', 'with', 'electrochemical', 'detection', 'ECD', 'on', 'a', 'semiconductor', 'based', 'oligonucleotide', 'microarray', 'The', 'assay', 'was', 'developed', 'to', 'detect', 'four', 'bacterial', 'pathogens', 'Bordetella', 'pertussis', 'Streptococcus', 'pyogenes', 'Chlamydia', 'pneumoniae', 'and', 'Mycoplasma', 'pneumoniae', 'and', '9', 'viral', 'pathogens', 'adenovirus', '4', 'coronavirus', 'OC43', '229E', 'and', 'HK', 'influenza', 'A', 'and', 'B', 'parainfluinza', 'types', '1', '2', 'and', '3', 'and', 'respiratory', 'syncytial', 'virus', 'This', 'new', 'platform', 'forms', 'the', 'basis', 'for', 'a', 'fully', 'automated', 'diagnostics', 'system', 'that', 'is', 'very', 'flexible', 'and', 'can', 'be', 'customized', 'to', 'suit', 'different', 'or', 'additional', 'pathogens', 'Multiple', 'probes', 'on', 'a', 'flexible', 'platform', 'allow', 'one', 'to', 'test', 'probes', 'empirically', 'and', 'then', 'select', 'highly', 'reactive', 'probes', 'for', 'further', 'iterative', 'evaluation', 'Because', 'ECD', 'uses', 'an', 'enzymatic', 'reaction', 'to', 'create', 'electrical', 'signals', 'that', 'can', 'be', 'read', 'directly', 'from', 'the', 'array', 'there', 'is', 'no', 'need', 'for', 'image', 'analysis', 'or', 'for', 'expensive', 'and', 'delicate', 'optical', 'scanning', 'equipment', 'We', 'show', 'assay', 'sensitivity', 'and', 'specificity', 'that', 'are', 'excellent', 'for', 'a', 'multiplexed', 'format', '']"
201237,A microbial detection array (MDA) for viral and bacterial detection,2010-11-25,BMC Genomics,https://www.ncbi.nlm.nih.gov/pubmed/21108826/; https://doi.org/10.1186/1471-2164-11-668,"BACKGROUND: Identifying the bacteria and viruses present in a complex sample is useful in disease diagnostics, product safety, environmental characterization, and research. Array-based methods have proven utility to detect in a single assay at a reasonable cost any microbe from the thousands that have been sequenced. METHODS: We designed a pan-Microbial Detection Array (MDA) to detect all known viruses (including phages), bacteria and plasmids and developed a novel statistical analysis method to identify mixtures of organisms from complex samples hybridized to the array. The array has broader coverage of bacterial and viral targets and is based on more recent sequence data and more probes per target than other microbial detection/discovery arrays in the literature. Family-specific probes were selected for all sequenced viral and bacterial complete genomes, segments, and plasmids. Probes were designed to tolerate some sequence variation to enable detection of divergent species with homology to sequenced organisms, and to have no significant matches to the human genome sequence. RESULTS: In blinded testing on spiked samples with single or multiple viruses, the MDA was able to correctly identify species or strains. In clinical fecal, serum, and respiratory samples, the MDA was able to detect and characterize multiple viruses, phage, and bacteria in a sample to the family and species level, as confirmed by PCR. CONCLUSIONS: The MDA can be used to identify the suite of viruses and bacteria present in complex samples.",10.1186/1471-2164-11-668,qi2knswx,"['BACKGROUND', 'Identifying', 'the', 'bacteria', 'and', 'viruses', 'present', 'in', 'a', 'complex', 'sample', 'is', 'useful', 'in', 'disease', 'diagnostics', 'product', 'safety', 'environmental', 'characterization', 'and', 'research', 'Array', 'based', 'methods', 'have', 'proven', 'utility', 'to', 'detect', 'in', 'a', 'single', 'assay', 'at', 'a', 'reasonable', 'cost', 'any', 'microbe', 'from', 'the', 'thousands', 'that', 'have', 'been', 'sequenced', 'METHODS', 'We', 'designed', 'a', 'pan', 'Microbial', 'Detection', 'Array', 'MDA', 'to', 'detect', 'all', 'known', 'viruses', 'including', 'phages', 'bacteria', 'and', 'plasmids', 'and', 'developed', 'a', 'novel', 'statistical', 'analysis', 'method', 'to', 'identify', 'mixtures', 'of', 'organisms', 'from', 'complex', 'samples', 'hybridized', 'to', 'the', 'array', 'The', 'array', 'has', 'broader', 'coverage', 'of', 'bacterial', 'and', 'viral', 'targets', 'and', 'is', 'based', 'on', 'more', 'recent', 'sequence', 'data', 'and', 'more', 'probes', 'per', 'target', 'than', 'other', 'microbial', 'detection', 'discovery', 'arrays', 'in', 'the', 'literature', 'Family', 'specific', 'probes', 'were', 'selected', 'for', 'all', 'sequenced', 'viral', 'and', 'bacterial', 'complete', 'genomes', 'segments', 'and', 'plasmids', 'Probes', 'were', 'designed', 'to', 'tolerate', 'some', 'sequence', 'variation', 'to', 'enable', 'detection', 'of', 'divergent', 'species', 'with', 'homology', 'to', 'sequenced', 'organisms', 'and', 'to', 'have', 'no', 'significant', 'matches', 'to', 'the', 'human', 'genome', 'sequence', 'RESULTS', 'In', 'blinded', 'testing', 'on', 'spiked', 'samples', 'with', 'single', 'or', 'multiple', 'viruses', 'the', 'MDA', 'was', 'able', 'to', 'correctly', 'identify', 'species', 'or', 'strains', 'In', 'clinical', 'fecal', 'serum', 'and', 'respiratory', 'samples', 'the', 'MDA', 'was', 'able', 'to', 'detect', 'and', 'characterize', 'multiple', 'viruses', 'phage', 'and', 'bacteria', 'in', 'a', 'sample', 'to', 'the', 'family', 'and', 'species', 'level', 'as', 'confirmed', 'by', 'PCR', 'CONCLUSIONS', 'The', 'MDA', 'can', 'be', 'used', 'to', 'identify', 'the', 'suite', 'of', 'viruses', 'and', 'bacteria', 'present', 'in', 'complex', 'samples', '']"
201595,"Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019",2020-02-06,Euro Surveill,https://doi.org/10.2807/1560-7917.es.2020.25.5.2000038; https://www.ncbi.nlm.nih.gov/pubmed/32046818/,"The Finnish new variant of Chlamydia trachomatis (FI-nvCT) is escaping diagnostics in Finland, Norway and Sweden. We have developed and validated an Aptima-format nucleic acid amplification test (NAAT) designed specifically to detect the FI-nvCT. This NAAT has high sensitivity (100%) and specificity (100%) for the FI-nvCT strain, enabling further investigation of the geographic distribution, prevalence and transmission of this diagnostic-escape mutant in screening populations in Europe.",10.2807/1560-7917.es.2020.25.5.2000038,6fdrssr8,"['The', 'Finnish', 'new', 'variant', 'of', 'Chlamydia', 'trachomatis', 'FI', 'nvCT', 'is', 'escaping', 'diagnostics', 'in', 'Finland', 'Norway', 'and', 'Sweden', 'We', 'have', 'developed', 'and', 'validated', 'an', 'Aptima', 'format', 'nucleic', 'acid', 'amplification', 'test', 'NAAT', 'designed', 'specifically', 'to', 'detect', 'the', 'FI', 'nvCT', 'This', 'NAAT', 'has', 'high', 'sensitivity', '100', 'and', 'specificity', '100', 'for', 'the', 'FI', 'nvCT', 'strain', 'enabling', 'further', 'investigation', 'of', 'the', 'geographic', 'distribution', 'prevalence', 'and', 'transmission', 'of', 'this', 'diagnostic', 'escape', 'mutant', 'in', 'screening', 'populations', 'in', 'Europe', '']"
201734,Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections,2014-07-28,ISBT Sci Ser,https://www.ncbi.nlm.nih.gov/pubmed/25210533/,"BACKGROUND: In August 2009, a group from the AABB (Stramer et al., Transfusion 2009;99:1S–29S, Emerging Infectious Disease Agents and their Potential Threat to Transfusion Safety; http://www.aabb.org/resources/bct/eid/Pages/default.aspx) published a Supplement to Transfusion that reviewed emerging infectious disease (EID) agents that pose a real or theoretical threat to transfusion safety, but for which an existing effective intervention is lacking. The necessary attributes for transfusion transmission were outlined including: presence of the agent in blood during the donor's asymptomatic phase, the agent's survival/persistence in blood during processing/storage, and lastly that the agent must be recognized as responsible for a clinically apparent outcome in at least a proportion of recipients who become infected. Without these attributes, agents are not considered as a transfusion-transmission threat and were excluded. Sixty-eight such agents were identified with enough evidence/likelihood of transfusion transmission (e.g., blood phase) and potential for clinical disease to warrant further consideration. In the Supplement, Fact Sheets (FS) were published providing information on: agent classification; disease agent's importance; clinical syndromes/diseases caused; transmission modes (including vectors/reservoirs); likelihood of transfusion transmission, and if proven to be transfusion-transmitted, information on known cases; the feasibility/predicted success of interventions for donor screening (questioning) and tests available for diagnostics/ adapted for donor screening; and finally, the efficacy, if known, of inactivation methods for plasma-derived products. The Supplement included a separate section on pathogen reduction using published data. Agents were prioritized relative to their scientific/epidemiologic threat and their perceived threat to the community including concerns expressed by the regulators of blood. Agents given the highest priority due to a known transfusion-transmission threat and severe/fatal disease in recipients were the vCJD prion, dengue viruses and the obligate red-cell parasite that causes babesiosis (B. microti and related Babesia). Although the focus of the Supplement was towards the United States and Canada, many of the agents (and the process) are applicable worldwide. NEXT STEPS: Since the publication of the Supplement, six new FSs (yellow fever viruses-including vaccine breakthrough infections, miscellaneous arboviruses, XMRV, human parvoviruses/bocaviruses other than B19, and most recently the Middle East respiratory syndrome coronavirus, MERS-CoV) were added and 14 existing FSs updated (Anaplasma, Babesia, Bartonella, Erhlichia, chronic wasting disease-CWD, human prions other than vCJD, vCJD, Coxiella burnetii-the agent of Q fever, dengue viruses, HAV, HEV, Japanese encephalitis-JE complex, tick-borne encephalitis viruses-TBEV, and human parvovirus B19). Also, tables were released outlining pathogen reduction clinical trials/results (published) and availability/commercial routine use of such technologies by country. Of necessity, the list of EID agents is not, and can never be, complete due to the nature of emergence. We recognized that a system of assessing the risk/threat of EIDs for their potential impact on blood safety and availability must include processes for monitoring, identifying, evaluating, estimating severity, assessing risk and developing interventions. Thus, a ‘toolkit’ containing the necessary ‘tools’ from EID monitoring (horizon scanning) to validation/effectiveness evaluations of interventions is being developed. The goal is, to develop a systematic approach to risk assessment and intervention development for the impact of emerging infectious upon blood safety intended to educate and provide advise about risks/interventions in a timely/accurate fashion. CONCLUSIONS: The process and final product (toolkit) including methods to monitor EID agent emergence, identification/recognition of a transfusion-transmission threat, methods for quantitative risk assessments, and the appropriate management of such threats should be considered for implementation by all blood systems.",10.1111/voxs.12070,nyocnvvj,"['BACKGROUND', 'In', 'August', '2009', 'a', 'group', 'from', 'the', 'AABB', 'Stramer', 'et', 'al', 'Transfusion', '2009', '99', '1S', '29S', 'Emerging', 'Infectious', 'Disease', 'Agents', 'and', 'their', 'Potential', 'Threat', 'to', 'Transfusion', 'Safety', 'http', 'www', 'aabb', 'org', 'resources', 'bct', 'eid', 'Pages', 'default', 'aspx', 'published', 'a', 'Supplement', 'to', 'Transfusion', 'that', 'reviewed', 'emerging', 'infectious', 'disease', 'EID', 'agents', 'that', 'pose', 'a', 'real', 'or', 'theoretical', 'threat', 'to', 'transfusion', 'safety', 'but', 'for', 'which', 'an', 'existing', 'effective', 'intervention', 'is', 'lacking', 'The', 'necessary', 'attributes', 'for', 'transfusion', 'transmission', 'were', 'outlined', 'including', 'presence', 'of', 'the', 'agent', 'in', 'blood', 'during', 'the', 'donor', 's', 'asymptomatic', 'phase', 'the', 'agent', 's', 'survival', 'persistence', 'in', 'blood', 'during', 'processing', 'storage', 'and', 'lastly', 'that', 'the', 'agent', 'must', 'be', 'recognized', 'as', 'responsible', 'for', 'a', 'clinically', 'apparent', 'outcome', 'in', 'at', 'least', 'a', 'proportion', 'of', 'recipients', 'who', 'become', 'infected', 'Without', 'these', 'attributes', 'agents', 'are', 'not', 'considered', 'as', 'a', 'transfusion', 'transmission', 'threat', 'and', 'were', 'excluded', 'Sixty', 'eight', 'such', 'agents', 'were', 'identified', 'with', 'enough', 'evidence', 'likelihood', 'of', 'transfusion', 'transmission', 'e', 'g', 'blood', 'phase', 'and', 'potential', 'for', 'clinical', 'disease', 'to', 'warrant', 'further', 'consideration', 'In', 'the', 'Supplement', 'Fact', 'Sheets', 'FS', 'were', 'published', 'providing', 'information', 'on', 'agent', 'classification', 'disease', 'agent', 's', 'importance', 'clinical', 'syndromes', 'diseases', 'caused', 'transmission', 'modes', 'including', 'vectors', 'reservoirs', 'likelihood', 'of', 'transfusion', 'transmission', 'and', 'if', 'proven', 'to', 'be', 'transfusion', 'transmitted', 'information', 'on', 'known', 'cases', 'the', 'feasibility', 'predicted', 'success', 'of', 'interventions', 'for', 'donor', 'screening', 'questioning', 'and', 'tests', 'available', 'for', 'diagnostics', 'adapted', 'for', 'donor', 'screening', 'and', 'finally', 'the', 'efficacy', 'if', 'known', 'of', 'inactivation', 'methods', 'for', 'plasma', 'derived', 'products', 'The', 'Supplement', 'included', 'a', 'separate', 'section', 'on', 'pathogen', 'reduction', 'using', 'published', 'data', 'Agents', 'were', 'prioritized', 'relative', 'to', 'their', 'scientific', 'epidemiologic', 'threat', 'and', 'their', 'perceived', 'threat', 'to', 'the', 'community', 'including', 'concerns', 'expressed', 'by', 'the', 'regulators', 'of', 'blood', 'Agents', 'given', 'the', 'highest', 'priority', 'due', 'to', 'a', 'known', 'transfusion', 'transmission', 'threat', 'and', 'severe', 'fatal', 'disease', 'in', 'recipients', 'were', 'the', 'vCJD', 'prion', 'dengue', 'viruses', 'and', 'the', 'obligate', 'red', 'cell', 'parasite', 'that', 'causes', 'babesiosis', 'B', 'microti', 'and', 'related', 'Babesia', 'Although', 'the', 'focus', 'of', 'the', 'Supplement', 'was', 'towards', 'the', 'United', 'States', 'and', 'Canada', 'many', 'of', 'the', 'agents', 'and', 'the', 'process', 'are', 'applicable', 'worldwide', 'NEXT', 'STEPS', 'Since', 'the', 'publication', 'of', 'the', 'Supplement', 'six', 'new', 'FSs', 'yellow', 'fever', 'viruses', 'including', 'vaccine', 'breakthrough', 'infections', 'miscellaneous', 'arboviruses', 'XMRV', 'human', 'parvoviruses', 'bocaviruses', 'other', 'than', 'B19', 'and', 'most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'were', 'added', 'and', '14', 'existing', 'FSs', 'updated', 'Anaplasma', 'Babesia', 'Bartonella', 'Erhlichia', 'chronic', 'wasting', 'disease', 'CWD', 'human', 'prions', 'other', 'than', 'vCJD', 'vCJD', 'Coxiella', 'burnetii', 'the', 'agent', 'of', 'Q', 'fever', 'dengue', 'viruses', 'HAV', 'HEV', 'Japanese', 'encephalitis', 'JE', 'complex', 'tick', 'borne', 'encephalitis', 'viruses', 'TBEV', 'and', 'human', 'parvovirus', 'B19', 'Also', 'tables', 'were', 'released', 'outlining', 'pathogen', 'reduction', 'clinical', 'trials', 'results', 'published', 'and', 'availability', 'commercial', 'routine', 'use', 'of', 'such', 'technologies', 'by', 'country', 'Of', 'necessity', 'the', 'list', 'of', 'EID', 'agents', 'is', 'not', 'and', 'can', 'never', 'be', 'complete', 'due', 'to', 'the', 'nature', 'of', 'emergence', 'We', 'recognized', 'that', 'a', 'system', 'of', 'assessing', 'the', 'risk', 'threat', 'of', 'EIDs', 'for', 'their', 'potential', 'impact', 'on', 'blood', 'safety', 'and', 'availability', 'must', 'include', 'processes', 'for', 'monitoring', 'identifying', 'evaluating', 'estimating', 'severity', 'assessing', 'risk', 'and', 'developing', 'interventions', 'Thus', 'a', 'toolkit', 'containing', 'the', 'necessary', 'tools', 'from', 'EID', 'monitoring', 'horizon', 'scanning', 'to', 'validation', 'effectiveness', 'evaluations', 'of', 'interventions', 'is', 'being', 'developed', 'The', 'goal', 'is', 'to', 'develop', 'a', 'systematic', 'approach', 'to', 'risk', 'assessment', 'and', 'intervention', 'development', 'for', 'the', 'impact', 'of', 'emerging', 'infectious', 'upon', 'blood', 'safety', 'intended', 'to', 'educate', 'and', 'provide', 'advise', 'about', 'risks', 'interventions', 'in', 'a', 'timely', 'accurate', 'fashion', 'CONCLUSIONS', 'The', 'process', 'and', 'final', 'product', 'toolkit', 'including', 'methods', 'to', 'monitor', 'EID', 'agent', 'emergence', 'identification', 'recognition', 'of', 'a', 'transfusion', 'transmission', 'threat', 'methods', 'for', 'quantitative', 'risk', 'assessments', 'and', 'the', 'appropriate', 'management', 'of', 'such', 'threats', 'should', 'be', 'considered', 'for', 'implementation', 'by', 'all', 'blood', 'systems', '']"
201890,Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus,2016-07-31,Emerg Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/27191188/; https://doi.org/10.3201/eid2207.160022,"Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.",10.3201/eid2207.160022,jtx7ni9b,"['Preclinical', 'development', 'of', 'and', 'research', 'on', 'potential', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'medical', 'countermeasures', 'remain', 'preliminary', 'advancements', 'are', 'needed', 'before', 'most', 'countermeasures', 'are', 'ready', 'to', 'be', 'tested', 'in', 'human', 'clinical', 'trials', 'Research', 'priorities', 'include', 'standardization', 'of', 'animal', 'models', 'and', 'virus', 'stocks', 'for', 'studying', 'disease', 'pathogenesis', 'and', 'efficacy', 'of', 'medical', 'countermeasures', 'development', 'of', 'MERS', 'CoV', 'diagnostics', 'improved', 'access', 'to', 'nonhuman', 'primates', 'to', 'support', 'preclinical', 'research', 'studies', 'to', 'better', 'understand', 'and', 'control', 'MERS', 'CoV', 'disease', 'including', 'vaccination', 'studies', 'in', 'camels', 'and', 'development', 'of', 'a', 'standardized', 'clinical', 'trial', 'protocol', 'Partnering', 'with', 'clinical', 'trial', 'networks', 'in', 'affected', 'countries', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'investigational', 'therapeutics', 'will', 'strengthen', 'efforts', 'to', 'identify', 'successful', 'medical', 'countermeasures', '']"
201952,10 Wochen alter Säugling mit Sepsisverdacht und SARS-CoV-2-Nachweis in Liquor und Rachen,2020-06-03,Monatsschr Kinderheilkd,https://doi.org/10.1007/s00112-020-00942-8,A young male infant was referred to the emergency department with apparent acute sepsis. The laboratory results were compatible with a viral infection except for a slightly elevated procalcitonin level. Due to the clinical severity intravenous antibiotic treatment was started immediately. Cerebrospinal fluid and urine testing initially showed no infection focus but then SARS-CoV‑2 was detected in the lower pharynx and cerebrospinal fluid. The clinical condition of the infant rapidly improved but whether this was due to symptomatic or antibiotic treatment remained unknown. There is still a considerable lack of experience regarding diagnostics and treatment of pediatric SARS-CoV-2 infections.,10.1007/s00112-020-00942-8,m8fl96zb,"['A', 'young', 'male', 'infant', 'was', 'referred', 'to', 'the', 'emergency', 'department', 'with', 'apparent', 'acute', 'sepsis', 'The', 'laboratory', 'results', 'were', 'compatible', 'with', 'a', 'viral', 'infection', 'except', 'for', 'a', 'slightly', 'elevated', 'procalcitonin', 'level', 'Due', 'to', 'the', 'clinical', 'severity', 'intravenous', 'antibiotic', 'treatment', 'was', 'started', 'immediately', 'Cerebrospinal', 'fluid', 'and', 'urine', 'testing', 'initially', 'showed', 'no', 'infection', 'focus', 'but', 'then', 'SARS', 'CoV', '2', 'was', 'detected', 'in', 'the', 'lower', 'pharynx', 'and', 'cerebrospinal', 'fluid', 'The', 'clinical', 'condition', 'of', 'the', 'infant', 'rapidly', 'improved', 'but', 'whether', 'this', 'was', 'due', 'to', 'symptomatic', 'or', 'antibiotic', 'treatment', 'remained', 'unknown', 'There', 'is', 'still', 'a', 'considerable', 'lack', 'of', 'experience', 'regarding', 'diagnostics', 'and', 'treatment', 'of', 'pediatric', 'SARS', 'CoV', '2', 'infections', '']"
202068,Olfactory Device for Large Scale Pre-screening for COVID-19,2020-06-26,Trans Indian Natl,https://doi.org/10.1007/s41403-020-00126-6,"Recent pandemic caused by COVID-19 has motivated lockdown in several countries for long duration and will have a long lasting impact on the social life and economics world wide. India is no exception although showing relatively delayed increase in number of cases. Multilayered diagnostics for mass scaled screening is inevitable during and especially after the peak is passed and life is moving towards normalcy. First level of screening currently used in India is mainly based on temperature and has possibility of false positives and false negative (fever as a symptom has not yet been developed although infected). We propose here another augmentation or an intermediate level of screening, depending on the usage, based on assessing olfactory functions. It is established with multiple publications reporting degrading (hyposmia) or loss of sense (anosmia) of smell for infected patients. This paper presents a recently developed technology and device that uses olfactory sense detection using a novel device that is capable of generating precise level of smell digitally, and repeatedly in contactless manner. The device is designed to work with a mobile app that can trigger selected smell or combinations and further can be programmed to give standard or customised smell tests. Estimated capital and running cost are low since one (out of 25) canister filled with of 0.1 ml volume of essential smell oil can serve hundreds of tests. The prototype is tested to work for a desired smell generation and is available for further tweaking for rapid screening of subjects as per the requirements.",10.1007/s41403-020-00126-6,fojv9fyw,"['Recent', 'pandemic', 'caused', 'by', 'COVID', '19', 'has', 'motivated', 'lockdown', 'in', 'several', 'countries', 'for', 'long', 'duration', 'and', 'will', 'have', 'a', 'long', 'lasting', 'impact', 'on', 'the', 'social', 'life', 'and', 'economics', 'world', 'wide', 'India', 'is', 'no', 'exception', 'although', 'showing', 'relatively', 'delayed', 'increase', 'in', 'number', 'of', 'cases', 'Multilayered', 'diagnostics', 'for', 'mass', 'scaled', 'screening', 'is', 'inevitable', 'during', 'and', 'especially', 'after', 'the', 'peak', 'is', 'passed', 'and', 'life', 'is', 'moving', 'towards', 'normalcy', 'First', 'level', 'of', 'screening', 'currently', 'used', 'in', 'India', 'is', 'mainly', 'based', 'on', 'temperature', 'and', 'has', 'possibility', 'of', 'false', 'positives', 'and', 'false', 'negative', 'fever', 'as', 'a', 'symptom', 'has', 'not', 'yet', 'been', 'developed', 'although', 'infected', 'We', 'propose', 'here', 'another', 'augmentation', 'or', 'an', 'intermediate', 'level', 'of', 'screening', 'depending', 'on', 'the', 'usage', 'based', 'on', 'assessing', 'olfactory', 'functions', 'It', 'is', 'established', 'with', 'multiple', 'publications', 'reporting', 'degrading', 'hyposmia', 'or', 'loss', 'of', 'sense', 'anosmia', 'of', 'smell', 'for', 'infected', 'patients', 'This', 'paper', 'presents', 'a', 'recently', 'developed', 'technology', 'and', 'device', 'that', 'uses', 'olfactory', 'sense', 'detection', 'using', 'a', 'novel', 'device', 'that', 'is', 'capable', 'of', 'generating', 'precise', 'level', 'of', 'smell', 'digitally', 'and', 'repeatedly', 'in', 'contactless', 'manner', 'The', 'device', 'is', 'designed', 'to', 'work', 'with', 'a', 'mobile', 'app', 'that', 'can', 'trigger', 'selected', 'smell', 'or', 'combinations', 'and', 'further', 'can', 'be', 'programmed', 'to', 'give', 'standard', 'or', 'customised', 'smell', 'tests', 'Estimated', 'capital', 'and', 'running', 'cost', 'are', 'low', 'since', 'one', 'out', 'of', '25', 'canister', 'filled', 'with', 'of', '0', '1', 'ml', 'volume', 'of', 'essential', 'smell', 'oil', 'can', 'serve', 'hundreds', 'of', 'tests', 'The', 'prototype', 'is', 'tested', 'to', 'work', 'for', 'a', 'desired', 'smell', 'generation', 'and', 'is', 'available', 'for', 'further', 'tweaking', 'for', 'rapid', 'screening', 'of', 'subjects', 'as', 'per', 'the', 'requirements', '']"
202235,Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management,2016-01-11,Eur Arch Otorhinolaryngol,https://www.ncbi.nlm.nih.gov/pubmed/26755048/; https://doi.org/10.1007/s00405-015-3872-6,"More than 120,000 patients are treated annually in Germany to resolve repeated episodes of acute tonsillitis. Therapy is aiming at symptom regression, avoidance of complications, reduction in the number of disease-related absences in school or at work, increased cost-effectiveness and improved quality of life. The purpose of this part of the guideline is to provide clinicians in any setting with a clinically focused multi-disciplinary guidance through different conservative treatment options in order to reduce inappropriate variation in clinical care, improve clinical outcome and reduce harm. Surgical management in terms of intracapsular as well as extracapsular tonsillectomy (i.e. tonsillotomy) is the subject of part II of this guideline. To estimate the probability of tonsillitis caused by β-hemolytic streptococci, a diagnostic scoring system according to Centor or McIsaac is suggested. If therapy is considered, a positive score of ≥3 should lead to pharyngeal swab or rapid test or culture in order to identify β-hemolytic streptococci. Routinely performed blood tests for acute tonsillitis are not indicated. After acute streptococcal tonsillitis, there is no need to repeat a pharyngeal swab or any other routine blood tests, urine examinations or cardiological diagnostics such as ECG. The determination of the antistreptolysin O-titer (ASLO titer) and other antistreptococcal antibody titers do not have any value in relation to acute tonsillitis with or without pharyngitis and should not be performed. First-line therapy of β-hemolytic streptococci consists of oral penicillin. Instead of phenoxymethylpenicillin–potassium (penicillin V potassium), also phenoxymethlpenicillin–benzathine with a clearly longer half-life can be used. Oral intake for 7 days of one of both the drugs is recommended. Alternative treatment with oral cephalosporins (e.g. cefadroxil, cefalexin) is indicated only in cases of penicillin failure, frequent recurrences, and whenever a more reliable eradication of β-hemolytic streptococci is desirable. In cases of allergy or incompatibility of penicillin, cephalosporins or macrolides (e.g. Erythromycin-estolate) are valuable alternatives.",10.1007/s00405-015-3872-6,jn063w1c,"['More', 'than', '120', '000', 'patients', 'are', 'treated', 'annually', 'in', 'Germany', 'to', 'resolve', 'repeated', 'episodes', 'of', 'acute', 'tonsillitis', 'Therapy', 'is', 'aiming', 'at', 'symptom', 'regression', 'avoidance', 'of', 'complications', 'reduction', 'in', 'the', 'number', 'of', 'disease', 'related', 'absences', 'in', 'school', 'or', 'at', 'work', 'increased', 'cost', 'effectiveness', 'and', 'improved', 'quality', 'of', 'life', 'The', 'purpose', 'of', 'this', 'part', 'of', 'the', 'guideline', 'is', 'to', 'provide', 'clinicians', 'in', 'any', 'setting', 'with', 'a', 'clinically', 'focused', 'multi', 'disciplinary', 'guidance', 'through', 'different', 'conservative', 'treatment', 'options', 'in', 'order', 'to', 'reduce', 'inappropriate', 'variation', 'in', 'clinical', 'care', 'improve', 'clinical', 'outcome', 'and', 'reduce', 'harm', 'Surgical', 'management', 'in', 'terms', 'of', 'intracapsular', 'as', 'well', 'as', 'extracapsular', 'tonsillectomy', 'i', 'e', 'tonsillotomy', 'is', 'the', 'subject', 'of', 'part', 'II', 'of', 'this', 'guideline', 'To', 'estimate', 'the', 'probability', 'of', 'tonsillitis', 'caused', 'by', 'β', 'hemolytic', 'streptococci', 'a', 'diagnostic', 'scoring', 'system', 'according', 'to', 'Centor', 'or', 'McIsaac', 'is', 'suggested', 'If', 'therapy', 'is', 'considered', 'a', 'positive', 'score', 'of', '3', 'should', 'lead', 'to', 'pharyngeal', 'swab', 'or', 'rapid', 'test', 'or', 'culture', 'in', 'order', 'to', 'identify', 'β', 'hemolytic', 'streptococci', 'Routinely', 'performed', 'blood', 'tests', 'for', 'acute', 'tonsillitis', 'are', 'not', 'indicated', 'After', 'acute', 'streptococcal', 'tonsillitis', 'there', 'is', 'no', 'need', 'to', 'repeat', 'a', 'pharyngeal', 'swab', 'or', 'any', 'other', 'routine', 'blood', 'tests', 'urine', 'examinations', 'or', 'cardiological', 'diagnostics', 'such', 'as', 'ECG', 'The', 'determination', 'of', 'the', 'antistreptolysin', 'O', 'titer', 'ASLO', 'titer', 'and', 'other', 'antistreptococcal', 'antibody', 'titers', 'do', 'not', 'have', 'any', 'value', 'in', 'relation', 'to', 'acute', 'tonsillitis', 'with', 'or', 'without', 'pharyngitis', 'and', 'should', 'not', 'be', 'performed', 'First', 'line', 'therapy', 'of', 'β', 'hemolytic', 'streptococci', 'consists', 'of', 'oral', 'penicillin', 'Instead', 'of', 'phenoxymethylpenicillin', 'potassium', 'penicillin', 'V', 'potassium', 'also', 'phenoxymethlpenicillin', 'benzathine', 'with', 'a', 'clearly', 'longer', 'half', 'life', 'can', 'be', 'used', 'Oral', 'intake', 'for', '7', 'days', 'of', 'one', 'of', 'both', 'the', 'drugs', 'is', 'recommended', 'Alternative', 'treatment', 'with', 'oral', 'cephalosporins', 'e', 'g', 'cefadroxil', 'cefalexin', 'is', 'indicated', 'only', 'in', 'cases', 'of', 'penicillin', 'failure', 'frequent', 'recurrences', 'and', 'whenever', 'a', 'more', 'reliable', 'eradication', 'of', 'β', 'hemolytic', 'streptococci', 'is', 'desirable', 'In', 'cases', 'of', 'allergy', 'or', 'incompatibility', 'of', 'penicillin', 'cephalosporins', 'or', 'macrolides', 'e', 'g', 'Erythromycin', 'estolate', 'are', 'valuable', 'alternatives', '']"
202352,Molecular Diagnostics and Comparative Genomics in Clinical Microbiology,2010-01-29,Molecular Diagnostics,https://api.elsevier.com/content/article/pii/B9780123745378000304; https://www.sciencedirect.com/science/article/pii/B9780123745378000304,"Initially, the availability of molecular diagnostics was considered a panacea, but replacement of conventional tests for detection and identification of microorganisms by molecular procedures eventually gathered momentum. This chapter describes current state-of-the-art molecular diagnostics and comparative genomics in medical microbiology to provide an understanding of infectious disease over the coming years. Nucleic acid-based tests are being introduced with increasing speed into routine clinical microbiology laboratories. Some of the problems remaining to be solved prior to general acceptance of nucleic acid-mediated detection and identification of microbial pathogens are reviewed. Historic objections are slowly being taken apart, and an accelerated introduction of molecular diagnostics is being pursued in many cases. Clear improvement in clinical testing is achieved by introducing molecular tests. Therefore, swift introduction of such tests into clinical practice is important to be pursued. Several PCR tests show increased sensitivity, excellent specificity, and cost effectiveness highlighting the success of the novel applications in the field of bacterial infections. Finally, some of the problems remaining to be solved prior to general acceptation of nucleic acid-mediated detection and identification of microbial pathogens are also reviewed.",10.1016/b978-0-12-374537-8.00030-4,iylfk82p,"['Initially', 'the', 'availability', 'of', 'molecular', 'diagnostics', 'was', 'considered', 'a', 'panacea', 'but', 'replacement', 'of', 'conventional', 'tests', 'for', 'detection', 'and', 'identification', 'of', 'microorganisms', 'by', 'molecular', 'procedures', 'eventually', 'gathered', 'momentum', 'This', 'chapter', 'describes', 'current', 'state', 'of', 'the', 'art', 'molecular', 'diagnostics', 'and', 'comparative', 'genomics', 'in', 'medical', 'microbiology', 'to', 'provide', 'an', 'understanding', 'of', 'infectious', 'disease', 'over', 'the', 'coming', 'years', 'Nucleic', 'acid', 'based', 'tests', 'are', 'being', 'introduced', 'with', 'increasing', 'speed', 'into', 'routine', 'clinical', 'microbiology', 'laboratories', 'Some', 'of', 'the', 'problems', 'remaining', 'to', 'be', 'solved', 'prior', 'to', 'general', 'acceptance', 'of', 'nucleic', 'acid', 'mediated', 'detection', 'and', 'identification', 'of', 'microbial', 'pathogens', 'are', 'reviewed', 'Historic', 'objections', 'are', 'slowly', 'being', 'taken', 'apart', 'and', 'an', 'accelerated', 'introduction', 'of', 'molecular', 'diagnostics', 'is', 'being', 'pursued', 'in', 'many', 'cases', 'Clear', 'improvement', 'in', 'clinical', 'testing', 'is', 'achieved', 'by', 'introducing', 'molecular', 'tests', 'Therefore', 'swift', 'introduction', 'of', 'such', 'tests', 'into', 'clinical', 'practice', 'is', 'important', 'to', 'be', 'pursued', 'Several', 'PCR', 'tests', 'show', 'increased', 'sensitivity', 'excellent', 'specificity', 'and', 'cost', 'effectiveness', 'highlighting', 'the', 'success', 'of', 'the', 'novel', 'applications', 'in', 'the', 'field', 'of', 'bacterial', 'infections', 'Finally', 'some', 'of', 'the', 'problems', 'remaining', 'to', 'be', 'solved', 'prior', 'to', 'general', 'acceptation', 'of', 'nucleic', 'acid', 'mediated', 'detection', 'and', 'identification', 'of', 'microbial', 'pathogens', 'are', 'also', 'reviewed', '']"
202639,Simultaneous detection of DNA and RNA virus species involved in bovine respiratory disease by PCR-free rapid tagmentation-based library preparation and MinION nanopore sequencing,2018-02-22,bioRxiv,https://doi.org/10.1101/269936,"The Oxford Nanopore MinION Mk1B is a portable 90 g device that sequences DNA directly at 450 bases/second generating sequence reads in excess of 400 kb. Recent improvements in error rate and speed of library preparation mean that this device has considerable potential for rapid molecular bovine pathogen diagnostics. We tested the MinION for rapid untargeted detection of viral pathogens associated with bovine respiratory disease (BRD), an economically important disease often involving primary infection of the lung by one or more of a number of DNA and/or RNA viruses. We combined three foetal lung cell cultures which were infected with either Bovine Respiratory Syncytial Virus (BRSV), Bovine Herpes Virus 1 (BoHV1) or Bovine Parainfluenza Virus 3 (BPI-3). BoHV1 is a DNA virus and BPI-3 and BRSV are RNA viruses. The cell cultures were treated with DNase and RNase to deplete bovine nucleic acid prior to viral nucleic acid extraction and double-stranded cDNA synthesis. Sequencing libraries were generated by PCR-free tagmentation in under 10 minutes and loaded onto a MinION sequencer. Approximately 7,000 sequencing reads were generated and analysed using high-throughput local BLAST against the NCBI nr/nt database. The top BLAST hit for 2,937 of these reads was identified as a virus. Of these, 2,926 (99.6%) were correctly identified either as BoHV1, BRSV or BPI-3.",10.1101/269936,7jlh5xff,"['The', 'Oxford', 'Nanopore', 'MinION', 'Mk1B', 'is', 'a', 'portable', '90', 'g', 'device', 'that', 'sequences', 'DNA', 'directly', 'at', '450', 'bases', 'second', 'generating', 'sequence', 'reads', 'in', 'excess', 'of', '400', 'kb', 'Recent', 'improvements', 'in', 'error', 'rate', 'and', 'speed', 'of', 'library', 'preparation', 'mean', 'that', 'this', 'device', 'has', 'considerable', 'potential', 'for', 'rapid', 'molecular', 'bovine', 'pathogen', 'diagnostics', 'We', 'tested', 'the', 'MinION', 'for', 'rapid', 'untargeted', 'detection', 'of', 'viral', 'pathogens', 'associated', 'with', 'bovine', 'respiratory', 'disease', 'BRD', 'an', 'economically', 'important', 'disease', 'often', 'involving', 'primary', 'infection', 'of', 'the', 'lung', 'by', 'one', 'or', 'more', 'of', 'a', 'number', 'of', 'DNA', 'and', 'or', 'RNA', 'viruses', 'We', 'combined', 'three', 'foetal', 'lung', 'cell', 'cultures', 'which', 'were', 'infected', 'with', 'either', 'Bovine', 'Respiratory', 'Syncytial', 'Virus', 'BRSV', 'Bovine', 'Herpes', 'Virus', '1', 'BoHV1', 'or', 'Bovine', 'Parainfluenza', 'Virus', '3', 'BPI', '3', 'BoHV1', 'is', 'a', 'DNA', 'virus', 'and', 'BPI', '3', 'and', 'BRSV', 'are', 'RNA', 'viruses', 'The', 'cell', 'cultures', 'were', 'treated', 'with', 'DNase', 'and', 'RNase', 'to', 'deplete', 'bovine', 'nucleic', 'acid', 'prior', 'to', 'viral', 'nucleic', 'acid', 'extraction', 'and', 'double', 'stranded', 'cDNA', 'synthesis', 'Sequencing', 'libraries', 'were', 'generated', 'by', 'PCR', 'free', 'tagmentation', 'in', 'under', '10', 'minutes', 'and', 'loaded', 'onto', 'a', 'MinION', 'sequencer', 'Approximately', '7', '000', 'sequencing', 'reads', 'were', 'generated', 'and', 'analysed', 'using', 'high', 'throughput', 'local', 'BLAST', 'against', 'the', 'NCBI', 'nr', 'nt', 'database', 'The', 'top', 'BLAST', 'hit', 'for', '2', '937', 'of', 'these', 'reads', 'was', 'identified', 'as', 'a', 'virus', 'Of', 'these', '2', '926', '99', '6', 'were', 'correctly', 'identified', 'either', 'as', 'BoHV1', 'BRSV', 'or', 'BPI', '3', '']"
202891,Detection of viral agents in fecal specimens of monkeys with diarrhea,2006-07-17,J Med Primatol,https://www.ncbi.nlm.nih.gov/pubmed/17493140/,"Background Diarrheal disease is a major cause of morbidity and mortality in humans and animals, including non human primates. While the diagnostics for gastrointestinal bacterial and parasitic pathogens and their etiological role in disease are well established, little is known about the epidemiology, prevalence and role of viral agents in diarrheal illness among monkeys. Methods We collected fecal specimens from monkeys with diarrhea that were housed in two primate colonies, the Institute of Laboratory Animal Sciences, Beijing, China and the Yerkes National Primate Research Center, Georgia, USA. We screened these fecal specimens for rotaviruses and enteric adenoviruses 40/41 by using commercial EIA kits (Rotaclone and Adenoclone), enteroviruses by RT‐PCR and Southern blot hybridization, and picobirnaviruses by polyacrylamide gel electrophoresis and silver staining. Some of the specimens were examined by EM for coronaviruses and noroviruses. Results Of the 92 specimens from China, we found 63 (68%) positive for viruses, including enteroviruses (52%), enteric adenoviruses (21%), rotaviruses (20%), and picobirnaviruses (2%). Coronaviruses were detected in some specimens. Mixed infection of two or more viral agents was seen in 23 (25%) specimens. In the US collection, we detected enteroviruses and enteric adenoviruses in 76% (45/59) and 14% (7/50) of the specimens, respectively. Electron microscopy showed norovirus‐like particles in some specimens from both colonies. Conclusions Our findings indicate endemic infections with enteric viruses in monkeys of both colonies. The availability of new simian rotaviruses, enteric adenoviruses, enteroviruses, and coronaviruses and the discovery of noroviruses and picobirnaviruses may allow us to develop better diagnostics for these agents and determine which of these agents are clearly associated with gastroenteritis in monkeys.",10.1111/j.1600-0684.2006.00167.x,z4c3bc6a,"['Background', 'Diarrheal', 'disease', 'is', 'a', 'major', 'cause', 'of', 'morbidity', 'and', 'mortality', 'in', 'humans', 'and', 'animals', 'including', 'non', 'human', 'primates', 'While', 'the', 'diagnostics', 'for', 'gastrointestinal', 'bacterial', 'and', 'parasitic', 'pathogens', 'and', 'their', 'etiological', 'role', 'in', 'disease', 'are', 'well', 'established', 'little', 'is', 'known', 'about', 'the', 'epidemiology', 'prevalence', 'and', 'role', 'of', 'viral', 'agents', 'in', 'diarrheal', 'illness', 'among', 'monkeys', 'Methods', 'We', 'collected', 'fecal', 'specimens', 'from', 'monkeys', 'with', 'diarrhea', 'that', 'were', 'housed', 'in', 'two', 'primate', 'colonies', 'the', 'Institute', 'of', 'Laboratory', 'Animal', 'Sciences', 'Beijing', 'China', 'and', 'the', 'Yerkes', 'National', 'Primate', 'Research', 'Center', 'Georgia', 'USA', 'We', 'screened', 'these', 'fecal', 'specimens', 'for', 'rotaviruses', 'and', 'enteric', 'adenoviruses', '40', '41', 'by', 'using', 'commercial', 'EIA', 'kits', 'Rotaclone', 'and', 'Adenoclone', 'enteroviruses', 'by', 'RT', 'PCR', 'and', 'Southern', 'blot', 'hybridization', 'and', 'picobirnaviruses', 'by', 'polyacrylamide', 'gel', 'electrophoresis', 'and', 'silver', 'staining', 'Some', 'of', 'the', 'specimens', 'were', 'examined', 'by', 'EM', 'for', 'coronaviruses', 'and', 'noroviruses', 'Results', 'Of', 'the', '92', 'specimens', 'from', 'China', 'we', 'found', '63', '68', 'positive', 'for', 'viruses', 'including', 'enteroviruses', '52', 'enteric', 'adenoviruses', '21', 'rotaviruses', '20', 'and', 'picobirnaviruses', '2', 'Coronaviruses', 'were', 'detected', 'in', 'some', 'specimens', 'Mixed', 'infection', 'of', 'two', 'or', 'more', 'viral', 'agents', 'was', 'seen', 'in', '23', '25', 'specimens', 'In', 'the', 'US', 'collection', 'we', 'detected', 'enteroviruses', 'and', 'enteric', 'adenoviruses', 'in', '76', '45', '59', 'and', '14', '7', '50', 'of', 'the', 'specimens', 'respectively', 'Electron', 'microscopy', 'showed', 'norovirus', 'like', 'particles', 'in', 'some', 'specimens', 'from', 'both', 'colonies', 'Conclusions', 'Our', 'findings', 'indicate', 'endemic', 'infections', 'with', 'enteric', 'viruses', 'in', 'monkeys', 'of', 'both', 'colonies', 'The', 'availability', 'of', 'new', 'simian', 'rotaviruses', 'enteric', 'adenoviruses', 'enteroviruses', 'and', 'coronaviruses', 'and', 'the', 'discovery', 'of', 'noroviruses', 'and', 'picobirnaviruses', 'may', 'allow', 'us', 'to', 'develop', 'better', 'diagnostics', 'for', 'these', 'agents', 'and', 'determine', 'which', 'of', 'these', 'agents', 'are', 'clearly', 'associated', 'with', 'gastroenteritis', 'in', 'monkeys', '']"
203136,Assessment of the Usefulness of Multiplex Real-Time PCR Tests in the Diagnostic and Therapeutic Process of Pneumonia in Hospitalized Children: A Single-Center Experience,2017-01-15,Biomed Res Int,https://doi.org/10.1155/2017/8037963; https://www.ncbi.nlm.nih.gov/pubmed/28182108/,"The aim of the study was assessment of the usefulness of multiplex real-time PCR tests in the diagnostic and therapeutic process in children hospitalized due to pneumonia and burdened with comorbidities. Methods. The study group included 97 children hospitalized due to pneumonia at the Karol Jonscher Teaching Hospital in Poznań, in whom multiplex real-time PCR tests (FTD respiratory pathogens 33; fast-track diagnostics) were used. Results. Positive test results of the test were achieved in 74 patients (76.3%). The average age in the group was 56 months. Viruses were detected in 61 samples (82% of all positive results); bacterial factors were found in 29 samples (39% of all positive results). The presence of comorbidities was established in 90 children (92.78%). On the basis of the obtained results, 5 groups of patients were established: viral etiology of infection, 34 patients; bacterial etiology, 7 patients; mixed etiology, 23 patients; pneumocystis, 9 patients; and no etiology diagnosed, 24 patients. Conclusions. Our analysis demonstrated that the participation of viruses in causing severe lung infections is significant in children with comorbidities. Multiplex real-time PCR tests proved to be more useful in establishing the etiology of pneumonia in hospitalized children than the traditional microbiological examinations.",10.1155/2017/8037963,ia1g5dt4,"['The', 'aim', 'of', 'the', 'study', 'was', 'assessment', 'of', 'the', 'usefulness', 'of', 'multiplex', 'real', 'time', 'PCR', 'tests', 'in', 'the', 'diagnostic', 'and', 'therapeutic', 'process', 'in', 'children', 'hospitalized', 'due', 'to', 'pneumonia', 'and', 'burdened', 'with', 'comorbidities', 'Methods', 'The', 'study', 'group', 'included', '97', 'children', 'hospitalized', 'due', 'to', 'pneumonia', 'at', 'the', 'Karol', 'Jonscher', 'Teaching', 'Hospital', 'in', 'Poznań', 'in', 'whom', 'multiplex', 'real', 'time', 'PCR', 'tests', 'FTD', 'respiratory', 'pathogens', '33', 'fast', 'track', 'diagnostics', 'were', 'used', 'Results', 'Positive', 'test', 'results', 'of', 'the', 'test', 'were', 'achieved', 'in', '74', 'patients', '76', '3', 'The', 'average', 'age', 'in', 'the', 'group', 'was', '56', 'months', 'Viruses', 'were', 'detected', 'in', '61', 'samples', '82', 'of', 'all', 'positive', 'results', 'bacterial', 'factors', 'were', 'found', 'in', '29', 'samples', '39', 'of', 'all', 'positive', 'results', 'The', 'presence', 'of', 'comorbidities', 'was', 'established', 'in', '90', 'children', '92', '78', 'On', 'the', 'basis', 'of', 'the', 'obtained', 'results', '5', 'groups', 'of', 'patients', 'were', 'established', 'viral', 'etiology', 'of', 'infection', '34', 'patients', 'bacterial', 'etiology', '7', 'patients', 'mixed', 'etiology', '23', 'patients', 'pneumocystis', '9', 'patients', 'and', 'no', 'etiology', 'diagnosed', '24', 'patients', 'Conclusions', 'Our', 'analysis', 'demonstrated', 'that', 'the', 'participation', 'of', 'viruses', 'in', 'causing', 'severe', 'lung', 'infections', 'is', 'significant', 'in', 'children', 'with', 'comorbidities', 'Multiplex', 'real', 'time', 'PCR', 'tests', 'proved', 'to', 'be', 'more', 'useful', 'in', 'establishing', 'the', 'etiology', 'of', 'pneumonia', 'in', 'hospitalized', 'children', 'than', 'the', 'traditional', 'microbiological', 'examinations', '']"
203689,Gastrointestinal Disease in Exotic Small Mammals,2013-09-05,J Exot Pet Med,https://www.ncbi.nlm.nih.gov/pubmed/32288678/; https://www.sciencedirect.com/science/article/pii/S1557506313000608; https://api.elsevier.com/content/article/pii/S1557506313000608; https://doi.org/10.1053/j.jepm.2013.05.004,"Exotic small mammal medicine is a relatively new specialty area within veterinary medicine. Ferrets, rabbits, and rodents have long been used as animal models in human medical research investigations, resulting in a body of basic anatomic and physiologic information that can be used by veterinarians treating these species. Unfortunately, there is a paucity of veterinary articles that describe clinical presentation, diagnosis, and treatment options of gastrointestinal (GI) disease as it affects exotic small mammals. Although there is little reference material relating to exotic small mammal GI disease, patients are commonly presented to veterinary hospitals with digestive tract disorders. This article provides the latest information available for GI disease in ferrets (Helicobacter mustelae gastritis, inflammatory bowel disease [IBD], GI lymphoma, systemic coronavirus, coccidiosis, and liver disease), rabbits (GI motility disorders, liver lobe torsion, astrovirus, and coccidiosis), guinea pigs (gastric dilatation volvulus [GDV]), rats (Taenia taeniaeformis), and hamsters (Clostridium difficile). Both noninfectious diseases and emerging infectious diseases are reviewed as well as the most up-to-date diagnostics and treatment options.",10.1053/j.jepm.2013.05.004,tya0rvxk,"['Exotic', 'small', 'mammal', 'medicine', 'is', 'a', 'relatively', 'new', 'specialty', 'area', 'within', 'veterinary', 'medicine', 'Ferrets', 'rabbits', 'and', 'rodents', 'have', 'long', 'been', 'used', 'as', 'animal', 'models', 'in', 'human', 'medical', 'research', 'investigations', 'resulting', 'in', 'a', 'body', 'of', 'basic', 'anatomic', 'and', 'physiologic', 'information', 'that', 'can', 'be', 'used', 'by', 'veterinarians', 'treating', 'these', 'species', 'Unfortunately', 'there', 'is', 'a', 'paucity', 'of', 'veterinary', 'articles', 'that', 'describe', 'clinical', 'presentation', 'diagnosis', 'and', 'treatment', 'options', 'of', 'gastrointestinal', 'GI', 'disease', 'as', 'it', 'affects', 'exotic', 'small', 'mammals', 'Although', 'there', 'is', 'little', 'reference', 'material', 'relating', 'to', 'exotic', 'small', 'mammal', 'GI', 'disease', 'patients', 'are', 'commonly', 'presented', 'to', 'veterinary', 'hospitals', 'with', 'digestive', 'tract', 'disorders', 'This', 'article', 'provides', 'the', 'latest', 'information', 'available', 'for', 'GI', 'disease', 'in', 'ferrets', 'Helicobacter', 'mustelae', 'gastritis', 'inflammatory', 'bowel', 'disease', 'IBD', 'GI', 'lymphoma', 'systemic', 'coronavirus', 'coccidiosis', 'and', 'liver', 'disease', 'rabbits', 'GI', 'motility', 'disorders', 'liver', 'lobe', 'torsion', 'astrovirus', 'and', 'coccidiosis', 'guinea', 'pigs', 'gastric', 'dilatation', 'volvulus', 'GDV', 'rats', 'Taenia', 'taeniaeformis', 'and', 'hamsters', 'Clostridium', 'difficile', 'Both', 'noninfectious', 'diseases', 'and', 'emerging', 'infectious', 'diseases', 'are', 'reviewed', 'as', 'well', 'as', 'the', 'most', 'up', 'to', 'date', 'diagnostics', 'and', 'treatment', 'options', '']"
204163,Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape,2020-07-18,Biosens Bioelectron,https://www.sciencedirect.com/science/article/pii/S0956566320304486?v=s5; https://doi.org/10.1016/j.bios.2020.112454; https://api.elsevier.com/content/article/pii/S0956566320304486,"The rapidly spreading outbreak of COVID-19 disease is caused by the SARS-CoV-2 virus, first reported in December 2019 in Wuhan, China. As of June 17, 2020, this virus has infected over 8.2 million people but ranges in symptom severity, making it difficult to assess its overall infection rate. There is a need for rapid and accurate diagnostics to better monitor and prevent the spread of COVID-19. In this review, we present and evaluate two main types of diagnostics with FDA-EUA status for COVID-19: nucleic acid testing for detection of SARS-CoV-2 RNA, and serological assays for detection of SARS-CoV-2 specific IgG and IgM patient antibodies, along with the necessary sample preparation for accurate diagnoses. In particular, we cover and compare tests such as the CDC 2019-nCoV RT-PCR Diagnostic Panel, Cellex's qSARS-CoV-2 IgG/IgM Rapid Test, and point-of-care tests such as Abbott's ID NOW COVID-19 Test. Antibody testing is especially important in understanding the prevalence of the virus in the community and to identify those who have gained immunity. We conclude by highlighting the future of COVID-19 diagnostics, which include the need for quantitative testing and the development of emerging biosensors as point-of-care tests.",10.1016/j.bios.2020.112454,3ejychjf,"['The', 'rapidly', 'spreading', 'outbreak', 'of', 'COVID', '19', 'disease', 'is', 'caused', 'by', 'the', 'SARS', 'CoV', '2', 'virus', 'first', 'reported', 'in', 'December', '2019', 'in', 'Wuhan', 'China', 'As', 'of', 'June', '17', '2020', 'this', 'virus', 'has', 'infected', 'over', '8', '2', 'million', 'people', 'but', 'ranges', 'in', 'symptom', 'severity', 'making', 'it', 'difficult', 'to', 'assess', 'its', 'overall', 'infection', 'rate', 'There', 'is', 'a', 'need', 'for', 'rapid', 'and', 'accurate', 'diagnostics', 'to', 'better', 'monitor', 'and', 'prevent', 'the', 'spread', 'of', 'COVID', '19', 'In', 'this', 'review', 'we', 'present', 'and', 'evaluate', 'two', 'main', 'types', 'of', 'diagnostics', 'with', 'FDA', 'EUA', 'status', 'for', 'COVID', '19', 'nucleic', 'acid', 'testing', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'and', 'serological', 'assays', 'for', 'detection', 'of', 'SARS', 'CoV', '2', 'specific', 'IgG', 'and', 'IgM', 'patient', 'antibodies', 'along', 'with', 'the', 'necessary', 'sample', 'preparation', 'for', 'accurate', 'diagnoses', 'In', 'particular', 'we', 'cover', 'and', 'compare', 'tests', 'such', 'as', 'the', 'CDC', '2019', 'nCoV', 'RT', 'PCR', 'Diagnostic', 'Panel', 'Cellex', 's', 'qSARS', 'CoV', '2', 'IgG', 'IgM', 'Rapid', 'Test', 'and', 'point', 'of', 'care', 'tests', 'such', 'as', 'Abbott', 's', 'ID', 'NOW', 'COVID', '19', 'Test', 'Antibody', 'testing', 'is', 'especially', 'important', 'in', 'understanding', 'the', 'prevalence', 'of', 'the', 'virus', 'in', 'the', 'community', 'and', 'to', 'identify', 'those', 'who', 'have', 'gained', 'immunity', 'We', 'conclude', 'by', 'highlighting', 'the', 'future', 'of', 'COVID', '19', 'diagnostics', 'which', 'include', 'the', 'need', 'for', 'quantitative', 'testing', 'and', 'the', 'development', 'of', 'emerging', 'biosensors', 'as', 'point', 'of', 'care', 'tests', '']"
204395,Chapter 15 Molecular Testing in Emerging Infectious Diseases,2017-12-31,Diagnostic Molecular Pathology,https://api.elsevier.com/content/article/pii/B9780128008867000157; https://www.sciencedirect.com/science/article/pii/B9780128008867000157,"Abstract It was widely believed in the late 1960s that infectious diseases had been conquered by vaccines and antibiotics and humans were no longer under threat by microbial pathogens. Yet, since that time more than 60 pathogens have been discovered that can cause serious emerging infectious diseases. Molecular methods have played critical roles in the discovery, monitoring, and clinical diagnostics of emerging pathogens. In this chapter, we present well-recognized emerging pathogens. We provide examples of the utility of molecular assays in research and clinical care of emerging infectious diseases. We also discuss some theoretical and practical limitations of molecular tests and the future prospects of expanding molecular diagnostics for emerging pathogens based on new advances of knowledge and technologies.",10.1016/b978-0-12-800886-7.00015-7,1h87wldg,"['Abstract', 'It', 'was', 'widely', 'believed', 'in', 'the', 'late', '1960s', 'that', 'infectious', 'diseases', 'had', 'been', 'conquered', 'by', 'vaccines', 'and', 'antibiotics', 'and', 'humans', 'were', 'no', 'longer', 'under', 'threat', 'by', 'microbial', 'pathogens', 'Yet', 'since', 'that', 'time', 'more', 'than', '60', 'pathogens', 'have', 'been', 'discovered', 'that', 'can', 'cause', 'serious', 'emerging', 'infectious', 'diseases', 'Molecular', 'methods', 'have', 'played', 'critical', 'roles', 'in', 'the', 'discovery', 'monitoring', 'and', 'clinical', 'diagnostics', 'of', 'emerging', 'pathogens', 'In', 'this', 'chapter', 'we', 'present', 'well', 'recognized', 'emerging', 'pathogens', 'We', 'provide', 'examples', 'of', 'the', 'utility', 'of', 'molecular', 'assays', 'in', 'research', 'and', 'clinical', 'care', 'of', 'emerging', 'infectious', 'diseases', 'We', 'also', 'discuss', 'some', 'theoretical', 'and', 'practical', 'limitations', 'of', 'molecular', 'tests', 'and', 'the', 'future', 'prospects', 'of', 'expanding', 'molecular', 'diagnostics', 'for', 'emerging', 'pathogens', 'based', 'on', 'new', 'advances', 'of', 'knowledge', 'and', 'technologies', '']"
